Citrus Sinensis ID: 005247
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 706 | 2.2.26 [Sep-21-2011] | |||||||
| Q05609 | 821 | Serine/threonine-protein | yes | no | 0.920 | 0.791 | 0.576 | 0.0 | |
| Q9FPR3 | 933 | Serine/threonine-protein | no | no | 0.368 | 0.278 | 0.603 | 4e-92 | |
| Q54TM7 | 1288 | Probable serine/threonine | yes | no | 0.368 | 0.201 | 0.449 | 2e-60 | |
| Q54H46 | 642 | Probable serine/threonine | no | no | 0.371 | 0.408 | 0.451 | 6e-59 | |
| Q54H45 | 690 | Probable serine/threonine | no | no | 0.382 | 0.391 | 0.443 | 5e-58 | |
| Q55GU0 | 916 | Probable serine/threonine | no | no | 0.405 | 0.312 | 0.418 | 6e-57 | |
| Q54TA1 | 749 | Probable serine/threonine | no | no | 0.365 | 0.344 | 0.441 | 2e-56 | |
| Q54Y55 | 506 | Dual specificity protein | no | no | 0.388 | 0.541 | 0.419 | 7e-53 | |
| Q7T6Y2 | 1624 | Putative serine/threonine | N/A | no | 0.364 | 0.158 | 0.4 | 5e-52 | |
| Q7T6X2 | 1657 | Putative serine/threonine | N/A | no | 0.382 | 0.162 | 0.359 | 9e-52 |
| >sp|Q05609|CTR1_ARATH Serine/threonine-protein kinase CTR1 OS=Arabidopsis thaliana GN=CTR1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 731 bits (1886), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 397/689 (57%), Positives = 489/689 (70%), Gaps = 39/689 (5%)
Query: 18 WAQQTEESYQLQLAMALRLSSQAASADDPHFLA----LSSCDRHTDSAETVSHRFWVNGC 73
WAQQTEESYQLQLA+ALRLSS+A ADDP+FL S+ SAETVSHRFWVNGC
Sbjct: 161 WAQQTEESYQLQLALALRLSSEATCADDPNFLDPVPDESALRTSPSSAETVSHRFWVNGC 220
Query: 74 LSYFDRILDGFYLIHGMDPYTWSIGTNQRDAGLIPPYKSLKAVDPCNNLSIKVILIDKSS 133
LSY+D++ DGFY+++G+DPY W++ + ++G IP +SL+AVD + S++ I++D+ S
Sbjct: 221 LSYYDKVPDGFYMMNGLDPYIWTLCIDLHESGRIPSIESLRAVDSGVDSSLEAIIVDRRS 280
Query: 134 DPNLKELHNRVLSLLCDRITAEEAVHQLANLVCNHMGGTTSTEEEEFDKQWSECAEHLKD 193
DP KELHNRV + C IT +E V QLA L+CN MGG E+E W EC + LK+
Sbjct: 281 DPAFKELHNRVHDISCSCITTKEVVDQLAKLICNRMGGPVIMGEDELVPMWKECIDGLKE 340
Query: 194 CLNSVVLPIGSLSVGLCVHRALLFKVLADLINLPCRIAKGCKYCRRDDASSCLVQIGPDR 253
VV+PIGSLSVGLC HRALLFKVLAD+I+LPCRIAKGCKYC RDDA+SCLV+ G DR
Sbjct: 341 IF-KVVVPIGSLSVGLCRHRALLFKVLADIIDLPCRIAKGCKYCNRDDAASCLVRFGLDR 399
Query: 254 EYLVDLLEDPGVLSKPDSSLNRTASVFVSSPLYHPRFKAVETVENIRSLAKLYFIDNHSP 313
EYLVDL+ PG L +PDS LN +S+ +SSPL PR K VE + R LAK YF D+ S
Sbjct: 400 EYLVDLVGKPGHLWEPDSLLNGPSSISISSPLRFPRPKPVEPAVDFRLLAKQYFSDSQS- 458
Query: 314 KFDLDDDPSGTAIDQDYKPDPQALFQRASWNVTADRDLQMQNPSG--PSTHVIDSSNFIK 371
+L DP+ D + ++F R N + D +N G P + + N +
Sbjct: 459 -LNLVFDPASD--DMGF-----SMFHRQYDNPGGENDALAENGGGSLPPSANMPPQNMM- 509
Query: 372 GPLLRSPVKPFRHRKSHETSAFSTLKPYVTNNHLLMEANLSVMSTSNRELYLEEEGLEIR 431
R S++ A P ++ V + +NREL L+ + ++I
Sbjct: 510 -------------RASNQIEAAPMNAPPISQ---------PVPNRANRELGLDGDDMDIP 547
Query: 432 WSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN 491
W +L IK+KIG GSFGTV+ AEW SDVAVKIL+EQ+FH +R EFLREVAIMK LRHPN
Sbjct: 548 WCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPN 607
Query: 492 IVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 551
IVL MGAVT+PPNLSIVTEYLSRGSLY+LLH AR +DER RL+MAYDVAKGMNYLH
Sbjct: 608 IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN 667
Query: 552 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDP 611
R PPIVHRDLKSPNLLVD YTVKVCDFGLSR K +T++SSK+AAGTPEWMAPEVLR++P
Sbjct: 668 RNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEP 727
Query: 612 SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC 671
SNEKSDV+SFGVILWEL TLQ+PW N P+QV++AVGFK +RLEIP+N+NP VAA+IE C
Sbjct: 728 SNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGC 787
Query: 672 WAEEPEIRPSFPSIMETLQQFLMSSVCQP 700
W EP RPSF +IM+ L+ + S+V P
Sbjct: 788 WTNEPWKRPSFATIMDLLRPLIKSAVPPP 816
|
Acts as a negative regulator in the ethylene response pathway. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9FPR3|EDR1_ARATH Serine/threonine-protein kinase EDR1 OS=Arabidopsis thaliana GN=EDR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 339 bits (870), Expect = 4e-92, Method: Compositional matrix adjust.
Identities = 158/262 (60%), Positives = 198/262 (75%), Gaps = 2/262 (0%)
Query: 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR 488
EI W++L+I ++IG GS+G VYHA+W ++VAVK ++Q+F EF EV IM+ LR
Sbjct: 663 EIPWNDLVIAERIGLGSYGEVYHADWHGTEVAVKKFLDQDFSGAALAEFRSEVRIMRRLR 722
Query: 489 HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 548
HPN+V +GAVT PPNLSIVTE+L RGSLY++LH P + + DER R+ MA DVA GMN
Sbjct: 723 HPNVVFFLGAVTRPPNLSIVTEFLPRGSLYRILHRPKSHI--DERRRIKMALDVAMGMNC 780
Query: 549 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLR 608
LH P IVHRDLK+PNLLVD+ + VKV DFGLSR K NT++SSK+ AGTPEWMAPEVLR
Sbjct: 781 LHTSTPTIVHRDLKTPNLLVDNNWNVKVGDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLR 840
Query: 609 EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI 668
+PSNEK DV+SFGVILWEL TL+ PWR P QV+ AVGF+ RRLEIPK ++P+V +I
Sbjct: 841 NEPSNEKCDVYSFGVILWELATLRLPWRGMNPMQVVGAVGFQNRRLEIPKELDPVVGRII 900
Query: 669 ETCWAEEPEIRPSFPSIMETLQ 690
CW +P +RPSF + E L+
Sbjct: 901 LECWQTDPNLRPSFAQLTEVLK 922
|
MAPKKK serine/threonine-protein kinase involved in the regulation of a MAP kinase cascade (probably including MPK3 and MPK6) that negatively regulates salicylic acid- (SA-) dependent defense responses, abscisic acid (ABA) signaling, and ethylene-induced senescence. Modulates also stress response (e.g. drought) signaling and cell death, in an ORE9-dependent manner. Functions at a point of cross talk between ethylene, ABA and SA signaling that impinges on senescence and cell death. In another hand, confers sensitivity to various pathogens such as the fungus Erysiphe cichoracearum, the oomycete Hyaloperonospora parasitica and the bacteria Pseudomonas syringae pv. tomato DC3000. Required for the resistance to some hemibiotrophic/necrotrophic fungal pathogens (e.g. Colletotrichum gloeosporioides, Colletotrichum higginsianum and Alternaria brassicicola) through the induction of defensins expression, probably by repressing MYC2, an inhibitor of defensin genes (PDFs). Together with KEG, may regulate endocytic trafficking and/or the formation of signaling complexes on trans-Golgi network (TGN)/ early endosome (EE) vesicles during stress responses. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54TM7|DRKD_DICDI Probable serine/threonine-protein kinase drkD OS=Dictyostelium discoideum GN=drkD PE=2 SV=1 | Back alignment and function description |
|---|
Score = 234 bits (597), Expect = 2e-60, Method: Compositional matrix adjust.
Identities = 119/265 (44%), Positives = 167/265 (63%), Gaps = 5/265 (1%)
Query: 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR 488
E+ SE+ I +IG G +G V+ WR ++VAVK+L + + +EV ++ LR
Sbjct: 845 EVPLSEIAIGARIGRGGYGQVFRGSWRGTEVAVKMLFNDNVNLKLISDLRKEVDLLCKLR 904
Query: 489 HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 548
HPNIVL MGA TEP + IVTEYLSRGSL +L D + +D LRL + +D A+GM Y
Sbjct: 905 HPNIVLFMGACTEPSSPCIVTEYLSRGSLANILL--DESIEMDWGLRLQLGFDCARGMTY 962
Query: 549 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLR 608
LH R P I+HRDLK+ NLLVD ++ VKV DFGL+ K +T+ +KT GT W+APEVL
Sbjct: 963 LHSRNPIIIHRDLKTDNLLVDDSWQVKVADFGLATVKSHTF--AKTMCGTTGWVAPEVLA 1020
Query: 609 EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI 668
E+ EK+DV+S+ ++LWEL+T P+ QV+ ++ +G RL +P P AAL+
Sbjct: 1021 EEGYTEKADVYSYAIVLWELLTRLIPYAGKNTMQVVRSID-RGERLPMPAWCPPKYAALM 1079
Query: 669 ETCWAEEPEIRPSFPSIMETLQQFL 693
CW +P RPSFP I+ ++ +
Sbjct: 1080 NRCWETDPTHRPSFPEILPIMEGMI 1104
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54H46|DRKA_DICDI Probable serine/threonine-protein kinase drkA OS=Dictyostelium discoideum GN=drkA PE=3 SV=1 | Back alignment and function description |
|---|
Score = 229 bits (584), Expect = 6e-59, Method: Compositional matrix adjust.
Identities = 120/266 (45%), Positives = 162/266 (60%), Gaps = 4/266 (1%)
Query: 425 EEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIM 484
++G +I ++ I +IG+G++G VY WR S VAVK L +E+ KEF RE+ +M
Sbjct: 364 KDGKDIDIHQIKIGVRIGKGNYGEVYLGTWRGSQVAVKKLPAHNINENILKEFHREINLM 423
Query: 485 KGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAK 544
K LRHPN++ +G+ PP++ I TEY+ RGSLY +LH D + + L + M D AK
Sbjct: 424 KNLRHPNVIQFLGSCLIPPDICICTEYMPRGSLYSILH--DQALQLQWSLLIKMMIDAAK 481
Query: 545 GMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAP 604
G+ YLH P I+HRDLKS NLLVD + VKV DFGLS + ++ TA GTP W +P
Sbjct: 482 GVIYLHNSTPVILHRDLKSHNLLVDENWKVKVADFGLSTIEQQG--ATMTACGTPCWTSP 539
Query: 605 EVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV 664
EVLR EK+DV+SFG+ILWE T Q P+ P QVI AVG +G R +P+N P
Sbjct: 540 EVLRSQRYTEKADVYSFGIILWECATRQDPYFGIPPFQVIFAVGREGMRPPVPQNGPPKY 599
Query: 665 AALIETCWAEEPEIRPSFPSIMETLQ 690
L+ C E P RP+ +E L+
Sbjct: 600 IQLLIDCLNENPSHRPTMEQCLERLE 625
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54H45|DRKB_DICDI Probable serine/threonine-protein kinase drkB OS=Dictyostelium discoideum GN=drkB PE=3 SV=1 | Back alignment and function description |
|---|
Score = 226 bits (576), Expect = 5e-58, Method: Compositional matrix adjust.
Identities = 122/275 (44%), Positives = 164/275 (59%), Gaps = 5/275 (1%)
Query: 417 SNRELYLE-EEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFK 475
S R Y + ++G +I ++ I +IG+G+FG VY WR S VAVK L +E+ K
Sbjct: 372 SKRSGYTQIKDGKDIDTQQIKIGVRIGKGNFGEVYLGTWRGSQVAVKKLPAHNINENILK 431
Query: 476 EFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLR 535
EF RE+ +MK LRHPN++ +G+ P++ I TEY+ RGSLY +LH + ++ + L
Sbjct: 432 EFHREINLMKNLRHPNVIQFLGSCLISPDICICTEYMPRGSLYSILH--NEKIKISWSLV 489
Query: 536 LNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTA 595
M D AKG+ YLH P I+HRDLKS NLLVD + VKV DFGLS + ++ TA
Sbjct: 490 KRMMIDAAKGIIYLHGSTPVILHRDLKSHNLLVDENWKVKVADFGLSTIEQQG--ATMTA 547
Query: 596 AGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLE 655
GTP W +PEVLR EK+DV+SFG+ILWE T Q P+ P QVI AVG +G R
Sbjct: 548 CGTPCWTSPEVLRSQRYTEKADVYSFGIILWECATRQDPYFGIPPFQVIFAVGREGMRPP 607
Query: 656 IPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQ 690
PK P L++ C E P RP+ +E L+
Sbjct: 608 TPKYGPPKYIQLLKDCLNENPSQRPTMEQCLEILE 642
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum GN=DDB_G0267514 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 223 bits (567), Expect = 6e-57, Method: Compositional matrix adjust.
Identities = 123/294 (41%), Positives = 176/294 (59%), Gaps = 8/294 (2%)
Query: 399 YVTNNHLLMEANLSVMSTSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD 458
Y ++L + V S ++ Y + +EI +SEL I K+GEG+FG VY WR S
Sbjct: 628 YNNQGNILKNSGSVVEPPSQQQQYFSD--IEISFSELKISSKLGEGTFGVVYKGLWRGSS 685
Query: 459 VAVK-ILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSL 517
VA+K I I ++ + +EF +E+ I+ LRHPNIVLLM A T PPNL +TEYL GSL
Sbjct: 686 VAIKQIKINEDVNNQVLEEFRKELTILSRLRHPNIVLLMAACTAPPNLCFITEYLPGGSL 745
Query: 518 YKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVC 577
Y LH ++ ++ +L +A +A+GMNYLH ++HRD+KS NLL+D VK+C
Sbjct: 746 YDALH--SKKIKMNMQLYKKLAIQIAQGMNYLHLSG--VIHRDIKSLNLLLDEHMNVKIC 801
Query: 578 DFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRN 637
DFGLS+ K + +K + G+P WM+PE+L + EK DV++FG+ILWEL T + P+
Sbjct: 802 DFGLSKLKSKSTEMTK-SIGSPIWMSPELLMGEDYTEKVDVYAFGIILWELGTGELPYSG 860
Query: 638 STPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 691
Q+ AV K R IP ++ LI+ CW ++P RPSF I+ L +
Sbjct: 861 LDSVQLALAVTTKSLRPPIPNAWPYQLSHLIQACWHQDPLKRPSFTEILNLLNE 914
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54TA1|DRKC_DICDI Probable serine/threonine-protein kinase drkC OS=Dictyostelium discoideum GN=drkC PE=3 SV=1 | Back alignment and function description |
|---|
Score = 220 bits (561), Expect = 2e-56, Method: Compositional matrix adjust.
Identities = 117/265 (44%), Positives = 161/265 (60%), Gaps = 7/265 (2%)
Query: 430 IRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVK-ILIEQEFHEDRFKEFLREVAIMKGLR 488
I SE++++ +IG GS V+ WR VA+K + E ED E +E IM LR
Sbjct: 486 IDISEIVVQNRIGRGSCAEVFTGTWRGIIVAIKKAKLLNEDDEDFLNELAQEATIMSQLR 545
Query: 489 HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 548
HPNI +G PP + IV EY+ GSLY++LH D + +D +MA D+AKGMNY
Sbjct: 546 HPNICQFLGTCNNPPEILIVMEYMPLGSLYRILH--DPSISLDWPRMKSMALDIAKGMNY 603
Query: 549 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTA---AGTPEWMAPE 605
LH P ++HRDLKS NLLVD Y VK+ DFGLS ++ ++ KTA GTP W APE
Sbjct: 604 LHCCDPIVIHRDLKSHNLLVDEHYRVKISDFGLS-TRFKKHLDKKTAMTPVGTPCWTAPE 662
Query: 606 VLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 665
VLR DP EK+DVFSF ++LWE++T + P++ Q++ +VG R +P V+
Sbjct: 663 VLRNDPYTEKADVFSFAIVLWEIVTREDPYQGMPTFQIVISVGQHKLRPIVPPQVSAPFT 722
Query: 666 ALIETCWAEEPEIRPSFPSIMETLQ 690
LI CW+E+P+ RPSF I++ L+
Sbjct: 723 RLITECWSEDPQQRPSFQEIVKRLE 747
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54Y55|SHKC_DICDI Dual specificity protein kinase shkC OS=Dictyostelium discoideum GN=shkC PE=3 SV=1 | Back alignment and function description |
|---|
Score = 209 bits (531), Expect = 7e-53, Method: Compositional matrix adjust.
Identities = 117/279 (41%), Positives = 160/279 (57%), Gaps = 5/279 (1%)
Query: 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR 488
EIR E+ ++ IG GSFG VY R VAVK+L +Q F F +EV +M +
Sbjct: 18 EIRPEEINFEELIGTGSFGKVYKGRCRQKAVAVKLLHKQNFDAATLSAFRKEVHLMSKIY 77
Query: 489 HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 548
HPNI L MGA T P IVTE + +G+L LLH D ++ + LR+ MA D A G+N+
Sbjct: 78 HPNICLFMGACTIPGRCVIVTELVPKGNLETLLH--DQKIQLPLYLRMRMARDAALGINW 135
Query: 549 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS--RSKPNTYISSKTAAGTPEWMAPEV 606
LH+ P VHRD+KS NLLVD VK+CDFGLS + K +A GTP +MAPEV
Sbjct: 136 LHESNPVFVHRDIKSSNLLVDENMRVKICDFGLSALKQKHKMLKDQSSAKGTPLYMAPEV 195
Query: 607 LREDPSNEKSDVFSFGVILWELITLQKPWRNSTP-SQVISAVGFKGRRLEIPKNVNPMVA 665
+ NE SDV+SFG++LWE++T ++P+ + + AV K R IP + +
Sbjct: 196 MMFKEFNESSDVYSFGIVLWEILTRKEPFSHHRELEKFREAVCVKHERPPIPNDCLDSLR 255
Query: 666 ALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQPLSAQ 704
LIE CW +EP RPSF I+ L ++ + L+ +
Sbjct: 256 RLIEKCWDKEPISRPSFKEIISALDHVIIDAAISDLNGR 294
|
Required for proper chemotaxis and phagocytosis; proper spatiotemporal control of F-actin levels in chemotaxing cells. Negative regulator of the PI3K (phosphatidylinositol 3 kinase) pathway. Predominantly phosphorylates serines and threonines and tyrosines at a lower level. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7T6Y2|YR831_MIMIV Putative serine/threonine-protein kinase/receptor R831 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R831 PE=4 SV=2 | Back alignment and function description |
|---|
Score = 206 bits (524), Expect = 5e-52, Method: Compositional matrix adjust.
Identities = 106/265 (40%), Positives = 161/265 (60%), Gaps = 8/265 (3%)
Query: 430 IRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRH 489
I + E+ I K+IG GS+G V++ +W+ DVAVK ++Q+ E + EF E+A + L+H
Sbjct: 1359 INYDEISIGKQIGLGSYGIVFNGKWKGVDVAVKKFVKQKLSETQLLEFRAEMAFLSELKH 1418
Query: 490 PNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 549
NIV +GA + PN+ IVTEY+ G+L +L PD ++ +L+L Y A G++YL
Sbjct: 1419 SNIVTFIGACIKKPNICIVTEYMRMGNLRDVLKNPDIKITFANKLKL--LYGAAMGIDYL 1476
Query: 550 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRE 609
H P IVHRD+K N+LVD + VK+ DFG +R K + ++ T GTP W APEV+R
Sbjct: 1477 HSSNPMIVHRDIKPANILVDEHFNVKIADFGFARIKEDN--TTMTRCGTPCWTAPEVIRG 1534
Query: 610 DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE 669
+ EK+DVFSFGV++WE++T ++P+ +V S +G R IP + A LI+
Sbjct: 1535 EKYCEKADVFSFGVVMWEVLTGKEPFAECNFMKV-SLDILEGGRPIIPSDCPHEFAKLIK 1593
Query: 670 TCWAEEPEIRPSFPSIMETLQQFLM 694
CW + R P++ E +QQ ++
Sbjct: 1594 KCWHAKAHKR---PTMTEVVQQLML 1615
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7T6X2|YR826_MIMIV Putative serine/threonine-protein kinase/receptor R826 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R826 PE=4 SV=2 | Back alignment and function description |
|---|
Score = 205 bits (522), Expect = 9e-52, Method: Compositional matrix adjust.
Identities = 100/278 (35%), Positives = 167/278 (60%), Gaps = 8/278 (2%)
Query: 418 NRELYLEEEGL---EIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRF 474
N E YL GL I + E+ + ++IG GS+G VY +W+N DVA+K I+Q+ E+
Sbjct: 1379 NNERYLTSAGLCSWVINYDEIKMGEQIGLGSYGVVYRGKWKNVDVAIKKFIKQKIDENHL 1438
Query: 475 KEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERL 534
E+A +K L HPNI+ ++GA + PN+ IVTEY+++G+L + ++ +++
Sbjct: 1439 LGIREEIAFLKKLHHPNIITMVGASLKKPNICIVTEYMAKGNLRDAMRTCTPKLEWHQKI 1498
Query: 535 RLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKT 594
++ ++AKG++YLH PPI+HRD+K N+L+D + VK+ DFG +R K I T
Sbjct: 1499 KI--LVNIAKGISYLHSFDPPIIHRDIKPSNILIDENWNVKIADFGFARIKEENAI--MT 1554
Query: 595 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRL 654
GTP W APE++R D +EK DVFSFG+++WE++T ++P+ + ++ + + R
Sbjct: 1555 RCGTPCWTAPEIIRNDIYDEKVDVFSFGIVMWEVLTCKEPFIGANFMKITMDI-LEDVRP 1613
Query: 655 EIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQF 692
+IP++ A L+ CW + RP+ ++ L +F
Sbjct: 1614 KIPQDCPEEFAKLMRKCWHAKSTKRPTMDDVIIVLAKF 1651
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 706 | ||||||
| 296090398 | 758 | unnamed protein product [Vitis vinifera] | 0.973 | 0.906 | 0.624 | 0.0 | |
| 225449728 | 767 | PREDICTED: serine/threonine-protein kina | 0.973 | 0.895 | 0.624 | 0.0 | |
| 255580106 | 700 | map3k delta-1 protein kinase, putative [ | 0.934 | 0.942 | 0.630 | 0.0 | |
| 224113505 | 765 | serine/threonine protein kinase 4, CTR4 | 0.977 | 0.901 | 0.570 | 0.0 | |
| 255575367 | 871 | map3k delta-1 protein kinase, putative [ | 0.968 | 0.785 | 0.582 | 0.0 | |
| 224068980 | 821 | serine/threonine protein kinase 1, CTR1 | 0.947 | 0.814 | 0.589 | 0.0 | |
| 237857405 | 843 | serine/threonine protein kinase [Prunus | 0.951 | 0.797 | 0.587 | 0.0 | |
| 384979221 | 845 | CTR1 [Fragaria x ananassa] | 0.960 | 0.802 | 0.590 | 0.0 | |
| 114229341 | 843 | ethylene control element variant [Malus | 0.958 | 0.803 | 0.581 | 0.0 | |
| 114229343 | 843 | ethylene control element variant [Malus | 0.958 | 0.803 | 0.580 | 0.0 |
| >gi|296090398|emb|CBI40217.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 844 bits (2181), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 445/713 (62%), Positives = 527/713 (73%), Gaps = 26/713 (3%)
Query: 16 KSWAQQTEESYQLQLAMALRLSSQAASADDPHFLALSSCDRHTDSAETVSHRFWVNGCLS 75
KSWAQQTEESYQLQLA+ALRLSS ++SA DP+FL ++ DR SA +SHRFWVNGCLS
Sbjct: 37 KSWAQQTEESYQLQLALALRLSSDSSSAADPYFLDSATGDRPIGSARDLSHRFWVNGCLS 96
Query: 76 YFDRILDGFYLIHGMDPYTWSIGTNQRDAGLIPPYKSLKAVDPCNNLSIKVILIDKSSDP 135
Y DR+ DGFYLIHGMDPY W+I T+ ++ G IP ++SLKAVDP ++ SI+V+L+DK DP
Sbjct: 97 YIDRVPDGFYLIHGMDPYVWTISTDLKETGRIPSFESLKAVDPRDDFSIEVVLVDKHRDP 156
Query: 136 NLKELHNRVLSLLCDRITAEEAVHQLANLVCNHMGGTTSTEEEEFDKQWSECAEHLKDCL 195
+LKEL NR LS I A++ V +LANLVCNHMGG S+ E+ F W E + LK+ L
Sbjct: 157 SLKELQNRALSHSSSWIKAKQVVDELANLVCNHMGGAASSGEDGFANHWKEFSGMLKNSL 216
Query: 196 NSVVLPIGSLSVGLCVHRALLFKVLADLINLPCRIAKGCKYCRRDDASSCLVQIGPDREY 255
SVVLPIGSLSVGLCVHRALLFKVLAD++NLPCRIAKGCKYCR + ASSCLV+ GP+REY
Sbjct: 217 GSVVLPIGSLSVGLCVHRALLFKVLADVVNLPCRIAKGCKYCRSNVASSCLVRFGPEREY 276
Query: 256 LVDLLEDPGVLSKPDSSLNRTASVFVSSPLYHPRFKAVETVENIRSLAKLYFIDNHSPKF 315
LVDL+ +PG L PDS LN T+S+ VSSPL HPRFK VET E+ R LA+LYF D S
Sbjct: 277 LVDLMCNPGALCSPDSLLNGTSSILVSSPLCHPRFKLVETAEDFRILARLYFFDCQSLNI 336
Query: 316 DLDDDPSGTAIDQDYKPDPQ-----------------------ALF--QRASWNVTADRD 350
DD SG A+ QD D + LF QR + V+ DRD
Sbjct: 337 AFDDPSSGAAVGQDDNSDSRFPKPFDRSYTESKNLVSTSNNHHELFLPQRTARLVSHDRD 396
Query: 351 LQMQNPSGPSTHVIDSSNFIKGPLLRSPVKPFRHRKSHETSAFSTLKPYVTNNHLLMEAN 410
QMQN P +VI+S + +KG + S + P +R F +P N ME N
Sbjct: 397 PQMQNSFNPLPNVINSKHLVKGAVRPSHILPMGNRDVQPILPFPRPRPGTNKNLGFMEKN 456
Query: 411 LSVMSTSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFH 470
SV S S+ + L EE LEI WSEL++K+ IG GSFGTV+ A+WR+SDVAVKIL+EQ+FH
Sbjct: 457 HSVTSRSSLKYSLVEEDLEIPWSELVLKENIGAGSFGTVHRAKWRDSDVAVKILMEQDFH 516
Query: 471 EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVV 530
+RF+EFLREVAIMK LRHPNIVL MGAVT+PP+LSIVTEYLSRGSLYKLL +PDA +V+
Sbjct: 517 AERFEEFLREVAIMKRLRHPNIVLFMGAVTQPPHLSIVTEYLSRGSLYKLLRMPDAGMVL 576
Query: 531 DERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 590
DER RLNMAYDVA GMNYLHQ +PPIVHRDLKSPNLLVD YTVKVCDFGLSRSK NT++
Sbjct: 577 DERRRLNMAYDVAMGMNYLHQLKPPIVHRDLKSPNLLVDGNYTVKVCDFGLSRSKANTFL 636
Query: 591 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK 650
SSKTAAGTPEWMAPEVLR++PSNEKSDV+SFGVILWEL+TLQ+PW++ P+QV++AV FK
Sbjct: 637 SSKTAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELVTLQRPWKHLNPAQVVAAVAFK 696
Query: 651 GRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQPLSA 703
G+RLEIP VN VA LIE CWA EP RP F I E LQ L+SS QP
Sbjct: 697 GKRLEIPAEVNHQVAYLIEACWANEPSKRPPFSFIKEYLQP-LISSSPQPFQG 748
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225449728|ref|XP_002267382.1| PREDICTED: serine/threonine-protein kinase CTR1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 844 bits (2180), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 445/713 (62%), Positives = 527/713 (73%), Gaps = 26/713 (3%)
Query: 16 KSWAQQTEESYQLQLAMALRLSSQAASADDPHFLALSSCDRHTDSAETVSHRFWVNGCLS 75
KSWAQQTEESYQLQLA+ALRLSS ++SA DP+FL ++ DR SA +SHRFWVNGCLS
Sbjct: 46 KSWAQQTEESYQLQLALALRLSSDSSSAADPYFLDSATGDRPIGSARDLSHRFWVNGCLS 105
Query: 76 YFDRILDGFYLIHGMDPYTWSIGTNQRDAGLIPPYKSLKAVDPCNNLSIKVILIDKSSDP 135
Y DR+ DGFYLIHGMDPY W+I T+ ++ G IP ++SLKAVDP ++ SI+V+L+DK DP
Sbjct: 106 YIDRVPDGFYLIHGMDPYVWTISTDLKETGRIPSFESLKAVDPRDDFSIEVVLVDKHRDP 165
Query: 136 NLKELHNRVLSLLCDRITAEEAVHQLANLVCNHMGGTTSTEEEEFDKQWSECAEHLKDCL 195
+LKEL NR LS I A++ V +LANLVCNHMGG S+ E+ F W E + LK+ L
Sbjct: 166 SLKELQNRALSHSSSWIKAKQVVDELANLVCNHMGGAASSGEDGFANHWKEFSGMLKNSL 225
Query: 196 NSVVLPIGSLSVGLCVHRALLFKVLADLINLPCRIAKGCKYCRRDDASSCLVQIGPDREY 255
SVVLPIGSLSVGLCVHRALLFKVLAD++NLPCRIAKGCKYCR + ASSCLV+ GP+REY
Sbjct: 226 GSVVLPIGSLSVGLCVHRALLFKVLADVVNLPCRIAKGCKYCRSNVASSCLVRFGPEREY 285
Query: 256 LVDLLEDPGVLSKPDSSLNRTASVFVSSPLYHPRFKAVETVENIRSLAKLYFIDNHSPKF 315
LVDL+ +PG L PDS LN T+S+ VSSPL HPRFK VET E+ R LA+LYF D S
Sbjct: 286 LVDLMCNPGALCSPDSLLNGTSSILVSSPLCHPRFKLVETAEDFRILARLYFFDCQSLNI 345
Query: 316 DLDDDPSGTAIDQDYKPDPQ-----------------------ALF--QRASWNVTADRD 350
DD SG A+ QD D + LF QR + V+ DRD
Sbjct: 346 AFDDPSSGAAVGQDDNSDSRFPKPFDRSYTESKNLVSTSNNHHELFLPQRTARLVSHDRD 405
Query: 351 LQMQNPSGPSTHVIDSSNFIKGPLLRSPVKPFRHRKSHETSAFSTLKPYVTNNHLLMEAN 410
QMQN P +VI+S + +KG + S + P +R F +P N ME N
Sbjct: 406 PQMQNSFNPLPNVINSKHLVKGAVRPSHILPMGNRDVQPILPFPRPRPGTNKNLGFMEKN 465
Query: 411 LSVMSTSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFH 470
SV S S+ + L EE LEI WSEL++K+ IG GSFGTV+ A+WR+SDVAVKIL+EQ+FH
Sbjct: 466 HSVTSRSSLKYSLVEEDLEIPWSELVLKENIGAGSFGTVHRAKWRDSDVAVKILMEQDFH 525
Query: 471 EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVV 530
+RF+EFLREVAIMK LRHPNIVL MGAVT+PP+LSIVTEYLSRGSLYKLL +PDA +V+
Sbjct: 526 AERFEEFLREVAIMKRLRHPNIVLFMGAVTQPPHLSIVTEYLSRGSLYKLLRMPDAGMVL 585
Query: 531 DERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 590
DER RLNMAYDVA GMNYLHQ +PPIVHRDLKSPNLLVD YTVKVCDFGLSRSK NT++
Sbjct: 586 DERRRLNMAYDVAMGMNYLHQLKPPIVHRDLKSPNLLVDGNYTVKVCDFGLSRSKANTFL 645
Query: 591 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK 650
SSKTAAGTPEWMAPEVLR++PSNEKSDV+SFGVILWEL+TLQ+PW++ P+QV++AV FK
Sbjct: 646 SSKTAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELVTLQRPWKHLNPAQVVAAVAFK 705
Query: 651 GRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQPLSA 703
G+RLEIP VN VA LIE CWA EP RP F I E LQ L+SS QP
Sbjct: 706 GKRLEIPAEVNHQVAYLIEACWANEPSKRPPFSFIKEYLQP-LISSSPQPFQG 757
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255580106|ref|XP_002530885.1| map3k delta-1 protein kinase, putative [Ricinus communis] gi|223529538|gb|EEF31491.1| map3k delta-1 protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 823 bits (2127), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 431/684 (63%), Positives = 524/684 (76%), Gaps = 24/684 (3%)
Query: 11 EMAPCKSWAQQTEESYQLQLAMALRLSSQAASADDPHFLALSSCDRH--------TDSAE 62
+ A W QQTEESYQLQLA+ALRLSSQAA A+D +FL S D ++SAE
Sbjct: 15 QTATFSRWVQQTEESYQLQLALALRLSSQAALANDSNFLDFKSNDHDHYHQLSSSSNSAE 74
Query: 63 TVSHRFWVNGCLSYFDRILDGFYLIHGMDPYTWSIGTNQRDAGLIPPYKSLKAVDPCNNL 122
+VSHRFWVNGCLSY+DRI DGFY+IHG+DPY W+I +Q+D GLIP ++SLKA+DP ++L
Sbjct: 75 SVSHRFWVNGCLSYYDRIPDGFYVIHGVDPYAWTISIDQKDIGLIPSFESLKALDPRDDL 134
Query: 123 SIKVILIDKSSDPNLKELHNRVLSLLCDRITAEEAVHQLANLVCNHMGGTTSTEEEEFDK 182
S+ V+LID+ DP LKEL NRV+ L + IT ++A+ QLA+LVCN MGG TSTE+ FD
Sbjct: 135 SVNVVLIDRFRDPGLKELSNRVIKLSSNWITTKDAIDQLADLVCNRMGGVTSTEQNTFDM 194
Query: 183 QWSECAEHLKDCLNSVVLPIGSLSVGLCVHRALLFKVLADLINLPCRIAKGCKYCRRDDA 242
W EC E L++ L SVVLPIG+L VGLCVHRALLFKVLAD INLPCRIAKGCK+CRRD A
Sbjct: 195 CWKECTEILRNRLGSVVLPIGNLPVGLCVHRALLFKVLADSINLPCRIAKGCKHCRRDVA 254
Query: 243 SSCLVQIGPDREYLVDLLEDPGVLSKPDSSLNRTASVFVSSPLYHPRFKAVETVENIRSL 302
+SCLVQ+G +REYLVDL PG LS+PDSSLNRT+S+ VSSPL HP FK+++T +++R+L
Sbjct: 255 ASCLVQVGSEREYLVDLFGKPGTLSQPDSSLNRTSSILVSSPLSHPSFKSLQTADDLRTL 314
Query: 303 AKLYFIDNHSPKFDLDDDPSGTAIDQDYK------PDPQALFQRASWNVTADRDLQMQNP 356
AK +FID+ DD PSGT IDQD K D + L +S + A ++
Sbjct: 315 AKHFFIDSQLLNLAFDDTPSGT-IDQDDKNSKTVIKDNKNLIPNSSNSHDASTPPLLKRV 373
Query: 357 SGPST-----HVIDSSNFIKGP----LLRSPVKPFRHRKSHETSAFSTLKPYVTNNHLLM 407
+G T H ++SS+ +L +P P HR + S S KP TNN L +
Sbjct: 374 AGNITNASGLHAVNSSSKSNSLSKDLILPNPALPIMHRDPYSISVTSNPKPDATNNQLFL 433
Query: 408 EANLSVMSTSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQ 467
+AN S +S S+ EL+LEEE L+I WSEL+IK+KIGEGSFGTV+ A+WR SDVAVKIL+EQ
Sbjct: 434 DANQSFVSRSSSELHLEEEDLDIPWSELVIKEKIGEGSFGTVHRADWRGSDVAVKILMEQ 493
Query: 468 EFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDAR 527
++H + F EFLREV IMK LRHPNIVL MGAVT+PP SIVTEYLSRGSL+KLLH+PDAR
Sbjct: 494 DYHAEHFNEFLREVTIMKRLRHPNIVLFMGAVTQPPKFSIVTEYLSRGSLHKLLHMPDAR 553
Query: 528 VVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 587
+++DE+ RLNMAYDVAKGMNYLHQ RPPIVHRDLKS NLLVDS YTVKVCDFGLSRSK
Sbjct: 554 IILDEKRRLNMAYDVAKGMNYLHQLRPPIVHRDLKSLNLLVDSQYTVKVCDFGLSRSKAK 613
Query: 588 TYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 647
TY+SSKTAAGTPEWMAPEVLR +PS+EKSDV+SFGVILWEL+TLQ+PWR+ +QV++AV
Sbjct: 614 TYLSSKTAAGTPEWMAPEVLRNEPSDEKSDVYSFGVILWELMTLQQPWRSLNQAQVVAAV 673
Query: 648 GFKGRRLEIPKNVNPMVAALIETC 671
GFK +RLEIP N+NP VAALI+ C
Sbjct: 674 GFKNQRLEIPNNINPSVAALIDRC 697
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224113505|ref|XP_002316514.1| serine/threonine protein kinase 4, CTR4 [Populus trichocarpa] gi|222865554|gb|EEF02685.1| serine/threonine protein kinase 4, CTR4 [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 820 bits (2117), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 438/768 (57%), Positives = 531/768 (69%), Gaps = 78/768 (10%)
Query: 4 EGFGVGNEMAPCKSWAQQTEESYQLQLAMALRLSSQAASADDPHFLALSSCDRH------ 57
E G E A KSWA++TEESYQLQLA+ALRLSSQAASA+DP FL +S D +
Sbjct: 2 EESGSWCEEATIKSWAKRTEESYQLQLALALRLSSQAASANDPSFLDWNSSDSNRGVSSF 61
Query: 58 TDSAETVSHRFW----------------------VNGCLSYFDRILDGFYLIHGMDPYTW 95
+DS E++SHRFW VNGCLSY DRI DGFY++HG+DPYTW
Sbjct: 62 SDSPESLSHRFWIRASLILLILSEFTSRKISTIEVNGCLSYNDRIPDGFYVMHGLDPYTW 121
Query: 96 SIGTNQRDAGLIPPYKSLKAVDPCNNLSIKVILIDKSSDPNLKELHNRVLSLLCDRITAE 155
SI + R +P ++SLKAV N+LSI+V+L+D+ DP LKELHNRV+ L T +
Sbjct: 122 SISADSR----VPSFESLKAV---NDLSIEVVLVDRLRDPGLKELHNRVIGLWSGSNTTK 174
Query: 156 EAVHQLANLVCNHMGGTTSTEEEE-FDKQWSECAEHLKDCLNSVVLPIGSLSVGLCVHRA 214
+ V QLANLVCN MGG E+++ F K W EC E +K L SVV+ +GSL++GLCVHRA
Sbjct: 175 DVVEQLANLVCNRMGGVVFNEDDDTFAKCWKECTEVMKRRLGSVVILVGSLTIGLCVHRA 234
Query: 215 LLFKVLADLINLPCRIAKGCKYCRRDDASSCLVQIGPDREYLVDLLEDPGVLSKPDSSLN 274
LLFKVLAD INLPCRI GCKYCR+D SSCLVQ+G DREY VDLL PG LS+PDSSLN
Sbjct: 235 LLFKVLADSINLPCRIVNGCKYCRKDVVSSCLVQVGDDREYFVDLLGKPGALSQPDSSLN 294
Query: 275 RTASVFVSSPLYHPRFKAVETVENIRSLA-KLYFIDNHSPKFDLDDDPSGTAIDQD---- 329
T+S+ VSSPL HPRFK+++T E+ R++A KLYF+D D+ SGT I +D
Sbjct: 295 CTSSILVSSPLSHPRFKSIQTTEDFRTMAAKLYFLDCQPLNLVFDNPSSGTTIHEDDRFI 354
Query: 330 -----------------YKPDPQALFQRASWNVTADRDLQMQNPSGPSTHVIDSSNFIKG 372
++ L Q + N+ D DLQ N P +V+ + NF++G
Sbjct: 355 SRLGKDMKNLPPTSINKHEASLSPLHQGVAQNIMHDMDLQAPNSYNPFLNVVKTKNFVEG 414
Query: 373 PLLRSPVKPFRHRKSHETSAFSTLKPYVTNNHLLMEANLSVMSTSNRELYLEEEGLEIRW 432
P + S + P + K H S KP TNN L ME N +++S SN +L+LEEE ++ W
Sbjct: 415 PNVPSSILPVK--KKHTDPVISNPKPVATNNLLFMEINQTILSKSNNQLHLEEEDFDVPW 472
Query: 433 SELLIKKKIGE------------------GSFGTVYHAEWRNSDVAVKILIEQEFHEDRF 474
SELL+KKKIG GSFGTVYHA+WR SDVAVKIL EQEFH +RF
Sbjct: 473 SELLLKKKIGSVCEFCEISFMKDTNQCFSGSFGTVYHADWRGSDVAVKILEEQEFHAERF 532
Query: 475 KEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERL 534
+EFL EV+IMK LRHPNIVL MGAVT+PPNLSIV EYLSRGSL+KLLH+PDA ++++ER
Sbjct: 533 EEFLSEVSIMKRLRHPNIVLFMGAVTQPPNLSIVMEYLSRGSLHKLLHLPDAALILNERR 592
Query: 535 RLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKT 594
RLNMA DVAKGMNYLHQ RPPI+HRDLKS NLLVDS Y VK+CDFGLSRSK TYISS
Sbjct: 593 RLNMANDVAKGMNYLHQFRPPIIHRDLKSLNLLVDSAYKVKICDFGLSRSKAKTYISSTN 652
Query: 595 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRL 654
AAGTPEWMAPEVLR + SNEKSDV+SFGV+LWEL+TLQ PWRN +Q+I+AVGF G RL
Sbjct: 653 AAGTPEWMAPEVLRNEQSNEKSDVYSFGVVLWELMTLQHPWRNLKQAQIIAAVGFMGGRL 712
Query: 655 EIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQPLS 702
EIP NVNP VAALI+ C EP RPSF IM+TLQ+ + S+ QP++
Sbjct: 713 EIPSNVNPSVAALIKVCLDSEPSKRPSFSYIMKTLQELINDSISQPVA 760
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255575367|ref|XP_002528586.1| map3k delta-1 protein kinase, putative [Ricinus communis] gi|223531982|gb|EEF33794.1| map3k delta-1 protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 790 bits (2039), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 411/706 (58%), Positives = 512/706 (72%), Gaps = 22/706 (3%)
Query: 16 KSWAQQTEESYQLQLAMALRLSSQAASADDPHFL---ALSSCDRHT--DSAETVSHRFWV 70
KSWAQQTEESYQLQLA+ALRLSS+A ADDP+FL S R T +S E +SHRFWV
Sbjct: 156 KSWAQQTEESYQLQLALALRLSSEATCADDPNFLDPVPDESTLRSTSSNSPEVLSHRFWV 215
Query: 71 NGCLSYFDRILDGFYLIHGMDPYTWSIGTNQRDAGLIPPYKSLKAVDPCNNLSIKVILID 130
NGCLSYFD++ DGFY IHGM+PY W++ T+ +++G IP +SLK+VDP + S++V+LID
Sbjct: 216 NGCLSYFDKVPDGFYQIHGMNPYVWTVCTDLQESGRIPSIESLKSVDPVADSSLEVVLID 275
Query: 131 KSSDPNLKELHNRVLSLLCDRITAEEAVHQLANLVCNHMGGTTSTEEEEFDKQWSECAEH 190
+ SDP+LKEL NRV + C IT +E V QLA LVC+ MGG+ + E++F W EC++
Sbjct: 276 RRSDPSLKELQNRVHGISCGCITTKEVVDQLAKLVCSRMGGSATIGEDDFTNIWRECSDD 335
Query: 191 LKDCLNSVVLPIGSLSVGLCVHRALLFKVLADLINLPCRIAKGCKYCRRDDASSCLVQIG 250
LKDCL S+V+PIGSLSVGLC HRALLFKVLAD I+LPCRIAKGCKYC+RDDASSCLV+ G
Sbjct: 336 LKDCLGSIVVPIGSLSVGLCRHRALLFKVLADTIDLPCRIAKGCKYCKRDDASSCLVRFG 395
Query: 251 PDREYLVDLLEDPGVLSKPDSSLNRTASVFVSSPLYHPRFKAVETVENIRSLAKLYFIDN 310
DREYLVDL+ PG L +PDS LN +S+ +SSPL PR K+ E + RSLAK YF D
Sbjct: 396 LDREYLVDLIGKPGCLCEPDSLLNGPSSISISSPLRFPRMKSAEPTVDFRSLAKQYFSDC 455
Query: 311 HSPKFDLDDDPSGTAIDQDYKPDPQ-----------------ALFQRASWNVTADRDLQM 353
S DD +GT ++ K D L + + DR+ M
Sbjct: 456 QSLNLVFDDASAGTIPEKIEKTDIDRINLVPIPSNTNEISQLPLPMKVARTNAQDRNSYM 515
Query: 354 QNPSGPSTHVIDSSNFIKGPLLRSPVKPFRHRKSHETSAFSTLKPYVTNNHLLMEANLSV 413
S +V S+N +K + + HR + + S + + N E + +
Sbjct: 516 IKSHNGSQNVKQSTNMVKDLIPLKHIPTIEHRDARPLLSISDQREDTSKNSKFSEGSQLI 575
Query: 414 MSTSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDR 473
S ++E L+ E L+I WS+L++K++IG GSFGTV+ A+W SDVAVKIL+EQ+FH +R
Sbjct: 576 SSRQSKEFSLDVEDLDIPWSDLVLKERIGAGSFGTVHRADWHGSDVAVKILMEQDFHAER 635
Query: 474 FKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDER 533
FKEFLREVAIMK LRHPNIVL MGAVT+PPNLSIVTEYLSRGSLY+LLH AR +DER
Sbjct: 636 FKEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREALDER 695
Query: 534 LRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSK 593
RL+MAYDVAKGMNYLH+R PPIVHRDLKSPNLLVD YTVKVCDFGLSR K NT++SSK
Sbjct: 696 RRLSMAYDVAKGMNYLHKRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSK 755
Query: 594 TAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR 653
+AAGTPEWMAPEVLR++PSNEKSDV+SFGVI+WEL TLQ+PW N P+QV++AVGFKGRR
Sbjct: 756 SAAGTPEWMAPEVLRDEPSNEKSDVYSFGVIMWELATLQQPWGNLNPAQVVAAVGFKGRR 815
Query: 654 LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQ 699
LEIP+++NP VA +IE CWA EP RPSF +IM++L+ + + + Q
Sbjct: 816 LEIPRDLNPQVATIIEACWANEPWKRPSFATIMDSLRLLIKAPIPQ 861
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224068980|ref|XP_002326245.1| serine/threonine protein kinase 1, CTR1 [Populus trichocarpa] gi|222833438|gb|EEE71915.1| serine/threonine protein kinase 1, CTR1 [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 783 bits (2022), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 412/699 (58%), Positives = 509/699 (72%), Gaps = 30/699 (4%)
Query: 9 GNEMAPCKSWAQQTEESYQLQLAMALRLSSQAASADDPHFL-------ALSSCDRHTDSA 61
N + KSWAQQTEESYQLQLA+ALRLSS+A ADDPHFL AL S ++S
Sbjct: 137 ANNGSSGKSWAQQTEESYQLQLALALRLSSEATCADDPHFLDPVPDESALRSST--SNSP 194
Query: 62 ETVSHRFWVNGCLSYFDRILDGFYLIHGMDPYTWSIGTNQRDAGLIPPYKSLKAVDPCNN 121
E +SHRFWVNGCLSYF++I DGFYLIHGMDPY W++ T+ +D G IP +SLK+VDP +
Sbjct: 195 EALSHRFWVNGCLSYFNKIPDGFYLIHGMDPYVWTVCTDLQDNGRIPSIESLKSVDPNAD 254
Query: 122 LSIKVILIDKSSDPNLKELHNRVLSLLCDRITAEEAVHQLANLVCNHMGGTTSTEEEEFD 181
S++V+LID+ SDPNLKEL NRV + C IT +E V QLA LVCN MGG S E++F
Sbjct: 255 SSMEVVLIDRRSDPNLKELQNRVHGISCSSITTKEVVDQLAKLVCNRMGGPASRGEDDFI 314
Query: 182 KQWSECAEHLKDCLNSVVLPIGSLSVGLCVHRALLFKVLADLINLPCRIAKGCKYCRRDD 241
W EC+++LKDCL S+V+PIGSLS+GLC HRALLFKVLAD I+LPCRIAKGCKYC+RDD
Sbjct: 315 SIWKECSDNLKDCLESIVVPIGSLSIGLCRHRALLFKVLADTIDLPCRIAKGCKYCKRDD 374
Query: 242 ASSCLVQIGPDREYLVDLLEDPGVLSKPDSSLNRTASVFVSSPLYHPRFKAVETVENIRS 301
SSCLV+ G DREYLVDL+ PG L +PDS LN +S+ +SSPL PR K+ E+ + R
Sbjct: 375 GSSCLVRFGLDREYLVDLVGRPGFLCEPDSLLNGPSSISISSPLRFPRIKSTESTVDFRQ 434
Query: 302 LAKLYFIDNHSPKFDLDDDPSGTAIDQDYKPDPQALFQRASWNVTADRDLQMQNPSGPST 361
LAK YF+D S DD +GT D + +++ + + ++ +Q PS
Sbjct: 435 LAKQYFLDCQSLNLVFDDASTGTV--HDGEAPGFSMYPKKTDRTDSEISNHVQLPS---- 488
Query: 362 HVIDSSNFIKGPLLRSPVKPFRHRKSHETSAFSTLKPYVTNNHLLMEANLSVMSTSNREL 421
+S+ + PL + S S + + + E + + +++EL
Sbjct: 489 ---NSNEISQLPL------------PQKVSRISNHVQLPSKDSMFSEGSQLLSGKTSKEL 533
Query: 422 YLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREV 481
L+ E +I W++L++K++IG GSFGTV+ A+W SDVAVKIL+EQ+FH DRFKEFLREV
Sbjct: 534 SLDAEDSDIPWNDLVLKERIGAGSFGTVHRADWHGSDVAVKILMEQDFHADRFKEFLREV 593
Query: 482 AIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYD 541
AIMK LRHPNIVL MGAVT+PPNLSIVTEYLSRGSLY+LL AR V+DER RLNMAYD
Sbjct: 594 AIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLRKSGAREVLDERRRLNMAYD 653
Query: 542 VAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEW 601
VAKGMNYLH+R PPIVHRDLKSPNLLVD YTVKVCDFGLSR K NT++SSK+AAGTPEW
Sbjct: 654 VAKGMNYLHKRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRFKANTFLSSKSAAGTPEW 713
Query: 602 MAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVN 661
MAPEVLR++ SNEKSDV+SFGVILWEL TLQ+PW N +QV++AVGFKG+RLEIP+++N
Sbjct: 714 MAPEVLRDELSNEKSDVYSFGVILWELATLQQPWSNLNAAQVVAAVGFKGKRLEIPRDLN 773
Query: 662 PMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQP 700
P VAALIE CWA EP RPSF SIM++L+ + QP
Sbjct: 774 PHVAALIEACWANEPWKRPSFASIMDSLRSLIKPPTPQP 812
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|237857405|gb|ACR23642.1| serine/threonine protein kinase [Prunus persica] | Back alignment and taxonomy information |
|---|
Score = 783 bits (2021), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 418/711 (58%), Positives = 509/711 (71%), Gaps = 39/711 (5%)
Query: 18 WAQQTEESYQLQLAMALRLSSQAASADDPHFLALS---SCDRHTDSAETVSHRFWVNGCL 74
WAQQTEESYQLQLA+ALRLSS+A DDP+FL L S R + S + VSHRFWVNGCL
Sbjct: 135 WAQQTEESYQLQLALALRLSSEATCTDDPNFLDLVPDVSSSRSSGSVDAVSHRFWVNGCL 194
Query: 75 SYFDRILDGFYLIHGMDPYTWSIGTNQRDAGLIPPYKSLKAVDPCNNLSIKVILIDKSSD 134
SYFD + DGFYLIHG+DPY W++ T+ ++ G IP +SL++VDP SI+V+LID+ SD
Sbjct: 195 SYFDIVPDGFYLIHGIDPYVWTVCTDMQENGRIPSIESLRSVDPGIGSSIEVVLIDRRSD 254
Query: 135 PNLKELHNRVLSLLCDRITAEEAVHQLANLVCNHMGGTTSTEEEEFDKQWSECAEHLKDC 194
P+LKEL NRV SL C IT +E V QLA LVCN MGG+ S E+EF W E ++ LKDC
Sbjct: 255 PSLKELQNRVFSLSCTCITTKEIVDQLAKLVCNRMGGSASVGEDEFVPIWRESSDDLKDC 314
Query: 195 LNSVVLPIGSLSVGLCVHRALLFKVLADLINLPCRIAKGCKYCRRDDASSCLVQIGPDRE 254
L SVV+PIGSLSVGLC HRALLFKVLAD I+L CRIAKGCKYC RDDASSCLV+ G DRE
Sbjct: 315 LGSVVVPIGSLSVGLCRHRALLFKVLADRIDLSCRIAKGCKYCTRDDASSCLVRFGLDRE 374
Query: 255 YLVDLLEDPGVLSKPDSSLNRTASVFVSSPLYHPRFKAVETVENIRSLAKLYFIDNHSPK 314
YLVDL+ +PG L +PDS LN +S+ +SSPL PR K VE + RSLAK YF D S
Sbjct: 375 YLVDLIANPGYLCEPDSLLNGPSSISISSPLRFPRLKPVEPTIDFRSLAKQYFSDCQSLN 434
Query: 315 FDLDDDPSGTAIDQDYKP-------------------------DPQALFQRASWNVTADR 349
D+ +G+A+D+D K D +++ + S DR
Sbjct: 435 LVFDEASAGSAVDEDNKEFSMYPKQLDRKITEGNNLLLVSSLNDNTSMYAKVSQPSFEDR 494
Query: 350 DLQMQNPSGPSTHVIDSSNFIKGPLLRSPVKPFRHRKSHETSAFSTLKPYVTNNHLLMEA 409
+ Q+ NPS +++ + +K P+ + P HR + S T T +E
Sbjct: 495 NPQLFNPS---QNIVHTPGMVKDPIPLKRIPPIGHR---DVSRVDT-----TKGSRFVEG 543
Query: 410 NLSVMSTSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEF 469
V S ++EL + E L+I W++L++K +IG GSFGTV+ A+W SDVAVKIL+EQ+F
Sbjct: 544 VQLVPSKPSKELTFDIEDLDIPWNDLVLKDRIGAGSFGTVHRADWHGSDVAVKILMEQDF 603
Query: 470 HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVV 529
H +RFKEFLREV IMK LRHPNIVL MGAVT+PPNLSIVTEYLSRGSLY+LLH P A
Sbjct: 604 HAERFKEFLREVTIMKRLRHPNIVLFMGAVTKPPNLSIVTEYLSRGSLYRLLHKPGAMEA 663
Query: 530 VDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 589
+DE+ RLNMAYDVAKGMNYLH+R PPIVHRDLKSPNLLVD YTVKVCDFGLSR K NT+
Sbjct: 664 LDEKRRLNMAYDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTF 723
Query: 590 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGF 649
+SSK+AAGTPEWMAPEVLR++PSNEKSDV+SFGVILWEL TLQ+PW N P+QV++AVGF
Sbjct: 724 LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGF 783
Query: 650 KGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQP 700
K +RLEIP+++NP VA++IE CWA EP RPSF SIME+L + QP
Sbjct: 784 KNKRLEIPRDLNPQVASIIEACWANEPWKRPSFASIMESLMPLIKPPATQP 834
|
Source: Prunus persica Species: Prunus persica Genus: Prunus Family: Rosaceae Order: Rosales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|384979221|gb|AFI38955.1| CTR1 [Fragaria x ananassa] | Back alignment and taxonomy information |
|---|
Score = 783 bits (2021), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 417/706 (59%), Positives = 509/706 (72%), Gaps = 28/706 (3%)
Query: 16 KSWAQQTEESYQLQLAMALRLSSQAASADDPHFL---ALSSCDRHTDSAETVSHRFWVNG 72
KSWAQQTEESYQLQLA+ALRLSS+A ADDP+FL S R + SA+ VSHRFWVNG
Sbjct: 144 KSWAQQTEESYQLQLALALRLSSEATCADDPNFLDPVPDESSSRLSSSADAVSHRFWVNG 203
Query: 73 CLSYFDRILDGFYLIHGMDPYTWSIGTNQRDAGLIPPYKSLKAVDPCNNLSIKVILIDKS 132
CLSYFD++ DGFYLIHG+D Y WS+ T+ +++G IP +SL++VDP N SI+VILID+
Sbjct: 204 CLSYFDKVPDGFYLIHGIDSYVWSMCTDMQESGRIPSIESLRSVDPGNGSSIEVILIDRR 263
Query: 133 SDPNLKELHNRVLSLLCDRITAEEAVHQLANLVCNHMGGTTSTEEEEFDKQWSECAEHLK 192
SDP+LKEL NRVLS+ IT E V QLA LVC+ MGG+ S E +F W E ++ LK
Sbjct: 264 SDPSLKELQNRVLSISHACITKTEIVDQLAKLVCSRMGGSASVGEADFFPIWRESSDELK 323
Query: 193 DCLNSVVLPIGSLSVGLCVHRALLFKVLADLINLPCRIAKGCKYCRRDDASSCLVQIGPD 252
DCL SVV+PIGSLS+GLC HRALLFKVLAD I+LPCRIAKGCKYC RDDASSCLV+ G D
Sbjct: 324 DCLGSVVVPIGSLSIGLCRHRALLFKVLADSIDLPCRIAKGCKYCTRDDASSCLVRFGVD 383
Query: 253 REYLVDLLEDPGVLSKPDSSLNRTASVFVSSPLYHPRFKAVETVENIRSLAKLYFIDNHS 312
RE VDL+ +PG L +PDS LN +++ +SSPL PR + VE + R+LAK YF D
Sbjct: 384 RELFVDLIGNPGCLCEPDSLLNGPSTISISSPLRFPRIRTVEPTIDFRTLAKQYFSDCQL 443
Query: 313 PKFDLDDDPSGTAIDQDYK----------PDPQALFQRASWNVTA-----DRDLQMQNPS 357
D+ P+G+A ++D K D LF +S + DR Q+
Sbjct: 444 LNLVFDEAPAGSAGNEDNKGFSMYPKQKFTDGNNLFLDSSLDDDTSMHVDDRSPQLLKSY 503
Query: 358 GPSTHVIDSSNFIKGPLLRSPVKPFRHRKSHETSAFSTLKPYVTNNHLLMEANLSVMSTS 417
PS +++ +K + + P HR + S T + + E V S
Sbjct: 504 NPSQNIVHQQTMLKDQIPLKRIPPIGHR---DISRLDT-----SRDSRFGEGLQVVPSKP 555
Query: 418 NRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEF 477
N+EL + + L+I WSEL +K++IG GSFGTV+ A+W SDVAVKIL+EQEFH +RFKEF
Sbjct: 556 NKELTFDVDDLDIPWSELALKERIGAGSFGTVHRADWHGSDVAVKILMEQEFHAERFKEF 615
Query: 478 LREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLN 537
LREV IMK LRHPNIVL MGAVT+PPNLSIVTEYLSRGSLY+LLH P V+DER RLN
Sbjct: 616 LREVTIMKRLRHPNIVLFMGAVTKPPNLSIVTEYLSRGSLYRLLHKPGP--VLDERRRLN 673
Query: 538 MAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAG 597
MA+DVAKGMNYLH+R PPIVHRDLKSPNLLVD YTVKVCDFGLSR K NT++SSK+AAG
Sbjct: 674 MAHDVAKGMNYLHRRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSKSAAG 733
Query: 598 TPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP 657
TPEWMAPEVLR++PSNEKSDV+SFGVILWEL TLQ+PW N P+QV++AVGFK +RLEIP
Sbjct: 734 TPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKNKRLEIP 793
Query: 658 KNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQPLSA 703
+++NP VA++IE CWA EP RPSF SIME+L+ + + QP A
Sbjct: 794 RDLNPQVASIIEACWANEPWKRPSFASIMESLKPLIKAPTPQPSHA 839
|
Source: Fragaria x ananassa Species: Fragaria x ananassa Genus: Fragaria Family: Rosaceae Order: Rosales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|114229341|gb|ABI58289.1| ethylene control element variant [Malus x domestica] | Back alignment and taxonomy information |
|---|
Score = 780 bits (2015), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 413/710 (58%), Positives = 513/710 (72%), Gaps = 33/710 (4%)
Query: 16 KSWAQQTEESYQLQLAMALRLSSQAASADDPHFL---ALSSCDRHTDSAETVSHRFWVNG 72
KSWAQQTEESYQLQLA+ALRLSS+A ADDP+FL S R + S + VSHRFWVNG
Sbjct: 139 KSWAQQTEESYQLQLALALRLSSEATCADDPNFLDPVPDESASRTSGSVDAVSHRFWVNG 198
Query: 73 CLSYFDRILDGFYLIHGMDPYTWSIGTNQRDAGLIPPYKSLKAVDPCNNLSIKVILIDKS 132
CLSYFD++ DGFYLIHG+D Y W++ T+ ++ G IP +SL++VDP SI+V+LID+
Sbjct: 199 CLSYFDKVPDGFYLIHGIDQYVWTVCTDLQENGRIPSIESLRSVDPGIGSSIEVVLIDRR 258
Query: 133 SDPNLKELHNRVLSLLCDRITAEEAVHQLANLVCNHMGGTTSTEEEEFDKQWSECAEHLK 192
SDP+LKEL NRVL++ C I +E V LA LVC+ MGG++S E+E W E ++ LK
Sbjct: 259 SDPSLKELQNRVLTISCTCINTKEIVDHLAKLVCSRMGGSSSVGEDEILSIWRESSDDLK 318
Query: 193 DCLNSVVLPIGSLSVGLCVHRALLFKVLADLINLPCRIAKGCKYCRRDDASSCLVQIGPD 252
DCL SVV+PIGSLSVGLC HRALLFKVLAD I+LPCRIAKGC+YC RDDASSCLV+ G D
Sbjct: 319 DCLGSVVVPIGSLSVGLCRHRALLFKVLADTIDLPCRIAKGCQYCTRDDASSCLVRFGLD 378
Query: 253 REYLVDLLEDPGVLSKPDSSLNRTASVFVSSPLYHPRFKAVETVENIRSLAKLYFIDNHS 312
REYLVDL+ +PG L +PDS LN +S+ +SSPL PR K VE + R LAK YF D S
Sbjct: 379 REYLVDLIANPGYLREPDSLLNGPSSISISSPLRFPRLKPVEPTIDFRLLAKQYFSDCQS 438
Query: 313 PKFDLDDDPSGTAIDQD---------YKPDPQALFQRASWNVTA----------DRDLQM 353
D+ P+G+A+D+D + + L S + +A DR+ Q+
Sbjct: 439 LNLVFDEAPAGSAVDEDNIHPKKFDRKSTEGKNLISNLSGDTSAHAKIPRTSGDDRNPQL 498
Query: 354 QNPSGPSTHVIDSSNFIKGPLLRSPVKPFRHRKSHETSAFSTLKPYVTNNHLLMEANLSV 413
NP +++ + + P+ + P HR +T++ + L V
Sbjct: 499 FNPL---QNILHTPPMVNDPIPLKCMPPVGHRDGPRVDT-------ITDSRFVEGVQL-V 547
Query: 414 MSTSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDR 473
S +REL + E L+I WSEL+IK++IG GSFGTV+ A+W SDVAVKIL+EQ+FH +R
Sbjct: 548 PSKPSRELGFDIEDLDIPWSELIIKERIGAGSFGTVHRADWHGSDVAVKILMEQDFHAER 607
Query: 474 FKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDER 533
FKEFL EV IMK LRHPNIVL MGAVT+PPNLSIVTEYLSRGSLY+LLH AR +DER
Sbjct: 608 FKEFLSEVTIMKRLRHPNIVLFMGAVTKPPNLSIVTEYLSRGSLYRLLHKAGAREALDER 667
Query: 534 LRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSK 593
RL+MAYDVAKGMNYLH+R+PPIVHRDLKSPNLLVD YTVKVCDFGLSR K NT++SSK
Sbjct: 668 RRLSMAYDVAKGMNYLHRRKPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSK 727
Query: 594 TAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR 653
+AAGTPEWMAPEVLR++PSNEKSD++SFGVILWEL T+Q+PW N P+QV++AVGFK +R
Sbjct: 728 SAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATMQQPWGNLNPAQVVAAVGFKNKR 787
Query: 654 LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQPLSA 703
LEIP+++NP VAA+IE CWA EP RPSF SIM++L + + V QP A
Sbjct: 788 LEIPRDLNPNVAAIIEACWANEPWKRPSFASIMDSLTPLIKAPVAQPSRA 837
|
Source: Malus x domestica Species: Malus x domestica Genus: Malus Family: Rosaceae Order: Rosales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|114229343|gb|ABI58290.1| ethylene control element variant [Malus x domestica] | Back alignment and taxonomy information |
|---|
Score = 780 bits (2014), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 412/710 (58%), Positives = 511/710 (71%), Gaps = 33/710 (4%)
Query: 16 KSWAQQTEESYQLQLAMALRLSSQAASADDPHFL---ALSSCDRHTDSAETVSHRFWVNG 72
KSWAQQTEESYQLQLA+ALRLSS+A ADDP+FL S R + S + VSHRFWVNG
Sbjct: 139 KSWAQQTEESYQLQLALALRLSSEATCADDPNFLDPVPDESASRTSGSVDAVSHRFWVNG 198
Query: 73 CLSYFDRILDGFYLIHGMDPYTWSIGTNQRDAGLIPPYKSLKAVDPCNNLSIKVILIDKS 132
CLSYFD++ DGFYLIHG+D Y W++ T+ ++ G IP +SL++VDP SI+V+LID+
Sbjct: 199 CLSYFDKVPDGFYLIHGIDQYVWTVCTDLQENGRIPSIESLRSVDPGIGSSIEVVLIDRR 258
Query: 133 SDPNLKELHNRVLSLLCDRITAEEAVHQLANLVCNHMGGTTSTEEEEFDKQWSECAEHLK 192
SDP+LKEL NRVL++ C I +E V LA LVC+ MGG++S E+E W E ++ LK
Sbjct: 259 SDPSLKELQNRVLTISCTCINTKEIVDHLAKLVCSRMGGSSSVGEDEILSIWRESSDDLK 318
Query: 193 DCLNSVVLPIGSLSVGLCVHRALLFKVLADLINLPCRIAKGCKYCRRDDASSCLVQIGPD 252
DCL SVV+PIGSLSVGLC HRALLFKVLAD I+LPCRIAKGC+YC RDDASSCLV+ G D
Sbjct: 319 DCLGSVVVPIGSLSVGLCRHRALLFKVLADTIDLPCRIAKGCQYCTRDDASSCLVRFGLD 378
Query: 253 REYLVDLLEDPGVLSKPDSSLNRTASVFVSSPLYHPRFKAVETVENIRSLAKLYFIDNHS 312
REYLVDL+ +PG L +PDS LN +S+ +SSPL PR K VE + R LAK YF D S
Sbjct: 379 REYLVDLIANPGYLREPDSLLNGPSSISISSPLRFPRLKPVEPTIDFRLLAKQYFSDCQS 438
Query: 313 PKFDLDDDPSGTAIDQD---------YKPDPQALFQRASWNVTA----------DRDLQM 353
D+ P+G+A+D+D + + L S + +A DR+ Q+
Sbjct: 439 LNLVFDEAPAGSAVDEDNIHPKKFDRKSTEGKNLISNLSGDTSAHAKIPRTSGDDRNPQL 498
Query: 354 QNPSGPSTHVIDSSNFIKGPLLRSPVKPFRHRKSHETSAFSTLKPYVTNNHLLMEANLSV 413
NP +++ + + P+ + P HR + + +E V
Sbjct: 499 FNPL---QNILHTPPMVNDPIPLKCMPPVGHRDGPRVDTITGSR--------FVEGVQLV 547
Query: 414 MSTSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDR 473
S +REL + E L+I WSEL+IK++IG GSFGTV+ A+W SDVAVKIL+EQ+FH +R
Sbjct: 548 PSKPSRELGFDIEDLDIPWSELIIKERIGAGSFGTVHRADWHGSDVAVKILMEQDFHAER 607
Query: 474 FKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDER 533
FKEFL EV IMK LRHPNIVL MGAVT+PPNLSIVTEYLSRGSLY+LLH AR +DER
Sbjct: 608 FKEFLSEVTIMKRLRHPNIVLFMGAVTKPPNLSIVTEYLSRGSLYRLLHKAGAREALDER 667
Query: 534 LRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSK 593
RL+MAYDVAKGMNYLH+R+PPIVHRDLKSPNLLVD YTVKVCDFGLSR K NT++SSK
Sbjct: 668 RRLSMAYDVAKGMNYLHRRKPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKANTFLSSK 727
Query: 594 TAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR 653
+AAGTPEWMAPEVLR++PSNEKSD++SFGVILWEL T+Q+PW N P+QV++AVGFK +R
Sbjct: 728 SAAGTPEWMAPEVLRDEPSNEKSDIYSFGVILWELATMQQPWGNLNPAQVVAAVGFKNKR 787
Query: 654 LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQPLSA 703
LEIP+++NP VAA+IE CWA EP RPSF SIM++L + + V QP A
Sbjct: 788 LEIPRDLNPNVAAIIEACWANEPWKRPSFASIMDSLTPLIKAPVAQPSRA 837
|
Source: Malus x domestica Species: Malus x domestica Genus: Malus Family: Rosaceae Order: Rosales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 706 | ||||||
| TAIR|locus:2144613 | 821 | CTR1 "CONSTITUTIVE TRIPLE RESP | 0.407 | 0.350 | 0.711 | 1.9e-203 | |
| TAIR|locus:2027794 | 1030 | AT1G73660 [Arabidopsis thalian | 0.369 | 0.253 | 0.596 | 8.2e-123 | |
| TAIR|locus:2143009 | 880 | AT5G11850 [Arabidopsis thalian | 0.369 | 0.296 | 0.596 | 3.5e-122 | |
| TAIR|locus:2025515 | 933 | EDR1 "ENHANCED DISEASE RESISTA | 0.430 | 0.325 | 0.538 | 1.2e-121 | |
| TAIR|locus:2194055 | 992 | AT1G18160 [Arabidopsis thalian | 0.369 | 0.263 | 0.596 | 1.5e-121 | |
| TAIR|locus:2200296 | 765 | AT1G67890 [Arabidopsis thalian | 0.368 | 0.339 | 0.558 | 2.1e-77 | |
| TAIR|locus:2084314 | 773 | AT3G06620 [Arabidopsis thalian | 0.392 | 0.358 | 0.519 | 1.1e-76 | |
| TAIR|locus:2084304 | 671 | AT3G06630 [Arabidopsis thalian | 0.342 | 0.360 | 0.577 | 2.2e-73 | |
| TAIR|locus:2127228 | 736 | AT4G23050 [Arabidopsis thalian | 0.389 | 0.373 | 0.492 | 5.9e-73 | |
| TAIR|locus:2158019 | 831 | AT5G49470 [Arabidopsis thalian | 0.247 | 0.210 | 0.557 | 6.3e-72 |
| TAIR|locus:2144613 CTR1 "CONSTITUTIVE TRIPLE RESPONSE 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1077 (384.2 bits), Expect = 1.9e-203, Sum P(2) = 1.9e-203
Identities = 205/288 (71%), Positives = 241/288 (83%)
Query: 413 VMSTSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHED 472
V + +NREL L+ + ++I W +L IK+KIG GSFGTV+ AEW SDVAVKIL+EQ+FH +
Sbjct: 529 VPNRANRELGLDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAE 588
Query: 473 RFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDE 532
R EFLREVAIMK LRHPNIVL MGAVT+PPNLSIVTEYLSRGSLY+LLH AR +DE
Sbjct: 589 RVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDE 648
Query: 533 RLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISS 592
R RL+MAYDVAKGMNYLH R PPIVHRDLKSPNLLVD YTVKVCDFGLSR K +T++SS
Sbjct: 649 RRRLSMAYDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSS 708
Query: 593 KTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR 652
K+AAGTPEWMAPEVLR++PSNEKSDV+SFGVILWEL TLQ+PW N P+QV++AVGFK +
Sbjct: 709 KSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCK 768
Query: 653 RLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQP 700
RLEIP+N+NP VAA+IE CW EP RPSF +IM+ L+ + S+V P
Sbjct: 769 RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPP 816
|
|
| TAIR|locus:2027794 AT1G73660 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 836 (299.3 bits), Expect = 8.2e-123, Sum P(2) = 8.2e-123
Identities = 157/263 (59%), Positives = 198/263 (75%)
Query: 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR 488
EI W E+ + ++IG GS+G VY +W ++VAVK ++Q+ + +EF EV IMK LR
Sbjct: 742 EILWEEITVGERIGLGSYGEVYRGDWHGTEVAVKKFLDQDLTGEALEEFRSEVRIMKKLR 801
Query: 489 HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 548
HPNIVL MGAVT PPNLSIVTE+L RGSLY+L+H P+ ++ DER RL MA D A+GMNY
Sbjct: 802 HPNIVLFMGAVTRPPNLSIVTEFLPRGSLYRLIHRPNNQL--DERRRLRMALDAARGMNY 859
Query: 549 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLR 608
LH P IVHRDLKSPNLLVD + VKVCDFGLSR K +TY+SSK+ AGT EWMAPEVLR
Sbjct: 860 LHSCNPMIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHSTYLSSKSTAGTAEWMAPEVLR 919
Query: 609 EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI 668
+P++EK DV+S+GVILWEL TLQ+PW P QV+ AVGF+ RRL+IP V+P +A LI
Sbjct: 920 NEPADEKCDVYSYGVILWELFTLQQPWGKMNPMQVVGAVGFQHRRLDIPDFVDPAIADLI 979
Query: 669 ETCWAEEPEIRPSFPSIMETLQQ 691
CW + ++RPSF IM +L++
Sbjct: 980 SKCWQTDSKLRPSFAEIMASLKR 1002
|
|
| TAIR|locus:2143009 AT5G11850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 852 (305.0 bits), Expect = 3.5e-122, Sum P(2) = 3.5e-122
Identities = 157/263 (59%), Positives = 199/263 (75%)
Query: 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR 488
EI W +L I ++IG GS+G VY AEW ++VAVK ++Q+F D +F E+ IM LR
Sbjct: 603 EIMWEDLQIGERIGIGSYGEVYRAEWNGTEVAVKKFLDQDFSGDALTQFKSEIEIMLRLR 662
Query: 489 HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 548
HPN+VL MGAVT PPN SI+TE+L RGSLY+LLH P+ ++ DE+ R+ MA DVAKGMNY
Sbjct: 663 HPNVVLFMGAVTRPPNFSILTEFLPRGSLYRLLHRPNHQL--DEKRRMRMALDVAKGMNY 720
Query: 549 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLR 608
LH P +VHRDLKSPNLLVD + VKVCDFGLSR K +TY+SSK+ AGTPEWMAPEVLR
Sbjct: 721 LHTSHPTVVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHHTYLSSKSTAGTPEWMAPEVLR 780
Query: 609 EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI 668
+P+NEK DV+SFGVILWEL T + PW+ P QV+ AVGF+ RRLEIP +++ VA +I
Sbjct: 781 NEPANEKCDVYSFGVILWELATSRVPWKGLNPMQVVGAVGFQNRRLEIPDDIDLTVAQII 840
Query: 669 ETCWAEEPEIRPSFPSIMETLQQ 691
CW EP +RPSF +M++L++
Sbjct: 841 RECWQTEPHLRPSFTQLMQSLKR 863
|
|
| TAIR|locus:2025515 EDR1 "ENHANCED DISEASE RESISTANCE 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 853 (305.3 bits), Expect = 1.2e-121, Sum P(2) = 1.2e-121
Identities = 167/310 (53%), Positives = 215/310 (69%)
Query: 384 HRKSHETSAFSTLKPYVTNNHLLMEANLSVMSTSNRELYLEEEGL---EIRWSELLIKKK 440
HRK + P + +H ++L S N L++ + EI W++L+I ++
Sbjct: 616 HRKYTSDDISTGCDPRL-KDHESTSSSLDSTSYRNDPQVLDDADVGECEIPWNDLVIAER 674
Query: 441 IGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 500
IG GS+G VYHA+W ++VAVK ++Q+F EF EV IM+ LRHPN+V +GAVT
Sbjct: 675 IGLGSYGEVYHADWHGTEVAVKKFLDQDFSGAALAEFRSEVRIMRRLRHPNVVFFLGAVT 734
Query: 501 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRD 560
PPNLSIVTE+L RGSLY++LH P + + DER R+ MA DVA GMN LH P IVHRD
Sbjct: 735 RPPNLSIVTEFLPRGSLYRILHRPKSHI--DERRRIKMALDVAMGMNCLHTSTPTIVHRD 792
Query: 561 LKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFS 620
LK+PNLLVD+ + VKV DFGLSR K NT++SSK+ AGTPEWMAPEVLR +PSNEK DV+S
Sbjct: 793 LKTPNLLVDNNWNVKVGDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYS 852
Query: 621 FGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRP 680
FGVILWEL TL+ PWR P QV+ AVGF+ RRLEIPK ++P+V +I CW +P +RP
Sbjct: 853 FGVILWELATLRLPWRGMNPMQVVGAVGFQNRRLEIPKELDPVVGRIILECWQTDPNLRP 912
Query: 681 SFPSIMETLQ 690
SF + E L+
Sbjct: 913 SFAQLTEVLK 922
|
|
| TAIR|locus:2194055 AT1G18160 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 840 (300.8 bits), Expect = 1.5e-121, Sum P(2) = 1.5e-121
Identities = 157/263 (59%), Positives = 199/263 (75%)
Query: 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR 488
EI W E+ + ++IG GS+G VY +W + VAVK I+Q+ + +EF EV +M+ LR
Sbjct: 709 EILWEEITVAERIGLGSYGEVYRGDWHGTAVAVKKFIDQDITGEALEEFRSEVRMMRRLR 768
Query: 489 HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 548
HPNIVL MGAVT PPNLSIVTE+L RGSLY+L+H P+ ++ DER RL MA D A+GMNY
Sbjct: 769 HPNIVLFMGAVTRPPNLSIVTEFLPRGSLYRLIHRPNNQL--DERKRLRMALDAARGMNY 826
Query: 549 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLR 608
LH P IVHRDLKSPNLLVD + VKVCDFGLSR K +TY+SSK+ AGT EWMAPEVLR
Sbjct: 827 LHSCNPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKVSTYLSSKSTAGTAEWMAPEVLR 886
Query: 609 EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI 668
+P++EK DV+S+GVILWEL TLQ+PW P QV+ AVGF+ RRL+IP+ V+P +A +I
Sbjct: 887 NEPADEKCDVYSYGVILWELFTLQQPWGKMNPMQVVGAVGFQHRRLDIPEFVDPGIADII 946
Query: 669 ETCWAEEPEIRPSFPSIMETLQQ 691
CW +P +RPSF IM++L+Q
Sbjct: 947 RKCWQTDPRLRPSFGEIMDSLKQ 969
|
|
| TAIR|locus:2200296 AT1G67890 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 779 (279.3 bits), Expect = 2.1e-77, P = 2.1e-77
Identities = 147/263 (55%), Positives = 194/263 (73%)
Query: 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR 488
EI W +L I ++IG+GS GTVYH W SDVAVK+ +QE+ E+ F +EV++MK LR
Sbjct: 481 EILWEDLTIGEQIGQGSCGTVYHGLWFGSDVAVKVFSKQEYSEEIITSFKQEVSLMKRLR 540
Query: 489 HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 548
HPN++L MGAV P L IVTE+L RGSL++LL +++ D R R++MA D+A+GMNY
Sbjct: 541 HPNVLLFMGAVASPQRLCIVTEFLPRGSLFRLLQRNKSKL--DLRRRIHMASDIARGMNY 598
Query: 549 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLR 608
LH PPI+HRDLKS NLLVD +TVKV DFGLSR K TY+++ GTP+WMAPEVLR
Sbjct: 599 LHHCSPPIIHRDLKSSNLLVDRNWTVKVADFGLSRIKHETYLTTN-GRGTPQWMAPEVLR 657
Query: 609 EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI 668
+ ++EKSDV+SFGV+LWEL+T + PW N QVI AVGF +RLE+PK+V+P AL+
Sbjct: 658 NEAADEKSDVYSFGVVLWELVTEKIPWENLNAMQVIGAVGFMNQRLEVPKDVDPQWIALM 717
Query: 669 ETCWAEEPEIRPSFPSIMETLQQ 691
E+CW EP+ RPSF +M+ L++
Sbjct: 718 ESCWHSEPQCRPSFQELMDKLRE 740
|
|
| TAIR|locus:2084314 AT3G06620 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 772 (276.8 bits), Expect = 1.1e-76, P = 1.1e-76
Identities = 146/281 (51%), Positives = 202/281 (71%)
Query: 412 SVMSTSNRELYLEEEGLE--IRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEF 469
S S+ ++ + EGLE I W +L I +++G+GS GTVYH W SDVAVK+ +QE+
Sbjct: 469 STSSSVMNKVDTDSEGLEYEILWDDLTIGEQVGQGSCGTVYHGLWFGSDVAVKVFSKQEY 528
Query: 470 HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVV 529
+ + F +EV +MK LRHPN++L MGAVT P L IV+E+L RGSL++LL +++
Sbjct: 529 SAEVIESFKQEVLLMKRLRHPNVLLFMGAVTSPQRLCIVSEFLPRGSLFRLLQKSTSKL- 587
Query: 530 VDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 589
D R R++MA D+A+GMNYLH PPI+HRDLKS NLLVD +TVKV DFGLSR K TY
Sbjct: 588 -DWRRRIHMALDIARGMNYLHHCSPPIIHRDLKSSNLLVDKNWTVKVADFGLSRIKHETY 646
Query: 590 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGF 649
++SK+ GTP+WMAPEVLR + ++EKSD++SFGV+LWEL T + PW QVI AVGF
Sbjct: 647 LTSKSGKGTPQWMAPEVLRNESADEKSDIYSFGVVLWELATEKIPWETLNSMQVIGAVGF 706
Query: 650 KGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQ 690
+RLEIPK+++P +L+E+CW + ++RP+F +M+ L+
Sbjct: 707 MDQRLEIPKDIDPRWISLMESCWHSDTKLRPTFQELMDKLR 747
|
|
| TAIR|locus:2084304 AT3G06630 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 741 (265.9 bits), Expect = 2.2e-73, P = 2.2e-73
Identities = 141/244 (57%), Positives = 181/244 (74%)
Query: 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR 488
EI W +L I ++IG GS GTVYH W SDVAVK+ +QE+ E K F +EV++MK LR
Sbjct: 428 EILWDDLTIGEQIGRGSCGTVYHGIWFGSDVAVKVFSKQEYSESVIKSFEKEVSLMKRLR 487
Query: 489 HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 548
HPN++L MGAVT P L IV+E++ RGSL++LL +++ D R R+NMA D+A+GMNY
Sbjct: 488 HPNVLLFMGAVTSPQRLCIVSEFVPRGSLFRLLQRSMSKL--DWRRRINMALDIARGMNY 545
Query: 549 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLR 608
LH PPI+HRDLKS NLLVD +TVKV DFGLSR K TY++SK+ GTP+WMAPEVLR
Sbjct: 546 LHCCSPPIIHRDLKSSNLLVDRNWTVKVADFGLSRIKHQTYLTSKSGKGTPQWMAPEVLR 605
Query: 609 EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI 668
+ ++EKSD++SFGV+LWEL T + PW N QVI AVGF +RLEIPK+ +P +LI
Sbjct: 606 NESADEKSDIYSFGVVLWELATEKIPWENLNSMQVIGAVGFMNQRLEIPKDTDPDWISLI 665
Query: 669 ETCW 672
E+CW
Sbjct: 666 ESCW 669
|
|
| TAIR|locus:2127228 AT4G23050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 737 (264.5 bits), Expect = 5.9e-73, P = 5.9e-73
Identities = 137/278 (49%), Positives = 190/278 (68%)
Query: 412 SVMSTSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHE 471
S ++ N L + + EIRW +L + +++G GSF V+ W SDVA+K+ + +++
Sbjct: 446 SPVNQRNNRL-VTDSSCEIRWEDLQLGEEVGRGSFAAVHRGVWNGSDVAIKVYFDGDYNA 504
Query: 472 DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVD 531
E +E+ IMK LRHPN++L MGAV +I+ EY+ RGSL+K+LH + +D
Sbjct: 505 MTLTECKKEINIMKKLRHPNVLLFMGAVCTEEKSAIIMEYMPRGSLFKILH--NTNQPLD 562
Query: 532 ERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS 591
++ RL MA DVA+GMNYLH+R PPIVHRDLKS NLLVD + VKV DFGLS+ K T++S
Sbjct: 563 KKRRLRMALDVARGMNYLHRRNPPIVHRDLKSSNLLVDKNWNVKVGDFGLSKWKNATFLS 622
Query: 592 SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG 651
+K+ GTP+WMAPEVLR +PSNEK DVFSFGVILWEL+T PW QV+ VGF
Sbjct: 623 TKSGKGTPQWMAPEVLRSEPSNEKCDVFSFGVILWELMTTLVPWDRLNSIQVVGVVGFMD 682
Query: 652 RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETL 689
RRL++P+ +NP +A++I+ CW +P RPSF ++ +
Sbjct: 683 RRLDLPEGLNPRIASIIQDCWQTDPAKRPSFEELISQM 720
|
|
| TAIR|locus:2158019 AT5G49470 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 515 (186.3 bits), Expect = 6.3e-72, Sum P(2) = 6.3e-72
Identities = 102/183 (55%), Positives = 130/183 (71%)
Query: 511 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVA--KGMNYLHQRRPPIVHRDLKSPNLLV 568
Y S SL +LL++ V L + + Y A +GMNYLH PPI+HRDLKS NLLV
Sbjct: 630 YYSLDSLIQLLYL------VYNMLHIFLTYFFAQARGMNYLHHCTPPIIHRDLKSSNLLV 683
Query: 569 DSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWEL 628
D +TVKV DFGLSR K TY+++KT GTP+WMAPEVLR + ++EKSDV+SFGVILWEL
Sbjct: 684 DKNWTVKVADFGLSRIKHETYLTTKTGRGTPQWMAPEVLRNEAADEKSDVYSFGVILWEL 743
Query: 629 ITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMET 688
+T + PW + QVI AVGF +RLE+PKNV+P +L+E+CW EP+ RPSF IME
Sbjct: 744 VTEKIPWESLNAMQVIGAVGFMNQRLEVPKNVDPQWISLMESCWHSEPQDRPSFQEIMEK 803
Query: 689 LQQ 691
L++
Sbjct: 804 LRE 806
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
ID ![]() | Name ![]() | Annotated EC number ![]() | Identity ![]() | Query coverage ![]() | Hit coverage ![]() | RBH(Q2H) ![]() | RBH(H2Q) ![]() |
| Q05609 | CTR1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.5761 | 0.9206 | 0.7917 | yes | no |
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 706 | |||
| pfam14381 | 203 | pfam14381, EDR1, Ethylene-responsive protein kinas | 2e-89 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-84 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 9e-83 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-82 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-78 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 7e-68 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 9e-68 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 6e-63 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-56 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-55 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 7e-54 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-53 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-52 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-51 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-50 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-50 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-49 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-48 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-48 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-48 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-48 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-48 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-47 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 8e-47 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-46 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 8e-45 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-44 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-44 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-44 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-44 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 5e-44 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-43 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-42 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-42 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 7e-42 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-41 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-41 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 6e-41 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-40 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-40 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-40 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-39 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 7e-39 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 8e-39 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-38 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-38 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-38 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-38 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 8e-38 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-37 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-37 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-37 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-37 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-37 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 5e-37 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-37 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 6e-37 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 6e-37 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 7e-37 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 8e-37 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 9e-37 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-36 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-36 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-36 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-36 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-36 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-36 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-36 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-36 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-35 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-35 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-35 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-35 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-35 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 5e-35 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 6e-35 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-34 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-34 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-34 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-34 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 7e-34 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-33 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-33 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-33 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-33 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-33 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 9e-33 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 9e-33 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-32 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-32 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-32 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-32 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-32 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-32 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-32 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 9e-32 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-31 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-31 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-31 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-31 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-31 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-31 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-31 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 6e-31 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 8e-31 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 9e-31 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-30 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-30 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-30 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-30 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-29 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-29 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-29 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-29 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-29 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 6e-29 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-28 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-28 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-27 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-27 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-27 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-27 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 5e-27 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 5e-27 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-27 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-26 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-26 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-26 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 5e-26 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-25 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-25 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-25 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-25 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-25 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-25 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-25 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 6e-25 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 6e-25 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 8e-25 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 9e-25 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 9e-25 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-24 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-24 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-24 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-24 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-24 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-24 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-24 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-24 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 7e-24 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 7e-24 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 8e-24 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 9e-24 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 9e-24 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-23 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-23 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-23 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-23 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-23 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-23 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 5e-23 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 6e-23 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 9e-23 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-22 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-22 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-22 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-22 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 6e-22 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 6e-22 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 9e-22 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-21 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-21 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-21 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-21 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-21 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-21 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-21 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-21 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-21 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 7e-21 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 7e-21 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 9e-21 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-20 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-20 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-20 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 4e-20 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 6e-20 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-19 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-19 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-19 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-19 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-19 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-19 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-19 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-19 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 7e-19 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 7e-19 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 9e-19 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-18 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-18 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-18 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-18 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-18 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-18 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-18 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-18 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-18 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-18 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 6e-18 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 6e-18 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 8e-18 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-17 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-17 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-17 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-17 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-17 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-17 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-17 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-17 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 5e-17 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 7e-17 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 8e-17 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 9e-17 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-16 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-16 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-16 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-16 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-16 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-16 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-16 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-16 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-16 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 6e-16 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 6e-16 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 8e-16 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-15 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-15 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-15 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-15 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-15 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-15 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-15 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-15 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 7e-15 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 7e-15 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-14 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-14 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-14 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-14 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-14 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-14 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-14 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-14 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-14 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 7e-14 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 7e-14 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 7e-14 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 9e-14 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 9e-14 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-13 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-13 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-13 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-13 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-13 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-13 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-13 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 5e-13 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 6e-13 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-13 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 7e-13 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-12 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-12 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-12 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-12 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-12 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-12 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 4e-12 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 5e-12 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 7e-12 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 7e-12 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 8e-12 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-11 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-11 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-10 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-10 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-10 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-10 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 5e-10 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 5e-10 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 6e-10 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-09 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-09 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-09 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-09 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 3e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 7e-08 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 4e-07 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-06 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 3e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 4e-06 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 5e-06 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 7e-05 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 6e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 8e-04 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 0.001 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.003 |
| >gnl|CDD|222722 pfam14381, EDR1, Ethylene-responsive protein kinase Le-CTR1 | Back alignment and domain information |
|---|
Score = 277 bits (712), Expect = 2e-89
Identities = 105/210 (50%), Positives = 133/210 (63%), Gaps = 10/210 (4%)
Query: 59 DSAETVSHRFWVNGCLSYFDRILDGFYLIHGMDPYTWSIGTNQRDAGLIPPYKSLKAVDP 118
SAE +SHR+WV GCLSY D+I DGFY I+GMDP + ++ G IP + L+AV P
Sbjct: 2 SSAEALSHRYWVYGCLSYDDKIPDGFYDIYGMDPCSDL-----KEFGRIPSLEDLQAVPP 56
Query: 119 CNNLSIKVILIDKSSDPNLKELHNRVLSLLCDRITA-EEAVHQLANLVCNHMGGTTSTEE 177
+ S +V+L+D+ +DP LKEL L+ T V +LA LV +HMGG E
Sbjct: 57 -GDSSFEVVLVDRRTDPKLKELEQLARCLVSGCGTNTAALVQKLAGLVSDHMGGPVKDAE 115
Query: 178 EEFDKQWSECAEHLKDCLNSVVLPIGSLSVGLCVHRALLFKVLADLINLPCRIAKGCKYC 237
+ W EC+ LK+ NS V+P+GSL +GLC HRALLFKVLAD I LPCR+ KGCKYC
Sbjct: 116 SMLAR-WKECSNELKE--NSGVVPLGSLKIGLCRHRALLFKVLADSIGLPCRLVKGCKYC 172
Query: 238 RRDDASSCLVQIGPDREYLVDLLEDPGVLS 267
DD +S LV+ REYLVDL+ PG L
Sbjct: 173 GSDDDASNLVKFDDGREYLVDLMGAPGTLI 202
|
EDR1 regulates disease resistance and ethylene-induced senescence, and is also involved in stress response signalling and cell death regulation. Length = 203 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 266 bits (682), Expect = 3e-84
Identities = 107/264 (40%), Positives = 146/264 (55%), Gaps = 15/264 (5%)
Query: 435 LLIKKKIGEGSFGTVYHAEWRNS------DVAVKILIEQEFHEDRFKEFLREVAIMKGLR 488
L + KK+GEG+FG VY + VAVK L E E+R +EFL E +IMK L
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEER-EEFLEEASIMKKLS 59
Query: 489 HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 548
HPNIV L+G T+ L IVTEY+ G L L ++ + + L MA +AKGM Y
Sbjct: 60 HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKD--LLQMALQIAKGMEY 117
Query: 549 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT-YISSKTAAGTP-EWMAPEV 606
L + VHRDL + N LV VK+ DFGLSR Y + P +WMAPE
Sbjct: 118 LESKN--FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPES 175
Query: 607 LREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 665
L++ KSDV+SFGV+LWE+ TL ++P+ + +V+ + G RL P+N +
Sbjct: 176 LKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELL-EDGYRLPRPENCPDELY 234
Query: 666 ALIETCWAEEPEIRPSFPSIMETL 689
L+ CWA +PE RP+F ++E L
Sbjct: 235 ELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 262 bits (672), Expect = 9e-83
Identities = 104/263 (39%), Positives = 143/263 (54%), Gaps = 14/263 (5%)
Query: 435 LLIKKKIGEGSFGTVYHAEWRNS------DVAVKILIEQEFHEDRFKEFLREVAIMKGLR 488
L + KK+GEG+FG VY + + +VAVK L E + +EFLRE IM+ L
Sbjct: 1 LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQI-EEFLREARIMRKLD 59
Query: 489 HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 548
HPN+V L+G TE L IV EY+ G L L R + L+ A +A+GM Y
Sbjct: 60 HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLR--KNRPKLSLSDLLSFALQIARGMEY 117
Query: 549 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT-YISSKTAAGTPEWMAPEVL 607
L + +HRDL + N LV VK+ DFGLSR + Y + WMAPE L
Sbjct: 118 LESKN--FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESL 175
Query: 608 REDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA 666
+E KSDV+SFGV+LWE+ TL ++P+ + +V+ + G RL P N P +
Sbjct: 176 KEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLK-NGYRLPQPPNCPPELYD 234
Query: 667 LIETCWAEEPEIRPSFPSIMETL 689
L+ CWAE+PE RP+F ++E L
Sbjct: 235 LMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 261 bits (669), Expect = 3e-82
Identities = 106/263 (40%), Positives = 143/263 (54%), Gaps = 13/263 (4%)
Query: 435 LLIKKKIGEGSFGTVYHAEWRNS------DVAVKILIEQEFHEDRFKEFLREVAIMKGLR 488
L + KK+GEG+FG VY + +VAVK L E + +EFLRE IM+ L
Sbjct: 1 LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQI-EEFLREARIMRKLD 59
Query: 489 HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 548
HPNIV L+G TE L IV EY+ G L L + L+ A +A+GM Y
Sbjct: 60 HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNR-PKELSLSDLLSFALQIARGMEY 118
Query: 549 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT-YISSKTAAGTPEWMAPEVL 607
L + +HRDL + N LV VK+ DFGLSR + Y K WMAPE L
Sbjct: 119 LESKN--FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESL 176
Query: 608 REDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA 666
+E KSDV+SFGV+LWE+ TL ++P+ + ++V+ + KG RL P N P +
Sbjct: 177 KEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLK-KGYRLPKPPNCPPELYK 235
Query: 667 LIETCWAEEPEIRPSFPSIMETL 689
L+ CWAE+PE RP+F ++E L
Sbjct: 236 LMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 250 bits (641), Expect = 4e-78
Identities = 103/266 (38%), Positives = 145/266 (54%), Gaps = 18/266 (6%)
Query: 439 KKIGEGSFGTVYHAEWRNS-----DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIV 493
KK+GEG+FG VY + + +VAVK L E E+R K+FL+E +MK L HPN+V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEER-KDFLKEARVMKKLGHPNVV 59
Query: 494 LLMGAVTEPPNLSIVTEYLSRGSLYKLL------HIPDARVVVDERLRLNMAYDVAKGMN 547
L+G TE L +V EY+ G L L + + + L+ A +AKGM
Sbjct: 60 RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119
Query: 548 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT-YISSKTAAGTP-EWMAPE 605
YL ++ VHRDL + N LV VK+ DFGLSR + Y KT P WMAPE
Sbjct: 120 YLASKK--FVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177
Query: 606 VLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV 664
L++ KSDV+SFGV+LWE+ TL P+ + +V+ + KG RL P+ +
Sbjct: 178 SLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLR-KGYRLPKPEYCPDEL 236
Query: 665 AALIETCWAEEPEIRPSFPSIMETLQ 690
L+ +CW +PE RP+F ++E L+
Sbjct: 237 YELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 223 bits (570), Expect = 7e-68
Identities = 87/255 (34%), Positives = 131/255 (51%), Gaps = 11/255 (4%)
Query: 437 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 494
I +K+GEGSFG VY A + + VA+K++ +++ +DR + LRE+ I+K L+HPNIV
Sbjct: 3 ILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDR-ERILREIKILKKLKHPNIVR 61
Query: 495 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 554
L + L +V EY G L+ LL R + E + + YLH +
Sbjct: 62 LYDVFEDEDKLYLVMEYCEGGDLFDLLK---KRGRLSEDEARFYLRQILSALEYLHSKG- 117
Query: 555 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNE 614
IVHRDLK N+L+D VK+ DFGL+R T GTPE+MAPEVL +
Sbjct: 118 -IVHRDLKPENILLDEDGHVKLADFGLARQLDPGE-KLTTFVGTPEYMAPEVLLGKGYGK 175
Query: 615 KSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPK--NVNPMVAALIETCW 672
D++S GVIL+EL+T + P+ + K + P +++P LI
Sbjct: 176 AVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLL 235
Query: 673 AEEPEIRPSFPSIME 687
++PE R + ++
Sbjct: 236 VKDPEKRLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 222 bits (569), Expect = 9e-68
Identities = 90/261 (34%), Positives = 138/261 (52%), Gaps = 17/261 (6%)
Query: 437 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 494
+ +K+G GSFGTVY A+ + + VAVKIL ++ + + RE+ I++ L HPNIV
Sbjct: 3 LLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVR 62
Query: 495 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 554
L+ A + +L +V EY G L+ L + E +A + +G+ YLH
Sbjct: 63 LIDAFEDKDHLYLVMEYCEGGDLFDYLS---RGGPLSEDEAKKIALQILRGLEYLHSNG- 118
Query: 555 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRE-DPSN 613
I+HRDLK N+L+D VK+ DFGL++ + S T GTP +MAPEVL +
Sbjct: 119 -IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYG 177
Query: 614 EKSDVFSFGVILWELITLQKPWRNS---TPSQVISAVGFKGRRLEIPK----NVNPMVAA 666
K DV+S GVIL+EL+T + P+ Q+I + G LE + + +
Sbjct: 178 PKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRI--LGPPLEFDEPKWSSGSEEAKD 235
Query: 667 LIETCWAEEPEIRPSFPSIME 687
LI+ C ++P RP+ I++
Sbjct: 236 LIKKCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 208 bits (532), Expect = 6e-63
Identities = 94/253 (37%), Positives = 127/253 (50%), Gaps = 42/253 (16%)
Query: 441 IGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA 498
+GEG FGTVY A + + VA+KI I++E +E LRE+ I+K L HPNIV L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKI-IKKEDSSSLLEELLREIEILKKLNHPNIVKLYGV 59
Query: 499 VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVH 558
+ +L +V EY GSL LL + + E L + + +G+ YLH I+H
Sbjct: 60 FEDENHLYLVMEYCEGGSLKDLLK--ENEGKLSEDEILRILLQILEGLEYLHSN--GIIH 115
Query: 559 RDLKSPNLLVDS-TYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPS-NEKS 616
RDLK N+L+DS VK+ DFGLS+ + KT GTP +MAPEVL +EKS
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKS 175
Query: 617 DVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEP 676
D++S GVIL+EL L+ LI ++P
Sbjct: 176 DIWSLGVILYELPELKD---------------------------------LIRKMLQKDP 202
Query: 677 EIRPSFPSIMETL 689
E RPS I+E L
Sbjct: 203 EKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 192 bits (489), Expect = 3e-56
Identities = 96/268 (35%), Positives = 143/268 (53%), Gaps = 14/268 (5%)
Query: 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGL 487
EI L +++K+G G FG V+ W + VAVK L + FL+E IMK L
Sbjct: 2 EIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPE---AFLQEAQIMKKL 58
Query: 488 RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 547
RH +V L +E + IVTEY+S+GSL L + + + +L ++MA +A+GM
Sbjct: 59 RHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQL-VDMAAQIAEGMA 117
Query: 548 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEV 606
YL R +HRDL + N+LV K+ DFGL+R + + Y + + A +W APE
Sbjct: 118 YLESRN--YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEA 175
Query: 607 LREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 665
KSDV+SFG++L E++T + P+ T +V+ V +G R+ P N +
Sbjct: 176 ANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVE-RGYRMPRPPNCPEELY 234
Query: 666 ALIETCWAEEPEIRPSFPSIMETLQQFL 693
L+ CW ++PE RP+F E LQ FL
Sbjct: 235 DLMLQCWDKDPEERPTF----EYLQSFL 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 189 bits (483), Expect = 2e-55
Identities = 96/260 (36%), Positives = 134/260 (51%), Gaps = 14/260 (5%)
Query: 439 KKIGEGSFGTVYHAEWRNS-----DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIV 493
KK+G+GSFG V EW S VAVK L + + D +FL+E AIM L H N++
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCL-KSDKLSDIMDDFLKEAAIMHSLDHENLI 59
Query: 494 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 553
L G V P L +VTE GSL L + L + A +A GM YL +R
Sbjct: 60 RLYGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTL-CDYAVQIANGMRYLESKR 117
Query: 554 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT---YISSKTAAGTPEWMAPEVLRED 610
+HRDL + N+L+ S VK+ DFGL R+ P Y+ + W APE LR
Sbjct: 118 --FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTR 175
Query: 611 PSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE 669
+ SDV+ FGV LWE+ T ++PW + SQ++ + +G RLE P+ + ++
Sbjct: 176 TFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVML 235
Query: 670 TCWAEEPEIRPSFPSIMETL 689
CWA P RP+F ++ E L
Sbjct: 236 QCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 185 bits (472), Expect = 7e-54
Identities = 99/266 (37%), Positives = 140/266 (52%), Gaps = 11/266 (4%)
Query: 428 LEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGL 487
I EL + IG+G FG V ++R VAVK L + + FL E ++M L
Sbjct: 1 WAINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKD---DSTAAQAFLAEASVMTTL 57
Query: 488 RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 547
RHPN+V L+G V + L IVTEY+++GSL L R V+ +L A DV +GM
Sbjct: 58 RHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLR-SRGRAVITLAQQLGFALDVCEGME 116
Query: 548 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVL 607
YL ++ VHRDL + N+LV KV DFGL++ S K +W APE L
Sbjct: 117 YLEEKN--FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPV---KWTAPEAL 171
Query: 608 REDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA 666
RE + KSDV+SFG++LWE+ + + P+ V+ V KG R+E P+ P V
Sbjct: 172 REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVE-KGYRMEAPEGCPPEVYK 230
Query: 667 LIETCWAEEPEIRPSFPSIMETLQQF 692
+++ CW +P RP+F + E L
Sbjct: 231 VMKDCWELDPAKRPTFKQLREQLALI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 183 bits (468), Expect = 3e-53
Identities = 82/256 (32%), Positives = 128/256 (50%), Gaps = 24/256 (9%)
Query: 439 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 496
+ +G GSFG+VY A +++ +AVK + E+ + RE+ I+ L+HPNIV
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 497 GA-VTEPPN-LSIVTEYLSRGSL------YKLLHIPDARVVVDERLRLNMAYDVAKGMNY 548
G+ E N L+I EY+S GSL + L P R + +G+ Y
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKY---------TRQILEGLAY 116
Query: 549 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS--SKTAAGTPEWMAPEV 606
LH IVHRD+K N+LVDS VK+ DFG ++ + + + GTP WMAPEV
Sbjct: 117 LHSNG--IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEV 174
Query: 607 LREDPSNEKSDVFSFGVILWELITLQKPWRNST-PSQVISAVGFKGRRLEIPKNVNPMVA 665
+R + +D++S G + E+ T + PW P + +G G EIP++++
Sbjct: 175 IRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAK 234
Query: 666 ALIETCWAEEPEIRPS 681
+ C +P+ RP+
Sbjct: 235 DFLRKCLRRDPKKRPT 250
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 181 bits (462), Expect = 1e-52
Identities = 96/260 (36%), Positives = 140/260 (53%), Gaps = 11/260 (4%)
Query: 433 SELLIKKKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN 491
SEL K++G G FG V+ +WR DVA+K++ E ED +F+ E +M L HPN
Sbjct: 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSED---DFIEEAKVMMKLSHPN 60
Query: 492 IVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 551
+V L G T+ + IVTEY++ G L L + + + L+M DV + M YL
Sbjct: 61 LVQLYGVCTKQRPIFIVTEYMANGCLLNYLR--ERKGKLGTEWLLDMCSDVCEAMEYL-- 116
Query: 552 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPNTYISSKTAAGTPEWMAPEVLRED 610
+HRDL + N LV VKV DFGL+R + Y SS+ +W PEV
Sbjct: 117 ESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYS 176
Query: 611 PSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE 669
+ KSDV+SFGV++WE+ + K P+ + S+V+ +V G RL PK V ++
Sbjct: 177 RFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVS-AGYRLYRPKLAPTEVYTIMY 235
Query: 670 TCWAEEPEIRPSFPSIMETL 689
+CW E+PE RP+F ++ L
Sbjct: 236 SCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 179 bits (455), Expect = 2e-51
Identities = 99/266 (37%), Positives = 146/266 (54%), Gaps = 11/266 (4%)
Query: 429 EIRWSELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKG 486
E+ +++ +K K+G G +G VY W+ + VAVK L E +EFL+E A+MK
Sbjct: 2 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKE 58
Query: 487 LRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM 546
++HPN+V L+G T P I+TE+++ G+L L + R V+ + L MA ++ M
Sbjct: 59 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-RQEVNAVVLLYMATQISSAM 117
Query: 547 NYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPNTYISSKTAAGTPEWMAPE 605
YL ++ +HRDL + N LV + VKV DFGLSR +TY + A +W APE
Sbjct: 118 EYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 175
Query: 606 VLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV 664
L + + KSDV++FGV+LWE+ T P+ SQV + KG R+E P+ P V
Sbjct: 176 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KGYRMERPEGCPPKV 234
Query: 665 AALIETCWAEEPEIRPSFPSIMETLQ 690
L+ CW P RPSF I + +
Sbjct: 235 YELMRACWQWNPSDRPSFAEIHQAFE 260
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 175 bits (447), Expect = 4e-50
Identities = 93/280 (33%), Positives = 150/280 (53%), Gaps = 23/280 (8%)
Query: 429 EIRWSELLIKKKIGEGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREV 481
E+ ++ + +++G+GSFG VY + + VA+K + E +R EFL E
Sbjct: 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRER-IEFLNEA 60
Query: 482 AIMKGLRHPNIVLLMGAV-TEPPNLSIVTEYLSRGSLYKLL--HIPDARV-----VVDER 533
++MK ++V L+G V T P L +V E +++G L L P+A +
Sbjct: 61 SVMKEFNCHHVVRLLGVVSTGQPTL-VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQ 119
Query: 534 LRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSK 593
+ MA ++A GM YL ++ VHRDL + N +V TVK+ DFG++R T K
Sbjct: 120 KFIQMAAEIADGMAYLAAKK--FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRK 177
Query: 594 TAAGT-P-EWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFK 650
G P WMAPE L++ KSDV+SFGV+LWE+ TL ++P++ + +V+ V
Sbjct: 178 GGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI-D 236
Query: 651 GRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQ 690
G L++P+N + L+ CW P++RP+F I+ +L+
Sbjct: 237 GGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 175 bits (445), Expect = 5e-50
Identities = 91/265 (34%), Positives = 141/265 (53%), Gaps = 14/265 (5%)
Query: 433 SELLIKKKIGEGSFGTVYHAEWRNS-DVAVKIL-IEQEFHEDRFKEFLREVAIMKGLRHP 490
E +++K+G G FG V+ W+N VA+KIL + + +F +EV +K LRH
Sbjct: 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQ---DFQKEVQALKRLRHK 62
Query: 491 NIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLH 550
+++ L + + I+TE + +GSL L P+ +V+ L ++MA VA+GM YL
Sbjct: 63 HLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASL-IDMACQVAEGMAYLE 121
Query: 551 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTP-EWMAPEVLR 608
++ +HRDL + N+LV KV DFGL+R K + Y+SS P +W APE
Sbjct: 122 EQN--SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKK--IPYKWTAPEAAS 177
Query: 609 EDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAAL 667
+ KSDV+SFG++L+E+ T Q P+ +V + G R+ P + +
Sbjct: 178 HGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT-AGYRMPCPAKCPQEIYKI 236
Query: 668 IETCWAEEPEIRPSFPSIMETLQQF 692
+ CWA EPE RPSF ++ E L
Sbjct: 237 MLECWAAEPEDRPSFKALREELDNI 261
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 174 bits (443), Expect = 1e-49
Identities = 95/265 (35%), Positives = 139/265 (52%), Gaps = 14/265 (5%)
Query: 437 IKKKIGEGSFGTVYHAEWRNS-----DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN 491
I+K IG G FG V + DVA+K L + R +FL E +IM HPN
Sbjct: 8 IEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRL-DFLTEASIMGQFDHPN 66
Query: 492 IVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 551
I+ L G VT+ + I+TEY+ GSL K L D + V +L + M +A GM YL +
Sbjct: 67 IIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTV-GQL-VGMLRGIASGMKYLSE 124
Query: 552 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAG-TP-EWMAPEVLRE 609
VHRDL + N+LV+S KV DFGLSR ++ + T G P W APE +
Sbjct: 125 MN--YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAY 182
Query: 610 DPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI 668
SDV+SFG+++WE+++ ++P+ + + VI AV G RL P + + L+
Sbjct: 183 RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVE-DGYRLPPPMDCPSALYQLM 241
Query: 669 ETCWAEEPEIRPSFPSIMETLQQFL 693
CW ++ RP+F I+ TL + +
Sbjct: 242 LDCWQKDRNERPTFSQIVSTLDKMI 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 171 bits (434), Expect = 1e-48
Identities = 95/260 (36%), Positives = 141/260 (54%), Gaps = 11/260 (4%)
Query: 433 SELLIKKKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN 491
SEL K++G G FG V+ +WR VA+K + E E+ +F+ E +M L HP
Sbjct: 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEE---DFIEEAKVMMKLSHPK 60
Query: 492 IVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 551
+V L G T+ L IVTE++ G L L + + + + L+M DV +GM YL
Sbjct: 61 LVQLYGVCTQQKPLYIVTEFMENGCLLNYLR--QRQGKLSKDMLLSMCQDVCEGMEYL-- 116
Query: 552 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK-PNTYISSKTAAGTPEWMAPEVLRED 610
R +HRDL + N LV ST VKV DFG++R + Y SS A +W PEV
Sbjct: 117 ERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFS 176
Query: 611 PSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE 669
+ KSDV+SFGV++WE+ T K P+ + +V+ + +G RL PK + V ++
Sbjct: 177 KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMIS-RGFRLYRPKLASMTVYEVMY 235
Query: 670 TCWAEEPEIRPSFPSIMETL 689
+CW E+PE RP+F ++ +
Sbjct: 236 SCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 170 bits (434), Expect = 2e-48
Identities = 84/257 (32%), Positives = 133/257 (51%), Gaps = 24/257 (9%)
Query: 437 IKKKIGEGSFGTVYHAEWRNSD---VAVKILIEQEFHEDRFKEF-LREVAIMKGLRHPNI 492
I K+IG+GSFG VY R SD +K I+ ++ +E L EV I+K L HPNI
Sbjct: 4 IIKQIGKGSFGKVYLVR-RKSDGKLYVLKE-IDLSNMSEKEREDALNEVKILKKLNHPNI 61
Query: 493 VLLMGAVTEPPNLSIVTEYLSRGSLYKLL--------HIPDARVVVDERLRLNMAYDVAK 544
+ + E L IV EY G L + + P+ ++ L+ +
Sbjct: 62 IKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQI-------LDWFVQLCL 114
Query: 545 GMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAP 604
+ YLH R+ I+HRD+K N+ + S VK+ DFG+S+ +T +KT GTP +++P
Sbjct: 115 ALKYLHSRK--ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSP 172
Query: 605 EVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV 664
E+ + P N KSD++S G +L+EL TL+ P+ ++ + KG+ IP + +
Sbjct: 173 ELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKI-LKGQYPPIPSQYSSEL 231
Query: 665 AALIETCWAEEPEIRPS 681
L+ + ++PE RPS
Sbjct: 232 RNLVSSLLQKDPEERPS 248
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 170 bits (432), Expect = 3e-48
Identities = 89/266 (33%), Positives = 138/266 (51%), Gaps = 25/266 (9%)
Query: 439 KKIGEGSFGTVYHAEWRNSD-----VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIV 493
K++G G+FG+V + VAVK L ++ + KEFLRE ++M L HP IV
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGK-KEFLREASVMAQLDHPCIV 59
Query: 494 LLMGAVTEPPNLSIVTEYLSRGSLYKLL----HIPDARVVVDERLRLNMAYDVAKGMNYL 549
L+G V + L +V E G L K L IP + + +A+ VA GM YL
Sbjct: 60 RLIG-VCKGEPLMLVMELAPLGPLLKYLKKRREIPVSDL-------KELAHQVAMGMAYL 111
Query: 550 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS--KPNTYISSKTAAGTP-EWMAPEV 606
+ VHRDL + N+L+ + + K+ DFG+SR+ + Y + TA P +W APE
Sbjct: 112 ESKH--FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPEC 169
Query: 607 LREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 665
+ + KSDV+S+GV LWE + KP+ ++VI+ + G RL P+ +
Sbjct: 170 INYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLE-SGERLPRPEECPQEIY 228
Query: 666 ALIETCWAEEPEIRPSFPSIMETLQQ 691
+++ +CW PE RP+F + T ++
Sbjct: 229 SIMLSCWKYRPEDRPTFSELESTFRR 254
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 170 bits (431), Expect = 3e-48
Identities = 96/260 (36%), Positives = 140/260 (53%), Gaps = 11/260 (4%)
Query: 434 ELLIKKKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNI 492
+L K++G G FG V + +WR DVA+K++ E ED EF+ E +M L H +
Sbjct: 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMKLSHEKL 61
Query: 493 VLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 552
V L G T+ + IVTEY+S G L L R + L M DV +GM YL +
Sbjct: 62 VQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLE--MCKDVCEGMAYLESK 119
Query: 553 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK-PNTYISSKTAAGTPEWMAPEVLREDP 611
+ +HRDL + N LVD VKV DFGLSR + Y SS + W PEVL
Sbjct: 120 Q--FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSK 177
Query: 612 SNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIET 670
+ KSDV++FGV++WE+ +L K P+ S+ + V +G RL P + V A++ +
Sbjct: 178 FSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVS-QGLRLYRPHLASEKVYAIMYS 236
Query: 671 CWAEEPEIRPSFPSIMETLQ 690
CW E+ E RP+F ++ +++
Sbjct: 237 CWHEKAEERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 169 bits (431), Expect = 4e-48
Identities = 91/256 (35%), Positives = 130/256 (50%), Gaps = 10/256 (3%)
Query: 439 KKIGEGSFGTVYHAEWR-NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMG 497
+KIG+G+FG VY + N++VAVK + + K FL+E I+K HPNIV L+G
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRK-FLQEAEILKQYDHPNIVKLIG 59
Query: 498 AVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 557
+ + IV E + GSL L R+ V + L M+ D A GM YL + +
Sbjct: 60 VCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTV--KKLLQMSLDAAAGMEYLESKN--CI 115
Query: 558 HRDLKSPNLLVDSTYTVKVCDFGLSRSK-PNTYISSKTAAGTP-EWMAPEVLREDPSNEK 615
HRDL + N LV +K+ DFG+SR + Y S P +W APE L +
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSE 175
Query: 616 SDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAE 674
SDV+S+G++LWE +L P+ + Q + G R+ P+ + L+ CWA
Sbjct: 176 SDVWSYGILLWETFSLGDTPYPGMSNQQTRERIE-SGYRMPAPQLCPEEIYRLMLQCWAY 234
Query: 675 EPEIRPSFPSIMETLQ 690
+PE RPSF I LQ
Sbjct: 235 DPENRPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 169 bits (429), Expect = 1e-47
Identities = 86/272 (31%), Positives = 138/272 (50%), Gaps = 20/272 (7%)
Query: 433 SELLIKKKIGEGSFGTVYHAEWRNS------DVAVKILIEQEFHEDRFKEFLREVAIMKG 486
+EL K +G G+FGTVY W VA+K+L E+ + KE L E +M
Sbjct: 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKA-NKEILDEAYVMAS 65
Query: 487 LRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM 546
+ HP++V L+G + + ++T+ + G L L ++ + + + + LN +AKGM
Sbjct: 66 VDHPHVVRLLG-ICLSSQVQLITQLMPLGCL--LDYVRNHKDNIGSQYLLNWCVQIAKGM 122
Query: 547 NYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR---SKPNTYISSKTAAGTP-EWM 602
+YL ++R +VHRDL + N+LV + VK+ DFGL++ Y + P +WM
Sbjct: 123 SYLEEKR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHA--EGGKVPIKWM 178
Query: 603 APEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVN 661
A E + KSDV+S+GV +WEL+T KP+ P+ I + KG RL P
Sbjct: 179 ALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEG-IPAVEIPDLLEKGERLPQPPICT 237
Query: 662 PMVAALIETCWAEEPEIRPSFPSIMETLQQFL 693
V ++ CW + E RP+F ++ +
Sbjct: 238 IDVYMVLVKCWMIDAESRPTFKELINEFSKMA 269
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 166 bits (422), Expect = 8e-47
Identities = 85/253 (33%), Positives = 134/253 (52%), Gaps = 20/253 (7%)
Query: 437 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 494
I +KIG+G FG VY A + + VA+K++ + +++ ++ + E+ I+K +HPNIV
Sbjct: 4 ILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLES--KEKKEKIINEIQILKKCKHPNIVK 61
Query: 495 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAY---DVAKGMNYLHQ 551
G+ + L IV E+ S GSL LL + E +AY ++ KG+ YLH
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLLK--STNQTLTES---QIAYVCKELLKGLEYLHS 116
Query: 552 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDP 611
I+HRD+K+ N+L+ S VK+ DFGLS +T + T GTP WMAPEV+ P
Sbjct: 117 NG--IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT-KARNTMVGTPYWMAPEVINGKP 173
Query: 612 SNEKSDVFSFGVILWELITLQKPWRNSTPSQV---ISAVGFKGRRLEIPKNVNPMVAALI 668
+ K+D++S G+ EL + P+ P + I+ G G L P+ + +
Sbjct: 174 YDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPG--LRNPEKWSDEFKDFL 231
Query: 669 ETCWAEEPEIRPS 681
+ C + PE RP+
Sbjct: 232 KKCLQKNPEKRPT 244
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 165 bits (420), Expect = 2e-46
Identities = 96/266 (36%), Positives = 142/266 (53%), Gaps = 16/266 (6%)
Query: 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGL 487
EI + + + +K+G G FG V+ W N+ VAVK L K+FL E IMK L
Sbjct: 2 EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDP---KDFLAEAQIMKKL 58
Query: 488 RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 547
RHP ++ L T + IVTE + GSL + L R + +L ++MA VA GM
Sbjct: 59 RHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQL-IDMAAQVASGMA 117
Query: 548 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTP-EWMAPE 605
YL + +HRDL + N+LV KV DFGL+R K + Y ++ A P +W APE
Sbjct: 118 YLEAQN--YIHRDLAARNVLVGENNICKVADFGLARVIKEDIY-EAREGAKFPIKWTAPE 174
Query: 606 VLREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVNPMV 664
+ + KSDV+SFG++L E++T + P+ T ++V+ V +G R+ P +
Sbjct: 175 AALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD-QGYRMPCPPGCPKEL 233
Query: 665 AALIETCWAEEPEIRPSFPSIMETLQ 690
++ CW E+P+ RP+F ETLQ
Sbjct: 234 YDIMLDCWKEDPDDRPTF----ETLQ 255
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 8e-45
Identities = 93/279 (33%), Positives = 134/279 (48%), Gaps = 32/279 (11%)
Query: 439 KKIGEGSFGTVYHAEWRNSD------VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNI 492
K++GEG FG V + VAVK L E +F RE+ I++ L H NI
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSL-NHSGEEQHRSDFEREIEILRTLDHENI 68
Query: 493 VLLMGAVTEP--PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLH 550
V G +P +L ++ EYL GSL L R ++ + L + + KGM+YL
Sbjct: 69 VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRLLLFSSQICKGMDYLG 126
Query: 551 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT--YISSKTAAGTP-EWMAPEVL 607
+R +HRDL + N+LV+S VK+ DFGL++ P Y K +P W APE L
Sbjct: 127 SQR--YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECL 184
Query: 608 REDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK---------------GR 652
R + SDV+SFGV L+EL T P S P++ + +G G
Sbjct: 185 RTSKFSSASDVWSFGVTLYELFTYGDP-SQSPPAEFLRMIGIAQGQMIVTRLLELLKEGE 243
Query: 653 RLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 691
RL P + V L++ CW EP+ RPSF ++ + +
Sbjct: 244 RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDR 282
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 2e-44
Identities = 94/260 (36%), Positives = 138/260 (53%), Gaps = 13/260 (5%)
Query: 433 SELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNI 492
+L + + IGEG FG V E+ VAVK + + + FL E A+M L H N+
Sbjct: 6 QKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIK----CDVTAQAFLEETAVMTKLHHKNL 61
Query: 493 VLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 552
V L+G + L IV E +S+G+L L R +V L + DVA+GM YL +
Sbjct: 62 VRLLGVILHN-GLYIVMELMSKGNLVNFLR-TRGRALVSVIQLLQFSLDVAEGMEYLESK 119
Query: 553 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPS 612
+ +VHRDL + N+LV KV DFGL+R +SK +W APE L+
Sbjct: 120 K--LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPV---KWTAPEALKHKKF 174
Query: 613 NEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC 671
+ KSDV+S+GV+LWE+ + + P+ + +V V KG R+E P+ V L+ +C
Sbjct: 175 SSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVE-KGYRMEPPEGCPADVYVLMTSC 233
Query: 672 WAEEPEIRPSFPSIMETLQQ 691
W EP+ RPSF + E L++
Sbjct: 234 WETEPKKRPSFHKLREKLEK 253
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 160 bits (406), Expect = 3e-44
Identities = 97/288 (33%), Positives = 147/288 (51%), Gaps = 26/288 (9%)
Query: 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD-------VAVKILIEQEFHEDRFKEFLREV 481
E+ L + K +GEG+FG V AE D VAVK+L + E + + E+
Sbjct: 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEM 66
Query: 482 AIMKGL-RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHI---------PDARVVVD 531
+MK + +H NI+ L+G T+ L +V EY + G+L L PD +
Sbjct: 67 EMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPE 126
Query: 532 ERLRL----NMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 587
E L + AY VA+GM +L ++ +HRDL + N+LV + +K+ DFGL+R +
Sbjct: 127 ETLTQKDLVSFAYQVARGMEFLASKK--CIHRDLAARNVLVTEDHVMKIADFGLARDIHH 184
Query: 588 TYISSKTAAGT-P-EWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVIS 645
KT G P +WMAPE L + +SDV+SFGV+LWE+ TL P + +
Sbjct: 185 IDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF 244
Query: 646 AVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 693
+ +G R+E P+N + L+ CW E P RP+F ++E L + L
Sbjct: 245 KLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 158 bits (403), Expect = 4e-44
Identities = 80/248 (32%), Positives = 132/248 (53%), Gaps = 11/248 (4%)
Query: 437 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 494
I +K+GEGS+G+VY A + + VA+K++ ED +E ++E++I+K P IV
Sbjct: 7 ILEKLGEGSYGSVYKAIHKETGQVVAIKVV---PVEED-LQEIIKEISILKQCDSPYIVK 62
Query: 495 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 554
G+ + +L IV EY GS+ ++ I + E + Y KG+ YLH +
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSDIMKI--TNKTLTEEEIAAILYQTLKGLEYLHSNK- 119
Query: 555 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNE 614
+HRD+K+ N+L++ K+ DFG+S +T T GTP WMAPEV++E N
Sbjct: 120 -KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNN 178
Query: 615 KSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-GRRLEIPKNVNPMVAALIETCWA 673
K+D++S G+ E+ + P+ + P + I + K L P+ +P ++ C
Sbjct: 179 KADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLV 238
Query: 674 EEPEIRPS 681
++PE RPS
Sbjct: 239 KDPEERPS 246
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 158 bits (402), Expect = 4e-44
Identities = 93/260 (35%), Positives = 139/260 (53%), Gaps = 13/260 (5%)
Query: 434 ELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIV 493
EL + + IG+G FG V ++R + VAVK + ++ + FL E ++M LRH N+V
Sbjct: 7 ELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK----NDATAQAFLAEASVMTQLRHSNLV 62
Query: 494 LLMGA-VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 552
L+G V E L IVTEY+++GSL L R V+ L + DV + M YL
Sbjct: 63 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLR-SRGRSVLGGDCLLKFSLDVCEAMEYLEAN 121
Query: 553 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPS 612
VHRDL + N+LV KV DFGL++ +T + K +W APE LRE
Sbjct: 122 N--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV---KWTAPEALREKKF 176
Query: 613 NEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC 671
+ KSDV+SFG++LWE+ + + P+ V+ V KG +++ P P+V +++ C
Sbjct: 177 STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPVVYDVMKQC 235
Query: 672 WAEEPEIRPSFPSIMETLQQ 691
W + RPSF + E L+
Sbjct: 236 WHLDAATRPSFLQLREQLEH 255
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 159 bits (403), Expect = 5e-44
Identities = 95/284 (33%), Positives = 138/284 (48%), Gaps = 25/284 (8%)
Query: 429 EIRWSELLIKKKIGEGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREV 481
++ +++K+++GEG+FG V+ E + VAVK L E ++ R K+F RE
Sbjct: 1 HVQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDAR-KDFEREA 59
Query: 482 AIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL--HIPDARVVVDERLR---- 535
++ +H NIV G TE +V EY+ G L K L H PDA +
Sbjct: 60 ELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGEL 119
Query: 536 -----LNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT-Y 589
L +A +A GM YL + VHRDL + N LV VK+ DFG+SR T Y
Sbjct: 120 TLSQLLQIAVQIASGMVYLASQH--FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDY 177
Query: 590 ISSKTAAGTP-EWMAPEVLREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAV 647
P WM PE + +SDV+SFGV+LWE+ T K PW + +VI +
Sbjct: 178 YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECI 237
Query: 648 GFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 691
+GR L+ P+ V ++ CW +P+ R + I E LQ+
Sbjct: 238 T-QGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 156 bits (395), Expect = 4e-43
Identities = 91/267 (34%), Positives = 146/267 (54%), Gaps = 11/267 (4%)
Query: 429 EIRWSELLIKKKIGEGSFGTVYHAEWRN-SDVAVKILIEQEFHEDRFKEFLREVAIMKGL 487
E+ L + KK+G G FG V+ + + VA+K L + + FL E +MK L
Sbjct: 2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPE---AFLAEANLMKQL 58
Query: 488 RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 547
+HP +V L VT+ P + I+TEY+ GSL L P+ + +L ++MA +A+GM
Sbjct: 59 QHPRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPEGIKLTINKL-IDMAAQIAEGMA 116
Query: 548 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPNTYISSKTAAGTPEWMAPEV 606
++ ++ +HRDL++ N+LV T K+ DFGL+R + N Y + + A +W APE
Sbjct: 117 FIERKN--YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 174
Query: 607 LREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 665
+ KSDV+SFG++L E++T + P+ T +VI + +G R+ P N +
Sbjct: 175 INYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLE-RGYRMPRPDNCPEELY 233
Query: 666 ALIETCWAEEPEIRPSFPSIMETLQQF 692
L+ CW E+PE RP+F + L+ F
Sbjct: 234 ELMRLCWKEKPEERPTFEYLRSVLEDF 260
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 1e-42
Identities = 92/265 (34%), Positives = 137/265 (51%), Gaps = 15/265 (5%)
Query: 441 IGEGSFGTVYHAEWRNSD-----VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 495
IG+G FG VYH +SD AVK L E+ ++FL+E IMK HPN++ L
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEE-VEQFLKEGIIMKDFSHPNVLSL 61
Query: 496 MGAVTEPPNLS-IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 554
+G +V Y+ G L + V + + + VAKGM YL ++
Sbjct: 62 LGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGL--QVAKGMEYLASKK- 118
Query: 555 PIVHRDLKSPNLLVDSTYTVKVCDFGLSR---SKPNTYISSKTAAGTP-EWMAPEVLRED 610
VHRDL + N ++D ++TVKV DFGL+R K + + T A P +WMA E L+
Sbjct: 119 -FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQ 177
Query: 611 PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIET 670
KSDV+SFGV+LWEL+T P S I+ +GRRL P+ + ++ +
Sbjct: 178 KFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLS 237
Query: 671 CWAEEPEIRPSFPSIMETLQQFLMS 695
CW +PE+RP+F ++ ++Q +
Sbjct: 238 CWHPKPEMRPTFSELVSRIEQIFST 262
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 154 bits (390), Expect = 2e-42
Identities = 93/260 (35%), Positives = 134/260 (51%), Gaps = 11/260 (4%)
Query: 433 SELLIKKKIGEGSFGTVYHAEWRNSD-VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN 491
SEL + ++IG G FG V+ W VA+K + E E+ F E E +M L HP
Sbjct: 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIE---EAQVMMKLSHPK 60
Query: 492 IVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 551
+V L G TE + +V E++ G L L R + L M DV +GM YL
Sbjct: 61 LVQLYGVCTERSPICLVFEFMEHGCLSDYLR--AQRGKFSQETLLGMCLDVCEGMAYLES 118
Query: 552 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP-EWMAPEVLRED 610
++HRDL + N LV VKV DFG++R + +S T P +W +PEV
Sbjct: 119 SN--VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFS 176
Query: 611 PSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE 669
+ KSDV+SFGV++WE+ + K P+ N + S+V+ + G RL P+ + V L++
Sbjct: 177 KYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETIN-AGFRLYKPRLASQSVYELMQ 235
Query: 670 TCWAEEPEIRPSFPSIMETL 689
CW E PE RPSF ++ L
Sbjct: 236 HCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 7e-42
Identities = 72/254 (28%), Positives = 131/254 (51%), Gaps = 16/254 (6%)
Query: 434 ELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN 491
+ IG G+FG VY + VA+K + ++ E+ K ++E+ ++K L+HPN
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 492 IVLLMGAVTEPPNLSIVTEYLSRGSLYKLL----HIPDARVVVDERLRLNMAYDVAKGMN 547
IV +G++ +L I+ EY GSL +++ P E L Y V +G+
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFP-------ESLVAVYVYQVLQGLA 113
Query: 548 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVL 607
YLH++ ++HRD+K+ N+L VK+ DFG++ + + GTP WMAPEV+
Sbjct: 114 YLHEQG--VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVI 171
Query: 608 REDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAAL 667
++ SD++S G + EL+T P+ + P + + + +P+ ++P +
Sbjct: 172 EMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV-QDDHPPLPEGISPELKDF 230
Query: 668 IETCWAEEPEIRPS 681
+ C+ ++P +RP+
Sbjct: 231 LMQCFQKDPNLRPT 244
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 2e-41
Identities = 96/274 (35%), Positives = 140/274 (51%), Gaps = 18/274 (6%)
Query: 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD-----VAVKILIEQEFHEDRFKEFLREVAI 483
EI+ ++ + + IGEG FG VY + + + VAVK R K FL+E I
Sbjct: 2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREK-FLQEAYI 60
Query: 484 MKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVA 543
M+ HP+IV L+G +TE P + IV E G L L + + + L L +Y ++
Sbjct: 61 MRQFDHPHIVKLIGVITENP-VWIVMELAPLGELRSYLQVNKYSLDL-ASLIL-YSYQLS 117
Query: 544 KGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR--SKPNTYISSKTAAGTP-E 600
+ YL +R VHRD+ + N+LV S VK+ DFGLSR + Y +SK P +
Sbjct: 118 TALAYLESKR--FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGK--LPIK 173
Query: 601 WMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKN 659
WMAPE + SDV+ FGV +WE++ L KP++ + VI + G RL +P N
Sbjct: 174 WMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIE-NGERLPMPPN 232
Query: 660 VNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 693
P + +L+ CWA +P RP F + L L
Sbjct: 233 CPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL 266
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 152 bits (385), Expect = 3e-41
Identities = 102/298 (34%), Positives = 139/298 (46%), Gaps = 45/298 (15%)
Query: 433 SELLIKKKIGEGSFGTVY--------------HAEWRNSD----VAVKILIEQEFHEDRF 474
L +K+GEG FG V+ AE N+D VAVK+L R
Sbjct: 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAR- 63
Query: 475 KEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL--HIPDARVVVDE 532
++FL+EV I+ L PNI L+G T P L ++ EY+ G L + L H+ + +
Sbjct: 64 EDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACN 123
Query: 533 RLRL------NMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP 586
L MA +A GM YL VHRDL + N LV YT+K+ DFG+SR
Sbjct: 124 SKSLSFSTLLYMATQIASGMRYLESLN--FVHRDLATRNCLVGKNYTIKIADFGMSR--- 178
Query: 587 NTYIS--SKTAAGTP---EWMAPEVLREDPSNEKSDVFSFGVILWELITL--QKPWRNST 639
N Y S + P WMA E + KSDV++FGV LWE++TL ++P+ + T
Sbjct: 179 NLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT 238
Query: 640 PSQVISAVGFKGRR------LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 691
QVI G R L P N + L+ CW + E RP+F I LQ+
Sbjct: 239 DQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 150 bits (379), Expect = 6e-41
Identities = 102/268 (38%), Positives = 143/268 (53%), Gaps = 15/268 (5%)
Query: 429 EIRWSELLIKKKIGEGSFGTVYHAEWR-NSDVAVKILIEQEFHEDRFKEFLREVAIMKGL 487
EI L + KK+G G FG V+ W N+ VAVK L + FL E IMK L
Sbjct: 2 EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPE---SFLEEAQIMKKL 58
Query: 488 RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 547
RH +V L V+E P + IVTEY+S+GSL L + R + L ++MA VA GM
Sbjct: 59 RHDKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKDGEGRALKLPNL-VDMAAQVAAGMA 116
Query: 548 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPNTYISSKTAAGTPEWMAPEV 606
Y+ R +HRDL+S N+LV K+ DFGL+R + N Y + + A +W APE
Sbjct: 117 YIE--RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEA 174
Query: 607 LREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 665
KSDV+SFG++L EL+T + P+ +V+ V +G R+ P++ +
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVE-RGYRMPCPQDCPISLH 233
Query: 666 ALIETCWAEEPEIRPSFPSIMETLQQFL 693
L+ CW ++PE RP+F E LQ FL
Sbjct: 234 ELMLQCWKKDPEERPTF----EYLQSFL 257
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 149 bits (377), Expect = 1e-40
Identities = 76/248 (30%), Positives = 124/248 (50%), Gaps = 14/248 (5%)
Query: 441 IGEGSFGTVYHAEWRNSD---VAVK---ILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 494
+G GSFG+VY D AVK + + + ++ K+ +E+A++ L+HPNIV
Sbjct: 8 LGSGSFGSVYEG-LNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 495 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 554
+G E NL I E + GSL KLL + E + + G+ YLH R
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAKLLKKYGS---FPEPVIRLYTRQILLGLEYLHDRN- 122
Query: 555 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVL-REDPSN 613
VHRD+K N+LVD+ VK+ DFG+++ + + +K+ G+P WMAPEV+ ++
Sbjct: 123 -TVHRDIKGANILVDTNGVVKLADFGMAK-QVVEFSFAKSFKGSPYWMAPEVIAQQGGYG 180
Query: 614 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWA 673
+D++S G + E+ T + PW + +G IP +++ I C
Sbjct: 181 LAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQ 240
Query: 674 EEPEIRPS 681
+P +RP+
Sbjct: 241 RDPSLRPT 248
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 1e-40
Identities = 79/257 (30%), Positives = 130/257 (50%), Gaps = 32/257 (12%)
Query: 439 KKIGEGSFGTVYHAEWR--NSDVAVK-ILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 495
+KIGEG+ G VY A R +VA+K + + + + + E+ IMK +HPNIV
Sbjct: 25 EKIGEGASGEVYKATDRATGKEVAIKKMRLRK----QNKELIINEILIMKDCKHPNIVDY 80
Query: 496 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLN---MAY---DVAKGMNYL 549
+ L +V EY+ GSL ++ +R+N +AY +V +G+ YL
Sbjct: 81 YDSYLVGDELWVVMEYMDGGSL--------TDIITQNFVRMNEPQIAYVCREVLQGLEYL 132
Query: 550 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFG----LSRSKPNTYISSKTAAGTPEWMAPE 605
H + ++HRD+KS N+L+ +VK+ DFG L++ K + GTP WMAPE
Sbjct: 133 HSQN--VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK----RNSVVGTPYWMAPE 186
Query: 606 VLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG-RRLEIPKNVNPMV 664
V++ K D++S G++ E+ + P+ P + + + KG L+ P+ +P
Sbjct: 187 VIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEF 246
Query: 665 AALIETCWAEEPEIRPS 681
+ C ++PE RPS
Sbjct: 247 KDFLNKCLVKDPEKRPS 263
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 2e-40
Identities = 92/257 (35%), Positives = 134/257 (52%), Gaps = 11/257 (4%)
Query: 439 KKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 496
++IG G+FG V+ R N+ VAVK E D +FL+E I+K HPNIV L+
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLI 59
Query: 497 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 556
G T+ + IV E + G L R+ V E ++ M + A GM YL +
Sbjct: 60 GVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQ--MVENAAAGMEYLESKH--C 115
Query: 557 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN-TYISSKTAAGTP-EWMAPEVLREDPSNE 614
+HRDL + N LV +K+ DFG+SR + + Y S+ P +W APE L +
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSS 175
Query: 615 KSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWA 673
+SDV+SFG++LWE +L P+ N + Q A+ +G RL P+ V L+E CW
Sbjct: 176 ESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE-QGVRLPCPELCPDAVYRLMERCWE 234
Query: 674 EEPEIRPSFPSIMETLQ 690
+P RPSF ++ + LQ
Sbjct: 235 YDPGQRPSFSTVHQELQ 251
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 1e-39
Identities = 90/267 (33%), Positives = 148/267 (55%), Gaps = 10/267 (3%)
Query: 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGL 487
EI + + KK+G G FG V+ + NS VAVK L + FL E +MK L
Sbjct: 2 EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM---SVQAFLEEANLMKTL 58
Query: 488 RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 547
+H +V L VT+ + I+TEY+++GSL L + V+ +L ++ + +A+GM
Sbjct: 59 QHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKL-IDFSAQIAEGMA 117
Query: 548 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEV 606
Y+ ++ +HRDL++ N+LV + K+ DFGL+R + N Y + + A +W APE
Sbjct: 118 YIERKN--YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEA 175
Query: 607 LREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 665
+ KSDV+SFG++L+E++T K P+ + S V+SA+ +G R+ +N +
Sbjct: 176 INFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQ-RGYRMPRMENCPDELY 234
Query: 666 ALIETCWAEEPEIRPSFPSIMETLQQF 692
+++TCW E+ E RP+F + L F
Sbjct: 235 DIMKTCWKEKAEERPTFDYLQSVLDDF 261
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 145 bits (366), Expect = 7e-39
Identities = 94/285 (32%), Positives = 150/285 (52%), Gaps = 21/285 (7%)
Query: 429 EIRWSELLIKKKIGEGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREV 481
E+ ++ + +++G+GSFG VY R+ + VAVK + E +R EFL E
Sbjct: 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFLNEA 60
Query: 482 AIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHI--PDA-----RVVVDERL 534
++MKG ++V L+G V++ +V E ++ G L L P+A R +
Sbjct: 61 SVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE 120
Query: 535 RLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKT 594
+ MA ++A GM YL+ ++ VHRDL + N +V +TVK+ DFG++R T K
Sbjct: 121 MIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKG 178
Query: 595 AAG--TPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKG 651
G WMAPE L++ SD++SFGV+LWE+ +L ++P++ + QV+ V G
Sbjct: 179 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV-MDG 237
Query: 652 RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 696
L+ P N V L+ CW P++RP+F I+ L+ L S
Sbjct: 238 GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPS 282
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 144 bits (364), Expect = 8e-39
Identities = 99/279 (35%), Positives = 139/279 (49%), Gaps = 42/279 (15%)
Query: 441 IGEGSFGTVYHAEWRNSD--------VAVKIL----IEQEFHEDRFKEFLREVAIMKGLR 488
+G G+FG VY + VAVK L +QE KEFL+E +M
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEK-----KEFLKEAHLMSNFN 57
Query: 489 HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARV---------VVDERLRLNMA 539
HPNIV L+G I+ E + G L L ++ DARV + + L++
Sbjct: 58 HPNIVKLLGVCLLNEPQYIIMELMEGGDL--LSYLRDARVERFGPPLLTLKE---LLDIC 112
Query: 540 YDVAKGMNYLHQRRPPIVHRDLKSPNLLV-----DSTYTVKVCDFGLSRS-KPNTYISSK 593
DVAKG YL Q +HRDL + N LV D+ VK+ DFGL+R + Y +
Sbjct: 113 LDVAKGCVYLEQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKE 170
Query: 594 TAAGTP-EWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKG 651
P WMAPE L + +SDV+SFGV++WE++TL Q+P+ +V+ V G
Sbjct: 171 GEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGG 230
Query: 652 RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQ 690
RL+ P+N + L+ CWA++P RP+F I E LQ
Sbjct: 231 -RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 2e-38
Identities = 99/283 (34%), Positives = 143/283 (50%), Gaps = 27/283 (9%)
Query: 430 IRWSELLIKKKIGEGSFGTVYHAEWRN----SD---VAVKILIEQEFHEDRFKEFLREVA 482
I+ ++++K ++GEG+FG V+ AE N D VAVK L +E E ++F RE
Sbjct: 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL--KEASESARQDFQREAE 59
Query: 483 IMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL--HIPDARVVVDERLR----- 535
++ L+H +IV G TE L +V EY+ G L + L H PDA+++
Sbjct: 60 LLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQL 119
Query: 536 -----LNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT-Y 589
L +A +A GM YL VHRDL + N LV VK+ DFG+SR +T Y
Sbjct: 120 TLGQMLAIASQIASGMVYLASLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY 177
Query: 590 ISSKTAAGTP-EWMAPEVLREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAV 647
P WM PE + +SD++SFGV+LWE+ T K PW + ++ I +
Sbjct: 178 YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI 237
Query: 648 GFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQ 690
+GR LE P+ P V A+++ CW EP+ R I LQ
Sbjct: 238 T-QGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 143 bits (361), Expect = 3e-38
Identities = 90/269 (33%), Positives = 139/269 (51%), Gaps = 19/269 (7%)
Query: 437 IKKKIGEGSFGTVY-----HAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN 491
I++ IG G FG V R VA+K L + + E + ++FL E +IM HPN
Sbjct: 8 IEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTL-KSGYTEKQRRDFLSEASIMGQFDHPN 66
Query: 492 IVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 551
I+ L G VT+ + I+TE++ G+L L D + V + + M +A GM YL +
Sbjct: 67 IIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQ--LVGMLRGIAAGMKYLSE 124
Query: 552 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR------SKPNTYISSKTAAGTPEWMAPE 605
VHRDL + N+LV+S KV DFGLSR S P TY SS W APE
Sbjct: 125 MN--YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDP-TYTSSLGGKIPIRWTAPE 181
Query: 606 VLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV 664
+ SDV+S+G+++WE+++ ++P+ + + VI+A+ + RL P + +
Sbjct: 182 AIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE-QDYRLPPPMDCPTAL 240
Query: 665 AALIETCWAEEPEIRPSFPSIMETLQQFL 693
L+ CW ++ RP F I+ TL + +
Sbjct: 241 HQLMLDCWQKDRNARPKFGQIVSTLDKMI 269
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 3e-38
Identities = 85/273 (31%), Positives = 133/273 (48%), Gaps = 21/273 (7%)
Query: 435 LLIKKKIGEGSFGTVYHA-------EWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGL 487
L K +G G+FG V A VAVK+L H + + E+ IM L
Sbjct: 37 LSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHL 95
Query: 488 -RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM 546
H NIV L+GA T + ++TEY G L L + L+ +Y VAKGM
Sbjct: 96 GNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLR-RKRESFLTLEDLLSFSYQVAKGM 154
Query: 547 NYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS--KPNTYISSKTAAGTPEWMAP 604
+L + +HRDL + N+L+ VK+CDFGL+R + Y+ A +WMAP
Sbjct: 155 AFLASKN--CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAP 212
Query: 605 EVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK----GRRLEIPKNV 660
E + +SDV+S+G++LWE+ +L N P + + +K G R+ P++
Sbjct: 213 ESIFNCVYTFESDVWSYGILLWEIFSLGS---NPYPGMPVDSKFYKLIKEGYRMAQPEHA 269
Query: 661 NPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 693
+ +++TCW +P RP+F I++ + + L
Sbjct: 270 PAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQL 302
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 143 bits (361), Expect = 3e-38
Identities = 91/294 (30%), Positives = 153/294 (52%), Gaps = 37/294 (12%)
Query: 435 LLIKKKIGEGSFGTV-----YHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGL 487
L++ K +GEG FG V + + R + VAVK+L E ++ L E ++K +
Sbjct: 2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQV 60
Query: 488 RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHI----------------------PD 525
HP+++ L GA ++ L ++ EY GSL L PD
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 526 ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS- 584
R + L ++ A+ +++GM YL + + +VHRDL + N+LV +K+ DFGLSR
Sbjct: 121 ERALTMGDL-ISFAWQISRGMQYLAEMK--LVHRDLAARNVLVAEGRKMKISDFGLSRDV 177
Query: 585 -KPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQ 642
+ ++Y+ +WMA E L + +SDV+SFGV+LWE++TL P+ P +
Sbjct: 178 YEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237
Query: 643 VISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 696
+ + + G R+E P+N + + L+ TCW +EP+ RP+F I + L++ ++ S
Sbjct: 238 LFNLLK-TGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVKS 290
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 8e-38
Identities = 83/276 (30%), Positives = 132/276 (47%), Gaps = 20/276 (7%)
Query: 435 LLIKKKIGEGSFGTVYHAEWRNSD-----VAVKILIEQEFHEDRFKEFLREVAIMKGLRH 489
L + K +GEG FG+V + D VAVK + +EFL E A MK H
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 490 PNIVLLMG------AVTEPPNLSIVTEYLSRGSLYKLL---HIPDARVVVDERLRLNMAY 540
PN++ L+G ++ + P ++ ++ G L+ L + + + L
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120
Query: 541 DVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN-TYISSKTAAGTP 599
D+A GM YL R +HRDL + N ++ TV V DFGLS+ + Y A P
Sbjct: 121 DIALGMEYLSNRN--FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMP 178
Query: 600 -EWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIP 657
+W+A E L + KSDV++FGV +WE+ T Q P+ ++ + G RL+ P
Sbjct: 179 VKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYL-RHGNRLKQP 237
Query: 658 KNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 693
++ + L+ +CW +P+ RP+F + E L+ L
Sbjct: 238 EDCLDELYDLMYSCWRADPKDRPTFTKLREVLENIL 273
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 1e-37
Identities = 81/265 (30%), Positives = 132/265 (49%), Gaps = 15/265 (5%)
Query: 437 IKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKE-----FLREVAIMKGLRHPN 491
+ + IG+GSFGTV R SD KIL+ +E E + EV I++ L+HPN
Sbjct: 4 VLETIGKGSFGTVRKVR-RKSDG--KILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPN 60
Query: 492 IVLLMGAVTEPPN--LSIVTEYLSRGSLYKLL-HIPDARVVVDERLRLNMAYDVAKGMNY 548
IV + + N L IV EY G L +L+ R ++E + + +
Sbjct: 61 IVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYE 120
Query: 549 LHQRRPP---IVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPE 605
H R P ++HRDLK N+ +D+ VK+ DFGL++ + +KT GTP +M+PE
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPE 180
Query: 606 VLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 665
L +EKSD++S G +++EL L P+ Q+ S + +G+ IP + +
Sbjct: 181 QLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIK-EGKFRRIPYRYSSELN 239
Query: 666 ALIETCWAEEPEIRPSFPSIMETLQ 690
+I++ +P+ RPS +++
Sbjct: 240 EVIKSMLNVDPDKRPSTEELLQLPL 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 140 bits (356), Expect = 1e-37
Identities = 80/256 (31%), Positives = 129/256 (50%), Gaps = 20/256 (7%)
Query: 437 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 494
+ ++IG G++G VY A + VA+K++ + D F+ +E++++K RHPNIV
Sbjct: 7 LIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP--GDDFEIIQQEISMLKECRHPNIVA 64
Query: 495 LMGAVTEPPNLSIVTEYLSRGSL---YKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 551
G+ L IV EY GSL Y++ P + E + + KG+ YLH+
Sbjct: 65 YFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGP-----LSELQIAYVCRETLKGLAYLHE 119
Query: 552 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVL---R 608
+HRD+K N+L+ VK+ DFG+S T K+ GTP WMAPEV R
Sbjct: 120 TG--KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVER 177
Query: 609 EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQV---ISAVGFKGRRLEIPKNVNPMVA 665
+ + K D+++ G+ EL LQ P + P + IS F +L+ + +P+
Sbjct: 178 KGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFH 237
Query: 666 ALIETCWAEEPEIRPS 681
I+ C ++P+ RP+
Sbjct: 238 DFIKKCLTKDPKKRPT 253
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 141 bits (356), Expect = 2e-37
Identities = 99/283 (34%), Positives = 145/283 (51%), Gaps = 28/283 (9%)
Query: 430 IRWSELLIKKKIGEGSFGTVYHAEWRNSD-------VAVKILIEQEFHEDRFKEFLREVA 482
I+ ++++K+++GEG+FG V+ AE N VAVK L + K+F RE
Sbjct: 2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR--KDFQREAE 59
Query: 483 IMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL--HIPDARVVVDERLR----- 535
++ L+H +IV G + L +V EY+ G L K L H PDA ++VD + R
Sbjct: 60 LLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGE 119
Query: 536 ------LNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT- 588
L++A +A GM YL + VHRDL + N LV + VK+ DFG+SR +T
Sbjct: 120 LGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD 177
Query: 589 YISSKTAAGTP-EWMAPEVLREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISA 646
Y P WM PE + +SDV+SFGVILWE+ T K PW + ++VI
Sbjct: 178 YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC 237
Query: 647 VGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETL 689
+ +GR LE P+ V ++ CW EP+ R + I + L
Sbjct: 238 IT-QGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKIL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 140 bits (353), Expect = 2e-37
Identities = 85/261 (32%), Positives = 141/261 (54%), Gaps = 15/261 (5%)
Query: 440 KIGEGSFGTV----YHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 495
++G G+FG V Y + DVA+K+L + R E +RE IM L +P IV +
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVR-DEMMREAEIMHQLDNPYIVRM 60
Query: 496 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 555
+G V E L +V E S G L K L + V + L + V+ GM YL +
Sbjct: 61 IG-VCEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVEL--MHQVSMGMKYLEGKN-- 115
Query: 556 IVHRDLKSPNLLVDSTYTVKVCDFGLSRS--KPNTYISSKTAAGTP-EWMAPEVLREDPS 612
VHRDL + N+L+ + + K+ DFGLS++ ++Y +++A P +W APE +
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKF 175
Query: 613 NEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC 671
+ +SDV+S+G+ +WE + QKP++ +V+S + +G+RL+ P P + AL++ C
Sbjct: 176 SSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIE-QGKRLDCPAECPPEMYALMKDC 234
Query: 672 WAEEPEIRPSFPSIMETLQQF 692
W + E RP+F + E ++ +
Sbjct: 235 WIYKWEDRPNFAKVEERMRTY 255
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 4e-37
Identities = 90/274 (32%), Positives = 137/274 (50%), Gaps = 15/274 (5%)
Query: 429 EIRWSELLIKKKIGEGSFGTVYHAEWR-----NSDVAVKILIEQEFHEDRFKEFLREVAI 483
EI S + +K IG G FG V+ + VA+K L + + E + ++FL E +I
Sbjct: 1 EIHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTL-KPGYTEKQRQDFLSEASI 59
Query: 484 MKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVA 543
M H NI+ L G VT+ I+TEY+ G+L K L D + + M +A
Sbjct: 60 MGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQ--LVGMLRGIA 117
Query: 544 KGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP---E 600
GM YL VHRDL + N+LV+S KV DFGLSR + + T +G
Sbjct: 118 AGMKYLSDMN--YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIR 175
Query: 601 WMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKN 659
W APE + SDV+SFG+++WE+++ ++P+ + + +V+ A+ G RL P +
Sbjct: 176 WTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIN-DGFRLPAPMD 234
Query: 660 VNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 693
V L+ CW ++ RP F I+ L + L
Sbjct: 235 CPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 5e-37
Identities = 80/254 (31%), Positives = 124/254 (48%), Gaps = 27/254 (10%)
Query: 439 KKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 496
+ IG+GSFG VY A + N VA+K+ I+ E ED ++ +E+ + R P I
Sbjct: 7 ECIGKGSFGEVYKAIDKRTNQVVAIKV-IDLEEAEDEIEDIQQEIQFLSQCRSPYITKYY 65
Query: 497 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 556
G+ + L I+ EY GS LL +DE + +V G+ YLH+
Sbjct: 66 GSFLKGSKLWIIMEYCGGGSCLDLLK----PGKLDETYIAFILREVLLGLEYLHEEGK-- 119
Query: 557 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKS 616
+HRD+K+ N+L+ VK+ DFG+S +T T GTP WMAPEV+++ +EK+
Sbjct: 120 IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKA 179
Query: 617 DVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA---------L 667
D++S G+ EL + P + P +V+ IPKN P +
Sbjct: 180 DIWSLGITAIELAKGEPPLSDLHPMRVL---------FLIPKNNPPSLEGNKFSKPFKDF 230
Query: 668 IETCWAEEPEIRPS 681
+ C ++P+ RPS
Sbjct: 231 VSLCLNKDPKERPS 244
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 5e-37
Identities = 66/203 (32%), Positives = 102/203 (50%), Gaps = 22/203 (10%)
Query: 438 KKKIGEGSFGTVYHAEWRNSD--VAVK-ILIEQEFHEDRF-KEFLREVAIMKGLRHPNIV 493
+K+GEG++G VY A + + VA+K I ++ E E+ LRE++++K L+HPNIV
Sbjct: 4 LEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNE--EEGIPSTALREISLLKELKHPNIV 61
Query: 494 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 553
L+ + L +V EY L K L + L ++ Y + +G+ Y H R
Sbjct: 62 KLLDVIHTERKLYLVFEYCDM-DLKKYLD--KRPGPLSPNLIKSIMYQLLRGLAYCHSHR 118
Query: 554 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPE----WM-APEVLR 608
I+HRDLK N+L++ +K+ DFGL+R T E W APE+L
Sbjct: 119 --ILHRDLKPQNILINRDGVLKLADFGLAR-----AFGIPLRTYTHEVVTLWYRAPEILL 171
Query: 609 EDPSNEKS-DVFSFGVILWELIT 630
+ D++S G I E+IT
Sbjct: 172 GSKHYSTAVDIWSVGCIFAEMIT 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 6e-37
Identities = 92/286 (32%), Positives = 149/286 (52%), Gaps = 28/286 (9%)
Query: 435 LLIKKKIGEGSFGTVYHAEW---------RNSDVAVKILIEQEFHEDRFKEFLREVAIMK 485
L++ K +GEG FG V AE + VAVK+L + +D + + E+ +MK
Sbjct: 14 LVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKD-LADLISEMELMK 72
Query: 486 GL-RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL---------HIPDARVVVDERLR 535
+ +H NI+ L+G T+ L ++ EY ++G+L + L + D V +E+L
Sbjct: 73 LIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLS 132
Query: 536 ----LNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS 591
++ AY VA+GM YL RR +HRDL + N+LV +K+ DFGL+R +
Sbjct: 133 FKDLVSCAYQVARGMEYLESRR--CIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYY 190
Query: 592 SKTAAG--TPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGF 649
KT+ G +WMAPE L + +SDV+SFG+++WE+ TL P + + +
Sbjct: 191 KKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLR 250
Query: 650 KGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS 695
+G R++ P N + L+ CW P RP+F ++E L + L +
Sbjct: 251 EGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 140 bits (353), Expect = 6e-37
Identities = 97/286 (33%), Positives = 149/286 (52%), Gaps = 30/286 (10%)
Query: 430 IRWSELLIKKKIGEGSFGTVYHAEWRNS----DVAVKILIEQEFHEDRFKEFLREVAIMK 485
+ W+++ + IGEG+FG V A + D A+K + E +D ++F E+ ++
Sbjct: 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH-RDFAGELEVLC 62
Query: 486 GL-RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVV--------------- 529
L HPNI+ L+GA L + EY G+L L +RV+
Sbjct: 63 KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLR--KSRVLETDPAFAIANSTAST 120
Query: 530 VDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 589
+ + L+ A DVA+GM+YL Q++ +HRDL + N+LV Y K+ DFGLSR + Y
Sbjct: 121 LSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIADFGLSRGQ-EVY 177
Query: 590 ISSKTAAGTP-EWMAPEVLREDPSNEKSDVFSFGVILWELITLQ-KPWRNSTPSQVISAV 647
+ KT P WMA E L SDV+S+GV+LWE+++L P+ T +++ +
Sbjct: 178 VK-KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 236
Query: 648 GFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 693
+G RLE P N + V L+ CW E+P RPSF I+ +L + L
Sbjct: 237 P-QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 281
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 7e-37
Identities = 90/270 (33%), Positives = 136/270 (50%), Gaps = 15/270 (5%)
Query: 433 SELLIKKKIGEGSFGTVYHAEW-----RNSDVAVKILIEQEFHEDRFKEFLREVAIMKGL 487
S + I+K IG G FG V R VA+K L + + E + ++FL E +IM
Sbjct: 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTL-KAGYTEKQRRDFLSEASIMGQF 62
Query: 488 RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 547
HPNI+ L G VT+ + IVTEY+ GSL L D + V + + M +A GM
Sbjct: 63 DHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQ--LVGMLRGIASGMK 120
Query: 548 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR---SKPNTYISSKTAAGTPEWMAP 604
YL VHRDL + N+LV+S KV DFGLSR P +++ W AP
Sbjct: 121 YLSDM--GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAP 178
Query: 605 EVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPM 663
E + SDV+S+G+++WE+++ ++P+ + VI A+ +G RL P +
Sbjct: 179 EAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIE-EGYRLPAPMDCPAA 237
Query: 664 VAALIETCWAEEPEIRPSFPSIMETLQQFL 693
+ L+ CW ++ RP F I+ L + +
Sbjct: 238 LHQLMLDCWQKDRNERPKFEQIVSILDKLI 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 8e-37
Identities = 80/264 (30%), Positives = 132/264 (50%), Gaps = 18/264 (6%)
Query: 441 IGEGSFGTVYHAEWRNSD-------VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIV 493
+G G FG V+ A+ + + V VK L + + E+ EF RE+ + + L H N+V
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVV 71
Query: 494 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDE------RLRLNMAYDVAKGMN 547
L+G E ++ EY G L + L ++ + + ++ + +A GM+
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 548 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT-YISSKTAAGTPEWMAPEV 606
+L R VHRDL + N LV S VKV LS+ N+ Y + A W+APE
Sbjct: 132 HLSNAR--FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEA 189
Query: 607 LREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 665
++ED + KSDV+SFGV++WE+ T + P+ + +V++ + L +P+ +
Sbjct: 190 VQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPSRLY 249
Query: 666 ALIETCWAEEPEIRPSFPSIMETL 689
L+ CWA P+ RPSF ++ L
Sbjct: 250 KLMTRCWAVNPKDRPSFSELVSAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 138 bits (348), Expect = 9e-37
Identities = 91/267 (34%), Positives = 142/267 (53%), Gaps = 11/267 (4%)
Query: 429 EIRWSELLIKKKIGEGSFGTVYHAEWR-NSDVAVKILIEQEFHEDRFKEFLREVAIMKGL 487
EI L + K+G+G FG V+ W + VA+K L + FL+E IMK L
Sbjct: 2 EIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPE---AFLQEAQIMKKL 58
Query: 488 RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 547
RH +V L V+E P + IVTE++ +GSL L D + + +L ++MA +A GM
Sbjct: 59 RHDKLVPLYAVVSEEP-IYIVTEFMGKGSLLDFLKEGDGKYLKLPQL-VDMAAQIADGMA 116
Query: 548 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPNTYISSKTAAGTPEWMAPEV 606
Y+ R +HRDL++ N+LV K+ DFGL+R + N Y + + A +W APE
Sbjct: 117 YI--ERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEA 174
Query: 607 LREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 665
KSDV+SFG++L EL+T + P+ +V+ V +G R+ P+ +
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVE-RGYRMPCPQGCPESLH 233
Query: 666 ALIETCWAEEPEIRPSFPSIMETLQQF 692
L++ CW ++P+ RP+F I L+ +
Sbjct: 234 ELMKLCWKKDPDERPTFEYIQSFLEDY 260
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 1e-36
Identities = 82/265 (30%), Positives = 132/265 (49%), Gaps = 19/265 (7%)
Query: 443 EGSFGTVYHAEWRNS------DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 496
EG+FG +++ + +V VK + + E + L+E ++ GL H NI+ ++
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA-SEIQVTLLLQESCLLYGLSHQNILPIL 74
Query: 497 GAVTEPPNLSIVTE-YLSRGSLYKLLHIP-----DARVVVDERLRLNMAYDVAKGMNYLH 550
E V Y++ G+L L + + + ++MA +A GM+YLH
Sbjct: 75 HVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH 134
Query: 551 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK-PNTYISSKTAAGTP-EWMAPEVLR 608
+R ++H+D+ + N ++D VK+ D LSR P Y P +WMA E L
Sbjct: 135 KRG--VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLV 192
Query: 609 EDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAAL 667
+ SDV+SFGV+LWEL+TL Q P+ P + ++A G RL P N + A+
Sbjct: 193 NKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE-MAAYLKDGYRLAQPINCPDELFAV 251
Query: 668 IETCWAEEPEIRPSFPSIMETLQQF 692
+ CWA +PE RPSF +++ L F
Sbjct: 252 MACCWALDPEERPSFSQLVQCLTDF 276
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 1e-36
Identities = 88/280 (31%), Positives = 148/280 (52%), Gaps = 21/280 (7%)
Query: 429 EIRWSELLIKKKIGEGSFGTVYHAEWR-------NSDVAVKILIEQEFHEDRFKEFLREV 481
E+ ++ + +++G+GSFG VY + + VA+K + E +R EFL E
Sbjct: 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERI-EFLNEA 60
Query: 482 AIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHI--PDARVVVDERL----- 534
++MK ++V L+G V++ ++ E ++RG L L P+ +
Sbjct: 61 SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKK 120
Query: 535 RLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKT 594
+ MA ++A GM YL+ + VHRDL + N +V +TVK+ DFG++R T K
Sbjct: 121 MIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 178
Query: 595 AAG--TPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKG 651
G WM+PE L++ SDV+SFGV+LWE+ TL ++P++ + QV+ V +G
Sbjct: 179 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV-MEG 237
Query: 652 RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 691
L+ P N M+ L+ CW P++RPSF I+ ++++
Sbjct: 238 GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 1e-36
Identities = 90/269 (33%), Positives = 127/269 (47%), Gaps = 21/269 (7%)
Query: 439 KKIGEGSFGTVYHAEWRNSD-------VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN 491
+ +G G+FG VY +R D VAVK L E +D +FL E IM H N
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDE-SDFLMEALIMSKFNHQN 70
Query: 492 IVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLR----LNMAYDVAKGMN 547
IV L+G E I+ E ++ G L L R L L A DVAKG
Sbjct: 71 IVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCK 130
Query: 548 YLHQRRPPIVHRDLKSPNLLVDST---YTVKVCDFGLSRS--KPNTYISSKTAAGTPEWM 602
YL + +HRD+ + N L+ K+ DFG++R + + Y A +WM
Sbjct: 131 YLEENH--FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWM 188
Query: 603 APEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVN 661
PE + K+DV+SFGV+LWE+ +L P+ T +V+ V G RL+ PK
Sbjct: 189 PPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFV-TGGGRLDPPKGCP 247
Query: 662 PMVAALIETCWAEEPEIRPSFPSIMETLQ 690
V ++ CW PE RP+F +I+E +Q
Sbjct: 248 GPVYRIMTDCWQHTPEDRPNFATILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 1e-36
Identities = 98/268 (36%), Positives = 141/268 (52%), Gaps = 15/268 (5%)
Query: 429 EIRWSELLIKKKIGEGSFGTVYHAEWR-NSDVAVKILIEQEFHEDRFKEFLREVAIMKGL 487
EI L ++ K+G+G FG V+ W + VA+K L + FL+E +MK L
Sbjct: 2 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMKKL 58
Query: 488 RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 547
RH +V L V+E P + IVTEY+S+GSL L + + +L ++MA +A GM
Sbjct: 59 RHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQL-VDMAAQIASGMA 116
Query: 548 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPNTYISSKTAAGTPEWMAPEV 606
Y+ R VHRDL++ N+LV KV DFGL+R + N Y + + A +W APE
Sbjct: 117 YV--ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 174
Query: 607 LREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 665
KSDV+SFG++L EL T + P+ +V+ V +G R+ P +
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPESLH 233
Query: 666 ALIETCWAEEPEIRPSFPSIMETLQQFL 693
L+ CW +EPE RP+F E LQ FL
Sbjct: 234 DLMCQCWRKEPEERPTF----EYLQAFL 257
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 2e-36
Identities = 94/303 (31%), Positives = 154/303 (50%), Gaps = 32/303 (10%)
Query: 424 EEEGLEIRWSELLIKKKIGEGSFGTVYHAEW---------RNSDVAVKILIEQEFHEDRF 474
E+ E+ L++ K +GEG FG V AE R + VAVK+L + + E
Sbjct: 9 EDPRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKML-KSDATEKDL 67
Query: 475 KEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL------------ 521
+ + E+ +MK + +H NI+ L+GA T+ L ++ EY S+G+L + L
Sbjct: 68 SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCY 127
Query: 522 ---HIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCD 578
+P+ ++ + + + AY VA+GM YL ++ +HRDL + N+LV +K+ D
Sbjct: 128 NPTQVPEEQLSFKDLV--SCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIAD 183
Query: 579 FGLSRSKPNTYISSKTAAG--TPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWR 636
FGL+R + KT G +WMAPE L + +SDV+SFGV+LWE+ TL
Sbjct: 184 FGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 243
Query: 637 NSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 696
P + + + +G R++ P N + ++ CW P RP+F ++E L + L +
Sbjct: 244 PGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303
Query: 697 VCQ 699
Q
Sbjct: 304 SNQ 306
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 3e-36
Identities = 80/256 (31%), Positives = 121/256 (47%), Gaps = 14/256 (5%)
Query: 437 IKKKIGEGSFGTVYHAEW--RNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 494
+ + IG G+ VY A N VA+K I+ E + E +EV M HPN+V
Sbjct: 5 LIEVIGVGATAVVYAAICLPNNEKVAIKR-IDLEKCQTSVDELRKEVQAMSQCNHPNVVK 63
Query: 495 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 554
+ L +V YLS GSL ++ R +DE + + +V KG+ YLH
Sbjct: 64 YYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG- 122
Query: 555 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRS----KPNTYISSKTAAGTPEWMAPEVLRED 610
+HRD+K+ N+L+ +VK+ DFG+S S T KT GTP WMAPEV+ +
Sbjct: 123 -QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQV 181
Query: 611 PS-NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG-RRLEIPKNVNPMVAA-- 666
+ K+D++SFG+ EL T P+ P +V+ LE + +
Sbjct: 182 HGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFR 241
Query: 667 -LIETCWAEEPEIRPS 681
+I C ++P RP+
Sbjct: 242 KMISLCLQKDPSKRPT 257
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 138 bits (348), Expect = 3e-36
Identities = 95/295 (32%), Positives = 149/295 (50%), Gaps = 28/295 (9%)
Query: 424 EEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD---------VAVKILIEQEFHEDRF 474
E+ E +L + K +GEG FG V AE D VAVK+L + +D
Sbjct: 6 EDPRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKD-L 64
Query: 475 KEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIP--------- 524
+ + E+ +MK + +H NI+ L+GA T+ L ++ EY S+G+L + L
Sbjct: 65 SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 124
Query: 525 DARVVVDERLR----LNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFG 580
D V DE++ ++ Y VA+GM YL ++ +HRDL + N+LV +K+ DFG
Sbjct: 125 DIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFG 182
Query: 581 LSRSKPNTYISSKTAAG--TPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNS 638
L+R N KT G +WMAPE L + +SDV+SFGV++WE+ TL
Sbjct: 183 LARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 242
Query: 639 TPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 693
P + + + +G R++ P N + ++ CW P RP+F ++E L + L
Sbjct: 243 IPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL 297
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 4e-36
Identities = 82/239 (34%), Positives = 123/239 (51%), Gaps = 15/239 (6%)
Query: 437 IKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKE-FLREVAIMKGLRHP-NIVL 494
I +K+GEGSFG VY A VA+K+L ++ + + E FLRE+ I+ L HP NIV
Sbjct: 4 ILRKLGEGSFGEVYLAR-DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVK 62
Query: 495 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 554
L + +L +V EY+ GSL LL + + E L + + + YLH +
Sbjct: 63 LYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG- 121
Query: 555 PIVHRDLKSPNLLVDSTYT-VKVCDFGLSRSKPNTYISS------KTAAGTPEWMAPEVL 607
I+HRD+K N+L+D VK+ DFGL++ P+ +S T+ GTP +MAPEVL
Sbjct: 122 -IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVL 180
Query: 608 R---EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPM 663
++ SD++S G+ L+EL+T P+ S S L P +P+
Sbjct: 181 LGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPL 239
|
Length = 384 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 1e-35
Identities = 69/208 (33%), Positives = 113/208 (54%), Gaps = 16/208 (7%)
Query: 437 IKKKIGEGSFGTVYHAE--WRNSDVAVK-ILIEQEFHEDRFKEFLREVAIMKGLRHPNIV 493
I+KKIG+G F VY A VA+K + I + ++ L+E+ ++K L HPN++
Sbjct: 6 IEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVI 65
Query: 494 LLMGAVTEPPNLSIVTEYLSRGSLYKLL-HIPDARVVVDERLRLNMAYDVAKGMNYLHQR 552
+ + E L+IV E G L +++ H + ++ ER + + ++H +
Sbjct: 66 KYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK 125
Query: 553 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAA-----GTPEWMAPEVL 607
R I+HRD+K N+ + +T VK+ D GL R + SSKT A GTP +M+PE +
Sbjct: 126 R--IMHRDIKPANVFITATGVVKLGDLGLGR-----FFSSKTTAAHSLVGTPYYMSPERI 178
Query: 608 REDPSNEKSDVFSFGVILWELITLQKPW 635
E+ N KSD++S G +L+E+ LQ P+
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSPF 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 1e-35
Identities = 93/282 (32%), Positives = 135/282 (47%), Gaps = 36/282 (12%)
Query: 439 KKIGEGSFGTV----YHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNI 492
+++G+G+FG+V Y N+ VAVK L Q + ++F RE+ I+K L+H NI
Sbjct: 10 QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKL--QHSTAEHLRDFEREIEILKSLQHDNI 67
Query: 493 VLLMGAVTEP--PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLH 550
V G NL +V EYL GSL L R+ D R L A + KGM YL
Sbjct: 68 VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERL--DHRKLLLYASQICKGMEYLG 125
Query: 551 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP--NTYISSKTAAGTPE-WMAPEVL 607
+R VHRDL + N+LV+S VK+ DFGL++ P Y + +P W APE L
Sbjct: 126 SKR--YVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESL 183
Query: 608 REDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQV-ISAVGF----------------K 650
E + SDV+SFGV+L+EL T ++ +P + +G
Sbjct: 184 TESKFSVASDVWSFGVVLYELFTYSD--KSCSPPAEFMRMMGNDKQGQMIVYHLIELLKN 241
Query: 651 GRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQF 692
RL P + A+++ CW +P RPSF + ++
Sbjct: 242 NGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 2e-35
Identities = 98/287 (34%), Positives = 146/287 (50%), Gaps = 25/287 (8%)
Query: 430 IRWSELLIKKKIGEGSFGTVYHAEWRN----SD---VAVKILIEQEFHEDRFKEFLREVA 482
I+ +++K+++GEG+FG V+ AE N D VAVK L ++ ++ K+F RE
Sbjct: 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTL--KDASDNARKDFHREAE 59
Query: 483 IMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL--HIPDARVVVD--------E 532
++ L+H +IV G E L +V EY+ G L K L H PDA ++ + +
Sbjct: 60 LLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQ 119
Query: 533 RLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT-YIS 591
L++A +A GM YL + VHRDL + N LV VK+ DFG+SR +T Y
Sbjct: 120 SQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYR 177
Query: 592 SKTAAGTP-EWMAPEVLREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGF 649
P WM PE + +SDV+S GV+LWE+ T K PW + ++VI +
Sbjct: 178 VGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT- 236
Query: 650 KGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 696
+GR L+ P+ V L+ CW EP +R + I LQ +S
Sbjct: 237 QGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKAS 283
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 3e-35
Identities = 88/267 (32%), Positives = 147/267 (55%), Gaps = 11/267 (4%)
Query: 429 EIRWSELLIKKKIGEGSFGTVYHAEW-RNSDVAVKILIEQEFHEDRFKEFLREVAIMKGL 487
EI L ++KK+G G FG V+ A + +++ VAVK + + FL E +MK L
Sbjct: 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM---SVEAFLAEANVMKTL 58
Query: 488 RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 547
+H +V L VT+ P + I+TE++++GSL L + +L ++ + +A+GM
Sbjct: 59 QHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKL-IDFSAQIAEGMA 116
Query: 548 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEV 606
++ QR +HRDL++ N+LV ++ K+ DFGL+R + N Y + + A +W APE
Sbjct: 117 FIEQRN--YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEA 174
Query: 607 LREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 665
+ KSDV+SFG++L E++T + P+ + +VI A+ +G R+ P+N +
Sbjct: 175 INFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-RGYRMPRPENCPEELY 233
Query: 666 ALIETCWAEEPEIRPSFPSIMETLQQF 692
++ CW PE RP+F I L F
Sbjct: 234 NIMMRCWKNRPEERPTFEYIQSVLDDF 260
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 3e-35
Identities = 96/281 (34%), Positives = 141/281 (50%), Gaps = 29/281 (10%)
Query: 429 EIRWSELLIKKKIGEGSFGTVYHAE-----WRNSDVAVKILIEQEFHE-DRFKEFLREVA 482
EI S + +++GEG+FG VY E R S +V I +E E +EF +E
Sbjct: 1 EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAE 60
Query: 483 IMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL--HIPDARVVVDERLR----- 535
+M L+HPNIV L+G T+ ++ EYL+ G L++ L + P + V +
Sbjct: 61 LMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSS 120
Query: 536 ------LNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNT 588
L++A +A GM YL VHRDL + N LV TVK+ DFGLSR
Sbjct: 121 LDCSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSAD 178
Query: 589 YISSKTAAGTP-EWMAPEVLREDPSNEKSDVFSFGVILWELIT--LQKPWRNSTPSQVIS 645
Y ++ + P WM PE + +SD++SFGV+LWE+ + LQ P+ + +VI
Sbjct: 179 YYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQ-PYYGFSNQEVIE 237
Query: 646 AVGFKGRR-LEIPKNVNPMVAALIETCWAEEPEIRPSFPSI 685
+ + R+ L P++ V AL+ CW E P RP F I
Sbjct: 238 MI--RSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 5e-35
Identities = 86/261 (32%), Positives = 139/261 (53%), Gaps = 21/261 (8%)
Query: 441 IGEGSFGTVYHAEWRNSD--VAVKILI---EQEFHEDRFKEFL----REVAIMKGLRHPN 491
IG GSFG+VY +S +AVK + +DR + L RE+A++K L+H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 492 IVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 551
IV +G+ + +L+I EY+ GS+ LL+ A +E L N + KG+NYLH
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGA---FEETLVRNFVRQILKGLNYLHN 124
Query: 552 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPE------WMAPE 605
R I+HRD+K N+LVD+ +K+ DFG+S+ +S+KT P WMAPE
Sbjct: 125 RG--IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPE 182
Query: 606 VLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 665
V+++ K+D++S G ++ E++T + P+ + T Q I +G EIP N++
Sbjct: 183 VVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASP-EIPSNISSEAI 241
Query: 666 ALIETCWAEEPEIRPSFPSIM 686
+E + + RP+ ++
Sbjct: 242 DFLEKTFEIDHNKRPTAAELL 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 133 bits (335), Expect = 6e-35
Identities = 83/266 (31%), Positives = 131/266 (49%), Gaps = 23/266 (8%)
Query: 439 KKIGEGSFGTV----YHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 494
++G G+FGTV Y + VAVKIL E LRE +M+ L +P IV
Sbjct: 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVR 60
Query: 495 LMGAVTEPPNLSIVTEYLSRGSLYKLL----HIPDARVVVDERLRLNMAYDVAKGMNYLH 550
++G + E + +V E G L K L H+ + + + + V+ GM YL
Sbjct: 61 MIG-ICEAESWMLVMELAELGPLNKFLQKNKHVTEKNIT-------ELVHQVSMGMKYLE 112
Query: 551 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR--SKPNTYISSKTAAGTP-EWMAPEVL 607
+ VHRDL + N+L+ + + K+ DFGLS+ Y +KT P +W APE +
Sbjct: 113 ETN--FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECM 170
Query: 608 REDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA 666
+ KSDV+SFGV++WE + QKP++ ++V + G R+E P+ P +
Sbjct: 171 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIE-SGERMECPQRCPPEMYD 229
Query: 667 LIETCWAEEPEIRPSFPSIMETLQQF 692
L++ CW + RP F + L+ +
Sbjct: 230 LMKLCWTYGVDERPGFAVVELRLRNY 255
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 133 bits (335), Expect = 1e-34
Identities = 95/280 (33%), Positives = 136/280 (48%), Gaps = 33/280 (11%)
Query: 441 IGEGSFGTVYHAEW-------RNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIV 493
IG+G+FG V+ A + VAVK+L E E D +F RE A+M HPNIV
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKE-EASADMQADFQREAALMAEFDHPNIV 71
Query: 494 LLMGAVTEPPNLSIVTEYLSRGSLYKLLH-------------IPDARVVVDERLRLN--- 537
L+G + ++ EY++ G L + L AR L L+
Sbjct: 72 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTE 131
Query: 538 ---MAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS--KPNTYISS 592
+A VA GM YL +R+ VHRDL + N LV VK+ DFGLSR+ + Y +S
Sbjct: 132 QLCIAKQVAAGMAYLSERK--FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 593 KTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKG 651
+ A WM PE + + +SDV+++GV+LWE+ + +P+ +VI V G
Sbjct: 190 ENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVR-DG 248
Query: 652 RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 691
L P N + L+ CW++ P RPSF SI LQ+
Sbjct: 249 NVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 1e-34
Identities = 95/290 (32%), Positives = 149/290 (51%), Gaps = 28/290 (9%)
Query: 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD---------VAVKILIEQEFHEDRFKEFLR 479
E+ + L + K +GEG FG V AE D VAVK+L + +D + +
Sbjct: 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKD-LSDLVS 66
Query: 480 EVAIMKGL-RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIP---------DARVV 529
E+ +MK + +H NI+ L+GA T+ L ++ EY S+G+L + L D +
Sbjct: 67 EMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKL 126
Query: 530 VDERLR----LNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK 585
+E+L ++ AY VA+GM YL ++ +HRDL + N+LV +K+ DFGL+R
Sbjct: 127 PEEQLTFKDLVSCAYQVARGMEYLASQK--CIHRDLAARNVLVTEDNVMKIADFGLARDV 184
Query: 586 PNTYISSKTAAG--TPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQV 643
N KT G +WMAPE L + +SDV+SFGV+LWE+ TL P +
Sbjct: 185 HNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 244
Query: 644 ISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 693
+ + +G R++ P N + ++ CW P RP+F ++E L + L
Sbjct: 245 LFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 95/284 (33%), Positives = 141/284 (49%), Gaps = 30/284 (10%)
Query: 432 WSELLIKKKIGEGSFGTVYHAEWRNS----DVAVKILIEQEFHEDRFKEFLREVAIMKGL 487
W ++ + IGEG+FG V A + + A+K+L E D ++F E+ ++ L
Sbjct: 1 WEDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDH-RDFAGELEVLCKL 59
Query: 488 -RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVV---------------VD 531
HPNI+ L+GA L I EY G+L L +RV+ +
Sbjct: 60 GHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLR--KSRVLETDPAFAKEHGTASTLT 117
Query: 532 ERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS 591
+ L A DVA GM YL +++ +HRDL + N+LV K+ DFGLSR + Y+
Sbjct: 118 SQQLLQFASDVATGMQYLSEKQ--FIHRDLAARNVLVGENLASKIADFGLSRGE-EVYVK 174
Query: 592 SKTAAGTP-EWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGF 649
KT P WMA E L KSDV+SFGV+LWE+++L P+ T +++ +
Sbjct: 175 -KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLP- 232
Query: 650 KGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 693
+G R+E P+N + V L+ CW + P RP F I L + L
Sbjct: 233 QGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRML 276
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 3e-34
Identities = 70/250 (28%), Positives = 130/250 (52%), Gaps = 8/250 (3%)
Query: 434 ELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIE---QEFHEDRFKEFLREVAIMKGLRHP 490
+ I KIG+GSFG V+ R +D V + + + + +E + E ++ L
Sbjct: 1 DFEILNKIGKGSFGVVFKVV-RKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSS 59
Query: 491 NIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLH 550
I+ + + L+IV EY G L+KLL + R + ++++ + G+ +LH
Sbjct: 60 YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQV-WRFFIQILLGLAHLH 118
Query: 551 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRED 610
++ I+HRD+KS NL +D+ VK+ D G+++ + + T GTP +++PE+ +
Sbjct: 119 SKK--ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDK 176
Query: 611 PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIET 670
P NEKSDV++ GV+L+E T + P+ + +I + +G + + + +A LI+
Sbjct: 177 PYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKI-IRGVFPPVSQMYSQQLAQLIDQ 235
Query: 671 CWAEEPEIRP 680
C ++ RP
Sbjct: 236 CLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 7e-34
Identities = 84/270 (31%), Positives = 131/270 (48%), Gaps = 35/270 (12%)
Query: 431 RWSELLIKKKIGEGSFGTVYHAEWRNSD----VAVKILIEQEFHEDRFKEFLREVAIMKG 486
RW KIG G+FG VY A N D +AVK + Q+ KE E+ +++
Sbjct: 1 RWQRG---NKIGGGTFGKVYTA--VNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLEL 55
Query: 487 LRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLH---IPDARVVVDERLRLNMAYDVA 543
L+HPN+V G + I EY S G+L +LL I D V+ Y +
Sbjct: 56 LKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVI--------RVYTLQ 107
Query: 544 --KGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYI---SSKTAAG 597
+G+ YLH IVHRD+K N+ +D +K+ DFG + + K NT ++ AG
Sbjct: 108 LLEGLAYLHSHG--IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAG 165
Query: 598 TPEWMAPEVLREDPSNEK---SDVFSFGVILWELITLQKPWRN-STPSQVISAVGFKGRR 653
TP +MAPEV+ +D++S G ++ E+ T ++PW Q++ VG G +
Sbjct: 166 TPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHK 224
Query: 654 LEIPKN--VNPMVAALIETCWAEEPEIRPS 681
IP + ++P ++ C +P+ RP+
Sbjct: 225 PPIPDSLQLSPEGKDFLDRCLESDPKKRPT 254
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 75/282 (26%), Positives = 121/282 (42%), Gaps = 37/282 (13%)
Query: 437 IKKKIGEGSFGTVYHAEWR--NSDVAVKIL----IEQEFHEDRFKEFLREVAIMKGL-RH 489
K IGEGSF TV A+ + N + A+KIL + +E K E ++ L H
Sbjct: 5 FGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKV---KYVKIEKEVLTRLNGH 61
Query: 490 PNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 549
P I+ L + NL V EY G L + + +DE+ A ++ + YL
Sbjct: 62 PGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYL 118
Query: 550 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFG----LSRSKPNT----------------Y 589
H + I+HRDLK N+L+D +K+ DFG L +
Sbjct: 119 HSKG--IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNR 176
Query: 590 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGF 649
+ GT E+++PE+L E P+ + SD+++ G I+++++T + P+R S +
Sbjct: 177 RRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKI-- 234
Query: 650 KGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 691
P N P LIE +P+ R + L+
Sbjct: 235 LKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 1e-33
Identities = 77/261 (29%), Positives = 127/261 (48%), Gaps = 27/261 (10%)
Query: 441 IGEGSFGTVYHAEWRNSDVAVKILIEQ--------EFHEDRFKEFLR----EVAIMKGLR 488
IG+G++G VY A N + ++Q H+ R K+ ++ E+ +K L
Sbjct: 9 IGKGTYGRVYLA--LNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66
Query: 489 HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 548
H NIV +G T LSI EY+ GS+ L +E+L V +G+ Y
Sbjct: 67 HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGR---FEEQLVRFFTEQVLEGLAY 123
Query: 549 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAA--GTPEWMAPEV 606
LH + I+HRDLK+ NLLVD+ K+ DFG+S+ + Y + + + G+ WMAPEV
Sbjct: 124 LHSKG--ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEV 181
Query: 607 LREDPS--NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPK----NV 660
+ + K D++S G ++ E+ ++PW + + +G K IP N+
Sbjct: 182 IHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNL 241
Query: 661 NPMVAALIETCWAEEPEIRPS 681
+P+ + C+ P+ RP+
Sbjct: 242 SPVALDFLNACFTINPDNRPT 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 130 bits (327), Expect = 1e-33
Identities = 86/269 (31%), Positives = 138/269 (51%), Gaps = 20/269 (7%)
Query: 439 KKIGEGSFGTVYHAEWRNSD-----VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIV 493
+ +G+G FG+V A+ ++ D VAVK+L F +EFLRE A MK HPN++
Sbjct: 5 RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVI 64
Query: 494 LLMG------AVTEPPNLSIVTEYLSRGSLYKLL---HIPDARVVVDERLRLNMAYDVAK 544
L+G A P ++ ++ G L+ L I + + + + D+A
Sbjct: 65 KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124
Query: 545 GMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTP-EWM 602
GM YL + +HRDL + N +++ TV V DFGLS+ Y A+ P +W+
Sbjct: 125 GMEYLSSKN--FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWL 182
Query: 603 APEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVN 661
A E L ++ SDV++FGV +WE++T Q P+ S++ + + KG RL+ P +
Sbjct: 183 ALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYL-IKGNRLKQPPDCL 241
Query: 662 PMVAALIETCWAEEPEIRPSFPSIMETLQ 690
V L+ CW+ EP+ RPSF + + L+
Sbjct: 242 EDVYELMCQCWSPEPKCRPSFQHLRDQLE 270
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 1e-33
Identities = 84/252 (33%), Positives = 126/252 (50%), Gaps = 9/252 (3%)
Query: 441 IGEGSFGTVYHAEWRN-SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAV 499
+G+G+FG V+ ++ + VAVK E E + K FL E I+K HPNIV L+G
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIK-FLSEARILKQYDHPNIVKLIGVC 61
Query: 500 TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHR 559
T+ + IV E + G L + + ++ A D A GM YL + +HR
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKF--ALDAAAGMAYLESKN--CIHR 117
Query: 560 DLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP-EWMAPEVLREDPSNEKSDV 618
DL + N LV +K+ DFG+SR + + SS P +W APE L + +SDV
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDV 177
Query: 619 FSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPE 677
+S+G++LWE +L P+ T Q V KG R+ P+ V +++ CW +PE
Sbjct: 178 WSYGILLWETFSLGVCPYPGMTNQQAREQVE-KGYRMSCPQKCPDDVYKVMQRCWDYKPE 236
Query: 678 IRPSFPSIMETL 689
RP F + + L
Sbjct: 237 NRPKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 4e-33
Identities = 95/301 (31%), Positives = 143/301 (47%), Gaps = 50/301 (16%)
Query: 434 ELLIKKKIGEGSFGTVYHAEW----------------RNSDVAVKILIEQEFHEDRFKEF 477
+L +K+K+GEG FG V+ E + VAVK+L + + +F
Sbjct: 6 QLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKML-RADVTKTARNDF 64
Query: 478 LREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL-------------HIP 524
L+E+ IM L++PNI+ L+G L ++TEY+ G L + L +IP
Sbjct: 65 LKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIP 124
Query: 525 DARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 584
V L MA +A GM YL VHRDL + N LV + YT+K+ DFG+SR+
Sbjct: 125 S----VSIANLLYMAVQIASGMKYLASLN--FVHRDLATRNCLVGNHYTIKIADFGMSRN 178
Query: 585 -KPNTYISSKTAAGTP-EWMAPEVLREDPSNEKSDVFSFGVILWELITL--QKPWRNSTP 640
Y + A P WMA E + SDV++FGV LWE+ TL ++P+ +
Sbjct: 179 LYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD 238
Query: 641 SQVISAVG--FKGRRLEIPKNVNPM----VAALIETCWAEEPEIRPSFPSIMETLQQFLM 694
QVI G F+ + +I + P+ V L+ CW+ + + RP+F + FL
Sbjct: 239 EQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTF----NKIHHFLR 294
Query: 695 S 695
Sbjct: 295 E 295
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (319), Expect = 9e-33
Identities = 93/274 (33%), Positives = 140/274 (51%), Gaps = 28/274 (10%)
Query: 441 IGEGSFGTVYHAEWRNS----DVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLL 495
IGEG+FG V A + D A+K + E +D ++F E+ ++ L HPNI+ L
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH-RDFAGELEVLCKLGHHPNIINL 61
Query: 496 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVV---------------VDERLRLNMAY 540
+GA L + EY G+L L +RV+ + + L+ A
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLR--KSRVLETDPAFAIANSTASTLSSQQLLHFAA 119
Query: 541 DVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPE 600
DVA+GM+YL Q++ +HRDL + N+LV Y K+ DFGLSR + Y+
Sbjct: 120 DVARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIADFGLSRGQ-EVYVKKTMGRLPVR 176
Query: 601 WMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKN 659
WMA E L SDV+S+GV+LWE+++L P+ T +++ + +G RLE P N
Sbjct: 177 WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-QGYRLEKPLN 235
Query: 660 VNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 693
+ V L+ CW E+P RPSF I+ +L + L
Sbjct: 236 CDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 128 bits (322), Expect = 9e-33
Identities = 97/294 (32%), Positives = 141/294 (47%), Gaps = 41/294 (13%)
Query: 435 LLIKKKIGEGSFGTVYHAE------WRNSD------------VAVKILIEQEFHEDRFKE 476
L K+K+GEG FG V+ E + + D VAVK+L E R +
Sbjct: 7 LTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNAR-ND 65
Query: 477 FLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL---------HIPDAR 527
FL+E+ IM L+ PNI+ L+ L ++TEY+ G L + L D
Sbjct: 66 FLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVV 125
Query: 528 VVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS--K 585
+ L MA +A GM YL VHRDL + N LV YT+K+ DFG+SR+
Sbjct: 126 TISYSTLI-FMATQIASGMKYLSSLN--FVHRDLATRNCLVGKNYTIKIADFGMSRNLYS 182
Query: 586 PNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL--QKPWRNSTPSQV 643
+ Y A WM+ E + SDV++FGV LWE++TL ++P+ + QV
Sbjct: 183 GDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQV 242
Query: 644 ISAVG--FK--GRRLEIPK-NVNP-MVAALIETCWAEEPEIRPSFPSIMETLQQ 691
I G F+ GR++ +PK + P + L+ +CW + RPSF I TL +
Sbjct: 243 IENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 77/252 (30%), Positives = 124/252 (49%), Gaps = 15/252 (5%)
Query: 439 KKIGEGSFGTVY--HAEWRNSDVAVK-ILIEQEFHEDR--FKEFLREVAIMKGLRHPNIV 493
K +G+G+FG VY + ++AVK + + + E + E+ ++K L+H IV
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 494 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 553
G + + LSI EY+ GS+ L A + E + + +G+ YLH
Sbjct: 68 QYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGA---LTETVTRKYTRQILEGVEYLHSNM 124
Query: 554 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISS----KTAAGTPEWMAPEVLRE 609
IVHRD+K N+L DS VK+ DFG S+ + T SS K+ GTP WM+PEV+
Sbjct: 125 --IVHRDIKGANILRDSAGNVKLGDFGASK-RLQTICSSGTGMKSVTGTPYWMSPEVISG 181
Query: 610 DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE 669
+ K+DV+S G + E++T + PW I + + ++P +V+P +
Sbjct: 182 EGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLR 241
Query: 670 TCWAEEPEIRPS 681
+ E + RPS
Sbjct: 242 RTFVENAKKRPS 253
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 1e-32
Identities = 90/280 (32%), Positives = 141/280 (50%), Gaps = 34/280 (12%)
Query: 439 KKIGEGSFGTV--YHAEWRNSD----VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNI 492
+ +GEG FG V Y + N VAVK L ++E + + +E+ I+K L H NI
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTL-KRECGQQNTSGWKKEINILKTLYHENI 68
Query: 493 VLLMGAVTEP--PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLH 550
V G +E L ++ EY+ GSL L P ++ + + L A + +GM YLH
Sbjct: 69 VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL--PKHKLNLAQLLLF--AQQICEGMAYLH 124
Query: 551 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP--NTYISSKTAAGTPE-WMAPEVL 607
+ +HRDL + N+L+D+ VK+ DFGL+++ P + Y + +P W A E L
Sbjct: 125 SQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECL 182
Query: 608 REDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGF---------------KGR 652
+E+ + SDV+SFGV L+EL+T + S P + +G +G
Sbjct: 183 KENKFSYASDVWSFGVTLYELLTHCDSKQ-SPPKKFEEMIGPKQGQMTVVRLIELLERGM 241
Query: 653 RLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQF 692
RL PKN V L++ CW E + RP+F S++ L++
Sbjct: 242 RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 73/260 (28%), Positives = 127/260 (48%), Gaps = 20/260 (7%)
Query: 441 IGEGSFGTVYHAEWRNSD--VAVKILIEQEFH-EDRFKEFLREVAIMKGLRHPNIVLLMG 497
I +G++G V+ A+ +++ A+K++ + + +++ + L E I+ + P +V L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 498 AVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 557
+ NL +V EYL G L LL + +DE + ++ + YLH I+
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGS---LDEDVARIYIAEIVLALEYLHSNG--II 115
Query: 558 HRDLKSPNLLVDSTYTVKVCDFGLSR--------SKPNTYISSKTAAGTPEWMAPEVLRE 609
HRDLK N+L+DS +K+ DFGLS+ + + K GTP+++APEV+
Sbjct: 116 HRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILG 175
Query: 610 DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA--L 667
++ D +S G IL+E + P+ TP ++ + ++E P++V A L
Sbjct: 176 QGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNI--LNGKIEWPEDVEVSDEAIDL 233
Query: 668 IETCWAEEPEIRPSFPSIME 687
I +PE R SI E
Sbjct: 234 ISKLLVPDPEKRLGAKSIEE 253
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 2e-32
Identities = 76/252 (30%), Positives = 133/252 (52%), Gaps = 8/252 (3%)
Query: 439 KKIGEGSFGTVYHAEWRNSD---VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 495
KKIGEGSFG + + V +I I + ++R +E +EVA++ ++HPNIV
Sbjct: 6 KKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKER-EESRKEVAVLSNMKHPNIVQY 64
Query: 496 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 555
+ E NL IV +Y G LYK ++ V+ E L+ + + ++H R+
Sbjct: 65 QESFEENGNLYIVMDYCEGGDLYKKINAQRG-VLFPEDQILDWFVQICLALKHVHDRK-- 121
Query: 556 IVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEK 615
I+HRD+KS N+ + T+K+ DFG++R +T ++T GTP +++PE+ P N K
Sbjct: 122 ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNK 181
Query: 616 SDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEE 675
SD+++ G +L+E+ TL+ + ++ + +G + + + + L+ +
Sbjct: 182 SDIWALGCVLYEMCTLKHAFEAGNMKNLVLKI-IRGSYPPVSSHYSYDLRNLVSQLFKRN 240
Query: 676 PEIRPSFPSIME 687
P RPS SI+E
Sbjct: 241 PRDRPSVNSILE 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 127 bits (319), Expect = 2e-32
Identities = 89/264 (33%), Positives = 133/264 (50%), Gaps = 14/264 (5%)
Query: 430 IRWSELLIKKKIGEGSFGTVYHAEWRNSD------VAVKILIEQEFHEDRFKEFLREVAI 483
++ +EL K +G G+FGTVY W VA+KIL E + EF+ E I
Sbjct: 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANV-EFMDEALI 62
Query: 484 MKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVA 543
M + HP++V L+G V P + +VT+ + G L +H + + + +L LN +A
Sbjct: 63 MASMDHPHLVRLLG-VCLSPTIQLVTQLMPHGCLLDYVH--EHKDNIGSQLLLNWCVQIA 119
Query: 544 KGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP--EW 601
KGM YL +RR +VHRDL + N+LV S VK+ DFGL+R G +W
Sbjct: 120 KGMMYLEERR--LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKW 177
Query: 602 MAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVN 661
MA E + +SDV+S+GV +WEL+T + P++ I + KG RL P
Sbjct: 178 MALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICT 237
Query: 662 PMVAALIETCWAEEPEIRPSFPSI 685
V ++ CW + + RP F +
Sbjct: 238 IDVYMVMVKCWMIDADSRPKFKEL 261
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 2e-32
Identities = 75/271 (27%), Positives = 132/271 (48%), Gaps = 32/271 (11%)
Query: 439 KKIGEGSFGTVYHAEWRNSDV------AVKILIEQEF----HEDRFKEFLREVAIMKGLR 488
+++G G+F + Y A DV AVK + E+ + +E+ +M L
Sbjct: 6 QQLGTGAFSSCYQAR----DVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN 61
Query: 489 HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 548
HP+I+ ++GA E + ++ E+++ GS+ LL A E + +N + +G++Y
Sbjct: 62 HPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGA---FKEAVIINYTEQLLRGLSY 118
Query: 549 LHQRRPPIVHRDLKSPNLLVDST-YTVKVCDFGLSRSKPNTYISSK-----TAAGTPEWM 602
LH+ + I+HRD+K NLL+DST +++ DFG + ++ + GT +M
Sbjct: 119 LHENQ--IIHRDVKGANLLIDSTGQRLRIADFG-AAARLAAKGTGAGEFQGQLLGTIAFM 175
Query: 603 APEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPS---QVISAVGFKGRRLEIPKN 659
APEVLR + DV+S G ++ E+ T + PW S +I + IP++
Sbjct: 176 APEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEH 235
Query: 660 VNPMVAALIETCWAEEPEIRPSFPSIMETLQ 690
++P + + C +PE R P E L+
Sbjct: 236 LSPGLRDVTLRCLELQPEDR---PPSRELLK 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 3e-32
Identities = 82/255 (32%), Positives = 138/255 (54%), Gaps = 9/255 (3%)
Query: 437 IKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKE---FLREVAIMKGLRHPNIV 493
I KKIGEGSFG +Y A+ + SD ++ E + + KE +EV ++ ++HPNIV
Sbjct: 4 IIKKIGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIV 62
Query: 494 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 553
+ E L IV EY G L K ++ V+ E L+ ++ G+ ++H R+
Sbjct: 63 TFFASFQENGRLFIVMEYCDGGDLMKRINRQRG-VLFSEDQILSWFVQISLGLKHIHDRK 121
Query: 554 PPIVHRDLKSPNLLVDSTYTV-KVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPS 612
I+HRD+KS N+ + V K+ DFG++R ++ + T GTP +++PE+ + P
Sbjct: 122 --ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPY 179
Query: 613 NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCW 672
N K+D++S G +L+EL TL+ P+ + Q++ + +G I N + + +LI +
Sbjct: 180 NNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKI-CQGYFAPISPNFSRDLRSLISQLF 238
Query: 673 AEEPEIRPSFPSIME 687
P RPS SI++
Sbjct: 239 KVSPRDRPSITSILK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 9e-32
Identities = 81/275 (29%), Positives = 134/275 (48%), Gaps = 19/275 (6%)
Query: 435 LLIKKKIGEGSFGTVYHAEWRNSD----VAVKILIEQEFHEDRFKEFLREVAIMKGLRHP 490
L + K +GEG FG+V + D VAVK + ++FL E MK HP
Sbjct: 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHP 60
Query: 491 NIVLLMGAVTEP------PNLSIVTEYLSRGSLYKLL---HIPDARVVVDERLRLNMAYD 541
N++ L+G + P+ ++ ++ G L+ L + D + ++ + D
Sbjct: 61 NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120
Query: 542 VAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT--YISSKTAAGTP 599
+A GM YL + +HRDL + N +++ V V DFGLS+ N Y + A
Sbjct: 121 IASGMEYLSSKS--FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPV 178
Query: 600 EWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPK 658
+W+A E L + KSDV+SFGV +WE+ T Q P+ S++ + +G RL+ P
Sbjct: 179 KWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLR-QGNRLKQPP 237
Query: 659 NVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 693
+ + +L+ +CW P+ RPSF ++ L++ L
Sbjct: 238 DCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKAL 272
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 70/208 (33%), Positives = 114/208 (54%), Gaps = 26/208 (12%)
Query: 437 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFH--EDRFKEFLREV-AIMKGLRHPN 491
+ K++G+G+FG+VY A + + VA+K + ++F+ E+ LREV ++ K HPN
Sbjct: 3 VIKQLGDGTFGSVYLARNKETGELVAIKKMK-KKFYSWEECMN--LREVKSLRKLNEHPN 59
Query: 492 IVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 551
IV L E L V EY+ G+LY+L+ + + +R ++ Y + +G+ ++H
Sbjct: 60 IVKLKEVFRENDELYFVFEYME-GNLYQLMKDRKGKPFSESVIR-SIIYQILQGLAHIH- 116
Query: 552 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR---SKP--NTYISSKTAAGTPEWM-APE 605
+ HRDLK NLLV VK+ DFGL+R S+P Y+S++ W APE
Sbjct: 117 -KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTR-------WYRAPE 168
Query: 606 VLREDPS-NEKSDVFSFGVILWELITLQ 632
+L S + D+++ G I+ EL TL+
Sbjct: 169 ILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 74/264 (28%), Positives = 139/264 (52%), Gaps = 32/264 (12%)
Query: 441 IGEGSFGTVYHAEWRNSDV--AVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA 498
+G+G+FG VY A+ + + + A KI+ + E+ ++F+ E+ I+ +HPNIV L A
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIES--EEELEDFMVEIDILSECKHPNIVGLYEA 70
Query: 499 VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVH 558
L I+ E+ G+L ++ + R + + ++R + + +N+LH + ++H
Sbjct: 71 YFYENKLWILIEFCDGGALDSIM-LELERGLTEPQIRYVC-RQMLEALNFLHSHK--VIH 126
Query: 559 RDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVL-----REDPSN 613
RDLK+ N+L+ VK+ DFG+S +T T GTP WMAPEV+ +++P +
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYD 186
Query: 614 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA------- 666
K+D++S G+ L EL ++ P P +V+ L+I K+ P +
Sbjct: 187 YKADIWSLGITLIELAQMEPPHHELNPMRVL---------LKILKSEPPTLDQPSKWSSS 237
Query: 667 ---LIETCWAEEPEIRPSFPSIME 687
+++C ++P+ RP+ +++
Sbjct: 238 FNDFLKSCLVKDPDDRPTAAELLK 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 1e-31
Identities = 71/253 (28%), Positives = 118/253 (46%), Gaps = 16/253 (6%)
Query: 441 IGEGSFGTVYHAEWRNSDV--AVKIL----IEQEFHEDRFKEFLREVAIMKGLRHPNIVL 494
+G+GSFG V +++ A+K+L I + + E I+ + HP IV
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLT---ERNILSRINHPFIVK 57
Query: 495 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 554
L A L +V EY G L+ H+ +ER R A ++ + YLH
Sbjct: 58 LHYAFQTEEKLYLVLEYAPGGELFS--HLSKEGRFSEERARFYAA-EIVLALEYLHSLG- 113
Query: 555 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNE 614
I++RDLK N+L+D+ +K+ DFGL++ + + T GTPE++APEVL +
Sbjct: 114 -IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGK 172
Query: 615 KSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAE 674
D +S GV+L+E++T + P+ ++ + L P+ ++P LI +
Sbjct: 173 AVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKI--LKDPLRFPEFLSPEARDLISGLLQK 230
Query: 675 EPEIRPSFPSIME 687
+P R E
Sbjct: 231 DPTKRLGSGGAEE 243
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 1e-31
Identities = 76/259 (29%), Positives = 133/259 (51%), Gaps = 20/259 (7%)
Query: 437 IKKKIGEGSFGTVYHAEWRNSD--------VAVKILIEQEFHEDRFKEFLREVAIMKGLR 488
+ KK+G+GS+G+VY + R SD V + + ++E + + E+ I+ +
Sbjct: 4 VLKKLGKGSYGSVYKVK-RLSDNQFYALKEVDLGSMSQKEREDA-----VNEIRILASVN 57
Query: 489 HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDA-RVVVDERLRLNMAYDVAKGMN 547
HPNI+ A + L IV EY G L K + R ++ E+ + + +G+
Sbjct: 58 HPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQ 117
Query: 548 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVL 607
LH+++ I+HRDLKS N+L+ + VK+ D G+S+ +KT GTP +MAPEV
Sbjct: 118 ALHEQK--ILHRDLKSANILLVANDLVKIGDLGISKVLKKNM--AKTQIGTPHYMAPEVW 173
Query: 608 REDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAAL 667
+ P + KSD++S G +L+E+ T P+ + + V +G+ IP + +
Sbjct: 174 KGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKV-QRGKYPPIPPIYSQDLQNF 232
Query: 668 IETCWAEEPEIRPSFPSIM 686
I + +P++RP+ I+
Sbjct: 233 IRSMLQVKPKLRPNCDKIL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 1e-31
Identities = 74/209 (35%), Positives = 115/209 (55%), Gaps = 8/209 (3%)
Query: 433 SELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHP 490
+L ++G G+ G V R + +AVK I E +E K+ LRE+ I+ P
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKT-IRLEINEAIQKQILRELDILHKCNSP 59
Query: 491 NIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLH 550
IV GA ++SI EY+ GSL K+L + + + ER+ +A V KG+ YLH
Sbjct: 60 YIVGFYGAFYNNGDISICMEYMDGGSLDKIL--KEVQGRIPERILGKIAVAVLKGLTYLH 117
Query: 551 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRED 610
++ I+HRD+K N+LV+S +K+CDFG+S N+ +KT GT +MAPE ++ +
Sbjct: 118 EKHK-IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL--AKTFVGTSSYMAPERIQGN 174
Query: 611 PSNEKSDVFSFGVILWELITLQKPWRNST 639
+ KSD++S G+ L EL T + P+
Sbjct: 175 DYSVKSDIWSLGLSLIELATGRFPYPPEN 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 2e-31
Identities = 80/254 (31%), Positives = 126/254 (49%), Gaps = 27/254 (10%)
Query: 441 IGEGSFGTVY---HAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRH---PNIVL 494
IG G++G VY H VA+KI I + +D + REVA++ LR PNI
Sbjct: 9 IGRGAYGAVYRGKHVP-TGRVVALKI-INLDTPDDDVSDIQREVALLSQLRQSQPPNITK 66
Query: 495 LMGAVTEPPNLSIVTEYLSRGSLYKLLHI-----PDARVVVDERLRLNMAYDVAKGMNYL 549
G+ + P L I+ EY GS+ L+ V++ E L VA + Y+
Sbjct: 67 YYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVL-------VA--LKYI 117
Query: 550 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRE 609
H + ++HRD+K+ N+LV +T VK+CDFG++ T GTP WMAPEV+ E
Sbjct: 118 H--KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITE 175
Query: 610 DPS-NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVG-FKGRRLEIPKNVNPMVAAL 667
+ K+D++S G+ ++E+ T P+ + + + + K RLE + ++
Sbjct: 176 GKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLE-DNGYSKLLREF 234
Query: 668 IETCWAEEPEIRPS 681
+ C EEP+ R S
Sbjct: 235 VAACLDEEPKERLS 248
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 91/280 (32%), Positives = 137/280 (48%), Gaps = 30/280 (10%)
Query: 439 KKIGEGSFGTV----YHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNI 492
+ +GEG FG V Y E N+ VAVK L + E + + +E+ I++ L H NI
Sbjct: 10 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL-KPESGGNHIADLKKEIEILRNLYHENI 68
Query: 493 VLLMGAVTEPPNLSI--VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLH 550
V G TE I + E+L GSL + L P + ++ + +L A + KGM+YL
Sbjct: 69 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PRNKNKINLKQQLKYAVQICKGMDYLG 126
Query: 551 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS--KPNTYISSKTAAGTPE-WMAPEVL 607
R+ VHRDL + N+LV+S + VK+ DFGL+++ Y + K +P W APE L
Sbjct: 127 SRQ--YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECL 184
Query: 608 REDPSNEKSDVFSFGVILWELIT--------------LQKPWRNSTPSQVISAVGFKGRR 653
+ SDV+SFGV L+EL+T + P + V +G+R
Sbjct: 185 IQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKR 244
Query: 654 LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 693
L P N V L+ CW +P R +F +++E + L
Sbjct: 245 LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAIL 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 6e-31
Identities = 66/250 (26%), Positives = 134/250 (53%), Gaps = 8/250 (3%)
Query: 441 IGEGSFG--TVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA 498
+G+G+FG T+Y +S V K + E ++ L E+ I+ L+HPNI+
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67
Query: 499 VTEPPNLSIVTEYLSRGSLY-KLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 557
+ L I EY + G+LY K++ + +E + L + + ++Y+H+ I+
Sbjct: 68 FMDDNTLLIEMEYANGGTLYDKIVRQKGQ--LFEEEMVLWYLFQIVSAVSYIHKAG--IL 123
Query: 558 HRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSD 617
HRD+K+ N+ + +K+ DFG+S+ + Y ++T GTP +M+PE+ + N KSD
Sbjct: 124 HRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSD 183
Query: 618 VFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPE 677
+++ G +L+EL+TL++ + + P ++ + +G + + + +L+ + ++PE
Sbjct: 184 IWALGCVLYELLTLKRTFDATNPLNLVVKI-VQGNYTPVVSVYSSELISLVHSLLQQDPE 242
Query: 678 IRPSFPSIME 687
RP+ +++
Sbjct: 243 KRPTADEVLD 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 122 bits (306), Expect = 8e-31
Identities = 80/264 (30%), Positives = 132/264 (50%), Gaps = 25/264 (9%)
Query: 434 ELLIK-KKIGEGSFGTVYHA-EWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN 491
EL K ++IG+GSFG VY + R +V +I+ E ED ++ +E+ ++ P
Sbjct: 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 492 IVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 551
I G+ + L I+ EYL GS LL P ++E + ++ KG++YLH
Sbjct: 64 ITRYYGSYLKGTKLWIIMEYLGGGSALDLLK-PGP---LEETYIATILREILKGLDYLHS 119
Query: 552 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDP 611
R +HRD+K+ N+L+ VK+ DFG++ +T I T GTP WMAPEV+++
Sbjct: 120 ERK--IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA 177
Query: 612 SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA----- 666
+ K+D++S G+ EL + P + P +V+ IPKN P +
Sbjct: 178 YDFKADIWSLGITAIELAKGEPPNSDLHPMRVL---------FLIPKNSPPTLEGQYSKP 228
Query: 667 ---LIETCWAEEPEIRPSFPSIME 687
+E C ++P RP+ +++
Sbjct: 229 FKEFVEACLNKDPRFRPTAKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 9e-31
Identities = 94/297 (31%), Positives = 135/297 (45%), Gaps = 47/297 (15%)
Query: 433 SELLIKKKIGEGSFGTVYHAEWRNSD------------------VAVKILIEQEFHEDRF 474
LL K+K+GEG FG V+ E N VAVKIL R
Sbjct: 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNAR- 63
Query: 475 KEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL---HIPDAR---- 527
+FL+EV I+ L+ PNI+ L+G + L ++TEY+ G L + L H+ D
Sbjct: 64 NDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGN 123
Query: 528 ---------VVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCD 578
+ L++A +A GM YL VHRDL + N LV T+K+ D
Sbjct: 124 DAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN--FVHRDLATRNCLVGENLTIKIAD 181
Query: 579 FGLSRS-KPNTYISSKTAAGTP-EWMAPEVLREDPSNEKSDVFSFGVILWELITL--QKP 634
FG+SR+ Y + A P WMA E + SDV++FGV LWE++ L ++P
Sbjct: 182 FGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241
Query: 635 WRNSTPSQVISAVG--FKGRRLEI----PKNVNPMVAALIETCWAEEPEIRPSFPSI 685
+ T QVI G F+ + ++ P + L+ CW+ + RPSF I
Sbjct: 242 YGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDI 298
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 68/202 (33%), Positives = 104/202 (51%), Gaps = 18/202 (8%)
Query: 439 KKIGEGSFGTVYHAEWRNSDVAVKI-LIEQEFHEDRF-KEFLREVAIMKGLRHPNIVLLM 496
KIGEG++G VY A + + V I I+ F + K LRE+ ++K L HPNI+ L+
Sbjct: 5 GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLL 64
Query: 497 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 556
+L +V E++ LYKL I D + + E L + Y + +G+ + H I
Sbjct: 65 DVFRHKGDLYLVFEFMDT-DLYKL--IKDRQRGLPESLIKSYLYQLLQGLAFCHSHG--I 119
Query: 557 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPE----WM-APEVLREDP 611
+HRDLK NLL+++ +K+ DFGL+RS S T W APE+L D
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARS-----FGSPVRPYTHYVVTRWYRAPELLLGDK 174
Query: 612 S-NEKSDVFSFGVILWELITLQ 632
+ D++S G I EL++ +
Sbjct: 175 GYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 83/264 (31%), Positives = 133/264 (50%), Gaps = 20/264 (7%)
Query: 430 IRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDR-----FKEFLREVAIM 484
++ +EL K +G G FGTV+ W ++KI + + +DR F+E + M
Sbjct: 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAM 63
Query: 485 KGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAK 544
L H IV L+G + +L +VT+ GSL L H+ R +D + LN +AK
Sbjct: 64 GSLDHAYIVRLLG-ICPGASLQLVTQLSPLGSL--LDHVRQHRDSLDPQRLLNWCVQIAK 120
Query: 545 GMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-----SKPNTYISSKTAAGTP 599
GM YL + R +VHR+L + N+L+ S V++ DFG++ K Y KT
Sbjct: 121 GMYYLEEHR--MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPI--- 175
Query: 600 EWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPK 658
+WMA E + +SDV+S+GV +WE+++ +P+ P +V + KG RL P+
Sbjct: 176 KWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE-KGERLAQPQ 234
Query: 659 NVNPMVAALIETCWAEEPEIRPSF 682
V ++ CW + +RP+F
Sbjct: 235 ICTIDVYMVMVKCWMIDENVRPTF 258
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 120 bits (301), Expect = 4e-30
Identities = 86/269 (31%), Positives = 136/269 (50%), Gaps = 16/269 (5%)
Query: 430 IRWSELLIKKKIGEGSFGTVYHAEWRNSD------VAVKILIEQEFHEDRFKEFLREVAI 483
++ +EL K +G G+FGTVY W VA+K+L E + KE L E +
Sbjct: 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKAN-KEILDEAYV 62
Query: 484 MKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVA 543
M G+ P + L+G + + +VT+ + G L L ++ + + + + LN +A
Sbjct: 63 MAGVGSPYVCRLLG-ICLTSTVQLVTQLMPYGCL--LDYVRENKDRIGSQDLLNWCVQIA 119
Query: 544 KGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR--SKPNTYISSKTAAGTPEW 601
KGM+YL + R +VHRDL + N+LV S VK+ DFGL+R T + +W
Sbjct: 120 KGMSYLEEVR--LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKW 177
Query: 602 MAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNV 660
MA E + +SDV+S+GV +WEL+T KP+ + P++ I + KG RL P
Sbjct: 178 MALESILHRRFTHQSDVWSYGVTVWELMTFGAKPY-DGIPAREIPDLLEKGERLPQPPIC 236
Query: 661 NPMVAALIETCWAEEPEIRPSFPSIMETL 689
V ++ CW + E RP F +++
Sbjct: 237 TIDVYMIMVKCWMIDSECRPRFRELVDEF 265
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 4e-30
Identities = 78/272 (28%), Positives = 129/272 (47%), Gaps = 13/272 (4%)
Query: 429 EIRWSELLIKKKIGEGSFGTVYHA-----EWRNSDVAVKILIEQEFHEDRFKEFLREVAI 483
E+ + I++ +G G FG + R VA+ L + R + FL E
Sbjct: 1 ELDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQR-RGFLAEALT 59
Query: 484 MKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVA 543
+ H NIV L G +T + IVTEY+S G+L L + ++V + + M +A
Sbjct: 60 LGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQ--LMGMLPGLA 117
Query: 544 KGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFG-LSRSKPNTYISSKTAAGTPEWM 602
GM YL + VH+ L + +LV+S K+ F L K ++ + W
Sbjct: 118 SGMKYLSEM--GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWA 175
Query: 603 APEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVN 661
APE ++ + SDV+SFG+++WE+++ ++P+ + + VI AV G RL P+N
Sbjct: 176 APEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVE-DGFRLPAPRNCP 234
Query: 662 PMVAALIETCWAEEPEIRPSFPSIMETLQQFL 693
++ L+ CW +E RP F I L + +
Sbjct: 235 NLLHQLMLDCWQKERGERPRFSQIHSILSKMV 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 88/291 (30%), Positives = 145/291 (49%), Gaps = 35/291 (12%)
Query: 429 EIRWSELLIKKKIGEGSFGTVY----------HAEWRNSDVAVKILIEQEFHEDRFKEFL 478
E+ S + +++GE +FG +Y HA+ VA+K L + + ++ EF
Sbjct: 1 ELPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQL----VAIKTLKDIN-NPQQWGEFQ 55
Query: 479 REVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHI--PDARV-------- 528
+E ++M L HPNIV L+G VT+ + ++ EYL++G L++ L + P + V
Sbjct: 56 QEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDG 115
Query: 529 ----VVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 584
+D L++A +A GM YL VH+DL + N+L+ VK+ D GLSR
Sbjct: 116 TVKSSLDHGDFLHIAIQIAAGMEYLSSHF--FVHKDLAARNILIGEQLHVKISDLGLSRE 173
Query: 585 -KPNTYISSKTAAGTP-EWMAPEVLREDPSNEKSDVFSFGVILWELITLQ-KPWRNSTPS 641
Y + + P WM PE + + SD++SFGV+LWE+ + +P+ +
Sbjct: 174 IYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ 233
Query: 642 QVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQF 692
+VI V K + L ++ P + +L+ CW E P RP F I L+ +
Sbjct: 234 EVIEMVR-KRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRSW 283
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 83/253 (32%), Positives = 130/253 (51%), Gaps = 16/253 (6%)
Query: 439 KKIGEGSFGTVYHAEWRNSD------VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNI 492
K +G G+FGTVY W VA+K L E + KE L E +M + +P++
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-KEILDEAYVMASVDNPHV 71
Query: 493 VLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 552
L+G + + ++T+ + G L L ++ + + + + LN +AKGMNYL +R
Sbjct: 72 CRLLG-ICLTSTVQLITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEER 128
Query: 553 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAG-TP-EWMAPEVLRED 610
R +VHRDL + N+LV + VK+ DFGL++ G P +WMA E +
Sbjct: 129 R--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHR 186
Query: 611 PSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE 669
+SDV+S+GV +WEL+T KP+ + P+ IS++ KG RL P V ++
Sbjct: 187 IYTHQSDVWSYGVTVWELMTFGSKPY-DGIPASEISSILEKGERLPQPPICTIDVYMIMV 245
Query: 670 TCWAEEPEIRPSF 682
CW + + RP F
Sbjct: 246 KCWMIDADSRPKF 258
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 1e-29
Identities = 78/264 (29%), Positives = 129/264 (48%), Gaps = 25/264 (9%)
Query: 434 ELLIK-KKIGEGSFGTVYHA-EWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN 491
EL K ++IG+GSFG V+ + R V +I+ E ED ++ +E+ ++ P
Sbjct: 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 492 IVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 551
+ G+ + L I+ EYL GS LL DE M ++ KG++YLH
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGP----FDEFQIATMLKEILKGLDYLHS 119
Query: 552 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDP 611
+ +HRD+K+ N+L+ VK+ DFG++ +T I T GTP WMAPEV+++
Sbjct: 120 EKK--IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSA 177
Query: 612 SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA----- 666
+ K+D++S G+ EL + P + P +V+ IPKN P +
Sbjct: 178 YDSKADIWSLGITAIELAKGEPPNSDMHPMRVL---------FLIPKNNPPTLTGEFSKP 228
Query: 667 ---LIETCWAEEPEIRPSFPSIME 687
I+ C ++P RP+ +++
Sbjct: 229 FKEFIDACLNKDPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 3e-29
Identities = 80/264 (30%), Positives = 130/264 (49%), Gaps = 25/264 (9%)
Query: 434 ELLIK-KKIGEGSFGTVYHA-EWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN 491
EL K +KIG+GSFG V+ + R V +I+ E ED ++ +E+ ++ P
Sbjct: 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 492 IVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 551
+ G+ + L I+ EYL GS LL P +DE + ++ KG++YLH
Sbjct: 64 VTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-PGP---LDETQIATILREILKGLDYLHS 119
Query: 552 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDP 611
+ +HRD+K+ N+L+ VK+ DFG++ +T I T GTP WMAPEV+++
Sbjct: 120 EKK--IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA 177
Query: 612 SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA----- 666
+ K+D++S G+ EL + P P +V+ IPKN P +
Sbjct: 178 YDSKADIWSLGITAIELAKGEPPHSELHPMKVL---------FLIPKNNPPTLEGNYSKP 228
Query: 667 ---LIETCWAEEPEIRPSFPSIME 687
+E C +EP RP+ +++
Sbjct: 229 LKEFVEACLNKEPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 5e-29
Identities = 77/260 (29%), Positives = 125/260 (48%), Gaps = 22/260 (8%)
Query: 433 SELLIKKKIGEGSFGTVYHA--EWRNSDVAVKILIEQEFHEDRF-KEFLREVAIMKGLRH 489
S+L K +G+GS G VY + A+K + ++ F K+ LRE+ ++
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKI--HVDGDEEFRKQLLRELKTLRSCES 58
Query: 490 PNIVLLMGAVTEPPNLSIVTEYLSRGSL----YKLLHIPDARVVVDERLRLNMAYDVAKG 545
P +V GA + +SIV EY+ GSL K+ IP E + +A + KG
Sbjct: 59 PYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIP-------EPVLAYIARQILKG 111
Query: 546 MNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPE 605
++YLH +R I+HRD+K NLL++S VK+ DFG+S+ NT T GT +M+PE
Sbjct: 112 LDYLHTKRH-IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPE 170
Query: 606 VLREDPSNEKSDVFSFGVILWELIT----LQKPWRNSTPSQVISAVGFKGRRLEIPKNVN 661
++ + + +D++S G+ L E P + S + + L + +
Sbjct: 171 RIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLP-AEEFS 229
Query: 662 PMVAALIETCWAEEPEIRPS 681
P I C ++P+ RPS
Sbjct: 230 PEFRDFISACLQKDPKKRPS 249
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 6e-29
Identities = 81/277 (29%), Positives = 136/277 (49%), Gaps = 26/277 (9%)
Query: 439 KKIGEGSFGTVYHAEWRNSD--VAVKI--LIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 494
KIGEGS G V A +++ VAVK L +Q+ E F E V IM+ +HPNIV
Sbjct: 25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNE----VVIMRDYQHPNIVE 80
Query: 495 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 554
+ + L +V E+L G+L ++ ++E + V K +++LH +
Sbjct: 81 MYSSYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIATVCLAVLKALSFLHAQG- 135
Query: 555 PIVHRDLKSPNLLVDSTYTVKVCDFG----LSRSKPNTYISSKTAAGTPEWMAPEVLRED 610
++HRD+KS ++L+ S VK+ DFG +S+ P K+ GTP WMAPEV+
Sbjct: 136 -VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR----RKSLVGTPYWMAPEVISRL 190
Query: 611 PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAV-GFKGRRLEIPKNVNPMVAALIE 669
P + D++S G+++ E++ + P+ N P Q + + +L+ V+P + + ++
Sbjct: 191 PYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLD 250
Query: 670 TCWAEEPEIRPSFPSIMETLQQFLMSSVCQPLSAQPL 706
+P R + E L ++ P S PL
Sbjct: 251 RMLVRDPAQR---ATAAELLNHPFLAKAGPPSSIVPL 284
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 73/256 (28%), Positives = 129/256 (50%), Gaps = 18/256 (7%)
Query: 439 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 496
+ +G G+FG V+ + V +K + ++ +D E ++K L HPNI+
Sbjct: 6 RVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYY 65
Query: 497 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 556
E L IV EY G+L + + ++DE L+ + ++++H + I
Sbjct: 66 ENFLEDKALMIVMEYAPGGTLAEYIQ-KRCNSLLDEDTILHFFVQILLALHHVHTKL--I 122
Query: 557 VHRDLKSPNLLVDSTYTV-KVCDFGLSRSKPNTYISSKTAA----GTPEWMAPEVLREDP 611
+HRDLK+ N+L+D V K+ DFG+S+ +SSK+ A GTP +++PE+ P
Sbjct: 123 LHRDLKTQNILLDKHKMVVKIGDFGISKI-----LSSKSKAYTVVGTPCYISPELCEGKP 177
Query: 612 SNEKSDVFSFGVILWELITLQKPWRNST-PSQVISAVGFKGRRLEIPKNVNPMVAALIET 670
N+KSD+++ G +L+EL +L++ + + P+ V+ + G I +P + LI +
Sbjct: 178 YNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIM--SGTFAPISDRYSPDLRQLILS 235
Query: 671 CWAEEPEIRPSFPSIM 686
+P RP IM
Sbjct: 236 MLNLDPSKRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 75/272 (27%), Positives = 137/272 (50%), Gaps = 22/272 (8%)
Query: 433 SELLIKKKIGEGSFGTVYHAE--WRNSDVAVK-ILIEQEFHEDRFKEFLREVAIMKGLRH 489
+ I+KKIG G F VY A VA+K + I + ++ ++E+ ++K L H
Sbjct: 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNH 61
Query: 490 PNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL-HIPDARVVVDERLRLNMAYDVAKGMNY 548
PN++ + + E L+IV E G L +++ + + ++ ER + + +
Sbjct: 62 PNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEH 121
Query: 549 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAA-----GTPEWMA 603
+H RR ++HRD+K N+ + +T VK+ D GL R + SSKT A GTP +M+
Sbjct: 122 MHSRR--VMHRDIKPANVFITATGVVKLGDLGLGR-----FFSSKTTAAHSLVGTPYYMS 174
Query: 604 PEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP----KN 659
PE + E+ N KSD++S G +L+E+ LQ P+ + + ++ K + + P ++
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN--LFSLCQKIEQCDYPPLPTEH 232
Query: 660 VNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 691
+ + L+ C +P+ RP + + +Q
Sbjct: 233 YSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQ 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 1e-27
Identities = 73/230 (31%), Positives = 114/230 (49%), Gaps = 21/230 (9%)
Query: 439 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEF-HEDRFKEFLREVAIMKGLRH-PNIVL 494
K I +G+FG+VY A+ R++ A+K+L + + +++ E AIM P +
Sbjct: 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAK 61
Query: 495 LMGAVTEPPNLSIVTEYLSRG---SLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 551
L + L +V EYL+ G SL K L + E +V G+ LHQ
Sbjct: 62 LYYSFQSKDYLYLVMEYLNGGDCASLIKTLG------GLPEDWAKQYIAEVVLGVEDLHQ 115
Query: 552 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDP 611
R I+HRD+K NLL+D T +K+ DFGLSR N + K GTP+++APE +
Sbjct: 116 RG--IIHRDIKPENLLIDQTGHLKLTDFGLSR---NGLEN-KKFVGTPDYLAPETILGVG 169
Query: 612 SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVN 661
++ SD +S G +++E + P+ TP V + RR+ P+ V
Sbjct: 170 DDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNI--LSRRINWPEEVK 217
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 77/248 (31%), Positives = 128/248 (51%), Gaps = 12/248 (4%)
Query: 441 IGEGSFGTVYHAEWRNSDVAVKILI-EQEFHEDRFKEFL-REVAIMKGLRHPNIVLLMGA 498
+G+G++G VY A R+ V+I I E + R+ + L E+A+ L+H NIV +G+
Sbjct: 16 LGKGTYGIVYAA--RDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGS 73
Query: 499 VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVH 558
+E I E + GSL LL + +E+ + + +G+ YLH + IVH
Sbjct: 74 DSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ--IVH 131
Query: 559 RDLKSPNLLVDSTYT--VKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPS--NE 614
RD+K N+LV+ TY+ VK+ DFG S+ ++T GT ++MAPEV+ + P
Sbjct: 132 RDIKGDNVLVN-TYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGA 190
Query: 615 KSDVFSFGVILWELITLQKPWRN-STPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWA 673
+D++S G + E+ T + P+ P + VG EIP++++ I C+
Sbjct: 191 PADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRCFE 250
Query: 674 EEPEIRPS 681
+P+ R S
Sbjct: 251 PDPDKRAS 258
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 3e-27
Identities = 75/257 (29%), Positives = 127/257 (49%), Gaps = 22/257 (8%)
Query: 437 IKKKIGEGSFGTVYHAEWRNSDVAV---KILIEQEFHEDRFKEFLREVAIMKGLRHPNIV 493
I+KKIG G F VY A V V K+ I + ++E+ ++K L HPN++
Sbjct: 6 IEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVI 65
Query: 494 LLMGAVTEPPNLSIVTEYLSRGSLYKLL-HIPDARVVVDERLRLNMAYDVAKGMNYLHQR 552
+ E L+IV E G L +++ H + ++ E+ + + ++H R
Sbjct: 66 KYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR 125
Query: 553 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAA-----GTPEWMAPEVL 607
R ++HRD+K N+ + +T VK+ D GL R + SSKT A GTP +M+PE +
Sbjct: 126 R--VMHRDIKPANVFITATGVVKLGDLGLGR-----FFSSKTTAAHSLVGTPYYMSPERI 178
Query: 608 REDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP----KNVNPM 663
E+ N KSD++S G +L+E+ LQ P+ + + ++ K + + P + +
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKKIEQCDYPPLPSDHYSEE 236
Query: 664 VAALIETCWAEEPEIRP 680
+ L+ C +PE RP
Sbjct: 237 LRQLVNMCINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 74/257 (28%), Positives = 117/257 (45%), Gaps = 47/257 (18%)
Query: 433 SELLIKKKIGEGSFGTVYHAEWRNSD--VAVKIL-----IE--QEFHEDRFKEFLREVAI 483
+ K +G GSFG V + S A+KIL ++ Q H L E I
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEH------VLNEKRI 54
Query: 484 MKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLH------IPDARVVVDERLRLN 537
++ +RHP +V L G+ + NL +V EY+ G L+ L P AR +
Sbjct: 55 LQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQ----- 109
Query: 538 MAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKTAA 596
V + YLH IV+RDLK NLL+DS +K+ DFG + R K TY T
Sbjct: 110 ----VVLALEYLHSLD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTY----TLC 159
Query: 597 GTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTP----SQVISAVGFKGR 652
GTPE++APE++ + D ++ G++++E++ P+ + P +++
Sbjct: 160 GTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG------ 213
Query: 653 RLEIPKNVNPMVAALIE 669
++ P +P LI
Sbjct: 214 KVRFPSFFSPDAKDLIR 230
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 5e-27
Identities = 71/261 (27%), Positives = 127/261 (48%), Gaps = 24/261 (9%)
Query: 440 KIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAV 499
++G+G+FG VY A+ + + + + E+ ++++ E+ I+ HP IV L+GA
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 500 TEPPNLSIVTEYLSRGS-------LYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 552
L I+ E+ G+ L + L P +V+ + L + + YLH
Sbjct: 79 YWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQML---------EALQYLHSM 129
Query: 553 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV-----L 607
+ I+HRDLK+ N+L+ +K+ DFG+S T + GTP WMAPEV +
Sbjct: 130 K--IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETM 187
Query: 608 REDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVG-FKGRRLEIPKNVNPMVAA 666
++ P + K+D++S G+ L E+ ++ P P +V+ + + L P +
Sbjct: 188 KDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRD 247
Query: 667 LIETCWAEEPEIRPSFPSIME 687
++T + PE RPS ++E
Sbjct: 248 FLKTALDKHPETRPSAAQLLE 268
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 5e-27
Identities = 69/257 (26%), Positives = 118/257 (45%), Gaps = 25/257 (9%)
Query: 441 IGEGSFGTVYHAEWRNSD-VAVKILI----EQEFHEDRFKEFLREVAIMKGLRHPNIVLL 495
+G+G++GTVY +AVK + E +++ EV ++K L+H NIV
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 496 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 555
+G + +SI E++ GS+ +L+ E + + G+ YLH
Sbjct: 68 LGTCLDDNTISIFMEFVPGGSISSILNRFGPLP---EPVFCKYTKQILDGVAYLHNNC-- 122
Query: 556 IVHRDLKSPNLLVDSTYTVKVCDFGLSR---------SKPNTYISSKTAAGTPEWMAPEV 606
+VHRD+K N+++ +K+ DFG +R + N K+ GTP WMAPEV
Sbjct: 123 VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNML---KSMHGTPYWMAPEV 179
Query: 607 LREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRL--EIPKNVNPMV 664
+ E KSD++S G ++E+ T + P + + +G R L +P + +
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIG-AHRGLMPRLPDSFSAAA 238
Query: 665 AALIETCWAEEPEIRPS 681
+ +C + RPS
Sbjct: 239 IDFVTSCLTRDQHERPS 255
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 5e-27
Identities = 75/252 (29%), Positives = 127/252 (50%), Gaps = 9/252 (3%)
Query: 439 KKIGEGSFGTV---YHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 495
+ +G+GS+G V H V K+ + +R K +E ++ L+HPNIV
Sbjct: 6 RVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRER-KAAEQEAQLLSQLKHPNIVAY 64
Query: 496 MGAVT-EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 554
+ E L IV + G LY L +++ E + +A + YLH++
Sbjct: 65 RESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLP-ENQVVEWFVQIAMALQYLHEKH- 122
Query: 555 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNE 614
I+HRDLK+ N+ + T +KV D G++R N + T GTP +M+PE+ P N
Sbjct: 123 -ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNY 181
Query: 615 KSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAE 674
KSDV++ G ++E+ TL+ + + ++ + +G+ +PK+ +P + LI T ++
Sbjct: 182 KSDVWALGCCVYEMATLKHAFNAKDMNSLVYRI-IEGKLPPMPKDYSPELGELIATMLSK 240
Query: 675 EPEIRPSFPSIM 686
PE RPS SI+
Sbjct: 241 RPEKRPSVKSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 69/202 (34%), Positives = 108/202 (53%), Gaps = 14/202 (6%)
Query: 440 KIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMG 497
++GEG+ G+V +N+ A+K + + D K+ LRE+ I K + P IV G
Sbjct: 8 RLGEGAGGSVTKCRLKNTGMIFALKTITTDP-NPDLQKQILRELEINKSCKSPYIVKYYG 66
Query: 498 AVTEPP--NLSIVTEYLSRGSL---YKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 552
A + ++ I EY GSL YK + R+ E++ +A V KG++YLH R
Sbjct: 67 AFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRI--GEKVLGKIAESVLKGLSYLHSR 124
Query: 553 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPS 612
+ I+HRD+K N+L+ VK+CDFG+S N+ + T GT +MAPE ++ P
Sbjct: 125 K--IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL--AGTFTGTSFYMAPERIQGKPY 180
Query: 613 NEKSDVFSFGVILWELITLQKP 634
+ SDV+S G+ L E+ + P
Sbjct: 181 SITSDVWSLGLTLLEVAQNRFP 202
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 1e-26
Identities = 70/253 (27%), Positives = 131/253 (51%), Gaps = 9/253 (3%)
Query: 437 IKKKIGEGSFGTVYHAEWRNSD---VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIV 493
+ + +GEGSFG + NSD +I + + ++ +E ++ ++HPNIV
Sbjct: 4 VLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSA--VEDSRKEAVLLAKMKHPNIV 61
Query: 494 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 553
+ +L IV EY G L + + + ++ ++ + L + G+ ++H++R
Sbjct: 62 AFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTI-LQWFVQMCLGVQHIHEKR 120
Query: 554 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSN 613
++HRD+KS N+ + VK+ DFG +R + + T GTP ++ PE+ P N
Sbjct: 121 --VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYN 178
Query: 614 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWA 673
KSD++S G IL+EL TL+ P++ ++ +I V +G +P + + + +LI+ +
Sbjct: 179 NKSDIWSLGCILYELCTLKHPFQANSWKNLILKV-CQGSYKPLPSHYSYELRSLIKQMFK 237
Query: 674 EEPEIRPSFPSIM 686
P RPS +I+
Sbjct: 238 RNPRSRPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 78/270 (28%), Positives = 136/270 (50%), Gaps = 19/270 (7%)
Query: 439 KKIGEGSFGTVYHAEWRNSDVAV--KILIEQ-EFHEDRFKEFL-REVAIMKGLRHPNIVL 494
+KIG+G+ GTV+ A DVA ++ I+Q + KE + E+ +MK L++PNIV
Sbjct: 25 EKIGQGASGTVFTA----IDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVN 80
Query: 495 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 554
+ + L +V EYL+ GSL ++ +DE + + + + +LH +
Sbjct: 81 FLDSFLVGDELFVVMEYLAGGSLTDVV----TETCMDEAQIAAVCRECLQALEFLHANQ- 135
Query: 555 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNE 614
++HRD+KS N+L+ +VK+ DFG T GTP WMAPEV+
Sbjct: 136 -VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 194
Query: 615 KSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR-RLEIPKNVNPMVAALIETCWA 673
K D++S G++ E++ + P+ N P + + + G L+ P+ ++P+ + C
Sbjct: 195 KVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLE 254
Query: 674 EEPEIRPSFPSIMETLQQFLMSSVCQPLSA 703
+ E R S +++ FL + +PLS+
Sbjct: 255 MDVEKRGSAKELLQ--HPFL--KLAKPLSS 280
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 5e-26
Identities = 74/241 (30%), Positives = 122/241 (50%), Gaps = 32/241 (13%)
Query: 437 IKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 496
I ++G+G+FG VY A+ + + V + E+ ++++ E+ I+ HPNIV L+
Sbjct: 9 IIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLL 68
Query: 497 GAVTEPPNLSIVTEYLSRGS-------LYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 549
A NL I+ E+ + G+ L + L P RVV + L + +NYL
Sbjct: 69 DAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTL---------EALNYL 119
Query: 550 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVL-- 607
H+ + I+HRDLK+ N+L +K+ DFG+S T + GTP WMAPEV+
Sbjct: 120 HENK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMC 177
Query: 608 ---REDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV 664
++ P + K+DV+S G+ L E+ ++ P P +V+ L+I K+ P +
Sbjct: 178 ETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVL---------LKIAKSEPPTL 228
Query: 665 A 665
A
Sbjct: 229 A 229
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 68/259 (26%), Positives = 122/259 (47%), Gaps = 18/259 (6%)
Query: 441 IGEGSFGTVYHAEWRNSD--VAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVLLMG 497
IG+G+FG V + R++ A+K + +Q+ E + L E I++ L HP +V L
Sbjct: 8 IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWY 67
Query: 498 AVTEPPNLSIVTEYLSRGSL-YKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 556
+ + N+ +V + L G L Y H+ +E+++ + ++ + YLH + I
Sbjct: 68 SFQDEENMYLVVDLLLGGDLRY---HLSQKVKFSEEQVKFWIC-EIVLALEYLHSKG--I 121
Query: 557 VHRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVLREDPSNEK 615
+HRD+K N+L+D V + DF ++ P+T +S +GTP +MAPEVL +
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTST--SGTPGYMAPEVLCRQGYSVA 179
Query: 616 SDVFSFGVILWELITLQKPWRN--STPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWA 673
D +S GV +E + ++P+R T I A + + P + I
Sbjct: 180 VDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAK-QETADVLYPATWSTEAIDAINKLLE 238
Query: 674 EEPEIRPSFPSIMETLQQF 692
+P+ R ++ L+
Sbjct: 239 RDPQKRLGDN--LKDLKNH 255
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 67/214 (31%), Positives = 109/214 (50%), Gaps = 36/214 (16%)
Query: 439 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKE-----FLREVAIMKGLRHPN 491
KK+GEG++ VY A + + VA+K + E E K+ LRE+ +++ L+HPN
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEA--KDGINFTALREIKLLQELKHPN 63
Query: 492 IVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVA------KG 545
I+ L+ N+++V E++ L K++ D+ + L A + +G
Sbjct: 64 IIGLLDVFGHKSNINLVFEFME-TDLEKVIK--------DKSIVLTPADIKSYMLMTLRG 114
Query: 546 MNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS--KPNTYISSKTAAGTPEWMA 603
+ YLH I+HRDLK NLL+ S +K+ DFGL+RS PN ++ + T + A
Sbjct: 115 LEYLHSNW--ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV--TRWYRA 170
Query: 604 PEVLREDPSNEKS---DVFSFGVILWELITLQKP 634
PE+L + D++S G I EL+ L+ P
Sbjct: 171 PELLFG--ARHYGVGVDMWSVGCIFAELL-LRVP 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 64/208 (30%), Positives = 103/208 (49%), Gaps = 25/208 (12%)
Query: 439 KKIGEGSFGTVYHAEWRNSD--VAVKIL----------IEQEFHEDRFKEFLREVAIMKG 486
K +G+GSFG V AE + +D AVK+L +E E R
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG------- 53
Query: 487 LRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM 546
+HP + L L V EY++ G L + HI + + R R A ++ G+
Sbjct: 54 -KHPFLTQLHSCFQTKDRLFFVMEYVNGGDL--MFHIQRSGRFDEPRARF-YAAEIVLGL 109
Query: 547 NYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV 606
+LH+R I++RDLK N+L+DS +K+ DFG+ + +++ T GTP+++APE+
Sbjct: 110 QFLHERG--IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEI 167
Query: 607 LREDPSNEKSDVFSFGVILWELITLQKP 634
L P D ++ GV+L+E++ Q P
Sbjct: 168 LSYQPYGPAVDWWALGVLLYEMLAGQSP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 89/338 (26%), Positives = 143/338 (42%), Gaps = 73/338 (21%)
Query: 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD-------VAVKILIEQEFHEDRFKEFLREV 481
E L + K +G G+FG V A + VAVK+L E + +K + E+
Sbjct: 3 EFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASE-YKALMTEL 61
Query: 482 AIMKGL-RHPNIVLLMGAVTEP--PNLSIV--------TEYL-SRGSLYKLLHIPDAR-- 527
I+ + H N+V L+GA T+P P + IV + YL S+ + R
Sbjct: 62 KILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKR 121
Query: 528 ---VVVDERLRLN-------------------------------------------MAYD 541
++ RL+ ++
Sbjct: 122 EMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQ 181
Query: 542 VAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS--KPNTYISSKTAAGTP 599
VA+GM +L R+ +HRDL + N+L+ VK+CDFGL+R K Y+ A
Sbjct: 182 VARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239
Query: 600 EWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPK 658
+WMAPE + + +SDV+SFGV+LWE+ +L P+ + +G R+ P+
Sbjct: 240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPE 299
Query: 659 NVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 696
P + +++ CW PE RP+F ++E L L +
Sbjct: 300 YATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQEN 337
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 75/260 (28%), Positives = 124/260 (47%), Gaps = 23/260 (8%)
Query: 433 SELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFK-EFLREVAIMKGLRH 489
SEL +IG G+ GTVY R + A+K++ HED + + RE+ I++ + H
Sbjct: 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGN--HEDTVRRQICREIEILRDVNH 131
Query: 490 PNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 549
PN+V + ++ E++ GSL + + DE+ ++A + G+ YL
Sbjct: 132 PNVVKCHDMFDHNGEIQVLLEFMDGGSL-------EGTHIADEQFLADVARQILSGIAYL 184
Query: 550 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRE 609
H+R IVHRD+K NLL++S VK+ DFG+SR T ++ GT +M+PE +
Sbjct: 185 HRRH--IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINT 242
Query: 610 DPSNEK-----SDVFSFGVILWELITLQKPW---RNSTPSQVISAVGFKGRRLEIPKNVN 661
D ++ D++S GV + E + P+ R + ++ A+ + E P +
Sbjct: 243 DLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMS-QPPEAPATAS 301
Query: 662 PMVAALIETCWAEEPEIRPS 681
I C EP R S
Sbjct: 302 REFRHFISCCLQREPAKRWS 321
|
Length = 353 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 69/208 (33%), Positives = 102/208 (49%), Gaps = 27/208 (12%)
Query: 437 IKKKIGEGSFGTVYHAEWRNSD----VAVK-ILIEQEFHEDRFK-EFLREVAIMKGLRHP 490
+IGEG++G VY A RN VA+K I +E E ++ F +RE+ +++ LRHP
Sbjct: 3 KIAQIGEGTYGQVYKA--RNKKTGELVALKKIRMENE--KEGFPITAIREIKLLQKLRHP 58
Query: 491 NIVLLMGAVTEPPNLSI--VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 548
NIV L VT SI V EY+ L LL P+ + + + +G+ Y
Sbjct: 59 NIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCY--MKQLLEGLQY 115
Query: 549 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPE----WM-A 603
LH I+HRD+K N+L+++ +K+ DFGL+R Y +A T W
Sbjct: 116 LHSNG--ILHRDIKGSNILINNDGVLKLADFGLAR----PYTKRNSADYTNRVITLWYRP 169
Query: 604 PEVLR-EDPSNEKSDVFSFGVILWELIT 630
PE+L + D++S G IL EL
Sbjct: 170 PELLLGATRYGPEVDMWSVGCILAELFL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 4e-25
Identities = 75/266 (28%), Positives = 125/266 (46%), Gaps = 41/266 (15%)
Query: 441 IGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLR-----------EVAIMK-GLR 488
+G G+FG VY +N+ + L E H F + R EV I+K LR
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 489 HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL--------HIPDARVVVDERLRLNMAY 540
HPNIV E L IV + + L + + R+ N+
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERI-------WNIFV 120
Query: 541 DVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK-PNTYISSKTAAGTP 599
+ + YLH+ + IVHRDL N+++ V + DFGL++ K P + ++S GT
Sbjct: 121 QMVLALRYLHKEKR-IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTS--VVGTI 177
Query: 600 EWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRN----STPSQVISAVGFKGRRLE 655
+ PE+++ +P EK+DV++FG IL+++ TLQ P+ + S ++++ AV
Sbjct: 178 LYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAV-----YEP 232
Query: 656 IPKNV-NPMVAALIETCWAEEPEIRP 680
+P+ + + V +I +C + E RP
Sbjct: 233 LPEGMYSEDVTDVITSCLTPDAEARP 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 6e-25
Identities = 54/158 (34%), Positives = 89/158 (56%), Gaps = 5/158 (3%)
Query: 539 AYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS--KPNTYISSKTAA 596
++ VA+GM +L R+ +HRDL + N+L+ VK+CDFGL+R K Y+ +A
Sbjct: 180 SFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSAR 237
Query: 597 GTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLE 655
+WMAPE + + +SDV+SFGV+LWE+ +L P+ ++ G R+
Sbjct: 238 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMR 297
Query: 656 IPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 693
P+N P + ++ CW +P+ RP+F +++E L L
Sbjct: 298 APENATPEIYRIMLACWQGDPKERPTFSALVEILGDLL 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 6e-25
Identities = 73/273 (26%), Positives = 130/273 (47%), Gaps = 28/273 (10%)
Query: 439 KKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKE---FLREVAIMKGLRHPNIVLL 495
+IG G FG V E ++++++ E FL+EV + L HPN++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 496 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVV----DERLRLNMAYDVAKGMNYLHQ 551
+G E +V E+ G L L R +V + + MA +VA G+ +LHQ
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLR--SNRGMVAQMAQKDVLQRMACEVASGLLWLHQ 118
Query: 552 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK-PNTYISSKTAAGTP-EWMAPEVLRE 609
+H DL N + + +VK+ D+GL+ + P Y +K P W+APE++
Sbjct: 119 AD--FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEI 176
Query: 610 DPSN-------EKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPK-NV 660
+ +KS+++S GV +WEL T +P+ + + QV+ V + + +++PK +
Sbjct: 177 RGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQV-VREQDIKLPKPQL 235
Query: 661 NPMVA----ALIETCWAEEPEIRPSFPSIMETL 689
+ + +++ CW +PE RP+ + E L
Sbjct: 236 DLKYSDRWYEVMQFCWL-DPETRPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 8e-25
Identities = 75/256 (29%), Positives = 123/256 (48%), Gaps = 20/256 (7%)
Query: 439 KKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREV-------AIMKGLRHPN 491
K +G G+FG VY ++D ++ ++Q + +E +EV ++K LRH
Sbjct: 8 KLLGRGAFGEVYLC--YDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDR 65
Query: 492 IVLLMGAVTEPPN--LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 549
IV G + +P LSI EY+ GS+ L A + E + + +G++YL
Sbjct: 66 IVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL---KAYGALTENVTRRYTRQILQGVSYL 122
Query: 550 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISS---KTAAGTPEWMAPEV 606
H IVHRD+K N+L DS VK+ DFG S+ +S K+ GTP WM+PEV
Sbjct: 123 HSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEV 180
Query: 607 LREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA 666
+ + K+DV+S + E++T + PW I + + + +P V+
Sbjct: 181 ISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRD 240
Query: 667 LIETCWAEEPEIRPSF 682
++ + EE + RP+
Sbjct: 241 FLKQIFVEE-KRRPTA 255
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 9e-25
Identities = 74/259 (28%), Positives = 132/259 (50%), Gaps = 12/259 (4%)
Query: 436 LIKKKIGEGSFGTVYHAEWRNSDV--AVKILIEQEFHEDRFKEFLR---EVAIMKGLRHP 490
++++++G+GSFGTVY + + + +K+L E E E ++ E ++ L HP
Sbjct: 3 ILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHP 62
Query: 491 NIVLLMGAVTEPPNLSIVTEYLSRGSL-YKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 549
IV + E I+TEY L KL + + E + G++Y+
Sbjct: 63 AIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYM 122
Query: 550 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRE 609
HQRR I+HRDLK+ N+ + + +K+ DFG+SR + + T GTP +M+PE L+
Sbjct: 123 HQRR--ILHRDLKAKNIFLKNN-LLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKH 179
Query: 610 DPSNEKSDVFSFGVILWELITLQKPWRNST-PSQVISAVGFKGRRLEIPKNVNPMVAALI 668
+ KSD++S G IL+E+ L + S V+ V +G +P+ + + +++
Sbjct: 180 QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIV--EGPTPSLPETYSRQLNSIM 237
Query: 669 ETCWAEEPEIRPSFPSIME 687
++ ++P +RPS I+
Sbjct: 238 QSMLNKDPSLRPSAAEILR 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 9e-25
Identities = 77/270 (28%), Positives = 135/270 (50%), Gaps = 19/270 (7%)
Query: 439 KKIGEGSFGTVYHAEWRNSDVAV--KILIEQEFHEDRFKEFL--REVAIMKGLRHPNIVL 494
+KIG+G+ GTVY A DVA ++ I+Q + + K+ L E+ +M+ +HPNIV
Sbjct: 25 EKIGQGASGTVYTA----IDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVN 80
Query: 495 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 554
+ + L +V EYL+ GSL ++ +DE + + + + +LH +
Sbjct: 81 YLDSYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHSNQ- 135
Query: 555 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNE 614
++HRD+KS N+L+ +VK+ DFG T GTP WMAPEV+
Sbjct: 136 -VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 194
Query: 615 KSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR-RLEIPKNVNPMVAALIETCWA 673
K D++S G++ E++ + P+ N P + + + G L+ P+ ++ + + C
Sbjct: 195 KVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLE 254
Query: 674 EEPEIRPSFPSIMETLQQFLMSSVCQPLSA 703
+ E R S +++ FL + +PLS+
Sbjct: 255 MDVEKRGSAKELLQ--HPFL--KIAKPLSS 280
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 2e-24
Identities = 70/244 (28%), Positives = 123/244 (50%), Gaps = 10/244 (4%)
Query: 439 KKIGEGSFGTVYHAEWRNSDV--AVKIL-IEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 495
K +G+G+FG V + + A+KIL E +D + E +++ RHP + L
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 496 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 555
A L V EY + G L+ H+ RV +ER R A ++ + YLH R
Sbjct: 61 KYAFQTHDRLCFVMEYANGGELF--FHLSRERVFTEERARFYGA-EIVSALEYLHSRD-- 115
Query: 556 IVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEK 615
+V+RD+K NL++D +K+ DFGL + + + KT GTPE++APEVL ++
Sbjct: 116 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRA 175
Query: 616 SDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEE 675
D + GV+++E++ + P+ N ++ + + R P+ ++P +L+ ++
Sbjct: 176 VDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF--PRTLSPEAKSLLAGLLKKD 233
Query: 676 PEIR 679
P+ R
Sbjct: 234 PKQR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 77/262 (29%), Positives = 121/262 (46%), Gaps = 20/262 (7%)
Query: 441 IGEGSFGTVYHAEWRNSDV--AVKILIEQEFHEDRFKEFLREV-AIMKGLRHPNIVLLMG 497
IG G+FGTV + S AVK I E K L ++ +M+ P IV G
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVK-RIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYG 70
Query: 498 AVTEPPNLSIVTEY--LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 555
A+ + I E +S YK ++ + V+ E + +A K +NYL +
Sbjct: 71 ALFREGDCWICMELMDISLDKFYKYVYE-VLKSVIPEEILGKIAVATVKALNYL-KEELK 128
Query: 556 IVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNE- 614
I+HRD+K N+L+D +K+CDFG+S ++ ++ A P +MAPE R DPS
Sbjct: 129 IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRP-YMAPE--RIDPSARD 185
Query: 615 ----KSDVFSFGVILWELITLQKPWR--NSTPSQVISAVGFKGRRL--EIPKNVNPMVAA 666
+SDV+S G+ L+E+ T + P+ NS Q+ V L + +P
Sbjct: 186 GYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVN 245
Query: 667 LIETCWAEEPEIRPSFPSIMET 688
I C ++ RP + ++E
Sbjct: 246 FINLCLIKDESKRPKYKELLEH 267
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 73/265 (27%), Positives = 128/265 (48%), Gaps = 14/265 (5%)
Query: 433 SELLIKKKIGEGSFGTVYHAEWRNSDVAVKIL-IEQEFHEDRFKEFLREVAIMKGLRHPN 491
E+ + ++G+G++G+VY R + V + + I E E +F + + E+ I+ P
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPY 60
Query: 492 IVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 551
IV GA + + EY+ GSL KL A + E + + Y V KG+ +L +
Sbjct: 61 IVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE 120
Query: 552 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS-SKTAAGTPEWMAPEVLRED 610
I+HRD+K N+LV+ VK+CDFG+S N S +KT G +MAPE ++
Sbjct: 121 EHN-IIHRDVKPTNVLVNGNGQVKLCDFGVS---GNLVASLAKTNIGCQSYMAPERIKSG 176
Query: 611 PSNE------KSDVFSFGVILWELITLQKPWRNSTPSQVISAVG--FKGRRLEIPKNVNP 662
N+ +SDV+S G+ + E+ + P+ T + + + + G +P +
Sbjct: 177 GPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSD 236
Query: 663 MVAALIETCWAEEPEIRPSFPSIME 687
+ C + P RP++ ++E
Sbjct: 237 DAQDFVAKCLNKIPNRRPTYAQLLE 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 83/285 (29%), Positives = 129/285 (45%), Gaps = 57/285 (20%)
Query: 437 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIV 493
+ + IGEG++G VY A + + VA+KI + ED +E E I++ HPNI
Sbjct: 10 LVEVIGEGTYGKVYKARHKKTGQLVAIKI---MDIIEDEEEEIKEEYNILRKYSNHPNIA 66
Query: 494 LLMGA------VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNM-AY---DVA 543
GA L +V E GS+ L+ + +RL+ AY +
Sbjct: 67 TFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKK---GKRLKEEWIAYILRETL 123
Query: 544 KGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR------SKPNTYISSKTAAG 597
+G+ YLH+ + ++HRD+K N+L+ VK+ DFG+S + NT+I G
Sbjct: 124 RGLAYLHENK--VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI------G 175
Query: 598 TPEWMAPEVLREDPSNE-----KSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR 652
TP WMAPEV+ D + +SDV+S G+ EL + P + P + + FK
Sbjct: 176 TPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRAL----FK-- 229
Query: 653 RLEIPKNVNPMVAA----------LIETCWAEEPEIRPSFPSIME 687
IP+N P + + I C + E RP ++E
Sbjct: 230 ---IPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 70/211 (33%), Positives = 102/211 (48%), Gaps = 34/211 (16%)
Query: 440 KIGEGSFGTVYHAEWR--NSDVAVK-ILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 496
KIGEG++G VY A + VA+K I +E E E +RE++++K L HPNIV L+
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETE-DEGVPSTAIREISLLKELNHPNIVRLL 64
Query: 497 GAVTEPPNLSIVTEYLSRGSLYKLL-HIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 555
V L +V E+L L K + P +D L + Y + +G+ Y H R
Sbjct: 65 DVVHSENKLYLVFEFLDL-DLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSHR-- 119
Query: 556 IVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPE----------WM-AP 604
++HRDLK NLL+D +K+ DFGL+R A G P W AP
Sbjct: 120 VLHRDLKPQNLLIDREGALKLADFGLAR-----------AFGVPVRTYTHEVVTLWYRAP 168
Query: 605 EVLREDPSNEKS-DVFSFGVILWELITLQKP 634
E+L D++S G I E++ ++P
Sbjct: 169 EILLGSRQYSTPVDIWSIGCIFAEMVN-RRP 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 70/211 (33%), Positives = 106/211 (50%), Gaps = 31/211 (14%)
Query: 439 KKIGEGSFGTVYHAEWRNSDVAV---KILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 495
+KIGEG++G VY + + V KI +E E E +RE++++K L+HPNIV L
Sbjct: 6 EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE-EEGVPSTAIREISLLKELQHPNIVCL 64
Query: 496 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 555
+ + L ++ E+LS L K L +D L + Y + +G+ + H RR
Sbjct: 65 QDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR-- 121
Query: 556 IVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPE-----------WMAP 604
++HRDLK NLL+D+ +K+ DFGL+R A G P + AP
Sbjct: 122 VLHRDLKPQNLLIDNKGVIKLADFGLAR-----------AFGIPVRVYTHEVVTLWYRAP 170
Query: 605 EVLREDPS-NEKSDVFSFGVILWELITLQKP 634
EVL P + D++S G I E+ T +KP
Sbjct: 171 EVLLGSPRYSTPVDIWSIGTIFAEMAT-KKP 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 5e-24
Identities = 78/270 (28%), Positives = 134/270 (49%), Gaps = 19/270 (7%)
Query: 439 KKIGEGSFGTVYHAEWRNSDVAV--KILIEQ-EFHEDRFKEFL-REVAIMKGLRHPNIVL 494
+KIG+G+ GTVY A DVA ++ I Q + KE + E+ +M+ ++PNIV
Sbjct: 26 EKIGQGASGTVYTA----MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 495 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 554
+ + L +V EYL+ GSL ++ +DE + + + + +LH +
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHSNQ- 136
Query: 555 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNE 614
++HRD+KS N+L+ +VK+ DFG T GTP WMAPEV+
Sbjct: 137 -VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195
Query: 615 KSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR-RLEIPKNVNPMVAALIETCWA 673
K D++S G++ E+I + P+ N P + + + G L+ P+ ++ + + C
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLD 255
Query: 674 EEPEIRPSFPSIMETLQQFLMSSVCQPLSA 703
+ E R S +++ QFL + +PLS+
Sbjct: 256 MDVEKRGSAKELLQ--HQFL--KIAKPLSS 281
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 6e-24
Identities = 58/207 (28%), Positives = 108/207 (52%), Gaps = 11/207 (5%)
Query: 440 KIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVLLM 496
++G+G +G V+ A+ +++ VA+K + + + + + L E I+ + +V L+
Sbjct: 8 QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL 67
Query: 497 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 556
A + L + EY+ G LL+ + V+ ++ R MA ++ LH+
Sbjct: 68 YAFQDDEYLYLAMEYVPGGDFRTLLN--NLGVLSEDHARFYMAEMFE-AVDALHEL--GY 122
Query: 557 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKS 616
+HRDLK N L+D++ +K+ DFGLS+ + + G+P++MAPEVLR +
Sbjct: 123 IHRDLKPENFLIDASGHIKLTDFGLSK---GIVTYANSVVGSPDYMAPEVLRGKGYDFTV 179
Query: 617 DVFSFGVILWELITLQKPWRNSTPSQV 643
D +S G +L+E + P+ STP++
Sbjct: 180 DYWSLGCMLYEFLCGFPPFSGSTPNET 206
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 7e-24
Identities = 67/201 (33%), Positives = 105/201 (52%), Gaps = 21/201 (10%)
Query: 440 KIGEGSFGTVYHAEWRNSD----VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 495
+GEG++G V RN VA+K E E ED K LREV +++ LRH NIV L
Sbjct: 8 VVGEGAYGVVLKC--RNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNL 65
Query: 496 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARV--VVDERLRLNMAYDVAKGMNYLHQRR 553
A L +V EY+ R LL + +A + + +R + + + + + Y H
Sbjct: 66 KEAFRRKGRLYLVFEYVER----TLLELLEASPGGLPPDAVRSYI-WQLLQAIAYCHSHN 120
Query: 554 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSR---SKPNTYISSKTAAGTPEWMAPEVLRED 610
I+HRD+K N+LV + +K+CDFG +R ++P + ++ A T + APE+L D
Sbjct: 121 --IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA--TRWYRAPELLVGD 176
Query: 611 PSNEKS-DVFSFGVILWELIT 630
+ K DV++ G I+ EL+
Sbjct: 177 TNYGKPVDVWAIGCIMAELLD 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 7e-24
Identities = 69/244 (28%), Positives = 124/244 (50%), Gaps = 10/244 (4%)
Query: 439 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLL 495
K +G+G+FG V + S A+KIL ++ +D L E ++K RHP + L
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 496 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 555
+ L V EY++ G L+ H+ RV ++R R A ++ ++YLH +
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELF--FHLSRERVFSEDRTRFYGA-EIVSALDYLHSGK-- 115
Query: 556 IVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEK 615
IV+RDLK NL++D +K+ DFGL + + KT GTPE++APEVL ++
Sbjct: 116 IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRA 175
Query: 616 SDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEE 675
D + GV+++E++ + P+ N ++ + + ++ P+ ++ +L+ ++
Sbjct: 176 VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMED--IKFPRTLSADAKSLLSGLLIKD 233
Query: 676 PEIR 679
P R
Sbjct: 234 PNKR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 8e-24
Identities = 84/289 (29%), Positives = 136/289 (47%), Gaps = 31/289 (10%)
Query: 429 EIRWSELLIKKKIGEGSFGTVYHAEW-------RNSDVAVKILIEQEFHEDRFKEFLREV 481
EI S + +++GE FG VY + VA+K L ++ E +E +
Sbjct: 1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHE 58
Query: 482 AIMKG-LRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHI--PDARV-------VVD 531
A+M+ L+HPNIV L+G VT+ LS++ Y S L++ L + P + V V
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118
Query: 532 ERLR----LNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS--K 585
L +++ +A GM +L +VH+DL + N+LV VK+ D GL R
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLSSHH--VVHKDLATRNVLVFDKLNVKISDLGLFREVYA 176
Query: 586 PNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQ-KPWRNSTPSQVI 644
+ Y + WM+PE + + SD++S+GV+LWE+ + +P+ + VI
Sbjct: 177 ADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVI 236
Query: 645 SAVGFKGRR-LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQF 692
+ + R+ L P + V L+ CW E P RP F I L+ +
Sbjct: 237 EMI--RNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRTW 283
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 9e-24
Identities = 72/211 (34%), Positives = 116/211 (54%), Gaps = 13/211 (6%)
Query: 439 KKIGEGSFGTVYHAEWRNSD---VAVKILIEQEFHEDRFKEFL---REVAIMKGLRHPNI 492
K IG+GSFG V A+ R SD AVK+L ++ + + + + R V ++K L+HP +
Sbjct: 1 KVIGKGSFGKVLLAK-RKSDGSFYAVKVLQKKTILKKKEQNHIMAERNV-LLKNLKHPFL 58
Query: 493 VLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 552
V L + L V +Y++ G L+ H+ R ++ R R A +VA + YLH
Sbjct: 59 VGLHYSFQTAEKLYFVLDYVNGGELF--FHLQRERCFLEPRARF-YAAEVASAIGYLHSL 115
Query: 553 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPS 612
I++RDLK N+L+DS V + DFGL + ++ T GTPE++APEVLR++P
Sbjct: 116 N--IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPY 173
Query: 613 NEKSDVFSFGVILWELITLQKPWRNSTPSQV 643
+ D + G +L+E++ P+ + SQ+
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPPFYSRDVSQM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 9e-24
Identities = 76/274 (27%), Positives = 130/274 (47%), Gaps = 37/274 (13%)
Query: 434 ELLIKKKIGEGSFGTVYHAEWRNSDV--AVKILIEQEFHEDRFKEFLREVAI-MKGLRHP 490
+L +IG G+ G VY ++ + AVK + E+ K L ++ + +K P
Sbjct: 16 DLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEEN-KRILMDLDVVLKSHDCP 74
Query: 491 NIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLH-----IPDARVVVDERLRLNMAYDVAKG 545
IV G ++ I E +S L KLL IP E + M + K
Sbjct: 75 YIVKCYGYFITDSDVFICMELMST-CLDKLLKRIQGPIP-------EDILGKMTVAIVKA 126
Query: 546 MNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS----RSKPNTYISSKTAAGTPEW 601
++YL ++ ++HRD+K N+L+D++ VK+CDFG+S SK T +AG +
Sbjct: 127 LHYLKEKHG-VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKT-----RSAGCAAY 180
Query: 602 MAPEVLREDPSNEK------SDVFSFGVILWELITLQKPWRN-STPSQVISAV-GFKGRR 653
MAPE R DP + +DV+S G+ L EL T Q P++N T +V++ + +
Sbjct: 181 MAPE--RIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPS 238
Query: 654 LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687
L + +P + ++ C ++ RP + +++
Sbjct: 239 LPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQ 272
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 74/259 (28%), Positives = 125/259 (48%), Gaps = 19/259 (7%)
Query: 439 KKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMG 497
++IG G++G VY A N+ ++A +I+ E ED F +E+ +MK +H NIV G
Sbjct: 15 QRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGED-FAVVQQEIIMMKDCKHSNIVAYFG 73
Query: 498 AVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAY---DVAKGMNYLHQRRP 554
+ L I E+ GSL + H V +AY + +G+ YLH +
Sbjct: 74 SYLRRDKLWICMEFCGGGSLQDIYH------VTGPLSESQIAYVSRETLQGLYYLHSKGK 127
Query: 555 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVL---REDP 611
+HRD+K N+L+ VK+ DFG+S T K+ GTP WMAPEV R+
Sbjct: 128 --MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGG 185
Query: 612 SNEKSDVFSFGVILWELITLQKPWRNSTPSQ---VISAVGFKGRRLEIPKNVNPMVAALI 668
N+ D+++ G+ EL LQ P + P + +++ F+ +L+ + +
Sbjct: 186 YNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFV 245
Query: 669 ETCWAEEPEIRPSFPSIME 687
+ + P+ RP+ +++
Sbjct: 246 KMALTKNPKKRPTAEKLLQ 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 1e-23
Identities = 68/244 (27%), Positives = 125/244 (51%), Gaps = 9/244 (3%)
Query: 439 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLL 495
K +G+G+FG V + + + A+KIL ++ +D L E +++ RHP + L
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 496 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 555
+ L V EY + G L+ H+ RV ++R R A ++ ++YLH +
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELF--FHLSRERVFSEDRARFYGA-EIVSALDYLHSEKN- 116
Query: 556 IVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEK 615
+V+RDLK NL++D +K+ DFGL + + KT GTPE++APEVL ++
Sbjct: 117 VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRA 176
Query: 616 SDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEE 675
D + GV+++E++ + P+ N ++ + + R P+ ++P +L+ ++
Sbjct: 177 VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRF--PRTLSPEAKSLLSGLLKKD 234
Query: 676 PEIR 679
P+ R
Sbjct: 235 PKQR 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 2e-23
Identities = 73/255 (28%), Positives = 123/255 (48%), Gaps = 20/255 (7%)
Query: 439 KKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVA-------IMKGLRHPN 491
K +G+G+FG VY ++D ++ ++Q + E +EV ++K L H
Sbjct: 8 KLLGQGAFGRVYLC--YDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHER 65
Query: 492 IVLLMGAVTEPP--NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 549
IV G + +P LSI E++ GS+ L A + E + + +G++YL
Sbjct: 66 IVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGA---LTENVTRKYTRQILEGVSYL 122
Query: 550 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISS---KTAAGTPEWMAPEV 606
H IVHRD+K N+L DS VK+ DFG S+ +S K+ GTP WM+PEV
Sbjct: 123 HSNM--IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEV 180
Query: 607 LREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA 666
+ + K+D++S G + E++T + PW I + + +P +V+
Sbjct: 181 ISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRD 240
Query: 667 LIETCWAEEPEIRPS 681
++ + E ++RPS
Sbjct: 241 FLKRIFVEA-KLRPS 254
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 67/212 (31%), Positives = 108/212 (50%), Gaps = 24/212 (11%)
Query: 437 IKKKIGEGSFGTVYHA--EWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 494
+ K IG G++G V A + VA+K + K LRE+ +++ LRH NI+
Sbjct: 4 LLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIG 63
Query: 495 LMGAVTEPPNLS------IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 548
L+ + PP+ IVTE + L+K++ P + + D+ ++ + Y + +G+ Y
Sbjct: 64 LL-DILRPPSPEDFNDVYIVTELM-ETDLHKVIKSP--QPLTDDHIQYFL-YQILRGLKY 118
Query: 549 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPE----WM-A 603
LH ++HRDLK N+LV+S +K+CDFGL+R + T W A
Sbjct: 119 LH--SANVIHRDLKPSNILVNSNCDLKICDFGLARG--VDPDEDEKGFLTEYVVTRWYRA 174
Query: 604 PEVLREDPSNEKS-DVFSFGVILWELITLQKP 634
PE+L K+ D++S G I EL+T +KP
Sbjct: 175 PELLLSSSRYTKAIDIWSVGCIFAELLT-RKP 205
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 3e-23
Identities = 72/268 (26%), Positives = 135/268 (50%), Gaps = 15/268 (5%)
Query: 439 KKIGEGSFGTVYHAE--WRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 496
+KIG+G+ GTVY A +VA+K + Q+ + + + + E+ +M+ ++PNIV +
Sbjct: 25 EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ--QPKKELIINEILVMRENKNPNIVNYL 82
Query: 497 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 556
+ L +V EYL+ GSL ++ +DE + + + +++LH + +
Sbjct: 83 DSYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALDFLHSNQ--V 136
Query: 557 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKS 616
+HRD+KS N+L+ +VK+ DFG T GTP WMAPEV+ K
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 196
Query: 617 DVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR-RLEIPKNVNPMVAALIETCWAEE 675
D++S G++ E++ + P+ N P + + + G L+ P+ ++ + + C +
Sbjct: 197 DIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEMD 256
Query: 676 PEIRPSFPSIMETLQQFLMSSVCQPLSA 703
+ R S +++ FL + +PLS+
Sbjct: 257 VDRRGSAKELLQ--HPFL--KLAKPLSS 280
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 5e-23
Identities = 75/271 (27%), Positives = 129/271 (47%), Gaps = 16/271 (5%)
Query: 440 KIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFL-REVAIMKGLRHPNIVLLM 496
KIGEGS G V A +++ VAVK + + + + +E L EV IM+ H N+V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVK---KMDLRKQQRRELLFNEVVIMRDYHHENVVDMY 85
Query: 497 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 556
+ L +V E+L G+L ++ ++E + V + ++YLH + +
Sbjct: 86 NSYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIATVCLSVLRALSYLHNQ--GV 139
Query: 557 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKS 616
+HRD+KS ++L+ S +K+ DFG K+ GTP WMAPEV+ P +
Sbjct: 140 IHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEV 199
Query: 617 DVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-GRRLEIPKNVNPMVAALIETCWAEE 675
D++S G+++ E+I + P+ N P Q + + R++ V+ ++ ++ E
Sbjct: 200 DIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVRE 259
Query: 676 PEIRPSFPSIMETLQQFLMSSVCQPLSAQPL 706
P R + E LQ + P PL
Sbjct: 260 PSQR---ATAQELLQHPFLKLAGPPSCIVPL 287
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 5e-23
Identities = 73/271 (26%), Positives = 129/271 (47%), Gaps = 31/271 (11%)
Query: 421 LYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQE-FHEDRFKEF 477
++ + + + S+ + + +G GSFG V A+ + + A+K L ++E + +
Sbjct: 6 MFTKPDTSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHV 65
Query: 478 LREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLN 537
+E +I+ L HP IV +M + + + + E++ G L+ L R
Sbjct: 66 AQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHL-----------RKAGR 114
Query: 538 MAYDVAK--------GMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN-T 588
DVAK YLH + I++RDLK NLL+D+ VKV DFG ++ P+ T
Sbjct: 115 FPNDVAKFYHAELVLAFEYLHSKD--IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT 172
Query: 589 YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVG 648
+ T GTPE++APEV++ + D ++ GV+L+E I P+ + TP ++ +
Sbjct: 173 F----TLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKI- 227
Query: 649 FKGRRLEIPKNVNPMVAALIETCWAEEPEIR 679
G RL+ P + L++ + R
Sbjct: 228 LAG-RLKFPNWFDGRARDLVKGLLQTDHTKR 257
|
Length = 329 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 6e-23
Identities = 62/210 (29%), Positives = 105/210 (50%), Gaps = 11/210 (5%)
Query: 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD-VAVKILIEQEFHEDRFKEFLREVAIMKGL 487
++R +L +G G+ G+V + + V K ++ K+ LRE+ IM
Sbjct: 1 DLRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHEC 60
Query: 488 RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHI--PDARVVVDERLRLNMAYDVAKG 545
R P IV GA N+ + E++ GSL ++ P ++ + +A V +G
Sbjct: 61 RSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGK-----IAVAVVEG 115
Query: 546 MNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPE 605
+ YL+ I+HRD+K N+LV+S +K+CDFG+S N+ + T GT +M+PE
Sbjct: 116 LTYLYNVHR-IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI--ADTFVGTSTYMSPE 172
Query: 606 VLREDPSNEKSDVFSFGVILWELITLQKPW 635
++ KSDV+S G+ + EL + P+
Sbjct: 173 RIQGGKYTVKSDVWSLGISIIELALGKFPF 202
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 9e-23
Identities = 72/257 (28%), Positives = 131/257 (50%), Gaps = 23/257 (8%)
Query: 440 KIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFL-REVAIMKGLRHPNIVLLM 496
KIGEGS G V A ++S VAVK++ + + + +E L EV IM+ +H N+V +
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMM---DLRKQQRRELLFNEVVIMRDYQHQNVVEMY 84
Query: 497 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 556
+ L ++ E+L G+L ++ ++ ++E + V + + YLH + +
Sbjct: 85 KSYLVGEELWVLMEFLQGGALTDIV----SQTRLNEEQIATVCESVLQALCYLHSQ--GV 138
Query: 557 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKS 616
+HRD+KS ++L+ VK+ DFG K+ GTP WMAPEV+ P +
Sbjct: 139 IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEV 198
Query: 617 DVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP---KN---VNPMVAALIET 670
D++S G+++ E++ + P+ + +P Q + K R P KN ++P++ +E
Sbjct: 199 DIWSLGIMVIEMVDGEPPYFSDSPVQAM-----KRLRDSPPPKLKNAHKISPVLRDFLER 253
Query: 671 CWAEEPEIRPSFPSIME 687
EP+ R + +++
Sbjct: 254 MLTREPQERATAQELLD 270
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 1e-22
Identities = 55/161 (34%), Positives = 85/161 (52%), Gaps = 5/161 (3%)
Query: 539 AYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS--KPNTYISSKTAA 596
++ VAKGM +L R+ +HRDL + N+L+ VK+CDFGL+R K Y+ A
Sbjct: 185 SFQVAKGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242
Query: 597 GTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLE 655
+WMAPE + + +SDV+SFGV+LWE+ +L P+ + +G R+
Sbjct: 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR 302
Query: 656 IPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 696
P P + + CW EP RP+F ++E L L ++
Sbjct: 303 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 343
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 97.7 bits (244), Expect = 2e-22
Identities = 58/202 (28%), Positives = 98/202 (48%), Gaps = 25/202 (12%)
Query: 440 KIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMG 497
+IGEG+ G V+ A+ R + VA+K + + + LRE+ ++ +HP +V L+
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 498 AVTEPPNLSIVTEYLSRGSLYKLLH-----IPDARVVVDERLRLNMAYDVAKGMNYLHQR 552
+V EY+ L ++L +P+A+V + + M + KG+ Y+H
Sbjct: 67 VFPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQV----KSYMRM---LLKGVAYMHAN 118
Query: 553 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVL---- 607
I+HRDLK NLL+ + +K+ DFGL+R T + APE+L
Sbjct: 119 G--IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGAR 176
Query: 608 REDPSNEKSDVFSFGVILWELI 629
+ DP D+++ G I EL+
Sbjct: 177 KYDPG---VDLWAVGCIFAELL 195
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 4e-22
Identities = 54/165 (32%), Positives = 89/165 (53%), Gaps = 13/165 (7%)
Query: 536 LNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS--KPNTYISSK 593
L+ Y VA+GM +L + VHRDL + N+L+ VK+CDFGL+R + Y+S
Sbjct: 240 LSFTYQVARGMEFLASKN--CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKG 297
Query: 594 TAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFK-- 650
+ +WMAPE + ++ SDV+S+G++LWE+ +L P+ P ++ + +
Sbjct: 298 STFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPY----PGMIVDSTFYNKI 353
Query: 651 --GRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 693
G R+ P + V ++ CW EPE RPSF + + ++ L
Sbjct: 354 KSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 5e-22
Identities = 72/237 (30%), Positives = 121/237 (51%), Gaps = 15/237 (6%)
Query: 439 KKIGEGSFGTVYHAEWRNSDV--AVKILIEQEFHEDRFKEFLREVA----IMKGLRHPNI 492
K IG+GSFG V A+ + AVK+L Q+ + KE +A ++K ++HP +
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVL--QKKAILKKKEQKHIMAERNVLLKNVKHPFL 58
Query: 493 VLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 552
V L + L V +Y++ G L+ H+ R + R R A ++A + YLH
Sbjct: 59 VGLHYSFQTADKLYFVLDYVNGGELF--FHLQRERSFPEPRARF-YAAEIASALGYLHSL 115
Query: 553 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPS 612
I++RDLK N+L+DS V + DFGL + ++ T GTPE++APEVLR+ P
Sbjct: 116 N--IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPY 173
Query: 613 NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE 669
+ D + G +L+E++ P+ + +++ + K L + N++ L+E
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNK--PLRLKPNISVSARHLLE 228
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 6e-22
Identities = 75/257 (29%), Positives = 122/257 (47%), Gaps = 27/257 (10%)
Query: 439 KKIGEGSFGTVYHAEWRNSDV----AVKIL-IEQEFHEDRFKEFLREVAIMKGLRHPNIV 493
+++G G++G VY A RN AVKI+ +E D F +E+ ++K +H NIV
Sbjct: 15 QRVGSGTYGDVYKA--RNLHTGELAAVKIIKLEPG---DDFSLIQQEIFMVKECKHCNIV 69
Query: 494 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAY---DVAKGMNYLH 550
G+ L I EY GSL + H V L +AY + +G+ YLH
Sbjct: 70 AYFGSYLSREKLWICMEYCGGGSLQDIYH------VTGPLSELQIAYVCRETLQGLAYLH 123
Query: 551 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRED 610
+ +HRD+K N+L+ VK+ DFG++ T K+ GTP WMAPEV +
Sbjct: 124 SKGK--MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVE 181
Query: 611 PS---NEKSDVFSFGVILWELITLQKPWRNSTPSQ---VISAVGFKGRRLEIPKNVNPMV 664
+ N+ D+++ G+ EL LQ P + P + ++S F+ +L+ +
Sbjct: 182 KNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTF 241
Query: 665 AALIETCWAEEPEIRPS 681
++ + P+ RP+
Sbjct: 242 HNFVKISLTKNPKKRPT 258
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 6e-22
Identities = 53/165 (32%), Positives = 91/165 (55%), Gaps = 13/165 (7%)
Query: 536 LNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN--TYISSK 593
L+ +Y VAKGM++L + +HRDL + N+L+ K+CDFGL+R N Y+
Sbjct: 217 LSFSYQVAKGMSFLASKN--CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKG 274
Query: 594 TAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFK-- 650
A +WMAPE + +SDV+S+G++LWE+ +L P+ P + + +K
Sbjct: 275 NARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPY----PGMPVDSKFYKMI 330
Query: 651 --GRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 693
G R+ P+ + ++++CW +P RP+F I++ ++Q L
Sbjct: 331 KEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQL 375
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 9e-22
Identities = 55/162 (33%), Positives = 88/162 (54%), Gaps = 7/162 (4%)
Query: 536 LNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS--KPNTYISSK 593
+ +Y VA GM +L + VHRDL + N+L+ VK+CDFGL+R + + YIS
Sbjct: 242 VGFSYQVANGMEFLASKN--CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKG 299
Query: 594 TAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTP--SQVISAVGFKG 651
+ +WMAPE + + SDV+SFG++LWE+ TL P Q +A+ +G
Sbjct: 300 STFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIK-RG 358
Query: 652 RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 693
R+ P + + + +++ CW E+ EIRP F ++ + L
Sbjct: 359 YRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 1e-21
Identities = 65/206 (31%), Positives = 103/206 (50%), Gaps = 22/206 (10%)
Query: 440 KIGEGSFGTVYHAEWRNSD----VAVKILIEQEFHEDRF--KEFLREVAIMKGLRHPNIV 493
KIGEGS+G V+ RN + VA+K +E E +D K LRE+ ++K L+HPN+V
Sbjct: 8 KIGEGSYGVVFKC--RNRETGQIVAIKKFVESE--DDPVIKKIALREIRMLKQLKHPNLV 63
Query: 494 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVV-VDERLRLNMAYDVAKGMNYLHQR 552
L+ L +V EY + +L+ + V E L + + + +N+ H+
Sbjct: 64 NLIEVFRRKRKLHLVFEYCD----HTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKH 119
Query: 553 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR--SKPNTYISSKTAAGTPEWMAPEVLRED 610
+HRD+K N+L+ +K+CDFG +R + P + A T + APE+L D
Sbjct: 120 N--CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVA--TRWYRAPELLVGD 175
Query: 611 PS-NEKSDVFSFGVILWELITLQKPW 635
DV++ G + EL+T Q W
Sbjct: 176 TQYGPPVDVWAIGCVFAELLTGQPLW 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 2e-21
Identities = 68/247 (27%), Positives = 121/247 (48%), Gaps = 27/247 (10%)
Query: 433 SELLIKKKIGEGSFGTVYHAEWRNSD--VAVKIL-------IEQEFHEDRFKEFLREVAI 483
+L K +G G+FG V+ R S+ A+K++ ++QE H K L+EV
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV-- 58
Query: 484 MKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVA 543
HP I+ L + L ++ EY+ G L+ L L A ++
Sbjct: 59 ----SHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLR---NSGRFSNSTGLFYASEIV 111
Query: 544 KGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWM 602
+ YLH + IV+RDLK N+L+D +K+ DFG ++ + T+ T GTPE++
Sbjct: 112 CALEYLHSKE--IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTW----TLCGTPEYL 165
Query: 603 APEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNP 662
APEV++ N+ D ++ G++++E++ P+ + P + + G +LE P++++
Sbjct: 166 APEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKI-LAG-KLEFPRHLDL 223
Query: 663 MVAALIE 669
LI+
Sbjct: 224 YAKDLIK 230
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 94.4 bits (234), Expect = 2e-21
Identities = 72/255 (28%), Positives = 120/255 (47%), Gaps = 20/255 (7%)
Query: 439 KKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVA-------IMKGLRHPN 491
K +G+G+FG VY + D ++ +Q + E +EV+ ++K L+H
Sbjct: 8 KLLGQGAFGRVYLC--YDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHER 65
Query: 492 IVLLMGAVTE--PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 549
IV G + + L+I EY+ GS+ L A + E + + +GM+YL
Sbjct: 66 IVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL---KAYGALTESVTRKYTRQILEGMSYL 122
Query: 550 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISS---KTAAGTPEWMAPEV 606
H IVHRD+K N+L DS VK+ DFG S+ +S ++ GTP WM+PEV
Sbjct: 123 HSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEV 180
Query: 607 LREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA 666
+ + K+DV+S G + E++T + PW I + + ++P +++
Sbjct: 181 ISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARD 240
Query: 667 LIETCWAEEPEIRPS 681
+ + E RPS
Sbjct: 241 FLGCIFVEARH-RPS 254
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 2e-21
Identities = 67/215 (31%), Positives = 103/215 (47%), Gaps = 16/215 (7%)
Query: 441 IGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFL----REVAIMKGLRHPNIVL 494
+G G FG V AE++ + A+K L + + E L R RHP +V
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 495 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 554
L ++ V EY + G L ++HI V E + A V G+ YLH+ +
Sbjct: 67 LFACFQTEDHVCFVMEYAAGGDL--MMHIHTD--VFSEPRAVFYAACVVLGLQYLHENK- 121
Query: 555 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAA--GTPEWMAPEVLREDPS 612
IV+RDLK NLL+D+ VK+ DFGL K +T+ GTPE++APEVL E
Sbjct: 122 -IVYRDLKLDNLLLDTEGFVKIADFGLC--KEGMGFGDRTSTFCGTPEFLAPEVLTETSY 178
Query: 613 NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 647
D + GV+++E++ + P+ +V ++
Sbjct: 179 TRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSI 213
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 94.2 bits (235), Expect = 2e-21
Identities = 71/247 (28%), Positives = 118/247 (47%), Gaps = 17/247 (6%)
Query: 441 IGEGSFGTVYHAEWRNSDV--AVKILIEQEFHEDRFKEFL-REVAIMKGLRHPNIVLLMG 497
+G G FG V + ++ + A+K + ++ E +E + E I++ HP IV L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 498 AVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 557
+ + ++ EY G L+ +L R + DE V YLH R I+
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILR---DRGLFDEYTARFYIACVVLAFEYLHNRG--II 115
Query: 558 HRDLKSPNLLVDSTYTVKVCDFGLSR---SKPNTYISSKTAAGTPEWMAPEVLREDPSNE 614
+RDLK NLL+DS VK+ DFG ++ S T+ T GTPE++APE++ +
Sbjct: 116 YRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW----TFCGTPEYVAPEIILNKGYDF 171
Query: 615 KSDVFSFGVILWELITLQKPWRNS--TPSQVISAVGFKGRRLEIPKNVNPMVAALIETCW 672
D +S G++L+EL+T + P+ P ++ + + +LE P ++ LI+
Sbjct: 172 SVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLL 231
Query: 673 AEEPEIR 679
PE R
Sbjct: 232 RRNPEER 238
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 2e-21
Identities = 72/271 (26%), Positives = 129/271 (47%), Gaps = 16/271 (5%)
Query: 440 KIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFL-REVAIMKGLRHPNIVLLM 496
KIGEGS G V A ++S VAVK + + + + +E L EV IM+ +H N+V +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVK---KMDLRKQQRRELLFNEVVIMRDYQHENVVEMY 83
Query: 497 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 556
+ L +V E+L G+L ++ ++E + V K ++ LH + +
Sbjct: 84 NSYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIAAVCLAVLKALSVLHAQ--GV 137
Query: 557 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKS 616
+HRD+KS ++L+ VK+ DFG K+ GTP WMAPE++ P +
Sbjct: 138 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEV 197
Query: 617 DVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-GRRLEIPKNVNPMVAALIETCWAEE 675
D++S G+++ E++ + P+ N P + + + +L+ V+P + ++ +
Sbjct: 198 DIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRD 257
Query: 676 PEIRPSFPSIMETLQQFLMSSVCQPLSAQPL 706
P R + E L+ ++ P PL
Sbjct: 258 PAQR---ATAAELLKHPFLAKAGPPSCIVPL 285
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 2e-21
Identities = 68/236 (28%), Positives = 123/236 (52%), Gaps = 13/236 (5%)
Query: 439 KKIGEGSFGTVYHAEWRNSDV--AVKILIEQEFHEDRFKEFL---REVAIMKGLRHPNIV 493
K IG+GSFG V A + + AVK+L ++ + + ++ + R V ++K ++HP +V
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNV-LLKNVKHPFLV 59
Query: 494 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 553
L + L V +Y++ G L+ H+ R ++ R R A ++A + YLH
Sbjct: 60 GLHFSFQTADKLYFVLDYINGGELF--YHLQRERCFLEPRARF-YAAEIASALGYLHSLN 116
Query: 554 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSN 613
IV+RDLK N+L+DS + + DFGL + ++ T GTPE++APEVL + P +
Sbjct: 117 --IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYD 174
Query: 614 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE 669
D + G +L+E++ P+ + +++ + + L++ N+ L+E
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI--LNKPLQLKPNITNSARHLLE 228
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 3e-21
Identities = 77/264 (29%), Positives = 130/264 (49%), Gaps = 26/264 (9%)
Query: 439 KKIGEGSFGTVYHAE----WRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 494
K+IG G FG V E + + V VK L +++ K FL E + L+H N++
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMK-FLEEAQPYRSLQHSNLLQ 59
Query: 495 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDA--RVVVDERLRLNMAYDVAKGMNYLHQR 552
+G TE +V E+ G L L + D MA ++A G+ +LH+
Sbjct: 60 CLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN 119
Query: 553 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLS--RSKPNTYISSKTAAGTPEWMAPEVLRED 610
+H DL N L+ + TVK+ D+GLS + K + Y++ W+APE++ E
Sbjct: 120 N--FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEV 177
Query: 611 PSN-------EKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNP 662
N ++S+V+S GV +WEL L +P+R+ + QV++ + ++L++PK
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYT-VREQQLKLPKPRLK 236
Query: 663 MVAA-----LIETCWAEEPEIRPS 681
+ + +++ CW +PE RPS
Sbjct: 237 LPLSDRWYEVMQFCWL-QPEQRPS 259
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 3e-21
Identities = 72/249 (28%), Positives = 119/249 (47%), Gaps = 19/249 (7%)
Query: 439 KKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKE---FLREVAIMKGLRHPNIV 493
K +G+GSFG V AE + N A+K L + ED E R V + HP +
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLAL-AWEHPFLT 59
Query: 494 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 553
L +L V EYL+ G L + HI + + R R A ++ G+ +LH++
Sbjct: 60 HLFCTFQTKEHLFFVMEYLNGGDL--MFHIQSSGRFDEARARF-YAAEIICGLQFLHKKG 116
Query: 554 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSN 613
I++RDLK N+L+D +K+ DFG+ + N + T GTP+++APE+L+ N
Sbjct: 117 --IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYN 174
Query: 614 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEI---PKNVNPMVAALIET 670
E D +SFGV+L+E++ Q P+ ++ F + P+ ++ +
Sbjct: 175 ESVDWWSFGVLLYEMLIGQSPFHGEDEDEL-----FDSILNDRPHFPRWISKEAKDCLSK 229
Query: 671 CWAEEPEIR 679
+ +P R
Sbjct: 230 LFERDPTKR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.1 bits (232), Expect = 7e-21
Identities = 71/210 (33%), Positives = 103/210 (49%), Gaps = 31/210 (14%)
Query: 441 IGEGSFGTVYHAEWRNS--DVAVK-ILIEQEFHEDRFKEF-LREVAIMKGLR---HPNIV 493
IGEG++GTVY A N+ VA+K + + E+ LRE+A++K L HPNIV
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLS--EEGIPLSTLREIALLKQLESFEHPNIV 64
Query: 494 LLMGAVTEPPN-----LSIVTEYLSRG-SLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 547
L+ P L++V E++ + + Y L P + ++ + +G++
Sbjct: 65 RLLDVCHGPRTDRELKLTLVFEHVDQDLATY-LSKCPKP--GLPPETIKDLMRQLLRGVD 121
Query: 548 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPE----WM- 602
+LH R IVHRDLK N+LV S VK+ DFGL+R I S A T W
Sbjct: 122 FLHSHR--IVHRDLKPQNILVTSDGQVKIADFGLAR------IYSFEMALTSVVVTLWYR 173
Query: 603 APEVLREDPSNEKSDVFSFGVILWELITLQ 632
APEVL + D++S G I EL +
Sbjct: 174 APEVLLQSSYATPVDMWSVGCIFAELFRRR 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 7e-21
Identities = 67/244 (27%), Positives = 123/244 (50%), Gaps = 10/244 (4%)
Query: 439 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLL 495
K +G+G+FG V + + A+KIL ++ +D L E +++ RHP + L
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 496 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 555
+ L V EY + G L+ H+ RV ++R R A ++ + YLH
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELF--FHLSRERVFSEDRARFYGA-EIVSALGYLHSCD-- 115
Query: 556 IVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEK 615
+V+RDLK NL++D +K+ DFGL + + + KT GTPE++APEVL ++
Sbjct: 116 VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRA 175
Query: 616 SDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEE 675
D + GV+++E++ + P+ N ++ + + + P+ ++P +L+ ++
Sbjct: 176 VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--EIRFPRTLSPEAKSLLAGLLKKD 233
Query: 676 PEIR 679
P+ R
Sbjct: 234 PKQR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 9e-21
Identities = 50/164 (30%), Positives = 97/164 (59%), Gaps = 8/164 (4%)
Query: 546 MNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISS---KTAAGTPEWM 602
++++H + ++HRD+KS N+L+ S VK+ DFG S+ T +S +T GTP ++
Sbjct: 156 VHHVHSKH--MIHRDIKSANILLCSNGLVKLGDFGFSKMYAAT-VSDDVGRTFCGTPYYV 212
Query: 603 APEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNP 662
APE+ R P ++K+D+FS GV+L+EL+TL++P+ +V+ GR +P +++P
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKT-LAGRYDPLPPSISP 271
Query: 663 MVAALIETCWAEEPEIRPSFPSIMET-LQQFLMSSVCQPLSAQP 705
+ ++ + +P+ RPS ++ + + +S + + + QP
Sbjct: 272 EMQEIVTALLSSDPKRRPSSSKLLNMPICKLFISGLLEIVQTQP 315
|
Length = 496 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 1e-20
Identities = 58/196 (29%), Positives = 101/196 (51%), Gaps = 12/196 (6%)
Query: 440 KIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMG 497
+GEGS+G V + + + VA+K +E E + K +RE+ ++K LRH N+V L+
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 498 AVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 557
L +V E++ L L P+ +DE + + +G+ + H I+
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDLEKYPNG---LDESRVRKYLFQILRGIEFCHSHN--II 122
Query: 558 HRDLKSPNLLVDSTYTVKVCDFGLSR--SKPNTYISSKTAAGTPEWMAPEVLREDPSNEK 615
HRD+K N+LV + VK+CDFG +R + P + A T + APE+L D +
Sbjct: 123 HRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVA--TRWYRAPELLVGDTKYGR 180
Query: 616 S-DVFSFGVILWELIT 630
+ D+++ G ++ E++T
Sbjct: 181 AVDIWAVGCLVTEMLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 3e-20
Identities = 72/222 (32%), Positives = 106/222 (47%), Gaps = 32/222 (14%)
Query: 437 IKKKIGEGSFGTVYHAEWRNSDVAV---KILIEQEFHEDRFK-EFLREVAIMKGLRHPNI 492
I K+GEG+FG VY A + V KIL+ E +D F LRE+ I+K L+HPN+
Sbjct: 12 ILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNE--KDGFPITALREIKILKKLKHPNV 69
Query: 493 VLLMGAVTEPPNLS--------IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAK 544
V L+ E P+ S +VT Y+ L LL P V + E + +
Sbjct: 70 VPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENP--SVKLTESQIKCYMLQLLE 126
Query: 545 GMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS------KPNTYISSKTAAGT 598
G+NYLH+ I+HRD+K+ N+L+D+ +K+ DFGL+R P T T
Sbjct: 127 GINYLHENH--ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYT 184
Query: 599 P----EWM-APE-VLREDPSNEKSDVFSFGVILWELITLQKP 634
W PE +L E D++ G + E+ T ++P
Sbjct: 185 NLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFT-RRP 225
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 3e-20
Identities = 65/197 (32%), Positives = 107/197 (54%), Gaps = 13/197 (6%)
Query: 439 KKIGEGSFGTVYHAEWRNSD---VAVKILIEQEFHEDRFKEFL---REVAIMKGLRHPNI 492
K IG+GSFG V A+ R D AVK+L ++ + ++ + R V ++K ++HP +
Sbjct: 1 KVIGKGSFGKVLLAK-RKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNV-LLKNVKHPFL 58
Query: 493 VLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 552
V L + L V ++++ G L+ H+ R + R R A ++A + YLH
Sbjct: 59 VGLHYSFQTTEKLYFVLDFVNGGELF--FHLQRERSFPEPRARFYAA-EIASALGYLHSI 115
Query: 553 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPS 612
IV+RDLK N+L+DS V + DFGL + ++ T GTPE++APEV+R+ P
Sbjct: 116 N--IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPY 173
Query: 613 NEKSDVFSFGVILWELI 629
+ D + G +L+E++
Sbjct: 174 DNTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 4e-20
Identities = 51/164 (31%), Positives = 91/164 (55%), Gaps = 11/164 (6%)
Query: 536 LNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN--TYISSK 593
L + VA+GM++L + +HRD+ + N+L+ K+CDFGL+R N Y+
Sbjct: 215 LRFSSQVAQGMDFLASKN--CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272
Query: 594 TAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK--- 650
A +WMAPE + + +SDV+S+G++LWE+ +L K + P ++++ +K
Sbjct: 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGK---SPYPGILVNSKFYKMVK 329
Query: 651 -GRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 693
G ++ P P + ++++ CW EP RP+F I + +Q+ L
Sbjct: 330 RGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 6e-20
Identities = 66/198 (33%), Positives = 105/198 (53%), Gaps = 13/198 (6%)
Query: 439 KKIGEGSFGTVYHAEWR--NSDVAVK-ILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 495
+K+GEG++ TVY R VA+K I ++ E E +RE+++MK L+H NIV L
Sbjct: 6 EKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKELKHENIVRL 63
Query: 496 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 555
+ L +V EY+ L K + R +D + Y + KG+ + H+ R
Sbjct: 64 HDVIHTENKLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR-- 120
Query: 556 IVHRDLKSPNLLVDSTYTVKVCDFGLSRS--KPNTYISSKTAAGTPEWMAPEVLREDPSN 613
++HRDLK NLL++ +K+ DFGL+R+ P S++ T + AP+VL +
Sbjct: 121 VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TLWYRAPDVLLGSRTY 178
Query: 614 EKS-DVFSFGVILWELIT 630
S D++S G I+ E+IT
Sbjct: 179 STSIDIWSVGCIMAEMIT 196
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 1e-19
Identities = 70/206 (33%), Positives = 105/206 (50%), Gaps = 33/206 (16%)
Query: 440 KIGEGSFGTVYHAEWRNSD--VAVK-ILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 496
K+GEGS+ TVY + + VA+K I +E E E +RE +++K L+H NIV L
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHE--EGAPFTAIREASLLKDLKHANIVTLH 69
Query: 497 GAVTEPPNLSIVTEYLSRG-SLY-----KLLHIPDARVVVDERLRLNMAYDVAKGMNYLH 550
+ L++V EYL Y L + + R+ + + LR G+ Y H
Sbjct: 70 DIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLR---------GLAYCH 120
Query: 551 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAG---TPEWMAPEVL 607
QRR ++HRDLK NLL+ +K+ DFGL+R+K + SKT + T + P+VL
Sbjct: 121 QRR--VLHRDLKPQNLLISERGELKLADFGLARAKS---VPSKTYSNEVVTLWYRPPDVL 175
Query: 608 REDPSNEKS---DVFSFGVILWELIT 630
S E S D++ G I +E+ T
Sbjct: 176 LG--STEYSTSLDMWGVGCIFYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 2e-19
Identities = 59/201 (29%), Positives = 105/201 (52%), Gaps = 9/201 (4%)
Query: 439 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQE-FHEDRFKEFLREVAIMK-GLRHPNIVL 494
K +G+GSFG V AE + +D A+K+L + +D + E I+ +HP +
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 495 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 554
L L V EY++ G L + I +R + R R A +V + +LH+
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDL--MFQIQRSRKFDEPRSRF-YAAEVTLALMFLHRH-- 115
Query: 555 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNE 614
+++RDLK N+L+D+ K+ DFG+ + +++ T GTP+++APE+L+E
Sbjct: 116 GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGP 175
Query: 615 KSDVFSFGVILWELITLQKPW 635
D ++ GV+++E++ Q P+
Sbjct: 176 SVDWWALGVLMYEMMAGQPPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 3e-19
Identities = 70/201 (34%), Positives = 104/201 (51%), Gaps = 11/201 (5%)
Query: 439 KKIGEGSFGTVYHAEWR--NSDVAVK-ILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 495
+KIGEG++G VY A R N +A+K I +EQE E +RE++++K ++H NIV L
Sbjct: 8 EKIGEGTYGVVYKARDRVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRL 66
Query: 496 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 555
V L +V EYL + PD + RL Y + +G+ Y H R
Sbjct: 67 QDVVHSEKRLYLVFEYLDLDLKKHMDSSPD--FAKNPRLIKTYLYQILRGIAYCHSHR-- 122
Query: 556 IVHRDLKSPNLLVD-STYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPS-N 613
++HRDLK NLL+D T +K+ DFGL+R+ + T + APE+L +
Sbjct: 123 VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYS 182
Query: 614 EKSDVFSFGVILWELITLQKP 634
D++S G I E++ QKP
Sbjct: 183 TPVDIWSVGCIFAEMVN-QKP 202
|
Length = 294 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 3e-19
Identities = 69/210 (32%), Positives = 107/210 (50%), Gaps = 19/210 (9%)
Query: 428 LEIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMK 485
+I++ E+L G G+ GTVY A + +AVK+ I + + K+ + E+ I+
Sbjct: 1 QDIQYQEIL-----GHGNGGTVYKAYHLLTRRILAVKV-IPLDITVELQKQIMSELEILY 54
Query: 486 GLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKG 545
P I+ GA +SI TE++ GSL IP E + +A V KG
Sbjct: 55 KCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVYRKIP-------EHVLGRIAVAVVKG 107
Query: 546 MNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPE 605
+ YL + I+HRD+K N+LV++ VK+CDFG+S N+ +KT GT +MAPE
Sbjct: 108 LTYLWSLK--ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--AKTYVGTNAYMAPE 163
Query: 606 VLREDPSNEKSDVFSFGVILWELITLQKPW 635
+ + SDV+S G+ EL + P+
Sbjct: 164 RISGEQYGIHSDVWSLGISFMELALGRFPY 193
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 4e-19
Identities = 70/233 (30%), Positives = 121/233 (51%), Gaps = 26/233 (11%)
Query: 441 IGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRH--------- 489
IG+G+FG VY +++ A+K+L ++E + EVA G R+
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKK------EVAHTIGERNILVRTLLDE 54
Query: 490 -PNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 548
P IV L + +L +VT+Y+S G L+ H+ ++R + +A ++ + +
Sbjct: 55 SPFIVGLKFSFQTDSDLYLVTDYMSGGELF--WHLQKEGRFSEDRAKFYIA-ELVLALEH 111
Query: 549 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLR 608
LH+ IV+RDLK N+L+D+T + +CDFGLS++ ++ T GT E++APEVL
Sbjct: 112 LHKYD--IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLL 169
Query: 609 EDPSNEKS-DVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNV 660
++ K D +S GV+++E+ P+ Q+ + F ++ PKNV
Sbjct: 170 DEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFG--KVRFPKNV 220
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 4e-19
Identities = 70/251 (27%), Positives = 128/251 (50%), Gaps = 22/251 (8%)
Query: 439 KKIGEGSFGTVYHA-EWRNSDV----AVKILIEQEFH-EDRFKEFLREVAIMKGLRHPNI 492
K +G+GSFG V+ + D A+K+L + DR + + E I+ + HP I
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKM-ERDILAEVNHPFI 60
Query: 493 VLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 552
V L A L ++ ++L G L+ L + +E ++ +A ++A +++LH
Sbjct: 61 VKLHYAFQTEGKLYLILDFLRGGDLFTRL--SKEVMFTEEDVKFYLA-ELALALDHLH-- 115
Query: 553 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPS 612
I++RDLK N+L+D +K+ DFGLS+ + + + GT E+MAPEV+
Sbjct: 116 SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGH 175
Query: 613 NEKSDVFSFGVILWELITLQKPW----RNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI 668
+ +D +SFGV+++E++T P+ R T + ++ A +L +P+ ++P +L+
Sbjct: 176 TQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKA------KLGMPQFLSPEAQSLL 229
Query: 669 ETCWAEEPEIR 679
+ P R
Sbjct: 230 RALFKRNPANR 240
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 4e-19
Identities = 58/199 (29%), Positives = 106/199 (53%), Gaps = 9/199 (4%)
Query: 441 IGEGSFGTVYHAEWRNSD--VAVKILIEQE-FHEDRFKEFLREVAIMK-GLRHPNIVLLM 496
+G+GSFG V AE + +D A+KIL + +D + + E ++ + P + L
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLH 67
Query: 497 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 556
L V EY++ G L + HI E + A ++A G+ +LH + I
Sbjct: 68 SCFQTMDRLYFVMEYVNGGDL--MYHIQQVGKF-KEPHAVFYAAEIAIGLFFLHSK--GI 122
Query: 557 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKS 616
++RDLK N+++D+ +K+ DFG+ + +++T GTP+++APE++ P +
Sbjct: 123 IYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSV 182
Query: 617 DVFSFGVILWELITLQKPW 635
D ++FGV+L+E++ Q P+
Sbjct: 183 DWWAFGVLLYEMLAGQPPF 201
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 5e-19
Identities = 85/277 (30%), Positives = 129/277 (46%), Gaps = 42/277 (15%)
Query: 437 IKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIV 493
I + IG+G++G VY + S AVKIL + D +E E I++ L HPN+V
Sbjct: 26 IIETIGKGTYGKVYKVTNKKDGSLAAVKIL---DPISDVDEEIEAEYNILQSLPNHPNVV 82
Query: 494 LLMGAVTEPPNLS-----IVTEYLSRGS---LYKLLHIPDARVVVDERLRLNMAYDVAKG 545
G + L +V E + GS L K L I R+ DE + + Y G
Sbjct: 83 KFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRL--DEAMISYILYGALLG 140
Query: 546 MNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPE 605
+ +LH R I+HRD+K N+L+ + VK+ DFG+S +T + T+ GTP WMAPE
Sbjct: 141 LQHLHNNR--IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPE 198
Query: 606 VL----REDPS-NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNV 660
V+ + D S + + DV+S G+ EL P + P + + +IP+N
Sbjct: 199 VIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTL---------FKIPRNP 249
Query: 661 NPMV----------AALIETCWAEEPEIRPSFPSIME 687
P + I C ++ E RPS ++E
Sbjct: 250 PPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 87.1 bits (215), Expect = 7e-19
Identities = 70/270 (25%), Positives = 125/270 (46%), Gaps = 38/270 (14%)
Query: 441 IGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMG 497
+G G++G VY + A+K++ + D +E +E+ ++K H NI G
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVM---DVTGDEEEEIKQEINMLKKYSHHRNIATYYG 70
Query: 498 AVTE--PPNLS----IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 551
A + PP + +V E+ GS+ L+ + +E + + ++ +G+++LHQ
Sbjct: 71 AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY-ICREILRGLSHLHQ 129
Query: 552 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDP 611
+ ++HRD+K N+L+ VK+ DFG+S T T GTP WMAPEV+ D
Sbjct: 130 HK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDE 187
Query: 612 SNE-----KSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA- 665
+ + KSD++S G+ E+ P + P + + IP+N P +
Sbjct: 188 NPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL---------FLIPRNPAPRLKS 238
Query: 666 --------ALIETCWAEEPEIRPSFPSIME 687
+ IE+C + RP+ +M+
Sbjct: 239 KKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 7e-19
Identities = 69/297 (23%), Positives = 137/297 (46%), Gaps = 33/297 (11%)
Query: 410 NLSVMSTSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEF 469
N+ S N +E + ++ ++ +LIK E ++Y + N +V ++ ++F
Sbjct: 2 NIITRSYINDIKCIESDDIDK-YTSVLIK----ENDQNSIYKGIFNNKEVIIRTF--KKF 54
Query: 470 HEDRFK---EFLREVAIMKGLRHPNIVLLMG----AVTEPPNLSIVTEYLSRGSLYKLLH 522
H+ E+ ++ + NI+ + G V + P LS++ EY +RG L ++L
Sbjct: 55 HKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVL- 113
Query: 523 IPDARVVVDERLRLNMAYDVAKGMNYLHQ--RRPPIVHRDLKSPNLLVDSTYTVKVCDFG 580
D + + +L+MA D KG+ L++ +P +++L S + LV Y +K+ G
Sbjct: 114 --DKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP---YKNLTSVSFLVTENYKLKIICHG 168
Query: 581 LSRSKPNTYISSKTAAGTPEWMA---PEVLRE--DPSNEKSDVFSFGVILWELITLQKPW 635
L + I S +M ++L + K D++S GV+LWE+ T + P+
Sbjct: 169 LEK------ILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPF 222
Query: 636 RNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQF 692
N T ++ + K L++P + + ++E C + + RP+ I+ L +
Sbjct: 223 ENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279
|
Length = 283 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 9e-19
Identities = 62/196 (31%), Positives = 104/196 (53%), Gaps = 18/196 (9%)
Query: 441 IGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA 498
+GEG++G V + + VA+K + E +E+ + LRE+ +++ L+ NIV L A
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 499 VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVH 558
L +V EY+ + L L +P+ V E++R + Y + K +++ H+ IVH
Sbjct: 69 FRRRGKLYLVFEYVEKNMLELLEEMPNG--VPPEKVR-SYIYQLIKAIHWCHKND--IVH 123
Query: 559 RDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMA------PEVLREDPS 612
RD+K NLL+ +K+CDFG +R+ +S + A E++A PE+L P
Sbjct: 124 RDIKPENLLISHNDVLKLCDFGFARN-----LSEGSNANYTEYVATRWYRSPELLLGAPY 178
Query: 613 NEKSDVFSFGVILWEL 628
+ D++S G IL EL
Sbjct: 179 GKAVDMWSVGCILGEL 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 1e-18
Identities = 74/260 (28%), Positives = 126/260 (48%), Gaps = 37/260 (14%)
Query: 439 KKIGEGSFGTVYHA-EWRNSDVAV--KILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 495
++IG GSFG VY A + R ++V K+ + +++++ ++EV ++ LRHPN +
Sbjct: 21 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80
Query: 496 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 555
G +V EY GS +L + + E + + +G+ YLH
Sbjct: 81 KGCYLREHTAWLVMEY-CLGSASDILEVHKKPLQEVEIAAI--CHGALQGLAYLHSHE-- 135
Query: 556 IVHRDLKSPNLLVDSTYTVKVCDFGLSR--SKPNTYISSKTAAGTPEWMAPEV---LRED 610
+HRD+K+ N+L+ TVK+ DFG + S N+++ GTP WMAPEV + E
Sbjct: 136 RIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV------GTPYWMAPEVILAMDEG 189
Query: 611 PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA---- 666
+ K DV+S G+ EL + P N +SA+ I +N +P +++
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFN---MNAMSAL------YHIAQNDSPTLSSNDWS 240
Query: 667 -----LIETCWAEEPEIRPS 681
+++C + P+ RPS
Sbjct: 241 DYFRNFVDSCLQKIPQDRPS 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 2e-18
Identities = 61/231 (26%), Positives = 101/231 (43%), Gaps = 48/231 (20%)
Query: 439 KKIGEGSFGTVYHAEWRNSD--VAVK----ILIEQEFHEDRFK--------EFLREVAIM 484
+GEG++G V A + VA+K I I + +DR LRE+ IM
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 485 KGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAY---- 540
++H NI+ L+ E +++V + ++ D + VVD ++RL +
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDIMAS----------DLKKVVDRKIRLTESQVKCI 124
Query: 541 --DVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAG- 597
+ G+N LH+ +HRDL N+ ++S K+ DFGL+R S +
Sbjct: 125 LLQILNGLNVLHKWY--FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDE 182
Query: 598 --------TPE-----WMAPEVLR-EDPSNEKSDVFSFGVILWELITLQKP 634
T + + APE+L + + D++S G I EL+T KP
Sbjct: 183 TMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLT-GKP 232
|
Length = 335 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 2e-18
Identities = 62/250 (24%), Positives = 132/250 (52%), Gaps = 16/250 (6%)
Query: 441 IGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLR--EVAIMKGLRHPNIVLLM 496
IG GS+ V + ++ A+K++ ++ ++D ++++ + + HP +V L
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 497 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 556
L V EY++ G L + H+ R + +E R A +++ +NYLH+R I
Sbjct: 63 SCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSA-EISLALNYLHER--GI 117
Query: 557 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKS 616
++RDLK N+L+DS +K+ D+G+ + ++ T GTP ++APE+LR +
Sbjct: 118 IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSV 177
Query: 617 DVFSFGVILWELITLQKPW----RNSTPSQVISAVGFK---GRRLEIPKNVNPMVAALIE 669
D ++ GV+++E++ + P+ + P Q F+ +++ IP++++ A++++
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLK 237
Query: 670 TCWAEEPEIR 679
+ ++P+ R
Sbjct: 238 SFLNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-18
Identities = 63/201 (31%), Positives = 101/201 (50%), Gaps = 9/201 (4%)
Query: 439 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKE--FLREVAIMKGLRHPNIVL 494
K +G+GSFG V+ AE + ++ A+K L + D E + + + HP +
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 495 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 554
L NL V EYL+ G L + HI R A ++ G+ +LH +
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDL--MFHIQSCHKFDLPRATF-YAAEIICGLQFLHSK-- 115
Query: 555 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNE 614
IV+RDLK N+L+D+ +K+ DFG+ + + T GTP+++APE+L N
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNT 175
Query: 615 KSDVFSFGVILWELITLQKPW 635
D +SFGV+L+E++ Q P+
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 3e-18
Identities = 66/245 (26%), Positives = 125/245 (51%), Gaps = 15/245 (6%)
Query: 441 IGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFL---REVAIMKGLRHPNIVLL 495
+G+GSFG V AE + +D A+KIL + +D E + V + G + P + L
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSG-KPPFLTQL 66
Query: 496 MGAVTEPPNLSIVTEYLSRGSL-YKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 554
L V EY++ G L Y++ + + E + A ++A G+ +LH +
Sbjct: 67 HSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFK----EPHAVFYAAEIAIGLFFLHSK-- 120
Query: 555 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNE 614
I++RDLK N+++DS +K+ DFG+ + +++KT GTP+++APE++ P +
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGK 180
Query: 615 KSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAE 674
D ++FGV+L+E++ Q P+ ++ ++ + PK+++ A+ + +
Sbjct: 181 SVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI--MEHNVAYPKSMSKEAVAICKGLMTK 238
Query: 675 EPEIR 679
P R
Sbjct: 239 HPGKR 243
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 3e-18
Identities = 76/275 (27%), Positives = 126/275 (45%), Gaps = 38/275 (13%)
Query: 437 IKKKIGEGSFGTVY--HAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIV 493
I + IG+G++G V+ + S AVKIL H D +E E I+K L HPN+V
Sbjct: 22 IIETIGKGTYGKVFKVLNKKNGSKAAVKIL--DPIH-DIDEEIEAEYNILKALSDHPNVV 78
Query: 494 LLMGA-----VTEPPNLSIVTEYLSRGSLYKLLHIPDAR-VVVDERLRLNMAYDVAKGMN 547
G V L +V E + GS+ L+ R ++E + + ++ G+
Sbjct: 79 KFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQ 138
Query: 548 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVL 607
+LH + +HRD+K N+L+ + VK+ DFG+S +T + T+ GTP WMAPEV+
Sbjct: 139 HLHVNK--TIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVI 196
Query: 608 R-----EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNP 662
+ + + DV+S G+ EL P + P + + +IP+N P
Sbjct: 197 ACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL---------FKIPRNPPP 247
Query: 663 MVAA----------LIETCWAEEPEIRPSFPSIME 687
+ I C ++ E RP+ +++
Sbjct: 248 TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQ 282
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 3e-18
Identities = 74/260 (28%), Positives = 126/260 (48%), Gaps = 37/260 (14%)
Query: 439 KKIGEGSFGTVYHA-EWRNSDVAV--KILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 495
++IG GSFG VY A + RNS+V K+ + +++++ ++EV ++ LRHPN +
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 496 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 555
G +V EY GS LL + + + E + + +G+ YLH
Sbjct: 81 RGCYLREHTAWLVMEY-CLGSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN-- 135
Query: 556 IVHRDLKSPNLLVDSTYTVKVCDFGLSR--SKPNTYISSKTAAGTPEWMAPEV---LRED 610
++HRD+K+ N+L+ VK+ DFG + + N ++ GTP WMAPEV + E
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV------GTPYWMAPEVILAMDEG 189
Query: 611 PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA---- 666
+ K DV+S G+ EL + P N +SA+ I +N +P + +
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFN---MNAMSAL------YHIAQNESPALQSGHWS 240
Query: 667 -----LIETCWAEEPEIRPS 681
+++C + P+ RP+
Sbjct: 241 EYFRNFVDSCLQKIPQDRPT 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 4e-18
Identities = 75/287 (26%), Positives = 133/287 (46%), Gaps = 52/287 (18%)
Query: 431 RWSELLIKKKIGEGSFGTVYHA--EWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR 488
R+ +L + +G G+FG V A + +VA+K +++ K RE+ ++K LR
Sbjct: 11 RYVDL---QPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLR 67
Query: 489 HPNIVLLMGAVTEP-PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 547
H NI+ L P ++ VTE L L++LL +R + + ++ Y + +G+
Sbjct: 68 HENIISLSDIFISPLEDIYFVTELLGT-DLHRLL---TSRPLEKQFIQY-FLYQILRGLK 122
Query: 548 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR---SKPNTYISSKTAAGTPEWMAP 604
Y+H +VHRDLK N+L++ +K+CDFGL+R + Y+S T + AP
Sbjct: 123 YVHS--AGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVS------TRYYRAP 174
Query: 605 EV-LREDPSNEKSDVFSFGVILWELITLQK--PWRN-------------STPSQVISAVG 648
E+ L + + D++S G I E++ + P ++ + P VI+ +
Sbjct: 175 EIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTIC 234
Query: 649 FKG---------RRLEIP-----KNVNPMVAALIETCWAEEPEIRPS 681
+ +R +P KN +P L+E +P+ R S
Sbjct: 235 SENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRIS 281
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 4e-18
Identities = 59/207 (28%), Positives = 97/207 (46%), Gaps = 23/207 (11%)
Query: 441 IGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKE------FLREVAIMKGLRHPNIVL 494
+G+G FG V + + + K+ ++ + R K+ L E I++ + IV
Sbjct: 1 LGKGGFGEVCACQVKATG---KMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVS 57
Query: 495 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 554
L A +L +V ++ G L ++ + R A + G+ +LHQRR
Sbjct: 58 LAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAA-QIICGLEHLHQRR- 115
Query: 555 PIVHRDLKSPNLLVDSTYTVKVCDFGLS-----RSKPNTYISSKTAAGTPEWMAPEVLRE 609
IV+RDLK N+L+D V++ D GL+ K AGTP +MAPEVL+
Sbjct: 116 -IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGR------AGTPGYMAPEVLQG 168
Query: 610 DPSNEKSDVFSFGVILWELITLQKPWR 636
+ + D F+ G L+E+I + P+R
Sbjct: 169 EVYDFSVDWFALGCTLYEMIAGRSPFR 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 4e-18
Identities = 71/260 (27%), Positives = 125/260 (48%), Gaps = 21/260 (8%)
Query: 441 IGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAI-MKGLRHPNIVLLMG 497
+G G++G V + +AVK I + K L ++ I M+ + P V G
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVK-RIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYG 67
Query: 498 AVTEPPNLSIVTEYLSRGSLYKLL-HIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 556
A+ ++ I E + SL K + D + + E + +A + K + YLH + +
Sbjct: 68 ALFREGDVWICMEVMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS-V 125
Query: 557 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTA-AGTPEWMAPEVLREDPSNE- 614
+HRD+K N+L++ VK+CDFG+S ++ +KT AG +MAPE R +P
Sbjct: 126 IHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV--AKTIDAGCKPYMAPE--RINPELNQ 181
Query: 615 -----KSDVFSFGVILWELITLQKPWRN-STPSQVISAVGFKGRRLEIPKN-VNPMVAAL 667
KSDV+S G+ + EL T + P+ + TP Q + V + ++P +P
Sbjct: 182 KGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQV-VEEPSPQLPAEKFSPEFQDF 240
Query: 668 IETCWAEEPEIRPSFPSIME 687
+ C + + RP++P +++
Sbjct: 241 VNKCLKKNYKERPNYPELLQ 260
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 6e-18
Identities = 66/196 (33%), Positives = 105/196 (53%), Gaps = 13/196 (6%)
Query: 439 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 496
+K+GEGS+ TVY + + + VA+K++ QE F +RE +++KGL+H NIVLL
Sbjct: 11 EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTA-IREASLLKGLKHANIVLLH 69
Query: 497 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 556
+ L++V EY+ + P + +L L + + +G++Y+HQR I
Sbjct: 70 DIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFL---FQLLRGLSYIHQRY--I 124
Query: 557 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKS 616
+HRDLK NLL+ T +K+ DFGL+R+K + T + P+VL S E S
Sbjct: 125 LHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLG--STEYS 182
Query: 617 ---DVFSFGVILWELI 629
D++ G I E+I
Sbjct: 183 TCLDMWGVGCIFVEMI 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 84.2 bits (209), Expect = 6e-18
Identities = 63/210 (30%), Positives = 104/210 (49%), Gaps = 36/210 (17%)
Query: 440 KIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLM 496
KIGEG+F V A+ R + A+K + + F LRE+ ++ L HPNI+ L+
Sbjct: 6 KIGEGTFSEVLKAQSRKTGKYYAIKCMK-KHFKSLEQVNNLREIQALRRLSPHPNILRLI 64
Query: 497 GAVTEPPN--LSIVTEYLSRGSLYKLL-----HIPDARVVVDERLRLNMAYDVAKGMNYL 549
+ + L++V E L +LY+L+ +P+ RV + Y + K ++++
Sbjct: 65 EVLFDRKTGRLALVFE-LMDMNLYELIKGRKRPLPEKRV-------KSYMYQLLKSLDHM 116
Query: 550 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS----KPNT-YISSKTAAGTPEWM-A 603
H R I HRD+K N+L+ +K+ DFG R P T YIS++ W A
Sbjct: 117 H--RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPYTEYISTR-------WYRA 166
Query: 604 PEVLREDPS-NEKSDVFSFGVILWELITLQ 632
PE L D K D+++ G + +E+++L
Sbjct: 167 PECLLTDGYYGPKMDIWAVGCVFFEILSLF 196
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 8e-18
Identities = 61/211 (28%), Positives = 105/211 (49%), Gaps = 9/211 (4%)
Query: 441 IGEGSFGTVYHAEWRNSD--VAVKILIEQE-FHEDRFKEFLREVAIMKGLR-HPNIVLLM 496
+G+GSFG V A + S AVK+L + +D + + E I+ R HP + L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 497 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 556
P L V E+++ G L + HI +R + R R A ++ + +LH + I
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEARARFYAA-EITSALMFLHDK--GI 117
Query: 557 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKS 616
++RDLK N+L+D K+ DFG+ + ++ T GTP+++APE+L+E
Sbjct: 118 IYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSV 177
Query: 617 DVFSFGVILWELITLQKPWRNSTPSQVISAV 647
D ++ GV+L+E++ P+ + A+
Sbjct: 178 DWWAMGVLLYEMLCGHAPFEAENEDDLFEAI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 1e-17
Identities = 65/245 (26%), Positives = 125/245 (51%), Gaps = 20/245 (8%)
Query: 455 RNSDVAVKILIE-QEFHEDRFKEFLR-EVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYL 512
R SD K++ + +++R + R E+ + H IV L ++ EY
Sbjct: 88 RGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147
Query: 513 SRGSLYKLLHIPDARVVVDERLRLN------MAYDVAKGMNYLHQRRPPIVHRDLKSPNL 566
S G L K + + + E L + Y + ++ +H R+ ++HRDLKS N+
Sbjct: 148 SGGDLNKQI-----KQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK--MMHRDLKSANI 200
Query: 567 LVDSTYTVKVCDFGLSRSKPNTYISSKTAA---GTPEWMAPEVLREDPSNEKSDVFSFGV 623
+ T +K+ DFG S+ ++ +S A+ GTP ++APE+ ++K+D++S GV
Sbjct: 201 FLMPTGIIKLGDFGFSKQYSDS-VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGV 259
Query: 624 ILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFP 683
IL+EL+TL +P++ + +++ V + G+ P V+ + AL++ ++ P +RP+
Sbjct: 260 ILYELLTLHRPFKGPSQREIMQQVLY-GKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQ 318
Query: 684 SIMET 688
++ T
Sbjct: 319 QLLHT 323
|
Length = 478 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 2e-17
Identities = 64/237 (27%), Positives = 105/237 (44%), Gaps = 39/237 (16%)
Query: 439 KKIGEGSFGTVYHAEWRNSD---VAVKILIEQEFHEDRFKEFLR-EVAIMKGLRHPNIVL 494
K IG G+FG V+ A+K+L + + + +R E I+ P IV
Sbjct: 7 KVIGRGAFGEVWLV-RDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVK 65
Query: 495 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 554
L + + +L +V EY+ G L LL D V +E R +A V ++ +H+
Sbjct: 66 LYYSFQDEEHLYLVMEYMPGGDLMNLLIRKD--VFPEETARFYIAELVL-ALDSVHKLG- 121
Query: 555 PIVHRDLKSPNLLVDSTYTVKVCDFGLS-----------------------------RSK 585
+HRD+K N+L+D+ +K+ DFGL R
Sbjct: 122 -FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDH 180
Query: 586 PNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQ 642
+ + + GTP+++APEVLR P + D +S GVIL+E++ P+ + T +
Sbjct: 181 KQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE 237
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 2e-17
Identities = 77/260 (29%), Positives = 128/260 (49%), Gaps = 39/260 (15%)
Query: 440 KIGEGSFGTVYHA--EWRNSDVAVKILIE--QEFHEDRFKEFLREVAIMKGLRHPNIVLL 495
+IG GSFG VY A N VAVK + ++ +E ++++ ++EV ++ L+HPN +
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNE-KWQDIIKEVKFLQQLKHPNTIEY 86
Query: 496 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 555
G + +V EY GS LL + + + E + + +G+ YLH
Sbjct: 87 KGCYLKEHTAWLVMEY-CLGSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN-- 141
Query: 556 IVHRDLKSPNLLVDSTYTVKVCDFG-LSRSKP-NTYISSKTAAGTPEWMAPEV---LRED 610
++HRD+K+ N+L+ VK+ DFG S+S P N+++ GTP WMAPEV + E
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV------GTPYWMAPEVILAMDEG 195
Query: 611 PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA---- 666
+ K DV+S G+ EL + P N +SA+ I +N +P + +
Sbjct: 196 QYDGKVDVWSLGITCIELAERKPPLFN---MNAMSAL------YHIAQNDSPTLQSNEWT 246
Query: 667 -----LIETCWAEEPEIRPS 681
++ C + P+ RP+
Sbjct: 247 DSFRGFVDYCLQKIPQERPA 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 3e-17
Identities = 70/273 (25%), Positives = 117/273 (42%), Gaps = 41/273 (15%)
Query: 441 IGEGSFGTVYHAEWRNS----------DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHP 490
+G+G+F +Y R +V+V + + H D F ++M L H
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHK 61
Query: 491 NIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLH 550
++V L G N+ +V EY+ G L LH + V +L++A +A ++YL
Sbjct: 62 HLVKLYGVCVRDENI-MVEEYVKFGPLDVFLHR--EKNNVSLHWKLDVAKQLASALHYLE 118
Query: 551 QRRPPIVHRDLKSPNLLV-----DSTYT--VKVCDFG-----LSRSKPNTYISSKTAAGT 598
++ +VH ++ N+LV + Y +K+ D G LSR + I
Sbjct: 119 DKK--LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERIP------- 169
Query: 599 PEWMAPEVLREDPSNEKS--DVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEI 656
W+APE +R ++ D +SFG L E+ + + ++ S RL +
Sbjct: 170 --WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLPM 227
Query: 657 PKNVNPMVAALIETCWAEEPEIRPSFPSIMETL 689
P +A LI CW +P RPSF +I+ L
Sbjct: 228 PDC--AELANLINQCWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 3e-17
Identities = 62/198 (31%), Positives = 94/198 (47%), Gaps = 17/198 (8%)
Query: 459 VAVKIL-IEQEFHEDRFKEFLREVAIMKGLRHPNIV-LLMGAVTEPPNLSIVTEYLSRGS 516
VA+K+L + E + F RE A+ L HPNIV LL P L V EY+ +
Sbjct: 6 VAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRT 65
Query: 517 LYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLV---DSTYT 573
L ++L D + E RL M V + H + IVHRDLK N++V
Sbjct: 66 LREVLA-ADGALPAGETGRL-ML-QVLDALACAHNQ--GIVHRDLKPQNIMVSQTGVRPH 120
Query: 574 VKVCDFGLSRSKPNTYISSKTAA-------GTPEWMAPEVLREDPSNEKSDVFSFGVILW 626
KV DFG+ P + GTP + APE LR +P SD++++G+I
Sbjct: 121 AKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFL 180
Query: 627 ELITLQKPWRNSTPSQVI 644
E +T Q+ + ++ ++++
Sbjct: 181 ECLTGQRVVQGASVAEIL 198
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 4e-17
Identities = 69/253 (27%), Positives = 119/253 (47%), Gaps = 18/253 (7%)
Query: 441 IGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKE------FLREVAIMKGLRHPNIVL 494
+G+G FG V + R + K+ ++ ++ R K+ + E I+ + IV
Sbjct: 1 LGKGGFGEVSACQMRATG---KLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVS 57
Query: 495 LMGAVTEPPNLSIVTEYLSRGSL-YKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 553
L A +L +V ++ G L Y + ++ + E + G+ +LHQRR
Sbjct: 58 LAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR 117
Query: 554 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSN 613
I++RDLK N+L+D+ V++ D GL+ + +K AGTP +MAPE+L+ + +
Sbjct: 118 --IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYD 175
Query: 614 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLE----IPKNVNPMVAALIE 669
D F+ GV L+E+I + P+R + + K R L P +P + E
Sbjct: 176 FSVDYFALGVTLYEMIAARGPFR--ARGEKVENKELKQRILNDSVTYPDKFSPASKSFCE 233
Query: 670 TCWAEEPEIRPSF 682
A++PE R F
Sbjct: 234 ALLAKDPEKRLGF 246
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 4e-17
Identities = 76/285 (26%), Positives = 140/285 (49%), Gaps = 41/285 (14%)
Query: 420 ELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHA-EWRNSDVAV--KILIEQEFHEDRFKE 476
EL+ +E+ E +++L ++IG GSFG VY A + R ++V K+ + +++++
Sbjct: 16 ELFFKEDP-EKLFTDL---REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQD 71
Query: 477 FLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRL 536
++EV ++ ++HPN + G +V EY GS LL + + + E
Sbjct: 72 IIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY-CLGSASDLLEV--HKKPLQEVEIA 128
Query: 537 NMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR--SKPNTYISSKT 594
+ + +G+ YLH ++HRD+K+ N+L+ VK+ DFG + S N+++
Sbjct: 129 AITHGALQGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV---- 182
Query: 595 AAGTPEWMAPEV---LREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG 651
GTP WMAPEV + E + K DV+S G+ EL + P N +SA+
Sbjct: 183 --GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN---MNAMSAL---- 233
Query: 652 RRLEIPKNVNPMVAA---------LIETCWAEEPEIRPSFPSIME 687
I +N +P + + +++C + P+ RP+ +++
Sbjct: 234 --YHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLK 276
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 5e-17
Identities = 63/198 (31%), Positives = 104/198 (52%), Gaps = 13/198 (6%)
Query: 439 KKIGEGSFGTVYHAEWRNSDVAV---KILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 495
+KIGEG++G VY A + + V KI ++ E E +RE++++K L HPNIV L
Sbjct: 6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKL 64
Query: 496 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAY--DVAKGMNYLHQRR 553
+ + L +V E+L + L K + DA + L L +Y + +G+ + H R
Sbjct: 65 LDVIHTENKLYLVFEFLHQ-DLKKFM---DASPLSGIPLPLIKSYLFQLLQGLAFCHSHR 120
Query: 554 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSN 613
++HRDLK NLL+++ +K+ DFGL+R+ + T + APE+L
Sbjct: 121 --VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 178
Query: 614 EKS-DVFSFGVILWELIT 630
+ D++S G I E++T
Sbjct: 179 STAVDIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 5e-17
Identities = 65/206 (31%), Positives = 111/206 (53%), Gaps = 15/206 (7%)
Query: 440 KIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMG 497
K+GEG++ TVY + +D VA+K I E E +REV+++K L+H NIV L
Sbjct: 13 KLGEGTYATVYKGRSKLTDNLVALK-EIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 498 AVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 557
+ +L++V EYL + L ++ + + +L L + + +G+NY H+R+ ++
Sbjct: 72 IIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFL---FQLLRGLNYCHRRK--VL 126
Query: 558 HRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAG--TPEWMAPE--VLREDPSN 613
HRDLK NLL++ +K+ DFGL+R+K I +KT + W P +L +
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKS---IPTKTYSNEVVTLWYRPPDILLGSTDYS 183
Query: 614 EKSDVFSFGVILWELITLQKPWRNST 639
+ D++ G I +E+ T + + ST
Sbjct: 184 TQIDMWGVGCIFYEMSTGRPLFPGST 209
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 7e-17
Identities = 68/213 (31%), Positives = 110/213 (51%), Gaps = 17/213 (7%)
Query: 439 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 496
+K+GEGS+ TVY R + VA+K+ I + E +RE +++KGL+H NIVLL
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVALKV-ISMKTEEGVPFTAIREASLLKGLKHANIVLLH 69
Query: 497 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 556
+ L+ V EY+ ++ P + +RL M + + +G+ Y+H + I
Sbjct: 70 DIIHTKETLTFVFEYMHTDLAQYMIQHPGG--LHPYNVRLFM-FQLLRGLAYIHGQH--I 124
Query: 557 VHRDLKSPNLLVDSTYTVKVCDFGLSRSK--PNTYISSKTAAGTPEWMAPEVL--REDPS 612
+HRDLK NLL+ +K+ DFGL+R+K P+ SS+ T + P+VL D S
Sbjct: 125 LHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLLGATDYS 182
Query: 613 NEKSDVFSFGVILWELITLQK--PWRNSTPSQV 643
+ D++ G I E++ Q P + Q+
Sbjct: 183 SA-LDIWGAGCIFIEMLQGQPAFPGVSDVFEQL 214
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 8e-17
Identities = 64/207 (30%), Positives = 99/207 (47%), Gaps = 32/207 (15%)
Query: 440 KIGEGSFGTVYHAEWRNSD--VAVK-ILIEQEFHEDRFKE-----FLREVAIMKGLRHPN 491
+IGEG++G VY A S VA+K + ++ E ++ LRE+ ++ LRHPN
Sbjct: 14 RIGEGTYGIVYRARDTTSGEIVALKKVRMDNE------RDGIPISSLREITLLLNLRHPN 67
Query: 492 IVLLMGAVTEPPNLSI--VTEYLSRGSLYKLLH-----IPDARVVVDERLRLNMAYDVAK 544
IV L V SI V EY + L LL +++V + + +
Sbjct: 68 IVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKC-------LMLQLLR 119
Query: 545 GMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAP 604
G+ YLH+ I+HRDLK NLL+ +K+ DFGL+R+ T + AP
Sbjct: 120 GLQYLHENF--IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAP 177
Query: 605 EVLREDPSNEKS-DVFSFGVILWELIT 630
E+L + + D+++ G IL EL+
Sbjct: 178 ELLLGCTTYTTAIDMWAVGCILAELLA 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 9e-17
Identities = 44/167 (26%), Positives = 80/167 (47%), Gaps = 12/167 (7%)
Query: 478 LREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLN 537
L E +++ + HP+++ + + +V + LY L + +D+ L +
Sbjct: 105 LIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKRSRPLPIDQALIIE 163
Query: 538 MAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR---SKPNTYISSKT 594
+ +G+ YLH +R I+HRD+K+ N+ ++ V + D G ++ P
Sbjct: 164 KQ--ILEGLRYLHAQR--IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL----G 215
Query: 595 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPS 641
AGT E APEVL D N K+D++S G++L+E++ PS
Sbjct: 216 LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPS 262
|
Length = 357 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 1e-16
Identities = 62/243 (25%), Positives = 123/243 (50%), Gaps = 11/243 (4%)
Query: 441 IGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKE--FLREVAIMKGLRHPNIVLLM 496
+G+GSFG V AE + +D A+KIL + +D E + + + + P + L
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLH 67
Query: 497 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 556
L V EY++ G L + HI E + A +++ G+ +LH+R I
Sbjct: 68 SCFQTVDRLYFVMEYVNGGDL--MYHIQQVGKF-KEPQAVFYAAEISVGLFFLHRR--GI 122
Query: 557 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKS 616
++RDLK N+++DS +K+ DFG+ + ++++T GTP+++APE++ P +
Sbjct: 123 IYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSV 182
Query: 617 DVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEP 676
D +++GV+L+E++ Q P+ ++ ++ + PK+++ ++ + + P
Sbjct: 183 DWWAYGVLLYEMLAGQPPFDGEDEDELFQSI--MEHNVSYPKSLSKEAVSICKGLMTKHP 240
Query: 677 EIR 679
R
Sbjct: 241 SKR 243
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 1e-16
Identities = 54/202 (26%), Positives = 96/202 (47%), Gaps = 25/202 (12%)
Query: 441 IGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA 498
+G G++G V A + VA+K L K RE+ ++K + H N++ L+
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDV 82
Query: 499 VTEPPNLS------IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 552
T +L +VT + L ++ + + D+ ++ + Y + +G+ Y+H
Sbjct: 83 FTPASSLEDFQDVYLVTHLMGA-DLNNIVKC---QKLSDDHIQF-LVYQILRGLKYIHSA 137
Query: 553 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR---SKPNTYISSKTAAGTPEWMAPEV-LR 608
I+HRDLK N+ V+ +K+ DFGL+R + Y+ T + APE+ L
Sbjct: 138 G--IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYV------ATRWYRAPEIMLN 189
Query: 609 EDPSNEKSDVFSFGVILWELIT 630
N+ D++S G I+ EL+T
Sbjct: 190 WMHYNQTVDIWSVGCIMAELLT 211
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 1e-16
Identities = 54/199 (27%), Positives = 108/199 (54%), Gaps = 9/199 (4%)
Query: 441 IGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLR-EVAIMK-GLRHPNIVLLM 496
IG GS+ V E + + A+K++ ++ ++D ++++ E + + HP +V L
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 497 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 556
L V E++S G L + H+ R + +E R A +++ +N+LH+R I
Sbjct: 63 SCFQTESRLFFVIEFVSGGDL--MFHMQRQRKLPEEHARFYSA-EISLALNFLHER--GI 117
Query: 557 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKS 616
++RDLK N+L+D+ +K+ D+G+ + ++ T GTP ++APE+LR +
Sbjct: 118 IYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSV 177
Query: 617 DVFSFGVILWELITLQKPW 635
D ++ GV+++E++ + P+
Sbjct: 178 DWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 2e-16
Identities = 61/201 (30%), Positives = 109/201 (54%), Gaps = 17/201 (8%)
Query: 440 KIGEGSFGTVYHAEWRNSD-VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA 498
++G G+ G V + + S + + LI E + +RE+ ++ P IV GA
Sbjct: 12 ELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 71
Query: 499 VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERL-RLNMAYDVAKGMNYLHQRRPPIV 557
+SI E++ GSL ++L +A+ + +E L ++++A V +G+ YL ++ I+
Sbjct: 72 FYSDGEISICMEHMDGGSLDQVLK--EAKRIPEEILGKVSIA--VLRGLAYLREKHQ-IM 126
Query: 558 HRDLKSPNLLVDSTYTVKVCDFGLS----RSKPNTYISSKTAAGTPEWMAPEVLREDPSN 613
HRD+K N+LV+S +K+CDFG+S S N+++ GT +M+PE L+ +
Sbjct: 127 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPERLQGTHYS 180
Query: 614 EKSDVFSFGVILWELITLQKP 634
+SD++S G+ L EL + P
Sbjct: 181 VQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 2e-16
Identities = 65/211 (30%), Positives = 109/211 (51%), Gaps = 16/211 (7%)
Query: 440 KIGEGSFGTVYHA-EWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLR---HPNIV 493
+IGEG++G V+ A + +N VA+K + Q E +REVA+++ L HPN+V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 494 LLMGAVT-----EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 548
L T L++V E++ + L +P+ V E ++ +M + + +G+++
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPT-ETIK-DMMFQLLRGLDF 125
Query: 549 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLR 608
LH R +VHRDLK N+LV S+ +K+ DFGL+R + T + APEVL
Sbjct: 126 LHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV-TLWYRAPEVLL 182
Query: 609 EDPSNEKSDVFSFGVILWELITLQKPWRNST 639
+ D++S G I E+ + +R S+
Sbjct: 183 QSSYATPVDLWSVGCIFAEMFRRKPLFRGSS 213
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 3e-16
Identities = 50/151 (33%), Positives = 80/151 (52%), Gaps = 15/151 (9%)
Query: 440 KIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMG 497
KIGEG++GTV+ A+ R + VA+K + + E LRE+ ++K L+H NIV L
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 498 AVTEPPNLSIVTEYLSRGSLYKLLHI----PDARVVVDERLRLNMAYDVAKGMNYLHQRR 553
+ L++V EY + L K D +V + M + + KG+ + H
Sbjct: 67 VLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIV-----KSFM-FQLLKGLAFCHSHN 119
Query: 554 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 584
++HRDLK NLL++ +K+ DFGL+R+
Sbjct: 120 --VLHRDLKPQNLLINKNGELKLADFGLARA 148
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-16
Identities = 70/270 (25%), Positives = 123/270 (45%), Gaps = 38/270 (14%)
Query: 441 IGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMG 497
+G G++G VY + A+K++ + ED +E E+ ++K H NI G
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVM---DVTEDEEEEIKLEINMLKKYSHHRNIATYYG 80
Query: 498 AVTE--PP----NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 551
A + PP L +V E+ GS+ L+ + ++ + + ++ +G+ +LH
Sbjct: 81 AFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY-ICREILRGLAHLHA 139
Query: 552 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVL--RE 609
+ ++HRD+K N+L+ VK+ DFG+S T T GTP WMAPEV+ E
Sbjct: 140 HK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDE 197
Query: 610 DPS---NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA 666
+P + +SD++S G+ E+ P + P + + IP+N P + +
Sbjct: 198 NPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL---------FLIPRNPPPKLKS 248
Query: 667 ---------LIETCWAEEPEIRPSFPSIME 687
IE C + RPS +++
Sbjct: 249 KKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 3e-16
Identities = 59/202 (29%), Positives = 99/202 (49%), Gaps = 23/202 (11%)
Query: 438 KKKIGEGSFGTVYHAEWRNSD-VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 496
++G G+ G V R S + + LI E + +RE+ ++ P IV
Sbjct: 6 LGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFY 65
Query: 497 GAVTEPPNLSIVTEYLSRGSLYKLL----HIPDARVVVDERLRLNMAYDVAKGMNYLHQR 552
GA +SI E++ GSL ++L IP E + ++ V +G+ YL ++
Sbjct: 66 GAFYSDGEISICMEHMDGGSLDQVLKKAGRIP-------ENILGKISIAVLRGLTYLREK 118
Query: 553 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLS----RSKPNTYISSKTAAGTPEWMAPEVLR 608
I+HRD+K N+LV+S +K+CDFG+S S N+++ GT +M+PE L+
Sbjct: 119 HK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPERLQ 171
Query: 609 EDPSNEKSDVFSFGVILWELIT 630
+SD++S G+ L E+
Sbjct: 172 GTHYTVQSDIWSLGLSLVEMAI 193
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 4e-16
Identities = 61/196 (31%), Positives = 105/196 (53%), Gaps = 13/196 (6%)
Query: 440 KIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMG 497
K+GEG++ TV+ + ++ VA+K I E E +REV+++K L+H NIV L
Sbjct: 12 KLGEGTYATVFKGRSKLTENLVALK-EIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHD 70
Query: 498 AVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 557
+ L++V EYL L + + + + ++ + + + +G++Y H+R+ I+
Sbjct: 71 IIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFM---FQLLRGLSYCHKRK--IL 125
Query: 558 HRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKS- 616
HRDLK NLL++ +K+ DFGL+R+K + T + P+VL S E S
Sbjct: 126 HRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLG--STEYST 183
Query: 617 --DVFSFGVILWELIT 630
D++ G IL+E+ T
Sbjct: 184 PIDMWGVGCILYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 78.8 bits (195), Expect = 6e-16
Identities = 66/210 (31%), Positives = 108/210 (51%), Gaps = 31/210 (14%)
Query: 440 KIGEGSFGTVYHAEWRNSD--VAVK-ILIEQEFHEDRFKE-F----LREVAIMKGLRHPN 491
+I EG++G VY A + + VA+K + +E+E KE F LRE+ I+ L+HPN
Sbjct: 12 RIEEGTYGVVYRARDKKTGEIVALKKLKMEKE------KEGFPITSLREINILLKLQHPN 65
Query: 492 IV----LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 547
IV +++G+ + + +V EY+ L L+ + E + + G+
Sbjct: 66 IVTVKEVVVGSNLD--KIYMVMEYVEH-DLKSLMETMKQPFLQSEVK--CLMLQLLSGVA 120
Query: 548 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR--SKPNTYISSKTAAGTPEWMAPE 605
+LH I+HRDLK+ NLL+++ +K+CDFGL+R P + T + APE
Sbjct: 121 HLHDNW--ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV--TLWYRAPE 176
Query: 606 VLREDPS-NEKSDVFSFGVILWELITLQKP 634
+L + D++S G I EL+T +KP
Sbjct: 177 LLLGAKEYSTAIDMWSVGCIFAELLT-KKP 205
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 6e-16
Identities = 69/238 (28%), Positives = 116/238 (48%), Gaps = 16/238 (6%)
Query: 434 ELLIKKKIGEGSFGTVYHA-EWRNSDV-AVKILI-EQEFHEDRFKEFLREVAIMKGLRHP 490
+ +K +G G FG V E D+ A+K++ ++ F E I+ P
Sbjct: 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSP 61
Query: 491 NIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERL-RLNMAYDVAKGMNYL 549
I L A + NL +V EY G L LL+ + + DE + + +A ++ ++ +
Sbjct: 62 WIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQF--DEDMAQFYLA-ELVLAIHSV 118
Query: 550 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKTAAGTPEWMAPEVLR 608
HQ VHRD+K N+L+D T +K+ DFG + R N ++SK GTP+++APEVL
Sbjct: 119 HQM--GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLT 176
Query: 609 EDPSNEKS------DVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNV 660
+ K D +S GVI +E+I + P+ T ++ + + R L+ P++
Sbjct: 177 TMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDP 234
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 8e-16
Identities = 53/199 (26%), Positives = 107/199 (53%), Gaps = 9/199 (4%)
Query: 441 IGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLR--EVAIMKGLRHPNIVLLM 496
IG GS+ V + +D A+K++ ++ H+D ++++ + + +P +V L
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 497 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 556
L +V EY++ G L + H+ R + +E R A ++ +N+LH+R I
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDL--MFHMQRQRKLPEEHARF-YAAEICIALNFLHER--GI 117
Query: 557 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKS 616
++RDLK N+L+D+ +K+ D+G+ + ++ T GTP ++APE+LR +
Sbjct: 118 IYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSV 177
Query: 617 DVFSFGVILWELITLQKPW 635
D ++ GV+++E++ + P+
Sbjct: 178 DWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 1e-15
Identities = 70/229 (30%), Positives = 102/229 (44%), Gaps = 27/229 (11%)
Query: 439 KKIGEGSFGTVY---HAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 495
K I G++G VY H E R KI + ++ ++ E I+ +P +V +
Sbjct: 7 KLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSM 66
Query: 496 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 555
+ +L +V EY+ G LL A V + R+ A V + YLH
Sbjct: 67 FCSFETKRHLCMVMEYVEGGDCATLLKNIGALPV--DMARMYFAETVL-ALEYLHNY--G 121
Query: 556 IVHRDLKSPNLLVDSTYTVKVCDFGLSR-----SKPNTY----------ISSKTAAGTPE 600
IVHRDLK NLL+ S +K+ DFGLS+ N Y K GTPE
Sbjct: 122 IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPE 181
Query: 601 WMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTP----SQVIS 645
++APEV+ + D ++ G+IL+E + P+ TP QVIS
Sbjct: 182 YIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS 230
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-15
Identities = 60/195 (30%), Positives = 105/195 (53%), Gaps = 13/195 (6%)
Query: 439 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 496
+K+GEG++ TV+ + ++ VA+K I E E +REV+++K L+H NIV L
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALK-EIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70
Query: 497 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 556
V +L++V EYL + + + + + ++ L Y + +G+ Y H+R+ +
Sbjct: 71 DIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFL---YQILRGLAYCHRRK--V 125
Query: 557 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKS 616
+HRDLK NLL++ +K+ DFGL+R+K + T + P+VL S+E S
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLG--SSEYS 183
Query: 617 ---DVFSFGVILWEL 628
D++ G I +E+
Sbjct: 184 TQIDMWGVGCIFFEM 198
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 78.4 bits (194), Expect = 1e-15
Identities = 68/219 (31%), Positives = 108/219 (49%), Gaps = 39/219 (17%)
Query: 437 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHE--DRFKEFLREVAIMKGLR-HPN 491
I +K+G+G++G V+ A R + VA+K I F D + F RE+ ++ L HPN
Sbjct: 11 ILQKLGKGAYGIVWKAIDRRTKEVVALK-KIFDAFRNATDAQRTF-REIMFLQELGDHPN 68
Query: 492 IVLLMGAVTEPPN---LSIVTEYLS-------RGSLYKLLHIPDARVVVDERLRLNMAYD 541
IV L+ V + N + +V EY+ R ++ + +H R ++ Y
Sbjct: 69 IVKLL-NVIKAENDKDIYLVFEYMETDLHAVIRANILEDVHK---RYIM---------YQ 115
Query: 542 VAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGT--- 598
+ K + Y+H ++HRDLK N+L++S VK+ DFGL+RS + + T
Sbjct: 116 LLKALKYIHSGN--VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYV 173
Query: 599 -PEWM-APEVLREDPSNEKS-DVFSFGVILWELITLQKP 634
W APE+L K D++S G IL E++ L KP
Sbjct: 174 ATRWYRAPEILLGSTRYTKGVDMWSVGCILGEML-LGKP 211
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 1e-15
Identities = 63/218 (28%), Positives = 104/218 (47%), Gaps = 44/218 (20%)
Query: 440 KIGEGSFGTVYHAEWRNSD--VAVK-ILIEQEFHEDRFKE-F----LREVAIMKGLRHPN 491
KIG+G+FG V+ A + + VA+K +L+E E KE F LRE+ I++ L+H N
Sbjct: 19 KIGQGTFGEVFKARHKKTKQIVALKKVLMENE------KEGFPITALREIKILQLLKHEN 72
Query: 492 IVLLMGAVTEPPNLSIVTEYLSRGSLY-----------KLLHIPDARVVVDERLRLNMAY 540
+V L+ +GS Y LL + + + E + +
Sbjct: 73 VVNLIEICRTKAT----PYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKK--VMK 126
Query: 541 DVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-------SKPNTYISSK 593
+ G+ Y+H R I+HRD+K+ N+L+ +K+ DFGL+R SKPN Y +++
Sbjct: 127 MLLNGLYYIH--RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRY-TNR 183
Query: 594 TAAGTPEWMAPEVLREDPS-NEKSDVFSFGVILWELIT 630
T + PE+L + D++ G I+ E+ T
Sbjct: 184 VV--TLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 2e-15
Identities = 73/284 (25%), Positives = 116/284 (40%), Gaps = 61/284 (21%)
Query: 459 VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLY 518
V V+I + E+ K EV + RHPNI+ T L +++ +++ GS
Sbjct: 28 VTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSAN 87
Query: 519 KLL--HIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKV 576
LL + P+ + E L N+ + +G+NYLHQ +HR++K+ ++L+ V +
Sbjct: 88 SLLKTYFPEG---MSEALIGNILFGALRGLNYLHQN--GYIHRNIKASHILISGDGLVSL 142
Query: 577 CDFGLSRSKPNTYISSKTAAGTPE-------WMAPEVLREDPS--NEKSDVFSFGVILWE 627
S +K P+ W++PE+LR+D N KSD++S G+ E
Sbjct: 143 SGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACE 202
Query: 628 LIT--------------LQK-------PWRNSTPSQ-----------VISAVG------- 648
L T LQK P +T V S +G
Sbjct: 203 LATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAG 262
Query: 649 ----FKGRRLEIP--KNVNPMVAALIETCWAEEPEIRPSFPSIM 686
RL P K +P L+E C ++PE RPS S++
Sbjct: 263 MTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLL 306
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-15
Identities = 58/200 (29%), Positives = 103/200 (51%), Gaps = 15/200 (7%)
Query: 440 KIGEGSFGTVYHAEWRNSD-VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA 498
++G G+ G V+ + S + + LI E + +RE+ ++ P IV GA
Sbjct: 12 ELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 71
Query: 499 VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVH 558
+SI E++ GSL ++L + E++ ++ V KG+ YL ++ I+H
Sbjct: 72 FYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLREKHK-IMH 127
Query: 559 RDLKSPNLLVDSTYTVKVCDFGLS----RSKPNTYISSKTAAGTPEWMAPEVLREDPSNE 614
RD+K N+LV+S +K+CDFG+S S N+++ GT +M+PE L+ +
Sbjct: 128 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPERLQGTHYSV 181
Query: 615 KSDVFSFGVILWELITLQKP 634
+SD++S G+ L E+ + P
Sbjct: 182 QSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 3e-15
Identities = 63/247 (25%), Positives = 107/247 (43%), Gaps = 52/247 (21%)
Query: 440 KIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEF-----------LREVAIMKGLR 488
IG G++G VY A+ +N + I++ FK RE+A+++ L+
Sbjct: 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKK------FKGDKEQYTGISQSACREIALLRELK 60
Query: 489 HPNIVLLMGAVTEPPNLSI--VTEYLSRGSLYKLLHI-----PDARVVVDERLRLNMAYD 541
H N+V L+ E + S+ + +Y + + L I RV + + ++ +
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDY----AEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQ 116
Query: 542 VAKGMNYLHQRRPPIVHRDLKSPNLLV----DSTYTVKVCDFGLSR---SKPNTYISSKT 594
+ G++YLH ++HRDLK N+LV VK+ D GL+R +
Sbjct: 117 ILNGVHYLHSNW--VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDP 174
Query: 595 AAGTPEWMAPEVLREDPSNEKS-DVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR 653
T + APE+L K+ D+++ G I EL+TL+ FKGR
Sbjct: 175 VVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPI--------------FKGRE 220
Query: 654 LEIPKNV 660
+I K+
Sbjct: 221 AKIKKSN 227
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 3e-15
Identities = 65/231 (28%), Positives = 109/231 (47%), Gaps = 33/231 (14%)
Query: 437 IKKKIGEGSFGTVY--HAEWRNSDVAVKILIEQEFHEDRF--KEFLREVAIMKGLRHPNI 492
I + IG+G G VY + + VA+K I ++ E+ K FLRE I L HP I
Sbjct: 6 IIRLIGKGGMGEVYLAYDPVCSRRVALK-KIREDLSENPLLKKRFLREAKIAADLIHPGI 64
Query: 493 VLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLR--------LNMAYDVAK 544
V + ++ + Y+ +L LL + + + L L++ + +
Sbjct: 65 VPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICA 124
Query: 545 GMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK--------------PNTYI 590
+ Y+H + ++HRDLK N+L+ V + D+G + K N
Sbjct: 125 TIEYVHSK--GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICY 182
Query: 591 SSKTA----AGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRN 637
SS T GTP++MAPE L P++E +D+++ GVIL++++TL P+R
Sbjct: 183 SSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR 233
|
Length = 932 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 7e-15
Identities = 69/210 (32%), Positives = 104/210 (49%), Gaps = 26/210 (12%)
Query: 440 KIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLR---HPNIVL 494
+IG G++GTVY A +S VA+K + Q + +REVA++K L HPNIV
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 495 LMGAVT-----EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 549
LM +++V E++ + L +P + E ++ ++ +G+++L
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPA-ETIK-DLMRQFLRGLDFL 124
Query: 550 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPE-----WMAP 604
H IVHRDLK N+LV S VK+ DFGL+R I S A TP + AP
Sbjct: 125 HANC--IVHRDLKPENILVTSGGQVKLADFGLAR------IYSCQMALTPVVVTLWYRAP 176
Query: 605 EVLREDPSNEKSDVFSFGVILWELITLQKP 634
EVL + D++S G I E+ +KP
Sbjct: 177 EVLLQSTYATPVDMWSVGCIFAEMFR-RKP 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 7e-15
Identities = 56/200 (28%), Positives = 105/200 (52%), Gaps = 7/200 (3%)
Query: 480 EVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMA 539
E I++ ++HP IV L+ A L ++ EYLS G L+ +H+ + +++ ++
Sbjct: 50 ERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELF--MHLEREGIFMEDTACFYLS 107
Query: 540 YDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP 599
+++ + +LHQ+ I++RDLK N+L+D+ VK+ DFGL + + + T GT
Sbjct: 108 -EISLALEHLHQQ--GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTI 164
Query: 600 EWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKN 659
E+MAPE+L + D +S G ++++++T P+ + I + KG +L +P
Sbjct: 165 EYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKI-LKG-KLNLPPY 222
Query: 660 VNPMVAALIETCWAEEPEIR 679
+ P L++ P R
Sbjct: 223 LTPEARDLLKKLLKRNPSSR 242
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 1e-14
Identities = 58/206 (28%), Positives = 104/206 (50%), Gaps = 21/206 (10%)
Query: 437 IKKKIGEGSFGTVYHA--EWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 494
IGEG++G V A + VA+K I H+ + LRE+ I++ +H NI+
Sbjct: 9 NLSYIGEGAYGMVCSATHKPTGVKVAIK-KISPFEHQTFCQRTLREIKILRRFKHENIIG 67
Query: 495 LMGAVTEPPNLS------IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 548
++ + PP+ IV E + LYKL+ + + ++ ++ Y + +G+ Y
Sbjct: 68 IL-DIIRPPSFESFNDVYIVQELMET-DLYKLIK---TQHLSNDHIQY-FLYQILRGLKY 121
Query: 549 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAA---GTPEWMAPE 605
+H ++HRDLK NLL+++ +K+CDFGL+R + + T + APE
Sbjct: 122 IHSAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPE 179
Query: 606 VLREDPSNEKS-DVFSFGVILWELIT 630
++ K+ D++S G IL E+++
Sbjct: 180 IMLNSKGYTKAIDIWSVGCILAEMLS 205
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 1e-14
Identities = 60/199 (30%), Positives = 100/199 (50%), Gaps = 17/199 (8%)
Query: 439 KKIGEGSFGTVYHAE--WRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 496
K IG G+ G V A +VA+K L + K RE+ +MK + H NI+ L+
Sbjct: 22 KPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLL 81
Query: 497 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARV--VVDERL---RLN-MAYDVAKGMNYLH 550
T +L + +Y ++ + DA + V+ L R++ + Y + G+ +LH
Sbjct: 82 NVFTPQKSLEEFQD------VYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH 135
Query: 551 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRED 610
I+HRDLK N++V S T+K+ DFGL+R+ +++ + T + APEV+
Sbjct: 136 S--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRAPEVILGM 192
Query: 611 PSNEKSDVFSFGVILWELI 629
E D++S G I+ E+I
Sbjct: 193 GYKENVDIWSVGCIMGEMI 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 2e-14
Identities = 61/220 (27%), Positives = 104/220 (47%), Gaps = 14/220 (6%)
Query: 424 EEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFL-RE 480
+ L+++ + + K IG G+FG V ++S A+K+L + E + F E
Sbjct: 34 KIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEE 93
Query: 481 VAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAY 540
IM P +V L A + L +V EY+ G L L+ D V E+
Sbjct: 94 RDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD----VPEKWAKFYTA 149
Query: 541 DVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT-YISSKTAAGTP 599
+V ++ +H ++HRD+K N+L+D +K+ DFG T + TA GTP
Sbjct: 150 EVVLALDAIHSM--GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTP 207
Query: 600 EWMAPEVLREDPSN----EKSDVFSFGVILWELITLQKPW 635
++++PEVL+ + + D +S GV L+E++ P+
Sbjct: 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 52/218 (23%), Positives = 100/218 (45%), Gaps = 16/218 (7%)
Query: 436 LIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 495
LI K + + + N+ VAVK + ++ K +E+ + L+HPNI+
Sbjct: 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPY 64
Query: 496 MGAVTEPPNLSIVTEYLSRGSLYKLL--HIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 553
+ + L +V+ ++ GS LL H P+ + E + DV ++Y+H +
Sbjct: 65 VTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEG---LPELAIAFILKDVLNALDYIHSKG 121
Query: 554 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS-------KPNTYISSKTAAGTPEWMAPEV 606
+HR +K+ ++L+ V + S S + + K++ W++PEV
Sbjct: 122 --FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEV 179
Query: 607 LREDPS--NEKSDVFSFGVILWELITLQKPWRNSTPSQ 642
L+++ NEKSD++S G+ EL P+++ +Q
Sbjct: 180 LQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ 217
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 3e-14
Identities = 63/215 (29%), Positives = 101/215 (46%), Gaps = 31/215 (14%)
Query: 439 KKIGEGSFGTVYHAEWRNSD----VAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIV 493
K++G+G++G V A + VA+K + + K LRE+ +++ R H NI
Sbjct: 6 KELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNIT 65
Query: 494 LLMGAVTEPPNLSIVTEYLSRGS-LYKLLHIPDARVVVDERLRLNMA------YDVAKGM 546
L ++ IV LY+ L D ++ L A Y + G+
Sbjct: 66 CLY-------DMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGL 118
Query: 547 NYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS------KPNTYISSKTAAGTPE 600
Y+H ++HRDLK NLLV++ +K+CDFGL+R + +++ A T
Sbjct: 119 KYIHSAN--VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVA--TRW 174
Query: 601 WMAPEVLREDPSNEKS-DVFSFGVILWELITLQKP 634
+ APE++ S K+ DV+S G IL EL+ KP
Sbjct: 175 YRAPEIMLSFQSYTKAIDVWSVGCILAELLGR-KP 208
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 3e-14
Identities = 59/205 (28%), Positives = 102/205 (49%), Gaps = 25/205 (12%)
Query: 439 KKIGEGSFGTVYHAEWRNSD------VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNI 492
+ IG G+FG V W +D VA+K + + K RE+ ++ +H N+
Sbjct: 6 RPIGYGAFGVV----WSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNV 61
Query: 493 VLLMGAVTEPPNLS------IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM 546
+ + + +PP++ +VTE L + L+K++ P + + +++ Y + +G+
Sbjct: 62 LSALD-ILQPPHIDPFEEIYVVTE-LMQSDLHKIIVSPQP--LSSDHVKV-FLYQILRGL 116
Query: 547 NYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPNTYISSKTAAGTPEWMAPE 605
YLH I+HRD+K NLLV+S +K+CDFGL+R +P+ T + APE
Sbjct: 117 KYLHSAG--ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPE 174
Query: 606 VLREDPS-NEKSDVFSFGVILWELI 629
+L D++S G I EL+
Sbjct: 175 ILMGSRHYTSAVDIWSVGCIFAELL 199
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 3e-14
Identities = 59/217 (27%), Positives = 104/217 (47%), Gaps = 14/217 (6%)
Query: 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD---VAVKILIEQEF-HEDRFKEFLREVAIM 484
++++ + + +G GSFG V A ++N D VA+K + + + + E I+
Sbjct: 26 KMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKIL 85
Query: 485 KGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAK 544
+ HP V L G+ + L +V E++ G + L + R D + A +
Sbjct: 86 NYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLR-RNKRFPND--VGCFYAAQIVL 142
Query: 545 GMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPNTYISSKTAAGTPEWMA 603
YL IV+RDLK NLL+D +K+ DFG ++ TY T GTPE++A
Sbjct: 143 IFEYLQSLN--IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTY----TLCGTPEYIA 196
Query: 604 PEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTP 640
PE+L + +D ++ G+ ++E++ P+ + P
Sbjct: 197 PEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP 233
|
Length = 340 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 4e-14
Identities = 68/244 (27%), Positives = 117/244 (47%), Gaps = 29/244 (11%)
Query: 441 IGEGSFGTVYHAEWRNSDV----AVKILIEQEFHEDRFKEFLREVAIMKGLRH----PNI 492
IG G FG VY R +D A+K L ++ + + IM L P I
Sbjct: 2 IGRGGFGEVYGC--RKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59
Query: 493 VLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 552
V + A P L + + ++ G L+ H+ V ++ +R A ++ G+ ++H R
Sbjct: 60 VCMTYAFHTPDKLCFILDLMNGGDLH--YHLSQHGVFSEKEMRF-YATEIILGLEHMHNR 116
Query: 553 RPPIVHRDLKSPNLLVDSTYTVKVCDFGL----SRSKPNTYISSKTAAGTPEWMAPEVLR 608
+V+RDLK N+L+D V++ D GL S+ KP+ + GT +MAPEVL+
Sbjct: 117 F--VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH------ASVGTHGYMAPEVLQ 168
Query: 609 EDPSNEKS-DVFSFGVILWELITLQKPWRN--STPSQVISAVGFKGRRLEIPKNVNPMVA 665
+ + + S D FS G +L++L+ P+R + I + +E+P + +P +
Sbjct: 169 KGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT-VNVELPDSFSPELK 227
Query: 666 ALIE 669
+L+E
Sbjct: 228 SLLE 231
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 4e-14
Identities = 69/243 (28%), Positives = 117/243 (48%), Gaps = 27/243 (11%)
Query: 441 IGEGSFGTVYHAEWRNSDV----AVKILIEQEFHEDRFKEFLREVAIMKGLRH----PNI 492
IG G FG VY R +D A+K L ++ + + IM L P I
Sbjct: 2 IGRGGFGEVYGC--RKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59
Query: 493 VLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 552
V + A P LS + + ++ G L+ H+ V + +R A ++ G+ ++H R
Sbjct: 60 VCMSYAFHTPDKLSFILDLMNGGDLH--YHLSQHGVFSEAEMRF-YAAEIILGLEHMHNR 116
Query: 553 RPPIVHRDLKSPNLLVDSTYTVKVCDFGL----SRSKPNTYISSKTAAGTPEWMAPEVLR 608
+V+RDLK N+L+D V++ D GL S+ KP+ + GT +MAPEVL+
Sbjct: 117 F--VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH------ASVGTHGYMAPEVLQ 168
Query: 609 EDPSNEKS-DVFSFGVILWELITLQKPWR-NSTPSQVISAVGFKGRRLEIPKNVNPMVAA 666
+ + + S D FS G +L++L+ P+R + T + +E+P + +P + +
Sbjct: 169 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS 228
Query: 667 LIE 669
L+E
Sbjct: 229 LLE 231
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 7e-14
Identities = 74/270 (27%), Positives = 135/270 (50%), Gaps = 39/270 (14%)
Query: 439 KKIGEGSFGTVYHAE-WRNSDVAVKILIEQEFHED--RFKEFLREVAIMKGLRHPNIVLL 495
++IG G FG V +E + ++ VA ++ E + + EFL++ + L+HPNI+
Sbjct: 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQC 60
Query: 496 MGAVTEPPNLSIVTEYLSRGSLYKLL-----HIPDARVVVDERLRLNMAYDVAKGMNYLH 550
+G E +V EY G L L H ++++++ +R MA ++A G+ ++H
Sbjct: 61 LGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQR----MACEIAAGVTHMH 116
Query: 551 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL--SRSKPNTYISSKTAAGTP-EWMAPEVL 607
+ +H DL N + S TVKV D+G+ SR K + YI ++ P W+APE++
Sbjct: 117 KHN--FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKED-YIETEDDKCVPLRWLAPELV 173
Query: 608 RE-------DPSNEKSDVFSFGVILWELI-TLQKPWRNSTPSQVISAVGFKGRRLEIPKN 659
E + S+V++ GV LWEL +P+ + + +V++ V K +++++ K
Sbjct: 174 GEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHV-IKDQQVKLFK- 231
Query: 660 VNPMVA--------ALIETCWAEEPEIRPS 681
P + +++ CW PE R +
Sbjct: 232 --PQLELPYSERWYEVLQFCWL-SPEKRAT 258
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 7e-14
Identities = 46/151 (30%), Positives = 81/151 (53%), Gaps = 8/151 (5%)
Query: 488 RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 547
R P +V L A L ++ +Y++ G L+ H+ + +R+ +A ++ ++
Sbjct: 63 RCPFLVTLHYAFQTDTKLHLILDYVNGGELFT--HLYQREHFTESEVRVYIA-EIVLALD 119
Query: 548 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEV 606
+LHQ I++RD+K N+L+DS V + DFGLS+ + + GT E+MAPEV
Sbjct: 120 HLHQLG--IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEV 177
Query: 607 LREDPS--NEKSDVFSFGVILWELITLQKPW 635
+R ++ D +S GV+ +EL+T P+
Sbjct: 178 IRGGSGGHDKAVDWWSLGVLTFELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 7e-14
Identities = 64/225 (28%), Positives = 110/225 (48%), Gaps = 18/225 (8%)
Query: 439 KKIGEGSFGTVYHAEW--RNSDVAVKILIEQEFHEDRFKE--FLREVAIMKGLRHPNIVL 494
K +G+GSFG V AE + AVK L + D E + + + +P +
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 495 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 554
L +L V E+L+ G L + HI D + D A ++ G+ +LH +
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDL--MFHIQD-KGRFDLYRATFYAAEIVCGLQFLHSKG- 116
Query: 555 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSK--TAAGTPEWMAPEVLREDPS 612
I++RDLK N+++D +K+ DFG+ K N + ++ T GTP+++APE+L+
Sbjct: 117 -IIYRDLKLDNVMLDRDGHIKIADFGMC--KENVFGDNRASTFCGTPDYIAPEILQGLKY 173
Query: 613 NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP 657
D +SFGV+L+E++ Q P+ ++ F+ R++ P
Sbjct: 174 TFSVDWWSFGVLLYEMLIGQSPFHGDDEDEL-----FESIRVDTP 213
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 9e-14
Identities = 82/295 (27%), Positives = 128/295 (43%), Gaps = 46/295 (15%)
Query: 439 KKIGEGSFGTVYHAEWRNSDVAV---KILIEQEFHEDRFKEFLREVAIMKGLRH-PNIVL 494
+KIGEG++G VY A +N+ V K +E + E LRE+++++ L IV
Sbjct: 7 EKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD-EEGIPPTALREISLLQMLSESIYIVR 65
Query: 495 LMGAV-----TEPPNLSIVTEYLSRG------SLYKLLHIPDARVVVDERLRLNMAYDVA 543
L+ P+L +V EYL S + P + + + Y +
Sbjct: 66 LLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRP-----LPAKTIKSFMYQLL 120
Query: 544 KGMNYLHQRRPPIVHRDLKSPNLLVDSTYTV-KVCDFGLSR--SKPNTYISSKTAAGTPE 600
KG+ + H+ ++HRDLK NLLVD + K+ D GL R S P + S T
Sbjct: 121 KGVAHCHKH--GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIP---VKSYTHEIVTL 175
Query: 601 WM-APEVLREDPSNEKS-DVFSFGVILWELITLQKPW-RNSTPSQVISAVGFKGRRLEIP 657
W APEVL D++S G I E+ Q + +S Q++ G E
Sbjct: 176 WYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTE-- 233
Query: 658 KNVNPMVAALIETCWAEEPEIRP-----SFPSI----METLQQFLMSSVCQPLSA 703
V P V+ L + W E P+ +P + P + ++ LQ+ L + +SA
Sbjct: 234 -QVWPGVSKLRD--WHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISA 285
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 9e-14
Identities = 61/268 (22%), Positives = 120/268 (44%), Gaps = 32/268 (11%)
Query: 441 IGEGSFGTVY---------HAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN 491
+G+G+F ++ + E ++V +K+L + H + + F ++M L H +
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVL--DKSHRNYSESFFEAASMMSQLSHKH 60
Query: 492 IVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 551
+VL G +V EY+ GSL ++ + +++ +L +A +A +++L
Sbjct: 61 LVLNYGVCVCGDESIMVQEYVKFGSLD--TYLKKNKNLINISWKLEVAKQLAWALHFLED 118
Query: 552 RRPPIVHRDLKSPNLLV-----DSTYT---VKVCDFGLSRSKPNTYISSKTAAGTPEWMA 603
+ + H ++ + N+L+ T +K+ D G+S T + + W+
Sbjct: 119 KG--LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI----TVLPKEILLERIPWVP 172
Query: 604 PEVLREDPS-NEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVN 661
PE + + + +D +SFG LWE+ + KP + + F R ++P
Sbjct: 173 PECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ---FYEDRHQLPAPKW 229
Query: 662 PMVAALIETCWAEEPEIRPSFPSIMETL 689
+A LI C EP+ RPSF +I+ L
Sbjct: 230 TELANLINQCMDYEPDFRPSFRAIIRDL 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 2e-13
Identities = 64/212 (30%), Positives = 100/212 (47%), Gaps = 28/212 (13%)
Query: 439 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEF---HEDRFKEFLREVAIMKGLRHPNIV 493
K IG G+FG V ++S A+K+L + E + F F E IM IV
Sbjct: 49 KVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAF--FWEERDIMAHANSEWIV 106
Query: 494 LLMGAVTEPPNLSIVTEYLSRGSLYKLL---HIPD--ARVVVDERLRLNMAYDVAKGMNY 548
L A + L +V EY+ G L L+ IP+ AR E + +A D M +
Sbjct: 107 QLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAE---VVLALDAIHSMGF 163
Query: 549 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKTAAGTPEWMAPEVL 607
+HRD+K N+L+D + +K+ DFG + N + TA GTP++++PEVL
Sbjct: 164 --------IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVL 215
Query: 608 REDPSN----EKSDVFSFGVILWELITLQKPW 635
+ + + D +S GV L+E++ P+
Sbjct: 216 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 62/207 (29%), Positives = 103/207 (49%), Gaps = 21/207 (10%)
Query: 439 KKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRF--KEFLREVAIMKGLRHPNIVL 494
K IG G++G V A+ N VA+K I F ++R K LRE+ +++ L H N++
Sbjct: 11 KPIGRGAYGIVCSAKNSETNEKVAIK-KIANAF-DNRIDAKRTLREIKLLRHLDHENVIA 68
Query: 495 LMGAVTEPPNLSIVTEYLSRGSLYKL----LH--IPDARVVVDERLRLNMAYDVAKGMNY 548
+ + P + Y+ Y+L LH I ++ + D+ + Y + +G+ Y
Sbjct: 69 IKDIMPPPHREAFNDVYIV----YELMDTDLHQIIRSSQTLSDDHCQY-FLYQLLRGLKY 123
Query: 549 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLR 608
+H ++HRDLK NLL+++ +K+CDFGL+R+ T + APE+L
Sbjct: 124 IHSAN--VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLL 181
Query: 609 EDPSNEKS-DVFSFGVILWELITLQKP 634
+ DV+S G I EL+ +KP
Sbjct: 182 NCSEYTTAIDVWSVGCIFAELLG-RKP 207
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 71.7 bits (175), Expect = 3e-13
Identities = 57/199 (28%), Positives = 100/199 (50%), Gaps = 17/199 (8%)
Query: 439 KKIGEGSFGTVYHA--EWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 496
K IG G+ G V A + +VA+K L ++ K RE+ +MK + H NI+ L+
Sbjct: 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 497 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLN------MAYDVAKGMNYLH 550
T +L + +Y ++ + DA + ++ L+ + Y + G+ +LH
Sbjct: 83 NVFTPQKSLEEFQD------VYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 136
Query: 551 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRED 610
I+HRDLK N++V S T+K+ DFGL+R+ +++ + T + APEV+
Sbjct: 137 S--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRAPEVILGM 193
Query: 611 PSNEKSDVFSFGVILWELI 629
E D++S G I+ E++
Sbjct: 194 GYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 3e-13
Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 439 KKIGEGSFGTVYHA--EWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 496
K IG G+ G V A +VA+K L ++ K RE+ +MK + H NI+ L+
Sbjct: 30 KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 497 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLN------MAYDVAKGMNYLH 550
T +L + +Y ++ + DA + ++ L+ + Y + G+ +LH
Sbjct: 90 NVFTPQKSLEEFQD------VYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 551 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRED 610
I+HRDLK N++V S T+K+ DFGL+R+ +++ + T + APEV+
Sbjct: 144 S--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRAPEVILGM 200
Query: 611 PSNEKSDVFSFGVILWELI 629
E D++S G I+ E+I
Sbjct: 201 GYKENVDIWSVGCIMGEMI 219
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 3e-13
Identities = 65/251 (25%), Positives = 110/251 (43%), Gaps = 58/251 (23%)
Query: 439 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLR-EVAIMKGLRHPNIVLL 495
K IG G+FG V + +++ A+K L + E E +R E I+ +P +V L
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKL 66
Query: 496 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPD------ARVVVDERLRLNMAYDVAKGMNYL 549
+ + L ++ EYL G + LL D R + E + +A D + Y
Sbjct: 67 YYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETI---LAIDSIHKLGY- 122
Query: 550 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL----------------SRSKPNTYI--- 590
+HRD+K NLL+D+ +K+ DFGL S + P+ ++
Sbjct: 123 -------IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFI 175
Query: 591 ----SSK---------------TAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL 631
SSK + GTP+++APEV + N++ D +S GVI++E++
Sbjct: 176 SKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235
Query: 632 QKPWRNSTPSQ 642
P+ + P +
Sbjct: 236 YPPFCSDNPQE 246
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 3e-13
Identities = 54/198 (27%), Positives = 94/198 (47%), Gaps = 8/198 (4%)
Query: 441 IGEGSFGTVYHAEWRNSDVAVKILIEQEFH---EDRFKEFLREVAIMKGLRHPNIVLLMG 497
IG+GSFG V R++ + ++ H L E ++ + P IV L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 498 AVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 557
+ P L +V +++ G L+ H+ R R A ++ + LH+ ++
Sbjct: 61 SFQSPEKLYLVLAFINGGELFH--HLQREGRFDLSRARFYTA-ELLCALENLHKFN--VI 115
Query: 558 HRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSD 617
+RDLK N+L+D + +CDFGL + + T GTPE++APE+L + D
Sbjct: 116 YRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVD 175
Query: 618 VFSFGVILWELITLQKPW 635
++ GV+L+E++T P+
Sbjct: 176 WWTLGVLLYEMLTGLPPF 193
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 4e-13
Identities = 59/223 (26%), Positives = 101/223 (45%), Gaps = 35/223 (15%)
Query: 439 KKIGEGSFGTVYHAEWRNSDV--AVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVLL 495
K +G+G G V+ + + A+K+L ++E + ++ K L E I+ L HP + L
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66
Query: 496 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 555
+ L +V +Y G L++LL + + +E R A +V + YLH
Sbjct: 67 YASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAA-EVLLALEYLHLL--G 123
Query: 556 IVHRDLKSPNLLVDSTYTVKVCDFGLS------------------RSKPNTYISSKTAA- 596
IV+RDLK N+L+ + + + DF LS R I S+T +
Sbjct: 124 IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSE 183
Query: 597 ----------GTPEWMAPEVLREDPSNEKSDVFSFGVILWELI 629
GT E++APEV+ D D ++ G++L+E++
Sbjct: 184 EPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEML 226
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 5e-13
Identities = 63/213 (29%), Positives = 102/213 (47%), Gaps = 30/213 (14%)
Query: 431 RWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRF-KEFLREVAIMKGL 487
R+ +L K++G G++GTV A R + VA+K L + F + F K RE+ ++K +
Sbjct: 16 RYRDL---KQVGSGAYGTVCSALDRRTGAKVAIKKL-YRPFQSELFAKRAYRELRLLKHM 71
Query: 488 RHPNIVLLMGAVTEPPNLSIVTEYL--------SRGSLYKLLHIPDARVVVDERLRLNMA 539
+H N++ L+ T +L ++ G L K + + R+ +
Sbjct: 72 KHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQF-------LV 124
Query: 540 YDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP 599
Y + KG+ Y+H I+HRDLK NL V+ +K+ DFGL+R S T
Sbjct: 125 YQMLKGLKYIHA--AGIIHRDLKPGNLAVNEDCELKILDFGLARQTD----SEMTGYVVT 178
Query: 600 EWM-APEV-LREDPSNEKSDVFSFGVILWELIT 630
W APEV L + D++S G I+ E++T
Sbjct: 179 RWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLT 211
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 6e-13
Identities = 62/207 (29%), Positives = 103/207 (49%), Gaps = 20/207 (9%)
Query: 431 RWSELLIKKKIGEGSFGTVYHA--EWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR 488
R+ +L K IG G+ G V A +VAVK L ++ K RE+ ++K +
Sbjct: 22 RYQQL---KPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVN 78
Query: 489 HPNIVLLMGAVT------EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDV 542
H NI+ L+ T E ++ +V E L +L +++H+ +D + Y +
Sbjct: 79 HKNIISLLNVFTPQKSLEEFQDVYLVME-LMDANLCQVIHME-----LDHERMSYLLYQM 132
Query: 543 AKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWM 602
G+ +LH I+HRDLK N++V S T+K+ DFGL+R+ ++ + T +
Sbjct: 133 LCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVV-TRYYR 189
Query: 603 APEVLREDPSNEKSDVFSFGVILWELI 629
APEV+ E D++S G I+ EL+
Sbjct: 190 APEVILGMGYKENVDIWSVGCIMGELV 216
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 6e-13
Identities = 66/218 (30%), Positives = 104/218 (47%), Gaps = 40/218 (18%)
Query: 441 IGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEF----LREVAIMKGLRHPNIVLLM 496
IGEG++G VY A R+ D + +++ ++ + F +RE+ I++ L H NIV L
Sbjct: 15 IGEGTYGQVYKA--RDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLK 72
Query: 497 GAVT----------EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM 546
VT + +V EY+ L LL V E + + +G+
Sbjct: 73 EIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLE--SGLVHFSEDHIKSFMKQLLEGL 129
Query: 547 NYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR------SKPNTYISSKTAAGTPE 600
NY H++ +HRD+K N+L+++ +K+ DFGL+R S+P T T
Sbjct: 130 NYCHKKN--FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYT-----NKVITLW 182
Query: 601 WMAPEVL----REDPSNEKSDVFSFGVILWELITLQKP 634
+ PE+L R P+ DV+S G IL EL T +KP
Sbjct: 183 YRPPELLLGEERYGPA---IDVWSCGCILGELFT-KKP 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 7e-13
Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 17/208 (8%)
Query: 433 SELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRF-KEFLREVAIMKGLRH 489
S + IG G++G V A S VA+K I F K LRE+ I++ +H
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIK-KIPHAFDVPTLAKRTLRELKILRHFKH 63
Query: 490 PNIVLLMGAVTEPPNLSI---VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM 546
NI+ + + P V L L+ ++H + + +E +R + Y + +G+
Sbjct: 64 DNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIH--SDQPLTEEHIRYFL-YQLLRGL 120
Query: 547 NYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR---SKPNTYISSKTAAGTPEWM- 602
Y+H ++HRDLK NLLV+ +++ DFG++R S P + T W
Sbjct: 121 KYIHSAN--VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYR 178
Query: 603 APEVLREDPS-NEKSDVFSFGVILWELI 629
APE+L P D++S G I E++
Sbjct: 179 APELLLSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 1e-12
Identities = 64/204 (31%), Positives = 101/204 (49%), Gaps = 27/204 (13%)
Query: 441 IGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAV- 499
IG GSFG VY A D + K+ I++ + ++K RE+ IMK L H NI+ L
Sbjct: 74 IGNGSFGVVYEAIC--IDTSEKVAIKKVLQDPQYKN--RELLIMKNLNHINIIFLKDYYY 129
Query: 500 TEPPN-------LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 552
TE L++V E++ + + H + L +Y + + + Y+H +
Sbjct: 130 TECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK 189
Query: 553 RPPIVHRDLKSPNLLVD-STYTVKVCDFG-----LSRSKPNTYISSKTAAGTPEWMAPEV 606
I HRDLK NLL+D +T+T+K+CDFG L+ + +YI S+ + APE+
Sbjct: 190 F--ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF------YRAPEL 241
Query: 607 -LREDPSNEKSDVFSFGVILWELI 629
L D++S G I+ E+I
Sbjct: 242 MLGATNYTTHIDLWSLGCIIAEMI 265
|
Length = 440 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 1e-12
Identities = 51/204 (25%), Positives = 102/204 (50%), Gaps = 15/204 (7%)
Query: 441 IGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKE------FLREVAIMKGLRHPNIVL 494
+G+G FG V + +N+ K+ ++ + R K+ L E I++ + P IV
Sbjct: 1 LGKGGFGEVCAVQVKNTG---KMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVN 57
Query: 495 LMGAVTEPPNLSIVTEYLSRGSL-YKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 553
L A +L +V ++ G L Y + ++ ++ ++ + + G+ +LH
Sbjct: 58 LAYAFESKTHLCLVMSLMNGGDLKYHIYNV--GERGLEMERVIHYSAQITCGILHLHSMD 115
Query: 554 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSN 613
IV+RD+K N+L+D ++ D GL+ + + AGT +MAPE+L+E+P +
Sbjct: 116 --IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-TITQRAGTNGYMAPEILKEEPYS 172
Query: 614 EKSDVFSFGVILWELITLQKPWRN 637
D F+ G ++E++ + P+++
Sbjct: 173 YPVDWFAMGCSIYEMVAGRTPFKD 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 56/203 (27%), Positives = 100/203 (49%), Gaps = 15/203 (7%)
Query: 441 IGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKE------FLREVAIMKGLRHPNIVL 494
+G+G FG V + R + K+ ++ + R K+ L E I++ + +V
Sbjct: 8 LGKGGFGEVCACQVRATG---KMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVS 64
Query: 495 LMGAVTEPPNLSIVTEYLSRGSL-YKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 553
L A L +V ++ G L + + H+ +A +E + A ++ G+ LHQ R
Sbjct: 65 LAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGF--EEGRAVFYAAEICCGLEDLHQER 122
Query: 554 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSN 613
IV+RDLK N+L+D +++ D GL+ P + K GT +MAPEV++ +
Sbjct: 123 --IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-TIKGRVGTVGYMAPEVVKNERYT 179
Query: 614 EKSDVFSFGVILWELITLQKPWR 636
D ++ G +L+E+I Q P++
Sbjct: 180 FSPDWWALGCLLYEMIAGQSPFQ 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 2e-12
Identities = 58/203 (28%), Positives = 103/203 (50%), Gaps = 24/203 (11%)
Query: 439 KKIGEGSFGTVYHA--EWRNSDVAVKILIEQEFHEDRF-KEFLREVAIMKGLRHPNIVLL 495
K++G G++G+V A + VA+K L + F + F K RE+ ++K ++H N++ L
Sbjct: 21 KQVGSGAYGSVCSAIDKRTGEKVAIKKL-SRPFQSEIFAKRAYRELTLLKHMQHENVIGL 79
Query: 496 MGAVTEPP------NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 549
+ T + +V Y+ + L K++ P + +++++ + Y + G+ Y+
Sbjct: 80 LDVFTSAVSGDEFQDFYLVMPYM-QTDLQKIMGHP----LSEDKVQY-LVYQMLCGLKYI 133
Query: 550 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWM-APEV-L 607
H I+HRDLK NL V+ +K+ DFGL+R + T W APEV L
Sbjct: 134 H--SAGIIHRDLKPGNLAVNEDCELKILDFGLARHAD----AEMTGYVVTRWYRAPEVIL 187
Query: 608 REDPSNEKSDVFSFGVILWELIT 630
N+ D++S G I+ E++T
Sbjct: 188 NWMHYNQTVDIWSVGCIMAEMLT 210
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-12
Identities = 65/247 (26%), Positives = 112/247 (45%), Gaps = 43/247 (17%)
Query: 439 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLR-EVAIMKGLRHPNIVLL 495
K IG G+FG V + +++ A+KIL + + E +R E I+ +V +
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKM 66
Query: 496 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 555
+ + NL ++ E+L G + LL D + +E + +A V ++ +HQ
Sbjct: 67 FYSFQDKLNLYLIMEFLPGGDMMTLLMKKDT--LTEEETQFYIAETVL-AIDSIHQL--G 121
Query: 556 IVHRDLKSPNLLVDSTYTVKVCDFGL------------------------------SRSK 585
+HRD+K NLL+DS VK+ DFGL S+ K
Sbjct: 122 FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRK 181
Query: 586 PNTYISSK-----TAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTP 640
T+ ++ + GTP+++APEV + N+ D +S GVI++E++ P+ + TP
Sbjct: 182 AETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETP 241
Query: 641 SQVISAV 647
+ V
Sbjct: 242 QETYKKV 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 3e-12
Identities = 64/233 (27%), Positives = 112/233 (48%), Gaps = 13/233 (5%)
Query: 437 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQE-FHEDRFKEFLREVAIMKGLRHPNIV 493
I K IG G+FG V + +N+D A+KIL + E F E ++ + I
Sbjct: 5 ILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWIT 64
Query: 494 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 553
L A + NL +V +Y G L LL + R+ D R +A ++ ++ +HQ
Sbjct: 65 TLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPED-MARFYLA-EMVIAIDSVHQLH 122
Query: 554 PPIVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKTAAGTPEWMAPEVLR--ED 610
VHRD+K N+L+D +++ DFG + + + S A GTP++++PE+L+ ED
Sbjct: 123 --YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMED 180
Query: 611 PSNE---KSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNV 660
+ + D +S GV ++E++ + P+ + + + R + P V
Sbjct: 181 GKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQV 233
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-12
Identities = 62/225 (27%), Positives = 105/225 (46%), Gaps = 21/225 (9%)
Query: 419 RELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKE 476
R+L ++ E E+ K IG G+FG V +++ A+K+L + E +
Sbjct: 36 RDLRMKAEDYEV-------VKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSA 88
Query: 477 FL-REVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLR 535
F E IM P +V L A + L +V EY+ G L L+ D V E+
Sbjct: 89 FFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD----VPEKWA 144
Query: 536 LNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKT 594
+V ++ +H +HRD+K N+L+D + +K+ DFG + + T
Sbjct: 145 RFYTAEVVLALDAIHSM--GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT 202
Query: 595 AAGTPEWMAPEVLREDPSN----EKSDVFSFGVILWELITLQKPW 635
A GTP++++PEVL+ + + D +S GV L+E++ P+
Sbjct: 203 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 66.8 bits (164), Expect = 4e-12
Identities = 58/241 (24%), Positives = 108/241 (44%), Gaps = 30/241 (12%)
Query: 434 ELLIKKKIGEGSFGTVY---HAEWRNSDVAVKILIEQEFHEDRFKEFLREVA-IMKGLRH 489
E++ K K+ +G FG V H + V KI+ + F+ V +MK +
Sbjct: 17 EIVKKLKLIDGKFGKVSVLKHKPTQKLFV-QKIIKAKNFNAIEPM-----VHQLMKD--N 68
Query: 490 PNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 549
PN + L +VT ++ +Y+ G L+ LL + E + + + +N L
Sbjct: 69 PNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGK---LSEAEVKKIIRQLVEALNDL 125
Query: 550 HQRRPPIVHRDLKSPNLLVD-STYTVKVCDFGLSRSK--PNTYISSKTAAGTPEWMAPEV 606
H+ I+H D+K N+L D + + +CD+GL + P+ Y GT ++ +PE
Sbjct: 126 HKHN--IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY------DGTLDYFSPEK 177
Query: 607 LREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR---RLEIPKNVNPM 663
++ + D ++ GV+ +EL+T + P++ + + R +L KNV+
Sbjct: 178 IKGHNYDVSFDWWAVGVLTYELLTGKHPFKED-EDEELDLESLLKRQQKKLPFIKNVSKN 236
Query: 664 V 664
Sbjct: 237 A 237
|
Length = 267 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.4 bits (169), Expect = 5e-12
Identities = 76/289 (26%), Positives = 128/289 (44%), Gaps = 51/289 (17%)
Query: 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKG 486
E R +E + KKIG G FG V+ + + + K + + E + + EV +M+
Sbjct: 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRE 68
Query: 487 LRHPNIVLLMGAVTEPPN--LSIVTEYLSRGSL-------YKLLHIPDARVVVDERLRLN 537
L+H NIV + N L I+ E+ G L YK+ + +VD +L
Sbjct: 69 LKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLL 128
Query: 538 MAYDVAKGMNYLHQRR-----PPIVHRDLKSPNLLVDSTY-----------------TVK 575
A + Y H + ++HRDLK N+ + + K
Sbjct: 129 HA------LAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAK 182
Query: 576 VCDFGLSRSKPNTYISS--KTAAGTPEWMAPEVLREDPS--NEKSDVFSFGVILWELITL 631
+ DFGLS+ N I S + GTP + +PE+L + ++KSD+++ G I++EL +
Sbjct: 183 IGDFGLSK---NIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSG 239
Query: 632 QKPWRNSTP-SQVISAVGFKGRRLEI---PKNVNPMVAALIETCWAEEP 676
+ P+ + SQ+IS + +G L I K +N ++ L+ E P
Sbjct: 240 KTPFHKANNFSQLISELK-RGPDLPIKGKSKELNILIKNLLNLSAKERP 287
|
Length = 1021 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 7e-12
Identities = 65/220 (29%), Positives = 108/220 (49%), Gaps = 37/220 (16%)
Query: 437 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQE---------FHEDRFKEFLREVAIMK 485
I K IG G+FG V + +N+ A+KIL + E F E+R +V ++
Sbjct: 5 ILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREER------DV-LVN 57
Query: 486 GLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAY----D 541
G R I L A + NL +V +Y G L LL ++RL +MA +
Sbjct: 58 GDRRW-ITNLHYAFQDENNLYLVMDYYVGGDLLTLLS------KFEDRLPEDMARFYLAE 110
Query: 542 VAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKTAAGTPE 600
+ ++ +HQ VHRD+K N+L+D +++ DFG R + + S A GTP+
Sbjct: 111 MVLAIDSVHQLG--YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPD 168
Query: 601 WMAPEVLR--EDPSNE---KSDVFSFGVILWELITLQKPW 635
+++PE+L+ ED + D +S GV ++E++ + P+
Sbjct: 169 YISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 7e-12
Identities = 73/275 (26%), Positives = 125/275 (45%), Gaps = 49/275 (17%)
Query: 434 ELLIKKKIGEGSFGTVY-----HAEWRNSDVAVKILIEQEF-HEDRFKEFLR-EVAIMKG 486
ELL K +G G++G V+ A+K+L + + + E R E +++
Sbjct: 3 ELL--KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 487 LRH-PNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKG 545
+R P +V L A L ++ +Y+S G ++ H+ ++ +R ++
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFT--HLYQRDNFSEDEVRFYSG-EIILA 117
Query: 546 MNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-----SKPNTYISSKTAAGTPE 600
+ +LH + IV+RD+K N+L+DS V + DFGLS+ K TY + GT E
Sbjct: 118 LEHLH--KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTY----SFCGTIE 171
Query: 601 WMAPEVLREDPSNEKS-DVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKN 659
+MAPE++R + K+ D +S G++++EL+T P+ LE +N
Sbjct: 172 YMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPF-----------------TLEGERN 214
Query: 660 VNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLM 694
V+ I C P FPS + Q L+
Sbjct: 215 TQSEVSRRILKC-------DPPFPSFIGPEAQDLL 242
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 8e-12
Identities = 64/247 (25%), Positives = 112/247 (45%), Gaps = 43/247 (17%)
Query: 439 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLR-EVAIMKGLRHPNIVLL 495
K IG G+FG V + +++ A+KIL + + E +R E I+ +V +
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKM 66
Query: 496 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 555
+ + NL ++ E+L G + LL D + +E + +A V ++ +HQ
Sbjct: 67 FYSFQDKRNLYLIMEFLPGGDMMTLLMKKDT--LSEEATQFYIAETVL-AIDAIHQL--G 121
Query: 556 IVHRDLKSPNLLVDSTYTVKVCDFGL------------------------------SRSK 585
+HRD+K NLL+D+ VK+ DFGL S+ K
Sbjct: 122 FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRK 181
Query: 586 PNTYISSK-----TAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTP 640
T+ ++ + GTP+++APEV + N+ D +S GVI++E++ P+ + TP
Sbjct: 182 AETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETP 241
Query: 641 SQVISAV 647
+ V
Sbjct: 242 QETYRKV 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 77/287 (26%), Positives = 131/287 (45%), Gaps = 49/287 (17%)
Query: 437 IKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 494
I++ IG+GS+G V A ++ VA+K + + H LRE+ +++ LRHP+IV
Sbjct: 4 IQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVE 63
Query: 495 LMGAVTEPPN------LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 548
+ + PP+ + +V E L L++++ D + E + + Y + + + Y
Sbjct: 64 IK-HIMLPPSRREFKDIYVVFE-LMESDLHQVIKANDD--LTPEHHQFFL-YQLLRALKY 118
Query: 549 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN---TYISSKTAAGTPEWMAPE 605
+H + HRDLK N+L ++ +K+CDFGL+R N T I T + APE
Sbjct: 119 IHTAN--VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE 176
Query: 606 VLREDPSNEKS--DVFSFGVILWELITLQK--PWRN-------------STPSQVISAVG 648
+ S D++S G I E++T + P +N + + IS V
Sbjct: 177 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVR 236
Query: 649 -FKGRR--------LEIP-----KNVNPMVAALIETCWAEEPEIRPS 681
K RR +P N +P+ L+E A +P+ RP+
Sbjct: 237 NEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPT 283
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 2e-11
Identities = 54/174 (31%), Positives = 87/174 (50%), Gaps = 8/174 (4%)
Query: 434 ELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEF-HEDRFKEFLREVAIMKGLRHP 490
E +I K I G+FG VY +N+ AVK++ + + +++ + E + + P
Sbjct: 5 EFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSP 64
Query: 491 NIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLH 550
IV L ++ N+ +V EYL G + LLHI DE + + +VA ++YLH
Sbjct: 65 FIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYG---YFDEEMAVKYISEVALALDYLH 121
Query: 551 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAP 604
R I+HRDLK N+L+ + +K+ DFGLS+ N ++ TP P
Sbjct: 122 --RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNMMDILTTPSMAKP 173
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 57/229 (24%), Positives = 102/229 (44%), Gaps = 20/229 (8%)
Query: 470 HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVV 529
H D F ++M + H ++ + G +V E++ G L L RV
Sbjct: 56 HRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVP 115
Query: 530 VDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLV-------DSTYTVKVCDFGLS 582
V ++ +A +A ++YL + +VH ++ + N+L+ ++ +K+ D G+S
Sbjct: 116 VA--WKITVAQQLASALSYLEDKN--LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS 171
Query: 583 RSKPNTYISSKTAAGTPEWMAPEVLREDPS-NEKSDVFSFGVILWEL-ITLQKPWRNSTP 640
T +S + W+APE + S + +D +SFG L E+ + P + TP
Sbjct: 172 F----TALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP 227
Query: 641 SQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETL 689
S+ F ++ +P+ +A LI C EP RPSF +I+ L
Sbjct: 228 SE---KERFYEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 47/158 (29%), Positives = 74/158 (46%), Gaps = 15/158 (9%)
Query: 480 EVAIMKGLRHPNIVLLMGAVT-EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNM 538
E I++ + HP+I+ L G T I+ Y + LY L + D L +
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRY--KTDLYCYLAAKRNIAICD---ILAI 187
Query: 539 AYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS----RSKPNTYISSKT 594
V + + YLH+ R I+HRD+K+ N+ ++ V + DFG + N Y
Sbjct: 188 ERSVLRAIQYLHENR--IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYG--- 242
Query: 595 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQ 632
AGT APE+L DP D++S G++L+E+ T
Sbjct: 243 WAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 62/238 (26%), Positives = 113/238 (47%), Gaps = 23/238 (9%)
Query: 437 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQE-FHEDRFKEFLREVAIMKGLRHPNIV 493
I K IG G+FG V + ++++ A+KIL + E F E ++ I
Sbjct: 5 IIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWIT 64
Query: 494 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAY----DVAKGMNYL 549
L A + L +V +Y G L LL ++RL +MA ++ ++ +
Sbjct: 65 TLHYAFQDENYLYLVMDYYVGGDLLTLLS------KFEDRLPEDMARFYIAEMVLAIHSI 118
Query: 550 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFG--LSRSKPNTYISSKTAAGTPEWMAPEVL 607
HQ VHRD+K N+L+D +++ DFG L ++ T + S A GTP++++PE+L
Sbjct: 119 HQLH--YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT-VQSSVAVGTPDYISPEIL 175
Query: 608 R--EDPSNE---KSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNV 660
+ ED + + D +S GV ++E++ + P+ + + + R + P ++
Sbjct: 176 QAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHI 233
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 56/198 (28%), Positives = 97/198 (48%), Gaps = 19/198 (9%)
Query: 441 IGEGSFGTV---YHAEWRNSDVAVKIL---IEQEFHEDRFKEFLREVAIMKGLRHPNIVL 494
+G G++G+V Y R VAVK L + H R RE+ ++K ++H N++
Sbjct: 23 VGSGAYGSVCSAYDTRLRQK-VAVKKLSRPFQSLIHARRT---YRELRLLKHMKHENVIG 78
Query: 495 LMGAVTEPPNLSIVTE-YLSRGSL-YKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 552
L+ T ++ E YL + L +I + + DE ++ + Y + +G+ Y+H
Sbjct: 79 LLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQF-LIYQLLRGLKYIHS- 136
Query: 553 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV-LREDP 611
I+HRDLK N+ V+ +++ DFGL+R + T + APE+ L
Sbjct: 137 -AGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGY---VATRWYRAPEIMLNWMH 192
Query: 612 SNEKSDVFSFGVILWELI 629
N+ D++S G I+ EL+
Sbjct: 193 YNQTVDIWSVGCIMAELL 210
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 5e-10
Identities = 58/210 (27%), Positives = 99/210 (47%), Gaps = 24/210 (11%)
Query: 439 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIV--- 493
+ +G GS G V+ A + D VAVK ++ + K LRE+ I++ L H NIV
Sbjct: 11 RPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQ--SVKHALREIKIIRRLDHDNIVKVY 68
Query: 494 --LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMA----YDVAKGMN 547
L ++ +TE S + + + A V+ L A Y + +G+
Sbjct: 69 EVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLK 128
Query: 548 YLHQRRPPIVHRDLKSPNLLVDS-TYTVKVCDFGLSRSKPNTYISSK---TAAGTPEWM- 602
Y+H ++HRDLK N+ +++ +K+ DFGL+R Y S K + +W
Sbjct: 129 YIHSAN--VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHY-SHKGYLSEGLVTKWYR 185
Query: 603 APEVLREDPSN--EKSDVFSFGVILWELIT 630
+P +L P+N + D+++ G I E++T
Sbjct: 186 SPRLLLS-PNNYTKAIDMWAAGCIFAEMLT 214
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 5e-10
Identities = 52/203 (25%), Positives = 98/203 (48%), Gaps = 15/203 (7%)
Query: 441 IGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKE------FLREVAIMKGLRHPNIVL 494
+G+G FG V + R + K+ ++ + R K+ L E I++ + +V
Sbjct: 8 LGKGGFGEVCACQVRATG---KMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVS 64
Query: 495 LMGAVTEPPNLSIVTEYLSRGSL-YKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 553
L A L +V ++ G L + + ++ + DE + A ++ G+ LH+ R
Sbjct: 65 LAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGF--DEERAVFYAAEITCGLEDLHRER 122
Query: 554 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSN 613
IV+RDLK N+L+D +++ D GL+ P + + GT +MAPEV++ +
Sbjct: 123 --IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-TIRGRVGTVGYMAPEVVKNERYT 179
Query: 614 EKSDVFSFGVILWELITLQKPWR 636
D + G +++E+I + P+R
Sbjct: 180 FSPDWWGLGCLIYEMIEGKSPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 5e-10
Identities = 57/199 (28%), Positives = 98/199 (49%), Gaps = 19/199 (9%)
Query: 441 IGEGSFGTVYHA-EWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA 498
+G G++G+V A + + VAVK L K RE+ ++K ++H N++ L+
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84
Query: 499 VTEPPNLS------IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 552
T +L +VT + L +I + + D+ ++ + Y + +G+ Y+H
Sbjct: 85 FTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHS- 138
Query: 553 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV-LREDP 611
I+HRDLK NL V+ +K+ DFGL+R +T T + APE+ L
Sbjct: 139 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEIMLNWMH 194
Query: 612 SNEKSDVFSFGVILWELIT 630
N+ D++S G I+ EL+T
Sbjct: 195 YNQTVDIWSVGCIMAELLT 213
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 6e-10
Identities = 62/259 (23%), Positives = 130/259 (50%), Gaps = 20/259 (7%)
Query: 434 ELLIKKKIGEGSFGTVYHAEWRNSD-----VAVKILIEQEF-HEDRFKEFLR-EVAIMKG 486
ELL K +G G++G V+ + A+K+L + + + E R E +++
Sbjct: 3 ELL--KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 487 LRH-PNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKG 545
+R P +V L A L ++ +Y++ G L+ H+ ++ +++ ++
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFT--HLSQRERFKEQEVQIYSG-EIVLA 117
Query: 546 MNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS-SKTAAGTPEWMAP 604
+ +LH + I++RD+K N+L+DS V + DFGLS+ + + + GT E+MAP
Sbjct: 118 LEHLH--KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAP 175
Query: 605 EVLR-EDPSNEKS-DVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLE--IPKNV 660
+++R D ++K+ D +S GV+++EL+T P+ + + + + E P+ +
Sbjct: 176 DIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM 235
Query: 661 NPMVAALIETCWAEEPEIR 679
+ + +I+ ++P+ R
Sbjct: 236 SALAKDIIQRLLMKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 55/203 (27%), Positives = 91/203 (44%), Gaps = 15/203 (7%)
Query: 441 IGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKE------FLREVAIMKGLRHPNIVL 494
+G+G FG V + R + K+ + + R K+ L E I++ + +V
Sbjct: 8 LGKGGFGEVCACQVRATG---KMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVN 64
Query: 495 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPD-ARVVVDERLRLNMAYDVAKGMNYLHQRR 553
L A L +V ++ G L HI + +E L A ++ G+ LH+
Sbjct: 65 LAYAYETKDALCLVLTIMNGGDLK--FHIYNMGNPGFEEERALFYAAEILCGLEDLHREN 122
Query: 554 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSN 613
V+RDLK N+L+D +++ D GL+ P S + GT +MAPEVL
Sbjct: 123 --TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-SIRGRVGTVGYMAPEVLNNQRYT 179
Query: 614 EKSDVFSFGVILWELITLQKPWR 636
D + G +++E+I Q P+R
Sbjct: 180 LSPDYWGLGCLIYEMIEGQSPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 63/261 (24%), Positives = 102/261 (39%), Gaps = 73/261 (27%)
Query: 439 KKIGEGSFGTVYHAEWRNSDV----AVKILIEQEFHEDRFKEFLR--EVAIMKGLR---- 488
K IG G+FG V R D A+K L R + L + A +K R
Sbjct: 7 KTIGIGAFGEVCLV--RKVDTNALYAMKTL--------RKADVLMRNQAAHVKAERDILA 56
Query: 489 ---HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERL-RLNMAYDVAK 544
+ +V L + + NL V +Y+ G + LL + +E L R +A ++
Sbjct: 57 EADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLL---IRLGIFEEDLARFYIA-ELTC 112
Query: 545 GMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL----------------------S 582
+ +H + +HRD+K N+L+D +K+ DFGL S
Sbjct: 113 AIESVH--KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDS 170
Query: 583 RSKPNTY---------------------ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSF 621
+ + + GTP ++APEVL + D +S
Sbjct: 171 MEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 230
Query: 622 GVILWELITLQKPWRNSTPSQ 642
GVIL+E++ Q P+ TP++
Sbjct: 231 GVILYEMLVGQPPFLADTPAE 251
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 54/203 (26%), Positives = 95/203 (46%), Gaps = 15/203 (7%)
Query: 441 IGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKE------FLREVAIMKGLRHPNIVL 494
+G+G FG V + R + K+ ++ + R K+ L E I++ + +V
Sbjct: 8 LGKGGFGEVCACQVRATG---KMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVS 64
Query: 495 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPD-ARVVVDERLRLNMAYDVAKGMNYLHQRR 553
L A L +V ++ G L HI + DE+ + A ++ G+ L + R
Sbjct: 65 LAYAYETKDALCLVLTIMNGGDLK--FHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER 122
Query: 554 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSN 613
IV+RDLK N+L+D +++ D GL+ P + + GT +MAPEV+ +
Sbjct: 123 --IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-TVRGRVGTVGYMAPEVINNEKYT 179
Query: 614 EKSDVFSFGVILWELITLQKPWR 636
D + G +++E+I Q P+R
Sbjct: 180 FSPDWWGLGCLIYEMIQGQSPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 4e-09
Identities = 63/236 (26%), Positives = 100/236 (42%), Gaps = 32/236 (13%)
Query: 480 EVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMA 539
E+A M L+HPNIV L+G ++ EY+ +L ++L R + ER R +A
Sbjct: 733 EIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL-----RNLSWER-RRKIA 786
Query: 540 YDVAKGMNYLHQRRPPIVHRDLKSP-NLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGT 598
+AK + +LH R P V SP +++D + S P + +
Sbjct: 787 IGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-----LSLPGLLCTDTKCFIS 841
Query: 599 PEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR------ 652
++APE EKSD++ FG+IL EL+T + P V ++ R
Sbjct: 842 SAYVAPETRETKDITEKSDIYGFGLILIELLTGKSP--ADAEFGVHGSIVEWARYCYSDC 899
Query: 653 ----------RLEIPKNVNPMVAA--LIETCWAEEPEIRPSFPSIMETLQQFLMSS 696
R ++ N N +V L C A +P RP +++TL+ SS
Sbjct: 900 HLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS 955
|
Length = 968 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 3e-08
Identities = 57/227 (25%), Positives = 99/227 (43%), Gaps = 22/227 (9%)
Query: 470 HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVV 529
H D F ++M+ + H +IVLL G +V E++ G L +H V
Sbjct: 44 HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMH--RKSDV 101
Query: 530 VDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLV-----DSTYT--VKVCDFGLS 582
+ + +A +A ++YL + +VH ++ + N+L+ D +K+ D G+
Sbjct: 102 LTTPWKFKVAKQLASALSYLEDKD--LVHGNVCTKNILLAREGIDGECGPFIKLSDPGI- 158
Query: 583 RSKPNTYISSKTAAGTPEWMAPEVLREDPSNEK--SDVFSFGVILWEL-ITLQKPWRNST 639
P T +S + W+APE + ED N +D +SFG LWE+ + P ++ T
Sbjct: 159 ---PITVLSRQECVERIPWIAPECV-EDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKT 214
Query: 640 PSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIM 686
+ F + + +A L+ C +P RP F +IM
Sbjct: 215 ---LAEKERFYEGQCMLVTPSCKELADLMTHCMNYDPNQRPFFRAIM 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 7e-08
Identities = 67/246 (27%), Positives = 105/246 (42%), Gaps = 44/246 (17%)
Query: 437 IKKKIGEGSFGTVY----HAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNI 492
I + GS G V+ H + + V VK + K RE+ I+K + H I
Sbjct: 96 ILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAI 148
Query: 493 VLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVD--ERLRLNMAYDVAKGM---- 546
+ L+ A + +V YK D VD L L A + + +
Sbjct: 149 INLIHAYRWKSTVCMVMPK------YKC----DLFTYVDRSGPLPLEQAITIQRRLLEAL 198
Query: 547 NYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFG------LSRSKPNTYISSKTAAGTPE 600
YLH R I+HRD+K+ N+ +D + DFG P Y +GT E
Sbjct: 199 AYLHGR--GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCY----GWSGTLE 252
Query: 601 WMAPEVLREDPSNEKSDVFSFGVILWEL----ITLQKPWRNSTPSQVISAV-GFKGRRLE 655
+PE+L DP K+D++S G++L+E+ +TL S+ SQ+ S + + LE
Sbjct: 253 TNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLE 312
Query: 656 IPKNVN 661
P+N +
Sbjct: 313 FPQNGS 318
|
Length = 392 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 54/238 (22%), Positives = 105/238 (44%), Gaps = 30/238 (12%)
Query: 440 KIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAV 499
K+G G++G VY A+ ++ + ++Q RE+A+++ L+HPN++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67
Query: 500 TEPPNLSIVTEY-LSRGSLYKLLHIPDARVVVDERLRL------NMAYDVAKGMNYLHQR 552
+ + + + L+ ++ A + ++L ++ Y + G++YLH
Sbjct: 68 LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN 127
Query: 553 RPPIVHRDLKSPNLLV----DSTYTVKVCDFGLSR--SKPNTYISSKTAAGTPEWM-APE 605
++HRDLK N+LV VK+ D G +R + P ++ W APE
Sbjct: 128 W--VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185
Query: 606 VLREDPSNEKS-DVFSFGVILWELITLQ-------------KPWRNSTPSQVISAVGF 649
+L K+ D+++ G I EL+T + P+ + ++ S +GF
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGF 243
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 4e-07
Identities = 50/206 (24%), Positives = 94/206 (45%), Gaps = 17/206 (8%)
Query: 440 KIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAV 499
K+G G++G VY A+ ++ ++Q RE+A+++ L+HPN++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67
Query: 500 TEPPNLSIVTEY-LSRGSLYKLLHIPDARVVVDERLRL------NMAYDVAKGMNYLHQR 552
+ + + + L+ ++ A + ++L ++ Y + G++YLH
Sbjct: 68 LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 127
Query: 553 RPPIVHRDLKSPNLLV----DSTYTVKVCDFGLSR--SKPNTYISSKTAAGTPEWM-APE 605
++HRDLK N+LV VK+ D G +R + P ++ W APE
Sbjct: 128 W--VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185
Query: 606 VLREDPSNEKS-DVFSFGVILWELIT 630
+L K+ D+++ G I EL+T
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 2e-06
Identities = 46/160 (28%), Positives = 78/160 (48%), Gaps = 27/160 (16%)
Query: 480 EVAIMKGLRHPNIVLLM-----GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERL 534
E +++ L HP ++ L+ G +T ++ +Y R LY L AR+
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLT----CLVLPKY--RSDLYTYL---GARLRPLGLA 260
Query: 535 RLN-MAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL------SRSKPN 587
++ +A + ++Y+H I+HRD+K+ N+LV+ + + DFG S S P
Sbjct: 261 QVTAVARQLLSAIDYIH--GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF 318
Query: 588 TYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWE 627
Y AGT + APEVL DP D++S G++++E
Sbjct: 319 HY----GIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 73/297 (24%), Positives = 117/297 (39%), Gaps = 71/297 (23%)
Query: 439 KKIGEGSFGTVYHAEWRNSDV--AVKILIEQE-FHEDRFKEFLREVAIMKGLRHPNIVLL 495
K +G G+FG V A ++ A+K L +++ + ++ E I+ + +V L
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66
Query: 496 MGAVTEPPNLSIVTEYLSRGSLYKLL----HIPD--ARVVVDERLRLNMAYDVAKGMNYL 549
+ + NL V +Y+ G + LL P+ AR + E L +A + M +
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAE---LTLAIESVHKMGF- 122
Query: 550 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS------------------ 591
+HRD+K N+L+D +K+ DFGL T+ S
Sbjct: 123 -------IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSD 175
Query: 592 -----------------------------SKTAAGTPEWMAPEVLREDPSNEKSDVFSFG 622
+ + GTP ++APEVL + D +S G
Sbjct: 176 LWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235
Query: 623 VILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNV--NPMVAALIET--CWAEE 675
VIL+E++ Q P+ TP++ V L IP V +P LI C AEE
Sbjct: 236 VILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEE 292
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 4e-06
Identities = 53/239 (22%), Positives = 101/239 (42%), Gaps = 55/239 (23%)
Query: 439 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQE-FHEDRFKEFLREVAIMKGLRHPNIVLL 495
K IG+G+FG V + +++ A+K L++ E F +D+ E ++ P +V L
Sbjct: 7 KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSL 66
Query: 496 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 555
+ + L ++ E+L G L +L D ++ R MA + + +H +
Sbjct: 67 YYSFQDAQYLYLIMEFLPGGDLMTMLIKYD--TFSEDVTRFYMA-ECVLAIEAVH--KLG 121
Query: 556 IVHRDLKSPNLLVDSTYTVKVCDFGLS--------------------------------- 582
+HRD+K N+L+D +K+ DFGLS
Sbjct: 122 FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAV 181
Query: 583 ---------RSKPNTYISSK-----TAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWE 627
+ + T+ ++ + GTP+++APE+ + ++ D +S G I++E
Sbjct: 182 DSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE 240
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 5e-06
Identities = 71/265 (26%), Positives = 116/265 (43%), Gaps = 48/265 (18%)
Query: 441 IGEG--SFGTVYHAEWRNSDVAVKIL-IEQEFHEDRFKEFLR-EVAIMKGLRHPNIVLLM 496
IG G TV A ++ + V + I E + FL+ E+ + K HPNIV
Sbjct: 6 IGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYR 65
Query: 497 GAVTEPPNLSIVTEYLSRGSLYKLL--HIPDARVVVDERLRLNMAY---DVAKGMNYLHQ 551
L +VT +++ GS L+ H D L +AY V K ++Y+H
Sbjct: 66 ATFIADNELWVVTSFMAYGSAKDLICTHFMDGMS------ELAIAYILQGVLKALDYIHH 119
Query: 552 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS-----------SKTAAGTPE 600
VHR +K+ ++L+ + KV GL RS + I+ K +
Sbjct: 120 M--GYVHRSVKASHILI--SVDGKVYLSGL-RSN-LSMINHGQRLRVVHDFPKYSVKVLP 173
Query: 601 WMAPEVLREDPS--NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPK 658
W++PEVL+++ + KSD++S G+ EL P+++ +Q+ LE
Sbjct: 174 WLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM---------LLE--- 221
Query: 659 NVNPMVAALIETCW--AEEPEIRPS 681
+N V L++T AEE ++PS
Sbjct: 222 KLNGTVPCLLDTTTIPAEELTMKPS 246
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 64/260 (24%), Positives = 102/260 (39%), Gaps = 71/260 (27%)
Query: 439 KKIGEGSFGTVYHAEWRNSDV----AVKILIEQE-FHEDRFKEFLREVAIMKGLRHPNIV 493
K +G G+FG V A R D A+K L +++ ++ E I+ + +V
Sbjct: 7 KTLGIGAFGEVCLA--RKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVV 64
Query: 494 LLMGAVTEPPNLSIVTEYLSRGSLYKLL----HIPD--ARVVVDERLRLNMAYDVAKGMN 547
L + + NL V +Y+ G + LL P+ AR + E L A + M
Sbjct: 65 RLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAE---LTCAVESVHKMG 121
Query: 548 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL-------------------------- 581
+ +HRD+K N+L+D +K+ DFGL
Sbjct: 122 F--------IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDF 173
Query: 582 -------------SRSKPNTYISSK--------TAAGTPEWMAPEVLREDPSNEKSDVFS 620
R KP +++ + GTP ++APEVL + D +S
Sbjct: 174 SNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS 233
Query: 621 FGVILWELITLQKPWRNSTP 640
GVIL+E++ Q P+ TP
Sbjct: 234 VGVILYEMLVGQPPFLAQTP 253
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 7e-05
Identities = 32/91 (35%), Positives = 45/91 (49%), Gaps = 9/91 (9%)
Query: 439 KKIGEGSFGTVYHA-------EWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHP 490
K +G G+FG V A E VAVK+L + H D + + E+ I+ L +H
Sbjct: 44 KTLGAGAFGKVVEATAFGLGKEDNVLRVAVKML-KASAHTDEREALMSELKILSHLGQHK 102
Query: 491 NIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL 521
NIV L+GA T + ++TEY G L L
Sbjct: 103 NIVNLLGACTHGGPVLVITEYCCYGDLLNFL 133
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 6e-04
Identities = 32/156 (20%), Positives = 64/156 (41%), Gaps = 33/156 (21%)
Query: 441 IGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLR------EVAIMK-----GLRH 489
I +G+ +Y ++ +K + + + E +R E ++ G+
Sbjct: 2 IAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNT 61
Query: 490 PNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 549
P +V + +P N +IV EY + + V++E + ++ + + L
Sbjct: 62 P-VVYDV----DPDNKTIVMEY---------IEGKPLKDVIEEG-NDELLREIGRLVGKL 106
Query: 550 HQRRPPIVHRDLKSPNLLVDSTYTVKVC--DFGLSR 583
H + IVH DL + N++V K+ DFGL +
Sbjct: 107 H--KAGIVHGDLTTSNIIVRDD---KLYLIDFGLGK 137
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 8e-04
Identities = 33/102 (32%), Positives = 49/102 (48%), Gaps = 9/102 (8%)
Query: 429 EIRWSELLIKKKIGEGSFGTVYHA-------EWRNSDVAVKILIEQEFHEDRFKEFLREV 481
E+ L++ + +G G+FG V A VAVK+L ++ + + E+
Sbjct: 33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEK-QALMSEL 91
Query: 482 AIMKGL-RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLH 522
IM L H NIV L+GA T+ + I+TEY G L LH
Sbjct: 92 KIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLH 133
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.7 bits (96), Expect = 0.001
Identities = 34/158 (21%), Positives = 64/158 (40%), Gaps = 30/158 (18%)
Query: 439 KKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLR------EVAIMK-----GL 487
K I G+ +Y ++ +K I + + E +R E IM G+
Sbjct: 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGV 61
Query: 488 RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDE--RLRLNMAYDVAKG 545
P V + +P N IV EY+ L + +++ L ++ ++ +
Sbjct: 62 NVP-AVYFV----DPENFIIVMEYIEGEPL---------KDLINSNGMEELELSREIGRL 107
Query: 546 MNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 583
+ LH I+H DL + N+++ S + + DFGL+
Sbjct: 108 VGKLHSAG--IIHGDLTTSNMIL-SGGKIYLIDFGLAE 142
|
Length = 211 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.003
Identities = 19/47 (40%), Positives = 29/47 (61%)
Query: 597 GTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQV 643
GTP+++APE+L P D ++ GV L+E +T P+ + TP QV
Sbjct: 542 GTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQV 588
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 706 | |||
| PF14381 | 204 | EDR1: Ethylene-responsive protein kinase Le-CTR1 | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.98 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.98 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.92 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.91 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.9 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.88 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.87 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.84 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.84 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.82 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.81 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.81 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.8 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.79 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.78 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.77 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.77 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.73 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.72 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.7 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.69 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.67 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.66 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.66 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.64 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.61 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.58 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.58 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.54 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.39 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.3 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.27 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.23 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.19 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.16 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.16 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.14 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.12 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.1 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.02 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.97 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.93 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.74 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.74 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.65 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.58 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.51 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.48 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.39 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.27 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.21 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.18 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.07 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.06 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.04 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.89 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.8 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.75 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.72 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.7 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.69 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.66 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.61 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.4 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.36 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.33 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.31 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.3 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.22 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.17 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.01 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.98 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.81 | |
| smart00460 | 68 | TGc Transglutaminase/protease-like homologues. Tra | 96.76 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.66 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.64 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.22 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.05 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.05 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.0 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 95.94 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.79 | |
| PLN02236 | 344 | choline kinase | 95.77 | |
| PF01841 | 113 | Transglut_core: Transglutaminase-like superfamily; | 95.47 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 95.27 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 94.98 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.82 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 94.82 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 94.76 | |
| COG5279 | 521 | CYK3 Uncharacterized protein involved in cytokines | 94.74 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 94.5 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 93.47 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 93.29 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 91.74 |
| >PF14381 EDR1: Ethylene-responsive protein kinase Le-CTR1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-68 Score=530.67 Aligned_cols=200 Identities=52% Similarity=0.870 Sum_probs=190.1
Q ss_pred ChhhhhhhhhhcccccccCCCCCCceeEeeecCCccccccc-cc-ccCCCCCCcccccccCCCCCcceeEEEEecCCChh
Q 005247 59 DSAETVSHRFWVNGCLSYFDRILDGFYLIHGMDPYTWSIGT-NQ-RDAGLIPPYKSLKAVDPCNNLSIKVILIDKSSDPN 136 (706)
Q Consensus 59 ~~~~~~s~~~~~~~~l~~~~~~~dgfy~i~~~~~~~~~~~~-~~-~~~~~~p~~~~L~~~~~~~~~~~evilvd~~~D~~ 136 (706)
+++|.+|||||++|+|||+||||||||+|+||| |+ ++ .+.||||||++|+++++ +.+++|||||||++|++
T Consensus 1 ~~~e~lS~r~W~~~~L~y~dki~DGFYdi~g~~------~~~~l~~~~~~~Psl~~L~~~~~-~~~~~EvIlVDr~~D~~ 73 (204)
T PF14381_consen 1 SSAESLSHRYWVNGCLSYDDKIPDGFYDIYGMD------CTNSLKEEFGRMPSLEDLQAVPP-DDSSREVILVDRRRDPS 73 (204)
T ss_pred CcHHHHHHHHHHcCCCCCCCcCCCCCcccccCC------CccccccccCCCCCHHHHhcCCC-CCCCeeEEEEccccCHH
Confidence 589999999999999999999999999999997 64 55 68999999999999995 88889999999999999
Q ss_pred HHHHHHHHHHHhcCcC-CHHHHHHHHHHHHHHhcCCCCCCchhhhhhhHHHHHHHHHhhhCCeeEEeeecccccchhhHH
Q 005247 137 LKELHNRVLSLLCDRI-TAEEAVHQLANLVCNHMGGTTSTEEEEFDKQWSECAEHLKDCLNSVVLPIGSLSVGLCVHRAL 215 (706)
Q Consensus 137 l~~l~~~~~~~~~~~~-~~~~~~~~la~~V~~~m~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~~g~~~~g~~r~ra~ 215 (706)
|++|+++|+++++++. ++++++++||++||++|||++.+++.. ..+|+.++.+||. +++++|||+|++|+||||||
T Consensus 74 L~~L~~~a~~~~~~~~~~~~~~v~~LA~lVa~~MGG~~~~~~~~-~~~w~~~s~~lk~--~s~~vplG~l~~G~~rhRAL 150 (204)
T PF14381_consen 74 LKELEQRAHELSKGLSTNTKELVQKLAKLVADRMGGPVSDAEDM-LFRWELRSEKLKE--NSGVVPLGSLRIGLCRHRAL 150 (204)
T ss_pred HHHHHHHHHHHHhccccCHHHHHHHHHHHHHHHhCCCCCcchhh-hHHHHHHHHHHHh--CCCeEEEeeecccchHHHHH
Confidence 9999999999999866 799999999999999999999997766 5699999888988 89999999999999999999
Q ss_pred HHHHHhhhcCCCcccccccccCCC-CCCCeeEEEeCCCchhhhhcccCCCCcCC
Q 005247 216 LFKVLADLINLPCRIAKGCKYCRR-DDASSCLVQIGPDREYLVDLLEDPGVLSK 268 (706)
Q Consensus 216 lfk~lad~~~~~~~lv~g~~~~~~-~~~~~~~~~~~~~~~~~vdl~~~pg~l~~ 268 (706)
|||||||+||||||||||++|||. +++++|+|++++++|||||||++||+|+|
T Consensus 151 LFKvLAD~iglpCrLvrG~~y~g~~~~~a~~~V~~~~~~eyiVDLm~~PG~L~P 204 (204)
T PF14381_consen 151 LFKVLADRIGLPCRLVRGCYYCGWDDDDASNLVKFDDGREYIVDLMGAPGQLIP 204 (204)
T ss_pred HHHHHHHhcCCCceEEeeccCCccCCCCceEEEEcCCCcEEEEEcCCCCCCcCC
Confidence 999999999999999999999999 99999999999999999999999999997
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-48 Score=418.31 Aligned_cols=271 Identities=48% Similarity=0.808 Sum_probs=246.4
Q ss_pred cCcccccCceEEEEEeccCCceEEEEEEEcCCc-eEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCC-
Q 005247 426 EGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD-VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP- 503 (706)
Q Consensus 426 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~-vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~- 503 (706)
....+...++.+.+.||.|+||+||+|.+.++. ||+|++..........+.|.+|+.+|++++|||||+++|++.++.
T Consensus 34 ~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~ 113 (362)
T KOG0192|consen 34 PEEEIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG 113 (362)
T ss_pred cceecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 335667777888888999999999999999999 999999887766666889999999999999999999999999988
Q ss_pred ceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCC-cEEEeecCcc
Q 005247 504 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY-TVKVCDFGLS 582 (706)
Q Consensus 504 ~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~-~vKL~DFGla 582 (706)
.+++||||+++|+|.++++.. ....++...+..|+.+|++||+|||++++ ||||||||+|||++.++ ++||+|||++
T Consensus 114 ~~~iVtEy~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~-iIHrDLK~~NiLv~~~~~~~KI~DFGls 191 (362)
T KOG0192|consen 114 SLCIVTEYMPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP-IIHRDLKSDNILVDLKGKTLKIADFGLS 191 (362)
T ss_pred ceEEEEEeCCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC-eeecccChhhEEEcCCCCEEEECCCccc
Confidence 799999999999999999764 34579999999999999999999999996 89999999999999997 9999999999
Q ss_pred ccCCCCcccCCCCCCCCCccCccccc--cCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCC
Q 005247 583 RSKPNTYISSKTAAGTPEWMAPEVLR--EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNV 660 (706)
Q Consensus 583 ~~~~~~~~~~~~~~Gt~~Y~APE~l~--~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~ 660 (706)
+.............||+.|||||++. ...|+.|+||||||++||||+||+.||....+.++...+.....++.+|..+
T Consensus 192 r~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~ 271 (362)
T KOG0192|consen 192 REKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKEC 271 (362)
T ss_pred eeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccC
Confidence 88766544445578999999999999 6699999999999999999999999999999988888888889999999999
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhccC
Q 005247 661 NPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVC 698 (706)
Q Consensus 661 s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~~~ 698 (706)
++.+..||.+||..||.+||++.+|+..|+.+......
T Consensus 272 ~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 272 PPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred CHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 99999999999999999999999999999998876543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-47 Score=420.53 Aligned_cols=248 Identities=29% Similarity=0.479 Sum_probs=228.1
Q ss_pred CceEEEEEeccCCceEEEEEEEc--CCceEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEE
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFH-EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 509 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKvl~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~ 509 (706)
..|+..+.||+|||+.||.+++. +..||+|++.+.... ....+...+|++|+++|+|||||+++++|++.++.|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 67999999999999999999884 445999999775443 345578899999999999999999999999999999999
Q ss_pred EeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCc
Q 005247 510 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 589 (706)
Q Consensus 510 E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 589 (706)
|+|.+++|..+++ .+..++|.+++.+..||+.||.|||+++ |||||||..|+|++++.+|||+|||+|.....+.
T Consensus 98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~--IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~ 172 (592)
T KOG0575|consen 98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG--IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG 172 (592)
T ss_pred EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC--ceecccchhheeecCcCcEEecccceeeeecCcc
Confidence 9999999999997 3447999999999999999999999999 9999999999999999999999999999988776
Q ss_pred ccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHHH
Q 005247 590 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE 669 (706)
Q Consensus 590 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI~ 669 (706)
....+.||||.|.|||++.....+..+||||+|||||.||+|++||+..+..+.+..|. .....+|..++.+.++||.
T Consensus 173 Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik--~~~Y~~P~~ls~~A~dLI~ 250 (592)
T KOG0575|consen 173 ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIK--LNEYSMPSHLSAEAKDLIR 250 (592)
T ss_pred cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHH--hcCcccccccCHHHHHHHH
Confidence 67789999999999999999999999999999999999999999999999999998884 4556678899999999999
Q ss_pred HhhhhCCCCCCCHHHHHH
Q 005247 670 TCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 670 ~cL~~dP~~RPS~~eIl~ 687 (706)
++|++||.+|||+++|+.
T Consensus 251 ~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 251 KLLRPNPSERPSLDEVLD 268 (592)
T ss_pred HHhcCCcccCCCHHHHhc
Confidence 999999999999999986
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-47 Score=398.14 Aligned_cols=251 Identities=31% Similarity=0.508 Sum_probs=225.5
Q ss_pred cccccCceEEEEEeccCCceEEEEEEEcCCc--eEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCc-
Q 005247 428 LEIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN- 504 (706)
Q Consensus 428 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~--vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~- 504 (706)
..+..++++.++.||+|..|+||++.|+.+. +|+|++ ....++...+++.+|++++++.+|||||.+|++|..++.
T Consensus 74 ~~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I-~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~ 152 (364)
T KOG0581|consen 74 NGISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVI-LLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEE 152 (364)
T ss_pred cccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEee-cccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCce
Confidence 4466678888999999999999999998776 899998 445567778899999999999999999999999999995
Q ss_pred eEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHh-cCCCcccccCCCCcEEECCCCcEEEeecCccc
Q 005247 505 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ-RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 583 (706)
Q Consensus 505 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs-~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~ 583 (706)
.+|+||||++|+|.+++... +.+++.....++.+|++||.|||+ ++ ||||||||+|||++..|.|||||||.+.
T Consensus 153 isI~mEYMDgGSLd~~~k~~---g~i~E~~L~~ia~~VL~GL~YLh~~~~--IIHRDIKPsNlLvNskGeVKicDFGVS~ 227 (364)
T KOG0581|consen 153 ISICMEYMDGGSLDDILKRV---GRIPEPVLGKIARAVLRGLSYLHEERK--IIHRDIKPSNLLVNSKGEVKICDFGVSG 227 (364)
T ss_pred EEeehhhcCCCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhccC--eeeccCCHHHeeeccCCCEEeccccccH
Confidence 99999999999999999744 459999999999999999999996 78 9999999999999999999999999998
Q ss_pred cCCCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC-----ChHHHHHHhhhcCcccCCCC
Q 005247 584 SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNS-----TPSQVISAVGFKGRRLEIPK 658 (706)
Q Consensus 584 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~-----~~~~~~~~i~~~~~~l~~p~ 658 (706)
...+. ...+++||..|||||.+.+..|+.++||||||++++|+++|+.||... ...+...+|. ...++.+|.
T Consensus 228 ~lvnS--~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv-~~ppP~lP~ 304 (364)
T KOG0581|consen 228 ILVNS--IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIV-DEPPPRLPE 304 (364)
T ss_pred Hhhhh--hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHh-cCCCCCCCc
Confidence 87665 457889999999999999999999999999999999999999999774 5556666663 456677787
Q ss_pred C-CcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 659 N-VNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 659 ~-~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
. +++++++||..||++||.+|||++|++.
T Consensus 305 ~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 305 GEFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred ccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 6 9999999999999999999999999987
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-46 Score=388.72 Aligned_cols=253 Identities=26% Similarity=0.431 Sum_probs=226.0
Q ss_pred ccccCceEEEEEeccCCceEEEEEEEcCCc--eEEEEEeccccch-HHHHHHHHHHHHHHcCCCCceeEEeccccCCCce
Q 005247 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNL 505 (706)
Q Consensus 429 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~--vAVKvl~~~~~~~-~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 505 (706)
.+..++|++++.||+|+||+||.++.++++ ||+|++++....+ ...+....|..||.+++||+||+++..|++...+
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL 100 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL 100 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence 455678999999999999999999887665 9999998766544 4677889999999999999999999999999999
Q ss_pred EEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccC
Q 005247 506 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK 585 (706)
Q Consensus 506 ~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~ 585 (706)
|+|+||+.||.|...|+.++ .+++..+.-++.+|+.||.|||++| ||||||||+|||+|..|+++|+|||+++..
T Consensus 101 ylVld~~~GGeLf~hL~~eg---~F~E~~arfYlaEi~lAL~~LH~~g--IiyRDlKPENILLd~~GHi~LtDFgL~k~~ 175 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQREG---RFSEDRARFYLAEIVLALGYLHSKG--IIYRDLKPENILLDEQGHIKLTDFGLCKED 175 (357)
T ss_pred EEEEeccCCccHHHHHHhcC---CcchhHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHeeecCCCcEEEeccccchhc
Confidence 99999999999999997544 5999999999999999999999999 999999999999999999999999999976
Q ss_pred CCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHH
Q 005247 586 PNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 665 (706)
Q Consensus 586 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~ 665 (706)
-.......+++||+.|||||++.+..|+..+|+||||+++|||++|.+||...+.......+.. ......|..++.+.+
T Consensus 176 ~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~-~k~~~~p~~ls~~ar 254 (357)
T KOG0598|consen 176 LKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILK-GKLPLPPGYLSEEAR 254 (357)
T ss_pred ccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhc-CcCCCCCccCCHHHH
Confidence 6555566789999999999999999999999999999999999999999999999888888843 333556666999999
Q ss_pred HHHHHhhhhCCCCCC----CHHHHHH
Q 005247 666 ALIETCWAEEPEIRP----SFPSIME 687 (706)
Q Consensus 666 dLI~~cL~~dP~~RP----S~~eIl~ 687 (706)
+|++++|.+||++|. ++.+|.+
T Consensus 255 dll~~LL~rdp~~RLg~~~d~~~ik~ 280 (357)
T KOG0598|consen 255 DLLKKLLKRDPRQRLGGPGDAEEIKR 280 (357)
T ss_pred HHHHHHhccCHHHhcCCCCChHHhhc
Confidence 999999999999995 4555443
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-47 Score=386.68 Aligned_cols=260 Identities=28% Similarity=0.481 Sum_probs=228.8
Q ss_pred ccCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEec-cccCCCc-eE
Q 005247 431 RWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMG-AVTEPPN-LS 506 (706)
Q Consensus 431 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~-~~~~~~~-~~ 506 (706)
...+|+|.++||+|.||.||++....+ .+|.|.+.....+....+.+..|+.+|++|+|||||++++ .|.+++. ++
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln 96 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN 96 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence 345788999999999999999987644 4899999888888888899999999999999999999999 5655555 89
Q ss_pred EEEEeccCCchhhhccc-CCCcccccHHHHHHHHHHHHHHHHHHHhcCC--CcccccCCCCcEEECCCCcEEEeecCccc
Q 005247 507 IVTEYLSRGSLYKLLHI-PDARVVVDERLRLNMAYDVAKGMNYLHQRRP--PIVHRDLKSPNLLVDSTYTVKVCDFGLSR 583 (706)
Q Consensus 507 lV~E~~~ggsL~~~l~~-~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~--~IIHrDLKp~NILl~~~~~vKL~DFGla~ 583 (706)
||||+|.+|+|..+++. .+.+..++++.+|+++.|++.||..+|++-+ .|+||||||.||+|+.+|.|||+|||+++
T Consensus 97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r 176 (375)
T KOG0591|consen 97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGR 176 (375)
T ss_pred HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHh
Confidence 99999999999999953 3445679999999999999999999999433 49999999999999999999999999999
Q ss_pred cCCCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCC-CCCcH
Q 005247 584 SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP-KNVNP 662 (706)
Q Consensus 584 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p-~~~s~ 662 (706)
..........+.+|||.||+||.+.+.+|+.||||||+||++|||+.-+.||.+.+-.+....|. ++.-.++| ...|.
T Consensus 177 ~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~-qgd~~~~p~~~YS~ 255 (375)
T KOG0591|consen 177 FLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIE-QGDYPPLPDEHYST 255 (375)
T ss_pred HhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHH-cCCCCCCcHHHhhh
Confidence 98887777778899999999999999999999999999999999999999999998888888885 34444566 77899
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 005247 663 MVAALIETCWAEEPEIRPSFPSIMETLQQ 691 (706)
Q Consensus 663 el~dLI~~cL~~dP~~RPS~~eIl~~L~~ 691 (706)
.+.+||..|+..||+.||+...++..++.
T Consensus 256 ~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 256 DLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred HHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 99999999999999999996666555544
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=401.16 Aligned_cols=266 Identities=38% Similarity=0.650 Sum_probs=239.3
Q ss_pred ccCcccccCceEEEEEeccCCceEEEEEEEcCC-ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCC
Q 005247 425 EEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP 503 (706)
Q Consensus 425 ~~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~-~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 503 (706)
...+++..+.+++++.||+|.||.||.|.++++ +||+|.++...... +.|++|+++|++|+|+|||++++++..+.
T Consensus 198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~---~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~ 274 (468)
T KOG0197|consen 198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSP---EAFLREAQIMKKLRHEKLVKLYGVCTKQE 274 (468)
T ss_pred cCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccCh---hHHHHHHHHHHhCcccCeEEEEEEEecCC
Confidence 345677778888899999999999999999987 79999998765443 47889999999999999999999999988
Q ss_pred ceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccc
Q 005247 504 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 583 (706)
Q Consensus 504 ~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~ 583 (706)
.++||||||+.|+|.++|+.. .+..+...+.+.++.||++|++||++++ +|||||...|||++++..+||+|||+|+
T Consensus 275 piyIVtE~m~~GsLl~yLr~~-~~~~l~~~~Ll~~a~qIaeGM~YLes~~--~IHRDLAARNiLV~~~~~vKIsDFGLAr 351 (468)
T KOG0197|consen 275 PIYIVTEYMPKGSLLDYLRTR-EGGLLNLPQLLDFAAQIAEGMAYLESKN--YIHRDLAARNILVDEDLVVKISDFGLAR 351 (468)
T ss_pred ceEEEEEecccCcHHHHhhhc-CCCccchHHHHHHHHHHHHHHHHHHhCC--ccchhhhhhheeeccCceEEEccccccc
Confidence 999999999999999999862 3446888999999999999999999999 9999999999999999999999999999
Q ss_pred cCCCCcc-cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCCCCCc
Q 005247 584 SKPNTYI-SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVN 661 (706)
Q Consensus 584 ~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s 661 (706)
...+... ......-+..|.|||.+....++.|||||||||+||||+| |+.||.+.+..+++..+. .+.|++-|..||
T Consensus 352 ~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le-~GyRlp~P~~CP 430 (468)
T KOG0197|consen 352 LIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLE-RGYRLPRPEGCP 430 (468)
T ss_pred ccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHh-ccCcCCCCCCCC
Confidence 7655543 3334455778999999999999999999999999999998 899999999999998884 889999999999
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhcc
Q 005247 662 PMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSV 697 (706)
Q Consensus 662 ~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~~ 697 (706)
++++++|..||..+|++||||+.+...|+.+.....
T Consensus 431 ~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~~ 466 (468)
T KOG0197|consen 431 DEVYELMKSCWHEDPEDRPTFETLREVLEDFFTSTE 466 (468)
T ss_pred HHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhccc
Confidence 999999999999999999999999999999887654
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-45 Score=386.69 Aligned_cols=248 Identities=28% Similarity=0.518 Sum_probs=222.5
Q ss_pred cCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEE
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 509 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~ 509 (706)
..+|.+.+.||.|+||+||+|+++.+ .||||.+.+.....+..+.+..|+.+|+.++|||||.+++++..++.+|+||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 46899999999999999999998755 4999999888777888888999999999999999999999999999999999
Q ss_pred EeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCC------CcEEEeecCccc
Q 005247 510 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST------YTVKVCDFGLSR 583 (706)
Q Consensus 510 E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~------~~vKL~DFGla~ 583 (706)
|||.||+|.+|++..+ .+++..++.++.||+.||++||+++ ||||||||+||||+.. -.+||+|||+|+
T Consensus 89 EyC~gGDLs~yi~~~~---~l~e~t~r~Fm~QLA~alq~L~~~~--IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRG---RLPEATARHFMQQLASALQFLHENN--IIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred EeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 9999999999998544 6999999999999999999999999 9999999999999764 468999999999
Q ss_pred cCCCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccC-CCCCCcH
Q 005247 584 SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLE-IPKNVNP 662 (706)
Q Consensus 584 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~-~p~~~s~ 662 (706)
...... ...+.+|++.|||||++...+|+.|+|+||+|+|||+|++|+.||...+..+....+.......+ ++..++.
T Consensus 164 ~L~~~~-~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~ 242 (429)
T KOG0595|consen 164 FLQPGS-MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSN 242 (429)
T ss_pred hCCchh-HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccC
Confidence 887654 44688999999999999999999999999999999999999999999999999988876655544 4445677
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHH
Q 005247 663 MVAALIETCWAEEPEIRPSFPSI 685 (706)
Q Consensus 663 el~dLI~~cL~~dP~~RPS~~eI 685 (706)
...+|+...++.+|.+|-++.+-
T Consensus 243 ~~~~Ll~~ll~~~~~~~~~~~~~ 265 (429)
T KOG0595|consen 243 PLRELLISLLQRNPKDRISFEDF 265 (429)
T ss_pred chhhhhhHHHhcCccccCchHHh
Confidence 88899999999999999776654
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-45 Score=386.64 Aligned_cols=251 Identities=27% Similarity=0.410 Sum_probs=212.5
Q ss_pred ccCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccch-----HHHHHHHHHHHHHHcCCCCceeEEeccccCCC
Q 005247 431 RWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHE-----DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP 503 (706)
Q Consensus 431 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~-----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 503 (706)
..+.|.+.+.||+|+||.|-+|..+.+ .||||++.+..... .......+|++||++|+|||||+++++|..++
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 456788999999999999999987655 49999997765433 12233579999999999999999999999999
Q ss_pred ceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCC---CcEEEeecC
Q 005247 504 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST---YTVKVCDFG 580 (706)
Q Consensus 504 ~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~---~~vKL~DFG 580 (706)
..||||||++||.|.+.+-.+ ..+.+..-..+++|++.|+.|||++| |+||||||+|||+..+ -.+||+|||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~n---k~l~ed~~K~~f~Qll~avkYLH~~G--I~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVAN---KYLREDLGKLLFKQLLTAVKYLHSQG--IIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred ceEEEEEEecCccHHHHHHhc---cccccchhHHHHHHHHHHHHHHHHcC--cccccCCcceEEeccCCcceEEEecccc
Confidence 999999999999999998633 35788888999999999999999999 9999999999999766 679999999
Q ss_pred ccccCCCCcccCCCCCCCCCccCccccccCCC---CchhHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHhhhcCccc--
Q 005247 581 LSRSKPNTYISSKTAAGTPEWMAPEVLREDPS---NEKSDVFSFGVILWELITLQKPWRNSTPSQ-VISAVGFKGRRL-- 654 (706)
Q Consensus 581 la~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~---s~ksDVwSLGviL~ELltG~~Pf~~~~~~~-~~~~i~~~~~~l-- 654 (706)
+|...+.. ....+.|||+.|.|||++.+... ..++|+||+||+||-+++|.+||....... ...++..+....
T Consensus 325 lAK~~g~~-sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p 403 (475)
T KOG0615|consen 325 LAKVSGEG-SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGP 403 (475)
T ss_pred hhhccccc-eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccC
Confidence 99988754 35678999999999999987653 458999999999999999999997765544 555564333322
Q ss_pred CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 655 EIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 655 ~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
..+..++.+..+||.+||..||++|||+.|+++
T Consensus 404 ~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 404 LQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred hhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 234568999999999999999999999999986
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=386.60 Aligned_cols=267 Identities=38% Similarity=0.661 Sum_probs=236.6
Q ss_pred cccCcccccCceEEEEEeccCCceEEEEEEEcCCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCC
Q 005247 424 EEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP 503 (706)
Q Consensus 424 ~~~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 503 (706)
..+.++|..+++.+.+.||+|.||+||+|++.| +||||++.......+.++.|++|+.++++-+|.||+-++|+++.+.
T Consensus 383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~ 461 (678)
T KOG0193|consen 383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP 461 (678)
T ss_pred cccccccCHHHhhccceeccccccceeeccccc-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence 447789999999999999999999999999887 6999999999999999999999999999999999999999999988
Q ss_pred ceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccc
Q 005247 504 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 583 (706)
Q Consensus 504 ~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~ 583 (706)
. .||+.+|+|.+|+.+++... ..++....+.|++||+.|+.|||.++ |||||||..||++.+++.|||+|||++.
T Consensus 462 ~-AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK~--IIHrDLKSnNIFl~~~~kVkIgDFGLat 536 (678)
T KOG0193|consen 462 L-AIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAKN--IIHRDLKSNNIFLHEDLKVKIGDFGLAT 536 (678)
T ss_pred e-eeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhhh--hhhhhccccceEEccCCcEEEeccccee
Confidence 7 99999999999999998655 45889999999999999999999999 9999999999999999999999999997
Q ss_pred cCCCC--cccCCCCCCCCCccCcccccc---CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhc---CcccC
Q 005247 584 SKPNT--YISSKTAAGTPEWMAPEVLRE---DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK---GRRLE 655 (706)
Q Consensus 584 ~~~~~--~~~~~~~~Gt~~Y~APE~l~~---~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~---~~~l~ 655 (706)
....- ........|...|||||+++. .+|++.+||||||+++|||++|..||...+.++++.++..+ .....
T Consensus 537 vk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~ 616 (678)
T KOG0193|consen 537 VKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSK 616 (678)
T ss_pred eeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchh
Confidence 64322 222334568889999999974 46899999999999999999999999977777777666544 22344
Q ss_pred CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhc
Q 005247 656 IPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 696 (706)
Q Consensus 656 ~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~ 696 (706)
...+++.++++|+..||..++++||.+.+|+..|+.++.+.
T Consensus 617 ~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~ 657 (678)
T KOG0193|consen 617 IRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSL 657 (678)
T ss_pred hhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcc
Confidence 55688899999999999999999999999999999999864
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=378.38 Aligned_cols=251 Identities=31% Similarity=0.519 Sum_probs=222.4
Q ss_pred ccccCceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccc---hHHHHHHHHHHHHHHcCC-CCceeEEeccccCC
Q 005247 429 EIRWSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFH---EDRFKEFLREVAIMKGLR-HPNIVLLMGAVTEP 502 (706)
Q Consensus 429 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~---~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~ 502 (706)
....+.|.+++.||+|+||+|++|.+.. ..||+|++.+.... ....+.+.+|+.+++.++ ||||+++++++...
T Consensus 13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~ 92 (370)
T KOG0583|consen 13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP 92 (370)
T ss_pred ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC
Confidence 3456789999999999999999998764 45999977664221 233456778999999999 99999999999999
Q ss_pred CceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCC-CcEEEeecCc
Q 005247 503 PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST-YTVKVCDFGL 581 (706)
Q Consensus 503 ~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~-~~vKL~DFGl 581 (706)
..+++||||+.||.|.+++.. ...+.+..+..++.|++.|++|||++| |+||||||+|||++.+ +++||+|||+
T Consensus 93 ~~~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g--i~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 93 TKIYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG--IVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred CeEEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEecCCCCCEEEecccc
Confidence 999999999999999999975 346889999999999999999999999 9999999999999999 9999999999
Q ss_pred cccCCCCcccCCCCCCCCCccCccccccCC-CC-chhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCC
Q 005247 582 SRSKPNTYISSKTAAGTPEWMAPEVLREDP-SN-EKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKN 659 (706)
Q Consensus 582 a~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~-~s-~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~ 659 (706)
+...........+.+||+.|+|||++.+.. |+ .++||||+|++||.|++|+.||...+.......+ ......+|..
T Consensus 168 s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki--~~~~~~~p~~ 245 (370)
T KOG0583|consen 168 SAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKI--RKGEFKIPSY 245 (370)
T ss_pred ccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHH--hcCCccCCCC
Confidence 998743344567899999999999999977 75 7899999999999999999999998877777765 5667888898
Q ss_pred C-cHHHHHHHHHhhhhCCCCCCCHHHHH
Q 005247 660 V-NPMVAALIETCWAEEPEIRPSFPSIM 686 (706)
Q Consensus 660 ~-s~el~dLI~~cL~~dP~~RPS~~eIl 686 (706)
+ ++++++||.+||..||.+|+++.+|+
T Consensus 246 ~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 246 LLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred cCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 8 99999999999999999999999998
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=380.55 Aligned_cols=251 Identities=28% Similarity=0.453 Sum_probs=223.4
Q ss_pred ccCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccc-hHHHHHHHHHHHHHHcC-CCCceeEEeccccCCCceE
Q 005247 431 RWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFH-EDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLS 506 (706)
Q Consensus 431 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~-~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~ 506 (706)
...+|.+++.||+|+|++|++|+.+.+ .||||++.+.... +...+.+.+|-++|.+| .||.|++|+..|+++..+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 346899999999999999999987655 4999998665443 33456677899999999 7999999999999999999
Q ss_pred EEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCC
Q 005247 507 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP 586 (706)
Q Consensus 507 lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~ 586 (706)
+|+||+++|+|.++++.- +.+++..++.++.+|+.||+|||++| ||||||||+|||++++|++||+|||.|....
T Consensus 151 FvLe~A~nGdll~~i~K~---Gsfde~caR~YAAeIldAleylH~~G--IIHRDlKPENILLd~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKY---GSFDETCARFYAAEILDALEYLHSNG--IIHRDLKPENILLDKDGHIKITDFGSAKILS 225 (604)
T ss_pred EEEEecCCCcHHHHHHHh---CcchHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeEcCCCcEEEeeccccccCC
Confidence 999999999999999744 46999999999999999999999999 9999999999999999999999999997644
Q ss_pred CCc-----------ccC--CCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcc
Q 005247 587 NTY-----------ISS--KTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR 653 (706)
Q Consensus 587 ~~~-----------~~~--~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~ 653 (706)
... ... .+++||..|.+||++.....+..+|+|+||||||+|+.|.+||...++.-.+..| ....
T Consensus 226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI--~~l~ 303 (604)
T KOG0592|consen 226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKI--QALD 303 (604)
T ss_pred hhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHH--HHhc
Confidence 211 112 5588999999999999999999999999999999999999999999988888877 4567
Q ss_pred cCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 005247 654 LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMET 688 (706)
Q Consensus 654 l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~ 688 (706)
..+|++.++.+.+||.+.|..||.+|++..||.+.
T Consensus 304 y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 304 YEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred ccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 78999999999999999999999999999999873
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=369.45 Aligned_cols=265 Identities=31% Similarity=0.584 Sum_probs=218.1
Q ss_pred cccccCceEEEEEeccCCceEEEEEEEc-------CCceEEEEEeccccchHHHHHHHHHHHHHHcC-CCCceeEEeccc
Q 005247 428 LEIRWSELLIKKKIGEGSFGTVYHAEWR-------NSDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAV 499 (706)
Q Consensus 428 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~-------~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~ 499 (706)
+++..++|++.+.||+|+||.||+|.+. +..||+|++.... .....+.+.+|+.+++.+ +||||+++++++
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (338)
T cd05102 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGAC 80 (338)
T ss_pred cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence 4566788999999999999999999752 2349999986432 334456789999999999 899999999987
Q ss_pred cCCC-ceEEEEEeccCCchhhhcccCCC----------------------------------------------------
Q 005247 500 TEPP-NLSIVTEYLSRGSLYKLLHIPDA---------------------------------------------------- 526 (706)
Q Consensus 500 ~~~~-~~~lV~E~~~ggsL~~~l~~~~~---------------------------------------------------- 526 (706)
...+ .++++|||+++|+|.+++.....
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 81 TKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred cCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 7644 58899999999999998863211
Q ss_pred -------cccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCC--cccCCCCCC
Q 005247 527 -------RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT--YISSKTAAG 597 (706)
Q Consensus 527 -------~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~--~~~~~~~~G 597 (706)
...+.+..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..... ........+
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~ 238 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCC
Confidence 124677888999999999999999999 999999999999999999999999999764322 112223456
Q ss_pred CCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHHHHhhhhCC
Q 005247 598 TPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEP 676 (706)
Q Consensus 598 t~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI~~cL~~dP 676 (706)
+..|+|||++.+..++.++||||||+++|||++ |..||......+........+.....+..+++.+.+||.+||+.||
T Consensus 239 ~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 318 (338)
T cd05102 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDP 318 (338)
T ss_pred CccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCCh
Confidence 778999999999999999999999999999997 9999987654444333333455566778899999999999999999
Q ss_pred CCCCCHHHHHHHHHHHHHh
Q 005247 677 EIRPSFPSIMETLQQFLMS 695 (706)
Q Consensus 677 ~~RPS~~eIl~~L~~ll~s 695 (706)
++|||+.+|++.|+.++..
T Consensus 319 ~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 319 KERPTFSALVEILGDLLQE 337 (338)
T ss_pred hhCcCHHHHHHHHHHHHhc
Confidence 9999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=354.64 Aligned_cols=240 Identities=27% Similarity=0.460 Sum_probs=220.8
Q ss_pred cccCceEEEEEeccCCceEEEEEEEcCCc--eEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceE
Q 005247 430 IRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFH-EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS 506 (706)
Q Consensus 430 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~--vAVKvl~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 506 (706)
...++|++++.||.|+||+|.+++.+.++ +|+|++.++... ..+.+...+|..+|+.+.||+++++++.+.+.+.++
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 55678999999999999999999887554 999999776543 456678889999999999999999999999999999
Q ss_pred EEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCC
Q 005247 507 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP 586 (706)
Q Consensus 507 lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~ 586 (706)
|||||.+||.|..+++..+ .+++..++.++.||+.||+|||+++ |++|||||+|||||.+|.+||+|||+|....
T Consensus 121 mvmeyv~GGElFS~Lrk~~---rF~e~~arFYAAeivlAleylH~~~--iiYRDLKPENiLlD~~G~iKitDFGFAK~v~ 195 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSG---RFSEPHARFYAAEIVLALEYLHSLD--IIYRDLKPENLLLDQNGHIKITDFGFAKRVS 195 (355)
T ss_pred EEEeccCCccHHHHHHhcC---CCCchhHHHHHHHHHHHHHHHHhcC--eeeccCChHHeeeccCCcEEEEeccceEEec
Confidence 9999999999999998543 6999999999999999999999999 9999999999999999999999999998876
Q ss_pred CCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHH
Q 005247 587 NTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA 666 (706)
Q Consensus 587 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~d 666 (706)
.. .-+.||||.|+|||++.+.++..++|+|+|||++|||+.|.+||...++..++.+| ......+|...++++++
T Consensus 196 ~r---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI--~~~~v~fP~~fs~~~kd 270 (355)
T KOG0616|consen 196 GR---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKI--LEGKVKFPSYFSSDAKD 270 (355)
T ss_pred Cc---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHH--HhCcccCCcccCHHHHH
Confidence 54 35789999999999999999999999999999999999999999999998888887 45678899999999999
Q ss_pred HHHHhhhhCCCCC
Q 005247 667 LIETCWAEEPEIR 679 (706)
Q Consensus 667 LI~~cL~~dP~~R 679 (706)
||+++|+.|-.+|
T Consensus 271 Ll~~LL~vD~t~R 283 (355)
T KOG0616|consen 271 LLKKLLQVDLTKR 283 (355)
T ss_pred HHHHHHhhhhHhh
Confidence 9999999999999
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=357.51 Aligned_cols=250 Identities=27% Similarity=0.443 Sum_probs=216.0
Q ss_pred CceEEEEEeccCCceEEEEEEEcCCc--eEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEE
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 510 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~~~--vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E 510 (706)
+.|+.+.++|+|+||.||++++++++ ||||++..++.++..-+-.++|+.+|++|+|+|+|.++++|.....+++|||
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 46888999999999999999998877 9999998888777777889999999999999999999999999999999999
Q ss_pred eccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcc
Q 005247 511 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 590 (706)
Q Consensus 511 ~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~ 590 (706)
||+..-|.++-+... -++...+.+++.|++.|+.|+|+++ +|||||||+||||+.+|.+||||||+|+....+..
T Consensus 82 ~~dhTvL~eLe~~p~---G~~~~~vk~~l~Q~l~ai~~cHk~n--~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd 156 (396)
T KOG0593|consen 82 YCDHTVLHELERYPN---GVPSELVKKYLYQLLKAIHFCHKNN--CIHRDIKPENILITQNGVVKLCDFGFARTLSAPGD 156 (396)
T ss_pred ecchHHHHHHHhccC---CCCHHHHHHHHHHHHHHhhhhhhcC--eecccCChhheEEecCCcEEeccchhhHhhcCCcc
Confidence 998855555544332 3789999999999999999999999 99999999999999999999999999998775555
Q ss_pred cCCCCCCCCCccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhc-------------------
Q 005247 591 SSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK------------------- 650 (706)
Q Consensus 591 ~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~------------------- 650 (706)
..+.++.|.+|+|||.+.+ .+|...+||||+||++.||++|.+.|.+.++-+....|...
T Consensus 157 ~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~ 236 (396)
T KOG0593|consen 157 NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFH 236 (396)
T ss_pred hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCcee
Confidence 5677889999999999988 78999999999999999999999999988776665544311
Q ss_pred CcccCCC----------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 651 GRRLEIP----------KNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 651 ~~~l~~p----------~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
+.+++-| ++++..+.+|+..||..||.+|++.+|++.
T Consensus 237 Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 237 GVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred eeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 1222222 244567899999999999999999999875
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=378.16 Aligned_cols=248 Identities=30% Similarity=0.527 Sum_probs=223.9
Q ss_pred cCceEEEEEeccCCceEEEEEEEcCCc--eEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEE
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 509 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~--vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~ 509 (706)
...|....+||+|+.|.||.|....+. ||||.+........ +-+++|+.+|+..+|+|||++++.+...+.+|+||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~k--eLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVM 349 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKK--ELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVM 349 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCch--hhhHHHHHHHHhccchHHHHHHHHhcccceeEEEE
Confidence 356778899999999999999876544 89998876654433 47889999999999999999999999889999999
Q ss_pred EeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCc
Q 005247 510 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 589 (706)
Q Consensus 510 E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 589 (706)
||++||+|.+.+.. ..++|.+++.|+++++.||+|||.+| |||||||.+|||++.+|.+||+|||++.......
T Consensus 350 Eym~ggsLTDvVt~----~~~~E~qIA~Icre~l~aL~fLH~~g--IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~ 423 (550)
T KOG0578|consen 350 EYMEGGSLTDVVTK----TRMTEGQIAAICREILQGLKFLHARG--IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ 423 (550)
T ss_pred eecCCCchhhhhhc----ccccHHHHHHHHHHHHHHHHHHHhcc--eeeeccccceeEeccCCcEEEeeeeeeecccccc
Confidence 99999999999853 24899999999999999999999999 9999999999999999999999999999877766
Q ss_pred ccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCc-ccCCCCCCcHHHHHHH
Q 005247 590 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR-RLEIPKNVNPMVAALI 668 (706)
Q Consensus 590 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~-~l~~p~~~s~el~dLI 668 (706)
..+.+.+|||+|||||++....|..|+||||||++++||+-|++||-..++......+...+. .+..++.+|+++++|+
T Consensus 424 ~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL 503 (550)
T KOG0578|consen 424 SKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFL 503 (550)
T ss_pred CccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHH
Confidence 677899999999999999999999999999999999999999999998888888877764443 5677889999999999
Q ss_pred HHhhhhCCCCCCCHHHHHH
Q 005247 669 ETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 669 ~~cL~~dP~~RPS~~eIl~ 687 (706)
.+||+.||++|+++.|+|+
T Consensus 504 ~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 504 DRCLVVDVEQRASAKELLE 522 (550)
T ss_pred HHHhhcchhcCCCHHHHhc
Confidence 9999999999999999987
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=393.66 Aligned_cols=269 Identities=36% Similarity=0.585 Sum_probs=235.6
Q ss_pred cCcccccCceEEEEEeccCCceEEEEEEEcCC-------ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEecc
Q 005247 426 EGLEIRWSELLIKKKIGEGSFGTVYHAEWRNS-------DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA 498 (706)
Q Consensus 426 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~-------~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~ 498 (706)
...++...+.+..+.||+|+||+||+|+..+- -||||.++... +....++|.+|++++..++|||||+++|+
T Consensus 479 ~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a-~~~~~~dF~REaeLla~l~H~nIVrLlGV 557 (774)
T KOG1026|consen 479 KVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA-ENQARQDFRREAELLAELQHPNIVRLLGV 557 (774)
T ss_pred ceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc-cHHHHHHHHHHHHHHHhccCCCeEEEEEE
Confidence 33567788899999999999999999976421 29999987654 44467899999999999999999999999
Q ss_pred ccCCCceEEEEEeccCCchhhhcccCC--C---------cccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEE
Q 005247 499 VTEPPNLSIVTEYLSRGSLYKLLHIPD--A---------RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLL 567 (706)
Q Consensus 499 ~~~~~~~~lV~E~~~ggsL~~~l~~~~--~---------~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NIL 567 (706)
|.+++.++||||||..|+|.++|.... . ...+...+.+.||.||+.|++||-++. +|||||-..|+|
T Consensus 558 C~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~--FVHRDLATRNCL 635 (774)
T KOG1026|consen 558 CREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH--FVHRDLATRNCL 635 (774)
T ss_pred EccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc--ccccchhhhhce
Confidence 999999999999999999999995321 1 234788899999999999999999999 999999999999
Q ss_pred ECCCCcEEEeecCccccCCCCccc-CC-CCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 005247 568 VDSTYTVKVCDFGLSRSKPNTYIS-SK-TAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVI 644 (706)
Q Consensus 568 l~~~~~vKL~DFGla~~~~~~~~~-~~-~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~ 644 (706)
|+++..|||+|||+++........ .. ...-..+|||||.|..++|+++||||||||+|||+++ |..||.+...++++
T Consensus 636 Vge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVI 715 (774)
T KOG1026|consen 636 VGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVI 715 (774)
T ss_pred eccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHH
Confidence 999999999999999976543222 11 3345779999999999999999999999999999998 89999999999999
Q ss_pred HHhhhcCcccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhccC
Q 005247 645 SAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVC 698 (706)
Q Consensus 645 ~~i~~~~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~~~ 698 (706)
..+. .+.-++.|++||.++++||..||+.+|.+||+|.||...|+.+......
T Consensus 716 e~i~-~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~~ 768 (774)
T KOG1026|consen 716 ECIR-AGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASPK 768 (774)
T ss_pred HHHH-cCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCcc
Confidence 9986 4555999999999999999999999999999999999999999887654
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=373.31 Aligned_cols=255 Identities=26% Similarity=0.429 Sum_probs=222.2
Q ss_pred CcccccCceEEEEEeccCCceEEEEEEEcCCc--eEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCceeEEeccccCCC
Q 005247 427 GLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFH-EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP 503 (706)
Q Consensus 427 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~--vAVKvl~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 503 (706)
...+..++|++++.||+|+||.||+|+-+.++ +|+|+++++... ..+.+.++.|-.+|....+|.||+++..|++..
T Consensus 135 R~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~ 214 (550)
T KOG0605|consen 135 RTRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKE 214 (550)
T ss_pred cccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCC
Confidence 34567789999999999999999999877665 999999887654 466788999999999999999999999999999
Q ss_pred ceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccc
Q 005247 504 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 583 (706)
Q Consensus 504 ~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~ 583 (706)
++|+||||++||++..+|...+ .+++..+..++.+++.|++.||+.| +|||||||+|+|||..|++||+|||++.
T Consensus 215 ~LYLiMEylPGGD~mTLL~~~~---~L~e~~arfYiaE~vlAI~~iH~~g--yIHRDIKPdNlLiD~~GHiKLSDFGLs~ 289 (550)
T KOG0605|consen 215 YLYLIMEYLPGGDMMTLLMRKD---TLTEDWARFYIAETVLAIESIHQLG--YIHRDIKPDNLLIDAKGHIKLSDFGLST 289 (550)
T ss_pred eeEEEEEecCCccHHHHHHhcC---cCchHHHHHHHHHHHHHHHHHHHcC--cccccCChhheeecCCCCEeeccccccc
Confidence 9999999999999999997444 6999999999999999999999999 9999999999999999999999999985
Q ss_pred cCCC-----------------------Cccc------------------------CCCCCCCCCccCccccccCCCCchh
Q 005247 584 SKPN-----------------------TYIS------------------------SKTAAGTPEWMAPEVLREDPSNEKS 616 (706)
Q Consensus 584 ~~~~-----------------------~~~~------------------------~~~~~Gt~~Y~APE~l~~~~~s~ks 616 (706)
-... .... ....+|||.|||||++.+..|+..+
T Consensus 290 gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~c 369 (550)
T KOG0605|consen 290 GLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKEC 369 (550)
T ss_pred hhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccc
Confidence 2110 0000 0113599999999999999999999
Q ss_pred HHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCC--CCcHHHHHHHHHhhhhCCCCCCC---HHHHHH
Q 005247 617 DVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPK--NVNPMVAALIETCWAEEPEIRPS---FPSIME 687 (706)
Q Consensus 617 DVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~--~~s~el~dLI~~cL~~dP~~RPS---~~eIl~ 687 (706)
|+||||||+||||.|.+||...++.+....+......+.+|. .++++..+||.+||+ ||++|.. ++||.+
T Consensus 370 DwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~ 444 (550)
T KOG0605|consen 370 DWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKK 444 (550)
T ss_pred cHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhc
Confidence 999999999999999999999999999998876666677775 467999999999999 9999964 666543
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=364.95 Aligned_cols=251 Identities=31% Similarity=0.528 Sum_probs=213.2
Q ss_pred CceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCC--ceEEE
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP--NLSIV 508 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~--~~~lV 508 (706)
.++...+.||+|+||.||++.+.. ...|||....... ...+.+.+|+.+|++++|||||++++...... .+++.
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~--~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~ 94 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDS--PTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF 94 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccc--hhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence 457788999999999999999875 5599999866522 22677899999999999999999999744333 69999
Q ss_pred EEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECC-CCcEEEeecCccccCCC
Q 005247 509 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS-TYTVKVCDFGLSRSKPN 587 (706)
Q Consensus 509 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~-~~~vKL~DFGla~~~~~ 587 (706)
|||+++|+|.+++...+. .+++..+..+..||++||+|||++| ||||||||+|||++. ++.+||+|||++.....
T Consensus 95 mEy~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g--~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 95 MEYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG--IVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred eeccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC--EeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 999999999999975543 5999999999999999999999999 999999999999999 79999999999887553
Q ss_pred ---CcccCCCCCCCCCccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCC-CChHHHHHHhhhcCcccCCCCCCcH
Q 005247 588 ---TYISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRN-STPSQVISAVGFKGRRLEIPKNVNP 662 (706)
Q Consensus 588 ---~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSLGviL~ELltG~~Pf~~-~~~~~~~~~i~~~~~~l~~p~~~s~ 662 (706)
.........||+.|||||++..+ ....++|||||||++.||+||..||.. ....+....+......+.+|..++.
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~ 250 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSD 250 (313)
T ss_pred ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCH
Confidence 11223467899999999999963 334599999999999999999999988 4555555555555555689999999
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 005247 663 MVAALIETCWAEEPEIRPSFPSIMETL 689 (706)
Q Consensus 663 el~dLI~~cL~~dP~~RPS~~eIl~~L 689 (706)
+.++||.+|+..||++||||+++++..
T Consensus 251 ~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 251 EAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred HHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 999999999999999999999998743
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=376.34 Aligned_cols=247 Identities=28% Similarity=0.469 Sum_probs=222.0
Q ss_pred cccccCceEEEEEeccCCceEEEEEEEcCCc--eEEEEEecccc-chHHHHHHHHHHHHHHcCC-CCceeEEeccccCCC
Q 005247 428 LEIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEF-HEDRFKEFLREVAIMKGLR-HPNIVLLMGAVTEPP 503 (706)
Q Consensus 428 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~--vAVKvl~~~~~-~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~ 503 (706)
..+...+|.++++||+|.||+|++++.++++ +|||++++... ..+..+....|..|+.... ||.+++++.+|+..+
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE 442 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence 3466789999999999999999999998766 99999988754 3455677888888888775 999999999999999
Q ss_pred ceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccc
Q 005247 504 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 583 (706)
Q Consensus 504 ~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~ 583 (706)
++++||||+.||++....+ ...+++..+..++..|+.||.|||++| ||+||||.+|||+|.+|++||+|||+++
T Consensus 443 ~l~fvmey~~Ggdm~~~~~----~~~F~e~rarfyaAev~l~L~fLH~~~--IIYRDlKLdNiLLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDLMHHIH----TDVFSEPRARFYAAEVVLGLQFLHENG--IIYRDLKLDNLLLDTEGHVKIADFGLCK 516 (694)
T ss_pred eEEEEEEecCCCcEEEEEe----cccccHHHHHHHHHHHHHHHHHHHhcC--ceeeecchhheEEcccCcEEeccccccc
Confidence 9999999999999554443 235999999999999999999999999 9999999999999999999999999999
Q ss_pred cCCCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHH
Q 005247 584 SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPM 663 (706)
Q Consensus 584 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~e 663 (706)
..........+++|||.|||||++.+..|+..+|+|||||+|||||.|+.||.+.+.++++..|. .....+|..++.+
T Consensus 517 e~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~--~d~~~yP~~ls~e 594 (694)
T KOG0694|consen 517 EGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIV--NDEVRYPRFLSKE 594 (694)
T ss_pred ccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh--cCCCCCCCcccHH
Confidence 87655556789999999999999999999999999999999999999999999999999999984 4456678899999
Q ss_pred HHHHHHHhhhhCCCCCCCH
Q 005247 664 VAALIETCWAEEPEIRPSF 682 (706)
Q Consensus 664 l~dLI~~cL~~dP~~RPS~ 682 (706)
..+||+++|.+||++|..+
T Consensus 595 a~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 595 AIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HHHHHHHHhccCcccccCC
Confidence 9999999999999999754
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=377.25 Aligned_cols=248 Identities=29% Similarity=0.478 Sum_probs=225.8
Q ss_pred CceEEEEEeccCCceEEEEEEEcCCc--eEEEEEecc-ccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEE
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQ-EFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 509 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~~~--vAVKvl~~~-~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~ 509 (706)
+-|++++.||+|+-|.|-+|++..++ +|||++.+. .........+.+|+-||+.+.||||+++|++|++..++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 56889999999999999999987554 999999765 555666678899999999999999999999999999999999
Q ss_pred EeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCc
Q 005247 510 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 589 (706)
Q Consensus 510 E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 589 (706)
||+++|-|.+++-.. +.+++.+++.++.||+.|+.|+|..+ |+||||||+|+|++..+++||+|||.|.....+.
T Consensus 92 Eyv~gGELFdylv~k---G~l~e~eaa~ff~QIi~gv~yCH~~~--icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk 166 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRK---GPLPEREAAHFFRQILDGVSYCHAFN--ICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK 166 (786)
T ss_pred EecCCchhHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHhhhc--ceeccCCchhhhhhcccCEeeeccceeecccCCc
Confidence 999999999999744 36999999999999999999999999 9999999999999999999999999998765543
Q ss_pred ccCCCCCCCCCccCccccccCCC-CchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHH
Q 005247 590 ISSKTAAGTPEWMAPEVLREDPS-NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI 668 (706)
Q Consensus 590 ~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI 668 (706)
...+.||++.|.|||++.+.+| ..++||||.|||||.||||+.||...+-...+.++ +...+++|.++++++++||
T Consensus 167 -lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV--~~G~f~MPs~Is~eaQdLL 243 (786)
T KOG0588|consen 167 -LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKV--QRGVFEMPSNISSEAQDLL 243 (786)
T ss_pred -cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHH--HcCcccCCCcCCHHHHHHH
Confidence 3468899999999999999988 57999999999999999999999999888888777 5667889999999999999
Q ss_pred HHhhhhCCCCCCCHHHHHHH
Q 005247 669 ETCWAEEPEIRPSFPSIMET 688 (706)
Q Consensus 669 ~~cL~~dP~~RPS~~eIl~~ 688 (706)
++||..||++|.|.++|++.
T Consensus 244 r~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 244 RRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred HHHhccCccccccHHHHhhC
Confidence 99999999999999999874
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=351.57 Aligned_cols=247 Identities=22% Similarity=0.378 Sum_probs=215.2
Q ss_pred EEeccCCceEEEEEEEcCCceEEEEEeccccch-HHHHHHHHHHHHHHcCCCCceeEEeccccC----CCceEEEEEecc
Q 005247 439 KKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVLLMGAVTE----PPNLSIVTEYLS 513 (706)
Q Consensus 439 ~~LG~G~fG~Vy~a~~~~~~vAVKvl~~~~~~~-~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~----~~~~~lV~E~~~ 513 (706)
..||+|++|.||+|...+..||+|++....... ...+.+.+|+.+|++++||||+++++++.+ ...+++||||++
T Consensus 26 ~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~ 105 (283)
T PHA02988 26 VLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCT 105 (283)
T ss_pred eEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCC
Confidence 578999999999999999899999986653332 335778899999999999999999998866 356899999999
Q ss_pred CCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhc-CCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcccC
Q 005247 514 RGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR-RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISS 592 (706)
Q Consensus 514 ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~-g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~ 592 (706)
+|+|.+++... ..+++.....++.+++.||.|||+. + ++||||||+|||+++++.+||+|||+++......
T Consensus 106 ~g~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~--~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--- 177 (283)
T PHA02988 106 RGYLREVLDKE---KDLSFKTKLDMAIDCCKGLYNLYKYTN--KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--- 177 (283)
T ss_pred CCcHHHHHhhC---CCCChhHHHHHHHHHHHHHHHHHhcCC--CCCCcCChhhEEECCCCcEEEcccchHhhhcccc---
Confidence 99999999743 2578889999999999999999984 7 8999999999999999999999999987654321
Q ss_pred CCCCCCCCccCcccccc--CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHHHH
Q 005247 593 KTAAGTPEWMAPEVLRE--DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIET 670 (706)
Q Consensus 593 ~~~~Gt~~Y~APE~l~~--~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI~~ 670 (706)
....|+..|+|||++.+ ..++.++|||||||++|||++|..||...+..+....+.....++.++..+++++++||.+
T Consensus 178 ~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~ 257 (283)
T PHA02988 178 FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEA 257 (283)
T ss_pred ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHH
Confidence 24568899999999976 6789999999999999999999999999888777777655566777777899999999999
Q ss_pred hhhhCCCCCCCHHHHHHHHHHHH
Q 005247 671 CWAEEPEIRPSFPSIMETLQQFL 693 (706)
Q Consensus 671 cL~~dP~~RPS~~eIl~~L~~ll 693 (706)
||+.||++|||+.++++.|+++.
T Consensus 258 cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 258 CTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred HhcCCcccCcCHHHHHHHHHHHH
Confidence 99999999999999999999874
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-42 Score=370.37 Aligned_cols=247 Identities=31% Similarity=0.560 Sum_probs=227.1
Q ss_pred CceEEEEEeccCCceEEEEEEEcCCc--eEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEE
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 510 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~~~--vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E 510 (706)
++|.+.+.||+|.||.||+|+.+.+. ||+|.+.+..-.++.++.+.+|++|++.++||||+.+++.|+...++|+|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 47888999999999999999877664 9999998888888889999999999999999999999999999999999999
Q ss_pred eccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcc
Q 005247 511 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 590 (706)
Q Consensus 511 ~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~ 590 (706)
|+.| +|..++... +.++++.+..++.+++.||.|||+++ |+|||+||.|||++++|++|+||||+|+.......
T Consensus 82 ~a~g-~L~~il~~d---~~lpEe~v~~~a~~LVsaL~yLhs~r--ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~ 155 (808)
T KOG0597|consen 82 YAVG-DLFTILEQD---GKLPEEQVRAIAYDLVSALYYLHSNR--ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTS 155 (808)
T ss_pred hhhh-hHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhcC--cccccCCcceeeecCCCceeechhhhhhhcccCce
Confidence 9987 999999743 46999999999999999999999999 99999999999999999999999999998777655
Q ss_pred cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHHHH
Q 005247 591 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIET 670 (706)
Q Consensus 591 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI~~ 670 (706)
..+...|||.|||||...+..|+..+|+||||||+|||++|++||......+.+..|. ......|.+.+..+.+|+..
T Consensus 156 vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~--~d~v~~p~~~S~~f~nfl~g 233 (808)
T KOG0597|consen 156 VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSIL--KDPVKPPSTASSSFVNFLQG 233 (808)
T ss_pred eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHh--cCCCCCcccccHHHHHHHHH
Confidence 5677789999999999999999999999999999999999999999988888888774 44556677999999999999
Q ss_pred hhhhCCCCCCCHHHHHH
Q 005247 671 CWAEEPEIRPSFPSIME 687 (706)
Q Consensus 671 cL~~dP~~RPS~~eIl~ 687 (706)
+|.+||.+|.+-.+++.
T Consensus 234 LL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 234 LLIKDPAQRLTWTDLLG 250 (808)
T ss_pred HhhcChhhcccHHHHhc
Confidence 99999999999999876
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=352.57 Aligned_cols=246 Identities=25% Similarity=0.428 Sum_probs=214.6
Q ss_pred CceEEEEEeccCCceEEEEEEEc--CCceEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEE
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFH-EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 509 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKvl~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~ 509 (706)
++|++.+.||+|+||.||+|.+. +..+|+|++...... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36899999999999999999887 445999998654332 234567889999999999999999999999999999999
Q ss_pred EeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCc
Q 005247 510 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 589 (706)
Q Consensus 510 E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 589 (706)
||+.+|+|.++++.. ..+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~- 154 (291)
T cd05612 81 EYVPGGELFSYLRNS---GRFSNSTGLFYASEIVCALEYLHSKE--IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR- 154 (291)
T ss_pred eCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEEEecCcchhccCC-
Confidence 999999999998643 35888999999999999999999999 999999999999999999999999998865432
Q ss_pred ccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHHH
Q 005247 590 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE 669 (706)
Q Consensus 590 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI~ 669 (706)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+. .....++..+++.+++||.
T Consensus 155 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~ 230 (291)
T cd05612 155 --TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKIL--AGKLEFPRHLDLYAKDLIK 230 (291)
T ss_pred --cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--hCCcCCCccCCHHHHHHHH
Confidence 234579999999999999999999999999999999999999999888777666653 3456778888999999999
Q ss_pred HhhhhCCCCCCC-----HHHHHHH
Q 005247 670 TCWAEEPEIRPS-----FPSIMET 688 (706)
Q Consensus 670 ~cL~~dP~~RPS-----~~eIl~~ 688 (706)
+||+.||.+||+ +.++++.
T Consensus 231 ~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 231 KLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred HHcCCCHHHccCCccCCHHHHhcC
Confidence 999999999995 8888763
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=358.19 Aligned_cols=249 Identities=27% Similarity=0.450 Sum_probs=217.0
Q ss_pred ccccCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEecccc-chHHHHHHHHHHHHHHcCCCCceeEEeccccCCCce
Q 005247 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNL 505 (706)
Q Consensus 429 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 505 (706)
.....+|++.+.||+|+||.||+|.+..+ .||+|++..... .....+.+.+|+.++++++||||+++++++.+++..
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 93 (329)
T PTZ00263 14 SWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRV 93 (329)
T ss_pred CCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEE
Confidence 34567899999999999999999988654 499999876543 224456788999999999999999999999999999
Q ss_pred EEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccC
Q 005247 506 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK 585 (706)
Q Consensus 506 ~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~ 585 (706)
++||||+.+|+|.+++... ..+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||++...
T Consensus 94 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 168 (329)
T PTZ00263 94 YFLLEFVVGGELFTHLRKA---GRFPNDVAKFYHAELVLAFEYLHSKD--IIYRDLKPENLLLDNKGHVKVTDFGFAKKV 168 (329)
T ss_pred EEEEcCCCCChHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEECCCCCEEEeeccCceEc
Confidence 9999999999999998643 35788899999999999999999999 999999999999999999999999999865
Q ss_pred CCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHH
Q 005247 586 PNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 665 (706)
Q Consensus 586 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~ 665 (706)
.... ....||+.|+|||++.+..++.++|||||||++|||++|..||...++.+....+. ...+.+|..++..++
T Consensus 169 ~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~--~~~~~~p~~~~~~~~ 243 (329)
T PTZ00263 169 PDRT---FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKIL--AGRLKFPNWFDGRAR 243 (329)
T ss_pred CCCc---ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHh--cCCcCCCCCCCHHHH
Confidence 4432 34679999999999999999999999999999999999999999888776666653 345677888999999
Q ss_pred HHHHHhhhhCCCCCCC-----HHHHHH
Q 005247 666 ALIETCWAEEPEIRPS-----FPSIME 687 (706)
Q Consensus 666 dLI~~cL~~dP~~RPS-----~~eIl~ 687 (706)
+||.+||+.||.+||+ +++++.
T Consensus 244 ~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 244 DLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred HHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 9999999999999986 688775
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=340.58 Aligned_cols=257 Identities=28% Similarity=0.505 Sum_probs=218.0
Q ss_pred cccCceEEEEEeccCCceEEEEEEEc-----CCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCc
Q 005247 430 IRWSELLIKKKIGEGSFGTVYHAEWR-----NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN 504 (706)
Q Consensus 430 i~~~~y~i~~~LG~G~fG~Vy~a~~~-----~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 504 (706)
+...+|++.+.||+|+||.||+|.++ +..+|+|++.... .......+.+|+.+++.++||||+++++++...+.
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 80 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT 80 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC
Confidence 45678999999999999999999764 2248888876543 33445678999999999999999999999999999
Q ss_pred eEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCcccc
Q 005247 505 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 584 (706)
Q Consensus 505 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~ 584 (706)
.++||||+++|+|.+++.... ..+++..++.++.||+.||+|||+++ ++||||||+|||++.++.+||+|||.+..
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~i~~al~~lH~~~--iiH~dikp~nili~~~~~~~l~dfg~~~~ 156 (266)
T cd05064 81 MMIVTEYMSNGALDSFLRKHE--GQLVAGQLMGMLPGLASGMKYLSEMG--YVHKGLAAHKVLVNSDLVCKISGFRRLQE 156 (266)
T ss_pred cEEEEEeCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC--EeeccccHhhEEEcCCCcEEECCCccccc
Confidence 999999999999999986432 35789999999999999999999999 99999999999999999999999998765
Q ss_pred CCCCcc-cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCCCCCcH
Q 005247 585 KPNTYI-SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNP 662 (706)
Q Consensus 585 ~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~ 662 (706)
...... ......++..|+|||.+.+..++.++|||||||++||+++ |..||......+....+. .....+.+..++.
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 235 (266)
T cd05064 157 DKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVE-DGFRLPAPRNCPN 235 (266)
T ss_pred ccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH-CCCCCCCCCCCCH
Confidence 432211 1122345678999999999999999999999999999875 999999888777666653 3445567888999
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 005247 663 MVAALIETCWAEEPEIRPSFPSIMETLQQF 692 (706)
Q Consensus 663 el~dLI~~cL~~dP~~RPS~~eIl~~L~~l 692 (706)
.+.+++.+||+.+|++||++++|++.|.++
T Consensus 236 ~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 236 LLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred HHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 999999999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=357.40 Aligned_cols=242 Identities=28% Similarity=0.458 Sum_probs=209.7
Q ss_pred EEeccCCceEEEEEEEcCC--ceEEEEEecccc-chHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEEeccCC
Q 005247 439 KKIGEGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRG 515 (706)
Q Consensus 439 ~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~~~gg 515 (706)
+.||+|+||.||++.+..+ .||+|++..... .......+.+|+.++++++||||+++++++...+..++||||+.+|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999987644 499999876432 2344567889999999999999999999999999999999999999
Q ss_pred chhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcccCCCC
Q 005247 516 SLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTA 595 (706)
Q Consensus 516 sL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~ 595 (706)
+|.+++... ..+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++............
T Consensus 81 ~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~--ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~ 155 (323)
T cd05571 81 ELFFHLSRE---RVFSEDRARFYGAEIVSALGYLHSCD--VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF 155 (323)
T ss_pred cHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccce
Confidence 999988643 35889999999999999999999999 9999999999999999999999999987643333333456
Q ss_pred CCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHHHHhhhhC
Q 005247 596 AGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEE 675 (706)
Q Consensus 596 ~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI~~cL~~d 675 (706)
.||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+. .....+|..+++++.+||.+||+.|
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~--~~~~~~p~~~~~~~~~li~~~L~~d 233 (323)
T cd05571 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL--MEEIRFPRTLSPEAKSLLAGLLKKD 233 (323)
T ss_pred ecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHHccCC
Confidence 79999999999999999999999999999999999999998887766666553 3456778889999999999999999
Q ss_pred CCCCC-----CHHHHHH
Q 005247 676 PEIRP-----SFPSIME 687 (706)
Q Consensus 676 P~~RP-----S~~eIl~ 687 (706)
|++|| ++.++++
T Consensus 234 P~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 234 PKQRLGGGPEDAKEIME 250 (323)
T ss_pred HHHcCCCCCCCHHHHHc
Confidence 99999 7998876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=366.34 Aligned_cols=253 Identities=29% Similarity=0.490 Sum_probs=232.6
Q ss_pred cCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCc-eEEE
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN-LSIV 508 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~-~~lV 508 (706)
.++|..++.+|+|+||.+++++++.. .+++|.+......+...+....|+.++++++|||||.+.+.|.+++. .+||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 45789999999999999999987654 49999998887777777789999999999999999999999999988 9999
Q ss_pred EEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCC
Q 005247 509 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 588 (706)
Q Consensus 509 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 588 (706)
|+||+||+|.+.+...+ ...++++.+..|+.|++.|+.|||+++ |+|||||+.|||+++++.|||+|||+|+.....
T Consensus 83 m~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~--iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR--VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred EeecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh--hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 99999999999997554 456999999999999999999999999 999999999999999999999999999998877
Q ss_pred cccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHH
Q 005247 589 YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI 668 (706)
Q Consensus 589 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI 668 (706)
.....+..||+.||+||.+.+.+|..|+|||||||++|||++-+++|...+....+..+. ...-.++|...+.+++.+|
T Consensus 160 ~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~-~~~~~Plp~~ys~el~~lv 238 (426)
T KOG0589|consen 160 DSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKIN-RGLYSPLPSMYSSELRSLV 238 (426)
T ss_pred hhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHh-hccCCCCCccccHHHHHHH
Confidence 656678899999999999999999999999999999999999999999999999888874 4446778899999999999
Q ss_pred HHhhhhCCCCCCCHHHHHHH
Q 005247 669 ETCWAEEPEIRPSFPSIMET 688 (706)
Q Consensus 669 ~~cL~~dP~~RPS~~eIl~~ 688 (706)
+.||..+|+.||++.+++..
T Consensus 239 ~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 239 KSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred HHHhhcCCccCCCHHHHhhC
Confidence 99999999999999999985
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=369.80 Aligned_cols=254 Identities=36% Similarity=0.654 Sum_probs=226.7
Q ss_pred cccCcccccCceEEEEEeccCCceEEEEEEEcCCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCC
Q 005247 424 EEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP 503 (706)
Q Consensus 424 ~~~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 503 (706)
..+.++|.++...-++-||.|+.|.||+|+.++..||||.++.. -..+|.-|++|+|+||+.+.++|....
T Consensus 115 q~e~WeiPFe~IsELeWlGSGaQGAVF~Grl~netVAVKKV~el---------kETdIKHLRkLkH~NII~FkGVCtqsP 185 (904)
T KOG4721|consen 115 QEELWEIPFEEISELEWLGSGAQGAVFLGRLHNETVAVKKVREL---------KETDIKHLRKLKHPNIITFKGVCTQSP 185 (904)
T ss_pred hhhhccCCHHHhhhhhhhccCcccceeeeeccCceehhHHHhhh---------hhhhHHHHHhccCcceeeEeeeecCCc
Confidence 35668888888888999999999999999999999999986332 125778899999999999999999999
Q ss_pred ceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccc
Q 005247 504 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 583 (706)
Q Consensus 504 ~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~ 583 (706)
.+|||||||..|.|+..|+.. ..+.......|..+|+.|+.|||.++ |||||||..||||+.+..|||+|||-++
T Consensus 186 cyCIiMEfCa~GqL~~VLka~---~~itp~llv~Wsk~IA~GM~YLH~hK--IIHRDLKSPNiLIs~~d~VKIsDFGTS~ 260 (904)
T KOG4721|consen 186 CYCIIMEFCAQGQLYEVLKAG---RPITPSLLVDWSKGIAGGMNYLHLHK--IIHRDLKSPNILISYDDVVKISDFGTSK 260 (904)
T ss_pred eeEEeeeccccccHHHHHhcc---CccCHHHHHHHHHHhhhhhHHHHHhh--HhhhccCCCceEeeccceEEeccccchH
Confidence 999999999999999999843 36888999999999999999999999 9999999999999999999999999888
Q ss_pred cCCCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHH
Q 005247 584 SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPM 663 (706)
Q Consensus 584 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~e 663 (706)
...+. ...-.++||..|||||++.+.+.++|+|||||||+|||||||..||.......++.-+..+.-.++.|..|+.-
T Consensus 261 e~~~~-STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~G 339 (904)
T KOG4721|consen 261 ELSDK-STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDG 339 (904)
T ss_pred hhhhh-hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchH
Confidence 76554 23457899999999999999999999999999999999999999999887766666665555568889999999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 005247 664 VAALIETCWAEEPEIRPSFPSIMETLQQF 692 (706)
Q Consensus 664 l~dLI~~cL~~dP~~RPS~~eIl~~L~~l 692 (706)
++=||++||+-.|..||+|.+|+..|.-+
T Consensus 340 fklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 340 FKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred HHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 99999999999999999999999988643
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=353.43 Aligned_cols=248 Identities=26% Similarity=0.408 Sum_probs=213.5
Q ss_pred CceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEE
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFH-EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 509 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~ 509 (706)
++|++.+.||+|+||.||+|.+.. ..||+|++...... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 469999999999999999999864 45999998765432 234567889999999999999999999999999999999
Q ss_pred EeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCc
Q 005247 510 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 589 (706)
Q Consensus 510 E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 589 (706)
||+++|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNL---GVLSEDHARFYMAEMFEAVDALHELG--YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred eCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence 999999999999643 35789999999999999999999999 99999999999999999999999999986544
Q ss_pred ccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCC------CCCcHH
Q 005247 590 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP------KNVNPM 663 (706)
Q Consensus 590 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p------~~~s~e 663 (706)
......||+.|+|||++.+..++.++|||||||++|||++|..||...+..+....+......+..+ ..++.+
T Consensus 154 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~ 232 (333)
T cd05600 154 -YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDE 232 (333)
T ss_pred -ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHH
Confidence 2345679999999999999999999999999999999999999999888877666554322222222 256899
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHH
Q 005247 664 VAALIETCWAEEPEIRPSFPSIMET 688 (706)
Q Consensus 664 l~dLI~~cL~~dP~~RPS~~eIl~~ 688 (706)
+.+||.+||..+|.+||++.++++.
T Consensus 233 ~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 233 AWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred HHHHHHHHhhChhhhcCCHHHHHhC
Confidence 9999999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=344.18 Aligned_cols=257 Identities=35% Similarity=0.535 Sum_probs=209.5
Q ss_pred ccCceEEEEEeccCCceEEEEEEEcC----------------C--ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCce
Q 005247 431 RWSELLIKKKIGEGSFGTVYHAEWRN----------------S--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNI 492 (706)
Q Consensus 431 ~~~~y~i~~~LG~G~fG~Vy~a~~~~----------------~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnI 492 (706)
..++|++.+.||+|+||.||+|.+.+ + .||+|++.... .......+.+|+.++++++||||
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni 81 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNI 81 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCe
Confidence 35689999999999999999997532 1 38999876543 34456789999999999999999
Q ss_pred eEEeccccCCCceEEEEEeccCCchhhhcccCC----------------CcccccHHHHHHHHHHHHHHHHHHHhcCCCc
Q 005247 493 VLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPD----------------ARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 556 (706)
Q Consensus 493 v~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~----------------~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~I 556 (706)
+++++++.+.+..++||||+.+|+|.+++.... ....+++..++.++.||+.||.|||++| |
T Consensus 82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i 159 (304)
T cd05096 82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN--F 159 (304)
T ss_pred eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC--c
Confidence 999999999999999999999999999885321 1123677888999999999999999999 9
Q ss_pred ccccCCCCcEEECCCCcEEEeecCccccCCCCc--ccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh--CC
Q 005247 557 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT--LQ 632 (706)
Q Consensus 557 IHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~--~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt--G~ 632 (706)
+||||||+|||++.++.+||+|||+++...... .......++..|+|||++.+..++.++||||||+++|||++ +.
T Consensus 160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~ 239 (304)
T cd05096 160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE 239 (304)
T ss_pred cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCC
Confidence 999999999999999999999999987643322 11223445788999999998899999999999999999987 56
Q ss_pred CCCCCCChHHHHHHhhh------cCcccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 005247 633 KPWRNSTPSQVISAVGF------KGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQ 690 (706)
Q Consensus 633 ~Pf~~~~~~~~~~~i~~------~~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~ 690 (706)
.||...+..+....+.. .......+..++..+.+||.+||+.+|++|||+.+|.+.|+
T Consensus 240 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 240 QPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 78887766655443321 11123345678899999999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=334.00 Aligned_cols=252 Identities=29% Similarity=0.501 Sum_probs=226.9
Q ss_pred cccCceEEEEEeccCCceEEEEEEEcCCc--eEEEEEeccccchHH-HHHHHHHHHHHHcCCCCceeEEeccccCCCceE
Q 005247 430 IRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDR-FKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS 506 (706)
Q Consensus 430 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~--vAVKvl~~~~~~~~~-~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 506 (706)
...++|++++.||+|.||.||.|..+.+. ||+|++.++...... ...+.+|++|-+.|+||||+++|++|.+....|
T Consensus 19 ~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riy 98 (281)
T KOG0580|consen 19 WTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIY 98 (281)
T ss_pred cchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeE
Confidence 34578999999999999999999888776 899999776654433 457889999999999999999999999999999
Q ss_pred EEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCC
Q 005247 507 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP 586 (706)
Q Consensus 507 lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~ 586 (706)
+++||..+|.|+..|+... ...+++..++.++.|++.||.|+|.++ ||||||||+|+|++..+.+||+|||.+...+
T Consensus 99 LilEya~~gel~k~L~~~~-~~~f~e~~~a~Yi~q~A~Al~y~h~k~--VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 99 LILEYAPRGELYKDLQEGR-MKRFDEQRAATYIKQLANALLYCHLKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EEEEecCCchHHHHHHhcc-cccccccchhHHHHHHHHHHHHhccCC--cccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 9999999999999997332 336899999999999999999999999 9999999999999999999999999998776
Q ss_pred CCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHH
Q 005247 587 NTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA 666 (706)
Q Consensus 587 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~d 666 (706)
. ....+.|||..|.+||...+..++..+|+|++|++.||++.|.+||...+..+.+.++ ...++.+|..++.++++
T Consensus 176 ~--~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI--~k~~~~~p~~is~~a~d 251 (281)
T KOG0580|consen 176 S--NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRI--RKVDLKFPSTISGGAAD 251 (281)
T ss_pred C--CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHH--HHccccCCcccChhHHH
Confidence 3 3567899999999999999999999999999999999999999999999988888777 45677888999999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHH
Q 005247 667 LIETCWAEEPEIRPSFPSIMET 688 (706)
Q Consensus 667 LI~~cL~~dP~~RPS~~eIl~~ 688 (706)
+|.+||..+|.+|.+..|++..
T Consensus 252 lI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 252 LISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred HHHHHhccCccccccHHHHhhh
Confidence 9999999999999999998763
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=343.09 Aligned_cols=250 Identities=23% Similarity=0.322 Sum_probs=208.2
Q ss_pred ceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccch-HHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEE
Q 005247 434 ELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 510 (706)
Q Consensus 434 ~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~-~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E 510 (706)
.|++.+.||+|+||.||++.+.. ..||+|++....... .....+.+|+.+++.++|+||+++++++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 37889999999999999998754 459999886554332 233467899999999999999999999999999999999
Q ss_pred eccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcc
Q 005247 511 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 590 (706)
Q Consensus 511 ~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~ 590 (706)
|+.+|+|.+++.... ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05631 81 IMNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQRER--IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE- 156 (285)
T ss_pred ecCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence 999999988775322 235889999999999999999999999 9999999999999999999999999998654322
Q ss_pred cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh--hcCcccCCCCCCcHHHHHHH
Q 005247 591 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVG--FKGRRLEIPKNVNPMVAALI 668 (706)
Q Consensus 591 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~--~~~~~l~~p~~~s~el~dLI 668 (706)
......||..|+|||++.+..++.++|||||||++|||++|+.||...........+. .......++..+++++.+||
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 236 (285)
T cd05631 157 TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSIC 236 (285)
T ss_pred eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHH
Confidence 2234578999999999999999999999999999999999999998765432221111 23334566778999999999
Q ss_pred HHhhhhCCCCCCC-----HHHHHH
Q 005247 669 ETCWAEEPEIRPS-----FPSIME 687 (706)
Q Consensus 669 ~~cL~~dP~~RPS-----~~eIl~ 687 (706)
++||+.||++||+ ++++++
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 237 RMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred HHHhhcCHHHhcCCCCCCHHHHhc
Confidence 9999999999997 788877
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=351.70 Aligned_cols=240 Identities=25% Similarity=0.399 Sum_probs=206.7
Q ss_pred eccCCceEEEEEEEcCC--ceEEEEEecccc-chHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEEeccCCch
Q 005247 441 IGEGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSL 517 (706)
Q Consensus 441 LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL 517 (706)
||+|+||.||+|.+..+ .||+|++..... .......+.+|+.++++++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 69999999999998754 499999865432 334456788999999999999999999999999999999999999999
Q ss_pred hhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcccCCCCCC
Q 005247 518 YKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAG 597 (706)
Q Consensus 518 ~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~G 597 (706)
.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.............|
T Consensus 81 ~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 155 (312)
T cd05585 81 FHHLQRE---GRFDLSRARFYTAELLCALENLHKFN--VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCG 155 (312)
T ss_pred HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccC
Confidence 9998643 35889999999999999999999999 999999999999999999999999998764333323345679
Q ss_pred CCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHHHHhhhhCCC
Q 005247 598 TPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPE 677 (706)
Q Consensus 598 t~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI~~cL~~dP~ 677 (706)
|+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+ ......++..+++++.+||.+||+.||+
T Consensus 156 t~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dp~ 233 (312)
T cd05585 156 TPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKI--LQEPLRFPDGFDRDAKDLLIGLLSRDPT 233 (312)
T ss_pred CcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHH--HcCCCCCCCcCCHHHHHHHHHHcCCCHH
Confidence 99999999999999999999999999999999999999988777766655 3445677888999999999999999999
Q ss_pred CCCC---HHHHHH
Q 005247 678 IRPS---FPSIME 687 (706)
Q Consensus 678 ~RPS---~~eIl~ 687 (706)
+||+ +.+++.
T Consensus 234 ~R~~~~~~~e~l~ 246 (312)
T cd05585 234 RRLGYNGAQEIKN 246 (312)
T ss_pred HcCCCCCHHHHHc
Confidence 9985 555544
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=364.99 Aligned_cols=273 Identities=32% Similarity=0.567 Sum_probs=243.5
Q ss_pred ccccccCcccccCceEEEEEeccCCceEEEEEEEcCC-----c-eEEEEEec-cccchHHHHHHHHHHHHHHcCCCCcee
Q 005247 421 LYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNS-----D-VAVKILIE-QEFHEDRFKEFLREVAIMKGLRHPNIV 493 (706)
Q Consensus 421 ~~~~~~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~-----~-vAVKvl~~-~~~~~~~~~~~~~Ei~iL~~L~HpnIv 493 (706)
..+....+++..++..+.++||+|+||.||+|+.... . ||+|..+. ........++|.+|+++|++++|||||
T Consensus 145 ~PI~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVV 224 (474)
T KOG0194|consen 145 RPIPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVV 224 (474)
T ss_pred ccccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEE
Confidence 3456677899999999999999999999999976432 2 78888875 346678889999999999999999999
Q ss_pred EEeccccCCCceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCc
Q 005247 494 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYT 573 (706)
Q Consensus 494 ~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~ 573 (706)
++||+......+++|||+|.||+|.++|+..+. .++..+...++.+.+.||+|||+++ +|||||-.+|+|++.++.
T Consensus 225 r~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k~--~IHRDIAARNcL~~~~~~ 300 (474)
T KOG0194|consen 225 RFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSKN--CIHRDIAARNCLYSKKGV 300 (474)
T ss_pred EEEEEEcCCCccEEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHCC--CcchhHhHHHheecCCCe
Confidence 999999999999999999999999999986543 5888999999999999999999999 999999999999999999
Q ss_pred EEEeecCccccCCCCcccCC-CCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcC
Q 005247 574 VKVCDFGLSRSKPNTYISSK-TAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKG 651 (706)
Q Consensus 574 vKL~DFGla~~~~~~~~~~~-~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~ 651 (706)
+||+|||+++... .+.... ...-...|+|||.+....|+.++|||||||++||+++ |..||.+....++...+...+
T Consensus 301 vKISDFGLs~~~~-~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~ 379 (474)
T KOG0194|consen 301 VKISDFGLSRAGS-QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNG 379 (474)
T ss_pred EEeCccccccCCc-ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcC
Confidence 9999999988765 222222 2235679999999999999999999999999999999 788999999999999998889
Q ss_pred cccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhccC
Q 005247 652 RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVC 698 (706)
Q Consensus 652 ~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~~~ 698 (706)
.+..+|...+.++..++.+||..+|++||+|.++.+.|+.+......
T Consensus 380 ~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 380 YRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred ccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 99999999999999999999999999999999999999999887654
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=356.09 Aligned_cols=251 Identities=24% Similarity=0.413 Sum_probs=217.8
Q ss_pred cccccCceEEEEEeccCCceEEEEEEEcCC---ceEEEEEecccc-chHHHHHHHHHHHHHHcCCCCceeEEeccccCCC
Q 005247 428 LEIRWSELLIKKKIGEGSFGTVYHAEWRNS---DVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP 503 (706)
Q Consensus 428 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~---~vAVKvl~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 503 (706)
..+...+|++.+.||+|+||.||+|.+.++ .||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+
T Consensus 25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~ 104 (340)
T PTZ00426 25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES 104 (340)
T ss_pred CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence 445677899999999999999999986543 489998865432 2344567889999999999999999999999999
Q ss_pred ceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccc
Q 005247 504 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 583 (706)
Q Consensus 504 ~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~ 583 (706)
..++||||+.+|+|.+++.... .+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.
T Consensus 105 ~~~lv~Ey~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~ikL~DFG~a~ 179 (340)
T PTZ00426 105 YLYLVLEFVIGGEFFTFLRRNK---RFPNDVGCFYAAQIVLIFEYLQSLN--IVYRDLKPENLLLDKDGFIKMTDFGFAK 179 (340)
T ss_pred EEEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCCCCEEEecCCCCe
Confidence 9999999999999999987433 5889999999999999999999999 9999999999999999999999999997
Q ss_pred cCCCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHH
Q 005247 584 SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPM 663 (706)
Q Consensus 584 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~e 663 (706)
..... .....||+.|+|||++.+..++.++|||||||++|||++|..||...++......+. .....+|..+++.
T Consensus 180 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~--~~~~~~p~~~~~~ 254 (340)
T PTZ00426 180 VVDTR---TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKIL--EGIIYFPKFLDNN 254 (340)
T ss_pred ecCCC---cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHh--cCCCCCCCCCCHH
Confidence 65432 235679999999999999889999999999999999999999999888766666653 3345678889999
Q ss_pred HHHHHHHhhhhCCCCCC-----CHHHHHHH
Q 005247 664 VAALIETCWAEEPEIRP-----SFPSIMET 688 (706)
Q Consensus 664 l~dLI~~cL~~dP~~RP-----S~~eIl~~ 688 (706)
+.++|.+||+.||++|+ +++++++.
T Consensus 255 ~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 255 CKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred HHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 99999999999999995 88888763
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=359.12 Aligned_cols=264 Identities=31% Similarity=0.520 Sum_probs=218.6
Q ss_pred CcccccCceEEEEEeccCCceEEEEEEEcC-------CceEEEEEeccccchHHHHHHHHHHHHHHcC-CCCceeEEecc
Q 005247 427 GLEIRWSELLIKKKIGEGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGA 498 (706)
Q Consensus 427 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~-------~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~ 498 (706)
.+.+..++|++.+.||+|+||.||+|.+.. ..||+|++.... .....+.+.+|+.+++.+ +|+||++++++
T Consensus 32 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~~h~nIv~~~~~ 110 (374)
T cd05106 32 KWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA-HTDEREALMSELKILSHLGQHKNIVNLLGA 110 (374)
T ss_pred cccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC-CHHHHHHHHHHHHHHHhhccCCceeeEeeE
Confidence 355667789999999999999999997532 249999986543 334456788999999999 89999999999
Q ss_pred ccCCCceEEEEEeccCCchhhhcccCC-----------------------------------------------------
Q 005247 499 VTEPPNLSIVTEYLSRGSLYKLLHIPD----------------------------------------------------- 525 (706)
Q Consensus 499 ~~~~~~~~lV~E~~~ggsL~~~l~~~~----------------------------------------------------- 525 (706)
+...+..++||||+++|+|.++++...
T Consensus 111 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (374)
T cd05106 111 CTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSS 190 (374)
T ss_pred ecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccc
Confidence 999999999999999999999874321
Q ss_pred --------------CcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcc-
Q 005247 526 --------------ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI- 590 (706)
Q Consensus 526 --------------~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~- 590 (706)
....+++..+++++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 191 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~ 268 (374)
T cd05106 191 SSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN--CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY 268 (374)
T ss_pred ccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--EEeccCchheEEEeCCCeEEEeeceeeeeccCCcce
Confidence 0124677889999999999999999999 99999999999999999999999999876543221
Q ss_pred -cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHH
Q 005247 591 -SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI 668 (706)
Q Consensus 591 -~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI 668 (706)
......++..|+|||++.+..++.++||||||+++|||++ |..||.................+...+..+++++.++|
T Consensus 269 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 348 (374)
T cd05106 269 VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIM 348 (374)
T ss_pred eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHH
Confidence 1122335668999999999999999999999999999997 99999876654444444334445566677899999999
Q ss_pred HHhhhhCCCCCCCHHHHHHHHHHHH
Q 005247 669 ETCWAEEPEIRPSFPSIMETLQQFL 693 (706)
Q Consensus 669 ~~cL~~dP~~RPS~~eIl~~L~~ll 693 (706)
.+||+.||.+|||+.+|++.|++++
T Consensus 349 ~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 349 KMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred HHHcCCChhhCcCHHHHHHHHHHHh
Confidence 9999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=348.26 Aligned_cols=260 Identities=29% Similarity=0.457 Sum_probs=218.9
Q ss_pred cccCcccccCceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccC
Q 005247 424 EEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE 501 (706)
Q Consensus 424 ~~~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~ 501 (706)
.+..+....++|++.+.||.|..++||+|.... ..||||++.....+.+ .+.+.+|+..|+.++||||++++..|..
T Consensus 17 ~~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv 95 (516)
T KOG0582|consen 17 SEKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVV 95 (516)
T ss_pred ccccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEe
Confidence 345577888999999999999999999998754 4599999977766555 7899999999999999999999999999
Q ss_pred CCceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCc
Q 005247 502 PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL 581 (706)
Q Consensus 502 ~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGl 581 (706)
+..+|+||.||.+|++.++++..-. .-++|..++.|.+++++||.|||.+| .||||||+.||||+.+|.|||+|||.
T Consensus 96 ~~~LWvVmpfMa~GS~ldIik~~~~-~Gl~E~~Ia~iLre~LkaL~YLH~~G--~IHRdvKAgnILi~~dG~VkLadFgv 172 (516)
T KOG0582|consen 96 DSELWVVMPFMAGGSLLDIIKTYYP-DGLEEASIATILREVLKALDYLHQNG--HIHRDVKAGNILIDSDGTVKLADFGV 172 (516)
T ss_pred cceeEEeehhhcCCcHHHHHHHHcc-ccccHHHHHHHHHHHHHHHHHHHhcC--ceecccccccEEEcCCCcEEEcCcee
Confidence 9999999999999999999964322 23899999999999999999999999 99999999999999999999999997
Q ss_pred cccCCC-C--cccC-CCCCCCCCccCcccccc--CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCccc-
Q 005247 582 SRSKPN-T--YISS-KTAAGTPEWMAPEVLRE--DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRL- 654 (706)
Q Consensus 582 a~~~~~-~--~~~~-~~~~Gt~~Y~APE~l~~--~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l- 654 (706)
+....+ + .... .++.||+.|||||++.. ..|+.|+||||||++..||.+|..||....+.++.-.-..+..+.
T Consensus 173 sa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~ 252 (516)
T KOG0582|consen 173 SASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTL 252 (516)
T ss_pred eeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCc
Confidence 654222 1 1112 56789999999999644 469999999999999999999999999999888765543222210
Q ss_pred ---CC----CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 655 ---EI----PKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 655 ---~~----p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
.+ ....+..++.+|..||.+||++|||+.++++
T Consensus 253 ~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 253 LTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred ccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 11 1245678999999999999999999999987
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=340.77 Aligned_cols=250 Identities=24% Similarity=0.341 Sum_probs=206.1
Q ss_pred CceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEE
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 510 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E 510 (706)
++|++.+.||+|+||.||+|.++++ .+|+|++..........+.+.+|+.+++.++|+||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 3699999999999999999998754 49999987665445556778899999999999999999999999999999999
Q ss_pred eccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcc
Q 005247 511 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 590 (706)
Q Consensus 511 ~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~ 590 (706)
|+.++.+..+... ...+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 81 YVEKNMLELLEEM---PNGVPPEKVRSYIYQLIKAIHWCHKND--IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred cCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence 9998877655432 235888999999999999999999999 99999999999999999999999999987543221
Q ss_pred -cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCc-----------------
Q 005247 591 -SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR----------------- 652 (706)
Q Consensus 591 -~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~----------------- 652 (706)
......|++.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+.....
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07848 156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH 235 (287)
T ss_pred ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence 22345789999999999998899999999999999999999999987665443322211000
Q ss_pred ccC-------------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 653 RLE-------------IPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 653 ~l~-------------~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
... ....++.++.+||.+||+.||++|||++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000 11236788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=340.13 Aligned_cols=257 Identities=34% Similarity=0.568 Sum_probs=218.0
Q ss_pred ccCceEEEEEeccCCceEEEEEEEcCC-------ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCC
Q 005247 431 RWSELLIKKKIGEGSFGTVYHAEWRNS-------DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP 503 (706)
Q Consensus 431 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~-------~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 503 (706)
...+|++.+.||+|+||.||+|.+.+. .+++|.+.... .......+.+|+.+++.++||||+++++++....
T Consensus 3 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~ 81 (283)
T cd05048 3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQ 81 (283)
T ss_pred ChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCC
Confidence 345789999999999999999987543 38888875443 3444567899999999999999999999999989
Q ss_pred ceEEEEEeccCCchhhhcccCCC-------------cccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECC
Q 005247 504 NLSIVTEYLSRGSLYKLLHIPDA-------------RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS 570 (706)
Q Consensus 504 ~~~lV~E~~~ggsL~~~l~~~~~-------------~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~ 570 (706)
..+++|||+++++|.+++..... ...+++..++.++.|++.||.|||+++ ++||||||+||++++
T Consensus 82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nil~~~ 159 (283)
T cd05048 82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLVGE 159 (283)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccccceEEEcC
Confidence 99999999999999999854211 145788899999999999999999999 999999999999999
Q ss_pred CCcEEEeecCccccCCCCc--ccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHh
Q 005247 571 TYTVKVCDFGLSRSKPNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAV 647 (706)
Q Consensus 571 ~~~vKL~DFGla~~~~~~~--~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i 647 (706)
++.+||+|||+++...... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||......+....+
T Consensus 160 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i 239 (283)
T cd05048 160 GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI 239 (283)
T ss_pred CCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999999987643321 12233456788999999998899999999999999999998 99999988887776665
Q ss_pred hhcCcccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 005247 648 GFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 691 (706)
Q Consensus 648 ~~~~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ 691 (706)
. .......+..++.++.+|+.+||+.||.+||++.+|++.|+.
T Consensus 240 ~-~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 240 R-SRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred H-cCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 3 444556678899999999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=354.33 Aligned_cols=250 Identities=28% Similarity=0.443 Sum_probs=214.8
Q ss_pred CceEEEEEeccCCceEEEEEEEc--CCceEEEEEeccccch-HHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEE
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 509 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKvl~~~~~~~-~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~ 509 (706)
++|++.+.||+|+||.||+|.+. +..||+|++....... .....+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 36899999999999999999987 4559999987654332 44567889999999999999999999999999999999
Q ss_pred EeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCc
Q 005247 510 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 589 (706)
Q Consensus 510 E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 589 (706)
||+.+++|.+++... ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g--iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG--FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence 999999999998744 35889999999999999999999999 9999999999999999999999999997654432
Q ss_pred -----------------------------ccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh
Q 005247 590 -----------------------------ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTP 640 (706)
Q Consensus 590 -----------------------------~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~ 640 (706)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 235 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL 235 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence 122345799999999999999999999999999999999999999998887
Q ss_pred HHHHHHhhhcCcccCCCC--CCcHHHHHHHHHhhhhCCCCCCC-HHHHHHH
Q 005247 641 SQVISAVGFKGRRLEIPK--NVNPMVAALIETCWAEEPEIRPS-FPSIMET 688 (706)
Q Consensus 641 ~~~~~~i~~~~~~l~~p~--~~s~el~dLI~~cL~~dP~~RPS-~~eIl~~ 688 (706)
.+....+........+|. .+++++.+||.+||. +|.+||+ +.++++.
T Consensus 236 ~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 236 QETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 776666644223333443 469999999999998 9999999 9999873
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=350.80 Aligned_cols=242 Identities=27% Similarity=0.462 Sum_probs=208.6
Q ss_pred EEeccCCceEEEEEEEcC--CceEEEEEecccc-chHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEEeccCC
Q 005247 439 KKIGEGSFGTVYHAEWRN--SDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRG 515 (706)
Q Consensus 439 ~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~~~gg 515 (706)
+.||+|+||.||++.+.. ..||+|++..... .......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 369999999999998764 4599999876432 2344567788999999999999999999999999999999999999
Q ss_pred chhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcccCCCC
Q 005247 516 SLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTA 595 (706)
Q Consensus 516 sL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~ 595 (706)
+|..++... ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++.............
T Consensus 81 ~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 155 (323)
T cd05595 81 ELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF 155 (323)
T ss_pred cHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccc
Confidence 998888643 25889999999999999999999999 9999999999999999999999999987543332233456
Q ss_pred CCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHHHHhhhhC
Q 005247 596 AGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEE 675 (706)
Q Consensus 596 ~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI~~cL~~d 675 (706)
.||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+. .....+|..+++++.+||.+||+.|
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~--~~~~~~p~~~~~~~~~li~~~L~~d 233 (323)
T cd05595 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL--MEEIRFPRTLSPEAKSLLAGLLKKD 233 (323)
T ss_pred cCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHh--cCCCCCCCCCCHHHHHHHHHHccCC
Confidence 79999999999999999999999999999999999999998887776666553 3345677889999999999999999
Q ss_pred CCCCC-----CHHHHHH
Q 005247 676 PEIRP-----SFPSIME 687 (706)
Q Consensus 676 P~~RP-----S~~eIl~ 687 (706)
|++|| ++.++++
T Consensus 234 P~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 234 PKQRLGGGPSDAKEVME 250 (323)
T ss_pred HHHhCCCCCCCHHHHHc
Confidence 99998 8888876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=357.46 Aligned_cols=262 Identities=31% Similarity=0.514 Sum_probs=215.4
Q ss_pred cccccCceEEEEEeccCCceEEEEEEEc-------CCceEEEEEeccccchHHHHHHHHHHHHHHcC-CCCceeEEeccc
Q 005247 428 LEIRWSELLIKKKIGEGSFGTVYHAEWR-------NSDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAV 499 (706)
Q Consensus 428 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~-------~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~ 499 (706)
+.+..++|++.+.||+|+||.||+|++. +..||+|+++... .....+.+.+|+.+++.+ +||||+++++++
T Consensus 30 ~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~ 108 (375)
T cd05104 30 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHINIVNLLGAC 108 (375)
T ss_pred cccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc-CcHHHHHHHHHHHHHHHhcCCcceeeeeeee
Confidence 4555678999999999999999999742 2248999886443 233456788999999999 899999999999
Q ss_pred cCCCceEEEEEeccCCchhhhcccCCC-----------------------------------------------------
Q 005247 500 TEPPNLSIVTEYLSRGSLYKLLHIPDA----------------------------------------------------- 526 (706)
Q Consensus 500 ~~~~~~~lV~E~~~ggsL~~~l~~~~~----------------------------------------------------- 526 (706)
...+..++||||+++|+|.++++....
T Consensus 109 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 109 TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 999999999999999999998853211
Q ss_pred -------------------cccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCC
Q 005247 527 -------------------RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 587 (706)
Q Consensus 527 -------------------~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 587 (706)
...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 266 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILLTHGRITKICDFGLARDIRN 266 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCchhhEEEECCCcEEEecCccceeccC
Confidence 124678889999999999999999999 99999999999999999999999999976543
Q ss_pred Ccc--cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHH
Q 005247 588 TYI--SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV 664 (706)
Q Consensus 588 ~~~--~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el 664 (706)
... ......++..|+|||++.+..++.++||||||+++|||++ |..||.................+...+...+.++
T Consensus 267 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 346 (375)
T cd05104 267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEM 346 (375)
T ss_pred cccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHH
Confidence 221 1122345667999999999999999999999999999998 8899987654444433333444555667788999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 005247 665 AALIETCWAEEPEIRPSFPSIMETLQQF 692 (706)
Q Consensus 665 ~dLI~~cL~~dP~~RPS~~eIl~~L~~l 692 (706)
++||.+||+.||++|||+.+|++.|++.
T Consensus 347 ~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 347 YDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred HHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 9999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=359.88 Aligned_cols=248 Identities=32% Similarity=0.537 Sum_probs=220.0
Q ss_pred CceEEEEEeccCCceEEEEEEEcCCc--eEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEE
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 510 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~~~--vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E 510 (706)
..|...+.||+|.||.||+|.+..+. ||+|++.... .+...+.+.+|+.++.+++++||.++|+.+..+..++++||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~-~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE-AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhh-cchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 35667799999999999999987654 9999986654 34556788999999999999999999999999999999999
Q ss_pred eccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcc
Q 005247 511 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 590 (706)
Q Consensus 511 ~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~ 590 (706)
||.||++.++++... .+.+..+..++++++.||.|||.++ .+|||||+.|||+..+|.|||+|||.+....+...
T Consensus 92 y~~gGsv~~lL~~~~---~~~E~~i~~ilre~l~~l~ylH~~~--kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 92 YCGGGSVLDLLKSGN---ILDEFEIAVILREVLKGLDYLHSEK--KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred HhcCcchhhhhccCC---CCccceeeeehHHHHHHhhhhhhcc--eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 999999999997443 4588888889999999999999999 99999999999999999999999999998887777
Q ss_pred cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHHHH
Q 005247 591 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIET 670 (706)
Q Consensus 591 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI~~ 670 (706)
...+++||+.|||||++.+..|+.|+||||||++.+||++|.+||....+..+...|. ...++.+...+++.+++||..
T Consensus 167 rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIp-k~~PP~L~~~~S~~~kEFV~~ 245 (467)
T KOG0201|consen 167 RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIP-KSAPPRLDGDFSPPFKEFVEA 245 (467)
T ss_pred ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEecc-CCCCCccccccCHHHHHHHHH
Confidence 7789999999999999999999999999999999999999999999988855544442 333444556899999999999
Q ss_pred hhhhCCCCCCCHHHHHH
Q 005247 671 CWAEEPEIRPSFPSIME 687 (706)
Q Consensus 671 cL~~dP~~RPS~~eIl~ 687 (706)
||++||+.||+|.++++
T Consensus 246 CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 246 CLDKNPEFRPSAKELLK 262 (467)
T ss_pred HhhcCcccCcCHHHHhh
Confidence 99999999999999987
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=349.73 Aligned_cols=252 Identities=32% Similarity=0.492 Sum_probs=211.4
Q ss_pred ccccCceEEEEEeccCCceEEEEEEEcCCc--eEEEEEeccccch------------HHHHHHHHHHHHHHcCCCCceeE
Q 005247 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHE------------DRFKEFLREVAIMKGLRHPNIVL 494 (706)
Q Consensus 429 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~--vAVKvl~~~~~~~------------~~~~~~~~Ei~iL~~L~HpnIv~ 494 (706)
....++|++++.||+|.||.|-+|.+..++ ||||++.+..... ...+...+|+.||++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 345678999999999999999999886554 9999996644321 22468899999999999999999
Q ss_pred EeccccCC--CceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCC
Q 005247 495 LMGAVTEP--PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY 572 (706)
Q Consensus 495 l~~~~~~~--~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~ 572 (706)
++++..++ +.+|||+|||..|.+...- .....+.+.++++|+.+++.||+|||.+| ||||||||+|+||+.+|
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Qg--iiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQG--IIHRDIKPSNLLLSSDG 247 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEEcCCC
Confidence 99999876 4699999999998875432 12222889999999999999999999999 99999999999999999
Q ss_pred cEEEeecCccccCCCC-----cccCCCCCCCCCccCccccccCC----CCchhHHHHHHHHHHHHHhCCCCCCCCChHHH
Q 005247 573 TVKVCDFGLSRSKPNT-----YISSKTAAGTPEWMAPEVLREDP----SNEKSDVFSFGVILWELITLQKPWRNSTPSQV 643 (706)
Q Consensus 573 ~vKL~DFGla~~~~~~-----~~~~~~~~Gt~~Y~APE~l~~~~----~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~ 643 (706)
+|||+|||.+...... ........|||.|+|||...++. ...+.||||+||+||.|+.|+.||......+.
T Consensus 248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l 327 (576)
T KOG0585|consen 248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELEL 327 (576)
T ss_pred cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHH
Confidence 9999999998865322 11223468999999999987733 35688999999999999999999999998888
Q ss_pred HHHhhhcCcccCCCCC--CcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 644 ISAVGFKGRRLEIPKN--VNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 644 ~~~i~~~~~~l~~p~~--~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
+..| ...++.+|.. +.+++++||.+||++||++|.+..+|..
T Consensus 328 ~~KI--vn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~ 371 (576)
T KOG0585|consen 328 FDKI--VNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKL 371 (576)
T ss_pred HHHH--hcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhhee
Confidence 8887 4556666654 7899999999999999999999988864
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=347.92 Aligned_cols=245 Identities=28% Similarity=0.458 Sum_probs=207.7
Q ss_pred eEEEEEeccCCceEEEEEEEcCC--ceEEEEEecccc-chHHHHHHHHHHHHH---HcCCCCceeEEeccccCCCceEEE
Q 005247 435 LLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIM---KGLRHPNIVLLMGAVTEPPNLSIV 508 (706)
Q Consensus 435 y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~-~~~~~~~~~~Ei~iL---~~L~HpnIv~l~~~~~~~~~~~lV 508 (706)
|++.+.||+|+||.||+|.+..+ .||+|++..... .....+.+.+|+.++ +.++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 67899999999999999988654 499999875432 223345666666655 566899999999999999999999
Q ss_pred EEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCC
Q 005247 509 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 588 (706)
Q Consensus 509 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 588 (706)
|||+++++|..+++. ..+++..++.++.||+.||.|||++| |+||||||+||+++.++.+||+|||++......
T Consensus 81 ~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 81 MEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHENK--IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred EcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 999999999888753 24889999999999999999999999 999999999999999999999999998754333
Q ss_pred cccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHH
Q 005247 589 YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI 668 (706)
Q Consensus 589 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI 668 (706)
........|++.|+|||.+.+..++.++|||||||++|||++|+.||...+..+....+. .....+|..+++.+.++|
T Consensus 155 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~li 232 (324)
T cd05589 155 GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIV--NDEVRYPRFLSREAISIM 232 (324)
T ss_pred CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHH--hCCCCCCCCCCHHHHHHH
Confidence 333345679999999999999999999999999999999999999999888777766653 334557788999999999
Q ss_pred HHhhhhCCCCCC-----CHHHHHH
Q 005247 669 ETCWAEEPEIRP-----SFPSIME 687 (706)
Q Consensus 669 ~~cL~~dP~~RP-----S~~eIl~ 687 (706)
.+||+.||.+|| ++.++++
T Consensus 233 ~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 233 RRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred HHHhhcCHhHcCCCCCCCHHHHhh
Confidence 999999999999 5777665
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=348.34 Aligned_cols=249 Identities=28% Similarity=0.461 Sum_probs=204.8
Q ss_pred ccccCceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceE
Q 005247 429 EIRWSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS 506 (706)
Q Consensus 429 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 506 (706)
.....+|++++.||+|+||.||+|.+.. ..||+|++.... .....+.+.+|+++++.++|+||+++++++...+.++
T Consensus 70 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 148 (353)
T PLN00034 70 AKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQ 148 (353)
T ss_pred CCCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEE
Confidence 3446778889999999999999998864 459999986543 3344567899999999999999999999999999999
Q ss_pred EEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCC
Q 005247 507 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP 586 (706)
Q Consensus 507 lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~ 586 (706)
+||||+.+++|.... ...+..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++...
T Consensus 149 lv~e~~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~ 219 (353)
T PLN00034 149 VLLEFMDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH--IVHRDIKPSNLLINSAKNVKIADFGVSRILA 219 (353)
T ss_pred EEEecCCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCEEEcccccceecc
Confidence 999999999986543 2456778899999999999999999 9999999999999999999999999998765
Q ss_pred CCcccCCCCCCCCCccCcccccc-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHhhhcCcccCCCC
Q 005247 587 NTYISSKTAAGTPEWMAPEVLRE-----DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQV---ISAVGFKGRRLEIPK 658 (706)
Q Consensus 587 ~~~~~~~~~~Gt~~Y~APE~l~~-----~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~---~~~i~~~~~~l~~p~ 658 (706)
..........||..|+|||.+.. ...+.++|||||||++|||++|+.||......+. ...+ ........+.
T Consensus 220 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~ 298 (353)
T PLN00034 220 QTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAI-CMSQPPEAPA 298 (353)
T ss_pred cccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHH-hccCCCCCCC
Confidence 44333345679999999998743 2345689999999999999999999974332222 2222 2334455667
Q ss_pred CCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 005247 659 NVNPMVAALIETCWAEEPEIRPSFPSIMET 688 (706)
Q Consensus 659 ~~s~el~dLI~~cL~~dP~~RPS~~eIl~~ 688 (706)
.++.++++||.+||+.||++|||+.|+++.
T Consensus 299 ~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 299 TASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 889999999999999999999999999873
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=351.01 Aligned_cols=243 Identities=28% Similarity=0.461 Sum_probs=209.5
Q ss_pred EEeccCCceEEEEEEEcCC--ceEEEEEecccc-chHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEEeccCC
Q 005247 439 KKIGEGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRG 515 (706)
Q Consensus 439 ~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~~~gg 515 (706)
+.||+|+||.||++.+..+ .||+|++..... .......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 3689999999999987644 499999876432 2344567889999999999999999999999999999999999999
Q ss_pred chhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcccCCCC
Q 005247 516 SLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTA 595 (706)
Q Consensus 516 sL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~ 595 (706)
+|..++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++............
T Consensus 81 ~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~ 155 (328)
T cd05593 81 ELFFHLSRE---RVFSEDRTRFYGAEIVSALDYLHSGK--IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTF 155 (328)
T ss_pred CHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccc
Confidence 998888643 25889999999999999999999999 9999999999999999999999999987643332233456
Q ss_pred CCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHHHHhhhhC
Q 005247 596 AGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEE 675 (706)
Q Consensus 596 ~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI~~cL~~d 675 (706)
.||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+ ......+|..+++++.+||.+||+.|
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~--~~~~~~~p~~~~~~~~~li~~~L~~d 233 (328)
T cd05593 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI--LMEDIKFPRTLSADAKSLLSGLLIKD 233 (328)
T ss_pred cCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHh--ccCCccCCCCCCHHHHHHHHHHcCCC
Confidence 7999999999999999999999999999999999999999887776666554 23455678889999999999999999
Q ss_pred CCCCC-----CHHHHHHH
Q 005247 676 PEIRP-----SFPSIMET 688 (706)
Q Consensus 676 P~~RP-----S~~eIl~~ 688 (706)
|++|| ++.++++.
T Consensus 234 P~~R~~~~~~~~~~il~h 251 (328)
T cd05593 234 PNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred HHHcCCCCCCCHHHHhcC
Confidence 99997 89998863
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=371.94 Aligned_cols=273 Identities=26% Similarity=0.411 Sum_probs=224.4
Q ss_pred ccccccccCcccccCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCC-CCceeEE
Q 005247 419 RELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLL 495 (706)
Q Consensus 419 ~~~~~~~~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l 495 (706)
...+.....+++...+++|.+.|.+|||+.||+|.+.+. .||+|.+... ++..++.+.+|+++|+.|. |+|||.+
T Consensus 23 ~~~~~~G~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~y 100 (738)
T KOG1989|consen 23 SENYFVGQTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSY 100 (738)
T ss_pred cccCCCceEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeE
Confidence 344445566788888999999999999999999998654 5999998766 6778899999999999996 9999999
Q ss_pred eccc-c---CC---CceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEE
Q 005247 496 MGAV-T---EP---PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLV 568 (706)
Q Consensus 496 ~~~~-~---~~---~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl 568 (706)
++.. . .. -.+.|.||||.||.|-+++...... .+.+.++++|++++++|+.+||...+||||||||-+||||
T Consensus 101 idss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~-~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLl 179 (738)
T KOG1989|consen 101 IDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQT-RLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLL 179 (738)
T ss_pred eccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhc-cCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEE
Confidence 9932 1 11 2367999999999999999644333 3999999999999999999999999999999999999999
Q ss_pred CCCCcEEEeecCccccCCCCcccC---------CCCCCCCCccCcccc---ccCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 005247 569 DSTYTVKVCDFGLSRSKPNTYISS---------KTAAGTPEWMAPEVL---REDPSNEKSDVFSFGVILWELITLQKPWR 636 (706)
Q Consensus 569 ~~~~~vKL~DFGla~~~~~~~~~~---------~~~~Gt~~Y~APE~l---~~~~~s~ksDVwSLGviL~ELltG~~Pf~ 636 (706)
+.+|+.||||||.|+......... -...-|+.|+|||.+ .+...++|+|||+|||+||-||+...||+
T Consensus 180 s~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe 259 (738)
T KOG1989|consen 180 SADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFE 259 (738)
T ss_pred cCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcC
Confidence 999999999999987533222111 112358999999986 57788999999999999999999999998
Q ss_pred CCChHHHHHHhhhcCcccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhccC
Q 005247 637 NSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVC 698 (706)
Q Consensus 637 ~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~~~ 698 (706)
...... |......++..+..+..+++||+.||+.||++||++-|+++.+..+.....+
T Consensus 260 ~sg~la----Ilng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~ 317 (738)
T KOG1989|consen 260 ESGKLA----ILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCP 317 (738)
T ss_pred cCccee----EEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCC
Confidence 775432 2223333443457899999999999999999999999999999988866543
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=340.19 Aligned_cols=250 Identities=25% Similarity=0.344 Sum_probs=204.7
Q ss_pred cCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEE
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 509 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~ 509 (706)
.++|++.+.||+|+||.||+|.+..+ .||+|++..... ......+.+|+.+++.++||||+++++++...+..++||
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVF 82 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc-CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence 46799999999999999999987644 499998864432 222346778999999999999999999999999999999
Q ss_pred EeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCc
Q 005247 510 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 589 (706)
Q Consensus 510 E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 589 (706)
||+.+ +|.+++.... ..+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++......
T Consensus 83 e~~~~-~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 83 EYLDS-DLKQYLDNCG--NLMSMHNVKIFMFQLLRGLSYCHKRK--ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT 157 (288)
T ss_pred eCCCc-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence 99975 8888875332 24788899999999999999999999 9999999999999999999999999997654433
Q ss_pred ccCCCCCCCCCccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCc----------------
Q 005247 590 ISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR---------------- 652 (706)
Q Consensus 590 ~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~---------------- 652 (706)
.......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....+.....
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07871 158 KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF 237 (288)
T ss_pred ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence 33345678999999999876 5689999999999999999999999988776555443321100
Q ss_pred -c-----------cCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 653 -R-----------LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 653 -~-----------l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
. ......++.++.+||.+||+.||.+|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0 0112346789999999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=357.55 Aligned_cols=250 Identities=28% Similarity=0.438 Sum_probs=210.6
Q ss_pred ccCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCC-CCceeEEeccccCCC-ceE
Q 005247 431 RWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGAVTEPP-NLS 506 (706)
Q Consensus 431 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~-~~~ 506 (706)
...+|.++++||.|.||.||+|+...+ .||||.++++-..-+ ...-+||+..|++|+ ||||+++.+++.+.+ .++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~e-e~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWE-ECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHH-HHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 346799999999999999999987654 499999877654422 234568999999998 999999999998888 899
Q ss_pred EEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCC
Q 005247 507 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP 586 (706)
Q Consensus 507 lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~ 586 (706)
+|||||+. +|+++++.. +..+++..+..|+.||++||+|+|.+| +.|||+||+|||+..+..+||+|||+||...
T Consensus 87 fVfE~Md~-NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G--fFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 87 FVFEFMDC-NLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG--FFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred eeHHhhhh-hHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC--cccccCChhheEecccceeEecccccccccc
Confidence 99999964 999999755 457999999999999999999999999 9999999999999988899999999999876
Q ss_pred CCcccCCCCCCCCCccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhc-Cc------------
Q 005247 587 NTYISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-GR------------ 652 (706)
Q Consensus 587 ~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~-~~------------ 652 (706)
... -.+.++.|.+|+|||++.. ..|+.+.|+|++|||++|+.+-++.|.+.+.-+.+.+|... +.
T Consensus 162 Skp-PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~L 240 (538)
T KOG0661|consen 162 SKP-PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNL 240 (538)
T ss_pred cCC-CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHH
Confidence 532 2356789999999999865 56899999999999999999999999988876666555311 00
Q ss_pred ----ccCCC-----------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 653 ----RLEIP-----------KNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 653 ----~l~~p-----------~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
.+.+| ++++.++.+||.+|+..||.+||||.|+++
T Consensus 241 a~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~ 290 (538)
T KOG0661|consen 241 ASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQ 290 (538)
T ss_pred HHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhc
Confidence 01111 357889999999999999999999999987
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=347.20 Aligned_cols=247 Identities=25% Similarity=0.419 Sum_probs=211.0
Q ss_pred ceEEEEEeccCCceEEEEEEEcCC--ceEEEEEecccc-chHHHHHHHHHHHHHHcCCC-CceeEEeccccCCCceEEEE
Q 005247 434 ELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGLRH-PNIVLLMGAVTEPPNLSIVT 509 (706)
Q Consensus 434 ~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~-~~~~~~~~~~Ei~iL~~L~H-pnIv~l~~~~~~~~~~~lV~ 509 (706)
+|++.+.||+|+||.||+|++.++ .||+|++..... .....+.+..|..++..+.| ++|+.+++++...+.+++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 588999999999999999988765 499999876432 23445678889999999976 56889999999999999999
Q ss_pred EeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCc
Q 005247 510 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 589 (706)
Q Consensus 510 E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 589 (706)
||+++|+|.+++... ..+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.......
T Consensus 81 E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 81 EYVNGGDLMYHIQQV---GKFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG 155 (324)
T ss_pred cCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence 999999999888633 24788999999999999999999999 9999999999999999999999999987543322
Q ss_pred ccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHHH
Q 005247 590 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE 669 (706)
Q Consensus 590 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI~ 669 (706)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+. .....+|..+++++.+||.
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~ 233 (324)
T cd05587 156 KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIM--EHNVSYPKSLSKEAVSICK 233 (324)
T ss_pred CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHH
Confidence 23345679999999999999999999999999999999999999999888777776663 3456677889999999999
Q ss_pred HhhhhCCCCCCCH-----HHHHH
Q 005247 670 TCWAEEPEIRPSF-----PSIME 687 (706)
Q Consensus 670 ~cL~~dP~~RPS~-----~eIl~ 687 (706)
+||..||.+|++. +++++
T Consensus 234 ~~l~~~P~~R~~~~~~~~~~~~~ 256 (324)
T cd05587 234 GLLTKHPAKRLGCGPTGERDIRE 256 (324)
T ss_pred HHhhcCHHHcCCCCCCCHHHHhc
Confidence 9999999999976 56654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=356.52 Aligned_cols=255 Identities=27% Similarity=0.372 Sum_probs=216.2
Q ss_pred cccccCceEEEEEeccCCceEEEEEEEcCCc--eEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCC--C
Q 005247 428 LEIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP--P 503 (706)
Q Consensus 428 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~--vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~--~ 503 (706)
.......|+.+++||+|.||.||+|++..++ ||+|.+......+.......+||.||++|+||||+++.+.+.+. .
T Consensus 112 ~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~ 191 (560)
T KOG0600|consen 112 GPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSG 191 (560)
T ss_pred cccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCc
Confidence 3455678899999999999999999988766 99999988877777777889999999999999999999998876 6
Q ss_pred ceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccc
Q 005247 504 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 583 (706)
Q Consensus 504 ~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~ 583 (706)
.+|||||||+. +|.-++...+. .+++.++.-+++||+.||+|||++| |+|||||..|||||.+|++||+|||+|+
T Consensus 192 siYlVFeYMdh-DL~GLl~~p~v--kft~~qIKc~mkQLl~Gl~~cH~~g--vlHRDIK~SNiLidn~G~LKiaDFGLAr 266 (560)
T KOG0600|consen 192 SIYLVFEYMDH-DLSGLLSSPGV--KFTEPQIKCYMKQLLEGLEYCHSRG--VLHRDIKGSNILIDNNGVLKIADFGLAR 266 (560)
T ss_pred eEEEEEecccc-hhhhhhcCCCc--ccChHHHHHHHHHHHHHHHHHhhcC--eeeccccccceEEcCCCCEEecccccee
Confidence 79999999987 88888875443 5999999999999999999999999 9999999999999999999999999999
Q ss_pred cCCCC-cccCCCCCCCCCccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhh-cCcc-------
Q 005247 584 SKPNT-YISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGF-KGRR------- 653 (706)
Q Consensus 584 ~~~~~-~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~-~~~~------- 653 (706)
..... ....+..+-|.+|+|||.+.|. .|+.++|+||.||||.||++|++.|.+.+..+....|-. .+.+
T Consensus 267 ~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~ 346 (560)
T KOG0600|consen 267 FYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPV 346 (560)
T ss_pred eccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccc
Confidence 65433 2234566789999999999885 589999999999999999999999999887666655521 1100
Q ss_pred cCCC-------------------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 654 LEIP-------------------KNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 654 l~~p-------------------~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
..+| ..+++...+|+..+|+.||.+|.|+.+++.
T Consensus 347 ~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 347 SKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred ccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 0111 245678899999999999999999998875
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=331.60 Aligned_cols=257 Identities=33% Similarity=0.576 Sum_probs=217.7
Q ss_pred ccccCceEEEEEeccCCceEEEEEEEcCC-ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEE
Q 005247 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI 507 (706)
Q Consensus 429 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~-~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l 507 (706)
.+..++|+++++||+|+||.||+|.+.++ .+|+|.+.... ...+.+.+|+.+++.++|+||+++++.+...+..++
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 78 (261)
T cd05072 2 EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT---MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYI 78 (261)
T ss_pred cCchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc---hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEE
Confidence 46678999999999999999999987654 48888865432 234678899999999999999999999999999999
Q ss_pred EEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCC
Q 005247 508 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 587 (706)
Q Consensus 508 V~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 587 (706)
+|||+.+++|.++++... ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++....
T Consensus 79 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05072 79 ITEYMAKGSLLDFLKSDE-GGKVLLPKLIDFSAQIAEGMAYIERKN--YIHRDLRAANVLVSESLMCKIADFGLARVIED 155 (261)
T ss_pred EEecCCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEecCCCcEEECCCccceecCC
Confidence 999999999999986432 235778889999999999999999999 99999999999999999999999999987654
Q ss_pred Cccc-CCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHH
Q 005247 588 TYIS-SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 665 (706)
Q Consensus 588 ~~~~-~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~ 665 (706)
.... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+. ...+.+.+..++.++.
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 234 (261)
T cd05072 156 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQ-RGYRMPRMENCPDELY 234 (261)
T ss_pred CceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHH
Confidence 3221 122345678999999998889999999999999999998 999998887776666653 3344555567899999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 005247 666 ALIETCWAEEPEIRPSFPSIMETLQQF 692 (706)
Q Consensus 666 dLI~~cL~~dP~~RPS~~eIl~~L~~l 692 (706)
++|.+||..+|++||+++++.+.|+++
T Consensus 235 ~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 235 DIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred HHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=346.94 Aligned_cols=248 Identities=27% Similarity=0.456 Sum_probs=219.0
Q ss_pred CceEEEEEeccCCceEEEEEEEc--CCceEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEE
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFH-EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 509 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKvl~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~ 509 (706)
.+|++.+.||+|.||+|-+|... ++.||||.+++.... +...-.+.+|++||+.|+||||+.+|++|+..+...|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 46888999999999999999764 445999998776554 345667889999999999999999999999999999999
Q ss_pred EeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCc
Q 005247 510 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 589 (706)
Q Consensus 510 E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 589 (706)
||..+|.|++|+... ..+++..+..+++||+.|+.|+|.++ ++|||||.+|||+|.++++||+|||++.......
T Consensus 133 EYaS~GeLYDYiSer---~~LsErEaRhfFRQIvSAVhYCHknr--VvHRDLKLENILLD~N~NiKIADFGLSNly~~~k 207 (668)
T KOG0611|consen 133 EYASGGELYDYISER---GSLSEREARHFFRQIVSAVHYCHKNR--VVHRDLKLENILLDQNNNIKIADFGLSNLYADKK 207 (668)
T ss_pred EecCCccHHHHHHHh---ccccHHHHHHHHHHHHHHHHHHhhcc--ceecccchhheeecCCCCeeeeccchhhhhcccc
Confidence 999999999999743 46999999999999999999999999 9999999999999999999999999998765543
Q ss_pred ccCCCCCCCCCccCccccccCCC-CchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHH
Q 005247 590 ISSKTAAGTPEWMAPEVLREDPS-NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI 668 (706)
Q Consensus 590 ~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI 668 (706)
..+++||++-|.+||++.+.+| .+.+|.||||++||.|.+|..||.+.+-...+.+|..+..+- +.-+....-||
T Consensus 208 -fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrE---P~~PSdA~gLI 283 (668)
T KOG0611|consen 208 -FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYRE---PETPSDASGLI 283 (668)
T ss_pred -HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccC---CCCCchHHHHH
Confidence 4578999999999999999988 578999999999999999999999999988888886554432 23456678899
Q ss_pred HHhhhhCCCCCCCHHHHHHHH
Q 005247 669 ETCWAEEPEIRPSFPSIMETL 689 (706)
Q Consensus 669 ~~cL~~dP~~RPS~~eIl~~L 689 (706)
++||..||++|.|+.+|...+
T Consensus 284 RwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 284 RWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred HHHHhcCcccchhHHHHhhhh
Confidence 999999999999999998754
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=330.97 Aligned_cols=258 Identities=26% Similarity=0.457 Sum_probs=214.3
Q ss_pred CceEEEEEeccCCceEEEEEEEc--CCceEEEEEeccc-cchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEE
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQE-FHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 509 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKvl~~~~-~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~ 509 (706)
++|++.+.||+|+||.||+|.+. +..||+|.+.... ........+.+|+.+++.++||||+++++++...+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57999999999999999999875 4559999875433 34455567889999999999999999999999999999999
Q ss_pred EeccCCchhhhcccC-CCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCC
Q 005247 510 EYLSRGSLYKLLHIP-DARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 588 (706)
Q Consensus 510 E~~~ggsL~~~l~~~-~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 588 (706)
||+++++|.+++... .....+++..+..++.|++.||+|||+++ ++|+||||+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~ 159 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence 999999999888532 22345788999999999999999999999 999999999999999999999999998876543
Q ss_pred cccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHhhhcCcccCCCCCCcHHHHH
Q 005247 589 YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTP--SQVISAVGFKGRRLEIPKNVNPMVAA 666 (706)
Q Consensus 589 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~--~~~~~~i~~~~~~l~~p~~~s~el~d 666 (706)
........++..|+|||.+.+..++.++|+||||+++|||++|+.||..... ......+.....+...+..++..+.+
T Consensus 160 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd08228 160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRE 239 (267)
T ss_pred hHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHH
Confidence 3333345788999999999988899999999999999999999999976532 33333332222222233467789999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHHHHHH
Q 005247 667 LIETCWAEEPEIRPSFPSIMETLQQF 692 (706)
Q Consensus 667 LI~~cL~~dP~~RPS~~eIl~~L~~l 692 (706)
+|.+||+.+|++||++.++++.++++
T Consensus 240 li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 240 LVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred HHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 99999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=345.20 Aligned_cols=257 Identities=26% Similarity=0.381 Sum_probs=223.0
Q ss_pred cccccCceEEEEEeccCCceEEEEEEEcCCc--eEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCceeEEeccccCCCc
Q 005247 428 LEIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFH-EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN 504 (706)
Q Consensus 428 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~--vAVKvl~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 504 (706)
..+..+.|++++.||.|.-|+||+++..++. +|+|++.+.... .+.......|-+||+.++||.++.+|..|+.+..
T Consensus 72 ~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~ 151 (459)
T KOG0610|consen 72 GSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKY 151 (459)
T ss_pred CccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccce
Confidence 4566778999999999999999999998864 999999776554 4556778889999999999999999999999999
Q ss_pred eEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCcccc
Q 005247 505 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 584 (706)
Q Consensus 505 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~ 584 (706)
.|++||||+||+|+.+++.+.. ..+++..++.++.+++-||+|||-.| ||.|||||+||||.++|+|.|+||.++..
T Consensus 152 ~cl~meyCpGGdL~~LrqkQp~-~~fse~~aRFYaAEvl~ALEYLHmlG--ivYRDLKPENILvredGHIMLsDFDLS~~ 228 (459)
T KOG0610|consen 152 SCLVMEYCPGGDLHSLRQKQPG-KRFSESAARFYAAEVLLALEYLHMLG--IVYRDLKPENILVREDGHIMLSDFDLSLR 228 (459)
T ss_pred eEEEEecCCCccHHHHHhhCCC-CccchhhHHHHHHHHHHHHHHHHhhc--eeeccCCcceeEEecCCcEEeeecccccc
Confidence 9999999999999999876543 46999999999999999999999999 99999999999999999999999998742
Q ss_pred CCC---------------------------------C-c----------------------ccCCCCCCCCCccCccccc
Q 005247 585 KPN---------------------------------T-Y----------------------ISSKTAAGTPEWMAPEVLR 608 (706)
Q Consensus 585 ~~~---------------------------------~-~----------------------~~~~~~~Gt~~Y~APE~l~ 608 (706)
... . . ..+..++||-+|+|||++.
T Consensus 229 ~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~ 308 (459)
T KOG0610|consen 229 CPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIR 308 (459)
T ss_pred CCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeee
Confidence 110 0 0 0112346999999999999
Q ss_pred cCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHHHHhhhhCCCCCCC----HHH
Q 005247 609 EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPS----FPS 684 (706)
Q Consensus 609 ~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS----~~e 684 (706)
+...+.++|+|+||++||||++|..||++.+..+.+..+..+...++-.+.++..+++||+++|.+||.+|.. ++|
T Consensus 309 G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~e 388 (459)
T KOG0610|consen 309 GEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAE 388 (459)
T ss_pred cCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHH
Confidence 9999999999999999999999999999999999888886555555544578899999999999999999987 777
Q ss_pred HHH
Q 005247 685 IME 687 (706)
Q Consensus 685 Il~ 687 (706)
|.+
T Consensus 389 IK~ 391 (459)
T KOG0610|consen 389 IKR 391 (459)
T ss_pred hhc
Confidence 754
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=351.27 Aligned_cols=250 Identities=26% Similarity=0.369 Sum_probs=209.8
Q ss_pred CceEEEEEeccCCceEEEEEEEcCC--ceEEEEEecccc-chHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEE
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 509 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~ 509 (706)
++|++.+.||+|+||+||+|.+..+ .||+|++..... .......+.+|+.++..++|+||+++++.+.+...+++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 3689999999999999999988654 499999876432 2334467888999999999999999999999999999999
Q ss_pred EeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCc
Q 005247 510 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 589 (706)
Q Consensus 510 E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 589 (706)
||+++|+|.+++... ..+++..+..++.|++.||+|||++| |+||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~g--ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 81 EFLPGGDMMTLLMKK---DTLTEEETQFYIAETVLAIDSIHQLG--FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred cCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 999999999998643 35889999999999999999999999 9999999999999999999999999987543210
Q ss_pred c-----------------------------------cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCC
Q 005247 590 I-----------------------------------SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKP 634 (706)
Q Consensus 590 ~-----------------------------------~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~P 634 (706)
. .....+||+.|+|||++.+..++.++|||||||++|||++|..|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P 235 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence 0 01235799999999999999999999999999999999999999
Q ss_pred CCCCChHHHHHHhhhcCcccCCCC--CCcHHHHHHHHHhhhhCCC---CCCCHHHHHHH
Q 005247 635 WRNSTPSQVISAVGFKGRRLEIPK--NVNPMVAALIETCWAEEPE---IRPSFPSIMET 688 (706)
Q Consensus 635 f~~~~~~~~~~~i~~~~~~l~~p~--~~s~el~dLI~~cL~~dP~---~RPS~~eIl~~ 688 (706)
|...+..+....+......+.+|+ .+++++++||.+|+. +|. .||++++|++.
T Consensus 236 f~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 236 FCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCC
Confidence 998888777776654334444554 468999999999775 444 45899999874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=348.33 Aligned_cols=242 Identities=26% Similarity=0.418 Sum_probs=207.7
Q ss_pred EEeccCCceEEEEEEEc-----CCceEEEEEeccccc--hHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEEe
Q 005247 439 KKIGEGSFGTVYHAEWR-----NSDVAVKILIEQEFH--EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY 511 (706)
Q Consensus 439 ~~LG~G~fG~Vy~a~~~-----~~~vAVKvl~~~~~~--~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~ 511 (706)
+.||+|+||.||+++.. +..||+|++...... ......+.+|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 67999999999999763 345999998764322 23345678899999999999999999999999999999999
Q ss_pred ccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCccc
Q 005247 512 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS 591 (706)
Q Consensus 512 ~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~ 591 (706)
+.+++|.+++... ..+.+..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++........
T Consensus 82 ~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 156 (323)
T cd05584 82 LSGGELFMHLERE---GIFMEDTACFYLSEISLALEHLHQQG--IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTV 156 (323)
T ss_pred CCCchHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCc
Confidence 9999999988643 34778889999999999999999999 999999999999999999999999998754333333
Q ss_pred CCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHHHHh
Q 005247 592 SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC 671 (706)
Q Consensus 592 ~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI~~c 671 (706)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||...+.......+. .....+|..+++++.+||.+|
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~ 234 (323)
T cd05584 157 THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKIL--KGKLNLPPYLTPEARDLLKKL 234 (323)
T ss_pred ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHH
Confidence 345679999999999999889999999999999999999999999888766666553 345677888999999999999
Q ss_pred hhhCCCCCC-----CHHHHHH
Q 005247 672 WAEEPEIRP-----SFPSIME 687 (706)
Q Consensus 672 L~~dP~~RP-----S~~eIl~ 687 (706)
|+.+|++|| ++.++++
T Consensus 235 l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 235 LKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred cccCHhHcCCCCCCCHHHHhc
Confidence 999999999 7888876
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=330.72 Aligned_cols=258 Identities=38% Similarity=0.653 Sum_probs=219.2
Q ss_pred ccccCceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceE
Q 005247 429 EIRWSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS 506 (706)
Q Consensus 429 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 506 (706)
++...+|.+.+.||+|+||.||+|.+.. +.+++|++.... ...+.+.+|+++++.++|+||+++++++...+.++
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (263)
T cd05052 2 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 78 (263)
T ss_pred CCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc---hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcE
Confidence 4556789999999999999999998764 458999875432 23467889999999999999999999999999999
Q ss_pred EEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCC
Q 005247 507 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP 586 (706)
Q Consensus 507 lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~ 586 (706)
++|||+++++|.+++.... ...+++..++.++.|++.||+|||+++ ++||||||+||+++.++.+||+|||++....
T Consensus 79 lv~e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~df~~~~~~~ 155 (263)
T cd05052 79 IITEFMTYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMT 155 (263)
T ss_pred EEEEeCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCCCcEEeCCCccccccc
Confidence 9999999999999986432 235788899999999999999999999 9999999999999999999999999988755
Q ss_pred CCcccC-CCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHH
Q 005247 587 NTYISS-KTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV 664 (706)
Q Consensus 587 ~~~~~~-~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el 664 (706)
...... ....++..|+|||.+.+..++.++||||||+++|||++ |..||......+....+. ...+...+..++.++
T Consensus 156 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 234 (263)
T cd05052 156 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KGYRMERPEGCPPKV 234 (263)
T ss_pred cceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-CCCCCCCCCCCCHHH
Confidence 432211 12234668999999999999999999999999999998 899998877766655543 344567778899999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 005247 665 AALIETCWAEEPEIRPSFPSIMETLQQFL 693 (706)
Q Consensus 665 ~dLI~~cL~~dP~~RPS~~eIl~~L~~ll 693 (706)
.++|.+||+.+|++||++.++++.|++++
T Consensus 235 ~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 263 (263)
T cd05052 235 YELMRACWQWNPSDRPSFAEIHQAFETMF 263 (263)
T ss_pred HHHHHHHccCCcccCCCHHHHHHHHHhhC
Confidence 99999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=328.54 Aligned_cols=250 Identities=36% Similarity=0.622 Sum_probs=213.3
Q ss_pred cCceEEEEEeccCCceEEEEEEEcCC-ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEE
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 510 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~~-~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E 510 (706)
.++|++.+.||+|+||.||++.++.. .+|+|.+...... .+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 79 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS---EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTE 79 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCcc---HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEE
Confidence 45789999999999999999988654 5899987644333 2468889999999999999999999999999999999
Q ss_pred eccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcc
Q 005247 511 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 590 (706)
Q Consensus 511 ~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~ 590 (706)
|+++|+|.++++... ..+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||.++.......
T Consensus 80 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05114 80 FMENGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERNS--FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY 155 (256)
T ss_pred cCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcceEEEcCCCeEEECCCCCccccCCCce
Confidence 999999999986432 24788999999999999999999999 99999999999999999999999999886543322
Q ss_pred c-CCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHH
Q 005247 591 S-SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI 668 (706)
Q Consensus 591 ~-~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI 668 (706)
. .....++..|+|||.+.+..++.++||||||+++|||++ |+.||...+..+....+. ...+...+...+.++.+|+
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~~~~li 234 (256)
T cd05114 156 TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMIS-RGFRLYRPKLASMTVYEVM 234 (256)
T ss_pred eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-CCCCCCCCCCCCHHHHHHH
Confidence 1 122345668999999998889999999999999999999 899998888777766664 3345556677889999999
Q ss_pred HHhhhhCCCCCCCHHHHHHHH
Q 005247 669 ETCWAEEPEIRPSFPSIMETL 689 (706)
Q Consensus 669 ~~cL~~dP~~RPS~~eIl~~L 689 (706)
.+||+.+|++||++.++++.|
T Consensus 235 ~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 235 YSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred HHHccCCcccCcCHHHHHHhh
Confidence 999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=352.62 Aligned_cols=249 Identities=25% Similarity=0.391 Sum_probs=211.0
Q ss_pred CceEEEEEeccCCceEEEEEEEcC--CceEEEEEecccc-chHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEE
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 509 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~ 509 (706)
++|++.+.||+|+||.||+|++.. ..||+|++..... .......+.+|+.+++.++|+||+++++++.+++.+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 378999999999999999999864 4599999876532 2344567889999999999999999999999999999999
Q ss_pred EeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCc
Q 005247 510 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 589 (706)
Q Consensus 510 E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 589 (706)
||+.+|+|.+++... ..+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||++.......
T Consensus 81 E~~~~g~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 81 EYLPGGDMMTLLMKK---DTFTEEETRFYIAETILAIDSIHKLG--YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred CCCCCcHHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence 999999999998643 25889999999999999999999999 9999999999999999999999999986532211
Q ss_pred c--------------------------------------cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhC
Q 005247 590 I--------------------------------------SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL 631 (706)
Q Consensus 590 ~--------------------------------------~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG 631 (706)
. .....+||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G 235 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence 0 01124699999999999999999999999999999999999
Q ss_pred CCCCCCCChHHHHHHhhhcCcccCCCC--CCcHHHHHHHHHhhhhCCCCCCC---HHHHHH
Q 005247 632 QKPWRNSTPSQVISAVGFKGRRLEIPK--NVNPMVAALIETCWAEEPEIRPS---FPSIME 687 (706)
Q Consensus 632 ~~Pf~~~~~~~~~~~i~~~~~~l~~p~--~~s~el~dLI~~cL~~dP~~RPS---~~eIl~ 687 (706)
..||...+..+....+......+.++. .+++++.+||.+||. +|.+|++ +.+++.
T Consensus 236 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 236 YPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 999998888777666543344444444 468999999999997 9999997 888876
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=335.77 Aligned_cols=249 Identities=41% Similarity=0.717 Sum_probs=209.3
Q ss_pred EEEEEeccCCceEEEEEEEc------CCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEE
Q 005247 436 LIKKKIGEGSFGTVYHAEWR------NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 509 (706)
Q Consensus 436 ~i~~~LG~G~fG~Vy~a~~~------~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~ 509 (706)
++.+.||.|.||.||+|.+. +..|+||+++. ....+..+.+.+|++++++++||||+++++++...+..++|+
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~ 80 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP-SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM 80 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST-TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc-ccccccceeeeecccccccccccccccccccccccccccccc
Confidence 56889999999999999988 33489999844 334555789999999999999999999999999888899999
Q ss_pred EeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCC-
Q 005247 510 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT- 588 (706)
Q Consensus 510 E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~- 588 (706)
||+++|+|.++++.. ....+++..++.|+.||+.||.|||+++ ++|+||+++||+++.++.+||+|||++......
T Consensus 81 e~~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~--iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 81 EYCPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN--IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp E--TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT--EEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred ccccccccccccccc-cccccccccccccccccccccccccccc--cccccccccccccccccccccccccccccccccc
Confidence 999999999999754 1235889999999999999999999999 999999999999999999999999998876322
Q ss_pred -cccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHH
Q 005247 589 -YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA 666 (706)
Q Consensus 589 -~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~d 666 (706)
............|+|||.+.+..++.++||||||+++|||++ |+.||......+....+ ....++..+..++..+.+
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 236 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKL-KQGQRLPIPDNCPKDIYS 236 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHH-HTTEETTSBTTSBHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-cccccceeccchhHHHHH
Confidence 112233456778999999999999999999999999999999 78999988887777776 566777888899999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHHH
Q 005247 667 LIETCWAEEPEIRPSFPSIMETL 689 (706)
Q Consensus 667 LI~~cL~~dP~~RPS~~eIl~~L 689 (706)
+|.+||..+|++|||+.+|++.|
T Consensus 237 li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 237 LIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HHHHHT-SSGGGS--HHHHHHHH
T ss_pred HHHHHcCCChhhCcCHHHHHhcC
Confidence 99999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=354.97 Aligned_cols=266 Identities=31% Similarity=0.521 Sum_probs=220.4
Q ss_pred cCcccccCceEEEEEeccCCceEEEEEEEcCC-------ceEEEEEeccccchHHHHHHHHHHHHHHcCC-CCceeEEec
Q 005247 426 EGLEIRWSELLIKKKIGEGSFGTVYHAEWRNS-------DVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMG 497 (706)
Q Consensus 426 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~-------~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~ 497 (706)
..+++..++|++++.||+|+||.||+|.+.+. .||+|++.... .....+.+.+|+.+++++. ||||+++++
T Consensus 30 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~ 108 (400)
T cd05105 30 SRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLLG 108 (400)
T ss_pred CceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEEE
Confidence 34667778999999999999999999986432 38999885443 3344568999999999996 999999999
Q ss_pred cccCCCceEEEEEeccCCchhhhcccCCC---------------------------------------------------
Q 005247 498 AVTEPPNLSIVTEYLSRGSLYKLLHIPDA--------------------------------------------------- 526 (706)
Q Consensus 498 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~--------------------------------------------------- 526 (706)
++.+.+..++||||+++|+|.++++....
T Consensus 109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (400)
T cd05105 109 ACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQY 188 (400)
T ss_pred EEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccccc
Confidence 99999999999999999999988753210
Q ss_pred ------------------------------------------cccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCC
Q 005247 527 ------------------------------------------RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSP 564 (706)
Q Consensus 527 ------------------------------------------~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~ 564 (706)
...+++..+..++.||+.||+|||+++ |+||||||+
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dikp~ 266 (400)
T cd05105 189 VPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN--CVHRDLAAR 266 (400)
T ss_pred chhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChH
Confidence 123677788999999999999999999 999999999
Q ss_pred cEEECCCCcEEEeecCccccCCCCc--ccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChH
Q 005247 565 NLLVDSTYTVKVCDFGLSRSKPNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPS 641 (706)
Q Consensus 565 NILl~~~~~vKL~DFGla~~~~~~~--~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~ 641 (706)
|||++.++.+||+|||+++...... .......++..|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus 267 Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~ 346 (400)
T cd05105 267 NVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD 346 (400)
T ss_pred hEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh
Confidence 9999999999999999987643321 12223456788999999999999999999999999999997 89999876544
Q ss_pred HHHHHhhhcCcccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 005247 642 QVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLM 694 (706)
Q Consensus 642 ~~~~~i~~~~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~ 694 (706)
...........++..+..++.++.++|.+||+.+|++||++.+|.+.|++++.
T Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 347 STFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred HHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 44333333445666778899999999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=330.01 Aligned_cols=256 Identities=36% Similarity=0.591 Sum_probs=217.6
Q ss_pred cCceEEEEEeccCCceEEEEEEEcCC-----ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceE
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRNS-----DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS 506 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~~-----~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 506 (706)
.++|++.+.||+|+||.||+|.+... .+|+|++.... .......+.+|+.+++.++|+||+++++++...+..+
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVM 81 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceE
Confidence 46799999999999999999987532 48888875433 3445567899999999999999999999999999999
Q ss_pred EEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCC
Q 005247 507 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP 586 (706)
Q Consensus 507 lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~ 586 (706)
++|||+++++|.+++.... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++...
T Consensus 82 iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 82 IITEYMENGSLDKFLREND--GKFTVGQLVGMLRGIASGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEEEcCCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 9999999999999986433 25789999999999999999999999 9999999999999999999999999998764
Q ss_pred CCcc--cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCCCCCcHH
Q 005247 587 NTYI--SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPM 663 (706)
Q Consensus 587 ~~~~--~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~e 663 (706)
.... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+. ...+.+.+..+++.
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 236 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVE-DGYRLPPPMDCPSA 236 (266)
T ss_pred ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHH
Confidence 2211 1122345678999999998899999999999999999998 999998877766666553 33455667788999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 005247 664 VAALIETCWAEEPEIRPSFPSIMETLQQFL 693 (706)
Q Consensus 664 l~dLI~~cL~~dP~~RPS~~eIl~~L~~ll 693 (706)
+.+|+.+||+.+|++||++.+|++.|.+++
T Consensus 237 l~~li~~cl~~~p~~Rp~~~ei~~~l~~~~ 266 (266)
T cd05033 237 LYQLMLDCWQKDRNERPTFSQIVSTLDKMI 266 (266)
T ss_pred HHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=353.15 Aligned_cols=250 Identities=28% Similarity=0.370 Sum_probs=208.1
Q ss_pred CceEEEEEeccCCceEEEEEEEcCC--ceEEEEEecccc-chHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEE
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 509 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~ 509 (706)
+.|++++.||+|+||+||+|.+..+ .||+|++..... .....+.+.+|+.+++.++|+||+++++++.+.+.+++||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence 3689999999999999999988655 499999876543 3345677899999999999999999999999999999999
Q ss_pred EeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCc
Q 005247 510 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 589 (706)
Q Consensus 510 E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 589 (706)
||+++|+|.+++.... .+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 81 DYIPGGDMMSLLIRME---VFPEVLARFYIAELTLAIESVHKMG--FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred ecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 9999999999986432 5888999999999999999999999 9999999999999999999999999875321000
Q ss_pred -----------------------------------------------ccCCCCCCCCCccCccccccCCCCchhHHHHHH
Q 005247 590 -----------------------------------------------ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFG 622 (706)
Q Consensus 590 -----------------------------------------------~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLG 622 (706)
.......||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 001235799999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCC--CCcHHHHHHHHHhhh--hCCCCCCCHHHHHH
Q 005247 623 VILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPK--NVNPMVAALIETCWA--EEPEIRPSFPSIME 687 (706)
Q Consensus 623 viL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~--~~s~el~dLI~~cL~--~dP~~RPS~~eIl~ 687 (706)
|++|||++|..||...++.+....+......+.++. .+++++.+||.+|++ .+|..||++.+++.
T Consensus 236 ~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~ 304 (381)
T cd05626 236 VILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKA 304 (381)
T ss_pred hHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence 999999999999998877666555543333344443 689999999999654 45556999999987
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=354.92 Aligned_cols=265 Identities=36% Similarity=0.540 Sum_probs=212.4
Q ss_pred cccccCceEEEEEeccCCceEEEEEEEcC-CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCC-ce
Q 005247 428 LEIRWSELLIKKKIGEGSFGTVYHAEWRN-SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP-NL 505 (706)
Q Consensus 428 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~-~~ 505 (706)
+....++|.-.+.||+|+||.||+|...+ +.||||.+....... .++|.+|+.++.+++|||+|+++|||.+.+ ..
T Consensus 70 l~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~ 147 (361)
T KOG1187|consen 70 LRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHR 147 (361)
T ss_pred HHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecCCceE
Confidence 45556788888999999999999999887 569999775544332 356999999999999999999999999998 49
Q ss_pred EEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcC-CCcccccCCCCcEEECCCCcEEEeecCcccc
Q 005247 506 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR-PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 584 (706)
Q Consensus 506 ~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g-~~IIHrDLKp~NILl~~~~~vKL~DFGla~~ 584 (706)
++|+||+++|+|.+.++..... .++|..+.+|+.++++||+|||... ++||||||||.|||+|.++++||+|||+|+.
T Consensus 148 ~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~ 226 (361)
T KOG1187|consen 148 LLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKL 226 (361)
T ss_pred EEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCccc
Confidence 9999999999999999865443 7899999999999999999999854 6899999999999999999999999999977
Q ss_pred CCCCcccCCCC-CCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHh---hhcCcc----
Q 005247 585 KPNTYISSKTA-AGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNST---PSQVISAV---GFKGRR---- 653 (706)
Q Consensus 585 ~~~~~~~~~~~-~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~---~~~~~~~i---~~~~~~---- 653 (706)
.+.......+. .||..|+|||.+..+..+.|+||||||++|.||+||+.|..... ......+. .....-
T Consensus 227 ~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eii 306 (361)
T KOG1187|consen 227 GPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIV 306 (361)
T ss_pred CCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhhee
Confidence 65411122223 89999999999999999999999999999999999998876532 11122211 011100
Q ss_pred -cCCC-CCCc-----HHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHh
Q 005247 654 -LEIP-KNVN-----PMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS 695 (706)
Q Consensus 654 -l~~p-~~~s-----~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s 695 (706)
..+. ...+ ..+..+..+|++.+|.+||++.||++.|+.+...
T Consensus 307 D~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 307 DPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred CCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 1111 1222 2366788899999999999999999999666544
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=342.56 Aligned_cols=251 Identities=25% Similarity=0.423 Sum_probs=208.6
Q ss_pred cccCceEEEEEeccCCceEEEEEEEcCCc--eEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEE
Q 005247 430 IRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI 507 (706)
Q Consensus 430 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~--vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l 507 (706)
+..++|++.+.||+|+||.||++.+..++ +|+|++.... .....+.+.+|+++++.++||||+++++++...+..++
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 44678999999999999999999987554 8888876542 34455679999999999999999999999999999999
Q ss_pred EEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhc-CCCcccccCCCCcEEECCCCcEEEeecCccccCC
Q 005247 508 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR-RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP 586 (706)
Q Consensus 508 V~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~-g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~ 586 (706)
||||+++++|.+++.... .+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||++....
T Consensus 81 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 155 (331)
T cd06649 81 CMEHMDGGSLDQVLKEAK---RIPEEILGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (331)
T ss_pred EeecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhhcCC--EEcCCCChhhEEEcCCCcEEEccCccccccc
Confidence 999999999999986432 478999999999999999999985 6 9999999999999999999999999987654
Q ss_pred CCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhh-----------------
Q 005247 587 NTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGF----------------- 649 (706)
Q Consensus 587 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~----------------- 649 (706)
... .....|++.|+|||++.+..++.++|||||||++|||++|+.||......+....+..
T Consensus 156 ~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (331)
T cd06649 156 DSM--ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRP 233 (331)
T ss_pred ccc--cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccc
Confidence 332 2345789999999999999999999999999999999999999976655443222110
Q ss_pred ----------------------------cCcccCCC-CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 005247 650 ----------------------------KGRRLEIP-KNVNPMVAALIETCWAEEPEIRPSFPSIMET 688 (706)
Q Consensus 650 ----------------------------~~~~l~~p-~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~ 688 (706)
...+...+ ..+++++++||.+||+.||++|||+++|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 234 RPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred ccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00011111 2467899999999999999999999999874
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=326.01 Aligned_cols=251 Identities=24% Similarity=0.340 Sum_probs=214.2
Q ss_pred CceEEEEEeccCCceEEEEEEEcCCc--eEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEE
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 510 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~~~--vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E 510 (706)
.+|...++||+|.||.||+|.+..++ ||||.++.....+......++|+..|+.++|+||+.++++|...+.+.+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 36778899999999999999987554 9999998776666556788999999999999999999999999999999999
Q ss_pred eccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcc
Q 005247 511 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 590 (706)
Q Consensus 511 ~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~ 590 (706)
|++. +|+..++... ..+....+..++.++++||+|||++. |+||||||+|+||+.+|.+||+|||+|+..+.+..
T Consensus 82 fm~t-dLe~vIkd~~--i~l~pa~iK~y~~m~LkGl~y~H~~~--IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKN--IILSPADIKSYMLMTLKGLAYCHSKW--ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred eccc-cHHHHhcccc--cccCHHHHHHHHHHHHHHHHHHHhhh--hhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence 9965 8999887544 46889999999999999999999999 99999999999999999999999999999888766
Q ss_pred cCCCCCCCCCccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhc--Cccc-------------
Q 005247 591 SSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK--GRRL------------- 654 (706)
Q Consensus 591 ~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~--~~~l------------- 654 (706)
.....+-|.+|+|||.+.|. .|+..+|+||.|||+.||+-|.+-|.+.++-+....+-.. ....
T Consensus 157 ~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~ 236 (318)
T KOG0659|consen 157 IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYV 236 (318)
T ss_pred ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHH
Confidence 66666889999999998875 6899999999999999999998888887766655444211 1110
Q ss_pred -----C------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 005247 655 -----E------IPKNVNPMVAALIETCWAEEPEIRPSFPSIMET 688 (706)
Q Consensus 655 -----~------~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~ 688 (706)
+ +-..++....+|+.+||..||.+|+++.|+++.
T Consensus 237 ~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 237 KIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 0 112456778999999999999999999998763
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=325.39 Aligned_cols=250 Identities=28% Similarity=0.456 Sum_probs=216.9
Q ss_pred ceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEEe
Q 005247 434 ELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY 511 (706)
Q Consensus 434 ~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~ 511 (706)
+|++.+.||+|+||.||+|.+.. ..|++|.+..........+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 47889999999999999998754 4599999876655666677899999999999999999999999999999999999
Q ss_pred ccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCccc
Q 005247 512 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS 591 (706)
Q Consensus 512 ~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~ 591 (706)
+++++|.++++... ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~--i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~ 157 (256)
T cd08529 81 AENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHSKK--ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF 157 (256)
T ss_pred CCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence 99999999987432 235888999999999999999999999 999999999999999999999999998876554333
Q ss_pred CCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHHHHh
Q 005247 592 SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC 671 (706)
Q Consensus 592 ~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI~~c 671 (706)
.....|++.|+|||++.+..++.++|+||||+++|+|++|+.||...+..+....+. ......++..++..+.++|.+|
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~ 236 (256)
T cd08529 158 ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKII-RGVFPPVSQMYSQQLAQLIDQC 236 (256)
T ss_pred hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-cCCCCCCccccCHHHHHHHHHH
Confidence 345578899999999999999999999999999999999999998887666555442 3344456667899999999999
Q ss_pred hhhCCCCCCCHHHHHH
Q 005247 672 WAEEPEIRPSFPSIME 687 (706)
Q Consensus 672 L~~dP~~RPS~~eIl~ 687 (706)
|+.+|++||++.++++
T Consensus 237 l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 237 LTKDYRQRPDTFQLLR 252 (256)
T ss_pred ccCCcccCcCHHHHhh
Confidence 9999999999999876
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=349.19 Aligned_cols=243 Identities=27% Similarity=0.462 Sum_probs=208.2
Q ss_pred EEeccCCceEEEEEEEcCC--ceEEEEEecccc-chHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEEeccCC
Q 005247 439 KKIGEGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRG 515 (706)
Q Consensus 439 ~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~~~gg 515 (706)
+.||+|+||.||++.+..+ .||+|++..... .......+.+|+.+++.++||||+++++++...+..++||||+.+|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999987644 499999876433 2334567788999999999999999999999999999999999999
Q ss_pred chhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHh-cCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcccCCC
Q 005247 516 SLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ-RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKT 594 (706)
Q Consensus 516 sL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs-~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 594 (706)
+|..++... ..+++..+..++.||+.||.|||+ +| |+||||||+|||++.++.+||+|||+++...........
T Consensus 81 ~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~~~--ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 155 (325)
T cd05594 81 ELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT 155 (325)
T ss_pred cHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccccc
Confidence 999888643 258899999999999999999997 78 999999999999999999999999998754333223345
Q ss_pred CCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHHHHhhhh
Q 005247 595 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAE 674 (706)
Q Consensus 595 ~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI~~cL~~ 674 (706)
..||+.|+|||++.+..++.++|||||||++|||++|..||...+..+....+. .....+|..+++++.+||.+||+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~li~~~L~~ 233 (325)
T cd05594 156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL--MEEIRFPRTLSPEAKSLLSGLLKK 233 (325)
T ss_pred ccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHh--cCCCCCCCCCCHHHHHHHHHHhhc
Confidence 679999999999999999999999999999999999999998887766665553 345667888999999999999999
Q ss_pred CCCCCC-----CHHHHHHH
Q 005247 675 EPEIRP-----SFPSIMET 688 (706)
Q Consensus 675 dP~~RP-----S~~eIl~~ 688 (706)
||++|+ ++.++++.
T Consensus 234 dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 234 DPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CHHHhCCCCCCCHHHHhcC
Confidence 999996 89998763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=344.72 Aligned_cols=247 Identities=26% Similarity=0.432 Sum_probs=210.7
Q ss_pred ceEEEEEeccCCceEEEEEEEcCC--ceEEEEEecccc-chHHHHHHHHHHHHHHcC-CCCceeEEeccccCCCceEEEE
Q 005247 434 ELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSIVT 509 (706)
Q Consensus 434 ~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~lV~ 509 (706)
+|++.+.||+|+||.||+|.+.++ .||+|++..... .....+.+..|..++..+ +|++|+++++++...+.+++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 588999999999999999988755 499999876432 223345667788888877 5899999999999999999999
Q ss_pred EeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCc
Q 005247 510 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 589 (706)
Q Consensus 510 E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 589 (706)
||+++|+|.+++... ..+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 81 EYVNGGDLMYQIQQV---GRFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG 155 (323)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--EEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence 999999999888643 24889999999999999999999999 9999999999999999999999999987644333
Q ss_pred ccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHHH
Q 005247 590 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE 669 (706)
Q Consensus 590 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI~ 669 (706)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+. .....+|..++.++.+||.
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~li~ 233 (323)
T cd05616 156 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM--EHNVAYPKSMSKEAVAICK 233 (323)
T ss_pred CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHH--hCCCCCCCcCCHHHHHHHH
Confidence 33445679999999999999999999999999999999999999999888777766653 3455677889999999999
Q ss_pred HhhhhCCCCCCCH-----HHHHH
Q 005247 670 TCWAEEPEIRPSF-----PSIME 687 (706)
Q Consensus 670 ~cL~~dP~~RPS~-----~eIl~ 687 (706)
+||+.+|++|++. .++++
T Consensus 234 ~~l~~~p~~R~~~~~~~~~~i~~ 256 (323)
T cd05616 234 GLMTKHPGKRLGCGPEGERDIKE 256 (323)
T ss_pred HHcccCHHhcCCCCCCCHHHHhc
Confidence 9999999999984 56654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=329.44 Aligned_cols=255 Identities=31% Similarity=0.557 Sum_probs=211.9
Q ss_pred EEEEEeccCCceEEEEEEEcCC----ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCC------Cce
Q 005247 436 LIKKKIGEGSFGTVYHAEWRNS----DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP------PNL 505 (706)
Q Consensus 436 ~i~~~LG~G~fG~Vy~a~~~~~----~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~------~~~ 505 (706)
.+.+.||+|+||.||+|.+... .+|+|.++.........+.+.+|+.+++.++|+||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 4678999999999999987654 378888766555566678899999999999999999999876322 246
Q ss_pred EEEEEeccCCchhhhccc---CCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCcc
Q 005247 506 SIVTEYLSRGSLYKLLHI---PDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS 582 (706)
Q Consensus 506 ~lV~E~~~ggsL~~~l~~---~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla 582 (706)
+++|||+.+|+|.+++.. ......+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS--FIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhheEEcCCCCEEECCCCcc
Confidence 899999999999888732 122345789999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCcc--cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCCCC
Q 005247 583 RSKPNTYI--SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKN 659 (706)
Q Consensus 583 ~~~~~~~~--~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p~~ 659 (706)
+....... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+....+. .......+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~ 238 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLR-QGNRLKQPPD 238 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-cCCCCCCCCC
Confidence 87543221 1123346778999999999999999999999999999999 789998877766665553 3445566778
Q ss_pred CcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 005247 660 VNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 693 (706)
Q Consensus 660 ~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll 693 (706)
++..+.++|.+||+.||++|||+.+|++.|++++
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 272 (272)
T cd05075 239 CLDGLYSLMSSCWLLNPKDRPSFETLRCELEKAL 272 (272)
T ss_pred CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 8999999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=329.71 Aligned_cols=256 Identities=31% Similarity=0.540 Sum_probs=215.7
Q ss_pred eEEEEEeccCCceEEEEEEEcC-----CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCc-----
Q 005247 435 LLIKKKIGEGSFGTVYHAEWRN-----SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN----- 504 (706)
Q Consensus 435 y~i~~~LG~G~fG~Vy~a~~~~-----~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~----- 504 (706)
|++.+.||+|+||.||+|.... ..+|+|.+............+.+|+.+++.++|+||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5678999999999999998653 349999987665556667789999999999999999999998765543
Q ss_pred -eEEEEEeccCCchhhhcccC---CCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecC
Q 005247 505 -LSIVTEYLSRGSLYKLLHIP---DARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFG 580 (706)
Q Consensus 505 -~~lV~E~~~ggsL~~~l~~~---~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFG 580 (706)
.+++|||+.+++|..++... .....+++..++.++.|++.||+|||+++ ++||||||+||++++++.+||+|||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~dfg 158 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN--FIHRDLAARNCMLREDMTVCVADFG 158 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchheEEECCCCeEEECCcc
Confidence 79999999999999888432 12235888999999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCcc--cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCC
Q 005247 581 LSRSKPNTYI--SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIP 657 (706)
Q Consensus 581 la~~~~~~~~--~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p 657 (706)
+++....... ......++..|+|||.+.+..++.++||||||+++|||++ |..||......+....+. .......+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~ 237 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLR-HGNRLKQP 237 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCC
Confidence 9886543221 1122345678999999988889999999999999999999 899998877777666553 44566678
Q ss_pred CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 005247 658 KNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 693 (706)
Q Consensus 658 ~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll 693 (706)
..++.++.++|.+||+.||.+||++.++++.|++++
T Consensus 238 ~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~~ 273 (273)
T cd05035 238 EDCLDELYDLMYSCWRADPKDRPTFTKLREVLENIL 273 (273)
T ss_pred cCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence 889999999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=330.76 Aligned_cols=258 Identities=32% Similarity=0.569 Sum_probs=219.0
Q ss_pred ccccCceEEEEEeccCCceEEEEEEEcC-------CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccC
Q 005247 429 EIRWSELLIKKKIGEGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE 501 (706)
Q Consensus 429 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~-------~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~ 501 (706)
++..++|++.+.||+|+||.||++.+.+ ..+|+|.+.... .......+.+|+.+++.++|+||+++++++..
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 80 (277)
T cd05032 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVST 80 (277)
T ss_pred ccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC
Confidence 4567789999999999999999998753 348999875433 33445678899999999999999999999999
Q ss_pred CCceEEEEEeccCCchhhhcccCC-------CcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcE
Q 005247 502 PPNLSIVTEYLSRGSLYKLLHIPD-------ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTV 574 (706)
Q Consensus 502 ~~~~~lV~E~~~ggsL~~~l~~~~-------~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~v 574 (706)
....++||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+
T Consensus 81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~di~p~nill~~~~~~ 158 (277)
T cd05032 81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK--FVHRDLAARNCMVAEDLTV 158 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccChheEEEcCCCCE
Confidence 999999999999999999985322 1224678889999999999999999999 9999999999999999999
Q ss_pred EEeecCccccCCCCc--ccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcC
Q 005247 575 KVCDFGLSRSKPNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKG 651 (706)
Q Consensus 575 KL~DFGla~~~~~~~--~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~ 651 (706)
||+|||+++...... .......++..|+|||.+.+..++.++||||||+++||+++ |..||...+..+....+. ..
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~-~~ 237 (277)
T cd05032 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI-DG 237 (277)
T ss_pred EECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh-cC
Confidence 999999987654322 12233456789999999988889999999999999999998 999998888777776664 44
Q ss_pred cccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 005247 652 RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQ 690 (706)
Q Consensus 652 ~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~ 690 (706)
....+|..++.++.++|.+||+.+|++|||+.++++.|+
T Consensus 238 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 238 GHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 556778889999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=349.01 Aligned_cols=239 Identities=27% Similarity=0.415 Sum_probs=207.2
Q ss_pred EEeccCCceEEEEEEEc-----CCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEEecc
Q 005247 439 KKIGEGSFGTVYHAEWR-----NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLS 513 (706)
Q Consensus 439 ~~LG~G~fG~Vy~a~~~-----~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~~~ 513 (706)
+.||+|+||.||+++.. +..+|+|++............+.+|++++++++||||+++++++.+++.+++||||+.
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 57999999999998752 3459999987655444445567889999999999999999999999999999999999
Q ss_pred CCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcccCC
Q 005247 514 RGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSK 593 (706)
Q Consensus 514 ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~ 593 (706)
+|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...........
T Consensus 82 ~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~ 156 (318)
T cd05582 82 GGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY 156 (318)
T ss_pred CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCcee
Confidence 99999988643 35889999999999999999999999 99999999999999999999999999886554433344
Q ss_pred CCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHHHHhhh
Q 005247 594 TAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWA 673 (706)
Q Consensus 594 ~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI~~cL~ 673 (706)
...|++.|+|||.+.+..++.++|||||||++|||++|+.||...+..+....+. .....+|..+++.+.+||.+||+
T Consensus 157 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~li~~~l~ 234 (318)
T cd05582 157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMIL--KAKLGMPQFLSPEAQSLLRALFK 234 (318)
T ss_pred cccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHHhh
Confidence 5679999999999999889999999999999999999999999888777666553 34556788899999999999999
Q ss_pred hCCCCCCCHHH
Q 005247 674 EEPEIRPSFPS 684 (706)
Q Consensus 674 ~dP~~RPS~~e 684 (706)
.||++||++.+
T Consensus 235 ~~P~~R~~a~~ 245 (318)
T cd05582 235 RNPANRLGAGP 245 (318)
T ss_pred cCHhHcCCCCC
Confidence 99999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=336.40 Aligned_cols=267 Identities=32% Similarity=0.584 Sum_probs=223.4
Q ss_pred CcccccCceEEEEEeccCCceEEEEEEEcC---------CceEEEEEeccccchHHHHHHHHHHHHHHcC-CCCceeEEe
Q 005247 427 GLEIRWSELLIKKKIGEGSFGTVYHAEWRN---------SDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLM 496 (706)
Q Consensus 427 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~---------~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~ 496 (706)
.+++..++|.+.+.||+|+||.||++.+.+ ..+|+|.+.... .......+.+|+.+++.+ +|+||++++
T Consensus 12 ~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~ 90 (307)
T cd05098 12 RWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLL 90 (307)
T ss_pred cceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence 356667899999999999999999997642 238888876542 334456788999999999 799999999
Q ss_pred ccccCCCceEEEEEeccCCchhhhcccCCC-------------cccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCC
Q 005247 497 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDA-------------RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKS 563 (706)
Q Consensus 497 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~-------------~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp 563 (706)
+++...+..++||||+.+|+|.+++..... ...+++..++.++.|++.||+|||++| ++||||||
T Consensus 91 ~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp 168 (307)
T cd05098 91 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK--CIHRDLAA 168 (307)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--cccccccH
Confidence 999999999999999999999999964321 124788899999999999999999999 99999999
Q ss_pred CcEEECCCCcEEEeecCccccCCCCccc--CCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCh
Q 005247 564 PNLLVDSTYTVKVCDFGLSRSKPNTYIS--SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTP 640 (706)
Q Consensus 564 ~NILl~~~~~vKL~DFGla~~~~~~~~~--~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~ 640 (706)
+||+++.++.+||+|||+++........ .....++..|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 169 ~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~ 248 (307)
T cd05098 169 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 248 (307)
T ss_pred HheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH
Confidence 9999999999999999998765432211 112234568999999999889999999999999999998 8899988776
Q ss_pred HHHHHHhhhcCcccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhcc
Q 005247 641 SQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSV 697 (706)
Q Consensus 641 ~~~~~~i~~~~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~~ 697 (706)
.+....+. ...+...+..++.++.+||.+||..+|++|||+.++++.|++++....
T Consensus 249 ~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~ 304 (307)
T cd05098 249 EELFKLLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTS 304 (307)
T ss_pred HHHHHHHH-cCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhh
Confidence 66555543 444567778899999999999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=377.51 Aligned_cols=267 Identities=34% Similarity=0.580 Sum_probs=230.5
Q ss_pred cccCceEEEEEeccCCceEEEEEEEcCC-----c--eEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCC
Q 005247 430 IRWSELLIKKKIGEGSFGTVYHAEWRNS-----D--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP 502 (706)
Q Consensus 430 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~-----~--vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~ 502 (706)
+.....++.+.||+|.||.||.|...+. + ||+|.+.+.. +.....+|++|..+|+.++|||||+++|++.+.
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~-~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~ 767 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS-SEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS 767 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC
Confidence 5678889999999999999999976432 2 7778775543 556678999999999999999999999999999
Q ss_pred CceEEEEEeccCCchhhhcccCC----CcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEee
Q 005247 503 PNLSIVTEYLSRGSLYKLLHIPD----ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCD 578 (706)
Q Consensus 503 ~~~~lV~E~~~ggsL~~~l~~~~----~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~D 578 (706)
...+|++|||.+|+|..+|+... ....+.....+.++.+|++|+.||++++ +|||||...|+|++....|||+|
T Consensus 768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~--fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH--FVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC--CcCcchhhhheeecccCcEEEcc
Confidence 99999999999999999997541 1335788899999999999999999999 99999999999999999999999
Q ss_pred cCccccCCC-CcccCCC-CCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccC
Q 005247 579 FGLSRSKPN-TYISSKT-AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLE 655 (706)
Q Consensus 579 FGla~~~~~-~~~~~~~-~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~ 655 (706)
||+|+...+ .+..... ..-...|||||.+....++.|+|||||||+|||++| |..||...+..++...+...+ |++
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-RL~ 924 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-RLD 924 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-ccC
Confidence 999994333 2222222 234568999999999999999999999999999999 799999999888887665444 999
Q ss_pred CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhccCCC
Q 005247 656 IPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQP 700 (706)
Q Consensus 656 ~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~~~~~ 700 (706)
.|..|+..++++|..||+.+|++||+|..|++.+.+++.......
T Consensus 925 ~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~~ 969 (1025)
T KOG1095|consen 925 PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGTI 969 (1025)
T ss_pred CCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccCc
Confidence 999999999999999999999999999999999999887765443
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=353.12 Aligned_cols=250 Identities=22% Similarity=0.350 Sum_probs=208.9
Q ss_pred CceEEEEEeccCCceEEEEEEEcCC--ceEEEEEecccc-chHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEE
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 509 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~ 509 (706)
++|++++.||+|+||.||++.+..+ .||+|++..... .....+.+.+|+++++.++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 3689999999999999999987644 499999865432 3345567889999999999999999999999999999999
Q ss_pred EeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCc
Q 005247 510 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 589 (706)
Q Consensus 510 E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 589 (706)
||+++|+|.+++... ..+++..+..++.|++.||+|||++| |+||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 81 EFLPGGDLMTMLIKY---DTFSEDVTRFYMAECVLAIEAVHKLG--FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 999999999998643 35889999999999999999999999 9999999999999999999999999986321100
Q ss_pred c-----------------------------------------------cCCCCCCCCCccCccccccCCCCchhHHHHHH
Q 005247 590 I-----------------------------------------------SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFG 622 (706)
Q Consensus 590 ~-----------------------------------------------~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLG 622 (706)
. .....+||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 235 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG 235 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence 0 00124699999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCC--CCcHHHHHHHHHhhhhCCCCC---CCHHHHHHH
Q 005247 623 VILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPK--NVNPMVAALIETCWAEEPEIR---PSFPSIMET 688 (706)
Q Consensus 623 viL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~--~~s~el~dLI~~cL~~dP~~R---PS~~eIl~~ 688 (706)
|++|||++|..||......+....+......+.+|. .++.++++||.+||. +|.+| +++.++++.
T Consensus 236 vil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 236 AIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred hhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 999999999999998887766665543334455554 578999999999998 77765 599988773
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=331.11 Aligned_cols=258 Identities=32% Similarity=0.582 Sum_probs=213.9
Q ss_pred ccccCceEEEEEeccCCceEEEEEEEcC-------CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccC
Q 005247 429 EIRWSELLIKKKIGEGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE 501 (706)
Q Consensus 429 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~-------~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~ 501 (706)
++..++|++.+.||+|+||.||+|.+.+ ..+|+|++.... .......+.+|+.+++.++|+||+++++++.+
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~ 80 (277)
T cd05062 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 80 (277)
T ss_pred cccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 3456789999999999999999997653 238998875432 23345678899999999999999999999999
Q ss_pred CCceEEEEEeccCCchhhhcccCCC-------cccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcE
Q 005247 502 PPNLSIVTEYLSRGSLYKLLHIPDA-------RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTV 574 (706)
Q Consensus 502 ~~~~~lV~E~~~ggsL~~~l~~~~~-------~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~v 574 (706)
....++||||+++++|.++++.... ...+....+..++.|++.||+|||+.+ ++||||||+||+++.++.+
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~vH~dlkp~Nil~~~~~~~ 158 (277)
T cd05062 81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTV 158 (277)
T ss_pred CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCcchheEEEcCCCCE
Confidence 9999999999999999999853221 123567788999999999999999999 9999999999999999999
Q ss_pred EEeecCccccCCCCccc--CCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcC
Q 005247 575 KVCDFGLSRSKPNTYIS--SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKG 651 (706)
Q Consensus 575 KL~DFGla~~~~~~~~~--~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~ 651 (706)
||+|||+++........ .....++..|+|||.+.+..++.++||||||+++|||++ |..||......+....+. ..
T Consensus 159 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~-~~ 237 (277)
T cd05062 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM-EG 237 (277)
T ss_pred EECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-cC
Confidence 99999998765432211 122345778999999999889999999999999999999 789998887766665543 33
Q ss_pred cccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 005247 652 RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQ 690 (706)
Q Consensus 652 ~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~ 690 (706)
.....+..++..+.++|.+||+.||++|||+.++++.|+
T Consensus 238 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 238 GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 345567788999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=332.01 Aligned_cols=258 Identities=31% Similarity=0.565 Sum_probs=215.4
Q ss_pred cccCceEEEEEeccCCceEEEEEEEc------CCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCC
Q 005247 430 IRWSELLIKKKIGEGSFGTVYHAEWR------NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP 503 (706)
Q Consensus 430 i~~~~y~i~~~LG~G~fG~Vy~a~~~------~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 503 (706)
+...+|++.+.||+|+||.||+|.+. +..+++|.+.... .......+.+|+.+++.++|+||+++++++...+
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 80 (283)
T cd05090 2 LPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ 80 (283)
T ss_pred CChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Confidence 34578999999999999999999752 2348888875432 3445567889999999999999999999999999
Q ss_pred ceEEEEEeccCCchhhhcccCC--------------CcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEEC
Q 005247 504 NLSIVTEYLSRGSLYKLLHIPD--------------ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVD 569 (706)
Q Consensus 504 ~~~lV~E~~~ggsL~~~l~~~~--------------~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~ 569 (706)
..+++|||+.+++|.+++.... ....+++..+..++.|++.||.|||+++ ++||||||+|||++
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~nili~ 158 (283)
T cd05090 81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF--FVHKDLAARNILIG 158 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC--eehhccccceEEEc
Confidence 9999999999999999884221 1234788889999999999999999999 99999999999999
Q ss_pred CCCcEEEeecCccccCCCCc--ccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 005247 570 STYTVKVCDFGLSRSKPNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISA 646 (706)
Q Consensus 570 ~~~~vKL~DFGla~~~~~~~--~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~ 646 (706)
.++.+||+|||+++...... .......++..|+|||.+.+..++.++||||||+++|||++ |..||....+......
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05090 159 EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM 238 (283)
T ss_pred CCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 99999999999997653321 11233445678999999998889999999999999999998 8999988777666555
Q ss_pred hhhcCcccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 005247 647 VGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 691 (706)
Q Consensus 647 i~~~~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ 691 (706)
+. ....+..+..+++.+.++|.+||+.||.+||++.+|++.|+.
T Consensus 239 ~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 239 VR-KRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HH-cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 53 344566778899999999999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=360.33 Aligned_cols=258 Identities=26% Similarity=0.412 Sum_probs=219.0
Q ss_pred cccccCceEEEEEeccCCceEEEEEEEc--CCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCC--
Q 005247 428 LEIRWSELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP-- 503 (706)
Q Consensus 428 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~-- 503 (706)
......+|++.+.||+|+||+||+|++. +..||+|++............+.+|+.++..++|+||++++..+....
T Consensus 27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR 106 (496)
T ss_pred ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence 3444579999999999999999999875 445999999777666667778899999999999999999988764332
Q ss_pred ------ceEEEEEeccCCchhhhcccC-CCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEE
Q 005247 504 ------NLSIVTEYLSRGSLYKLLHIP-DARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKV 576 (706)
Q Consensus 504 ------~~~lV~E~~~ggsL~~~l~~~-~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL 576 (706)
.+++||||+.+|+|.++++.. .....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||
T Consensus 107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~--IiHrDLKP~NILl~~~~~vkL 184 (496)
T PTZ00283 107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH--MIHRDIKSANILLCSNGLVKL 184 (496)
T ss_pred CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEeCCCCEEE
Confidence 367999999999999988532 22346889999999999999999999999 999999999999999999999
Q ss_pred eecCccccCCCCc--ccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCccc
Q 005247 577 CDFGLSRSKPNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRL 654 (706)
Q Consensus 577 ~DFGla~~~~~~~--~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l 654 (706)
+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+. .....
T Consensus 185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~-~~~~~ 263 (496)
T PTZ00283 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTL-AGRYD 263 (496)
T ss_pred EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh-cCCCC
Confidence 9999987654321 12345679999999999999999999999999999999999999999888777666553 33444
Q ss_pred CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 005247 655 EIPKNVNPMVAALIETCWAEEPEIRPSFPSIMET 688 (706)
Q Consensus 655 ~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~ 688 (706)
+++..+++++.+||.+||+.||.+||++.+++..
T Consensus 264 ~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 264 PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 6778899999999999999999999999999863
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=345.52 Aligned_cols=237 Identities=25% Similarity=0.418 Sum_probs=204.0
Q ss_pred EEeccCCceEEEEEEEcCC--ceEEEEEecccc-chHHHHHHHHHHHHHHcC-CCCceeEEeccccCCCceEEEEEeccC
Q 005247 439 KKIGEGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSIVTEYLSR 514 (706)
Q Consensus 439 ~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~lV~E~~~g 514 (706)
+.||+|+||.||+|+++.+ .||+|++..... .....+.+..|..+++.+ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999998654 499999875432 234456777888888876 699999999999999999999999999
Q ss_pred CchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcccCCC
Q 005247 515 GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKT 594 (706)
Q Consensus 515 gsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 594 (706)
|+|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++............
T Consensus 81 g~L~~~i~~~---~~l~~~~~~~~~~ql~~~L~~lH~~~--ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~ 155 (320)
T cd05590 81 GDLMFHIQKS---RRFDEARARFYAAEITSALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST 155 (320)
T ss_pred chHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccc
Confidence 9999888643 25889999999999999999999999 999999999999999999999999998764333223345
Q ss_pred CCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHHHHhhhh
Q 005247 595 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAE 674 (706)
Q Consensus 595 ~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI~~cL~~ 674 (706)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+. .....++..++.++.+||.+||+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~L~~ 233 (320)
T cd05590 156 FCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL--NDEVVYPTWLSQDAVDILKAFMTK 233 (320)
T ss_pred cccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHh--cCCCCCCCCCCHHHHHHHHHHccc
Confidence 679999999999999999999999999999999999999999988877776663 344566778999999999999999
Q ss_pred CCCCCCCH
Q 005247 675 EPEIRPSF 682 (706)
Q Consensus 675 dP~~RPS~ 682 (706)
||++||++
T Consensus 234 dP~~R~~~ 241 (320)
T cd05590 234 NPTMRLGS 241 (320)
T ss_pred CHHHCCCC
Confidence 99999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=351.67 Aligned_cols=255 Identities=25% Similarity=0.369 Sum_probs=215.5
Q ss_pred cccccCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCceeEEeccccCCCc
Q 005247 428 LEIRWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFH-EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN 504 (706)
Q Consensus 428 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 504 (706)
..+...+|++.+.||+|+||.||++++..+ .||+|++...... ....+.+.+|+.+++.++||||+++++++.+++.
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~ 117 (370)
T cd05596 38 LRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKY 117 (370)
T ss_pred CCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 455678999999999999999999988654 4999998654322 2334567789999999999999999999999999
Q ss_pred eEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCcccc
Q 005247 505 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 584 (706)
Q Consensus 505 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~ 584 (706)
.++||||+++|+|.+++... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~kL~DfG~~~~ 191 (370)
T cd05596 118 LYMVMEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (370)
T ss_pred EEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEcCCCCEEEEeccceee
Confidence 99999999999999998632 3788899999999999999999999 99999999999999999999999999876
Q ss_pred CCCCc-ccCCCCCCCCCccCccccccC----CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCC-
Q 005247 585 KPNTY-ISSKTAAGTPEWMAPEVLRED----PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPK- 658 (706)
Q Consensus 585 ~~~~~-~~~~~~~Gt~~Y~APE~l~~~----~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~- 658 (706)
..... .......||+.|+|||++.+. .++.++|||||||++|||++|..||...+.......+......+.+|.
T Consensus 192 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 271 (370)
T cd05596 192 MDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDD 271 (370)
T ss_pred ccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCc
Confidence 54322 123456799999999998754 378899999999999999999999998887777766654444455555
Q ss_pred -CCcHHHHHHHHHhhhhCCCC--CCCHHHHHHH
Q 005247 659 -NVNPMVAALIETCWAEEPEI--RPSFPSIMET 688 (706)
Q Consensus 659 -~~s~el~dLI~~cL~~dP~~--RPS~~eIl~~ 688 (706)
.++.++.+||.+||+.+|.+ |+++.+++..
T Consensus 272 ~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 272 IEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 57999999999999999988 9999999763
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=334.02 Aligned_cols=261 Identities=34% Similarity=0.593 Sum_probs=216.9
Q ss_pred cCceEEEEEeccCCceEEEEEEEcCCc----eEEEEEeccccchHHHHHHHHHHHHHHcC-CCCceeEEeccccCCCceE
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRNSD----VAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLS 506 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~----vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~ 506 (706)
+++|++.+.||+|+||.||+|....+. +++|.++.. ......+.+.+|+.++.++ +||||+++++++...+..+
T Consensus 1 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 1 WEDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF-ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred CccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc-CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 368999999999999999999875442 577766532 2334456789999999999 7999999999999999999
Q ss_pred EEEEeccCCchhhhcccCC-------------CcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCc
Q 005247 507 IVTEYLSRGSLYKLLHIPD-------------ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYT 573 (706)
Q Consensus 507 lV~E~~~ggsL~~~l~~~~-------------~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~ 573 (706)
++|||+++++|.++++... ....+++..++.++.|++.||+|||++| |+||||||+|||++.++.
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~ 157 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ--FIHRDLAARNVLVGENLA 157 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCcCCcceEEECCCCe
Confidence 9999999999999985422 1134788999999999999999999999 999999999999999999
Q ss_pred EEEeecCccccCCCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCc
Q 005247 574 VKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGR 652 (706)
Q Consensus 574 vKL~DFGla~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~ 652 (706)
+||+|||++....... .......+..|+|||.+.+..++.++|||||||++|||++ |..||......+....+. ...
T Consensus 158 ~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~-~~~ 235 (297)
T cd05089 158 SKIADFGLSRGEEVYV-KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLP-QGY 235 (297)
T ss_pred EEECCcCCCcccccee-ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh-cCC
Confidence 9999999986432211 1112233557999999999889999999999999999997 999999888777666553 334
Q ss_pred ccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhcc
Q 005247 653 RLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSV 697 (706)
Q Consensus 653 ~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~~ 697 (706)
....+..++..+.+||.+||+.+|.+||+++++++.|..++....
T Consensus 236 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~ 280 (297)
T cd05089 236 RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARK 280 (297)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 556677899999999999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=333.16 Aligned_cols=256 Identities=34% Similarity=0.564 Sum_probs=216.4
Q ss_pred ccCceEEEEEeccCCceEEEEEEEcC-------CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCC
Q 005247 431 RWSELLIKKKIGEGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP 503 (706)
Q Consensus 431 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-------~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 503 (706)
...+|.+.+.||+|+||.||+|.+.+ ..+|+|++.... ..+..+.+.+|+++++.++|+||+++++++....
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 81 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA-SNDARKDFEREAELLTNFQHENIVKFYGVCTEGD 81 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC-CHHHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence 35678899999999999999997643 348999876543 3334578999999999999999999999999999
Q ss_pred ceEEEEEeccCCchhhhcccCC-----------CcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCC
Q 005247 504 NLSIVTEYLSRGSLYKLLHIPD-----------ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY 572 (706)
Q Consensus 504 ~~~lV~E~~~ggsL~~~l~~~~-----------~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~ 572 (706)
..+++|||+++++|.++++..+ ....+++..+..++.|++.||.|||+++ ++||||||+||+++.++
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~h~dlkp~nili~~~~ 159 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH--FVHRDLATRNCLVGYDL 159 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eeccccccceEEEcCCC
Confidence 9999999999999999986432 2245788899999999999999999999 99999999999999999
Q ss_pred cEEEeecCccccCCCCc--ccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhh
Q 005247 573 TVKVCDFGLSRSKPNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGF 649 (706)
Q Consensus 573 ~vKL~DFGla~~~~~~~--~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~ 649 (706)
.+||+|||+++...... .......++..|+|||.+.+..++.++||||||+++|||++ |..||...+..+....+.
T Consensus 160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~- 238 (280)
T cd05049 160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT- 238 (280)
T ss_pred eEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-
Confidence 99999999987543221 11233456788999999999999999999999999999998 999998877777666654
Q ss_pred cCcccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 005247 650 KGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQ 690 (706)
Q Consensus 650 ~~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~ 690 (706)
.+.....+..++..++++|.+||+.||++||++.++++.|+
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 239 QGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 33444556788999999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=331.87 Aligned_cols=262 Identities=34% Similarity=0.582 Sum_probs=219.9
Q ss_pred cccCceEEEEEeccCCceEEEEEEEcC-----C--ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCC
Q 005247 430 IRWSELLIKKKIGEGSFGTVYHAEWRN-----S--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP 502 (706)
Q Consensus 430 i~~~~y~i~~~LG~G~fG~Vy~a~~~~-----~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~ 502 (706)
+...+|.+.+.||+|+||.||++.... + .+|+|.+... .....+.+.+|+.++++++|+||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG 79 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 456789999999999999999997522 2 2777776543 344456789999999999999999999999999
Q ss_pred CceEEEEEeccCCchhhhcccCC----------CcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCC
Q 005247 503 PNLSIVTEYLSRGSLYKLLHIPD----------ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY 572 (706)
Q Consensus 503 ~~~~lV~E~~~ggsL~~~l~~~~----------~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~ 572 (706)
+..+++|||+.+++|.+++.... ....+++..++.++.|++.||+|||++| ++||||||+||+++.++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~--i~H~dlkp~Nili~~~~ 157 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGENL 157 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEccCC
Confidence 99999999999999999985322 1234889999999999999999999999 99999999999999999
Q ss_pred cEEEeecCccccCCCCcc--cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhh
Q 005247 573 TVKVCDFGLSRSKPNTYI--SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGF 649 (706)
Q Consensus 573 ~vKL~DFGla~~~~~~~~--~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~ 649 (706)
.+||+|||+++....... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+.
T Consensus 158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~- 236 (288)
T cd05093 158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT- 236 (288)
T ss_pred cEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-
Confidence 999999999876533221 1223345778999999999889999999999999999998 899998887777666653
Q ss_pred cCcccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhc
Q 005247 650 KGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 696 (706)
Q Consensus 650 ~~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~ 696 (706)
.......+..++.++.+|+.+||+.||.+|||+.+++..|+++.+..
T Consensus 237 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~ 283 (288)
T cd05093 237 QGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKAS 283 (288)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhc
Confidence 33444566778999999999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=343.61 Aligned_cols=242 Identities=28% Similarity=0.466 Sum_probs=204.7
Q ss_pred EEeccCCceEEEEEEEcCCc--eEEEEEecccc-chHHHHHHHHHHHHHHcC-CCCceeEEeccccCCCceEEEEEeccC
Q 005247 439 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEF-HEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSIVTEYLSR 514 (706)
Q Consensus 439 ~~LG~G~fG~Vy~a~~~~~~--vAVKvl~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~lV~E~~~g 514 (706)
+.||+|+||.||+|.+.+++ ||+|++..... .....+.+..|..++..+ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999887654 99999876432 223345566677777654 799999999999999999999999999
Q ss_pred CchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcccCCC
Q 005247 515 GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKT 594 (706)
Q Consensus 515 gsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 594 (706)
|+|..+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++............
T Consensus 81 g~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~ 155 (316)
T cd05592 81 GDLMFHIQSS---GRFDEARARFYAAEIICGLQFLHKKG--IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST 155 (316)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcccc
Confidence 9999988643 25889999999999999999999999 999999999999999999999999999765433333445
Q ss_pred CCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHHHHhhhh
Q 005247 595 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAE 674 (706)
Q Consensus 595 ~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI~~cL~~ 674 (706)
..||+.|+|||++.+..++.++|||||||++|||++|..||...+..+....+. .....+|..++.++.+||.+||+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~ll~~~l~~ 233 (316)
T cd05592 156 FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSIL--NDRPHFPRWISKEAKDCLSKLFER 233 (316)
T ss_pred ccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHHccC
Confidence 679999999999999999999999999999999999999999888777766653 345567788999999999999999
Q ss_pred CCCCCCCHH-HHHH
Q 005247 675 EPEIRPSFP-SIME 687 (706)
Q Consensus 675 dP~~RPS~~-eIl~ 687 (706)
||++||++. ++++
T Consensus 234 ~P~~R~~~~~~l~~ 247 (316)
T cd05592 234 DPTKRLGVDGDIRQ 247 (316)
T ss_pred CHHHcCCChHHHHc
Confidence 999999875 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=325.25 Aligned_cols=252 Identities=38% Similarity=0.667 Sum_probs=219.2
Q ss_pred cccCceEEEEEeccCCceEEEEEEEcCCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEE
Q 005247 430 IRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 509 (706)
Q Consensus 430 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~ 509 (706)
+...+|++.+.||.|+||.||+|...+..+|+|.+..... ..+.+.+|+.+++.++|+||+++++++...+..++||
T Consensus 3 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 79 (256)
T cd05039 3 INSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVT 79 (256)
T ss_pred cChhhccceeeeecCCCceEEEEEecCcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEE
Confidence 4567899999999999999999999988899999865432 4578899999999999999999999999889999999
Q ss_pred EeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCc
Q 005247 510 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 589 (706)
Q Consensus 510 E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 589 (706)
||+++++|.++++.... ..+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||.++......
T Consensus 80 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 80 EYMAKGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEEKN--FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred EecCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC--ccchhcccceEEEeCCCCEEEccccccccccccc
Confidence 99999999999864332 25889999999999999999999999 9999999999999999999999999998764322
Q ss_pred ccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHH
Q 005247 590 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI 668 (706)
Q Consensus 590 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI 668 (706)
.....+..|+|||.+.+..++.++||||||+++||+++ |..||...+..+....+. ...+...+..+++++.++|
T Consensus 157 ---~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li 232 (256)
T cd05039 157 ---DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVE-KGYRMEAPEGCPPEVYKVM 232 (256)
T ss_pred ---ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh-cCCCCCCccCCCHHHHHHH
Confidence 13344667999999998889999999999999999997 999998887776665553 3335566778899999999
Q ss_pred HHhhhhCCCCCCCHHHHHHHHHH
Q 005247 669 ETCWAEEPEIRPSFPSIMETLQQ 691 (706)
Q Consensus 669 ~~cL~~dP~~RPS~~eIl~~L~~ 691 (706)
.+||..+|++|||+.++++.|++
T Consensus 233 ~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 233 KDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred HHHhccChhhCcCHHHHHHHHhc
Confidence 99999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=326.94 Aligned_cols=257 Identities=35% Similarity=0.568 Sum_probs=217.0
Q ss_pred ccccCceEEEEEeccCCceEEEEEEEcCC-ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEE
Q 005247 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI 507 (706)
Q Consensus 429 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~-~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l 507 (706)
++...+|++.+.||+|+||.||+|.+.++ .||+|.+..... ..+.+.+|+.++++++|+||+++++++...+..++
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 78 (261)
T cd05068 2 EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM---DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYI 78 (261)
T ss_pred ccchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc---cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeee
Confidence 45567899999999999999999987554 489998765432 23568899999999999999999999999999999
Q ss_pred EEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCC
Q 005247 508 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 587 (706)
Q Consensus 508 V~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 587 (706)
+|||+.+++|.+++.... ...+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++.....
T Consensus 79 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05068 79 VTELMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN--YIHRDLAARNVLVGENNICKVADFGLARVIKE 155 (261)
T ss_pred eeecccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence 999999999999986433 235789999999999999999999999 99999999999999999999999999887553
Q ss_pred Cccc-CCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHH
Q 005247 588 TYIS-SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 665 (706)
Q Consensus 588 ~~~~-~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~ 665 (706)
.... ......+..|+|||.+.+..++.++||||||+++|||++ |+.||...........+. .......+..++..+.
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 234 (261)
T cd05068 156 DIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD-QGYRMPCPPGCPKELY 234 (261)
T ss_pred CcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCCCcCCHHHH
Confidence 2211 111223457999999999899999999999999999999 999998887776666553 3344556678899999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 005247 666 ALIETCWAEEPEIRPSFPSIMETLQQF 692 (706)
Q Consensus 666 dLI~~cL~~dP~~RPS~~eIl~~L~~l 692 (706)
+++.+||+.+|++||++.++.+.|+.+
T Consensus 235 ~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 235 DIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred HHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=344.54 Aligned_cols=242 Identities=25% Similarity=0.410 Sum_probs=207.2
Q ss_pred EEeccCCceEEEEEEEcCC--ceEEEEEecccc-chHHHHHHHHHHHHHHcC-CCCceeEEeccccCCCceEEEEEeccC
Q 005247 439 KKIGEGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSIVTEYLSR 514 (706)
Q Consensus 439 ~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~lV~E~~~g 514 (706)
+.||+|+||.||+|++.++ .||+|++..... .....+.+..|..+++.+ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 3689999999999988754 499999876432 233445677889998866 799999999999999999999999999
Q ss_pred CchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcccCCC
Q 005247 515 GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKT 594 (706)
Q Consensus 515 gsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 594 (706)
++|..++... ..+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||++............
T Consensus 81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~ 155 (321)
T cd05591 81 GDLMFQIQRS---RKFDEPRSRFYAAEVTLALMFLHRHG--VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTT 155 (321)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEeecccceecccCCccccc
Confidence 9999888633 24788999999999999999999999 999999999999999999999999998764433333445
Q ss_pred CCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHHHHhhhh
Q 005247 595 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAE 674 (706)
Q Consensus 595 ~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI~~cL~~ 674 (706)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+. .....+|..+++++.+||.+||+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~ll~~~L~~ 233 (321)
T cd05591 156 FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESIL--HDDVLYPVWLSKEAVSILKAFMTK 233 (321)
T ss_pred cccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHHhcc
Confidence 679999999999999999999999999999999999999999988877776663 334556677899999999999999
Q ss_pred CCCCCC-------CHHHHHH
Q 005247 675 EPEIRP-------SFPSIME 687 (706)
Q Consensus 675 dP~~RP-------S~~eIl~ 687 (706)
||++|| ++.++++
T Consensus 234 dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 234 NPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred CHHHcCCCCCCCCCHHHHhc
Confidence 999999 7777765
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=340.82 Aligned_cols=248 Identities=25% Similarity=0.404 Sum_probs=198.1
Q ss_pred ceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCC-----CceE
Q 005247 434 ELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP-----PNLS 506 (706)
Q Consensus 434 ~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~-----~~~~ 506 (706)
+|++.+.||+|+||.||+|.+.. ..||+|++............+.+|+.+++.++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 58999999999999999998764 4499998865433334456788999999999999999999987533 3479
Q ss_pred EEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCC
Q 005247 507 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP 586 (706)
Q Consensus 507 lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~ 586 (706)
+||||+. ++|.+++... ..+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++...
T Consensus 81 lv~e~~~-~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 81 VVFELME-SDLHQVIKAN---DDLTPEHHQFFLYQLLRALKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred EEEecCC-CCHHHHHHhc---ccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 9999995 6888887633 24889999999999999999999999 9999999999999999999999999997643
Q ss_pred CCc---ccCCCCCCCCCccCcccccc--CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhh------------
Q 005247 587 NTY---ISSKTAAGTPEWMAPEVLRE--DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGF------------ 649 (706)
Q Consensus 587 ~~~---~~~~~~~Gt~~Y~APE~l~~--~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~------------ 649 (706)
... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+.......+..
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 221 11234578999999999876 5788999999999999999999999977654332211100
Q ss_pred --------------cCcccCC---CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 650 --------------KGRRLEI---PKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 650 --------------~~~~l~~---p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
......+ .+.+++.+.++|.+||+.||++|||+.++++
T Consensus 235 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 0000111 1346788999999999999999999999987
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=332.52 Aligned_cols=263 Identities=33% Similarity=0.608 Sum_probs=222.0
Q ss_pred CcccccCceEEEEEeccCCceEEEEEEEcC-------CceEEEEEeccccchHHHHHHHHHHHHHHcC-CCCceeEEecc
Q 005247 427 GLEIRWSELLIKKKIGEGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGA 498 (706)
Q Consensus 427 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~-------~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~ 498 (706)
.+.+..++|++.+.||+|+||.||++.+.+ ..+|+|.+.... .......+.+|+.+++.+ +|+||++++++
T Consensus 6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 84 (293)
T cd05053 6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGV 84 (293)
T ss_pred ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 356777889999999999999999998753 238888876443 344456788999999999 79999999999
Q ss_pred ccCCCceEEEEEeccCCchhhhcccC-------------CCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCc
Q 005247 499 VTEPPNLSIVTEYLSRGSLYKLLHIP-------------DARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPN 565 (706)
Q Consensus 499 ~~~~~~~~lV~E~~~ggsL~~~l~~~-------------~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~N 565 (706)
+...+..+++|||+.+|+|.++++.. .....+++..++.++.|++.||+|||+++ |+||||||+|
T Consensus 85 ~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~N 162 (293)
T cd05053 85 CTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK--CIHRDLAARN 162 (293)
T ss_pred EcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--ccccccceee
Confidence 99999999999999999999998532 22346888999999999999999999999 9999999999
Q ss_pred EEECCCCcEEEeecCccccCCCCccc--CCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHH
Q 005247 566 LLVDSTYTVKVCDFGLSRSKPNTYIS--SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQ 642 (706)
Q Consensus 566 ILl~~~~~vKL~DFGla~~~~~~~~~--~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~ 642 (706)
|+++.++.+||+|||+++........ .....++..|+|||.+.+..++.++|||||||++|||++ |..||......+
T Consensus 163 il~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 242 (293)
T cd05053 163 VLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 242 (293)
T ss_pred EEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH
Confidence 99999999999999999865443211 122335678999999999999999999999999999997 999998887766
Q ss_pred HHHHhhhcCcccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 005247 643 VISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 693 (706)
Q Consensus 643 ~~~~i~~~~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll 693 (706)
....+. .......+..++..+.+|+.+||..||++|||+.++++.|+.++
T Consensus 243 ~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 243 LFKLLK-EGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHHHH-cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 666553 44455677788999999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=352.45 Aligned_cols=250 Identities=26% Similarity=0.343 Sum_probs=208.2
Q ss_pred CceEEEEEeccCCceEEEEEEEcCC--ceEEEEEecccc-chHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEE
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 509 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~ 509 (706)
++|++++.||+|+||.||+|++..+ .||+|++..... .......+.+|+.+++.++|+||+++++.+.+++.+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 4799999999999999999988654 499999865432 2233467889999999999999999999999999999999
Q ss_pred EeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCC-
Q 005247 510 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT- 588 (706)
Q Consensus 510 E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~- 588 (706)
||+++|+|.+++... ..+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||++......
T Consensus 81 E~~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 81 DYIPGGDMMSLLIRL---GIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 999999999998643 35788999999999999999999999 999999999999999999999999997532100
Q ss_pred ------------------------------------------cccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHH
Q 005247 589 ------------------------------------------YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILW 626 (706)
Q Consensus 589 ------------------------------------------~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ 626 (706)
........||+.|+|||++.+..++.++|||||||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 00012347999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHhhhcCcccCCC--CCCcHHHHHHHHHhhhhCCCCCC---CHHHHHHH
Q 005247 627 ELITLQKPWRNSTPSQVISAVGFKGRRLEIP--KNVNPMVAALIETCWAEEPEIRP---SFPSIMET 688 (706)
Q Consensus 627 ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p--~~~s~el~dLI~~cL~~dP~~RP---S~~eIl~~ 688 (706)
||++|+.||....+.+....+........++ ..+++++.++|.+|+ .+|.+|+ ++.+++..
T Consensus 236 ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 236 EMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred ehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 9999999999888766655554333333333 468899999999976 5999999 88988763
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=329.38 Aligned_cols=256 Identities=34% Similarity=0.591 Sum_probs=219.9
Q ss_pred ccCceEEEEEeccCCceEEEEEEEcC-CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEE
Q 005247 431 RWSELLIKKKIGEGSFGTVYHAEWRN-SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 509 (706)
Q Consensus 431 ~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~ 509 (706)
...+|++.+.||.|+||.||+|.+.+ ..+++|++.... ......+.+|+.+++.++|+||+++++++......++||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD--LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIIT 81 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc--hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEE
Confidence 34578899999999999999998765 448888876543 223457889999999999999999999999999999999
Q ss_pred EeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCc
Q 005247 510 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 589 (706)
Q Consensus 510 E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 589 (706)
||+++++|.++++... ...+++..+..++.||+.||.|||++| ++||||||+||+++.++.+||+|||.+.......
T Consensus 82 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~--i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 82 ELMEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQN--SIHRDLAARNILVGEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred eecccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence 9999999999997543 235788999999999999999999999 9999999999999999999999999998765443
Q ss_pred ccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHH
Q 005247 590 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI 668 (706)
Q Consensus 590 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI 668 (706)
.......++..|+|||.+.+..++.++||||||+++|+|++ |+.||......+....+. ...+...+..+++.+.++|
T Consensus 159 ~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i 237 (261)
T cd05148 159 YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT-AGYRMPCPAKCPQEIYKIM 237 (261)
T ss_pred ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH-hCCcCCCCCCCCHHHHHHH
Confidence 33334456778999999998889999999999999999998 899998887777666654 4445667788999999999
Q ss_pred HHhhhhCCCCCCCHHHHHHHHHHH
Q 005247 669 ETCWAEEPEIRPSFPSIMETLQQF 692 (706)
Q Consensus 669 ~~cL~~dP~~RPS~~eIl~~L~~l 692 (706)
.+||+.||++|||+.++++.|+.+
T Consensus 238 ~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 238 LECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred HHHcCCCchhCcCHHHHHHHHhcC
Confidence 999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=334.29 Aligned_cols=250 Identities=28% Similarity=0.374 Sum_probs=200.8
Q ss_pred CceEEEEEeccCCceEEEEEEEcC---CceEEEEEeccccchHHHHHHHHHHHHHHcC---CCCceeEEecccc-----C
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRN---SDVAVKILIEQEFHEDRFKEFLREVAIMKGL---RHPNIVLLMGAVT-----E 501 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~---~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L---~HpnIv~l~~~~~-----~ 501 (706)
.+|++.+.||+|+||.||+|++.. ..+|+|++............+.+|+.+++.+ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 368999999999999999998742 3489998866544433334566777777665 6999999999874 3
Q ss_pred CCceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCc
Q 005247 502 PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL 581 (706)
Q Consensus 502 ~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGl 581 (706)
...+++||||+. ++|.+++.... ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~--iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEcCCCCEEEccccc
Confidence 456899999996 58888886432 234788999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcc--------
Q 005247 582 SRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR-------- 653 (706)
Q Consensus 582 a~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~-------- 653 (706)
++..... .......||+.|+|||++.+..++.++|||||||++|||++|..||...+..+....+......
T Consensus 157 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~ 235 (290)
T cd07862 157 ARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 235 (290)
T ss_pred eEeccCC-cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchh
Confidence 9765433 2234567899999999999989999999999999999999999999987766655444211000
Q ss_pred -----------------cCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 654 -----------------LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 654 -----------------l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
..+.+.+++.+.+||.+||+.||++|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 236 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0112356788999999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=335.94 Aligned_cols=263 Identities=34% Similarity=0.615 Sum_probs=217.3
Q ss_pred cccCceEEEEEeccCCceEEEEEEEcCCc----eEEEEEeccccchHHHHHHHHHHHHHHcC-CCCceeEEeccccCCCc
Q 005247 430 IRWSELLIKKKIGEGSFGTVYHAEWRNSD----VAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPN 504 (706)
Q Consensus 430 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~----vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~ 504 (706)
+.+++|++.+.||+|+||.||+|.+..++ +++|.+.. .........+.+|+.++.++ +|+||+++++++...+.
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~-~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~ 82 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 82 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecc-cCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCC
Confidence 45678999999999999999999875432 45555432 22344456788999999999 89999999999999999
Q ss_pred eEEEEEeccCCchhhhcccCCC-------------cccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCC
Q 005247 505 LSIVTEYLSRGSLYKLLHIPDA-------------RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST 571 (706)
Q Consensus 505 ~~lV~E~~~ggsL~~~l~~~~~-------------~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~ 571 (706)
+++||||+++++|.++++.... ...+++..++.++.||+.||+|||++| ++||||||+|||++.+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dlkp~Nili~~~ 160 (303)
T cd05088 83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGEN 160 (303)
T ss_pred ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEecCC
Confidence 9999999999999999864321 235788999999999999999999999 9999999999999999
Q ss_pred CcEEEeecCccccCCCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhc
Q 005247 572 YTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFK 650 (706)
Q Consensus 572 ~~vKL~DFGla~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~ 650 (706)
+.+||+|||++...... .......++..|+|||.+.+..++.++||||||+++|||+| |..||...+..+....+. .
T Consensus 161 ~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~-~ 238 (303)
T cd05088 161 YVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-Q 238 (303)
T ss_pred CcEEeCccccCcccchh-hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHh-c
Confidence 99999999998643211 11122234667999999988889999999999999999998 999998877766665542 3
Q ss_pred CcccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhcc
Q 005247 651 GRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSV 697 (706)
Q Consensus 651 ~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~~ 697 (706)
..+...+..+++++.+||.+||+.+|++||++.+++..|.+++....
T Consensus 239 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 239 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 33455666789999999999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=326.55 Aligned_cols=246 Identities=32% Similarity=0.541 Sum_probs=209.7
Q ss_pred EeccCCceEEEEEEEc----CCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEEeccCC
Q 005247 440 KIGEGSFGTVYHAEWR----NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRG 515 (706)
Q Consensus 440 ~LG~G~fG~Vy~a~~~----~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~~~gg 515 (706)
.||+|+||.||+|.+. +..+|+|++..........+.+.+|+.+++.+.|+||+++++++.. ...++||||+.++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 5899999999999653 3349999987665555566789999999999999999999998754 5678999999999
Q ss_pred chhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCccc---C
Q 005247 516 SLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS---S 592 (706)
Q Consensus 516 sL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~---~ 592 (706)
+|.+++... ..+++..+..++.|++.||+|||++| |+||||||.||+++.++.+||+|||+++........ .
T Consensus 81 ~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 81 PLNKFLQKN---KHVTEKNITELVHQVSMGMKYLEETN--FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred cHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence 999998643 25889999999999999999999999 999999999999999999999999999765433211 1
Q ss_pred CCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHHHHh
Q 005247 593 KTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC 671 (706)
Q Consensus 593 ~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI~~c 671 (706)
....++..|+|||.+....++.++||||||+++|||++ |..||......+....+. .......|..+++++.+||.+|
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~l~~li~~~ 234 (257)
T cd05116 156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIE-SGERMECPQRCPPEMYDLMKLC 234 (257)
T ss_pred CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHH
Confidence 22334578999999988889999999999999999998 999999887777666664 4445677888999999999999
Q ss_pred hhhCCCCCCCHHHHHHHHHHH
Q 005247 672 WAEEPEIRPSFPSIMETLQQF 692 (706)
Q Consensus 672 L~~dP~~RPS~~eIl~~L~~l 692 (706)
|+.||++||++.+|.+.|+++
T Consensus 235 ~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 235 WTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred hccCchhCcCHHHHHHHHhcc
Confidence 999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=336.80 Aligned_cols=250 Identities=27% Similarity=0.361 Sum_probs=198.7
Q ss_pred cCceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEE
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 509 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~ 509 (706)
.++|++.+.||+|+||.||+|.+.. ..+|+|++...... .....+.+|+.+++.++||||+++++++.+....++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE-GTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc-ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence 3679999999999999999998864 45999998654322 22346778999999999999999999999999999999
Q ss_pred EeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCc
Q 005247 510 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 589 (706)
Q Consensus 510 E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 589 (706)
||+. ++|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 83 e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 83 EYVH-TDLCQYMDKH--PGGLHPENVKLFLFQLLRGLSYIHQRY--ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred ECCC-cCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 9996 5777776532 234788899999999999999999999 9999999999999999999999999987654333
Q ss_pred ccCCCCCCCCCccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHhhhc-Cc--------------
Q 005247 590 ISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPS-QVISAVGFK-GR-------------- 652 (706)
Q Consensus 590 ~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~-~~~~~i~~~-~~-------------- 652 (706)
.......+|+.|+|||++.+. .++.++|||||||++|+|++|..||...... +....+... +.
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T cd07869 158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPH 237 (303)
T ss_pred ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccc
Confidence 333456789999999998764 5788999999999999999999999875432 222221100 00
Q ss_pred ----cc--CCC---------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 653 ----RL--EIP---------KNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 653 ----~l--~~p---------~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
.. ..+ ...+..+.+||.+||+.||++|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred cccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 00 001 123467899999999999999999999976
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=326.60 Aligned_cols=255 Identities=34% Similarity=0.617 Sum_probs=215.9
Q ss_pred ccccCceEEEEEeccCCceEEEEEEEcC-CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEE
Q 005247 429 EIRWSELLIKKKIGEGSFGTVYHAEWRN-SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI 507 (706)
Q Consensus 429 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l 507 (706)
++...+|+++++||+|+||.||+|...+ ..+|+|.+...... ...+.+|+.+++.++|+||+++++++. .+..++
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~ 77 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS---PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYI 77 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc---HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEE
Confidence 4567789999999999999999998754 45999988654433 347889999999999999999999874 456899
Q ss_pred EEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCC
Q 005247 508 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 587 (706)
Q Consensus 508 V~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 587 (706)
+|||+.+++|.+++.... ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++.....
T Consensus 78 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05067 78 ITEYMENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERKN--YIHRDLRAANILVSETLCCKIADFGLARLIED 154 (260)
T ss_pred EEEcCCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence 999999999999986433 235788999999999999999999999 99999999999999999999999999876542
Q ss_pred C-cccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHH
Q 005247 588 T-YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 665 (706)
Q Consensus 588 ~-~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~ 665 (706)
. ........++..|+|||.+.+..++.++||||||+++|||++ |..||...+..+....+. ...+.+.+..++.++.
T Consensus 155 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 233 (260)
T cd05067 155 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLE-RGYRMPRPDNCPEELY 233 (260)
T ss_pred CCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHH-cCCCCCCCCCCCHHHH
Confidence 2 212223345678999999998889999999999999999999 999998877766666553 3445567778899999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHHHH
Q 005247 666 ALIETCWAEEPEIRPSFPSIMETLQQ 691 (706)
Q Consensus 666 dLI~~cL~~dP~~RPS~~eIl~~L~~ 691 (706)
++|.+||+.+|++||+++++++.|++
T Consensus 234 ~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 234 ELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred HHHHHHccCChhhCCCHHHHHHHhhc
Confidence 99999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=326.10 Aligned_cols=251 Identities=36% Similarity=0.599 Sum_probs=212.9
Q ss_pred cCceEEEEEeccCCceEEEEEEEcCC-ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEE
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 510 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~~-~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E 510 (706)
.++|++.+.||+|+||.||++.+.+. .+|+|.+...... .+.+.+|+.++++++||||+++++++.+....+++||
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTE 79 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCccc---HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEE
Confidence 45789999999999999999987665 4999987654332 2568899999999999999999999999889999999
Q ss_pred eccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcc
Q 005247 511 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 590 (706)
Q Consensus 511 ~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~ 590 (706)
|+.+++|.+++..... .+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||.++.......
T Consensus 80 ~~~~~~l~~~i~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05113 80 YMSNGCLLNYLREHGK--RFQPSQLLEMCKDVCEGMAYLESKQ--FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY 155 (256)
T ss_pred cCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCCCCEEECCCccceecCCCce
Confidence 9999999999864322 5789999999999999999999999 99999999999999999999999999876543321
Q ss_pred -cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHH
Q 005247 591 -SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI 668 (706)
Q Consensus 591 -~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI 668 (706)
......++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+. ...+...+...+..+++++
T Consensus 156 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li 234 (256)
T cd05113 156 TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVS-QGLRLYRPHLASEKVYAIM 234 (256)
T ss_pred eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHh-cCCCCCCCCCCCHHHHHHH
Confidence 1122335678999999998889999999999999999998 999998877766655553 4445556677889999999
Q ss_pred HHhhhhCCCCCCCHHHHHHHHH
Q 005247 669 ETCWAEEPEIRPSFPSIMETLQ 690 (706)
Q Consensus 669 ~~cL~~dP~~RPS~~eIl~~L~ 690 (706)
.+||+.+|.+||++.+|++.|+
T Consensus 235 ~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 235 YSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred HHHcCCCcccCCCHHHHHHhhC
Confidence 9999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=344.23 Aligned_cols=265 Identities=31% Similarity=0.561 Sum_probs=217.0
Q ss_pred cccccCceEEEEEeccCCceEEEEEEEcC-------CceEEEEEeccccchHHHHHHHHHHHHHHcC-CCCceeEEeccc
Q 005247 428 LEIRWSELLIKKKIGEGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAV 499 (706)
Q Consensus 428 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~-------~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~ 499 (706)
+++..++|++.+.||+|+||.||+|...+ +.||+|++.... .....+.+..|+.+++++ +|+||+++++++
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~ 80 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGAC 80 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeE
Confidence 45566789999999999999999996533 349999876433 344456788999999999 799999999987
Q ss_pred cC-CCceEEEEEeccCCchhhhcccCCC----------------------------------------------------
Q 005247 500 TE-PPNLSIVTEYLSRGSLYKLLHIPDA---------------------------------------------------- 526 (706)
Q Consensus 500 ~~-~~~~~lV~E~~~ggsL~~~l~~~~~---------------------------------------------------- 526 (706)
.. ...++++|||+++++|.+++.....
T Consensus 81 ~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (337)
T cd05054 81 TKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE 160 (337)
T ss_pred ecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence 54 4568899999999999998853211
Q ss_pred ------cccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCc--ccCCCCCCC
Q 005247 527 ------RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY--ISSKTAAGT 598 (706)
Q Consensus 527 ------~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~--~~~~~~~Gt 598 (706)
...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++....... .......++
T Consensus 161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~ 238 (337)
T cd05054 161 EGDELYKEPLTLEDLISYSFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238 (337)
T ss_pred hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCC
Confidence 125788899999999999999999999 9999999999999999999999999998653321 112234556
Q ss_pred CCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHHHHhhhhCCC
Q 005247 599 PEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPE 677 (706)
Q Consensus 599 ~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI~~cL~~dP~ 677 (706)
..|+|||++.+..++.++|||||||++|||++ |..||......+..........+...+..+++++.+++.+||+.+|+
T Consensus 239 ~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~ 318 (337)
T cd05054 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPE 318 (337)
T ss_pred ccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChh
Confidence 78999999999999999999999999999998 99999875544444333334445566778899999999999999999
Q ss_pred CCCCHHHHHHHHHHHHHh
Q 005247 678 IRPSFPSIMETLQQFLMS 695 (706)
Q Consensus 678 ~RPS~~eIl~~L~~ll~s 695 (706)
+||++.+|++.|++++..
T Consensus 319 ~RPs~~ell~~l~~~~~~ 336 (337)
T cd05054 319 DRPTFSELVEILGDLLQE 336 (337)
T ss_pred hCcCHHHHHHHHHHHHhc
Confidence 999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=342.07 Aligned_cols=242 Identities=27% Similarity=0.459 Sum_probs=207.1
Q ss_pred EEeccCCceEEEEEEEcCC--ceEEEEEecccc-chHHHHHHHHHHHHHHcC-CCCceeEEeccccCCCceEEEEEeccC
Q 005247 439 KKIGEGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSIVTEYLSR 514 (706)
Q Consensus 439 ~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~lV~E~~~g 514 (706)
+.||+|+||+||+|.+..+ .||+|++.+... .......+.+|..+++.+ +||||+++++++...+.+++||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999988654 499999876532 233456677899999888 699999999999999999999999999
Q ss_pred CchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcccCCC
Q 005247 515 GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKT 594 (706)
Q Consensus 515 gsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 594 (706)
|+|..++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...........
T Consensus 81 ~~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (318)
T cd05570 81 GDLMFHIQRS---GRFDEPRARFYAAEIVLGLQFLHERG--IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTST 155 (318)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccc
Confidence 9999888643 25889999999999999999999999 999999999999999999999999998753333223345
Q ss_pred CCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHHHHhhhh
Q 005247 595 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAE 674 (706)
Q Consensus 595 ~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI~~cL~~ 674 (706)
..|++.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+. .....++..++.++.+||.+||..
T Consensus 156 ~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~l~~ 233 (318)
T cd05570 156 FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSIL--EDEVRYPRWLSKEAKSILKSFLTK 233 (318)
T ss_pred eecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHH--cCCCCCCCcCCHHHHHHHHHHccC
Confidence 579999999999999999999999999999999999999999888776666553 344567788999999999999999
Q ss_pred CCCCCCCH-----HHHHH
Q 005247 675 EPEIRPSF-----PSIME 687 (706)
Q Consensus 675 dP~~RPS~-----~eIl~ 687 (706)
||.+||++ .++++
T Consensus 234 dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 234 NPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CHHHcCCCCCCCHHHHhc
Confidence 99999999 77765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=330.79 Aligned_cols=258 Identities=33% Similarity=0.609 Sum_probs=215.8
Q ss_pred ceEEEEEeccCCceEEEEEEEcC-------CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceE
Q 005247 434 ELLIKKKIGEGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS 506 (706)
Q Consensus 434 ~y~i~~~LG~G~fG~Vy~a~~~~-------~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 506 (706)
+|++.+.||+|+||.||+|.... ..+++|.+.... .......+.+|+.+++.++||||+++++.+...+..+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL 79 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence 47889999999999999998643 237777765433 3344578899999999999999999999999999999
Q ss_pred EEEEeccCCchhhhcccCC---------------------CcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCc
Q 005247 507 IVTEYLSRGSLYKLLHIPD---------------------ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPN 565 (706)
Q Consensus 507 lV~E~~~ggsL~~~l~~~~---------------------~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~N 565 (706)
+++||+.+++|.+++.... ....+++..++.++.|++.||.|||+++ ++||||||+|
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--ivH~dikp~n 157 (290)
T cd05045 80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK--LVHRDLAARN 157 (290)
T ss_pred EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC--eehhhhhhhe
Confidence 9999999999999875311 1234778899999999999999999999 9999999999
Q ss_pred EEECCCCcEEEeecCccccCCCCc--ccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHH
Q 005247 566 LLVDSTYTVKVCDFGLSRSKPNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQ 642 (706)
Q Consensus 566 ILl~~~~~vKL~DFGla~~~~~~~--~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~ 642 (706)
||++.++.+||+|||+++...... .......++..|+|||.+.+..++.++||||||+++|||++ |..||....+.+
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 999999999999999987643221 11223345678999999988889999999999999999998 999998888777
Q ss_pred HHHHhhhcCcccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHh
Q 005247 643 VISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS 695 (706)
Q Consensus 643 ~~~~i~~~~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s 695 (706)
....+. .......+..++.++.++|.+||+.+|++||++.++++.|++++..
T Consensus 238 ~~~~~~-~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 238 LFNLLK-TGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred HHHHHh-CCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 665543 3345556778899999999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=325.95 Aligned_cols=250 Identities=37% Similarity=0.630 Sum_probs=212.7
Q ss_pred cCceEEEEEeccCCceEEEEEEEcCC-ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEE
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 510 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~~-~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E 510 (706)
..+|++.+.||+|+||.||++.+..+ .+|+|++....... ..+.+|+.+++.++|+||+++++++...+..++|||
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~---~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSE---DDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTE 79 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCH---HHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEe
Confidence 45688999999999999999987654 58999876544332 367889999999999999999999999999999999
Q ss_pred eccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcc
Q 005247 511 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 590 (706)
Q Consensus 511 ~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~ 590 (706)
|+++++|.+++.... ..+++..++.++.|++.||+|||+++ ++||||||+||+++.++.+||+|||+++...+...
T Consensus 80 ~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~ 155 (256)
T cd05059 80 YMANGCLLNYLRERK--GKLGTEWLLDMCSDVCEAMEYLESNG--FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY 155 (256)
T ss_pred cCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHhhEEECCCCcEEECCcccceecccccc
Confidence 999999999986433 25789999999999999999999999 99999999999999999999999999876544322
Q ss_pred cC-CCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHH
Q 005247 591 SS-KTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI 668 (706)
Q Consensus 591 ~~-~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI 668 (706)
.. ....++..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+. ...+...+..++.++.+++
T Consensus 156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li 234 (256)
T cd05059 156 TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVS-AGYRLYRPKLAPTEVYTIM 234 (256)
T ss_pred cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH-cCCcCCCCCCCCHHHHHHH
Confidence 11 11223457999999999899999999999999999999 899998877776666553 3445666778899999999
Q ss_pred HHhhhhCCCCCCCHHHHHHHH
Q 005247 669 ETCWAEEPEIRPSFPSIMETL 689 (706)
Q Consensus 669 ~~cL~~dP~~RPS~~eIl~~L 689 (706)
.+||+.+|++|||+.++++.|
T Consensus 235 ~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 235 YSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred HHHhcCChhhCcCHHHHHHHh
Confidence 999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=350.56 Aligned_cols=248 Identities=27% Similarity=0.366 Sum_probs=207.5
Q ss_pred ceEEEEEeccCCceEEEEEEEcCC--ceEEEEEecccc-chHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEE
Q 005247 434 ELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 510 (706)
Q Consensus 434 ~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E 510 (706)
.|++++.||+|+||.||+|.+..+ .+|+|++..... .......+.+|+.+++.++|+||+++++.+.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 588999999999999999988654 499999876432 23445678899999999999999999999999999999999
Q ss_pred eccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCC--
Q 005247 511 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT-- 588 (706)
Q Consensus 511 ~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~-- 588 (706)
|+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~al~~lH~~~--ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 82 YIPGGDMMSLLIRM---GIFPEDLARFYIAELTCAVESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred CCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 99999999998643 25788999999999999999999999 999999999999999999999999997532100
Q ss_pred ---------------------------------------------cccCCCCCCCCCccCccccccCCCCchhHHHHHHH
Q 005247 589 ---------------------------------------------YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGV 623 (706)
Q Consensus 589 ---------------------------------------------~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGv 623 (706)
........||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 00012346899999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCC--CCCcHHHHHHHHHhhhhCCCCCCC---HHHHHH
Q 005247 624 ILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP--KNVNPMVAALIETCWAEEPEIRPS---FPSIME 687 (706)
Q Consensus 624 iL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p--~~~s~el~dLI~~cL~~dP~~RPS---~~eIl~ 687 (706)
++|||++|+.||...++.+....+........+| ..+++++.++|.+|+ .+|++|++ +.++++
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 304 (382)
T cd05625 237 ILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA 304 (382)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence 9999999999999888776665554333334444 467999999999976 59999987 888765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=334.36 Aligned_cols=258 Identities=29% Similarity=0.505 Sum_probs=215.9
Q ss_pred cccCceEEEEEeccCCceEEEEEEEcC-------CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCC
Q 005247 430 IRWSELLIKKKIGEGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP 502 (706)
Q Consensus 430 i~~~~y~i~~~LG~G~fG~Vy~a~~~~-------~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~ 502 (706)
+...+|++.+.||+|+||.||+|.+.+ ..+|+|++.... .....+.+.+|+.+++.++||||+++++++...
T Consensus 2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~ 80 (283)
T cd05091 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE 80 (283)
T ss_pred CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence 345568888999999999999998753 348999886443 233456788999999999999999999999999
Q ss_pred CceEEEEEeccCCchhhhcccCC-------------CcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEEC
Q 005247 503 PNLSIVTEYLSRGSLYKLLHIPD-------------ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVD 569 (706)
Q Consensus 503 ~~~~lV~E~~~ggsL~~~l~~~~-------------~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~ 569 (706)
...++++||+.+++|.+++.... ....+++..+..++.|++.||.|||++| |+||||||+||+++
T Consensus 81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g--i~H~dlkp~Nil~~ 158 (283)
T cd05091 81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH--VVHKDLATRNVLVF 158 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC--ccccccchhheEec
Confidence 99999999999999999974211 1234778889999999999999999999 99999999999999
Q ss_pred CCCcEEEeecCccccCCCCcc--cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 005247 570 STYTVKVCDFGLSRSKPNTYI--SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISA 646 (706)
Q Consensus 570 ~~~~vKL~DFGla~~~~~~~~--~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~ 646 (706)
+++.+||+|||+++....... ......+++.|+|||.+.+..++.++||||||+++|||++ |..||......+....
T Consensus 159 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05091 159 DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEM 238 (283)
T ss_pred CCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 999999999999876543221 1223445789999999988889999999999999999998 8889988887777666
Q ss_pred hhhcCcccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 005247 647 VGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 691 (706)
Q Consensus 647 i~~~~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ 691 (706)
+. .......+..++.++.+|+.+||+.+|++||++++|+..|++
T Consensus 239 i~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 239 IR-NRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HH-cCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 53 334455678899999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=336.21 Aligned_cols=259 Identities=31% Similarity=0.521 Sum_probs=216.2
Q ss_pred ccCceEEEEEeccCCceEEEEEEEcC--C----ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCc
Q 005247 431 RWSELLIKKKIGEGSFGTVYHAEWRN--S----DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN 504 (706)
Q Consensus 431 ~~~~y~i~~~LG~G~fG~Vy~a~~~~--~----~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 504 (706)
...+|++.+.||+|+||.||+|.+.. . .||+|++... ......+.+.+|+.+++.++||||+++++++... .
T Consensus 5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~ 82 (316)
T cd05108 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 82 (316)
T ss_pred chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence 45679999999999999999998642 2 2788887543 2344556788999999999999999999998764 5
Q ss_pred eEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCcccc
Q 005247 505 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 584 (706)
Q Consensus 505 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~ 584 (706)
.++++||+.+|+|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~--iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEERR--LVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred ceeeeecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEecCCCcEEEcccccccc
Confidence 689999999999999987433 24778889999999999999999999 99999999999999999999999999987
Q ss_pred CCCCccc--CCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCCCCCc
Q 005247 585 KPNTYIS--SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVN 661 (706)
Q Consensus 585 ~~~~~~~--~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s 661 (706)
....... .....++..|+|||.+.+..++.++||||||+++|||++ |..||......+....+ ........+..++
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~ 237 (316)
T cd05108 159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-EKGERLPQPPICT 237 (316)
T ss_pred ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-hCCCCCCCCCCCC
Confidence 5533221 122334678999999999999999999999999999997 99999887766554433 3445566677889
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhc
Q 005247 662 PMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 696 (706)
Q Consensus 662 ~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~ 696 (706)
..+.++|.+||..+|.+||++.+++..|.++....
T Consensus 238 ~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 238 IDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 99999999999999999999999999999888654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=323.94 Aligned_cols=250 Identities=28% Similarity=0.474 Sum_probs=214.7
Q ss_pred ceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEEe
Q 005247 434 ELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY 511 (706)
Q Consensus 434 ~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~ 511 (706)
+|++.+.||+|+||.||++.+..+ .+++|.+.... .....+.+.+|+.+++.++|+||+++++.+...+.++++|||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK-SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY 79 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc-chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence 588999999999999999988644 48999876543 234456788999999999999999999999999999999999
Q ss_pred ccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCccc
Q 005247 512 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS 591 (706)
Q Consensus 512 ~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~ 591 (706)
+++++|.+++.... ...+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||.+.........
T Consensus 80 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 156 (255)
T cd08219 80 CDGGDLMQKIKLQR-GKLFPEDTILQWFVQMCLGVQHIHEKR--VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY 156 (255)
T ss_pred CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEECCCCcEEEcccCcceeecccccc
Confidence 99999999885432 234789999999999999999999999 999999999999999999999999998766544333
Q ss_pred CCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHHHHh
Q 005247 592 SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC 671 (706)
Q Consensus 592 ~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI~~c 671 (706)
.....++..|+|||++.+..++.++|+||||+++|+|++|..||...+.......+. ......++..++..+.+||.+|
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~ 235 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVC-QGSYKPLPSHYSYELRSLIKQM 235 (255)
T ss_pred cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHh-cCCCCCCCcccCHHHHHHHHHH
Confidence 345678999999999999889999999999999999999999999887766655553 3344456778899999999999
Q ss_pred hhhCCCCCCCHHHHHHH
Q 005247 672 WAEEPEIRPSFPSIMET 688 (706)
Q Consensus 672 L~~dP~~RPS~~eIl~~ 688 (706)
|+.||++||++.+|+..
T Consensus 236 l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 236 FKRNPRSRPSATTILSR 252 (255)
T ss_pred HhCCcccCCCHHHHhhc
Confidence 99999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=329.60 Aligned_cols=261 Identities=34% Similarity=0.567 Sum_probs=218.6
Q ss_pred cccCceEEEEEeccCCceEEEEEEEcC-----C--ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCC
Q 005247 430 IRWSELLIKKKIGEGSFGTVYHAEWRN-----S--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP 502 (706)
Q Consensus 430 i~~~~y~i~~~LG~G~fG~Vy~a~~~~-----~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~ 502 (706)
+...+|.+.+.||+|+||.||++++.+ + .+++|.+... .....+.+.+|+.++++++|+||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (291)
T cd05094 2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP--TLAARKDFQREAELLTNLQHEHIVKFYGVCGDG 79 (291)
T ss_pred CchHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc--cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence 345679999999999999999997543 1 2666765433 334446788999999999999999999999999
Q ss_pred CceEEEEEeccCCchhhhcccCC-------------CcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEEC
Q 005247 503 PNLSIVTEYLSRGSLYKLLHIPD-------------ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVD 569 (706)
Q Consensus 503 ~~~~lV~E~~~ggsL~~~l~~~~-------------~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~ 569 (706)
+..++||||+++++|.+++.... ....+++..++.++.||+.||+|||+++ |+||||||+||+++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~Nil~~ 157 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVG 157 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEc
Confidence 99999999999999999985432 1234788999999999999999999999 99999999999999
Q ss_pred CCCcEEEeecCccccCCCCcc--cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 005247 570 STYTVKVCDFGLSRSKPNTYI--SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISA 646 (706)
Q Consensus 570 ~~~~vKL~DFGla~~~~~~~~--~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~ 646 (706)
.++.+||+|||++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||......+....
T Consensus 158 ~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~ 237 (291)
T cd05094 158 ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC 237 (291)
T ss_pred cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 999999999999876443221 1233456788999999999999999999999999999998 9999988777666655
Q ss_pred hhhcCcccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHh
Q 005247 647 VGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS 695 (706)
Q Consensus 647 i~~~~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s 695 (706)
+. .......+..++..+.+++.+||+.+|++||++.++++.|+++.+.
T Consensus 238 ~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 238 IT-QGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred Hh-CCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 42 3444455667889999999999999999999999999999999775
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=341.96 Aligned_cols=241 Identities=25% Similarity=0.393 Sum_probs=203.6
Q ss_pred EEeccCCceEEEEEEEcCC--ceEEEEEeccccc-hHHHHHHHHHHHHHHcC-CCCceeEEeccccCCCceEEEEEeccC
Q 005247 439 KKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFH-EDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSIVTEYLSR 514 (706)
Q Consensus 439 ~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~-~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~lV~E~~~g 514 (706)
+.||+|+||.||+|++..+ .||+|++...... ....+.+..|..++... +||||+++++++.+.+..++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4699999999999998654 4999998764321 23345667788888754 899999999999999999999999999
Q ss_pred CchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcccCCC
Q 005247 515 GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKT 594 (706)
Q Consensus 515 gsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 594 (706)
|+|..++... ..+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++...........
T Consensus 81 g~L~~~i~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (316)
T cd05620 81 GDLMFHIQDK---GRFDLYRATFYAAEIVCGLQFLHSKG--IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST 155 (316)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceec
Confidence 9999888643 35788999999999999999999999 999999999999999999999999998753322223345
Q ss_pred CCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHHHHhhhh
Q 005247 595 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAE 674 (706)
Q Consensus 595 ~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI~~cL~~ 674 (706)
..||+.|+|||++.+..++.++|||||||++|||++|..||...+..+....+. .....++..++.++++||.+||+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~ 233 (316)
T cd05620 156 FCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIR--VDTPHYPRWITKESKDILEKLFER 233 (316)
T ss_pred cCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH--hCCCCCCCCCCHHHHHHHHHHccC
Confidence 679999999999999999999999999999999999999999888777666553 234556778899999999999999
Q ss_pred CCCCCCCHH-HHH
Q 005247 675 EPEIRPSFP-SIM 686 (706)
Q Consensus 675 dP~~RPS~~-eIl 686 (706)
||++||++. +++
T Consensus 234 dP~~R~~~~~~~~ 246 (316)
T cd05620 234 DPTRRLGVVGNIR 246 (316)
T ss_pred CHHHcCCChHHHH
Confidence 999999984 555
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=344.68 Aligned_cols=250 Identities=27% Similarity=0.390 Sum_probs=210.9
Q ss_pred CceEEEEEeccCCceEEEEEEEcCC--ceEEEEEecccc-chHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEE
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 509 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~ 509 (706)
++|++.+.||+|+||.||++.+..+ .||+|++..... .....+.+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 3689999999999999999987644 499999876543 2334567889999999999999999999999999999999
Q ss_pred EeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCc
Q 005247 510 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 589 (706)
Q Consensus 510 E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 589 (706)
||+++|+|.+++.... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~--i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 81 EYQPGGDLLSLLNRYE--DQFDEDMAQFYLAELVLAIHSVHQMG--YVHRDIKPENVLIDRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred CCCCCCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence 9999999999986432 35889999999999999999999999 9999999999999999999999999997654322
Q ss_pred c-cCCCCCCCCCccCccccc------cCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCC--CCC
Q 005247 590 I-SSKTAAGTPEWMAPEVLR------EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP--KNV 660 (706)
Q Consensus 590 ~-~~~~~~Gt~~Y~APE~l~------~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p--~~~ 660 (706)
. ......||+.|+|||++. +..++.++|||||||++|||++|..||...+.......+........+| ..+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (330)
T cd05601 157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKV 236 (330)
T ss_pred ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCC
Confidence 1 223457899999999987 4567889999999999999999999998887766666554333333333 357
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 661 NPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 661 s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
+.++.+||.+||+ +|.+||++.+++.
T Consensus 237 ~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 237 SSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred CHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 8999999999998 9999999999875
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=324.19 Aligned_cols=252 Identities=37% Similarity=0.657 Sum_probs=215.3
Q ss_pred cccCceEEEEEeccCCceEEEEEEEcCCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccc-cCCCceEEE
Q 005247 430 IRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAV-TEPPNLSIV 508 (706)
Q Consensus 430 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~-~~~~~~~lV 508 (706)
+...+|++.+.||+|+||.||++...+..+++|.+.... ..+.+.+|+.+++.++|+|++++++++ ...+..+++
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv 78 (256)
T cd05082 3 LNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 78 (256)
T ss_pred ccHHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCc----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEE
Confidence 456789999999999999999999998899999875432 245788999999999999999999875 455678999
Q ss_pred EEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCC
Q 005247 509 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 588 (706)
Q Consensus 509 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 588 (706)
|||+++++|.++++... ...+++..++.++.|++.||+|||++| ++||||||+||+++.++.+||+|||++......
T Consensus 79 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 79 TEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEANN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155 (256)
T ss_pred EECCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccccchheEEEcCCCcEEecCCccceecccc
Confidence 99999999999986433 234788999999999999999999999 999999999999999999999999998764432
Q ss_pred cccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHH
Q 005247 589 YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAAL 667 (706)
Q Consensus 589 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dL 667 (706)
. ....++..|+|||++.+..++.++||||||+++|||++ |+.||......+....+. .......+..+++.+.++
T Consensus 156 ~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l 231 (256)
T cd05082 156 Q---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPVVYDV 231 (256)
T ss_pred C---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-cCCCCCCCCCCCHHHHHH
Confidence 2 23345678999999998889999999999999999997 999998877766666553 334556677889999999
Q ss_pred HHHhhhhCCCCCCCHHHHHHHHHHH
Q 005247 668 IETCWAEEPEIRPSFPSIMETLQQF 692 (706)
Q Consensus 668 I~~cL~~dP~~RPS~~eIl~~L~~l 692 (706)
|.+||+.+|++|||+.++++.|+++
T Consensus 232 i~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 232 MKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred HHHHhcCChhhCcCHHHHHHHHhcC
Confidence 9999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=331.50 Aligned_cols=245 Identities=26% Similarity=0.389 Sum_probs=202.6
Q ss_pred eccCCceEEEEEEEcC--CceEEEEEeccccch-HHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEEeccCCch
Q 005247 441 IGEGSFGTVYHAEWRN--SDVAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSL 517 (706)
Q Consensus 441 LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~-~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL 517 (706)
||+|+||+||++.+.. ..+|+|++....... ...+.+..|+.+++.++|+||+++.+++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 6999999999998764 459999986544322 3346778899999999999999999999999999999999999999
Q ss_pred hhhccc-CCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcccCCCCC
Q 005247 518 YKLLHI-PDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAA 596 (706)
Q Consensus 518 ~~~l~~-~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~ 596 (706)
..++.. ......+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++..............
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 158 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR--IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA 158 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccC
Confidence 887742 223346889999999999999999999999 99999999999999999999999999876554433334567
Q ss_pred CCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHH--hhhcCcccCCCCCCcHHHHHHHHHhhhh
Q 005247 597 GTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISA--VGFKGRRLEIPKNVNPMVAALIETCWAE 674 (706)
Q Consensus 597 Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~--i~~~~~~l~~p~~~s~el~dLI~~cL~~ 674 (706)
||+.|+|||.+.+..++.++||||||+++|||++|+.||........... .........++..+++.+.+++.+||+.
T Consensus 159 g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 238 (280)
T cd05608 159 GTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLAK 238 (280)
T ss_pred CCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhcC
Confidence 89999999999999999999999999999999999999976543211111 1112334556778999999999999999
Q ss_pred CCCCCC-----CHHHHHH
Q 005247 675 EPEIRP-----SFPSIME 687 (706)
Q Consensus 675 dP~~RP-----S~~eIl~ 687 (706)
||++|| +++++++
T Consensus 239 ~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 239 DPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred CHHHhcCCCCCCHHHHhc
Confidence 999999 6777776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=329.89 Aligned_cols=263 Identities=33% Similarity=0.578 Sum_probs=217.0
Q ss_pred ccccCceEEEEEeccCCceEEEEEEEcC-------CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccC
Q 005247 429 EIRWSELLIKKKIGEGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE 501 (706)
Q Consensus 429 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~-------~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~ 501 (706)
++...+|++.+.||+|+||.||+|..++ ..||+|.+.... .......+.+|+.+++.++|+||+++++++.+
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVVSK 80 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 4567889999999999999999997542 248888865433 23334568899999999999999999999999
Q ss_pred CCceEEEEEeccCCchhhhcccCCC-------cccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcE
Q 005247 502 PPNLSIVTEYLSRGSLYKLLHIPDA-------RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTV 574 (706)
Q Consensus 502 ~~~~~lV~E~~~ggsL~~~l~~~~~-------~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~v 574 (706)
.+..++||||+.+|+|.++++.... ........+..++.|++.||.|||+++ |+||||||+||+++.++.+
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dikp~nili~~~~~~ 158 (288)
T cd05061 81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHDFTV 158 (288)
T ss_pred CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCCChheEEEcCCCcE
Confidence 9999999999999999999963211 223456788899999999999999999 9999999999999999999
Q ss_pred EEeecCccccCCCCccc--CCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcC
Q 005247 575 KVCDFGLSRSKPNTYIS--SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKG 651 (706)
Q Consensus 575 KL~DFGla~~~~~~~~~--~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~ 651 (706)
||+|||+++........ .....++..|+|||.+.+..++.++|||||||++|||++ |..||......+....+. ..
T Consensus 159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~-~~ 237 (288)
T cd05061 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM-DG 237 (288)
T ss_pred EECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cC
Confidence 99999998764332211 122345678999999998889999999999999999998 788998877766655442 34
Q ss_pred cccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHh
Q 005247 652 RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS 695 (706)
Q Consensus 652 ~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s 695 (706)
.....+..+++.+.++|.+||+.+|++|||+.++++.|+..+..
T Consensus 238 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~ 281 (288)
T cd05061 238 GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHP 281 (288)
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCC
Confidence 44556777889999999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=322.52 Aligned_cols=267 Identities=22% Similarity=0.381 Sum_probs=217.9
Q ss_pred ccCcccccCceEEEEEeccCCceEEEEEEEcCCc--eEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCC
Q 005247 425 EEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP 502 (706)
Q Consensus 425 ~~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~--vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~ 502 (706)
...+-|+.++|.+.+.||+|||+.||+++...++ ||+|.+.... .+..+..++|++..++++|||+++++++...+
T Consensus 13 ~~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~ 90 (302)
T KOG2345|consen 13 RGTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLRE 90 (302)
T ss_pred CCcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHh
Confidence 3456788899999999999999999999865443 9999987765 45567899999999999999999999986443
Q ss_pred C-----ceEEEEEeccCCchhhhcccCCCcc-cccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEE
Q 005247 503 P-----NLSIVTEYLSRGSLYKLLHIPDARV-VVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKV 576 (706)
Q Consensus 503 ~-----~~~lV~E~~~ggsL~~~l~~~~~~~-~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL 576 (706)
. ..|++++|+..|+|.+.+......+ .+++.+++.|+.+|++||++||+..++++||||||.|||+.+.+.++|
T Consensus 91 ~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl 170 (302)
T KOG2345|consen 91 EKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVL 170 (302)
T ss_pred hccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEE
Confidence 3 3899999999999999996544333 689999999999999999999999999999999999999999999999
Q ss_pred eecCccccCCCCcc---------cCCCCCCCCCccCcccccc---CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 005247 577 CDFGLSRSKPNTYI---------SSKTAAGTPEWMAPEVLRE---DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVI 644 (706)
Q Consensus 577 ~DFGla~~~~~~~~---------~~~~~~Gt~~Y~APE~l~~---~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~ 644 (706)
.|||.++...-... ......-|..|+|||.+.- ...++++|||||||+||+|++|.-||...-.....
T Consensus 171 ~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgS 250 (302)
T KOG2345|consen 171 MDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGS 250 (302)
T ss_pred EeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCe
Confidence 99999886543211 1123456889999999853 45688999999999999999999999653322222
Q ss_pred HHhhhcCcccCCCC--CCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 005247 645 SAVGFKGRRLEIPK--NVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 693 (706)
Q Consensus 645 ~~i~~~~~~l~~p~--~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll 693 (706)
.+.......+.+|. -.+..+.+||++||++||.+||++.+++..+..++
T Consensus 251 laLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 251 LALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred EEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 22222333444553 37899999999999999999999999999998775
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=348.82 Aligned_cols=255 Identities=26% Similarity=0.393 Sum_probs=214.1
Q ss_pred cccccCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEecccc-chHHHHHHHHHHHHHHcCCCCceeEEeccccCCCc
Q 005247 428 LEIRWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN 504 (706)
Q Consensus 428 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 504 (706)
......+|++.+.||+|+||.||++.+..+ .+|+|++.+... .....+.+.+|+.+++.++||||+++++++.+++.
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 445567899999999999999999998754 499999865332 22334567899999999999999999999999999
Q ss_pred eEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCcccc
Q 005247 505 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 584 (706)
Q Consensus 505 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~ 584 (706)
+++||||+++|+|.+++... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~~--IvHrDLKp~NILl~~~~~~kL~DFG~a~~ 191 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSMG--LIHRDVKPDNMLLDKHGHLKLADFGTCMK 191 (370)
T ss_pred EEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCCCCEEEEeccccee
Confidence 99999999999999998632 3788999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCc-ccCCCCCCCCCccCccccccCC----CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCC-
Q 005247 585 KPNTY-ISSKTAAGTPEWMAPEVLREDP----SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPK- 658 (706)
Q Consensus 585 ~~~~~-~~~~~~~Gt~~Y~APE~l~~~~----~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~- 658 (706)
..... .......||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+.......+......+.+|.
T Consensus 192 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~ 271 (370)
T cd05621 192 MDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPED 271 (370)
T ss_pred cccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCc
Confidence 54322 1224567999999999997643 77899999999999999999999998887777776654444555555
Q ss_pred -CCcHHHHHHHHHhhhhCCCC--CCCHHHHHHH
Q 005247 659 -NVNPMVAALIETCWAEEPEI--RPSFPSIMET 688 (706)
Q Consensus 659 -~~s~el~dLI~~cL~~dP~~--RPS~~eIl~~ 688 (706)
.++..++++|.+||..++.+ |+++.++++.
T Consensus 272 ~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 272 VEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred ccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 46899999999999865544 8899998874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=341.21 Aligned_cols=247 Identities=24% Similarity=0.359 Sum_probs=204.0
Q ss_pred ceEEEEEeccCCceEEEEEEEc-----CCceEEEEEeccccc--hHHHHHHHHHHHHHHcC-CCCceeEEeccccCCCce
Q 005247 434 ELLIKKKIGEGSFGTVYHAEWR-----NSDVAVKILIEQEFH--EDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNL 505 (706)
Q Consensus 434 ~y~i~~~LG~G~fG~Vy~a~~~-----~~~vAVKvl~~~~~~--~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~ 505 (706)
+|++.+.||+|+||.||+++.. +..||+|++.+.... ....+.+.+|+.+++.+ +|+||+++++++...+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4889999999999999999763 345999998654322 23345678899999999 499999999999999999
Q ss_pred EEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccC
Q 005247 506 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK 585 (706)
Q Consensus 506 ~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~ 585 (706)
++||||+.+|+|.+++... ..+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR---DNFSEDEVRFYSGEIILALEHLHKLG--IVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 9999999999999988643 34889999999999999999999999 999999999999999999999999998764
Q ss_pred CCCc-ccCCCCCCCCCccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHhhhcCcccCCCCC
Q 005247 586 PNTY-ISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTP----SQVISAVGFKGRRLEIPKN 659 (706)
Q Consensus 586 ~~~~-~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSLGviL~ELltG~~Pf~~~~~----~~~~~~i~~~~~~l~~p~~ 659 (706)
.... .......||+.|+|||++.+. .++.++|||||||++|||++|..||..... ......+ ......++..
T Consensus 156 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~ 233 (332)
T cd05614 156 LSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRI--LKCDPPFPSF 233 (332)
T ss_pred cccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHH--hcCCCCCCCC
Confidence 3322 122346799999999999875 478899999999999999999999964322 2222222 2344567778
Q ss_pred CcHHHHHHHHHhhhhCCCCCC-----CHHHHHH
Q 005247 660 VNPMVAALIETCWAEEPEIRP-----SFPSIME 687 (706)
Q Consensus 660 ~s~el~dLI~~cL~~dP~~RP-----S~~eIl~ 687 (706)
+++.+.+||.+||+.||++|| ++.++++
T Consensus 234 ~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 234 IGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 999999999999999999999 7777765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=343.79 Aligned_cols=240 Identities=28% Similarity=0.443 Sum_probs=201.2
Q ss_pred EEeccCCceEEEEEEEcCCc--eEEEEEeccccch-HHHHHHHHHH-HHHHcCCCCceeEEeccccCCCceEEEEEeccC
Q 005247 439 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHE-DRFKEFLREV-AIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSR 514 (706)
Q Consensus 439 ~~LG~G~fG~Vy~a~~~~~~--vAVKvl~~~~~~~-~~~~~~~~Ei-~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~~~g 514 (706)
+.||+|+||.||+|.+..++ +|+|++....... .....+..|. .+++.++|+||+++++++...+..++||||+.+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999887543 9999987643222 2223444444 456788999999999999999999999999999
Q ss_pred CchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcccCCC
Q 005247 515 GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKT 594 (706)
Q Consensus 515 gsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 594 (706)
++|.+++... ..+.+..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++...........
T Consensus 81 ~~L~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~g--iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~ 155 (325)
T cd05602 81 GELFYHLQRE---RCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST 155 (325)
T ss_pred CcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCccc
Confidence 9999988643 24778888899999999999999999 999999999999999999999999998764333333445
Q ss_pred CCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHHHHhhhh
Q 005247 595 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAE 674 (706)
Q Consensus 595 ~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI~~cL~~ 674 (706)
..||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+. .....+++.++..+.++|.+||+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~l~~ 233 (325)
T cd05602 156 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL--NKPLQLKPNITNSARHLLEGLLQK 233 (325)
T ss_pred ccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHH--hCCcCCCCCCCHHHHHHHHHHccc
Confidence 679999999999999999999999999999999999999999888777666553 334556778999999999999999
Q ss_pred CCCCCCCHHHH
Q 005247 675 EPEIRPSFPSI 685 (706)
Q Consensus 675 dP~~RPS~~eI 685 (706)
||.+||++.+.
T Consensus 234 ~p~~R~~~~~~ 244 (325)
T cd05602 234 DRTKRLGAKDD 244 (325)
T ss_pred CHHHCCCCCCC
Confidence 99999987743
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=322.08 Aligned_cols=251 Identities=29% Similarity=0.483 Sum_probs=213.7
Q ss_pred CceEEEEEeccCCceEEEEEEEc--CCceEEEEEeccccc---hHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEE
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFH---EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI 507 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKvl~~~~~~---~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l 507 (706)
++|++.+.||+|++|.||++.+. +..+++|++...... ....+.+.+|++++++++||||+++++++.+....++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 46889999999999999999875 455999987654322 2335678899999999999999999999999999999
Q ss_pred EEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCC
Q 005247 508 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 587 (706)
Q Consensus 508 V~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 587 (706)
++||+++++|.+++... ..+++..+..++.|++.||.|||+.| ++||||||+||+++.++.++|+|||++.....
T Consensus 82 v~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY---GALTETVTRKYTRQILEGVEYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred EEEECCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence 99999999999988643 24788899999999999999999999 99999999999999999999999999875433
Q ss_pred CcccC---CCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHH
Q 005247 588 TYISS---KTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV 664 (706)
Q Consensus 588 ~~~~~---~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el 664 (706)
..... ....++..|+|||.+.+..++.++||||||+++|||++|+.||...........+........++..++..+
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (263)
T cd06625 157 ICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDA 236 (263)
T ss_pred cccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHH
Confidence 21111 234678899999999998899999999999999999999999987766665555544555667788899999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHH
Q 005247 665 AALIETCWAEEPEIRPSFPSIMET 688 (706)
Q Consensus 665 ~dLI~~cL~~dP~~RPS~~eIl~~ 688 (706)
.++|.+||..+|.+|||+.++++.
T Consensus 237 ~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 237 RNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred HHHHHHHhhcCcccCCCHHHHhhC
Confidence 999999999999999999999763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=340.10 Aligned_cols=242 Identities=28% Similarity=0.433 Sum_probs=204.1
Q ss_pred EEeccCCceEEEEEEEcCC--ceEEEEEeccccc-hHHHHHHHHHHHHHHcC-CCCceeEEeccccCCCceEEEEEeccC
Q 005247 439 KKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFH-EDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSIVTEYLSR 514 (706)
Q Consensus 439 ~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~-~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~lV~E~~~g 514 (706)
+.||+|+||.||+|.+.++ .||+|++...... ....+.+..|..+++.. +||||+++++++.+.+.+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 3699999999999998754 4999998765321 23345566788888764 899999999999999999999999999
Q ss_pred CchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcccCCC
Q 005247 515 GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKT 594 (706)
Q Consensus 515 gsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 594 (706)
|+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++............
T Consensus 81 g~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~LH~~~--ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (316)
T cd05619 81 GDLMFHIQSC---HKFDLPRATFYAAEIICGLQFLHSKG--IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT 155 (316)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceee
Confidence 9999988633 24788899999999999999999999 999999999999999999999999998754333223345
Q ss_pred CCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHHHHhhhh
Q 005247 595 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAE 674 (706)
Q Consensus 595 ~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI~~cL~~ 674 (706)
..||+.|+|||++.+..++.++|||||||++|||++|..||...+..+....+.. ....++..++.++++||.+||+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~li~~~l~~ 233 (316)
T cd05619 156 FCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRM--DNPCYPRWLTREAKDILVKLFVR 233 (316)
T ss_pred ecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCCCCCccCCHHHHHHHHHHhcc
Confidence 6799999999999999999999999999999999999999998887777666543 23456677899999999999999
Q ss_pred CCCCCCCHH-HHHH
Q 005247 675 EPEIRPSFP-SIME 687 (706)
Q Consensus 675 dP~~RPS~~-eIl~ 687 (706)
||++||++. +++.
T Consensus 234 ~P~~R~~~~~~l~~ 247 (316)
T cd05619 234 EPERRLGVKGDIRQ 247 (316)
T ss_pred CHhhcCCChHHHHc
Confidence 999999996 5643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=347.96 Aligned_cols=265 Identities=32% Similarity=0.541 Sum_probs=221.4
Q ss_pred cCcccccCceEEEEEeccCCceEEEEEEEcC-------CceEEEEEeccccchHHHHHHHHHHHHHHcCC-CCceeEEec
Q 005247 426 EGLEIRWSELLIKKKIGEGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMG 497 (706)
Q Consensus 426 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~-------~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~ 497 (706)
..+++..++|.+.+.||+|+||.||+|.+.+ ..||+|++.... .....+.+.+|+.++.++. ||||+++++
T Consensus 30 ~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~~H~niv~~~~ 108 (401)
T cd05107 30 SAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA-RSSEKQALMSELKIMSHLGPHLNIVNLLG 108 (401)
T ss_pred CcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC-ChhHHHHHHHHHHHHHhcCCCCCeEEEEE
Confidence 3477788899999999999999999998653 249999986543 2333457889999999997 999999999
Q ss_pred cccCCCceEEEEEeccCCchhhhcccCCC---------------------------------------------------
Q 005247 498 AVTEPPNLSIVTEYLSRGSLYKLLHIPDA--------------------------------------------------- 526 (706)
Q Consensus 498 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~--------------------------------------------------- 526 (706)
++...+..++||||+.+|+|.++++....
T Consensus 109 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (401)
T cd05107 109 ACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESAD 188 (401)
T ss_pred EEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccC
Confidence 99999999999999999999999854211
Q ss_pred --------------------------------------------cccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCC
Q 005247 527 --------------------------------------------RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLK 562 (706)
Q Consensus 527 --------------------------------------------~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLK 562 (706)
...+++..++.++.||+.||+|||+.+ ++|||||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrdlk 266 (401)
T cd05107 189 YVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN--CVHRDLA 266 (401)
T ss_pred ccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--cCcccCC
Confidence 123566778889999999999999999 9999999
Q ss_pred CCcEEECCCCcEEEeecCccccCCCCc--ccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 005247 563 SPNLLVDSTYTVKVCDFGLSRSKPNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNST 639 (706)
Q Consensus 563 p~NILl~~~~~vKL~DFGla~~~~~~~--~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~ 639 (706)
|+|||++.++.+||+|||+++...... .......++..|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus 267 p~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~ 346 (401)
T cd05107 267 ARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP 346 (401)
T ss_pred cceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 999999999999999999987643221 12223456789999999998889999999999999999998 899998766
Q ss_pred hHHHHHHhhhcCcccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 005247 640 PSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 693 (706)
Q Consensus 640 ~~~~~~~i~~~~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll 693 (706)
..+........+.++..|..++.++.+||.+||..+|++||++.+|++.|++++
T Consensus 347 ~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 347 MNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred chHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 555544443455566778889999999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=339.08 Aligned_cols=242 Identities=24% Similarity=0.431 Sum_probs=207.0
Q ss_pred ceEEEEEeccCCceEEEEEEEcCC--ceEEEEEecccc-chHHHHHHHHHHHHHHcCC-CCceeEEeccccCCCceEEEE
Q 005247 434 ELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGLR-HPNIVLLMGAVTEPPNLSIVT 509 (706)
Q Consensus 434 ~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~-~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~lV~ 509 (706)
+|++.+.||+|+||.||+|++..+ .||+|++..... .....+.+..|..+++.+. |++|+++++++...+.+++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 477899999999999999988644 499999876432 2334466778999998886 577888999999999999999
Q ss_pred EeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCc
Q 005247 510 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 589 (706)
Q Consensus 510 E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 589 (706)
||+++|+|.+++... ..+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++......
T Consensus 81 Ey~~~g~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~~--ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 81 EYVNGGDLMYHIQQV---GKFKEPQAVFYAAEISVGLFFLHRRG--IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred cCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 999999999988643 35889999999999999999999999 9999999999999999999999999987644333
Q ss_pred ccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHHH
Q 005247 590 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE 669 (706)
Q Consensus 590 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI~ 669 (706)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+. .....+|..++.++.+++.
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~li~ 233 (323)
T cd05615 156 VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIM--EHNVSYPKSLSKEAVSICK 233 (323)
T ss_pred ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH--hCCCCCCccCCHHHHHHHH
Confidence 33345679999999999999999999999999999999999999999888777766653 3445677889999999999
Q ss_pred HhhhhCCCCCCCH
Q 005247 670 TCWAEEPEIRPSF 682 (706)
Q Consensus 670 ~cL~~dP~~RPS~ 682 (706)
+||+.+|.+|++.
T Consensus 234 ~~l~~~p~~R~~~ 246 (323)
T cd05615 234 GLMTKHPSKRLGC 246 (323)
T ss_pred HHcccCHhhCCCC
Confidence 9999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=338.75 Aligned_cols=250 Identities=24% Similarity=0.422 Sum_probs=205.7
Q ss_pred cccCceEEEEEeccCCceEEEEEEEcCCc--eEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEE
Q 005247 430 IRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI 507 (706)
Q Consensus 430 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~--vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l 507 (706)
+..++|++.+.||+|+||.||++.+..++ +|+|++.... .....+.+.+|+++++.++|+||+++++++.+.+..++
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence 45578999999999999999999987544 7888765432 34445678999999999999999999999999999999
Q ss_pred EEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhc-CCCcccccCCCCcEEECCCCcEEEeecCccccCC
Q 005247 508 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR-RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP 586 (706)
Q Consensus 508 V~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~-g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~ 586 (706)
||||+.+++|.+++... ..+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||++....
T Consensus 81 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~ 155 (333)
T cd06650 81 CMEHMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (333)
T ss_pred EEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence 99999999999998643 2478899999999999999999974 6 9999999999999999999999999987653
Q ss_pred CCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh------------------
Q 005247 587 NTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVG------------------ 648 (706)
Q Consensus 587 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~------------------ 648 (706)
.. ......|+..|+|||++.+..++.++|||||||++|+|++|+.||......+....+.
T Consensus 156 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (333)
T cd06650 156 DS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRP 233 (333)
T ss_pred hh--ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCC
Confidence 32 1234578999999999999889999999999999999999999997655433322110
Q ss_pred -------------------------hcCcccCCCC-CCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 649 -------------------------FKGRRLEIPK-NVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 649 -------------------------~~~~~l~~p~-~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
.......++. ..+.++++||.+||+.||++|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~ 298 (333)
T cd06650 234 PGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV 298 (333)
T ss_pred ccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence 0011111111 35788999999999999999999999975
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=328.63 Aligned_cols=250 Identities=27% Similarity=0.439 Sum_probs=219.3
Q ss_pred cCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEE
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 509 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~ 509 (706)
.++|++.+.||+|.|+.|+++.+..+ ++|+|++.-..+.....+++.+|+.|.+.|+||||+++.+...+.+..++||
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 35688889999999999999977654 5999998777777777889999999999999999999999999999999999
Q ss_pred EeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECC---CCcEEEeecCccccCC
Q 005247 510 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS---TYTVKVCDFGLSRSKP 586 (706)
Q Consensus 510 E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~---~~~vKL~DFGla~~~~ 586 (706)
|++.|+.|..-+- .+..+.+..+-.+++||++||.|+|.++ |||||+||+|+++.. .--+||+|||+|....
T Consensus 90 e~m~G~dl~~eIV---~R~~ySEa~aSH~~rQiLeal~yCH~n~--IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 90 DLVTGGELFEDIV---AREFYSEADASHCIQQILEALAYCHSNG--IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred ecccchHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 9999999865542 2246788889999999999999999999 999999999999943 3469999999998877
Q ss_pred CCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccC--CCCCCcHHH
Q 005247 587 NTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLE--IPKNVNPMV 664 (706)
Q Consensus 587 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~--~p~~~s~el 664 (706)
++ .......|||.|||||++...+|+..+|||+.|+|||-|+.|+.||.+.+...++..|.......+ ..++++++.
T Consensus 165 ~g-~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~A 243 (355)
T KOG0033|consen 165 DG-EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEA 243 (355)
T ss_pred Cc-cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHH
Confidence 43 345678899999999999999999999999999999999999999999888888888865554433 456899999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHH
Q 005247 665 AALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 665 ~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
++||++||..||.+|.|+.|.++
T Consensus 244 k~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 244 KSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred HHHHHHHhccChhhhccHHHHhC
Confidence 99999999999999999998875
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=323.82 Aligned_cols=256 Identities=34% Similarity=0.570 Sum_probs=213.9
Q ss_pred cccCceEEEEEeccCCceEEEEEEEcCC-ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEE
Q 005247 430 IRWSELLIKKKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIV 508 (706)
Q Consensus 430 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~-~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV 508 (706)
+..++|++.++||+|+||.||+|.+.++ .+|+|++...... .+.+.+|+.+++.++|+||+++++.+.+ ...++|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv 78 (262)
T cd05071 3 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 78 (262)
T ss_pred CChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccC---HHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEE
Confidence 4556799999999999999999987654 4899987653332 2468899999999999999999998754 557999
Q ss_pred EEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCC
Q 005247 509 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 588 (706)
Q Consensus 509 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 588 (706)
|||+.+|+|.++++... ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||.++.....
T Consensus 79 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~ 155 (262)
T cd05071 79 TEYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDN 155 (262)
T ss_pred EEcCCCCcHHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence 99999999999996432 234788899999999999999999999 999999999999999999999999999765433
Q ss_pred cc-cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHH
Q 005247 589 YI-SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA 666 (706)
Q Consensus 589 ~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~d 666 (706)
.. ......++..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+. .......+..++..+.+
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~ 234 (262)
T cd05071 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPESLHD 234 (262)
T ss_pred ccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHh-cCCCCCCccccCHHHHH
Confidence 21 1123346678999999988889999999999999999999 888998877766665553 33345556778999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 005247 667 LIETCWAEEPEIRPSFPSIMETLQQFL 693 (706)
Q Consensus 667 LI~~cL~~dP~~RPS~~eIl~~L~~ll 693 (706)
||.+||+.+|++||++.++++.|+.++
T Consensus 235 li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 235 LMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred HHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=321.29 Aligned_cols=258 Identities=28% Similarity=0.487 Sum_probs=215.3
Q ss_pred CceEEEEEeccCCceEEEEEEEc--CCceEEEEEecccc-chHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEE
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 509 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKvl~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~ 509 (706)
++|++.+.||+|+||.||+|.+. +..+++|.++.... .....+.+.+|+.++++++|+||+++++++...+..+++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57999999999999999999886 44599998764332 3344678899999999999999999999999999999999
Q ss_pred EeccCCchhhhcccC-CCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCC
Q 005247 510 EYLSRGSLYKLLHIP-DARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 588 (706)
Q Consensus 510 E~~~ggsL~~~l~~~-~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 588 (706)
||+++++|..++... .....+++..++.++.+++.||.|||+.| ++||||||+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~ 159 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR--IMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence 999999999988532 22345889999999999999999999999 999999999999999999999999998765443
Q ss_pred cccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHhhhcCcccCCCC-CCcHHHH
Q 005247 589 YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTP--SQVISAVGFKGRRLEIPK-NVNPMVA 665 (706)
Q Consensus 589 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~--~~~~~~i~~~~~~l~~p~-~~s~el~ 665 (706)
........++..|+|||.+.+..++.++||||||+++|+|++|+.||..... .+....+. .....+.+. .++..+.
T Consensus 160 ~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 238 (267)
T cd08224 160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE-KCDYPPLPADHYSEELR 238 (267)
T ss_pred CcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhh-cCCCCCCChhhcCHHHH
Confidence 3333445788999999999988899999999999999999999999965432 22333332 222233343 6788999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 005247 666 ALIETCWAEEPEIRPSFPSIMETLQQFL 693 (706)
Q Consensus 666 dLI~~cL~~dP~~RPS~~eIl~~L~~ll 693 (706)
++|.+||..+|++|||+.+|++.|+++.
T Consensus 239 ~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 239 DLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred HHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 9999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=325.43 Aligned_cols=259 Identities=32% Similarity=0.531 Sum_probs=215.4
Q ss_pred ccCceEEEEEeccCCceEEEEEEEcCC------ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCc
Q 005247 431 RWSELLIKKKIGEGSFGTVYHAEWRNS------DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN 504 (706)
Q Consensus 431 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~------~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 504 (706)
...+|++.+.||+|+||.||+|.+..+ .||+|++.... .....+.+.+|+.+++.++|+||+++++++... .
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~ 82 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-T 82 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-C
Confidence 456799999999999999999986433 26888875443 344556788999999999999999999998754 4
Q ss_pred eEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCcccc
Q 005247 505 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 584 (706)
Q Consensus 505 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~ 584 (706)
.++++||+++|+|.++++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 83 ~~l~~~~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~--iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 83 VQLVTQLMPYGCLLDYVRENK--DRIGSQDLLNWCVQIAKGMSYLEEVR--LVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred cEEEEEcCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceEEEcCCCcEEECCCCceee
Confidence 689999999999999986432 35889999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCccc--CCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCCCCCc
Q 005247 585 KPNTYIS--SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVN 661 (706)
Q Consensus 585 ~~~~~~~--~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s 661 (706)
....... .....++..|+|||.+.+..++.++|||||||++|||++ |..||...........+. .....+.+..++
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 237 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLE-KGERLPQPPICT 237 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-CCCcCCCCccCC
Confidence 5432211 122334678999999999899999999999999999998 899998777666555443 444556677889
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhc
Q 005247 662 PMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 696 (706)
Q Consensus 662 ~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~ 696 (706)
..+.++|.+||..||++||++.++++.|+.+....
T Consensus 238 ~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 238 IDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 99999999999999999999999999998886553
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=326.46 Aligned_cols=259 Identities=25% Similarity=0.460 Sum_probs=214.3
Q ss_pred CceEEEEEeccCCceEEEEEEEc--CCceEEEEEecccc-chHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEE
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 509 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKvl~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~ 509 (706)
.+|++.+.||+|+||.||++.+. +..+++|.+..... .......+.+|+.+++.++|+||+++++++.+.+..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 46888999999999999999864 44599998755332 3344568889999999999999999999999999999999
Q ss_pred EeccCCchhhhccc-CCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCC
Q 005247 510 EYLSRGSLYKLLHI-PDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 588 (706)
Q Consensus 510 E~~~ggsL~~~l~~-~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 588 (706)
||+.+++|.+++.. ......+++..++.++.||+.||.|||++| ++|+||||+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence 99999999998853 222345889999999999999999999999 999999999999999999999999998765543
Q ss_pred cccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHhhhcCcccCCCCCCcHHHHH
Q 005247 589 YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPS--QVISAVGFKGRRLEIPKNVNPMVAA 666 (706)
Q Consensus 589 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~--~~~~~i~~~~~~l~~p~~~s~el~d 666 (706)
........++..|+|||.+.+..++.++||||||+++|+|++|..||...... .....+.....+...+..+++++++
T Consensus 160 ~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd08229 160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQ 239 (267)
T ss_pred CcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHH
Confidence 32333457889999999999888999999999999999999999999765432 2223332222222233468899999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 005247 667 LIETCWAEEPEIRPSFPSIMETLQQFL 693 (706)
Q Consensus 667 LI~~cL~~dP~~RPS~~eIl~~L~~ll 693 (706)
+|.+||..+|++|||+.+|++.++++.
T Consensus 240 li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 240 LVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred HHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 999999999999999999999998874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=342.12 Aligned_cols=238 Identities=29% Similarity=0.447 Sum_probs=201.3
Q ss_pred EEeccCCceEEEEEEEcC--CceEEEEEeccccc-hHHHHHHHHHHH-HHHcCCCCceeEEeccccCCCceEEEEEeccC
Q 005247 439 KKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFH-EDRFKEFLREVA-IMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSR 514 (706)
Q Consensus 439 ~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~-~~~~~~~~~Ei~-iL~~L~HpnIv~l~~~~~~~~~~~lV~E~~~g 514 (706)
+.||+|+||+||+|.+.. ..||+|++...... ....+.+.+|.. +++.++||||+++++.+.+.+..++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 369999999999999864 44999998654322 223345555555 56789999999999999999999999999999
Q ss_pred CchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcccCCC
Q 005247 515 GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKT 594 (706)
Q Consensus 515 gsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 594 (706)
|+|..+++.. ..+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||++............
T Consensus 81 g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~g--ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (323)
T cd05575 81 GELFFHLQRE---RSFPEPRARFYAAEIASALGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST 155 (323)
T ss_pred CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcccc
Confidence 9999988643 35889999999999999999999999 999999999999999999999999998764333333345
Q ss_pred CCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHHHHhhhh
Q 005247 595 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAE 674 (706)
Q Consensus 595 ~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI~~cL~~ 674 (706)
..||+.|+|||++.+..++.++|||||||++|||++|..||...+..+....+. .....++..+++.+.++|.+||+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~l~~ 233 (323)
T cd05575 156 FCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNIL--NKPLRLKPNISVSARHLLEGLLQK 233 (323)
T ss_pred ccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHHhhc
Confidence 679999999999999999999999999999999999999999888777666653 334556778899999999999999
Q ss_pred CCCCCCCHH
Q 005247 675 EPEIRPSFP 683 (706)
Q Consensus 675 dP~~RPS~~ 683 (706)
||.+||++.
T Consensus 234 ~p~~R~~~~ 242 (323)
T cd05575 234 DRTKRLGAK 242 (323)
T ss_pred CHHhCCCCC
Confidence 999999874
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=321.04 Aligned_cols=256 Identities=35% Similarity=0.588 Sum_probs=217.1
Q ss_pred ccccCceEEEEEeccCCceEEEEEEEcCC-ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEE
Q 005247 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI 507 (706)
Q Consensus 429 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~-~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l 507 (706)
++..++|++.+.||+|+||.||+|.+.++ .+++|.+...... .+.+.+|+.+++.++|+||+++++++......++
T Consensus 2 ~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 78 (261)
T cd05034 2 EIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS---PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYI 78 (261)
T ss_pred ccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccC---HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEE
Confidence 46678899999999999999999987654 4899987654432 3578899999999999999999999998889999
Q ss_pred EEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCC
Q 005247 508 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 587 (706)
Q Consensus 508 V~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 587 (706)
+|||+++++|.+++.... ...+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++.....
T Consensus 79 v~e~~~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~~~--i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 79 VTEYMSKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESRN--YIHRDLAARNILVGENLVCKIADFGLARLIED 155 (261)
T ss_pred EEeccCCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcchheEEEcCCCCEEECccccceeccc
Confidence 999999999999986432 235788999999999999999999999 99999999999999999999999999876543
Q ss_pred Ccc-cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHH
Q 005247 588 TYI-SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 665 (706)
Q Consensus 588 ~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~ 665 (706)
... ......++..|+|||.+.+..++.++||||||+++|+|++ |+.||...+.......+. ...+...+..++.++.
T Consensus 156 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 234 (261)
T cd05034 156 DEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVE-RGYRMPRPPNCPEELY 234 (261)
T ss_pred hhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHH
Confidence 211 1122234568999999998889999999999999999998 999998877766666553 3345566677899999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHHHH
Q 005247 666 ALIETCWAEEPEIRPSFPSIMETLQQ 691 (706)
Q Consensus 666 dLI~~cL~~dP~~RPS~~eIl~~L~~ 691 (706)
+++.+||+.+|++||+++++.+.|+.
T Consensus 235 ~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 235 DLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred HHHHHHcccCcccCCCHHHHHHHHhc
Confidence 99999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=330.95 Aligned_cols=266 Identities=32% Similarity=0.574 Sum_probs=223.1
Q ss_pred CcccccCceEEEEEeccCCceEEEEEEEcC---------CceEEEEEeccccchHHHHHHHHHHHHHHcC-CCCceeEEe
Q 005247 427 GLEIRWSELLIKKKIGEGSFGTVYHAEWRN---------SDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLM 496 (706)
Q Consensus 427 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~---------~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~ 496 (706)
.+++...+|++.+.||+|+||.||+|+..+ ..+|+|..... ........+.+|+.+++.+ +||||++++
T Consensus 9 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~i~~~~ 87 (304)
T cd05101 9 RWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLL 87 (304)
T ss_pred cccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc-cchHHHHHHHHHHHHHHhhccCCCchhee
Confidence 356777899999999999999999997521 13788877543 2344557889999999999 799999999
Q ss_pred ccccCCCceEEEEEeccCCchhhhcccCCC-------------cccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCC
Q 005247 497 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDA-------------RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKS 563 (706)
Q Consensus 497 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~-------------~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp 563 (706)
+++...+..+++|||+.+|+|.+++..... ...++...+..++.||+.||.|||++| ++||||||
T Consensus 88 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp 165 (304)
T cd05101 88 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--CIHRDLAA 165 (304)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC--eeeccccc
Confidence 999999999999999999999999864211 234677889999999999999999999 99999999
Q ss_pred CcEEECCCCcEEEeecCccccCCCCccc--CCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCh
Q 005247 564 PNLLVDSTYTVKVCDFGLSRSKPNTYIS--SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTP 640 (706)
Q Consensus 564 ~NILl~~~~~vKL~DFGla~~~~~~~~~--~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~ 640 (706)
+||+++.++.+||+|||+++........ .....++..|+|||++.+..++.++||||||+++|+|++ |..||...+.
T Consensus 166 ~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 245 (304)
T cd05101 166 RNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 245 (304)
T ss_pred ceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence 9999999999999999999866443221 223345678999999998889999999999999999998 7889988877
Q ss_pred HHHHHHhhhcCcccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhc
Q 005247 641 SQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 696 (706)
Q Consensus 641 ~~~~~~i~~~~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~ 696 (706)
.+....+. ...+...+..++.++.+||.+||..+|.+|||+.++++.|++++...
T Consensus 246 ~~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~ 300 (304)
T cd05101 246 EELFKLLK-EGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT 300 (304)
T ss_pred HHHHHHHH-cCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence 77766653 44455667789999999999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=323.11 Aligned_cols=255 Identities=36% Similarity=0.589 Sum_probs=213.7
Q ss_pred ccccCceEEEEEeccCCceEEEEEEEcCC-ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEE
Q 005247 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI 507 (706)
Q Consensus 429 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~-~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l 507 (706)
++..++|++.+.||+|+||.||+|.+.+. .+|+|.+....... +.+.+|+.++++++|+||+++++++.. ...++
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~---~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~l 77 (260)
T cd05070 2 EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSP---ESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYI 77 (260)
T ss_pred CCchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCH---HHHHHHHHHHHhcCCCceEEEEeEECC-CCcEE
Confidence 34567899999999999999999987643 58888876544332 468899999999999999999998854 56789
Q ss_pred EEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCC
Q 005247 508 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 587 (706)
Q Consensus 508 V~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 587 (706)
+|||+.+++|.++++... ...+++..+..++.|++.||+|||+++ ++||||||+||+++.++.++|+|||++.....
T Consensus 78 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05070 78 VTEYMSKGSLLDFLKDGE-GRALKLPNLVDMAAQVAAGMAYIERMN--YIHRDLRSANILVGDGLVCKIADFGLARLIED 154 (260)
T ss_pred EEEecCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence 999999999999986432 234789999999999999999999999 99999999999999999999999999976543
Q ss_pred Ccc-cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHH
Q 005247 588 TYI-SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 665 (706)
Q Consensus 588 ~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~ 665 (706)
... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+. .....+.+...+..+.
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 233 (260)
T cd05070 155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVE-RGYRMPCPQDCPISLH 233 (260)
T ss_pred cccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCCCcCCHHHH
Confidence 321 1122345668999999988889999999999999999999 899998877766666553 3445566778899999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHHHH
Q 005247 666 ALIETCWAEEPEIRPSFPSIMETLQQ 691 (706)
Q Consensus 666 dLI~~cL~~dP~~RPS~~eIl~~L~~ 691 (706)
+|+.+||..+|++|||+.++.+.|++
T Consensus 234 ~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 234 ELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred HHHHHHcccCcccCcCHHHHHHHHhc
Confidence 99999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=346.10 Aligned_cols=256 Identities=25% Similarity=0.387 Sum_probs=213.5
Q ss_pred CcccccCceEEEEEeccCCceEEEEEEEcCCc--eEEEEEecccc-chHHHHHHHHHHHHHHcCCCCceeEEeccccCCC
Q 005247 427 GLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP 503 (706)
Q Consensus 427 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~--vAVKvl~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 503 (706)
...+...+|++.+.||+|+||.||++.+..+. +|+|++..... .....+.+.+|+.+++.++||||+++++.+.+++
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 34566789999999999999999999987554 89999865432 2233456788999999999999999999999999
Q ss_pred ceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccc
Q 005247 504 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 583 (706)
Q Consensus 504 ~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~ 583 (706)
.+++||||+++|+|.++++.. .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NIll~~~~~ikL~DfG~a~ 190 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCM 190 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence 999999999999999998632 3788889999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCc-ccCCCCCCCCCccCccccccCC----CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCC-
Q 005247 584 SKPNTY-ISSKTAAGTPEWMAPEVLREDP----SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP- 657 (706)
Q Consensus 584 ~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~----~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p- 657 (706)
...... .......||+.|+|||++.+.. ++.++|||||||++|||++|..||...+.......+......+.+|
T Consensus 191 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 270 (371)
T cd05622 191 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPD 270 (371)
T ss_pred EcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCC
Confidence 654322 1234567999999999987543 7889999999999999999999999988877777765444444444
Q ss_pred -CCCcHHHHHHHHHhhhhCCCC--CCCHHHHHHH
Q 005247 658 -KNVNPMVAALIETCWAEEPEI--RPSFPSIMET 688 (706)
Q Consensus 658 -~~~s~el~dLI~~cL~~dP~~--RPS~~eIl~~ 688 (706)
..++.++++||.+||..++.+ |+++.++++.
T Consensus 271 ~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 271 DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 368999999999999844433 6899988874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=319.83 Aligned_cols=248 Identities=39% Similarity=0.665 Sum_probs=214.9
Q ss_pred EEeccCCceEEEEEEEc-----CCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEEecc
Q 005247 439 KKIGEGSFGTVYHAEWR-----NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLS 513 (706)
Q Consensus 439 ~~LG~G~fG~Vy~a~~~-----~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~~~ 513 (706)
+.||+|+||.||+|.+. +..+++|++....... ..+.+.+|+.+++.++|+||+++++++......+++|||++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence 46899999999999887 4458999986654333 56788999999999999999999999999999999999999
Q ss_pred CCchhhhcccCCC------cccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCC
Q 005247 514 RGSLYKLLHIPDA------RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 587 (706)
Q Consensus 514 ggsL~~~l~~~~~------~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 587 (706)
+++|.++++.... ...+++..++.++.|++.||+|||+++ ++||||||+||+++.++.+||+|||.+.....
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK--FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC--cccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999975411 256899999999999999999999999 99999999999999999999999999987654
Q ss_pred Cc--ccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHH
Q 005247 588 TY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV 664 (706)
Q Consensus 588 ~~--~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el 664 (706)
.. .......++..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+. ...+...+..++.++
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 236 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLR-KGYRLPKPEYCPDEL 236 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCCccCChHH
Confidence 32 22344567889999999998889999999999999999999 699999888777766664 355667788899999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHHHH
Q 005247 665 AALIETCWAEEPEIRPSFPSIMETLQ 690 (706)
Q Consensus 665 ~dLI~~cL~~dP~~RPS~~eIl~~L~ 690 (706)
.+++.+||+.+|++|||+.++++.|+
T Consensus 237 ~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 237 YELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred HHHHHHHccCCcccCcCHHHHHHhhC
Confidence 99999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=328.52 Aligned_cols=250 Identities=23% Similarity=0.329 Sum_probs=208.5
Q ss_pred ceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccch-HHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEE
Q 005247 434 ELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 510 (706)
Q Consensus 434 ~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~-~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E 510 (706)
.|++.+.||+|+||.||++.+.. +.||+|++....... .....+.+|+.+++.++|+||+++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 48899999999999999998764 459999986544332 223467889999999999999999999999999999999
Q ss_pred eccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcc
Q 005247 511 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 590 (706)
Q Consensus 511 ~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~ 590 (706)
|+.+|+|.+++.... ...+++..+..++.|++.||.|||+++ ++||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 156 (285)
T cd05605 81 LMNGGDLKFHIYNMG-NPGFDEERAVFYAAEITCGLEDLHRER--IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE- 156 (285)
T ss_pred ccCCCcHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-
Confidence 999999998875432 235889999999999999999999999 9999999999999999999999999987654332
Q ss_pred cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh--hcCcccCCCCCCcHHHHHHH
Q 005247 591 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVG--FKGRRLEIPKNVNPMVAALI 668 (706)
Q Consensus 591 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~--~~~~~l~~p~~~s~el~dLI 668 (706)
......|+..|+|||++.+..++.++||||||+++|||++|+.||...........+. .......++..++..+.+||
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05605 157 TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSIC 236 (285)
T ss_pred ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHH
Confidence 2234578999999999999889999999999999999999999998765533222221 12334456677899999999
Q ss_pred HHhhhhCCCCCC-----CHHHHHH
Q 005247 669 ETCWAEEPEIRP-----SFPSIME 687 (706)
Q Consensus 669 ~~cL~~dP~~RP-----S~~eIl~ 687 (706)
.+||..||.+|| ++++++.
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 237 RQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred HHHccCCHHHhcCCCCCCHHHHhc
Confidence 999999999999 8888866
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=353.62 Aligned_cols=250 Identities=24% Similarity=0.427 Sum_probs=212.4
Q ss_pred CceEEEEEeccCCceEEEEEEEcCC---ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEE
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRNS---DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 509 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~~---~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~ 509 (706)
..|.+.+.||+|+||.||+|....+ .+++|.+... .......+.+|+.+++.++||||+++++++...+.+++||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~ 144 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN--DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIM 144 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEE
Confidence 3499999999999999999976544 3777765333 2344457788999999999999999999999999999999
Q ss_pred EeccCCchhhhcccC-CCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCC
Q 005247 510 EYLSRGSLYKLLHIP-DARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 588 (706)
Q Consensus 510 E~~~ggsL~~~l~~~-~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 588 (706)
||+++|+|.++++.. .....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 145 E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK--MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred ECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 999999999887532 22345889999999999999999999999 999999999999999999999999999865433
Q ss_pred cc--cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHH
Q 005247 589 YI--SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA 666 (706)
Q Consensus 589 ~~--~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~d 666 (706)
.. .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+.. ....+++..++.++++
T Consensus 223 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~~ 301 (478)
T PTZ00267 223 VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLY-GKYDPFPCPVSSGMKA 301 (478)
T ss_pred cccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-CCCCCCCccCCHHHHH
Confidence 21 23456799999999999999999999999999999999999999998887776666543 3334567788999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHH
Q 005247 667 LIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 667 LI~~cL~~dP~~RPS~~eIl~ 687 (706)
||.+||..||++||++.+++.
T Consensus 302 li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 302 LLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred HHHHHhccChhhCcCHHHHHh
Confidence 999999999999999999865
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=331.48 Aligned_cols=262 Identities=32% Similarity=0.531 Sum_probs=218.4
Q ss_pred cccccCceEEEEEeccCCceEEEEEEEcC-------CceEEEEEeccccchHHHHHHHHHHHHHHcC-CCCceeEEeccc
Q 005247 428 LEIRWSELLIKKKIGEGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAV 499 (706)
Q Consensus 428 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~-------~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~ 499 (706)
+.+..++|.+.+.||+|+||.||++...+ ..+|+|++.... .....+.+.+|+.+++++ +|+||+++++++
T Consensus 30 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 108 (302)
T cd05055 30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGAC 108 (302)
T ss_pred ccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEEE
Confidence 45666789999999999999999997521 138888875443 344456789999999999 799999999999
Q ss_pred cCCCceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeec
Q 005247 500 TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDF 579 (706)
Q Consensus 500 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DF 579 (706)
...+..+++|||+.+|+|.++++.... ..+++..+..++.|++.||+|||+++ |+|+||||+|||++.++.+||+||
T Consensus 109 ~~~~~~~lv~e~~~~~~L~~~i~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~l~df 185 (302)
T cd05055 109 TIGGPILVITEYCCYGDLLNFLRRKRE-SFLTLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNVLLTHGKIVKICDF 185 (302)
T ss_pred ecCCceEEEEEcCCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eehhhhccceEEEcCCCeEEECCC
Confidence 999999999999999999999864322 23789999999999999999999999 999999999999999999999999
Q ss_pred CccccCCCCcc--cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCC
Q 005247 580 GLSRSKPNTYI--SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEI 656 (706)
Q Consensus 580 Gla~~~~~~~~--~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~ 656 (706)
|++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||......+..........+...
T Consensus 186 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~ 265 (302)
T cd05055 186 GLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQ 265 (302)
T ss_pred cccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCC
Confidence 99876543221 1123345778999999999999999999999999999998 99999877665554444334445556
Q ss_pred CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 005247 657 PKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 693 (706)
Q Consensus 657 p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll 693 (706)
+...++++.+||.+||..+|++|||+.++++.|++++
T Consensus 266 ~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~~ 302 (302)
T cd05055 266 PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQL 302 (302)
T ss_pred CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhhC
Confidence 6678999999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=340.47 Aligned_cols=242 Identities=23% Similarity=0.420 Sum_probs=202.1
Q ss_pred EEeccCCceEEEEEEEcCC--ceEEEEEeccccc-hHHHHHHHHHHHHHHcC-CCCceeEEeccccCCCceEEEEEeccC
Q 005247 439 KKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFH-EDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSIVTEYLSR 514 (706)
Q Consensus 439 ~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~-~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~lV~E~~~g 514 (706)
+.||+|+||.||+|++..+ .||+|+++..... ....+.+.+|..+++.+ +||||+++++++.+.+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 3689999999999988654 4999998765433 33456688899999988 699999999999999999999999999
Q ss_pred CchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcccCCC
Q 005247 515 GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKT 594 (706)
Q Consensus 515 gsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 594 (706)
|+|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++............
T Consensus 81 g~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~ 155 (329)
T cd05588 81 GDLMFHMQRQ---RKLPEEHARFYSAEISLALNFLHERG--IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST 155 (329)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEECcCccccccccCCCcccc
Confidence 9999888633 35899999999999999999999999 999999999999999999999999998753332223345
Q ss_pred CCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh--------HH-HHHHhhhcCcccCCCCCCcHHHH
Q 005247 595 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTP--------SQ-VISAVGFKGRRLEIPKNVNPMVA 665 (706)
Q Consensus 595 ~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~--------~~-~~~~i~~~~~~l~~p~~~s~el~ 665 (706)
..||+.|+|||++.+..++.++|||||||++|+|++|+.||..... .+ ....+ ......+|..++.++.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~p~~~~~~~~ 233 (329)
T cd05588 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVI--LEKQIRIPRSLSVKAS 233 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHH--HcCCCCCCCCCCHHHH
Confidence 6899999999999999999999999999999999999999963211 11 12222 3445667888999999
Q ss_pred HHHHHhhhhCCCCCCC------HHHHHH
Q 005247 666 ALIETCWAEEPEIRPS------FPSIME 687 (706)
Q Consensus 666 dLI~~cL~~dP~~RPS------~~eIl~ 687 (706)
++|.+||+.||.+||+ +.++++
T Consensus 234 ~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 234 SVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred HHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 9999999999999997 567654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=324.30 Aligned_cols=257 Identities=34% Similarity=0.565 Sum_probs=215.6
Q ss_pred ccCceEEEEEeccCCceEEEEEEEcC---C--ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCce
Q 005247 431 RWSELLIKKKIGEGSFGTVYHAEWRN---S--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNL 505 (706)
Q Consensus 431 ~~~~y~i~~~LG~G~fG~Vy~a~~~~---~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 505 (706)
...+|++.+.||+|+||.||+|.+.. + .+|+|.+.... .....+.+.+|+.+++.++||||+++++++...+..
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 34678999999999999999998642 1 37888775433 344567889999999999999999999999999999
Q ss_pred EEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccC
Q 005247 506 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK 585 (706)
Q Consensus 506 ~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~ 585 (706)
++||||+++++|.+++.... ..+++..+..++.|++.||+|||+++ ++||||||+||+++.++.++|+|||++...
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~--i~h~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHD--GQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILVNSNLVCKVSDFGLSRVL 156 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--EeehhhchhcEEECCCCeEEeCCCCccccc
Confidence 99999999999999986443 34788899999999999999999999 999999999999999999999999998865
Q ss_pred CCCcccC---CCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCCCCCc
Q 005247 586 PNTYISS---KTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVN 661 (706)
Q Consensus 586 ~~~~~~~---~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s 661 (706)
....... ....++..|+|||.+.+..++.++|+||||+++||+++ |..||......+....+. ...+.+.+..++
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 235 (267)
T cd05066 157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIE-EGYRLPAPMDCP 235 (267)
T ss_pred ccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHh-CCCcCCCCCCCC
Confidence 4432111 11223568999999998889999999999999999886 999998877766666553 334555667789
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 005247 662 PMVAALIETCWAEEPEIRPSFPSIMETLQQFL 693 (706)
Q Consensus 662 ~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll 693 (706)
+.+.+++.+||+.+|.+||++.++++.|++++
T Consensus 236 ~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 267 (267)
T cd05066 236 AALHQLMLDCWQKDRNERPKFEQIVSILDKLI 267 (267)
T ss_pred HHHHHHHHHHcccCchhCCCHHHHHHHHHhhC
Confidence 99999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=330.97 Aligned_cols=266 Identities=32% Similarity=0.591 Sum_probs=221.8
Q ss_pred CcccccCceEEEEEeccCCceEEEEEEEcC---------CceEEEEEeccccchHHHHHHHHHHHHHHcC-CCCceeEEe
Q 005247 427 GLEIRWSELLIKKKIGEGSFGTVYHAEWRN---------SDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLM 496 (706)
Q Consensus 427 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~---------~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~ 496 (706)
.+.+...+|.+.+.||+|+||.||++++.+ ..+|+|.+.... .......+.+|+.+++.+ +||||++++
T Consensus 6 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 84 (314)
T cd05099 6 KWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLL 84 (314)
T ss_pred cccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEE
Confidence 355667789999999999999999997532 238888876433 344567788999999999 599999999
Q ss_pred ccccCCCceEEEEEeccCCchhhhcccCC-------------CcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCC
Q 005247 497 GAVTEPPNLSIVTEYLSRGSLYKLLHIPD-------------ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKS 563 (706)
Q Consensus 497 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~-------------~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp 563 (706)
+++...+.++++|||+.+|+|.+++.... ....+++..+..++.||+.||.|||++| ++||||||
T Consensus 85 ~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp 162 (314)
T cd05099 85 GVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR--CIHRDLAA 162 (314)
T ss_pred EEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeeccccc
Confidence 99999899999999999999999985421 1234788889999999999999999999 99999999
Q ss_pred CcEEECCCCcEEEeecCccccCCCCccc--CCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCh
Q 005247 564 PNLLVDSTYTVKVCDFGLSRSKPNTYIS--SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTP 640 (706)
Q Consensus 564 ~NILl~~~~~vKL~DFGla~~~~~~~~~--~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~ 640 (706)
+|||++.++.+||+|||+++........ .....++..|+|||++.+..++.++||||||+++|||++ |..||.....
T Consensus 163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~ 242 (314)
T cd05099 163 RNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV 242 (314)
T ss_pred eeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999999865432211 122234567999999999889999999999999999999 8999988877
Q ss_pred HHHHHHhhhcCcccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhc
Q 005247 641 SQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 696 (706)
Q Consensus 641 ~~~~~~i~~~~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~ 696 (706)
.+....+. .......+..++.++.+||.+||..+|++|||+.++++.|+++....
T Consensus 243 ~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 243 EELFKLLR-EGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred HHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence 77666653 34455667888999999999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=319.77 Aligned_cols=246 Identities=35% Similarity=0.595 Sum_probs=206.0
Q ss_pred EEeccCCceEEEEEEEc--CCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEEeccCCc
Q 005247 439 KKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGS 516 (706)
Q Consensus 439 ~~LG~G~fG~Vy~a~~~--~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~~~ggs 516 (706)
+.||+|+||.||+|.+. ++.+|+|..... ...+....+.+|+++++.++|+||+++++++......++||||+.+++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 36899999999999875 445899986543 344455678999999999999999999999999999999999999999
Q ss_pred hhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcccC--CC
Q 005247 517 LYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISS--KT 594 (706)
Q Consensus 517 L~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~--~~ 594 (706)
|.+++.... ..+++..++.++.|++.||+|||+++ ++||||||+||+++.++.+||+|||++.......... ..
T Consensus 80 L~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 80 FLTFLRTEG--PRLKVKELIQMVENAAAGMEYLESKH--CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 999986432 34788999999999999999999999 9999999999999999999999999987644321111 11
Q ss_pred CCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHHHHhhh
Q 005247 595 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWA 673 (706)
Q Consensus 595 ~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI~~cL~ 673 (706)
...+..|+|||.+.+..++.++||||||+++|||++ |..||...........+. ...+...+..++..+.+|+.+||+
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~ 234 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE-QGVRLPCPELCPDAVYRLMERCWE 234 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHH-cCCCCCCcccCCHHHHHHHHHHcC
Confidence 123457999999999889999999999999999998 889998777665555443 344556777889999999999999
Q ss_pred hCCCCCCCHHHHHHHHH
Q 005247 674 EEPEIRPSFPSIMETLQ 690 (706)
Q Consensus 674 ~dP~~RPS~~eIl~~L~ 690 (706)
.+|++|||+.++++.|+
T Consensus 235 ~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 235 YDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CChhhCcCHHHHHHHHh
Confidence 99999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=317.95 Aligned_cols=250 Identities=29% Similarity=0.478 Sum_probs=212.3
Q ss_pred ceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccC-CCceEEEEE
Q 005247 434 ELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE-PPNLSIVTE 510 (706)
Q Consensus 434 ~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~-~~~~~lV~E 510 (706)
.|++.+.||+|++|.||++.+..+ .+++|.+..........+.+.+|+++++.++|+|++++++.+.. ...++++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 488999999999999999987643 49999987665555566778999999999999999999988764 446789999
Q ss_pred eccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcc
Q 005247 511 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 590 (706)
Q Consensus 511 ~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~ 590 (706)
|+++++|.+++.... ...+++..++.++.|++.||++||++| ++||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~l~~~l~~~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~--i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 81 FCEGGDLYHKLKEQK-GKLLPENQVVEWFVQIAMALQYLHEKH--ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD 157 (257)
T ss_pred ccCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence 999999999886432 235889999999999999999999999 99999999999999999999999999876654433
Q ss_pred cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHHHH
Q 005247 591 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIET 670 (706)
Q Consensus 591 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI~~ 670 (706)
......+++.|+|||++.+..++.++||||||+++|+|++|+.||...+.......+. .......+...++++.+||.+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~ 236 (257)
T cd08223 158 MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRII-EGKLPPMPKDYSPELGELIAT 236 (257)
T ss_pred ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-hcCCCCCccccCHHHHHHHHH
Confidence 3445678999999999999999999999999999999999999998777655544432 233335567789999999999
Q ss_pred hhhhCCCCCCCHHHHHH
Q 005247 671 CWAEEPEIRPSFPSIME 687 (706)
Q Consensus 671 cL~~dP~~RPS~~eIl~ 687 (706)
||+.+|++||++.++++
T Consensus 237 ~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 237 MLSKRPEKRPSVKSILR 253 (257)
T ss_pred HhccCcccCCCHHHHhc
Confidence 99999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=325.48 Aligned_cols=251 Identities=28% Similarity=0.382 Sum_probs=204.0
Q ss_pred ceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEEe
Q 005247 434 ELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY 511 (706)
Q Consensus 434 ~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~ 511 (706)
+|++.+.||+|+||.||+|.+.. ..||+|++..........+.+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 58899999999999999998864 4499998865544444456788999999999999999999999999999999999
Q ss_pred ccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCccc
Q 005247 512 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS 591 (706)
Q Consensus 512 ~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~ 591 (706)
+. ++|.+++........+++..++.++.||+.||+|||+++ ++||||||+||+++.++.+||+|||++.........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 157 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR--VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRV 157 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEEcCCCcEEECcccceeecCCCccc
Confidence 97 588888764433456899999999999999999999999 999999999999999999999999998765443323
Q ss_pred CCCCCCCCCccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhc--------------------
Q 005247 592 SKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-------------------- 650 (706)
Q Consensus 592 ~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~-------------------- 650 (706)
.....+++.|+|||++.+. .++.++||||||+++|+|++|+.||...........+...
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (285)
T cd07861 158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKN 237 (285)
T ss_pred ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHh
Confidence 3345678899999998764 4688999999999999999999999876543332221100
Q ss_pred -------CcccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 651 -------GRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 651 -------~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
.........+++++.+||.+||+.||++|||+.+|++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 238 TFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0001112357899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=344.06 Aligned_cols=249 Identities=25% Similarity=0.379 Sum_probs=208.9
Q ss_pred CceEEEEEeccCCceEEEEEEEcCC--ceEEEEEecccc-chHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEE
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 509 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~ 509 (706)
++|++.+.||+|+||.||++.+..+ .||+|++..... .......+.+|+.++..++|+||+++++.+.+.+.+++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 3689999999999999999988654 499999865432 2344567888999999999999999999999999999999
Q ss_pred EeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCc
Q 005247 510 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 589 (706)
Q Consensus 510 E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 589 (706)
||+++|+|.+++... ..+++..+..++.|++.||+|||++| |+||||||+|||++.++.+||+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~~L~~lH~~g--ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 81 EFLPGGDMMTLLMKK---DTLSEEATQFYIAETVLAIDAIHQLG--FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred eCCCCccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence 999999999998643 35889999999999999999999999 9999999999999999999999999986432110
Q ss_pred -----------------------------------ccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCC
Q 005247 590 -----------------------------------ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKP 634 (706)
Q Consensus 590 -----------------------------------~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~P 634 (706)
......+||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P 235 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence 001235799999999999999999999999999999999999999
Q ss_pred CCCCChHHHHHHhhhcCcccCCCC--CCcHHHHHHHHHhhhhCCCCCCC---HHHHHH
Q 005247 635 WRNSTPSQVISAVGFKGRRLEIPK--NVNPMVAALIETCWAEEPEIRPS---FPSIME 687 (706)
Q Consensus 635 f~~~~~~~~~~~i~~~~~~l~~p~--~~s~el~dLI~~cL~~dP~~RPS---~~eIl~ 687 (706)
|...++.+....+......+.+|. .+++++++||.+|+ .||.+|++ +.++++
T Consensus 236 f~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 236 FCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKS 292 (360)
T ss_pred CCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence 999888777766644344444554 36899999999977 49999985 566655
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=324.94 Aligned_cols=259 Identities=29% Similarity=0.481 Sum_probs=213.6
Q ss_pred ccCceEEEEEeccCCceEEEEEEEcC--Cc----eEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCc
Q 005247 431 RWSELLIKKKIGEGSFGTVYHAEWRN--SD----VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN 504 (706)
Q Consensus 431 ~~~~y~i~~~LG~G~fG~Vy~a~~~~--~~----vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 504 (706)
...+|++.+.||+|+||.||+|.+.. .. +++|.+... ........+..|+.+++++.||||+++++++.. ..
T Consensus 5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~ 82 (279)
T cd05111 5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-AS 82 (279)
T ss_pred CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-Cc
Confidence 34678899999999999999998743 32 566665322 223445678889999999999999999998764 45
Q ss_pred eEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCcccc
Q 005247 505 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 584 (706)
Q Consensus 505 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~ 584 (706)
.++++||+++|+|.+++.... ..+++..+..++.||+.||+|||+++ ++||||||+||+++.++.+||+|||+++.
T Consensus 83 ~~~i~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~kl~Dfg~~~~ 158 (279)
T cd05111 83 LQLVTQLSPLGSLLDHVRQHR--DSLDPQRLLNWCVQIAKGMYYLEEHR--MVHRNLAARNILLKSDSIVQIADFGVADL 158 (279)
T ss_pred cEEEEEeCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCCCcEEEcCCcccee
Confidence 788999999999999996432 35889999999999999999999999 99999999999999999999999999976
Q ss_pred CCCCcc--cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCCCCCc
Q 005247 585 KPNTYI--SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVN 661 (706)
Q Consensus 585 ~~~~~~--~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s 661 (706)
...... ......++..|+|||.+.+..++.++||||||+++|||++ |..||....+......+ ..+.++..+..++
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~ 237 (279)
T cd05111 159 LYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL-EKGERLAQPQICT 237 (279)
T ss_pred ccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-HCCCcCCCCCCCC
Confidence 533211 1223456778999999998899999999999999999998 99999888776654444 3445566677788
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhc
Q 005247 662 PMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 696 (706)
Q Consensus 662 ~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~ 696 (706)
..+.+++.+||..||++|||+.++++.|..+....
T Consensus 238 ~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~ 272 (279)
T cd05111 238 IDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP 272 (279)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=318.51 Aligned_cols=251 Identities=25% Similarity=0.469 Sum_probs=217.5
Q ss_pred ceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEEe
Q 005247 434 ELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY 511 (706)
Q Consensus 434 ~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~ 511 (706)
+|++.+.||.|+||.||.++... ..+++|.+..........+.+.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 58899999999999999888754 4489998876655666677889999999999999999999999999999999999
Q ss_pred ccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCccc
Q 005247 512 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS 591 (706)
Q Consensus 512 ~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~ 591 (706)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~ 157 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG--ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSM 157 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChHhEEEeCCCCEEECcCcceEEccccccc
Confidence 99999999986442 345789999999999999999999999 999999999999999999999999998866544333
Q ss_pred CCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHHHHh
Q 005247 592 SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC 671 (706)
Q Consensus 592 ~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI~~c 671 (706)
.....+++.|+|||.+.+..++.++||||||+++|||++|..||...+..+....+. .......+..++.++.++|.+|
T Consensus 158 ~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~ 236 (256)
T cd08221 158 AETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIV-QGNYTPVVSVYSSELISLVHSL 236 (256)
T ss_pred ccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH-cCCCCCCccccCHHHHHHHHHH
Confidence 345678999999999988888999999999999999999999999887777666653 3333445567899999999999
Q ss_pred hhhCCCCCCCHHHHHHH
Q 005247 672 WAEEPEIRPSFPSIMET 688 (706)
Q Consensus 672 L~~dP~~RPS~~eIl~~ 688 (706)
|+.+|++||++.++++.
T Consensus 237 l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 237 LQQDPEKRPTADEVLDQ 253 (256)
T ss_pred cccCcccCCCHHHHhhC
Confidence 99999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=339.67 Aligned_cols=238 Identities=29% Similarity=0.441 Sum_probs=200.7
Q ss_pred EEeccCCceEEEEEEEcCC--ceEEEEEeccccc-hHHHHHHHHHHH-HHHcCCCCceeEEeccccCCCceEEEEEeccC
Q 005247 439 KKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFH-EDRFKEFLREVA-IMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSR 514 (706)
Q Consensus 439 ~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~-~~~~~~~~~Ei~-iL~~L~HpnIv~l~~~~~~~~~~~lV~E~~~g 514 (706)
+.||+|+||.||+|++..+ .||+|++...... ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999998644 4999998654332 223345555554 67889999999999999999999999999999
Q ss_pred CchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcccCCC
Q 005247 515 GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKT 594 (706)
Q Consensus 515 gsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 594 (706)
++|...+... ..+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++...........
T Consensus 81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (321)
T cd05603 81 GELFFHLQRE---RCFLEPRARFYAAEVASAIGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST 155 (321)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcccc
Confidence 9998887633 34788889999999999999999999 999999999999999999999999998764333333345
Q ss_pred CCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHHHHhhhh
Q 005247 595 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAE 674 (706)
Q Consensus 595 ~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI~~cL~~ 674 (706)
..||+.|+|||++.+..++.++|||||||++|||++|..||...+..+....+. .....++...+.++.++|.+||+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~l~~ 233 (321)
T cd05603 156 FCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNIL--HKPLQLPGGKTVAACDLLVGLLHK 233 (321)
T ss_pred ccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHh--cCCCCCCCCCCHHHHHHHHHHccC
Confidence 679999999999999999999999999999999999999999888766666553 345677788899999999999999
Q ss_pred CCCCCCCHH
Q 005247 675 EPEIRPSFP 683 (706)
Q Consensus 675 dP~~RPS~~ 683 (706)
+|.+||++.
T Consensus 234 ~p~~R~~~~ 242 (321)
T cd05603 234 DQRRRLGAK 242 (321)
T ss_pred CHhhcCCCC
Confidence 999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=328.13 Aligned_cols=258 Identities=36% Similarity=0.534 Sum_probs=212.6
Q ss_pred ccCceEEEEEeccCCceEEEEEEEcCC------------------ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCce
Q 005247 431 RWSELLIKKKIGEGSFGTVYHAEWRNS------------------DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNI 492 (706)
Q Consensus 431 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~------------------~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnI 492 (706)
...+|++++.||+|+||.||+|.+... .+|+|.+.... .....+.+.+|++++++++|+||
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i 81 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDPNI 81 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCCCE
Confidence 346789999999999999999976542 27888876543 33556788999999999999999
Q ss_pred eEEeccccCCCceEEEEEeccCCchhhhcccCC--------CcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCC
Q 005247 493 VLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPD--------ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSP 564 (706)
Q Consensus 493 v~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~--------~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~ 564 (706)
+++++++...+..+++|||+.+++|.+++.... ....+++..++.++.|++.||+|||+++ |+||||||+
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~--i~H~dlkp~ 159 (296)
T cd05051 82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN--FVHRDLATR 159 (296)
T ss_pred eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccccchh
Confidence 999999999999999999999999999986432 1125789999999999999999999999 999999999
Q ss_pred cEEECCCCcEEEeecCccccCCCCc--ccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh--CCCCCCCCCh
Q 005247 565 NLLVDSTYTVKVCDFGLSRSKPNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT--LQKPWRNSTP 640 (706)
Q Consensus 565 NILl~~~~~vKL~DFGla~~~~~~~--~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt--G~~Pf~~~~~ 640 (706)
||+++.++.++|+|||+++...... .......++..|+|||.+.+..++.++||||||+++|||++ +..||...+.
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05051 160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD 239 (296)
T ss_pred ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence 9999999999999999987643322 11233456778999999998889999999999999999998 6789987766
Q ss_pred HHHHHHhhhc------CcccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 005247 641 SQVISAVGFK------GRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 691 (706)
Q Consensus 641 ~~~~~~i~~~------~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ 691 (706)
.+....+... ......+..++.++.+||.+||+.||++|||+.+|++.|++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 240 QQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred HHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 6655444321 11233455678999999999999999999999999988863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=322.15 Aligned_cols=256 Identities=32% Similarity=0.566 Sum_probs=215.6
Q ss_pred cCceEEEEEeccCCceEEEEEEEcCC-----ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceE
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRNS-----DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS 506 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~~-----~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 506 (706)
...|++.+.||+|+||.||+|.+..+ .|++|++... ......+.|..|+.+++.++||||+++++++.+....+
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 81 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVM 81 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceE
Confidence 45689999999999999999987533 3899987543 24555678999999999999999999999999999999
Q ss_pred EEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCC
Q 005247 507 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP 586 (706)
Q Consensus 507 lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~ 586 (706)
+||||+.+++|.+++.... ..+++..++.++.|++.||+|||++| ++|+||||+||+++.++.+||+|||++....
T Consensus 82 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~l~~al~~lH~~g--~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 82 IITEFMENGALDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred EEEecCCCCcHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccChheEEEcCCCcEEECCCccccccc
Confidence 9999999999999986433 35788999999999999999999999 9999999999999999999999999987544
Q ss_pred CCccc---CCCCC--CCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCCCCC
Q 005247 587 NTYIS---SKTAA--GTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNV 660 (706)
Q Consensus 587 ~~~~~---~~~~~--Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~ 660 (706)
..... ..... .+..|+|||.+.+..++.++||||||+++||+++ |..||......+....+. ...+.+.+..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~ 236 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE-QDYRLPPPMDC 236 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHH-cCCcCCCcccC
Confidence 32211 01111 2457999999999999999999999999999886 999998877776666653 34455667788
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 005247 661 NPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 693 (706)
Q Consensus 661 s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll 693 (706)
+..+.+++.+||..+|.+||++.+|+..|++++
T Consensus 237 ~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 269 (269)
T cd05065 237 PTALHQLMLDCWQKDRNARPKFGQIVSTLDKMI 269 (269)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence 999999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=323.45 Aligned_cols=263 Identities=29% Similarity=0.495 Sum_probs=219.1
Q ss_pred ccccCceEEEEEeccCCceEEEEEEEcC------CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccC-
Q 005247 429 EIRWSELLIKKKIGEGSFGTVYHAEWRN------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE- 501 (706)
Q Consensus 429 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~------~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~- 501 (706)
.+..++|++.+.||+|+||.||+|.+.. ..+++|.+.. .......+.+.+|+.+++.++|+||+++++++..
T Consensus 2 ~~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 80 (280)
T cd05043 2 AISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKD-HASEIQVTLLLQESCLLYGLSHQNILPILHVCIED 80 (280)
T ss_pred ccchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccC-CCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 3556789999999999999999998765 3478887653 3345566788999999999999999999998655
Q ss_pred CCceEEEEEeccCCchhhhcccCCCc-----ccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEE
Q 005247 502 PPNLSIVTEYLSRGSLYKLLHIPDAR-----VVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKV 576 (706)
Q Consensus 502 ~~~~~lV~E~~~ggsL~~~l~~~~~~-----~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL 576 (706)
+...++++||+.+++|.+++...... ..+++..++.++.|++.||+|||+++ ++||||||+||++++++.+||
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~di~p~nil~~~~~~~kl 158 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG--VIHKDIAARNCVIDEELQVKI 158 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCHhhEEEcCCCcEEE
Confidence 56789999999999999998643221 45889999999999999999999999 999999999999999999999
Q ss_pred eecCccccCCCCcc--cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcc
Q 005247 577 CDFGLSRSKPNTYI--SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRR 653 (706)
Q Consensus 577 ~DFGla~~~~~~~~--~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~ 653 (706)
+|||+++....... ......++..|+|||.+.+..++.++||||||+++||+++ |..||...++.+....+. ...+
T Consensus 159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~ 237 (280)
T cd05043 159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLK-DGYR 237 (280)
T ss_pred CCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHH-cCCC
Confidence 99999975432211 1123345678999999998889999999999999999999 999998887766655543 3344
Q ss_pred cCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHh
Q 005247 654 LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS 695 (706)
Q Consensus 654 l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s 695 (706)
+..+..+++++.+++.+||..+|++|||+.++++.|+.+...
T Consensus 238 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 238 LAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 455667899999999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=324.57 Aligned_cols=248 Identities=35% Similarity=0.573 Sum_probs=208.2
Q ss_pred eEEEEEeccCCceEEEEEEEcCCc--eEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEEec
Q 005247 435 LLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYL 512 (706)
Q Consensus 435 y~i~~~LG~G~fG~Vy~a~~~~~~--vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~~ 512 (706)
|++++.||+|+||+||++.+.++. +|+|++..............+|+.++++++|+||+++++++......+++||++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 789999999999999999998775 999999887666555555667999999999999999999999999999999999
Q ss_pred cCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcccC
Q 005247 513 SRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISS 592 (706)
Q Consensus 513 ~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~ 592 (706)
.+++|.+++. ....+++..++.++.||++||.+||+++ |+|+||||+||+++.++.++|+|||.+..........
T Consensus 81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~--i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~ 155 (260)
T PF00069_consen 81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG--IVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENF 155 (260)
T ss_dssp TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT--EEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEB
T ss_pred cccccccccc---cccccccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccc
Confidence 9999999997 2335899999999999999999999999 9999999999999999999999999987543333344
Q ss_pred CCCCCCCCccCccccc-cCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHh---hhcCcccC--CCCCCcHHHHH
Q 005247 593 KTAAGTPEWMAPEVLR-EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAV---GFKGRRLE--IPKNVNPMVAA 666 (706)
Q Consensus 593 ~~~~Gt~~Y~APE~l~-~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i---~~~~~~l~--~p~~~s~el~d 666 (706)
....++..|+|||++. +...+.++||||||+++|+|++|..||...........+ ........ .....++++.+
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (260)
T PF00069_consen 156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRD 235 (260)
T ss_dssp SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHH
Confidence 5677899999999998 788999999999999999999999999987332322222 11111111 11223489999
Q ss_pred HHHHhhhhCCCCCCCHHHHHH
Q 005247 667 LIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 667 LI~~cL~~dP~~RPS~~eIl~ 687 (706)
+|.+||+.||++||++.++++
T Consensus 236 li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 236 LIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HHHHHSSSSGGGSTTHHHHHT
T ss_pred HHHHHccCChhHCcCHHHHhc
Confidence 999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=320.08 Aligned_cols=254 Identities=33% Similarity=0.582 Sum_probs=212.1
Q ss_pred cccCceEEEEEeccCCceEEEEEEEcCC-ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEE
Q 005247 430 IRWSELLIKKKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIV 508 (706)
Q Consensus 430 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~-~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV 508 (706)
+...+|++.+.||+|+||.||+|.+.++ .+++|.+..... ..+.+.+|+.+++.++|+|++++++++.. +..+++
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v 78 (260)
T cd05069 3 IPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM---MPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIV 78 (260)
T ss_pred CChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc---cHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEE
Confidence 4456799999999999999999987665 588887654332 23568899999999999999999998754 567899
Q ss_pred EEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCC
Q 005247 509 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 588 (706)
Q Consensus 509 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 588 (706)
|||+.+++|.++++... ...+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++......
T Consensus 79 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05069 79 TEFMGKGSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIERMN--YIHRDLRAANILVGDNLVCKIADFGLARLIEDN 155 (260)
T ss_pred EEcCCCCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCCCeEEECCCccceEccCC
Confidence 99999999999986432 234788889999999999999999999 999999999999999999999999999765432
Q ss_pred cc-cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHH
Q 005247 589 YI-SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA 666 (706)
Q Consensus 589 ~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~d 666 (706)
.. ......++..|+|||.+.+...+.++||||||+++|||++ |..||......+....+. .......+...+..+.+
T Consensus 156 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 234 (260)
T cd05069 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVE-RGYRMPCPQGCPESLHE 234 (260)
T ss_pred cccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCcccCHHHHH
Confidence 21 1122345678999999998889999999999999999999 899998877766655543 33445566788999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHHHHH
Q 005247 667 LIETCWAEEPEIRPSFPSIMETLQQ 691 (706)
Q Consensus 667 LI~~cL~~dP~~RPS~~eIl~~L~~ 691 (706)
+|.+||..||++||+++++++.|++
T Consensus 235 li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 235 LMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred HHHHHccCCcccCcCHHHHHHHHhc
Confidence 9999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=339.55 Aligned_cols=237 Identities=23% Similarity=0.422 Sum_probs=198.2
Q ss_pred EEeccCCceEEEEEEEcCC--ceEEEEEeccccc-hHHHHHHHHHHHHHHcC-CCCceeEEeccccCCCceEEEEEeccC
Q 005247 439 KKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFH-EDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSIVTEYLSR 514 (706)
Q Consensus 439 ~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~-~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~lV~E~~~g 514 (706)
+.||+|+||.||+|.+..+ .+|+|++...... ....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 3699999999999988654 4999998765332 33455678899888777 799999999999999999999999999
Q ss_pred CchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcccCCC
Q 005247 515 GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKT 594 (706)
Q Consensus 515 gsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 594 (706)
|+|..++... ..+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++...........
T Consensus 81 ~~L~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~ 155 (329)
T cd05618 81 GDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST 155 (329)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcccc
Confidence 9998887533 35889999999999999999999999 999999999999999999999999998764333333345
Q ss_pred CCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC---------hHHHHHHhhhcCcccCCCCCCcHHHH
Q 005247 595 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNST---------PSQVISAVGFKGRRLEIPKNVNPMVA 665 (706)
Q Consensus 595 ~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~---------~~~~~~~i~~~~~~l~~p~~~s~el~ 665 (706)
..||+.|+|||++.+..++.++|||||||++|||++|+.||.... .......+ ......+|..++.++.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i--~~~~~~~p~~~~~~~~ 233 (329)
T cd05618 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI--LEKQIRIPRSLSVKAA 233 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHH--hcCCCCCCCCCCHHHH
Confidence 679999999999999999999999999999999999999995311 11112222 3445678889999999
Q ss_pred HHHHHhhhhCCCCCCCH
Q 005247 666 ALIETCWAEEPEIRPSF 682 (706)
Q Consensus 666 dLI~~cL~~dP~~RPS~ 682 (706)
+||.+||+.||++||++
T Consensus 234 ~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 234 SVLKSFLNKDPKERLGC 250 (329)
T ss_pred HHHHHHhcCCHHHcCCC
Confidence 99999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=323.93 Aligned_cols=257 Identities=33% Similarity=0.538 Sum_probs=212.3
Q ss_pred cccCceEEEEEeccCCceEEEEEEEcC-----C--ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCC
Q 005247 430 IRWSELLIKKKIGEGSFGTVYHAEWRN-----S--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP 502 (706)
Q Consensus 430 i~~~~y~i~~~LG~G~fG~Vy~a~~~~-----~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~ 502 (706)
+..++|++.+.||+|+||.||+|.+.+ . .|++|...... .......+.+|+.+++.++|+||+++++++.+.
T Consensus 3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (277)
T cd05036 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFER 81 (277)
T ss_pred CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 345679999999999999999998865 3 36777654332 233346789999999999999999999999988
Q ss_pred CceEEEEEeccCCchhhhcccCC----CcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCC---cEE
Q 005247 503 PNLSIVTEYLSRGSLYKLLHIPD----ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY---TVK 575 (706)
Q Consensus 503 ~~~~lV~E~~~ggsL~~~l~~~~----~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~---~vK 575 (706)
...++||||+.+++|.+++.... ....+++..++.++.||+.||+|||+++ ++||||||+||+++.++ .+|
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~nil~~~~~~~~~~k 159 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH--FIHRDIAARNCLLTCKGPGRVAK 159 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchheEEEeccCCCcceE
Confidence 89999999999999999985432 1235788999999999999999999999 99999999999998654 599
Q ss_pred EeecCccccCCCCccc--CCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCc
Q 005247 576 VCDFGLSRSKPNTYIS--SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGR 652 (706)
Q Consensus 576 L~DFGla~~~~~~~~~--~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~ 652 (706)
|+|||+++........ ......+..|+|||++.+..++.++|||||||++|||++ |..||...+..+....+. ...
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~-~~~ 238 (277)
T cd05036 160 IADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVT-GGG 238 (277)
T ss_pred eccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-cCC
Confidence 9999999865322111 112234568999999999999999999999999999997 999998877766655543 344
Q ss_pred ccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 005247 653 RLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQ 690 (706)
Q Consensus 653 ~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~ 690 (706)
+...+..++..+.++|.+||+.+|++||++.++++.|+
T Consensus 239 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 239 RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 56677889999999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=337.39 Aligned_cols=247 Identities=27% Similarity=0.342 Sum_probs=199.6
Q ss_pred cCceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCC------
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP------ 503 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~------ 503 (706)
.++|++.+.||+|+||.||++.+.. ..+|+|++............+.+|+.+++.++||||+++++++...+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 4789999999999999999998764 45999998765545555678889999999999999999999886443
Q ss_pred ceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccc
Q 005247 504 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 583 (706)
Q Consensus 504 ~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~ 583 (706)
..++||||+.+ +|...++. .+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++
T Consensus 100 ~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlkp~NIl~~~~~~~kl~Dfg~a~ 171 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIHM-----ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR 171 (359)
T ss_pred eeEEEEeCCCc-CHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEecCCCcc
Confidence 47999999976 55555531 3778889999999999999999999 9999999999999999999999999997
Q ss_pred cCCCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhh--------------
Q 005247 584 SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGF-------------- 649 (706)
Q Consensus 584 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~-------------- 649 (706)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+..
T Consensus 172 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (359)
T cd07876 172 TACTNF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQ 250 (359)
T ss_pred ccccCc-cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHH
Confidence 643322 22456789999999999999999999999999999999999999987654332211100
Q ss_pred ------cCccc--------------------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 650 ------KGRRL--------------------EIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 650 ------~~~~l--------------------~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
..... ......++++++||.+||+.||++|||+.|++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 314 (359)
T cd07876 251 PTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR 314 (359)
T ss_pred HHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000 011234678999999999999999999999988
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=340.40 Aligned_cols=238 Identities=27% Similarity=0.413 Sum_probs=200.9
Q ss_pred EEeccCCceEEEEEEEcC--CceEEEEEecccc-chHHHHHHHHHHH-HHHcCCCCceeEEeccccCCCceEEEEEeccC
Q 005247 439 KKIGEGSFGTVYHAEWRN--SDVAVKILIEQEF-HEDRFKEFLREVA-IMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSR 514 (706)
Q Consensus 439 ~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~-~~~~~~~~~~Ei~-iL~~L~HpnIv~l~~~~~~~~~~~lV~E~~~g 514 (706)
+.||+|+||.||+|.+.. ..+|+|++..... .....+.+..|.. +++.++||||+++++++...+..++||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 369999999999998764 4599999865432 2233345566655 46778999999999999999999999999999
Q ss_pred CchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcccCCC
Q 005247 515 GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKT 594 (706)
Q Consensus 515 gsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 594 (706)
|+|..++... ..+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++...........
T Consensus 81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~g--ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~ 155 (325)
T cd05604 81 GELFFHLQRE---RSFPEPRARFYAAEIASALGYLHSIN--IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTT 155 (325)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCccc
Confidence 9998888633 35889999999999999999999999 999999999999999999999999998764333333445
Q ss_pred CCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHHHHhhhh
Q 005247 595 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAE 674 (706)
Q Consensus 595 ~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI~~cL~~ 674 (706)
..||+.|+|||++.+..++.++|||||||++|||++|..||...+..+....+. .....+++..+..+.++|.+||..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ll~~ll~~ 233 (325)
T cd05604 156 FCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNIL--HKPLVLRPGASLTAWSILEELLEK 233 (325)
T ss_pred ccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHH--cCCccCCCCCCHHHHHHHHHHhcc
Confidence 679999999999999999999999999999999999999999888777666553 334556677899999999999999
Q ss_pred CCCCCCCHH
Q 005247 675 EPEIRPSFP 683 (706)
Q Consensus 675 dP~~RPS~~ 683 (706)
+|.+||++.
T Consensus 234 ~p~~R~~~~ 242 (325)
T cd05604 234 DRQRRLGAK 242 (325)
T ss_pred CHHhcCCCC
Confidence 999999875
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=320.32 Aligned_cols=246 Identities=31% Similarity=0.558 Sum_probs=206.5
Q ss_pred EeccCCceEEEEEEEc--CC--ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEEeccCC
Q 005247 440 KIGEGSFGTVYHAEWR--NS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRG 515 (706)
Q Consensus 440 ~LG~G~fG~Vy~a~~~--~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~~~gg 515 (706)
.||+|+||.||+|.+. +. .+|+|++.... .....+.+.+|+.++++++|+||+++++++.. ...++||||++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~ 79 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGG 79 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCC
Confidence 3899999999999764 22 38888875442 34445679999999999999999999998754 5789999999999
Q ss_pred chhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCccc---C
Q 005247 516 SLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS---S 592 (706)
Q Consensus 516 sL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~---~ 592 (706)
+|.+++.... ..+++..++.++.|++.||.|||++| ++||||||+||+++.++.+||+|||++......... .
T Consensus 80 ~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 80 PLNKFLSGKK--DEITVSNVVELMHQVSMGMKYLEGKN--FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhcC--eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 9999986332 35889999999999999999999999 999999999999999999999999998754332211 1
Q ss_pred CCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHHHHh
Q 005247 593 KTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC 671 (706)
Q Consensus 593 ~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI~~c 671 (706)
....++..|+|||.+.+..++.++||||||+++||+++ |..||......+....+. .+.+..++..+++++.++|.+|
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~c 234 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIE-QGKRLDCPAECPPEMYALMKDC 234 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHH
Confidence 12234578999999988889999999999999999996 999999888777665553 4556778888999999999999
Q ss_pred hhhCCCCCCCHHHHHHHHHHH
Q 005247 672 WAEEPEIRPSFPSIMETLQQF 692 (706)
Q Consensus 672 L~~dP~~RPS~~eIl~~L~~l 692 (706)
|..+|++||++.+|.+.|+.+
T Consensus 235 ~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 235 WIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred cCCChhhCcCHHHHHHHHhhh
Confidence 999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=330.46 Aligned_cols=256 Identities=24% Similarity=0.344 Sum_probs=205.8
Q ss_pred cCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEE
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 509 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~ 509 (706)
..+|++.+.||+|+||.||+|.+..+ .+|+|.+..... ......+.+|+.++++++|+||+++++++..++..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 83 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVF 83 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc-CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEE
Confidence 46799999999999999999987644 499998865432 222346778999999999999999999999999999999
Q ss_pred EeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCc
Q 005247 510 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 589 (706)
Q Consensus 510 E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 589 (706)
||+.+ +|.+++.... ..+++..+..++.||+.||+|||++| |+||||||+||+++.++.+||+|||+++......
T Consensus 84 e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 84 EYLDK-DLKQYMDDCG--NIMSMHNVKIFLYQILRGLAYCHRRK--VLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred eCCCC-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 99975 7777775332 24788889999999999999999999 9999999999999999999999999997654443
Q ss_pred ccCCCCCCCCCccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCc----------------
Q 005247 590 ISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR---------------- 652 (706)
Q Consensus 590 ~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~---------------- 652 (706)
.......+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||...+..+....+.....
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07872 159 KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF 238 (309)
T ss_pred cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence 33345578999999999865 4578999999999999999999999987765544333211000
Q ss_pred -cc-----------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH--HHHHHH
Q 005247 653 -RL-----------EIPKNVNPMVAALIETCWAEEPEIRPSFPSIME--TLQQFL 693 (706)
Q Consensus 653 -~l-----------~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~--~L~~ll 693 (706)
.. .....+++++.+||.+||+.||++|||+.++++ .++.+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 00 111356889999999999999999999999987 444443
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=319.55 Aligned_cols=258 Identities=34% Similarity=0.550 Sum_probs=215.6
Q ss_pred cccCceEEEEEeccCCceEEEEEEEcCC-----ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCc
Q 005247 430 IRWSELLIKKKIGEGSFGTVYHAEWRNS-----DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN 504 (706)
Q Consensus 430 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~-----~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 504 (706)
+...+|+..+.||+|+||.||+|.+..+ .+++|.+.... .....+.+..|+.+++.++|+||+++.+++...+.
T Consensus 2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (268)
T cd05063 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP 80 (268)
T ss_pred CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence 3456788999999999999999987532 37888765432 34445678999999999999999999999999999
Q ss_pred eEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCcccc
Q 005247 505 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 584 (706)
Q Consensus 505 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~ 584 (706)
.++||||+++++|.++++... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++..
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nili~~~~~~kl~dfg~~~~ 156 (268)
T cd05063 81 AMIITEYMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLSDMN--YVHRDLAARNILVNSNLECKVSDFGLSRV 156 (268)
T ss_pred cEEEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEEcCCCcEEECCCcccee
Confidence 999999999999999986432 35788899999999999999999999 99999999999999999999999999876
Q ss_pred CCCCcccC---CCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCCCCC
Q 005247 585 KPNTYISS---KTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNV 660 (706)
Q Consensus 585 ~~~~~~~~---~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~ 660 (706)
........ .....+..|+|||.+.+..++.++||||||+++|||++ |..||...+..+....+. ...+.+.+..+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~ 235 (268)
T cd05063 157 LEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIN-DGFRLPAPMDC 235 (268)
T ss_pred cccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHh-cCCCCCCCCCC
Confidence 54322111 11223457999999998889999999999999999997 999998877766666654 33455556678
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 005247 661 NPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 693 (706)
Q Consensus 661 s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll 693 (706)
+..+.+++.+||+.+|++||++.+|++.|++++
T Consensus 236 ~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~ 268 (268)
T cd05063 236 PSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268 (268)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 999999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=325.91 Aligned_cols=258 Identities=35% Similarity=0.571 Sum_probs=214.6
Q ss_pred cccCceEEEEEeccCCceEEEEEEEcC-------CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCC
Q 005247 430 IRWSELLIKKKIGEGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP 502 (706)
Q Consensus 430 i~~~~y~i~~~LG~G~fG~Vy~a~~~~-------~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~ 502 (706)
+...+|++.+.||+|+||.||+|.+.+ ..+|+|++.... .......+.+|+.+++.++||||+++++++.++
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~ 80 (288)
T cd05050 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVG 80 (288)
T ss_pred CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence 345689999999999999999998642 348999875433 344456788999999999999999999999999
Q ss_pred CceEEEEEeccCCchhhhcccCC-------------------CcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCC
Q 005247 503 PNLSIVTEYLSRGSLYKLLHIPD-------------------ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKS 563 (706)
Q Consensus 503 ~~~~lV~E~~~ggsL~~~l~~~~-------------------~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp 563 (706)
...+++|||+.+++|.+++.... ....+++..++.++.|++.||+|||+++ ++||||||
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~--i~H~dl~p 158 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK--FVHRDLAT 158 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--eecccccH
Confidence 99999999999999999985321 1124678889999999999999999999 99999999
Q ss_pred CcEEECCCCcEEEeecCccccCCCCc--ccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCh
Q 005247 564 PNLLVDSTYTVKVCDFGLSRSKPNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTP 640 (706)
Q Consensus 564 ~NILl~~~~~vKL~DFGla~~~~~~~--~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~ 640 (706)
+||+++.++.+||+|||++....... ........+..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 159 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~ 238 (288)
T cd05050 159 RNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH 238 (288)
T ss_pred hheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999999987543221 11122344667999999998899999999999999999997 8889988877
Q ss_pred HHHHHHhhhcCcccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 005247 641 SQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 691 (706)
Q Consensus 641 ~~~~~~i~~~~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ 691 (706)
.+....+. .......+..++.++.+||.+||+.+|++|||+.|++..|++
T Consensus 239 ~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 239 EEVIYYVR-DGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHHHHHHh-cCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 77666553 333445667889999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=324.13 Aligned_cols=250 Identities=27% Similarity=0.441 Sum_probs=204.8
Q ss_pred cCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEE
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 509 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~ 509 (706)
..+|++.+.||+|+||.||+|.+..+ .+|+|++.... ......+.+|+.+++.++|+||+++++++...+..++||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~ 85 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP--GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM 85 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc--cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence 45799999999999999999987544 48999886543 233456788999999999999999999999999999999
Q ss_pred EeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCc
Q 005247 510 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 589 (706)
Q Consensus 510 E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 589 (706)
||+++++|.++++.. ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++.......
T Consensus 86 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 86 EYCGGGSLQDIYHVT---GPLSELQIAYVCRETLQGLAYLHSKG--KMHRDIKGANILLTDNGDVKLADFGVAAKITATI 160 (267)
T ss_pred eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence 999999999988643 35789999999999999999999999 9999999999999999999999999998654433
Q ss_pred ccCCCCCCCCCccCccccc---cCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcc---cCCCCCCcHH
Q 005247 590 ISSKTAAGTPEWMAPEVLR---EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR---LEIPKNVNPM 663 (706)
Q Consensus 590 ~~~~~~~Gt~~Y~APE~l~---~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~---l~~p~~~s~e 663 (706)
.......++..|+|||.+. ...++.++||||||+++|||++|+.||....+.+....+...... ......++..
T Consensus 161 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (267)
T cd06646 161 AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSST 240 (267)
T ss_pred cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHH
Confidence 2334457889999999984 344788999999999999999999999765544333222111111 1122357899
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHH
Q 005247 664 VAALIETCWAEEPEIRPSFPSIMET 688 (706)
Q Consensus 664 l~dLI~~cL~~dP~~RPS~~eIl~~ 688 (706)
+.+||++||+.+|++|||+++|++.
T Consensus 241 ~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 241 FHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred HHHHHHHHhhCChhhCcCHHHHhcC
Confidence 9999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=318.92 Aligned_cols=246 Identities=33% Similarity=0.543 Sum_probs=207.8
Q ss_pred EEeccCCceEEEEEEEcC-----CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEEecc
Q 005247 439 KKIGEGSFGTVYHAEWRN-----SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLS 513 (706)
Q Consensus 439 ~~LG~G~fG~Vy~a~~~~-----~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~~~ 513 (706)
+.||+|+||.||+|.+.. ..+|+|.+...... ...+.+.+|+.+++.+.|+||+++++++. .+..++||||+.
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCC
Confidence 469999999999997643 34888987655433 45568899999999999999999999876 456899999999
Q ss_pred CCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCccc--
Q 005247 514 RGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS-- 591 (706)
Q Consensus 514 ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~-- 591 (706)
+++|.+++.... .+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||+++........
T Consensus 79 ~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 79 LGPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESKH--FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhcC--eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 999999997433 5789999999999999999999999 999999999999999999999999998865432211
Q ss_pred -CCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHHH
Q 005247 592 -SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE 669 (706)
Q Consensus 592 -~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI~ 669 (706)
.....++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+. ...+...+..++..++++|.
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~ 232 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLE-SGERLPRPEECPQEIYSIML 232 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH-cCCcCCCCCCCCHHHHHHHH
Confidence 112223567999999998899999999999999999998 999998887777666653 44456777889999999999
Q ss_pred HhhhhCCCCCCCHHHHHHHHHHH
Q 005247 670 TCWAEEPEIRPSFPSIMETLQQF 692 (706)
Q Consensus 670 ~cL~~dP~~RPS~~eIl~~L~~l 692 (706)
+||+.+|++||++.++++.|+.+
T Consensus 233 ~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 233 SCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred HHhcCChhhCcCHHHHHHHHHhc
Confidence 99999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=336.23 Aligned_cols=265 Identities=31% Similarity=0.555 Sum_probs=214.3
Q ss_pred cccccCceEEEEEeccCCceEEEEEEEc-------CCceEEEEEeccccchHHHHHHHHHHHHHHcC-CCCceeEEeccc
Q 005247 428 LEIRWSELLIKKKIGEGSFGTVYHAEWR-------NSDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAV 499 (706)
Q Consensus 428 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~-------~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~ 499 (706)
++...++|++.+.||+|+||.||+|.+. ++.||||++.... .......+.+|+.++.++ +|+||+++++++
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (343)
T cd05103 2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGAC 80 (343)
T ss_pred cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhccee
Confidence 3455678999999999999999999753 2359999986543 334456788999999999 689999999987
Q ss_pred cCC-CceEEEEEeccCCchhhhcccCCC----------------------------------------------------
Q 005247 500 TEP-PNLSIVTEYLSRGSLYKLLHIPDA---------------------------------------------------- 526 (706)
Q Consensus 500 ~~~-~~~~lV~E~~~ggsL~~~l~~~~~---------------------------------------------------- 526 (706)
... ...+++|||+++|+|.++++....
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (343)
T cd05103 81 TKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD 160 (343)
T ss_pred ecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence 654 467899999999999998853210
Q ss_pred ------------cccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCc--ccC
Q 005247 527 ------------RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY--ISS 592 (706)
Q Consensus 527 ------------~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~--~~~ 592 (706)
...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++....... ...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 238 (343)
T cd05103 161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK 238 (343)
T ss_pred chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhc
Confidence 123677788899999999999999999 9999999999999999999999999987643221 111
Q ss_pred CCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHHHHh
Q 005247 593 KTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC 671 (706)
Q Consensus 593 ~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI~~c 671 (706)
....++..|+|||.+.+..++.++||||||+++|+|++ |..||.................+...+..+++++.+++.+|
T Consensus 239 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~c 318 (343)
T cd05103 239 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDC 318 (343)
T ss_pred CCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHH
Confidence 22345678999999999899999999999999999997 89999765543333333334455666777889999999999
Q ss_pred hhhCCCCCCCHHHHHHHHHHHHHh
Q 005247 672 WAEEPEIRPSFPSIMETLQQFLMS 695 (706)
Q Consensus 672 L~~dP~~RPS~~eIl~~L~~ll~s 695 (706)
|+.+|++|||+.+|++.|+++++.
T Consensus 319 l~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 319 WHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred ccCChhhCcCHHHHHHHHHHHHhc
Confidence 999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=323.96 Aligned_cols=256 Identities=35% Similarity=0.578 Sum_probs=213.5
Q ss_pred cccCceEEEEEeccCCceEEEEEEEc-------CCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCC
Q 005247 430 IRWSELLIKKKIGEGSFGTVYHAEWR-------NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP 502 (706)
Q Consensus 430 i~~~~y~i~~~LG~G~fG~Vy~a~~~-------~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~ 502 (706)
+...+|.+.++||+|+||.||++... +..+++|.+... .....+.+.+|+++++.++|+||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTEG 79 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence 45678899999999999999999642 223777776433 345556899999999999999999999999999
Q ss_pred CceEEEEEeccCCchhhhcccCCC------------cccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECC
Q 005247 503 PNLSIVTEYLSRGSLYKLLHIPDA------------RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS 570 (706)
Q Consensus 503 ~~~~lV~E~~~ggsL~~~l~~~~~------------~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~ 570 (706)
+..+++|||+.+++|.+++..... ...+++..++.++.||+.||+|||+++ ++||||||+|||+++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~nil~~~ 157 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH--FVHRDLATRNCLVGQ 157 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC--eecccccHhhEEEcC
Confidence 999999999999999999864321 134788999999999999999999999 999999999999999
Q ss_pred CCcEEEeecCccccCCCCc--ccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHh
Q 005247 571 TYTVKVCDFGLSRSKPNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAV 647 (706)
Q Consensus 571 ~~~vKL~DFGla~~~~~~~--~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i 647 (706)
++.+||+|||+++...... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||......+....+
T Consensus 158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 237 (280)
T cd05092 158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI 237 (280)
T ss_pred CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH
Confidence 9999999999987543221 11123345678999999999999999999999999999998 89999887776666555
Q ss_pred hhcCcccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 005247 648 GFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQ 690 (706)
Q Consensus 648 ~~~~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~ 690 (706)
. .......+..+++.+.+||.+||+.||.+||++.+|++.|+
T Consensus 238 ~-~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 238 T-QGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred H-cCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 3 33445667789999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=319.22 Aligned_cols=259 Identities=33% Similarity=0.582 Sum_probs=216.7
Q ss_pred cccCceEEEEEeccCCceEEEEEEEcCC-----ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCc
Q 005247 430 IRWSELLIKKKIGEGSFGTVYHAEWRNS-----DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN 504 (706)
Q Consensus 430 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~-----~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 504 (706)
+...+|.+.+.||+|+||.||+|.+.+. .+++|...... .....+.+.+|+.+++.++|+||+++++++.+ ..
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~ 80 (270)
T cd05056 3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NP 80 (270)
T ss_pred echhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CC
Confidence 4556789999999999999999986543 37888764432 34456789999999999999999999998875 45
Q ss_pred eEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCcccc
Q 005247 505 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 584 (706)
Q Consensus 505 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~ 584 (706)
.++||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~--~~H~dl~p~nili~~~~~~~l~d~g~~~~ 156 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVNK--YSLDLASLILYSYQLSTALAYLESKR--FVHRDIAARNVLVSSPDCVKLGDFGLSRY 156 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccChheEEEecCCCeEEccCceeee
Confidence 789999999999999996432 24789999999999999999999999 99999999999999999999999999876
Q ss_pred CCCCcc-cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCCCCCcH
Q 005247 585 KPNTYI-SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNP 662 (706)
Q Consensus 585 ~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~ 662 (706)
...... ......++..|+|||.+....++.++||||||+++||+++ |..||......+....+. ...++..+..++.
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~ 235 (270)
T cd05056 157 LEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIE-NGERLPMPPNCPP 235 (270)
T ss_pred cccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-cCCcCCCCCCCCH
Confidence 543321 1122334568999999988889999999999999999986 999998887766665553 4455667788999
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHh
Q 005247 663 MVAALIETCWAEEPEIRPSFPSIMETLQQFLMS 695 (706)
Q Consensus 663 el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s 695 (706)
++.++|.+||..+|++|||+.++++.|+++...
T Consensus 236 ~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 236 TLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=321.12 Aligned_cols=249 Identities=35% Similarity=0.624 Sum_probs=206.3
Q ss_pred EeccCCceEEEEEEEcCCc----eEEEEEeccccchHHHHHHHHHHHHHHcC-CCCceeEEeccccCCCceEEEEEeccC
Q 005247 440 KIGEGSFGTVYHAEWRNSD----VAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSIVTEYLSR 514 (706)
Q Consensus 440 ~LG~G~fG~Vy~a~~~~~~----vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~lV~E~~~g 514 (706)
.||+|+||.||+|.+.++. +++|.+... ......+.+.+|+++++++ +||||+++++++...+..+++|||+++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 5899999999999886543 466665432 2344456788999999999 799999999999999999999999999
Q ss_pred CchhhhcccCC-------------CcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCc
Q 005247 515 GSLYKLLHIPD-------------ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL 581 (706)
Q Consensus 515 gsL~~~l~~~~-------------~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGl 581 (706)
|+|.+++.... ....+++..+..++.|++.||+|||+++ ++||||||+||+++.++.+||+|||+
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccccceEEEcCCCeEEECCCCC
Confidence 99999986422 1224778999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCCCCC
Q 005247 582 SRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNV 660 (706)
Q Consensus 582 a~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~ 660 (706)
+...... ........+..|+|||++.+..++.++||||||+++|||++ |..||...+..+....+. ...+...+..+
T Consensus 159 ~~~~~~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~ 236 (270)
T cd05047 159 SRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-QGYRLEKPLNC 236 (270)
T ss_pred ccccchh-hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHh-CCCCCCCCCcC
Confidence 8643221 11122234567999999988889999999999999999997 999998877766665553 33455566778
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 005247 661 NPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 693 (706)
Q Consensus 661 s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll 693 (706)
+.++.+|+.+||..+|.+|||+.+++..|++++
T Consensus 237 ~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 237 DDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 899999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=330.88 Aligned_cols=267 Identities=32% Similarity=0.576 Sum_probs=222.5
Q ss_pred CcccccCceEEEEEeccCCceEEEEEEEcC---------CceEEEEEeccccchHHHHHHHHHHHHHHcC-CCCceeEEe
Q 005247 427 GLEIRWSELLIKKKIGEGSFGTVYHAEWRN---------SDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLM 496 (706)
Q Consensus 427 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~---------~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~ 496 (706)
.+++...+|++.+.||+|+||.||+|.+.+ ..+|+|++... ......+.+.+|+.+++++ +|+||++++
T Consensus 6 ~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 84 (334)
T cd05100 6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINLL 84 (334)
T ss_pred ccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeeee
Confidence 466777789999999999999999997532 13788876543 3344567899999999999 799999999
Q ss_pred ccccCCCceEEEEEeccCCchhhhcccCC-------------CcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCC
Q 005247 497 GAVTEPPNLSIVTEYLSRGSLYKLLHIPD-------------ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKS 563 (706)
Q Consensus 497 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~-------------~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp 563 (706)
+++...+..+++|||+.+|+|.+++.... ....+....+..++.|++.||+|||++| ++||||||
T Consensus 85 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp 162 (334)
T cd05100 85 GACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--CIHRDLAA 162 (334)
T ss_pred EEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--eecccccc
Confidence 99999999999999999999999986421 1234677888999999999999999999 99999999
Q ss_pred CcEEECCCCcEEEeecCccccCCCCccc--CCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCh
Q 005247 564 PNLLVDSTYTVKVCDFGLSRSKPNTYIS--SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTP 640 (706)
Q Consensus 564 ~NILl~~~~~vKL~DFGla~~~~~~~~~--~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~ 640 (706)
+|||++.++.+||+|||+++........ .....++..|+|||++.+..++.++||||||+++|||++ |..||...+.
T Consensus 163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 242 (334)
T cd05100 163 RNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 242 (334)
T ss_pred ceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence 9999999999999999998765432211 122334567999999999999999999999999999998 8899988877
Q ss_pred HHHHHHhhhcCcccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhcc
Q 005247 641 SQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSV 697 (706)
Q Consensus 641 ~~~~~~i~~~~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~~ 697 (706)
.+....+. .......+..++.++.+||.+||+.+|++|||+.++++.|+++.....
T Consensus 243 ~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~ 298 (334)
T cd05100 243 EELFKLLK-EGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS 298 (334)
T ss_pred HHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcC
Confidence 77666553 344556677889999999999999999999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=339.01 Aligned_cols=248 Identities=27% Similarity=0.444 Sum_probs=222.1
Q ss_pred CceEEEEEeccCCceEEEEEEEc--CCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEE
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 510 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E 510 (706)
+-|.+.+.||+|.|..|-+|++. +..||||++.+...+.-.-..+..|+..|+.++|||||++|++...+..+|+|+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 45788899999999999999874 6679999998887777666788899999999999999999999999999999999
Q ss_pred eccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEE-CCCCcEEEeecCccccCCCCc
Q 005247 511 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLV-DSTYTVKVCDFGLSRSKPNTY 589 (706)
Q Consensus 511 ~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl-~~~~~vKL~DFGla~~~~~~~ 589 (706)
+-++|+|++|+-.... -+.+..+.+++.||+.|+.|+|+.. +|||||||+||.+ .+-|.|||+|||++..+..+.
T Consensus 98 LGD~GDl~DyImKHe~--Gl~E~La~kYF~QI~~AI~YCHqLH--VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~ 173 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEE--GLNEDLAKKYFAQIVHAISYCHQLH--VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK 173 (864)
T ss_pred ecCCchHHHHHHhhhc--cccHHHHHHHHHHHHHHHHHHhhhh--hhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence 9999999999954433 3889999999999999999999999 9999999999965 567899999999997765443
Q ss_pred ccCCCCCCCCCccCccccccCCCC-chhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHH
Q 005247 590 ISSKTAAGTPEWMAPEVLREDPSN-EKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI 668 (706)
Q Consensus 590 ~~~~~~~Gt~~Y~APE~l~~~~~s-~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI 668 (706)
...+.||+..|-|||++.+..|+ +++||||||||||-|.+|+.||+.-+..+.+..| .......|.+++.++++||
T Consensus 174 -kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmI--mDCKYtvPshvS~eCrdLI 250 (864)
T KOG4717|consen 174 -KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMI--MDCKYTVPSHVSKECRDLI 250 (864)
T ss_pred -hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhh--hcccccCchhhhHHHHHHH
Confidence 45788999999999999999885 5789999999999999999999998888877776 5677888999999999999
Q ss_pred HHhhhhCCCCCCCHHHHHH
Q 005247 669 ETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 669 ~~cL~~dP~~RPS~~eIl~ 687 (706)
.+||.+||.+|.+.++|..
T Consensus 251 ~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 251 QSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred HHHHhcCchhhccHHHHhc
Confidence 9999999999999998865
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=326.88 Aligned_cols=259 Identities=34% Similarity=0.519 Sum_probs=210.1
Q ss_pred cccCceEEEEEeccCCceEEEEEEEcCC----------------ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCcee
Q 005247 430 IRWSELLIKKKIGEGSFGTVYHAEWRNS----------------DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIV 493 (706)
Q Consensus 430 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~----------------~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv 493 (706)
+...+|++.+.||+|+||.||++.+.+. .||+|.+... ........+.+|++++++++|+||+
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~ei~~l~~l~h~~i~ 80 (295)
T cd05097 2 FPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD-VTKTARNDFLKEIKIMSRLKNPNII 80 (295)
T ss_pred CchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCcC
Confidence 3456899999999999999999976432 2788887543 2344556799999999999999999
Q ss_pred EEeccccCCCceEEEEEeccCCchhhhcccCCC---------cccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCC
Q 005247 494 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDA---------RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSP 564 (706)
Q Consensus 494 ~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~---------~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~ 564 (706)
++++++...+..++||||+.+++|.+++..... ...+++..++.++.|++.||+|||+++ ++||||||+
T Consensus 81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~ 158 (295)
T cd05097 81 RLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN--FVHRDLATR 158 (295)
T ss_pred eEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC--eeccccChh
Confidence 999999999999999999999999998853221 123678889999999999999999999 999999999
Q ss_pred cEEECCCCcEEEeecCccccCCCCcc--cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh--CCCCCCCCCh
Q 005247 565 NLLVDSTYTVKVCDFGLSRSKPNTYI--SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT--LQKPWRNSTP 640 (706)
Q Consensus 565 NILl~~~~~vKL~DFGla~~~~~~~~--~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt--G~~Pf~~~~~ 640 (706)
||+++.++.+||+|||++........ ......++..|+|||.+.+..++.++||||||+++|+|++ +..||...+.
T Consensus 159 Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~ 238 (295)
T cd05097 159 NCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD 238 (295)
T ss_pred hEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh
Confidence 99999999999999999876433211 1122345678999999998889999999999999999998 6788988776
Q ss_pred HHHHHHhhh------cCcccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 005247 641 SQVISAVGF------KGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 691 (706)
Q Consensus 641 ~~~~~~i~~------~~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ 691 (706)
.+....+.. .......+..+++.+.+||.+||+.+|++|||+++|++.|++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 239 EQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 665443321 111233455678999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=334.64 Aligned_cols=252 Identities=24% Similarity=0.348 Sum_probs=207.2
Q ss_pred CceEEEEEeccCCceEEEEEEEcCC--ceEEEEEecccc-chHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEE
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 509 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~ 509 (706)
++|++.+.||+|+||.||++++..+ .||+|++.+... .....+.+.+|+.+++.++|+||+++++++.+++.+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 4789999999999999999988654 499999865332 2334456888999999999999999999999999999999
Q ss_pred EeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCc
Q 005247 510 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 589 (706)
Q Consensus 510 E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 589 (706)
||+.+|+|.+++.... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 81 DYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVLAIDSVHQLG--YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred ecCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--eEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence 9999999999986422 34889999999999999999999999 9999999999999999999999999987644322
Q ss_pred c-cCCCCCCCCCccCcccccc-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCC---CC
Q 005247 590 I-SSKTAAGTPEWMAPEVLRE-----DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPK---NV 660 (706)
Q Consensus 590 ~-~~~~~~Gt~~Y~APE~l~~-----~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~---~~ 660 (706)
. ......||+.|+|||++.. ..++.++|||||||++|||++|+.||......+....+........++. .+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 236 (331)
T cd05597 157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDV 236 (331)
T ss_pred CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCC
Confidence 1 2223569999999999863 4568899999999999999999999988877666665543333344443 47
Q ss_pred cHHHHHHHHHhhhhCCCC--CCCHHHHHHH
Q 005247 661 NPMVAALIETCWAEEPEI--RPSFPSIMET 688 (706)
Q Consensus 661 s~el~dLI~~cL~~dP~~--RPS~~eIl~~ 688 (706)
+.++++||++||+.++++ |+++.++++.
T Consensus 237 ~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 237 SEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred CHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 899999999999764443 7899888874
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=335.13 Aligned_cols=238 Identities=23% Similarity=0.405 Sum_probs=199.5
Q ss_pred EEeccCCceEEEEEEEcCC--ceEEEEEeccccc-hHHHHHHHHHHHHHHcC-CCCceeEEeccccCCCceEEEEEeccC
Q 005247 439 KKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFH-EDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSIVTEYLSR 514 (706)
Q Consensus 439 ~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~-~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~lV~E~~~g 514 (706)
+.||+|+||.||+|++..+ .+|+|++...... ....+.+.+|+.++.++ +|+||+.+++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 3699999999999988654 4999998765432 34456788999999888 599999999999999999999999999
Q ss_pred CchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcccCCC
Q 005247 515 GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKT 594 (706)
Q Consensus 515 gsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 594 (706)
|+|..++... ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++...........
T Consensus 81 ~~L~~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (327)
T cd05617 81 GDLMFHMQRQ---RKLPEEHARFYAAEICIALNFLHERG--IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTST 155 (327)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceec
Confidence 9999888633 25889999999999999999999999 999999999999999999999999998754333223345
Q ss_pred CCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHhhhcCcccCCCCCCcHHHHHHH
Q 005247 595 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNST------PSQVISAVGFKGRRLEIPKNVNPMVAALI 668 (706)
Q Consensus 595 ~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~------~~~~~~~i~~~~~~l~~p~~~s~el~dLI 668 (706)
..||+.|+|||++.+..++.++|||||||++|||++|..||.... ..+..... .......+|..++..+.++|
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~p~~~~~~~~~li 234 (327)
T cd05617 156 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQV-ILEKPIRIPRFLSVKASHVL 234 (327)
T ss_pred ccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHH-HHhCCCCCCCCCCHHHHHHH
Confidence 679999999999999999999999999999999999999996421 11222222 23445667888999999999
Q ss_pred HHhhhhCCCCCCCH
Q 005247 669 ETCWAEEPEIRPSF 682 (706)
Q Consensus 669 ~~cL~~dP~~RPS~ 682 (706)
.+||+.||++|+++
T Consensus 235 ~~~L~~dP~~R~~~ 248 (327)
T cd05617 235 KGFLNKDPKERLGC 248 (327)
T ss_pred HHHhccCHHHcCCC
Confidence 99999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=315.60 Aligned_cols=250 Identities=29% Similarity=0.502 Sum_probs=216.0
Q ss_pred ceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEEe
Q 005247 434 ELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY 511 (706)
Q Consensus 434 ~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~ 511 (706)
+|++.+.||+|+||.||++.... ..+++|.+..........+.+.+|+.+++.++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 58899999999999999998754 4499999876555555567889999999999999999999999999999999999
Q ss_pred ccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCccc
Q 005247 512 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS 591 (706)
Q Consensus 512 ~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~ 591 (706)
+.+++|.+++.... ...+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 157 (256)
T cd08218 81 CEGGDLYKKINAQR-GVLFPEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL 157 (256)
T ss_pred CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh
Confidence 99999999886432 224788899999999999999999999 999999999999999999999999999876554333
Q ss_pred CCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHHHHh
Q 005247 592 SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC 671 (706)
Q Consensus 592 ~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI~~c 671 (706)
.....|++.|+|||++.+...+.++|+||||+++|+|++|..||......+....+. .+.....+..++.++.++|.+|
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~ 236 (256)
T cd08218 158 ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKII-RGSYPPVSSHYSYDLRNLVSQL 236 (256)
T ss_pred hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHh-cCCCCCCcccCCHHHHHHHHHH
Confidence 334568889999999998889999999999999999999999998877776666553 3344456778899999999999
Q ss_pred hhhCCCCCCCHHHHHH
Q 005247 672 WAEEPEIRPSFPSIME 687 (706)
Q Consensus 672 L~~dP~~RPS~~eIl~ 687 (706)
|+.+|.+||++.++++
T Consensus 237 l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 237 FKRNPRDRPSVNSILE 252 (256)
T ss_pred hhCChhhCcCHHHHhh
Confidence 9999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=319.89 Aligned_cols=260 Identities=31% Similarity=0.544 Sum_probs=219.0
Q ss_pred cccCceEEEEEeccCCceEEEEEEEcCC------ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCC
Q 005247 430 IRWSELLIKKKIGEGSFGTVYHAEWRNS------DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP 503 (706)
Q Consensus 430 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~------~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 503 (706)
+...+|++.+.||+|+||.||+|.+..+ .+|+|...... .......+.+|+.+++.++|+||+++++++.. .
T Consensus 4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~ 81 (279)
T cd05057 4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET-SPKANKEILDEAYVMASVDHPHVVRLLGICLS-S 81 (279)
T ss_pred cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-C
Confidence 3456899999999999999999986532 27888765443 24455788999999999999999999999877 7
Q ss_pred ceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccc
Q 005247 504 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 583 (706)
Q Consensus 504 ~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~ 583 (706)
..++||||+.+|+|.+++.... ..+++..++.++.||+.||+|||+++ ++||||||+||+++.++.+||+|||.++
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~di~p~nil~~~~~~~kL~dfg~~~ 157 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRNHK--DNIGSQYLLNWCVQIAKGMSYLEEKR--LVHRDLAARNVLVKTPQHVKITDFGLAK 157 (279)
T ss_pred ceEEEEecCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC--EEecccCcceEEEcCCCeEEECCCcccc
Confidence 8899999999999999986433 24889999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCcccC--CCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCCCCC
Q 005247 584 SKPNTYISS--KTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNV 660 (706)
Q Consensus 584 ~~~~~~~~~--~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~ 660 (706)
......... ....++..|+|||.+....++.++||||||+++||+++ |..||......+....+. .......+..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~ 236 (279)
T cd05057 158 LLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE-KGERLPQPPIC 236 (279)
T ss_pred cccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh-CCCCCCCCCCC
Confidence 654322111 12223568999999988889999999999999999998 999999888777666553 44556667788
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhc
Q 005247 661 NPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 696 (706)
Q Consensus 661 s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~ 696 (706)
+..+.+++.+||..+|.+||++.++++.|.++.+..
T Consensus 237 ~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05057 237 TIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDP 272 (279)
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCC
Confidence 999999999999999999999999999999997753
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=316.16 Aligned_cols=255 Identities=33% Similarity=0.579 Sum_probs=214.2
Q ss_pred ccccCceEEEEEeccCCceEEEEEEEcC-CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEE
Q 005247 429 EIRWSELLIKKKIGEGSFGTVYHAEWRN-SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI 507 (706)
Q Consensus 429 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l 507 (706)
++...+|++.+.||+|+||.||++.+.+ ..+++|.+... ....+.+.+|+.+++.++|+||+++++++.+ ...++
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~ 77 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYI 77 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEecCCccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEE
Confidence 4567789999999999999999998654 45888876543 2234678899999999999999999999887 77899
Q ss_pred EEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCC
Q 005247 508 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 587 (706)
Q Consensus 508 V~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 587 (706)
+|||+++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||.+.....
T Consensus 78 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 78 ITEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred EEEeCCCCcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 999999999999986432 235778889999999999999999999 99999999999999999999999999876543
Q ss_pred Ccc-cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHH
Q 005247 588 TYI-SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 665 (706)
Q Consensus 588 ~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~ 665 (706)
... ......++..|+|||.+.+..++.++|+||||+++|++++ |..||...+..+....+. .....+.+...+.++.
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 233 (260)
T cd05073 155 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-RGYRMPRPENCPEELY 233 (260)
T ss_pred CCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh-CCCCCCCcccCCHHHH
Confidence 221 1122345678999999998889999999999999999998 899998877766665543 3445556677889999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHHHH
Q 005247 666 ALIETCWAEEPEIRPSFPSIMETLQQ 691 (706)
Q Consensus 666 dLI~~cL~~dP~~RPS~~eIl~~L~~ 691 (706)
+++.+||+.+|++||++.++++.|++
T Consensus 234 ~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 234 NIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred HHHHHHcccCcccCcCHHHHHHHHhc
Confidence 99999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=342.13 Aligned_cols=264 Identities=38% Similarity=0.642 Sum_probs=234.8
Q ss_pred cCcccccCceEEEEEeccCCceEEEEEEEcCCc--eEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCC
Q 005247 426 EGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP 503 (706)
Q Consensus 426 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~--vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 503 (706)
..|+....+..+..+||.|.||.||.|.|+.-. ||||.++... -..++|+.|..+|+.++|||+|+++++|..+.
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt---MeveEFLkEAAvMKeikHpNLVqLLGVCT~Ep 336 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP 336 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc---hhHHHHHHHHHHHHhhcCccHHHHhhhhccCC
Confidence 447777888899999999999999999998765 8999887654 34579999999999999999999999999999
Q ss_pred ceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccc
Q 005247 504 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 583 (706)
Q Consensus 504 ~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~ 583 (706)
.+|||+|||..|+|.+||+..+. .-++-...+.++.||..|++||..++ +|||||...|+|+.++..||++|||+++
T Consensus 337 PFYIiTEfM~yGNLLdYLRecnr-~ev~avvLlyMAtQIsSaMeYLEkkn--FIHRDLAARNCLVgEnhiVKvADFGLsR 413 (1157)
T KOG4278|consen 337 PFYIITEFMCYGNLLDYLRECNR-SEVPAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHIVKVADFGLSR 413 (1157)
T ss_pred CeEEEEecccCccHHHHHHHhch-hhcchhHHHHHHHHHHHHHHHHHHhh--hhhhhhhhhhccccccceEEeeccchhh
Confidence 99999999999999999975542 34667788899999999999999999 9999999999999999999999999999
Q ss_pred cCC-CCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCCCCCc
Q 005247 584 SKP-NTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVN 661 (706)
Q Consensus 584 ~~~-~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s 661 (706)
... +.+.......-...|.|||-+.-..++.|+|||+|||+|||+.| |-.||.+.+..+++..+ ..+.++.-|+.|+
T Consensus 414 lMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LL-EkgyRM~~PeGCP 492 (1157)
T KOG4278|consen 414 LMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLL-EKGYRMDGPEGCP 492 (1157)
T ss_pred hhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHH-hccccccCCCCCC
Confidence 754 44444444455778999999999999999999999999999998 78899998887777766 5788999999999
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhc
Q 005247 662 PMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 696 (706)
Q Consensus 662 ~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~ 696 (706)
+.+++||+.||+.+|.+||+|.+|.+.++.++.+.
T Consensus 493 pkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~s 527 (1157)
T KOG4278|consen 493 PKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSS 527 (1157)
T ss_pred HHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccc
Confidence 99999999999999999999999999999998764
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=314.40 Aligned_cols=252 Identities=29% Similarity=0.478 Sum_probs=214.8
Q ss_pred ceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccC--CCceEEEE
Q 005247 434 ELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE--PPNLSIVT 509 (706)
Q Consensus 434 ~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~--~~~~~lV~ 509 (706)
+|++.+.||.|+||.||++.+..+ .+++|++..........+.+.+|+.+++.++|+||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 588999999999999999987644 48999887766666667789999999999999999999997653 45578999
Q ss_pred EeccCCchhhhcccC-CCcccccHHHHHHHHHHHHHHHHHHH-----hcCCCcccccCCCCcEEECCCCcEEEeecCccc
Q 005247 510 EYLSRGSLYKLLHIP-DARVVVDERLRLNMAYDVAKGMNYLH-----QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 583 (706)
Q Consensus 510 E~~~ggsL~~~l~~~-~~~~~l~~~~~~~ia~qIl~aL~yLH-----s~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~ 583 (706)
||+++++|.+++... .....+++..++.++.||+.||+||| +.+ ++|+||||+||+++.++.+||+|||++.
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~--i~h~dl~p~nili~~~~~~kl~d~g~~~ 158 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT--VLHRDLKPANIFLDANNNVKLGDFGLAK 158 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc--ceecCCCHHHEEEecCCCEEEecccccc
Confidence 999999999998532 22346889999999999999999999 778 9999999999999999999999999998
Q ss_pred cCCCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHH
Q 005247 584 SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPM 663 (706)
Q Consensus 584 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~e 663 (706)
.............++..|+|||.+.+..++.++|+||||+++|+|++|+.||......+....+. ......++...+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 237 (265)
T cd08217 159 ILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIK-EGKFRRIPYRYSSE 237 (265)
T ss_pred cccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHh-cCCCCCCccccCHH
Confidence 76654432345678999999999999889999999999999999999999999887666555543 33344567788999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHH
Q 005247 664 VAALIETCWAEEPEIRPSFPSIMET 688 (706)
Q Consensus 664 l~dLI~~cL~~dP~~RPS~~eIl~~ 688 (706)
+.+++.+||+.+|++||++.+|++.
T Consensus 238 ~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 238 LNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred HHHHHHHHccCCcccCCCHHHHhhC
Confidence 9999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=346.19 Aligned_cols=254 Identities=24% Similarity=0.330 Sum_probs=199.0
Q ss_pred cccCceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCC-----
Q 005247 430 IRWSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP----- 502 (706)
Q Consensus 430 i~~~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~----- 502 (706)
....+|++++.||+|+||.||+|.+.. ..||+|++.... ....+|+.+++.++|+||+++++++...
T Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~ 136 (440)
T PTZ00036 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKN 136 (440)
T ss_pred CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccC
Confidence 345689999999999999999998754 459999875432 1334799999999999999998875321
Q ss_pred ---CceEEEEEeccCCchhhhccc-CCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCC-cEEEe
Q 005247 503 ---PNLSIVTEYLSRGSLYKLLHI-PDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY-TVKVC 577 (706)
Q Consensus 503 ---~~~~lV~E~~~ggsL~~~l~~-~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~-~vKL~ 577 (706)
..+++||||+++ +|.+++.. ......+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+
T Consensus 137 ~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~--IiHrDLKp~NILl~~~~~~vkL~ 213 (440)
T PTZ00036 137 EKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF--ICHRDLKPQNLLIDPNTHTLKLC 213 (440)
T ss_pred CCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCcCHHHEEEcCCCCceeee
Confidence 246799999975 66666532 223346889999999999999999999999 99999999999998654 79999
Q ss_pred ecCccccCCCCcccCCCCCCCCCccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcC-----
Q 005247 578 DFGLSRSKPNTYISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG----- 651 (706)
Q Consensus 578 DFGla~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~----- 651 (706)
|||+++...... ......||+.|+|||++.+. .++.++|||||||++|||++|.+||.+.+..+....+....
T Consensus 214 DFGla~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~ 292 (440)
T PTZ00036 214 DFGSAKNLLAGQ-RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE 292 (440)
T ss_pred ccccchhccCCC-CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 999998654332 22356789999999998764 68999999999999999999999998876654443332100
Q ss_pred ----------------------cccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH--HHHHHH
Q 005247 652 ----------------------RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME--TLQQFL 693 (706)
Q Consensus 652 ----------------------~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~--~L~~ll 693 (706)
.+..+|...++++.+||.+||+.||.+|||+.|++. .++.+.
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~ 358 (440)
T PTZ00036 293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR 358 (440)
T ss_pred HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence 001234567889999999999999999999999985 455543
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=317.06 Aligned_cols=249 Identities=37% Similarity=0.634 Sum_probs=212.0
Q ss_pred ccCceEEEEEeccCCceEEEEEEEcCCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEE
Q 005247 431 RWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 510 (706)
Q Consensus 431 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E 510 (706)
...+|++.+.||+|+||.||++...+..+|+|...... ..+.+.+|+.+++.++|+||+++++++... ..+++||
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e 78 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVME 78 (254)
T ss_pred cHHHceeeeeeccCCCCceEecccCCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEE
Confidence 34679999999999999999999888889999875432 235788999999999999999999998664 4799999
Q ss_pred eccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcc
Q 005247 511 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 590 (706)
Q Consensus 511 ~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~ 590 (706)
|+.+++|.+++.... ...+++..++.++.|++.||.|||+.| ++||||||+||+++.++.+||+|||++.......
T Consensus 79 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~--~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~- 154 (254)
T cd05083 79 LMSKGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESKK--LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV- 154 (254)
T ss_pred CCCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCCCcEEECCCccceeccccC-
Confidence 999999999986433 235788899999999999999999999 9999999999999999999999999987643321
Q ss_pred cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHHH
Q 005247 591 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE 669 (706)
Q Consensus 591 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI~ 669 (706)
.....+..|+|||.+.+..++.++|+||||+++|||++ |..||......+....+. ...++..+..++..+.++|.
T Consensus 155 --~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~ 231 (254)
T cd05083 155 --DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVE-KGYRMEPPEGCPADVYVLMT 231 (254)
T ss_pred --CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh-CCCCCCCCCcCCHHHHHHHH
Confidence 22334568999999998889999999999999999998 999998887766665553 34455566778999999999
Q ss_pred HhhhhCCCCCCCHHHHHHHHHH
Q 005247 670 TCWAEEPEIRPSFPSIMETLQQ 691 (706)
Q Consensus 670 ~cL~~dP~~RPS~~eIl~~L~~ 691 (706)
+||+.+|++||++.++++.|+.
T Consensus 232 ~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 232 SCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred HHcCCChhhCcCHHHHHHHHcc
Confidence 9999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=324.40 Aligned_cols=257 Identities=34% Similarity=0.549 Sum_probs=208.5
Q ss_pred cCceEEEEEeccCCceEEEEEEEcC----------------C--ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCcee
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRN----------------S--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIV 493 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~----------------~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv 493 (706)
.++|++.+.||+|+||.||++.+.+ + .+|+|++.... .....+.+.+|+.+++.++|+||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcc
Confidence 4579999999999999999986432 1 27888875442 344456889999999999999999
Q ss_pred EEeccccCCCceEEEEEeccCCchhhhcccCCC--------cccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCc
Q 005247 494 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDA--------RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPN 565 (706)
Q Consensus 494 ~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~--------~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~N 565 (706)
++++++...+..+++|||+.+++|.+++..... ...+++..+..++.|++.||+|||+++ ++||||||+|
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dlkp~N 160 (296)
T cd05095 83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN--FVHRDLATRN 160 (296)
T ss_pred eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--eecccCChhe
Confidence 999999999999999999999999999864221 124677889999999999999999999 9999999999
Q ss_pred EEECCCCcEEEeecCccccCCCCcc--cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh--CCCCCCCCChH
Q 005247 566 LLVDSTYTVKVCDFGLSRSKPNTYI--SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT--LQKPWRNSTPS 641 (706)
Q Consensus 566 ILl~~~~~vKL~DFGla~~~~~~~~--~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt--G~~Pf~~~~~~ 641 (706)
||++.++.++|+|||+++....... ......++..|++||...+..++.++|||||||++|||++ |..||...+..
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 9999999999999999876433211 1122334678999999988889999999999999999998 77899877665
Q ss_pred HHHHHhhh------cCcccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 005247 642 QVISAVGF------KGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 691 (706)
Q Consensus 642 ~~~~~i~~------~~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ 691 (706)
+....... .....+.+..+++.+.+||.+||+.||.+||++.+|.+.|++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 241 QVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 55433211 111234456788999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=334.05 Aligned_cols=252 Identities=24% Similarity=0.371 Sum_probs=209.0
Q ss_pred CceEEEEEeccCCceEEEEEEEcCCc--eEEEEEecccc-chHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEE
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 509 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~~~--vAVKvl~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~ 509 (706)
++|++.+.||+|+||.||++++++++ +|+|++.+... .......+.+|+.++..++|+||+++++++.+.+.+++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 36899999999999999999887554 89999865332 2233456788999999999999999999999999999999
Q ss_pred EeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCc
Q 005247 510 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 589 (706)
Q Consensus 510 E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 589 (706)
||+.+|+|.++++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 81 ey~~~g~L~~~l~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~--iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 81 DYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred eccCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence 9999999999996432 24788899999999999999999999 9999999999999999999999999987543221
Q ss_pred -ccCCCCCCCCCccCccccc-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCC---CC
Q 005247 590 -ISSKTAAGTPEWMAPEVLR-----EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPK---NV 660 (706)
Q Consensus 590 -~~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~---~~ 660 (706)
.......||+.|+|||++. ...++.++|||||||++|||++|+.||...+..+....+.....+..+|. .+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 236 (332)
T cd05623 157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDV 236 (332)
T ss_pred cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccC
Confidence 1223457999999999986 34578899999999999999999999998887777776654444444443 57
Q ss_pred cHHHHHHHHHhhhhCCCC--CCCHHHHHHH
Q 005247 661 NPMVAALIETCWAEEPEI--RPSFPSIMET 688 (706)
Q Consensus 661 s~el~dLI~~cL~~dP~~--RPS~~eIl~~ 688 (706)
++++++||.+||+.++.+ |+++.++++.
T Consensus 237 s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 237 SEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred CHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 899999999999765554 6889988775
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=321.20 Aligned_cols=252 Identities=33% Similarity=0.510 Sum_probs=203.1
Q ss_pred eEEEEEeccCCceEEEEEEEc------CCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCC--CceE
Q 005247 435 LLIKKKIGEGSFGTVYHAEWR------NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP--PNLS 506 (706)
Q Consensus 435 y~i~~~LG~G~fG~Vy~a~~~------~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~--~~~~ 506 (706)
|++.+.||+|+||+||++... +..+|+|++.... .......+.+|+++++.++||||+++++++... ...+
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQ 84 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEE
Confidence 488999999999999887532 3348999886543 233456788999999999999999999987543 4588
Q ss_pred EEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCC
Q 005247 507 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP 586 (706)
Q Consensus 507 lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~ 586 (706)
++|||+.+++|.+++... .+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++...
T Consensus 85 lv~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 85 LIMEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred EEecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCC--eeccccChheEEEcCCCcEEEeecccccccC
Confidence 999999999999998643 3889999999999999999999999 9999999999999999999999999988654
Q ss_pred CCccc---CCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH--H------------HHHhhh
Q 005247 587 NTYIS---SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQ--V------------ISAVGF 649 (706)
Q Consensus 587 ~~~~~---~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~--~------------~~~i~~ 649 (706)
..... .....++..|+|||.+.+..++.++||||||+++|||++|..||......- . ......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE 238 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhh
Confidence 43211 122345667999999998889999999999999999999999986533210 0 000111
Q ss_pred cCcccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 005247 650 KGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 693 (706)
Q Consensus 650 ~~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll 693 (706)
.....+.+..++.++.+++.+||+.+|++|||+.++++.|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 12234456778899999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=316.36 Aligned_cols=247 Identities=37% Similarity=0.613 Sum_probs=211.0
Q ss_pred EEeccCCceEEEEEEEcC---C--ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEEecc
Q 005247 439 KKIGEGSFGTVYHAEWRN---S--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLS 513 (706)
Q Consensus 439 ~~LG~G~fG~Vy~a~~~~---~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~~~ 513 (706)
+.||+|++|.||+|.+.. + .+|+|.+...... ...+.+.+|+.++++++|+||+++++++.. ...+++|||++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence 368999999999998743 2 3789988665543 556789999999999999999999999888 88999999999
Q ss_pred CCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcc---
Q 005247 514 RGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI--- 590 (706)
Q Consensus 514 ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~--- 590 (706)
+++|.+++..... ..+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++........
T Consensus 79 ~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 79 LGSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR--FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CCcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC--ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 9999999865432 35789999999999999999999999 99999999999999999999999999987544221
Q ss_pred cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHHH
Q 005247 591 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE 669 (706)
Q Consensus 591 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI~ 669 (706)
......++..|+|||.+.+..++.++||||||+++|||++ |..||...+..+....+.........+..++..+.+++.
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 235 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVML 235 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHH
Confidence 1123456788999999999899999999999999999998 999998888777766665445555666778999999999
Q ss_pred HhhhhCCCCCCCHHHHHHHHH
Q 005247 670 TCWAEEPEIRPSFPSIMETLQ 690 (706)
Q Consensus 670 ~cL~~dP~~RPS~~eIl~~L~ 690 (706)
+||+.+|++||++.++++.|.
T Consensus 236 ~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 236 QCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred HHCCCCcccCCCHHHHHHHhc
Confidence 999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=334.61 Aligned_cols=251 Identities=23% Similarity=0.355 Sum_probs=208.1
Q ss_pred CceEEEEEeccCCceEEEEEEEcCCc--eEEEEEecccc-chHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEE
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 509 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~~~--vAVKvl~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~ 509 (706)
++|++.+.||+|+||.||++++..++ ||+|++.+... .......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999886544 89999865332 2233456788999999999999999999999999999999
Q ss_pred EeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCc
Q 005247 510 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 589 (706)
Q Consensus 510 E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 589 (706)
||+.+|+|.+++.... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 81 Ey~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~lH~~~--iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 81 DYYVGGDLLTLLSKFE--DRLPEDMARFYIAEMVLAIHSIHQLH--YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred eCCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence 9999999999997432 35788999999999999999999999 9999999999999999999999999987654332
Q ss_pred c-cCCCCCCCCCccCcccccc-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCC---CC
Q 005247 590 I-SSKTAAGTPEWMAPEVLRE-----DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPK---NV 660 (706)
Q Consensus 590 ~-~~~~~~Gt~~Y~APE~l~~-----~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~---~~ 660 (706)
. ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||...+..+....+.....+..+|. .+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 236 (331)
T cd05624 157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDV 236 (331)
T ss_pred ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccC
Confidence 2 2234579999999999876 4578899999999999999999999998887777666654444455554 46
Q ss_pred cHHHHHHHHHhhhhCCCC--CCCHHHHHH
Q 005247 661 NPMVAALIETCWAEEPEI--RPSFPSIME 687 (706)
Q Consensus 661 s~el~dLI~~cL~~dP~~--RPS~~eIl~ 687 (706)
++++++||.+||+..+++ |++++++++
T Consensus 237 ~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 237 SEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred CHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 899999999999976554 467888765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=322.73 Aligned_cols=249 Identities=27% Similarity=0.318 Sum_probs=197.3
Q ss_pred ceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcC---CCCceeEEeccccC-----CC
Q 005247 434 ELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGL---RHPNIVLLMGAVTE-----PP 503 (706)
Q Consensus 434 ~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L---~HpnIv~l~~~~~~-----~~ 503 (706)
+|++.+.||+|+||.||+|.+..+ .||+|.+............+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 588999999999999999988654 499998865433322223455677777655 69999999998754 34
Q ss_pred ceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccc
Q 005247 504 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 583 (706)
Q Consensus 504 ~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~ 583 (706)
..+++|||+.+ +|.+++.... ...+++..+..++.||+.||.|||++| |+||||||+||+++.++.+||+|||+++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVP-PPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEECccCccc
Confidence 57899999975 7888875432 234789999999999999999999999 9999999999999999999999999987
Q ss_pred cCCCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCc---------c-
Q 005247 584 SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR---------R- 653 (706)
Q Consensus 584 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~---------~- 653 (706)
...... ......+|..|+|||++.+..++.++|||||||++|+|++|..||......+....+..... .
T Consensus 157 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07863 157 IYSCQM-ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV 235 (288)
T ss_pred cccCcc-cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccc
Confidence 654332 22345689999999999999999999999999999999999999987766554433321000 0
Q ss_pred ---------------cCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 654 ---------------LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 654 ---------------l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
..+.+.++.++.+||.+||+.||++|||+.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 236 TLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred cccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0112356788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=318.67 Aligned_cols=259 Identities=22% Similarity=0.373 Sum_probs=218.5
Q ss_pred cCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEecccc------chHHHHHHHHHHHHHHcC-CCCceeEEeccccCC
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEF------HEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEP 502 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~------~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~ 502 (706)
+.+|.-.+.||.|..++|.++.++.+ .+|+|++..... .....++-..|+.||+++ .||+|+.+.++++.+
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 45677788999999999999977644 489998854321 223455667899999998 599999999999999
Q ss_pred CceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCcc
Q 005247 503 PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS 582 (706)
Q Consensus 503 ~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla 582 (706)
..+++|+|.|+.|.|.+++. ....+.++....|+.|+++|++|||.++ ||||||||+|||++++.++||+|||++
T Consensus 96 sF~FlVFdl~prGELFDyLt---s~VtlSEK~tR~iMrqlfegVeylHa~~--IVHRDLKpENILlddn~~i~isDFGFa 170 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLT---SKVTLSEKETRRIMRQLFEGVEYLHARN--IVHRDLKPENILLDDNMNIKISDFGFA 170 (411)
T ss_pred chhhhhhhhcccchHHHHhh---hheeecHHHHHHHHHHHHHHHHHHHHhh--hhhcccChhheeeccccceEEecccee
Confidence 99999999999999999996 4457999999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCcccCCCCCCCCCccCcccccc------CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccC-
Q 005247 583 RSKPNTYISSKTAAGTPEWMAPEVLRE------DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLE- 655 (706)
Q Consensus 583 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~------~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~- 655 (706)
+....+. ..+..||||+|+|||.+.. ..|+..+|+|++|+|+|.|+.|.+||......-+...|..+...+.
T Consensus 171 ~~l~~Ge-kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~s 249 (411)
T KOG0599|consen 171 CQLEPGE-KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRS 249 (411)
T ss_pred eccCCch-hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCC
Confidence 9877654 3467899999999999853 3578899999999999999999999987766556665544443333
Q ss_pred -CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH--HHHHHHHhc
Q 005247 656 -IPKNVNPMVAALIETCWAEEPEIRPSFPSIME--TLQQFLMSS 696 (706)
Q Consensus 656 -~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~--~L~~ll~s~ 696 (706)
-+.+++...++||.+||+.||.+|.|++|++. ++.++..+.
T Consensus 250 peWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~~ 293 (411)
T KOG0599|consen 250 PEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQQ 293 (411)
T ss_pred cchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHhc
Confidence 34578999999999999999999999999987 566666554
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=337.44 Aligned_cols=248 Identities=24% Similarity=0.383 Sum_probs=202.2
Q ss_pred ceEEEEEeccCCceEEEEEEEc--CCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCC-----ceE
Q 005247 434 ELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP-----NLS 506 (706)
Q Consensus 434 ~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~-----~~~ 506 (706)
+|++.+.||+|+||.||++.+. ++.||+|++..........+.+.+|+.+++.++|+||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4788999999999999999875 455999988654434445578889999999999999999999998776 789
Q ss_pred EEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCC
Q 005247 507 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP 586 (706)
Q Consensus 507 lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~ 586 (706)
+||||+. ++|.+++... ..+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++...
T Consensus 81 lv~e~~~-~~l~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP---QPLSSDHVKVFLYQILRGLKYLHSAG--ILHRDIKPGNLLVNSNCVLKICDFGLARVEE 154 (372)
T ss_pred EEeeccc-cCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHHEEECCCCCEEeccccceeecc
Confidence 9999996 4777776532 35889999999999999999999999 9999999999999999999999999998644
Q ss_pred CCc-ccCCCCCCCCCccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhc--------------
Q 005247 587 NTY-ISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-------------- 650 (706)
Q Consensus 587 ~~~-~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~-------------- 650 (706)
... .......+++.|+|||.+.+. .++.++|||||||++|||++|+.||...++.+....+...
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 234 (372)
T cd07853 155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE 234 (372)
T ss_pred cCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH
Confidence 322 122344678999999999875 4789999999999999999999999887765544333110
Q ss_pred ---------Ccc-------cCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 651 ---------GRR-------LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 651 ---------~~~-------l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
... ..+....++++.+||.+||+.||++|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287 (372)
T ss_pred HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence 000 1233456889999999999999999999999986
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=314.15 Aligned_cols=250 Identities=35% Similarity=0.628 Sum_probs=211.6
Q ss_pred cCceEEEEEeccCCceEEEEEEEc-CCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEE
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWR-NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 510 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~-~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E 510 (706)
..+|++.+.||+|+||.||++.+. +..+++|++....... ..+.+|+++++.++||||+++++++......+++||
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~---~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE---EDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFE 79 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCH---HHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEE
Confidence 457899999999999999999876 4568999876544332 468889999999999999999999999999999999
Q ss_pred eccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcc
Q 005247 511 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 590 (706)
Q Consensus 511 ~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~ 590 (706)
|+.+++|.++++... ..+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.......
T Consensus 80 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 155 (256)
T cd05112 80 FMEHGCLSDYLRAQR--GKFSQETLLGMCLDVCEGMAYLESSN--VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY 155 (256)
T ss_pred cCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccccceEEEcCCCeEEECCCcceeecccCcc
Confidence 999999999986432 34788899999999999999999999 99999999999999999999999999876543321
Q ss_pred c-CCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHH
Q 005247 591 S-SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI 668 (706)
Q Consensus 591 ~-~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI 668 (706)
. .....++..|+|||.+.+..++.++||||||+++|||++ |..||...........+. ...+...+...+..+.+|+
T Consensus 156 ~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~ 234 (256)
T cd05112 156 TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETIN-AGFRLYKPRLASQSVYELM 234 (256)
T ss_pred cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHh-CCCCCCCCCCCCHHHHHHH
Confidence 1 122335678999999998889999999999999999998 999998877766666553 2334455666789999999
Q ss_pred HHhhhhCCCCCCCHHHHHHHH
Q 005247 669 ETCWAEEPEIRPSFPSIMETL 689 (706)
Q Consensus 669 ~~cL~~dP~~RPS~~eIl~~L 689 (706)
.+||+.+|++||++.++++.|
T Consensus 235 ~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 235 QHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred HHHcccChhhCCCHHHHHHhh
Confidence 999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=324.06 Aligned_cols=241 Identities=23% Similarity=0.327 Sum_probs=195.1
Q ss_pred eccCCceEEEEEEEcC--CceEEEEEeccccch-HHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEEeccCCch
Q 005247 441 IGEGSFGTVYHAEWRN--SDVAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSL 517 (706)
Q Consensus 441 LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~-~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL 517 (706)
||+|+||.||++.... ..||+|.+....... .....+..|++++++++||||+++++++......++||||+.+++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 7999999999998764 459999886543322 2234566799999999999999999999999999999999999999
Q ss_pred hhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcccCCCCCC
Q 005247 518 YKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAG 597 (706)
Q Consensus 518 ~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~G 597 (706)
.+++.... ...+++..+..++.|++.||+|||+.| |+||||||+||+++.++.++|+|||++....... ......|
T Consensus 81 ~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~ 156 (277)
T cd05607 81 KYHIYNVG-ERGLEMERVIHYSAQITCGILHLHSMD--IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-TITQRAG 156 (277)
T ss_pred HHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC--EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-eeeccCC
Confidence 88875432 234788889999999999999999999 9999999999999999999999999987654432 2234578
Q ss_pred CCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH----HHHHHhhhcCcccCCCCCCcHHHHHHHHHhhh
Q 005247 598 TPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPS----QVISAVGFKGRRLEIPKNVNPMVAALIETCWA 673 (706)
Q Consensus 598 t~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~----~~~~~i~~~~~~l~~p~~~s~el~dLI~~cL~ 673 (706)
+..|+|||++.+..++.++|||||||++|||++|+.||...... +..... ...........+++++.+||.+||+
T Consensus 157 ~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~ 235 (277)
T cd05607 157 TNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRT-LEDEVKFEHQNFTEESKDICRLFLA 235 (277)
T ss_pred CCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHh-hccccccccccCCHHHHHHHHHHhc
Confidence 99999999999988999999999999999999999999764321 222211 1111111224689999999999999
Q ss_pred hCCCCCCCHHHHH
Q 005247 674 EEPEIRPSFPSIM 686 (706)
Q Consensus 674 ~dP~~RPS~~eIl 686 (706)
.||++||++.|++
T Consensus 236 ~~P~~R~~~~~~~ 248 (277)
T cd05607 236 KKPEDRLGSREKN 248 (277)
T ss_pred cCHhhCCCCccch
Confidence 9999999997654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=342.17 Aligned_cols=261 Identities=35% Similarity=0.612 Sum_probs=228.4
Q ss_pred CcccccCceEEEEEeccCCceEEEEEEEcC----Cc--eEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEecccc
Q 005247 427 GLEIRWSELLIKKKIGEGSFGTVYHAEWRN----SD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 500 (706)
Q Consensus 427 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~----~~--vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~ 500 (706)
++++.....++.+.||.|-||.||+|.... .. ||||..+... +.+..+.|+.|..+|++++||||++++|++.
T Consensus 383 nyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~-t~d~tekflqEa~iMrnfdHphIikLIGv~~ 461 (974)
T KOG4257|consen 383 NYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC-TPDDTEKFLQEASIMRNFDHPHIIKLIGVCV 461 (974)
T ss_pred cceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC-ChhhHHHHHHHHHHHHhCCCcchhheeeeee
Confidence 455666667778899999999999997542 22 7888876544 4455789999999999999999999999998
Q ss_pred CCCceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecC
Q 005247 501 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFG 580 (706)
Q Consensus 501 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFG 580 (706)
+.. .|||||+++-|.|..|++.++. .++......+++||+.||.|||+++ +|||||...|||+....-|||+|||
T Consensus 462 e~P-~WivmEL~~~GELr~yLq~nk~--sL~l~tL~ly~~Qi~talaYLeSkr--fVHRDIAaRNiLVsSp~CVKLaDFG 536 (974)
T KOG4257|consen 462 EQP-MWIVMELAPLGELREYLQQNKD--SLPLRTLTLYCYQICTALAYLESKR--FVHRDIAARNILVSSPQCVKLADFG 536 (974)
T ss_pred ccc-eeEEEecccchhHHHHHHhccc--cchHHHHHHHHHHHHHHHHHHHhhc--hhhhhhhhhheeecCcceeeecccc
Confidence 754 7999999999999999986554 5888999999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCC-cccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCCC
Q 005247 581 LSRSKPNT-YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPK 658 (706)
Q Consensus 581 la~~~~~~-~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p~ 658 (706)
+++...+. +.......-+..|||||.+.-..++.++|||-|||++||++. |..||.+....+++..+ .++.|++.|+
T Consensus 537 LSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~i-EnGeRlP~P~ 615 (974)
T KOG4257|consen 537 LSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHI-ENGERLPCPP 615 (974)
T ss_pred hhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEe-cCCCCCCCCC
Confidence 99986654 333344455778999999999999999999999999999986 89999998888887776 4788999999
Q ss_pred CCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 005247 659 NVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLM 694 (706)
Q Consensus 659 ~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~ 694 (706)
+|++.++.|+.+||..+|.+||++++|...|..++.
T Consensus 616 nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 616 NCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred CCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 999999999999999999999999999999988876
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=338.13 Aligned_cols=250 Identities=29% Similarity=0.454 Sum_probs=220.3
Q ss_pred cCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccch-HHHHHHHHHHHHHHcCC-CCceeEEeccccCCCceEE
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHE-DRFKEFLREVAIMKGLR-HPNIVLLMGAVTEPPNLSI 507 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~-~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~l 507 (706)
...|++.+.||+|.||.||++..+.+ .+|+|++.+..... ...+.+.+|+.+|+++. |||||.+++++++...+++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 45789999999999999999988764 49999997765543 23568889999999998 9999999999999999999
Q ss_pred EEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECC----CCcEEEeecCccc
Q 005247 508 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS----TYTVKVCDFGLSR 583 (706)
Q Consensus 508 V~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~----~~~vKL~DFGla~ 583 (706)
|||++.||.|.+.+... .+++..+..++.|++.++.|||+.| |+||||||+|+|+.. ++.+|++|||++.
T Consensus 114 vmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g--vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~ 187 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG--VVHRDLKPENLLLASKDEGSGRIKLIDFGLAK 187 (382)
T ss_pred EEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence 99999999999998644 2899999999999999999999999 999999999999953 3479999999999
Q ss_pred cCCCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcc--cCCCCCCc
Q 005247 584 SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR--LEIPKNVN 661 (706)
Q Consensus 584 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~--l~~p~~~s 661 (706)
.... .......+||+.|+|||++....|+..+||||+|+++|.|++|..||...+.......+...... .+....++
T Consensus 188 ~~~~-~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is 266 (382)
T KOG0032|consen 188 FIKP-GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDIS 266 (382)
T ss_pred EccC-CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccC
Confidence 8776 33456789999999999999999999999999999999999999999999988887777544443 23345789
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 005247 662 PMVAALIETCWAEEPEIRPSFPSIMET 688 (706)
Q Consensus 662 ~el~dLI~~cL~~dP~~RPS~~eIl~~ 688 (706)
..++++|++||..||.+|+|+.++++.
T Consensus 267 ~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 267 ESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred HHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 999999999999999999999999884
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=333.79 Aligned_cols=249 Identities=26% Similarity=0.334 Sum_probs=201.1
Q ss_pred ccCceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCC------
Q 005247 431 RWSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP------ 502 (706)
Q Consensus 431 ~~~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~------ 502 (706)
..++|++.+.||+|+||.||++.+.. ..+|+|++..........+.+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 35789999999999999999998754 4599999876554555667888999999999999999999987543
Q ss_pred CceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCcc
Q 005247 503 PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS 582 (706)
Q Consensus 503 ~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla 582 (706)
...++||||+.+ +|.+.+.. .+++..+..++.|++.||.|||++| |+||||||+|||++.++.+||+|||++
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDikp~Nill~~~~~~kl~Dfg~~ 166 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEECCCCCEEEeeCccc
Confidence 347999999976 56665542 3778889999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhc------------
Q 005247 583 RSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK------------ 650 (706)
Q Consensus 583 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~------------ 650 (706)
+...... ......||..|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+...
T Consensus 167 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (355)
T cd07874 167 RTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_pred ccCCCcc-ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 8654432 224567899999999999999999999999999999999999999876643332211100
Q ss_pred --------Cc-----cc---------------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 005247 651 --------GR-----RL---------------EIPKNVNPMVAALIETCWAEEPEIRPSFPSIMET 688 (706)
Q Consensus 651 --------~~-----~l---------------~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~ 688 (706)
.. .. ..+...+.++++||.+||+.||++|||+.|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred cHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 00 00 0112245678999999999999999999999873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=325.97 Aligned_cols=251 Identities=26% Similarity=0.335 Sum_probs=210.1
Q ss_pred cCceEEEEEeccCCceEEEEEEEcCCc--eEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEecccc--CCCceEE
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT--EPPNLSI 507 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~--vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~--~~~~~~l 507 (706)
.++|+.++.|++|.||.||+|+++.++ ||+|.++...-....--..++||.+|.+.+|||||.+-.++. +-+..||
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 357889999999999999999998776 999998766533333346789999999999999999988764 4456999
Q ss_pred EEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCC
Q 005247 508 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 587 (706)
Q Consensus 508 V~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 587 (706)
|||||+. +|..++..-. .++...++.-+..|+++|++|||.+. |+||||||+|+|++..|.+||+|||+|+..++
T Consensus 155 VMe~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~w--ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs 229 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDNW--ILHRDLKTSNLLLSHKGILKIADFGLAREYGS 229 (419)
T ss_pred eHHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhce--eEecccchhheeeccCCcEEecccchhhhhcC
Confidence 9999987 8888886433 46888899999999999999999999 99999999999999999999999999999988
Q ss_pred CcccCCCCCCCCCccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhc-Ccc------------
Q 005247 588 TYISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-GRR------------ 653 (706)
Q Consensus 588 ~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~-~~~------------ 653 (706)
+....+..+-|.+|+|||.+.+. .|++.+|+||+|||+.||+++.+.|.+...-+.+..|-.. +.+
T Consensus 230 p~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp 309 (419)
T KOG0663|consen 230 PLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELP 309 (419)
T ss_pred CcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccc
Confidence 86666778889999999999886 5899999999999999999999999988776665554211 100
Q ss_pred ----cC------------CCC-CCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 654 ----LE------------IPK-NVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 654 ----l~------------~p~-~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
.. ++. .++..-.+|+..+|..||.+|.|+.+.++
T Consensus 310 ~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 310 AVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred hhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 11 111 14577899999999999999999999875
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=315.06 Aligned_cols=249 Identities=30% Similarity=0.510 Sum_probs=209.8
Q ss_pred CceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEE
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 510 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E 510 (706)
++|++.+.||+|+||.||+|.+.. ..+++|++..... ...+.+.+|+.+++.++||||+++++++...+.++++||
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e 80 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG--DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVME 80 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch--hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEe
Confidence 579999999999999999998754 4489998865432 255788999999999999999999999999999999999
Q ss_pred eccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcc
Q 005247 511 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 590 (706)
Q Consensus 511 ~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~ 590 (706)
|+.+++|.+++.... ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 156 (262)
T cd06613 81 YCGGGSLQDIYQVTR--GPLSELQIAYVCRETLKGLAYLHETG--KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA 156 (262)
T ss_pred CCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCChhhEEECCCCCEEECccccchhhhhhhh
Confidence 999999999886432 35889999999999999999999999 99999999999999999999999999876554332
Q ss_pred cCCCCCCCCCccCccccccC---CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCc---ccCCCCCCcHHH
Q 005247 591 SSKTAAGTPEWMAPEVLRED---PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR---RLEIPKNVNPMV 664 (706)
Q Consensus 591 ~~~~~~Gt~~Y~APE~l~~~---~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~---~l~~p~~~s~el 664 (706)
......++..|+|||.+.+. .++.++||||||+++|+|++|..||....+......+..... ....+..++.++
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (262)
T cd06613 157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVF 236 (262)
T ss_pred ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHH
Confidence 33455788899999999877 788999999999999999999999988776555444332211 122334567889
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHH
Q 005247 665 AALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 665 ~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
.+||.+||+.+|.+|||+.+|+.
T Consensus 237 ~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 237 HDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred HHHHHHHcCCChhhCCCHHHHhc
Confidence 99999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=323.32 Aligned_cols=248 Identities=27% Similarity=0.458 Sum_probs=209.4
Q ss_pred cCceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEE
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 509 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~ 509 (706)
..+|++.+.||+|+||.||+|.+.. ..+++|.+...... ..+.+.+|+.+++.+.|+||+++++.+......++||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~ 96 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc--hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEee
Confidence 3589999999999999999998754 45899988655433 2467889999999999999999999999999999999
Q ss_pred EeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCc
Q 005247 510 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 589 (706)
Q Consensus 510 E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 589 (706)
||+++++|.++++.. .+++..+..++.|++.||+|||+.| |+||||||+||+++.++.+||+|||++.......
T Consensus 97 e~~~~~~L~~~~~~~----~~~~~~~~~i~~ql~~aL~~LH~~g--i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~ 170 (296)
T cd06654 97 EYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (296)
T ss_pred cccCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence 999999999998532 3778899999999999999999999 9999999999999999999999999987654333
Q ss_pred ccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhc-CcccCCCCCCcHHHHHHH
Q 005247 590 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-GRRLEIPKNVNPMVAALI 668 (706)
Q Consensus 590 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~-~~~l~~p~~~s~el~dLI 668 (706)
.......+++.|+|||.+.+..++.++|||||||++|+|++|+.||....+......+... ......+..++..+.+||
T Consensus 171 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 250 (296)
T cd06654 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFL 250 (296)
T ss_pred cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHH
Confidence 2334457899999999999888999999999999999999999999877664443332211 223344567889999999
Q ss_pred HHhhhhCCCCCCCHHHHHH
Q 005247 669 ETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 669 ~~cL~~dP~~RPS~~eIl~ 687 (706)
.+||..+|++||++.++++
T Consensus 251 ~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 251 NRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred HHHCcCCcccCcCHHHHhh
Confidence 9999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=319.00 Aligned_cols=250 Identities=26% Similarity=0.418 Sum_probs=205.0
Q ss_pred cCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcC-CCCceeEEeccccCC------
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEP------ 502 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~------ 502 (706)
.+.|++.+.||+|+||.||+|.+.++ .+|+|++..... ....+.+|+.+++.+ +|+||+++++++...
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc---cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 35678889999999999999987654 489998765432 234678899999998 699999999988642
Q ss_pred CceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCcc
Q 005247 503 PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS 582 (706)
Q Consensus 503 ~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla 582 (706)
..++++|||+.+++|.+++.... ...+.+..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHEEECCCCCEEEccCCCc
Confidence 45899999999999999986432 235789999999999999999999999 999999999999999999999999998
Q ss_pred ccCCCCcccCCCCCCCCCccCccccc-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCC
Q 005247 583 RSKPNTYISSKTAAGTPEWMAPEVLR-----EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP 657 (706)
Q Consensus 583 ~~~~~~~~~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p 657 (706)
..............|+..|+|||++. +..++.++|||||||++|||++|..||....+............+...+
T Consensus 159 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 238 (272)
T cd06637 159 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKS 238 (272)
T ss_pred eecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCC
Confidence 86544333345567899999999986 3357889999999999999999999998766555544443333333344
Q ss_pred CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 658 KNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 658 ~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
..++.++.+||.+||..+|.+|||+.++++
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 239 KKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred CCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 568899999999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=319.89 Aligned_cols=242 Identities=29% Similarity=0.446 Sum_probs=200.6
Q ss_pred ceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEEe
Q 005247 434 ELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY 511 (706)
Q Consensus 434 ~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~ 511 (706)
+|++.+.||+|+||.||+|.+..+ .+|+|++.... .....+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 678899999999999999987544 49999876543 344456789999999999999999999999999999999999
Q ss_pred ccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCccc
Q 005247 512 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS 591 (706)
Q Consensus 512 ~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~ 591 (706)
+++++|..+. .+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~-- 149 (279)
T cd06619 81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK--ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI-- 149 (279)
T ss_pred CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCCHHHEEECCCCCEEEeeCCcceeccccc--
Confidence 9999986553 3678888999999999999999999 9999999999999999999999999987654432
Q ss_pred CCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-------HHHHHhhhcCcccCC-CCCCcHH
Q 005247 592 SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPS-------QVISAVGFKGRRLEI-PKNVNPM 663 (706)
Q Consensus 592 ~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~-------~~~~~i~~~~~~l~~-p~~~s~e 663 (706)
.....|+..|+|||.+.+..++.++||||||+++|+|++|..||...... +....+. ....... ....+++
T Consensus 150 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 228 (279)
T cd06619 150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIV-DEDPPVLPVGQFSEK 228 (279)
T ss_pred ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHh-ccCCCCCCCCcCCHH
Confidence 23457899999999999989999999999999999999999999653221 1111111 1112222 3457889
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHH
Q 005247 664 VAALIETCWAEEPEIRPSFPSIMET 688 (706)
Q Consensus 664 l~dLI~~cL~~dP~~RPS~~eIl~~ 688 (706)
+.+||.+||+.+|++||+++++++.
T Consensus 229 ~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 229 FVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred HHHHHHHHhhCChhhCCCHHHHhcC
Confidence 9999999999999999999998763
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=318.11 Aligned_cols=256 Identities=32% Similarity=0.539 Sum_probs=213.6
Q ss_pred cCceEEEEEeccCCceEEEEEEEcC-------CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCc
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN 504 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~-------~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 504 (706)
.++|++.+.||+|+||.||+|+.+. ..+++|.+.... .....+.+.+|+.++++++|+||+++++++.+.+.
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 82 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP 82 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc
Confidence 4678999999999999999998642 237888764432 23356789999999999999999999999999899
Q ss_pred eEEEEEeccCCchhhhcccCCCc------ccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEee
Q 005247 505 LSIVTEYLSRGSLYKLLHIPDAR------VVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCD 578 (706)
Q Consensus 505 ~~lV~E~~~ggsL~~~l~~~~~~------~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~D 578 (706)
.++||||+++++|.++++..... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.++|+|
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR--FVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC--cccCcCccceEEEeCCCcEEEcc
Confidence 99999999999999998644322 15889999999999999999999999 99999999999999999999999
Q ss_pred cCccccCCCC-cccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCC
Q 005247 579 FGLSRSKPNT-YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEI 656 (706)
Q Consensus 579 FGla~~~~~~-~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~ 656 (706)
||++...... ........++..|+|||.+.+...+.++||||||+++|+|++ |..||...........+.........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 240 (275)
T cd05046 161 LSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPV 240 (275)
T ss_pred cccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCC
Confidence 9998653322 112233456778999999988888999999999999999998 78899877776666665434444455
Q ss_pred CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 005247 657 PKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQ 690 (706)
Q Consensus 657 p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~ 690 (706)
+..++..+.++|.+||+.+|++|||+.+++..|.
T Consensus 241 ~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 241 PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 6678999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=314.50 Aligned_cols=250 Identities=33% Similarity=0.595 Sum_probs=202.9
Q ss_pred EEeccCCceEEEEEEEcC-----CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEecccc-CCCceEEEEEec
Q 005247 439 KKIGEGSFGTVYHAEWRN-----SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT-EPPNLSIVTEYL 512 (706)
Q Consensus 439 ~~LG~G~fG~Vy~a~~~~-----~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~-~~~~~~lV~E~~ 512 (706)
+.||+|+||.||+|.+.. ..+|+|.+... ......+.+.+|+.+++.++||||+++++++. .++..+++|||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 79 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM 79 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc-CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence 368999999999998643 23788876432 23445678889999999999999999999764 455688999999
Q ss_pred cCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCc---
Q 005247 513 SRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY--- 589 (706)
Q Consensus 513 ~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~--- 589 (706)
.+++|.+++..... ...+..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++......
T Consensus 80 ~~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 80 KHGDLRNFIRSETH--NPTVKDLIGFGLQVAKGMEYLASKK--FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 99999999864322 3566778889999999999999999 9999999999999999999999999987543321
Q ss_pred -ccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhC-CCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHH
Q 005247 590 -ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAAL 667 (706)
Q Consensus 590 -~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG-~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dL 667 (706)
.......++..|+|||.+.+..++.++||||||+++|||++| ..||...+..+....+ ........+..++..+.++
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l 234 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYL-LQGRRLLQPEYCPDPLYEV 234 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-hcCCCCCCCCcCCHHHHHH
Confidence 111233457789999999888899999999999999999995 5667766665555544 3444555667788999999
Q ss_pred HHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 005247 668 IETCWAEEPEIRPSFPSIMETLQQFLM 694 (706)
Q Consensus 668 I~~cL~~dP~~RPS~~eIl~~L~~ll~ 694 (706)
|.+||..+|++||++.+|++.|++++.
T Consensus 235 i~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 235 MLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred HHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=320.90 Aligned_cols=247 Identities=28% Similarity=0.498 Sum_probs=206.6
Q ss_pred eEEEEEeccCCceEEEEEEEcCCc--eEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEEec
Q 005247 435 LLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYL 512 (706)
Q Consensus 435 y~i~~~LG~G~fG~Vy~a~~~~~~--vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~~ 512 (706)
|++.+.||+|+||.||++.+..+. +++|.+... .....+.+.+|+++++.++|+||+++++++...+..++|+||+
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~ 84 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 84 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence 577889999999999999987655 666766433 3445678899999999999999999999999999999999999
Q ss_pred cCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcccC
Q 005247 513 SRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISS 592 (706)
Q Consensus 513 ~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~ 592 (706)
.+++|..++... ...+++..+..++.|++.||.|||+.| ++||||||+||+++.++.+||+|||++..........
T Consensus 85 ~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~~L~~LH~~~--i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~ 160 (282)
T cd06643 85 AGGAVDAVMLEL--ERPLTEPQIRVVCKQTLEALNYLHENK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR 160 (282)
T ss_pred CCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEccCCCEEEcccccccccccccccc
Confidence 999998887532 235889999999999999999999999 9999999999999999999999999987655443333
Q ss_pred CCCCCCCCccCccccc-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhc-CcccCCCCCCcHHHHH
Q 005247 593 KTAAGTPEWMAPEVLR-----EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-GRRLEIPKNVNPMVAA 666 (706)
Q Consensus 593 ~~~~Gt~~Y~APE~l~-----~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~-~~~l~~p~~~s~el~d 666 (706)
....++..|+|||++. +..++.++|||||||++|||++|+.||...+..+....+... ......+..++.++.+
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (282)
T cd06643 161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKD 240 (282)
T ss_pred ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHH
Confidence 4567899999999984 345678999999999999999999999887766655444322 1233456678899999
Q ss_pred HHHHhhhhCCCCCCCHHHHHH
Q 005247 667 LIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 667 LI~~cL~~dP~~RPS~~eIl~ 687 (706)
||.+||+.||.+||++.++++
T Consensus 241 li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 241 FLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred HHHHHccCChhhCcCHHHHhc
Confidence 999999999999999998865
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=322.71 Aligned_cols=249 Identities=24% Similarity=0.358 Sum_probs=206.3
Q ss_pred ceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccch-HHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEE
Q 005247 434 ELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 510 (706)
Q Consensus 434 ~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~-~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E 510 (706)
.|++.+.||+|+||.||++.+..+ .+|+|.+....... .....+.+|+.+++.++|+||+.+++.+.+.+..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 377889999999999999988754 59999886554332 233567889999999999999999999999999999999
Q ss_pred eccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcc
Q 005247 511 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 590 (706)
Q Consensus 511 ~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~ 590 (706)
|+.+++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~g~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 156 (285)
T cd05630 81 LMNGGDLKFHIYHMG-EAGFEEGRAVFYAAEICCGLEDLHQER--IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ- 156 (285)
T ss_pred ecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-
Confidence 999999999885332 234889999999999999999999999 9999999999999999999999999987654332
Q ss_pred cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHhhhcCcccCCCCCCcHHHHHH
Q 005247 591 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPS---QVISAVGFKGRRLEIPKNVNPMVAAL 667 (706)
Q Consensus 591 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~---~~~~~i~~~~~~l~~p~~~s~el~dL 667 (706)
......|+..|+|||.+.+..++.++||||||+++|+|++|+.||...... +..... ........+..+++++.+|
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l 235 (285)
T cd05630 157 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERL-VKEVQEEYSEKFSPDARSL 235 (285)
T ss_pred cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhh-hhhhhhhcCccCCHHHHHH
Confidence 123457899999999999999999999999999999999999999865432 111111 1222334567789999999
Q ss_pred HHHhhhhCCCCCCC-----HHHHHH
Q 005247 668 IETCWAEEPEIRPS-----FPSIME 687 (706)
Q Consensus 668 I~~cL~~dP~~RPS-----~~eIl~ 687 (706)
|.+||+.||++||| +.++++
T Consensus 236 i~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 236 CKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred HHHHhhcCHHHccCCCCCchHHHHc
Confidence 99999999999999 889887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=319.68 Aligned_cols=250 Identities=22% Similarity=0.300 Sum_probs=207.6
Q ss_pred ceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccch-HHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEE
Q 005247 434 ELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 510 (706)
Q Consensus 434 ~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~-~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E 510 (706)
.|+..+.||+|+||+||++.+..+ .+|+|.+....... .....+.+|+.+++.++|+||+.+++.+..++..+++||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 367889999999999999988644 49999886654332 234567889999999999999999999999999999999
Q ss_pred eccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcc
Q 005247 511 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 590 (706)
Q Consensus 511 ~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~ 590 (706)
|+.+++|.+++.... ...+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~--iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05632 81 IMNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHREN--TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE- 156 (285)
T ss_pred eccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEECCCCCEEEecCCcceecCCCC-
Confidence 999999998875432 235899999999999999999999999 9999999999999999999999999987643322
Q ss_pred cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh--hcCcccCCCCCCcHHHHHHH
Q 005247 591 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVG--FKGRRLEIPKNVNPMVAALI 668 (706)
Q Consensus 591 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~--~~~~~l~~p~~~s~el~dLI 668 (706)
......|+..|+|||.+.+..++.++|+||||+++|+|++|..||...........+. .......++..++.++.+|+
T Consensus 157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05632 157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSIC 236 (285)
T ss_pred cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHH
Confidence 2234578999999999999899999999999999999999999998766543322221 12223455677899999999
Q ss_pred HHhhhhCCCCCCC-----HHHHHH
Q 005247 669 ETCWAEEPEIRPS-----FPSIME 687 (706)
Q Consensus 669 ~~cL~~dP~~RPS-----~~eIl~ 687 (706)
.+||+.||++||+ +.+++.
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 237 KMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred HHHccCCHhHcCCCcccChHHHHc
Confidence 9999999999999 777776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=319.02 Aligned_cols=247 Identities=30% Similarity=0.505 Sum_probs=211.9
Q ss_pred CceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEE
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 510 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E 510 (706)
++|++.+.||.|+||.||+|.+.. ..+++|++.... .......+.+|+.+++.++|+||+++++++.++...++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME 79 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence 368889999999999999998764 349999886543 23445678899999999999999999999999999999999
Q ss_pred eccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcc
Q 005247 511 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 590 (706)
Q Consensus 511 ~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~ 590 (706)
|+.+++|.+++... .+++..++.++.|++.||.|||+++ ++||||+|+||+++.++.++|+|||+++.......
T Consensus 80 ~~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 153 (274)
T cd06609 80 YCGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEG--KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS 153 (274)
T ss_pred eeCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence 99999999998743 5889999999999999999999999 99999999999999999999999999987665433
Q ss_pred cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCC-CcHHHHHHHH
Q 005247 591 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKN-VNPMVAALIE 669 (706)
Q Consensus 591 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~-~s~el~dLI~ 669 (706)
......++..|+|||.+.+..++.++||||||+++|+|++|..||...++......+. ......++.. ++.++.+++.
T Consensus 154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~ 232 (274)
T cd06609 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIP-KNNPPSLEGNKFSKPFKDFVS 232 (274)
T ss_pred ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhh-hcCCCCCcccccCHHHHHHHH
Confidence 3445678889999999999889999999999999999999999998777655554443 2233334444 8899999999
Q ss_pred HhhhhCCCCCCCHHHHHH
Q 005247 670 TCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 670 ~cL~~dP~~RPS~~eIl~ 687 (706)
+||..+|++|||+.++++
T Consensus 233 ~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 233 LCLNKDPKERPSAKELLK 250 (274)
T ss_pred HHhhCChhhCcCHHHHhh
Confidence 999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=336.18 Aligned_cols=240 Identities=27% Similarity=0.429 Sum_probs=198.9
Q ss_pred eccCCceEEEEEEEcC--CceEEEEEeccccc-hHHHHHHHHHHHHHHcC---CCCceeEEeccccCCCceEEEEEeccC
Q 005247 441 IGEGSFGTVYHAEWRN--SDVAVKILIEQEFH-EDRFKEFLREVAIMKGL---RHPNIVLLMGAVTEPPNLSIVTEYLSR 514 (706)
Q Consensus 441 LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~-~~~~~~~~~Ei~iL~~L---~HpnIv~l~~~~~~~~~~~lV~E~~~g 514 (706)
||+|+||+||+|++.. ..||+|++...... ......+..|..++... +||||+++++.+.+.+.+++||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 7999999999998864 45999998654332 23344556677777655 699999999999999999999999999
Q ss_pred CchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcccCCC
Q 005247 515 GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKT 594 (706)
Q Consensus 515 gsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 594 (706)
|+|..++... ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++............
T Consensus 81 g~L~~~l~~~---~~~~~~~~~~~~~qil~al~~LH~~~--ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~ 155 (330)
T cd05586 81 GELFWHLQKE---GRFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT 155 (330)
T ss_pred ChHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccC
Confidence 9999888643 35889999999999999999999999 999999999999999999999999998764433333456
Q ss_pred CCCCCCccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCC-CCCcHHHHHHHHHhh
Q 005247 595 AAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP-KNVNPMVAALIETCW 672 (706)
Q Consensus 595 ~~Gt~~Y~APE~l~~~-~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p-~~~s~el~dLI~~cL 672 (706)
.+||..|+|||++.+. .++.++|||||||++|+|++|..||...+..+....+.... ..++ ..+++++.+||.+||
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~~li~~~L 233 (330)
T cd05586 156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGK--VRFPKNVLSDEGRQFVKGLL 233 (330)
T ss_pred ccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCC--CCCCCccCCHHHHHHHHHHc
Confidence 6799999999998765 47899999999999999999999999888777766664333 3333 347899999999999
Q ss_pred hhCCCCCC----CHHHHHH
Q 005247 673 AEEPEIRP----SFPSIME 687 (706)
Q Consensus 673 ~~dP~~RP----S~~eIl~ 687 (706)
+.||.+|| ++.++++
T Consensus 234 ~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 234 NRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred CCCHHHCCCCCCCHHHHhc
Confidence 99999998 5666655
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=312.02 Aligned_cols=249 Identities=27% Similarity=0.455 Sum_probs=213.5
Q ss_pred ceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEEe
Q 005247 434 ELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY 511 (706)
Q Consensus 434 ~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~ 511 (706)
+|++.+.||+|+||.||++.+..+ .+++|.+..........+.+.+|+.+++.++|+||+++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 588999999999999999987544 499999876655566677899999999999999999999999999999999999
Q ss_pred ccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCC-CcEEEeecCccccCCCCcc
Q 005247 512 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST-YTVKVCDFGLSRSKPNTYI 590 (706)
Q Consensus 512 ~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~-~~vKL~DFGla~~~~~~~~ 590 (706)
+++++|.+++.... ...+++..+..++.+++.||+|||+++ ++|+||||+||+++.+ +.+||+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 81 APGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTKL--ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred CCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence 99999999996432 234789999999999999999999999 9999999999999854 4689999999987654432
Q ss_pred cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHHHH
Q 005247 591 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIET 670 (706)
Q Consensus 591 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI~~ 670 (706)
.....++..|+|||.+.+...+.++||||||+++|+|++|..||...+.......+. ......++..++.++.++|.+
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~ 235 (256)
T cd08220 158 -AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIM-SGTFAPISDRYSPDLRQLILS 235 (256)
T ss_pred -ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHH-hcCCCCCCCCcCHHHHHHHHH
Confidence 234568889999999998888999999999999999999999998877666555543 333445677889999999999
Q ss_pred hhhhCCCCCCCHHHHHH
Q 005247 671 CWAEEPEIRPSFPSIME 687 (706)
Q Consensus 671 cL~~dP~~RPS~~eIl~ 687 (706)
||..+|++|||+.+++.
T Consensus 236 ~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 236 MLNLDPSKRPQLSQIMA 252 (256)
T ss_pred HccCChhhCCCHHHHhh
Confidence 99999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=332.70 Aligned_cols=248 Identities=26% Similarity=0.320 Sum_probs=201.3
Q ss_pred cCceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCC------C
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP------P 503 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~------~ 503 (706)
.++|++.+.||+|+||.||++.+.. ..||+|++..........+.+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 4689999999999999999998754 4599999876544455567788999999999999999999887543 3
Q ss_pred ceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccc
Q 005247 504 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 583 (706)
Q Consensus 504 ~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~ 583 (706)
..++||||+.+ +|.+.+.. .+++..+..++.|++.||+|||++| |+||||||+|||++.++.+||+|||+++
T Consensus 103 ~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 174 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR 174 (364)
T ss_pred eEEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence 57999999975 66666642 3678889999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCc-----------
Q 005247 584 SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR----------- 652 (706)
Q Consensus 584 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~----------- 652 (706)
...... ......+|..|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+.....
T Consensus 175 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (364)
T cd07875 175 TAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 253 (364)
T ss_pred ccCCCC-cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhh
Confidence 654432 23456789999999999999999999999999999999999999987765544433321000
Q ss_pred ---------cc--------------------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 005247 653 ---------RL--------------------EIPKNVNPMVAALIETCWAEEPEIRPSFPSIMET 688 (706)
Q Consensus 653 ---------~l--------------------~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~ 688 (706)
+. ......+.++++||.+||+.||.+|||++++++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00 0011234678999999999999999999999873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=317.94 Aligned_cols=250 Identities=27% Similarity=0.406 Sum_probs=204.6
Q ss_pred CceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEE
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 510 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E 510 (706)
++|++.+.||+|+||.||+|.+.. ..+|+|++..........+.+.+|+.+++.++|+||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 368999999999999999998864 459999886554333334567899999999999999999999999999999999
Q ss_pred eccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcc
Q 005247 511 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 590 (706)
Q Consensus 511 ~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~ 590 (706)
|+++++|..++... ..+++..++.++.||+.||+|||+++ ++||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~ql~~~l~~LH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 81 YCDHTVLNELEKNP---RGVPEHLIKKIIWQTLQAVNFCHKHN--CIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred ccCccHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 99998888876533 24889999999999999999999999 99999999999999999999999999987654432
Q ss_pred cCCCCCCCCCccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcC------------------
Q 005247 591 SSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG------------------ 651 (706)
Q Consensus 591 ~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~------------------ 651 (706)
......++..|+|||.+.+ ..++.++||||||+++|+|++|..||.+....+....+....
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07847 156 DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFK 235 (286)
T ss_pred cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccc
Confidence 3334567889999999876 457889999999999999999999998776544433221100
Q ss_pred -cccC----------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 652 -RRLE----------IPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 652 -~~l~----------~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
...+ ....++..+.+||.+||+.+|++||++.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 236 GLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0000 01246788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=315.04 Aligned_cols=248 Identities=31% Similarity=0.548 Sum_probs=208.5
Q ss_pred ceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccc-------hHHHHHHHHHHHHHHcCCCCceeEEeccccCCCc
Q 005247 434 ELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFH-------EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN 504 (706)
Q Consensus 434 ~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~-------~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 504 (706)
+|.+.+.||+|+||.||+|.+.. ..+++|.+...... ....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 36778899999999999998754 45999987544322 1234678899999999999999999999999999
Q ss_pred eEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCcccc
Q 005247 505 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 584 (706)
Q Consensus 505 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~ 584 (706)
.+++|||+++++|.+++... ..+++..+..++.|++.||+|||+++ ++||||||+||+++.++.+||+|||.++.
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lH~~~--ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY---GAFEETLVRNFVRQILKGLNYLHNRG--IIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHhcC--cccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 99999999999999999643 34788899999999999999999999 99999999999999999999999999876
Q ss_pred CCCCcc------cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCC
Q 005247 585 KPNTYI------SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPK 658 (706)
Q Consensus 585 ~~~~~~------~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~ 658 (706)
...... ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||...+.......+. ......++.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~ 234 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIG-ENASPEIPS 234 (267)
T ss_pred cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHh-ccCCCcCCc
Confidence 542211 1123457889999999999889999999999999999999999998766554444432 234456777
Q ss_pred CCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 659 NVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 659 ~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
.++..+.++|.+||+.+|.+||++.++++
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 235 NISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 89999999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=320.66 Aligned_cols=250 Identities=28% Similarity=0.494 Sum_probs=209.0
Q ss_pred cCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEE
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 509 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~ 509 (706)
.+.|++.+.||+|+||.||+|++..+ .+++|++... .....+.+.+|+.+++.++|+||+++++.+..++.+++||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 88 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMI 88 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEE
Confidence 46799999999999999999988654 4888887543 3455678889999999999999999999999999999999
Q ss_pred EeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCc
Q 005247 510 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 589 (706)
Q Consensus 510 E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 589 (706)
||+++++|..++.... ..+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++.......
T Consensus 89 e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 164 (292)
T cd06644 89 EFCPGGAVDAIMLELD--RGLTEPQIQVICRQMLEALQYLHSMK--IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL 164 (292)
T ss_pred ecCCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCC--eeecCCCcceEEEcCCCCEEEccCccceeccccc
Confidence 9999999988775332 34789999999999999999999999 9999999999999999999999999987654433
Q ss_pred ccCCCCCCCCCccCccccc-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcC-cccCCCCCCcHH
Q 005247 590 ISSKTAAGTPEWMAPEVLR-----EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG-RRLEIPKNVNPM 663 (706)
Q Consensus 590 ~~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~-~~l~~p~~~s~e 663 (706)
.......++..|+|||.+. ...++.++|||||||++|||++|..||...+.......+.... .....+..++.+
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (292)
T cd06644 165 QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSME 244 (292)
T ss_pred cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHH
Confidence 3334556889999999985 3446789999999999999999999998877655554442221 123345678899
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 664 VAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 664 l~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
+.+||.+||+.+|++||++.++++
T Consensus 245 ~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 245 FRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred HHHHHHHHhcCCcccCcCHHHHhc
Confidence 999999999999999999999976
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=320.02 Aligned_cols=248 Identities=27% Similarity=0.456 Sum_probs=204.3
Q ss_pred CceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEE
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 510 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E 510 (706)
++|++.+.||+|+||.||+|.+.+ ..||+|++.... ......+.+|+.+++.++||||+++++.+...+..+++||
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e 86 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP--GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICME 86 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Confidence 467888999999999999998754 448999876543 2334567889999999999999999999999999999999
Q ss_pred eccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcc
Q 005247 511 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 590 (706)
Q Consensus 511 ~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~ 590 (706)
|+++++|.+++... ..+++..++.++.|++.||.|||++| ++|+||||+||+++.++.+||+|||++........
T Consensus 87 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06645 87 FCGGGSLQDIYHVT---GPLSESQIAYVSRETLQGLYYLHSKG--KMHRDIKGANILLTDNGHVKLADFGVSAQITATIA 161 (267)
T ss_pred ccCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECcceeeeEccCccc
Confidence 99999999998643 35889999999999999999999999 99999999999999999999999999876544333
Q ss_pred cCCCCCCCCCccCccccc---cCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccC-C--CCCCcHHH
Q 005247 591 SSKTAAGTPEWMAPEVLR---EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLE-I--PKNVNPMV 664 (706)
Q Consensus 591 ~~~~~~Gt~~Y~APE~l~---~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~-~--p~~~s~el 664 (706)
......|+..|+|||.+. ...++.++|||||||++|+|++|..||....+............... . ...++..+
T Consensus 162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (267)
T cd06645 162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSF 241 (267)
T ss_pred ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHH
Confidence 334567899999999974 45578899999999999999999999976655443333221211111 1 12467899
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHH
Q 005247 665 AALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 665 ~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
.++|.+||..+|++||++.+|+.
T Consensus 242 ~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 242 HHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred HHHHHHHccCCchhCcCHHHHhc
Confidence 99999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=321.00 Aligned_cols=250 Identities=28% Similarity=0.506 Sum_probs=209.2
Q ss_pred CceEEEEEeccCCceEEEEEEEc--CCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEE
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 510 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E 510 (706)
++|++++.||+|+||.||++.+. +..+|+|.+... ........+.+|+.++++++|+||+++++.+..++..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE-LDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME 79 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence 36889999999999999999886 445999987643 344455788999999999999999999999999999999999
Q ss_pred eccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHh-cCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCc
Q 005247 511 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ-RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 589 (706)
Q Consensus 511 ~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs-~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 589 (706)
|+++++|..+++.......+++..+..++.|++.||.|||+ .+ |+||||||+||+++.++.+||+|||++.......
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (286)
T cd06622 80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157 (286)
T ss_pred ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC--EeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence 99999999988754333468999999999999999999997 57 9999999999999999999999999987654332
Q ss_pred ccCCCCCCCCCccCccccccCC------CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh--hcCcccCCCCCCc
Q 005247 590 ISSKTAAGTPEWMAPEVLREDP------SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVG--FKGRRLEIPKNVN 661 (706)
Q Consensus 590 ~~~~~~~Gt~~Y~APE~l~~~~------~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~--~~~~~l~~p~~~s 661 (706)
.....++..|+|||.+.+.. ++.++|||||||++|+|++|+.||...........+. .......++..++
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd06622 158 --AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYS 235 (286)
T ss_pred --cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccC
Confidence 23456888999999986543 4789999999999999999999997765544433322 1233455677799
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 662 PMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 662 ~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
.++.+||.+||+.+|++||++.+++.
T Consensus 236 ~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 236 DDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred HHHHHHHHHHcccCcccCCCHHHHhc
Confidence 99999999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=337.28 Aligned_cols=245 Identities=23% Similarity=0.289 Sum_probs=195.1
Q ss_pred ccccCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceE
Q 005247 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS 506 (706)
Q Consensus 429 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 506 (706)
.+....|++.+.||+|+||.||+|.+..+ .||+|... ...+.+|+.++++++||||+++++++......+
T Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~--------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 159 (391)
T PHA03212 88 GIEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ--------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTC 159 (391)
T ss_pred ccccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh--------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeE
Confidence 34557899999999999999999988654 48888642 135678999999999999999999999999999
Q ss_pred EEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCC
Q 005247 507 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP 586 (706)
Q Consensus 507 lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~ 586 (706)
+|+|++. ++|..++... ..+++..++.++.||+.||.|||++| ||||||||+|||++.++.+||+|||+++...
T Consensus 160 lv~e~~~-~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~ylH~~~--IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~ 233 (391)
T PHA03212 160 LILPRYK-TDLYCYLAAK---RNIAICDILAIERSVLRAIQYLHENR--IIHRDIKAENIFINHPGDVCLGDFGAACFPV 233 (391)
T ss_pred EEEecCC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHhEEEcCCCCEEEEeCCcccccc
Confidence 9999985 6888877533 24788899999999999999999999 9999999999999999999999999987533
Q ss_pred CCc-ccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-------HHHHHHhhh-c-------
Q 005247 587 NTY-ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTP-------SQVISAVGF-K------- 650 (706)
Q Consensus 587 ~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~-------~~~~~~i~~-~------- 650 (706)
... .......||+.|+|||++.+..++.++|||||||++|||++|..||..... ......+.. .
T Consensus 234 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~ 313 (391)
T PHA03212 234 DINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEF 313 (391)
T ss_pred cccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhc
Confidence 221 122346799999999999999999999999999999999999988643211 011110000 0
Q ss_pred ----------------CcccCCC---------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 651 ----------------GRRLEIP---------KNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 651 ----------------~~~l~~p---------~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
......+ ..++.++.+||.+||+.||++|||+.|+++
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 314 PIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred CcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000 134678999999999999999999999986
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=319.72 Aligned_cols=245 Identities=28% Similarity=0.470 Sum_probs=212.9
Q ss_pred CceEEEEEeccCCceEEEEEEEcC--CceEEEEEecccc-chHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEE
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 509 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~ 509 (706)
++|++.+.||+|+||.||++.+.. ..+|+|++..... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 468999999999999999998864 4599999865443 2344567889999999999999999999999999999999
Q ss_pred EeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCc
Q 005247 510 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 589 (706)
Q Consensus 510 E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 589 (706)
||+++++|.++++.. ..+++..+..++.||+.||.|||++| ++|+||+|+||+++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH~~~--i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 81 EYVPGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLHSLD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence 999999999998644 35889999999999999999999999 999999999999999999999999998876544
Q ss_pred ccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHHH
Q 005247 590 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE 669 (706)
Q Consensus 590 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI~ 669 (706)
.....+++.|+|||.+.+...+.++||||||+++|+|++|..||......+....+. .....++..++..++++|.
T Consensus 155 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~ 230 (290)
T cd05580 155 --TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKIL--EGKVRFPSFFSPDAKDLIR 230 (290)
T ss_pred --CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh--cCCccCCccCCHHHHHHHH
Confidence 234578999999999988888999999999999999999999998877655555543 4456678888999999999
Q ss_pred HhhhhCCCCCC-----CHHHHHH
Q 005247 670 TCWAEEPEIRP-----SFPSIME 687 (706)
Q Consensus 670 ~cL~~dP~~RP-----S~~eIl~ 687 (706)
+||..||.+|+ +++++++
T Consensus 231 ~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 231 NLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred HHccCCHHHccCcccCCHHHHHc
Confidence 99999999998 7777764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=313.90 Aligned_cols=249 Identities=27% Similarity=0.459 Sum_probs=207.6
Q ss_pred ceEEEEEeccCCceEEEEEEEc-CCceEEEEEecccc----chHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEE
Q 005247 434 ELLIKKKIGEGSFGTVYHAEWR-NSDVAVKILIEQEF----HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIV 508 (706)
Q Consensus 434 ~y~i~~~LG~G~fG~Vy~a~~~-~~~vAVKvl~~~~~----~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV 508 (706)
+|++.+.||+|+||.||+|... +..+|+|.+..... .....+.+.+|+++++.++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 4778899999999999999874 34489998765432 223446788999999999999999999999999999999
Q ss_pred EEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCC
Q 005247 509 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 588 (706)
Q Consensus 509 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 588 (706)
+||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 81 MEFVPGGSISSILNRF---GPLPEPVFCKYTKQILDGVAYLHNNC--VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence 9999999999998643 24788999999999999999999999 999999999999999999999999998754221
Q ss_pred ------cccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhc-CcccCCCCCCc
Q 005247 589 ------YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-GRRLEIPKNVN 661 (706)
Q Consensus 589 ------~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~-~~~l~~p~~~s 661 (706)
........++..|+|||.+.+..++.++||||||+++|+|++|..||...+.......+... .....++..++
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFS 235 (265)
T ss_pred cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCC
Confidence 11123456889999999999988999999999999999999999999876654443333222 23345677889
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 662 PMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 662 ~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
.++.++|.+||+.+|++||++.++++
T Consensus 236 ~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 236 AAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred HHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 99999999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=312.44 Aligned_cols=247 Identities=32% Similarity=0.553 Sum_probs=210.4
Q ss_pred CceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEE
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 510 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E 510 (706)
++|++.+.||+|+||.||++.+.. ..+++|.+..... .+.+.+|+++++.++|+||+++++++.+...+++++|
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e 78 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME 78 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence 578899999999999999998875 4588898754321 5789999999999999999999999999999999999
Q ss_pred eccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcc
Q 005247 511 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 590 (706)
Q Consensus 511 ~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~ 590 (706)
|+.+++|.+++.... ..+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.+||+|||++........
T Consensus 79 ~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (256)
T cd06612 79 YCGAGSVSDIMKITN--KTLTEEEIAAILYQTLKGLEYLHSNK--KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA 154 (256)
T ss_pred cCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence 999999999986432 35889999999999999999999999 99999999999999999999999999887655443
Q ss_pred cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhh-cCcccCCCCCCcHHHHHHHH
Q 005247 591 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGF-KGRRLEIPKNVNPMVAALIE 669 (706)
Q Consensus 591 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~-~~~~l~~p~~~s~el~dLI~ 669 (706)
......++..|+|||.+.+..++.++||||||+++|+|++|+.||....+......+.. .......+..++.++.++|.
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 234 (256)
T cd06612 155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVK 234 (256)
T ss_pred ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHH
Confidence 33445688999999999998999999999999999999999999987766554433321 11223345567889999999
Q ss_pred HhhhhCCCCCCCHHHHHH
Q 005247 670 TCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 670 ~cL~~dP~~RPS~~eIl~ 687 (706)
+||+.||++|||+.++++
T Consensus 235 ~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 235 KCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred HHHhcChhhCcCHHHHhc
Confidence 999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=319.09 Aligned_cols=249 Identities=26% Similarity=0.352 Sum_probs=199.3
Q ss_pred ceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEEe
Q 005247 434 ELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY 511 (706)
Q Consensus 434 ~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~ 511 (706)
+|++.+.||+|+||.||+|.+.. ..+++|.+............+.+|+.+++.++|+||+++++++.+.+..++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 48899999999999999998864 4599998866544433445678899999999999999999999999999999999
Q ss_pred ccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCccc
Q 005247 512 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS 591 (706)
Q Consensus 512 ~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~ 591 (706)
+.+ +|.+++.... ..+++..++.++.||++||.|||+++ |+||||||+||+++.++.+||+|||+++........
T Consensus 81 ~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 155 (284)
T cd07839 81 CDQ-DLKKYFDSCN--GDIDPEIVKSFMFQLLKGLAFCHSHN--VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC 155 (284)
T ss_pred CCC-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC
Confidence 975 7777765322 35899999999999999999999999 999999999999999999999999998865443333
Q ss_pred CCCCCCCCCccCccccccCC-CCchhHHHHHHHHHHHHHhCCCCCCC-CChHHHHHHhhhcC---------------c--
Q 005247 592 SKTAAGTPEWMAPEVLREDP-SNEKSDVFSFGVILWELITLQKPWRN-STPSQVISAVGFKG---------------R-- 652 (706)
Q Consensus 592 ~~~~~Gt~~Y~APE~l~~~~-~s~ksDVwSLGviL~ELltG~~Pf~~-~~~~~~~~~i~~~~---------------~-- 652 (706)
.....++..|+|||.+.+.. ++.++|||||||++|+|++|..||.. .+..+....+.... .
T Consensus 156 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07839 156 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYK 235 (284)
T ss_pred cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccc
Confidence 34456789999999987754 68999999999999999999888643 33332222211000 0
Q ss_pred -c---------cCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 653 -R---------LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 653 -~---------l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
. ......+++++.+||.+||+.||.+|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 236 PYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred ccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0 0112356789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=319.13 Aligned_cols=248 Identities=28% Similarity=0.478 Sum_probs=210.8
Q ss_pred cCceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEE
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 509 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~ 509 (706)
..+|++.+.||.|+||.||++.+.. ..+++|.+..... ...+.+.+|+.+++.++|+||+++++++...+..++|+
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 95 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ--PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM 95 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC--chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence 3579999999999999999998654 4599998865432 23457889999999999999999999999999999999
Q ss_pred EeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCc
Q 005247 510 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 589 (706)
Q Consensus 510 E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 589 (706)
||+.+++|..++... .+++..+..++.|++.||+|||++| ++||||||+||+++.++.+||+|||++.......
T Consensus 96 e~~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~~--i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~ 169 (296)
T cd06655 96 EYLAGGSLTDVVTET----CMDEAQIAAVCRECLQALEFLHANQ--VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ 169 (296)
T ss_pred EecCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEccCccchhccccc
Confidence 999999999988532 4789999999999999999999999 9999999999999999999999999987654433
Q ss_pred ccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhc-CcccCCCCCCcHHHHHHH
Q 005247 590 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-GRRLEIPKNVNPMVAALI 668 (706)
Q Consensus 590 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~-~~~l~~p~~~s~el~dLI 668 (706)
.......++..|+|||.+.+..++.++|||||||++|+|++|..||...++......+... ...+..+..+++.+.+||
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 249 (296)
T cd06655 170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFL 249 (296)
T ss_pred ccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHH
Confidence 2233457889999999999888999999999999999999999999887765544443222 223445677899999999
Q ss_pred HHhhhhCCCCCCCHHHHHH
Q 005247 669 ETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 669 ~~cL~~dP~~RPS~~eIl~ 687 (706)
.+||..+|++||++.+++.
T Consensus 250 ~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 250 NRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred HHHhhcChhhCCCHHHHhh
Confidence 9999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=310.37 Aligned_cols=246 Identities=35% Similarity=0.582 Sum_probs=207.7
Q ss_pred EEeccCCceEEEEEEEc-CCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEEeccCCch
Q 005247 439 KKIGEGSFGTVYHAEWR-NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSL 517 (706)
Q Consensus 439 ~~LG~G~fG~Vy~a~~~-~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL 517 (706)
++||+|+||.||++.+. +..+++|++...... ...+.+.+|++++++++|+||+++++++......++||||+.+++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 36899999999999876 556999987655433 4557889999999999999999999999999999999999999999
Q ss_pred hhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcccC--CCC
Q 005247 518 YKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISS--KTA 595 (706)
Q Consensus 518 ~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~--~~~ 595 (706)
.+++.... ..+++..+..++.+++.||.|||+++ ++||||||+||+++.++.+||+|||++.......... ...
T Consensus 80 ~~~l~~~~--~~~~~~~~~~~~~~~~~~l~~lH~~~--i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 80 LTFLRKKK--NRLTVKKLLQMSLDAAAGMEYLESKN--CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC--EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 99986432 24788889999999999999999999 9999999999999999999999999987654321111 122
Q ss_pred CCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHHHHhhhh
Q 005247 596 AGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAE 674 (706)
Q Consensus 596 ~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI~~cL~~ 674 (706)
..+..|+|||.+.+..++.++||||||+++|||++ |..||...........+. ...+...+..++.++.+||.+||+.
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~ 234 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIE-SGYRMPAPQLCPEEIYRLMLQCWAY 234 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHh-cCCCCCCCccCCHHHHHHHHHHhcc
Confidence 33567999999988889999999999999999999 889998877666555553 3345566778899999999999999
Q ss_pred CCCCCCCHHHHHHHHH
Q 005247 675 EPEIRPSFPSIMETLQ 690 (706)
Q Consensus 675 dP~~RPS~~eIl~~L~ 690 (706)
+|.+||++.++++.|+
T Consensus 235 ~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 235 DPENRPSFSEIYNELQ 250 (251)
T ss_pred ChhhCcCHHHHHHHhh
Confidence 9999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=309.34 Aligned_cols=246 Identities=33% Similarity=0.559 Sum_probs=207.2
Q ss_pred EEeccCCceEEEEEEEcCC-ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEEeccCCch
Q 005247 439 KKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSL 517 (706)
Q Consensus 439 ~~LG~G~fG~Vy~a~~~~~-~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL 517 (706)
+.||+|+||.||+|...+. .+|+|++.... .......+.+|+++++.++||||+++++++...+..++||||+++++|
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 3689999999999986543 48988875432 344445788999999999999999999999999999999999999999
Q ss_pred hhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCccc-CCCCC
Q 005247 518 YKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS-SKTAA 596 (706)
Q Consensus 518 ~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~-~~~~~ 596 (706)
.+++.... ..+++..+..++.|++.||.|||++| ++||||||+||+++.++.+||+|||++......... .....
T Consensus 80 ~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (250)
T cd05085 80 LSFLRKKK--DELKTKQLVKFALDAAAGMAYLESKN--CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ 155 (250)
T ss_pred HHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccChheEEEcCCCeEEECCCccceeccccccccCCCCC
Confidence 99886432 34788999999999999999999999 999999999999999999999999998764433211 12224
Q ss_pred CCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHHHHhhhhC
Q 005247 597 GTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEE 675 (706)
Q Consensus 597 Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI~~cL~~d 675 (706)
++..|+|||.+.+..++.++||||||+++|++++ |..||...........+. ...+...+..++..+.+|+.+||+.+
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~ 234 (250)
T cd05085 156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVE-KGYRMSCPQKCPDDVYKVMQRCWDYK 234 (250)
T ss_pred CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcccC
Confidence 4667999999998889999999999999999998 999998887766665553 44455667789999999999999999
Q ss_pred CCCCCCHHHHHHHHH
Q 005247 676 PEIRPSFPSIMETLQ 690 (706)
Q Consensus 676 P~~RPS~~eIl~~L~ 690 (706)
|++||++.++.+.|.
T Consensus 235 p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 235 PENRPKFSELQKELA 249 (250)
T ss_pred cccCCCHHHHHHHhc
Confidence 999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=321.23 Aligned_cols=251 Identities=25% Similarity=0.353 Sum_probs=203.1
Q ss_pred ccCceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEE
Q 005247 431 RWSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIV 508 (706)
Q Consensus 431 ~~~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV 508 (706)
..++|++.+.||+|+||.||+|.+.. ..||+|.+..... ......+.+|+.+++.++|+||+++++++...+..++|
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 82 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 82 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc-cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEE
Confidence 35679999999999999999998764 4489998764432 22234677899999999999999999999999999999
Q ss_pred EEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCC
Q 005247 509 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 588 (706)
Q Consensus 509 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 588 (706)
|||+. ++|.+++.... ..+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 83 ~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 157 (301)
T cd07873 83 FEYLD-KDLKQYLDDCG--NSINMHNVKLFLFQLLRGLNYCHRRK--VLHRDLKPQNLLINERGELKLADFGLARAKSIP 157 (301)
T ss_pred Eeccc-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHHHEEECCCCcEEECcCcchhccCCC
Confidence 99997 58888875432 24788899999999999999999999 999999999999999999999999998765443
Q ss_pred cccCCCCCCCCCccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcC----------------
Q 005247 589 YISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG---------------- 651 (706)
Q Consensus 589 ~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~---------------- 651 (706)
........+++.|+|||.+.+. .++.++||||||+++|||++|+.||...+..+....+....
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (301)
T cd07873 158 TKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE 237 (301)
T ss_pred CCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccc
Confidence 3233345678999999998764 47889999999999999999999998776554433221100
Q ss_pred -cccC-----------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 652 -RRLE-----------IPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 652 -~~l~-----------~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
.... ....+++++++||.+||+.||.+|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0001 12357889999999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=330.77 Aligned_cols=246 Identities=22% Similarity=0.331 Sum_probs=199.6
Q ss_pred cCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCC------C
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP------P 503 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~------~ 503 (706)
.++|++.+.||+|+||.||+|.+..+ .||+|++..........+.+.+|+.+++.++|+||+++++++... .
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN 93 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence 36799999999999999999987644 499998865543444456788999999999999999999987543 3
Q ss_pred ceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccc
Q 005247 504 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 583 (706)
Q Consensus 504 ~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~ 583 (706)
..+++++++ +++|.++++. ..+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++
T Consensus 94 ~~~~~~~~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrdikp~Nil~~~~~~~kl~Dfg~~~ 166 (343)
T cd07878 94 EVYLVTNLM-GADLNNIVKC----QKLSDEHVQFLIYQLLRGLKYIHSAG--IIHRDLKPSNVAVNEDCELRILDFGLAR 166 (343)
T ss_pred cEEEEeecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCChhhEEECCCCCEEEcCCccce
Confidence 478999987 7788888753 24889999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCcccCCCCCCCCCccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCc----------
Q 005247 584 SKPNTYISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR---------- 652 (706)
Q Consensus 584 ~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~---------- 652 (706)
..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....+.....
T Consensus 167 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd07878 167 QADDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKI 243 (343)
T ss_pred ecCCC---cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 65442 235578999999999977 5688999999999999999999999987655443332211000
Q ss_pred -----------ccC--------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 653 -----------RLE--------IPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 653 -----------~l~--------~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
... .....++.+.+||.+||..||.+|||+.+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 244 SSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred chhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000 11245677899999999999999999999986
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=348.82 Aligned_cols=264 Identities=34% Similarity=0.568 Sum_probs=236.2
Q ss_pred ccccCceEEEEEeccCCceEEEEEEEcC--C---ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCC
Q 005247 429 EIRWSELLIKKKIGEGSFGTVYHAEWRN--S---DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP 503 (706)
Q Consensus 429 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~--~---~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 503 (706)
+|+.+..+|.++||.|.||.|++|..+- + .||||.++. ...+++...|+.|+.||-++.||||++|.+++....
T Consensus 625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~-GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~ 703 (996)
T KOG0196|consen 625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKA-GYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSK 703 (996)
T ss_pred hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeecc-CccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCc
Confidence 5777888999999999999999998752 2 299999865 456778889999999999999999999999999999
Q ss_pred ceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccc
Q 005247 504 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 583 (706)
Q Consensus 504 ~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~ 583 (706)
..+||.|||++|+|..+|+..+ +.+..-+...+.+.|+.|++||-+++ +|||||...|||++.+...|++|||+++
T Consensus 704 PvMIiTEyMENGsLDsFLR~~D--GqftviQLVgMLrGIAsGMkYLsdm~--YVHRDLAARNILVNsnLvCKVsDFGLSR 779 (996)
T KOG0196|consen 704 PVMIITEYMENGSLDSFLRQND--GQFTVIQLVGMLRGIASGMKYLSDMN--YVHRDLAARNILVNSNLVCKVSDFGLSR 779 (996)
T ss_pred eeEEEhhhhhCCcHHHHHhhcC--CceEeehHHHHHHHHHHHhHHHhhcC--chhhhhhhhheeeccceEEEecccccee
Confidence 9999999999999999998665 45888899999999999999999999 9999999999999999999999999999
Q ss_pred cCCCCcccCCCCC---CCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCCCC
Q 005247 584 SKPNTYISSKTAA---GTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKN 659 (706)
Q Consensus 584 ~~~~~~~~~~~~~---Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p~~ 659 (706)
...+......+.. -..+|.|||.+.-.+++.+|||||+|+++||.++ |..||...+.+++++.+. .+.+++.|-+
T Consensus 780 vledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe-~gyRLPpPmD 858 (996)
T KOG0196|consen 780 VLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE-QGYRLPPPMD 858 (996)
T ss_pred ecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHH-hccCCCCCCC
Confidence 7654432222222 2568999999999999999999999999999875 999999999999999994 7889999999
Q ss_pred CcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhccC
Q 005247 660 VNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVC 698 (706)
Q Consensus 660 ~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~~~ 698 (706)
||..+.+||..||++|-.+||.|.||+..|.+++.+...
T Consensus 859 CP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~S 897 (996)
T KOG0196|consen 859 CPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNS 897 (996)
T ss_pred CcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchh
Confidence 999999999999999999999999999999999987543
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=316.80 Aligned_cols=247 Identities=29% Similarity=0.515 Sum_probs=211.1
Q ss_pred ceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEEe
Q 005247 434 ELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY 511 (706)
Q Consensus 434 ~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~ 511 (706)
.|+..+.||.|+||.||+|.+.. ..+|+|++.... .....+.+.+|+.+++.+.|+||+++++++.+.+..++||||
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 57778899999999999998764 458999876543 234557889999999999999999999999999999999999
Q ss_pred ccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCccc
Q 005247 512 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS 591 (706)
Q Consensus 512 ~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~ 591 (706)
+++++|.+++... .+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.........
T Consensus 84 ~~~~~L~~~i~~~----~l~~~~~~~~~~~l~~~l~~lh~~~--ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06640 84 LGGGSALDLLRAG----PFDEFQIATMLKEILKGLDYLHSEK--KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK 157 (277)
T ss_pred CCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC--ccCcCCChhhEEEcCCCCEEEcccccceeccCCccc
Confidence 9999999988632 4788889999999999999999999 999999999999999999999999999765544333
Q ss_pred CCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHHHHh
Q 005247 592 SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC 671 (706)
Q Consensus 592 ~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI~~c 671 (706)
.....++..|+|||.+.+...+.++|+||||+++|||++|..||....+......+. ......++..++..+.+||.+|
T Consensus 158 ~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~ 236 (277)
T cd06640 158 RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIP-KNNPPTLTGEFSKPFKEFIDAC 236 (277)
T ss_pred cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhh-cCCCCCCchhhhHHHHHHHHHH
Confidence 344568889999999998889999999999999999999999998877665554432 2334455667889999999999
Q ss_pred hhhCCCCCCCHHHHHHH
Q 005247 672 WAEEPEIRPSFPSIMET 688 (706)
Q Consensus 672 L~~dP~~RPS~~eIl~~ 688 (706)
|+.+|++||++.+++..
T Consensus 237 l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 237 LNKDPSFRPTAKELLKH 253 (277)
T ss_pred cccCcccCcCHHHHHhC
Confidence 99999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=309.67 Aligned_cols=248 Identities=31% Similarity=0.497 Sum_probs=212.0
Q ss_pred ceEEEEEeccCCceEEEEEEEc--CCceEEEEEecccc---chHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEE
Q 005247 434 ELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEF---HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIV 508 (706)
Q Consensus 434 ~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKvl~~~~~---~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV 508 (706)
+|+..+.||+|+||.||+|... +..+++|.+..... ..+..+.+.+|+.+++.++|+||+++++++.....++++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3677889999999999999875 45599998865432 234567889999999999999999999999999999999
Q ss_pred EEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCC
Q 005247 509 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 588 (706)
Q Consensus 509 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 588 (706)
+||+++++|.+++... ..+++..+..++.||+.||+|||+.+ ++|+||+|+||+++.++.+||+|||.+......
T Consensus 81 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 81 LELVPGGSLAKLLKKY---GSFPEPVIRLYTRQILLGLEYLHDRN--TVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred EEecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 9999999999998643 24788999999999999999999999 999999999999999999999999998765443
Q ss_pred cccCCCCCCCCCccCccccccCC-CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHH
Q 005247 589 YISSKTAAGTPEWMAPEVLREDP-SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAAL 667 (706)
Q Consensus 589 ~~~~~~~~Gt~~Y~APE~l~~~~-~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dL 667 (706)
. ......++..|++||.+.... ++.++|+||||+++|+|++|+.||...........+........++..+++.+.++
T Consensus 156 ~-~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 234 (258)
T cd06632 156 S-FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDF 234 (258)
T ss_pred c-cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHH
Confidence 2 224556889999999987776 89999999999999999999999988776555555544344556777889999999
Q ss_pred HHHhhhhCCCCCCCHHHHHH
Q 005247 668 IETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 668 I~~cL~~dP~~RPS~~eIl~ 687 (706)
|.+||+.+|.+||++.+++.
T Consensus 235 i~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 235 ILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred HHHHhhcCcccCcCHHHHhc
Confidence 99999999999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=314.27 Aligned_cols=255 Identities=34% Similarity=0.542 Sum_probs=203.4
Q ss_pred cCceEEEEEeccCCceEEEEEEEc------CCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccC--CC
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWR------NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE--PP 503 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~------~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~--~~ 503 (706)
..+|++.+.||+|+||.||++... +..|++|.+... .....+.+.+|+++++.++||||+++++++.. ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 80 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence 357899999999999999999742 345899987543 34455788999999999999999999997643 34
Q ss_pred ceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccc
Q 005247 504 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 583 (706)
Q Consensus 504 ~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~ 583 (706)
.+++||||+++++|.+++.... ..+++..++.++.|++.||+|||++| |+||||||+||+++.++.+||+|||+++
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~aL~~LH~~~--i~H~dlkp~nili~~~~~~~l~dfg~~~ 156 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHR--ERLDHRKLLLYASQICKGMEYLGSKR--YVHRDLATRNILVESENRVKIGDFGLTK 156 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHhhEEECCCCeEEECCCcccc
Confidence 6899999999999999986432 34789999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCccc---CCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH---------------HH
Q 005247 584 SKPNTYIS---SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQV---------------IS 645 (706)
Q Consensus 584 ~~~~~~~~---~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~---------------~~ 645 (706)
........ .....++..|+|||.+.+..++.++||||||+++|||++|..|+........ ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05081 157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI 236 (284)
T ss_pred cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHH
Confidence 65432211 1122334569999999988899999999999999999998777643221100 00
Q ss_pred HhhhcCcccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 005247 646 AVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQF 692 (706)
Q Consensus 646 ~i~~~~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~l 692 (706)
.......+...+..++.++.+||.+||..+|++|||+.+|++.|+.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 237 ELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 11122234455677899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=316.26 Aligned_cols=256 Identities=28% Similarity=0.413 Sum_probs=205.7
Q ss_pred cccccCceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcC-CCCceeEEecccc----
Q 005247 428 LEIRWSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVT---- 500 (706)
Q Consensus 428 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~---- 500 (706)
+.....+|++.+.||+|+||.||++.+.. +.+++|++.... .....+.+|+.+++.+ +|+||+++++++.
T Consensus 13 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 89 (286)
T cd06638 13 FPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV 89 (286)
T ss_pred CCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc---chHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence 34456789999999999999999998754 458999875432 1224677899999999 6999999999873
Q ss_pred -CCCceEEEEEeccCCchhhhcccC-CCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEee
Q 005247 501 -EPPNLSIVTEYLSRGSLYKLLHIP-DARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCD 578 (706)
Q Consensus 501 -~~~~~~lV~E~~~ggsL~~~l~~~-~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~D 578 (706)
..+..++||||+++++|.+++... .....+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~~~~~~kl~d 167 (286)
T cd06638 90 KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK--TIHRDVKGNNILLTTEGGVKLVD 167 (286)
T ss_pred CCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC--ccccCCCHHhEEECCCCCEEEcc
Confidence 445689999999999999887421 22345788999999999999999999999 99999999999999999999999
Q ss_pred cCccccCCCCcccCCCCCCCCCccCcccccc-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcC-c
Q 005247 579 FGLSRSKPNTYISSKTAAGTPEWMAPEVLRE-----DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG-R 652 (706)
Q Consensus 579 FGla~~~~~~~~~~~~~~Gt~~Y~APE~l~~-----~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~-~ 652 (706)
||+++.............|+..|+|||.+.. ..++.++|||||||++|||++|+.||................ .
T Consensus 168 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~ 247 (286)
T cd06638 168 FGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPP 247 (286)
T ss_pred CCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCC
Confidence 9998765543333345578999999999853 447889999999999999999999998776544433322111 1
Q ss_pred ccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 005247 653 RLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMET 688 (706)
Q Consensus 653 ~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~ 688 (706)
....+..++..+.+||.+||+.||++|||+.++++.
T Consensus 248 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 248 TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 233455678899999999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=316.64 Aligned_cols=251 Identities=25% Similarity=0.409 Sum_probs=204.2
Q ss_pred ccCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcC-CCCceeEEeccccC------
Q 005247 431 RWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTE------ 501 (706)
Q Consensus 431 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~------ 501 (706)
..+.|++.+.||+|+||.||+|.+..+ .+|+|+..... .....+..|+.+++++ +|+||+++++++..
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 90 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE---DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH 90 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh---HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence 346889999999999999999988654 48999875432 3345678899999998 69999999998853
Q ss_pred CCceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCc
Q 005247 502 PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL 581 (706)
Q Consensus 502 ~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGl 581 (706)
...++++|||+.+|+|.+++.... ...+++..+..++.||+.||.|||+++ |+|+||||+||+++.++.++|+|||+
T Consensus 91 ~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dl~~~nili~~~~~~~l~dfg~ 167 (282)
T cd06636 91 DDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHAHK--VIHRDIKGQNVLLTENAEVKLVDFGV 167 (282)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEeeCcc
Confidence 456899999999999999986432 234778889999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCcccCCCCCCCCCccCccccc-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCC
Q 005247 582 SRSKPNTYISSKTAAGTPEWMAPEVLR-----EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEI 656 (706)
Q Consensus 582 a~~~~~~~~~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~ 656 (706)
+..............|+..|+|||.+. +..++.++||||||+++|||++|..||....+......+.........
T Consensus 168 ~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 247 (282)
T cd06636 168 SAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLK 247 (282)
T ss_pred hhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCc
Confidence 876543333334567899999999986 345788999999999999999999999876655544433222222223
Q ss_pred CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 657 PKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 657 p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
...++.++.+||.+||+.||.+|||+.+|++
T Consensus 248 ~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 248 SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred ccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 4468899999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=309.82 Aligned_cols=249 Identities=30% Similarity=0.507 Sum_probs=208.3
Q ss_pred ceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEEe
Q 005247 434 ELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY 511 (706)
Q Consensus 434 ~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~ 511 (706)
+|++.+.||+|+||.||++.+.. ..+++|++..........+.+.+|+.+++.++|+||+++++++...+.+++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 48899999999999999998754 4599999877665556778899999999999999999999999999999999999
Q ss_pred ccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCccc
Q 005247 512 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS 591 (706)
Q Consensus 512 ~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~ 591 (706)
+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.........
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 81 CSGGTLEELLEHG---RILDEHVIRVYTLQLLEGLAYLHSHG--IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred CCCCcHHHHHhhc---CCCChHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 9999999998743 24788899999999999999999999 999999999999999999999999998775443222
Q ss_pred C----CCCCCCCCccCccccccCC---CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCC--CcH
Q 005247 592 S----KTAAGTPEWMAPEVLREDP---SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKN--VNP 662 (706)
Q Consensus 592 ~----~~~~Gt~~Y~APE~l~~~~---~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~--~s~ 662 (706)
. ....++..|+|||.+.+.. .+.++||||||+++|++++|+.||....................+|.. +++
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSP 235 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCH
Confidence 1 1346788999999998766 789999999999999999999999765332222222122334445544 489
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 663 MVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 663 el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
.+.++|.+||+.+|++||++.+++.
T Consensus 236 ~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 236 EGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred HHHHHHHHHccCCcccCCCHHHHhc
Confidence 9999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=311.48 Aligned_cols=252 Identities=31% Similarity=0.461 Sum_probs=209.2
Q ss_pred CceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEE
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 510 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E 510 (706)
++|++.+.||.|+||+||+|....+ .+++|++....... ..+.+.+|+.+++.++|+||+++++.+...+..+++||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 79 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP 79 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence 3689999999999999999987543 48899876544333 56789999999999999999999999999999999999
Q ss_pred eccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcc
Q 005247 511 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 590 (706)
Q Consensus 511 ~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~ 590 (706)
++.+++|.++++.......+++..+..++.|++.||+|||++| ++||||||+||++++++.++|+|||++........
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~--i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG--QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 9999999999965433345889999999999999999999999 99999999999999999999999999876544322
Q ss_pred c----CCCCCCCCCccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCc-ccCCC---CCCc
Q 005247 591 S----SKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR-RLEIP---KNVN 661 (706)
Q Consensus 591 ~----~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~-~l~~p---~~~s 661 (706)
. .....|+..|+|||.+... .++.++|+||||+++|+|++|+.||...+..+.......... ..... ..++
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYS 237 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCcccccccc
Confidence 1 2344688999999998877 788999999999999999999999987766555444322211 11111 2568
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 662 PMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 662 ~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
+++.+++.+||+.||++||++.+|++
T Consensus 238 ~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 238 KSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 99999999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=320.27 Aligned_cols=259 Identities=34% Similarity=0.569 Sum_probs=213.2
Q ss_pred ccCceEEEEEeccCCceEEEEEEEcCCc------eEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCc
Q 005247 431 RWSELLIKKKIGEGSFGTVYHAEWRNSD------VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN 504 (706)
Q Consensus 431 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~------vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 504 (706)
...+|+..+.||+|+||.||+|.+..++ +|+|.+.... .......+.+|+.+++.++|+||+++++++... .
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~ 82 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-T 82 (303)
T ss_pred chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-C
Confidence 4567889999999999999999874332 5777765433 233345788999999999999999999988754 4
Q ss_pred eEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCcccc
Q 005247 505 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 584 (706)
Q Consensus 505 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~ 584 (706)
.++++||+++|+|.+++.... ..+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++.
T Consensus 83 ~~~v~e~~~~g~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 83 IQLVTQLMPHGCLLDYVHEHK--DNIGSQLLLNWCVQIAKGMMYLEERR--LVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred ceeeehhcCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHhhcC--eeccccccceeeecCCCceEEcccccccc
Confidence 679999999999999986432 24788899999999999999999999 99999999999999999999999999986
Q ss_pred CCCCcc--cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCCCCCc
Q 005247 585 KPNTYI--SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVN 661 (706)
Q Consensus 585 ~~~~~~--~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s 661 (706)
...... ......++..|+|||.+.+..++.++||||||+++|||++ |..||......+....+ .....+..+..++
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~ 237 (303)
T cd05110 159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL-EKGERLPQPPICT 237 (303)
T ss_pred ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HCCCCCCCCCCCC
Confidence 543221 1122345678999999999999999999999999999997 89999877665554444 3444556667788
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhc
Q 005247 662 PMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 696 (706)
Q Consensus 662 ~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~ 696 (706)
..+.++|.+||..+|++||++.++++.|+.+....
T Consensus 238 ~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 238 IDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 99999999999999999999999999999987554
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=311.17 Aligned_cols=249 Identities=28% Similarity=0.485 Sum_probs=206.9
Q ss_pred CceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccc---cchHHHHHHHHHHHHHHcCCCCceeEEeccccCC--Cce
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQE---FHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP--PNL 505 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~---~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~--~~~ 505 (706)
.+|++.+.||+|+||.||++.+..+ .|++|.+.... ......+.+.+|+.+++.++|+||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4789999999999999999987654 49999875432 1234457888999999999999999999988764 457
Q ss_pred EEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccC
Q 005247 506 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK 585 (706)
Q Consensus 506 ~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~ 585 (706)
+++|||+++++|.+++.... .+++..+..++.|++.||+|||+++ ++|+||||+||+++.++.++|+|||+++..
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~ 156 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG---ALTENVTRKYTRQILEGVSYLHSNM--IVHRDIKGANILRDSVGNVKLGDFGASKRL 156 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEecCCCCEEECcCcccccc
Confidence 89999999999999986332 4778889999999999999999999 999999999999999999999999998754
Q ss_pred CCCc---ccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcH
Q 005247 586 PNTY---ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNP 662 (706)
Q Consensus 586 ~~~~---~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~ 662 (706)
.... .......++..|+|||++.+..++.++||||||+++|+|++|+.||....................+|...+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (265)
T cd06652 157 QTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSD 236 (265)
T ss_pred ccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCH
Confidence 3211 1123346888999999998888999999999999999999999999877655555554444445556778889
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 663 MVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 663 el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
.+.++|.+||. +|++||++++|++
T Consensus 237 ~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 237 HCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred HHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 99999999995 9999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=311.83 Aligned_cols=255 Identities=29% Similarity=0.467 Sum_probs=205.6
Q ss_pred ccccCceEEEEEeccCCceEEEEEEEcCCc--eEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceE
Q 005247 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS 506 (706)
Q Consensus 429 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~--vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 506 (706)
++...++.....||+|+||.||+|.+..++ +++|.+.... ....+.+.+|+.+++.++|+||+++++++..++..+
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 344455555678999999999999876544 8888765442 334568889999999999999999999999999999
Q ss_pred EEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECC-CCcEEEeecCccccC
Q 005247 507 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS-TYTVKVCDFGLSRSK 585 (706)
Q Consensus 507 lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~-~~~vKL~DFGla~~~ 585 (706)
+++||+++++|.++++........++..+..++.||+.||+|||+++ |+||||||+||+++. ++.++|+|||++...
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~ 159 (268)
T cd06624 82 IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 159 (268)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence 99999999999999864322212378888899999999999999999 999999999999976 679999999998765
Q ss_pred CCCcccCCCCCCCCCccCccccccCC--CCchhHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHhhhcCcccCCCCCCcH
Q 005247 586 PNTYISSKTAAGTPEWMAPEVLREDP--SNEKSDVFSFGVILWELITLQKPWRNSTPSQ-VISAVGFKGRRLEIPKNVNP 662 (706)
Q Consensus 586 ~~~~~~~~~~~Gt~~Y~APE~l~~~~--~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~-~~~~i~~~~~~l~~p~~~s~ 662 (706)
...........++..|+|||.+.+.. ++.++||||||+++|+|++|..||....... .............++..+++
T Consensus 160 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (268)
T cd06624 160 AGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSA 239 (268)
T ss_pred ccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCH
Confidence 43332333456889999999986643 7889999999999999999999997654322 22222223344557778999
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 663 MVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 663 el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
++.+||.+||+.+|.+|||+.++++
T Consensus 240 ~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 240 EAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred HHHHHHHHHcCCCchhCCCHHHHHh
Confidence 9999999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=318.51 Aligned_cols=251 Identities=29% Similarity=0.509 Sum_probs=211.5
Q ss_pred cCceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEE
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 509 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~ 509 (706)
.++|++.+.||.|+||.||++.+.. ..+++|+.... .....+.+.+|+.++++++|+||+++++++..+...++||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI 81 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence 3568899999999999999998864 44898987543 3445578899999999999999999999999999999999
Q ss_pred EeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCc
Q 005247 510 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 589 (706)
Q Consensus 510 E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 589 (706)
||+++++|.+++.... ..+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (280)
T cd06611 82 EFCDGGALDSIMLELE--RGLTEPQIRYVCRQMLEALNFLHSHK--VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL 157 (280)
T ss_pred eccCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEECCCCCEEEccCccchhhcccc
Confidence 9999999999986432 35889999999999999999999999 9999999999999999999999999987655443
Q ss_pred ccCCCCCCCCCccCccccc-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcC-cccCCCCCCcHH
Q 005247 590 ISSKTAAGTPEWMAPEVLR-----EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG-RRLEIPKNVNPM 663 (706)
Q Consensus 590 ~~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~-~~l~~p~~~s~e 663 (706)
.......++..|+|||.+. ...++.++||||||+++|+|++|+.||......+....+.... ..+..+..++.+
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (280)
T cd06611 158 QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSS 237 (280)
T ss_pred cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHH
Confidence 3334567899999999975 3446789999999999999999999998877666555443222 123456678999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHH
Q 005247 664 VAALIETCWAEEPEIRPSFPSIMET 688 (706)
Q Consensus 664 l~dLI~~cL~~dP~~RPS~~eIl~~ 688 (706)
+.++|.+||+.+|.+||++.++++.
T Consensus 238 ~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 238 FNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred HHHHHHHHhccChhhCcCHHHHhcC
Confidence 9999999999999999999999763
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=358.59 Aligned_cols=258 Identities=24% Similarity=0.397 Sum_probs=208.6
Q ss_pred cccccCceEEEEEeccCCceEEEEEEEcCCc--eEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccC--CC
Q 005247 428 LEIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE--PP 503 (706)
Q Consensus 428 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~--vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~--~~ 503 (706)
.+....+|++++.||+|+||+||+|++..+. +|+|++............+..|+.+++.++||||++++++|.. ..
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~ 87 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ 87 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence 4566779999999999999999999987654 8899887766666667789999999999999999999998854 45
Q ss_pred ceEEEEEeccCCchhhhcccC-CCcccccHHHHHHHHHHHHHHHHHHHhcC-----CCcccccCCCCcEEECC-------
Q 005247 504 NLSIVTEYLSRGSLYKLLHIP-DARVVVDERLRLNMAYDVAKGMNYLHQRR-----PPIVHRDLKSPNLLVDS------- 570 (706)
Q Consensus 504 ~~~lV~E~~~ggsL~~~l~~~-~~~~~l~~~~~~~ia~qIl~aL~yLHs~g-----~~IIHrDLKp~NILl~~------- 570 (706)
.++|||||+.+++|.+++... .....+++..++.|+.||+.||.|||+.+ .+||||||||+||||+.
T Consensus 88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~ 167 (1021)
T PTZ00266 88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK 167 (1021)
T ss_pred EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence 689999999999999998632 22346899999999999999999999843 23999999999999954
Q ss_pred ----------CCcEEEeecCccccCCCCcccCCCCCCCCCccCcccccc--CCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 005247 571 ----------TYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRE--DPSNEKSDVFSFGVILWELITLQKPWRNS 638 (706)
Q Consensus 571 ----------~~~vKL~DFGla~~~~~~~~~~~~~~Gt~~Y~APE~l~~--~~~s~ksDVwSLGviL~ELltG~~Pf~~~ 638 (706)
.+.+||+|||++....... ......||+.|+|||++.+ ..++.++||||||||||||++|..||...
T Consensus 168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s-~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 168 ITAQANNLNGRPIAKIGDFGLSKNIGIES-MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred ccccccccCCCCceEEccCCccccccccc-cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 3359999999998654332 2234579999999999864 45789999999999999999999999765
Q ss_pred ChHHHHHHhhhcCcccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 639 TPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 639 ~~~~~~~~i~~~~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
...............+ .....+.++.+||.+||..+|.+||++.|++.
T Consensus 247 ~~~~qli~~lk~~p~l-pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 247 NNFSQLISELKRGPDL-PIKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CcHHHHHHHHhcCCCC-CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 5433332222222222 22457899999999999999999999999985
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=309.91 Aligned_cols=250 Identities=42% Similarity=0.701 Sum_probs=211.7
Q ss_pred eEEEEEeccCCceEEEEEEEcC------CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEE
Q 005247 435 LLIKKKIGEGSFGTVYHAEWRN------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIV 508 (706)
Q Consensus 435 y~i~~~LG~G~fG~Vy~a~~~~------~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV 508 (706)
+++.+.||.|+||.||++.+.. ..+|+|++.... .....+.+..|+.+++.++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i 79 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA-DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIV 79 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC-ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEE
Confidence 3567899999999999998875 448999885443 223567889999999999999999999999999999999
Q ss_pred EEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCC
Q 005247 509 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 588 (706)
Q Consensus 509 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 588 (706)
|||+++++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 80 ~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~--~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 80 MEYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN--FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred EeccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC--eeecccccceEEEccCCeEEEcccCCceecccc
Confidence 999999999999864322 12789999999999999999999999 999999999999999999999999999766543
Q ss_pred cccCC-CCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHH
Q 005247 589 YISSK-TAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA 666 (706)
Q Consensus 589 ~~~~~-~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~d 666 (706)
..... ...++..|+|||.+.+..++.++||||||+++|+|++ |..||...+.......+. .......+..++.++.+
T Consensus 157 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 235 (258)
T smart00219 157 DYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLK-KGYRLPKPENCPPEIYK 235 (258)
T ss_pred cccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-cCCCCCCCCcCCHHHHH
Confidence 21111 2336789999999988889999999999999999998 789998877766666653 34455667778999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHHH
Q 005247 667 LIETCWAEEPEIRPSFPSIMETL 689 (706)
Q Consensus 667 LI~~cL~~dP~~RPS~~eIl~~L 689 (706)
++.+||+.+|++|||+.++++.|
T Consensus 236 ~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 236 LMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HHHHHCcCChhhCcCHHHHHhhC
Confidence 99999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=320.84 Aligned_cols=248 Identities=24% Similarity=0.411 Sum_probs=204.5
Q ss_pred CceEEEEEeccCCceEEEEEEEcCCc--eEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEE
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 510 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~~~--vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E 510 (706)
++|++.+.||+|+||.||++.+..+. +++|.+... ........+.+|++++++++||||+++++++.+++.+++|||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLE-IKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME 79 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence 36899999999999999999887554 777776543 234455678899999999999999999999999999999999
Q ss_pred eccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHh-cCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCc
Q 005247 511 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ-RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 589 (706)
Q Consensus 511 ~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs-~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 589 (706)
|+++++|.++++.. ..+++..+..++.|++.||.|||+ .+ ++||||||+|||++.++.+||+|||++.......
T Consensus 80 y~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 80 HMDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154 (308)
T ss_pred ccCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhCC--EEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence 99999999998643 357899999999999999999997 57 9999999999999999999999999987654332
Q ss_pred ccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcC------------------
Q 005247 590 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG------------------ 651 (706)
Q Consensus 590 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~------------------ 651 (706)
.....++..|+|||.+.+..++.++||||||+++|+|++|..||...+.......+....
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (308)
T cd06615 155 --ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPD 232 (308)
T ss_pred --cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCC
Confidence 234578999999999988889999999999999999999999997655433332221110
Q ss_pred -----------------cccCCC-CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 005247 652 -----------------RRLEIP-KNVNPMVAALIETCWAEEPEIRPSFPSIMET 688 (706)
Q Consensus 652 -----------------~~l~~p-~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~ 688 (706)
.+...| ..++.++++||.+||..+|++||++.+++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 233 SPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred ccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111111 1367889999999999999999999999874
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=312.97 Aligned_cols=255 Identities=31% Similarity=0.563 Sum_probs=210.5
Q ss_pred eEEEEEeccCCceEEEEEEEc-----CCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCC------
Q 005247 435 LLIKKKIGEGSFGTVYHAEWR-----NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP------ 503 (706)
Q Consensus 435 y~i~~~LG~G~fG~Vy~a~~~-----~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~------ 503 (706)
|++.+.||+|+||.||+|.+. +..+|+|++..........+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567889999999999999764 234999998776666666778999999999999999999999875432
Q ss_pred ceEEEEEeccCCchhhhcccC---CCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecC
Q 005247 504 NLSIVTEYLSRGSLYKLLHIP---DARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFG 580 (706)
Q Consensus 504 ~~~lV~E~~~ggsL~~~l~~~---~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFG 580 (706)
..+++++|+.+|+|.+++... .....+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~nili~~~~~~kl~dfg 158 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN--FIHRDLAARNCMLNENMTVCVADFG 158 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccchhhEEEcCCCCEEECccc
Confidence 247889999999998886421 22234788899999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCc--ccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCC
Q 005247 581 LSRSKPNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIP 657 (706)
Q Consensus 581 la~~~~~~~--~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p 657 (706)
+++...... .......++..|++||.+.+..++.++||||||+++|||++ |..||......+....+. .......+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~ 237 (273)
T cd05074 159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLI-KGNRLKQP 237 (273)
T ss_pred ccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHH-cCCcCCCC
Confidence 988654321 11223345678999999999889999999999999999999 889998777666555543 33445566
Q ss_pred CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 005247 658 KNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQF 692 (706)
Q Consensus 658 ~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~l 692 (706)
...+..+.+++.+||+.+|++||++.++++.|+++
T Consensus 238 ~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 238 PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 67889999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=313.15 Aligned_cols=246 Identities=29% Similarity=0.477 Sum_probs=194.8
Q ss_pred EeccCCceEEEEEEEcCC----ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEEeccCC
Q 005247 440 KIGEGSFGTVYHAEWRNS----DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRG 515 (706)
Q Consensus 440 ~LG~G~fG~Vy~a~~~~~----~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~~~gg 515 (706)
.||+|+||.||+|..... .+++|.+... ........+.+|+.+++.++|+||+++++.+.....+++||||+++|
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRAS-ATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCcc-CChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 589999999999975432 3666665432 23444567889999999999999999999999999999999999999
Q ss_pred chhhhcccCCC--cccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCc--cc
Q 005247 516 SLYKLLHIPDA--RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY--IS 591 (706)
Q Consensus 516 sL~~~l~~~~~--~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~--~~ 591 (706)
+|.+++..... ....++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD--FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC--EecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 99999864322 223567788999999999999999999 9999999999999999999999999986533221 11
Q ss_pred CCCCCCCCCccCcccccc-------CCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCc----ccCCCCC
Q 005247 592 SKTAAGTPEWMAPEVLRE-------DPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGR----RLEIPKN 659 (706)
Q Consensus 592 ~~~~~Gt~~Y~APE~l~~-------~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~----~l~~p~~ 659 (706)
.....++..|+|||++.. ..++.++|||||||++|||++ |..||....+.+....+..... ...++..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLK 238 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCccccc
Confidence 223345678999999743 356789999999999999999 7889987776655544422221 1233456
Q ss_pred CcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 005247 660 VNPMVAALIETCWAEEPEIRPSFPSIMETL 689 (706)
Q Consensus 660 ~s~el~dLI~~cL~~dP~~RPS~~eIl~~L 689 (706)
++..+.+++..|| .||++|||+.+|++.|
T Consensus 239 ~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 239 YSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred CCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 7899999999999 5999999999999886
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=356.14 Aligned_cols=262 Identities=26% Similarity=0.361 Sum_probs=211.6
Q ss_pred CceEEEEEeccCCceEEEEEEEcC--CceEEEEEecccc-chHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEE
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 509 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~ 509 (706)
++|++.+.||+|+||.||+|.+.. ..||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+..+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 579999999999999999998864 4599999865432 2334567999999999999999999999999999999999
Q ss_pred EeccCCchhhhcccCC--------CcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCc
Q 005247 510 EYLSRGSLYKLLHIPD--------ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL 581 (706)
Q Consensus 510 E~~~ggsL~~~l~~~~--------~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGl 581 (706)
||++|++|.+++.... .....+...++.++.||+.||+|||++| |+||||||+||+++.++.+||+|||+
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G--IIHRDLKPeNILLd~dg~vKLiDFGL 159 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG--VLHRDLKPDNILLGLFGEVVILDWGA 159 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchheEEEcCCCCEEEEecCc
Confidence 9999999999885311 1123456678899999999999999999 99999999999999999999999999
Q ss_pred cccCCCC------------------cccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH
Q 005247 582 SRSKPNT------------------YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQV 643 (706)
Q Consensus 582 a~~~~~~------------------~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~ 643 (706)
++..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki 239 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI 239 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence 9765210 0011234699999999999999999999999999999999999999987655443
Q ss_pred HHHhhhcC-cccCCCCCCcHHHHHHHHHhhhhCCCCCC-CHHHHHHHHHHHHHhc
Q 005247 644 ISAVGFKG-RRLEIPKNVNPMVAALIETCWAEEPEIRP-SFPSIMETLQQFLMSS 696 (706)
Q Consensus 644 ~~~i~~~~-~~l~~p~~~s~el~dLI~~cL~~dP~~RP-S~~eIl~~L~~ll~s~ 696 (706)
........ ........+++.+.+++.+||+.||++|| +++++.+.|++++...
T Consensus 240 ~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~ 294 (932)
T PRK13184 240 SYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGS 294 (932)
T ss_pred hhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcC
Confidence 32221111 11112246789999999999999999995 7788888899888754
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=319.73 Aligned_cols=252 Identities=26% Similarity=0.407 Sum_probs=210.2
Q ss_pred CceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccch-HHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEE
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 509 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~-~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~ 509 (706)
.+|++.+.||+|+||.||+|.+.+ ..+|+|.+....... ...+.+.+|+++++.++|+||+++++.+......++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 368999999999999999998865 459999987654443 45567899999999999999999999999999999999
Q ss_pred EeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCc
Q 005247 510 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 589 (706)
Q Consensus 510 E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 589 (706)
||+.+++|.++++... ...+++..+..++.|++.||+|||+.| ++|+||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 81 DYCPGGELFRLLQRQP-GKCLSEEVARFYAAEVLLALEYLHLLG--IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EecCCCCHHHHHHhCC-CCccCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 9999999999986432 245889999999999999999999999 9999999999999999999999999886532211
Q ss_pred -----------------------------ccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh
Q 005247 590 -----------------------------ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTP 640 (706)
Q Consensus 590 -----------------------------~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~ 640 (706)
.......|+..|+|||.+.+..++.++||||||+++|+|++|..||...+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 011234678899999999998899999999999999999999999988777
Q ss_pred HHHHHHhhhcCcccCCCCCCcHHHHHHHHHhhhhCCCCCCC----HHHHHH
Q 005247 641 SQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPS----FPSIME 687 (706)
Q Consensus 641 ~~~~~~i~~~~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS----~~eIl~ 687 (706)
......+.............+.++.++|.+||+.+|++||+ +.+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 238 DETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred HHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 66655543222222222336899999999999999999999 777766
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=317.28 Aligned_cols=255 Identities=32% Similarity=0.513 Sum_probs=206.0
Q ss_pred CceEEEEEeccCCceEEEEEEEc------CCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCC--Cc
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWR------NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP--PN 504 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~------~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~--~~ 504 (706)
..|++++.||+|+||.||+++.. +..+|+|.+... ......+.+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE-SGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcc-ccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 35788999999999999999743 334899987543 2344556899999999999999999999988765 56
Q ss_pred eEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCcccc
Q 005247 505 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 584 (706)
Q Consensus 505 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~ 584 (706)
.++||||+++++|.+++.... ..+++..+..++.|++.||+|||++| ++||||||+||+++.++.+||+|||+++.
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~~i~~aL~~lH~~g--i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNK--NKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred eEEEEEccCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccchheEEEcCCCCEEECCCccccc
Confidence 889999999999999986432 24788999999999999999999999 99999999999999999999999999886
Q ss_pred CCCCcc---cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC---------------hHHHHHH
Q 005247 585 KPNTYI---SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNST---------------PSQVISA 646 (706)
Q Consensus 585 ~~~~~~---~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~---------------~~~~~~~ 646 (706)
...... ......++..|+|||.+.+..++.++||||||+++|||++++.|+.... .......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV 238 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 543221 1223456778999999988889999999999999999999876643211 0111111
Q ss_pred hhhcCcccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 005247 647 VGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 693 (706)
Q Consensus 647 i~~~~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll 693 (706)
.....+.+.+..++..+.+||.+||+.+|++||++.++++.|+.++
T Consensus 239 -~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~ 284 (284)
T cd05079 239 -LEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAIL 284 (284)
T ss_pred -HHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhhC
Confidence 1223345566788999999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=320.21 Aligned_cols=248 Identities=27% Similarity=0.455 Sum_probs=209.2
Q ss_pred cCceEEEEEeccCCceEEEEEEEc--CCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEE
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 509 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~ 509 (706)
..+|++.+.||+|+||.||++.+. +..||+|.+...... ..+.+.+|+.+++.++|+||+++++++...+..++||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 95 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 95 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence 368999999999999999999875 445999988654433 2356889999999999999999999999999999999
Q ss_pred EeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCc
Q 005247 510 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 589 (706)
Q Consensus 510 E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 589 (706)
||+++++|.+++... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 96 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~l~~~L~~LH~~~--i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 96 EYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALDFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred cccCCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence 999999999998532 4788899999999999999999999 9999999999999999999999999987654433
Q ss_pred ccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhc-CcccCCCCCCcHHHHHHH
Q 005247 590 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-GRRLEIPKNVNPMVAALI 668 (706)
Q Consensus 590 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~-~~~l~~p~~~s~el~dLI 668 (706)
.......+++.|+|||.+.+..++.++||||||+++|+|++|..||...++......+... ......+..++..+.+||
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 249 (297)
T cd06656 170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFL 249 (297)
T ss_pred cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHH
Confidence 3334557889999999999988999999999999999999999999876654433222211 222335567889999999
Q ss_pred HHhhhhCCCCCCCHHHHHH
Q 005247 669 ETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 669 ~~cL~~dP~~RPS~~eIl~ 687 (706)
.+||..+|++||++.++++
T Consensus 250 ~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 250 NRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred HHHccCChhhCcCHHHHhc
Confidence 9999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=312.75 Aligned_cols=248 Identities=28% Similarity=0.481 Sum_probs=206.1
Q ss_pred ceEEEEEeccCCceEEEEEEEcC--CceEEEEEecccc---chHHHHHHHHHHHHHHcCCCCceeEEeccccC--CCceE
Q 005247 434 ELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEF---HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE--PPNLS 506 (706)
Q Consensus 434 ~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~---~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~--~~~~~ 506 (706)
+|++.+.||+|+||.||+|.+.. ..|++|++..... .....+.+.+|+.+++.++|+||+++++++.+ ....+
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 68889999999999999998754 4599998764432 22345678899999999999999999998765 35678
Q ss_pred EEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCC
Q 005247 507 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP 586 (706)
Q Consensus 507 lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~ 586 (706)
+++||+++++|.+++.... .+++...+.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++....
T Consensus 83 l~~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~--i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~ 157 (266)
T cd06651 83 IFMEYMPGGSVKDQLKAYG---ALTESVTRKYTRQILEGMSYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 157 (266)
T ss_pred EEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence 9999999999999986432 4788889999999999999999999 9999999999999999999999999987543
Q ss_pred CCc---ccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHH
Q 005247 587 NTY---ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPM 663 (706)
Q Consensus 587 ~~~---~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~e 663 (706)
... .......++..|+|||.+.+..++.++||||||+++|||++|+.||....................++..+++.
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (266)
T cd06651 158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEH 237 (266)
T ss_pred cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHH
Confidence 221 11123458889999999999889999999999999999999999998776555555444444456677788999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 664 VAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 664 l~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
++++| +||..+|++||++++|++
T Consensus 238 ~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 238 ARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred HHHHH-HHhcCChhhCcCHHHHhc
Confidence 99999 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=308.72 Aligned_cols=250 Identities=31% Similarity=0.521 Sum_probs=211.7
Q ss_pred ceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEEe
Q 005247 434 ELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY 511 (706)
Q Consensus 434 ~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~ 511 (706)
+|++.+.||+|+||.||++.++. ..+|+|.+..........+.+.+|+.+++.++|+||+++++.+...+..++++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 58899999999999999998865 4489998866544444556788999999999999999999999999999999999
Q ss_pred ccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCC-cEEEeecCccccCCCCcc
Q 005247 512 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY-TVKVCDFGLSRSKPNTYI 590 (706)
Q Consensus 512 ~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~-~vKL~DFGla~~~~~~~~ 590 (706)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++ .+||+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 81 CDGGDLMKRINRQR-GVLFSEDQILSWFVQISLGLKHIHDRK--ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 99999999886432 234789999999999999999999999 99999999999998875 469999999887654433
Q ss_pred cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHHHH
Q 005247 591 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIET 670 (706)
Q Consensus 591 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI~~ 670 (706)
......|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....+. ......++...+.++.++|.+
T Consensus 158 ~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~ 236 (257)
T cd08225 158 LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKIC-QGYFAPISPNFSRDLRSLISQ 236 (257)
T ss_pred cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh-cccCCCCCCCCCHHHHHHHHH
Confidence 3334568899999999988889999999999999999999999998777666554442 333344566788999999999
Q ss_pred hhhhCCCCCCCHHHHHH
Q 005247 671 CWAEEPEIRPSFPSIME 687 (706)
Q Consensus 671 cL~~dP~~RPS~~eIl~ 687 (706)
||..+|++|||+.++++
T Consensus 237 ~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 237 LFKVSPRDRPSITSILK 253 (257)
T ss_pred HhccChhhCcCHHHHhh
Confidence 99999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=314.14 Aligned_cols=247 Identities=36% Similarity=0.594 Sum_probs=206.1
Q ss_pred EeccCCceEEEEEEEcC--------CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEEe
Q 005247 440 KIGEGSFGTVYHAEWRN--------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY 511 (706)
Q Consensus 440 ~LG~G~fG~Vy~a~~~~--------~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~ 511 (706)
.||+|+||.||+|++.. ..+++|.+.... .......+.+|+.+++.++||||+++++++...+..+++|||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 58999999999998753 237888765432 234456788999999999999999999999999999999999
Q ss_pred ccCCchhhhcccCC----CcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCC-----cEEEeecCcc
Q 005247 512 LSRGSLYKLLHIPD----ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY-----TVKVCDFGLS 582 (706)
Q Consensus 512 ~~ggsL~~~l~~~~----~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~-----~vKL~DFGla 582 (706)
+++++|.++++... ....+.+..+..++.|++.||+|||+.+ ++|+||||+||+++.++ .+||+|||++
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC--cccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 99999999985321 1234678899999999999999999999 99999999999999877 8999999998
Q ss_pred ccCCCCcc--cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCCCC
Q 005247 583 RSKPNTYI--SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKN 659 (706)
Q Consensus 583 ~~~~~~~~--~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p~~ 659 (706)
........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||...+..+....+. ...++..+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~ 237 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVT-AGGRLQKPEN 237 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHh-cCCccCCccc
Confidence 76543221 1123345778999999999999999999999999999998 999998777666655543 3445667778
Q ss_pred CcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 005247 660 VNPMVAALIETCWAEEPEIRPSFPSIMETLQ 690 (706)
Q Consensus 660 ~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~ 690 (706)
++..+.+||.+||..+|.+||++.++++.|+
T Consensus 238 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 238 CPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred chHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 8999999999999999999999999999886
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=342.61 Aligned_cols=249 Identities=28% Similarity=0.518 Sum_probs=218.9
Q ss_pred CceEEEEEeccCCceEEEEEEEcCCc--eEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEE
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 510 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~~~--vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E 510 (706)
+.|+|+..||.|+||+||+|.++.+. .|-|++.-. .++.++.|+-|++||....||+||++++.+.-.+.+||+.|
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk--seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE 109 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK--SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE 109 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc--chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence 45778999999999999999988776 455665333 46778899999999999999999999999999999999999
Q ss_pred eccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcc
Q 005247 511 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 590 (706)
Q Consensus 511 ~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~ 590 (706)
||.||-...++-. ....+.+.++..+++|++.||.|||+++ |||||||..|||++-+|.++|+|||.+........
T Consensus 110 FC~GGAVDaimlE--L~r~LtE~QIqvvc~q~ldALn~LHs~~--iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~q 185 (1187)
T KOG0579|consen 110 FCGGGAVDAIMLE--LGRVLTEDQIQVVCYQVLDALNWLHSQN--IIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQ 185 (1187)
T ss_pred ecCCchHhHHHHH--hccccchHHHHHHHHHHHHHHHHHhhcc--hhhhhccccceEEEecCcEeeecccccccchhHHh
Confidence 9999988776532 2336899999999999999999999999 99999999999999999999999999877666656
Q ss_pred cCCCCCCCCCccCccccc-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCc-ccCCCCCCcHHH
Q 005247 591 SSKTAAGTPEWMAPEVLR-----EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR-RLEIPKNVNPMV 664 (706)
Q Consensus 591 ~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~-~l~~p~~~s~el 664 (706)
...++.|||+|||||+.. ..+|+.++||||||++|.||.-+.+|-...++..++..+..... .+..|..++..+
T Consensus 186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F 265 (1187)
T KOG0579|consen 186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSF 265 (1187)
T ss_pred hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHH
Confidence 667899999999999974 46789999999999999999999999999999888888764443 355678999999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHH
Q 005247 665 AALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 665 ~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
.+|+.+||.+||+.||++.++++
T Consensus 266 ~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 266 SDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred HHHHHHHHhcCCccCCCHHHHhh
Confidence 99999999999999999999876
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=324.02 Aligned_cols=254 Identities=26% Similarity=0.364 Sum_probs=208.1
Q ss_pred cCceEEEEEeccCCceEEEEEEEcCCc--eEEEEEeccccchHHHHHHHHHHHHHHcCCCCc-eeEEeccccCCC-----
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN-IVLLMGAVTEPP----- 503 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~--vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~Hpn-Iv~l~~~~~~~~----- 503 (706)
...|+.+++||+|+||+||+|..+.++ ||+|++.-....+..-....+|+.++++|+|+| |+.+++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 345667788999999999999886554 999998665433333456789999999999999 999999998777
Q ss_pred -ceEEEEEeccCCchhhhcccCCCc-ccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCc
Q 005247 504 -NLSIVTEYLSRGSLYKLLHIPDAR-VVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL 581 (706)
Q Consensus 504 -~~~lV~E~~~ggsL~~~l~~~~~~-~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGl 581 (706)
.+++||||++. +|..++...... ..++...+..++.||+.||+|||+++ |+||||||.||||+++|.+||+|||+
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~--IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG--ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCcceEEECCCCcEeeeccch
Confidence 78999999965 899888643321 24667899999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCcccCCCCCCCCCccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcc-------
Q 005247 582 SRSKPNTYISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR------- 653 (706)
Q Consensus 582 a~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~------- 653 (706)
|+...-+....+...+|..|+|||++.+. .|+..+||||+|||++||++++..|.+....+....|-..-..
T Consensus 167 Ara~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp 246 (323)
T KOG0594|consen 167 ARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWP 246 (323)
T ss_pred HHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCC
Confidence 99776555556677899999999999987 6899999999999999999999999998876665554211110
Q ss_pred ---------cCCC------------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 005247 654 ---------LEIP------------KNVNPMVAALIETCWAEEPEIRPSFPSIMET 688 (706)
Q Consensus 654 ---------l~~p------------~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~ 688 (706)
..++ +..++...+++.+||+.+|.+|.|+..++..
T Consensus 247 ~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 247 GVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 0111 1223578999999999999999999999875
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=311.90 Aligned_cols=252 Identities=29% Similarity=0.454 Sum_probs=206.0
Q ss_pred ccCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcC-CCCceeEEeccccCCC----
Q 005247 431 RWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPP---- 503 (706)
Q Consensus 431 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~---- 503 (706)
..++|++.+.||+|+||.||+|.+..+ .+++|++..... ..+.+.+|+.+++++ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED---EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 357899999999999999999998644 489998765432 335788999999999 6999999999986544
Q ss_pred --ceEEEEEeccCCchhhhcccCC-CcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecC
Q 005247 504 --NLSIVTEYLSRGSLYKLLHIPD-ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFG 580 (706)
Q Consensus 504 --~~~lV~E~~~ggsL~~~l~~~~-~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFG 580 (706)
.+++||||+++++|.++++... ....+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK--VIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEEccCCeEEECCCc
Confidence 4899999999999999886422 2346889999999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCcccCCCCCCCCCccCcccccc-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCc-cc
Q 005247 581 LSRSKPNTYISSKTAAGTPEWMAPEVLRE-----DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR-RL 654 (706)
Q Consensus 581 la~~~~~~~~~~~~~~Gt~~Y~APE~l~~-----~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~-~l 654 (706)
++..............++..|+|||.+.. ..++.++||||||+++|+|++|..||...........+..... ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 238 (275)
T cd06608 159 VSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTL 238 (275)
T ss_pred cceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCC
Confidence 98765544433445678999999998754 3467789999999999999999999987665554444432211 22
Q ss_pred CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 655 EIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 655 ~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
..+..++.++.+||.+||..||++|||+.++++
T Consensus 239 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 239 KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 333457889999999999999999999999875
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=321.84 Aligned_cols=255 Identities=24% Similarity=0.382 Sum_probs=207.5
Q ss_pred CceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccC-----CCce
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE-----PPNL 505 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~-----~~~~ 505 (706)
..|..++.||+|+||.|+.+.+..+ .||+|.+...-...-..+..++|+.+|+.++|+||+.+.+++.. -+..
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv 101 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV 101 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence 3455589999999999999988755 49999886444455667889999999999999999999998865 3458
Q ss_pred EEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccC
Q 005247 506 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK 585 (706)
Q Consensus 506 ~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~ 585 (706)
|+|+|+| +.+|...++.++ .+.+..+..+++||++||+|+|+.+ |+||||||.|+|++.+..+||+|||+|+..
T Consensus 102 YiV~elM-etDL~~iik~~~---~L~d~H~q~f~YQiLrgLKyiHSAn--ViHRDLKPsNll~n~~c~lKI~DFGLAR~~ 175 (359)
T KOG0660|consen 102 YLVFELM-ETDLHQIIKSQQ---DLTDDHAQYFLYQILRGLKYIHSAN--VIHRDLKPSNLLLNADCDLKICDFGLARYL 175 (359)
T ss_pred EEehhHH-hhHHHHHHHcCc---cccHHHHHHHHHHHHHhcchhhccc--ccccccchhheeeccCCCEEeccccceeec
Confidence 9999999 558999997543 4889999999999999999999999 999999999999999999999999999986
Q ss_pred CCC--cccCCCCCCCCCccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhc------------
Q 005247 586 PNT--YISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK------------ 650 (706)
Q Consensus 586 ~~~--~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~------------ 650 (706)
... ....+..+.|.+|+|||++.. ..|+...||||+|||+.||++|++.|.+.+.-+.+..+...
T Consensus 176 ~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i 255 (359)
T KOG0660|consen 176 DKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKI 255 (359)
T ss_pred cccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHh
Confidence 531 223356778999999999865 56899999999999999999999999876554433332110
Q ss_pred ------------CcccC-----CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH--HHHHHH
Q 005247 651 ------------GRRLE-----IPKNVNPMVAALIETCWAEEPEIRPSFPSIME--TLQQFL 693 (706)
Q Consensus 651 ------------~~~l~-----~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~--~L~~ll 693 (706)
..... +-++.++...+|+.+||..||.+|+|++|.++ .|..+.
T Consensus 256 ~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~h 317 (359)
T KOG0660|consen 256 RSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYH 317 (359)
T ss_pred ccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhc
Confidence 00011 11477899999999999999999999999987 444444
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=314.78 Aligned_cols=250 Identities=26% Similarity=0.384 Sum_probs=206.3
Q ss_pred CceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEE
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 510 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E 510 (706)
++|++.+.||+|+||.||+|.+.++ .|++|++..........+.+.+|+++++.++|+||+++++++...+..+++||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 3699999999999999999988643 49999886655445556788999999999999999999999999999999999
Q ss_pred eccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcc
Q 005247 511 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 590 (706)
Q Consensus 511 ~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~ 590 (706)
|+.++.+..+.... ..+++..++.++.||+.||.|||+++ ++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 81 YVERTLLELLEASP---GGLPPDAVRSYIWQLLQAIAYCHSHN--IIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred cCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 99987777665432 24789999999999999999999999 99999999999999999999999999887654432
Q ss_pred -cCCCCCCCCCccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCc----------------
Q 005247 591 -SSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR---------------- 652 (706)
Q Consensus 591 -~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~---------------- 652 (706)
......++..|+|||.+.+. .++.++||||||+++|+|++|+.||......+....+.....
T Consensus 156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07833 156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRF 235 (288)
T ss_pred ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccc
Confidence 23345678899999999888 789999999999999999999999987655443322211000
Q ss_pred ---c-----------cCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 653 ---R-----------LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 653 ---~-----------l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
. ...+..++.++.+||++||..+|++||+++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0 0123345889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=307.97 Aligned_cols=249 Identities=31% Similarity=0.487 Sum_probs=213.2
Q ss_pred CceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEE
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 510 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E 510 (706)
.+|++.+.||+|++|.||+|.+.. ..+++|++...... ...+.+.+|+.++++++|+||+++++++...+..+++||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE 79 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence 368899999999999999998875 44999987655432 456789999999999999999999999999999999999
Q ss_pred eccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHh-cCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCc
Q 005247 511 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ-RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 589 (706)
Q Consensus 511 ~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs-~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 589 (706)
|+++++|.+++... ..+++..++.++.|+++||+|||+ .+ ++||||+|+||+++.++.++|+|||.+.......
T Consensus 80 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~--~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 80 YMDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred ecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC--CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 99999999999643 458899999999999999999999 99 9999999999999999999999999988765443
Q ss_pred ccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHhhhcCcccCCCCC-CcHHHH
Q 005247 590 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNST---PSQVISAVGFKGRRLEIPKN-VNPMVA 665 (706)
Q Consensus 590 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~---~~~~~~~i~~~~~~l~~p~~-~s~el~ 665 (706)
.......++..|+|||.+.+..++.++|+||||+++|+|++|..||.... ..+....+. .......+.. ++..+.
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~ 233 (264)
T cd06623 155 DQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC-DGPPPSLPAEEFSPEFR 233 (264)
T ss_pred CcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh-cCCCCCCCcccCCHHHH
Confidence 33335568899999999999989999999999999999999999997763 334444432 3344455666 899999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHH
Q 005247 666 ALIETCWAEEPEIRPSFPSIMET 688 (706)
Q Consensus 666 dLI~~cL~~dP~~RPS~~eIl~~ 688 (706)
++|.+||..+|++||++.++++.
T Consensus 234 ~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 234 DFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred HHHHHHccCChhhCCCHHHHHhC
Confidence 99999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=329.16 Aligned_cols=246 Identities=24% Similarity=0.304 Sum_probs=196.8
Q ss_pred cccCceEEEEEeccCCceEEEEEEEcC----CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCce
Q 005247 430 IRWSELLIKKKIGEGSFGTVYHAEWRN----SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNL 505 (706)
Q Consensus 430 i~~~~y~i~~~LG~G~fG~Vy~a~~~~----~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 505 (706)
+...+|++++.||+|+||.||++...+ ..+++|.+... +...+|+.+++.++|+||+++++++......
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~ 161 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRWKSTV 161 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEeeCCEE
Confidence 345679999999999999999997643 23788876432 2345899999999999999999999999999
Q ss_pred EEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccC
Q 005247 506 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK 585 (706)
Q Consensus 506 ~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~ 585 (706)
+++||++. ++|.+++.. ...+++..++.++.||+.||.|||++| ||||||||+|||++.++.+||+|||+++..
T Consensus 162 ~lv~e~~~-~~l~~~l~~---~~~l~~~~~~~i~~ql~~aL~~LH~~g--ivHrDlkp~Nill~~~~~~~l~DfG~a~~~ 235 (392)
T PHA03207 162 CMVMPKYK-CDLFTYVDR---SGPLPLEQAITIQRRLLEALAYLHGRG--IIHRDVKTENIFLDEPENAVLGDFGAACKL 235 (392)
T ss_pred EEEehhcC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence 99999985 578887742 235889999999999999999999999 999999999999999999999999999765
Q ss_pred CCCcc--cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHhhh--cCc------
Q 005247 586 PNTYI--SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQ---VISAVGF--KGR------ 652 (706)
Q Consensus 586 ~~~~~--~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~---~~~~i~~--~~~------ 652 (706)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+..... ....+.. ...
T Consensus 236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~ 315 (392)
T PHA03207 236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ 315 (392)
T ss_pred CcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCC
Confidence 43321 1234579999999999999999999999999999999999999997643211 1111100 000
Q ss_pred -----------------c--cCCC-----CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 005247 653 -----------------R--LEIP-----KNVNPMVAALIETCWAEEPEIRPSFPSIMET 688 (706)
Q Consensus 653 -----------------~--l~~p-----~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~ 688 (706)
+ ..++ ..++.++.++|.+||..||++|||+.+++..
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 316 NGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred ccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0 1111 2346788999999999999999999999874
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=318.01 Aligned_cols=246 Identities=30% Similarity=0.518 Sum_probs=207.8
Q ss_pred ceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEEe
Q 005247 434 ELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY 511 (706)
Q Consensus 434 ~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~ 511 (706)
.|+..+.||+|+||.||+|.+..+ .+|+|.+.... .....+.+.+|+.+++.++|+||+++++++..++..++||||
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc-chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 355667899999999999987543 48999875443 234456889999999999999999999999999999999999
Q ss_pred ccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCccc
Q 005247 512 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS 591 (706)
Q Consensus 512 ~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~ 591 (706)
+++++|.+++.. ..+.+..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++.........
T Consensus 84 ~~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06642 84 LGGGSALDLLKP----GPLEETYIATILREILKGLDYLHSER--KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK 157 (277)
T ss_pred cCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcCC--eeccCCChheEEEeCCCCEEEccccccccccCcchh
Confidence 999999998853 24788999999999999999999999 999999999999999999999999998765543333
Q ss_pred CCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHHHHh
Q 005247 592 SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC 671 (706)
Q Consensus 592 ~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI~~c 671 (706)
.....++..|+|||.+.+..++.++||||||+++|||++|..||....+......+. ......++..++.++.++|.+|
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~ 236 (277)
T cd06642 158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIP-KNSPPTLEGQYSKPFKEFVEAC 236 (277)
T ss_pred hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhh-cCCCCCCCcccCHHHHHHHHHH
Confidence 334568899999999999889999999999999999999999998766555444332 2233445567889999999999
Q ss_pred hhhCCCCCCCHHHHHH
Q 005247 672 WAEEPEIRPSFPSIME 687 (706)
Q Consensus 672 L~~dP~~RPS~~eIl~ 687 (706)
|+.+|++||++.+++.
T Consensus 237 l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 237 LNKDPRFRPTAKELLK 252 (277)
T ss_pred ccCCcccCcCHHHHHH
Confidence 9999999999999987
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=315.43 Aligned_cols=250 Identities=26% Similarity=0.395 Sum_probs=204.3
Q ss_pred CceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEE
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 510 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E 510 (706)
++|++.+.||+|+||.||+|.+.+ ..+|+|++..........+.+.+|+++++.++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 368999999999999999999864 459999876554444445678899999999999999999999999999999999
Q ss_pred eccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcc
Q 005247 511 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 590 (706)
Q Consensus 511 ~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~ 590 (706)
|+.+++|..+..... .+++..++.++.||+.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~--i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07846 81 FVDHTVLDDLEKYPN---GLDESRVRKYLFQILRGIEFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 155 (286)
T ss_pred cCCccHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc
Confidence 999999888765332 3789999999999999999999999 99999999999999999999999999886544433
Q ss_pred cCCCCCCCCCccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCc-----------------
Q 005247 591 SSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR----------------- 652 (706)
Q Consensus 591 ~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~----------------- 652 (706)
......++..|+|||.+.+. .++.++||||||+++|||++|..||......+....+.....
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07846 156 VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFA 235 (286)
T ss_pred ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhh
Confidence 33445688999999998764 467899999999999999999999976654333222110000
Q ss_pred --c----------cCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 653 --R----------LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 653 --~----------l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
. ....+.++..+.+||.+||+.+|++||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 236 GMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred ccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0 0112356889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=335.63 Aligned_cols=254 Identities=20% Similarity=0.280 Sum_probs=195.5
Q ss_pred cccccCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCCC------CceeEEeccc
Q 005247 428 LEIRWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRH------PNIVLLMGAV 499 (706)
Q Consensus 428 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~H------pnIv~l~~~~ 499 (706)
+....++|++.+.||+|+||+||+|.+..+ .||||++.... .....+..|+.+++.++| .+++++++++
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 345568899999999999999999988644 49999985432 222345567777766644 4588888888
Q ss_pred cCC-CceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHh-cCCCcccccCCCCcEEECCCC-----
Q 005247 500 TEP-PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ-RRPPIVHRDLKSPNLLVDSTY----- 572 (706)
Q Consensus 500 ~~~-~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs-~g~~IIHrDLKp~NILl~~~~----- 572 (706)
... .++++|||++ +++|.+++... ..+++..+..|+.||+.||+|||+ .| ||||||||+|||++.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~g--IiHrDlKP~NILl~~~~~~~~~ 274 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMKH---GPFSHRHLAQIIFQTGVALDYFHTELH--LMHTDLKPENILMETSDTVVDP 274 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEecCCccccc
Confidence 654 5688999988 66888877533 358899999999999999999998 58 99999999999998765
Q ss_pred -----------cEEEeecCccccCCCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH
Q 005247 573 -----------TVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPS 641 (706)
Q Consensus 573 -----------~vKL~DFGla~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~ 641 (706)
.+||+|||.+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..
T Consensus 275 ~~~~~~~~~~~~vkl~DfG~~~~~~~---~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~ 351 (467)
T PTZ00284 275 VTNRALPPDPCRVRICDLGGCCDERH---SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL 351 (467)
T ss_pred ccccccCCCCceEEECCCCccccCcc---ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 499999998765332 234568999999999999999999999999999999999999999887665
Q ss_pred HHHHHhhhcCccc-------------------------CC-C--------------CCCcHHHHHHHHHhhhhCCCCCCC
Q 005247 642 QVISAVGFKGRRL-------------------------EI-P--------------KNVNPMVAALIETCWAEEPEIRPS 681 (706)
Q Consensus 642 ~~~~~i~~~~~~l-------------------------~~-p--------------~~~s~el~dLI~~cL~~dP~~RPS 681 (706)
+....+.....++ .. + ...++.+.+||.+||+.||++|||
T Consensus 352 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t 431 (467)
T PTZ00284 352 EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLN 431 (467)
T ss_pred HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCC
Confidence 4433321110000 00 0 011456789999999999999999
Q ss_pred HHHHHH--HHHHHH
Q 005247 682 FPSIME--TLQQFL 693 (706)
Q Consensus 682 ~~eIl~--~L~~ll 693 (706)
++|+++ .+++..
T Consensus 432 a~e~L~Hp~~~~~~ 445 (467)
T PTZ00284 432 ARQMTTHPYVLKYY 445 (467)
T ss_pred HHHHhcCccccccC
Confidence 999987 555443
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=311.75 Aligned_cols=247 Identities=29% Similarity=0.439 Sum_probs=195.3
Q ss_pred EeccCCceEEEEEEEcCC----ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEEeccCC
Q 005247 440 KIGEGSFGTVYHAEWRNS----DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRG 515 (706)
Q Consensus 440 ~LG~G~fG~Vy~a~~~~~----~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~~~gg 515 (706)
.||+|+||.||+|...+. .+++|.+..... ......+.+|+.+++.++||||+++++++.+....++||||+++|
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 689999999999976532 378887755432 233457889999999999999999999999999999999999999
Q ss_pred chhhhcccCC--CcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcc--c
Q 005247 516 SLYKLLHIPD--ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI--S 591 (706)
Q Consensus 516 sL~~~l~~~~--~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~--~ 591 (706)
+|.++++... .....++..+..++.|++.||+|||+.+ ++||||||+||+++.++++||+|||++........ .
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN--FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 9999986422 1224566778889999999999999999 99999999999999999999999999876443321 1
Q ss_pred CCCCCCCCCccCccccccC-------CCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhc-Cccc---CCCCC
Q 005247 592 SKTAAGTPEWMAPEVLRED-------PSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFK-GRRL---EIPKN 659 (706)
Q Consensus 592 ~~~~~Gt~~Y~APE~l~~~-------~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~-~~~l---~~p~~ 659 (706)
.....++..|+|||++.+. .++.++||||||+++|||++ |..||......+........ ..+. .+...
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLP 238 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCC
Confidence 2234577889999998643 35789999999999999996 99999877665554332211 1111 22234
Q ss_pred CcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 005247 660 VNPMVAALIETCWAEEPEIRPSFPSIMETLQ 690 (706)
Q Consensus 660 ~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~ 690 (706)
.++.+.++|.+|| .+|++|||+++|+..|.
T Consensus 239 ~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 239 LSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 6788999999999 68999999999998764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=338.87 Aligned_cols=245 Identities=27% Similarity=0.346 Sum_probs=205.6
Q ss_pred CceEEEEEeccCCceEEEEEEEcCCc--eEEEEEeccccchHHHHHHHHHHHHHHcCC-C-----CceeEEeccccCCCc
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLR-H-----PNIVLLMGAVTEPPN 504 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~~~--vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~-H-----pnIv~l~~~~~~~~~ 504 (706)
.+|++.+.||+|.||.|.+|.+.+++ ||||+++.. .....+...|+.+|..|+ | -|||+++++|...++
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~---k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK---KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC---hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 38999999999999999999987665 999998764 345567778999999996 4 389999999999999
Q ss_pred eEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCC--CcEEEeecCcc
Q 005247 505 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST--YTVKVCDFGLS 582 (706)
Q Consensus 505 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~--~~vKL~DFGla 582 (706)
.|||+|.+.. +|+++++.++-. .++...++.|+.||+.||.+||+.+ |||+||||+||||... ..|||+|||.|
T Consensus 263 lciVfELL~~-NLYellK~n~f~-Glsl~~ir~~~~Qil~~L~~L~~l~--IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 263 LCIVFELLST-NLYELLKNNKFR-GLSLPLVRKFAQQILTALLFLHELG--IIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred eeeeehhhhh-hHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCChhheeeccCCcCceeEEecccc
Confidence 9999999954 999999866544 4889999999999999999999999 9999999999999653 37999999999
Q ss_pred ccCCCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhc-Cc---------
Q 005247 583 RSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-GR--------- 652 (706)
Q Consensus 583 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~-~~--------- 652 (706)
+...... .+.+.+..|+|||++.|.+|+.+.||||||||+.||++|.+.|.+.+..+.+..|... +.
T Consensus 339 c~~~q~v---ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~ 415 (586)
T KOG0667|consen 339 CFESQRV---YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTA 415 (586)
T ss_pred cccCCcc---eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 9877654 2778899999999999999999999999999999999998889888776665444200 00
Q ss_pred ----------------------------------------ccCCCC-----------CCcHHHHHHHHHhhhhCCCCCCC
Q 005247 653 ----------------------------------------RLEIPK-----------NVNPMVAALIETCWAEEPEIRPS 681 (706)
Q Consensus 653 ----------------------------------------~l~~p~-----------~~s~el~dLI~~cL~~dP~~RPS 681 (706)
....|. .-...+.+||.+||..||.+|+|
T Consensus 416 ~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t 495 (586)
T KOG0667|consen 416 KKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT 495 (586)
T ss_pred cccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC
Confidence 000110 11246899999999999999999
Q ss_pred HHHHHH
Q 005247 682 FPSIME 687 (706)
Q Consensus 682 ~~eIl~ 687 (706)
..|.++
T Consensus 496 p~qal~ 501 (586)
T KOG0667|consen 496 PAQALN 501 (586)
T ss_pred HHHHhc
Confidence 999987
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=312.27 Aligned_cols=245 Identities=25% Similarity=0.394 Sum_probs=210.3
Q ss_pred ceEEEEEeccCCceEEEEEEEc--CCceEEEEEeccccch-HHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEE
Q 005247 434 ELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 510 (706)
Q Consensus 434 ~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKvl~~~~~~~-~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E 510 (706)
+|++.+.||.|+||.||+|.+. +..+++|++....... ...+.+.+|++++++++||||+++++++.++...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4889999999999999999886 4459999987654332 456789999999999999999999999999999999999
Q ss_pred eccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcc
Q 005247 511 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 590 (706)
Q Consensus 511 ~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~ 590 (706)
|+.+++|.+++... ..+++..+..++.||++||.|||+++ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 154 (258)
T cd05578 81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG--IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT- 154 (258)
T ss_pred CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence 99999999998643 35889999999999999999999999 9999999999999999999999999988755432
Q ss_pred cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHhhhcCcccCCCCCCcHHHHHH
Q 005247 591 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTP---SQVISAVGFKGRRLEIPKNVNPMVAAL 667 (706)
Q Consensus 591 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~---~~~~~~i~~~~~~l~~p~~~s~el~dL 667 (706)
......|+..|+|||.+.+..++.++|+||||+++|+|++|..||..... ....... ......++..++..+.++
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 232 (258)
T cd05578 155 LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQ--ETADVLYPATWSTEAIDA 232 (258)
T ss_pred cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHh--ccccccCcccCcHHHHHH
Confidence 22345688899999999988899999999999999999999999987763 3332222 225566778899999999
Q ss_pred HHHhhhhCCCCCCCH--HHHH
Q 005247 668 IETCWAEEPEIRPSF--PSIM 686 (706)
Q Consensus 668 I~~cL~~dP~~RPS~--~eIl 686 (706)
|.+||+.||.+||++ .+++
T Consensus 233 i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 233 INKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred HHHHccCChhHcCCccHHHHh
Confidence 999999999999999 5544
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=323.84 Aligned_cols=253 Identities=23% Similarity=0.333 Sum_probs=199.3
Q ss_pred EEEEeccC--CceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEEec
Q 005247 437 IKKKIGEG--SFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYL 512 (706)
Q Consensus 437 i~~~LG~G--~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~~ 512 (706)
++++||+| +|++||++.+..+ .||+|++..........+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 46789999 7899999987654 4999998766555555667888999999999999999999999999999999999
Q ss_pred cCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcc--
Q 005247 513 SRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI-- 590 (706)
Q Consensus 513 ~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~-- 590 (706)
++|+|.+++.... ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++.++|+||+.+........
T Consensus 82 ~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 9999999985432 224788999999999999999999999 99999999999999999999999986543221110
Q ss_pred -----cCCCCCCCCCccCcccccc--CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcc----------
Q 005247 591 -----SSKTAAGTPEWMAPEVLRE--DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR---------- 653 (706)
Q Consensus 591 -----~~~~~~Gt~~Y~APE~l~~--~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~---------- 653 (706)
......++..|+|||++.+ ..++.++|||||||++|||++|..||..................
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPA 238 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhh
Confidence 1122346778999999976 45889999999999999999999999765543332221110000
Q ss_pred ----------------------------------cCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH--HHHHH
Q 005247 654 ----------------------------------LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME--TLQQF 692 (706)
Q Consensus 654 ----------------------------------l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~--~L~~l 692 (706)
.+....+++++.+||.+||+.||++|||++++++ .++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~ 313 (327)
T cd08227 239 EELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 313 (327)
T ss_pred hhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence 0111235678999999999999999999999987 45443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=334.77 Aligned_cols=256 Identities=24% Similarity=0.368 Sum_probs=212.9
Q ss_pred cCcccccCceEEEEEeccCCceEEEEEEEcCCc-eEEEEEeccccchHHHHHHHHHHHHHHcCC-CCceeEEeccccCCC
Q 005247 426 EGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD-VAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGAVTEPP 503 (706)
Q Consensus 426 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~-vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~ 503 (706)
+.+.++...|+++++||.||.+.||++...+.. ||+|.+.....+...+..|.+|+..|.+|+ |.+|+++|+|-..++
T Consensus 354 ~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~ 433 (677)
T KOG0596|consen 354 EIIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDG 433 (677)
T ss_pred eeEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCc
Confidence 446778889999999999999999999876544 888888777888888999999999999995 999999999999999
Q ss_pred ceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccc
Q 005247 504 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 583 (706)
Q Consensus 504 ~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~ 583 (706)
.+|||||+- ..+|..+|+..... ++.-.+..+..|++.|+.++|++| |||.||||.|+|+- .|.+||+|||+|.
T Consensus 434 ~lYmvmE~G-d~DL~kiL~k~~~~--~~~~~lk~ywkqML~aV~~IH~~g--IVHSDLKPANFLlV-kG~LKLIDFGIA~ 507 (677)
T KOG0596|consen 434 YLYMVMECG-DIDLNKILKKKKSI--DPDWFLKFYWKQMLLAVKTIHQHG--IVHSDLKPANFLLV-KGRLKLIDFGIAN 507 (677)
T ss_pred eEEEEeecc-cccHHHHHHhccCC--CchHHHHHHHHHHHHHHHHHHHhc--eeecCCCcccEEEE-eeeEEeeeechhc
Confidence 999999976 45999999754432 332377889999999999999999 99999999999995 4689999999998
Q ss_pred cCCCC--cccCCCCCCCCCccCccccccCC-----------CCchhHHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHhhh
Q 005247 584 SKPNT--YISSKTAAGTPEWMAPEVLREDP-----------SNEKSDVFSFGVILWELITLQKPWRNST-PSQVISAVGF 649 (706)
Q Consensus 584 ~~~~~--~~~~~~~~Gt~~Y~APE~l~~~~-----------~s~ksDVwSLGviL~ELltG~~Pf~~~~-~~~~~~~i~~ 649 (706)
..... .+...+.+||+.||+||.+.... .++++||||||||||+|++|+.||.... ....+.++..
T Consensus 508 aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~ 587 (677)
T KOG0596|consen 508 AIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITD 587 (677)
T ss_pred ccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcC
Confidence 76543 33456789999999999986433 3578999999999999999999998754 3334444544
Q ss_pred cCcccCCCCCCcHH-HHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 650 KGRRLEIPKNVNPM-VAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 650 ~~~~l~~p~~~s~e-l~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
-...+++|..-+.. +.++|+.||.+||.+||+..+++.
T Consensus 588 P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 588 PNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred CCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 44566777665544 999999999999999999999876
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=313.68 Aligned_cols=250 Identities=25% Similarity=0.364 Sum_probs=202.6
Q ss_pred ceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEEe
Q 005247 434 ELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY 511 (706)
Q Consensus 434 ~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~ 511 (706)
+|++++.||.|+||.||+|.+.. ..+++|.+............+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 48899999999999999998864 4599998765544444446788999999999999999999999999999999999
Q ss_pred ccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCccc
Q 005247 512 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS 591 (706)
Q Consensus 512 ~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~ 591 (706)
+. ++|..++.... ...+++..++.++.|++.||+|||+++ ++||||+|+||+++.++.+||+|||++.........
T Consensus 81 ~~-~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 156 (284)
T cd07860 81 LH-QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 156 (284)
T ss_pred cc-cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEeeccchhhcccCccc
Confidence 96 57888875432 235889999999999999999999999 999999999999999999999999998765443333
Q ss_pred CCCCCCCCCccCccccccCC-CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhc-Cc-----------------
Q 005247 592 SKTAAGTPEWMAPEVLREDP-SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-GR----------------- 652 (706)
Q Consensus 592 ~~~~~Gt~~Y~APE~l~~~~-~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~-~~----------------- 652 (706)
.....++..|+|||.+.+.. ++.++||||||+++|||+||+.||...+.......+... ..
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07860 157 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKP 236 (284)
T ss_pred cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHh
Confidence 34456788999999987654 588999999999999999999999876654333221100 00
Q ss_pred ---------ccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 653 ---------RLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 653 ---------~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
...+...++++++++|.+||+.||.+|||++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 237 SFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred hcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 00112356789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=316.74 Aligned_cols=254 Identities=26% Similarity=0.377 Sum_probs=209.3
Q ss_pred CceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEE
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFH-EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 509 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~ 509 (706)
.+|++.+.||+|+||.||++.+..+ .|++|.+...... ....+.+.+|+.+++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 3689999999999999999988754 4999988665432 234567889999999999999999999999999999999
Q ss_pred EeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCc
Q 005247 510 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 589 (706)
Q Consensus 510 E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 589 (706)
||+++++|.+++... ..+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||+++......
T Consensus 81 e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 81 EYVEGGDCATLLKNI---GALPVDMARMYFAETVLALEYLHNYG--IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred ecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence 999999999998643 35888999999999999999999999 9999999999999999999999999886421100
Q ss_pred ---------------ccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcc-
Q 005247 590 ---------------ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR- 653 (706)
Q Consensus 590 ---------------~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~- 653 (706)
.......++..|+|||.+.+..++.++|+||||+++|||++|..||.+....+....+......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 235 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEW 235 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCC
Confidence 0111245788999999999888999999999999999999999999888777666655333222
Q ss_pred cCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 005247 654 LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 691 (706)
Q Consensus 654 l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ 691 (706)
+..+..++.++.+||.+||+.+|++||++.++.+.|+.
T Consensus 236 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 236 PEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred CCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 22223678999999999999999999997666665544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=313.20 Aligned_cols=256 Identities=33% Similarity=0.534 Sum_probs=209.0
Q ss_pred cCceEEEEEeccCCceEEEEEEEc------CCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccC--CC
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWR------NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE--PP 503 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~------~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~--~~ 503 (706)
...|++.+.||+|+||.||++.+. +..+|+|++...... ...+.+.+|+++++.++|+||+++++++.. ..
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence 356788899999999999999864 234999998655433 456789999999999999999999998877 55
Q ss_pred ceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccc
Q 005247 504 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 583 (706)
Q Consensus 504 ~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~ 583 (706)
..+++|||+++++|.+++.... ..+++..+..++.|++.||+|||++| ++|+||||+||+++.++.++|+|||.+.
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHR--DQINLKRLLLFSSQICKGMDYLGSQR--YIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCc--cccCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCCCCEEEccccccc
Confidence 7899999999999999996433 24889999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCccc---CCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH--------------HHHH
Q 005247 584 SKPNTYIS---SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQ--------------VISA 646 (706)
Q Consensus 584 ~~~~~~~~---~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~--------------~~~~ 646 (706)
........ .....++..|+|||.+.+..++.++||||||+++|||++|..||....... ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE 237 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence 76532211 112345567999999988889999999999999999999999986532211 1111
Q ss_pred hhhcCcccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 005247 647 VGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQF 692 (706)
Q Consensus 647 i~~~~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~l 692 (706)
......+...+..++.++.+|+.+||+.+|++||++.+|++.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 238 LLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 1122334445667889999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=329.12 Aligned_cols=261 Identities=35% Similarity=0.542 Sum_probs=222.8
Q ss_pred ccccCceEEEEEeccCCceEEEEEEEcC-CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEE
Q 005247 429 EIRWSELLIKKKIGEGSFGTVYHAEWRN-SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI 507 (706)
Q Consensus 429 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l 507 (706)
++..+.+.++++||+|.||.|.+++..+ ..||||+++... .....++|..|+.+|.+|+||||++++++|..++.+++
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a-~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicm 612 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDA-TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCM 612 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEecCceEEEEeecCccc-chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHH
Confidence 5667788999999999999999998877 679999986554 34446899999999999999999999999999999999
Q ss_pred EEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCC
Q 005247 508 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 587 (706)
Q Consensus 508 V~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 587 (706)
++||+++|+|.+++....... +.-.....|+.||+.|++||.+.+ +|||||.+.|||+++++++||+|||.++....
T Consensus 613 I~EYmEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~n--fVHrd~a~rNcLv~~e~~iKiadfgmsR~lys 689 (807)
T KOG1094|consen 613 ITEYMENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLN--FVHRDLATRNCLVDGEFTIKIADFGMSRNLYS 689 (807)
T ss_pred HHHHHhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhc--hhhccccccceeecCcccEEecCccccccccc
Confidence 999999999999997654432 344556679999999999999999 99999999999999999999999999996544
Q ss_pred Cccc--CCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh--CCCCCCCCChHHHHHHhhhc------CcccCCC
Q 005247 588 TYIS--SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT--LQKPWRNSTPSQVISAVGFK------GRRLEIP 657 (706)
Q Consensus 588 ~~~~--~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt--G~~Pf~~~~~~~~~~~i~~~------~~~l~~p 657 (706)
.... .....-..+|||||.+..+++++++|||+||+++||+++ ...||...+.++++...... ..-+..|
T Consensus 690 g~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P 769 (807)
T KOG1094|consen 690 GDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRP 769 (807)
T ss_pred CCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCC
Confidence 3222 234456789999999999999999999999999999875 68999998888777554311 1125567
Q ss_pred CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 005247 658 KNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 693 (706)
Q Consensus 658 ~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll 693 (706)
..|+..+.++|.+||..+-++||+++++...|++..
T Consensus 770 ~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 770 PACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred CcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 889999999999999999999999999999998753
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=311.52 Aligned_cols=249 Identities=25% Similarity=0.343 Sum_probs=205.6
Q ss_pred ceEEEEEeccCCceEEEEEEEc--CCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEEe
Q 005247 434 ELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY 511 (706)
Q Consensus 434 ~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~ 511 (706)
+|++.+.||+|+||.||+|.+. ++.+++|++..........+.+.+|+.++++++|+||+++++++......++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 5889999999999999999875 44599999877655455567899999999999999999999999999999999999
Q ss_pred ccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcc-
Q 005247 512 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI- 590 (706)
Q Consensus 512 ~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~- 590 (706)
+ +++|.+++.... ..+++..++.++.||+.||+|||+++ ++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 155 (286)
T cd07832 81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG--IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR 155 (286)
T ss_pred c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC
Confidence 9 999999986433 35889999999999999999999999 99999999999999999999999999887654321
Q ss_pred cCCCCCCCCCccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcc----------------
Q 005247 591 SSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR---------------- 653 (706)
Q Consensus 591 ~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~---------------- 653 (706)
......++..|+|||.+.+. .++.++||||||+++|||++|..||...........+......
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYN 235 (286)
T ss_pred ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhh
Confidence 12345689999999998754 4688999999999999999998888776654443332110000
Q ss_pred ------------cCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 654 ------------LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 654 ------------l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
....+..+..+.+||.+||..+|++||+++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 236 KITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred cccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 0111356789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=302.46 Aligned_cols=249 Identities=33% Similarity=0.556 Sum_probs=214.9
Q ss_pred ceEEEEEeccCCceEEEEEEEc--CCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCC--CceEEEE
Q 005247 434 ELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP--PNLSIVT 509 (706)
Q Consensus 434 ~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~--~~~~lV~ 509 (706)
+|++.+.||+|++|.||+|.+. +..+++|+...........+.+.+|+.++++++|+||+++++.+... ..+++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4788899999999999999987 44599999876655556678899999999999999999999999888 8899999
Q ss_pred EeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCc
Q 005247 510 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 589 (706)
Q Consensus 510 E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 589 (706)
||+.+++|.+++.... .+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~--~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 81 EYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSNG--IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred EecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence 9999999999986433 6889999999999999999999999 9999999999999999999999999988765543
Q ss_pred c--cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHhhhcCcccCCCCCCcHHHHH
Q 005247 590 I--SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNST-PSQVISAVGFKGRRLEIPKNVNPMVAA 666 (706)
Q Consensus 590 ~--~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~-~~~~~~~i~~~~~~l~~p~~~s~el~d 666 (706)
. ......++..|+|||.+.+...+.++||||||+++|+|++|..||.... .......+........++..++..+.+
T Consensus 156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (260)
T cd06606 156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKD 235 (260)
T ss_pred ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHH
Confidence 2 1345678899999999988889999999999999999999999998765 333333333334556677888999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHH
Q 005247 667 LIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 667 LI~~cL~~dP~~RPS~~eIl~ 687 (706)
+|.+||+.+|++||++.+++.
T Consensus 236 ~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 236 FLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred HHHHhCcCChhhCCCHHHHhh
Confidence 999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=310.18 Aligned_cols=254 Identities=27% Similarity=0.455 Sum_probs=209.6
Q ss_pred ceEEEEEeccCCceEEEEEEEcC---CceEEEEEeccc--------cchHHHHHHHHHHHHHHc-CCCCceeEEeccccC
Q 005247 434 ELLIKKKIGEGSFGTVYHAEWRN---SDVAVKILIEQE--------FHEDRFKEFLREVAIMKG-LRHPNIVLLMGAVTE 501 (706)
Q Consensus 434 ~y~i~~~LG~G~fG~Vy~a~~~~---~~vAVKvl~~~~--------~~~~~~~~~~~Ei~iL~~-L~HpnIv~l~~~~~~ 501 (706)
.|++.+.||+|+||.||++.+.. ..+|+|.+.... ........+.+|+.++.+ ++|+||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788999999999999998865 348999875432 223445667889988875 789999999999999
Q ss_pred CCceEEEEEeccCCchhhhccc-CCCcccccHHHHHHHHHHHHHHHHHHHh-cCCCcccccCCCCcEEECCCCcEEEeec
Q 005247 502 PPNLSIVTEYLSRGSLYKLLHI-PDARVVVDERLRLNMAYDVAKGMNYLHQ-RRPPIVHRDLKSPNLLVDSTYTVKVCDF 579 (706)
Q Consensus 502 ~~~~~lV~E~~~ggsL~~~l~~-~~~~~~l~~~~~~~ia~qIl~aL~yLHs-~g~~IIHrDLKp~NILl~~~~~vKL~DF 579 (706)
.+..+++|||+++++|.+++.. ......+++..++.++.|++.||.|||+ .+ ++|+||||+||+++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~--i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc--eeecCCCHHHEEECCCCcEEEecc
Confidence 9999999999999999988742 1223458899999999999999999996 67 999999999999999999999999
Q ss_pred CccccCCCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCC
Q 005247 580 GLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKN 659 (706)
Q Consensus 580 Gla~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~ 659 (706)
|.+....... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||...........+............
T Consensus 159 g~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (269)
T cd08528 159 GLAKQKQPES-KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGM 237 (269)
T ss_pred cceeeccccc-ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCccc
Confidence 9987655433 234556889999999999888999999999999999999999999887766555554322222222236
Q ss_pred CcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 005247 660 VNPMVAALIETCWAEEPEIRPSFPSIMETLQ 690 (706)
Q Consensus 660 ~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~ 690 (706)
+++++.++|.+||+.||++||++.++...+.
T Consensus 238 ~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 238 YSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred CCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 7899999999999999999999999998874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=308.83 Aligned_cols=236 Identities=26% Similarity=0.464 Sum_probs=192.8
Q ss_pred EEeccCCceEEEEEEEcCCc------------eEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceE
Q 005247 439 KKIGEGSFGTVYHAEWRNSD------------VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS 506 (706)
Q Consensus 439 ~~LG~G~fG~Vy~a~~~~~~------------vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 506 (706)
+.||+|+||.||+|.+.++. +++|++..... ....+.+|+.+++.++|+||+++++++.. ...+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 76 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR---DSLAFFETASLMSQLSHKHLVKLYGVCVR-DENI 76 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh---hHHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence 46899999999999886544 56666543321 15688899999999999999999999887 7789
Q ss_pred EEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCC-------cEEEeec
Q 005247 507 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY-------TVKVCDF 579 (706)
Q Consensus 507 lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~-------~vKL~DF 579 (706)
+||||+++|+|.+++..... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+||
T Consensus 77 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df 152 (259)
T cd05037 77 MVEEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDKK--LVHGNVCGKNILVARYGLNEGYVPFIKLSDP 152 (259)
T ss_pred EEEEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCC--eecccCccceEEEecCccccCCceeEEeCCC
Confidence 99999999999999874332 5788899999999999999999999 99999999999999887 7999999
Q ss_pred CccccCCCCcccCCCCCCCCCccCccccccC--CCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCC
Q 005247 580 GLSRSKPNTYISSKTAAGTPEWMAPEVLRED--PSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEI 656 (706)
Q Consensus 580 Gla~~~~~~~~~~~~~~Gt~~Y~APE~l~~~--~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~ 656 (706)
|++..... .....++..|+|||.+.+. .++.++||||||+++|+|++ |..||......+...... ... ..
T Consensus 153 g~a~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-~~~--~~ 225 (259)
T cd05037 153 GIPITVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-DQH--RL 225 (259)
T ss_pred Cccccccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-cCC--CC
Confidence 99886543 2234567789999999877 78999999999999999999 588887765443333221 122 22
Q ss_pred CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 005247 657 PKNVNPMVAALIETCWAEEPEIRPSFPSIMETL 689 (706)
Q Consensus 657 p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L 689 (706)
+......+.++|.+||..+|++|||+.++++.|
T Consensus 226 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 226 PMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred CCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 222348999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=303.80 Aligned_cols=251 Identities=32% Similarity=0.519 Sum_probs=218.3
Q ss_pred ceEEEEEeccCCceEEEEEEEc--CCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEEe
Q 005247 434 ELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY 511 (706)
Q Consensus 434 ~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~ 511 (706)
+|.+.+.||.|+||.||++.+. +..+++|++..........+.+.+|+++++.++|+|++++.+.+......++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5889999999999999999987 45599999877666566677899999999999999999999999999999999999
Q ss_pred ccCCchhhhcccCC-CcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcc
Q 005247 512 LSRGSLYKLLHIPD-ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 590 (706)
Q Consensus 512 ~~ggsL~~~l~~~~-~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~ 590 (706)
+++++|.+++.... ....+++..+..++.+++.||.|||++| ++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 158 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK--ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD 158 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHHeEEcCCCcEEECCccceeecccCcc
Confidence 99999999986431 1246889999999999999999999999 99999999999999999999999999987655432
Q ss_pred cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHHHH
Q 005247 591 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIET 670 (706)
Q Consensus 591 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI~~ 670 (706)
......|++.|+|||.+.+..++.++|+||+|+++|+|++|..||......+...... ......++..++..+.++|.+
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~ 237 (258)
T cd08215 159 LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKIL-KGQYPPIPSQYSSELRNLVSS 237 (258)
T ss_pred eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHh-cCCCCCCCCCCCHHHHHHHHH
Confidence 3344578899999999998889999999999999999999999998877666665553 334455667889999999999
Q ss_pred hhhhCCCCCCCHHHHHH
Q 005247 671 CWAEEPEIRPSFPSIME 687 (706)
Q Consensus 671 cL~~dP~~RPS~~eIl~ 687 (706)
||..+|++|||+.++++
T Consensus 238 ~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 238 LLQKDPEERPSIAQILQ 254 (258)
T ss_pred HcCCChhhCcCHHHHhc
Confidence 99999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=340.61 Aligned_cols=245 Identities=30% Similarity=0.494 Sum_probs=209.8
Q ss_pred EEeccCCceEEEEEEEcCCc--eEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEEeccCCc
Q 005247 439 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGS 516 (706)
Q Consensus 439 ~~LG~G~fG~Vy~a~~~~~~--vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~~~ggs 516 (706)
-+||+|.||+||.|++..++ .|||.+... +....+-+.+|+.+.++|+|.|||+++|.+.+++.+-|.||.++||+
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpek--dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEK--DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccc--cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 37999999999999998887 466655433 34445678899999999999999999999999999999999999999
Q ss_pred hhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEEC-CCCcEEEeecCccccCCCCcccCCCC
Q 005247 517 LYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVD-STYTVKVCDFGLSRSKPNTYISSKTA 595 (706)
Q Consensus 517 L~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~-~~~~vKL~DFGla~~~~~~~~~~~~~ 595 (706)
|.++++..=....-.+..+..+.+||++||.|||++. |||||||-+|||++ -.|.+||+|||-++....-..-..++
T Consensus 659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~--IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETF 736 (1226)
T KOG4279|consen 659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK--IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETF 736 (1226)
T ss_pred HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc--eeeccccCCcEEEeeccceEEecccccchhhccCCcccccc
Confidence 9999974322212267888889999999999999999 99999999999996 47899999999988765544455688
Q ss_pred CCCCCccCccccccC--CCCchhHHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHhhhcCcccCCCCCCcHHHHHHHHHhh
Q 005247 596 AGTPEWMAPEVLRED--PSNEKSDVFSFGVILWELITLQKPWRNS-TPSQVISAVGFKGRRLEIPKNVNPMVAALIETCW 672 (706)
Q Consensus 596 ~Gt~~Y~APE~l~~~--~~s~ksDVwSLGviL~ELltG~~Pf~~~-~~~~~~~~i~~~~~~l~~p~~~s~el~dLI~~cL 672 (706)
.||..|||||++..+ .|..++|||||||++.||.||++||... +++....++.+-..-+++|+.++.+.++||.+|+
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcF 816 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCF 816 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHc
Confidence 999999999999765 5889999999999999999999999764 4555556666666778899999999999999999
Q ss_pred hhCCCCCCCHHHHHH
Q 005247 673 AEEPEIRPSFPSIME 687 (706)
Q Consensus 673 ~~dP~~RPS~~eIl~ 687 (706)
.++|.+||++.+++.
T Consensus 817 epd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 817 EPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CCCcccCccHHHhcc
Confidence 999999999999875
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=318.57 Aligned_cols=252 Identities=28% Similarity=0.460 Sum_probs=222.6
Q ss_pred ccccCceEEEEEeccCCceEEEEEEEcCCc--eEEEEEecccc-chHHHHHHHHHHHHHHcCCCCceeEEeccccCCCce
Q 005247 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNL 505 (706)
Q Consensus 429 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~--vAVKvl~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 505 (706)
.+..++|..+++||+|.||+|-+++.+.++ ||+|++++... ..+....-+.|-.+|+..+||.+..+...|+.++.+
T Consensus 164 kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drl 243 (516)
T KOG0690|consen 164 KVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRL 243 (516)
T ss_pred eeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceE
Confidence 345678889999999999999999877554 99999877644 345566778899999999999999999999999999
Q ss_pred EEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccC
Q 005247 506 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK 585 (706)
Q Consensus 506 ~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~ 585 (706)
|+||||..||.|.-.+... ..+.+..++.+-..|+.||.|||+++ ||.||||.+|+|+|++|++||+|||++...
T Consensus 244 CFVMeyanGGeLf~HLsre---r~FsE~RtRFYGaEIvsAL~YLHs~~--ivYRDlKLENLlLDkDGHIKitDFGLCKE~ 318 (516)
T KOG0690|consen 244 CFVMEYANGGELFFHLSRE---RVFSEDRTRFYGAEIVSALGYLHSRN--IVYRDLKLENLLLDKDGHIKITDFGLCKEE 318 (516)
T ss_pred EEEEEEccCceEeeehhhh---hcccchhhhhhhHHHHHHhhhhhhCC--eeeeechhhhheeccCCceEeeecccchhc
Confidence 9999999999998887643 35889999999999999999999999 999999999999999999999999999875
Q ss_pred CCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHH
Q 005247 586 PNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 665 (706)
Q Consensus 586 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~ 665 (706)
-.......++||||.|+|||++....|..++|+|.+||++|||++|+.||...+....+..| ....+.+|..++++.+
T Consensus 319 I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLI--l~ed~kFPr~ls~eAk 396 (516)
T KOG0690|consen 319 IKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELI--LMEDLKFPRTLSPEAK 396 (516)
T ss_pred ccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHH--HhhhccCCccCCHHHH
Confidence 55445667899999999999999999999999999999999999999999998888877776 3456788999999999
Q ss_pred HHHHHhhhhCCCCCC-----CHHHHHH
Q 005247 666 ALIETCWAEEPEIRP-----SFPSIME 687 (706)
Q Consensus 666 dLI~~cL~~dP~~RP-----S~~eIl~ 687 (706)
.|+..+|.+||.+|. ++.||.+
T Consensus 397 tLLsGLL~kdP~kRLGgGpdDakEi~~ 423 (516)
T KOG0690|consen 397 TLLSGLLKKDPKKRLGGGPDDAKEIMR 423 (516)
T ss_pred HHHHHHhhcChHhhcCCCchhHHHHHh
Confidence 999999999999994 4555554
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=311.93 Aligned_cols=246 Identities=33% Similarity=0.514 Sum_probs=206.4
Q ss_pred ceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEEe
Q 005247 434 ELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY 511 (706)
Q Consensus 434 ~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~ 511 (706)
+|++.+.||.|+||.||++.+.. ..+++|.+..... ....+.+.+|++++++++||||+++++.+...+.+++++||
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 57788999999999999999874 4489998765432 35557889999999999999999999999999999999999
Q ss_pred ccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHh-cCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcc
Q 005247 512 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ-RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 590 (706)
Q Consensus 512 ~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs-~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~ 590 (706)
+.+++|.+++.... ..+++..+..++.|++.||+|||+ .+ ++|+||||+||+++.++.++|+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~--i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC--eecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence 99999999986432 468899999999999999999999 88 99999999999999999999999999876543321
Q ss_pred cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHhhhcCcccCCCCC-CcHHH
Q 005247 591 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNST-----PSQVISAVGFKGRRLEIPKN-VNPMV 664 (706)
Q Consensus 591 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~-----~~~~~~~i~~~~~~l~~p~~-~s~el 664 (706)
....++..|+|||.+.+..++.++||||||+++|+|++|..||.... ..+....+ ........+.. ++.++
T Consensus 157 --~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 233 (265)
T cd06605 157 --KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYI-VNEPPPRLPSGKFSPDF 233 (265)
T ss_pred --hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHH-hcCCCCCCChhhcCHHH
Confidence 22678889999999999999999999999999999999999996542 22222222 23333444444 88999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHH
Q 005247 665 AALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 665 ~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
.++|.+||..||++|||+.+++.
T Consensus 234 ~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 234 QDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred HHHHHHHcCCCchhCcCHHHHhh
Confidence 99999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=316.09 Aligned_cols=249 Identities=27% Similarity=0.449 Sum_probs=206.7
Q ss_pred ccCceEEEEEeccCCceEEEEEEEc--CCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEE
Q 005247 431 RWSELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIV 508 (706)
Q Consensus 431 ~~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV 508 (706)
+.++|++.+.||+|+||+||++.+. +..+|+|++.... .....+.+.+|+++++.++||||+++++++...+.+++|
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMC 81 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEE
Confidence 4567889999999999999999886 4458999876543 344457889999999999999999999999999999999
Q ss_pred EEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHh-cCCCcccccCCCCcEEECCCCcEEEeecCccccCCC
Q 005247 509 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ-RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 587 (706)
Q Consensus 509 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs-~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 587 (706)
|||+++++|.+++... ..+++..+..++.+++.||.|||+ ++ ++||||||+||+++.++.++|+|||++.....
T Consensus 82 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~ 156 (284)
T cd06620 82 MEFMDCGSLDRIYKKG---GPIPVEILGKIAVAVVEGLTYLYNVHR--IMHRDIKPSNILVNSRGQIKLCDFGVSGELIN 156 (284)
T ss_pred EecCCCCCHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHhcC--eeccCCCHHHEEECCCCcEEEccCCcccchhh
Confidence 9999999999988643 358899999999999999999997 57 99999999999999999999999999865433
Q ss_pred CcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-----------HHHHHhhhcCcccCC
Q 005247 588 TYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPS-----------QVISAVGFKGRRLEI 656 (706)
Q Consensus 588 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~-----------~~~~~i~~~~~~l~~ 656 (706)
.. .....|+..|+|||++.+..++.++|||||||++|+|++|..||...... +....+ .......+
T Consensus 157 ~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 233 (284)
T cd06620 157 SI--ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQI-VQEPPPRL 233 (284)
T ss_pred hc--cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHH-hhccCCCC
Confidence 22 23457899999999998888999999999999999999999999865542 111222 11222233
Q ss_pred CC-CCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 005247 657 PK-NVNPMVAALIETCWAEEPEIRPSFPSIMET 688 (706)
Q Consensus 657 p~-~~s~el~dLI~~cL~~dP~~RPS~~eIl~~ 688 (706)
+. .++.++.+||.+||+.||++|||+.++++.
T Consensus 234 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~ 266 (284)
T cd06620 234 PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266 (284)
T ss_pred CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 33 378899999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=309.96 Aligned_cols=247 Identities=30% Similarity=0.524 Sum_probs=210.6
Q ss_pred ceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEEe
Q 005247 434 ELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY 511 (706)
Q Consensus 434 ~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~ 511 (706)
-|++.+.||+|+||.||+|.+.. ..+|+|+...... ....+.+.+|+.+++.++|+||+++++++...+..++||||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 46788999999999999998754 4589998754432 34456788999999999999999999999999999999999
Q ss_pred ccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCccc
Q 005247 512 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS 591 (706)
Q Consensus 512 ~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~ 591 (706)
+++++|.+++... .+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++.........
T Consensus 84 ~~~~~l~~~i~~~----~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06641 84 LGGGSALDLLEPG----PLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 157 (277)
T ss_pred CCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHccCC--eecCCCCHHhEEECCCCCEEEeecccceecccchhh
Confidence 9999999988632 4788999999999999999999999 999999999999999999999999998765443323
Q ss_pred CCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHHHHh
Q 005247 592 SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC 671 (706)
Q Consensus 592 ~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI~~c 671 (706)
.....++..|+|||.+.+...+.++|+||||+++|+|++|..||...........+. ......++..++.++.++|.+|
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~ 236 (277)
T cd06641 158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIP-KNNPPTLEGNYSKPLKEFVEAC 236 (277)
T ss_pred hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHh-cCCCCCCCcccCHHHHHHHHHH
Confidence 344568889999999988888999999999999999999999998777655554442 3334456677899999999999
Q ss_pred hhhCCCCCCCHHHHHHH
Q 005247 672 WAEEPEIRPSFPSIMET 688 (706)
Q Consensus 672 L~~dP~~RPS~~eIl~~ 688 (706)
|+.+|.+||++.++++.
T Consensus 237 l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 237 LNKEPSFRPTAKELLKH 253 (277)
T ss_pred ccCChhhCcCHHHHHhC
Confidence 99999999999999983
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=310.65 Aligned_cols=238 Identities=23% Similarity=0.415 Sum_probs=191.6
Q ss_pred EEeccCCceEEEEEEEcCC--------------ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCc
Q 005247 439 KKIGEGSFGTVYHAEWRNS--------------DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN 504 (706)
Q Consensus 439 ~~LG~G~fG~Vy~a~~~~~--------------~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 504 (706)
+.||+|+||.||+|....+ .+++|++... .......+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~ 78 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS--HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE 78 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh--hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 3689999999999975321 2677765432 23445678899999999999999999999999899
Q ss_pred eEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCc-------EEEe
Q 005247 505 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYT-------VKVC 577 (706)
Q Consensus 505 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~-------vKL~ 577 (706)
.+++|||+++++|..++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++. +|++
T Consensus 79 ~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHRKS--DVLTTPWKFKVAKQLASALSYLEDKD--LVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred CEEEEecccCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhhhCC--eECCCCCcccEEEecCCccCCCCceeEeC
Confidence 999999999999988876432 35888999999999999999999999 999999999999987654 8999
Q ss_pred ecCccccCCCCcccCCCCCCCCCccCccccc-cCCCCchhHHHHHHHHHHHHH-hCCCCCCCCChHHHHHHhhhcCcccC
Q 005247 578 DFGLSRSKPNTYISSKTAAGTPEWMAPEVLR-EDPSNEKSDVFSFGVILWELI-TLQKPWRNSTPSQVISAVGFKGRRLE 655 (706)
Q Consensus 578 DFGla~~~~~~~~~~~~~~Gt~~Y~APE~l~-~~~~s~ksDVwSLGviL~ELl-tG~~Pf~~~~~~~~~~~i~~~~~~l~ 655 (706)
|||++...... ....++..|+|||.+. +..++.++||||||+++|||+ +|..||......+.... ......
T Consensus 155 d~g~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~---~~~~~~ 227 (262)
T cd05077 155 DPGIPITVLSR----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERF---YEGQCM 227 (262)
T ss_pred CCCCCccccCc----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHH---HhcCcc
Confidence 99988654322 2346788999999987 466889999999999999998 58888876654443221 122223
Q ss_pred CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 005247 656 IPKNVNPMVAALIETCWAEEPEIRPSFPSIMETL 689 (706)
Q Consensus 656 ~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L 689 (706)
.....++++++||.+||+.||++||++.+|++.|
T Consensus 228 ~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 228 LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 3344568899999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=307.02 Aligned_cols=241 Identities=28% Similarity=0.452 Sum_probs=207.1
Q ss_pred eccCCceEEEEEEEc--CCceEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEEeccCCch
Q 005247 441 IGEGSFGTVYHAEWR--NSDVAVKILIEQEFH-EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSL 517 (706)
Q Consensus 441 LG~G~fG~Vy~a~~~--~~~vAVKvl~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL 517 (706)
||.|+||.||++.+. +..+++|++...... ....+.+.+|+.+++.++|+||+++++.+.+++..++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999987 456999998665432 34456789999999999999999999999999999999999999999
Q ss_pred hhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcccCCCCCC
Q 005247 518 YKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAG 597 (706)
Q Consensus 518 ~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~G 597 (706)
.+++.... .+++..+..++.||+.||.|||+++ ++|+||||+||+++.++.++|+|||++....... ......+
T Consensus 81 ~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lH~~~--~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~~ 154 (262)
T cd05572 81 WTILRDRG---LFDEYTARFYIACVVLAFEYLHNRG--IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFCG 154 (262)
T ss_pred HHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-ccccccC
Confidence 99986432 4788999999999999999999999 9999999999999999999999999998765442 2234568
Q ss_pred CCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHhhhcCcccCCCCCCcHHHHHHHHHhhhhC
Q 005247 598 TPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNST--PSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEE 675 (706)
Q Consensus 598 t~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~--~~~~~~~i~~~~~~l~~p~~~s~el~dLI~~cL~~d 675 (706)
+..|++||.+.+..++.++|+||||+++|+|++|..||.... ..+....+........+|..+++++.++|.+||+.+
T Consensus 155 ~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~ 234 (262)
T cd05572 155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRN 234 (262)
T ss_pred CcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCC
Confidence 899999999988889999999999999999999999998776 445555544335567777788999999999999999
Q ss_pred CCCCCC-----HHHHHH
Q 005247 676 PEIRPS-----FPSIME 687 (706)
Q Consensus 676 P~~RPS-----~~eIl~ 687 (706)
|++||+ +.|+++
T Consensus 235 p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 235 PEERLGNLKGGIKDIKK 251 (262)
T ss_pred hhhCcCCcccCHHHHhc
Confidence 999999 777765
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=339.41 Aligned_cols=245 Identities=30% Similarity=0.510 Sum_probs=208.8
Q ss_pred EEEEEeccCCceEEEEEEEcCCc--eEEEEEeccc--cchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCc--eEEEE
Q 005247 436 LIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQE--FHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN--LSIVT 509 (706)
Q Consensus 436 ~i~~~LG~G~fG~Vy~a~~~~~~--vAVKvl~~~~--~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~--~~lV~ 509 (706)
+....||+|+|-+||+|.+..++ ||--.++... ..+...+.|..|+.+|+.|+|+||+++|++|.+... ..+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 45789999999999999887666 4332222222 234556899999999999999999999999987766 67899
Q ss_pred EeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECC-CCcEEEeecCccccCCCC
Q 005247 510 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS-TYTVKVCDFGLSRSKPNT 588 (706)
Q Consensus 510 E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~-~~~vKL~DFGla~~~~~~ 588 (706)
|.+..|+|..|++..+ .+..+.+..|++||++||.|||++.|||||||||-+||+|+. .|.|||+|+|+|+.....
T Consensus 123 EL~TSGtLr~Y~kk~~---~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHR---RVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred ecccCCcHHHHHHHhc---cCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 9999999999997543 478889999999999999999999999999999999999975 579999999999887655
Q ss_pred cccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCC-CChHHHHHHhhhcCcccCCCCCCcHHHHHH
Q 005247 589 YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRN-STPSQVISAVGFKGRRLEIPKNVNPMVAAL 667 (706)
Q Consensus 589 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~-~~~~~~~~~i~~~~~~l~~p~~~s~el~dL 667 (706)
+ .....|||.|||||.+. ..|+..+||||||+++.||+|+.+||.. .++.++++++.-+..+-.+..--++++++|
T Consensus 200 ~--aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~f 276 (632)
T KOG0584|consen 200 H--AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREF 276 (632)
T ss_pred c--cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHH
Confidence 3 34578999999999987 7799999999999999999999999965 678888888865555555555668999999
Q ss_pred HHHhhhhCCCCCCCHHHHHH
Q 005247 668 IETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 668 I~~cL~~dP~~RPS~~eIl~ 687 (706)
|.+||.. .++|||+.|+|.
T Consensus 277 IekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 277 IEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred HHHHhcC-chhccCHHHHhh
Confidence 9999999 999999999986
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=312.91 Aligned_cols=249 Identities=26% Similarity=0.320 Sum_probs=203.8
Q ss_pred ceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccc---hHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEE
Q 005247 434 ELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFH---EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIV 508 (706)
Q Consensus 434 ~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~---~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV 508 (706)
+|++.+.||+|+||.||+|.+.. ..|++|.+...... ......+..|+.+++.++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 47889999999999999998764 45999998765543 33345677899999999999999999999999999999
Q ss_pred EEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCC
Q 005247 509 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 588 (706)
Q Consensus 509 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 588 (706)
|||+ +++|.+++.... ..+++..++.++.||++||.|||++| ++|+||||+||+++.++.+||+|||++......
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW--ILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 9999 889999997443 35889999999999999999999999 999999999999999999999999999876554
Q ss_pred cccCCCCCCCCCccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcC-c--------------
Q 005247 589 YISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG-R-------------- 652 (706)
Q Consensus 589 ~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~-~-------------- 652 (706)
........++..|+|||.+.+ ..++.++|||||||++|||++|..||......+....+.... .
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (298)
T cd07841 156 NRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPD 235 (298)
T ss_pred CccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccc
Confidence 333344567889999999865 457889999999999999999988887666544333321100 0
Q ss_pred ------c-----cCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 653 ------R-----LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 653 ------~-----l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
. .......+.++.++|.+||+.+|++|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 236 YVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred cccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 0 0011345788999999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=309.84 Aligned_cols=249 Identities=27% Similarity=0.482 Sum_probs=198.2
Q ss_pred CceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHH-HHcCCCCceeEEeccccCCCceEEEE
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAI-MKGLRHPNIVLLMGAVTEPPNLSIVT 509 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~i-L~~L~HpnIv~l~~~~~~~~~~~lV~ 509 (706)
++|++.+.||+|+||.||++.+.. ..||+|.+......... ..+..|+.+ ++.++|+||+++++++..++..+++|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 79 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQ-KRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM 79 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHH-HHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence 368999999999999999998864 45999988765433333 345556654 66678999999999999999999999
Q ss_pred EeccCCchhhhccc-CCCcccccHHHHHHHHHHHHHHHHHHHhc-CCCcccccCCCCcEEECCCCcEEEeecCccccCCC
Q 005247 510 EYLSRGSLYKLLHI-PDARVVVDERLRLNMAYDVAKGMNYLHQR-RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 587 (706)
Q Consensus 510 E~~~ggsL~~~l~~-~~~~~~l~~~~~~~ia~qIl~aL~yLHs~-g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 587 (706)
||++ |+|.++++. ......+++..++.++.||+.||+|||++ + ++||||||+||+++.++.+||+|||++.....
T Consensus 80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~--i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 9996 578777743 22234689999999999999999999997 8 99999999999999999999999999886543
Q ss_pred CcccCCCCCCCCCccCcccccc----CCCCchhHHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHhhhcCcccCCC-CCCc
Q 005247 588 TYISSKTAAGTPEWMAPEVLRE----DPSNEKSDVFSFGVILWELITLQKPWRNST-PSQVISAVGFKGRRLEIP-KNVN 661 (706)
Q Consensus 588 ~~~~~~~~~Gt~~Y~APE~l~~----~~~s~ksDVwSLGviL~ELltG~~Pf~~~~-~~~~~~~i~~~~~~l~~p-~~~s 661 (706)
.. ......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.... ..+....+. ......++ ..++
T Consensus 157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 234 (283)
T cd06617 157 SV-AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVV-EEPSPQLPAEKFS 234 (283)
T ss_pred cc-ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHH-hcCCCCCCccccC
Confidence 32 1233568889999999865 446889999999999999999999997532 223333322 22233333 3578
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 662 PMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 662 ~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
.++.++|.+||..+|++||++.++++
T Consensus 235 ~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 235 PEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhc
Confidence 99999999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=301.03 Aligned_cols=248 Identities=29% Similarity=0.571 Sum_probs=215.4
Q ss_pred ceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEEe
Q 005247 434 ELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY 511 (706)
Q Consensus 434 ~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~ 511 (706)
+|++.+.||+|++|.||++.+.. ..+++|............+.+.+|++++++++|+|++++++++.+.+..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 47889999999999999998764 3599999877665556667899999999999999999999999998999999999
Q ss_pred ccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCccc
Q 005247 512 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS 591 (706)
Q Consensus 512 ~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~ 591 (706)
+++++|.+++... ..+++..++.++.|++.||.|||++| ++||||||+||+++.++.++|+|||.+.........
T Consensus 81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQG--VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence 9999999998643 35889999999999999999999999 999999999999999999999999999876654433
Q ss_pred CCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHHHHh
Q 005247 592 SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC 671 (706)
Q Consensus 592 ~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI~~c 671 (706)
.....++..|+|||...+...+.++|||+||+++|+|++|+.||............. ......++..++..+.++|.+|
T Consensus 156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~ 234 (254)
T cd06627 156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV-QDDHPPLPEGISPELKDFLMQC 234 (254)
T ss_pred ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh-ccCCCCCCCCCCHHHHHHHHHH
Confidence 345678999999999988888999999999999999999999998766555444442 3444567778899999999999
Q ss_pred hhhCCCCCCCHHHHHH
Q 005247 672 WAEEPEIRPSFPSIME 687 (706)
Q Consensus 672 L~~dP~~RPS~~eIl~ 687 (706)
|..+|++||++.+++.
T Consensus 235 l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 235 FQKDPNLRPTAKQLLK 250 (254)
T ss_pred HhCChhhCcCHHHHhc
Confidence 9999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=310.12 Aligned_cols=246 Identities=29% Similarity=0.513 Sum_probs=205.7
Q ss_pred ceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCC---CCceeEEeccccCCCceEEE
Q 005247 434 ELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLR---HPNIVLLMGAVTEPPNLSIV 508 (706)
Q Consensus 434 ~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~---HpnIv~l~~~~~~~~~~~lV 508 (706)
.|++.+.||+|+||.||+|.+.. ..+++|++.... .....+.+.+|+.+++.++ |+|++++++++......++|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv 80 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII 80 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence 47788999999999999998754 449999876442 3344567889999999986 99999999999999999999
Q ss_pred EEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCC
Q 005247 509 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 588 (706)
Q Consensus 509 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 588 (706)
|||+.+++|.++++.. .+++..++.++.|++.||.|||+.| ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 81 MEYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKVG--VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred EecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 9999999999998642 5889999999999999999999999 999999999999999999999999998876544
Q ss_pred cccCCCCCCCCCccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCC-CCcHHHHH
Q 005247 589 YISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPK-NVNPMVAA 666 (706)
Q Consensus 589 ~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~-~~s~el~d 666 (706)
........|+..|+|||.+.+. .++.++||||||+++|+|++|..||...........+.. .....++. ..+.++.+
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 233 (277)
T cd06917 155 SSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPK-SKPPRLEDNGYSKLLRE 233 (277)
T ss_pred ccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcccc-CCCCCCCcccCCHHHHH
Confidence 3334455789999999998654 468899999999999999999999987766554433321 12223333 37889999
Q ss_pred HHHHhhhhCCCCCCCHHHHHH
Q 005247 667 LIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 667 LI~~cL~~dP~~RPS~~eIl~ 687 (706)
+|.+||+.||++||++.++++
T Consensus 234 ~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 234 FVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred HHHHHcCCCcccCcCHHHHhh
Confidence 999999999999999999977
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=307.59 Aligned_cols=249 Identities=31% Similarity=0.518 Sum_probs=204.3
Q ss_pred ceEEEEEeccCCceEEEEEEEc--CCceEEEEEeccccc--------hHHHHHHHHHHHHHHcCCCCceeEEeccccCCC
Q 005247 434 ELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFH--------EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP 503 (706)
Q Consensus 434 ~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKvl~~~~~~--------~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 503 (706)
+|.+.+.||+|+||.||+|... +..+|+|.+...... ....+.+.+|+.+++.++|+||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 5788999999999999999765 445999987532211 123456888999999999999999999999999
Q ss_pred ceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccc
Q 005247 504 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 583 (706)
Q Consensus 504 ~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~ 583 (706)
..++||||+.+++|.++++.. ..+++..+..++.||+.||.|||+++ ++||||+|+||+++.++.++|+|||++.
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~~~nil~~~~~~~~l~d~~~~~ 156 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG--ILHRDLKADNLLVDADGICKISDFGISK 156 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC--eeecCCChhhEEEcCCCeEEEeeccccc
Confidence 999999999999999998744 35888999999999999999999999 9999999999999999999999999987
Q ss_pred cCCCCcc--cCCCCCCCCCccCccccccCC--CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCC--
Q 005247 584 SKPNTYI--SSKTAAGTPEWMAPEVLREDP--SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP-- 657 (706)
Q Consensus 584 ~~~~~~~--~~~~~~Gt~~Y~APE~l~~~~--~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p-- 657 (706)
....... ......++..|+|||.+.... ++.++|+||||+++|++++|..||......+....+........++
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (272)
T cd06629 157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPD 236 (272)
T ss_pred cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCcc
Confidence 6543221 123456888999999987654 7889999999999999999999997665544443332233333333
Q ss_pred --CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 658 --KNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 658 --~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
..++.++.++|.+||..+|++||++.++++
T Consensus 237 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 237 VSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred ccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 346899999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=310.13 Aligned_cols=253 Identities=30% Similarity=0.439 Sum_probs=204.7
Q ss_pred cccCceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcC-CCCceeEEeccccCC----
Q 005247 430 IRWSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEP---- 502 (706)
Q Consensus 430 i~~~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~---- 502 (706)
...++|++.+.||+|+||.||++.... ..+|+|++.... .....+.+|+.+++++ +|||++++++++...
T Consensus 19 ~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~ 95 (291)
T cd06639 19 DPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLV 95 (291)
T ss_pred CCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc---cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccC
Confidence 346789999999999999999998854 448999875432 2234677899999998 799999999988643
Q ss_pred -CceEEEEEeccCCchhhhcccC-CCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecC
Q 005247 503 -PNLSIVTEYLSRGSLYKLLHIP-DARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFG 580 (706)
Q Consensus 503 -~~~~lV~E~~~ggsL~~~l~~~-~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFG 580 (706)
+..++||||+++++|.++++.. .....+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||
T Consensus 96 ~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~nili~~~~~~kl~dfg 173 (291)
T cd06639 96 GGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR--IIHRDVKGNNILLTTEGGVKLVDFG 173 (291)
T ss_pred CCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCCCCEEEeecc
Confidence 3589999999999999988532 12235789999999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCcccCCCCCCCCCccCccccccCC-----CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhc-Cccc
Q 005247 581 LSRSKPNTYISSKTAAGTPEWMAPEVLREDP-----SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-GRRL 654 (706)
Q Consensus 581 la~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~-----~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~-~~~l 654 (706)
++..............|+..|+|||.+.... ++.++|||||||++|||++|+.||....+......+... ....
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 253 (291)
T cd06639 174 VSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTL 253 (291)
T ss_pred cchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCC
Confidence 9886554333334457889999999986543 678999999999999999999999887665544443211 1223
Q ss_pred CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 655 EIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 655 ~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
..+..++..+.+||.+||+.+|++||++.+++.
T Consensus 254 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 254 LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred CcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 345567789999999999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=303.47 Aligned_cols=249 Identities=29% Similarity=0.504 Sum_probs=214.3
Q ss_pred ceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEEe
Q 005247 434 ELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY 511 (706)
Q Consensus 434 ~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~ 511 (706)
+|++.+.||+|+||.||++.+..+ .+++|.+............+.+|+.+++.++|+||+++++++.+....++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 488999999999999999987644 489999876555555567888999999999999999999999999999999999
Q ss_pred ccCCchhhhcccC-CCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcc
Q 005247 512 LSRGSLYKLLHIP-DARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 590 (706)
Q Consensus 512 ~~ggsL~~~l~~~-~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~ 590 (706)
+++++|.+++... .....+++..++.++.|++.||+|||+.| ++|+||+|+||+++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~--i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK--ILHRDLKSANILLVANDLVKIGDLGISKVLKKN-- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEEecCCcEEEeeccchhhhccC--
Confidence 9999999988542 12345788999999999999999999999 999999999999999999999999999876554
Q ss_pred cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHHHH
Q 005247 591 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIET 670 (706)
Q Consensus 591 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI~~ 670 (706)
......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+..+....+. .......+..++.++.++|.+
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~ 235 (256)
T cd08530 157 MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQ-RGKYPPIPPIYSQDLQNFIRS 235 (256)
T ss_pred CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh-cCCCCCCchhhCHHHHHHHHH
Confidence 2234568899999999999889999999999999999999999999888766655543 333344556788999999999
Q ss_pred hhhhCCCCCCCHHHHHH
Q 005247 671 CWAEEPEIRPSFPSIME 687 (706)
Q Consensus 671 cL~~dP~~RPS~~eIl~ 687 (706)
||+.+|++||++.+++.
T Consensus 236 ~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 236 MLQVKPKLRPNCDKILA 252 (256)
T ss_pred HcCCCcccCCCHHHHhc
Confidence 99999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=312.39 Aligned_cols=238 Identities=25% Similarity=0.452 Sum_probs=195.6
Q ss_pred EEeccCCceEEEEEEEcCC---------ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEE
Q 005247 439 KKIGEGSFGTVYHAEWRNS---------DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 509 (706)
Q Consensus 439 ~~LG~G~fG~Vy~a~~~~~---------~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~ 509 (706)
+.||+|+||.||+|.+... .+++|.+... .....+.+.+|+.+++.+.||||+++++++..+...++||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS--HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch--hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 3689999999999976432 2677776432 2344567889999999999999999999999988999999
Q ss_pred EeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCc--------EEEeecCc
Q 005247 510 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYT--------VKVCDFGL 581 (706)
Q Consensus 510 E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~--------vKL~DFGl 581 (706)
||+.+|+|.++++.... .+++..++.++.||+.||+|||+++ |+||||||+||+++.++. ++++|||+
T Consensus 79 e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 79 EYVKFGSLDTYLKKNKN--LINISWKLEVAKQLAWALHFLEDKG--LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred ecCCCCcHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccceEEEecccccccCCCceEEeccccc
Confidence 99999999999874432 5788899999999999999999999 999999999999987664 69999998
Q ss_pred cccCCCCcccCCCCCCCCCccCccccccC-CCCchhHHHHHHHHHHHHHhC-CCCCCCCChHHHHHHhhhcCcccCCCCC
Q 005247 582 SRSKPNTYISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKN 659 (706)
Q Consensus 582 a~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSLGviL~ELltG-~~Pf~~~~~~~~~~~i~~~~~~l~~p~~ 659 (706)
+...... ....++..|+|||++.+. .++.++||||||+++|||++| ..||........... ...+..+|..
T Consensus 155 ~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~---~~~~~~~~~~ 227 (258)
T cd05078 155 SITVLPK----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQF---YEDRHQLPAP 227 (258)
T ss_pred ccccCCc----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHH---HHccccCCCC
Confidence 8654332 245678899999999874 578999999999999999998 466666555443322 2334566777
Q ss_pred CcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 005247 660 VNPMVAALIETCWAEEPEIRPSFPSIMETL 689 (706)
Q Consensus 660 ~s~el~dLI~~cL~~dP~~RPS~~eIl~~L 689 (706)
.+.++.+||.+||+.+|++|||+++|++.|
T Consensus 228 ~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 228 KWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred CcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 889999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=311.63 Aligned_cols=237 Identities=24% Similarity=0.428 Sum_probs=192.2
Q ss_pred EeccCCceEEEEEEEcC--------------------------CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCcee
Q 005247 440 KIGEGSFGTVYHAEWRN--------------------------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIV 493 (706)
Q Consensus 440 ~LG~G~fG~Vy~a~~~~--------------------------~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv 493 (706)
+||+|+||.||+|.... ..+++|++... .......+.+|+.+++.++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS--HRDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH--HHHHHHHHHHHHHHHhcCCCCCee
Confidence 59999999999986421 12677776433 233446788999999999999999
Q ss_pred EEeccccCCCceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCC-
Q 005247 494 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY- 572 (706)
Q Consensus 494 ~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~- 572 (706)
++++++.+.+..++||||+++|+|..++.... ..+++..+..++.||+.||+|||+++ |+||||||+|||++..+
T Consensus 80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRKEK--GRVPVAWKITVAQQLASALSYLEDKN--LVHGNVCAKNILLARLGL 155 (274)
T ss_pred eEEEEEEeCCceEEEEecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHcCC--ccCCCCCcccEEEeccCc
Confidence 99999999999999999999999999886432 35788999999999999999999999 99999999999997644
Q ss_pred ------cEEEeecCccccCCCCcccCCCCCCCCCccCcccccc-CCCCchhHHHHHHHHHHHHH-hCCCCCCCCChHHHH
Q 005247 573 ------TVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELI-TLQKPWRNSTPSQVI 644 (706)
Q Consensus 573 ------~vKL~DFGla~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~ELl-tG~~Pf~~~~~~~~~ 644 (706)
.+||+|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|..||....+.+..
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~ 231 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE 231 (274)
T ss_pred ccCccceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHH
Confidence 4899999987653322 23457788999998876 56789999999999999995 689999877665543
Q ss_pred HHhhhcCcccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 005247 645 SAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETL 689 (706)
Q Consensus 645 ~~i~~~~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L 689 (706)
... .....++...++.+.++|.+||+.+|++|||+.+|++.|
T Consensus 232 ~~~---~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 232 RFY---EKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHH---HhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 322 123344555678899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=316.10 Aligned_cols=243 Identities=23% Similarity=0.390 Sum_probs=184.8
Q ss_pred EEEeccCCceEEEEEEEcC----CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccC--CCceEEEEEe
Q 005247 438 KKKIGEGSFGTVYHAEWRN----SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE--PPNLSIVTEY 511 (706)
Q Consensus 438 ~~~LG~G~fG~Vy~a~~~~----~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~--~~~~~lV~E~ 511 (706)
.++||+|+||.||+|.+.. ..+|+|.+...... ..+.+|+.++++++||||+++++++.. ....+++|||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 81 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc----HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence 4689999999999998653 34899987554322 356789999999999999999998854 4568899999
Q ss_pred ccCCchhhhcccCC------CcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEE----CCCCcEEEeecCc
Q 005247 512 LSRGSLYKLLHIPD------ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLV----DSTYTVKVCDFGL 581 (706)
Q Consensus 512 ~~ggsL~~~l~~~~------~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl----~~~~~vKL~DFGl 581 (706)
+.+ +|.+++.... ....+++..+..++.||+.||.|||++| |+||||||+|||+ +.++.+||+|||+
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 82 AEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred cCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 864 7777764221 1235889999999999999999999999 9999999999999 4567899999999
Q ss_pred cccCCCCcc---cCCCCCCCCCccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChH---------HHHHHh-
Q 005247 582 SRSKPNTYI---SSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPS---------QVISAV- 647 (706)
Q Consensus 582 a~~~~~~~~---~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~---------~~~~~i- 647 (706)
++....... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... .....+
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~ 238 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 238 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHH
Confidence 986544321 22345789999999999874 5789999999999999999999999653321 000000
Q ss_pred hhcCcc-------------------------c----------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 648 GFKGRR-------------------------L----------EIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 648 ~~~~~~-------------------------l----------~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
...+.+ . ......+.++.+||.+||+.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~ 313 (317)
T cd07868 239 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 313 (317)
T ss_pred HhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000000 0 000123467889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=304.84 Aligned_cols=249 Identities=29% Similarity=0.492 Sum_probs=209.4
Q ss_pred CceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccc---cchHHHHHHHHHHHHHHcCCCCceeEEeccccCC--Cce
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQE---FHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP--PNL 505 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~---~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~--~~~ 505 (706)
.+|++.+.||+|+||.||++.+.. ..+++|++.... ........+.+|+.++++++|+||+++++++.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 478999999999999999998754 459999875321 2334557888999999999999999999988654 458
Q ss_pred EEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccC
Q 005247 506 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK 585 (706)
Q Consensus 506 ~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~ 585 (706)
++++||+++++|.+++...+ .+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||+++..
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 156 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG---ALTENVTRRYTRQILQGVSYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRI 156 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEECcccccccc
Confidence 89999999999999886332 4788889999999999999999999 999999999999999999999999999865
Q ss_pred CCCcc---cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcH
Q 005247 586 PNTYI---SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNP 662 (706)
Q Consensus 586 ~~~~~---~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~ 662 (706)
..... ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...........+.....+..+|..+++
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~ 236 (264)
T cd06653 157 QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSD 236 (264)
T ss_pred ccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCH
Confidence 43211 112356889999999999888999999999999999999999999887666666555444555678889999
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 663 MVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 663 el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
++.++|.+||. +|.+||++.+++.
T Consensus 237 ~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 237 ACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred HHHHHHHHHhc-CcccCccHHHHhc
Confidence 99999999999 5799999998865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=323.51 Aligned_cols=245 Identities=29% Similarity=0.491 Sum_probs=218.0
Q ss_pred eEEEEEeccCCceEEEEEEEcCCc--eEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEEec
Q 005247 435 LLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYL 512 (706)
Q Consensus 435 y~i~~~LG~G~fG~Vy~a~~~~~~--vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~~ 512 (706)
|.++++||+|+||.||+|.++.++ +|+|.+. .+..+++++.|+.||++...+++|++|+.+..+..+|||||||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VP----V~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVP----VDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecC----ccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 567889999999999999888776 6777653 2345689999999999999999999999999999999999999
Q ss_pred cCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcccC
Q 005247 513 SRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISS 592 (706)
Q Consensus 513 ~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~ 592 (706)
..|++.++++... .++.+.++..+++..++||+|||... -||||||..|||++.+|.+||+|||.|....+.....
T Consensus 111 GAGSiSDI~R~R~--K~L~E~EIs~iL~~TLKGL~YLH~~~--KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKR 186 (502)
T KOG0574|consen 111 GAGSISDIMRARR--KPLSEQEISAVLRDTLKGLQYLHDLK--KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKR 186 (502)
T ss_pred CCCcHHHHHHHhc--CCccHHHHHHHHHHHHhHHHHHHHHH--HHHhhcccccEEEcccchhhhhhccccchhhhhHHhh
Confidence 9999999997543 46999999999999999999999998 8999999999999999999999999999988887777
Q ss_pred CCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCc-ccCCCCCCcHHHHHHHHHh
Q 005247 593 KTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR-RLEIPKNVNPMVAALIETC 671 (706)
Q Consensus 593 ~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~-~l~~p~~~s~el~dLI~~c 671 (706)
.+..||+.|||||++..-.|+.++||||||++..||..|++||....+...+..+-.... .+.-|+.++.++.+||++|
T Consensus 187 NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~C 266 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSC 266 (502)
T ss_pred CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHHH
Confidence 889999999999999999999999999999999999999999998887766655532222 2345677899999999999
Q ss_pred hhhCCCCCCCHHHHHH
Q 005247 672 WAEEPEIRPSFPSIME 687 (706)
Q Consensus 672 L~~dP~~RPS~~eIl~ 687 (706)
|-++|++|-|+.++++
T Consensus 267 LiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 267 LIKKPEERKTALRLCE 282 (502)
T ss_pred hcCCHHHHHHHHHHhh
Confidence 9999999999999887
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=306.67 Aligned_cols=249 Identities=29% Similarity=0.508 Sum_probs=205.5
Q ss_pred ceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccc----hHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEE
Q 005247 434 ELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFH----EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI 507 (706)
Q Consensus 434 ~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~----~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l 507 (706)
+|+..+.||+|+||.||++.+.. ..+|+|++...... ....+.+.+|+.+++.++|+||+++++++.+.+.+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 47788999999999999998743 45999988643321 2345788999999999999999999999999999999
Q ss_pred EEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCC-cEEEeecCccccCC
Q 005247 508 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY-TVKVCDFGLSRSKP 586 (706)
Q Consensus 508 V~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~-~vKL~DFGla~~~~ 586 (706)
||||+.+++|.+++... ..+++..++.++.||+.||.|||++| ++|+||||+||+++.++ .+||+|||.+....
T Consensus 81 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~ql~~al~~LH~~~--i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY---GAFKEAVIINYTEQLLRGLSYLHENQ--IIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred EEeccCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 99999999999998643 25788999999999999999999999 99999999999998775 69999999987654
Q ss_pred CCccc----CCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHhhhcCcccCCCCC
Q 005247 587 NTYIS----SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQV---ISAVGFKGRRLEIPKN 659 (706)
Q Consensus 587 ~~~~~----~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~---~~~i~~~~~~l~~p~~ 659 (706)
..... .....++..|+|||.+.+..++.++||||||+++|+|++|..||........ ...+........++..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (268)
T cd06630 156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEH 235 (268)
T ss_pred cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchh
Confidence 43211 1234678899999999888899999999999999999999999975443222 2222222334556677
Q ss_pred CcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 660 VNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 660 ~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
+++++.+++.+||..+|.+||++.+++.
T Consensus 236 ~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 236 LSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred hCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 8999999999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=316.16 Aligned_cols=246 Identities=28% Similarity=0.469 Sum_probs=205.3
Q ss_pred eEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEEec
Q 005247 435 LLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYL 512 (706)
Q Consensus 435 y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~~ 512 (706)
|.....||+|+||.||++.+.. ..+|+|.+.... ....+.+.+|+.+++.++|+||+++++.+...+..++||||+
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 101 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL 101 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch--HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence 4445679999999999998754 458999875432 334567889999999999999999999999999999999999
Q ss_pred cCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcccC
Q 005247 513 SRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISS 592 (706)
Q Consensus 513 ~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~ 592 (706)
++++|.+++... .+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++..........
T Consensus 102 ~~~~L~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~ 175 (292)
T cd06658 102 EGGALTDIVTHT----RMNEEQIATVCLSVLRALSYLHNQG--VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR 175 (292)
T ss_pred CCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCEEEccCcchhhcccccccC
Confidence 999999987532 4788899999999999999999999 9999999999999999999999999987654433333
Q ss_pred CCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhc-CcccCCCCCCcHHHHHHHHHh
Q 005247 593 KTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-GRRLEIPKNVNPMVAALIETC 671 (706)
Q Consensus 593 ~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~-~~~l~~p~~~s~el~dLI~~c 671 (706)
....++..|+|||.+.+..++.++||||||+++|||++|+.||......+....+... ..........+..+.++|.+|
T Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 255 (292)
T cd06658 176 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLM 255 (292)
T ss_pred ceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHHH
Confidence 4456899999999998888999999999999999999999999887766555444221 122223345788999999999
Q ss_pred hhhCCCCCCCHHHHHHH
Q 005247 672 WAEEPEIRPSFPSIMET 688 (706)
Q Consensus 672 L~~dP~~RPS~~eIl~~ 688 (706)
|..||.+|||+.++++.
T Consensus 256 l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 256 LVREPSQRATAQELLQH 272 (292)
T ss_pred ccCChhHCcCHHHHhhC
Confidence 99999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=306.33 Aligned_cols=247 Identities=28% Similarity=0.449 Sum_probs=194.1
Q ss_pred EeccCCceEEEEEEEcCC-c---eEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEEeccCC
Q 005247 440 KIGEGSFGTVYHAEWRNS-D---VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRG 515 (706)
Q Consensus 440 ~LG~G~fG~Vy~a~~~~~-~---vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~~~gg 515 (706)
.||+|+||.||+++.... . +++|.+.... .....+.+.+|+.+++.++||||+++++.+......++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC-ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 589999999999975433 2 3444443322 2344578999999999999999999999999999999999999999
Q ss_pred chhhhcccCCC-cccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCC-c-ccC
Q 005247 516 SLYKLLHIPDA-RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT-Y-ISS 592 (706)
Q Consensus 516 sL~~~l~~~~~-~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~-~-~~~ 592 (706)
+|.++++.... ....++..+..++.||+.||+|||+++ ++||||||+|||++.++.+||+|||++...... . ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN--FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--eeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 99999864322 234667778899999999999999999 999999999999999999999999998643221 1 122
Q ss_pred CCCCCCCCccCcccccc-------CCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCc----ccCCCCCC
Q 005247 593 KTAAGTPEWMAPEVLRE-------DPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGR----RLEIPKNV 660 (706)
Q Consensus 593 ~~~~Gt~~Y~APE~l~~-------~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~----~l~~p~~~ 660 (706)
....++..|+|||++.. ..++.++||||||+++|||++ |..||......+....+..... +..++..+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPY 238 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCC
Confidence 34567889999999753 235779999999999999997 5778887776665554422221 23344567
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 005247 661 NPMVAALIETCWAEEPEIRPSFPSIMETLQ 690 (706)
Q Consensus 661 s~el~dLI~~cL~~dP~~RPS~~eIl~~L~ 690 (706)
++.+.+++..|| .+|++||++++|++.|.
T Consensus 239 ~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 239 SERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred cHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 889999999999 68999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=336.62 Aligned_cols=253 Identities=34% Similarity=0.605 Sum_probs=222.5
Q ss_pred cccCceEEEEEeccCCceEEEEEEEcCC-----ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCc
Q 005247 430 IRWSELLIKKKIGEGSFGTVYHAEWRNS-----DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN 504 (706)
Q Consensus 430 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~-----~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 504 (706)
|..++..+.++||+|.||.|++|.|+.- .||||.+....... ....|++|+.+|.+|+|+|++++||++.+ ..
T Consensus 107 Ipee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~-qp 184 (1039)
T KOG0199|consen 107 IPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD-QP 184 (1039)
T ss_pred ccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc-ch
Confidence 4445667788999999999999998742 28999986655433 66899999999999999999999999987 56
Q ss_pred eEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCcccc
Q 005247 505 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 584 (706)
Q Consensus 505 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~ 584 (706)
..||||+++.|+|.+.|+. ..+..+.......++.||+.|+.||.+++ +|||||...|+|+-....|||+|||+.+.
T Consensus 185 ~mMV~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr--lvHRDLAARNlllasprtVKI~DFGLmRa 261 (1039)
T KOG0199|consen 185 AMMVFELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR--LVHRDLAARNLLLASPRTVKICDFGLMRA 261 (1039)
T ss_pred hhHHhhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh--hhhhhhhhhhheecccceeeeecccceec
Confidence 7899999999999999986 45567888999999999999999999999 99999999999999888999999999998
Q ss_pred CCCCccc---CCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCCCCC
Q 005247 585 KPNTYIS---SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNV 660 (706)
Q Consensus 585 ~~~~~~~---~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~ 660 (706)
.+..... .....-...|+|||.+....++.++|||+|||+||||++ |+.||.+....+++..+. .+.+++-|+.|
T Consensus 262 Lg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD-~~erLpRPk~c 340 (1039)
T KOG0199|consen 262 LGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID-AGERLPRPKYC 340 (1039)
T ss_pred cCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc-ccccCCCCCCC
Confidence 6654321 112234567999999999999999999999999999998 699999999999999997 88899999999
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 005247 661 NPMVAALIETCWAEEPEIRPSFPSIMET 688 (706)
Q Consensus 661 s~el~dLI~~cL~~dP~~RPS~~eIl~~ 688 (706)
+..+++++..||..+|.+||+|..|.+.
T Consensus 341 sedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 341 SEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred hHHHHHHHHHhccCCccccccHHHHHHh
Confidence 9999999999999999999999999753
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=309.16 Aligned_cols=250 Identities=27% Similarity=0.399 Sum_probs=203.1
Q ss_pred ceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEEe
Q 005247 434 ELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY 511 (706)
Q Consensus 434 ~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~ 511 (706)
+|++.+.||.|++|.||+|++..+ .||+|++..... ....+.+.+|+.+++.++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY 79 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc-ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence 588999999999999999998644 499998865432 22335677899999999999999999999999999999999
Q ss_pred ccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCccc
Q 005247 512 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS 591 (706)
Q Consensus 512 ~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~ 591 (706)
+.+ +|.+++........+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++.........
T Consensus 80 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 156 (284)
T cd07836 80 MDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR--VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT 156 (284)
T ss_pred CCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc
Confidence 985 88888765444456899999999999999999999999 999999999999999999999999998765443323
Q ss_pred CCCCCCCCCccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcC--------------c--c-
Q 005247 592 SKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG--------------R--R- 653 (706)
Q Consensus 592 ~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~--------------~--~- 653 (706)
.....++..|++||.+.+. .++.++||||||+++|+|++|..||...+..+....+.... . .
T Consensus 157 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07836 157 FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKP 236 (284)
T ss_pred cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcc
Confidence 3345678899999998664 56889999999999999999999998776554433321100 0 0
Q ss_pred ----------cCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 654 ----------LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 654 ----------l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
..+.+.++..+.++|.+||+.||.+||++.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 237 TFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred cccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0011345788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=297.53 Aligned_cols=246 Identities=32% Similarity=0.554 Sum_probs=208.6
Q ss_pred ceEEEEEeccCCceEEEEEEEc--CCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEEe
Q 005247 434 ELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY 511 (706)
Q Consensus 434 ~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~ 511 (706)
+|++.+.||+|++|.||++.+. +..+++|++..... ...+.+.+|+.+++.++|+||+++++++......++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~ 78 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF 78 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence 4788999999999999999986 44588998765433 4557888999999999999999999999999999999999
Q ss_pred ccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCccc
Q 005247 512 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS 591 (706)
Q Consensus 512 ~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~ 591 (706)
+++++|.+++.... ..+++..+..++.|++.||.+||+++ ++||||+|+||+++.++.++|+|||.+........
T Consensus 79 ~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 153 (253)
T cd05122 79 CSGGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG--IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA- 153 (253)
T ss_pred CCCCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC--EecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence 99999999986432 35889999999999999999999999 99999999999999999999999999887654432
Q ss_pred CCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCC--CCCcHHHHHHHH
Q 005247 592 SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP--KNVNPMVAALIE 669 (706)
Q Consensus 592 ~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p--~~~s~el~dLI~ 669 (706)
.....++..|+|||.+.+...+.++||||||+++|+|++|+.||...+.......... ......+ ..++..+.++|.
T Consensus 154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~ 232 (253)
T cd05122 154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT-NGPPGLRNPEKWSDEFKDFLK 232 (253)
T ss_pred ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-cCCCCcCcccccCHHHHHHHH
Confidence 3456788999999999888899999999999999999999999988765555444432 2222222 234899999999
Q ss_pred HhhhhCCCCCCCHHHHHH
Q 005247 670 TCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 670 ~cL~~dP~~RPS~~eIl~ 687 (706)
+||+.||++|||+.++++
T Consensus 233 ~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 233 KCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred HHccCChhhCCCHHHHhc
Confidence 999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=312.43 Aligned_cols=250 Identities=26% Similarity=0.336 Sum_probs=204.0
Q ss_pred CceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCC--CceEEE
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP--PNLSIV 508 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~--~~~~lV 508 (706)
++|++.+.||+|+||.||+|.+..+ .+++|.++...........+.+|+.++++++||||+++++++... +..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 5788999999999999999998644 489998876554444445677899999999999999999998776 889999
Q ss_pred EEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCC
Q 005247 509 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 588 (706)
Q Consensus 509 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 588 (706)
|||+.+ +|.+++.... ..+++..++.++.||+.||+|||+++ ++|+||||+||+++.++.+||+|||++......
T Consensus 85 ~e~~~~-~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 85 MEYVEH-DLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLHDNW--ILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159 (293)
T ss_pred ehhcCc-CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence 999975 8888886433 25889999999999999999999999 999999999999999999999999998876554
Q ss_pred cccCCCCCCCCCccCccccccCC-CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcC----------------
Q 005247 589 YISSKTAAGTPEWMAPEVLREDP-SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG---------------- 651 (706)
Q Consensus 589 ~~~~~~~~Gt~~Y~APE~l~~~~-~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~---------------- 651 (706)
........+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||......+....+...-
T Consensus 160 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (293)
T cd07843 160 LKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPG 239 (293)
T ss_pred ccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccch
Confidence 33334456788999999987654 6889999999999999999999998776554443321000
Q ss_pred -------------cccCCCCC-CcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 652 -------------RRLEIPKN-VNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 652 -------------~~l~~p~~-~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
....++.. +++.+.+||.+||+.+|++|||+.|++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 240 AKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 00112223 5888999999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=332.99 Aligned_cols=252 Identities=29% Similarity=0.440 Sum_probs=225.3
Q ss_pred cccccCceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCce
Q 005247 428 LEIRWSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNL 505 (706)
Q Consensus 428 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 505 (706)
.......|.+.+.||+|.|++|.+|.+.. +.||+|++.+...+....+.+.+|+++|+.|+|||||+++.+......+
T Consensus 51 ~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~l 130 (596)
T KOG0586|consen 51 DSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATL 130 (596)
T ss_pred ccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeeccee
Confidence 34556789999999999999999998864 4599999999888888878899999999999999999999999999999
Q ss_pred EEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccC
Q 005247 506 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK 585 (706)
Q Consensus 506 ~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~ 585 (706)
|+||||+.+|.+++++...+ ...+..+..++.|+++|++|||+++ |||||||++||||+.+.++||+|||++...
T Consensus 131 ylV~eya~~ge~~~yl~~~g---r~~e~~ar~~F~q~vsaveYcH~k~--ivHrdLk~eNilL~~~mnikIaDfgfS~~~ 205 (596)
T KOG0586|consen 131 YLVMEYASGGELFDYLVKHG---RMKEKEARAKFRQIVSAVEYCHSKN--IVHRDLKAENILLDENMNIKIADFGFSTFF 205 (596)
T ss_pred EEEEEeccCchhHHHHHhcc---cchhhhhhhhhHHHHHHHHHHhhcc--eeccccchhhcccccccceeeeccccceee
Confidence 99999999999999997443 4667889999999999999999999 999999999999999999999999999887
Q ss_pred CCCcccCCCCCCCCCccCccccccCCC-CchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHH
Q 005247 586 PNTYISSKTAAGTPEWMAPEVLREDPS-NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV 664 (706)
Q Consensus 586 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el 664 (706)
... ....+.+|++.|.|||++.+..| .+.+|+||+|++||.|+.|..||.+.+-.+....+... .+.+|--++.++
T Consensus 206 ~~~-~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~g--k~rIp~~ms~dc 282 (596)
T KOG0586|consen 206 DYG-LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRG--KYRIPFYMSCDC 282 (596)
T ss_pred ccc-ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheee--eecccceeechh
Confidence 644 34578999999999999999877 67899999999999999999999998877766665433 445566778899
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHH
Q 005247 665 AALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 665 ~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
.+||+++|-.+|.+|++.++|.+
T Consensus 283 e~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 283 EDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred HHHHHHhhccCccccCCHHHhhh
Confidence 99999999999999999999987
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=310.10 Aligned_cols=252 Identities=27% Similarity=0.310 Sum_probs=199.5
Q ss_pred CceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCC-CCceeEEeccccCCCc-----
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGAVTEPPN----- 504 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~----- 504 (706)
++|++.+.||+|+||.||+|.+.. ..||+|++............+.+|+.+++.+. |+||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 368999999999999999998864 44999987654333334457888999999995 6999999998876655
Q ss_pred eEEEEEeccCCchhhhcccCCC--cccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECC-CCcEEEeecCc
Q 005247 505 LSIVTEYLSRGSLYKLLHIPDA--RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS-TYTVKVCDFGL 581 (706)
Q Consensus 505 ~~lV~E~~~ggsL~~~l~~~~~--~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~-~~~vKL~DFGl 581 (706)
.+++|||+.+ +|.+++..... ...+++..++.++.||+.||.|||+++ |+||||||+||+++. ++.+||+|||+
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~~~nil~~~~~~~~kl~dfg~ 157 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG--VMHRDLKPQNLLVDKQKGLLKIADLGL 157 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEecCCCeEEEeeccc
Confidence 8999999986 78887743221 245789999999999999999999999 999999999999998 88999999999
Q ss_pred cccCCCCcccCCCCCCCCCccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhc-Cc-------
Q 005247 582 SRSKPNTYISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-GR------- 652 (706)
Q Consensus 582 a~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~-~~------- 652 (706)
+..............+++.|+|||.+.+ ..++.++||||||+++|+|++|..||...+..+....+... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (295)
T cd07837 158 GRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWP 237 (295)
T ss_pred ceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCc
Confidence 8765443323334467889999998865 45789999999999999999999999876654443322110 00
Q ss_pred --------------c----cCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 653 --------------R----LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 653 --------------~----l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
. ....+.++.++.+||.+||..||.+||++.+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 238 GVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred chhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0 0011357889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=308.21 Aligned_cols=249 Identities=27% Similarity=0.371 Sum_probs=201.6
Q ss_pred eEEEEEeccCCceEEEEEEEc--CCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEEec
Q 005247 435 LLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYL 512 (706)
Q Consensus 435 y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~~ 512 (706)
|++.+.||.|++|.||+|.+. +..|++|++..........+.+.+|+.+++.++|+||+++++++.+.+..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567899999999999999875 455999988665444444457888999999999999999999999999999999999
Q ss_pred cCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcccC
Q 005247 513 SRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISS 592 (706)
Q Consensus 513 ~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~ 592 (706)
. ++|.+++..... ..+++..++.++.|+++||+|||+++ ++||||+|+||+++.++.++|+|||++..........
T Consensus 81 ~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~~--~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~ 156 (283)
T cd07835 81 D-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSHR--VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY 156 (283)
T ss_pred C-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcccc
Confidence 5 689888864321 35889999999999999999999999 9999999999999999999999999987654333223
Q ss_pred CCCCCCCCccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcC--------------------
Q 005247 593 KTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG-------------------- 651 (706)
Q Consensus 593 ~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~-------------------- 651 (706)
....++..|+|||++.+. .++.++||||||+++|+|++|+.||...+.......+....
T Consensus 157 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd07835 157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPT 236 (283)
T ss_pred CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhh
Confidence 344568899999988764 46889999999999999999999998766543322211000
Q ss_pred -------cccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 652 -------RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 652 -------~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
........++.++.++|.+||+.+|++|||++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 237 FPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred cccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 001123456789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=323.67 Aligned_cols=243 Identities=24% Similarity=0.354 Sum_probs=191.0
Q ss_pred ccCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEE
Q 005247 431 RWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIV 508 (706)
Q Consensus 431 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV 508 (706)
....|++++.||+|+||.||+|.+.++ .||+|+.... ....|+.++++++|+||+++++++...+..++|
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence 345799999999999999999998765 4888874322 235689999999999999999999999999999
Q ss_pred EEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCC
Q 005247 509 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 588 (706)
Q Consensus 509 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 588 (706)
||++. ++|.+++.... ..+++..+..++.||+.||.|||++| ||||||||+|||++.++.+||+|||+++.....
T Consensus 136 ~e~~~-~~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 210 (357)
T PHA03209 136 LPHYS-SDLYTYLTKRS--RPLPIDQALIIEKQILEGLRYLHAQR--IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA 210 (357)
T ss_pred EEccC-CcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence 99995 57888775332 35889999999999999999999999 999999999999999999999999998753322
Q ss_pred cccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCC-CCCChH----------HHHHHhhh-cCcccCC
Q 005247 589 YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPW-RNSTPS----------QVISAVGF-KGRRLEI 656 (706)
Q Consensus 589 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf-~~~~~~----------~~~~~i~~-~~~~l~~ 656 (706)
. ......||..|+|||++.+..++.++|||||||++|||+++..|+ ...... .....+.. ...+..+
T Consensus 211 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 289 (357)
T PHA03209 211 P-AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEF 289 (357)
T ss_pred c-ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhc
Confidence 1 223457899999999999999999999999999999999875554 321110 01110100 0001111
Q ss_pred C------------------------------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 657 P------------------------------KNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 657 p------------------------------~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
+ .+++.++.+||.+||+.||++|||+.|+++
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~ 350 (357)
T PHA03209 290 PRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILN 350 (357)
T ss_pred CCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhc
Confidence 1 145667788999999999999999999986
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=308.41 Aligned_cols=250 Identities=26% Similarity=0.357 Sum_probs=197.6
Q ss_pred cCceEEEEEeccCCceEEEEEEEc--CCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEE
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 509 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~ 509 (706)
.++|++.+.||+|+||.||+|.+. +..||+|.+...... .....+.+|+++++.++|+||+++++++.+.+..++||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVF 82 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEE
Confidence 467999999999999999999875 345999998654322 22245678999999999999999999999999999999
Q ss_pred EeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCc
Q 005247 510 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 589 (706)
Q Consensus 510 E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 589 (706)
||+.+ +|.+++.... ..+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++......
T Consensus 83 e~~~~-~L~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 83 EYLDT-DLKQYMDDCG--GGLSMHNVRLFLFQLLRGLAYCHQRR--VLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157 (291)
T ss_pred ecCCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence 99975 8888876432 25788999999999999999999999 9999999999999999999999999987654332
Q ss_pred ccCCCCCCCCCccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHhhhc-C---------------
Q 005247 590 ISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNST-PSQVISAVGFK-G--------------- 651 (706)
Q Consensus 590 ~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~ELltG~~Pf~~~~-~~~~~~~i~~~-~--------------- 651 (706)
.......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.... ..+....+... .
T Consensus 158 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07844 158 KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE 237 (291)
T ss_pred ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence 22233457889999999876 457899999999999999999999997654 22222111100 0
Q ss_pred ---ccc---------CCCCCCc--HHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 652 ---RRL---------EIPKNVN--PMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 652 ---~~l---------~~p~~~s--~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
... .....++ .++.++|.+||+.+|++|||+.+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 000 0001233 78899999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=312.44 Aligned_cols=252 Identities=26% Similarity=0.344 Sum_probs=202.9
Q ss_pred ccCceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCC--CceE
Q 005247 431 RWSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP--PNLS 506 (706)
Q Consensus 431 ~~~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~--~~~~ 506 (706)
...+|++.+.||+|+||.||+|.+.. ..||+|++............+.+|+.++++++|+||+++++++... +..+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 34689999999999999999998864 4599998865543333334567899999999999999999998654 5689
Q ss_pred EEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCC
Q 005247 507 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP 586 (706)
Q Consensus 507 lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~ 586 (706)
+||||+.+ +|.+++.... ..+++..++.++.||+.||.|||+.| ++||||||+||+++.++.+||+|||++....
T Consensus 85 lv~e~~~~-~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 85 LVMEYCEQ-DLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHENF--IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEEecCCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 99999965 7887775432 35889999999999999999999999 9999999999999999999999999998765
Q ss_pred CCcccCCCCCCCCCccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCc-------------
Q 005247 587 NTYISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR------------- 652 (706)
Q Consensus 587 ~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~------------- 652 (706)
..........++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+..+....+.....
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07845 160 LPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDL 239 (309)
T ss_pred CccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcc
Confidence 43323334456788999999876 4578999999999999999999999988877666544421100
Q ss_pred ----ccCCC-----------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 653 ----RLEIP-----------KNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 653 ----~l~~p-----------~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
...++ ...++++.+||.+||+.||++|||++++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 240 PLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred cccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00111 125788999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=309.08 Aligned_cols=249 Identities=30% Similarity=0.510 Sum_probs=210.5
Q ss_pred cCceEEEEEeccCCceEEEEEEEc--CCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEE
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 509 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~ 509 (706)
...|++.+.||+|+||.||++.+. +..+++|++..... ..+.+.+|+++++.++|+||+++++++...+..++++
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 456888899999999999999887 45599999865433 4567889999999999999999999999999999999
Q ss_pred EeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCc
Q 005247 510 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 589 (706)
Q Consensus 510 E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 589 (706)
||+.+++|.+++.... ..+++..+..++.|++.||+|||+.| ++|+||+|+||+++.++.++|+|||++.......
T Consensus 95 e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g--i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 95 EYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN--VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred eccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 9999999999997543 35889999999999999999999999 9999999999999999999999999887554433
Q ss_pred ccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCc-ccCCCCCCcHHHHHHH
Q 005247 590 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR-RLEIPKNVNPMVAALI 668 (706)
Q Consensus 590 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~-~l~~p~~~s~el~dLI 668 (706)
.......++..|+|||.+.+..++.++||||||+++|+|++|..||....+......+..... ....+..++.++.++|
T Consensus 171 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 250 (286)
T cd06614 171 SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFL 250 (286)
T ss_pred hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHH
Confidence 233445678899999999988899999999999999999999999988776555444422221 2223344889999999
Q ss_pred HHhhhhCCCCCCCHHHHHH
Q 005247 669 ETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 669 ~~cL~~dP~~RPS~~eIl~ 687 (706)
.+||+.+|.+||++.++++
T Consensus 251 ~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 251 NKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred HHHhccChhhCcCHHHHhh
Confidence 9999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=313.59 Aligned_cols=245 Identities=27% Similarity=0.475 Sum_probs=205.8
Q ss_pred eEEEEEeccCCceEEEEEEEc--CCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEEec
Q 005247 435 LLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYL 512 (706)
Q Consensus 435 y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~~ 512 (706)
|.....||+|+||.||++.+. +..||+|++..... ...+.+.+|+.+++.++||||+++++++...+..+++|||+
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~ 100 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFL 100 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc--chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecC
Confidence 334557999999999999875 45599999865432 23456889999999999999999999999999999999999
Q ss_pred cCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcccC
Q 005247 513 SRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISS 592 (706)
Q Consensus 513 ~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~ 592 (706)
++++|..++.. ..+++..++.++.|++.||+|||+++ ++||||||+||+++.++.+||+|||++..........
T Consensus 101 ~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~ 174 (297)
T cd06659 101 QGGALTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQG--VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR 174 (297)
T ss_pred CCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHeEEccCCcEEEeechhHhhcccccccc
Confidence 99999988753 24788999999999999999999999 9999999999999999999999999987654443333
Q ss_pred CCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcC-cccCCCCCCcHHHHHHHHHh
Q 005247 593 KTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG-RRLEIPKNVNPMVAALIETC 671 (706)
Q Consensus 593 ~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~-~~l~~p~~~s~el~dLI~~c 671 (706)
....++..|+|||.+.+..++.++||||||+++|||++|+.||....+.+....+.... .....+..++..+.++|.+|
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~ 254 (297)
T cd06659 175 KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERM 254 (297)
T ss_pred cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHH
Confidence 45678999999999998889999999999999999999999998777666555443211 12233456789999999999
Q ss_pred hhhCCCCCCCHHHHHH
Q 005247 672 WAEEPEIRPSFPSIME 687 (706)
Q Consensus 672 L~~dP~~RPS~~eIl~ 687 (706)
|+.+|++||++.++++
T Consensus 255 l~~~P~~Rps~~~ll~ 270 (297)
T cd06659 255 LTREPQERATAQELLD 270 (297)
T ss_pred hcCCcccCcCHHHHhh
Confidence 9999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=307.72 Aligned_cols=251 Identities=27% Similarity=0.396 Sum_probs=201.9
Q ss_pred CceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEE
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 510 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E 510 (706)
++|++.+.||+|++|.||+|.+.. ..|++|.+..........+.+.+|+.++++++|+||+++++++......++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 579999999999999999998764 349999876554444445678899999999999999999999999999999999
Q ss_pred eccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECC-CCcEEEeecCccccCCCCc
Q 005247 511 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS-TYTVKVCDFGLSRSKPNTY 589 (706)
Q Consensus 511 ~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~-~~~vKL~DFGla~~~~~~~ 589 (706)
|+.+ +|.+.+.... ...+++..++.++.||+.||+|||+++ ++||||||+||+++. ++.+||+|||++.......
T Consensus 82 ~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 82 YLDL-DLKKHMDSSP-DFAKNPRLIKTYLYQILRGIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred cccc-cHHHHHHhCC-CCCcCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 9964 7777764322 224678888999999999999999999 999999999999985 5579999999997654433
Q ss_pred ccCCCCCCCCCccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhc-Ccc--------------
Q 005247 590 ISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-GRR-------------- 653 (706)
Q Consensus 590 ~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~-~~~-------------- 653 (706)
.......+++.|+|||.+.+. .++.++||||||+++|+|++|+.||......+....+... ...
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (294)
T PLN00009 158 RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDY 237 (294)
T ss_pred cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhh
Confidence 233445678899999998764 5788999999999999999999999877665544332110 000
Q ss_pred ------------cCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 654 ------------LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 654 ------------l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
....+..++++.++|.+||+.+|++||++.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 238 KSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred hhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0012456889999999999999999999999986
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=306.26 Aligned_cols=250 Identities=26% Similarity=0.347 Sum_probs=195.4
Q ss_pred cCceEEEEEeccCCceEEEEEEEc--CCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEE
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 509 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~ 509 (706)
..+|++.+.||+|+||.||+|.+. +..+++|++..... ......+.+|+.+++.++|+||+++++++...+..++||
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 367999999999999999999875 45599999865432 222345678999999999999999999999999999999
Q ss_pred EeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCc
Q 005247 510 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 589 (706)
Q Consensus 510 E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 589 (706)
||+. ++|.+++.... ..+.+..+..++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||+++......
T Consensus 83 e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 157 (291)
T cd07870 83 EYMH-TDLAQYMIQHP--GGLHPYNVRLFMFQLLRGLAYIHGQH--ILHRDLKPQNLLISYLGELKLADFGLARAKSIPS 157 (291)
T ss_pred eccc-CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence 9996 56666654322 24677888899999999999999999 9999999999999999999999999987654433
Q ss_pred ccCCCCCCCCCccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHhhh-cC---------------
Q 005247 590 ISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPS-QVISAVGF-KG--------------- 651 (706)
Q Consensus 590 ~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~-~~~~~i~~-~~--------------- 651 (706)
.......++..|+|||.+.+. .++.++||||||+++|+|++|..||...... +....+.. .+
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07870 158 QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPN 237 (291)
T ss_pred CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccc
Confidence 333445678999999998764 4788999999999999999999999765432 11111100 00
Q ss_pred c-----ccCCC-------C--CCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 652 R-----RLEIP-------K--NVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 652 ~-----~l~~p-------~--~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
. ....+ . ..+..+.+++.+||..||.+|||+.+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 238 YKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred ccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0 00000 0 12578999999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=304.56 Aligned_cols=249 Identities=30% Similarity=0.481 Sum_probs=201.7
Q ss_pred CceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccC--CCceEEE
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE--PPNLSIV 508 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~--~~~~~lV 508 (706)
++|+..+.||.|++|.||++.+.++ .+|+|.+..... ......+.+|+++++.++|+||+++++++.+ .+.+++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 3688999999999999999998643 489998865432 3445778999999999999999999998754 3468999
Q ss_pred EEeccCCchhhhccc-CCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCC
Q 005247 509 TEYLSRGSLYKLLHI-PDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 587 (706)
Q Consensus 509 ~E~~~ggsL~~~l~~-~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 587 (706)
|||+++++|.+++.. ......+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~--i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK--IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999999988742 122345788899999999999999999999 99999999999999999999999999876543
Q ss_pred CcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC-----ChHHHHHHhhhcCcccCCC-----
Q 005247 588 TYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNS-----TPSQVISAVGFKGRRLEIP----- 657 (706)
Q Consensus 588 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~-----~~~~~~~~i~~~~~~l~~p----- 657 (706)
.. .....++..|+|||.+.+..++.++||||||+++|+|++|..||... ...+....+. ......++
T Consensus 158 ~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 234 (287)
T cd06621 158 SL--AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIV-NMPNPELKDEPGN 234 (287)
T ss_pred cc--cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHh-cCCchhhccCCCC
Confidence 32 12456788999999999989999999999999999999999999765 2223333222 11122222
Q ss_pred -CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 658 -KNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 658 -~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
..+++.+.+||.+||..+|.+|||+.|+++
T Consensus 235 ~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 235 GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred CCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 234678999999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=309.93 Aligned_cols=246 Identities=28% Similarity=0.450 Sum_probs=203.5
Q ss_pred CceEEEEEeccCCceEEEEEEEc--CCceEEEEEeccc-cchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEE
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQE-FHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 509 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKvl~~~~-~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~ 509 (706)
..|.+.+.||+|+||.||+|.+. +..|++|++.... ......+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45888999999999999999875 4459999885443 33445567899999999999999999999999999999999
Q ss_pred EeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCc
Q 005247 510 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 589 (706)
Q Consensus 510 E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 589 (706)
||+. |++.+++.... ..+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.+||+|||++......
T Consensus 95 e~~~-g~l~~~~~~~~--~~l~~~~~~~~~~ql~~~L~~LH~~~--i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~- 168 (307)
T cd06607 95 EYCL-GSASDILEVHK--KPLQEVEIAAICHGALQGLAYLHSHE--RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA- 168 (307)
T ss_pred HhhC-CCHHHHHHHcc--cCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEECCCCCEEEeecCcceecCCC-
Confidence 9997 46666664322 24889999999999999999999999 999999999999999999999999998754322
Q ss_pred ccCCCCCCCCCccCccccc---cCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHH
Q 005247 590 ISSKTAAGTPEWMAPEVLR---EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA 666 (706)
Q Consensus 590 ~~~~~~~Gt~~Y~APE~l~---~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~d 666 (706)
....++..|+|||++. ...++.++||||||+++|||++|..||...+.......+.........+..++..+.+
T Consensus 169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (307)
T cd06607 169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRN 245 (307)
T ss_pred ---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHH
Confidence 3456788999999884 3567889999999999999999999998877666555443322222223457889999
Q ss_pred HHHHhhhhCCCCCCCHHHHHH
Q 005247 667 LIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 667 LI~~cL~~dP~~RPS~~eIl~ 687 (706)
+|.+||+.+|++||++.+|+.
T Consensus 246 li~~~l~~~p~~Rp~~~~il~ 266 (307)
T cd06607 246 FVDSCLQKIPQDRPSSEELLK 266 (307)
T ss_pred HHHHHhcCChhhCcCHHHHhc
Confidence 999999999999999999987
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=329.44 Aligned_cols=244 Identities=27% Similarity=0.440 Sum_probs=209.5
Q ss_pred eEEEEEeccCCceEEEEEEEcCCc--eEEEEEecccc-chHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEEe
Q 005247 435 LLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY 511 (706)
Q Consensus 435 y~i~~~LG~G~fG~Vy~a~~~~~~--vAVKvl~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~ 511 (706)
|.-++.||.|+||.||-|.+..+. ||||.+..+.. ..+....++.|+..|++++|||++.+-+++..+...|+||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 344678999999999999886544 89999866543 346678999999999999999999999999999999999999
Q ss_pred ccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCccc
Q 005247 512 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS 591 (706)
Q Consensus 512 ~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~ 591 (706)
|-| +-.+++...+ .++-+..++.|..+.+.||+|||+++ .||||||..|||+++.|.|||+|||.|.....
T Consensus 108 ClG-SAsDlleVhk--KplqEvEIAAi~~gaL~gLaYLHS~~--~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P---- 178 (948)
T KOG0577|consen 108 CLG-SASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSHN--RIHRDIKAGNILLSEPGLVKLADFGSASIMAP---- 178 (948)
T ss_pred Hhc-cHHHHHHHHh--ccchHHHHHHHHHHHHHHHHHHHHhh--HHhhhccccceEecCCCeeeeccccchhhcCc----
Confidence 954 7777775332 35889999999999999999999999 99999999999999999999999998875432
Q ss_pred CCCCCCCCCccCcccccc---CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHH
Q 005247 592 SKTAAGTPEWMAPEVLRE---DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI 668 (706)
Q Consensus 592 ~~~~~Gt~~Y~APE~l~~---~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI 668 (706)
..+++|||+|||||++.. +.|+-|+||||||++..||...++|+...+....+..|..+..+.-....++..+++|+
T Consensus 179 AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fv 258 (948)
T KOG0577|consen 179 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFV 258 (948)
T ss_pred hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHH
Confidence 257899999999999864 67999999999999999999999999888888887777544433333456899999999
Q ss_pred HHhhhhCCCCCCCHHHHHH
Q 005247 669 ETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 669 ~~cL~~dP~~RPS~~eIl~ 687 (706)
..||++-|.+|||.+++++
T Consensus 259 d~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 259 DSCLQKIPQERPTSEELLK 277 (948)
T ss_pred HHHHhhCcccCCcHHHHhh
Confidence 9999999999999999876
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=303.78 Aligned_cols=248 Identities=29% Similarity=0.487 Sum_probs=211.1
Q ss_pred CceEEEEEeccCCceEEEEEEEc--CCceEEEEEecccc-chHHHHHHHHHHHHHHcCC-CCceeEEeccccCCCceEEE
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEF-HEDRFKEFLREVAIMKGLR-HPNIVLLMGAVTEPPNLSIV 508 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKvl~~~~~-~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~lV 508 (706)
++|++.+.||+|+||.||++... +..+++|++..... .....+.+.+|+.++++++ |+||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 37899999999999999999885 44599999866433 3344567889999999998 99999999999999999999
Q ss_pred EEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCC
Q 005247 509 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 588 (706)
Q Consensus 509 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 588 (706)
||++.+++|.+++.... .+++..++.++.|++.||.|||++| ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~Lh~~~--~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 81 LEYAPNGELLQYIRKYG---SLDEKCTRFYAAEILLALEYLHSKG--IIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred EcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 99999999999997432 5899999999999999999999999 999999999999999999999999998765432
Q ss_pred c--------------------ccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh
Q 005247 589 Y--------------------ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVG 648 (706)
Q Consensus 589 ~--------------------~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~ 648 (706)
. .......++..|+|||++.+...+.++||||||+++|++++|+.||...........+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~ 235 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKIL 235 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH
Confidence 2 11223457889999999988889999999999999999999999999877655554442
Q ss_pred hcCcccCCCCCCcHHHHHHHHHhhhhCCCCCCCH----HHHHH
Q 005247 649 FKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSF----PSIME 687 (706)
Q Consensus 649 ~~~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~----~eIl~ 687 (706)
.....++..+++.+.+||.+||+.+|.+||++ .+++.
T Consensus 236 --~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 236 --KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred --hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 34456777889999999999999999999999 66653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=311.76 Aligned_cols=243 Identities=22% Similarity=0.378 Sum_probs=184.3
Q ss_pred EEEeccCCceEEEEEEEcC----CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEecccc--CCCceEEEEEe
Q 005247 438 KKKIGEGSFGTVYHAEWRN----SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT--EPPNLSIVTEY 511 (706)
Q Consensus 438 ~~~LG~G~fG~Vy~a~~~~----~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~--~~~~~~lV~E~ 511 (706)
..+||+|+||.||+|...+ ..+|+|.+..... ...+.+|+.+++.++||||+++++++. .+...++||||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 3689999999999998653 3489998754432 235678999999999999999999874 45568999999
Q ss_pred ccCCchhhhcccC------CCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEE----CCCCcEEEeecCc
Q 005247 512 LSRGSLYKLLHIP------DARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLV----DSTYTVKVCDFGL 581 (706)
Q Consensus 512 ~~ggsL~~~l~~~------~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl----~~~~~vKL~DFGl 581 (706)
+.+ +|.+++... .....+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 82 AEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred eCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 865 676666321 12235788999999999999999999999 9999999999999 4567899999999
Q ss_pred cccCCCCcc---cCCCCCCCCCccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHH----------HHHHh
Q 005247 582 SRSKPNTYI---SSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQ----------VISAV 647 (706)
Q Consensus 582 a~~~~~~~~---~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~----------~~~~i 647 (706)
++....... ......+|+.|+|||++.+. .++.++|||||||++|||+||..||....... .....
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~ 238 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIF 238 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHH
Confidence 987554322 12345689999999998774 57899999999999999999999997543210 00000
Q ss_pred hhcC-------------------------cc----------cCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 648 GFKG-------------------------RR----------LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 648 ~~~~-------------------------~~----------l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
...+ .. .......+..+.+||.+||+.||.+|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~ 313 (317)
T cd07867 239 SVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ 313 (317)
T ss_pred HhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc
Confidence 0000 00 0001123467889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=316.55 Aligned_cols=247 Identities=26% Similarity=0.330 Sum_probs=199.4
Q ss_pred cCceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCC------C
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP------P 503 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~------~ 503 (706)
..+|++.+.||+|+||.||+|.+.. ..+|+|++..........+.+.+|+.+++.++|+||+++++++... .
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 4679999999999999999998754 4599998865444445556788999999999999999999987543 3
Q ss_pred ceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccc
Q 005247 504 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 583 (706)
Q Consensus 504 ~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~ 583 (706)
..++||||+.+ +|.+.+.. .+++..+..++.|++.||+|||++| |+||||||+||+++.++.+||+|||+++
T Consensus 95 ~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 166 (353)
T cd07850 95 DVYLVMELMDA-NLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR 166 (353)
T ss_pred cEEEEEeccCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEccCccce
Confidence 57999999964 77777652 2778889999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhc-------------
Q 005247 584 SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK------------- 650 (706)
Q Consensus 584 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~------------- 650 (706)
...... ......++..|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+...
T Consensus 167 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (353)
T cd07850 167 TAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQ 245 (353)
T ss_pred eCCCCC-CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence 765432 223456889999999999999999999999999999999999999866543322221100
Q ss_pred -------Cccc--------------CC-------CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 651 -------GRRL--------------EI-------PKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 651 -------~~~l--------------~~-------p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
..+. .. +...+.++.+||.+||+.||++|||+.+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 246 PTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred hhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0000 00 1134667899999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=301.75 Aligned_cols=243 Identities=30% Similarity=0.486 Sum_probs=205.1
Q ss_pred eccCCceEEEEEEEc--CCceEEEEEecccc-chHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEEeccCCch
Q 005247 441 IGEGSFGTVYHAEWR--NSDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSL 517 (706)
Q Consensus 441 LG~G~fG~Vy~a~~~--~~~vAVKvl~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL 517 (706)
||.|+||.||++.+. +..+++|++..... .....+.+.+|++++++++|+||+++++.+......++++||+.+++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999986 44599998865433 234556788999999999999999999999999999999999999999
Q ss_pred hhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcc-------
Q 005247 518 YKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI------- 590 (706)
Q Consensus 518 ~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~------- 590 (706)
.++++... .+++..+..++.||+.||+|||+++ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 81 ASLLENVG---SLDEDVARIYIAEIVLALEYLHSNG--IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcC--eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 99987433 5889999999999999999999999 99999999999999999999999999876433311
Q ss_pred -cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCC--cHHHHHH
Q 005247 591 -SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNV--NPMVAAL 667 (706)
Q Consensus 591 -~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~--s~el~dL 667 (706)
......++..|+|||.+.+...+.++||||||+++|+|++|..||......+....+.. .....+..+ +..+.++
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 233 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN--GKIEWPEDVEVSDEAIDL 233 (265)
T ss_pred ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--CCcCCCccccCCHHHHHH
Confidence 22344678899999999888899999999999999999999999998887777666543 334445544 8999999
Q ss_pred HHHhhhhCCCCCCCHHHHHHHHH
Q 005247 668 IETCWAEEPEIRPSFPSIMETLQ 690 (706)
Q Consensus 668 I~~cL~~dP~~RPS~~eIl~~L~ 690 (706)
|.+||+.+|.+|||+.++.+.|+
T Consensus 234 i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 234 ISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred HHHHhcCCHhhcCCCccHHHHhc
Confidence 99999999999999955555443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=313.06 Aligned_cols=253 Identities=26% Similarity=0.383 Sum_probs=200.0
Q ss_pred ceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCC-----ceE
Q 005247 434 ELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP-----NLS 506 (706)
Q Consensus 434 ~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~-----~~~ 506 (706)
.|.-.+.+|.|+||.||+|....+ .+|||......- .--+|+++|+.+.|||||+++.+|.... ...
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 577789999999999999987654 499988754432 1227999999999999999998875322 345
Q ss_pred EEEEeccCCchhhhccc-CCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCC-CcEEEeecCcccc
Q 005247 507 IVTEYLSRGSLYKLLHI-PDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST-YTVKVCDFGLSRS 584 (706)
Q Consensus 507 lV~E~~~ggsL~~~l~~-~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~-~~vKL~DFGla~~ 584 (706)
+||||++. +|++.++. ...+..++...++-+..||++||+|||+.| |+||||||.|+|+|.+ |.+||||||.|+.
T Consensus 99 lVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~--IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 99 LVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG--ICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC--cccCCCChheEEEcCCCCeEEeccCCccee
Confidence 89999976 88888862 223345788888889999999999999999 9999999999999965 8999999999987
Q ss_pred CCCCcccCCCCCCCCCccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCc-----------
Q 005247 585 KPNTYISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR----------- 652 (706)
Q Consensus 585 ~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~----------- 652 (706)
...+..+ .+..-|..|+|||.+.+. .|+.+.||||.||++.||+.|++.|.+.+..+....+...-.
T Consensus 176 L~~~epn-iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn 254 (364)
T KOG0658|consen 176 LVKGEPN-ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMN 254 (364)
T ss_pred eccCCCc-eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcC
Confidence 6554332 456678999999999885 589999999999999999999999998776555444321100
Q ss_pred ----ccC------------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH--HHHHHHHhc
Q 005247 653 ----RLE------------IPKNVNPMVAALIETCWAEEPEIRPSFPSIME--TLQQFLMSS 696 (706)
Q Consensus 653 ----~l~------------~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~--~L~~ll~s~ 696 (706)
... +....+++..+|+.++|..+|.+|.++.|++. ++..+....
T Consensus 255 ~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~ 316 (364)
T KOG0658|consen 255 PNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPN 316 (364)
T ss_pred cccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcC
Confidence 001 23457899999999999999999999999886 455554443
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=304.95 Aligned_cols=243 Identities=28% Similarity=0.376 Sum_probs=199.2
Q ss_pred eccCCceEEEEEEEcC--CceEEEEEeccccch-HHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEEeccCCch
Q 005247 441 IGEGSFGTVYHAEWRN--SDVAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSL 517 (706)
Q Consensus 441 LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~-~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL 517 (706)
||+|+||+||++.+.. ..+++|++....... .....+.+|+.+++.++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 6899999999998764 459999886543322 2345677899999999999999999999999999999999999999
Q ss_pred hhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcccCCCCCC
Q 005247 518 YKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAG 597 (706)
Q Consensus 518 ~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~G 597 (706)
.+++..... ..+++..+..++.|++.||.|||+++ ++||||+|+||+++.++.+||+|||++...... .......+
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~ 156 (277)
T cd05577 81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR--IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG-KKIKGRAG 156 (277)
T ss_pred HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEccCcchhhhccC-CccccccC
Confidence 998864332 35889999999999999999999999 999999999999999999999999998765432 12234567
Q ss_pred CCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHh--hhcCcccCCCCCCcHHHHHHHHHhhhhC
Q 005247 598 TPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAV--GFKGRRLEIPKNVNPMVAALIETCWAEE 675 (706)
Q Consensus 598 t~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i--~~~~~~l~~p~~~s~el~dLI~~cL~~d 675 (706)
+..|+|||.+.+..++.++||||||+++|+|++|+.||...........+ .........+..+++.+.++|.+||+.+
T Consensus 157 ~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 236 (277)
T cd05577 157 TPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKD 236 (277)
T ss_pred CCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCC
Confidence 88999999998888999999999999999999999999765431111111 1123345567778999999999999999
Q ss_pred CCCCC-----CHHHHHH
Q 005247 676 PEIRP-----SFPSIME 687 (706)
Q Consensus 676 P~~RP-----S~~eIl~ 687 (706)
|++|| ++.+++.
T Consensus 237 p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 237 PEKRLGCRGGSADEVRE 253 (277)
T ss_pred hhHccCCCcccHHHHHh
Confidence 99999 6666764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=308.68 Aligned_cols=249 Identities=27% Similarity=0.468 Sum_probs=207.6
Q ss_pred cCceEEEEEeccCCceEEEEEEEc--CCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEE
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 509 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~ 509 (706)
..+|++.+.||+|+||.||++... +..+++|.+.... ....+.+.+|+.+++.++||||+++++.+...+..++|+
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~ 95 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ--QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM 95 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc--chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence 468999999999999999999764 3459999875432 233467889999999999999999999999999999999
Q ss_pred EeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCc
Q 005247 510 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 589 (706)
Q Consensus 510 E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 589 (706)
||+++++|.+++... .+++..+..++.|++.||.|||++| ++||||||+||+++.++.+||+|||++.......
T Consensus 96 e~~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~g--i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~ 169 (293)
T cd06647 96 EYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (293)
T ss_pred ecCCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC--EeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence 999999999998632 3678889999999999999999999 9999999999999999999999999887654433
Q ss_pred ccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhc-CcccCCCCCCcHHHHHHH
Q 005247 590 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-GRRLEIPKNVNPMVAALI 668 (706)
Q Consensus 590 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~-~~~l~~p~~~s~el~dLI 668 (706)
.......+++.|+|||.+.+..++.++||||||+++|++++|+.||...+.......+... ......+..++..++++|
T Consensus 170 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 249 (293)
T cd06647 170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFL 249 (293)
T ss_pred cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHH
Confidence 3334456888999999998888999999999999999999999999877654443332211 112233455788999999
Q ss_pred HHhhhhCCCCCCCHHHHHHH
Q 005247 669 ETCWAEEPEIRPSFPSIMET 688 (706)
Q Consensus 669 ~~cL~~dP~~RPS~~eIl~~ 688 (706)
.+||..+|++||++.+++..
T Consensus 250 ~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 250 NRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred HHHccCChhhCcCHHHHhcC
Confidence 99999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=328.92 Aligned_cols=244 Identities=22% Similarity=0.298 Sum_probs=193.7
Q ss_pred cCceEEEEEeccCCceEEEEEEEcCCc--eEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEE
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 509 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~--vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~ 509 (706)
...|.+.+.||+|+||.||++.+.... ||+|.... ..+.+|++++++++|+||+++++++...+..++||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~ 239 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVL 239 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 457999999999999999999987654 88885321 24568999999999999999999999999999999
Q ss_pred EeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCc
Q 005247 510 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 589 (706)
Q Consensus 510 E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 589 (706)
|++. ++|.+++.... ..+++..++.++.||+.||.|||++| ||||||||+|||++.++.+||+|||+++......
T Consensus 240 e~~~-~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 240 PKYR-SDLYTYLGARL--RPLGLAQVTAVARQLLSAIDYIHGEG--IIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred EccC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--EEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 9995 68888775322 25889999999999999999999999 9999999999999999999999999997653321
Q ss_pred c--cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHhhhcCcc-cCCC-
Q 005247 590 I--SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNST--------PSQVISAVGFKGRR-LEIP- 657 (706)
Q Consensus 590 ~--~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~--------~~~~~~~i~~~~~~-l~~p- 657 (706)
. ......||..|+|||++.+..++.++|||||||+||||++|..|+.... ..++...+...... ..++
T Consensus 315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~ 394 (461)
T PHA03211 315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ 394 (461)
T ss_pred ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence 1 1224579999999999999999999999999999999999876543211 12222222111100 0000
Q ss_pred ------------------------------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 005247 658 ------------------------------KNVNPMVAALIETCWAEEPEIRPSFPSIMET 688 (706)
Q Consensus 658 ------------------------------~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~ 688 (706)
..++..+.+||.+||+.||++|||+.|+++.
T Consensus 395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred CcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 1345689999999999999999999999863
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=307.01 Aligned_cols=255 Identities=19% Similarity=0.238 Sum_probs=187.8
Q ss_pred ccccCceEEEEEeccCCceEEEEEEEcCC-----ceEEEEEeccccch--HH-------HHHHHHHHHHHHcCCCCceeE
Q 005247 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNS-----DVAVKILIEQEFHE--DR-------FKEFLREVAIMKGLRHPNIVL 494 (706)
Q Consensus 429 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~-----~vAVKvl~~~~~~~--~~-------~~~~~~Ei~iL~~L~HpnIv~ 494 (706)
++...+|++.+.||+|+||.||+|.+.++ .+++|+........ +. ......++..+..+.|+||++
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~ 87 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK 87 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence 45567899999999999999999987665 35666543222110 00 011233445566778999999
Q ss_pred EeccccCCC----ceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECC
Q 005247 495 LMGAVTEPP----NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS 570 (706)
Q Consensus 495 l~~~~~~~~----~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~ 570 (706)
+++++.... ..+++++++.. ++.+++... ...++..+..++.|++.||+|||+++ |+||||||+|||++.
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~--iiHrDiKp~Nill~~ 161 (294)
T PHA02882 88 YYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRI---KCKNKKLIKNIMKDMLTTLEYIHEHG--ISHGDIKPENIMVDG 161 (294)
T ss_pred EEEeeeEecCCceEEEEEEehhcc-CHHHHHHhh---ccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcC
Confidence 998765433 24677887643 565655422 13567888999999999999999999 999999999999999
Q ss_pred CCcEEEeecCccccCCCCc-------ccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HH
Q 005247 571 TYTVKVCDFGLSRSKPNTY-------ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTP-SQ 642 (706)
Q Consensus 571 ~~~vKL~DFGla~~~~~~~-------~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~-~~ 642 (706)
++.++|+|||+|+...... .......||+.|+|||++.+..++.++|||||||++|||++|..||..... ..
T Consensus 162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~ 241 (294)
T PHA02882 162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN 241 (294)
T ss_pred CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH
Confidence 9999999999997643211 111234699999999999999999999999999999999999999987632 22
Q ss_pred HHHHh-----hhcCcccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 005247 643 VISAV-----GFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETL 689 (706)
Q Consensus 643 ~~~~i-----~~~~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L 689 (706)
..... ............+++++.+++..||..+|++||++++|++.|
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 242 LIHAAKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHHhHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 11111 000111112346789999999999999999999999998876
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=300.83 Aligned_cols=250 Identities=28% Similarity=0.493 Sum_probs=206.6
Q ss_pred ceEEEEEeccCCceEEEEEEEcCC--ceEEEEEecc---ccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEE
Q 005247 434 ELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQ---EFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIV 508 (706)
Q Consensus 434 ~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~---~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV 508 (706)
+|.+.+.||+|+||.||++.+... .+++|+++.. .........+.+|+.+++.++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 488999999999999999987654 3666665432 22333345677899999999999999999999999999999
Q ss_pred EEeccCCchhhhcccC-CCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCC
Q 005247 509 TEYLSRGSLYKLLHIP-DARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 587 (706)
Q Consensus 509 ~E~~~ggsL~~~l~~~-~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 587 (706)
|||+++++|.+++... .....+++..++.++.|++.||.|||+++ ++|+||||+||+++. +.+||+|||++.....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR--ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC--ccccCCChhheEeec-CCEeecccCceeecCC
Confidence 9999999999888531 22346889999999999999999999999 999999999999975 5799999999876544
Q ss_pred CcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHH
Q 005247 588 TYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAAL 667 (706)
Q Consensus 588 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dL 667 (706)
.........++..|+|||.+.+..++.++|+||||+++|+|++|..||...........+. .......+..++.++.++
T Consensus 158 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l 236 (260)
T cd08222 158 SCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIV-EGPTPSLPETYSRQLNSI 236 (260)
T ss_pred CcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH-cCCCCCCcchhcHHHHHH
Confidence 4333345668899999999988888999999999999999999999998766655554442 334445567788999999
Q ss_pred HHHhhhhCCCCCCCHHHHHH
Q 005247 668 IETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 668 I~~cL~~dP~~RPS~~eIl~ 687 (706)
|.+||+.+|++||++.++++
T Consensus 237 i~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 237 MQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred HHHHhcCChhhCcCHHHHhh
Confidence 99999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=308.88 Aligned_cols=251 Identities=24% Similarity=0.389 Sum_probs=196.0
Q ss_pred ceEEEEEeccCCceEEEEEEEcC----CceEEEEEeccc-cchHHHHHHHHHHHHHHcCCCCceeEEeccccCC--CceE
Q 005247 434 ELLIKKKIGEGSFGTVYHAEWRN----SDVAVKILIEQE-FHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP--PNLS 506 (706)
Q Consensus 434 ~y~i~~~LG~G~fG~Vy~a~~~~----~~vAVKvl~~~~-~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~--~~~~ 506 (706)
.|++.+.||+|+||.||+|.+.. ..||+|.+.... ......+.+.+|+.+++.++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 47899999999999999998854 459999987633 1122335678899999999999999999999888 7899
Q ss_pred EEEEeccCCchhhhcccC--CCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECC----CCcEEEeecC
Q 005247 507 IVTEYLSRGSLYKLLHIP--DARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS----TYTVKVCDFG 580 (706)
Q Consensus 507 lV~E~~~ggsL~~~l~~~--~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~----~~~vKL~DFG 580 (706)
+||||+.+ +|.+++... .....+++..++.++.||+.||.|||+++ |+||||||+||+++. ++.+||+|||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW--VLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 99999975 666665321 12236889999999999999999999999 999999999999999 8999999999
Q ss_pred ccccCCCCcc---cCCCCCCCCCccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHH---------HHHHh
Q 005247 581 LSRSKPNTYI---SSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQ---------VISAV 647 (706)
Q Consensus 581 la~~~~~~~~---~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~---------~~~~i 647 (706)
++........ ......++..|+|||.+.+. .++.++||||||+++|+|++|+.||....... ....+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI 237 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence 9886543322 22344678899999988764 57899999999999999999999997654322 00000
Q ss_pred -h-----------------------hcCcccCCC-----------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 648 -G-----------------------FKGRRLEIP-----------KNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 648 -~-----------------------~~~~~l~~p-----------~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
. .......++ ...+..+.++|.+||+.||++|||+.++++
T Consensus 238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0 000011111 156678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=313.55 Aligned_cols=256 Identities=24% Similarity=0.385 Sum_probs=204.2
Q ss_pred CceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCC-----Cce
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP-----PNL 505 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~-----~~~ 505 (706)
.+|++.+.||+|+||.||++.+.. ..||+|.+............+.+|+.+++.++|+||+++++++... ...
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 84 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV 84 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence 479999999999999999998764 4599998765433344456778899999999999999999987644 347
Q ss_pred EEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccC
Q 005247 506 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK 585 (706)
Q Consensus 506 ~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~ 585 (706)
++++||+. ++|.+++... ..+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++...
T Consensus 85 ~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 158 (337)
T cd07858 85 YIVYELMD-TDLHQIIRSS---QTLSDDHCQYFLYQLLRGLKYIHSAN--VLHRDLKPSNLLLNANCDLKICDFGLARTT 158 (337)
T ss_pred EEEEeCCC-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence 99999996 5888887633 35889999999999999999999999 999999999999999999999999999876
Q ss_pred CCCcccCCCCCCCCCccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhc--------------
Q 005247 586 PNTYISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-------------- 650 (706)
Q Consensus 586 ~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~-------------- 650 (706)
...........++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+.......+...
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07858 159 SEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRN 238 (337)
T ss_pred CCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCc
Confidence 544333345568899999998865 46889999999999999999999999765433222111100
Q ss_pred ----------C--cc---cCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH--HHHHHH
Q 005247 651 ----------G--RR---LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMET--LQQFLM 694 (706)
Q Consensus 651 ----------~--~~---l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~--L~~ll~ 694 (706)
. .. ....+.+++++.+||.+||+.+|++|||+.++++. ++.+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~ 299 (337)
T cd07858 239 EKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHD 299 (337)
T ss_pred hhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcC
Confidence 0 00 11234678999999999999999999999999985 665543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=308.57 Aligned_cols=248 Identities=25% Similarity=0.430 Sum_probs=205.8
Q ss_pred ceEEEEEeccCCceEEEEEEEcC--CceEEEEEecccc-chHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEE
Q 005247 434 ELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 510 (706)
Q Consensus 434 ~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E 510 (706)
.|...+.||+|+||.||++.+.. ..+|+|++..... ..+..+.+.+|+.+++.++|+|++++++++.+.+..++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 37788999999999999998754 4489998865432 33455678899999999999999999999999999999999
Q ss_pred eccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcc
Q 005247 511 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 590 (706)
Q Consensus 511 ~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~ 590 (706)
|+.+ +|.+++... ...+++..+..++.|++.||.|||+++ |+||||+|+||+++.++.+||+|||++......
T Consensus 106 ~~~g-~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~--i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-- 178 (317)
T cd06635 106 YCLG-SASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASIASPA-- 178 (317)
T ss_pred CCCC-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcccEEECCCCCEEEecCCCccccCCc--
Confidence 9975 777776432 234789999999999999999999999 999999999999999999999999988654332
Q ss_pred cCCCCCCCCCccCccccc---cCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHH
Q 005247 591 SSKTAAGTPEWMAPEVLR---EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAAL 667 (706)
Q Consensus 591 ~~~~~~Gt~~Y~APE~l~---~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dL 667 (706)
....++..|+|||.+. ...++.++||||||+++|||++|..||...........+............+++.+++|
T Consensus 179 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 256 (317)
T cd06635 179 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNF 256 (317)
T ss_pred --ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHH
Confidence 3456888999999974 45678899999999999999999999988776665555543333333445688999999
Q ss_pred HHHhhhhCCCCCCCHHHHHHHHH
Q 005247 668 IETCWAEEPEIRPSFPSIMETLQ 690 (706)
Q Consensus 668 I~~cL~~dP~~RPS~~eIl~~L~ 690 (706)
|.+||+.+|.+||++.++++.+-
T Consensus 257 i~~~l~~~p~~Rpt~~~il~~~~ 279 (317)
T cd06635 257 VDSCLQKIPQDRPTSEELLKHMF 279 (317)
T ss_pred HHHHccCCcccCcCHHHHHhChh
Confidence 99999999999999999988543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=304.74 Aligned_cols=246 Identities=29% Similarity=0.472 Sum_probs=205.8
Q ss_pred ceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEEe
Q 005247 434 ELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY 511 (706)
Q Consensus 434 ~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~ 511 (706)
.|...+.||+|++|.||++.+.. ..+++|++.... ....+.+.+|+.+++.++|+||+++++++...+..++++||
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~ 97 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK--QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEF 97 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEec
Confidence 34456799999999999998754 448999875432 23345688999999999999999999999999999999999
Q ss_pred ccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCccc
Q 005247 512 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS 591 (706)
Q Consensus 512 ~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~ 591 (706)
+.+++|.+++.. ..+++..+..++.|++.||+|||++| ++||||+|+||+++.++.++|+|||.+.........
T Consensus 98 ~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~ 171 (285)
T cd06648 98 LEGGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG--VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR 171 (285)
T ss_pred cCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChhhEEEcCCCcEEEcccccchhhccCCcc
Confidence 999999999864 24788899999999999999999999 999999999999999999999999988765443323
Q ss_pred CCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCc-ccCCCCCCcHHHHHHHHH
Q 005247 592 SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR-RLEIPKNVNPMVAALIET 670 (706)
Q Consensus 592 ~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~-~l~~p~~~s~el~dLI~~ 670 (706)
.....|+..|+|||.+.+..++.++||||||+++|+|++|+.||...++.+....+..... ....+..++..+.+||.+
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 251 (285)
T cd06648 172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDR 251 (285)
T ss_pred cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHH
Confidence 3445689999999999988899999999999999999999999988776665555432211 122233478999999999
Q ss_pred hhhhCCCCCCCHHHHHH
Q 005247 671 CWAEEPEIRPSFPSIME 687 (706)
Q Consensus 671 cL~~dP~~RPS~~eIl~ 687 (706)
||+.+|++||++.++++
T Consensus 252 ~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 252 MLVRDPAQRATAAELLN 268 (285)
T ss_pred HcccChhhCcCHHHHcc
Confidence 99999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=307.41 Aligned_cols=249 Identities=28% Similarity=0.441 Sum_probs=196.8
Q ss_pred CceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCC-CCceeEEeccccCCCceEEEE
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGAVTEPPNLSIVT 509 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~lV~ 509 (706)
.+|+..+.||+|+||.||++.+..+ .+|+|.+...... .....+.+|+.++.++. |+||+++++++..++..+++|
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~ 82 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM 82 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence 4566778999999999999988654 4999987654333 44567889999999996 999999999999999999999
Q ss_pred EeccCCchhhhccc--CCCcccccHHHHHHHHHHHHHHHHHHHhc-CCCcccccCCCCcEEECCCCcEEEeecCccccCC
Q 005247 510 EYLSRGSLYKLLHI--PDARVVVDERLRLNMAYDVAKGMNYLHQR-RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP 586 (706)
Q Consensus 510 E~~~ggsL~~~l~~--~~~~~~l~~~~~~~ia~qIl~aL~yLHs~-g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~ 586 (706)
||+.. ++.++... ......+++..+..++.|++.||+|||+. + ++||||||+||+++.++.+||+|||+++...
T Consensus 83 e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 83 ELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred ecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC--eeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 99864 55544321 11224588999999999999999999974 8 9999999999999999999999999987654
Q ss_pred CCcccCCCCCCCCCccCccccccC---CCCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHhhhcCcccC----CCC
Q 005247 587 NTYISSKTAAGTPEWMAPEVLRED---PSNEKSDVFSFGVILWELITLQKPWRNSTPS-QVISAVGFKGRRLE----IPK 658 (706)
Q Consensus 587 ~~~~~~~~~~Gt~~Y~APE~l~~~---~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~-~~~~~i~~~~~~l~----~p~ 658 (706)
... ......|+..|+|||.+.+. .++.++||||||+++|+|++|+.||...... +....+. ...... .+.
T Consensus 160 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 237 (288)
T cd06616 160 DSI-AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVV-KGDPPILSNSEER 237 (288)
T ss_pred cCC-ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhc-CCCCCcCCCcCCC
Confidence 332 12344688999999999776 6889999999999999999999999765421 1222211 111111 223
Q ss_pred CCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 659 NVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 659 ~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
.++.++.+||.+||+.+|++|||+++|++
T Consensus 238 ~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 238 EFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 57899999999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=297.58 Aligned_cols=255 Identities=25% Similarity=0.447 Sum_probs=208.9
Q ss_pred cCcccccCceEEEEEeccCCceEEEEEEEcCCc--eEEEEEeccccchHHHHHHHHHHHHHHcCC-CCceeEEeccccCC
Q 005247 426 EGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGAVTEP 502 (706)
Q Consensus 426 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~--vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~ 502 (706)
+....+.++.++++.||.|.-|.|+++..+.++ .|||.+.+.. +.++.+.++..+.++..-+ +|+||+.+++|..+
T Consensus 85 ~r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~-Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n 163 (391)
T KOG0983|consen 85 QRYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG-NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITN 163 (391)
T ss_pred cccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC-CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeC
Confidence 334455677888999999999999999988755 7899987665 5566688888888877664 89999999999999
Q ss_pred CceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCcc
Q 005247 503 PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS 582 (706)
Q Consensus 503 ~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla 582 (706)
...+|.||.|.. .+..+++... .+++|..+-++...+++||.||.++. +|||||+||+|||+|..|++||||||++
T Consensus 164 ~dV~IcMelMs~-C~ekLlkrik--~piPE~ilGk~tva~v~AL~YLKeKH-~viHRDvKPSNILlDe~GniKlCDFGIs 239 (391)
T KOG0983|consen 164 TDVFICMELMST-CAEKLLKRIK--GPIPERILGKMTVAIVKALYYLKEKH-GVIHRDVKPSNILLDERGNIKLCDFGIS 239 (391)
T ss_pred chHHHHHHHHHH-HHHHHHHHhc--CCchHHhhhhhHHHHHHHHHHHHHhc-ceeecccCccceEEccCCCEEeeccccc
Confidence 999999999854 4556665333 35999999999999999999999754 4999999999999999999999999999
Q ss_pred ccCCCCcccCCCCCCCCCccCcccccc---CCCCchhHHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHhhhcCcccCCCC
Q 005247 583 RSKPNTYISSKTAAGTPEWMAPEVLRE---DPSNEKSDVFSFGVILWELITLQKPWRNST-PSQVISAVGFKGRRLEIPK 658 (706)
Q Consensus 583 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~---~~~s~ksDVwSLGviL~ELltG~~Pf~~~~-~~~~~~~i~~~~~~l~~p~ 658 (706)
....+.. ..+..+|.+.|||||.+.- ..|+-++||||||++|+||.||+.||.+.+ .-+....+.. ..++-++.
T Consensus 240 GrlvdSk-AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln-~ePP~L~~ 317 (391)
T KOG0983|consen 240 GRLVDSK-AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN-EEPPLLPG 317 (391)
T ss_pred ceeeccc-ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh-cCCCCCCc
Confidence 7765543 2345689999999999864 468889999999999999999999998843 4455555533 33333443
Q ss_pred --CCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 659 --NVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 659 --~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
..++.+.+|+..||++|+.+||.+.++++
T Consensus 318 ~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 318 HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred ccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 47999999999999999999999999876
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=305.32 Aligned_cols=252 Identities=25% Similarity=0.341 Sum_probs=196.8
Q ss_pred ccCceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCC-----
Q 005247 431 RWSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP----- 503 (706)
Q Consensus 431 ~~~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~----- 503 (706)
..++|++.+.||+|+||.||+|.+.. ..||+|++............+.+|+.++++++||||+++++++....
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 34679999999999999999998864 44999988654433333345678999999999999999999876543
Q ss_pred ---ceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecC
Q 005247 504 ---NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFG 580 (706)
Q Consensus 504 ---~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFG 580 (706)
..++||||+.+ +|.+++.... ..+++..++.++.||+.||+|||+++ ++|+||||+||+++.++.+||+|||
T Consensus 90 ~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 90 YKGSFYLVFEFCEH-DLAGLLSNKN--VKFTLSEIKKVMKMLLNGLYYIHRNK--ILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred CCceEEEEEcCCCc-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEECCCCcEEECcCC
Confidence 45999999965 7777775332 35889999999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCccc----CCCCCCCCCccCccccccCC-CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcc--
Q 005247 581 LSRSKPNTYIS----SKTAAGTPEWMAPEVLREDP-SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR-- 653 (706)
Q Consensus 581 la~~~~~~~~~----~~~~~Gt~~Y~APE~l~~~~-~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~-- 653 (706)
++......... .....++..|+|||.+.+.. ++.++||||||+++|||++|+.||...+.......+......
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT 244 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 98765432211 12345788899999887653 688999999999999999999999877665443322211000
Q ss_pred ---------------cCCC-------------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 654 ---------------LEIP-------------KNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 654 ---------------l~~p-------------~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
..++ ...+..+.+||.+||+.||.+|||++++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 0011 123567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=349.81 Aligned_cols=255 Identities=27% Similarity=0.398 Sum_probs=224.1
Q ss_pred CcccccCceEEEEEeccCCceEEEEEEEcCCc--eEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCceeEEeccccCCC
Q 005247 427 GLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFH-EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP 503 (706)
Q Consensus 427 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~--vAVKvl~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 503 (706)
.+.....+|+|++.||+|+||.|.+++++++. ||+|++.+-..- .....-|..|-.+|..-+.+=|+.++..|+++.
T Consensus 69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~ 148 (1317)
T KOG0612|consen 69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER 148 (1317)
T ss_pred HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence 35567789999999999999999999998776 999998764332 233456888999999888999999999999999
Q ss_pred ceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccc
Q 005247 504 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 583 (706)
Q Consensus 504 ~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~ 583 (706)
++|+||||++||+|..++...+ .+++.+++.++..|+.||..||+.| +|||||||+|||||..|++||+|||.+-
T Consensus 149 ~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~mg--yVHRDiKPDNvLld~~GHikLADFGsCl 223 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSMG--YVHRDIKPDNVLLDKSGHIKLADFGSCL 223 (1317)
T ss_pred ceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhcc--ceeccCCcceeEecccCcEeeccchhHH
Confidence 9999999999999999997544 6999999999999999999999999 9999999999999999999999999887
Q ss_pred cCC-CCcccCCCCCCCCCccCcccccc-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCC
Q 005247 584 SKP-NTYISSKTAAGTPEWMAPEVLRE-----DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP 657 (706)
Q Consensus 584 ~~~-~~~~~~~~~~Gt~~Y~APE~l~~-----~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p 657 (706)
... ++.......+|||.|.+||++.. +.|+..+|+||+||++|||++|..||+..+-.+.+..|......+.+|
T Consensus 224 km~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP 303 (1317)
T KOG0612|consen 224 KMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFP 303 (1317)
T ss_pred hcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCC
Confidence 655 56666778899999999999853 458899999999999999999999999999888888887666678888
Q ss_pred --CCCcHHHHHHHHHhhhhCCCCCCC---HHHHHH
Q 005247 658 --KNVNPMVAALIETCWAEEPEIRPS---FPSIME 687 (706)
Q Consensus 658 --~~~s~el~dLI~~cL~~dP~~RPS---~~eIl~ 687 (706)
..+|++.++||++.++ +|+.|.. ++++..
T Consensus 304 ~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 304 DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN 337 (1317)
T ss_pred cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence 5689999999999998 7888987 777765
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=302.54 Aligned_cols=248 Identities=28% Similarity=0.385 Sum_probs=203.9
Q ss_pred eEEEEEeccCCceEEEEEEEc--CCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEEec
Q 005247 435 LLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYL 512 (706)
Q Consensus 435 y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~~ 512 (706)
|++.+.||+|++|.||++.+. +..+++|.+............+.+|+.+++.++|+||+++++++..++..++++||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 567889999999999999875 344899988766555445578889999999999999999999999999999999999
Q ss_pred cCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcccC
Q 005247 513 SRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISS 592 (706)
Q Consensus 513 ~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~ 592 (706)
.+ +|.+++.... ..+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||.+..........
T Consensus 81 ~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~ 155 (283)
T cd05118 81 DT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSHG--ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPY 155 (283)
T ss_pred CC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHCC--eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccc
Confidence 75 7877775432 35889999999999999999999999 9999999999999999999999999987765543223
Q ss_pred CCCCCCCCccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcc------------------
Q 005247 593 KTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR------------------ 653 (706)
Q Consensus 593 ~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~------------------ 653 (706)
....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+..+....+......
T Consensus 156 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd05118 156 THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKF 235 (283)
T ss_pred cCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhh
Confidence 345678899999998876 7899999999999999999999999877654443332111000
Q ss_pred ----------cCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 654 ----------LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 654 ----------l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
....+.++.++.++|.+||+.||.+||++.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 236 SFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0112346789999999999999999999999875
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=358.89 Aligned_cols=250 Identities=30% Similarity=0.481 Sum_probs=215.3
Q ss_pred CceEEEEEeccCCceEEEEEEEcCCc--eEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEE
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 510 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~~~--vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E 510 (706)
-+++-..+||.|.||.||.|.+.+++ .|+|.++.+.........+.+|+.++..++|||+|++|++-.+....+|.||
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence 34566789999999999999887665 8999887776666667788899999999999999999999998899999999
Q ss_pred eccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcc
Q 005247 511 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 590 (706)
Q Consensus 511 ~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~ 590 (706)
||++|+|.++++... ..++.....+..|++.|+.|||++| ||||||||+||+++.+|.+|++|||.|....+...
T Consensus 1315 yC~~GsLa~ll~~gr---i~dE~vt~vyt~qll~gla~LH~~g--IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~ 1389 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGR---IEDEMVTRVYTKQLLEGLAYLHEHG--IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQ 1389 (1509)
T ss_pred HhccCcHHHHHHhcc---hhhhhHHHHHHHHHHHHHHHHHhcC--ceecCCCccceeeecCCcEEeecccceeEecCchh
Confidence 999999999997432 4677778888999999999999999 99999999999999999999999999987665431
Q ss_pred ----cCCCCCCCCCccCccccccCC---CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHH
Q 005247 591 ----SSKTAAGTPEWMAPEVLREDP---SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPM 663 (706)
Q Consensus 591 ----~~~~~~Gt~~Y~APE~l~~~~---~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~e 663 (706)
......||+.|||||++.+.. ...+.|||||||++.||+||+.||...+.+-.+-...-.+..+++|..++.+
T Consensus 1390 ~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~ 1469 (1509)
T KOG4645|consen 1390 TMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSE 1469 (1509)
T ss_pred cCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHh
Confidence 224568999999999998754 4568999999999999999999998766544443333577889999999999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 664 VAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 664 l~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
-++||.+||..||++|-++.||++
T Consensus 1470 g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1470 GRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred HHHHHHHHHhcCchhhhHHHHHHH
Confidence 999999999999999988887765
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=300.70 Aligned_cols=245 Identities=24% Similarity=0.342 Sum_probs=194.8
Q ss_pred eEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCC-CCceeEEeccccCC--CceEEEE
Q 005247 435 LLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGAVTEP--PNLSIVT 509 (706)
Q Consensus 435 y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~--~~~~lV~ 509 (706)
|++.+.||+|+||.||+|.+.. ..+|+|++........ .....+|+.+++++. |+||+++++++.+. +..++||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE-QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch-hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 6789999999999999998754 4489998765432222 234457889999885 99999999999877 8899999
Q ss_pred EeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCc
Q 005247 510 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 589 (706)
Q Consensus 510 E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 589 (706)
||+.+ +|.+.+.... ..+++..++.++.|++.||+|||+++ ++||||||+||+++. +.+||+|||++.......
T Consensus 80 e~~~~-~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 80 ELMDM-NLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMHRNG--IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred ecCCc-cHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 99975 7777775322 35889999999999999999999999 999999999999999 999999999998654432
Q ss_pred ccCCCCCCCCCccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcC----------------c
Q 005247 590 ISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG----------------R 652 (706)
Q Consensus 590 ~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~----------------~ 652 (706)
. .....++..|+|||.+.+ ..++.++|||||||++|||++|..||...+..+....+.... .
T Consensus 154 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07831 154 P-YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHM 232 (282)
T ss_pred C-cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccc
Confidence 2 234567899999998754 456889999999999999999999998776654433321100 0
Q ss_pred ccCC-----------CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 653 RLEI-----------PKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 653 ~l~~-----------p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
...+ ...++.++.+||.+||..+|++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 233 NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 1111 1356789999999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=299.31 Aligned_cols=242 Identities=30% Similarity=0.433 Sum_probs=197.3
Q ss_pred EEeccCCceEEEEEEEcC--CceEEEEEeccccc-hHHHHHHHHHHHHH-HcCCCCceeEEeccccCCCceEEEEEeccC
Q 005247 439 KKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFH-EDRFKEFLREVAIM-KGLRHPNIVLLMGAVTEPPNLSIVTEYLSR 514 (706)
Q Consensus 439 ~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~-~~~~~~~~~Ei~iL-~~L~HpnIv~l~~~~~~~~~~~lV~E~~~g 514 (706)
+.||+|+||.||+|.+.. ..+|+|++...... ......+..|..++ ...+|+||+++++++...+..++++||+.+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 568999999999998754 45999998654322 22233445555544 455899999999999999999999999999
Q ss_pred CchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcccCCC
Q 005247 515 GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKT 594 (706)
Q Consensus 515 gsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 594 (706)
++|.++++.. ..+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.+||+|||++..... ...
T Consensus 82 ~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~~ 152 (260)
T cd05611 82 GDCASLIKTL---GGLPEDWAKQYIAEVVLGVEDLHQRG--IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----NKK 152 (260)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCcEEEeecccceeccc----ccc
Confidence 9999998643 25889999999999999999999999 99999999999999999999999999876443 234
Q ss_pred CCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCc--ccCCCCCCcHHHHHHHHHhh
Q 005247 595 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR--RLEIPKNVNPMVAALIETCW 672 (706)
Q Consensus 595 ~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~--~l~~p~~~s~el~dLI~~cL 672 (706)
..++..|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+..... .......+++++.++|.+||
T Consensus 153 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 232 (260)
T cd05611 153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLL 232 (260)
T ss_pred CCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHc
Confidence 5688899999999888889999999999999999999999988877666555432221 12233467899999999999
Q ss_pred hhCCCCCCCHHHHHHHH
Q 005247 673 AEEPEIRPSFPSIMETL 689 (706)
Q Consensus 673 ~~dP~~RPS~~eIl~~L 689 (706)
+.+|++||++.++.+.|
T Consensus 233 ~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 233 CMDPAKRLGANGYQEIK 249 (260)
T ss_pred cCCHHHccCCCcHHHHH
Confidence 99999999776555444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=302.32 Aligned_cols=241 Identities=26% Similarity=0.389 Sum_probs=193.1
Q ss_pred EeccCCceEEEEEEEcC--CceEEEEEeccccchH-HHHHHHHHHHHH---HcCCCCceeEEeccccCCCceEEEEEecc
Q 005247 440 KIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHED-RFKEFLREVAIM---KGLRHPNIVLLMGAVTEPPNLSIVTEYLS 513 (706)
Q Consensus 440 ~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~-~~~~~~~Ei~iL---~~L~HpnIv~l~~~~~~~~~~~lV~E~~~ 513 (706)
.||+|+||.||++.+.. ..+|+|.+........ ....+.+|..++ ...+|+||+.+++++..++..++||||+.
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 38999999999998764 4599998865443222 122334444433 34479999999999999999999999999
Q ss_pred CCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcccCC
Q 005247 514 RGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSK 593 (706)
Q Consensus 514 ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~ 593 (706)
+++|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.++|+|||++....... ..
T Consensus 81 ~~~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--~~ 153 (279)
T cd05633 81 GGDLHYHLSQH---GVFSEKEMRFYATEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--PH 153 (279)
T ss_pred CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cCCCCCCHHHEEECCCCCEEEccCCcceeccccC--cc
Confidence 99999888643 25899999999999999999999999 9999999999999999999999999987554322 23
Q ss_pred CCCCCCCccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHhhhcCcccCCCCCCcHHHHHHHHH
Q 005247 594 TAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQ--VISAVGFKGRRLEIPKNVNPMVAALIET 670 (706)
Q Consensus 594 ~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~--~~~~i~~~~~~l~~p~~~s~el~dLI~~ 670 (706)
...|+..|+|||.+.+ ..++.++|||||||++|+|++|..||....... ..... .......++..++.++.++|.+
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~ 232 (279)
T cd05633 154 ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM-TLTVNVELPDSFSPELKSLLEG 232 (279)
T ss_pred CcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHH-hhcCCcCCccccCHHHHHHHHH
Confidence 4578999999999864 567899999999999999999999997543221 22221 2234556778899999999999
Q ss_pred hhhhCCCCCC-----CHHHHHHH
Q 005247 671 CWAEEPEIRP-----SFPSIMET 688 (706)
Q Consensus 671 cL~~dP~~RP-----S~~eIl~~ 688 (706)
||..||.+|| +++++++.
T Consensus 233 ~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 233 LLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred HhcCCHHHhcCCCCCCHHHHHhC
Confidence 9999999999 69998873
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=303.33 Aligned_cols=253 Identities=26% Similarity=0.326 Sum_probs=200.7
Q ss_pred cccCceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCC----
Q 005247 430 IRWSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP---- 503 (706)
Q Consensus 430 i~~~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~---- 503 (706)
...++|++.+.||+|+||.||+|.+.. ..|++|++............+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 445689999999999999999999864 45999998655433333456778999999999999999999886654
Q ss_pred ------ceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEe
Q 005247 504 ------NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVC 577 (706)
Q Consensus 504 ------~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~ 577 (706)
.+++|+||+++ ++..++... ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~~~~~~kl~ 158 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKKN--FLHRDIKCSNILLNNKGQIKLA 158 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCcEEeC
Confidence 78999999976 666666533 235889999999999999999999999 9999999999999999999999
Q ss_pred ecCccccCCCCcc-cCCCCCCCCCccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcC-cc-
Q 005247 578 DFGLSRSKPNTYI-SSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG-RR- 653 (706)
Q Consensus 578 DFGla~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~-~~- 653 (706)
|||++........ ......++..|+|||.+.+. .++.++|||||||++|||++|+.||...+..+....+.... ..
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~ 238 (302)
T cd07864 159 DFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPC 238 (302)
T ss_pred cccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 9999876543321 11223467789999988654 46889999999999999999999998766544443332110 00
Q ss_pred --------------------------cCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 654 --------------------------LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 654 --------------------------l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
......++..+.++|.+||+.+|.+||++.+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 239 PAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred hhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0012246889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=302.91 Aligned_cols=257 Identities=25% Similarity=0.437 Sum_probs=204.1
Q ss_pred cccCcccccCceEEEEEeccCCceEEEEEEEc--CCceEEEEEeccccchHHHHHHHHHHHHHHcCC-CCceeEEecccc
Q 005247 424 EEEGLEIRWSELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGAVT 500 (706)
Q Consensus 424 ~~~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~ 500 (706)
..+.+.+..++|++.+.||+|+||.||+|.+. +..+|+|.+...... .....+.+|+.++.... |+||+++++++.
T Consensus 6 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~ 84 (296)
T cd06618 6 DGQKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK-EENKRILMDLDVVLKSHDCPYIVKCYGYFI 84 (296)
T ss_pred cceeccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh-HHHHHHHHHHHHHHhccCCCchHhhheeee
Confidence 44556677889999999999999999999987 556999998755432 33456677887776665 999999999999
Q ss_pred CCCceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHh-cCCCcccccCCCCcEEECCCCcEEEeec
Q 005247 501 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ-RRPPIVHRDLKSPNLLVDSTYTVKVCDF 579 (706)
Q Consensus 501 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs-~g~~IIHrDLKp~NILl~~~~~vKL~DF 579 (706)
+....+++|||+.+ +|.+++.... ..+++..+..++.|++.||.|||+ .+ |+||||+|+||+++.++.+||+||
T Consensus 85 ~~~~~~~v~e~~~~-~l~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~~--i~H~dl~p~nill~~~~~~kL~df 159 (296)
T cd06618 85 TDSDVFICMELMST-CLDKLLKRIQ--GPIPEDILGKMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDF 159 (296)
T ss_pred cCCeEEEEeeccCc-CHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCC--EecCCCcHHHEEEcCCCCEEECcc
Confidence 99999999999854 6776664322 258889999999999999999997 58 999999999999999999999999
Q ss_pred CccccCCCCcccCCCCCCCCCccCccccccCC----CCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHhhhcCcc-
Q 005247 580 GLSRSKPNTYISSKTAAGTPEWMAPEVLREDP----SNEKSDVFSFGVILWELITLQKPWRNSTP-SQVISAVGFKGRR- 653 (706)
Q Consensus 580 Gla~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~----~s~ksDVwSLGviL~ELltG~~Pf~~~~~-~~~~~~i~~~~~~- 653 (706)
|++........ .....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||..... .+....+. ....
T Consensus 160 g~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~-~~~~~ 237 (296)
T cd06618 160 GISGRLVDSKA-KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKIL-QEEPP 237 (296)
T ss_pred ccchhccCCCc-ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHh-cCCCC
Confidence 99876544322 22345788999999987654 78899999999999999999999976433 22333322 2222
Q ss_pred -cCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 005247 654 -LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMET 688 (706)
Q Consensus 654 -l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~ 688 (706)
.+....++.++.+||.+||..||++||++.++++.
T Consensus 238 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 238 SLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 22223478999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=297.72 Aligned_cols=248 Identities=27% Similarity=0.376 Sum_probs=201.1
Q ss_pred eEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCC--CceEEEEE
Q 005247 435 LLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP--PNLSIVTE 510 (706)
Q Consensus 435 y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~--~~~~lV~E 510 (706)
|++.+.||.|+||.||+|.+.+ ..+++|++............+.+|+.+++.++|+|++++++++... +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 6789999999999999998865 4599999876643344456788999999999999999999999887 78999999
Q ss_pred eccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcc
Q 005247 511 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 590 (706)
Q Consensus 511 ~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~ 590 (706)
|+++ +|.+++.... ..+++..++.++.||+.||+|||+++ ++|+||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~~--~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 81 YMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSNG--ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred cccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 9975 8888875432 35889999999999999999999999 99999999999999999999999999886554321
Q ss_pred -cCCCCCCCCCccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcc---------------
Q 005247 591 -SSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR--------------- 653 (706)
Q Consensus 591 -~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~--------------- 653 (706)
......++..|+|||.+.+ ..++.++||||||+++|||++|..||...+.......+......
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWF 235 (287)
T ss_pred ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhh
Confidence 1223456888999998765 45789999999999999999999999877765444333211000
Q ss_pred ------c--------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 654 ------L--------EIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 654 ------l--------~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
. .+...+++.+.++|.+||+.+|++||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 236 ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0 001113789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=307.97 Aligned_cols=255 Identities=27% Similarity=0.383 Sum_probs=208.5
Q ss_pred ceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCC-----ceE
Q 005247 434 ELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP-----NLS 506 (706)
Q Consensus 434 ~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~-----~~~ 506 (706)
+|++.+.||.|+||.||+|.+.. ..+++|++..........+.+.+|+.+++.++|+||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 58899999999999999998764 45999988655433455678899999999999999999999988775 789
Q ss_pred EEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCC
Q 005247 507 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP 586 (706)
Q Consensus 507 lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~ 586 (706)
++|||+. ++|.+++.... .+++..++.++.||+.||+|||++| |+||||||+|||++.++.++|+|||++....
T Consensus 81 lv~e~~~-~~l~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH~~g--i~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ---PLTDDHIQYFLYQILRGLKYLHSAN--VIHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred EEecchh-hhHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 9999997 47888886432 6889999999999999999999999 9999999999999999999999999998765
Q ss_pred CCc---ccCCCCCCCCCccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcc---------
Q 005247 587 NTY---ISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR--------- 653 (706)
Q Consensus 587 ~~~---~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~--------- 653 (706)
... .......++..|+|||.+.+. .++.++|+||||+++|+|++|..||...+..+....+......
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 234 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI 234 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhc
Confidence 442 122345678899999999888 7899999999999999999999999887765544333211000
Q ss_pred --------------------cCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH--HHHHHHH
Q 005247 654 --------------------LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME--TLQQFLM 694 (706)
Q Consensus 654 --------------------l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~--~L~~ll~ 694 (706)
....+.++..+.++|.+||+.+|++||++++++. .++++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred cccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 0112346788999999999999999999999988 3555443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=310.41 Aligned_cols=245 Identities=27% Similarity=0.457 Sum_probs=216.5
Q ss_pred ccccCceEEEEEeccCCceEEEEEEEcCCc--eEEEEEeccccch-HHHHHHHHHHHHHHcC-CCCceeEEeccccCCCc
Q 005247 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHE-DRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPN 504 (706)
Q Consensus 429 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~--vAVKvl~~~~~~~-~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~ 504 (706)
.+...+|.++.+||+|+||+|.+++.++++ ||||++++..... +..+--..|-.+|... +-|.++++..+|+.-+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 567789999999999999999999988876 9999987764432 2233344566777665 46789999999999999
Q ss_pred eEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCcccc
Q 005247 505 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 584 (706)
Q Consensus 505 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~ 584 (706)
+|+||||+.||+|-..++.- +.+.+..+..++.+|+-||-+||++| ||.||||.+|||++.+|++||+|||++..
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~---GkFKEp~AvFYAaEiaigLFFLh~kg--IiYRDLKLDNvmLd~eGHiKi~DFGmcKE 499 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQV---GKFKEPVAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKE 499 (683)
T ss_pred eeeEEEEecCchhhhHHHHh---cccCCchhhhhhHHHHHHhhhhhcCC--eeeeeccccceEeccCCceEeeecccccc
Confidence 99999999999998777633 35889999999999999999999999 99999999999999999999999999987
Q ss_pred CCCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHH
Q 005247 585 KPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV 664 (706)
Q Consensus 585 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el 664 (706)
.--......+++|||.|+|||++...+|...+|+||+||+||||+.|++||.+.+..+.+..| ......+|..+|.+.
T Consensus 500 ni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI--~ehnvsyPKslSkEA 577 (683)
T KOG0696|consen 500 NIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAI--MEHNVSYPKSLSKEA 577 (683)
T ss_pred cccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH--HHccCcCcccccHHH
Confidence 555555678899999999999999999999999999999999999999999999999999887 566778899999999
Q ss_pred HHHHHHhhhhCCCCCC
Q 005247 665 AALIETCWAEEPEIRP 680 (706)
Q Consensus 665 ~dLI~~cL~~dP~~RP 680 (706)
.+++...|.+.|.+|.
T Consensus 578 v~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 578 VAICKGLLTKHPGKRL 593 (683)
T ss_pred HHHHHHHhhcCCcccc
Confidence 9999999999999994
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=299.66 Aligned_cols=240 Identities=27% Similarity=0.392 Sum_probs=193.7
Q ss_pred EeccCCceEEEEEEEcC--CceEEEEEeccccchHH-HHHHHHHH---HHHHcCCCCceeEEeccccCCCceEEEEEecc
Q 005247 440 KIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDR-FKEFLREV---AIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLS 513 (706)
Q Consensus 440 ~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~-~~~~~~Ei---~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~~~ 513 (706)
.||+|+||.||+|.+.. ..||+|++......... ...+..|. ..++...|+||+.+++++...+..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 38999999999998754 45999998665433211 12233343 34455679999999999999999999999999
Q ss_pred CCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcccCC
Q 005247 514 RGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSK 593 (706)
Q Consensus 514 ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~ 593 (706)
+++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++....... ..
T Consensus 81 g~~L~~~l~~~---~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--~~ 153 (278)
T cd05606 81 GGDLHYHLSQH---GVFSEAEMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--PH 153 (278)
T ss_pred CCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCCCCHHHEEECCCCCEEEccCcCccccCccC--Cc
Confidence 99999888633 35899999999999999999999999 9999999999999999999999999987554322 23
Q ss_pred CCCCCCCccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHhhhcCcccCCCCCCcHHHHHHHHH
Q 005247 594 TAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQ--VISAVGFKGRRLEIPKNVNPMVAALIET 670 (706)
Q Consensus 594 ~~~Gt~~Y~APE~l~~~-~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~--~~~~i~~~~~~l~~p~~~s~el~dLI~~ 670 (706)
...|+..|+|||.+.+. .++.++||||+|+++|+|++|+.||....... ..... .......++..++.++.+++.+
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~~li~~ 232 (278)
T cd05606 154 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM-TLTMAVELPDSFSPELRSLLEG 232 (278)
T ss_pred CcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHH-hhccCCCCCCcCCHHHHHHHHH
Confidence 45789999999999754 58899999999999999999999997663221 11111 2334566777889999999999
Q ss_pred hhhhCCCCCC-----CHHHHHH
Q 005247 671 CWAEEPEIRP-----SFPSIME 687 (706)
Q Consensus 671 cL~~dP~~RP-----S~~eIl~ 687 (706)
||..+|.+|| ++.++++
T Consensus 233 ~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 233 LLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred HhhcCHHhccCCCCCCHHHHHh
Confidence 9999999999 9999986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=330.44 Aligned_cols=253 Identities=17% Similarity=0.236 Sum_probs=187.8
Q ss_pred cCceEEEEEeccCCceEEEEEEEcCCc---eEEEE--------------E-eccccchHHHHHHHHHHHHHHcCCCCcee
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRNSD---VAVKI--------------L-IEQEFHEDRFKEFLREVAIMKGLRHPNIV 493 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~---vAVKv--------------l-~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv 493 (706)
..+|++++.||+|+||+||++..+... .+.|. + +...........+.+|+.++++++|+||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 468999999999999999998754321 12110 0 11111223345688999999999999999
Q ss_pred EEeccccCCCceEEEEEeccCCchhhhcccCCC--cccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCC
Q 005247 494 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDA--RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST 571 (706)
Q Consensus 494 ~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~--~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~ 571 (706)
++++++...+..+++++++. ++|.+++..... ........++.++.||+.||.|||++| ||||||||+|||++.+
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g--IiHrDLKP~NILl~~~ 303 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK--LIHRDIKLENIFLNCD 303 (501)
T ss_pred cEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCC
Confidence 99999999999999999985 466666532211 122345667889999999999999999 9999999999999999
Q ss_pred CcEEEeecCccccCCCCcc-cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCC-CCCCC--h-HHHHHH
Q 005247 572 YTVKVCDFGLSRSKPNTYI-SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKP-WRNST--P-SQVISA 646 (706)
Q Consensus 572 ~~vKL~DFGla~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~P-f~~~~--~-~~~~~~ 646 (706)
+.+||+|||+++....... ......||..|+|||++.+..++.++|||||||++|||++|..+ |.... + .+....
T Consensus 304 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~ 383 (501)
T PHA03210 304 GKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKI 383 (501)
T ss_pred CCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHH
Confidence 9999999999986544322 22346799999999999999999999999999999999998754 43322 1 111111
Q ss_pred hhhcC-cccCC----------------------------CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 647 VGFKG-RRLEI----------------------------PKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 647 i~~~~-~~l~~----------------------------p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
+.... ...++ ...++..+.++|.+||+.||.+|||+.|++.
T Consensus 384 ~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 384 IDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 11000 00000 0134567888999999999999999999986
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=309.64 Aligned_cols=249 Identities=22% Similarity=0.351 Sum_probs=199.4
Q ss_pred CceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccC----CCceE
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE----PPNLS 506 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~----~~~~~ 506 (706)
.+|++.+.||+|+||.||+|.... ..|++|++..........+.+.+|+.+++.++|+||+++++++.. ....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 679999999999999999998764 459999886544333445678889999999999999999998753 34689
Q ss_pred EEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCC
Q 005247 507 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP 586 (706)
Q Consensus 507 lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~ 586 (706)
+||||+. ++|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++....
T Consensus 85 lv~e~~~-~~l~~~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 158 (334)
T cd07855 85 VVMDLME-SDLHHIIHSDQ---PLTEEHIRYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLVNEDCELRIGDFGMARGLS 158 (334)
T ss_pred EEEehhh-hhHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEecccccceeec
Confidence 9999995 58888886432 4889999999999999999999999 9999999999999999999999999987643
Q ss_pred CCccc----CCCCCCCCCccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhc-----------
Q 005247 587 NTYIS----SKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK----------- 650 (706)
Q Consensus 587 ~~~~~----~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~----------- 650 (706)
..... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+.......+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~ 238 (334)
T cd07855 159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNR 238 (334)
T ss_pred ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhh
Confidence 32211 123468899999999866 45789999999999999999999999776543332221110
Q ss_pred -------------CcccC-----CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 651 -------------GRRLE-----IPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 651 -------------~~~l~-----~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
..... +....+.++.++|.+||+.+|++||++.+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 239 IGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred hchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 00011 11456889999999999999999999999876
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=291.63 Aligned_cols=237 Identities=29% Similarity=0.440 Sum_probs=204.8
Q ss_pred eccCCceEEEEEEEc--CCceEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEEeccCCch
Q 005247 441 IGEGSFGTVYHAEWR--NSDVAVKILIEQEFH-EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSL 517 (706)
Q Consensus 441 LG~G~fG~Vy~a~~~--~~~vAVKvl~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL 517 (706)
||+|+||.||++.+. +..+++|++...... ......+.+|+.+++.++|+||+++++.+..++..+++|||+.+++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999886 445999988665433 23556888999999999999999999999999999999999999999
Q ss_pred hhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcccCCCCCC
Q 005247 518 YKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAG 597 (706)
Q Consensus 518 ~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~G 597 (706)
.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+..............+
T Consensus 81 ~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh~~~--~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~ 155 (250)
T cd05123 81 FSHLSKEG---RFSEERARFYAAEIVLALEYLHSLG--IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCG 155 (250)
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcC
Confidence 99986442 4789999999999999999999999 999999999999999999999999998775543223345678
Q ss_pred CCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHHHHhhhhCCC
Q 005247 598 TPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPE 677 (706)
Q Consensus 598 t~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI~~cL~~dP~ 677 (706)
+..|+|||.+.+...+.++|+||||+++|++++|..||......+....+. .....++...+..+.++|.+||..||+
T Consensus 156 ~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~~i~~~l~~~p~ 233 (250)
T cd05123 156 TPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKIL--KDPLRFPEFLSPEARDLISGLLQKDPT 233 (250)
T ss_pred CccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh--cCCCCCCCCCCHHHHHHHHHHhcCCHh
Confidence 889999999988888999999999999999999999998777655555543 256778888899999999999999999
Q ss_pred CCCCHHH
Q 005247 678 IRPSFPS 684 (706)
Q Consensus 678 ~RPS~~e 684 (706)
+||++.+
T Consensus 234 ~R~~~~~ 240 (250)
T cd05123 234 KRLGSGG 240 (250)
T ss_pred hCCCccc
Confidence 9999943
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=298.36 Aligned_cols=239 Identities=23% Similarity=0.397 Sum_probs=192.8
Q ss_pred CceEEEEEe--ccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcC-CCCceeEEeccccCCCceEE
Q 005247 433 SELLIKKKI--GEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSI 507 (706)
Q Consensus 433 ~~y~i~~~L--G~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~l 507 (706)
++|++.+.+ |+|+||.||++....+ .+++|+......... |+.....+ +|+||+++++.+..++..++
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-------e~~~~~~~~~h~~iv~~~~~~~~~~~~~i 86 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-------EPMVHQLMKDNPNFIKLYYSVTTLKGHVL 86 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-------hHHHHHHhhcCCCEEEEEEEEecCCeeEE
Confidence 455666655 9999999999987644 488888765432221 22222222 69999999999999999999
Q ss_pred EEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCC-cEEEeecCccccCC
Q 005247 508 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY-TVKVCDFGLSRSKP 586 (706)
Q Consensus 508 V~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~-~vKL~DFGla~~~~ 586 (706)
||||+++++|.+++.... .+++..++.++.|+++||.|||+.+ ++||||||+||+++.++ .++|+|||++....
T Consensus 87 v~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 161 (267)
T PHA03390 87 IMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG 161 (267)
T ss_pred EEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEeCCCCeEEEecCccceecC
Confidence 999999999999987443 6899999999999999999999999 99999999999999988 99999999987654
Q ss_pred CCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHH--HHhhhcCcccCCCCCCcHHH
Q 005247 587 NTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVI--SAVGFKGRRLEIPKNVNPMV 664 (706)
Q Consensus 587 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~--~~i~~~~~~l~~p~~~s~el 664 (706)
.. ....++..|+|||++.+..++.++||||||+++|+|++|..||......... ............++.+++.+
T Consensus 162 ~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T PHA03390 162 TP----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNA 237 (267)
T ss_pred CC----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHH
Confidence 32 2456889999999999989999999999999999999999999855433221 11111234445666899999
Q ss_pred HHHHHHhhhhCCCCCCC-HHHHHH
Q 005247 665 AALIETCWAEEPEIRPS-FPSIME 687 (706)
Q Consensus 665 ~dLI~~cL~~dP~~RPS-~~eIl~ 687 (706)
++||.+||+.+|.+||+ ++++++
T Consensus 238 ~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 238 NDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred HHHHHHHhccChhhCCchHHHHhc
Confidence 99999999999999995 688874
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=307.90 Aligned_cols=255 Identities=25% Similarity=0.423 Sum_probs=199.4
Q ss_pred CceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCC-----Cce
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP-----PNL 505 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~-----~~~ 505 (706)
++|++.+.||+|+||.||+|.+.. ..||+|++.... .......+.+|+.+++.++|+||+++++++... ...
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 579999999999999999998764 459999875322 223446788899999999999999999876543 357
Q ss_pred EEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccC
Q 005247 506 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK 585 (706)
Q Consensus 506 ~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~ 585 (706)
++++||+.+ +|..++... .+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++...
T Consensus 84 ~lv~e~~~~-~l~~~~~~~----~l~~~~~~~i~~ql~~aL~~LH~~~--ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 156 (336)
T cd07849 84 YIVQELMET-DLYKLIKTQ----HLSNDHIQYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIA 156 (336)
T ss_pred EEEehhccc-CHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCCCCEEECcccceeec
Confidence 999999965 777776532 4889999999999999999999999 999999999999999999999999998764
Q ss_pred CCCcc---cCCCCCCCCCccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhh------------
Q 005247 586 PNTYI---SSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGF------------ 649 (706)
Q Consensus 586 ~~~~~---~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~------------ 649 (706)
..... ......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+.......+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (336)
T cd07849 157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNC 236 (336)
T ss_pred cccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence 43221 1123568899999998765 4688999999999999999999999976543322211100
Q ss_pred ------------c--CcccC---CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH--HHHHHHh
Q 005247 650 ------------K--GRRLE---IPKNVNPMVAALIETCWAEEPEIRPSFPSIMET--LQQFLMS 695 (706)
Q Consensus 650 ------------~--~~~l~---~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~--L~~ll~s 695 (706)
. ..... ..+..++++.+||.+||+.+|++|||+.++++. +++....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~ 301 (336)
T cd07849 237 IISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDP 301 (336)
T ss_pred hhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCC
Confidence 0 00000 113467889999999999999999999999985 6666543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=306.01 Aligned_cols=249 Identities=23% Similarity=0.325 Sum_probs=198.0
Q ss_pred EEEEEeccCCceEEEEEEEcCCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEEeccCC
Q 005247 436 LIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRG 515 (706)
Q Consensus 436 ~i~~~LG~G~fG~Vy~a~~~~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~~~gg 515 (706)
.+.+.+|.|+++.|+++...+..||+|++..........+.+.+|+.+++.++|+||+++++++.+.+..+++|||+.++
T Consensus 5 ~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 34556667777777777766777999998776556667788999999999999999999999999999999999999999
Q ss_pred chhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCc------
Q 005247 516 SLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY------ 589 (706)
Q Consensus 516 sL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~------ 589 (706)
+|.+++.... ...+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||.+.......
T Consensus 85 ~l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~~--ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 85 SCEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHSKG--FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred CHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 9999986432 224788999999999999999999999 9999999999999999999999999886543211
Q ss_pred -ccCCCCCCCCCccCccccccC--CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCc--------------
Q 005247 590 -ISSKTAAGTPEWMAPEVLRED--PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR-------------- 652 (706)
Q Consensus 590 -~~~~~~~Gt~~Y~APE~l~~~--~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~-------------- 652 (706)
.......++..|+|||.+.+. .++.++||||||+++|||++|..||.................
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYED 241 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcC
Confidence 112334577889999998763 578899999999999999999999987654433221110000
Q ss_pred ------------------ccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 653 ------------------RLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 653 ------------------~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
.......++.++.+||.+||+.||++|||+.++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred CcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 00111233467899999999999999999999987
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=311.46 Aligned_cols=250 Identities=26% Similarity=0.359 Sum_probs=212.8
Q ss_pred cccccCceEEEEEeccCCceEEEEEEEcCCc--eEEEEEeccccchHH-HHHHHHHHHHHHcCCCCceeEEeccccCCCc
Q 005247 428 LEIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDR-FKEFLREVAIMKGLRHPNIVLLMGAVTEPPN 504 (706)
Q Consensus 428 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~--vAVKvl~~~~~~~~~-~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 504 (706)
..+..+.|..-+.||+||||.||-+....++ ||.|.+.+....... ....++|-.||++++.+.||.+-.+|+..+.
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~ 259 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDA 259 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCc
Confidence 4566778999999999999999988766554 898887555443322 2457889999999999999999999999999
Q ss_pred eEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCcccc
Q 005247 505 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 584 (706)
Q Consensus 505 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~ 584 (706)
+|+|+..|.||+|.-.|...+. ..+++..+..++.+|+.||++||+.+ ||.|||||+|||+|+.|+|+|+|+|+|+.
T Consensus 260 LClVLtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~--iVYRDLKPeNILLDd~GhvRISDLGLAve 336 (591)
T KOG0986|consen 260 LCLVLTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR--IVYRDLKPENILLDDHGHVRISDLGLAVE 336 (591)
T ss_pred eEEEEEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc--eeeccCChhheeeccCCCeEeeccceEEe
Confidence 9999999999999888865443 46999999999999999999999999 99999999999999999999999999998
Q ss_pred CCCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHhhhcCcccCCCCCCc
Q 005247 585 KPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQ---VISAVGFKGRRLEIPKNVN 661 (706)
Q Consensus 585 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~---~~~~i~~~~~~l~~p~~~s 661 (706)
....... +..+||.+|||||++.+..|+...|+|||||+||||+.|+.||....... .+.+. ......++++..+
T Consensus 337 i~~g~~~-~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr-~~~~~~ey~~kFS 414 (591)
T KOG0986|consen 337 IPEGKPI-RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRR-TLEDPEEYSDKFS 414 (591)
T ss_pred cCCCCcc-ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHH-HhcchhhcccccC
Confidence 8776433 44599999999999999999999999999999999999999997644322 22222 3455667889999
Q ss_pred HHHHHHHHHhhhhCCCCCCCH
Q 005247 662 PMVAALIETCWAEEPEIRPSF 682 (706)
Q Consensus 662 ~el~dLI~~cL~~dP~~RPS~ 682 (706)
++.++|.+..|++||++|...
T Consensus 415 ~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 415 EEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred HHHHHHHHHHHccCHHHhccC
Confidence 999999999999999999643
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=306.34 Aligned_cols=252 Identities=25% Similarity=0.353 Sum_probs=202.5
Q ss_pred cCceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCC------
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP------ 503 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~------ 503 (706)
.++|++.+.||+|+||.||++.+.. ..||+|++..........+.+.+|+.+++.++|+||+++++++....
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH 93 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence 4679999999999999999998764 44999988654433444567889999999999999999999886554
Q ss_pred ceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccc
Q 005247 504 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 583 (706)
Q Consensus 504 ~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~ 583 (706)
.+++||||+ +++|.+++.. ..+++..+..++.||+.||.|||++| |+||||||+||+++.++.+||+|||++.
T Consensus 94 ~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~~g--i~H~dlkp~Nill~~~~~~kl~dfg~~~ 166 (343)
T cd07880 94 DFYLVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLAR 166 (343)
T ss_pred eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeeccccc
Confidence 358999998 6788888753 24889999999999999999999999 9999999999999999999999999988
Q ss_pred cCCCCcccCCCCCCCCCccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCc----------
Q 005247 584 SKPNTYISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR---------- 652 (706)
Q Consensus 584 ~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~---------- 652 (706)
..... .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+.....
T Consensus 167 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd07880 167 QTDSE---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKL 243 (343)
T ss_pred ccccC---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence 65432 234567889999999876 4578899999999999999999999987654333322211000
Q ss_pred -------------------ccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH--HHHHHH
Q 005247 653 -------------------RLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME--TLQQFL 693 (706)
Q Consensus 653 -------------------~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~--~L~~ll 693 (706)
...+...+++++.++|.+||+.||++|||+.+++. .++.+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~ 305 (343)
T cd07880 244 QSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH 305 (343)
T ss_pred cchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence 00122467889999999999999999999999984 555543
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=299.31 Aligned_cols=252 Identities=24% Similarity=0.346 Sum_probs=204.9
Q ss_pred ceEEEEEeccCCceEEEEEEEc-----CCceEEEEEeccccc--hHHHHHHHHHHHHHHcC-CCCceeEEeccccCCCce
Q 005247 434 ELLIKKKIGEGSFGTVYHAEWR-----NSDVAVKILIEQEFH--EDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNL 505 (706)
Q Consensus 434 ~y~i~~~LG~G~fG~Vy~a~~~-----~~~vAVKvl~~~~~~--~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~ 505 (706)
+|++.+.||+|+||.||++... ++.+|+|+++..... ....+.+.+|+.+++++ +|+||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4789999999999999999753 345999998654322 23345688999999999 599999999999999999
Q ss_pred EEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccC
Q 005247 506 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK 585 (706)
Q Consensus 506 ~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~ 585 (706)
++||||+.+++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||+++..
T Consensus 81 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~--~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR---EHFTESEVRVYIAEIVLALDHLHQLG--IIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred EEEEecCCCCcHHHHHhhc---CCcCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 9999999999999988643 24788899999999999999999999 999999999999999999999999998764
Q ss_pred CCCcc-cCCCCCCCCCccCccccccCC--CCchhHHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHhhhcCcccCCCC
Q 005247 586 PNTYI-SSKTAAGTPEWMAPEVLREDP--SNEKSDVFSFGVILWELITLQKPWRNSTP----SQVISAVGFKGRRLEIPK 658 (706)
Q Consensus 586 ~~~~~-~~~~~~Gt~~Y~APE~l~~~~--~s~ksDVwSLGviL~ELltG~~Pf~~~~~----~~~~~~i~~~~~~l~~p~ 658 (706)
..... ......|+..|+|||.+.+.. .+.++||||||+++|+|++|..||..... .+....+ .......+.
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~ 233 (288)
T cd05583 156 LAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRI--LKSKPPFPK 233 (288)
T ss_pred ccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHH--HccCCCCCc
Confidence 43321 122346889999999987765 68899999999999999999999964322 2222222 233455677
Q ss_pred CCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 005247 659 NVNPMVAALIETCWAEEPEIRPSFPSIMETLQQF 692 (706)
Q Consensus 659 ~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~l 692 (706)
.++..++++|.+||+.||++|||+.++.+.|+..
T Consensus 234 ~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 234 TMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred ccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 7899999999999999999999988887766543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=299.32 Aligned_cols=247 Identities=22% Similarity=0.378 Sum_probs=201.2
Q ss_pred ceEEEEEeccCCceEEEEEEEc-----CCceEEEEEecccc--chHHHHHHHHHHHHHHcC-CCCceeEEeccccCCCce
Q 005247 434 ELLIKKKIGEGSFGTVYHAEWR-----NSDVAVKILIEQEF--HEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNL 505 (706)
Q Consensus 434 ~y~i~~~LG~G~fG~Vy~a~~~-----~~~vAVKvl~~~~~--~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~ 505 (706)
+|++.+.||+|+||.||++... +..||+|++..... .....+.+.+|+.+++.+ +|+||+.+++.+..++..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4789999999999999999863 45599999865432 123345678899999999 599999999999998999
Q ss_pred EEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccC
Q 005247 506 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK 585 (706)
Q Consensus 506 ~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~ 585 (706)
++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++...
T Consensus 81 ~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 81 HLILDYINGGELFTHLSQR---ERFKEQEVQIYSGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred EEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 9999999999999998643 24788899999999999999999999 999999999999999999999999998765
Q ss_pred CCCcc-cCCCCCCCCCccCccccccC--CCCchhHHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHhhhcCcccCCCC
Q 005247 586 PNTYI-SSKTAAGTPEWMAPEVLRED--PSNEKSDVFSFGVILWELITLQKPWRNSTP----SQVISAVGFKGRRLEIPK 658 (706)
Q Consensus 586 ~~~~~-~~~~~~Gt~~Y~APE~l~~~--~~s~ksDVwSLGviL~ELltG~~Pf~~~~~----~~~~~~i~~~~~~l~~p~ 658 (706)
..... ......|+..|+|||.+.+. .++.++||||||+++|+|++|..||..... .+....+ .....+++.
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~ 233 (290)
T cd05613 156 HEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRI--LKSEPPYPQ 233 (290)
T ss_pred ccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHh--hccCCCCCc
Confidence 43221 22345688999999998753 467899999999999999999999964332 2222222 223345677
Q ss_pred CCcHHHHHHHHHhhhhCCCCCC-----CHHHHHH
Q 005247 659 NVNPMVAALIETCWAEEPEIRP-----SFPSIME 687 (706)
Q Consensus 659 ~~s~el~dLI~~cL~~dP~~RP-----S~~eIl~ 687 (706)
.+++.+.+++.+||+.+|++|| ++++++.
T Consensus 234 ~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 234 EMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 8899999999999999999997 7777766
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=300.39 Aligned_cols=251 Identities=27% Similarity=0.411 Sum_probs=195.7
Q ss_pred cCceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCC------
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP------ 503 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~------ 503 (706)
.++|++.+.||+|+||.||+|.+.. ..+++|++............+.+|+++++.++|+||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 4789999999999999999998864 44999988655433333346678999999999999999999875433
Q ss_pred --ceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCc
Q 005247 504 --NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL 581 (706)
Q Consensus 504 --~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGl 581 (706)
.+++|+||+.+ +|...+... ...+++..+..++.|+++||+|||++| |+||||||+||+++.++.+||+|||+
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~ 161 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENP--SVKLTESQIKCYMLQLLEGINYLHENH--ILHRDIKAANILIDNQGILKIADFGL 161 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEECcCcc
Confidence 46899999865 566665432 235899999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCccc-----------CCCCCCCCCccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhh
Q 005247 582 SRSKPNTYIS-----------SKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGF 649 (706)
Q Consensus 582 a~~~~~~~~~-----------~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~ 649 (706)
++........ .....+++.|+|||.+.+. .++.++||||||+++|||++|..||...+.......+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~ 241 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK 241 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 8764332211 1223567889999988654 578999999999999999999999987766544333211
Q ss_pred cCcc---------------------cCCC-------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 650 KGRR---------------------LEIP-------KNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 650 ~~~~---------------------l~~p-------~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
.... ...+ ...++.+.++|.+||..||++|||+.+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 1000 0000 234468899999999999999999998874
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=307.33 Aligned_cols=254 Identities=27% Similarity=0.411 Sum_probs=199.3
Q ss_pred EEeccC--CceEEEEEEEc--CCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEEeccC
Q 005247 439 KKIGEG--SFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSR 514 (706)
Q Consensus 439 ~~LG~G--~fG~Vy~a~~~--~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~~~g 514 (706)
..||+| +||+||++++. ++.||+|++..........+.+.+|+.+++.++||||+++++++..++..++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 99999999885 45699999876655556668899999999999999999999999999999999999999
Q ss_pred CchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCccc---
Q 005247 515 GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS--- 591 (706)
Q Consensus 515 gsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~--- 591 (706)
++|.+++..... ..+++..+..++.|++.||+|||+++ ++||||||+||+++.++.++++||+.+.........
T Consensus 84 ~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~--ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 84 GSANSLLKTYFP-EGMSEALIGNILFGALRGLNYLHQNG--YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 999998864322 24788999999999999999999999 999999999999999999999999865432111100
Q ss_pred ----CCCCCCCCCccCccccccC--CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCc-------------
Q 005247 592 ----SKTAAGTPEWMAPEVLRED--PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR------------- 652 (706)
Q Consensus 592 ----~~~~~Gt~~Y~APE~l~~~--~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~------------- 652 (706)
.....++..|+|||++.+. .++.++|||||||++|||++|..||.................
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEE 240 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhh
Confidence 1112345679999999764 478899999999999999999999987654433322211000
Q ss_pred --------------------------------ccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH--HHHHHHHh
Q 005247 653 --------------------------------RLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME--TLQQFLMS 695 (706)
Q Consensus 653 --------------------------------~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~--~L~~ll~s 695 (706)
+...+..+++.+.+||++||+.||++|||+.++++ .++++..+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~~ 317 (328)
T cd08226 241 SRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQ 317 (328)
T ss_pred hhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHHh
Confidence 01112345678999999999999999999999975 56666554
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=296.02 Aligned_cols=248 Identities=29% Similarity=0.345 Sum_probs=198.9
Q ss_pred eEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcC---CCCceeEEeccccCCCc-----
Q 005247 435 LLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGL---RHPNIVLLMGAVTEPPN----- 504 (706)
Q Consensus 435 y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L---~HpnIv~l~~~~~~~~~----- 504 (706)
|++.+.||+|+||.||+|++.. ..+|+|++............+.+|+.+++++ +|+||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 6789999999999999999864 4599999875544433345666788777666 59999999999987776
Q ss_pred eEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCcccc
Q 005247 505 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 584 (706)
Q Consensus 505 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~ 584 (706)
.+++|||+.+ +|.+++..... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++..
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~--i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLHSHR--IVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhccc-CHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhEEEccCCCEEEeccCccee
Confidence 8999999975 78888764322 25889999999999999999999999 99999999999999999999999999876
Q ss_pred CCCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCc---c--------
Q 005247 585 KPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR---R-------- 653 (706)
Q Consensus 585 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~---~-------- 653 (706)
..... ......++..|+|||.+.+..++.++||||||+++|||++|..||......+....+..... .
T Consensus 157 ~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07838 157 YSFEM-ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVS 235 (287)
T ss_pred ccCCc-ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcc
Confidence 54332 12234578899999999998999999999999999999999999988776555443321100 0
Q ss_pred --------------cCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 654 --------------LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 654 --------------l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
....+.+++.+.++|.+||+.||.+||++.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 236 LPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred cchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0001234578899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=300.45 Aligned_cols=245 Identities=27% Similarity=0.457 Sum_probs=201.1
Q ss_pred eEEEEEeccCCceEEEEEEEcC--CceEEEEEecccc-chHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEEe
Q 005247 435 LLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY 511 (706)
Q Consensus 435 y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~ 511 (706)
|...+.||+|+||.||+|.+.. ..+++|++..... .....+.+.+|+.+++.++|+|++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 5567889999999999998754 4489998865433 334456788999999999999999999999999999999999
Q ss_pred ccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCccc
Q 005247 512 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS 591 (706)
Q Consensus 512 ~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~ 591 (706)
+. ++|.+++.... ..+++..++.++.||+.||.|||++| ++|+||||+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---- 173 (313)
T cd06633 103 CL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASKSSP---- 173 (313)
T ss_pred CC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChhhEEECCCCCEEEeecCCCcccCC----
Confidence 96 47777765332 34788999999999999999999999 99999999999999999999999998864322
Q ss_pred CCCCCCCCCccCccccc---cCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHH
Q 005247 592 SKTAAGTPEWMAPEVLR---EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI 668 (706)
Q Consensus 592 ~~~~~Gt~~Y~APE~l~---~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI 668 (706)
.....|+..|+|||.+. ...++.++||||||+++|+|++|..||...+.......+............++..+++||
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 253 (313)
T cd06633 174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFV 253 (313)
T ss_pred CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHH
Confidence 23456889999999984 456788999999999999999999999887765555544333222233345778899999
Q ss_pred HHhhhhCCCCCCCHHHHHHH
Q 005247 669 ETCWAEEPEIRPSFPSIMET 688 (706)
Q Consensus 669 ~~cL~~dP~~RPS~~eIl~~ 688 (706)
.+||+.+|.+||++.+++..
T Consensus 254 ~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 254 DYCLQKIPQERPASAELLRH 273 (313)
T ss_pred HHHccCChhhCcCHHHHhcC
Confidence 99999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=302.38 Aligned_cols=246 Identities=27% Similarity=0.430 Sum_probs=201.1
Q ss_pred ceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccc-cchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEE
Q 005247 434 ELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQE-FHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 510 (706)
Q Consensus 434 ~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~-~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E 510 (706)
.|...+.||+|+||.||+|.+..+ .+++|.+.... ......+.+.+|+.+++.++|+|++++++++......++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 466788999999999999988644 48999875432 233445678899999999999999999999999999999999
Q ss_pred eccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcc
Q 005247 511 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 590 (706)
Q Consensus 511 ~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~ 590 (706)
|+. |+|.+++.... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 96 ~~~-~~l~~~~~~~~--~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-- 168 (308)
T cd06634 96 YCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 168 (308)
T ss_pred ccC-CCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHhEEECCCCcEEECCcccceeecCc--
Confidence 996 57777664332 34788999999999999999999999 999999999999999999999999998764332
Q ss_pred cCCCCCCCCCccCccccc---cCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHH
Q 005247 591 SSKTAAGTPEWMAPEVLR---EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAAL 667 (706)
Q Consensus 591 ~~~~~~Gt~~Y~APE~l~---~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dL 667 (706)
....++..|+|||.+. ...++.++|||||||++|+|++|..||......+....+.........+..++..+++|
T Consensus 169 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 246 (308)
T cd06634 169 --NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNF 246 (308)
T ss_pred --ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHH
Confidence 3456888999999975 34578899999999999999999999987665554444432222222344688999999
Q ss_pred HHHhhhhCCCCCCCHHHHHHH
Q 005247 668 IETCWAEEPEIRPSFPSIMET 688 (706)
Q Consensus 668 I~~cL~~dP~~RPS~~eIl~~ 688 (706)
|.+||+.+|++||++.++++.
T Consensus 247 i~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 247 VDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred HHHHhhCCcccCCCHHHHhhC
Confidence 999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=298.85 Aligned_cols=242 Identities=27% Similarity=0.457 Sum_probs=202.7
Q ss_pred EEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEEeccCC
Q 005247 438 KKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRG 515 (706)
Q Consensus 438 ~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~~~gg 515 (706)
...||+|+||.||++.... ..+|+|++... .......+.+|+.+++.++|+||+++++.+...+..+++|||++++
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 102 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR--KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG 102 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc--chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCC
Confidence 3579999999999998754 44899886433 2234567889999999999999999999999999999999999999
Q ss_pred chhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcccCCCC
Q 005247 516 SLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTA 595 (706)
Q Consensus 516 sL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~ 595 (706)
+|.+++... .+++..+..++.|++.||+|||++| ++||||||+||+++.++.++|+|||++.............
T Consensus 103 ~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~g--ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~ 176 (292)
T cd06657 103 ALTDIVTHT----RMNEEQIAAVCLAVLKALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL 176 (292)
T ss_pred cHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEcccccceeccccccccccc
Confidence 999987532 3788899999999999999999999 9999999999999999999999999887654433333445
Q ss_pred CCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhc-CcccCCCCCCcHHHHHHHHHhhhh
Q 005247 596 AGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-GRRLEIPKNVNPMVAALIETCWAE 674 (706)
Q Consensus 596 ~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~-~~~l~~p~~~s~el~dLI~~cL~~ 674 (706)
.++..|+|||.+.+..++.++|+||||+++|+|++|..||......+....+... .........+++.+.++|.+||+.
T Consensus 177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 256 (292)
T cd06657 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVR 256 (292)
T ss_pred ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhC
Confidence 6889999999998888899999999999999999999999877665554443221 122333456789999999999999
Q ss_pred CCCCCCCHHHHHH
Q 005247 675 EPEIRPSFPSIME 687 (706)
Q Consensus 675 dP~~RPS~~eIl~ 687 (706)
+|.+||++.++++
T Consensus 257 ~P~~R~~~~~ll~ 269 (292)
T cd06657 257 DPAQRATAAELLK 269 (292)
T ss_pred CcccCcCHHHHhc
Confidence 9999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=306.29 Aligned_cols=257 Identities=25% Similarity=0.382 Sum_probs=202.1
Q ss_pred cCceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcC-CCCceeEEeccccCC--CceE
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEP--PNLS 506 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~--~~~~ 506 (706)
.++|++.+.||+|+||.||+|.+.. ..+++|.+............+.+|+.+++++ +|+||+++++++... ...+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 3578889999999999999998754 4589998755433334456677899999999 999999999987643 3589
Q ss_pred EEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCC
Q 005247 507 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP 586 (706)
Q Consensus 507 lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~ 586 (706)
+||||+. ++|..++... .+++..+..++.||+.||+|||++| |+||||||+||+++.++.+||+|||++....
T Consensus 86 lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~--i~H~dl~p~nill~~~~~~kl~d~g~~~~~~ 158 (337)
T cd07852 86 LVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSGN--VIHRDLKPSNILLNSDCRVKLADFGLARSLS 158 (337)
T ss_pred EEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence 9999997 4888887632 4778888999999999999999999 9999999999999999999999999987654
Q ss_pred CCcc-----cCCCCCCCCCccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcC---------
Q 005247 587 NTYI-----SSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG--------- 651 (706)
Q Consensus 587 ~~~~-----~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~--------- 651 (706)
.... ......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||......+....+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07852 159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIE 238 (337)
T ss_pred cccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 3221 2233568899999998865 457889999999999999999999997665443322221110
Q ss_pred -----------------cc---cCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH--HHHHHHh
Q 005247 652 -----------------RR---LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMET--LQQFLMS 695 (706)
Q Consensus 652 -----------------~~---l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~--L~~ll~s 695 (706)
.. ....+.++.++.++|.+||+.+|++|||+.++++. ++++-..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~ 304 (337)
T cd07852 239 SIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNP 304 (337)
T ss_pred HHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccC
Confidence 00 11123478899999999999999999999999974 5555443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=295.03 Aligned_cols=248 Identities=27% Similarity=0.379 Sum_probs=202.8
Q ss_pred eEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEEec
Q 005247 435 LLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYL 512 (706)
Q Consensus 435 y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~~ 512 (706)
|++.+.||+|+||.||+|++.. ..+++|++..........+.+..|+.+++.++|+||+++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 5678899999999999998864 45999998765434444567788999999999999999999999999999999999
Q ss_pred cCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcccC
Q 005247 513 SRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISS 592 (706)
Q Consensus 513 ~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~ 592 (706)
. ++|.+++.... ..+++..+..++.|++.||.|||+++ |+||||+|+||+++.++.+||+|||++..........
T Consensus 81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~ 155 (282)
T cd07829 81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR--ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY 155 (282)
T ss_pred C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChheEEEcCCCCEEEecCCcccccCCCcccc
Confidence 7 58999987442 35889999999999999999999999 9999999999999999999999999988765443333
Q ss_pred CCCCCCCCccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhc------------------Ccc
Q 005247 593 KTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK------------------GRR 653 (706)
Q Consensus 593 ~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~------------------~~~ 653 (706)
....++..|+|||.+.+. .++.++||||||+++|||++|..||......+....+... ...
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
T cd07829 156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPT 235 (282)
T ss_pred CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccc
Confidence 345567889999998776 7889999999999999999999999877654443322100 000
Q ss_pred c---------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 654 L---------EIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 654 l---------~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
. ...+..+..+.++|.+||..+|++||++.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 236 FPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0 111234788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=330.81 Aligned_cols=264 Identities=35% Similarity=0.597 Sum_probs=226.3
Q ss_pred CcccccCceEEEEEeccCCceEEEEEEEc---------CCceEEEEEeccccchHHHHHHHHHHHHHHcCC-CCceeEEe
Q 005247 427 GLEIRWSELLIKKKIGEGSFGTVYHAEWR---------NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLM 496 (706)
Q Consensus 427 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~---------~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~ 496 (706)
.+++...+..+.+.||+|.||.|++|... ...||||.++..... ...+.+..|+++|+.+. |+||+.++
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~ll 368 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLL 368 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhhe
Confidence 57888888888899999999999999643 123899998776655 67789999999999995 99999999
Q ss_pred ccccCCCceEEEEEeccCCchhhhcccCC-----------Cc--ccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCC
Q 005247 497 GAVTEPPNLSIVTEYLSRGSLYKLLHIPD-----------AR--VVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKS 563 (706)
Q Consensus 497 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~-----------~~--~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp 563 (706)
+++...+..++|+||+..|+|.++++... .. ..+.....+.++.||+.|++||++.. +|||||-.
T Consensus 369 G~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~--~vHRDLAa 446 (609)
T KOG0200|consen 369 GACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP--CVHRDLAA 446 (609)
T ss_pred eeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC--ccchhhhh
Confidence 99999999999999999999999996443 00 23788899999999999999999999 99999999
Q ss_pred CcEEECCCCcEEEeecCccccCCCCc-ccCCCCC--CCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 005247 564 PNLLVDSTYTVKVCDFGLSRSKPNTY-ISSKTAA--GTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNST 639 (706)
Q Consensus 564 ~NILl~~~~~vKL~DFGla~~~~~~~-~~~~~~~--Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~ 639 (706)
.|||++++..+||+|||+|+...... ....... -...|||||.+....|+.++||||||++||||++ |..||.+..
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~ 526 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP 526 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence 99999999999999999999644332 2212222 2456999999999999999999999999999998 789998866
Q ss_pred -hHHHHHHhhhcCcccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 005247 640 -PSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLM 694 (706)
Q Consensus 640 -~~~~~~~i~~~~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~ 694 (706)
..+... ....+.++..|.+|+.+++++|+.||+.+|++||++.++.+.+...+.
T Consensus 527 ~~~~l~~-~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 527 PTEELLE-FLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred cHHHHHH-HHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 445544 456889999999999999999999999999999999999999999664
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=306.56 Aligned_cols=246 Identities=24% Similarity=0.358 Sum_probs=201.6
Q ss_pred cCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCc-----
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN----- 504 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~----- 504 (706)
.++|++.+.||+|+||.||+|.+..+ .+|+|++..........+.+.+|+.+++.++|+||+++.+++...+.
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ 93 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence 46799999999999999999988644 49999876544344455678899999999999999999988766554
Q ss_pred -eEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccc
Q 005247 505 -LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 583 (706)
Q Consensus 505 -~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~ 583 (706)
.++|+||+ +++|.+++.. ..+++..++.++.|++.||.|||+.| |+||||||+||+++.++.+||+|||++.
T Consensus 94 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nill~~~~~~kL~dfg~~~ 166 (343)
T cd07851 94 DVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG--IIHRDLKPSNIAVNEDCELKILDFGLAR 166 (343)
T ss_pred cEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEccccccc
Confidence 89999998 6699988863 24889999999999999999999999 9999999999999999999999999988
Q ss_pred cCCCCcccCCCCCCCCCccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcc---------
Q 005247 584 SKPNTYISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR--------- 653 (706)
Q Consensus 584 ~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~--------- 653 (706)
..... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||......+....+......
T Consensus 167 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (343)
T cd07851 167 HTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKI 243 (343)
T ss_pred ccccc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Confidence 65433 234567889999999865 36788999999999999999999999877665544433211000
Q ss_pred --------------------cCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 654 --------------------LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 654 --------------------l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
.......++++.+||.+||+.+|++|||+.+|+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 244 SSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred cchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 0111345889999999999999999999999976
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=303.86 Aligned_cols=248 Identities=24% Similarity=0.283 Sum_probs=196.9
Q ss_pred ceE-EEEEeccCCceEEEEEEEcC--CceEEEEEeccccchH------------HHHHHHHHHHHHHcCCCCceeEEecc
Q 005247 434 ELL-IKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHED------------RFKEFLREVAIMKGLRHPNIVLLMGA 498 (706)
Q Consensus 434 ~y~-i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~------------~~~~~~~Ei~iL~~L~HpnIv~l~~~ 498 (706)
+|. +.+.||.|+||.||+|.+.. ..||+|++........ ....+.+|+++++.++|+||++++++
T Consensus 9 ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 88 (335)
T PTZ00024 9 RYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDV 88 (335)
T ss_pred chhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEE
Confidence 443 45789999999999998764 4599998865432221 01257789999999999999999999
Q ss_pred ccCCCceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEee
Q 005247 499 VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCD 578 (706)
Q Consensus 499 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~D 578 (706)
+...+..+++|||+. |+|.+++... ..+++..+..++.|++.||.|||++| ++|+||||+||+++.++.+||+|
T Consensus 89 ~~~~~~~~lv~e~~~-~~l~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~--i~H~dl~~~nill~~~~~~kl~d 162 (335)
T PTZ00024 89 YVEGDFINLVMDIMA-SDLKKVVDRK---IRLTESQVKCILLQILNGLNVLHKWY--FMHRDLSPANIFINSKGICKIAD 162 (335)
T ss_pred EecCCcEEEEEeccc-cCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHeEECCCCCEEECC
Confidence 999999999999997 5888888632 35889999999999999999999999 99999999999999999999999
Q ss_pred cCccccCCCC--------------cccCCCCCCCCCccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH
Q 005247 579 FGLSRSKPNT--------------YISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQV 643 (706)
Q Consensus 579 FGla~~~~~~--------------~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~ 643 (706)
||++...... ........++..|+|||.+.+. .++.++||||||+++|||++|..||...+..+.
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~ 242 (335)
T PTZ00024 163 FGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQ 242 (335)
T ss_pred ccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 9998765411 1111233568889999998764 468899999999999999999999988776554
Q ss_pred HHHhhhcCc---c-----------------------cCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 644 ISAVGFKGR---R-----------------------LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 644 ~~~i~~~~~---~-----------------------l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
...+..... . .......+.++.++|.+||+.+|++||++++++.
T Consensus 243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 243 LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 433321000 0 0012345788999999999999999999999986
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=305.05 Aligned_cols=251 Identities=24% Similarity=0.349 Sum_probs=199.9
Q ss_pred CceEEEEEeccCCceEEEEEEEc--CCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCC------c
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP------N 504 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~------~ 504 (706)
.+|.+.+.||+|+||.||+|.+. +..+|+|++............+.+|+.+++.++|+||+++++++.... .
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 57999999999999999999875 445999988654433444457889999999999999999999886543 4
Q ss_pred eEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCcccc
Q 005247 505 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 584 (706)
Q Consensus 505 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~ 584 (706)
+++|+||+.. +|..+.. ..+++..+..++.|++.||+|||+++ ++||||||+||+++.++.+||+|||+++.
T Consensus 95 ~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dlkp~NIll~~~~~~kL~dfg~~~~ 166 (342)
T cd07879 95 FYLVMPYMQT-DLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHSAG--IIHRDLKPGNLAVNEDCELKILDFGLARH 166 (342)
T ss_pred EEEEeccccc-CHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence 6899999864 6666542 24788899999999999999999999 99999999999999999999999999876
Q ss_pred CCCCcccCCCCCCCCCccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCc-----------
Q 005247 585 KPNTYISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR----------- 652 (706)
Q Consensus 585 ~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~----------- 652 (706)
.... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+.......+.....
T Consensus 167 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (342)
T cd07879 167 ADAE---MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLE 243 (342)
T ss_pred CCCC---CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhc
Confidence 4332 234567889999999876 4578999999999999999999999987765444332211000
Q ss_pred ----------cc--------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH--HHHHHHH
Q 005247 653 ----------RL--------EIPKNVNPMVAALIETCWAEEPEIRPSFPSIME--TLQQFLM 694 (706)
Q Consensus 653 ----------~l--------~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~--~L~~ll~ 694 (706)
.. ...+..++.+.+||.+||+.||++||++.+++. .++.+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 244 DKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred ccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 00 011346788999999999999999999999985 3666543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=301.14 Aligned_cols=247 Identities=26% Similarity=0.387 Sum_probs=197.8
Q ss_pred ccCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccC-CCceEE
Q 005247 431 RWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE-PPNLSI 507 (706)
Q Consensus 431 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~-~~~~~l 507 (706)
..++|++.+.||.|+||.||+|.+..+ .+|+|++..........+.+.+|+.+++.++||||+++++++.. ....++
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l 87 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF 87 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence 346799999999999999999987644 49999876544344445678899999999999999999998865 557899
Q ss_pred EEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCC
Q 005247 508 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 587 (706)
Q Consensus 508 V~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 587 (706)
++||+ +++|..+++.. .+++..+..++.|+++||.|||+++ |+||||||+||+++.++.+||+|||++.....
T Consensus 88 v~e~~-~~~L~~~~~~~----~~~~~~~~~~~~ql~~aL~~LH~~~--iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~ 160 (328)
T cd07856 88 VTELL-GTDLHRLLTSR----PLEKQFIQYFLYQILRGLKYVHSAG--VVHRDLKPSNILINENCDLKICDFGLARIQDP 160 (328)
T ss_pred Eeehh-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEeECCCCCEEeCccccccccCC
Confidence 99998 56888887532 3678888899999999999999999 99999999999999999999999999875433
Q ss_pred CcccCCCCCCCCCccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhh-----------------
Q 005247 588 TYISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGF----------------- 649 (706)
Q Consensus 588 ~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~----------------- 649 (706)
. .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...........+..
T Consensus 161 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (328)
T cd07856 161 Q---MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSEN 237 (328)
T ss_pred C---cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchh
Confidence 2 234567889999999866 5689999999999999999999999977654322211110
Q ss_pred -------cCc--ccC---CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 650 -------KGR--RLE---IPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 650 -------~~~--~l~---~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
... ..+ ....++..+.++|.+||+.+|++||++.+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~ 287 (328)
T cd07856 238 TLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA 287 (328)
T ss_pred hHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000 001 11356789999999999999999999998865
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=303.89 Aligned_cols=246 Identities=24% Similarity=0.358 Sum_probs=195.4
Q ss_pred CceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCC--------
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP-------- 502 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~-------- 502 (706)
.+|.+.+.||.|+||.||+|.+..+ .|++|++..... ...+.+.+|+++++.++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV 82 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence 6899999999999999999988654 489998765543 3446788999999999999999999876543
Q ss_pred ------CceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECC-CCcEE
Q 005247 503 ------PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS-TYTVK 575 (706)
Q Consensus 503 ------~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~-~~~vK 575 (706)
...++||||+. ++|.+++.. ..+++..++.++.||+.||.|||++| |+||||||+||+++. ++.+|
T Consensus 83 ~~~~~~~~~~lv~e~~~-~~L~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~g--ivH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 83 GSLTELNSVYIVQEYME-TDLANVLEQ----GPLSEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred ccccccceEEEEeeccc-ccHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCCCceEE
Confidence 35789999997 588887752 24789999999999999999999999 999999999999974 55789
Q ss_pred EeecCccccCCCCccc---CCCCCCCCCccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcC
Q 005247 576 VCDFGLSRSKPNTYIS---SKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG 651 (706)
Q Consensus 576 L~DFGla~~~~~~~~~---~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~ 651 (706)
|+|||.+......... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...++.+....+....
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~ 235 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESV 235 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 9999998765332211 122357889999998754 557889999999999999999999998776544433321100
Q ss_pred -----------------------cc-----cCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 652 -----------------------RR-----LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 652 -----------------------~~-----l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
.. ..+.+.++.++.+||.+||+.||++|||+.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 236 PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred CCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 00 0112357789999999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=292.05 Aligned_cols=247 Identities=29% Similarity=0.445 Sum_probs=196.9
Q ss_pred eEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCC-CCceeEEeccccCCCceEEEEEe
Q 005247 435 LLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGAVTEPPNLSIVTEY 511 (706)
Q Consensus 435 y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~lV~E~ 511 (706)
|++.+.||+|+||.||+|...+ ..+++|.+...... .......+|+..+++++ |+||+++++++..++..++||||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 79 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY 79 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence 6788999999999999999864 44899987554322 22234567999999999 99999999999999999999999
Q ss_pred ccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCccc
Q 005247 512 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS 591 (706)
Q Consensus 512 ~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~ 591 (706)
+ +|+|.+++.... ...+++..+..++.|++.+|.|||+++ ++|+||+|+||+++.++.++|+|||++....... .
T Consensus 80 ~-~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~-~ 154 (283)
T cd07830 80 M-EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG--FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP-P 154 (283)
T ss_pred C-CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCCCCEEEeecccceeccCCC-C
Confidence 9 789988886433 235789999999999999999999999 9999999999999999999999999987654432 1
Q ss_pred CCCCCCCCCccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhc-Cc----------------c
Q 005247 592 SKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-GR----------------R 653 (706)
Q Consensus 592 ~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~-~~----------------~ 653 (706)
.....++..|+|||.+.+ ..++.++|+||||+++|||++|+.||......+....+... +. .
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 234567889999998854 45788999999999999999999999776554433222100 00 0
Q ss_pred -----------cCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 654 -----------LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 654 -----------l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
.......+..+.++|++||+.+|++||++.|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 0011123678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=317.00 Aligned_cols=248 Identities=25% Similarity=0.393 Sum_probs=228.3
Q ss_pred cccccCceEEEEEeccCCceEEEEEEEcCCc--eEEEEEecccc-chHHHHHHHHHHHHHHcCCCCceeEEeccccCCCc
Q 005247 428 LEIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN 504 (706)
Q Consensus 428 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~--vAVKvl~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 504 (706)
-.+..++++++..||-||||.|=+++.++.. +|+|++++... +..+.+.+..|-.||...+.|.||++|..|.+..+
T Consensus 415 a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~ky 494 (732)
T KOG0614|consen 415 AQVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKY 494 (732)
T ss_pred cccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchh
Confidence 4566788899999999999999999887776 89999877654 34556788899999999999999999999999999
Q ss_pred eEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCcccc
Q 005247 505 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 584 (706)
Q Consensus 505 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~ 584 (706)
.|+.||-|-||.|+..++.. +.+++..+..++..+++|++|||++| ||.|||||+|++++.+|-+||.|||+|..
T Consensus 495 vYmLmEaClGGElWTiLrdR---g~Fdd~tarF~~acv~EAfeYLH~k~--iIYRDLKPENllLd~~Gy~KLVDFGFAKk 569 (732)
T KOG0614|consen 495 VYMLMEACLGGELWTILRDR---GSFDDYTARFYVACVLEAFEYLHRKG--IIYRDLKPENLLLDNRGYLKLVDFGFAKK 569 (732)
T ss_pred hhhhHHhhcCchhhhhhhhc---CCcccchhhhhHHHHHHHHHHHHhcC--ceeccCChhheeeccCCceEEeehhhHHH
Confidence 99999999999999999844 46999999999999999999999999 99999999999999999999999999999
Q ss_pred CCCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHH
Q 005247 585 KPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV 664 (706)
Q Consensus 585 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el 664 (706)
.+.... .-++||||.|.|||++.+...+.++|.||||+++|||++|.+||.+.++...+..|..+...+.+|..++...
T Consensus 570 i~~g~K-TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a 648 (732)
T KOG0614|consen 570 IGSGRK-TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTA 648 (732)
T ss_pred hccCCc-eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhH
Confidence 887653 3488999999999999999999999999999999999999999999999999999988888999999999999
Q ss_pred HHHHHHhhhhCCCCCCC
Q 005247 665 AALIETCWAEEPEIRPS 681 (706)
Q Consensus 665 ~dLI~~cL~~dP~~RPS 681 (706)
.+||+++...+|.+|..
T Consensus 649 ~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 649 TDLIKKLCRDNPTERLG 665 (732)
T ss_pred HHHHHHHHhcCcHhhhc
Confidence 99999999999999975
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=300.07 Aligned_cols=248 Identities=25% Similarity=0.367 Sum_probs=195.0
Q ss_pred ceEEEEEeccCCceEEEEEEEcCC----ceEEEEEeccccchHHHHHHHHHHHHHHcC-CCCceeEEeccccC----CCc
Q 005247 434 ELLIKKKIGEGSFGTVYHAEWRNS----DVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTE----PPN 504 (706)
Q Consensus 434 ~y~i~~~LG~G~fG~Vy~a~~~~~----~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~----~~~ 504 (706)
+|++.+.||+|+||.||++.+.++ .+|+|.+..........+.+.+|+.+++++ +|+||+++++.+.. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 488999999999999999998754 599998764433333456788999999999 59999999986432 245
Q ss_pred eEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCcccc
Q 005247 505 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 584 (706)
Q Consensus 505 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~ 584 (706)
.++++||+. ++|.+++... ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g--ivH~dlkp~Nili~~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSG---QPLTDAHFQSFIYQILCGLKYIHSAN--VLHRDLKPGNLLVNADCELKICDFGLARG 154 (332)
T ss_pred EEEEEeccc-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence 788899885 5888887532 35889999999999999999999999 99999999999999999999999999976
Q ss_pred CCCCcc----cCCCCCCCCCccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhc---------
Q 005247 585 KPNTYI----SSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK--------- 650 (706)
Q Consensus 585 ~~~~~~----~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~--------- 650 (706)
...... ......|+..|+|||.+.+ ..++.++||||||+++|+|++|..||...+.......+...
T Consensus 155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 234 (332)
T cd07857 155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETL 234 (332)
T ss_pred cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 443211 1223468999999998766 46889999999999999999999999876543332211100
Q ss_pred -----------------Cccc---CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 651 -----------------GRRL---EIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 651 -----------------~~~l---~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
.... ......+.++.+||.+||+.||++|||+.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 235 SRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0001 112346789999999999999999999999876
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=302.27 Aligned_cols=247 Identities=23% Similarity=0.339 Sum_probs=197.4
Q ss_pred ccCceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCC------
Q 005247 431 RWSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP------ 502 (706)
Q Consensus 431 ~~~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~------ 502 (706)
..++|++.+.||+|+||.||++.+.. ..||+|++..........+.+.+|+.++++++|+||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 94 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence 34789999999999999999998754 4499998865443344456788999999999999999999887532
Q ss_pred CceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCcc
Q 005247 503 PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS 582 (706)
Q Consensus 503 ~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla 582 (706)
...+++++++ +++|.++++.. .+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++
T Consensus 95 ~~~~lv~~~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kl~dfg~~ 167 (345)
T cd07877 95 NDVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLA 167 (345)
T ss_pred ccEEEEehhc-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEcCCCCEEEeccccc
Confidence 3467888876 77898887532 3788999999999999999999999 999999999999999999999999998
Q ss_pred ccCCCCcccCCCCCCCCCccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCc---------
Q 005247 583 RSKPNTYISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR--------- 652 (706)
Q Consensus 583 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~--------- 652 (706)
+..... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...........+.....
T Consensus 168 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (345)
T cd07877 168 RHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 244 (345)
T ss_pred cccccc---ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence 765432 234567889999999876 4678899999999999999999999976654433322211000
Q ss_pred ---------------c--c---CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 653 ---------------R--L---EIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 653 ---------------~--l---~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
. . ......++++.+||.+||+.||.+||++.+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 299 (345)
T cd07877 245 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 299 (345)
T ss_pred cccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence 0 0 011245788999999999999999999999886
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=292.01 Aligned_cols=242 Identities=26% Similarity=0.412 Sum_probs=199.0
Q ss_pred CceEEE-EEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcC-CCCceeEEeccccCC----Cc
Q 005247 433 SELLIK-KKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEP----PN 504 (706)
Q Consensus 433 ~~y~i~-~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~----~~ 504 (706)
++|.+- ++||-|-.|+|..+.++.+ ++|+|++... ....+|+++.-.. .|||||.+++++.+. ..
T Consensus 61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred hhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 345443 6899999999999987655 4999998543 3566888877655 599999999987543 34
Q ss_pred eEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECC---CCcEEEeecCc
Q 005247 505 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS---TYTVKVCDFGL 581 (706)
Q Consensus 505 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~---~~~vKL~DFGl 581 (706)
+.+|||.++||.|...++..+ ...++++++..|+.||..|+.|||+.+ |.||||||+|+|... +-.+||+|||+
T Consensus 134 LLiVmE~meGGeLfsriq~~g-~~afTErea~eI~~qI~~Av~~lH~~n--IAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRG-DQAFTEREASEIMKQIGLAVRYLHSMN--IAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred eEeeeecccchHHHHHHHHcc-cccchHHHHHHHHHHHHHHHHHHHhcc--hhhccCChhheeeecCCCCcceEeccccc
Confidence 679999999999999997554 346999999999999999999999999 999999999999965 44799999999
Q ss_pred cccCCCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH----HHHHhhhcCcccCCC
Q 005247 582 SRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQ----VISAVGFKGRRLEIP 657 (706)
Q Consensus 582 a~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~----~~~~i~~~~~~l~~p 657 (706)
|+..... ....+.+.|++|.|||++....|+...|+||+||++|-|++|.+||+.+.... +..+|..+ ...+|
T Consensus 211 AK~t~~~-~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~g--qy~FP 287 (400)
T KOG0604|consen 211 AKETQEP-GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTG--QYEFP 287 (400)
T ss_pred ccccCCC-ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhcc--CccCC
Confidence 9875533 24567889999999999999999999999999999999999999998765432 33444333 33444
Q ss_pred ----CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 658 ----KNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 658 ----~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
..+|+..+++|+.+|..+|.+|.|+++++.
T Consensus 288 ~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 288 EPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred ChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 367899999999999999999999999875
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=330.28 Aligned_cols=247 Identities=26% Similarity=0.481 Sum_probs=193.3
Q ss_pred ccCceEEEEEeccCCceEEEEEEEc--CCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEecccc--------
Q 005247 431 RWSELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT-------- 500 (706)
Q Consensus 431 ~~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~-------- 500 (706)
...+|+.++.||+||||.||+++++ +..||||.+.... .......+.+|+..+.+|+|||||+++..|.
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 3467788899999999999999875 6669999997776 6667788999999999999999999864330
Q ss_pred --------------------------------------------------------------------------------
Q 005247 501 -------------------------------------------------------------------------------- 500 (706)
Q Consensus 501 -------------------------------------------------------------------------------- 500 (706)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ------------------------CC-------CceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHH
Q 005247 501 ------------------------EP-------PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 549 (706)
Q Consensus 501 ------------------------~~-------~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yL 549 (706)
+. ..+||-||||+..+|.++++.+... -.....|.++++|++||.|+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~--~~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN--SQRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc--hhhHHHHHHHHHHHHHHHHH
Confidence 00 1257889999998888888755422 14678899999999999999
Q ss_pred HhcCCCcccccCCCCcEEECCCCcEEEeecCccccCC------------------CCcccCCCCCCCCCccCccccccCC
Q 005247 550 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP------------------NTYISSKTAAGTPEWMAPEVLREDP 611 (706)
Q Consensus 550 Hs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~------------------~~~~~~~~~~Gt~~Y~APE~l~~~~ 611 (706)
|++| ||||||||.||+++..+.|||+|||+|+... ......+..+||.-|+|||++.+..
T Consensus 714 H~~g--iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 714 HDQG--IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred HhCc--eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence 9999 9999999999999999999999999998611 1111345678999999999997655
Q ss_pred ---CCchhHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHhhhcCcccCCCCC----CcHHHHHHHHHhhhhCCCCCCCHH
Q 005247 612 ---SNEKSDVFSFGVILWELITLQKPWRNSTPSQ-VISAVGFKGRRLEIPKN----VNPMVAALIETCWAEEPEIRPSFP 683 (706)
Q Consensus 612 ---~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~-~~~~i~~~~~~l~~p~~----~s~el~dLI~~cL~~dP~~RPS~~ 683 (706)
|+.|+|+||||+|++||+ +||...-... .+..+. ...++.+.. --+.-+.+|++||+.||.+||||.
T Consensus 792 ~~~Yn~KiDmYSLGIVlFEM~---yPF~TsMERa~iL~~LR--~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~ 866 (1351)
T KOG1035|consen 792 SNKYNSKIDMYSLGIVLFEML---YPFGTSMERASILTNLR--KGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTAT 866 (1351)
T ss_pred cccccchhhhHHHHHHHHHHh---ccCCchHHHHHHHHhcc--cCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHH
Confidence 999999999999999998 4565543222 222222 233333321 124567799999999999999999
Q ss_pred HHHH
Q 005247 684 SIME 687 (706)
Q Consensus 684 eIl~ 687 (706)
|++.
T Consensus 867 eLL~ 870 (1351)
T KOG1035|consen 867 ELLN 870 (1351)
T ss_pred HHhh
Confidence 9875
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=315.98 Aligned_cols=259 Identities=27% Similarity=0.403 Sum_probs=207.5
Q ss_pred CceEEEEEeccCCceEEEEEEEcCCc--eEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCC------c
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP------N 504 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~~~--vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~------~ 504 (706)
..|...+.||+|+||.||+++++.++ +|||.+.... .....+..-+|+++|++|+|+|||+++++-.+.. .
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~ 91 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRL 91 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCccccc
Confidence 34677889999999999999987654 9999986644 3444567889999999999999999998865443 4
Q ss_pred eEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEEC--CCC--cEEEeecC
Q 005247 505 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVD--STY--TVKVCDFG 580 (706)
Q Consensus 505 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~--~~~--~vKL~DFG 580 (706)
..+|||||.||+|...++.+....-+++..++.+...+..||.|||++| ||||||||.||++- .+| ..||+|||
T Consensus 92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~--IvHRDlKP~NIvl~~Gedgq~IyKLtDfG 169 (732)
T KOG4250|consen 92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG--IVHRDLKPGNIVLQIGEDGQSIYKLTDFG 169 (732)
T ss_pred ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEeecCCCceEEeeeccc
Confidence 6899999999999999998888888999999999999999999999999 99999999999983 223 57999999
Q ss_pred ccccCCCCcccCCCCCCCCCccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChH----HHHHHhhhcC----
Q 005247 581 LSRSKPNTYISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPS----QVISAVGFKG---- 651 (706)
Q Consensus 581 la~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~----~~~~~i~~~~---- 651 (706)
.|+...+.. ...+..||..|++||.+.. ..|+..+|.|||||++|+++||..||...... ++...+....
T Consensus 170 ~Arel~d~s-~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v 248 (732)
T KOG4250|consen 170 AARELDDNS-LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGV 248 (732)
T ss_pred ccccCCCCC-eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCce
Confidence 999887765 4568899999999999985 78899999999999999999999999764332 2222221111
Q ss_pred ---------------cccCCCCCCcHH----HHHHHHHhhhhCCCCCC--CHHHHHHHHHHHHHh
Q 005247 652 ---------------RRLEIPKNVNPM----VAALIETCWAEEPEIRP--SFPSIMETLQQFLMS 695 (706)
Q Consensus 652 ---------------~~l~~p~~~s~e----l~dLI~~cL~~dP~~RP--S~~eIl~~L~~ll~s 695 (706)
..+++|-+.++. +-..+..+|..+|++|- .+.+....+..++..
T Consensus 249 ~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~ 313 (732)
T KOG4250|consen 249 AIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNL 313 (732)
T ss_pred eEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhh
Confidence 013444455543 44566788899999998 777777777666643
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=322.23 Aligned_cols=147 Identities=33% Similarity=0.529 Sum_probs=131.1
Q ss_pred cCceEEEEEeccCCceEEEEEEEc--CCceEEEEEecccc-chHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEE
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIV 508 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKvl~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV 508 (706)
..+|++.++||+|+||.||+|.+. +..||+|++..... .......+.+|+.+++.++|+||+++++++...+..++|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 468999999999999999999987 45699999875433 344456788999999999999999999999999999999
Q ss_pred EEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccc
Q 005247 509 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 583 (706)
Q Consensus 509 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~ 583 (706)
|||+.+++|.+++...+ .+++..++.|+.||+.||.|||+++ ||||||||+|||++.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~~---~l~~~~~~~i~~qil~aL~yLH~~g--IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYG---YFDEEMAVKYISEVALALDYLHRHG--IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999986432 4788899999999999999999999 9999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=295.36 Aligned_cols=255 Identities=34% Similarity=0.600 Sum_probs=207.0
Q ss_pred cCceEEEEEeccCCceEEEEEEEcCCceEEEEEeccccchHHHHHHHHHHHHHHcC--CCCceeEEeccccCCC----ce
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGL--RHPNIVLLMGAVTEPP----NL 505 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L--~HpnIv~l~~~~~~~~----~~ 505 (706)
..+..+.+.||+|.||.||+|.++|..||||++...+ .+.+.+|.+|.+.. +|+||+.+++.-..++ ++
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srd-----E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL 284 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRD-----ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL 284 (513)
T ss_pred hheeEEEEEecCccccceeeccccCCceEEEEecccc-----hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence 4678899999999999999999999999999985432 25788899888754 8999999998764433 58
Q ss_pred EEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHh-----cC-CCcccccCCCCcEEECCCCcEEEeec
Q 005247 506 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ-----RR-PPIVHRDLKSPNLLVDSTYTVKVCDF 579 (706)
Q Consensus 506 ~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs-----~g-~~IIHrDLKp~NILl~~~~~vKL~DF 579 (706)
|+|.+|.+.|+|+|||... .++.+..++++..++.||++||- +| |.|.|||||..|||+.++|..-|+|+
T Consensus 285 wLvTdYHe~GSL~DyL~r~----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL 360 (513)
T KOG2052|consen 285 WLVTDYHEHGSLYDYLNRN----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 360 (513)
T ss_pred EEeeecccCCcHHHHHhhc----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence 9999999999999999753 58899999999999999999996 23 78999999999999999999999999
Q ss_pred CccccCCCC----cccCCCCCCCCCccCccccccCCC------CchhHHHHHHHHHHHHHhC----------CCCCCCCC
Q 005247 580 GLSRSKPNT----YISSKTAAGTPEWMAPEVLREDPS------NEKSDVFSFGVILWELITL----------QKPWRNST 639 (706)
Q Consensus 580 Gla~~~~~~----~~~~~~~~Gt~~Y~APE~l~~~~~------s~ksDVwSLGviL~ELltG----------~~Pf~~~~ 639 (706)
|+|...... .......+||.+|||||++..... -..+||||||.++||++.. +.||....
T Consensus 361 GLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~V 440 (513)
T KOG2052|consen 361 GLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVV 440 (513)
T ss_pred eeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCC
Confidence 999764432 223456789999999999865432 2468999999999999842 57886543
Q ss_pred h-----HHHHHHhhhcCcccCCCCCCc-----HHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHh
Q 005247 640 P-----SQVISAVGFKGRRLEIPKNVN-----PMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS 695 (706)
Q Consensus 640 ~-----~~~~~~i~~~~~~l~~p~~~s-----~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s 695 (706)
+ +++..-+-....++.+|..+. ..+..||+.||..||.-|.|+-.|.+.|.++...
T Consensus 441 p~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~ 506 (513)
T KOG2052|consen 441 PSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNS 506 (513)
T ss_pred CCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcC
Confidence 2 334444444555666665432 4678899999999999999999999999998854
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=292.99 Aligned_cols=260 Identities=27% Similarity=0.395 Sum_probs=204.6
Q ss_pred cccCcccccCceEEEEEeccCCceEEEEEEEcCCc--eEEEEEeccccchHHHHHHHHHHHHHH-cCCCCceeEEecccc
Q 005247 424 EEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMK-GLRHPNIVLLMGAVT 500 (706)
Q Consensus 424 ~~~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~--vAVKvl~~~~~~~~~~~~~~~Ei~iL~-~L~HpnIv~l~~~~~ 500 (706)
.+...++...+++-++.||.|+||+|++-.++.++ .|||.+..... +...+.++.|.+... .-++||||++||+..
T Consensus 55 ~~~~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F 133 (361)
T KOG1006|consen 55 DAHLHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALF 133 (361)
T ss_pred cccccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhh
Confidence 44555666777788899999999999999888665 78898876654 455577888887654 447999999999999
Q ss_pred CCCceEEEEEeccCCchhhhccc--CCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEee
Q 005247 501 EPPNLSIVTEYLSRGSLYKLLHI--PDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCD 578 (706)
Q Consensus 501 ~~~~~~lV~E~~~ggsL~~~l~~--~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~D 578 (706)
.++.+||.||+|+- +|..+.+. ......+++...-.|....+.||.||...- .|||||+||+|||++..|.|||||
T Consensus 134 ~EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l-kiIHRDvKPSNILldr~G~vKLCD 211 (361)
T KOG1006|consen 134 SEGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL-KIIHRDVKPSNILLDRHGDVKLCD 211 (361)
T ss_pred cCCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh-hhhhccCChhheEEecCCCEeeec
Confidence 99999999999964 55443321 112335889999999999999999998642 299999999999999999999999
Q ss_pred cCccccCCCCcccCCCCCCCCCccCcccccc--CCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHhhhcCc-cc
Q 005247 579 FGLSRSKPNTYISSKTAAGTPEWMAPEVLRE--DPSNEKSDVFSFGVILWELITLQKPWRNSTPS-QVISAVGFKGR-RL 654 (706)
Q Consensus 579 FGla~~~~~~~~~~~~~~Gt~~Y~APE~l~~--~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~-~~~~~i~~~~~-~l 654 (706)
||++...-+.. ..+..+|...|||||.+.. ..|+-+|||||||++|||+.||..||..++.. +.+..+..+.. .+
T Consensus 212 FGIcGqLv~Si-AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l 290 (361)
T KOG1006|consen 212 FGICGQLVDSI-AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPIL 290 (361)
T ss_pred ccchHhHHHHH-HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCee
Confidence 99987655433 3345678999999999964 35899999999999999999999999987652 22222222222 23
Q ss_pred CCCCC---CcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 655 EIPKN---VNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 655 ~~p~~---~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
..+.+ .+..+..+|.-||.+|-.+||.+.++.+
T Consensus 291 ~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 291 LFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred cCcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 33333 7899999999999999999999999876
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=300.16 Aligned_cols=258 Identities=31% Similarity=0.494 Sum_probs=210.8
Q ss_pred cCceEEEEEeccCCceEEEEEEEcCCceEEEEEeccccchHHHHHHHHHHHHHHcC--CCCceeEEeccccCCC----ce
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGL--RHPNIVLLMGAVTEPP----NL 505 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L--~HpnIv~l~~~~~~~~----~~ 505 (706)
....++.+.||+|+||.||+|+..++.||||++. ....+.|.+|-+|.+.. +|+||++++++-.... .+
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp-----~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ey 283 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFP-----EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEY 283 (534)
T ss_pred CCchhhHHHhhcCccceeehhhccCceeEEEecC-----HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccce
Confidence 3456678899999999999999999999999974 44557899999998865 7999999999876555 79
Q ss_pred EEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhc-------CCCcccccCCCCcEEECCCCcEEEee
Q 005247 506 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR-------RPPIVHRDLKSPNLLVDSTYTVKVCD 578 (706)
Q Consensus 506 ~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~-------g~~IIHrDLKp~NILl~~~~~vKL~D 578 (706)
++|++|.+.|+|.+||+.. .+++....+|+..+++||+|||+. +|+|+|||||..|||+..+++..|+|
T Consensus 284 wLVt~fh~kGsL~dyL~~n----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD 359 (534)
T KOG3653|consen 284 WLVTEFHPKGSLCDYLKAN----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD 359 (534)
T ss_pred eEEeeeccCCcHHHHHHhc----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence 9999999999999999754 488999999999999999999983 36899999999999999999999999
Q ss_pred cCccccCCCCc--ccCCCCCCCCCccCccccccCCC-C-----chhHHHHHHHHHHHHHhCC------------CCCC--
Q 005247 579 FGLSRSKPNTY--ISSKTAAGTPEWMAPEVLREDPS-N-----EKSDVFSFGVILWELITLQ------------KPWR-- 636 (706)
Q Consensus 579 FGla~~~~~~~--~~~~~~~Gt~~Y~APE~l~~~~~-s-----~ksDVwSLGviL~ELltG~------------~Pf~-- 636 (706)
||+|....... ......+||.+|||||++.+... . .+.||||+|.+||||++.. .||+
T Consensus 360 FGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~e 439 (534)
T KOG3653|consen 360 FGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAE 439 (534)
T ss_pred cceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHH
Confidence 99998754322 12234789999999999987532 2 3689999999999999753 3343
Q ss_pred ---CCChHHHHHHhhhcCcccCCCCCC-----cHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhccC
Q 005247 637 ---NSTPSQVISAVGFKGRRLEIPKNV-----NPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVC 698 (706)
Q Consensus 637 ---~~~~~~~~~~i~~~~~~l~~p~~~-----s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~~~ 698 (706)
..+-+++...+.....|+.+|..+ ...+++.|..||..||+.|.|+.-+.+++.++.+....
T Consensus 440 vG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~ 509 (534)
T KOG3653|consen 440 VGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED 509 (534)
T ss_pred hcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence 123344445555566777777644 36789999999999999999999999999999877643
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=314.15 Aligned_cols=254 Identities=28% Similarity=0.443 Sum_probs=217.2
Q ss_pred cccccCceEEEEEeccCCceEEEEEEEc--CCceEEEEEeccccchHHHHHHHHHHHHHHcC-CCCceeEEecccc----
Q 005247 428 LEIRWSELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVT---- 500 (706)
Q Consensus 428 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~---- 500 (706)
+.-....|++.+.||.|.+|.||++++. ++.+|+|++......+ +++..|.++++.+ .|||++.+++++.
T Consensus 14 lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d---eEiE~eynil~~~~~hpnv~~fyg~~~k~~~ 90 (953)
T KOG0587|consen 14 LPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE---EEIELEYNMLKKYSHHPNVATFYGAFIKKDP 90 (953)
T ss_pred CCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc---HHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence 3445677999999999999999999765 4559999986654333 4667799999988 5999999999874
Q ss_pred -CCCceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeec
Q 005247 501 -EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDF 579 (706)
Q Consensus 501 -~~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DF 579 (706)
.++++|+|||||.+|+..|+++.-. ...+.|..++.|++.++.|+.+||.+. +||||||-.|||++.++.|||+||
T Consensus 91 ~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk--viHRDikG~NiLLT~e~~VKLvDF 167 (953)
T KOG0587|consen 91 GNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK--VIHRDIKGQNVLLTENAEVKLVDF 167 (953)
T ss_pred CCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc--eeeecccCceEEEeccCcEEEeee
Confidence 3567999999999999999997544 567999999999999999999999999 999999999999999999999999
Q ss_pred CccccCCCCcccCCCCCCCCCccCccccccC-----CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCc-c
Q 005247 580 GLSRSKPNTYISSKTAAGTPEWMAPEVLRED-----PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR-R 653 (706)
Q Consensus 580 Gla~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-----~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~-~ 653 (706)
|.+.....+.....+..||+.|||||++... .|+..+|+||||++..||.-|.+|+....+......|..... .
T Consensus 168 GvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPk 247 (953)
T KOG0587|consen 168 GVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPK 247 (953)
T ss_pred eeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCcc
Confidence 9999988887788899999999999999643 467789999999999999999999998888776655532222 2
Q ss_pred cCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 654 LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 654 l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
+.-|+.++.++.++|..||.+|-++||+..++++
T Consensus 248 Lkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 248 LKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred ccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 3346788999999999999999999999998875
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=312.79 Aligned_cols=257 Identities=34% Similarity=0.566 Sum_probs=223.1
Q ss_pred CceEEEEEeccCCceEEEEEEEcC------CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceE
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRN------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS 506 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~------~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 506 (706)
.+.+..++||+|+||+||+|.+-. -+||+|++.... ..+..++++.|+-+|.+++|||++++++++.... +.
T Consensus 696 telkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t-~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~q 773 (1177)
T KOG1025|consen 696 TELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT-SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQ 773 (1177)
T ss_pred hhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC-CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HH
Confidence 345567899999999999997632 248999986654 3445678999999999999999999999998766 88
Q ss_pred EEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCC
Q 005247 507 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP 586 (706)
Q Consensus 507 lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~ 586 (706)
||++|++.|+|.++++.. +..+..+..+.|..||++||.|||.++ +|||||-..|||+..-..+||.|||+++...
T Consensus 774 lvtq~mP~G~LlDyvr~h--r~~igsq~lLnw~~QIAkgM~YLe~qr--lVHrdLaaRNVLVksP~hvkitdfgla~ll~ 849 (1177)
T KOG1025|consen 774 LVTQLMPLGCLLDYVREH--RDNIGSQDLLNWCYQIAKGMKYLEEQR--LVHRDLAARNVLVKSPNHVKITDFGLAKLLA 849 (1177)
T ss_pred HHHHhcccchHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhcc--hhhhhhhhhheeecCCCeEEEEecchhhccC
Confidence 999999999999999854 345888999999999999999999999 9999999999999999999999999998765
Q ss_pred CCccc--CCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCCCCCcHH
Q 005247 587 NTYIS--SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPM 663 (706)
Q Consensus 587 ~~~~~--~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~e 663 (706)
..... .....-.+.|||-|.+....|+.++|||||||++||++| |..||.+....++-..+ ..+.|+..|+.++-+
T Consensus 850 ~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dll-e~geRLsqPpiCtiD 928 (1177)
T KOG1025|consen 850 PDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLL-EKGERLSQPPICTID 928 (1177)
T ss_pred cccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHH-hccccCCCCCCccHH
Confidence 43322 223334678999999999999999999999999999998 89999999887776666 467779999999999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhc
Q 005247 664 VAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 696 (706)
Q Consensus 664 l~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~ 696 (706)
+..+|.+||..|+..||+|+++...+..+.++.
T Consensus 929 Vy~~mvkCwmid~~~rp~fkel~~~fs~~ardp 961 (1177)
T KOG1025|consen 929 VYMVMVKCWMIDADSRPTFKELAEEFSRMARDP 961 (1177)
T ss_pred HHHHHHHHhccCcccCccHHHHHHHHHHHhcCc
Confidence 999999999999999999999999999888764
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=304.75 Aligned_cols=243 Identities=30% Similarity=0.443 Sum_probs=207.1
Q ss_pred EEEeccCCceEEEEEEEc--CCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEEeccCC
Q 005247 438 KKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRG 515 (706)
Q Consensus 438 ~~~LG~G~fG~Vy~a~~~--~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~~~gg 515 (706)
.+.||.|.||+||-|+++ +++||||++.+..+..+....+.+|+.||+++.||.||.+.-.|+.++..++|||-+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 479999999999999876 456999999888888777788999999999999999999999999999999999999664
Q ss_pred chhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECC---CCcEEEeecCccccCCCCcccC
Q 005247 516 SLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS---TYTVKVCDFGLSRSKPNTYISS 592 (706)
Q Consensus 516 sL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~---~~~vKL~DFGla~~~~~~~~~~ 592 (706)
-|.-+|... .+.++++....++.||+.||.|||-++ |+|+||||+|||+.. -..+||||||+|+..+... ..
T Consensus 649 MLEMILSsE--kgRL~er~TkFlvtQIL~ALr~LH~kn--IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks-FR 723 (888)
T KOG4236|consen 649 MLEMILSSE--KGRLPERITKFLVTQILVALRYLHFKN--IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS-FR 723 (888)
T ss_pred HHHHHHHhh--cccchHHHHHHHHHHHHHHHHHhhhcc--eeeccCCchheeeccCCCCCceeeccccceeecchhh-hh
Confidence 444444433 346999999999999999999999999 999999999999964 3479999999999988754 45
Q ss_pred CCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhc--CcccCCCCCCcHHHHHHHHH
Q 005247 593 KTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK--GRRLEIPKNVNPMVAALIET 670 (706)
Q Consensus 593 ~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~--~~~l~~p~~~s~el~dLI~~ 670 (706)
++.+||+.|+|||++.+..|...-|+||.|+|+|--++|..||.... ++..+|... ..+...+.+++++..+||..
T Consensus 724 rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE--dIndQIQNAaFMyPp~PW~eis~~AidlIn~ 801 (888)
T KOG4236|consen 724 RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE--DINDQIQNAAFMYPPNPWSEISPEAIDLINN 801 (888)
T ss_pred hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc--chhHHhhccccccCCCchhhcCHHHHHHHHH
Confidence 78899999999999999999999999999999999999999997543 233333211 12344456789999999999
Q ss_pred hhhhCCCCCCCHHHHHH
Q 005247 671 CWAEEPEIRPSFPSIME 687 (706)
Q Consensus 671 cL~~dP~~RPS~~eIl~ 687 (706)
+|+..-++|-|.+..+.
T Consensus 802 LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 802 LLQVKMRKRYSVDKSLS 818 (888)
T ss_pred HHHHHHHHhcchHhhcc
Confidence 99999999999887654
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=300.44 Aligned_cols=256 Identities=28% Similarity=0.393 Sum_probs=205.6
Q ss_pred ccccCceEEEEEeccCCceEEEEEEEcC--CceEEEEEecccc-----chHHHHHHHHHHHHHHcCCCCceeEEeccccC
Q 005247 429 EIRWSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEF-----HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE 501 (706)
Q Consensus 429 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~-----~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~ 501 (706)
.....+|.++..||+|||+.||+|.+.. +-||+|+-..... .+...+..-+|..|.+.|.||.||++|++|.-
T Consensus 459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl 538 (775)
T KOG1151|consen 459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL 538 (775)
T ss_pred cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence 4456778899999999999999997754 3489998643322 22345667799999999999999999999864
Q ss_pred -CCceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECC---CCcEEEe
Q 005247 502 -PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS---TYTVKVC 577 (706)
Q Consensus 502 -~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~---~~~vKL~ 577 (706)
.+.+|-|+|||+|.+|.-||+... .+.+..+..|+.||+.||.||.+..+||||-||||.|||+-. -|.+||+
T Consensus 539 DtdsFCTVLEYceGNDLDFYLKQhk---lmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKIT 615 (775)
T KOG1151|consen 539 DTDSFCTVLEYCEGNDLDFYLKQHK---LMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKIT 615 (775)
T ss_pred ccccceeeeeecCCCchhHHHHhhh---hhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEee
Confidence 456899999999999999997443 589999999999999999999999999999999999999943 4689999
Q ss_pred ecCccccCCCCccc-------CCCCCCCCCccCccccccC----CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH-HH
Q 005247 578 DFGLSRSKPNTYIS-------SKTAAGTPEWMAPEVLRED----PSNEKSDVFSFGVILWELITLQKPWRNSTPSQV-IS 645 (706)
Q Consensus 578 DFGla~~~~~~~~~-------~~~~~Gt~~Y~APE~l~~~----~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~-~~ 645 (706)
|||++....+.... .....||.+|++||++.-. ..+.|+||||+|||+|++++|+.||..+...+- +.
T Consensus 616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILq 695 (775)
T KOG1151|consen 616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQ 695 (775)
T ss_pred ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHh
Confidence 99999876543222 2345799999999998543 457899999999999999999999987654333 22
Q ss_pred Hhh-hcCcccCCC--CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 646 AVG-FKGRRLEIP--KNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 646 ~i~-~~~~~l~~p--~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
.-. .......+| +.++.+.++||++||...-++|.+..++..
T Consensus 696 eNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 696 ENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred hhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 211 222233344 568999999999999999999999888765
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=304.89 Aligned_cols=245 Identities=27% Similarity=0.376 Sum_probs=204.8
Q ss_pred cccCceEEEEEeccCCceEEEEEEEcCCc--eEEEEEecccc-chHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceE
Q 005247 430 IRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS 506 (706)
Q Consensus 430 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~--vAVKvl~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 506 (706)
.+.+-|..++.||-|+||.|.++...++. ||+|.+.+... ...+....+.|-.||..-.++-||+||..|++.+.+|
T Consensus 626 MdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLY 705 (1034)
T KOG0608|consen 626 MDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLY 705 (1034)
T ss_pred ccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceE
Confidence 34567889999999999999999766655 89999866543 3455677889999999999999999999999999999
Q ss_pred EEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCC
Q 005247 507 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP 586 (706)
Q Consensus 507 lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~ 586 (706)
+||+|++||++-.+|-+. +.++|..++.++.++..|+++.|..| +|||||||+|||||.+|++||+|||+++-+.
T Consensus 706 FVMdYIPGGDmMSLLIrm---gIFeE~LARFYIAEltcAiesVHkmG--FIHRDiKPDNILIDrdGHIKLTDFGLCTGfR 780 (1034)
T KOG0608|consen 706 FVMDYIPGGDMMSLLIRM---GIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 780 (1034)
T ss_pred EEEeccCCccHHHHHHHh---ccCHHHHHHHHHHHHHHHHHHHHhcc--ceecccCccceEEccCCceeeeeccccccce
Confidence 999999999999988533 36899999999999999999999999 9999999999999999999999999986211
Q ss_pred ---------CCc---------------------------------ccCCCCCCCCCccCccccccCCCCchhHHHHHHHH
Q 005247 587 ---------NTY---------------------------------ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVI 624 (706)
Q Consensus 587 ---------~~~---------------------------------~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGvi 624 (706)
++. ...-..+||+.|+|||++....++..+|+||.|||
T Consensus 781 WTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvi 860 (1034)
T KOG0608|consen 781 WTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVI 860 (1034)
T ss_pred eccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHH
Confidence 000 00011359999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHhhhcCcccCCC--CCCcHHHHHHHHHhhhhCCCCCC
Q 005247 625 LWELITLQKPWRNSTPSQVISAVGFKGRRLEIP--KNVNPMVAALIETCWAEEPEIRP 680 (706)
Q Consensus 625 L~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p--~~~s~el~dLI~~cL~~dP~~RP 680 (706)
||||+.|+.||...++.+...++..-...+.++ .+++++..+||.++.+ +++.|.
T Consensus 861 l~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RL 917 (1034)
T KOG0608|consen 861 LYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRL 917 (1034)
T ss_pred HHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-Chhhhh
Confidence 999999999999888877665554444445555 5789999999998655 677774
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=285.54 Aligned_cols=241 Identities=26% Similarity=0.438 Sum_probs=198.1
Q ss_pred EEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCC-CCceeEEeccccCCCceEEEEEeccC
Q 005247 438 KKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGAVTEPPNLSIVTEYLSR 514 (706)
Q Consensus 438 ~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~lV~E~~~g 514 (706)
.+.||+|+|+.|-.+....+ .||||++.++..+ ....+.+|++++.+.+ |+||++++++|+++..+|+|||-|.|
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gH--sR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~G 160 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGH--SRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRG 160 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCch--HHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccC
Confidence 35799999999999876544 5999999877443 3468899999999996 99999999999999999999999999
Q ss_pred CchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCC---cEEEeecCccccCCC--C-
Q 005247 515 GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY---TVKVCDFGLSRSKPN--T- 588 (706)
Q Consensus 515 gsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~---~vKL~DFGla~~~~~--~- 588 (706)
|+|...++.. ..+.+.++.+++++|+.||.+||.+| |.||||||+|||-.+.. -||||||.++..... .
T Consensus 161 GplLshI~~~---~~F~E~EAs~vvkdia~aLdFlH~kg--IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~ 235 (463)
T KOG0607|consen 161 GPLLSHIQKR---KHFNEREASRVVKDIASALDFLHTKG--IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDC 235 (463)
T ss_pred chHHHHHHHh---hhccHHHHHHHHHHHHHHHHHHhhcC--cccccCCccceeecCCCCcCceeeeccccccccccCCCC
Confidence 9999888743 35999999999999999999999999 99999999999996544 489999998753221 1
Q ss_pred ----cccCCCCCCCCCccCccccc-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCC-------Ch--------HHHH
Q 005247 589 ----YISSKTAAGTPEWMAPEVLR-----EDPSNEKSDVFSFGVILWELITLQKPWRNS-------TP--------SQVI 644 (706)
Q Consensus 589 ----~~~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDVwSLGviL~ELltG~~Pf~~~-------~~--------~~~~ 644 (706)
.....+.+|+..|||||+.. ...|+.+.|.||||+|||-|++|.+||.+. +. +..+
T Consensus 236 spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LF 315 (463)
T KOG0607|consen 236 SPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLF 315 (463)
T ss_pred CCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHH
Confidence 11234567999999999863 346899999999999999999999999652 11 2223
Q ss_pred HHhhhcCcccCCCC----CCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 645 SAVGFKGRRLEIPK----NVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 645 ~~i~~~~~~l~~p~----~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
..| +....++|. ++|.+.+++|..+|.+++.+|.++.+++.
T Consensus 316 esI--QEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 316 ESI--QEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HHH--hccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 333 444566664 68999999999999999999999998876
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=266.53 Aligned_cols=249 Identities=25% Similarity=0.339 Sum_probs=206.0
Q ss_pred ceEEEEEeccCCceEEEEEEEcCCc--eEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEEe
Q 005247 434 ELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY 511 (706)
Q Consensus 434 ~y~i~~~LG~G~fG~Vy~a~~~~~~--vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~ 511 (706)
+|...++||+|.||+||+|++.++. ||+|.+.....++..-...++|+.+++.++|.|||++++....+..+.+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 4556789999999999999988776 99999877766665566889999999999999999999999999999999999
Q ss_pred ccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCccc
Q 005247 512 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS 591 (706)
Q Consensus 512 ~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~ 591 (706)
|.. +|..++..- ++.++.+.+..++.|+++||.++|+++ +.|||+||.|+||+.+|.+||+|||+++.++-+..-
T Consensus 83 cdq-dlkkyfdsl--ng~~d~~~~rsfmlqllrgl~fchshn--vlhrdlkpqnllin~ngelkladfglarafgipvrc 157 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSL--NGDLDPEIVRSFMLQLLRGLGFCHSHN--VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC 157 (292)
T ss_pred hhH-HHHHHHHhc--CCcCCHHHHHHHHHHHHhhhhhhhhhh--hhhccCCcceEEeccCCcEEecccchhhhcCCceEe
Confidence 965 888887533 345889999999999999999999999 999999999999999999999999999988766544
Q ss_pred CCCCCCCCCccCccccccCC-CCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCccc---------------
Q 005247 592 SKTAAGTPEWMAPEVLREDP-SNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRL--------------- 654 (706)
Q Consensus 592 ~~~~~Gt~~Y~APE~l~~~~-~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l--------------- 654 (706)
.....-|..|.+|.++.+.. |++..|+||-|||+.|+.. |++.|.+.+..+...++-..-..+
T Consensus 158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk 237 (292)
T KOG0662|consen 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYK 237 (292)
T ss_pred eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCc
Confidence 44566799999999998865 7889999999999999997 556688887777666653221110
Q ss_pred --C-CC---------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 655 --E-IP---------KNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 655 --~-~p---------~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
+ +| +.++..=++|+++.|.-+|.+|.+++..++
T Consensus 238 ~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 238 PYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred ccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 0 01 122234589999999999999999998764
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=279.34 Aligned_cols=218 Identities=22% Similarity=0.241 Sum_probs=180.7
Q ss_pred CCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEEeccCCchhhhc
Q 005247 444 GSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL 521 (706)
Q Consensus 444 G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l 521 (706)
|.||.||++.+..+ .+|+|.+.... .+.+|...+....||||+++++++.+.+..+++|||+++|+|.+++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 76 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI 76 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence 89999999988654 49999886542 2234455555667999999999999999999999999999999988
Q ss_pred ccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcccCCCCCCCCCc
Q 005247 522 HIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEW 601 (706)
Q Consensus 522 ~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~Gt~~Y 601 (706)
.... .+++..+..++.|++.||+|||+++ |+||||||+||+++.++.++|+|||.+....... ....++..|
T Consensus 77 ~~~~---~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~y 148 (237)
T cd05576 77 SKFL---NIPEECVKRWAAEMVVALDALHREG--IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC---DGEAVENMY 148 (237)
T ss_pred HHhc---CCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCCCCEEEecccchhcccccc---ccCCcCccc
Confidence 6432 4889999999999999999999999 9999999999999999999999999876554322 234567789
Q ss_pred cCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHHHHhhhhCCCCCCC
Q 005247 602 MAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPS 681 (706)
Q Consensus 602 ~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS 681 (706)
+|||.+.+..++.++||||+|+++|||++|..||...... . .......+|..+++.++++|.+||+.||++||+
T Consensus 149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-~-----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~ 222 (237)
T cd05576 149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-I-----NTHTTLNIPEWVSEEARSLLQQLLQFNPTERLG 222 (237)
T ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-c-----ccccccCCcccCCHHHHHHHHHHccCCHHHhcC
Confidence 9999998888999999999999999999999887643221 0 112234567788999999999999999999999
Q ss_pred H
Q 005247 682 F 682 (706)
Q Consensus 682 ~ 682 (706)
+
T Consensus 223 ~ 223 (237)
T cd05576 223 A 223 (237)
T ss_pred C
Confidence 6
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=306.84 Aligned_cols=238 Identities=25% Similarity=0.350 Sum_probs=199.5
Q ss_pred ccCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcC-CCCceeEEeccccCCCceEE
Q 005247 431 RWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSI 507 (706)
Q Consensus 431 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~l 507 (706)
....|++...+|.|+|+.|..+.+..+ ..++|++.+... .-.+|+.++... +||||+++.+.+.++.+.|+
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~ 393 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD------DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYL 393 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccccc------ccccccchhhhhcCCCcceeecceecCCceeee
Confidence 456788889999999999999987655 489999876622 223566565555 69999999999999999999
Q ss_pred EEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEE-CCCCcEEEeecCccccCC
Q 005247 508 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLV-DSTYTVKVCDFGLSRSKP 586 (706)
Q Consensus 508 V~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl-~~~~~vKL~DFGla~~~~ 586 (706)
|||.+.|+-+.+.+.... .....+..|+.+|+.|+.|||++| +|||||||+|||+ +..++++|+|||.++...
T Consensus 394 v~e~l~g~ell~ri~~~~----~~~~e~~~w~~~lv~Av~~LH~~g--vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~ 467 (612)
T KOG0603|consen 394 VMELLDGGELLRRIRSKP----EFCSEASQWAAELVSAVDYLHEQG--VVHRDLKPGNILLDGSAGHLRLTYFGFWSELE 467 (612)
T ss_pred eehhccccHHHHHHHhcc----hhHHHHHHHHHHHHHHHHHHHhcC--eeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence 999999998877765332 223677789999999999999999 9999999999999 688999999999998766
Q ss_pred CCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHhhhcCcccCCCCCCcHHHH
Q 005247 587 NTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPS-QVISAVGFKGRRLEIPKNVNPMVA 665 (706)
Q Consensus 587 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~-~~~~~i~~~~~~l~~p~~~s~el~ 665 (706)
.. ..+.+-|..|.|||++....|+.++||||||++||+||+|+.||...... ++..++ ....+...+|.+.+
T Consensus 468 ~~---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i----~~~~~s~~vS~~AK 540 (612)
T KOG0603|consen 468 RS---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRI----QMPKFSECVSDEAK 540 (612)
T ss_pred hh---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhh----cCCccccccCHHHH
Confidence 54 34567899999999999999999999999999999999999999877665 333333 23344488999999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHH
Q 005247 666 ALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 666 dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
+||++||+.||.+||++.++..
T Consensus 541 dLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 541 DLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred HHHHHhccCChhhCcChhhhcc
Confidence 9999999999999999999865
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=285.89 Aligned_cols=254 Identities=25% Similarity=0.399 Sum_probs=196.9
Q ss_pred cCceEEEEEeccCCceEEEEEEEcCC------ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccC-CCc
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRNS------DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE-PPN 504 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~~------~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~-~~~ 504 (706)
...|++++.||+|.||.||+|...++ .+|+|.++.+...........+|+.+++.++|||++.+..+|.. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 45789999999999999999954322 48999886653322333567899999999999999999999877 677
Q ss_pred eEEEEEeccCCchhhhccc--CCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCC----CcEEEee
Q 005247 505 LSIVTEYLSRGSLYKLLHI--PDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST----YTVKVCD 578 (706)
Q Consensus 505 ~~lV~E~~~ggsL~~~l~~--~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~----~~vKL~D 578 (706)
.++++||.+. +|.++++. ......++...+..|+.||+.|+.|||++- |+||||||.|||+..+ |.|||+|
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW--vlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW--VLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh--eeeccCCcceEEEeccCCccCeeEeec
Confidence 9999999987 78888743 222246889999999999999999999999 9999999999999877 8999999
Q ss_pred cCccccCCCCcc---cCCCCCCCCCccCccccccCC-CCchhHHHHHHHHHHHHHhCCCCCCCCChH-------H--HHH
Q 005247 579 FGLSRSKPNTYI---SSKTAAGTPEWMAPEVLREDP-SNEKSDVFSFGVILWELITLQKPWRNSTPS-------Q--VIS 645 (706)
Q Consensus 579 FGla~~~~~~~~---~~~~~~Gt~~Y~APE~l~~~~-~s~ksDVwSLGviL~ELltG~~Pf~~~~~~-------~--~~~ 645 (706)
||+++...++.. .....+-|.+|+|||.+.+.. |+.+.|||+.|||+.||+|-.+.|.+.... + ...
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~ 259 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD 259 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence 999998776543 234456789999999998864 788999999999999999988877543211 0 011
Q ss_pred Hhh-hcCcc--------cCCC--------------------------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 005247 646 AVG-FKGRR--------LEIP--------------------------KNVNPMVAALIETCWAEEPEIRPSFPSIMET 688 (706)
Q Consensus 646 ~i~-~~~~~--------l~~p--------------------------~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~ 688 (706)
+|- ..+.+ -..| ..-++...+|+.+||+.||-+|.|+++.++.
T Consensus 260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 110 00000 0001 1224458899999999999999999998774
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.9e-33 Score=290.34 Aligned_cols=248 Identities=24% Similarity=0.320 Sum_probs=202.3
Q ss_pred cccCceEEEEEeccCCceEEEEEEEcCCc--eEEEEEeccccchHHHHHHHHHHHHHHcCC--CC----ceeEEeccccC
Q 005247 430 IRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLR--HP----NIVLLMGAVTE 501 (706)
Q Consensus 430 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~--vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~--Hp----nIv~l~~~~~~ 501 (706)
+...+|+++..+|+|.||.|..+.+..++ ||+|+++.- ....++.+-|+++++++. .| -++.+.++|+-
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V---~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdy 162 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV---DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDY 162 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH---HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhc
Confidence 34678999999999999999999887654 999997543 344467778999999994 23 37888899999
Q ss_pred CCceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECC-----------
Q 005247 502 PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS----------- 570 (706)
Q Consensus 502 ~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~----------- 570 (706)
.++.|||+|.+ |-++++++..++ ..+++...+..|+.|+++++++||+.+ ++|.||||+|||+.+
T Consensus 163 rghiCivfell-G~S~~dFlk~N~-y~~fpi~~ir~m~~QL~~sv~fLh~~k--l~HTDLKPENILfvss~~~~~~~~k~ 238 (415)
T KOG0671|consen 163 RGHICIVFELL-GLSTFDFLKENN-YIPFPIDHIRHMGYQLLESVAFLHDLK--LTHTDLKPENILFVSSEYFKTYNPKK 238 (415)
T ss_pred cCceEEEEecc-ChhHHHHhccCC-ccccchHHHHHHHHHHHHHHHHHHhcc--eeecCCChheEEEeccceEEEeccCC
Confidence 99999999988 569999998544 457899999999999999999999999 999999999999831
Q ss_pred ---------CCcEEEeecCccccCCCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH
Q 005247 571 ---------TYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPS 641 (706)
Q Consensus 571 ---------~~~vKL~DFGla~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~ 641 (706)
+..|+|+|||.|+...... .+.+.|..|+|||++.+.+++.++||||+||||+|+++|...|++....
T Consensus 239 ~~~~~r~~ks~~I~vIDFGsAtf~~e~h---s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~ 315 (415)
T KOG0671|consen 239 KVCFIRPLKSTAIKVIDFGSATFDHEHH---STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENL 315 (415)
T ss_pred ccceeccCCCcceEEEecCCcceeccCc---ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcH
Confidence 3459999999998765543 5678899999999999999999999999999999999999999988766
Q ss_pred HHHHHhhhcCc-------------------ccCCCCC------------C-------------cHHHHHHHHHhhhhCCC
Q 005247 642 QVISAVGFKGR-------------------RLEIPKN------------V-------------NPMVAALIETCWAEEPE 677 (706)
Q Consensus 642 ~~~~~i~~~~~-------------------~l~~p~~------------~-------------s~el~dLI~~cL~~dP~ 677 (706)
+....+...-. ++..+.. + -.++.+||++||..||.
T Consensus 316 EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~ 395 (415)
T KOG0671|consen 316 EHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPA 395 (415)
T ss_pred HHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcc
Confidence 64433221111 1221111 0 13689999999999999
Q ss_pred CCCCHHHHHH
Q 005247 678 IRPSFPSIME 687 (706)
Q Consensus 678 ~RPS~~eIl~ 687 (706)
+|+|+.|++.
T Consensus 396 ~RiTl~EAL~ 405 (415)
T KOG0671|consen 396 RRITLREALS 405 (415)
T ss_pred ccccHHHHhc
Confidence 9999999875
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.8e-32 Score=329.38 Aligned_cols=247 Identities=25% Similarity=0.360 Sum_probs=191.3
Q ss_pred CceEEEEEeccCCceEEEEEEEc--CCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEE
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 510 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E 510 (706)
..+...+.||+|+||.||+|.+. +..||+|.+..... ....|++++++++||||+++++++.+++..++|||
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E 763 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE 763 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence 34566789999999999999875 44589998754321 11246888999999999999999999999999999
Q ss_pred eccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhc-CCCcccccCCCCcEEECCCCcEEEeecCccccCCCCc
Q 005247 511 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR-RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 589 (706)
Q Consensus 511 ~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~-g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 589 (706)
|+++|+|.++++ .+++..+..++.|+++||+|||.. .++|+||||||+||+++.++..++. ||.......
T Consensus 764 y~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~-- 834 (968)
T PLN00113 764 YIEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT-- 834 (968)
T ss_pred CCCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc--
Confidence 999999999985 267888999999999999999943 2339999999999999998888775 665443221
Q ss_pred ccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHhhh--cC--------ccc---
Q 005247 590 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTP--SQVISAVGF--KG--------RRL--- 654 (706)
Q Consensus 590 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~--~~~~~~i~~--~~--------~~l--- 654 (706)
.....+|+.|+|||++.+..++.++|||||||++|||+||+.||..... ......... .. ..+
T Consensus 835 --~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (968)
T PLN00113 835 --DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGD 912 (968)
T ss_pred --CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCC
Confidence 1234688999999999999999999999999999999999999854221 111111110 00 000
Q ss_pred -CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhc
Q 005247 655 -EIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 696 (706)
Q Consensus 655 -~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~ 696 (706)
..+.....++.+++.+||+.+|++||++.|+++.|+++..+.
T Consensus 913 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~ 955 (968)
T PLN00113 913 VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS 955 (968)
T ss_pred CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccc
Confidence 111112246788999999999999999999999999998754
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-31 Score=264.24 Aligned_cols=235 Identities=34% Similarity=0.540 Sum_probs=196.4
Q ss_pred CceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEEeccCCchhhhcc
Q 005247 445 SFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLH 522 (706)
Q Consensus 445 ~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~ 522 (706)
+||.||+|.+.+ ..+++|++........ .+.+.+|+..+++++|+||+++++++......++++||+.+++|.+++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 589999999875 4599999865543322 5788999999999999999999999999899999999999999999986
Q ss_pred cCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcccCCCCCCCCCcc
Q 005247 523 IPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWM 602 (706)
Q Consensus 523 ~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~Gt~~Y~ 602 (706)
... .++...++.++.+++.++.+||+.+ ++|+||+|.||+++.++.++|+|||.+....... ......++..|+
T Consensus 80 ~~~---~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~ 153 (244)
T smart00220 80 KRG---RLSEDEARFYARQILSALEYLHSNG--IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPEYM 153 (244)
T ss_pred hcc---CCCHHHHHHHHHHHHHHHHHHHHcC--eecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcCCC
Confidence 433 2788999999999999999999999 9999999999999999999999999988765532 234566888999
Q ss_pred CccccccCCCCchhHHHHHHHHHHHHHhCCCCCCC-CChHHHHHHhhhcCcccCCCCC--CcHHHHHHHHHhhhhCCCCC
Q 005247 603 APEVLREDPSNEKSDVFSFGVILWELITLQKPWRN-STPSQVISAVGFKGRRLEIPKN--VNPMVAALIETCWAEEPEIR 679 (706)
Q Consensus 603 APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~-~~~~~~~~~i~~~~~~l~~p~~--~s~el~dLI~~cL~~dP~~R 679 (706)
+||.+.+..++.++|||+||+++|+|++|..||.. ........... .......+.. ++.++.+++.+||..+|++|
T Consensus 154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R 232 (244)
T smart00220 154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIG-KPKPPFPPPEWKISPEAKDLIRKLLVKDPEKR 232 (244)
T ss_pred CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHh-ccCCCCccccccCCHHHHHHHHHHccCCchhc
Confidence 99999988889999999999999999999999987 44444444332 2222222222 88999999999999999999
Q ss_pred CCHHHHHH
Q 005247 680 PSFPSIME 687 (706)
Q Consensus 680 PS~~eIl~ 687 (706)
|++.++++
T Consensus 233 p~~~~~~~ 240 (244)
T smart00220 233 LTAEEALQ 240 (244)
T ss_pred cCHHHHhh
Confidence 99999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=272.60 Aligned_cols=248 Identities=21% Similarity=0.398 Sum_probs=210.2
Q ss_pred CcccccCceEEEEEeccCCceEEEEEEEcCCc--eEEEEEeccccch-HHHHHHHHHHHHHHcC-CCCceeEEeccccCC
Q 005247 427 GLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHE-DRFKEFLREVAIMKGL-RHPNIVLLMGAVTEP 502 (706)
Q Consensus 427 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~--vAVKvl~~~~~~~-~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~ 502 (706)
...+...+|.++++||+|+|.+|..++++.+. ||+|++++...+. +.+.-...|-.+...- +||.+|-+..+|+.+
T Consensus 244 ~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqte 323 (593)
T KOG0695|consen 244 SQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTE 323 (593)
T ss_pred ccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhccc
Confidence 34567789999999999999999999988776 9999987765544 3344556676666655 699999999999999
Q ss_pred CceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCcc
Q 005247 503 PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS 582 (706)
Q Consensus 503 ~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla 582 (706)
..+++|.||++||+|--.++.. ..++++.+..+...|..||.|||++| ||.||||.+|+|++..|++||+|+|.+
T Consensus 324 srlffvieyv~ggdlmfhmqrq---rklpeeharfys~ei~lal~flh~rg--iiyrdlkldnvlldaeghikltdygmc 398 (593)
T KOG0695|consen 324 SRLFFVIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEICLALNFLHERG--IIYRDLKLDNVLLDAEGHIKLTDYGMC 398 (593)
T ss_pred ceEEEEEEEecCcceeeehhhh---hcCcHHHhhhhhHHHHHHHHHHhhcC--eeeeeccccceEEccCCceeecccchh
Confidence 9999999999999986555432 35899999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC-------ChHHHHHHhhhcCcccC
Q 005247 583 RSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNS-------TPSQVISAVGFKGRRLE 655 (706)
Q Consensus 583 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~-------~~~~~~~~i~~~~~~l~ 655 (706)
+..-.+.....+++|||.|.|||++.+..|...+|+|+||++++||+.|+.||.-. +.++...++ .....+.
T Consensus 399 ke~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqv-ilekqir 477 (593)
T KOG0695|consen 399 KEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQV-ILEKQIR 477 (593)
T ss_pred hcCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHH-Hhhhccc
Confidence 87665555678999999999999999999999999999999999999999999531 112222222 2456678
Q ss_pred CCCCCcHHHHHHHHHhhhhCCCCCC
Q 005247 656 IPKNVNPMVAALIETCWAEEPEIRP 680 (706)
Q Consensus 656 ~p~~~s~el~dLI~~cL~~dP~~RP 680 (706)
+|..++-....+++.-|++||.+|.
T Consensus 478 iprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 478 IPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred ccceeehhhHHHHHHhhcCCcHHhc
Confidence 8999999999999999999999994
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=271.51 Aligned_cols=267 Identities=28% Similarity=0.495 Sum_probs=225.1
Q ss_pred cCcccccCceEEEEEeccCCceEEEEEEEcCC-------ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEecc
Q 005247 426 EGLEIRWSELLIKKKIGEGSFGTVYHAEWRNS-------DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA 498 (706)
Q Consensus 426 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~-------~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~ 498 (706)
..+.+...+++....+-+|.||.||+|.+.+. .|.+|.++.. ..+-+...++.|-..+..+.|||+..+.++
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~-AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH-ASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc-ccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 34556667788889999999999999966533 2667776443 355566788999999999999999999988
Q ss_pred cc-CCCceEEEEEeccCCchhhhcc-----cCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCC
Q 005247 499 VT-EPPNLSIVTEYLSRGSLYKLLH-----IPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY 572 (706)
Q Consensus 499 ~~-~~~~~~lV~E~~~ggsL~~~l~-----~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~ 572 (706)
.. +....++++.++.-|+|..+++ .......+...+...++.|++.|++|||+++ |||.||...|++|++..
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~--ViHkDiAaRNCvIdd~L 433 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG--VIHKDIAARNCVIDDQL 433 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC--cccchhhhhcceehhhe
Confidence 64 4456788999999999999997 3333445677788889999999999999999 99999999999999999
Q ss_pred cEEEeecCccccC-CCCccc-CCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhh
Q 005247 573 TVKVCDFGLSRSK-PNTYIS-SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGF 649 (706)
Q Consensus 573 ~vKL~DFGla~~~-~~~~~~-~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~ 649 (706)
+|||+|=.+++.. +..+.- ......+..||+||.+....|+.++||||||++||||+| |+.||...+|.++...+ .
T Consensus 434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~yl-k 512 (563)
T KOG1024|consen 434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYL-K 512 (563)
T ss_pred eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHH-h
Confidence 9999999998853 332211 123345678999999999999999999999999999998 89999999998888777 5
Q ss_pred cCcccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhc
Q 005247 650 KGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 696 (706)
Q Consensus 650 ~~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~ 696 (706)
.+.|+..|-+||.++..+|.-||...|++||+++|+..-|..+..+.
T Consensus 513 dGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ql 559 (563)
T KOG1024|consen 513 DGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQL 559 (563)
T ss_pred ccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHH
Confidence 88999999999999999999999999999999999999999987654
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-32 Score=271.05 Aligned_cols=255 Identities=25% Similarity=0.335 Sum_probs=200.2
Q ss_pred cccccCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCC---
Q 005247 428 LEIRWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP--- 502 (706)
Q Consensus 428 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~--- 502 (706)
+-...+.|+-..+||+|.||.||+|+.+++ .||+|++....-....-...++|+.+|..|.|+|++.+++.|...
T Consensus 12 ~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp 91 (376)
T KOG0669|consen 12 FCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATP 91 (376)
T ss_pred ceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCC
Confidence 344556788888999999999999977654 478876544322223335678999999999999999999987432
Q ss_pred -----CceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEe
Q 005247 503 -----PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVC 577 (706)
Q Consensus 503 -----~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~ 577 (706)
..+++||.+|+. +|..++.... ..+...++.+++.+++.||.|+|... |+|||+|++|+||+++|.+||+
T Consensus 92 ~~r~r~t~ylVf~~ceh-DLaGlLsn~~--vr~sls~Ikk~Mk~Lm~GL~~iHr~k--ilHRDmKaaNvLIt~dgilklA 166 (376)
T KOG0669|consen 92 TNRDRATFYLVFDFCEH-DLAGLLSNRK--VRFSLSEIKKVMKGLMNGLYYIHRNK--ILHRDMKAANVLITKDGILKLA 166 (376)
T ss_pred cccccceeeeeHHHhhh-hHHHHhcCcc--ccccHHHHHHHHHHHHHHHHHHHHhh--HHhhcccHhhEEEcCCceEEee
Confidence 248999999977 7888886433 45888899999999999999999999 9999999999999999999999
Q ss_pred ecCccccCCCCcc----cCCCCCCCCCccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcC-
Q 005247 578 DFGLSRSKPNTYI----SSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG- 651 (706)
Q Consensus 578 DFGla~~~~~~~~----~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~- 651 (706)
|||+++.+..... ..+..+-|..|++||.+.+. .|+++.|||.-|||+.||+++.+-+.+++..+.+..|...-
T Consensus 167 DFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcG 246 (376)
T KOG0669|consen 167 DFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCG 246 (376)
T ss_pred ccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhc
Confidence 9999975432211 12344568999999999885 58899999999999999999999999988877665553110
Q ss_pred -cc---------------c--C-CCC-------------CCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 652 -RR---------------L--E-IPK-------------NVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 652 -~~---------------l--~-~p~-------------~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
.. + + +|+ .-+++..+|+.++|..||.+|+++++++.
T Consensus 247 s~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 247 SITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred cCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 00 1 0 111 11347889999999999999999999875
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-30 Score=293.20 Aligned_cols=250 Identities=18% Similarity=0.225 Sum_probs=167.9
Q ss_pred cccCceEEEEEeccCCceEEEEEEEcCC------ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEecc-----
Q 005247 430 IRWSELLIKKKIGEGSFGTVYHAEWRNS------DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA----- 498 (706)
Q Consensus 430 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~------~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~----- 498 (706)
...++|++.+.||+|+||.||+|.+..+ .||+|.+...... +.+..| .+....+.++..++..
T Consensus 129 ~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~----e~~~~e--~l~~~~~~~~~~~~~~~~~~~ 202 (566)
T PLN03225 129 FKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV----EIWMNE--RVRRACPNSCADFVYGFLEPV 202 (566)
T ss_pred CccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh----HHHHHH--HHHhhchhhHHHHHHhhhccc
Confidence 3557899999999999999999988654 4899986543211 111111 1122222222222221
Q ss_pred -ccCCCceEEEEEeccCCchhhhcccCCCc-----------------ccccHHHHHHHHHHHHHHHHHHHhcCCCccccc
Q 005247 499 -VTEPPNLSIVTEYLSRGSLYKLLHIPDAR-----------------VVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRD 560 (706)
Q Consensus 499 -~~~~~~~~lV~E~~~ggsL~~~l~~~~~~-----------------~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrD 560 (706)
......+++|+||+.+++|.++++..... .......+..++.||+.||.|||+++ |||||
T Consensus 203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g--IiHRD 280 (566)
T PLN03225 203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG--IVHRD 280 (566)
T ss_pred ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC--EEeCc
Confidence 24556789999999999999988643211 01123456789999999999999999 99999
Q ss_pred CCCCcEEECC-CCcEEEeecCccccCCCC-cccCCCCCCCCCccCccccccC----------------------CCCchh
Q 005247 561 LKSPNLLVDS-TYTVKVCDFGLSRSKPNT-YISSKTAAGTPEWMAPEVLRED----------------------PSNEKS 616 (706)
Q Consensus 561 LKp~NILl~~-~~~vKL~DFGla~~~~~~-~~~~~~~~Gt~~Y~APE~l~~~----------------------~~s~ks 616 (706)
|||+|||++. ++.+||+|||+++..... ........+|+.|+|||.+... .++.++
T Consensus 281 LKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~ 360 (566)
T PLN03225 281 VKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 360 (566)
T ss_pred CCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence 9999999985 579999999999754322 1223456789999999976432 234567
Q ss_pred HHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCc-----------c--------cCCCCCCcHHHHHHHHHhhhhCCC
Q 005247 617 DVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR-----------R--------LEIPKNVNPMVAALIETCWAEEPE 677 (706)
Q Consensus 617 DVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~-----------~--------l~~p~~~s~el~dLI~~cL~~dP~ 677 (706)
|||||||+||||+++..|+.... ......+..... . ..+.........+||.+||+.||+
T Consensus 361 DVwSlGviL~el~~~~~~~~~~~-~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~ 439 (566)
T PLN03225 361 DIYSAGLIFLQMAFPNLRSDSNL-IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGR 439 (566)
T ss_pred ccHHHHHHHHHHHhCcCCCchHH-HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcc
Confidence 99999999999999776654221 111111110000 0 001111223456899999999999
Q ss_pred CCCCHHHHHHH
Q 005247 678 IRPSFPSIMET 688 (706)
Q Consensus 678 ~RPS~~eIl~~ 688 (706)
+|||+.++++.
T Consensus 440 kR~ta~e~L~H 450 (566)
T PLN03225 440 QRISAKAALAH 450 (566)
T ss_pred cCCCHHHHhCC
Confidence 99999999873
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.4e-29 Score=279.77 Aligned_cols=256 Identities=20% Similarity=0.184 Sum_probs=181.5
Q ss_pred cccCceEEEEEeccCCceEEEEEEE------------------cCCceEEEEEeccccch--H----------HHHHHHH
Q 005247 430 IRWSELLIKKKIGEGSFGTVYHAEW------------------RNSDVAVKILIEQEFHE--D----------RFKEFLR 479 (706)
Q Consensus 430 i~~~~y~i~~~LG~G~fG~Vy~a~~------------------~~~~vAVKvl~~~~~~~--~----------~~~~~~~ 479 (706)
...++|.+.++||+|+||.||+|.. .+..||||.+....... + ..+....
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 4567899999999999999999964 12348999875432110 0 1122345
Q ss_pred HHHHHHcCCCCce-----eEEeccccC--------CCceEEEEEeccCCchhhhcccCCC--------------------
Q 005247 480 EVAIMKGLRHPNI-----VLLMGAVTE--------PPNLSIVTEYLSRGSLYKLLHIPDA-------------------- 526 (706)
Q Consensus 480 Ei~iL~~L~HpnI-----v~l~~~~~~--------~~~~~lV~E~~~ggsL~~~l~~~~~-------------------- 526 (706)
|+.++.+++|.++ +++++++.. .+..++||||+++++|.++++....
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 6777777766544 567776643 3568999999999999998863211
Q ss_pred -cccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcc-cCCCCCCCCCccCc
Q 005247 527 -RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI-SSKTAAGTPEWMAP 604 (706)
Q Consensus 527 -~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~-~~~~~~Gt~~Y~AP 604 (706)
...+++..++.++.|++.+|.|||+++ |+||||||+|||++.++.+||+|||++........ ......+|+.|+||
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~--ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIG--IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 112356778899999999999999999 99999999999999999999999999875433221 11223458899999
Q ss_pred cccccCCC----------------------CchhHHHHHHHHHHHHHhCCC-CCCCCChHH-H--------H--HHhhhc
Q 005247 605 EVLREDPS----------------------NEKSDVFSFGVILWELITLQK-PWRNSTPSQ-V--------I--SAVGFK 650 (706)
Q Consensus 605 E~l~~~~~----------------------s~ksDVwSLGviL~ELltG~~-Pf~~~~~~~-~--------~--~~i~~~ 650 (706)
|.+..... ..+.||||+||++|+|+++.. ||....... . . ......
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~ 459 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ 459 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence 99864321 234799999999999999875 675321100 0 0 011111
Q ss_pred CcccCCCCCCcHHHHHHHHHhhhhCC---CCCCCHHHHHH
Q 005247 651 GRRLEIPKNVNPMVAALIETCWAEEP---EIRPSFPSIME 687 (706)
Q Consensus 651 ~~~l~~p~~~s~el~dLI~~cL~~dP---~~RPS~~eIl~ 687 (706)
...+.....+++...+|+.+||..+| .+|+|+.|+++
T Consensus 460 ~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 460 KYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred CCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 22233445678999999999999876 68999999975
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=246.53 Aligned_cols=222 Identities=27% Similarity=0.453 Sum_probs=179.5
Q ss_pred cccccCcccccCceEEEEEeccCCceEEEEEEEcCCc--eEEEEEeccccchHHHHHHHHHHHHHHcC-CCCceeEEecc
Q 005247 422 YLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGA 498 (706)
Q Consensus 422 ~~~~~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~--vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~ 498 (706)
++...++++..+.+..+..||+|+||.|-+.++..++ .|+|.+.... +....+..++|+++..+. .+|.+|.+|+.
T Consensus 35 ~I~~~~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv-n~q~q~r~L~dldi~~r~~~CPf~V~FyGa 113 (282)
T KOG0984|consen 35 YIGDRNFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV-NSQEQKRLLMDLDIIMRTVDCPFTVHFYGA 113 (282)
T ss_pred EEecCccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc-ChHHHHHHHHhhhhhccCCCCCeEEEeehh
Confidence 3344557778888888999999999999888877665 7888875543 445567788899887665 69999999999
Q ss_pred ccCCCceEEEEEeccCCchhhhcc-cCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEe
Q 005247 499 VTEPPNLSIVTEYLSRGSLYKLLH-IPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVC 577 (706)
Q Consensus 499 ~~~~~~~~lV~E~~~ggsL~~~l~-~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~ 577 (706)
.......+|.||.|.- +|..+.+ .-+....++|..+-+|+..++.||.|||++= .+||||+||.||||+..|+||||
T Consensus 114 ~~regdvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL-~vIHRDvKPsNiLIn~~GqVKiC 191 (282)
T KOG0984|consen 114 LFREGDVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL-SVIHRDVKPSNILINYDGQVKIC 191 (282)
T ss_pred hhccccEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh-hhhhccCCcceEEEccCCcEEEc
Confidence 9999999999999964 6665542 2234457999999999999999999999863 39999999999999999999999
Q ss_pred ecCccccCCCCcccCCCCCCCCCccCcccccc----CCCCchhHHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHh
Q 005247 578 DFGLSRSKPNTYISSKTAAGTPEWMAPEVLRE----DPSNEKSDVFSFGVILWELITLQKPWRNS-TPSQVISAV 647 (706)
Q Consensus 578 DFGla~~~~~~~~~~~~~~Gt~~Y~APE~l~~----~~~s~ksDVwSLGviL~ELltG~~Pf~~~-~~~~~~~~i 647 (706)
|||++....+.. ..+...|...|||||.+.. ..|+-|+||||||++++||.++++||..+ ++-+.+.++
T Consensus 192 DFGIsG~L~dSi-Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqv 265 (282)
T KOG0984|consen 192 DFGISGYLVDSI-AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQV 265 (282)
T ss_pred ccccceeehhhh-HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHH
Confidence 999987655432 2233678899999999854 36889999999999999999999999875 455555555
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.1e-30 Score=274.61 Aligned_cols=255 Identities=24% Similarity=0.295 Sum_probs=208.7
Q ss_pred ccCcccccCceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCC------CceeEEe
Q 005247 425 EEGLEIRWSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRH------PNIVLLM 496 (706)
Q Consensus 425 ~~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~H------pnIv~l~ 496 (706)
....++.-..|.+....|+|-|++|.+|.+.. ..||||++...+ -..+.=+.|++||++|+. -|+++++
T Consensus 424 v~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE---~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~ 500 (752)
T KOG0670|consen 424 VRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE---VMHKTGLKELEILKKLNDADPEDKFHCLRLF 500 (752)
T ss_pred EehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch---HHhhhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence 33446667889999999999999999998764 459999997654 334567789999999953 4899999
Q ss_pred ccccCCCceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCC-CcEE
Q 005247 497 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST-YTVK 575 (706)
Q Consensus 497 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~-~~vK 575 (706)
..|...+++|||||-+. .+|.+.|+.-+.+.-+-...+..++.|+.-||..|...| |+|.||||+|||++++ ..+|
T Consensus 501 r~F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~--vlHaDIKPDNiLVNE~k~iLK 577 (752)
T KOG0670|consen 501 RHFKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG--VLHADIKPDNILVNESKNILK 577 (752)
T ss_pred HHhhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC--eeecccCccceEeccCcceee
Confidence 99999999999999884 589999987777777888999999999999999999999 9999999999999865 4689
Q ss_pred EeecCccccCCCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcc--
Q 005247 576 VCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR-- 653 (706)
Q Consensus 576 L~DFGla~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~-- 653 (706)
|||||.|-....... +.+.-+..|.|||++.|..|+...|+||.||+||||+||+..|.+.+..+++.........
T Consensus 578 LCDfGSA~~~~enei--tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p 655 (752)
T KOG0670|consen 578 LCDFGSASFASENEI--TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFP 655 (752)
T ss_pred eccCccccccccccc--cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCc
Confidence 999999987766543 4555677899999999999999999999999999999999999988887776443211100
Q ss_pred -----------------cCC---------------------C-----------CCCc-------HHHHHHHHHhhhhCCC
Q 005247 654 -----------------LEI---------------------P-----------KNVN-------PMVAALIETCWAEEPE 677 (706)
Q Consensus 654 -----------------l~~---------------------p-----------~~~s-------~el~dLI~~cL~~dP~ 677 (706)
+.+ | +.++ ..+++|+.+||..||+
T Consensus 656 ~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~ 735 (752)
T KOG0670|consen 656 NKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPE 735 (752)
T ss_pred HHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChh
Confidence 000 0 0111 3589999999999999
Q ss_pred CCCCHHHHHH
Q 005247 678 IRPSFPSIME 687 (706)
Q Consensus 678 ~RPS~~eIl~ 687 (706)
+|.|..|.|.
T Consensus 736 KRit~nqAL~ 745 (752)
T KOG0670|consen 736 KRITVNQALK 745 (752)
T ss_pred hcCCHHHHhc
Confidence 9999888764
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=263.31 Aligned_cols=133 Identities=26% Similarity=0.402 Sum_probs=110.6
Q ss_pred cccCceEEEEEeccCCceEEEEEEEcCCc--eEEEEEeccccchHHHHHHHHHHHHHHcCC-----C---CceeEEeccc
Q 005247 430 IRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLR-----H---PNIVLLMGAV 499 (706)
Q Consensus 430 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~--vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~-----H---pnIv~l~~~~ 499 (706)
+...+|.++++||.|.|++||++.+.... ||+|+.+... ...+..+.||.+|++++ | .+||++++.|
T Consensus 75 F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq---hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~F 151 (590)
T KOG1290|consen 75 FNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ---HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHF 151 (590)
T ss_pred ccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh---HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccc
Confidence 44589999999999999999999987654 9999986543 23457788999999883 2 4699999998
Q ss_pred cC----CCceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEE
Q 005247 500 TE----PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLV 568 (706)
Q Consensus 500 ~~----~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl 568 (706)
.. +.+.|||+|++ |.+|..+|.....+ -++...+.+|++||+.||.|||..- +|||.||||+|||+
T Consensus 152 khsGpNG~HVCMVfEvL-GdnLLklI~~s~Yr-Glpl~~VK~I~~qvL~GLdYLH~ec-gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 152 KHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYR-GLPLSCVKEICRQVLTGLDYLHREC-GIIHTDLKPENVLL 221 (590)
T ss_pred eecCCCCcEEEEEehhh-hhHHHHHHHHhCCC-CCcHHHHHHHHHHHHHHHHHHHHhc-CccccCCCcceeee
Confidence 64 45799999999 66888888766554 4889999999999999999999752 39999999999998
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-28 Score=235.89 Aligned_cols=210 Identities=43% Similarity=0.672 Sum_probs=183.1
Q ss_pred eccCCceEEEEEEEc--CCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEEeccCCchh
Q 005247 441 IGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLY 518 (706)
Q Consensus 441 LG~G~fG~Vy~a~~~--~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~ 518 (706)
||+|.+|.||++... +..+++|+........ ..+.+.+|+.+++.+.|++|+++++++......++++|++.+++|.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 689999999999987 5669999986554322 3467889999999999999999999999989999999999999999
Q ss_pred hhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECC-CCcEEEeecCccccCCCCcccCCCCCC
Q 005247 519 KLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS-TYTVKVCDFGLSRSKPNTYISSKTAAG 597 (706)
Q Consensus 519 ~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~-~~~vKL~DFGla~~~~~~~~~~~~~~G 597 (706)
+++.... ..++...++.++.++++++.+||+++ ++|+||+|.||+++. ++.++|+|||.+..............+
T Consensus 80 ~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~--~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~ 155 (215)
T cd00180 80 DLLKENE--GKLSEDEILRILLQILEGLEYLHSNG--IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVG 155 (215)
T ss_pred HHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccC
Confidence 9986432 34788999999999999999999999 999999999999999 899999999998866544222344567
Q ss_pred CCCccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHHHHhhhhCC
Q 005247 598 TPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEP 676 (706)
Q Consensus 598 t~~Y~APE~l~~~-~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI~~cL~~dP 676 (706)
...|++||.+... ..+.+.|+|++|+++++| ..+.+++.+|++.+|
T Consensus 156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------~~~~~~l~~~l~~~p 202 (215)
T cd00180 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------PELKDLIRKMLQKDP 202 (215)
T ss_pred CCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------HHHHHHHHHHhhCCc
Confidence 8899999999887 788999999999999999 788999999999999
Q ss_pred CCCCCHHHHHHH
Q 005247 677 EIRPSFPSIMET 688 (706)
Q Consensus 677 ~~RPS~~eIl~~ 688 (706)
++||++.++++.
T Consensus 203 ~~R~~~~~l~~~ 214 (215)
T cd00180 203 EKRPSAKEILEH 214 (215)
T ss_pred ccCcCHHHHhhC
Confidence 999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=280.97 Aligned_cols=249 Identities=29% Similarity=0.478 Sum_probs=216.8
Q ss_pred cCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEE
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 509 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~ 509 (706)
..+|++...+|.|.||.||++++..+ ..|+|+++.... .....+..|+-+++..+|+||+.+++.+......+|+|
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~--dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG--DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCC--ccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 35788999999999999999988755 489999876543 33456778999999999999999999999999999999
Q ss_pred EeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCc
Q 005247 510 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 589 (706)
Q Consensus 510 E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 589 (706)
|||.+|+|.+..+ ..+++.+.++..+.+..+.||+|||++| =+|||||-.|||+++.|.+||.|||.+-..+...
T Consensus 92 EycgggslQdiy~---~TgplselqiayvcRetl~gl~ylhs~g--k~hRdiKGanilltd~gDvklaDfgvsaqitati 166 (829)
T KOG0576|consen 92 EYCGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHSQG--KIHRDIKGANILLTDEGDVKLADFGVSAQITATI 166 (829)
T ss_pred EecCCCcccceee---ecccchhHHHHHHHhhhhccchhhhcCC--cccccccccceeecccCceeecccCchhhhhhhh
Confidence 9999999999887 4457999999999999999999999999 8999999999999999999999999998888777
Q ss_pred ccCCCCCCCCCccCcccc---ccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCc---ccCCCCCCcHH
Q 005247 590 ISSKTAAGTPEWMAPEVL---REDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR---RLEIPKNVNPM 663 (706)
Q Consensus 590 ~~~~~~~Gt~~Y~APE~l---~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~---~l~~p~~~s~e 663 (706)
..+..+.||++|||||+. +.+.|..++|||++|++..|+-.-+.|-....+............ .++-+..+++.
T Consensus 167 ~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~ 246 (829)
T KOG0576|consen 167 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEF 246 (829)
T ss_pred hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHH
Confidence 777889999999999986 467789999999999999999999999777777777666543333 23344568899
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 664 VAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 664 l~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
+.+|++.||.++|.+||+++.++.
T Consensus 247 fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 247 FHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred HHHHHHHHhcCCCccCCChhhhee
Confidence 999999999999999999998764
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-29 Score=283.66 Aligned_cols=242 Identities=29% Similarity=0.453 Sum_probs=190.4
Q ss_pred EEEEEeccCCceE-EEEEEEcCCceEEEEEeccccchHHHHHHHHHHHHHHcC-CCCceeEEeccccCCCceEEEEEecc
Q 005247 436 LIKKKIGEGSFGT-VYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSIVTEYLS 513 (706)
Q Consensus 436 ~i~~~LG~G~fG~-Vy~a~~~~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~lV~E~~~ 513 (706)
.-.+.+|.|..|+ ||+|...++.||||.+... ...-+.+|+..|+.- .||||+++++.-.+....||+.|.|.
T Consensus 512 ~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e-----~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 512 SPKEILGYGSNGTVVFRGVYEGREVAVKRLLEE-----FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred ccHHHcccCCCCcEEEEEeeCCceehHHHHhhH-----hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 3346789999887 7999999999999987443 334667999999887 59999999999999999999999995
Q ss_pred CCchhhhcccCCCcccc-cHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECC-----CCcEEEeecCccccCCC
Q 005247 514 RGSLYKLLHIPDARVVV-DERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS-----TYTVKVCDFGLSRSKPN 587 (706)
Q Consensus 514 ggsL~~~l~~~~~~~~l-~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~-----~~~vKL~DFGla~~~~~ 587 (706)
.+|.+++......... .....+.+..|+++||++||+.+ ||||||||.||||+. ...++|+|||++.....
T Consensus 587 -~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~--iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~ 663 (903)
T KOG1027|consen 587 -CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK--IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG 663 (903)
T ss_pred -hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc--cccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence 5999999753111111 11345778899999999999999 999999999999975 24799999999987654
Q ss_pred Cc---ccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhC-CCCCCCCChHHHHHHhhhcCccc-CCCCCCcH
Q 005247 588 TY---ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRL-EIPKNVNP 662 (706)
Q Consensus 588 ~~---~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG-~~Pf~~~~~~~~~~~i~~~~~~l-~~p~~~s~ 662 (706)
.. .......||.+|+|||++....-+.++|||||||++|+.++| .+||...-..+.- |......+ .+.+....
T Consensus 664 ~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~N--Il~~~~~L~~L~~~~d~ 741 (903)
T KOG1027|consen 664 GKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQAN--ILTGNYTLVHLEPLPDC 741 (903)
T ss_pred CcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhh--hhcCccceeeeccCchH
Confidence 32 223456799999999999999888999999999999999996 8999876544322 22222221 12222223
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 663 MVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 663 el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
+..+||.+|+.++|..||++.+|+.
T Consensus 742 eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 742 EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 9999999999999999999999974
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-29 Score=273.68 Aligned_cols=201 Identities=26% Similarity=0.456 Sum_probs=172.6
Q ss_pred cccCceEEEEEeccCCceEEEEEEEcCCc--eEEEEEeccccc------hHHHHHHHHHHHHHHcCC---CCceeEEecc
Q 005247 430 IRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFH------EDRFKEFLREVAIMKGLR---HPNIVLLMGA 498 (706)
Q Consensus 430 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~--vAVKvl~~~~~~------~~~~~~~~~Ei~iL~~L~---HpnIv~l~~~ 498 (706)
-++.+|..++.+|.|+||.|++|.++... |++|.+.+...- ...+-.+-.|+.||..++ |+||++++++
T Consensus 558 ~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf 637 (772)
T KOG1152|consen 558 KKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF 637 (772)
T ss_pred cccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe
Confidence 45677999999999999999999887654 888887665421 122334567999999997 9999999999
Q ss_pred ccCCCceEEEEEecc-CCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEe
Q 005247 499 VTEPPNLSIVTEYLS-RGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVC 577 (706)
Q Consensus 499 ~~~~~~~~lV~E~~~-ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~ 577 (706)
|++++++|++||-.. +-+|.+++.... .++|..+..|++||+.|+++||++| |||||||-+|++++.+|-+||+
T Consensus 638 FEddd~yyl~te~hg~gIDLFd~IE~kp---~m~E~eAk~IFkQV~agi~hlh~~~--ivhrdikdenvivd~~g~~kli 712 (772)
T KOG1152|consen 638 FEDDDYYYLETEVHGEGIDLFDFIEFKP---RMDEPEAKLIFKQVVAGIKHLHDQG--IVHRDIKDENVIVDSNGFVKLI 712 (772)
T ss_pred eecCCeeEEEecCCCCCcchhhhhhccC---ccchHHHHHHHHHHHhccccccccC--ceecccccccEEEecCCeEEEe
Confidence 999999999999764 457888887443 5999999999999999999999999 9999999999999999999999
Q ss_pred ecCccccCCCCcccCCCCCCCCCccCccccccCCC-CchhHHHHHHHHHHHHHhCCCCCCC
Q 005247 578 DFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPS-NEKSDVFSFGVILWELITLQKPWRN 637 (706)
Q Consensus 578 DFGla~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDVwSLGviL~ELltG~~Pf~~ 637 (706)
|||.+....++. ...+.||..|.|||++.+..| ...-|||+||++||.+.+...||+.
T Consensus 713 dfgsaa~~ksgp--fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 713 DFGSAAYTKSGP--FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred eccchhhhcCCC--cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 999987655442 357899999999999999887 6678999999999999999999864
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.7e-29 Score=250.98 Aligned_cols=245 Identities=25% Similarity=0.408 Sum_probs=191.4
Q ss_pred EEEeccCCceEEEEEEEc--CCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCC-----ceEEEEE
Q 005247 438 KKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP-----NLSIVTE 510 (706)
Q Consensus 438 ~~~LG~G~fG~Vy~a~~~--~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~-----~~~lV~E 510 (706)
.+.||-|+||.||-+.+. ++.+++|.+..-...-...+.+.+|+.+|..++|.|++..+++.+-++ .+|+++|
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE 137 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE 137 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence 568999999999999875 445888887543333344578999999999999999999988776543 2578888
Q ss_pred eccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCC-c
Q 005247 511 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT-Y 589 (706)
Q Consensus 511 ~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~-~ 589 (706)
.+. .+|..++-.. ..++.+.+.-+.+||++||+|||+.+ |.||||||.|+|++.|-.+||||||+++..... .
T Consensus 138 LmQ-SDLHKIIVSP---Q~Ls~DHvKVFlYQILRGLKYLHsA~--ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~ 211 (449)
T KOG0664|consen 138 LMQ-SDLHKIIVSP---QALTPDHVKVFVYQILRGLKYLHTAN--ILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDR 211 (449)
T ss_pred HHH-hhhhheeccC---CCCCcchhhhhHHHHHhhhHHHhhcc--hhhccCCCccEEeccCceEEecccccccccchhhh
Confidence 885 4787777533 35788889999999999999999999 999999999999999999999999999975433 2
Q ss_pred ccCCCCCCCCCccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcC-----------------
Q 005247 590 ISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG----------------- 651 (706)
Q Consensus 590 ~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~----------------- 651 (706)
.+.+...-|.+|+|||++.+. .|+.++||||.|||+.||+-.+..|+..++-+....|...-
T Consensus 212 ~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~ 291 (449)
T KOG0664|consen 212 LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKN 291 (449)
T ss_pred hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHH
Confidence 233344568899999999886 58899999999999999999999998877755554432110
Q ss_pred ------c-cc--------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 005247 652 ------R-RL--------EIPKNVNPMVAALIETCWAEEPEIRPSFPSIMET 688 (706)
Q Consensus 652 ------~-~l--------~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~ 688 (706)
. .+ ..+.+...+...++..++..||++|.+.++.+..
T Consensus 292 H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~ 343 (449)
T KOG0664|consen 292 HVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQH 343 (449)
T ss_pred HhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccc
Confidence 0 01 1112334578889999999999999998877653
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7e-28 Score=248.56 Aligned_cols=245 Identities=27% Similarity=0.353 Sum_probs=194.7
Q ss_pred CceEEEEEeccCCceEEEEEEE--cCCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCC------Cc
Q 005247 433 SELLIKKKIGEGSFGTVYHAEW--RNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP------PN 504 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~------~~ 504 (706)
.+|.-++.+|.|.- .|.-+-+ .+..||+|.+...-......+...+|..++..++|+||++++.+|.-. ..
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 46777888999988 5665644 466799988765544445567888999999999999999999998543 34
Q ss_pred eEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCcccc
Q 005247 505 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 584 (706)
Q Consensus 505 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~ 584 (706)
.|+|||+|.. +|...++. .++-+.+..+..|++.|++|||+.| |+||||||+||++..+..+||.|||+|+.
T Consensus 96 ~y~v~e~m~~-nl~~vi~~-----elDH~tis~i~yq~~~~ik~lhs~~--IihRdLkPsnivv~~~~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 96 VYLVMELMDA-NLCQVILM-----ELDHETISYILYQMLCGIKHLHSAG--IIHRDLKPSNIVVNSDCTLKILDFGLART 167 (369)
T ss_pred HHHHHHhhhh-HHHHHHHH-----hcchHHHHHHHHHHHHHHHHHHhcc--eeecccCcccceecchhheeeccchhhcc
Confidence 7899999965 88887762 3678889999999999999999999 99999999999999999999999999998
Q ss_pred CCCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhc-C------------
Q 005247 585 KPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-G------------ 651 (706)
Q Consensus 585 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~-~------------ 651 (706)
....+ ..+....|..|.|||++.+..+.+.+||||+||++.||++|...|.+.+.-+...++... +
T Consensus 168 e~~~~-~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~ 246 (369)
T KOG0665|consen 168 EDTDF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQP 246 (369)
T ss_pred cCccc-ccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhH
Confidence 76552 446778899999999999999999999999999999999999888765432222221100 0
Q ss_pred -------cc-----cCCC---------------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 652 -------RR-----LEIP---------------KNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 652 -------~~-----l~~p---------------~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
.+ ..++ +.-...+++++.+||-.||++|.|++++++
T Consensus 247 ~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 247 TVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred HHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 00 1111 112246899999999999999999999876
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.7e-28 Score=238.46 Aligned_cols=242 Identities=22% Similarity=0.377 Sum_probs=190.6
Q ss_pred cCceEEEEEeccCCceEEEEEEE--cCCceEEEEEeccccchHHHHHHHHHHHHHHcCC-CCceeEEeccccCCC--ceE
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEW--RNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGAVTEPP--NLS 506 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~--~~~ 506 (706)
.++|++++++|+|.|+.||.|.+ .+.+++||+++. -..+.+.+|+.||+.|. ||||++++++..++. ...
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP-----VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa 111 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP-----VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS 111 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeech-----HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence 46789999999999999999974 455688998854 23468899999999997 999999999998765 467
Q ss_pred EEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCC-CcEEEeecCccccC
Q 005247 507 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST-YTVKVCDFGLSRSK 585 (706)
Q Consensus 507 lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~-~~vKL~DFGla~~~ 585 (706)
++|||..+.+...+.. .+....+..++.++++||.|+|++| |+|||+||.|++|+.. -.++|+|+|+|...
T Consensus 112 LiFE~v~n~Dfk~ly~------tl~d~dIryY~~elLkALdyCHS~G--ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 112 LIFEYVNNTDFKQLYP------TLTDYDIRYYIYELLKALDYCHSMG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred hHhhhhccccHHHHhh------hhchhhHHHHHHHHHHHHhHHHhcC--cccccCCcceeeechhhceeeeeecchHhhc
Confidence 9999998877666543 4677788999999999999999999 9999999999999864 46999999999875
Q ss_pred CCCcccCCCCCCCCCccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCC-CCChHHHHHHhhhc-----------Cc
Q 005247 586 PNTYISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWR-NSTPSQVISAVGFK-----------GR 652 (706)
Q Consensus 586 ~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSLGviL~ELltG~~Pf~-~~~~~~~~~~i~~~-----------~~ 652 (706)
.... .-.....+..|.-||.+... .|+..-|+|||||+|..|+..+.||. +.+..+....+... ..
T Consensus 184 Hp~~-eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY 262 (338)
T KOG0668|consen 184 HPGK-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKY 262 (338)
T ss_pred CCCc-eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHH
Confidence 4432 22345667889999998765 47888999999999999999999974 33333322222100 00
Q ss_pred ccCCC------------------------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 653 RLEIP------------------------KNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 653 ~l~~p------------------------~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
.+.++ .-+++++.+|+.++|..|-.+|+|+.|.+.
T Consensus 263 ~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 263 QIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred ccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 11111 124689999999999999999999999876
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-26 Score=229.41 Aligned_cols=208 Identities=38% Similarity=0.567 Sum_probs=174.6
Q ss_pred eEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEEec
Q 005247 435 LLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYL 512 (706)
Q Consensus 435 y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~~ 512 (706)
|.+.+.||.|++|.||++.+.+ ..+++|........ ...+.+.+|++.+++++|+|++++++++......++++|++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC 79 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence 5678999999999999998875 55999998655433 24578889999999999999999999999889999999999
Q ss_pred cCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCc-cc
Q 005247 513 SRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY-IS 591 (706)
Q Consensus 513 ~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~-~~ 591 (706)
.+++|.+++..... .+++..++.++.+++.++.+||+++ ++|+||+|.||+++.++.++|+|||.+....... ..
T Consensus 80 ~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~ 155 (225)
T smart00221 80 EGGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSLG--IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAAL 155 (225)
T ss_pred CCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccc
Confidence 99999999864321 1788899999999999999999999 9999999999999999999999999988765432 12
Q ss_pred CCCCCCCCCccCcccc-ccCCCCchhHHHHHHHHHHHHHhCCCCCCC-CChH-HHHHHh
Q 005247 592 SKTAAGTPEWMAPEVL-REDPSNEKSDVFSFGVILWELITLQKPWRN-STPS-QVISAV 647 (706)
Q Consensus 592 ~~~~~Gt~~Y~APE~l-~~~~~s~ksDVwSLGviL~ELltG~~Pf~~-~~~~-~~~~~i 647 (706)
.....++..|++||.+ ....++.++|||+||+++++|++|+.||.. .++. .+...+
T Consensus 156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~ 214 (225)
T smart00221 156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVW 214 (225)
T ss_pred ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHH
Confidence 2345678899999998 666778899999999999999999999977 4444 444444
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.4e-27 Score=237.66 Aligned_cols=248 Identities=24% Similarity=0.373 Sum_probs=191.5
Q ss_pred cCceEEEEEeccCCceEEEEEEEcCCc--eEEEEEeccccchHHHHHHHHHHHHHHcCC-CCceeEEecc-ccCCCceEE
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGA-VTEPPNLSI 507 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~--vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~-~~~~~~~~l 507 (706)
.+.|.|.+.||+|.||.+-++++++++ +++|.+.... ...++|.+|...--.|. |.||+..|+. |+..+.+.+
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~---tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF 99 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ---TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVF 99 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch---hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEE
Confidence 357899999999999999999998776 7778765443 33568889987766664 8999988876 677788889
Q ss_pred EEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEEC--CCCcEEEeecCccccC
Q 005247 508 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVD--STYTVKVCDFGLSRSK 585 (706)
Q Consensus 508 V~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~--~~~~vKL~DFGla~~~ 585 (706)
++||++.|+|..-+...+ +.+.....++.|+++||.|||+++ +||||||.+||||- +...|||||||+.+..
T Consensus 100 ~qE~aP~gdL~snv~~~G----igE~~~K~v~~ql~SAi~fMHskn--lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 100 VQEFAPRGDLRSNVEAAG----IGEANTKKVFAQLLSAIEFMHSKN--LVHRDLKAENILIFDADFYRVKLCDFGLTRKV 173 (378)
T ss_pred eeccCccchhhhhcCccc----ccHHHHHHHHHHHHHHHHHhhccc--hhhcccccceEEEecCCccEEEeeeccccccc
Confidence 999999999998876443 778889999999999999999999 99999999999994 3348999999998876
Q ss_pred CCCcccCCCCCCCCCccCccccccC-----CCCchhHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHhhhcCcccCCC
Q 005247 586 PNTYISSKTAAGTPEWMAPEVLRED-----PSNEKSDVFSFGVILWELITLQKPWRNSTP---SQVISAVGFKGRRLEIP 657 (706)
Q Consensus 586 ~~~~~~~~~~~Gt~~Y~APE~l~~~-----~~s~ksDVwSLGviL~ELltG~~Pf~~~~~---~~~~~~i~~~~~~l~~p 657 (706)
+... .....+..|.+||..... ...+.+|+|.||+++|.++||..||+.... .-.......++.....|
T Consensus 174 g~tV---~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P 250 (378)
T KOG1345|consen 174 GTTV---KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALP 250 (378)
T ss_pred Ccee---hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCc
Confidence 6543 223456689999987543 235678999999999999999999975321 11112222233444555
Q ss_pred CC---CcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 005247 658 KN---VNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 691 (706)
Q Consensus 658 ~~---~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ 691 (706)
.. .++.+..+.++-|.++|++|--..+..+....
T Consensus 251 ~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~ 287 (378)
T KOG1345|consen 251 KKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKC 287 (378)
T ss_pred hhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHH
Confidence 54 56788899999999999999666665554433
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-24 Score=232.55 Aligned_cols=257 Identities=23% Similarity=0.258 Sum_probs=204.0
Q ss_pred ceEEEEEeccCCceEEEEEEEcCCc---eEEEEEeccccchHHHHHHHHHHHHHHcCCC----CceeEEeccc-cCCCce
Q 005247 434 ELLIKKKIGEGSFGTVYHAEWRNSD---VAVKILIEQEFHEDRFKEFLREVAIMKGLRH----PNIVLLMGAV-TEPPNL 505 (706)
Q Consensus 434 ~y~i~~~LG~G~fG~Vy~a~~~~~~---vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~H----pnIv~l~~~~-~~~~~~ 505 (706)
+|++.+.||+|+||.||++.+.... +|+|+......... ..+..|..++..+.. .++..+++.. ..+...
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence 8999999999999999999987653 88888755422211 156678888888862 6899999998 577788
Q ss_pred EEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCC-----CcEEEeecC
Q 005247 506 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST-----YTVKVCDFG 580 (706)
Q Consensus 506 ~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~-----~~vKL~DFG 580 (706)
++||+.+ |.+|.++..... ...++..++..++.|++.+|++||+.| +|||||||+|+++... ..++|+|||
T Consensus 97 ~iVM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G--~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 97 FIVMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG--FIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred EEEEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC--cccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 9999987 779999885444 457999999999999999999999999 9999999999999765 369999999
Q ss_pred ccc--cCCCCc----cc----CCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhc
Q 005247 581 LSR--SKPNTY----IS----SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK 650 (706)
Q Consensus 581 la~--~~~~~~----~~----~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~ 650 (706)
+++ ...... .. .....||..|+++.++.+...+.+.|+||++.++.++..|..||...........+...
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~ 252 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKD 252 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHH
Confidence 998 321111 11 12355999999999999999999999999999999999999999776643333332222
Q ss_pred CcccC---CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhc
Q 005247 651 GRRLE---IPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 696 (706)
Q Consensus 651 ~~~l~---~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~ 696 (706)
..... .....+.++.++...+-..+...+|.+..+...|++.....
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 253 PRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred hhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 22211 23445678888888888899999999999999999888765
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.5e-25 Score=215.03 Aligned_cols=164 Identities=20% Similarity=0.295 Sum_probs=130.0
Q ss_pred CchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcccCCC
Q 005247 515 GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKT 594 (706)
Q Consensus 515 gsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 594 (706)
|+|.++++..+ ..+++..++.++.||+.||.|||+++ ||+|||++.++.+|+ ||++...... .
T Consensus 1 GsL~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~lH~~~--------kp~Nil~~~~~~~~~--fG~~~~~~~~-----~ 63 (176)
T smart00750 1 VSLADILEVRG--RPLNEEEIWAVCLQCLRALRELHRQA--------KSGNILLTWDGLLKL--DGSVAFKTPE-----Q 63 (176)
T ss_pred CcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcC--------CcccEeEcCccceee--ccceEeeccc-----c
Confidence 68888886432 35899999999999999999999887 999999999999999 9998765432 2
Q ss_pred CCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHhhhcCccc-----CCCCCCcH--HHHH
Q 005247 595 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQ-VISAVGFKGRRL-----EIPKNVNP--MVAA 666 (706)
Q Consensus 595 ~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~-~~~~i~~~~~~l-----~~p~~~s~--el~d 666 (706)
..||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+....... ..+..++. ++.+
T Consensus 64 ~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 143 (176)
T smart00750 64 SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFAD 143 (176)
T ss_pred CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHH
Confidence 368999999999999999999999999999999999999997654322 222221111111 11223333 6999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHHHHHHHHh
Q 005247 667 LIETCWAEEPEIRPSFPSIMETLQQFLMS 695 (706)
Q Consensus 667 LI~~cL~~dP~~RPS~~eIl~~L~~ll~s 695 (706)
+|.+||..+|++||++.++++.+..+...
T Consensus 144 ~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 144 FMRVCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred HHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence 99999999999999999999998877654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-25 Score=268.60 Aligned_cols=194 Identities=22% Similarity=0.251 Sum_probs=140.8
Q ss_pred cCCC-CceeEEeccc-------cCCCceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcc
Q 005247 486 GLRH-PNIVLLMGAV-------TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 557 (706)
Q Consensus 486 ~L~H-pnIv~l~~~~-------~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~II 557 (706)
.++| +||++++++| .+...++.+||++ +++|.+++... ...+++..++.++.||++||+|||++| ||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g--Iv 102 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQG--IV 102 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhCC--ee
Confidence 4445 5788888877 2334567888987 56999999643 235899999999999999999999999 99
Q ss_pred cccCCCCcEEECCCC-------------------cEEEeecCccccCCCCc----------------ccCCCCCCCCCcc
Q 005247 558 HRDLKSPNLLVDSTY-------------------TVKVCDFGLSRSKPNTY----------------ISSKTAAGTPEWM 602 (706)
Q Consensus 558 HrDLKp~NILl~~~~-------------------~vKL~DFGla~~~~~~~----------------~~~~~~~Gt~~Y~ 602 (706)
||||||+||||+..+ .+||+|||+++...... .......||+.||
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 999999999996544 45566666654321100 0011245788999
Q ss_pred CccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHHHHhhhhCCCCCCCH
Q 005247 603 APEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSF 682 (706)
Q Consensus 603 APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~ 682 (706)
|||++.+..++.++|||||||+||||++|..|+..... ....+.....+... ....+...+++.+||+++|.+||++
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~~~~~~-~~~~~~~~~~~~~~L~~~P~~Rps~ 259 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRVLPPQI-LLNWPKEASFCLWLLHPEPSCRPSM 259 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhhcChhh-hhcCHHHHHHHHHhCCCChhhCcCh
Confidence 99999999999999999999999999999888754321 11111111111111 1224567789999999999999999
Q ss_pred HHHHH
Q 005247 683 PSIME 687 (706)
Q Consensus 683 ~eIl~ 687 (706)
.|+++
T Consensus 260 ~eil~ 264 (793)
T PLN00181 260 SELLQ 264 (793)
T ss_pred HHHhh
Confidence 99976
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.5e-23 Score=211.83 Aligned_cols=251 Identities=34% Similarity=0.510 Sum_probs=203.5
Q ss_pred eEEEEEeccCCceEEEEEEEcCCceEEEEEeccccchH-HHHHHHHHHHHHHcCCCC-ceeEEeccccCCCceEEEEEec
Q 005247 435 LLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHED-RFKEFLREVAIMKGLRHP-NIVLLMGAVTEPPNLSIVTEYL 512 (706)
Q Consensus 435 y~i~~~LG~G~fG~Vy~a~~~~~~vAVKvl~~~~~~~~-~~~~~~~Ei~iL~~L~Hp-nIv~l~~~~~~~~~~~lV~E~~ 512 (706)
|.+.+.||.|+||.||++.+. ..+++|.+........ ....+.+|+.++..+.|+ +|+++++.+......+++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 80 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV 80 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence 778999999999999999887 6688898876654443 567899999999999988 7999999997777789999999
Q ss_pred cCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCC-cEEEeecCccccCCCCcc-
Q 005247 513 SRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY-TVKVCDFGLSRSKPNTYI- 590 (706)
Q Consensus 513 ~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~-~vKL~DFGla~~~~~~~~- 590 (706)
.++++.+++........+.......++.|++.++.|+|+.+ ++|||+||+||+++..+ .++++|||.+........
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~--~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred CCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 99999977653321135888999999999999999999999 99999999999999988 799999999875544321
Q ss_pred -----cCCCCCCCCCccCcccccc---CCCCchhHHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHhhhcCcc-cCCC
Q 005247 591 -----SSKTAAGTPEWMAPEVLRE---DPSNEKSDVFSFGVILWELITLQKPWRNSTP----SQVISAVGFKGRR-LEIP 657 (706)
Q Consensus 591 -----~~~~~~Gt~~Y~APE~l~~---~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~----~~~~~~i~~~~~~-l~~p 657 (706)
......|+..|++||.+.+ .......|+|++|++++++++|..||..... ......+...... ...+
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccc
Confidence 2356789999999999988 5788899999999999999999999877663 3444444333322 1111
Q ss_pred --CCC----cHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 005247 658 --KNV----NPMVAALIETCWAEEPEIRPSFPSIMET 688 (706)
Q Consensus 658 --~~~----s~el~dLI~~cL~~dP~~RPS~~eIl~~ 688 (706)
... ...+.+++.+|+..+|..|.+..+....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 121 2589999999999999999988877664
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-24 Score=232.01 Aligned_cols=247 Identities=27% Similarity=0.407 Sum_probs=189.5
Q ss_pred ccccCceEEEEEeccCCceEEEEEEEcC-----CceEEEEEeccccchHHHHHHHHHHHHHHcCC-CCceeEEeccccCC
Q 005247 429 EIRWSELLIKKKIGEGSFGTVYHAEWRN-----SDVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGAVTEP 502 (706)
Q Consensus 429 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~-----~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~ 502 (706)
..-...|.++++||.|.|++||++.+.. ..||+|.+...... ..+.+|+++|..+. +.||+++.+++..+
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p----~ri~~El~~L~~~gG~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP----SRILNELEMLYRLGGSDNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc----hHHHHHHHHHHHhccchhhhcchhhhccC
Confidence 3445678999999999999999997644 34899987554322 35889999999995 99999999999999
Q ss_pred CceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECC-CCcEEEeecCc
Q 005247 503 PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS-TYTVKVCDFGL 581 (706)
Q Consensus 503 ~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~-~~~vKL~DFGl 581 (706)
++..+|+||++...-.++.. .++...+..++..++.||.++|.+| ||||||||.|+|.+. .+.-.|+|||+
T Consensus 108 d~v~ivlp~~~H~~f~~l~~------~l~~~~i~~Yl~~ll~Al~~~h~~G--IvHRDiKpsNFL~n~~t~rg~LvDFgL 179 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYR------SLSLAEIRWYLRNLLKALAHLHKNG--IVHRDIKPSNFLYNRRTQRGVLVDFGL 179 (418)
T ss_pred CeeEEEecccCccCHHHHHh------cCCHHHHHHHHHHHHHHhhhhhccC--ccccCCCccccccccccCCceEEechh
Confidence 99999999999988888775 3567888999999999999999999 999999999999974 56789999999
Q ss_pred ccc-CCC----------------------------------Ccc---------cCCCCCCCCCccCccccccCC-CCchh
Q 005247 582 SRS-KPN----------------------------------TYI---------SSKTAAGTPEWMAPEVLREDP-SNEKS 616 (706)
Q Consensus 582 a~~-~~~----------------------------------~~~---------~~~~~~Gt~~Y~APE~l~~~~-~s~ks 616 (706)
|.. ... .+. ......||++|.|||++...+ .++++
T Consensus 180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai 259 (418)
T KOG1167|consen 180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI 259 (418)
T ss_pred HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence 861 000 000 011235999999999998765 58899
Q ss_pred HHHHHHHHHHHHHhCCCCCCCCC-hHHHH-------------HHhhhcCc-------c-------------c--------
Q 005247 617 DVFSFGVILWELITLQKPWRNST-PSQVI-------------SAVGFKGR-------R-------------L-------- 654 (706)
Q Consensus 617 DVwSLGviL~ELltG~~Pf~~~~-~~~~~-------------~~i~~~~~-------~-------------l-------- 654 (706)
||||.|+|+..++++++||.... .-+.. +.....+. + +
T Consensus 260 Diws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~ 339 (418)
T KOG1167|consen 260 DIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKS 339 (418)
T ss_pred ceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccc
Confidence 99999999999999999984321 11111 10000000 0 0
Q ss_pred --------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 655 --------EIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 655 --------~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
...+..+..+.+|+.+||..||.+|.|+++.++
T Consensus 340 ~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 340 RQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred cccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 000123457899999999999999999999876
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-24 Score=217.56 Aligned_cols=256 Identities=32% Similarity=0.622 Sum_probs=220.9
Q ss_pred cccCceEEEEEeccCCceEEEEEEEcCCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEE
Q 005247 430 IRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 509 (706)
Q Consensus 430 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~ 509 (706)
+..+++.+..+|.+...|..|+|++.+.+++.|++...+......+.|..|.-.|+-+.||||+.+++.|..+.++.++.
T Consensus 187 id~~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~is 266 (448)
T KOG0195|consen 187 IDVSSLNLITKLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIIS 266 (448)
T ss_pred cchhhhhhhhhhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEee
Confidence 34456667788999999999999999999999999888877777788999999999999999999999999999999999
Q ss_pred EeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEe--ecCccccCCC
Q 005247 510 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVC--DFGLSRSKPN 587 (706)
Q Consensus 510 E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~--DFGla~~~~~ 587 (706)
.||+.|+|+..++.. .....+..++.+++.++++|++|||+..+-|----|....++||++.+.+|. |--++..
T Consensus 267 q~mp~gslynvlhe~-t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfq--- 342 (448)
T KOG0195|consen 267 QYMPFGSLYNVLHEQ-TSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ--- 342 (448)
T ss_pred eeccchHHHHHHhcC-ccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeee---
Confidence 999999999999854 3456788899999999999999999998544455688899999999887764 2211111
Q ss_pred CcccCCCCCCCCCccCccccccCCCC---chhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHH
Q 005247 588 TYISSKTAAGTPEWMAPEVLREDPSN---EKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV 664 (706)
Q Consensus 588 ~~~~~~~~~Gt~~Y~APE~l~~~~~s---~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el 664 (706)
.......|.||+||.+...+.+ .++|+|||+++||||-|...||....+.+.--++...+-+..+|+.+++-+
T Consensus 343 ----e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm 418 (448)
T KOG0195|consen 343 ----EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHM 418 (448)
T ss_pred ----ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHH
Confidence 1233557899999999887654 478999999999999999999999999998888888899999999999999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 005247 665 AALIETCWAEEPEIRPSFPSIMETLQQFL 693 (706)
Q Consensus 665 ~dLI~~cL~~dP~~RPS~~eIl~~L~~ll 693 (706)
..||.-|++.||.+||.++.|.-.|++++
T Consensus 419 ~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 419 NKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred HHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 99999999999999999999998888764
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.1e-23 Score=212.76 Aligned_cols=258 Identities=19% Similarity=0.274 Sum_probs=213.2
Q ss_pred cccCceEEEEEeccCCceEEEEEEE--cCCceEEEEEeccccchHHHHHHHHHHHHHHcCC-CCceeEEeccccCCCceE
Q 005247 430 IRWSELLIKKKIGEGSFGTVYHAEW--RNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGAVTEPPNLS 506 (706)
Q Consensus 430 i~~~~y~i~~~LG~G~fG~Vy~a~~--~~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~ 506 (706)
+..-+|.++++||+|.||..+.|++ ++..||||.-..... .-.+..|....+.|. .++|...|.+..++.+-.
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~----APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~Ni 100 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE----APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNI 100 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEeccccCC----cchHHHHHHHHHHHcCCCCCCceeeeccccchhh
Confidence 4556899999999999999999986 466799998544322 225566777788774 799999999999999999
Q ss_pred EEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCC-----CcEEEeecCc
Q 005247 507 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST-----YTVKVCDFGL 581 (706)
Q Consensus 507 lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~-----~~vKL~DFGl 581 (706)
+|+|++ |.+|+|++...+. .+..++++.+|.|++.-++|+|+++ +|.|||||+|+||..- ..|.|+|||+
T Consensus 101 LVidLL-GPSLEDLFD~CgR--~FSvKTV~miA~Qmi~rie~vH~k~--LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGm 175 (449)
T KOG1165|consen 101 LVIDLL-GPSLEDLFDLCGR--RFSVKTVAMIAKQMITRIEYVHEKD--LIYRDIKPDNFLIGRPGTKDANVIHIIDFGM 175 (449)
T ss_pred hhhhhh-CcCHHHHHHHhcC--cccHHhHHHHHHHHHHHHHHHHhcc--eeecccCccceeecCCCCCCCceEEEEeccc
Confidence 999998 7799999976654 4889999999999999999999999 9999999999999643 3699999999
Q ss_pred cccCCC-------CcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC---ChHHHHHHhhhcC
Q 005247 582 SRSKPN-------TYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNS---TPSQVISAVGFKG 651 (706)
Q Consensus 582 a~~~~~-------~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~---~~~~~~~~i~~~~ 651 (706)
|....+ ++.......||.+||+-....+...+.+.|+-|||-+++.+|-|..||++. +..+.+.+|....
T Consensus 176 AK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~K 255 (449)
T KOG1165|consen 176 AKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETK 255 (449)
T ss_pred hhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcccc
Confidence 986443 344456778999999999999999999999999999999999999999874 4455555554333
Q ss_pred cccC---CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhc
Q 005247 652 RRLE---IPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 696 (706)
Q Consensus 652 ~~l~---~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~ 696 (706)
...+ +-.++|.++..-++..=..+-.+-|+++-+...+..++...
T Consensus 256 r~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~ 303 (449)
T KOG1165|consen 256 RSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRL 303 (449)
T ss_pred ccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhc
Confidence 3332 23578899999999999999999999999999888888653
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.8e-23 Score=205.00 Aligned_cols=259 Identities=21% Similarity=0.292 Sum_probs=209.3
Q ss_pred ccccCceEEEEEeccCCceEEEEEEEc--CCceEEEEEeccccchHHHHHHHHHHHHHHcCC-CCceeEEeccccCCCce
Q 005247 429 EIRWSELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGAVTEPPNL 505 (706)
Q Consensus 429 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~ 505 (706)
.+..++|.++++||.|+||.+|.|... +..||+|+-....-.+ .+..|..+...|+ ...|..+..++.+..+-
T Consensus 11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hp----qL~yEskvY~iL~~g~GiP~i~~y~~e~~yn 86 (341)
T KOG1163|consen 11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHP----QLLYESKVYRILQGGVGIPHIRHYGTEKDYN 86 (341)
T ss_pred heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCc----chhHHHHHHHHhccCCCCchhhhhccccccc
Confidence 356789999999999999999999875 4459999975544333 4567888888886 46788888889999999
Q ss_pred EEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECC---CCcEEEeecCcc
Q 005247 506 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS---TYTVKVCDFGLS 582 (706)
Q Consensus 506 ~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~---~~~vKL~DFGla 582 (706)
.+||+.+ |.+|.+++..... .++..+++-++-|++.-++|+|.++ +|||||||+|+|+.- -..+.|+|||+|
T Consensus 87 vlVMdLL-GPsLEdLfnfC~R--~ftmkTvLMLaDQml~RiEyvH~r~--fiHRDIKPdNFLMGlgrh~~kl~LIDFGLa 161 (341)
T KOG1163|consen 87 VLVMDLL-GPSLEDLFNFCSR--RFTMKTVLMLADQMLSRIEYVHLRN--FIHRDIKPDNFLMGLGRHCNKLYLIDFGLA 161 (341)
T ss_pred eeeeecc-CccHHHHHHHHhh--hhhHHhHHHHHHHHHHHHHHHHhhc--cccccCCccceeeccccccceEEEEeccch
Confidence 9999998 7799999975543 4888899999999999999999999 999999999999963 346999999999
Q ss_pred ccCCC-------CcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHhhhcCc
Q 005247 583 RSKPN-------TYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQ---VISAVGFKGR 652 (706)
Q Consensus 583 ~~~~~-------~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~---~~~~i~~~~~ 652 (706)
....+ ++.......||.+|.+-....+...+.+.|+-|+|.+|..+.-|..||++..... ....|.....
T Consensus 162 Kky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~ 241 (341)
T KOG1163|consen 162 KKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKM 241 (341)
T ss_pred hhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhc
Confidence 76433 3334566789999999998888888999999999999999999999999865433 3333322222
Q ss_pred ccC---CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhc
Q 005247 653 RLE---IPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 696 (706)
Q Consensus 653 ~l~---~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~ 696 (706)
..+ +-...|.++.-.+..|-..--++-|++.-+.+.++-+..+.
T Consensus 242 s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~l 288 (341)
T KOG1163|consen 242 STPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTL 288 (341)
T ss_pred CCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhc
Confidence 111 23577899999999999999999999999988887776553
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.3e-22 Score=216.39 Aligned_cols=173 Identities=17% Similarity=0.145 Sum_probs=131.9
Q ss_pred cccccCcccccCceEEEEEeccCCceEEEEEEEcC---CceEEEEEecccc---chHHHHHHHHHHHHHHcCCCCceeE-
Q 005247 422 YLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRN---SDVAVKILIEQEF---HEDRFKEFLREVAIMKGLRHPNIVL- 494 (706)
Q Consensus 422 ~~~~~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~---~~vAVKvl~~~~~---~~~~~~~~~~Ei~iL~~L~HpnIv~- 494 (706)
.+...........|.+.+.||+|+||+||+|.+.. ..+|||++..... .....+.+.+|+++|++++|+||+.
T Consensus 7 ~~~~~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~ 86 (365)
T PRK09188 7 PLPGDQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQ 86 (365)
T ss_pred CCcccccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcE
Confidence 34455566677889999999999999999998753 3378988653211 2334567899999999999999884
Q ss_pred EeccccCCCceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccC-CCCcEEECCCCc
Q 005247 495 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDL-KSPNLLVDSTYT 573 (706)
Q Consensus 495 l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDL-Kp~NILl~~~~~ 573 (706)
+++. +..++||||++|++|... .. .. ...++.|+++||.|||++| |+|||| ||+|||++.++.
T Consensus 87 l~~~----~~~~LVmE~~~G~~L~~~-~~------~~---~~~~~~~i~~aL~~lH~~g--IiHrDL~KP~NILv~~~~~ 150 (365)
T PRK09188 87 LLAT----GKDGLVRGWTEGVPLHLA-RP------HG---DPAWFRSAHRALRDLHRAG--ITHNDLAKPQNWLMGPDGE 150 (365)
T ss_pred EEEc----CCcEEEEEccCCCCHHHh-Cc------cc---hHHHHHHHHHHHHHHHHCC--CeeCCCCCcceEEEcCCCC
Confidence 5542 457999999999999632 10 11 1457889999999999999 999999 999999999999
Q ss_pred EEEeecCccccCCCCcc--------cCCCCCCCCCccCccccccC
Q 005247 574 VKVCDFGLSRSKPNTYI--------SSKTAAGTPEWMAPEVLRED 610 (706)
Q Consensus 574 vKL~DFGla~~~~~~~~--------~~~~~~Gt~~Y~APE~l~~~ 610 (706)
+||+|||+|+....... ......++..|+|||.+...
T Consensus 151 ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 151 AAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred EEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 99999999986543221 11345678889999998543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.1e-23 Score=237.07 Aligned_cols=246 Identities=24% Similarity=0.318 Sum_probs=188.6
Q ss_pred EEEEEeccCCceEEEEEEEcC--CceEEEEEe----ccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEE
Q 005247 436 LIKKKIGEGSFGTVYHAEWRN--SDVAVKILI----EQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 509 (706)
Q Consensus 436 ~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~----~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~ 509 (706)
...+.+|.|++|.|+.+.... ..++.|... ...........+..|+.+-..+.|+|++..+..+.+.....-.|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 356789999999887775432 223333322 22222222233778888999999999999888888777766669
Q ss_pred EeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCc
Q 005247 510 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 589 (706)
Q Consensus 510 E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 589 (706)
|||++ +|..++... ..+....+..++.|++.|++|||+.| |.|||+|++|++++.+|.+||+|||.+.....+.
T Consensus 401 E~~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h~~G--iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLHSMG--LAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred hcccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHHhcC--ceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 99999 999988643 34778888999999999999999999 9999999999999999999999999987654433
Q ss_pred c----cCCCCCCCCCccCccccccCCCCc-hhHHHHHHHHHHHHHhCCCCCCCCChHHHH-HHhhhcC------cccCCC
Q 005247 590 I----SSKTAAGTPEWMAPEVLREDPSNE-KSDVFSFGVILWELITLQKPWRNSTPSQVI-SAVGFKG------RRLEIP 657 (706)
Q Consensus 590 ~----~~~~~~Gt~~Y~APE~l~~~~~s~-ksDVwSLGviL~ELltG~~Pf~~~~~~~~~-~~i~~~~------~~l~~p 657 (706)
. .....+|+..|+|||++.+..|++ ..||||.|++++.|.+|+.||......+.. ....... ....+.
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~ 554 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLL 554 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHH
Confidence 2 235668999999999999999876 589999999999999999999765433221 1111111 112233
Q ss_pred CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 658 KNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 658 ~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
..++...+.+|.+||+.+|.+|.|+++|++
T Consensus 555 ~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 555 SLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred HhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 456788999999999999999999999987
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=3e-21 Score=223.78 Aligned_cols=245 Identities=21% Similarity=0.254 Sum_probs=183.8
Q ss_pred ceEEEEEeccCCceEEEEEEEcCCceEEEEEecccc--chHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEEe
Q 005247 434 ELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEF--HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY 511 (706)
Q Consensus 434 ~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKvl~~~~~--~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~ 511 (706)
++...+.||.+.|=+|.+|++.+..++||++.++.. .-...++-+.|+. ...+++||++.+.-....+...|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 788899999999999999999988899999877652 2233344445555 5566899999999888888888999999
Q ss_pred ccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCccc
Q 005247 512 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS 591 (706)
Q Consensus 512 ~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~ 591 (706)
..+ +|+|.+. .+..+...+.+.|+.|++.||..+|..| |+|||||.+||||+..+-+.|+||..-+...-++..
T Consensus 103 vkh-nLyDRlS---TRPFL~~iEKkWiaFQLL~al~qcH~~g--VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 103 VKH-NLYDRLS---TRPFLVLIEKKWIAFQLLKALSQCHKLG--VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred Hhh-hhhhhhc---cchHHHHHHHHHHHHHHHHHHHHHHHcC--ccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 976 8999886 4445777788889999999999999999 999999999999999999999999865432211111
Q ss_pred C-------CCCCCCCCccCccccccCC-----------CCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCc
Q 005247 592 S-------KTAAGTPEWMAPEVLREDP-----------SNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGR 652 (706)
Q Consensus 592 ~-------~~~~Gt~~Y~APE~l~~~~-----------~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~ 652 (706)
. .+......|.|||.+.... .+++-||||+||++.||++ |++||.-. +..........
T Consensus 177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS---QL~aYr~~~~~ 253 (1431)
T KOG1240|consen 177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS---QLLAYRSGNAD 253 (1431)
T ss_pred cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH---HHHhHhccCcc
Confidence 1 1122345799999985421 4678899999999999998 68888421 11111100000
Q ss_pred --ccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 005247 653 --RLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMET 688 (706)
Q Consensus 653 --~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~ 688 (706)
...+..--+..+++||..|++.||.+|.++++.++.
T Consensus 254 ~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 254 DPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred CHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 000111124578999999999999999999999875
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.2e-22 Score=221.11 Aligned_cols=225 Identities=27% Similarity=0.387 Sum_probs=187.6
Q ss_pred eccCCceEEEEEEE-----cCCceEEEEEeccccchHHHHHHHHHHHHHHcCC-CCceeEEeccccCCCceEEEEEeccC
Q 005247 441 IGEGSFGTVYHAEW-----RNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGAVTEPPNLSIVTEYLSR 514 (706)
Q Consensus 441 LG~G~fG~Vy~a~~-----~~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~lV~E~~~g 514 (706)
+|+|.||.|+++.- .+.-+|+|+.++.............|..++...+ ||.++++...++.++..++++++..|
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 79999999997732 3444899988665433322224556788888887 99999999999999999999999999
Q ss_pred CchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcccCCC
Q 005247 515 GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKT 594 (706)
Q Consensus 515 gsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 594 (706)
|.|...+... ..+++.....+...++-+++++|+.+ |+|||+|++||+++.+|++++.|||+++..-... .
T Consensus 82 g~lft~l~~~---~~f~~~~~~~~~aelaLald~lh~l~--iiyrd~k~enilld~~Ghi~~tdfglske~v~~~----~ 152 (612)
T KOG0603|consen 82 GDLFTRLSKE---VMFDELDVAFYLAELALALDHLHKLG--IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK----I 152 (612)
T ss_pred chhhhccccC---CchHHHHHHHHHHHHHHHHhhcchhH--HHHhcccccceeecccCccccCCchhhhHhHhhh----h
Confidence 9988777633 34778888888889999999999999 9999999999999999999999999988654432 2
Q ss_pred CCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHHHHhhhh
Q 005247 595 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAE 674 (706)
Q Consensus 595 ~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI~~cL~~ 674 (706)
.|||..|||||++. .....+|+||||++++||++|..||.. +....| ....+.+|..++.++++++.+++.+
T Consensus 153 ~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~I--l~~~~~~p~~l~~~a~~~~~~l~~r 224 (612)
T KOG0603|consen 153 ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRI--LKAELEMPRELSAEARSLFRQLFKR 224 (612)
T ss_pred cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHH--hhhccCCchhhhHHHHHHHHHHHhh
Confidence 29999999999998 667889999999999999999999988 333333 4456788999999999999999999
Q ss_pred CCCCCCCH
Q 005247 675 EPEIRPSF 682 (706)
Q Consensus 675 dP~~RPS~ 682 (706)
+|..|.-.
T Consensus 225 ~p~nrLg~ 232 (612)
T KOG0603|consen 225 NPENRLGA 232 (612)
T ss_pred CHHHHhcc
Confidence 99999644
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.6e-20 Score=194.99 Aligned_cols=196 Identities=25% Similarity=0.381 Sum_probs=148.8
Q ss_pred CCCceeEEeccccC---------------------------CCceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHH
Q 005247 488 RHPNIVLLMGAVTE---------------------------PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAY 540 (706)
Q Consensus 488 ~HpnIv~l~~~~~~---------------------------~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~ 540 (706)
+|||||++.++|.+ +..+|+||..+.. +|.+++-... .......-++.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~----~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH----RSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC----CchHHHHHHHH
Confidence 59999999887732 2347899988754 8999985333 45667778899
Q ss_pred HHHHHHHHHHhcCCCcccccCCCCcEEEC--CC--CcEEEeecCccccCCC-----Cccc-CCCCCCCCCccCccccccC
Q 005247 541 DVAKGMNYLHQRRPPIVHRDLKSPNLLVD--ST--YTVKVCDFGLSRSKPN-----TYIS-SKTAAGTPEWMAPEVLRED 610 (706)
Q Consensus 541 qIl~aL~yLHs~g~~IIHrDLKp~NILl~--~~--~~vKL~DFGla~~~~~-----~~~~-~~~~~Gt~~Y~APE~l~~~ 610 (706)
|+++|+.|||.+| |.|||+|.+|||+. ++ ..+.|+|||++-...+ ++.+ ....-|...-||||+....
T Consensus 349 QlLEav~hL~~hg--vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~ 426 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG--VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV 426 (598)
T ss_pred HHHHHHHHHHHcc--chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence 9999999999999 99999999999993 33 3689999998754322 2222 2234577789999998654
Q ss_pred C------CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHH
Q 005247 611 P------SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPS 684 (706)
Q Consensus 611 ~------~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~e 684 (706)
+ ...|+|.|+.|.+.||++....||+.........+-....+-+.+|+.+++.+++++...|++||.+|++..=
T Consensus 427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~i 506 (598)
T KOG4158|consen 427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNI 506 (598)
T ss_pred CCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccH
Confidence 3 2458999999999999999999998855433333322233446688899999999999999999999998765
Q ss_pred HHHHHH
Q 005247 685 IMETLQ 690 (706)
Q Consensus 685 Il~~L~ 690 (706)
....|+
T Consensus 507 AANvl~ 512 (598)
T KOG4158|consen 507 AANVLN 512 (598)
T ss_pred HHhHHH
Confidence 555443
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=5.4e-20 Score=188.17 Aligned_cols=174 Identities=13% Similarity=0.133 Sum_probs=134.3
Q ss_pred cccCceEEEEEeccCCceEEEEEEEcCCceEEEEEeccccchH-HHHH------HHHHHHHHHcCCCCceeEEeccccCC
Q 005247 430 IRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHED-RFKE------FLREVAIMKGLRHPNIVLLMGAVTEP 502 (706)
Q Consensus 430 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKvl~~~~~~~~-~~~~------~~~Ei~iL~~L~HpnIv~l~~~~~~~ 502 (706)
+-..+|++++.||.|+||.||++...+..+|+|++........ .... +.+|+..+.++.|++|..+.+++...
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 4568999999999999999999887777899999865433222 2223 57899999999999999988875432
Q ss_pred --------CceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcE
Q 005247 503 --------PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTV 574 (706)
Q Consensus 503 --------~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~v 574 (706)
+..+++|||++|.+|.++.. +++ ....+++.+|..||+.| ++|||+||+||+++.+| +
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g--i~H~Dikp~Nili~~~g-i 173 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG--MVSGDPHKGNFIVSKNG-L 173 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC--CccCCCChHHEEEeCCC-E
Confidence 35789999999999988742 222 23558999999999999 99999999999999988 9
Q ss_pred EEeecCccccCCCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHH
Q 005247 575 KVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELI 629 (706)
Q Consensus 575 KL~DFGla~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELl 629 (706)
+|+|||........... ........+..++|+|+||+++.-+.
T Consensus 174 ~liDfg~~~~~~e~~a~------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 174 RIIDLSGKRCTAQRKAK------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEECCCcccccchhhH------------HHHHHHhHhcccccccceeEeehHHH
Confidence 99999987654221100 11334445667899999999987764
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.4e-19 Score=190.36 Aligned_cols=235 Identities=19% Similarity=0.271 Sum_probs=153.8
Q ss_pred CceEEEEEeccCCceEEEEEEEcCC--ceEEEEEecccc-chHHHHHHHHHHHHHHcCCC----------CceeEEeccc
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGLRH----------PNIVLLMGAV 499 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~-~~~~~~~~~~Ei~iL~~L~H----------pnIv~l~~~~ 499 (706)
..+...+.||.|+++.||.+++.++ .+|+|+...... .....+.+.+|.-....+.+ -.++..++..
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~ 91 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL 91 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence 3567889999999999999999875 499998765442 23456777777655555322 1122111111
Q ss_pred ---------cCC---C-----ceEEEEEeccCCchhhhccc----CCCcccccHHHHHHHHHHHHHHHHHHHhcCCCccc
Q 005247 500 ---------TEP---P-----NLSIVTEYLSRGSLYKLLHI----PDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVH 558 (706)
Q Consensus 500 ---------~~~---~-----~~~lV~E~~~ggsL~~~l~~----~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIH 558 (706)
... + +.+++|+-+ .++|.+++.. ......+.......+..|+++.+++||..| +||
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G--lVH 168 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG--LVH 168 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--EEE
T ss_pred EEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc--eEe
Confidence 111 1 235677776 4588777632 111223445556677799999999999999 999
Q ss_pred ccCCCCcEEECCCCcEEEeecCccccCCCCcccCCCCCCCCCccCcccccc--------CCCCchhHHHHHHHHHHHHHh
Q 005247 559 RDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRE--------DPSNEKSDVFSFGVILWELIT 630 (706)
Q Consensus 559 rDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~Gt~~Y~APE~l~~--------~~~s~ksDVwSLGviL~ELlt 630 (706)
+||||+|++++.+|.++|+||+.....+..... ...+..|.+||.... ..++.+.|.|+||+++|.|++
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~---~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC 245 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC---SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC 245 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG---GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCceeec---cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence 999999999999999999999988776654321 344578999997643 246889999999999999999
Q ss_pred CCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHHHHhhhhCCCCC
Q 005247 631 LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIR 679 (706)
Q Consensus 631 G~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI~~cL~~dP~~R 679 (706)
+..||....+...... .+..-.+++..+++||+.+|++||++|
T Consensus 246 ~~lPf~~~~~~~~~~~------~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 246 GRLPFGLSSPEADPEW------DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp SS-STCCCGGGSTSGG------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred ccCCCCCCCccccccc------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 9999987654322211 122222788999999999999999988
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.4e-19 Score=180.94 Aligned_cols=142 Identities=20% Similarity=0.162 Sum_probs=105.5
Q ss_pred EEEeccCCceEEEEEEEc-CCceEEEEEeccccchHH------------------------HHHHHHHHHHHHcCCCCce
Q 005247 438 KKKIGEGSFGTVYHAEWR-NSDVAVKILIEQEFHEDR------------------------FKEFLREVAIMKGLRHPNI 492 (706)
Q Consensus 438 ~~~LG~G~fG~Vy~a~~~-~~~vAVKvl~~~~~~~~~------------------------~~~~~~Ei~iL~~L~HpnI 492 (706)
.+.||+|+||.||+|.+. +..||+|+++........ .....+|+.+++++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 467999999999999875 556999998654321110 1123459999999977665
Q ss_pred eEEeccccCCCceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHH-HhcCCCcccccCCCCcEEECCC
Q 005247 493 VLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL-HQRRPPIVHRDLKSPNLLVDST 571 (706)
Q Consensus 493 v~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yL-Hs~g~~IIHrDLKp~NILl~~~ 571 (706)
.....+.. ...++||||+.++++...... ...++...+..++.|++.+|.+| |+.| |+||||||+|||++ +
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~---~~~~~~~~~~~i~~qi~~~L~~l~H~~g--iiHrDlkP~NIli~-~ 153 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK---DAPLSESKARELYLQVIQIMRILYQDCR--LVHADLSEYNLLYH-D 153 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhh---cCCCCHHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEE-C
Confidence 33222211 223899999998776544321 13578899999999999999999 7999 99999999999998 4
Q ss_pred CcEEEeecCccccCCC
Q 005247 572 YTVKVCDFGLSRSKPN 587 (706)
Q Consensus 572 ~~vKL~DFGla~~~~~ 587 (706)
+.++|+|||+|.....
T Consensus 154 ~~v~LiDFG~a~~~~~ 169 (190)
T cd05147 154 GKLYIIDVSQSVEHDH 169 (190)
T ss_pred CcEEEEEccccccCCC
Confidence 7899999999875433
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.9e-19 Score=176.65 Aligned_cols=188 Identities=16% Similarity=0.165 Sum_probs=141.9
Q ss_pred EEEEEeccCCceEEEEEEEcCCceEEEEEeccccchH--HHHHHHHHHHHHHcCC-CCceeEEeccccCCCceEEEEEec
Q 005247 436 LIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHED--RFKEFLREVAIMKGLR-HPNIVLLMGAVTEPPNLSIVTEYL 512 (706)
Q Consensus 436 ~i~~~LG~G~fG~Vy~a~~~~~~vAVKvl~~~~~~~~--~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~lV~E~~ 512 (706)
.+...|++|+||+||.+...+.+++.+.+........ ....+.+|+++|++|. |++|++++++ +..+++|||+
T Consensus 5 ~~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred ccceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 3577899999999999887777777776655443222 2235789999999995 5889999886 4469999999
Q ss_pred cCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccC-CCCcEEECCCCcEEEeecCccccCCCCccc
Q 005247 513 SRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDL-KSPNLLVDSTYTVKVCDFGLSRSKPNTYIS 591 (706)
Q Consensus 513 ~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDL-Kp~NILl~~~~~vKL~DFGla~~~~~~~~~ 591 (706)
.|.+|...+.. ....++.|++.+|.++|++| |+|||| ||+|||++.++.++|+|||++.........
T Consensus 81 ~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~G--IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~ 148 (218)
T PRK12274 81 AGAAMYQRPPR----------GDLAYFRAARRLLQQLHRCG--VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW 148 (218)
T ss_pred cCccHHhhhhh----------hhHHHHHHHHHHHHHHHHCc--CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence 99888654321 11347789999999999999 999999 799999999999999999999865432210
Q ss_pred -------------CCCCCCCCCccCccccccC-CCC-chhHHHHHHHHHHHHHhCCCCCCCCC
Q 005247 592 -------------SKTAAGTPEWMAPEVLRED-PSN-EKSDVFSFGVILWELITLQKPWRNST 639 (706)
Q Consensus 592 -------------~~~~~Gt~~Y~APE~l~~~-~~s-~ksDVwSLGviL~ELltG~~Pf~~~~ 639 (706)
..-..+++.|++|+...-. ..+ ...++++-|+.+|.++|++.|..+.+
T Consensus 149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 0012368888888875433 222 46789999999999999998865543
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=8.7e-19 Score=174.83 Aligned_cols=141 Identities=21% Similarity=0.194 Sum_probs=107.8
Q ss_pred EEEeccCCceEEEEEEEc-CCceEEEEEeccccch------------------------HHHHHHHHHHHHHHcCCCCce
Q 005247 438 KKKIGEGSFGTVYHAEWR-NSDVAVKILIEQEFHE------------------------DRFKEFLREVAIMKGLRHPNI 492 (706)
Q Consensus 438 ~~~LG~G~fG~Vy~a~~~-~~~vAVKvl~~~~~~~------------------------~~~~~~~~Ei~iL~~L~HpnI 492 (706)
.+.||+|+||.||+|.+. +..||||++....... .....+.+|...+.++.|++|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 468999999999999875 6679999987642110 001234578999999988877
Q ss_pred eEEeccccCCCceEEEEEeccCCchhhh-cccCCCcccccHHHHHHHHHHHHHHHHHHHh-cCCCcccccCCCCcEEECC
Q 005247 493 VLLMGAVTEPPNLSIVTEYLSRGSLYKL-LHIPDARVVVDERLRLNMAYDVAKGMNYLHQ-RRPPIVHRDLKSPNLLVDS 570 (706)
Q Consensus 493 v~l~~~~~~~~~~~lV~E~~~ggsL~~~-l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs-~g~~IIHrDLKp~NILl~~ 570 (706)
.....+... ..++||||++|+++... +. ...++...+..++.|++.++.+||+ +| |+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~----~~~~~~~~~~~i~~~l~~~l~~lH~~~g--ivHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLK----DVPLEEEEAEELYEQVVEQMRRLYQEAG--LVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhh----hccCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCChhhEEEE-
Confidence 433333222 24899999998755433 32 1246778899999999999999999 99 99999999999998
Q ss_pred CCcEEEeecCccccCCC
Q 005247 571 TYTVKVCDFGLSRSKPN 587 (706)
Q Consensus 571 ~~~vKL~DFGla~~~~~ 587 (706)
++.++|+|||++.....
T Consensus 153 ~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 DGKPYIIDVSQAVELDH 169 (190)
T ss_pred CCCEEEEEcccceecCC
Confidence 78999999999886544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.3e-17 Score=197.43 Aligned_cols=249 Identities=23% Similarity=0.294 Sum_probs=186.3
Q ss_pred ccCcccccCceEEEEEeccCCceEEEEEEEcCC-ceEEEEEeccccchHHHHHHHHHHHHHHcCC---CCceeEEecccc
Q 005247 425 EEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLR---HPNIVLLMGAVT 500 (706)
Q Consensus 425 ~~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~-~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~---HpnIv~l~~~~~ 500 (706)
....++....|.|.+.||+|+||+||+|...+. .||+|+-+.....+-. --.+++.+|+ -+.|..+..+..
T Consensus 690 ~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfY-----I~~q~~~RLk~~~~~~~~~~~~a~~ 764 (974)
T KOG1166|consen 690 NTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFY-----ICLQVMERLKPQMLPSIMHISSAHV 764 (974)
T ss_pred cceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeee-----ehHHHHHhhchhhhcchHHHHHHHc
Confidence 445677888999999999999999999987654 4999997665443211 1123344444 244555666666
Q ss_pred CCCceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECC-------CCc
Q 005247 501 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS-------TYT 573 (706)
Q Consensus 501 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~-------~~~ 573 (706)
-.+..++|+||.+-|+|.+++. ....+++..+..++.|++..++.||..+ |||+||||+|+||.. +.-
T Consensus 765 ~~~~S~lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~--IIHgDiKPDNfll~~~~~~~~~~~~ 839 (974)
T KOG1166|consen 765 FQNASVLVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG--IIHGDIKPDNFLLRREICADSDSKG 839 (974)
T ss_pred cCCcceeeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc--eecccCCcceeEeecccCCCCcccc
Confidence 6777899999999999999997 3446899999999999999999999999 999999999999942 335
Q ss_pred EEEeecCcccc---CCCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhc
Q 005247 574 VKVCDFGLSRS---KPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK 650 (706)
Q Consensus 574 vKL~DFGla~~---~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~ 650 (706)
++|+|||.+.- .++.. .....++|-.+-.+|...|..++...|.|.|+.+++-||.|++-= ...
T Consensus 840 l~lIDfG~siDm~lfp~~~-~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q------------~~~ 906 (974)
T KOG1166|consen 840 LYLIDFGRSIDMKLFPDGT-KFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME------------VKN 906 (974)
T ss_pred eEEEecccceeeeEcCCCc-EEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH------------hcC
Confidence 99999998853 33331 234557888999999999999999999999999999999996410 112
Q ss_pred CcccC----CCCCCc-HHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhc
Q 005247 651 GRRLE----IPKNVN-PMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 696 (706)
Q Consensus 651 ~~~l~----~p~~~s-~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~ 696 (706)
+.... ++..+. ....+|+..+|+.|-..=|...+|...|+..+.+.
T Consensus 907 g~~~~~~~~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~~ 957 (974)
T KOG1166|consen 907 GSSWMVKTNFPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAEH 957 (974)
T ss_pred CcceeccccchhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHHH
Confidence 22222 223222 34577888889844444488888888888877654
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.7e-19 Score=205.88 Aligned_cols=204 Identities=32% Similarity=0.475 Sum_probs=152.4
Q ss_pred CceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEE
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 510 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E 510 (706)
.+|..++.|-.|+||.||.++++. ..+|+|+ .++.. +++- ++....+|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l-------ilRn--ilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL-------ILRN--ILTFAGNPFVV----------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhcc-cccch-------hhhc--cccccCCccee-----------------
Confidence 578899999999999999998874 4588854 22221 1111 33333444444
Q ss_pred eccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCC---
Q 005247 511 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN--- 587 (706)
Q Consensus 511 ~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~--- 587 (706)
|+=..+++..+ .++. +++.+++|||+.+ |+|||+||+|.+|+.-|++|++|||++....-
T Consensus 136 ----gDc~tllk~~g---~lPv--------dmvla~Eylh~yg--ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 ----GDCATLLKNIG---PLPV--------DMVLAVEYLHSYG--IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred ----chhhhhcccCC---CCcc--------hhhHHhHhhccCC--eecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence 23333343222 2332 2378999999999 99999999999999999999999999864211
Q ss_pred -----Ccc-------cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhc-Cccc
Q 005247 588 -----TYI-------SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-GRRL 654 (706)
Q Consensus 588 -----~~~-------~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~-~~~l 654 (706)
.++ .....+||+.|.|||++....|...+|+|++|+|+||++.|+.||.+.++++.+..+.-. ...+
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wp 278 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP 278 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccc
Confidence 111 123358999999999999999999999999999999999999999999999988776321 2223
Q ss_pred CCCCCCcHHHHHHHHHhhhhCCCCCC
Q 005247 655 EIPKNVNPMVAALIETCWAEEPEIRP 680 (706)
Q Consensus 655 ~~p~~~s~el~dLI~~cL~~dP~~RP 680 (706)
+-.+.++++++++|.++|..+|..|.
T Consensus 279 E~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 279 EEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred ccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 33456789999999999999999994
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.5e-17 Score=167.19 Aligned_cols=131 Identities=21% Similarity=0.286 Sum_probs=101.6
Q ss_pred EEEeccCCceEEEEEEEcCC-ceEEEEEeccccchHHHHHHHHHHHHHHcC-----CCCceeEEeccccCCC---c-eEE
Q 005247 438 KKKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGL-----RHPNIVLLMGAVTEPP---N-LSI 507 (706)
Q Consensus 438 ~~~LG~G~fG~Vy~a~~~~~-~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L-----~HpnIv~l~~~~~~~~---~-~~l 507 (706)
.+.||+|+||.||. +... ..+||++..... ...+.+.+|+.+++.+ .||||+++++++.++. . +.+
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~--~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGD--GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred cceecCCCceEEEE--CCCCcCeEEEEEecccc--chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 46899999999996 4333 257888755322 2346789999999999 5799999999998763 3 347
Q ss_pred EEEe--ccCCchhhhcccCCCcccccHHHHHHHHHHHHHHH-HHHHhcCCCcccccCCCCcEEECC----CCcEEEeecC
Q 005247 508 VTEY--LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM-NYLHQRRPPIVHRDLKSPNLLVDS----TYTVKVCDFG 580 (706)
Q Consensus 508 V~E~--~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL-~yLHs~g~~IIHrDLKp~NILl~~----~~~vKL~DFG 580 (706)
|+|| +.+++|.++++.. .+++. ..++.|++.++ +|||+++ ||||||||+|||++. ++.++|+||+
T Consensus 83 I~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~~--IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDNR--IVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred EecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 8999 5579999999642 25554 35577888777 9999999 999999999999974 3379999944
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.5e-17 Score=185.45 Aligned_cols=208 Identities=33% Similarity=0.567 Sum_probs=164.6
Q ss_pred HHcCCCCceeEEeccccCCCceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCc-ccccCC
Q 005247 484 MKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI-VHRDLK 562 (706)
Q Consensus 484 L~~L~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~I-IHrDLK 562 (706)
|+.+.|.|+.++++.+.++...++|.+||..|+|.+.+... ...++..-...++++|+.||+|||.-- | .|+.++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~--~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE--DIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc--ccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence 45688999999999999999999999999999999999753 335788888899999999999999865 4 999999
Q ss_pred CCcEEECCCCcEEEeecCccccCCCC--cccCCCCCCCCCccCccccccCC-------CCchhHHHHHHHHHHHHHhCCC
Q 005247 563 SPNLLVDSTYTVKVCDFGLSRSKPNT--YISSKTAAGTPEWMAPEVLREDP-------SNEKSDVFSFGVILWELITLQK 633 (706)
Q Consensus 563 p~NILl~~~~~vKL~DFGla~~~~~~--~~~~~~~~Gt~~Y~APE~l~~~~-------~s~ksDVwSLGviL~ELltG~~ 633 (706)
+.|++++....+||+|||+....... ........-..-|.|||.+.... .+.+.||||||++++|+++...
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 99999999999999999997765321 11111222345699999997642 3667999999999999999999
Q ss_pred CCCCC----ChHHHHHHhhhcCcc---cCCC--CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHh
Q 005247 634 PWRNS----TPSQVISAVGFKGRR---LEIP--KNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS 695 (706)
Q Consensus 634 Pf~~~----~~~~~~~~i~~~~~~---l~~p--~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s 695 (706)
||... .+.++...+...... +.++ ....+++..++..||..+|++||+++++...++.+...
T Consensus 157 ~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 157 PFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred ccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 99762 333455554431222 2222 14556899999999999999999999999999888765
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=7.3e-17 Score=162.31 Aligned_cols=136 Identities=24% Similarity=0.386 Sum_probs=112.8
Q ss_pred EEeccCCceEEEEEEEcCCceEEEEEeccccchH------HHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEEec
Q 005247 439 KKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHED------RFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYL 512 (706)
Q Consensus 439 ~~LG~G~fG~Vy~a~~~~~~vAVKvl~~~~~~~~------~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~~ 512 (706)
+.||+|++|.||+|.+.+..+++|+......... ....+.+|+.++..+.|++|.....++...+..+++|||+
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 5789999999999999888899998754332211 1245778999999999988876666666667789999999
Q ss_pred cCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCcccc
Q 005247 513 SRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 584 (706)
Q Consensus 513 ~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~ 584 (706)
+|++|.+++.... . ....++.+++.+|.+||+.+ ++|||++|.|||++ ++.++|+|||.+..
T Consensus 82 ~G~~L~~~~~~~~------~-~~~~i~~~i~~~l~~lH~~~--i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 82 EGEPLKDLINSNG------M-EELELSREIGRLVGKLHSAG--IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CCcCHHHHHHhcc------H-HHHHHHHHHHHHHHHHHhCC--cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999885321 1 77889999999999999999 99999999999998 78899999998764
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.69 E-value=8.7e-17 Score=160.45 Aligned_cols=133 Identities=20% Similarity=0.344 Sum_probs=106.7
Q ss_pred EeccCCceEEEEEEEcCCceEEEEEeccccch------HHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEEecc
Q 005247 440 KIGEGSFGTVYHAEWRNSDVAVKILIEQEFHE------DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLS 513 (706)
Q Consensus 440 ~LG~G~fG~Vy~a~~~~~~vAVKvl~~~~~~~------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~~~ 513 (706)
.||+|+||.||++...+.++++|+........ .....+.+|+++++.+.|+++.....++...+..+++|||++
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~ 80 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE 80 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence 37999999999999888889999875443221 123567789999999988765544444445566799999999
Q ss_pred CCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccC
Q 005247 514 RGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK 585 (706)
Q Consensus 514 ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~ 585 (706)
|++|.+++.... . .++.+++.+|.+||+.| ++|||++|.||+++ ++.++++|||++...
T Consensus 81 g~~l~~~~~~~~----~------~~~~~i~~~l~~lH~~g--i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 81 GKPLKDVIEEGN----D------ELLREIGRLVGKLHKAG--IVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CccHHHHHhhcH----H------HHHHHHHHHHHHHHHCC--eecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 999998875221 0 78899999999999999 99999999999998 789999999988753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.67 E-value=3e-16 Score=180.70 Aligned_cols=136 Identities=22% Similarity=0.331 Sum_probs=113.0
Q ss_pred eEEEEEeccCCceEEEEEEEcCCceEEEEEeccccch------HHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEE
Q 005247 435 LLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHE------DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIV 508 (706)
Q Consensus 435 y~i~~~LG~G~fG~Vy~a~~~~~~vAVKvl~~~~~~~------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV 508 (706)
|...+.||+|+||+||++.+.+..+++|+........ ...+.+.+|+++++.++|++++....++......++|
T Consensus 335 ~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv 414 (535)
T PRK09605 335 KIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIV 414 (535)
T ss_pred cCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEE
Confidence 3557889999999999999888887777654332211 1235688999999999999998877777667778999
Q ss_pred EEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCcccc
Q 005247 509 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 584 (706)
Q Consensus 509 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~ 584 (706)
|||+++++|.+++. ....++.+++.+|.+||+.+ ++||||||+|||+ .++.++|+|||+++.
T Consensus 415 ~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g--iiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 415 MEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG--IVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC--CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999999998774 34678899999999999999 9999999999999 677899999999875
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.66 E-value=4.9e-17 Score=178.67 Aligned_cols=171 Identities=25% Similarity=0.375 Sum_probs=130.9
Q ss_pred ceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccc
Q 005247 504 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 583 (706)
Q Consensus 504 ~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~ 583 (706)
+++|.|++|...+|.+++.........+....+.++.|++.|++| ++ .+|+|+||.||+...+..+||.|||+..
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~--~ihrdlkp~nif~~~d~q~kIgDFgl~t 404 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG--LIHRDLKPSNIFFSDDDQLKIGDFGLVT 404 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc--chhhhccccccccccchhhhhhhhhhee
Confidence 578999999999999999755555567788899999999999999 77 9999999999999999999999999987
Q ss_pred cCCCCc------ccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCC
Q 005247 584 SKPNTY------ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEI 656 (706)
Q Consensus 584 ~~~~~~------~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~ 656 (706)
...... ...+...||..||+||++.+..|+.|+|||+||+||+|+++ -..+|..... ...+.....+..+
T Consensus 405 s~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t---~~d~r~g~ip~~~ 481 (516)
T KOG1033|consen 405 SQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIAT---LTDIRDGIIPPEF 481 (516)
T ss_pred ecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHh---hhhhhcCCCChHH
Confidence 655432 23456689999999999999999999999999999999997 3333322111 0111111111112
Q ss_pred CCCCcHHHHHHHHHhhhhCCCCCCCHH
Q 005247 657 PKNVNPMVAALIETCWAEEPEIRPSFP 683 (706)
Q Consensus 657 p~~~s~el~dLI~~cL~~dP~~RPS~~ 683 (706)
..+. ++-+.|+.++|.+.|.+||++.
T Consensus 482 ~~d~-p~e~~ll~~lls~~p~~RP~~~ 507 (516)
T KOG1033|consen 482 LQDY-PEEYTLLQQLLSPSPEERPSAI 507 (516)
T ss_pred hhcC-cHHHHHHHHhcCCCcccCchHH
Confidence 1222 4557899999999999999443
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.66 E-value=4e-16 Score=161.36 Aligned_cols=146 Identities=21% Similarity=0.154 Sum_probs=110.1
Q ss_pred CceEEEEEeccCCceEEEEEE-E--cCCceEEEEEeccccch----------------------HHHHHHHHHHHHHHcC
Q 005247 433 SELLIKKKIGEGSFGTVYHAE-W--RNSDVAVKILIEQEFHE----------------------DRFKEFLREVAIMKGL 487 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~-~--~~~~vAVKvl~~~~~~~----------------------~~~~~~~~Ei~iL~~L 487 (706)
.-|.+.+.||+|+||.||+|. + .+..||+|++....... .....+.+|+.+++++
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 357889999999999999998 3 45669999986543110 0112456899999999
Q ss_pred CCC--ceeEEeccccCCCceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCc
Q 005247 488 RHP--NIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPN 565 (706)
Q Consensus 488 ~Hp--nIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~N 565 (706)
.+. .+.++++. ...++||||+.+++|...... ........+..++.|++.+|.+||++| .|+||||||+|
T Consensus 108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~g-~iiH~Dikp~N 179 (237)
T smart00090 108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK---DVEPEEEEEFELYDDILEEMRKLYKEG-ELVHGDLSEYN 179 (237)
T ss_pred HhcCCCCCeeeEe----cCceEEEEEecCCcccccccc---cCCcchHHHHHHHHHHHHHHHHHHhcC-CEEeCCCChhh
Confidence 753 34444443 235899999999888765421 123556667889999999999999987 49999999999
Q ss_pred EEECCCCcEEEeecCccccCCC
Q 005247 566 LLVDSTYTVKVCDFGLSRSKPN 587 (706)
Q Consensus 566 ILl~~~~~vKL~DFGla~~~~~ 587 (706)
|+++ ++.++|+|||.+.....
T Consensus 180 Ili~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 180 ILVH-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred EEEE-CCCEEEEEChhhhccCC
Confidence 9998 78999999998875444
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.64 E-value=8e-16 Score=154.11 Aligned_cols=139 Identities=20% Similarity=0.178 Sum_probs=106.8
Q ss_pred ceEEEEEeccCCceEEEEEEEc-CCceEEEEEeccccch--------------------HHHHHHHHHHHHHHcCCCCc-
Q 005247 434 ELLIKKKIGEGSFGTVYHAEWR-NSDVAVKILIEQEFHE--------------------DRFKEFLREVAIMKGLRHPN- 491 (706)
Q Consensus 434 ~y~i~~~LG~G~fG~Vy~a~~~-~~~vAVKvl~~~~~~~--------------------~~~~~~~~Ei~iL~~L~Hpn- 491 (706)
.|.+.+.||+|+||.||++.+. +..+|||++....... .....+.+|+.++..+.|++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 3677889999999999999874 5669999875432110 01123667889998887763
Q ss_pred -eeEEeccccCCCceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECC
Q 005247 492 -IVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS 570 (706)
Q Consensus 492 -Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~ 570 (706)
++..++. ...++||||++|++|..+... .....++.+++.++.++|+.| |+||||||+||+++.
T Consensus 96 ~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~g--i~H~Dl~p~Nill~~ 160 (198)
T cd05144 96 PVPKPIDW----NRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHG--IIHGDLSEFNILVDD 160 (198)
T ss_pred CCCceeec----CCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCC--CCcCCCCcccEEEcC
Confidence 4444432 345899999999998765431 235678899999999999999 999999999999999
Q ss_pred CCcEEEeecCccccCCC
Q 005247 571 TYTVKVCDFGLSRSKPN 587 (706)
Q Consensus 571 ~~~vKL~DFGla~~~~~ 587 (706)
++.++|+|||.+.....
T Consensus 161 ~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 161 DEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CCcEEEEECCccccCCC
Confidence 99999999999865543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.61 E-value=5.4e-17 Score=187.88 Aligned_cols=252 Identities=25% Similarity=0.362 Sum_probs=195.4
Q ss_pred cCceEEEEEeccCCceEEEEEEEcCCc---eEEEEEeccccchHHHHHHHHHHHHHHcCC-CCceeEEeccccCCCceEE
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRNSD---VAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGAVTEPPNLSI 507 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~---vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~l 507 (706)
...|.+.+.||+|.|+.|-.....+.. +|+|.+..........+....|..+-+.+. |.|++.+++...+...+++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 345677788999999999988664332 555554333323344455666888888887 9999999999999999999
Q ss_pred EEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHH-hcCCCcccccCCCCcEEECCCC-cEEEeecCccccC
Q 005247 508 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLH-QRRPPIVHRDLKSPNLLVDSTY-TVKVCDFGLSRSK 585 (706)
Q Consensus 508 V~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLH-s~g~~IIHrDLKp~NILl~~~~-~vKL~DFGla~~~ 585 (706)
++++..|+++.+.+.... ....+...+..++.|+..++.|+| ..+ +.|+||||+|.+++..+ ..++.|||+|...
T Consensus 99 ~~~~s~g~~~f~~i~~~~-~~~~~~~~~~~~~~ql~s~l~~~H~~~~--~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPD-STGTSSSSASRYLPQLNSGLSYLHPENG--VTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred ccCcccccccccccccCC-ccCCCCcchhhhhhhhccCccccCcccc--cccCCCCCccchhccCCCcccCCCchhhccc
Confidence 999999999988883121 113566677789999999999999 888 99999999999999999 9999999999875
Q ss_pred CC---CcccCCCCCC-CCCccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCc----ccCC
Q 005247 586 PN---TYISSKTAAG-TPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR----RLEI 656 (706)
Q Consensus 586 ~~---~~~~~~~~~G-t~~Y~APE~l~~~-~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~----~l~~ 656 (706)
.. ........+| ++.|+|||...+. ......|+||.|+++..+++|..||...........- +... ....
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~ 254 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSS-WKSNKGRFTQLP 254 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccccee-ecccccccccCc
Confidence 54 2223345678 9999999999885 4567889999999999999999999765443322111 1111 2445
Q ss_pred CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 657 PKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 657 p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
...++....+++.+++..+|..|.+.+++..
T Consensus 255 ~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 255 WNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred cccCChhhhhcccccccCCchhccccccccc
Confidence 5678899999999999999999999887743
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.1e-14 Score=135.87 Aligned_cols=134 Identities=22% Similarity=0.233 Sum_probs=112.0
Q ss_pred EEEEeccCCceEEEEEEEcCCceEEEEEeccccchHHHHHHHHHHHHHHcCCC--CceeEEeccccCCCceEEEEEeccC
Q 005247 437 IKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRH--PNIVLLMGAVTEPPNLSIVTEYLSR 514 (706)
Q Consensus 437 i~~~LG~G~fG~Vy~a~~~~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~H--pnIv~l~~~~~~~~~~~lV~E~~~g 514 (706)
+++.||+|.++.||++...+..+++|....... ...+.+|+.+++.+.| .++++++.+....+..+++|||+.+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g 77 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG 77 (155)
T ss_pred cceecccccccceEEEEecCCeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence 457899999999999998887899998754432 3578889999999976 5889999888888889999999998
Q ss_pred CchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcC-CCcccccCCCCcEEECCCCcEEEeecCcccc
Q 005247 515 GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR-PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 584 (706)
Q Consensus 515 gsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g-~~IIHrDLKp~NILl~~~~~vKL~DFGla~~ 584 (706)
+.+..+ +......++.+++++|++||... .+++|+|++|+||++++.+.++++|||.++.
T Consensus 78 ~~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 78 ETLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred eecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 777654 34556678899999999999852 2399999999999999989999999998764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.58 E-value=6.6e-15 Score=145.25 Aligned_cols=138 Identities=22% Similarity=0.142 Sum_probs=96.9
Q ss_pred EEEeccCCceEEEEEEEc-CCceEEEEEeccccchHHHHH----------------------HHHHHHHHHcCCCC--ce
Q 005247 438 KKKIGEGSFGTVYHAEWR-NSDVAVKILIEQEFHEDRFKE----------------------FLREVAIMKGLRHP--NI 492 (706)
Q Consensus 438 ~~~LG~G~fG~Vy~a~~~-~~~vAVKvl~~~~~~~~~~~~----------------------~~~Ei~iL~~L~Hp--nI 492 (706)
.+.||+|+||.||+|.+. +..||||++............ ...|...+..+.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 467999999999999877 556999998654322211111 13456666655433 23
Q ss_pred eEEeccccCCCceEEEEEeccCCchhhh-cccCCCcccccHHHHHHHHHHHHHHHHHHHh-cCCCcccccCCCCcEEECC
Q 005247 493 VLLMGAVTEPPNLSIVTEYLSRGSLYKL-LHIPDARVVVDERLRLNMAYDVAKGMNYLHQ-RRPPIVHRDLKSPNLLVDS 570 (706)
Q Consensus 493 v~l~~~~~~~~~~~lV~E~~~ggsL~~~-l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs-~g~~IIHrDLKp~NILl~~ 570 (706)
.+.+++ ...++||||++++.+... +... .....+..++.+++.++.++|. .+ |+||||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-----~~~~~~~~~~~~~~~~l~~lh~~~~--ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-----RLLEDPEELYDQILELMRKLYREAG--LVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh-----hhcccHHHHHHHHHHHHHHHhhccC--cCcCCCChhhEEEE-
Confidence 444433 235899999998554321 1110 0115678899999999999999 88 99999999999999
Q ss_pred CCcEEEeecCccccCCC
Q 005247 571 TYTVKVCDFGLSRSKPN 587 (706)
Q Consensus 571 ~~~vKL~DFGla~~~~~ 587 (706)
++.++|+|||.+.....
T Consensus 150 ~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 150 DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred CCcEEEEECcccccccC
Confidence 88999999999875443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.54 E-value=4.7e-14 Score=146.19 Aligned_cols=136 Identities=15% Similarity=0.176 Sum_probs=104.0
Q ss_pred EEec-cCCceEEEEEEEcCCceEEEEEecccc-----------chHHHHHHHHHHHHHHcCCCCce--eEEeccccCC-C
Q 005247 439 KKIG-EGSFGTVYHAEWRNSDVAVKILIEQEF-----------HEDRFKEFLREVAIMKGLRHPNI--VLLMGAVTEP-P 503 (706)
Q Consensus 439 ~~LG-~G~fG~Vy~a~~~~~~vAVKvl~~~~~-----------~~~~~~~~~~Ei~iL~~L~HpnI--v~l~~~~~~~-~ 503 (706)
..|| .||.|+||.++..+..++||....... .......+.+|+.++..|.|++| +..+++.... .
T Consensus 37 ~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~ 116 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG 116 (239)
T ss_pred ceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence 4677 888899999988888899998754221 11233567889999999988774 6666654332 2
Q ss_pred c---eEEEEEeccC-CchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeec
Q 005247 504 N---LSIVTEYLSR-GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDF 579 (706)
Q Consensus 504 ~---~~lV~E~~~g-gsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DF 579 (706)
. .++|||+++| .+|.+++... .+++. .+.+|+.+|.+||++| |+||||||+|||++.++.++|+||
T Consensus 117 ~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~----~~~~i~~~l~~lH~~G--I~HrDlkp~NILv~~~~~v~LIDf 186 (239)
T PRK01723 117 LFYRADILIERIEGARDLVALLQEA----PLSEE----QWQAIGQLIARFHDAG--VYHADLNAHNILLDPDGKFWLIDF 186 (239)
T ss_pred cceeeeEEEEecCCCCCHHHHHhcC----CCCHH----HHHHHHHHHHHHHHCC--CCCCCCCchhEEEcCCCCEEEEEC
Confidence 2 3599999997 6888887532 23433 3568999999999999 999999999999998889999999
Q ss_pred Ccccc
Q 005247 580 GLSRS 584 (706)
Q Consensus 580 Gla~~ 584 (706)
|.++.
T Consensus 187 g~~~~ 191 (239)
T PRK01723 187 DRGEL 191 (239)
T ss_pred CCccc
Confidence 98765
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.39 E-value=7.4e-13 Score=148.30 Aligned_cols=251 Identities=24% Similarity=0.215 Sum_probs=186.7
Q ss_pred cccccCceEEEEEecc--CCceEEEEEEE--cC--CceEEEEEeccccchHHHHHHHHHHHHHHcCC-CCceeEEecccc
Q 005247 428 LEIRWSELLIKKKIGE--GSFGTVYHAEW--RN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGAVT 500 (706)
Q Consensus 428 ~~i~~~~y~i~~~LG~--G~fG~Vy~a~~--~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~ 500 (706)
.+..-..+.+.+.+|. |.+|.||.+.. .. ..+|+|.-+.....+.....=.+|+...+.++ |+|.++.+..+.
T Consensus 109 ~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e 188 (524)
T KOG0601|consen 109 DSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWE 188 (524)
T ss_pred cchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccc
Confidence 3444455677889999 99999999876 32 33777763332222222234456777777775 999999999999
Q ss_pred CCCceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHH----HHHHHHhcCCCcccccCCCCcEEECCC-CcEE
Q 005247 501 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAK----GMNYLHQRRPPIVHRDLKSPNLLVDST-YTVK 575 (706)
Q Consensus 501 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~----aL~yLHs~g~~IIHrDLKp~NILl~~~-~~vK 575 (706)
..+..++-+|++. .+|..+.+.. ...++...++.+..+... ||.++|+.+ ++|-|+||+||++..+ ...+
T Consensus 189 ~~~~lfiqtE~~~-~sl~~~~~~~--~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~--~~~~~~kp~~i~~~~~~~s~~ 263 (524)
T KOG0601|consen 189 GSGILFIQTELCG-ESLQSYCHTP--CNFLPDNLLWNSLRDWLSRDVTALSHLHSNN--IVHDDLKPANIFTTSDWTSCK 263 (524)
T ss_pred cCCcceeeecccc-chhHHhhhcc--cccCCchhhhhHHhhhhhcccccccccCCCc--ccccccchhheecccccceee
Confidence 9999999999985 6777776532 234788899999999999 999999999 9999999999999998 8899
Q ss_pred EeecCccccCCCCcccCCCC-----CCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC--ChHHHHHHhh
Q 005247 576 VCDFGLSRSKPNTYISSKTA-----AGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNS--TPSQVISAVG 648 (706)
Q Consensus 576 L~DFGla~~~~~~~~~~~~~-----~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~--~~~~~~~~i~ 648 (706)
++|||+.....+........ .|...|++||...+ .++..+|+|++|.++.+-.++..+.... ..... +.
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~---~r 339 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ---LR 339 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCCccc---cc
Confidence 99999998776654333222 68889999998754 4778999999999999999886554332 11111 11
Q ss_pred hcCcccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 649 FKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 649 ~~~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
....+.++-...+..+...+..|++.+|..|+++..+..
T Consensus 340 ~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred cccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 111233344455677788999999999999999887654
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.30 E-value=2.3e-12 Score=134.64 Aligned_cols=201 Identities=21% Similarity=0.349 Sum_probs=140.7
Q ss_pred HHHcCCCCceeEEeccccCCC-----ceEEEEEeccCCchhhhcccCC-CcccccHHHHHHHHHHHHHHHHHHHhcCCCc
Q 005247 483 IMKGLRHPNIVLLMGAVTEPP-----NLSIVTEYLSRGSLYKLLHIPD-ARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 556 (706)
Q Consensus 483 iL~~L~HpnIv~l~~~~~~~~-----~~~lV~E~~~ggsL~~~l~~~~-~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~I 556 (706)
.+-.+.|.|||+++.+|.+.. ...++.||++.|++..+|+.-. ....+......+|+.||+.||.|||+..|+|
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppi 199 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPI 199 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcc
Confidence 344556999999999986544 3678999999999999996422 2335677888899999999999999999999
Q ss_pred ccccCCCCcEEECCCCcEEEeecCccccCCC---C-cccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCC
Q 005247 557 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN---T-YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQ 632 (706)
Q Consensus 557 IHrDLKp~NILl~~~~~vKL~DFGla~~~~~---~-~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~ 632 (706)
+|+++..+-|++..+|-+||.----...-.. . ........+-++|.+||.=.....+.++|||+||....||..+.
T Consensus 200 ihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailE 279 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILE 279 (458)
T ss_pred ccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhe
Confidence 9999999999999999888853111100000 0 00112234678899999877777788999999999999998875
Q ss_pred CC-CCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 005247 633 KP-WRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMET 688 (706)
Q Consensus 633 ~P-f~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~ 688 (706)
.- =......+....+. ...+.. -...-+.+|.+|++..|..||++++++..
T Consensus 280 iq~tnseS~~~~ee~ia--~~i~~l---en~lqr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 280 IQSTNSESKVEVEENIA--NVIIGL---ENGLQRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred eccCCCcceeehhhhhh--hheeec---cCccccCcCcccccCCCCCCcchhhhhcC
Confidence 43 22211111111111 000000 11223668999999999999999988753
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.27 E-value=1.5e-11 Score=119.08 Aligned_cols=130 Identities=18% Similarity=0.094 Sum_probs=95.3
Q ss_pred EEEeccCCceEEEEEEEcCCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCce-eEEeccccCCCceEEEEEeccCCc
Q 005247 438 KKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNI-VLLMGAVTEPPNLSIVTEYLSRGS 516 (706)
Q Consensus 438 ~~~LG~G~fG~Vy~a~~~~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnI-v~l~~~~~~~~~~~lV~E~~~ggs 516 (706)
++.|+.|.++.||+++..+..+++|+...... ....+..|+.+++.+.+.++ .+++.+.. ...++||||++|.+
T Consensus 3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~ 77 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSE 77 (170)
T ss_pred eeecCCcccCceEEEEECCeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCc
Confidence 56789999999999998888899998644321 11245678888888754443 44554433 23579999999988
Q ss_pred hhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCC---CcccccCCCCcEEECCCCcEEEeecCcccc
Q 005247 517 LYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP---PIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 584 (706)
Q Consensus 517 L~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~---~IIHrDLKp~NILl~~~~~vKL~DFGla~~ 584 (706)
+.... . ....++.+++++|+.||+.+. .++|+|++|.||+++ ++.++++|||.+..
T Consensus 78 l~~~~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 78 LLTED--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccccc--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 76430 0 112356789999999999871 249999999999998 66899999997653
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.23 E-value=4.3e-11 Score=134.58 Aligned_cols=140 Identities=21% Similarity=0.260 Sum_probs=95.5
Q ss_pred EEeccCCceEEEEEEEc-CCceEEEEEeccccch----------------------------HHH----------HHHHH
Q 005247 439 KKIGEGSFGTVYHAEWR-NSDVAVKILIEQEFHE----------------------------DRF----------KEFLR 479 (706)
Q Consensus 439 ~~LG~G~fG~Vy~a~~~-~~~vAVKvl~~~~~~~----------------------------~~~----------~~~~~ 479 (706)
+.||.|++|.||+|+.. ++.||||+........ ... -.|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 67999999999999875 5669999975431000 000 02445
Q ss_pred HHHHHHcC----C-CCcee--EEeccccCCCceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHH-HHHHHHh
Q 005247 480 EVAIMKGL----R-HPNIV--LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAK-GMNYLHQ 551 (706)
Q Consensus 480 Ei~iL~~L----~-HpnIv--~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~-aL~yLHs 551 (706)
|...+.++ . ++++. +++. ...+..++||||++|++|.++....... . ....++.+++. .+..+|.
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~--~~~~~~vLvmE~i~G~~L~~~~~~~~~~--~---~~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYW--DRTSERVLTMEWIDGIPLSDIAALDEAG--L---DRKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEeh--hhcCCceEEEEeECCcccccHHHHHhcC--C---CHHHHHHHHHHHHHHHHHh
Confidence 55555554 2 33332 2332 2234469999999999998876432111 1 22345556655 4788999
Q ss_pred cCCCcccccCCCCcEEECCCCcEEEeecCccccCCC
Q 005247 552 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 587 (706)
Q Consensus 552 ~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 587 (706)
.| ++|+|+||.||+++.++.++|+|||++.....
T Consensus 276 ~g--~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 276 DG--FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred CC--ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 99 99999999999999999999999999876553
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.19 E-value=1.6e-11 Score=137.57 Aligned_cols=250 Identities=20% Similarity=0.197 Sum_probs=184.7
Q ss_pred cccccCceEEEEEeccCCceEEEEEEEc---CCceEEEEEeccccchHHHHHHHHHHHHHHcCC-CCceeEEeccccCCC
Q 005247 428 LEIRWSELLIKKKIGEGSFGTVYHAEWR---NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGAVTEPP 503 (706)
Q Consensus 428 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~---~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~ 503 (706)
......+|..+..||.|.|+.|+..... +..|++|...........-..-+.|+.+...+. |.+++.++..|....
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence 4566778999999999999999988644 223788877655444333334456777776664 999999999999888
Q ss_pred ceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCC-CcEEEeecCcc
Q 005247 504 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST-YTVKVCDFGLS 582 (706)
Q Consensus 504 ~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~-~~vKL~DFGla 582 (706)
+.++--|||.++++...+. ....+++...+.+..|++.++.++|++. ++|+|+||+||++..+ +.-++.|||..
T Consensus 340 ~~~ip~e~~~~~s~~l~~~---~~~~~d~~~~~~~~~q~~~~l~~i~s~~--~~~~d~~psni~i~~~~~~~~~~~~~~~ 414 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRSV---TSQMLDEDPRLRLTAQILTALNVIHSKL--FVHLDVKPSNILISNDGFFSKLGDFGCW 414 (524)
T ss_pred cccCchhhhcCcchhhhhH---HHHhcCcchhhhhHHHHHhccccccchh--hhcccccccceeeccchhhhhccccccc
Confidence 8899999999998876653 2234778888999999999999999999 9999999999999875 78899999988
Q ss_pred ccCCCCcccCCCCCCCCCcc--CccccccCCCCchhHHHHHHHHHHHHHhCCCC-CCCCChHHHHHHhhhcCcccCCCCC
Q 005247 583 RSKPNTYISSKTAAGTPEWM--APEVLREDPSNEKSDVFSFGVILWELITLQKP-WRNSTPSQVISAVGFKGRRLEIPKN 659 (706)
Q Consensus 583 ~~~~~~~~~~~~~~Gt~~Y~--APE~l~~~~~s~ksDVwSLGviL~ELltG~~P-f~~~~~~~~~~~i~~~~~~l~~p~~ 659 (706)
...... .....+.-++. +++......+-.+.|+++||..+.+.+++... +....- ........+....
T Consensus 415 t~~~~~---~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~------~~i~~~~~p~~~~ 485 (524)
T KOG0601|consen 415 TRLAFS---SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS------LTIRSGDTPNLPG 485 (524)
T ss_pred ccccee---cccccccccccccchhhccccccccccccccccccccccccCcccCcccccc------eeeecccccCCCc
Confidence 652211 12223333444 55556667788899999999999999988542 322221 1122333444444
Q ss_pred CcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 005247 660 VNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 691 (706)
Q Consensus 660 ~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ 691 (706)
...++..+...+..+++..||.+.++....+-
T Consensus 486 ~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 486 LKLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred hHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 55889999999999999999999887665443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.16 E-value=1.3e-11 Score=144.68 Aligned_cols=250 Identities=23% Similarity=0.272 Sum_probs=186.2
Q ss_pred ccccCceEEEEEeccCCceEEEEEEEcCCc--eEEEEEeccc-cchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCce
Q 005247 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQE-FHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNL 505 (706)
Q Consensus 429 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~--vAVKvl~~~~-~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 505 (706)
......+.+.+.+-.|.++.++.++-.++. .+.|+..... ......+....+-.++-..++|-++.....+......
T Consensus 800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~ 879 (1205)
T KOG0606|consen 800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL 879 (1205)
T ss_pred cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence 345567888889999999999987644333 4444432211 1112233444444444445567777766666667778
Q ss_pred EEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccC
Q 005247 506 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK 585 (706)
Q Consensus 506 ~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~ 585 (706)
+++++|+.+++|...++... ....+.+...+..+..+++|||... ++|+|++|.|+++..++..++.|||.....
T Consensus 880 ~L~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~~--r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 880 PLVGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSSL--RKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred chhhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccch--hhcccccccchhhcccCCcccCcccccccc
Confidence 99999999999999988554 3556667778888999999999998 999999999999999999999999843221
Q ss_pred CCC--------------------------c-----ccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCC
Q 005247 586 PNT--------------------------Y-----ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKP 634 (706)
Q Consensus 586 ~~~--------------------------~-----~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~P 634 (706)
+.. . .......+|+.|.+||...+......+|+|++|++++|.++|..|
T Consensus 955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence 100 0 001223589999999999999999999999999999999999999
Q ss_pred CCCCChHHHHHHhhhcCc-ccCCCCCCcHHHHHHHHHhhhhCCCCCCCHH
Q 005247 635 WRNSTPSQVISAVGFKGR-RLEIPKNVNPMVAALIETCWAEEPEIRPSFP 683 (706)
Q Consensus 635 f~~~~~~~~~~~i~~~~~-~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~ 683 (706)
|....++.++..+..... ...-+...+++.++++.+.+..+|.+|..+.
T Consensus 1035 ~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1035 FNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 999999998876643222 2233456789999999999999999997654
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.16 E-value=2.6e-11 Score=138.53 Aligned_cols=148 Identities=19% Similarity=0.211 Sum_probs=92.8
Q ss_pred cccCceEEEEEeccCCceEEEEEEEc--CCceEEEEEecccc---------------------------c-----hHHHH
Q 005247 430 IRWSELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEF---------------------------H-----EDRFK 475 (706)
Q Consensus 430 i~~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKvl~~~~~---------------------------~-----~~~~~ 475 (706)
-.+.+|.. +.||.|++|.||+|..+ ++.||||+...... . .+..+
T Consensus 117 ~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~ 195 (537)
T PRK04750 117 EWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEK 195 (537)
T ss_pred HHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHH
Confidence 33556776 79999999999999886 46699999864310 0 01112
Q ss_pred HH------HHHHHHHHcCC----CCceeEEeccc-cCCCceEEEEEeccCCchhhhc--ccCC-CcccccHHHHHHHHHH
Q 005247 476 EF------LREVAIMKGLR----HPNIVLLMGAV-TEPPNLSIVTEYLSRGSLYKLL--HIPD-ARVVVDERLRLNMAYD 541 (706)
Q Consensus 476 ~~------~~Ei~iL~~L~----HpnIv~l~~~~-~~~~~~~lV~E~~~ggsL~~~l--~~~~-~~~~l~~~~~~~ia~q 541 (706)
.+ .+|+..+.++. +.+.+.+-.++ .-.+..++||||+.|+.+.++- ...+ ....+.+..+..++.|
T Consensus 196 ~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q 275 (537)
T PRK04750 196 TLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ 275 (537)
T ss_pred HHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH
Confidence 22 33443343331 22222222222 1133467999999999998753 2111 1112334444444444
Q ss_pred HHHHHHHHHhcCCCcccccCCCCcEEECCCC----cEEEeecCccccCCC
Q 005247 542 VAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY----TVKVCDFGLSRSKPN 587 (706)
Q Consensus 542 Il~aL~yLHs~g~~IIHrDLKp~NILl~~~~----~vKL~DFGla~~~~~ 587 (706)
+ +..| ++|+|+||.||+++.++ .++++|||++.....
T Consensus 276 i-------f~~G--ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 276 V-------FRDG--FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred H-------HhCC--eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 4 4578 99999999999999887 999999999876543
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.14 E-value=2.5e-10 Score=114.64 Aligned_cols=139 Identities=19% Similarity=0.171 Sum_probs=98.2
Q ss_pred EEEeccCCceEEEEEEEcC--------CceEEEEEecccc--------------------chHHHHHH----HHHHHHHH
Q 005247 438 KKKIGEGSFGTVYHAEWRN--------SDVAVKILIEQEF--------------------HEDRFKEF----LREVAIMK 485 (706)
Q Consensus 438 ~~~LG~G~fG~Vy~a~~~~--------~~vAVKvl~~~~~--------------------~~~~~~~~----~~Ei~iL~ 485 (706)
...||.|--+.||.|...+ ..+|||+.+-... ..+..+.+ .+|+..|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3578999999999997542 5699998753210 01112233 38999999
Q ss_pred cCCC--CceeEEeccccCCCceEEEEEeccCCchhh-hcccCCCcccccHHHHHHHHHHHHHHHHHH-HhcCCCcccccC
Q 005247 486 GLRH--PNIVLLMGAVTEPPNLSIVTEYLSRGSLYK-LLHIPDARVVVDERLRLNMAYDVAKGMNYL-HQRRPPIVHRDL 561 (706)
Q Consensus 486 ~L~H--pnIv~l~~~~~~~~~~~lV~E~~~ggsL~~-~l~~~~~~~~l~~~~~~~ia~qIl~aL~yL-Hs~g~~IIHrDL 561 (706)
++.. -++...+++ ...++||||+.+..+.. .++. ..++......+..+++.+|..| |+.| +||+||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd----~~~~~~~~~~i~~~i~~~l~~l~H~~g--lVHGDL 151 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD----AKLNDEEMKNAYYQVLSMMKQLYKECN--LVHADL 151 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc----cccCHHHHHHHHHHHHHHHHHHHHhCC--eecCCC
Confidence 8853 455666654 45689999997643321 2221 1244556677889999999999 8999 999999
Q ss_pred CCCcEEECCCCcEEEeecCccccCCC
Q 005247 562 KSPNLLVDSTYTVKVCDFGLSRSKPN 587 (706)
Q Consensus 562 Kp~NILl~~~~~vKL~DFGla~~~~~ 587 (706)
++.|||++ ++.++|+|||.+.....
T Consensus 152 s~~NIL~~-~~~v~iIDF~qav~~~h 176 (197)
T cd05146 152 SEYNMLWH-DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred CHHHEEEE-CCcEEEEECCCceeCCC
Confidence 99999996 46799999998876544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.12 E-value=1.1e-09 Score=124.42 Aligned_cols=162 Identities=19% Similarity=0.240 Sum_probs=119.6
Q ss_pred CCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEEeccCCchhhhcccCCCcccccHHHH
Q 005247 456 NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLR 535 (706)
Q Consensus 456 ~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~ 535 (706)
+..+.|++.+.... .......+-+.-|+.++||||+++++.+...+..|+|+|-+. .|..+++. +....+
T Consensus 37 ~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~~v 106 (690)
T KOG1243|consen 37 GGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKEEV 106 (690)
T ss_pred CCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHHHH
Confidence 44567766655432 344556677888999999999999999999999999999884 56666652 235566
Q ss_pred HHHHHHHHHHHHHHHh-cCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcccCCCCCCCCCccCccccccCCCCc
Q 005247 536 LNMAYDVAKGMNYLHQ-RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNE 614 (706)
Q Consensus 536 ~~ia~qIl~aL~yLHs-~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ 614 (706)
...+.||+.||.|||+ .+ ++|++|.-+-|+++..|..||++|-.+..............---.|..|+.+.... -
T Consensus 107 ~~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~--~ 182 (690)
T KOG1243|consen 107 CLGLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE--W 182 (690)
T ss_pred HHHHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc--c
Confidence 6778999999999985 55 99999999999999999999999998765433221111111122355666543332 3
Q ss_pred hhHHHHHHHHHHHHHhC
Q 005247 615 KSDVFSFGVILWELITL 631 (706)
Q Consensus 615 ksDVwSLGviL~ELltG 631 (706)
..|.|.||++++|++.|
T Consensus 183 s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 183 SIDSWGLGCLIEELFNG 199 (690)
T ss_pred chhhhhHHHHHHHHhCc
Confidence 46999999999999998
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.10 E-value=4.9e-10 Score=110.01 Aligned_cols=132 Identities=24% Similarity=0.359 Sum_probs=101.9
Q ss_pred EeccCCceEEEEEEEcCCceEEEEEeccccchHHH------HHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEEecc
Q 005247 440 KIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRF------KEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLS 513 (706)
Q Consensus 440 ~LG~G~fG~Vy~a~~~~~~vAVKvl~~~~~~~~~~------~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~~~ 513 (706)
.+++|+-+.+|.+.+.+.++.+|.-..+.+....+ ..-.+|..++.++.--.|..-+-+..+++...|+|||++
T Consensus 3 ~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~ 82 (204)
T COG3642 3 LIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIE 82 (204)
T ss_pred hhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeC
Confidence 57899999999998888888888765554433222 345679999988864444443444556777899999999
Q ss_pred CCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCcccc
Q 005247 514 RGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 584 (706)
Q Consensus 514 ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~ 584 (706)
|-.|.+++... ...++..+-.-+.-||..| |||+||.++||++...+ +.++|||++..
T Consensus 83 G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g--ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 83 GELLKDALEEA----------RPDLLREVGRLVGKLHKAG--IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred ChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC--eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99999888533 2456777888888999999 99999999999997664 99999999864
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.02 E-value=2.1e-09 Score=108.11 Aligned_cols=142 Identities=18% Similarity=0.208 Sum_probs=106.3
Q ss_pred EEEeccCCceEEEEEEEcC-CceEEEEEeccccchHHHHHHHHHHHHHHcCCC--CceeEEeccccCC---CceEEEEEe
Q 005247 438 KKKIGEGSFGTVYHAEWRN-SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRH--PNIVLLMGAVTEP---PNLSIVTEY 511 (706)
Q Consensus 438 ~~~LG~G~fG~Vy~a~~~~-~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~H--pnIv~l~~~~~~~---~~~~lV~E~ 511 (706)
.+.|+.|.++.||++...+ ..+++|+....... .....+.+|+.+++.+.+ .++.+++.+.... +..+++|||
T Consensus 3 ~~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~ 81 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER 81 (223)
T ss_pred ceecCCCccceEEEEEecCCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence 3678999999999998776 67999986443221 123467889999999865 3456677766553 356899999
Q ss_pred ccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 005247 512 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR-------------------------------------- 553 (706)
Q Consensus 512 ~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g-------------------------------------- 553 (706)
++|.++.+.+.. ..+++.....++.+++++|.+||+..
T Consensus 82 i~G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 82 VDGRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred eCCEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 999888776531 23566677778888888888888521
Q ss_pred ----------------CCcccccCCCCcEEECC--CCcEEEeecCcccc
Q 005247 554 ----------------PPIVHRDLKSPNLLVDS--TYTVKVCDFGLSRS 584 (706)
Q Consensus 554 ----------------~~IIHrDLKp~NILl~~--~~~vKL~DFGla~~ 584 (706)
..++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 23699999999999988 66789999997654
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.97 E-value=3.2e-09 Score=103.97 Aligned_cols=146 Identities=18% Similarity=0.209 Sum_probs=105.8
Q ss_pred EEEEeccCCceEEEEEEEcCCceEEEEEeccccchHH------HHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEE
Q 005247 437 IKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDR------FKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 510 (706)
Q Consensus 437 i~~~LG~G~fG~Vy~a~~~~~~vAVKvl~~~~~~~~~------~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E 510 (706)
....|-+|+-+.|+++.+.+....||.-..+.+.... .+..++|+.++.++.--.|.--.-++.+...-.|.||
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 5678899999999999999998888875444332222 2456678888887754343332333445566689999
Q ss_pred eccC-CchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCC---cEEEeecCccccC
Q 005247 511 YLSR-GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY---TVKVCDFGLSRSK 585 (706)
Q Consensus 511 ~~~g-gsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~---~vKL~DFGla~~~ 585 (706)
|++| .++.+++....... ........++.+|-+.+.-||..+ |||+||..+||++..++ .+.|+|||++...
T Consensus 91 ~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~nd--iiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHDND--IIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred eccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhhCC--eecccccccceEEecCCCcCceEEEeecchhcc
Confidence 9977 47888875433322 223333678899999999999999 99999999999996554 4689999997643
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.93 E-value=4.2e-08 Score=106.20 Aligned_cols=253 Identities=17% Similarity=0.191 Sum_probs=162.2
Q ss_pred EEEEeccCCceEEEEEEEcCCceEEEEEeccccchHHHHHHHHHHHHHHcC-CCCceeEEecc------ccCCC-ceEEE
Q 005247 437 IKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGA------VTEPP-NLSIV 508 (706)
Q Consensus 437 i~~~LG~G~fG~Vy~a~~~~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~------~~~~~-~~~lV 508 (706)
..+.||+|+-+.+|....-.+.|| |+....... ...+ .+..|... .||-+..-+.+ .-+.. ..-+.
T Consensus 15 ~gr~LgqGgea~ly~l~e~~d~VA-KIYh~Pppa--~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEVRDQVA-KIYHAPPPA--AQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCccccCCccceeeecchhhchhh-eeecCCCch--HHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 356899999999997754455555 665433211 1111 12223333 45533221111 11112 25577
Q ss_pred EEeccCC-chhhhcc---cCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCcccc
Q 005247 509 TEYLSRG-SLYKLLH---IPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 584 (706)
Q Consensus 509 ~E~~~gg-sL~~~l~---~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~ 584 (706)
|..+++. ....++. +........+.-.++.++.++.+.+.||..| .+-+|+.++|+|+++++.|.|.|=..-..
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G--h~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG--HVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC--CcccccCccceeeecCceEEEEcccceee
Confidence 7777664 2333332 2333344678889999999999999999999 99999999999999999999998653332
Q ss_pred CCCCcccCCCCCCCCCccCccccc-----cCCCCchhHHHHHHHHHHHHHhC-CCCCCCC-------ChHH-HHHHhhhc
Q 005247 585 KPNTYISSKTAAGTPEWMAPEVLR-----EDPSNEKSDVFSFGVILWELITL-QKPWRNS-------TPSQ-VISAVGFK 650 (706)
Q Consensus 585 ~~~~~~~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDVwSLGviL~ELltG-~~Pf~~~-------~~~~-~~~~i~~~ 650 (706)
..+ .......+|...|.+||.-. +...+...|.|.||+++++++.| ++||.+. ++.+ .+..-.+.
T Consensus 167 ~~n-g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ 245 (637)
T COG4248 167 NAN-GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFA 245 (637)
T ss_pred ccC-CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceee
Confidence 222 22335667999999999754 33456789999999999999987 9999652 2222 11111110
Q ss_pred -----C-cccCCC-----CCCcHHHHHHHHHhhhh--CCCCCCCHHHHHHHHHHHHHhccC
Q 005247 651 -----G-RRLEIP-----KNVNPMVAALIETCWAE--EPEIRPSFPSIMETLQQFLMSSVC 698 (706)
Q Consensus 651 -----~-~~l~~p-----~~~s~el~dLI~~cL~~--dP~~RPS~~eIl~~L~~ll~s~~~ 698 (706)
+ ...+.| .-+++.+..|..+|+.. ++.-|||++..+..|..+-.+..+
T Consensus 246 ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~ 306 (637)
T COG4248 246 YASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKK 306 (637)
T ss_pred echhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhh
Confidence 1 111122 24578999999999965 366899999988877666655443
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.74 E-value=3.4e-07 Score=101.56 Aligned_cols=220 Identities=16% Similarity=0.220 Sum_probs=153.8
Q ss_pred EEeccCCceEEEEEEEc--CCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEecccc----CCCceEEEEEec
Q 005247 439 KKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT----EPPNLSIVTEYL 512 (706)
Q Consensus 439 ~~LG~G~fG~Vy~a~~~--~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~----~~~~~~lV~E~~ 512 (706)
+..+.=--.+.|++... |..|++|.+.... .........-+++++++.|.|||++.++|. .+..+++|++|+
T Consensus 282 ~~~~~~~~~Ttyk~~s~~DG~~YvLkRlhg~r--~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYy 359 (655)
T KOG3741|consen 282 ELLNDLFSITTYKATSNVDGNAYVLKRLHGDR--DQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYY 359 (655)
T ss_pred ccccccccceeEeeeeccCCceeeeeeecccc--ccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecC
Confidence 33333245667888764 3447777762111 111112335578899999999999998886 344588999999
Q ss_pred cC-Cchhhhccc------------CCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeec
Q 005247 513 SR-GSLYKLLHI------------PDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDF 579 (706)
Q Consensus 513 ~g-gsL~~~l~~------------~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DF 579 (706)
++ ++|.++... ...+...++..+|.++.|+..||.++|+.| +.-+-|.|.+||++.+.+++|.-.
T Consensus 360 P~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG--LAck~L~~~kIlv~G~~RIriS~C 437 (655)
T KOG3741|consen 360 PSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG--LACKTLDLKKILVTGKMRIRISGC 437 (655)
T ss_pred CCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC--ceeecccHhHeEeeCcceEEEecc
Confidence 86 467766521 112335778999999999999999999999 888999999999999999999877
Q ss_pred CccccCCCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCC-CCCCCChHHH-HHHhhhcCcccCCC
Q 005247 580 GLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQV-ISAVGFKGRRLEIP 657 (706)
Q Consensus 580 Gla~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~-Pf~~~~~~~~-~~~i~~~~~~l~~p 657 (706)
|+........ . |-+ ....+-|.=.||.++..|.||.. -|.....++. ... +.
T Consensus 438 ~i~Dvl~~d~------------~--~~l---e~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~---------I~ 491 (655)
T KOG3741|consen 438 GIMDVLQEDP------------T--EPL---ESQQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTR---------IT 491 (655)
T ss_pred cceeeecCCC------------C--cch---hHHhhhhHHHHHHHHHHHhhcccccccccchHHHHHHH---------hh
Confidence 7654332211 0 111 12346799999999999999954 3544444333 222 33
Q ss_pred CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 005247 658 KNVNPMVAALIETCWAEEPEIRPSFPSIMETL 689 (706)
Q Consensus 658 ~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L 689 (706)
..++.+++++|......++++ -++++++.++
T Consensus 492 ~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~ 522 (655)
T KOG3741|consen 492 TTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI 522 (655)
T ss_pred hhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence 568899999999999999997 5777776643
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.74 E-value=7.1e-08 Score=101.77 Aligned_cols=136 Identities=19% Similarity=0.092 Sum_probs=93.9
Q ss_pred CCceEEEEEEEcCCceEEEEEeccccchHHHH----------HHHHHHHHHHcCCCCce--eEEeccccC-----CCceE
Q 005247 444 GSFGTVYHAEWRNSDVAVKILIEQEFHEDRFK----------EFLREVAIMKGLRHPNI--VLLMGAVTE-----PPNLS 506 (706)
Q Consensus 444 G~fG~Vy~a~~~~~~vAVKvl~~~~~~~~~~~----------~~~~Ei~iL~~L~HpnI--v~l~~~~~~-----~~~~~ 506 (706)
.....|++++..+..+.||........ ...+ .+.+|...+..+...+| +..+++... ....+
T Consensus 33 ~~~rrvvr~~~~g~~~~vKr~~~~~~~-~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~ 111 (268)
T PRK15123 33 LEGRRTLRFELAGKSYFLKWHRGTGWG-EIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSF 111 (268)
T ss_pred CCCceEEEEEECCEEEEEEEecCCcHH-HHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeE
Confidence 333446677777777888865332211 1111 37788888887743322 333333322 23468
Q ss_pred EEEEeccCC-chhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECC-------CCcEEEee
Q 005247 507 IVTEYLSRG-SLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS-------TYTVKVCD 578 (706)
Q Consensus 507 lV~E~~~gg-sL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~-------~~~vKL~D 578 (706)
+|+|++++. +|.+++.... ....+......++.+++..+..||..| |+|+|+++.|||++. ++.+.|+|
T Consensus 112 LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G--i~HgDL~~~NiLl~~~~~~~~~~~~~~LID 188 (268)
T PRK15123 112 IITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG--INHRDCYICHFLLHLPFPGREEDLKLSVID 188 (268)
T ss_pred EEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc--CccCCCChhhEEEeccccCCCCCceEEEEE
Confidence 999999886 7888874211 123456677789999999999999999 999999999999975 46899999
Q ss_pred cCccc
Q 005247 579 FGLSR 583 (706)
Q Consensus 579 FGla~ 583 (706)
|+.+.
T Consensus 189 l~r~~ 193 (268)
T PRK15123 189 LHRAQ 193 (268)
T ss_pred CCccc
Confidence 99775
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.65 E-value=2.4e-07 Score=92.64 Aligned_cols=128 Identities=26% Similarity=0.251 Sum_probs=81.3
Q ss_pred EEEEEEEc-CCceEEEEEecccc-----------------------c-hHHHHHHHHHHHHHHcCCCC--ceeEEecccc
Q 005247 448 TVYHAEWR-NSDVAVKILIEQEF-----------------------H-EDRFKEFLREVAIMKGLRHP--NIVLLMGAVT 500 (706)
Q Consensus 448 ~Vy~a~~~-~~~vAVKvl~~~~~-----------------------~-~~~~~~~~~Ei~iL~~L~Hp--nIv~l~~~~~ 500 (706)
.||.|... +..+|+|+.+.... . ........+|.+.|+++..- ++.+.+++-
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 37888764 44699998753210 0 11124567899999999755 456666542
Q ss_pred CCCceEEEEEecc--CCchhhhcccCCCcccccHHHHHHHHHHHHHHHHH-HHhcCCCcccccCCCCcEEECCCCcEEEe
Q 005247 501 EPPNLSIVTEYLS--RGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY-LHQRRPPIVHRDLKSPNLLVDSTYTVKVC 577 (706)
Q Consensus 501 ~~~~~~lV~E~~~--ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~y-LHs~g~~IIHrDLKp~NILl~~~~~vKL~ 577 (706)
..++||||+. |..+..+.... +.......++.+++..+.. +|..| |||+||.+.|||++.+ .+.|+
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~g--ivHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKAG--IVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCTT--EEESS-STTSEEEETT-CEEE-
T ss_pred ---CCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhcC--ceecCCChhhEEeecc-eEEEE
Confidence 3489999998 65565543311 1234456677788885555 57999 9999999999999877 89999
Q ss_pred ecCccccCCC
Q 005247 578 DFGLSRSKPN 587 (706)
Q Consensus 578 DFGla~~~~~ 587 (706)
|||.+....+
T Consensus 149 Df~qav~~~~ 158 (188)
T PF01163_consen 149 DFGQAVDSSH 158 (188)
T ss_dssp -GTTEEETTS
T ss_pred ecCcceecCC
Confidence 9998876443
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.58 E-value=2e-08 Score=114.63 Aligned_cols=146 Identities=17% Similarity=0.293 Sum_probs=108.6
Q ss_pred HHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCccc----C-----CCCCCCCCccCccccccCC
Q 005247 541 DVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS----S-----KTAAGTPEWMAPEVLREDP 611 (706)
Q Consensus 541 qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~----~-----~~~~Gt~~Y~APE~l~~~~ 611 (706)
+++.|+.|+|..- ++||++|.|++|.++.++..||+.|+++.....+... . ....-...|.|||.+....
T Consensus 107 ~v~dgl~flh~sA-k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~ 185 (700)
T KOG2137|consen 107 NVADGLAFLHRSA-KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT 185 (700)
T ss_pred cccchhhhhccCc-ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence 4559999999752 4999999999999999999999999988654431110 0 0112356799999999988
Q ss_pred CCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHH--HHhhhcCcccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 612 SNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVI--SAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 612 ~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~--~~i~~~~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
.+.++|+||+|+++|.+.. |+.-+...+..... ..............+++.++++=+.+++..++.-||++.++..
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhc
Confidence 8999999999999999994 45545544322222 1112223344556789999999999999999999998877654
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.51 E-value=7.6e-07 Score=92.53 Aligned_cols=139 Identities=24% Similarity=0.196 Sum_probs=101.4
Q ss_pred eEEEEEeccCCceEEEEEEEc-CCceEEEEEeccccc--------------------hHHHHHHHHHHHHHHcCCCC--c
Q 005247 435 LLIKKKIGEGSFGTVYHAEWR-NSDVAVKILIEQEFH--------------------EDRFKEFLREVAIMKGLRHP--N 491 (706)
Q Consensus 435 y~i~~~LG~G~fG~Vy~a~~~-~~~vAVKvl~~~~~~--------------------~~~~~~~~~Ei~iL~~L~Hp--n 491 (706)
..++..||-|--+.||.|... +.+++||.-...... .-......+|.++|+.|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 346789999999999999886 667999975322110 11234567899999998644 5
Q ss_pred eeEEeccccCCCceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCC
Q 005247 492 IVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST 571 (706)
Q Consensus 492 Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~ 571 (706)
+.+.+++ +...+|||+++|-.|...- ++......++..|++-+..+-..| |||+|+.+-||+++++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G--iVHGDlSefNIlV~~d 238 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG--IVHGDLSEFNILVTED 238 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC--ccccCCchheEEEecC
Confidence 6665543 5668999999997665532 233444556666777666666788 9999999999999999
Q ss_pred CcEEEeecCccccCCC
Q 005247 572 YTVKVCDFGLSRSKPN 587 (706)
Q Consensus 572 ~~vKL~DFGla~~~~~ 587 (706)
|.+.++||-.+.....
T Consensus 239 g~~~vIDwPQ~v~~~h 254 (304)
T COG0478 239 GDIVVIDWPQAVPISH 254 (304)
T ss_pred CCEEEEeCcccccCCC
Confidence 9999999987665443
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.48 E-value=4.8e-07 Score=91.67 Aligned_cols=104 Identities=24% Similarity=0.228 Sum_probs=78.4
Q ss_pred HHHHHHHHHHcCCCC--ceeEEeccccCC----CceEEEEEeccCC-chhhhcccCCCcccccHHHHHHHHHHHHHHHHH
Q 005247 476 EFLREVAIMKGLRHP--NIVLLMGAVTEP----PNLSIVTEYLSRG-SLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 548 (706)
Q Consensus 476 ~~~~Ei~iL~~L~Hp--nIv~l~~~~~~~----~~~~lV~E~~~gg-sL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~y 548 (706)
.+.+|...+..|... .++..+++.... ...++|+|++++. +|.+++..... .+......++.+++..+.-
T Consensus 57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 57 RAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLIAK 133 (206)
T ss_pred HHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHHHH
Confidence 566788777776432 233444444332 2357999999884 78888864221 4566678899999999999
Q ss_pred HHhcCCCcccccCCCCcEEECCCC---cEEEeecCcccc
Q 005247 549 LHQRRPPIVHRDLKSPNLLVDSTY---TVKVCDFGLSRS 584 (706)
Q Consensus 549 LHs~g~~IIHrDLKp~NILl~~~~---~vKL~DFGla~~ 584 (706)
||..| |+|+|+++.|||++.++ .+.|+||+-++.
T Consensus 134 lH~~g--i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 134 LHDAG--IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHCc--CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99999 99999999999998887 899999997664
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.39 E-value=3.9e-06 Score=85.49 Aligned_cols=140 Identities=20% Similarity=0.212 Sum_probs=95.4
Q ss_pred cccCceEEEEEeccCCceEEEEEEEcCCceEEEEEeccccch-HHHHH------HHHHHHHHHcCCCC---ceeEEecc-
Q 005247 430 IRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHE-DRFKE------FLREVAIMKGLRHP---NIVLLMGA- 498 (706)
Q Consensus 430 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKvl~~~~~~~-~~~~~------~~~Ei~iL~~L~Hp---nIv~l~~~- 498 (706)
+...+|.+.+.+-......|.+....+..+.+|.-....... ..... ..+++..+..+... ....++.+
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 456789999999999999999999999999999865433211 11111 22344444444322 22222221
Q ss_pred ----ccCCCceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcE
Q 005247 499 ----VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTV 574 (706)
Q Consensus 499 ----~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~v 574 (706)
+.-....+++|||++|..|.++.. +++ .++..+..++..||+.| +.|+|..|.|+++++++ +
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G--~~HGD~hpgNFlv~~~~-i 173 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG--FYHGDPHPGNFLVSNNG-I 173 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC--CccCCCCcCcEEEECCc-E
Confidence 222234578999999988877643 222 24456778899999999 99999999999998665 9
Q ss_pred EEeecCccc
Q 005247 575 KVCDFGLSR 583 (706)
Q Consensus 575 KL~DFGla~ 583 (706)
+++||+..+
T Consensus 174 ~iID~~~k~ 182 (229)
T PF06176_consen 174 RIIDTQGKR 182 (229)
T ss_pred EEEECcccc
Confidence 999998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.27 E-value=5.1e-06 Score=84.27 Aligned_cols=140 Identities=17% Similarity=0.085 Sum_probs=99.3
Q ss_pred ccCCceEEEEEEEcCCceEEEEEeccc----cchHHHHHHHHHHHHHHcCCCC--ceeEEeccc--cCC--CceEEEEEe
Q 005247 442 GEGSFGTVYHAEWRNSDVAVKILIEQE----FHEDRFKEFLREVAIMKGLRHP--NIVLLMGAV--TEP--PNLSIVTEY 511 (706)
Q Consensus 442 G~G~fG~Vy~a~~~~~~vAVKvl~~~~----~~~~~~~~~~~Ei~iL~~L~Hp--nIv~l~~~~--~~~--~~~~lV~E~ 511 (706)
|+||-+-|++....+..+-+|.-.... ..+.-...|.+|+..++.|... .+.+..... ..+ -..+||+|-
T Consensus 27 ~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe~ 106 (216)
T PRK09902 27 RRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTED 106 (216)
T ss_pred CCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEEe
Confidence 579999999998877777777643110 0022345899999999988532 244444211 111 125799997
Q ss_pred ccC-CchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCc--EEEeecCcccc
Q 005247 512 LSR-GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYT--VKVCDFGLSRS 584 (706)
Q Consensus 512 ~~g-gsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~--vKL~DFGla~~ 584 (706)
+.+ -+|.+++.... ....+......++.+++..+.-||+.| +.|+|+.+.||+++.++. ++++||--++.
T Consensus 107 L~g~~~L~~~l~~~~-~~~~~~~~k~~il~~va~~ia~LH~~G--v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 107 MAGFISIADWYAQHA-VSPYSDEVRQAMLKAVALAFKKMHSVN--RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred CCCCccHHHHHhcCC-cCCcchHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 764 47888775322 124567777889999999999999999 999999999999986667 99999986553
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.21 E-value=1.1e-05 Score=83.12 Aligned_cols=138 Identities=14% Similarity=0.187 Sum_probs=82.1
Q ss_pred EEeccCCceEEEEEEEcCCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCc--eeEEeccccCCCceEEEEEeccCCc
Q 005247 439 KKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN--IVLLMGAVTEPPNLSIVTEYLSRGS 516 (706)
Q Consensus 439 ~~LG~G~fG~Vy~a~~~~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~Hpn--Iv~l~~~~~~~~~~~lV~E~~~ggs 516 (706)
..||+|..+.||+. .+.++++|...... . .....+|.++++.+..-. +.+.+.+....+...++||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~-~---~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTH--KTGKWMLKLYNPGF-D---KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEe--cCCCEEEEeCCCCC-C---HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 57899999999984 35567778764322 1 234578999998875332 4566777767777889999999863
Q ss_pred -hhhhc---------------------ccCCC-cccccHHHHHHHHH----------HHHH-HHHHHH--hcCCCccccc
Q 005247 517 -LYKLL---------------------HIPDA-RVVVDERLRLNMAY----------DVAK-GMNYLH--QRRPPIVHRD 560 (706)
Q Consensus 517 -L~~~l---------------------~~~~~-~~~l~~~~~~~ia~----------qIl~-aL~yLH--s~g~~IIHrD 560 (706)
+...+ |.... ...++.. ...+.. .+.. ...+|. ...+.++|+|
T Consensus 81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~-~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD 159 (226)
T TIGR02172 81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSY-KEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD 159 (226)
T ss_pred chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHH-HHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence 21111 11000 0011100 000100 0111 112222 2223478999
Q ss_pred CCCCcEEECCCCcEEEeecCcccc
Q 005247 561 LKSPNLLVDSTYTVKVCDFGLSRS 584 (706)
Q Consensus 561 LKp~NILl~~~~~vKL~DFGla~~ 584 (706)
+.|.||++++++ +.|+||+.+..
T Consensus 160 ~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 160 FQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCCCcEEEcCCC-cEEEechhcCc
Confidence 999999999888 99999997653
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.18 E-value=2e-05 Score=79.33 Aligned_cols=142 Identities=19% Similarity=0.208 Sum_probs=81.4
Q ss_pred EEEeccCCceEEEEEEEcCCceEEEEEeccccchHHHHHHHHHHHHHHcCCCC--ceeEEeccc---cCCCceEEEEEec
Q 005247 438 KKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHP--NIVLLMGAV---TEPPNLSIVTEYL 512 (706)
Q Consensus 438 ~~~LG~G~fG~Vy~a~~~~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~Hp--nIv~l~~~~---~~~~~~~lV~E~~ 512 (706)
++.|+.|..+.||++...+..+++|..... .....+.+|..+++.+... .+.+++... ......+++|+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i 77 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDDGRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI 77 (239)
T ss_dssp EEEEEESSSSEEEEEEETTSEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECCcEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence 578999999999999988878999985433 3345677888888777422 344555432 2233478999999
Q ss_pred cCCchhh----------------hc---ccC--CCcccccHH--------HHHHH------------HHHHHH-HHHHHH
Q 005247 513 SRGSLYK----------------LL---HIP--DARVVVDER--------LRLNM------------AYDVAK-GMNYLH 550 (706)
Q Consensus 513 ~ggsL~~----------------~l---~~~--~~~~~l~~~--------~~~~i------------a~qIl~-aL~yLH 550 (706)
+|..+.. .+ +.. ......... ..... ...+.. .+..++
T Consensus 78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (239)
T PF01636_consen 78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE 157 (239)
T ss_dssp SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence 9987777 11 111 000000000 00000 111222 333343
Q ss_pred h-----cCCCcccccCCCCcEEEC-CCCcEEEeecCccc
Q 005247 551 Q-----RRPPIVHRDLKSPNLLVD-STYTVKVCDFGLSR 583 (706)
Q Consensus 551 s-----~g~~IIHrDLKp~NILl~-~~~~vKL~DFGla~ 583 (706)
+ ....++|+|+.|.|||++ .++.+-|+||+.+.
T Consensus 158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 2 223499999999999999 66667899998654
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.07 E-value=2.8e-05 Score=80.35 Aligned_cols=75 Identities=17% Similarity=0.165 Sum_probs=52.1
Q ss_pred EeccCCc-eEEEEEEEcCCceEEEEEeccccchHHHHHHHHHHHHHHcCC-CCceeEEeccccCCCceEEEEEeccCCch
Q 005247 440 KIGEGSF-GTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGAVTEPPNLSIVTEYLSRGSL 517 (706)
Q Consensus 440 ~LG~G~f-G~Vy~a~~~~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~lV~E~~~ggsL 517 (706)
.|-.|.+ ..||++...+.++.+|+..... ...+.+|+.+++.+. +--+.+++.+....+..++|||+++|.+|
T Consensus 5 ~~~~g~~~~~v~~~~~~~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l 79 (244)
T cd05150 5 RVTEGQSGATVYRLDGKNPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPA 79 (244)
T ss_pred ecCCCCCcCeEEEEcCCCCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccH
Confidence 4555665 7899997766678888764332 234567888887773 34456777777666678999999998776
Q ss_pred hh
Q 005247 518 YK 519 (706)
Q Consensus 518 ~~ 519 (706)
..
T Consensus 80 ~~ 81 (244)
T cd05150 80 AA 81 (244)
T ss_pred hH
Confidence 54
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.06 E-value=8.1e-07 Score=100.72 Aligned_cols=232 Identities=19% Similarity=0.208 Sum_probs=155.9
Q ss_pred eEEEEEeccCCceEEEEEEEcCCc-eEEEEEeccccchHHHHHHHHHHHHHHcCCCCc-eeEEeccccCCCceEEEEEec
Q 005247 435 LLIKKKIGEGSFGTVYHAEWRNSD-VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN-IVLLMGAVTEPPNLSIVTEYL 512 (706)
Q Consensus 435 y~i~~~LG~G~fG~Vy~a~~~~~~-vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~Hpn-Iv~l~~~~~~~~~~~lV~E~~ 512 (706)
+.....+++|+++++++.+...+. ...+.+... ....-++++|.+++||| .+..++-.+.++..+++++++
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~ 316 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRIC 316 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhheeceeeccc-------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhh
Confidence 334455689999999987654443 223332221 24456889999999999 777777788888899999999
Q ss_pred cCC-chhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCccc
Q 005247 513 SRG-SLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS 591 (706)
Q Consensus 513 ~gg-sL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~ 591 (706)
.++ +...... .....+.+.+...+...-++++++||+.. =+|+| ||+..+ +..+..||+......... .
T Consensus 317 s~~rs~~~~~~--~se~~~~~~~~~~~~r~et~~l~~l~~~~--~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-~ 386 (829)
T KOG0576|consen 317 STGRSSALEMT--VSEIALEQYQFAYPLRKETRPLAELHSSY--KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-K 386 (829)
T ss_pred cCCccccccCC--hhhHhhhhhhhhhhhhhhccccccccccc--ccCcc----cccccc-cccccccccCCcccCccc-c
Confidence 887 3322221 12234556667777888889999999875 58998 777755 579999999887766554 4
Q ss_pred CCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCC--CCCcHHHH-HHH
Q 005247 592 SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP--KNVNPMVA-ALI 668 (706)
Q Consensus 592 ~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p--~~~s~el~-dLI 668 (706)
.++..+++.++|||+.....+..+.|+|++|.--.++.-|-.|-.. +......+........+. ...++... ++.
T Consensus 387 ~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~--P~~~~~~~g~~p~s~~L~~~~aw~~~~~~~~~ 464 (829)
T KOG0576|consen 387 PRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS--PPAVLPMIGNGPNSPMLTDKSAWSPVFHRDFP 464 (829)
T ss_pred cccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC--CccccCCCCCCCCccccchhhhcCcccccCCc
Confidence 5678899999999999999999999999999877777777665432 212111111111111111 11122222 366
Q ss_pred HHhhhhCCCCCCCHHHH
Q 005247 669 ETCWAEEPEIRPSFPSI 685 (706)
Q Consensus 669 ~~cL~~dP~~RPS~~eI 685 (706)
..|+...|..|+..-..
T Consensus 465 ~~~~~g~P~~pkv~mga 481 (829)
T KOG0576|consen 465 APCLNGLPPTPKVHMGA 481 (829)
T ss_pred ccccCCCCCCCcchhhH
Confidence 67888888877765443
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.04 E-value=7.9e-05 Score=76.99 Aligned_cols=142 Identities=21% Similarity=0.150 Sum_probs=94.5
Q ss_pred EEEEeccCCceEEEEEEEc-CCceEEEEEeccccchHH----------------------HHHHHHHHHHHHcCC--CCc
Q 005247 437 IKKKIGEGSFGTVYHAEWR-NSDVAVKILIEQEFHEDR----------------------FKEFLREVAIMKGLR--HPN 491 (706)
Q Consensus 437 i~~~LG~G~fG~Vy~a~~~-~~~vAVKvl~~~~~~~~~----------------------~~~~~~Ei~iL~~L~--Hpn 491 (706)
+...|..|.-+.||+|... +..+|+|+.+........ ..-...|...|+++. +-.
T Consensus 52 ~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr 131 (268)
T COG1718 52 LVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR 131 (268)
T ss_pred eEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 4568889999999999764 566999998653321111 011235777777663 333
Q ss_pred eeEEeccccCCCceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHh-cCCCcccccCCCCcEEECC
Q 005247 492 IVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ-RRPPIVHRDLKSPNLLVDS 570 (706)
Q Consensus 492 Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs-~g~~IIHrDLKp~NILl~~ 570 (706)
+.+-+++.. ..+||||+... ..-.=... ...+....+..+..++++.+.-|-. .+ +||+||..-|||+.
T Consensus 132 vP~Pi~~~~----nVLvMEfIg~~-g~pAP~Lk--Dv~~e~~e~~~~~~~~v~~~~~l~~~a~--LVHgDLSEyNiL~~- 201 (268)
T COG1718 132 VPEPIAFRN----NVLVMEFIGDD-GLPAPRLK--DVPLELEEAEGLYEDVVEYMRRLYKEAG--LVHGDLSEYNILVH- 201 (268)
T ss_pred CCCceeecC----CeEEEEeccCC-CCCCCCcc--cCCcCchhHHHHHHHHHHHHHHHHHhcC--cccccchhhheEEE-
Confidence 444444432 47999999653 11110111 1123344677788899999988877 77 99999999999998
Q ss_pred CCcEEEeecCccccCCCC
Q 005247 571 TYTVKVCDFGLSRSKPNT 588 (706)
Q Consensus 571 ~~~vKL~DFGla~~~~~~ 588 (706)
++.+.|+|||.|....++
T Consensus 202 ~~~p~iID~~QaV~~~hp 219 (268)
T COG1718 202 DGEPYIIDVSQAVTIDHP 219 (268)
T ss_pred CCeEEEEECccccccCCC
Confidence 778999999988765544
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.89 E-value=4.5e-05 Score=87.29 Aligned_cols=142 Identities=19% Similarity=0.240 Sum_probs=89.2
Q ss_pred EEeccCCceEEEEEEEc-CCceEEEEEecccc---------------------------c-----hHHHH------HHHH
Q 005247 439 KKIGEGSFGTVYHAEWR-NSDVAVKILIEQEF---------------------------H-----EDRFK------EFLR 479 (706)
Q Consensus 439 ~~LG~G~fG~Vy~a~~~-~~~vAVKvl~~~~~---------------------------~-----~~~~~------~~~~ 479 (706)
+.|+.++-|.||+|+.+ |..||||+...... . .+..+ .+.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 68999999999999988 67799999753210 0 01111 1334
Q ss_pred HHHHHHcC----C-CCceeEEeccccCCCceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHH-HHHHHhcC
Q 005247 480 EVAIMKGL----R-HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKG-MNYLHQRR 553 (706)
Q Consensus 480 Ei~iL~~L----~-HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~a-L~yLHs~g 553 (706)
|...+.++ . .+++.--.=+++-.+.-.++|||++|-.+.+....... .++.+. ++..++.+ +..+=..|
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~--g~d~k~---ia~~~~~~f~~q~~~dg 285 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA--GIDRKE---LAELLVRAFLRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhc--CCCHHH---HHHHHHHHHHHHHHhcC
Confidence 44444444 1 23333222223334556899999999998888532221 133222 22222222 22333467
Q ss_pred CCcccccCCCCcEEECCCCcEEEeecCccccCCC
Q 005247 554 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 587 (706)
Q Consensus 554 ~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 587 (706)
++|.|.+|.||+++.+|.+.+.|||+......
T Consensus 286 --ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 286 --FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred --ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 99999999999999999999999999876554
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00031 Score=70.37 Aligned_cols=103 Identities=18% Similarity=0.180 Sum_probs=79.7
Q ss_pred HHHHHHHcCCC-CceeEEeccccCCCceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcC-CCc
Q 005247 479 REVAIMKGLRH-PNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR-PPI 556 (706)
Q Consensus 479 ~Ei~iL~~L~H-pnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g-~~I 556 (706)
.|.-+++.+++ +++++++|+|-. .++.||...+++......-..-...++..+.+|+.++++.+.+|+..- ..+
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~ 83 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF 83 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence 58888888875 699999999843 789999987766432100001123679999999999999999999732 128
Q ss_pred ccccCCCCcEEECCCCcEEEeecCccccC
Q 005247 557 VHRDLKSPNLLVDSTYTVKVCDFGLSRSK 585 (706)
Q Consensus 557 IHrDLKp~NILl~~~~~vKL~DFGla~~~ 585 (706)
.-.|++++|+-++.++++|++|...+...
T Consensus 84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 84 YLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEeecchHHeEEeCCCcEEEEechhcchh
Confidence 88999999999999999999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.0003 Score=71.08 Aligned_cols=127 Identities=24% Similarity=0.317 Sum_probs=90.5
Q ss_pred CceEEEEEeccCCc-eEEEEEEEcCCceEEEEEecc---c-------cch---------HHHHHHHHHHHHHHcCC---C
Q 005247 433 SELLIKKKIGEGSF-GTVYHAEWRNSDVAVKILIEQ---E-------FHE---------DRFKEFLREVAIMKGLR---H 489 (706)
Q Consensus 433 ~~y~i~~~LG~G~f-G~Vy~a~~~~~~vAVKvl~~~---~-------~~~---------~~~~~~~~Ei~iL~~L~---H 489 (706)
.+++.++.||.|.- |.||+++..+..||+|+...- . ... ....-|..|.+...+|+ +
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~ 116 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR 116 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence 67889999999999 999999999999999994321 0 000 12235677887777764 4
Q ss_pred Cce--eEEeccccCC------------------CceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHH
Q 005247 490 PNI--VLLMGAVTEP------------------PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 549 (706)
Q Consensus 490 pnI--v~l~~~~~~~------------------~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yL 549 (706)
.++ |+++|+..-. ....||.||.+... .+. ..-+.+|.+-|..+
T Consensus 117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~----~~~~~~~~~dl~~~ 180 (207)
T PF13095_consen 117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQ----IRDIPQMLRDLKIL 180 (207)
T ss_pred cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccc----hhHHHHHHHHHHHH
Confidence 456 8888876211 12457888776533 111 22345778888899
Q ss_pred HhcCCCcccccCCCCcEEECCCCcEEEeecCcc
Q 005247 550 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS 582 (706)
Q Consensus 550 Hs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla 582 (706)
|..| |+-+|+|+.|.. + =||+|||.+
T Consensus 181 ~k~g--I~~~Dv~~~ny~---~--G~lvDfs~~ 206 (207)
T PF13095_consen 181 HKLG--IVPRDVKPRNYR---G--GKLVDFSSS 206 (207)
T ss_pred HHCC--eeeccCcccccc---C--CEEEecccC
Confidence 9999 999999999975 2 489999864
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.00022 Score=73.39 Aligned_cols=74 Identities=12% Similarity=0.116 Sum_probs=45.7
Q ss_pred EEEeccCCceE-EEEEEEcCCceEEEEEeccccchHHHHHHHHHHHHHHcCCCC---ceeEEeccccCC---CceEEEEE
Q 005247 438 KKKIGEGSFGT-VYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHP---NIVLLMGAVTEP---PNLSIVTE 510 (706)
Q Consensus 438 ~~~LG~G~fG~-Vy~a~~~~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~Hp---nIv~l~~~~~~~---~~~~lV~E 510 (706)
++.|+.|+... ||+. +..+++|+-.... ....+.+|..++..+... -+.++++..... ...+++|+
T Consensus 2 ~~~~~~gG~~n~vy~~---~~~~VlR~~~~~~----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~ 74 (235)
T cd05155 2 IEPVDSGGTDNATFRL---GDDMSVRLPSAAG----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYR 74 (235)
T ss_pred ceeccCCCcccceEEc---CCceEEEcCCccc----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEE
Confidence 35677777774 9976 3457777643211 234677899888877421 344444443332 23588999
Q ss_pred eccCCchh
Q 005247 511 YLSRGSLY 518 (706)
Q Consensus 511 ~~~ggsL~ 518 (706)
+++|.++.
T Consensus 75 ~i~G~~l~ 82 (235)
T cd05155 75 WLEGETAT 82 (235)
T ss_pred eecCCCCC
Confidence 99987764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00016 Score=71.24 Aligned_cols=132 Identities=23% Similarity=0.265 Sum_probs=92.2
Q ss_pred eEEEEEeccCCceEEEEEEEcCCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCcee-EEeccccCCCceEEEEEecc
Q 005247 435 LLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIV-LLMGAVTEPPNLSIVTEYLS 513 (706)
Q Consensus 435 y~i~~~LG~G~fG~Vy~a~~~~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv-~l~~~~~~~~~~~lV~E~~~ 513 (706)
..+.+.|++|++|.||++.+.+..+|+|+-.... ....+..|+++|..+.-.++. ++|.+..+ .+.|||+.
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds----~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~ 95 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWRGGEVALKVRRRDS----PRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYID 95 (201)
T ss_pred hhhhhhhhcccccEEEEeeccCceEEEEEecCCc----chhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhc
Confidence 3456789999999999999999999999965543 234677899999888755543 45554333 35599999
Q ss_pred CCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCC-CCcEEECCCCcEEEeecCccccCC
Q 005247 514 RGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLK-SPNLLVDSTYTVKVCDFGLSRSKP 586 (706)
Q Consensus 514 ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLK-p~NILl~~~~~vKL~DFGla~~~~ 586 (706)
|-.|.+..... +. +-...++++---|-..| |-|+.|. |..++|.+++.+.|+||..|+...
T Consensus 96 G~~L~~~~~~~------~r----k~l~~vlE~a~~LD~~G--I~H~El~~~~k~vlv~~~~~~iIDFd~At~k~ 157 (201)
T COG2112 96 GRPLGKLEIGG------DR----KHLLRVLEKAYKLDRLG--IEHGELSRPWKNVLVNDRDVYIIDFDSATFKK 157 (201)
T ss_pred Ccchhhhhhcc------cH----HHHHHHHHHHHHHHHhc--cchhhhcCCceeEEecCCcEEEEEccchhhcc
Confidence 98877654311 12 22335556655677778 9999986 444444455589999999887543
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00055 Score=73.44 Aligned_cols=79 Identities=14% Similarity=0.029 Sum_probs=57.1
Q ss_pred eEEEEEeccCCceEEEEEEEcCCceEEEEEeccccchHHHHHHHHHHHHHHcCCC---CceeEEeccccC---CCceEEE
Q 005247 435 LLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRH---PNIVLLMGAVTE---PPNLSIV 508 (706)
Q Consensus 435 y~i~~~LG~G~fG~Vy~a~~~~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~H---pnIv~l~~~~~~---~~~~~lV 508 (706)
..-.+.||.|..+.||+....+..+++|..+. ... ...+.+|...|+.|.. ..+.++++++.. .+..++|
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~~~~~~~~k~~~~-~~~---~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV 91 (297)
T PRK10593 16 LSRVECISEQPYAALWALYDSQGNPMPLMARS-FST---PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL 91 (297)
T ss_pred hheeeecCCccceeEEEEEcCCCCEEEEEecc-ccc---chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence 34567899999999999987666777787432 111 1367789998888742 357777776543 4668999
Q ss_pred EEeccCCch
Q 005247 509 TEYLSRGSL 517 (706)
Q Consensus 509 ~E~~~ggsL 517 (706)
||+++++++
T Consensus 92 mE~i~G~~~ 100 (297)
T PRK10593 92 LERLRGVSV 100 (297)
T ss_pred EeccCCEec
Confidence 999998765
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00045 Score=84.16 Aligned_cols=146 Identities=20% Similarity=0.262 Sum_probs=89.0
Q ss_pred EEEeccCCceEEEEEEEcCC----ceEEEEEeccccchHHHHHHHHHHHHHHcCC-CCce--eEEeccccCC---CceEE
Q 005247 438 KKKIGEGSFGTVYHAEWRNS----DVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNI--VLLMGAVTEP---PNLSI 507 (706)
Q Consensus 438 ~~~LG~G~fG~Vy~a~~~~~----~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~-HpnI--v~l~~~~~~~---~~~~l 507 (706)
++.++.|.+..+|+....+. .+++|+....... .....+.+|+.+++.+. |.++ .+++.++.+. +..++
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~-~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl 121 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL-QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY 121 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC-ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence 67889999999999876552 4666664332211 12246779999999985 6654 6777777654 46789
Q ss_pred EEEeccCCchhhh-----------------------cccCCCc--------cc--ccHHHHHHHHH--------------
Q 005247 508 VTEYLSRGSLYKL-----------------------LHIPDAR--------VV--VDERLRLNMAY-------------- 540 (706)
Q Consensus 508 V~E~~~ggsL~~~-----------------------l~~~~~~--------~~--l~~~~~~~ia~-------------- 540 (706)
||||++|..+.+. ||..... .+ ....++..+..
T Consensus 122 VME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~ 201 (822)
T PLN02876 122 IMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRN 201 (822)
T ss_pred EEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCC
Confidence 9999988653321 1111000 00 00112221111
Q ss_pred -HHHHHHHHHHhcCC---------CcccccCCCCcEEECCC-C-cEEEeecCcccc
Q 005247 541 -DVAKGMNYLHQRRP---------PIVHRDLKSPNLLVDST-Y-TVKVCDFGLSRS 584 (706)
Q Consensus 541 -qIl~aL~yLHs~g~---------~IIHrDLKp~NILl~~~-~-~vKL~DFGla~~ 584 (706)
.+...+.+|..+-| .+||+|++++|||++.+ + .+-|+||.++..
T Consensus 202 ~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 202 PKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred hhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 12334566654322 39999999999999752 3 357999998764
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.00056 Score=69.15 Aligned_cols=131 Identities=22% Similarity=0.346 Sum_probs=91.7
Q ss_pred EEeccCCceEEEEEEEcCCceEEEEEeccc--------------cchHHHHHHHHHHHHHHcCC------CCceeEEecc
Q 005247 439 KKIGEGSFGTVYHAEWRNSDVAVKILIEQE--------------FHEDRFKEFLREVAIMKGLR------HPNIVLLMGA 498 (706)
Q Consensus 439 ~~LG~G~fG~Vy~a~~~~~~vAVKvl~~~~--------------~~~~~~~~~~~Ei~iL~~L~------HpnIv~l~~~ 498 (706)
..||+|+.-.||.-- .+...+||+..... ......++..+|+.....+. +.+|.+++|+
T Consensus 7 ~~i~~G~~R~cy~HP-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~ 85 (199)
T PF10707_consen 7 DLIAQGGERDCYQHP-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYGF 85 (199)
T ss_pred cccccCCCceEEECC-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeEE
Confidence 478999999999642 22347889986655 11123456667777666665 7889999999
Q ss_pred ccCCCceEEEEEeccC------CchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCC
Q 005247 499 VTEPPNLSIVTEYLSR------GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY 572 (706)
Q Consensus 499 ~~~~~~~~lV~E~~~g------gsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~ 572 (706)
.+.+-..-+|+|.+.. .+|.++++... ++. .+...+-+-..||-+++ |+.+|++|.||++....
T Consensus 86 veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~----~~~----~~~~~L~~f~~~l~~~~--Iv~~dl~~~NIv~~~~~ 155 (199)
T PF10707_consen 86 VETNLGLGLVVELIRDADGNISPTLEDYLKEGG----LTE----ELRQALDEFKRYLLDHH--IVIRDLNPHNIVVQRRD 155 (199)
T ss_pred EecCCceEEEEEEEECCCCCcCccHHHHHHcCC----ccH----HHHHHHHHHHHHHHHcC--CeecCCCcccEEEEecC
Confidence 9999889999998743 35777774332 333 23344455567888888 99999999999995322
Q ss_pred ----cEEEee-cC
Q 005247 573 ----TVKVCD-FG 580 (706)
Q Consensus 573 ----~vKL~D-FG 580 (706)
.+.|+| ||
T Consensus 156 ~~~~~lvlIDG~G 168 (199)
T PF10707_consen 156 SGEFRLVLIDGLG 168 (199)
T ss_pred CCceEEEEEeCCC
Confidence 578887 44
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.0013 Score=67.43 Aligned_cols=73 Identities=18% Similarity=0.205 Sum_probs=45.9
Q ss_pred EEEeccCCceEEEEEEEc---CCceEEEEEeccccchHHHHHHHHHHHHHHcCCC-CceeEEeccccCCCceEEEEEecc
Q 005247 438 KKKIGEGSFGTVYHAEWR---NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRH-PNIVLLMGAVTEPPNLSIVTEYLS 513 (706)
Q Consensus 438 ~~~LG~G~fG~Vy~a~~~---~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~H-pnIv~l~~~~~~~~~~~lV~E~~~ 513 (706)
++.|..|-...+|++... +..|++|+..... . ......+|+.+++.+.. .-.++++..+.. .++|||++
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~--~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~~----~~l~e~i~ 75 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKT--E-LIIDRERELRIHKLLSKHGLAPKLYATFQN----GLIYEFIP 75 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCc--c-ceecHHHHHHHHHHHHhCCCCCeEEEEeCC----cEEEEeeC
Confidence 467888889999999866 3568888754321 1 11122368888887743 223445544331 48999999
Q ss_pred CCch
Q 005247 514 RGSL 517 (706)
Q Consensus 514 ggsL 517 (706)
|.++
T Consensus 76 G~~l 79 (235)
T cd05157 76 GRTL 79 (235)
T ss_pred CCcC
Confidence 8765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.00065 Score=82.34 Aligned_cols=232 Identities=18% Similarity=0.176 Sum_probs=152.7
Q ss_pred eccCCceEEEEEEEcCC------ceEEEEEecccc-chHHHHHHHHHHHHHHcCCCCceeEEeccccCCCce----EEEE
Q 005247 441 IGEGSFGTVYHAEWRNS------DVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNL----SIVT 509 (706)
Q Consensus 441 LG~G~fG~Vy~a~~~~~------~vAVKvl~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~----~lV~ 509 (706)
+..-.+|+++..++... .+.++.-..... ....+.....|+..+..+.|+|++.++.+..+.-.. .+..
T Consensus 186 ls~~~~~~l~l~k~~~~~qs~~~~~~~s~~~~~~~~~k~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~ 265 (1351)
T KOG1035|consen 186 LSHLTQGTLLLVKWVEQAQSLSEPIEISHDYESTPCGKKEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQ 265 (1351)
T ss_pred eccccCceEEEEehhhhHHhhcCcccccCcccCccchHHHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHH
Confidence 55666777777765321 122211111111 123334445677788888999999998886544322 2445
Q ss_pred EeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCC---cEEECCCCcEEEe--ecCcccc
Q 005247 510 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSP---NLLVDSTYTVKVC--DFGLSRS 584 (706)
Q Consensus 510 E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~---NILl~~~~~vKL~--DFGla~~ 584 (706)
++++..++...++.. ..++....+.+..++.+||+|+|+.. ..|.-+... +--.+..+.+.+. ||+....
T Consensus 266 ~~~s~~~~~~~~q~v---~~i~~~~~r~~~~~~~~GL~~~h~~~--l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~ 340 (1351)
T KOG1035|consen 266 EICSKVELRSLLQSV---GSIPLETLRILHQKLLEGLAYLHSLS--LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKP 340 (1351)
T ss_pred hhcCccchHHHHhhc---cccCHHHHHHHHHHHhhhHHHHHHhc--cceeEEecccccccccCccceeecchhhhccccc
Confidence 778887887777633 35888899999999999999999987 666655555 4444566677777 9998877
Q ss_pred CCCCcccCCCCCCCCCccCccccccCCCCc--hhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcH
Q 005247 585 KPNTYISSKTAAGTPEWMAPEVLREDPSNE--KSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNP 662 (706)
Q Consensus 585 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~--ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~ 662 (706)
.++.... ....-+..|.++|......++. ..|+|.+|..+..+..|..+-...... ..-++.....
T Consensus 341 l~d~~~~-~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~~~-----------~~~l~~~~~~ 408 (1351)
T KOG1035|consen 341 LPDNEKS-FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSAVP-----------VSLLDVLSTS 408 (1351)
T ss_pred CCCcccc-hhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCcccccccch-----------hhhhccccch
Confidence 6665432 2334456778888877666554 479999999999999876542211100 0011122223
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 005247 663 MVAALIETCWAEEPEIRPSFPSIMETL 689 (706)
Q Consensus 663 el~dLI~~cL~~dP~~RPS~~eIl~~L 689 (706)
+..+...+|+..++++|+++.+++...
T Consensus 409 ~~~d~~~~~~~~~~~~Rl~~~~ll~~~ 435 (1351)
T KOG1035|consen 409 ELLDALPKCLDEDSEERLSALELLTHP 435 (1351)
T ss_pred hhhhhhhhhcchhhhhccchhhhhhch
Confidence 788899999999999999999988743
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.0017 Score=69.04 Aligned_cols=142 Identities=15% Similarity=0.118 Sum_probs=83.8
Q ss_pred EEEeccCCceEEEEEEEcCCceEEEEEeccccchHHHHHHHHHHHHHHcCCCC--ceeEEecc------ccCCCceEEEE
Q 005247 438 KKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHP--NIVLLMGA------VTEPPNLSIVT 509 (706)
Q Consensus 438 ~~~LG~G~fG~Vy~a~~~~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~Hp--nIv~l~~~------~~~~~~~~lV~ 509 (706)
.+.|..|....+|+....+..+++|+... .. ......|+.++..+.+. .+.+++.. ....+..++++
T Consensus 19 i~~i~~G~~n~~y~v~~~~~~~vLr~~~~--~~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~ 93 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSGRYVLTLFEK--VS---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV 93 (296)
T ss_pred eecccCccccceEEEEeCCCcEEEEEcCC--CC---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence 66788888899999987777899998643 11 13455677777776432 24444432 12345578999
Q ss_pred EeccCCchhhh--------------cccC--CCc------ccccHHH----------HHHHHHHHHHHHHHHHh-----c
Q 005247 510 EYLSRGSLYKL--------------LHIP--DAR------VVVDERL----------RLNMAYDVAKGMNYLHQ-----R 552 (706)
Q Consensus 510 E~~~ggsL~~~--------------l~~~--~~~------~~l~~~~----------~~~ia~qIl~aL~yLHs-----~ 552 (706)
++++|..+... +|.. ... ....+.. .......+..++.++.+ .
T Consensus 94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~ 173 (296)
T cd05153 94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL 173 (296)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 99998765320 0100 000 0000000 00111223334445443 1
Q ss_pred CCCcccccCCCCcEEECCCCcEEEeecCcccc
Q 005247 553 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 584 (706)
Q Consensus 553 g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~ 584 (706)
...++|+|+.|.||++++++.+.|+||+.+..
T Consensus 174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 174 PRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 12499999999999999887778999987654
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.0011 Score=76.20 Aligned_cols=142 Identities=19% Similarity=0.220 Sum_probs=86.7
Q ss_pred EEEeccCCceEEEEEEEcCC-ceEEEEEeccccc-----------------------------hHHHH------HHHHHH
Q 005247 438 KKKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFH-----------------------------EDRFK------EFLREV 481 (706)
Q Consensus 438 ~~~LG~G~fG~Vy~a~~~~~-~vAVKvl~~~~~~-----------------------------~~~~~------~~~~Ei 481 (706)
.+.||.-+.|.||+|+.++. .||||+-...-.. .+..+ .|.+|.
T Consensus 166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 47899999999999988764 4999986432100 01111 133444
Q ss_pred HHHHcC----CCCc------eeEEeccccCCCceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHh
Q 005247 482 AIMKGL----RHPN------IVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 551 (706)
Q Consensus 482 ~iL~~L----~Hpn------Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs 551 (706)
+...+. .|-+ |.+++-.+ .....++||||+|..+.++-...... ++...+..-+.+... +-|=.
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~g--i~~~~i~~~l~~~~~--~qIf~ 319 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKRG--ISPHDILNKLVEAYL--EQIFK 319 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHcC--CCHHHHHHHHHHHHH--HHHHh
Confidence 433322 3434 44444332 23468999999999888775332221 444433333222221 22234
Q ss_pred cCCCcccccCCCCcEEECC----CCcEEEeecCccccCCC
Q 005247 552 RRPPIVHRDLKSPNLLVDS----TYTVKVCDFGLSRSKPN 587 (706)
Q Consensus 552 ~g~~IIHrDLKp~NILl~~----~~~vKL~DFGla~~~~~ 587 (706)
.| ++|+|=.|.||++.. ++.+.+.|||+......
T Consensus 320 ~G--ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 320 TG--FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred cC--CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 57 999999999999983 66899999999876543
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.30 E-value=3.8e-05 Score=94.18 Aligned_cols=206 Identities=14% Similarity=0.011 Sum_probs=135.2
Q ss_pred HHHHHHHHHHcCCCCceeEEecccc--CCCceEEEEEeccCCchhhhcccCC-CcccccHHHHHHHHHHHHHHHHHHHhc
Q 005247 476 EFLREVAIMKGLRHPNIVLLMGAVT--EPPNLSIVTEYLSRGSLYKLLHIPD-ARVVVDERLRLNMAYDVAKGMNYLHQR 552 (706)
Q Consensus 476 ~~~~Ei~iL~~L~HpnIv~l~~~~~--~~~~~~lV~E~~~ggsL~~~l~~~~-~~~~l~~~~~~~ia~qIl~aL~yLHs~ 552 (706)
..+.|.+.++...|+++...+.-.. +....+..++++.+|.+.+.+-... ....++..-+.....+.+.+..-+|+.
T Consensus 1275 mll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~ 1354 (2724)
T KOG1826|consen 1275 MLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSL 1354 (2724)
T ss_pred hhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhc
Confidence 3444555566678998887665442 2334678999999999999884332 222333333333344446666666653
Q ss_pred ---CCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHH
Q 005247 553 ---RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELI 629 (706)
Q Consensus 553 ---g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELl 629 (706)
|...+|+++|+-|.+|..+.++|+.++|+.+.............+++.|+.|++...-.++.++|+|..|+-+|+..
T Consensus 1355 tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1355 TNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred ccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence 34579999999999999999999999999995555444556678899999999999989999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHHHHhhhhCCCCCCCH
Q 005247 630 TLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSF 682 (706)
Q Consensus 630 tG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~ 682 (706)
.|..+|....... ...+........++.-.|.+...+...+|-..-..||.-
T Consensus 1435 ~~n~~fi~flq~~-Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q 1486 (2724)
T KOG1826|consen 1435 DGNAYFIFFLQPA-LKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQ 1486 (2724)
T ss_pred cccHHHHHHHHHH-HcCcccccccccccccCCCcccHHHHHHHHHHhhhcchh
Confidence 8877764332211 111212222233333334444444444444444555543
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.0013 Score=68.68 Aligned_cols=138 Identities=12% Similarity=0.065 Sum_probs=75.8
Q ss_pred EeccCCceEEEEEEEcCCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCce-eEEeccccCCCceEEEEEeccCCchh
Q 005247 440 KIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNI-VLLMGAVTEPPNLSIVTEYLSRGSLY 518 (706)
Q Consensus 440 ~LG~G~fG~Vy~a~~~~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnI-v~l~~~~~~~~~~~lV~E~~~ggsL~ 518 (706)
.+..|-...+|+....+..+++|+..... ....-...+|..+++.+....+ .+++.... -++||||++|..+.
T Consensus 3 ~~~~G~tn~~y~~~~~~~~~vlR~~~~~~--~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~ 76 (256)
T TIGR02721 3 TLSGGLTNRSWRIEHPGISFVWRPQSPVC--KALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVIT 76 (256)
T ss_pred cCCCcCcCCeEEEEeCCccEEEeeCCccc--ccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccc
Confidence 34568888999998777778888643221 1100124568888887753222 33443322 36899999987654
Q ss_pred hh-----------------cccCCC-cccccH-HHHHHHHHHH---------HHHHHHHHhc------CCCcccccCCCC
Q 005247 519 KL-----------------LHIPDA-RVVVDE-RLRLNMAYDV---------AKGMNYLHQR------RPPIVHRDLKSP 564 (706)
Q Consensus 519 ~~-----------------l~~~~~-~~~l~~-~~~~~ia~qI---------l~aL~yLHs~------g~~IIHrDLKp~ 564 (706)
.. +|.... ...++. ..+..+..++ ...+..+-.. .+.++|+|+.|.
T Consensus 77 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~ 156 (256)
T TIGR02721 77 LDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY 156 (256)
T ss_pred cccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence 21 111111 111111 1111111111 1112222211 124899999999
Q ss_pred cEEECCCCcEEEeecCcccc
Q 005247 565 NLLVDSTYTVKVCDFGLSRS 584 (706)
Q Consensus 565 NILl~~~~~vKL~DFGla~~ 584 (706)
||++++++ +.|+||..+..
T Consensus 157 Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 157 NLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred cEEEeCCC-CEEEeccccCc
Confidence 99999877 78999987654
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.0058 Score=65.58 Aligned_cols=147 Identities=20% Similarity=0.221 Sum_probs=83.4
Q ss_pred ceEEEEEeccCCceEEEEEEEcCCceEEEEEeccccchHHHHHHHHHHHHHHcCCCC--ceeEEeccc------cCCCce
Q 005247 434 ELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHP--NIVLLMGAV------TEPPNL 505 (706)
Q Consensus 434 ~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~Hp--nIv~l~~~~------~~~~~~ 505 (706)
....++.++.|....+|+++..+..+++|+..... .. +....|++++..|... .+.+++... ...+..
T Consensus 23 ~~~~i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~-~~---~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~ 98 (307)
T TIGR00938 23 ELLSLKGIAEGVENSNYLLTTDVGRYILTLYEKRV-KA---EELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKP 98 (307)
T ss_pred CceeccccCCccccceEEEEeCCCcEEEEEecCCC-CH---HHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeE
Confidence 34456778888888999998776678888764321 12 2344566666666321 233443321 224567
Q ss_pred EEEEEeccCCchhhh--------------cccCCCc------c--cc-cHHHH------------HHHHHHHHHHHHHHH
Q 005247 506 SIVTEYLSRGSLYKL--------------LHIPDAR------V--VV-DERLR------------LNMAYDVAKGMNYLH 550 (706)
Q Consensus 506 ~lV~E~~~ggsL~~~--------------l~~~~~~------~--~l-~~~~~------------~~ia~qIl~aL~yLH 550 (706)
+++++|++|..+... +|..... . .. .+... ......+...++++.
T Consensus 99 ~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~ 178 (307)
T TIGR00938 99 ACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLD 178 (307)
T ss_pred EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHH
Confidence 899999988553211 1110000 0 00 00000 001122334455554
Q ss_pred h-----cCCCcccccCCCCcEEECCCCcEEEeecCcccc
Q 005247 551 Q-----RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 584 (706)
Q Consensus 551 s-----~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~ 584 (706)
. ....++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 179 ~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 179 KFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred hhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 3 123499999999999999888778999997643
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.01 E-value=0.0065 Score=65.35 Aligned_cols=142 Identities=15% Similarity=0.152 Sum_probs=75.6
Q ss_pred EEEeccCCceEEEEEEEcCCceEEEEEeccccchHHHHHHHHHHHHHHcCC-----CCceeEEe-c--cccCCCceEEEE
Q 005247 438 KKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR-----HPNIVLLM-G--AVTEPPNLSIVT 509 (706)
Q Consensus 438 ~~~LG~G~fG~Vy~a~~~~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~-----HpnIv~l~-~--~~~~~~~~~lV~ 509 (706)
.+.|+.|....+|+.+..+..+++|+.. ..... ....|+.++..|. .|.++... + +....+..++++
T Consensus 27 ~~~l~~G~~n~~y~v~t~~g~~vLK~~~--~~~~~---~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~ 101 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTTQGEYVLTLFE--RLTAE---DLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIV 101 (319)
T ss_pred cchhccccccceEEEEeCCCcEEEEEec--cCChH---HhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEE
Confidence 4567778888999998777789999864 22222 2233444444442 33333211 0 112245678999
Q ss_pred EeccCCchhh-----h------c---ccCCCc--------ccc-cHHH-HH-----------HHHHH-HHHHHHHHHh--
Q 005247 510 EYLSRGSLYK-----L------L---HIPDAR--------VVV-DERL-RL-----------NMAYD-VAKGMNYLHQ-- 551 (706)
Q Consensus 510 E~~~ggsL~~-----~------l---~~~~~~--------~~l-~~~~-~~-----------~ia~q-Il~aL~yLHs-- 551 (706)
+|++|..+.. . + |..... ..+ .+.. .. ..+.+ +...++.+..
T Consensus 102 ~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 181 (319)
T PRK05231 102 TFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAA 181 (319)
T ss_pred EecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccc
Confidence 9998865321 1 1 110000 000 0000 00 01111 1112233321
Q ss_pred ---cCCCcccccCCCCcEEECCCCcEEEeecCcccc
Q 005247 552 ---RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 584 (706)
Q Consensus 552 ---~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~ 584 (706)
...++||+|+.|.||+++++...-|+||+.+..
T Consensus 182 ~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 182 WPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 112499999999999998765568999997754
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.98 E-value=0.0073 Score=67.42 Aligned_cols=77 Identities=18% Similarity=0.099 Sum_probs=52.0
Q ss_pred EEEeccCCceEEEEEEEcCC--ceEEEEEecc-----ccchHHHHHHHHHHHHHHcCC---CCceeEEeccccCCCceEE
Q 005247 438 KKKIGEGSFGTVYHAEWRNS--DVAVKILIEQ-----EFHEDRFKEFLREVAIMKGLR---HPNIVLLMGAVTEPPNLSI 507 (706)
Q Consensus 438 ~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~-----~~~~~~~~~~~~Ei~iL~~L~---HpnIv~l~~~~~~~~~~~l 507 (706)
.+.||.|.+..||++...+. .++||.-... ....-..+.+..|.+.|+.+. ..++++++.+. +...++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCCCEE
Confidence 56899999999999988764 6888874211 100123346667788887763 24577777763 355789
Q ss_pred EEEeccCCc
Q 005247 508 VTEYLSRGS 516 (706)
Q Consensus 508 V~E~~~ggs 516 (706)
|||++++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999997643
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.81 E-value=0.0073 Score=64.44 Aligned_cols=74 Identities=19% Similarity=0.281 Sum_probs=45.0
Q ss_pred EEEeccCCceEEEEEEEcC--------CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCc-eeEEeccccCCCceEEE
Q 005247 438 KKKIGEGSFGTVYHAEWRN--------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN-IVLLMGAVTEPPNLSIV 508 (706)
Q Consensus 438 ~~~LG~G~fG~Vy~a~~~~--------~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~Hpn-Iv~l~~~~~~~~~~~lV 508 (706)
++.|..|-...+|++...+ ..+++|+..... .......+|..+++.+.... ..+++.++.. .+|
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v 75 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV---ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRI 75 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC---cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cch
Confidence 4566677778899987653 458888854321 11234457777777774322 3345554432 358
Q ss_pred EEeccCCchh
Q 005247 509 TEYLSRGSLY 518 (706)
Q Consensus 509 ~E~~~ggsL~ 518 (706)
+||++|..+.
T Consensus 76 ~e~i~G~~l~ 85 (302)
T cd05156 76 EEFIPSRTLT 85 (302)
T ss_pred hheeCCCcCC
Confidence 9999887664
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >smart00460 TGc Transglutaminase/protease-like homologues | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.0012 Score=54.28 Aligned_cols=53 Identities=23% Similarity=0.255 Sum_probs=42.9
Q ss_pred cccccchhhHHHHHHHhhhcCCCcccccccccC---------CCCCCCeeEEEeCCCchhhhh
Q 005247 205 LSVGLCVHRALLFKVLADLINLPCRIAKGCKYC---------RRDDASSCLVQIGPDREYLVD 258 (706)
Q Consensus 205 ~~~g~~r~ra~lfk~lad~~~~~~~lv~g~~~~---------~~~~~~~~~~~~~~~~~~~vd 258 (706)
-+.|.|.+.|.||+.|+-.+|||||+|.|..-. ....|+++.|.++ ++=+.+|
T Consensus 4 ~~~G~C~~~a~l~~~llr~~GIpar~v~g~~~~~~~~~~~~~~~~~H~W~ev~~~-~~W~~~D 65 (68)
T smart00460 4 TKYGTCGEFAALFVALLRSLGIPARVVSGYLKAPDTIGGLRSIWEAHAWAEVYLE-GGWVPVD 65 (68)
T ss_pred ccceeeHHHHHHHHHHHHHCCCCeEEEeeeecCCCCCcccccCCCcEEEEEEEEC-CCeEEEe
Confidence 368999999999999999999999999994332 2678889999985 5544444
|
Transglutaminases are enzymes that establish covalent links between proteins. A subset of transglutaminase homologues appear to catalyse the reverse reaction, the hydrolysis of peptide bonds. Proteins with this domain are both extracellular and intracellular, and it is likely that the eukaryotic intracellular proteins are involved in signalling events. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.66 E-value=0.023 Score=61.49 Aligned_cols=143 Identities=20% Similarity=0.227 Sum_probs=87.6
Q ss_pred ceEEEEEeccCCceEEEEEEEcCCceEEEEEeccccchHHHHHHHHHHHHHHcCCC--CceeEEeccccCCC--ceEEEE
Q 005247 434 ELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRH--PNIVLLMGAVTEPP--NLSIVT 509 (706)
Q Consensus 434 ~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~H--pnIv~l~~~~~~~~--~~~lV~ 509 (706)
...+++.+-.|..-.+|.....+..+++. +..............+|+.+++.+.- .-+...++.+.++. ..+.||
T Consensus 26 ~~~~v~~~~~G~sn~t~~~~~~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~ 104 (321)
T COG3173 26 GLLIVEEISGGWSNDTFRLGDTGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVM 104 (321)
T ss_pred CCceeeeccCCcccceEEEecCCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEE
Confidence 34455566555555566666666667777 33222233444566788888887743 23445566665554 679999
Q ss_pred EeccCCchhhhcccCCCcccccHHHHHHHHH-HHHHHHHHHHh-------------------------------------
Q 005247 510 EYLSRGSLYKLLHIPDARVVVDERLRLNMAY-DVAKGMNYLHQ------------------------------------- 551 (706)
Q Consensus 510 E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~-qIl~aL~yLHs------------------------------------- 551 (706)
+|++|..+...+.... .. .+++. .+.+.|+.||+
T Consensus 105 ~~veGe~~~~~~~~~~----~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~ 176 (321)
T COG3173 105 EWVEGEVVWSALPPES----LG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGR 176 (321)
T ss_pred EEecceeccCcCCccc----ch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCC
Confidence 9998854433332111 00 11222 44444444444
Q ss_pred -------------cC------CCcccccCCCCcEEECCCCcEEEeecCccccC
Q 005247 552 -------------RR------PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK 585 (706)
Q Consensus 552 -------------~g------~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~ 585 (706)
+- +.++|+|+.+.||+++.++-+=++||+.+...
T Consensus 177 ~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 177 IPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred CchHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 22 14899999999999999888999999987653
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.64 E-value=0.0021 Score=68.86 Aligned_cols=141 Identities=19% Similarity=0.166 Sum_probs=97.5
Q ss_pred ccccCceEEEEEeccCCceEEEEEEEc-CCceEEEEEeccccc--------------------hHHHHHHHHHHHHHHcC
Q 005247 429 EIRWSELLIKKKIGEGSFGTVYHAEWR-NSDVAVKILIEQEFH--------------------EDRFKEFLREVAIMKGL 487 (706)
Q Consensus 429 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~-~~~vAVKvl~~~~~~--------------------~~~~~~~~~Ei~iL~~L 487 (706)
..+..-+.+++.||-|.-+.||.+-+. +++.++|.-...... .-..-...+|...|+.|
T Consensus 88 ~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL 167 (465)
T KOG2268|consen 88 SNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKAL 167 (465)
T ss_pred HhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHH
Confidence 333445678899999999999999876 667887753211100 00012345688888877
Q ss_pred CC-C-ceeEEeccccCCCceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCc
Q 005247 488 RH-P-NIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPN 565 (706)
Q Consensus 488 ~H-p-nIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~N 565 (706)
.. . -+.+.++ .+..++|||++.|-+|...-+..+ ...+...+..-+--|-.+| +||+|+.-=|
T Consensus 168 ~e~gfpVPkpiD----~~RH~Vvmelv~g~Pl~~v~~v~d---------~~~ly~~lm~~Iv~la~~G--lIHgDFNEFN 232 (465)
T KOG2268|consen 168 YERGFPVPKPID----HNRHCVVMELVDGYPLRQVRHVED---------PPTLYDDLMGLIVRLANHG--LIHGDFNEFN 232 (465)
T ss_pred HHcCCCCCCccc----ccceeeHHHhhcccceeeeeecCC---------hHHHHHHHHHHHHHHHHcC--ceecccchhe
Confidence 42 2 1333333 355799999999988877654332 2345556666677888899 9999999999
Q ss_pred EEECCCCcEEEeecCcccc
Q 005247 566 LLVDSTYTVKVCDFGLSRS 584 (706)
Q Consensus 566 ILl~~~~~vKL~DFGla~~ 584 (706)
|++.+++.++++||-....
T Consensus 233 imv~dd~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 233 IMVKDDDKIVVIDFPQMVS 251 (465)
T ss_pred eEEecCCCEEEeechHhhc
Confidence 9999999999999986544
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.22 E-value=0.024 Score=60.69 Aligned_cols=76 Identities=16% Similarity=0.167 Sum_probs=47.3
Q ss_pred eEEEEEeccCCceEEEEEEEcCCceEEEEEeccccchHHHHHHHHHHHHHHcCC---CCceeEEeccccCCCceEEEEEe
Q 005247 435 LLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR---HPNIVLLMGAVTEPPNLSIVTEY 511 (706)
Q Consensus 435 y~i~~~LG~G~fG~Vy~a~~~~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~---HpnIv~l~~~~~~~~~~~lV~E~ 511 (706)
.+-.+.++.|....+|+....+..+.||+-.... ...|..|..-|+.|. --.+.+.+++....+..+++|||
T Consensus 19 i~~~~~v~GG~i~~a~~~~~~~~~~FvK~~~~~~-----~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~ 93 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLDTDGGSYFVKVNSESG-----RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEF 93 (288)
T ss_dssp --EEEEE--SSSSEEEEEETTS-EEEEEEEEGGG-----CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-
T ss_pred eeeeEecCCCChhheEEEECCCccEEEEecChhh-----HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEe
Confidence 3456789999999999998777779999875221 135667777777773 44577888887766777999999
Q ss_pred ccCC
Q 005247 512 LSRG 515 (706)
Q Consensus 512 ~~gg 515 (706)
++.+
T Consensus 94 l~~~ 97 (288)
T PF03881_consen 94 LEMG 97 (288)
T ss_dssp ----
T ss_pred ecCC
Confidence 9776
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.05 E-value=0.048 Score=57.97 Aligned_cols=30 Identities=23% Similarity=0.422 Sum_probs=24.9
Q ss_pred CcccccCCCCcEEECCCCc-EEEeecCcccc
Q 005247 555 PIVHRDLKSPNLLVDSTYT-VKVCDFGLSRS 584 (706)
Q Consensus 555 ~IIHrDLKp~NILl~~~~~-vKL~DFGla~~ 584 (706)
.++|+|++|.|||+++++. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999987554 56999997654
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.05 E-value=0.037 Score=59.00 Aligned_cols=28 Identities=29% Similarity=0.423 Sum_probs=24.5
Q ss_pred CcccccCCCCcEEECCCCcEEEeecCccc
Q 005247 555 PIVHRDLKSPNLLVDSTYTVKVCDFGLSR 583 (706)
Q Consensus 555 ~IIHrDLKp~NILl~~~~~vKL~DFGla~ 583 (706)
+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 188 ~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 188 GFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred ceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 4899999999999987 678999998654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.00 E-value=0.057 Score=60.42 Aligned_cols=76 Identities=14% Similarity=0.107 Sum_probs=50.4
Q ss_pred EEEEeccCCceEEEEEEEcCCceEEEEEec-----cccchHHHHHHHHHHHHHHcCC---CCceeEEeccccCCCceEEE
Q 005247 437 IKKKIGEGSFGTVYHAEWRNSDVAVKILIE-----QEFHEDRFKEFLREVAIMKGLR---HPNIVLLMGAVTEPPNLSIV 508 (706)
Q Consensus 437 i~~~LG~G~fG~Vy~a~~~~~~vAVKvl~~-----~~~~~~~~~~~~~Ei~iL~~L~---HpnIv~l~~~~~~~~~~~lV 508 (706)
..+.||.|....||+....+..++||.-.. ....+-.......|...|+.+. ..++.+++.++. +..+++
T Consensus 36 ~~~eiggGn~N~VyrV~~~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSSSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred eEEEcCCCceeeEEEEEcCCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 477899999999999988766688887431 1100012233344566666553 247788888776 346788
Q ss_pred EEeccC
Q 005247 509 TEYLSR 514 (706)
Q Consensus 509 ~E~~~g 514 (706)
||++++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999976
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.94 E-value=0.061 Score=58.88 Aligned_cols=144 Identities=24% Similarity=0.227 Sum_probs=94.6
Q ss_pred EEEEEeccCCceEEEEEEEc-CCceEEEEEecccc-----------------------chHHHH-HHHHHHHHHHcCCCC
Q 005247 436 LIKKKIGEGSFGTVYHAEWR-NSDVAVKILIEQEF-----------------------HEDRFK-EFLREVAIMKGLRHP 490 (706)
Q Consensus 436 ~i~~~LG~G~fG~Vy~a~~~-~~~vAVKvl~~~~~-----------------------~~~~~~-~~~~Ei~iL~~L~Hp 490 (706)
.+...|..|--+.||.|... |..+|||+.+-+.. .....+ -...|+..|++++..
T Consensus 147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 46678999999999999764 45599998753221 111122 234688888888665
Q ss_pred ceeEEeccccCCCceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHh-cCCCcccccCCCCcEEEC
Q 005247 491 NIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ-RRPPIVHRDLKSPNLLVD 569 (706)
Q Consensus 491 nIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs-~g~~IIHrDLKp~NILl~ 569 (706)
.|.----+.. ....+||+|+.+ +-+-.=.. ....+....+..+..+++.-+.-|-+ .+ +||.||.--|+|+
T Consensus 227 GIP~PePIlL--k~hVLVM~FlGr-dgw~aPkL--Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c~--LVHADLSEfN~Ly- 298 (520)
T KOG2270|consen 227 GIPCPEPILL--KNHVLVMEFLGR-DGWAAPKL--KDASLSTSKARELYQQCVRIMRRLYQKCR--LVHADLSEFNLLY- 298 (520)
T ss_pred CCCCCCceee--ecceEeeeeccC-CCCcCccc--ccccCChHHHHHHHHHHHHHHHHHHHHhc--eeccchhhhhheE-
Confidence 5432111111 224799999954 32221111 12235666788888888888887764 45 9999999999999
Q ss_pred CCCcEEEeecCccccCCC
Q 005247 570 STYTVKVCDFGLSRSKPN 587 (706)
Q Consensus 570 ~~~~vKL~DFGla~~~~~ 587 (706)
.+|.++|+|-+.+.....
T Consensus 299 hdG~lyiIDVSQSVE~DH 316 (520)
T KOG2270|consen 299 HDGKLYIIDVSQSVEHDH 316 (520)
T ss_pred ECCEEEEEEccccccCCC
Confidence 556899999997765443
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.79 E-value=0.073 Score=57.24 Aligned_cols=30 Identities=23% Similarity=0.234 Sum_probs=27.1
Q ss_pred CcccccCCCCcEEECCCCcEEEeecCcccc
Q 005247 555 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 584 (706)
Q Consensus 555 ~IIHrDLKp~NILl~~~~~vKL~DFGla~~ 584 (706)
+++|+|+.++|||+++++.+.++||..++.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 499999999999999998999999987654
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=95.77 E-value=0.044 Score=60.09 Aligned_cols=140 Identities=19% Similarity=0.251 Sum_probs=75.5
Q ss_pred EEEeccCCceEEEEEEEcC------CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCce-eEEeccccCCCceEEEEE
Q 005247 438 KKKIGEGSFGTVYHAEWRN------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNI-VLLMGAVTEPPNLSIVTE 510 (706)
Q Consensus 438 ~~~LG~G~fG~Vy~a~~~~------~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnI-v~l~~~~~~~~~~~lV~E 510 (706)
++.|-.|-.-.+|++...+ ..+++|+.-... .. .-.-.+|..+++.+..-++ .++++.+... .|.+
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t--~~-~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~e 113 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV--EL-FFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEE 113 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC--Ce-eechHHHHHHHHHHHHcCCCCceEEEECCc----eEEE
Confidence 4456568888999987532 347777753321 11 1122467777777753332 3445555332 5789
Q ss_pred eccCCchhhh-----------------cccCCC---cccccHHHHHHHHHHH-----------------HHHHHHHH---
Q 005247 511 YLSRGSLYKL-----------------LHIPDA---RVVVDERLRLNMAYDV-----------------AKGMNYLH--- 550 (706)
Q Consensus 511 ~~~ggsL~~~-----------------l~~~~~---~~~l~~~~~~~ia~qI-----------------l~aL~yLH--- 550 (706)
|+++.+|... +|.... ........+.++..++ ...+..|.
T Consensus 114 fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~ 193 (344)
T PLN02236 114 FIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKEL 193 (344)
T ss_pred eeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHh
Confidence 9877665321 111110 1011122222332111 11222222
Q ss_pred -hc--CCCcccccCCCCcEEECC-CCcEEEeecCcccc
Q 005247 551 -QR--RPPIVHRDLKSPNLLVDS-TYTVKVCDFGLSRS 584 (706)
Q Consensus 551 -s~--g~~IIHrDLKp~NILl~~-~~~vKL~DFGla~~ 584 (706)
.. ...++|+|+++.|||+++ ++.+.|+||..+..
T Consensus 194 ~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 194 SGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred cccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 11 124899999999999976 46899999987653
|
|
| >PF01841 Transglut_core: Transglutaminase-like superfamily; InterPro: IPR002931 This domain is found in many proteins known to have transglutaminase activity, i | Back alignment and domain information |
|---|
Probab=95.47 E-value=0.0048 Score=55.59 Aligned_cols=53 Identities=23% Similarity=0.270 Sum_probs=39.8
Q ss_pred ccccchhhHHHHHHHhhhcCCCcccccccccC----------CCCCCCeeEEEeCCCchhhhh
Q 005247 206 SVGLCVHRALLFKVLADLINLPCRIAKGCKYC----------RRDDASSCLVQIGPDREYLVD 258 (706)
Q Consensus 206 ~~g~~r~ra~lfk~lad~~~~~~~lv~g~~~~----------~~~~~~~~~~~~~~~~~~~vd 258 (706)
+.|.|.+-|.||..|+-.+|||||+|.|.... +.+.|+|+.|.+++++=+.+|
T Consensus 50 ~~G~C~~~a~l~~allr~~Gipar~v~g~~~~~~~~~~~~~~~~~~H~w~ev~~~~~~W~~~D 112 (113)
T PF01841_consen 50 GRGDCEDYASLFVALLRALGIPARVVSGYVKGPDPDGDYSVDGNDNHAWVEVYLPGGGWIPLD 112 (113)
T ss_dssp EEESHHHHHHHHHHHHHHHT--EEEEEEEEEECSSTTCTSTSSEEEEEEEEEEETTTEEEEEE
T ss_pred CCCccHHHHHHHHHHHhhCCCceEEEEEEcCCccccccccCCCCCCEEEEEEEEcCCcEEEcC
Confidence 46999999999999999999999999994432 245689999999555443333
|
e. which cross-link proteins through an acyl-transfer reaction between the gamma-carboxamide group of peptide-bound glutamine and the epsilon-amino group of peptide-bound lysine, resulting in a epsilon-(gamma-glutamyl)lysine isopeptide bond. Tranglutaminases have been found in a diverse range of species, from bacteria through to mammals. The enzymes require calcium binding and their activity leads to post-translational modification of proteins through acyl-transfer reactions, involving peptidyl glutamine residues as acyl donors and a variety of primary amines as acyl acceptors, with the generation of proteinase resistant isopeptide bonds []. Sequence conservation in this superfamily primarily involves three motifs that centre around conserved cysteine, histidine, and aspartate residues that form the catalytic triad in the structurally characterised transglutaminase, the human blood clotting factor XIIIa' []. On the basis of the experimentally demonstrated activity of the Methanobacterium phage psiM2 pseudomurein endoisopeptidase [], it is proposed that many, if not all, microbial homologs of the transglutaminases are proteases and that the eukaryotic transglutaminases have evolved from an ancestral protease []. A subunit of plasma Factor XIII revealed that each Factor XIIIA subunit is composed of four domains (termed N-terminal beta-sandwich, core domain (containing the catalytic and the regulatory sites), and C-terminal beta-barrels 1 and 2) and that two monomers assemble into the native dimer through the surfaces in domains 1 and 2, in opposite orientation. This organisation in four domains is highly conserved during evolution among transglutaminase isoforms [].; PDB: 2F4M_A 2F4O_A 1GGY_B 1FIE_B 1GGU_B 1GGT_B 1F13_A 1QRK_B 1EVU_A 1EX0_B .... |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.27 E-value=0.04 Score=62.42 Aligned_cols=156 Identities=20% Similarity=0.200 Sum_probs=95.1
Q ss_pred HHHHHHHHHHHcCCCCceeEEeccccCC-CceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcC
Q 005247 475 KEFLREVAIMKGLRHPNIVLLMGAVTEP-PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 553 (706)
Q Consensus 475 ~~~~~Ei~iL~~L~HpnIv~l~~~~~~~-~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g 553 (706)
.+++....+++.+.|+|...++++-... ....+|||++ +.+|++++...... . .+++ .++
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~l~-~----------~s~~-------~~~ 87 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGNLK-D----------ESLL-------AHG 87 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcccc-h----------hhhc-------ccc
Confidence 5677788999999999999999876543 3477899998 55899988643210 0 0111 222
Q ss_pred CCcccccCCCCcEEECCCCcEEEeecCccccCCCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCC
Q 005247 554 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQK 633 (706)
Q Consensus 554 ~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~ 633 (706)
+.|-. .++++| -++... .... .+|+|||++|.++.|+.-|..
T Consensus 88 --~~~~~------------~~~~td-~~~t~~-------~~~~----------------~pKsdVwsl~~i~~el~L~~~ 129 (725)
T KOG1093|consen 88 --VLHLN------------IIYITD-HFLTKY-------PSPI----------------GPKSDVWSLGFIILELYLGIS 129 (725)
T ss_pred --cceeh------------hhhccc-cccccC-------CCCC----------------CcchhhhhHHHHHHHHHHhhH
Confidence 33322 233333 111100 0111 149999999999999999987
Q ss_pred CCCCCChHHHHHHhhhcCc-cc---------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 634 PWRNSTPSQVISAVGFKGR-RL---------EIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 634 Pf~~~~~~~~~~~i~~~~~-~l---------~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
.|.....-+....+..-.. .. .+-..++..+.++..+|+...|..||...++.+
T Consensus 130 l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k 193 (725)
T KOG1093|consen 130 LEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSK 193 (725)
T ss_pred HHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhc
Confidence 7766544443332221110 00 111245677888999999999999987666544
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=94.98 E-value=0.11 Score=56.72 Aligned_cols=30 Identities=27% Similarity=0.351 Sum_probs=25.5
Q ss_pred CcccccCCCCcEEECC-CCcEEEeecCcccc
Q 005247 555 PIVHRDLKSPNLLVDS-TYTVKVCDFGLSRS 584 (706)
Q Consensus 555 ~IIHrDLKp~NILl~~-~~~vKL~DFGla~~ 584 (706)
.++|+|+.+.|||+++ ++.++++||..|..
T Consensus 183 v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 183 VFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred EEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 3689999999999974 56899999987654
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.82 E-value=0.13 Score=52.90 Aligned_cols=117 Identities=12% Similarity=0.080 Sum_probs=75.0
Q ss_pred CCceEEEEEEEcCCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEEeccCCchhhhccc
Q 005247 444 GSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHI 523 (706)
Q Consensus 444 G~fG~Vy~a~~~~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~ 523 (706)
|+.++.-.++-+-.+..+|.+......- ...-|.++..++.+++ .|+++..- ....+-++.|+|.....
T Consensus 73 ~gNsTl~~~kt~iG~L~lKKi~slp~~~-~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------ 141 (308)
T PF07387_consen 73 NGNSTLLIGKTKIGPLFLKKIRSLPCCI-NDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------ 141 (308)
T ss_pred CCceEEEEeccccchhhhhhccCCCccc-chhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc------
Confidence 4555555554444456666654433221 1235677888888763 57777632 34456799999854111
Q ss_pred CCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCc
Q 005247 524 PDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL 581 (706)
Q Consensus 524 ~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGl 581 (706)
. ...++..=+++|.-.|+.+...+|+|-.|+||+-|+.|.+||.|-+.
T Consensus 142 ------~----~~N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 142 ------N----FSNFITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred ------c----hhHHHHHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhh
Confidence 1 11222222567888897655699999999999999999999999874
|
The function of this family is unknown. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.82 E-value=0.083 Score=57.80 Aligned_cols=76 Identities=22% Similarity=0.273 Sum_probs=55.4
Q ss_pred CCCceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecC
Q 005247 501 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFG 580 (706)
Q Consensus 501 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFG 580 (706)
+.-+.|++|++. |+++.- ++ .....++..|+.+.+..+.-+..+ .+.=|||+..+||||+ +|+|.|+||-
T Consensus 297 e~~y~yl~~kdh-gt~is~-ik------~~~~~e~lsff~s~~sil~~lekk-f~fehrnlt~~niLId-~GnvtLIDfk 366 (488)
T COG5072 297 ETLYLYLHFKDH-GTPISI-IK------ADRSEEELSFFWSCISILDILEKK-FPFEHRNLTLDNILID-EGNVTLIDFK 366 (488)
T ss_pred CceEEEEEEecC-Cceeee-ee------cccHHHHHHHHHHHHHHHhhhhhc-CCcccccccccceeee-cCceEEEEee
Confidence 334567778765 445432 22 245677888888887776666554 4689999999999999 8999999999
Q ss_pred ccccCC
Q 005247 581 LSRSKP 586 (706)
Q Consensus 581 la~~~~ 586 (706)
+++...
T Consensus 367 lsRl~~ 372 (488)
T COG5072 367 LSRLSY 372 (488)
T ss_pred eeeccc
Confidence 998543
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=94.76 E-value=0.16 Score=52.43 Aligned_cols=76 Identities=16% Similarity=0.229 Sum_probs=56.9
Q ss_pred EEEeccCCceEEEEEEEcCCceEEEEEeccccchHHHHHHHHHHHHHHcC---CCCceeEEeccccCCCceEEEEEeccC
Q 005247 438 KKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGL---RHPNIVLLMGAVTEPPNLSIVTEYLSR 514 (706)
Q Consensus 438 ~~~LG~G~fG~Vy~a~~~~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L---~HpnIv~l~~~~~~~~~~~lV~E~~~g 514 (706)
.+.+-.|.--..|+..+....+.||+- .......|..|+.-|..+ +--.+.+++.+..+.++.++||||++-
T Consensus 21 r~~v~gG~inea~~v~dg~~~~FvK~n-----~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~ 95 (286)
T COG3001 21 REEVSGGDINEAWRLRDGTDPFFVKCN-----QREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPT 95 (286)
T ss_pred ccccCCccccceeEeecCCcceEEEec-----chhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccC
Confidence 455666777778888877778999973 233445677787777666 346688889999999999999999987
Q ss_pred Cchh
Q 005247 515 GSLY 518 (706)
Q Consensus 515 gsL~ 518 (706)
+.+.
T Consensus 96 ~~~d 99 (286)
T COG3001 96 GPLD 99 (286)
T ss_pred CCCC
Confidence 6654
|
|
| >COG5279 CYK3 Uncharacterized protein involved in cytokinesis, contains TGc (transglutaminase/protease-like) domain [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.74 E-value=0.022 Score=63.73 Aligned_cols=56 Identities=32% Similarity=0.519 Sum_probs=46.6
Q ss_pred ccccchhhHHHHHHHhhhcCCCcccccccc-----cCC--CCCCCeeEEEeCCCchhhhhcccC
Q 005247 206 SVGLCVHRALLFKVLADLINLPCRIAKGCK-----YCR--RDDASSCLVQIGPDREYLVDLLED 262 (706)
Q Consensus 206 ~~g~~r~ra~lfk~lad~~~~~~~lv~g~~-----~~~--~~~~~~~~~~~~~~~~~~vdl~~~ 262 (706)
--++|-.=|.|||.||-..||||.+|+|.- |.. .-.|+|++|++++ .-|+||.-..
T Consensus 208 heavCtgYa~lfK~lcn~lgIp~~iIegf~k~~~~~~~~~~iNHaWN~VkiD~-~yy~VDtTwg 270 (521)
T COG5279 208 HEAVCTGYAELFKELCNALGIPCEIIEGFLKSPIYYTRDININHAWNIVKIDN-EYYLVDTTWG 270 (521)
T ss_pred cccccchHHHHHHHHHHhcCCceEEEeecccccccccCCccccceeeEEEECC-eEEEEeeecC
Confidence 357888889999999999999999999951 222 7789999999955 8899997654
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.50 E-value=0.34 Score=52.88 Aligned_cols=142 Identities=19% Similarity=0.247 Sum_probs=82.8
Q ss_pred EEEeccCCceEEEEEEEcCCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCc------eeEE----eccccCCCceEE
Q 005247 438 KKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN------IVLL----MGAVTEPPNLSI 507 (706)
Q Consensus 438 ~~~LG~G~fG~Vy~a~~~~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~Hpn------Iv~l----~~~~~~~~~~~l 507 (706)
...|.+ .-..||+.+..++.+++|+.... ... .++..|+..+..|.... +... +..+..+....-
T Consensus 31 ~~~l~s-~eN~~f~~~~~~g~~iLki~~~~-~~~---~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~ 105 (331)
T COG2334 31 LRGLNS-EENSNFRVQTEDGRYILKIYRPG-WTR---AEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAA 105 (331)
T ss_pred cccccc-ccCceEEEEecCCCeEEEEecCC-CCH---HHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEE
Confidence 344555 56678999988888888887654 333 35556777777663222 1221 222222236788
Q ss_pred EEEeccCCchhh-hc--------------cc---------CCCcccccHH-------------HHHHHHHHHHHHHHHHH
Q 005247 508 VTEYLSRGSLYK-LL--------------HI---------PDARVVVDER-------------LRLNMAYDVAKGMNYLH 550 (706)
Q Consensus 508 V~E~~~ggsL~~-~l--------------~~---------~~~~~~l~~~-------------~~~~ia~qIl~aL~yLH 550 (706)
+++|++|..+.. .. +. ........+. .-.....++...++.+.
T Consensus 106 lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~ 185 (331)
T COG2334 106 LFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLL 185 (331)
T ss_pred EEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHH
Confidence 999999987772 10 10 0001011111 01112334445555555
Q ss_pred hcC------CC--cccccCCCCcEEECCCCc-EEEeecCcccc
Q 005247 551 QRR------PP--IVHRDLKSPNLLVDSTYT-VKVCDFGLSRS 584 (706)
Q Consensus 551 s~g------~~--IIHrDLKp~NILl~~~~~-vKL~DFGla~~ 584 (706)
+.- .+ +||+|+.|+||+++.+.. +.++||+-++.
T Consensus 186 ~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 186 ARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred hhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 421 12 899999999999998874 99999997654
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=93.47 E-value=0.2 Score=55.24 Aligned_cols=73 Identities=18% Similarity=0.170 Sum_probs=44.6
Q ss_pred EeccCCceEEEEEEEcCC--ceEEEEEec-----cccchHHHHHHHHHHHHHHcCC--CC-ceeEEeccccCCCceEEEE
Q 005247 440 KIGEGSFGTVYHAEWRNS--DVAVKILIE-----QEFHEDRFKEFLREVAIMKGLR--HP-NIVLLMGAVTEPPNLSIVT 509 (706)
Q Consensus 440 ~LG~G~fG~Vy~a~~~~~--~vAVKvl~~-----~~~~~~~~~~~~~Ei~iL~~L~--Hp-nIv~l~~~~~~~~~~~lV~ 509 (706)
.||.|....||++...+. .++||.-.. ....+-..+...-|.+.|+... .| .++++|.+ ++....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 579999999999987653 578775321 1111222334456777776653 34 45555543 445567999
Q ss_pred EeccC
Q 005247 510 EYLSR 514 (706)
Q Consensus 510 E~~~g 514 (706)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=93.29 E-value=0.19 Score=56.11 Aligned_cols=75 Identities=20% Similarity=0.096 Sum_probs=47.6
Q ss_pred EEEeccCCceEEEEEEEc--CCceEEEEEe----ccccchHHHHHHHHHHHHHHcCC--CC-ceeEEeccccCCCceEEE
Q 005247 438 KKKIGEGSFGTVYHAEWR--NSDVAVKILI----EQEFHEDRFKEFLREVAIMKGLR--HP-NIVLLMGAVTEPPNLSIV 508 (706)
Q Consensus 438 ~~~LG~G~fG~Vy~a~~~--~~~vAVKvl~----~~~~~~~~~~~~~~Ei~iL~~L~--Hp-nIv~l~~~~~~~~~~~lV 508 (706)
.+.||.|.-..||++.+. ++.++||--. .....+-..+...-|.++|+... .| ++++++.+ ++....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 678999999999999875 4458887531 11111223345566777777653 34 45556544 34556788
Q ss_pred EEeccC
Q 005247 509 TEYLSR 514 (706)
Q Consensus 509 ~E~~~g 514 (706)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 988854
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=91.74 E-value=2 Score=53.94 Aligned_cols=31 Identities=29% Similarity=0.512 Sum_probs=26.0
Q ss_pred CcccccCCCCcEEECCCC--cEE-EeecCccccC
Q 005247 555 PIVHRDLKSPNLLVDSTY--TVK-VCDFGLSRSK 585 (706)
Q Consensus 555 ~IIHrDLKp~NILl~~~~--~vK-L~DFGla~~~ 585 (706)
.+||+|+.+.|||++.++ .+. |+|||.+...
T Consensus 204 ~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~~ 237 (1013)
T PRK06148 204 QVIHNDANDYNILVDADDGERISGLIDFGDAVHA 237 (1013)
T ss_pred ceECCCCCcccEEEcCCCCcceEEEEECcccccc
Confidence 499999999999998775 555 9999987653
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 706 | ||||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-116 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-115 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-41 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-40 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-39 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-39 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 6e-39 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-39 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-39 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 9e-39 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-38 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-38 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-38 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-38 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-38 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-38 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-38 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-38 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-38 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-38 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-38 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-38 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-38 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-38 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-38 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 5e-38 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-38 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 5e-38 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 6e-38 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 6e-38 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-38 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 7e-38 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 8e-38 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 9e-38 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-37 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-37 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-37 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-37 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-37 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-37 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-37 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-37 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-37 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 5e-37 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-37 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-36 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-36 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-36 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 6e-36 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 6e-36 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 6e-36 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 8e-36 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 8e-36 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 9e-36 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-35 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-35 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-35 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-35 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-35 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 7e-35 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 7e-35 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 7e-35 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 7e-35 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 7e-35 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 7e-35 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 8e-35 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-34 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-34 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-34 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-34 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-34 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-34 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-34 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-34 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-34 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-34 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-34 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-34 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-34 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 5e-34 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 6e-34 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 8e-34 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 8e-34 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 8e-34 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 9e-34 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 9e-34 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-33 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-33 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-33 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-33 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-33 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-33 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-33 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 4e-33 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-33 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 4e-33 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 5e-33 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 5e-33 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-33 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 6e-33 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 7e-33 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 7e-33 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 7e-33 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-33 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 8e-33 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-33 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 9e-33 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-32 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-32 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-32 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-32 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-32 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-32 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-32 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-32 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-32 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-32 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-32 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-32 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-32 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-32 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-32 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-32 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-32 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-32 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-32 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-32 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-32 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-32 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-32 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-32 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-32 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-32 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-32 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-32 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-32 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-32 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-32 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-32 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-32 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-32 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-32 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-32 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-32 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-32 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-32 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 4e-32 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-32 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 6e-32 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 6e-32 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 6e-32 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-32 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 7e-32 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 7e-32 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 7e-32 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 8e-32 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-32 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-32 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 8e-32 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 8e-32 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 9e-32 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-31 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-31 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-31 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-31 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-31 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-31 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-31 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-31 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-31 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-31 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-31 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-31 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-31 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-31 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-31 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-31 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-31 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-31 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-31 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-31 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-31 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-31 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-31 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-31 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-31 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-31 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 7e-31 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-31 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-31 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 9e-31 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-30 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-30 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-30 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-30 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-30 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-30 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-30 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-30 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-30 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-30 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-30 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-30 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-30 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-30 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-30 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-30 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-30 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 5e-30 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 6e-30 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 6e-30 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 6e-30 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 6e-30 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 6e-30 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 6e-30 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 7e-30 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 7e-30 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 7e-30 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-29 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-29 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-29 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-29 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-29 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-29 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-29 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-29 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-29 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-29 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-29 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 7e-29 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 8e-29 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-28 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-28 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-28 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 6e-28 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-28 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 8e-28 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-27 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-27 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-27 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-27 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-27 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-27 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-27 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 6e-27 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 8e-27 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 8e-27 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 9e-27 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-26 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-26 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-26 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-26 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-26 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-26 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-26 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-26 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-26 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-26 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-26 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-26 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-26 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-26 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-26 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-26 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-26 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-26 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-26 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-26 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-26 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 5e-26 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 6e-26 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 6e-26 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 7e-26 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 8e-26 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 8e-26 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 8e-26 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 9e-26 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 9e-26 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 9e-26 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-25 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-25 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-25 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-25 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-25 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-25 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-25 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-25 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-25 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-25 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-25 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-25 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-25 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-25 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-25 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 5e-25 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 6e-25 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 6e-25 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 6e-25 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 7e-25 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 9e-25 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-24 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-24 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-24 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-24 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-24 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-24 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-24 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-24 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-24 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-24 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-24 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-24 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-24 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-24 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-24 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-24 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-24 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-24 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-24 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-24 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-24 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-24 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-24 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-24 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-24 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-24 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-24 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-24 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-24 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-24 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-24 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-24 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-24 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-24 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-24 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-24 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 6e-24 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 7e-24 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 7e-24 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 8e-24 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 9e-24 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 9e-24 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-23 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-23 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-23 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-23 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-23 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-23 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-23 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-23 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-23 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-23 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-23 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-23 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-23 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-23 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-23 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-23 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-23 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-23 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-23 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-23 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-23 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-23 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-23 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-23 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-23 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-23 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-23 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-23 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-23 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-23 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-23 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 4e-23 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-23 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-23 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-23 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 5e-23 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 5e-23 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 6e-23 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 6e-23 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-23 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-23 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 6e-23 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 6e-23 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-23 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-23 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 7e-23 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 7e-23 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 8e-23 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 8e-23 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 8e-23 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 8e-23 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 8e-23 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 9e-23 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 9e-23 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-22 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-22 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-22 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-22 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-22 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-22 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-22 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-22 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-22 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-22 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-22 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-22 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-22 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-22 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-22 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-22 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 5e-22 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-22 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 5e-22 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 5e-22 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 5e-22 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-22 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-22 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 6e-22 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 7e-22 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 8e-22 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 9e-22 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-21 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-21 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-21 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-21 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-21 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-21 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-21 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-21 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-21 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-21 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-21 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-21 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-21 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-21 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-21 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-21 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-21 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-21 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 5e-21 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 6e-21 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 6e-21 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-21 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 7e-21 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-21 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 8e-21 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 8e-21 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-20 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-20 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-20 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-20 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-20 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-20 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-20 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-20 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-20 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-20 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-20 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-20 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-20 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-20 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-20 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-20 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-20 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-20 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-20 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-20 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 5e-20 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 5e-20 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 6e-20 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 6e-20 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 6e-20 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-19 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-19 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-19 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-19 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-19 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-19 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-19 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-19 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-19 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-19 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-19 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-19 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-19 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-19 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-19 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-19 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 4e-19 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-19 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-19 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-19 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 5e-19 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-19 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 6e-19 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 6e-19 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 7e-19 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 7e-19 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 7e-19 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-19 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 8e-19 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 8e-19 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 9e-19 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-18 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-18 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-18 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-18 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-18 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-18 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-18 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-18 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-18 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-18 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-18 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-18 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-18 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-18 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 7e-18 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-18 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 8e-18 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 8e-18 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 9e-18 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 9e-18 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 9e-18 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 9e-18 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-17 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-17 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-17 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-17 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-17 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-17 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-17 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-17 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-17 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-17 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-17 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-17 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-17 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-17 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-17 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-17 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 7e-17 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 9e-17 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-16 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-16 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-16 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-16 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-16 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-16 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-16 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-16 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-16 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-16 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-16 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-16 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-16 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-16 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-16 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-16 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-16 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-16 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 5e-16 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 5e-16 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 5e-16 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-16 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-16 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 6e-16 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 6e-16 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 6e-16 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 6e-16 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-16 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 7e-16 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 7e-16 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 8e-16 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 8e-16 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 8e-16 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 9e-16 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 9e-16 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-16 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-16 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 9e-16 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-15 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-15 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-15 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-15 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-15 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-15 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-15 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-15 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-15 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-15 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-15 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-15 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-15 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-15 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-15 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-15 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-15 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-15 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-15 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-15 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-15 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-15 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-15 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-15 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-15 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-15 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-15 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-15 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-15 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-15 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-15 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-15 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-15 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-15 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-15 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-15 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-15 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-15 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-15 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-15 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-15 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-15 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-15 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-15 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-15 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-15 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-15 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-15 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-15 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-15 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-15 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-15 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-15 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-15 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-15 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-15 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-15 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-15 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-15 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-15 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-15 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-15 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-15 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-15 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-15 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-15 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-15 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-15 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-15 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-15 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-15 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-15 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-15 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-15 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-15 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-15 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-15 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-15 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-15 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-15 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-15 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-15 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-15 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-15 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-15 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-15 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-15 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-15 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-15 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-15 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-15 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-15 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-15 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 5e-15 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 5e-15 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 5e-15 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 5e-15 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-15 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 5e-15 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-15 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 5e-15 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-15 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 5e-15 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-15 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 5e-15 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-15 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 6e-15 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 6e-15 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 6e-15 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 6e-15 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 6e-15 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 6e-15 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 6e-15 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 6e-15 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 6e-15 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 6e-15 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 6e-15 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-15 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 7e-15 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-15 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 7e-15 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 7e-15 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 7e-15 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 7e-15 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 7e-15 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-15 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 7e-15 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-15 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-15 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 7e-15 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 7e-15 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 8e-15 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 8e-15 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 8e-15 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 8e-15 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 8e-15 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-15 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 8e-15 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 8e-15 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 8e-15 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 8e-15 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 8e-15 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 8e-15 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 9e-15 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 9e-15 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-15 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 9e-15 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-14 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-14 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-14 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-14 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-14 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-14 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-14 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-14 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-14 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-14 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-14 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-14 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-14 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-14 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-14 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-14 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-14 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-14 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-14 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-14 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-14 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-14 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-14 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-14 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-14 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-14 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-14 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-14 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-14 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-14 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-14 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-14 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-14 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-14 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-14 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-14 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-14 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-14 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-14 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 5e-14 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 5e-14 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-14 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 5e-14 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 6e-14 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 6e-14 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 6e-14 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 6e-14 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 9e-14 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 9e-14 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-13 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-13 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-13 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-13 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-13 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-13 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-13 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-13 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-13 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-13 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-13 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-13 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-13 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-13 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-13 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-13 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-13 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-13 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-13 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-13 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-13 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-13 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-13 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-13 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-13 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-13 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-13 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-13 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-13 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-13 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-13 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-13 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-13 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-13 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-13 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-13 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-13 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-13 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-13 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-13 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-13 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-13 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-13 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-13 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-13 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-13 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-13 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-13 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-13 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-13 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 5e-13 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-13 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 5e-13 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 5e-13 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 5e-13 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 5e-13 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-13 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 5e-13 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-13 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-13 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 8e-13 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-12 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-12 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-12 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-12 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-12 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-12 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-12 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-12 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-12 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-12 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-12 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-12 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-12 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-12 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-12 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-12 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-12 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-12 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-12 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 3e-12 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 4e-12 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 6e-12 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 6e-12 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 7e-12 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 8e-12 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-11 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-11 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-11 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-11 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 3e-11 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-11 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-11 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-11 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-11 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-11 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-11 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 5e-11 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 5e-11 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 6e-11 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 7e-11 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 7e-11 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 8e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 8e-11 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-10 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-10 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-10 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-10 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-10 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-10 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-10 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-10 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-10 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-10 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-10 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-10 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-10 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-10 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-10 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-10 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-10 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-10 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-10 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-10 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-10 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-10 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-10 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-10 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-10 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-10 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-10 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-10 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-10 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-10 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-10 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-10 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-10 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-10 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-10 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-10 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-10 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-10 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-10 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-10 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-10 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-10 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-10 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-10 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-10 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-10 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-10 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-10 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-10 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-10 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-10 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-10 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 3e-10 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-10 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-10 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-10 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-10 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-10 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-10 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 4e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-10 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 6e-10 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 7e-10 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 7e-10 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 8e-10 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 8e-10 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 8e-10 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 9e-10 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 9e-10 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-09 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-09 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-09 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-09 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-09 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 5e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 6e-09 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-08 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-08 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-08 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-08 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-08 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-08 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 7e-08 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-07 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-07 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-07 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-07 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-07 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-07 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-07 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-07 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-07 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-07 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 6e-07 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 8e-07 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-06 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 1e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-06 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-06 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-06 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-06 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-06 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-06 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 2e-06 |
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 706 | |||
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 1e-158 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 1e-140 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 1e-139 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 1e-134 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 1e-133 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 1e-132 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 1e-132 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 1e-131 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 1e-131 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 1e-112 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 1e-110 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 1e-108 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 1e-105 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 1e-104 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 1e-96 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 3e-79 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 1e-78 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 7e-78 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 8e-78 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 4e-77 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 6e-77 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 1e-76 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 2e-76 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 2e-76 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 4e-76 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 4e-76 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 8e-76 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 8e-76 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 2e-75 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 2e-75 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 2e-75 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 4e-75 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 7e-75 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 9e-75 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 2e-74 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 2e-74 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 4e-74 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 4e-74 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 4e-74 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 8e-74 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 2e-73 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 2e-73 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 5e-73 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 6e-73 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 8e-73 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 8e-73 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 1e-72 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 3e-72 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 4e-72 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 5e-72 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 6e-72 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 8e-72 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 2e-71 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 2e-71 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 4e-71 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 5e-71 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 8e-71 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 2e-70 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 2e-70 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 4e-70 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 8e-70 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 1e-69 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 3e-69 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 5e-68 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 6e-68 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 8e-68 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 1e-67 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 4e-66 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 2e-58 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 2e-58 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 1e-57 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 5e-54 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 1e-52 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 2e-52 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 4e-52 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 7e-52 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 8e-52 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 2e-51 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 4e-51 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 4e-51 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 7e-51 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 9e-51 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 1e-50 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 1e-50 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 2e-49 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-48 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 7e-48 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 1e-47 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 9e-47 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 4e-46 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 5e-46 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 8e-46 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 1e-45 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 2e-45 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 3e-45 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 8e-45 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 8e-45 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 2e-44 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 1e-43 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 2e-43 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 2e-43 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 2e-43 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 1e-42 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 3e-42 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 2e-41 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 2e-41 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 2e-41 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 3e-41 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 4e-41 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 1e-40 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 1e-40 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 1e-40 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 3e-40 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 5e-19 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 5e-40 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 7e-40 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 1e-39 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 2e-39 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 3e-39 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 4e-39 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 4e-39 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 4e-39 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 4e-39 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 4e-39 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 5e-39 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 7e-39 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 9e-39 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 9e-39 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 2e-38 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 4e-38 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 4e-38 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 5e-38 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 9e-38 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 1e-37 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 2e-37 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 2e-37 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 3e-37 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 3e-37 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 3e-37 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 4e-37 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 7e-37 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 7e-37 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 7e-37 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 8e-37 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 1e-36 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 1e-36 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 1e-36 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 1e-36 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 2e-36 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 2e-36 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 6e-36 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 7e-36 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 1e-35 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 2e-35 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 3e-35 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 4e-35 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 5e-35 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 5e-35 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 2e-34 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 4e-34 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 5e-34 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 1e-33 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 1e-33 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 2e-06 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 2e-33 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 5e-33 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 6e-33 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 1e-32 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 1e-32 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 4e-32 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 1e-31 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 2e-31 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 2e-31 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 8e-31 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 1e-30 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 1e-30 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 2e-30 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 5e-30 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 1e-29 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 2e-29 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 3e-29 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 3e-29 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 3e-29 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 4e-29 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 6e-29 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 2e-28 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 4e-28 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 5e-28 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 1e-27 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 2e-27 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 5e-27 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 5e-27 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 1e-26 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 1e-26 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 2e-26 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 3e-26 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 4e-26 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 5e-26 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 6e-26 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 7e-26 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 8e-26 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 9e-26 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 1e-25 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 2e-25 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 2e-25 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 3e-25 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 3e-25 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 4e-25 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 2e-24 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 2e-24 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 7e-24 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 2e-23 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 4e-23 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 4e-23 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 5e-23 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 8e-23 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 1e-22 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 2e-22 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 8e-22 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 2e-21 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 6e-21 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 1e-20 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 2e-20 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 9e-19 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 2e-18 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 7e-18 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 1e-15 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 1e-15 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 5e-15 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 6e-15 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 2e-11 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 2e-09 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 2e-09 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 6e-09 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 1e-08 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 1e-08 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 6e-08 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 7e-08 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 3e-05 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 1e-04 |
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 457 bits (1179), Expect = e-158
Identities = 199/297 (67%), Positives = 240/297 (80%)
Query: 404 HLLMEANLSVMSTSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKI 463
H + + ++ + ++ + ++I W +L IK+KIG GSFGTV+ AEW SDVAVKI
Sbjct: 8 HPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKI 67
Query: 464 LIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHI 523
L+EQ+FH +R EFLREVAIMK LRHPNIVL MGAVT+PPNLSIVTEYLSRGSLY+LLH
Sbjct: 68 LMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK 127
Query: 524 PDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 583
AR +DER RL+MAYDVAKGMNYLH R PPIVHR+LKSPNLLVD YTVKVCDFGLSR
Sbjct: 128 SGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR 187
Query: 584 SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQV 643
K +T++SSK+AAGTPEWMAPEVLR++PSNEKSDV+SFGVILWEL TLQ+PW N P+QV
Sbjct: 188 LKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQV 247
Query: 644 ISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQP 700
++AVGFK +RLEIP+N+NP VAA+IE CW EP RPSF +IM+ L+ + S+V P
Sbjct: 248 VAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPP 304
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 411 bits (1058), Expect = e-140
Identities = 77/269 (28%), Positives = 142/269 (52%), Gaps = 11/269 (4%)
Query: 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR 488
I + +L K+ E G ++ W+ +D+ VK+L +++ + ++F E ++
Sbjct: 6 GIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFS 65
Query: 489 HPNIVLLMGAVTEPP--NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM 546
HPN++ ++GA PP + +++T ++ GSLY +LH VVD+ + A D+A+GM
Sbjct: 66 HPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLH-EGTNFVVDQSQAVKFALDMARGM 124
Query: 547 NYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV 606
+LH P I L S ++++D T ++ + S S P W+APE
Sbjct: 125 AFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF-----QSPGRMYAPAWVAPEA 179
Query: 607 LREDPSN---EKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPM 663
L++ P + +D++SF V+LWEL+T + P+ + + ++ V +G R IP ++P
Sbjct: 180 LQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPH 239
Query: 664 VAALIETCWAEEPEIRPSFPSIMETLQQF 692
V+ L++ C E+P RP F I+ L++
Sbjct: 240 VSKLMKICMNEDPAKRPKFDMIVPILEKM 268
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 408 bits (1051), Expect = e-139
Identities = 100/275 (36%), Positives = 144/275 (52%), Gaps = 17/275 (6%)
Query: 428 LEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHE--DRFKEFLREVAIMK 485
LEI ++EL +++ IG G FG VY A W +VAVK + + +E +
Sbjct: 2 LEIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFA 61
Query: 486 GLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKG 545
L+HPNI+ L G + PNL +V E+ G L ++L + + +N A +A+G
Sbjct: 62 MLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR----IPPDILVNWAVQIARG 117
Query: 546 MNYLHQRRP-PIVHRDLKSPNLLVDSTY--------TVKVCDFGLSRSKPNTYISSKTAA 596
MNYLH PI+HRDLKS N+L+ +K+ DFGL+R T + +AA
Sbjct: 118 MNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT--TKMSAA 175
Query: 597 GTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEI 656
G WMAPEV+R ++ SDV+S+GV+LWEL+T + P+R V V L I
Sbjct: 176 GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPI 235
Query: 657 PKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 691
P A L+E CW +P RPSF +I++ L
Sbjct: 236 PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 397 bits (1021), Expect = e-134
Identities = 95/280 (33%), Positives = 152/280 (54%), Gaps = 23/280 (8%)
Query: 429 EIRWSELLIKKKIGEGSFGTVYHAEW--RNSDVAVKILIEQEFHED-----RFKEFLREV 481
+ +E+ +K+IG+G FG V+ S VA+K LI + + +F+EF REV
Sbjct: 15 TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREV 74
Query: 482 AIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYD 541
IM L HPNIV L G + PP +V E++ G LY L D + ++L + D
Sbjct: 75 FIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLL--DKAHPIKWSVKLRLMLD 130
Query: 542 VAKGMNYLHQRRPPIVHRDLKSPNLLVDS-----TYTVKVCDFGLSRSKPNTYISSKTAA 596
+A G+ Y+ + PPIVHRDL+SPN+ + S KV DFGLS+ ++
Sbjct: 131 IALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS---VSGLL 187
Query: 597 GTPEWMAPEVL--REDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQV--ISAVGFKGR 652
G +WMAPE + E+ EK+D +SF +IL+ ++T + P+ + ++ I+ + +G
Sbjct: 188 GNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL 247
Query: 653 RLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQF 692
R IP++ P + +IE CW+ +P+ RP F I++ L +
Sbjct: 248 RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 393 bits (1012), Expect = e-133
Identities = 91/305 (29%), Positives = 153/305 (50%), Gaps = 22/305 (7%)
Query: 403 NHLLMEANLSVMSTSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVK 462
N L+ A S ++L+E +I + +L I + IG+G FG VYH W +VA++
Sbjct: 5 NLSLLSARSFPRKASQTSIFLQE--WDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIR 61
Query: 463 ILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLH 522
++ + +ED+ K F REV + RH N+VL MGA PP+L+I+T +LY ++
Sbjct: 62 LIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVR 121
Query: 523 IPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS 582
++V+D +A ++ KGM YLH + I+H+DLKS N+ D+ V + DFGL
Sbjct: 122 DA--KIVLDVNKTRQIAQEIVKGMGYLHAK--GILHKDLKSKNVFYDN-GKVVITDFGLF 176
Query: 583 RSKPNTYISSKT-----AAGTPEWMAPEVLR---------EDPSNEKSDVFSFGVILWEL 628
+ G +APE++R + P ++ SDVF+ G I +EL
Sbjct: 177 SISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYEL 236
Query: 629 ITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMET 688
+ P++ +I +G + + ++ ++ CWA E E RP+F +M+
Sbjct: 237 HAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM 296
Query: 689 LQQFL 693
L++
Sbjct: 297 LEKLP 301
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 391 bits (1006), Expect = e-132
Identities = 98/288 (34%), Positives = 155/288 (53%), Gaps = 15/288 (5%)
Query: 415 STSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRF 474
+ + EI ++ + ++IG GSFGTVY +W DVAVK+L +
Sbjct: 6 HHHHHGSRDAADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQL 64
Query: 475 KEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERL 534
+ F EV +++ RH NI+L MG T P L+IVT++ SLY LH + + + +
Sbjct: 65 QAFKNEVGVLRKTRHVNILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHASETK--FEMKK 121
Query: 535 RLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSK- 593
+++A A+GM+YLH + I+HRDLKS N+ + TVK+ DFGL+ K S +
Sbjct: 122 LIDIARQTARGMDYLHAK--SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQF 179
Query: 594 -TAAGTPEWMAPEVLREDPSN---EKSDVFSFGVILWELITLQKPWRNSTP-SQVISAVG 648
+G+ WMAPEV+R SN +SDV++FG++L+EL+T Q P+ N Q+I VG
Sbjct: 180 EQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVG 239
Query: 649 FKGRR---LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 693
++ N + L+ C ++ + RPSFP I+ +++
Sbjct: 240 RGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 389 bits (1000), Expect = e-131
Identities = 85/282 (30%), Positives = 130/282 (46%), Gaps = 19/282 (6%)
Query: 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR 488
R S+L+ + +G+G FG R + + + F E+ + FL+EV +M+ L
Sbjct: 6 IFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLE 65
Query: 489 HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 548
HPN++ +G + + L+ +TEY+ G+L ++ D++ R++ A D+A GM Y
Sbjct: 66 HPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQ--YPWSQRVSFAKDIASGMAY 123
Query: 549 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR--------------SKPNTYISSKT 594
LH I+HRDL S N LV V V DFGL+R K T
Sbjct: 124 LHSMN--IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYT 181
Query: 595 AAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-GRR 653
G P WMAPE++ +EK DVFSFG++L E+I + P + + +
Sbjct: 182 VVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD 241
Query: 654 LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS 695
P N P + C +PE RPSF + L+ M
Sbjct: 242 RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 388 bits (998), Expect = e-131
Identities = 94/270 (34%), Positives = 146/270 (54%), Gaps = 12/270 (4%)
Query: 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR 488
I + E+ +++ +G G+FG V A+WR DVA+K + E K F+ E+ + +
Sbjct: 4 MIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQI----ESESERKAFIVELRQLSRVN 59
Query: 489 HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 548
HPNIV L GA P + +V EY GSLY +LH + ++ ++G+ Y
Sbjct: 60 HPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAY 117
Query: 549 LHQRRP-PIVHRDLKSPNLLVDSTYTV-KVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV 606
LH +P ++HRDLK PNLL+ + TV K+CDFG + ++K G+ WMAPEV
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK---GSAAWMAPEV 174
Query: 607 LREDPSNEKSDVFSFGVILWELITLQKPWRN-STPSQVISAVGFKGRRLEIPKNVNPMVA 665
+EK DVFS+G+ILWE+IT +KP+ P+ I G R + KN+ +
Sbjct: 175 FEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIE 234
Query: 666 ALIETCWAEEPEIRPSFPSIMETLQQFLMS 695
+L+ CW+++P RPS I++ + +
Sbjct: 235 SLMTRCWSKDPSQRPSMEEIVKIMTHLMRY 264
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 340 bits (873), Expect = e-112
Identities = 92/330 (27%), Positives = 138/330 (41%), Gaps = 51/330 (15%)
Query: 406 LMEANLSVMSTSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILI 465
L+E + S S S L ++ ++ + K+IG+G +G V+ +WR VAVK+
Sbjct: 14 LIEQSQSSGSGSGLPLLVQR----TIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFF 69
Query: 466 EQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP----PNLSIVTEYLSRGSLYKLL 521
E + E+ +RH NI+ + A + L ++T+Y GSLY L
Sbjct: 70 TTEEASWFRE---TEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL 126
Query: 522 HIPDARVVVDERLRLNMAYDVAKGMNYLH------QRRPPIVHRDLKSPNLLVDSTYTVK 575
+D + L +AY G+ +LH Q +P I HRDLKS N+LV T
Sbjct: 127 K----STTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCC 182
Query: 576 VCDFGLSR----SKPNTYISSKTAAGTPEWMAPEVLRED------PSNEKSDVFSFGVIL 625
+ D GL+ I T GT +M PEVL E S +D++SFG+IL
Sbjct: 183 IADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLIL 242
Query: 626 WELIT----------LQKPWRNSTPSQ-----VISAVGFKGRRLEIPKN-----VNPMVA 665
WE+ Q P+ + PS + V K R P +
Sbjct: 243 WEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMG 302
Query: 666 ALIETCWAEEPEIRPSFPSIMETLQQFLMS 695
L+ CWA P R + + +TL + S
Sbjct: 303 KLMTECWAHNPASRLTALRVKKTLAKMSES 332
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 333 bits (857), Expect = e-110
Identities = 78/300 (26%), Positives = 131/300 (43%), Gaps = 51/300 (17%)
Query: 434 ELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAI--MKGLRHPN 491
++ + + +G+G +G V+ W+ +VAVKI ++ K + RE + LRH N
Sbjct: 9 DITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDE-----KSWFRETELYNTVMLRHEN 63
Query: 492 IVLLMGAVT----EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 547
I+ + + L ++T Y GSLY L +D L + +A G+
Sbjct: 64 ILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLA 119
Query: 548 YLH------QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY----ISSKTAAG 597
+LH Q +P I HRDLKS N+LV + D GL+ + + + G
Sbjct: 120 HLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVG 179
Query: 598 TPEWMAPEVLREDP------SNEKSDVFSFGVILWELIT----------LQKPWRNSTPS 641
T +MAPEVL E S ++ D+++FG++LWE+ + P+ + P+
Sbjct: 180 TKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPN 239
Query: 642 Q-----VISAVGFKGRRLEIPKNVN-----PMVAALIETCWAEEPEIRPSFPSIMETLQQ 691
+ V +R IP +A L++ CW + P R + I +TL +
Sbjct: 240 DPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 323 bits (830), Expect = e-105
Identities = 88/342 (25%), Positives = 146/342 (42%), Gaps = 48/342 (14%)
Query: 394 STLKPYVTNNHLLMEANLSVMSTSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAE 453
S +P+++ L + + M+TS L +++++ IG+G FG V+ +
Sbjct: 4 SLDRPFISEGTTLKDL-IYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGK 62
Query: 454 WRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT----EPPNLSIVT 509
WR +VAVKI +E + E+ LRH NI+ + A L +V+
Sbjct: 63 WRGEEVAVKIFSSREERSWFRE---AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 119
Query: 510 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLH------QRRPPIVHRDLKS 563
+Y GSL+ L+ R V + +A A G+ +LH Q +P I HRDLKS
Sbjct: 120 DYHEHGSLFDYLN----RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKS 175
Query: 564 PNLLVDSTYTVKVCDFGLSRSKPNTY----ISSKTAAGTPEWMAPEVLRED------PSN 613
N+LV T + D GL+ + I+ GT +MAPEVL + S
Sbjct: 176 KNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESF 235
Query: 614 EKSDVFSFGVILWELITL----------QKPWRNSTPS-----QVISAVGFKGRRLEIPK 658
+++D+++ G++ WE+ Q P+ + PS ++ V + R IP
Sbjct: 236 KRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPN 295
Query: 659 N-----VNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS 695
++A ++ CW R + I +TL Q
Sbjct: 296 RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 337
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 320 bits (823), Expect = e-104
Identities = 80/317 (25%), Positives = 135/317 (42%), Gaps = 49/317 (15%)
Query: 415 STSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRF 474
+S +L E L + L + + G FG V+ A+ N VAVKI Q+ +
Sbjct: 8 HSSGVDLGTEN--LYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQN 65
Query: 475 KEFLREVAIMKGLRHPNIVLLMGAVTEPPN----LSIVTEYLSRGSLYKLLHIPDARVVV 530
+ EV + G++H NI+ +GA + L ++T + +GSL L VV
Sbjct: 66 E---YEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK----ANVV 118
Query: 531 DERLRLNMAYDVAKGMNYLHQ--------RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS 582
++A +A+G+ YLH+ +P I HRD+KS N+L+ + T + DFGL+
Sbjct: 119 SWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA 178
Query: 583 RSKP--NTYISSKTAAGTPEWMAPEVLR-----EDPSNEKSDVFSFGVILWELITLQKP- 634
+ + GT +MAPEVL + + + D+++ G++LWEL +
Sbjct: 179 LKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAA 238
Query: 635 ---------------WRNSTPSQVISAVGFKGRRLEIPKNVNP-----MVAALIETCWAE 674
++ + + V K +R + M+ IE CW
Sbjct: 239 DGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDH 298
Query: 675 EPEIRPSFPSIMETLQQ 691
+ E R S + E + Q
Sbjct: 299 DAEARLSAGCVGERITQ 315
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 300 bits (771), Expect = 1e-96
Identities = 78/331 (23%), Positives = 123/331 (37%), Gaps = 63/331 (19%)
Query: 428 LEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMK-- 485
+ L + + IG G +G VY VAVK+ + F+ E I +
Sbjct: 8 PSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANR-----QNFINEKNIYRVP 62
Query: 486 GLRHPNIVLLMGAVTEPP-----NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAY 540
+ H NI + +V EY GSL K L D +A+
Sbjct: 63 LMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS----LHTSDWVSSCRLAH 118
Query: 541 DVAKGMNYLH-------QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY---- 589
V +G+ YLH +P I HRDL S N+LV + T + DFGLS
Sbjct: 119 SVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRP 178
Query: 590 ----ISSKTAAGTPEWMAPEVLRE-------DPSNEKSDVFSFGVILWELI---TLQKPW 635
++ + GT +MAPEVL + + ++ D+++ G+I WE+ T P
Sbjct: 179 GEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG 238
Query: 636 RNSTPSQV---------------ISAVGFKGRRLEIPKNVNP------MVAALIETCWAE 674
+ Q+ V + +R + P+ + IE CW +
Sbjct: 239 ESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQ 298
Query: 675 EPEIRPSFPSIMETLQQFLMSSVCQPLSAQP 705
+ E R + E + + LM + S P
Sbjct: 299 DAEARLTAQXAEERMAE-LMMIWERNKSVSP 328
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 256 bits (657), Expect = 3e-79
Identities = 98/270 (36%), Positives = 139/270 (51%), Gaps = 11/270 (4%)
Query: 429 EIRWSELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKG 486
+ +L++ ++IG G+FG V+ R N+ VAVK E + + +FL+E I+K
Sbjct: 110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLK-AKFLQEARILKQ 168
Query: 487 LRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM 546
HPNIV L+G T+ + IV E + G L AR+ V L+ M D A GM
Sbjct: 169 YSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQ--MVGDAAAGM 226
Query: 547 NYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP-NTYISSKTAAGTP-EWMAP 604
YL + +HRDL + N LV +K+ DFG+SR + Y +S P +W AP
Sbjct: 227 EYLESKC--CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAP 284
Query: 605 EVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPM 663
E L + +SDV+SFG++LWE +L P+ N + Q V KG RL P+
Sbjct: 285 EALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE-KGGRLPCPELCPDA 343
Query: 664 VAALIETCWAEEPEIRPSFPSIMETLQQFL 693
V L+E CWA EP RPSF +I + LQ
Sbjct: 344 VFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 251 bits (643), Expect = 1e-78
Identities = 92/275 (33%), Positives = 138/275 (50%), Gaps = 13/275 (4%)
Query: 423 LEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVA 482
G + EL + + IG+G FG V ++R + VAVK + + FL E +
Sbjct: 11 FYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQA----FLAEAS 66
Query: 483 IMKGLRHPNIVLLMGAVT-EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYD 541
+M LRH N+V L+G + E L IVTEY+++GSL L V+ + L L + D
Sbjct: 67 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL-LKFSLD 125
Query: 542 VAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEW 601
V + M YL VHRDL + N+LV KV DFGL++ + T +W
Sbjct: 126 VCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKW 180
Query: 602 MAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNV 660
APE LRE + KSDV+SFG++LWE+ + + P+ V+ V KG +++ P
Sbjct: 181 TAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGC 239
Query: 661 NPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS 695
P V +++ CW + +RPSF + E L+
Sbjct: 240 PPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 250 bits (640), Expect = 7e-78
Identities = 92/280 (32%), Positives = 137/280 (48%), Gaps = 17/280 (6%)
Query: 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD-----VAVKILIEQEF-HEDRFKEFLREVA 482
I +L + +K+G+GSFG V EW VAVK L + +F+REV
Sbjct: 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVN 73
Query: 483 IMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDV 542
M L H N++ L G V PP + +VTE GSL L ++ A V
Sbjct: 74 AMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLS--RYAVQV 130
Query: 543 AKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR---SKPNTYISSKTAAGTP 599
A+GM YL +R +HRDL + NLL+ + VK+ DFGL R + Y+ P
Sbjct: 131 AEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQ-EHRKVP 187
Query: 600 -EWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIP 657
W APE L+ + SD + FGV LWE+ T Q+PW SQ++ + +G RL P
Sbjct: 188 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRP 247
Query: 658 KNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSV 697
++ + ++ CWA +PE RP+F ++ + L + + +
Sbjct: 248 EDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDM 287
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 251 bits (643), Expect = 8e-78
Identities = 82/276 (29%), Positives = 128/276 (46%), Gaps = 16/276 (5%)
Query: 430 IRWSELLIKKKIGEGSFGTVYHAEWRNSD------VAVKILIEQEFHEDRFKEFLREVAI 483
++ +E K +G G+FGTVY W VA+K L E KE L E +
Sbjct: 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE-ATSPKANKEILDEAYV 70
Query: 484 MKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVA 543
M + +P++ L+G + ++T+ + G L + + + L LN +A
Sbjct: 71 MASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGS-QYL-LNWCVQIA 127
Query: 544 KGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTP-EW 601
KGMNYL RR +VHRDL + N+LV + VK+ DFGL++ P +W
Sbjct: 128 KGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 602 MAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNV 660
MA E + +SDV+S+GV +WEL+T KP+ S++ S + KG RL P
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLPQPPIC 244
Query: 661 NPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 696
V ++ CW + + RP F ++ +
Sbjct: 245 TIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDP 280
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 249 bits (637), Expect = 4e-77
Identities = 90/306 (29%), Positives = 143/306 (46%), Gaps = 20/306 (6%)
Query: 418 NRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD-----VAVKILIEQEFHED 472
+ EL + E + I + + + +G+G FG+V A+ + D VAVK+L
Sbjct: 8 SDELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASS 67
Query: 473 RFKEFLREVAIMKGLRHPNIVLLMGAVTE------PPNLSIVTEYLSRGSLYKLL---HI 523
+EFLRE A MK HP++ L+G P ++ ++ G L+ L I
Sbjct: 68 DIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRI 127
Query: 524 PDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 583
+ + + + D+A GM YL R +HRDL + N ++ TV V DFGLSR
Sbjct: 128 GENPFNLPLQTLVRFMVDIACGMEYLSSRN--FIHRDLAARNCMLAEDMTVCVADFGLSR 185
Query: 584 S-KPNTYISSKTAAGTP-EWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTP 640
Y A+ P +W+A E L ++ SDV++FGV +WE++T Q P+
Sbjct: 186 KIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN 245
Query: 641 SQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQP 700
+++ + + G RL+ P V L+ CW+ +P+ RPSF + L+ L
Sbjct: 246 AEIYNYLI-GGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLS 304
Query: 701 LSAQPL 706
S PL
Sbjct: 305 TSQDPL 310
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 248 bits (635), Expect = 6e-77
Identities = 88/312 (28%), Positives = 147/312 (47%), Gaps = 22/312 (7%)
Query: 401 TNNHLLMEANLSVMSTSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD-- 458
+++H ++ ++ + EL + E + I + L++ K +GEG FG+V + D
Sbjct: 3 SSHHHHHHSS-GLVPRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGT 61
Query: 459 ---VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE-----PPNLSIVTE 510
VAVK + + +EFL E A MK HPN++ L+G E P ++
Sbjct: 62 SLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILP 121
Query: 511 YLSRGSLYKLL----HIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNL 566
++ G L+ L + + + L L D+A GM YL R +HRDL + N
Sbjct: 122 FMKYGDLHTYLLYSRLETGPKHIPLQTL-LKFMVDIALGMEYLSNRN--FLHRDLAARNC 178
Query: 567 LVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTP-EWMAPEVLREDPSNEKSDVFSFGVI 624
++ TV V DFGLS+ Y A P +W+A E L + KSDV++FGV
Sbjct: 179 MLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVT 238
Query: 625 LWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFP 683
+WE+ T P+ ++ + G RL+ P++ + ++ +CW +P RP+F
Sbjct: 239 MWEIATRGMTPYPGVQNHEMYDYLL-HGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFS 297
Query: 684 SIMETLQQFLMS 695
+ L++ L S
Sbjct: 298 VLRLQLEKLLES 309
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 246 bits (631), Expect = 1e-76
Identities = 92/274 (33%), Positives = 145/274 (52%), Gaps = 11/274 (4%)
Query: 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGL 487
E+ L + +++G G FG V+ + VAVK L + D FL E +MK L
Sbjct: 9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---AFLAEANLMKQL 65
Query: 488 RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 547
+H +V L VT+ P I+TEY+ GSL L P + +L L+MA +A+GM
Sbjct: 66 QHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKL-LDMAAQIAEGMA 123
Query: 548 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP-EWMAPEV 606
++ +R +HRDL++ N+LV T + K+ DFGL+R + +++ A P +W APE
Sbjct: 124 FIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 181
Query: 607 LREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 665
+ KSDV+SFG++L E++T + P+ T +VI + +G R+ P N +
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRPDNCPEELY 240
Query: 666 ALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQ 699
L+ CW E PE RP+F + L+ F ++ Q
Sbjct: 241 QLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQ 274
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 245 bits (628), Expect = 2e-76
Identities = 89/268 (33%), Positives = 136/268 (50%), Gaps = 11/268 (4%)
Query: 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGL 487
I SEL ++IG G FG V+ W N VA+K + E E+ +F+ E +M L
Sbjct: 4 VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKL 60
Query: 488 RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 547
HP +V L G E + +VTE++ G L L + L M DV +GM
Sbjct: 61 SHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAET--LLGMCLDVCEGMA 118
Query: 548 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP-EWMAPEV 606
YL + ++HRDL + N LV +KV DFG++R + +S T P +W +PEV
Sbjct: 119 YLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEV 176
Query: 607 LREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 665
+ KSDV+SFGV++WE+ + + P+ N + S+V+ + G RL P+ + V
Sbjct: 177 FSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKPRLASTHVY 235
Query: 666 ALIETCWAEEPEIRPSFPSIMETLQQFL 693
++ CW E PE RP+F ++ L +
Sbjct: 236 QIMNHCWRERPEDRPAFSRLLRQLAEIA 263
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 251 bits (643), Expect = 2e-76
Identities = 91/273 (33%), Positives = 137/273 (50%), Gaps = 13/273 (4%)
Query: 423 LEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVA 482
G + EL + + IG+G FG V ++R + VAVK + + FL E +
Sbjct: 183 FYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQA----FLAEAS 238
Query: 483 IMKGLRHPNIVLLMGAVT-EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYD 541
+M LRH N+V L+G + E L IVTEY+++GSL L V+ + L L + D
Sbjct: 239 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL-LKFSLD 297
Query: 542 VAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEW 601
V + M YL VHRDL + N+LV KV DFGL++ + T +W
Sbjct: 298 VCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKW 352
Query: 602 MAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNV 660
APE LRE + KSDV+SFG++LWE+ + + P+ V+ V KG +++ P
Sbjct: 353 TAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGC 411
Query: 661 NPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 693
P V +++ CW + RP+F + E L+
Sbjct: 412 PPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR 444
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 251 bits (642), Expect = 4e-76
Identities = 107/374 (28%), Positives = 173/374 (46%), Gaps = 32/374 (8%)
Query: 347 ADRDLQMQNPSGPSTHVIDSSN---------FIKGPLLRSPVKPFRHRKSH-------ET 390
++R L + V +S VK ++ RK
Sbjct: 77 SERLLLNAENPRGTFLVRESETTKGAYCLSVSDFDNAKGLNVKHYKIRKLDSGGFYITSR 136
Query: 391 SAFSTLKPYV---TNNHLLMEANLS--VMSTSNRELYLEEEGLEIRWSELLIKKKIGEGS 445
+ F++L+ V + + + L+ ++ + L ++ EI L ++ K+G+G
Sbjct: 137 TQFNSLQQLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGC 196
Query: 446 FGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN 504
FG V+ W + VA+K L + FL+E +MK LRH +V L V+E P
Sbjct: 197 FGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMKKLRHEKLVQLYAVVSEEPI 253
Query: 505 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSP 564
IVTEY+S+GSL L + + +L ++MA +A GM Y+ + VHRDL++
Sbjct: 254 Y-IVTEYMSKGSLLDFLKGETGKYLRLPQL-VDMAAQIASGMAYVERMN--YVHRDLRAA 309
Query: 565 NLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGV 623
N+LV KV DFGL+R + N Y + + A +W APE KSDV+SFG+
Sbjct: 310 NILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGI 369
Query: 624 ILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSF 682
+L EL T + P+ +V+ V +G R+ P + L+ CW +EPE RP+F
Sbjct: 370 LLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPESLHDLMCQCWRKEPEERPTF 428
Query: 683 PSIMETLQQFLMSS 696
+ L+ + S+
Sbjct: 429 EYLQAFLEDYFTST 442
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 244 bits (626), Expect = 4e-76
Identities = 91/268 (33%), Positives = 142/268 (52%), Gaps = 11/268 (4%)
Query: 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGL 487
E++ E+ + K++G G FG V +W+ DVAVK++ E ED EF +E M L
Sbjct: 4 ELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED---EFFQEAQTMMKL 60
Query: 488 RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 547
HP +V G ++ + IVTEY+S G L L + + L M YDV +GM
Sbjct: 61 SHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQ--LLEMCYDVCEGMA 118
Query: 548 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP-EWMAPEV 606
+L + +HRDL + N LVD VKV DFG++R + S P +W APEV
Sbjct: 119 FLESHQ--FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEV 176
Query: 607 LREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 665
+ KSDV++FG+++WE+ +L + P+ T S+V+ V +G RL P + +
Sbjct: 177 FHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS-QGHRLYRPHLASDTIY 235
Query: 666 ALIETCWAEEPEIRPSFPSIMETLQQFL 693
++ +CW E PE RP+F ++ +++
Sbjct: 236 QIMYSCWHELPEKRPTFQQLLSSIEPLR 263
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 244 bits (625), Expect = 8e-76
Identities = 90/274 (32%), Positives = 140/274 (51%), Gaps = 11/274 (4%)
Query: 423 LEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREV 481
L EI +L K++G G FG V + +WR DVA+K++ E ED EF+ E
Sbjct: 14 LGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEA 70
Query: 482 AIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYD 541
+M L H +V L G T+ + I+TEY++ G L L R + L M D
Sbjct: 71 KVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQ--LLEMCKD 128
Query: 542 VAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP-E 600
V + M YL ++ +HRDL + N LV+ VKV DFGLSR + +S + P
Sbjct: 129 VCEAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR 186
Query: 601 WMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKN 659
W PEVL + KSD+++FGV++WE+ +L + P+ T S+ + +G RL P
Sbjct: 187 WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRPHL 245
Query: 660 VNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 693
+ V ++ +CW E+ + RP+F ++ + +
Sbjct: 246 ASEKVYTIMYSCWHEKADERPTFKILLSNILDVM 279
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 251 bits (643), Expect = 8e-76
Identities = 97/278 (34%), Positives = 144/278 (51%), Gaps = 11/278 (3%)
Query: 423 LEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLRE 480
+ E+ +++ +K K+G G +G VY W+ VAVK L E + EFL+E
Sbjct: 210 PNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKE 266
Query: 481 VAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAY 540
A+MK ++HPN+V L+G T P I+TE+++ G+L L + + V L L MA
Sbjct: 267 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL-LYMAT 325
Query: 541 DVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTP 599
++ M YL ++ +HR+L + N LV + VKV DFGLSR +TY + A
Sbjct: 326 QISSAMEYLEKKN--FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 383
Query: 600 EWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPK 658
+W APE L + + KSDV++FGV+LWE+ T P+ SQV + K R+E P+
Sbjct: 384 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPE 442
Query: 659 NVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 696
V L+ CW P RPSF I + + S
Sbjct: 443 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 480
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 243 bits (623), Expect = 2e-75
Identities = 82/272 (30%), Positives = 128/272 (47%), Gaps = 14/272 (5%)
Query: 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD-----VAVKILIEQEFHEDRFKEFLREVAI 483
I ++++ + +GEG FG VY + N VAVK + +++ ++F+ E I
Sbjct: 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK-EKFMSEAVI 66
Query: 484 MKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVA 543
MK L HP+IV L+G + E P I+ E G L L + V + + +
Sbjct: 67 MKNLDHPHIVKLIGIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLT--LVLYSLQIC 123
Query: 544 KGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP-EWM 602
K M YL VHRD+ N+LV S VK+ DFGLSR + + P +WM
Sbjct: 124 KAMAYLESIN--CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM 181
Query: 603 APEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVN 661
+PE + SDV+ F V +WE+++ ++P+ VI + KG RL P
Sbjct: 182 SPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE-KGDRLPKPDLCP 240
Query: 662 PMVAALIETCWAEEPEIRPSFPSIMETLQQFL 693
P++ L+ CW +P RP F ++ +L
Sbjct: 241 PVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY 272
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 244 bits (624), Expect = 2e-75
Identities = 89/296 (30%), Positives = 135/296 (45%), Gaps = 19/296 (6%)
Query: 414 MSTSNRELY--LEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD-----VAVKILIE 466
+S N EL ++ + + + IG G FG VYH ++D AVK L
Sbjct: 4 LSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR 63
Query: 467 QEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP-PNLSIVTEYLSRGSLYKLLHIPD 525
+ +FL E IMK HPN++ L+G + +V Y+ G L +
Sbjct: 64 ITDIGEV-SQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET 122
Query: 526 ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS- 584
V + + VAKGM YL ++ VHRDL + N ++D +TVKV DFGL+R
Sbjct: 123 HNPTVKDLIG--FGLQVAKGMKYLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDM 178
Query: 585 -KPNTYISSKTAAGT-P-EWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTP 640
Y P +WMA E L+ KSDV+SFGV+LWEL+T P+ +
Sbjct: 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 238
Query: 641 SQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 696
+ + +GRRL P+ + ++ CW + E+RPSF ++ + +
Sbjct: 239 FDITVYLL-QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 243 bits (623), Expect = 2e-75
Identities = 97/272 (35%), Positives = 142/272 (52%), Gaps = 11/272 (4%)
Query: 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKG 486
E+ +++ +K K+G G +G VY W+ VAVK L E + EFL+E A+MK
Sbjct: 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKE 65
Query: 487 LRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM 546
++HPN+V L+G T P I+TE+++ G+L L + + V L L MA ++ M
Sbjct: 66 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL-LYMATQISSAM 124
Query: 547 NYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP-EWMAPE 605
YL ++ +HRDL + N LV + VKV DFGLSR ++ A P +W APE
Sbjct: 125 EYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 182
Query: 606 VLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV 664
L + + KSDV++FGV+LWE+ T P+ SQV + K R+E P+ V
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCPEKV 241
Query: 665 AALIETCWAEEPEIRPSFPSIMETLQQFLMSS 696
L+ CW P RPSF I + + S
Sbjct: 242 YELMRACWQWNPSDRPSFAEIHQAFETMFQES 273
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 248 bits (635), Expect = 4e-75
Identities = 103/335 (30%), Positives = 169/335 (50%), Gaps = 22/335 (6%)
Query: 379 VKPFRHRKS-------HETSAFSTLKPYV---TNNHLLMEANLSV-MSTSNRELYLEEEG 427
VK ++ R S FSTL+ V + + LSV +S + E++
Sbjct: 123 VKHYKIRTLDNGGFYISPRSTFSTLQELVDHYKKGNDGLCQKLSVPCMSSKPQKPWEKDA 182
Query: 428 LEIRWSELLIKKKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKG 486
EI L ++KK+G G FG V+ A + VAVK + + FL E +MK
Sbjct: 183 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE---AFLAEANVMKT 239
Query: 487 LRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM 546
L+H +V L VT+ P I+TE++++GSL L + +L ++ + +A+GM
Sbjct: 240 LQHDKLVKLHAVVTKEPIY-IITEFMAKGSLLDFLKSDEGSKQPLPKL-IDFSAQIAEGM 297
Query: 547 NYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPE 605
++ QR +HRDL++ N+LV ++ K+ DFGL+R + N Y + + A +W APE
Sbjct: 298 AFIEQRN--YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE 355
Query: 606 VLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV 664
+ KSDV+SFG++L E++T + P+ + +VI A+ +G R+ P+N +
Sbjct: 356 AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-RGYRMPRPENCPEEL 414
Query: 665 AALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQ 699
++ CW PE RP+F I L F ++ Q
Sbjct: 415 YNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQ 449
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 242 bits (620), Expect = 7e-75
Identities = 98/291 (33%), Positives = 149/291 (51%), Gaps = 28/291 (9%)
Query: 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD-------VAVKILIEQEFHEDRFKEFLREV 481
I+ ++++K+++GEG+FG V+ AE N VAVK L ++ K+F RE
Sbjct: 11 HIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL--KDPTLAARKDFQREA 68
Query: 482 AIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL--HIPDARVVVDERLR---- 535
++ L+H +IV G + L +V EY+ G L K L H PDA ++VD + R
Sbjct: 69 ELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKG 128
Query: 536 -------LNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 588
L++A +A GM YL + VHRDL + N LV + VK+ DFG+SR +T
Sbjct: 129 ELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVGANLLVKIGDFGMSRDVYST 186
Query: 589 -YISSKTAAGTP-EWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVIS 645
Y P WM PE + +SDV+SFGVILWE+ T ++PW + ++VI
Sbjct: 187 DYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE 246
Query: 646 AVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 696
+ +GR LE P+ V ++ CW EP+ R + I + L ++
Sbjct: 247 CIT-QGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHALGKAT 296
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 243 bits (622), Expect = 9e-75
Identities = 79/277 (28%), Positives = 130/277 (46%), Gaps = 16/277 (5%)
Query: 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD------VAVKILIEQEFHEDRFKEFLREVA 482
+ +EL K +G G FGTV+ W V +K++ ++ + + +
Sbjct: 9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSF-QAVTDHML 67
Query: 483 IMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDV 542
+ L H +IV L+G L +VT+YL GSL + + + L LN +
Sbjct: 68 AIGSLDHAHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGALGP-QLL-LNWGVQI 124
Query: 543 AKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTP-E 600
AKGM YL + +VHR+L + N+L+ S V+V DFG++ P+ + A TP +
Sbjct: 125 AKGMYYLEEHG--MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIK 182
Query: 601 WMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKN 659
WMA E + +SDV+S+GV +WEL+T +P+ ++V + KG RL P+
Sbjct: 183 WMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE-KGERLAQPQI 241
Query: 660 VNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 696
V ++ CW + IRP+F + +
Sbjct: 242 CTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDP 278
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 241 bits (617), Expect = 2e-74
Identities = 90/293 (30%), Positives = 149/293 (50%), Gaps = 21/293 (7%)
Query: 418 NRELYLEEEGLEI--RWSELLIKKKIGEGSFGTVYHAEWRNSD-----VAVKILIEQEFH 470
+ L E + + I + IG+G FG VYH E+ + A+K L
Sbjct: 4 DSALLAEVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEM 63
Query: 471 EDRFKEFLREVAIMKGLRHPNIVLLMGAVT--EPPNLSIVTEYLSRGSLYKLLHIPDARV 528
+ + FLRE +M+GL HPN++ L+G + E ++ Y+ G L + + P
Sbjct: 64 QQV-EAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH-VLLPYMCHGDLLQFIRSPQRNP 121
Query: 529 VVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS-KPN 587
V + + + VA+GM YL +++ VHRDL + N ++D ++TVKV DFGL+R
Sbjct: 122 TVKDLI--SFGLQVARGMEYLAEQK--FVHRDLAARNCMLDESFTVKVADFGLARDILDR 177
Query: 588 TYISSKTAAGT--P-EWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQV 643
Y S + P +W A E L+ KSDV+SFGV+LWEL+T P+R+ P +
Sbjct: 178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDL 237
Query: 644 ISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 696
+ +GRRL P+ + +++ CW +P +RP+F ++ ++Q + +
Sbjct: 238 THFLA-QGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL 289
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 244 bits (624), Expect = 2e-74
Identities = 101/359 (28%), Positives = 155/359 (43%), Gaps = 23/359 (6%)
Query: 355 NPSGPST--HVIDSSNFIKGPLLRSPVKPFRHRKSHETSAFSTLKPYVTNNHLLMEANLS 412
+P G H ++ G L+ S E + S K + N AN
Sbjct: 5 DPMGHHHHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTV 64
Query: 413 V--MSTSNRELY--LEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD-----VAVKI 463
+S N EL ++ + + + IG G FG VYH ++D AVK
Sbjct: 65 HIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS 124
Query: 464 LIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP-PNLSIVTEYLSRGSLYKLLH 522
L + +FL E IMK HPN++ L+G + +V Y+ G L +
Sbjct: 125 LNRITDIGEV-SQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR 183
Query: 523 IPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS 582
V + + VAKGM +L ++ VHRDL + N ++D +TVKV DFGL+
Sbjct: 184 NETHNPTVKDLIG--FGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLA 239
Query: 583 RS-KPNTYISSKTAAGT--P-EWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRN 637
R + S G P +WMA E L+ KSDV+SFGV+LWEL+T P+ +
Sbjct: 240 RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 299
Query: 638 STPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 696
+ + +GRRL P+ + ++ CW + E+RPSF ++ + +
Sbjct: 300 VNTFDITVYLL-QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 357
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 241 bits (618), Expect = 4e-74
Identities = 101/311 (32%), Positives = 149/311 (47%), Gaps = 28/311 (9%)
Query: 416 TSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD-------VAVKILIEQE 468
N + + + I+ ++++K ++GEG+FG V+ AE N VAVK L +E
Sbjct: 24 IENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL--KE 81
Query: 469 FHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL--HIPDA 526
E ++F RE ++ L+H +IV G TE L +V EY+ G L + L H PDA
Sbjct: 82 ASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDA 141
Query: 527 RVVVDERLR----------LNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKV 576
+++ L +A VA GM YL VHRDL + N LV VK+
Sbjct: 142 KLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQGLVVKI 199
Query: 577 CDFGLSRSKPNT-YISSKTAAGTP-EWMAPEVLREDPSNEKSDVFSFGVILWELITL-QK 633
DFG+SR +T Y P WM PE + +SDV+SFGV+LWE+ T ++
Sbjct: 200 GDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQ 259
Query: 634 PWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 693
PW + ++ I + +GR LE P+ P V A++ CW EP+ R S + LQ
Sbjct: 260 PWYQLSNTEAIDCIT-QGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALA 318
Query: 694 -MSSVCQPLSA 703
V +
Sbjct: 319 QAPPVYLDVLG 329
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 241 bits (617), Expect = 4e-74
Identities = 91/300 (30%), Positives = 154/300 (51%), Gaps = 22/300 (7%)
Query: 417 SNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD-------VAVKILIEQEF 469
S ++Y+ +E E+ ++ + +++G+GSFG VY + VA+K + E
Sbjct: 10 SAADVYVPDE-WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS 68
Query: 470 HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL--HIPDAR 527
+R EFL E ++MK ++V L+G V++ ++ E ++RG L L P
Sbjct: 69 MRER-IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMA 127
Query: 528 VVVDERLR-----LNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS 582
+ MA ++A GM YL+ + VHRDL + N +V +TVK+ DFG++
Sbjct: 128 NNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMT 185
Query: 583 RSKPNT-YISSKTAAGTP-EWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNST 639
R T Y P WM+PE L++ SDV+SFGV+LWE+ TL ++P++ +
Sbjct: 186 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 245
Query: 640 PSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQ 699
QV+ V +G L+ P N M+ L+ CW P++RPSF I+ ++++ + +
Sbjct: 246 NEQVLRFV-MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 304
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 248 bits (634), Expect = 4e-74
Identities = 106/333 (31%), Positives = 164/333 (49%), Gaps = 23/333 (6%)
Query: 379 VKPFRHRKSH-------ETSAFSTLKPYV----TNNHLLMEANLSVMSTS-NRELYLEEE 426
VK ++ RK + F++L+ V + L +V TS + L ++
Sbjct: 201 VKHYKIRKLDSGGFYITSRTQFNSLQQLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKD 260
Query: 427 GLEIRWSELLIKKKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMK 485
EI L ++ K+G+G FG V+ W + VA+K L + FL+E +MK
Sbjct: 261 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMK 317
Query: 486 GLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKG 545
LRH +V L V+E P IVTEY+S+GSL L + + +L ++MA +A G
Sbjct: 318 KLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQL-VDMAAQIASG 375
Query: 546 MNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAP 604
M Y+ + VHRDL++ N+LV KV DFGL+R + N Y + + A +W AP
Sbjct: 376 MAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 433
Query: 605 EVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPM 663
E KSDV+SFG++L EL T + P+ +V+ V +G R+ P
Sbjct: 434 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPES 492
Query: 664 VAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 696
+ L+ CW +EPE RP+F + L+ + S+
Sbjct: 493 LHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 240 bits (615), Expect = 8e-74
Identities = 99/312 (31%), Positives = 145/312 (46%), Gaps = 33/312 (10%)
Query: 420 ELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWR------NSDVAVKILIEQEFHEDR 473
+LY ++ L ++G+G+FG+V + + VAVK L Q D+
Sbjct: 10 QLYACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL--QHSGPDQ 67
Query: 474 FKEFLREVAIMKGLRHPNIVLLMGAVTEP--PNLSIVTEYLSRGSLYKLLHIPDARVVVD 531
++F RE+ I+K L IV G P +L +V EYL G L L AR+
Sbjct: 68 QRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDA- 126
Query: 532 ERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP--NTY 589
RL L + + KGM YL RR VHRDL + N+LV+S VK+ DFGL++ P Y
Sbjct: 127 SRL-LLYSSQICKGMEYLGSRR--CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDY 183
Query: 590 ISSKTAAGTP-EWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTP------- 640
+ +P W APE L ++ + +SDV+SFGV+L+EL T K S
Sbjct: 184 YVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGC 243
Query: 641 -------SQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 693
S+++ + +G+RL P V L++ CWA P+ RPSF ++ L
Sbjct: 244 ERDVPALSRLLELLE-EGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLW 302
Query: 694 MSSVCQPLSAQP 705
S A
Sbjct: 303 SGSRGCETHAFT 314
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 239 bits (613), Expect = 2e-73
Identities = 82/276 (29%), Positives = 129/276 (46%), Gaps = 16/276 (5%)
Query: 430 IRWSELLIKKKIGEGSFGTVYHAEWRNSD------VAVKILIEQEFHEDRFKEFLREVAI 483
++ +E K +G G+FGTVY W VA+K L E + KE L E +
Sbjct: 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-KEILDEAYV 70
Query: 484 MKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVA 543
M + +P++ L+G + ++T+ + G L + + + L LN +A
Sbjct: 71 MASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGS-QYL-LNWCVQIA 127
Query: 544 KGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTP-EW 601
KGMNYL RR +VHRDL + N+LV + VK+ DFGL++ P +W
Sbjct: 128 KGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 602 MAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNV 660
MA E + +SDV+S+GV +WEL+T KP+ S++ S + KG RL P
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLPQPPIC 244
Query: 661 NPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 696
V ++ CW + + RP F ++ +
Sbjct: 245 TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 280
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 238 bits (610), Expect = 2e-73
Identities = 84/292 (28%), Positives = 126/292 (43%), Gaps = 34/292 (11%)
Query: 429 EIRWSELLIKKKIGEGSFGTVYHAEWR------NSDVAVKILIEQEFHEDRFKEFLREVA 482
+ L +++G+G+FG+V + VAVK L Q E+ ++F RE+
Sbjct: 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFEREIE 63
Query: 483 IMKGLRHPNIVLLMGAVTEPPNLS--IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAY 540
I+K L+H NIV G + ++ EYL GSL L R+ +L L
Sbjct: 64 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDH-IKL-LQYTS 121
Query: 541 DVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP--NTYISSKTAAGT 598
+ KGM YL +R +HRDL + N+LV++ VK+ DFGL++ P + K +
Sbjct: 122 QICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGES 179
Query: 599 P-EWMAPEVLREDPSNEKSDVFSFGVILWELITL----------------QKPWRNSTPS 641
P W APE L E + SDV+SFGV+L+EL T
Sbjct: 180 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 239
Query: 642 QVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 693
+I + RL P + ++ CW RPSF + + Q
Sbjct: 240 HLIELLK-NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 290
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 237 bits (607), Expect = 5e-73
Identities = 87/287 (30%), Positives = 140/287 (48%), Gaps = 16/287 (5%)
Query: 423 LEEEGLEIRWSEL-LIKKKIGEGSFGTVYHAEWRNS----DVAVKILIEQEFHEDRFKEF 477
+ + + + L L K++G G+FGTV ++ VAVKIL + E
Sbjct: 6 IRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDEL 65
Query: 478 LREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLN 537
L E +M+ L +P IV ++G + +V E G L K L R V D+ + +
Sbjct: 66 LAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQ--QNRHVKDKNI-IE 121
Query: 538 MAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR--SKPNTYISSKTA 595
+ + V+ GM YL + VHRDL + N+L+ + + K+ DFGLS+ Y ++T
Sbjct: 122 LVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 179
Query: 596 AGTP-EWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRR 653
P +W APE + + KSDV+SFGV++WE + QKP+R S+V + + KG R
Sbjct: 180 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGER 238
Query: 654 LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQP 700
+ P + L+ CW + E RP F ++ L+ + V +
Sbjct: 239 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEG 285
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 237 bits (606), Expect = 6e-73
Identities = 83/280 (29%), Positives = 148/280 (52%), Gaps = 16/280 (5%)
Query: 425 EEGLEIRWSEL-LIKKKIGEGSFGTVYHAEWRNS----DVAVKILIEQEFHEDRFKEFLR 479
++ L ++ L + ++G G+FG+V +R DVA+K+L + D +E +R
Sbjct: 1 DKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT-EEMMR 59
Query: 480 EVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMA 539
E IM L +P IV L+G + +V E G L+K L + V +
Sbjct: 60 EAQIMHQLDNPYIVRLIGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSN--VAELL 116
Query: 540 YDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR--SKPNTYISSKTAAG 597
+ V+ GM YL ++ VHRDL + N+L+ + + K+ DFGLS+ ++Y ++++A
Sbjct: 117 HQVSMGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 174
Query: 598 TP-EWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLE 655
P +W APE + + +SDV+S+GV +WE ++ QKP++ +V++ + +G+R+E
Sbjct: 175 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRME 233
Query: 656 IPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS 695
P P + AL+ CW + E RP F ++ + ++ S
Sbjct: 234 CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 273
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 236 bits (605), Expect = 8e-73
Identities = 87/272 (31%), Positives = 136/272 (50%), Gaps = 14/272 (5%)
Query: 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD-----VAVKILIEQEFHEDRFKEFLREVAI 483
EI+ + + + IGEG FG V+ + + + VA+K R ++FL+E
Sbjct: 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR-EKFLQEALT 69
Query: 484 MKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVA 543
M+ HP+IV L+G +TE P I+ E + G L L + + + + AY ++
Sbjct: 70 MRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKYSLDLAS--LILYAYQLS 126
Query: 544 KGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWM 602
+ YL +R VHRD+ + N+LV S VK+ DFGLSR + +TY + +WM
Sbjct: 127 TALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM 184
Query: 603 APEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVN 661
APE + SDV+ FGV +WE++ KP++ + VI + G RL +P N
Sbjct: 185 APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPNCP 243
Query: 662 PMVAALIETCWAEEPEIRPSFPSIMETLQQFL 693
P + +L+ CWA +P RP F + L L
Sbjct: 244 PTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 238 bits (608), Expect = 8e-73
Identities = 86/292 (29%), Positives = 126/292 (43%), Gaps = 34/292 (11%)
Query: 429 EIRWSELLIKKKIGEGSFGTVYHAEWR------NSDVAVKILIEQEFHEDRFKEFLREVA 482
+ L +++G+G+FG+V + VAVK L Q E+ ++F RE+
Sbjct: 37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFEREIE 94
Query: 483 IMKGLRHPNIVLLMGAVTEPPN--LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAY 540
I+K L+H NIV G L ++ EYL GSL L R+ +L L
Sbjct: 95 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDH-IKL-LQYTS 152
Query: 541 DVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP--NTYISSKTAAGT 598
+ KGM YL +R +HRDL + N+LV++ VK+ DFGL++ P Y K +
Sbjct: 153 QICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGES 210
Query: 599 P-EWMAPEVLREDPSNEKSDVFSFGVILWELITL----------------QKPWRNSTPS 641
P W APE L E + SDV+SFGV+L+EL T
Sbjct: 211 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 270
Query: 642 QVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 693
+I + RL P + ++ CW RPSF + + Q
Sbjct: 271 HLIELLK-NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 237 bits (608), Expect = 1e-72
Identities = 92/275 (33%), Positives = 137/275 (49%), Gaps = 16/275 (5%)
Query: 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNS------DVAVKILIEQEFHEDRFKEFLREVA 482
EI S + +K IG G FG VY + S VA+K L + R +FL E
Sbjct: 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQR-VDFLGEAG 98
Query: 483 IMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDV 542
IM H NI+ L G +++ + I+TEY+ G+L K L D V + + M +
Sbjct: 99 IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQ--LVGMLRGI 156
Query: 543 AKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGT--P- 599
A GM YL VHRDL + N+LV+S KV DFGLSR + ++ T +G P
Sbjct: 157 AAGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPI 214
Query: 600 EWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPK 658
W APE + SDV+SFG+++WE++T ++P+ + +V+ A+ G RL P
Sbjct: 215 RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN-DGFRLPTPM 273
Query: 659 NVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 693
+ + L+ CW +E RP F I+ L + +
Sbjct: 274 DCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 308
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 236 bits (605), Expect = 3e-72
Identities = 86/299 (28%), Positives = 133/299 (44%), Gaps = 25/299 (8%)
Query: 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD-------VAVKILIEQEFHEDRFKEFLREV 481
E+ + + + +G G+FG VY + VAVK L E +D +FL E
Sbjct: 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE-LDFLMEA 84
Query: 482 AIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLR----LN 537
I+ H NIV +G + I+ E ++ G L L R L L+
Sbjct: 85 LIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 144
Query: 538 MAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST---YTVKVCDFGLSRSKPNT-YISSK 593
+A D+A G YL + +HRD+ + N L+ K+ DFG++R Y
Sbjct: 145 VARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKG 202
Query: 594 TAAGTP-EWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKG 651
A P +WM PE E K+D +SFGV+LWE+ +L P+ + + +V+ V G
Sbjct: 203 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT-SG 261
Query: 652 RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS----VCQPLSAQPL 706
R++ PKN V ++ CW +PE RP+F I+E ++ P+ PL
Sbjct: 262 GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEYGPL 320
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 236 bits (605), Expect = 4e-72
Identities = 96/323 (29%), Positives = 159/323 (49%), Gaps = 31/323 (9%)
Query: 401 TNNHLLMEANLSVMSTSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD-- 458
+++H + + S EL + + E +L + K +GEG+FG V AE D
Sbjct: 4 SHHHHHHSQDPMLAGVSEYELPEDPK-WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKD 62
Query: 459 -------VAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSIVTE 510
VAVK+L + + E + + E+ +MK + +H NI+ L+GA T+ L ++ E
Sbjct: 63 KPKEAVTVAVKMLKD-DATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVE 121
Query: 511 YLSRGSLYKLL--HIPDARVVVDERLR-----------LNMAYDVAKGMNYLHQRRPPIV 557
Y S+G+L + L P + R ++ Y +A+GM YL ++ +
Sbjct: 122 YASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CI 179
Query: 558 HRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGT-P-EWMAPEVLREDPSNEK 615
HRDL + N+LV +K+ DFGL+R N KT G P +WMAPE L + +
Sbjct: 180 HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ 239
Query: 616 SDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAE 674
SDV+SFGV++WE+ TL P+ ++ + +G R++ P N + ++ CW
Sbjct: 240 SDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK-EGHRMDKPANCTNELYMMMRDCWHA 298
Query: 675 EPEIRPSFPSIMETLQQFLMSSV 697
P RP+F ++E L + L +
Sbjct: 299 VPSQRPTFKQLVEDLDRILTLTT 321
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 236 bits (603), Expect = 5e-72
Identities = 97/277 (35%), Positives = 134/277 (48%), Gaps = 15/277 (5%)
Query: 429 EIRWSELLIKKKIGEGSFGTVYHAEWR-----NSDVAVKILIEQEFHEDRFKEFLREVAI 483
EI S + I+K IG G G V + R + VA+K L R ++FL E +I
Sbjct: 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQR-RDFLSEASI 103
Query: 484 MKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVA 543
M HPNI+ L G VT IVTEY+ GSL L D + + + + M V
Sbjct: 104 MGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQ--LVGMLRGVG 161
Query: 544 KGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR---SKPNTYISSKTAAGTPE 600
GM YL VHRDL + N+LVDS KV DFGLSR P+ ++
Sbjct: 162 AGMRYLSDLG--YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIR 219
Query: 601 WMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKN 659
W APE + + SDV+SFGV++WE++ ++P+ N T VIS+V +G RL P
Sbjct: 220 WTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE-EGYRLPAPMG 278
Query: 660 VNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 696
+ L+ CW ++ RP F I+ L + S
Sbjct: 279 CPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 237 bits (607), Expect = 6e-72
Identities = 101/365 (27%), Positives = 167/365 (45%), Gaps = 46/365 (12%)
Query: 379 VKPFRHRKSH-------ETSAFSTLKPYVTNNHL--------LMEANLSVMSTSNRELYL 423
+ + H H E F+ + Y ++H + + S EL
Sbjct: 1 MGYYHHHHHHDYDIPTTENLYFNGMGYYHHHHHHDYDIPTTENLYFQGMLAGVSEYELPE 60
Query: 424 EEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRN---------SDVAVKILIEQEFHEDRF 474
+ E+ L++ K +GEG+FG V AE + VAVK+L +D
Sbjct: 61 DPR-WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDL- 118
Query: 475 KEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL--HIPDARVVVD 531
+ + E+ +MK + +H NI+ L+GA T+ L ++ EY S+G+L + L P
Sbjct: 119 SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSY 178
Query: 532 ERLR-----------LNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFG 580
++ AY VA+GM YL ++ +HRDL + N+LV +K+ DFG
Sbjct: 179 NPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIADFG 236
Query: 581 LSRSKPNTYISSKTAAGT-P-EWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRN 637
L+R + KT G P +WMAPE L + +SDV+SFGV+LWE+ TL P+
Sbjct: 237 LARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 296
Query: 638 STPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSV 697
++ + +G R++ P N + ++ CW P RP+F ++E L + + +
Sbjct: 297 VPVEELFKLLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS 355
Query: 698 CQPLS 702
Q +
Sbjct: 356 NQEMG 360
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 234 bits (598), Expect = 8e-72
Identities = 85/287 (29%), Positives = 132/287 (45%), Gaps = 27/287 (9%)
Query: 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD-------VAVKILIEQEFHEDRFKEFLREV 481
EI S + +++GE FG VY VA+K L ++ R +EF E
Sbjct: 5 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLR-EEFRHEA 63
Query: 482 AIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL--HIPDARVVVDERLR---- 535
+ L+HPN+V L+G VT+ LS++ Y S G L++ L P + V + R
Sbjct: 64 MLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKS 123
Query: 536 -------LNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 588
+++ +A GM YL +VH+DL + N+LV VK+ D GL R
Sbjct: 124 ALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLVYDKLNVKISDLGLFREVYAA 181
Query: 589 -YISSKTAAGTP-EWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVIS 645
Y + P WMAPE + + SD++S+GV+LWE+ + +P+ + V+
Sbjct: 182 DYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE 241
Query: 646 AVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQF 692
+ + L P + V AL+ CW E P RP F I L+ +
Sbjct: 242 MIR-NRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 287
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 236 bits (603), Expect = 2e-71
Identities = 86/299 (28%), Positives = 133/299 (44%), Gaps = 25/299 (8%)
Query: 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD-------VAVKILIEQEFHEDRFKEFLREV 481
E+ + + + +G G+FG VY + VAVK L E +D +FL E
Sbjct: 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE-LDFLMEA 125
Query: 482 AIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLR----LN 537
I+ H NIV +G + I+ E ++ G L L R L L+
Sbjct: 126 LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 185
Query: 538 MAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST---YTVKVCDFGLSRSKPNT-YISSK 593
+A D+A G YL + +HRD+ + N L+ K+ DFG++R Y
Sbjct: 186 VARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKG 243
Query: 594 TAAGTP-EWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKG 651
A P +WM PE E K+D +SFGV+LWE+ +L P+ + + +V+ V G
Sbjct: 244 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT-SG 302
Query: 652 RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS----VCQPLSAQPL 706
R++ PKN V ++ CW +PE RP+F I+E ++ P+ PL
Sbjct: 303 GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEYGPL 361
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 235 bits (602), Expect = 2e-71
Identities = 102/355 (28%), Positives = 164/355 (46%), Gaps = 33/355 (9%)
Query: 371 KGPLLRSPVKPFRHRKSHETSAFSTLKPYVTNNHLLMEANLSVMSTSNRELYLEEEGLEI 430
K LR V S S ++ +T + S EL + + E
Sbjct: 22 KRIPLRRQVTVSAESSSSMNSNTPLVR--ITTRLSSTADTPMLAGVSEYELPEDPK-WEF 78
Query: 431 RWSELLIKKKIGEGSFGTVYHAEWRNSD---------VAVKILIEQEFHEDRFKEFLREV 481
+L + K +GEG FG V AE D VAVK+L + + E + + E+
Sbjct: 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD-DATEKDLSDLVSEM 137
Query: 482 AIMKGL-RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL--HIPDARVVVDERLR--- 535
+MK + +H NI+ L+GA T+ L ++ EY S+G+L + L P + R
Sbjct: 138 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 197
Query: 536 --------LNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 587
++ Y +A+GM YL ++ +HRDL + N+LV +K+ DFGL+R N
Sbjct: 198 EQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINN 255
Query: 588 TYISSKTAAGT-P-EWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVI 644
KT G P +WMAPE L + +SDV+SFGV++WE+ TL P+ ++
Sbjct: 256 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 315
Query: 645 SAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQ 699
+ +G R++ P N + ++ CW P RP+F ++E L + L + +
Sbjct: 316 KLLK-EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNE 369
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 232 bits (594), Expect = 4e-71
Identities = 88/304 (28%), Positives = 140/304 (46%), Gaps = 32/304 (10%)
Query: 416 TSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWR------NSDVAVKILIEQEF 469
S ++ E + L + +GEG FG V + VAVK L +
Sbjct: 4 VSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG 63
Query: 470 HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN--LSIVTEYLSRGSLYKLLHIPDAR 527
+ +E+ I++ L H NIV G TE + ++ E+L GSL + L +
Sbjct: 64 GNHI-ADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK 122
Query: 528 VVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP- 586
+ + ++ L A + KGM+YL R+ VHRDL + N+LV+S + VK+ DFGL+++
Sbjct: 123 INL-KQQ-LKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGLTKAIET 178
Query: 587 -NTYISSKTAAGTP-EWMAPEVLREDPSNEKSDVFSFGVILWELITL------------- 631
Y + K +P W APE L + SDV+SFGV L EL+T
Sbjct: 179 DKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLK 238
Query: 632 --QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETL 689
T +++++ + +G+RL P N V L+ CW +P R SF +++E
Sbjct: 239 MIGPTHGQMTVTRLVNTLK-EGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGF 297
Query: 690 QQFL 693
+ L
Sbjct: 298 EALL 301
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 234 bits (598), Expect = 5e-71
Identities = 92/297 (30%), Positives = 138/297 (46%), Gaps = 35/297 (11%)
Query: 428 LEIRWSELLIKKKIGEGSFGTVYHAEWRNSD-------VAVKILIEQEFHEDRFKEFLRE 480
LE + + + IGEG+FG V+ A VAVK+L E+ + + +F RE
Sbjct: 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ-ADFQRE 100
Query: 481 VAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL--HIPDARVVVDERLR--- 535
A+M +PNIV L+G + ++ EY++ G L + L P +
Sbjct: 101 AALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTR 160
Query: 536 ----------------LNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDF 579
L +A VA GM YL +R+ VHRDL + N LV VK+ DF
Sbjct: 161 ARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLATRNCLVGENMVVKIADF 218
Query: 580 GLSRSKPNT-YISSKTAAGTP-EWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWR 636
GLSR+ + Y + P WM PE + + +SDV+++GV+LWE+ + +P+
Sbjct: 219 GLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 278
Query: 637 NSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 693
+VI V G L P+N + L+ CW++ P RPSF SI LQ+
Sbjct: 279 GMAHEEVIYYVR-DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 334
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 242 bits (619), Expect = 8e-71
Identities = 95/345 (27%), Positives = 151/345 (43%), Gaps = 27/345 (7%)
Query: 374 LLRSPVKPFRHRKSHETSAFSTLKPYVTNNHLLMEANLSVMSTSNRELYLE--------- 424
L+ + F R + + N+ +S S + Y E
Sbjct: 320 LVNGATQSFIIRP-QKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYT 378
Query: 425 ---EEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD-----VAVKILIEQEFHEDRFKE 476
EI+ + + + IGEG FG V+ + + + VA+K R ++
Sbjct: 379 MPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVR-EK 437
Query: 477 FLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRL 536
FL+E M+ HP+IV L+G +TE P I+ E + G L L + + + +
Sbjct: 438 FLQEALTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKFSLDLAS--LI 494
Query: 537 NMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAA 596
AY ++ + YL +R VHRD+ + N+LV S VK+ DFGLSR ++ +
Sbjct: 495 LYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG 552
Query: 597 GTP-EWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRL 654
P +WMAPE + SDV+ FGV +WE++ KP++ + VI + G RL
Sbjct: 553 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERL 611
Query: 655 EIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQ 699
+P N P + +L+ CWA +P RP F + L L Q
Sbjct: 612 PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKLQ 656
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 233 bits (597), Expect = 2e-70
Identities = 88/274 (32%), Positives = 135/274 (49%), Gaps = 15/274 (5%)
Query: 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD-----VAVKILIEQEFHEDRFKEFLREVAI 483
E+ + + I K +G G FG V + VA+K L + R ++FL E +I
Sbjct: 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR-RDFLGEASI 99
Query: 484 MKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVA 543
M HPNI+ L G VT+ + IVTEY+ GSL L DA+ V + + M +A
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ--LVGMLRGIA 157
Query: 544 KGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR---SKPNTYISSKTAAGTPE 600
GM YL VHRDL + N+L++S KV DFGL R P +++
Sbjct: 158 SGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIR 215
Query: 601 WMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKN 659
W +PE + SDV+S+G++LWE+++ ++P+ + VI AV +G RL P +
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-EGYRLPPPMD 274
Query: 660 VNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 693
+ L+ CW ++ RP F I+ L + +
Sbjct: 275 CPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 2e-70
Identities = 87/315 (27%), Positives = 148/315 (46%), Gaps = 36/315 (11%)
Query: 413 VMSTSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD-------VAVKILI 465
+S ++ + + E L++ K +GEG FG V A + VAVK+L
Sbjct: 4 SLSVDAFKILEDPK-WEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK 62
Query: 466 EQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL--HI 523
E ++ L E ++K + HP+++ L GA ++ L ++ EY GSL L
Sbjct: 63 E-NASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESR 121
Query: 524 PDARVVVDERLR-------------------LNMAYDVAKGMNYLHQRRPPIVHRDLKSP 564
+ ++ A+ +++GM YL + + +VHRDL +
Sbjct: 122 KVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--LVHRDLAAR 179
Query: 565 NLLVDSTYTVKVCDFGLSRSKPNT-YISSKTAAGTP-EWMAPEVLREDPSNEKSDVFSFG 622
N+LV +K+ DFGLSR ++ P +WMA E L + +SDV+SFG
Sbjct: 180 NILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFG 239
Query: 623 VILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPS 681
V+LWE++TL P+ P ++ + + G R+E P N + + L+ CW +EP+ RP
Sbjct: 240 VLLWEIVTLGGNPYPGIPPERLFNLLK-TGHRMERPDNCSEEMYRLMLQCWKQEPDKRPV 298
Query: 682 FPSIMETLQQFLMSS 696
F I + L++ ++
Sbjct: 299 FADISKDLEKMMVKR 313
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 231 bits (590), Expect = 4e-70
Identities = 93/288 (32%), Positives = 139/288 (48%), Gaps = 26/288 (9%)
Query: 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD----VAVKILIEQEFHEDRFKEFLREVAIM 484
+ W+++ + IGEG+FG V A + A+K + E +D ++F E+ ++
Sbjct: 21 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVL 79
Query: 485 KGL-RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL--HIPDARVVVDERLR------ 535
L HPNI+ L+GA L + EY G+L L
Sbjct: 80 CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 139
Query: 536 -----LNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 590
L+ A DVA+GM+YL Q++ +HRDL + N+LV Y K+ DFGLSR
Sbjct: 140 SSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIADFGLSRG--QEVY 195
Query: 591 SSKTAAGTP-EWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVG 648
KT P WMA E L SDV+S+GV+LWE+++L P+ T +++ +
Sbjct: 196 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 255
Query: 649 FKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 696
+G RLE P N + V L+ CW E+P RPSF I+ +L + L
Sbjct: 256 -QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 228 bits (584), Expect = 8e-70
Identities = 65/289 (22%), Positives = 120/289 (41%), Gaps = 34/289 (11%)
Query: 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD---------VAVKILIEQEFHEDRFKEFLR 479
+IR +L+ + +G+G+F ++ R V +K+L + H + + F
Sbjct: 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVL--DKAHRNYSESFFE 61
Query: 480 EVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMA 539
++M L H ++VL G +V E++ GSL L + + +L +A
Sbjct: 62 AASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVA 119
Query: 540 YDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYT--------VKVCDFGLSRSKPNTYIS 591
+A M++L + ++H ++ + N+L+ +K+ D G+S +
Sbjct: 120 KQLAAAMHFLEENT--LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI-----TVL 172
Query: 592 SKTAAGTP-EWMAPEVLREDPS-NEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVG 648
K W+ PE + + N +D +SFG LWE+ + KP + +
Sbjct: 173 PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE 232
Query: 649 FKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSV 697
+L PK +A LI C EP+ RPSF +I+ L +
Sbjct: 233 -DRHQLPAPK--AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDL 278
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 1e-69
Identities = 82/301 (27%), Positives = 129/301 (42%), Gaps = 42/301 (13%)
Query: 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD------VAVKILIEQEFHEDRFKEFLREVA 482
L + +GEG FG V + ++ VAVK L + R + +E+
Sbjct: 27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHR-SGWKQEID 85
Query: 483 IMKGLRHPNIVLLMGAVTEP--PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLR----L 536
I++ L H +I+ G + +L +V EY+ GSL L + L
Sbjct: 86 ILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLP--------RHSIGLAQLL 137
Query: 537 NMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT--YISSKT 594
A + +GM YLH + +HRDL + N+L+D+ VK+ DFGL+++ P Y +
Sbjct: 138 LFAQQICEGMAYLHAQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRE 195
Query: 595 AAGTP-EWMAPEVLREDPSNEKSDVFSFGVILWELITL---------------QKPWRNS 638
+P W APE L+E SDV+SFGV L+EL+T
Sbjct: 196 DGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQM 255
Query: 639 TPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVC 698
T ++ + +G RL P V L++ CW E RP+F +++ L+
Sbjct: 256 TVLRLTELLE-RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQG 314
Query: 699 Q 699
Q
Sbjct: 315 Q 315
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 3e-69
Identities = 86/312 (27%), Positives = 138/312 (44%), Gaps = 32/312 (10%)
Query: 415 STSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRN-------SDVAVKILIEQ 467
+L + + E + L K +G G+FG V A VAVK+L
Sbjct: 6 YIDPTQLPYDHK-WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS 64
Query: 468 EFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL--HIP 524
+R + + E+ ++ L H NIV L+GA T ++TEY G L L
Sbjct: 65 AHLTER-EALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRD 123
Query: 525 DARVVVDERLR-------------LNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST 571
L+ +Y VAKGM +L + +HRDL + N+L+
Sbjct: 124 SFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLTHG 181
Query: 572 YTVKVCDFGLSRSKPNT-YISSKTAAGTP-EWMAPEVLREDPSNEKSDVFSFGVILWELI 629
K+CDFGL+R N K A P +WMAPE + +SDV+S+G+ LWEL
Sbjct: 182 RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 241
Query: 630 TL-QKPWRN-STPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687
+L P+ S+ + +G R+ P++ + +++TCW +P RP+F I++
Sbjct: 242 SLGSSPYPGMPVDSKFYKMIK-EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300
Query: 688 TLQQFLMSSVCQ 699
+++ + S
Sbjct: 301 LIEKQISESTNH 312
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 233 bits (596), Expect = 5e-68
Identities = 90/355 (25%), Positives = 164/355 (46%), Gaps = 20/355 (5%)
Query: 354 QNPSGPSTHVIDSSNFIKGPLLRSPVKPFRHRKSHETSAFSTLKPYVTNNH-----LLME 408
+ S + P S + + R S T +P + + M+
Sbjct: 252 EACPNSSASNASGAAAPTLPAHPSTLTHPQRRIDTLNSDGYTPEPARITSPDKPRPMPMD 311
Query: 409 ANLSVMSTSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNS----DVAVKIL 464
++ S+ E +++ R + L+ ++G G+FG+V +R DVA+K+L
Sbjct: 312 TSVFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL 371
Query: 465 IEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIP 524
+ D +E +RE IM L +P IV L+G + +V E G L+K L
Sbjct: 372 KQGTEKADT-EEMMREAQIMHQLDNPYIVRLIGVCQAEALM-LVMEMAGGGPLHKFLVGK 429
Query: 525 DARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR- 583
+ V + + V+ GM YL ++ VHR+L + N+L+ + + K+ DFGLS+
Sbjct: 430 REEIPVSN--VAELLHQVSMGMKYLEEKN--FVHRNLAARNVLLVNRHYAKISDFGLSKA 485
Query: 584 --SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTP 640
+ + Y + +W APE + + +SDV+S+GV +WE ++ QKP++
Sbjct: 486 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG 545
Query: 641 SQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS 695
+V++ + +G+R+E P P + AL+ CW + E RP F ++ + ++ S
Sbjct: 546 PEVMAFIE-QGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 599
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 224 bits (574), Expect = 6e-68
Identities = 87/298 (29%), Positives = 135/298 (45%), Gaps = 32/298 (10%)
Query: 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD-------VAVKILIEQEFHEDRFKEFLREV 481
E L + K +G G+FG V A+ D VAVK+L E + + E+
Sbjct: 23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKE-GATHSEHRALMSEL 81
Query: 482 AIMKGL-RHPNIVLLMGAVT--EPPNLSIVTEYLSRGSLYKLL--HIPDARVVVDERLR- 535
I+ + H N+V L+GA T P L ++ E+ G+L L +
Sbjct: 82 KILIHIGHHLNVVNLLGACTKPGGP-LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 140
Query: 536 ----------LNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK 585
+ ++ VAKGM +L R+ +HRDL + N+L+ VK+CDFGL+R
Sbjct: 141 YKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDI 198
Query: 586 PNT-YISSKTAAGTP-EWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRN-STPS 641
K A P +WMAPE + + +SDV+SFGV+LWE+ +L P+
Sbjct: 199 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 258
Query: 642 QVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQ 699
+ + +G R+ P P + + CW EP RP+F ++E L L ++ Q
Sbjct: 259 EFCRRLK-EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQ 315
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 8e-68
Identities = 91/329 (27%), Positives = 147/329 (44%), Gaps = 30/329 (9%)
Query: 397 KPYVTNNHLLMEANLSVMST--SNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEW 454
KP ++E+ T +L E+ E + L K +G G+FG V A
Sbjct: 9 KPKYQVRWKIIESYEGNSYTFIDPTQLPYNEK-WEFPRNNLQFGKTLGAGAFGKVVEATA 67
Query: 455 RN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLS 506
VAVK+L H D + + E+ IM L +H NIV L+GA T +
Sbjct: 68 FGLGKEDAVLKVAVKMLKS-TAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVL 126
Query: 507 IVTEYLSRGSLYKLL-------HIPDARVVVDERLR----LNMAYDVAKGMNYLHQRRPP 555
++TEY G L L A + + L+ + VA+GM +L +
Sbjct: 127 VITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN-- 184
Query: 556 IVHRDLKSPNLLVDSTYTVKVCDFGLSRS--KPNTYISSKTAAGTPEWMAPEVLREDPSN 613
+HRD+ + N+L+ + + K+ DFGL+R + YI A +WMAPE + +
Sbjct: 185 CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYT 244
Query: 614 EKSDVFSFGVILWELITL-QKPWRNS-TPSQVISAVGFKGRRLEIPKNVNPMVAALIETC 671
+SDV+S+G++LWE+ +L P+ S+ V G ++ P + ++++ C
Sbjct: 245 VQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVK-DGYQMAQPAFAPKNIYSIMQAC 303
Query: 672 WAEEPEIRPSFPSIMETLQQFLMSSVCQP 700
WA EP RP+F I LQ+ +
Sbjct: 304 WALEPTHRPTFQQICSFLQEQAQEDRRER 332
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 224 bits (574), Expect = 1e-67
Identities = 92/327 (28%), Positives = 142/327 (43%), Gaps = 37/327 (11%)
Query: 402 NNHLLMEANLSVMSTSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRN----- 456
+ ++ RE + + E L K +G G+FG V +A
Sbjct: 15 MVQVTGSSDNEYFYVDFREYEYDLK-WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTG 73
Query: 457 --SDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSIVTEYLS 513
VAVK+L E + + + E+ +M L H NIV L+GA T + ++ EY
Sbjct: 74 VSIQVAVKMLKE-KADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCC 132
Query: 514 RGSL--------------------YKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 553
G L K L + V+ L AY VAKGM +L +
Sbjct: 133 YGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS 192
Query: 554 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT-YISSKTAAGTP-EWMAPEVLREDP 611
VHRDL + N+LV VK+CDFGL+R + + A P +WMAPE L E
Sbjct: 193 --CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI 250
Query: 612 SNEKSDVFSFGVILWELITL-QKPWRN-STPSQVISAVGFKGRRLEIPKNVNPMVAALIE 669
KSDV+S+G++LWE+ +L P+ + + G +++ P + +++
Sbjct: 251 YTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQ-NGFKMDQPFYATEEIYIIMQ 309
Query: 670 TCWAEEPEIRPSFPSIMETLQQFLMSS 696
+CWA + RPSFP++ L L +
Sbjct: 310 SCWAFDSRKRPSFPNLTSFLGCQLADA 336
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 219 bits (559), Expect = 4e-66
Identities = 79/280 (28%), Positives = 134/280 (47%), Gaps = 20/280 (7%)
Query: 414 MSTSNRELYLEEEGLEI----RWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQ 467
+ LE + + + R+ + +IG GSF TVY + +VA L ++
Sbjct: 5 NQQQDDIEELETKAVGMSNDGRFLKF--DIEIGRGSFKTVYKGLDTETTVEVAWCELQDR 62
Query: 468 EFHEDRFKEFLREVAIMKGLRHPNIVLLMGA----VTEPPNLSIVTEYLSRGSLYKLLHI 523
+ + + F E ++KGL+HPNIV + V + +VTE ++ G+L L
Sbjct: 63 KLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR 122
Query: 524 PDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY-TVKVCDFGLS 582
+ ++ + + KG+ +LH R PPI+HRDLK N+ + +VK+ D GL+
Sbjct: 123 FKV---MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179
Query: 583 RSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTP-S 641
K ++ +K GTPE+MAPE+ E +E DV++FG+ + E+ T + P+ +
Sbjct: 180 TLKRASF--AKAVIGTPEFMAPEMYEEK-YDESVDVYAFGMCMLEMATSEYPYSECQNAA 236
Query: 642 QVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPS 681
Q+ V + K P V +IE C + + R S
Sbjct: 237 QIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYS 276
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 2e-58
Identities = 71/269 (26%), Positives = 131/269 (48%), Gaps = 12/269 (4%)
Query: 437 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 494
+KIGEGSFG + +K + +E REVA++ ++HPNIV
Sbjct: 28 RLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQ 87
Query: 495 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 554
+ E +L IV +Y G L+K ++ V+ E L+ + + ++H R+
Sbjct: 88 YRESFEENGSLYIVMDYCEGGDLFKRIN-AQKGVLFQEDQILDWFVQICLALKHVHDRK- 145
Query: 555 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNE 614
I+HRD+KS N+ + TV++ DFG++R +T ++ GTP +++PE+ P N
Sbjct: 146 -ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNN 204
Query: 615 KSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAE 674
KSD+++ G +L+EL TL+ + + ++ + G + + + + +L+ +
Sbjct: 205 KSDIWALGCVLYELCTLKHAFEAGSMKNLVLKII-SGSFPPVSLHYSYDLRSLVSQLFKR 263
Query: 675 EPEIRPS------FPSIMETLQQFLMSSV 697
P RPS I + +++FL +
Sbjct: 264 NPRDRPSVNSILEKGFIAKRIEKFLSPQL 292
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 2e-58
Identities = 74/261 (28%), Positives = 122/261 (46%), Gaps = 13/261 (4%)
Query: 437 IKKKIGEGSFGTVYHAEWRNSD---VAVK-ILIEQEFHEDRFKEFLREVAIMKGLRHPNI 492
+ IG GS+G R SD + K + ++ + + EV +++ L+HPNI
Sbjct: 10 VLYTIGTGSYGRCQKIR-RKSDGKILVWKELDYGSMTEAEK-QMLVSEVNLLRELKHPNI 67
Query: 493 VLLMGAVTEPPN--LSIVTEYLSRGSLYKLL-HIPDARVVVDERLRLNMAYDVAKGMNYL 549
V + + N L IV EY G L ++ R +DE L + + +
Sbjct: 68 VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 127
Query: 550 HQRRPP---IVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV 606
H+R ++HRDLK N+ +D VK+ DFGL+R + +KT GTP +M+PE
Sbjct: 128 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQ 187
Query: 607 LREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA 666
+ NEKSD++S G +L+EL L P+ + ++ + +G+ IP + +
Sbjct: 188 MNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR-EGKFRRIPYRYSDELNE 246
Query: 667 LIETCWAEEPEIRPSFPSIME 687
+I + RPS I+E
Sbjct: 247 IITRMLNLKDYHRPSVEEILE 267
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 1e-57
Identities = 72/260 (27%), Positives = 129/260 (49%), Gaps = 14/260 (5%)
Query: 437 IKKKIGEGSFGTVYHAEWRNSD---VAVK-ILIEQEFHEDRFKEFLREVAIMKGLRHPNI 492
I+KKIG G F VY A D VA+K + I + ++E+ ++K L HPN+
Sbjct: 36 IEKKIGRGQFSEVYRAA-CLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNV 94
Query: 493 VLLMGAVTEPPNLSIVTEYLSRGSLYKLL-HIPDARVVVDERLRLNMAYDVAKGMNYLHQ 551
+ + E L+IV E G L +++ H + ++ ER + + ++H
Sbjct: 95 IKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS 154
Query: 552 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDP 611
RR ++HRD+K N+ + +T VK+ D GL R + ++ + GTP +M+PE + E+
Sbjct: 155 RR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENG 212
Query: 612 SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPK----NVNPMVAAL 667
N KSD++S G +L+E+ LQ P+ + + ++ K + + P + + + L
Sbjct: 213 YNFKSDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKKIEQCDYPPLPSDHYSEELRQL 270
Query: 668 IETCWAEEPEIRPSFPSIME 687
+ C +PE RP + +
Sbjct: 271 VNMCINPDPEKRPDVTYVYD 290
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 5e-54
Identities = 65/271 (23%), Positives = 120/271 (44%), Gaps = 34/271 (12%)
Query: 437 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIV- 493
+ IG G FG V+ A+ R +K ++ ++ REV + L H NIV
Sbjct: 15 EIELIGSGGFGQVFKAKHRIDGKTYVIKR-VKYNN-----EKAEREVKALAKLDHVNIVH 68
Query: 494 ---------------LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNM 538
+ ++ L I E+ +G+L + + +D+ L L +
Sbjct: 69 YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK-RRGEKLDKVLALEL 127
Query: 539 AYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGT 598
+ KG++Y+H ++ +++RDLK N+ + T VK+ DFGL S N + GT
Sbjct: 128 FEQITKGVDYIHSKK--LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND-GKRTRSKGT 184
Query: 599 PEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPK 658
+M+PE + ++ D+++ G+IL EL+ + + S+ + R I
Sbjct: 185 LRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFFT----DLRDGIISD 238
Query: 659 NVNPMVAALIETCWAEEPEIRPSFPSIMETL 689
+ L++ +++PE RP+ I+ TL
Sbjct: 239 IFDKKEKTLLQKLLSKKPEDRPNTSEILRTL 269
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 1e-52
Identities = 83/276 (30%), Positives = 133/276 (48%), Gaps = 26/276 (9%)
Query: 440 KIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDR--FKEFLREVAIMKGLRHPNIVLLMG 497
K+GEG FG VY N+ VAVK L ++F +E+ +M +H N+V L+G
Sbjct: 38 KMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLG 97
Query: 498 AVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 557
++ +L +V Y+ GSL L D + +R +A A G+N+LH+ +
Sbjct: 98 FSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE--NHHI 155
Query: 558 HRDLKSPNLLVDSTYTVKVCDFGLSRSKP---NTYISSKTAAGTPEWMAPEVLREDPSNE 614
HRD+KS N+L+D +T K+ DFGL+R+ T ++S+ GT +MAPE LR +
Sbjct: 156 HRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSR-IVGTTAYMAPEALRGE-ITP 213
Query: 615 KSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV---------- 664
KSD++SFGV+L E+IT Q++ + K + K + +
Sbjct: 214 KSDIYSFGVVLLEIITGLPAVDEHREPQLL--LDIKEEIEDEEKTIEDYIDKKMNDADST 271
Query: 665 -----AALIETCWAEEPEIRPSFPSIMETLQQFLMS 695
++ C E+ RP + + LQ+ S
Sbjct: 272 SVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 2e-52
Identities = 78/286 (27%), Positives = 123/286 (43%), Gaps = 27/286 (9%)
Query: 407 MEANLSVMSTSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD----VAVK 462
E N V+ T + E E+ W + ++G GSFG V+ ++ AVK
Sbjct: 34 TEDNEGVLLTEKLKPVDYEYREEVHWMTH--QPRVGRGSFGEVHRM--KDKQTGFQCAVK 89
Query: 463 ILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLH 522
+ + F + E+ GL P IV L GAV E P ++I E L GSL +L+
Sbjct: 90 KVRLEVFRVE-------ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI- 141
Query: 523 IPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST-YTVKVCDFGL 581
+ E L +G+ YLH RR I+H D+K+ N+L+ S +CDFG
Sbjct: 142 --KQMGCLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFGH 197
Query: 582 SR-----SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWR 636
+ + ++ GT MAPEV+ P + K D++S ++ ++ PW
Sbjct: 198 ALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWT 257
Query: 637 NSTPSQVISAVGFKGR-RLEIPKNVNPMVAALIETCWAEEPEIRPS 681
+ + + EIP + P+ A I+ +EP R S
Sbjct: 258 QYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRAS 303
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 4e-52
Identities = 74/279 (26%), Positives = 135/279 (48%), Gaps = 16/279 (5%)
Query: 412 SVMSTSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD----VAVKILIEQ 467
S+ ST + + + + E + +G+G++G VY R+ +A+K I +
Sbjct: 1 SMRSTEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAG--RDLSNQVRIAIKE-IPE 57
Query: 468 EFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDAR 527
+ E+A+ K L+H NIV +G+ +E + I E + GSL LL
Sbjct: 58 RDSRY-SQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGP 116
Query: 528 VVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY-TVKVCDFGLSRSKP 586
+ +E+ + +G+ YLH + IVHRD+K N+L+++ +K+ DFG S+
Sbjct: 117 LKDNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRLA 174
Query: 587 NTYISSKTAAGTPEWMAPEVLREDPS--NEKSDVFSFG-VILWELITLQKPWRN-STPSQ 642
++T GT ++MAPE++ + P + +D++S G I+ E+ T + P+ P
Sbjct: 175 GINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTII-EMATGKPPFYELGEPQA 233
Query: 643 VISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPS 681
+ VG EIP++++ A I C+ +P+ R
Sbjct: 234 AMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRAC 272
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 7e-52
Identities = 56/253 (22%), Positives = 101/253 (39%), Gaps = 15/253 (5%)
Query: 439 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLL 495
++G GS+G V+ + AVK + L EV + + +HP V L
Sbjct: 63 SRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRL 122
Query: 496 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 555
A E L + TE SL + H + E D + +LH +
Sbjct: 123 EQAWEEGGILYLQTEL-CGPSLQQ--HCEAWGASLPEAQVWGYLRDTLLALAHLHSQG-- 177
Query: 556 IVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEK 615
+VH D+K N+ + K+ DFGL T + + G P +MAPE+L+
Sbjct: 178 LVHLDVKPANIFLGPRGRCKLGDFGLLVEL-GTAGAGEVQEGDPRYMAPELLQGSY-GTA 235
Query: 616 SDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR-RLEIPKNVNPMVAALIETCWAE 674
+DVFS G+ + E+ + Q + +G E ++ + +++
Sbjct: 236 ADVFSLGLTILEVACNMELPHGGEGWQQL----RQGYLPPEFTAGLSSELRSVLVMMLEP 291
Query: 675 EPEIRPSFPSIME 687
+P++R + +++
Sbjct: 292 DPKLRATAEALLA 304
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 8e-52
Identities = 58/268 (21%), Positives = 109/268 (40%), Gaps = 24/268 (8%)
Query: 437 IKKKIGEGSFGTVYHAEWRNSD-VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN--IV 493
I K+IG G V+ A+K + +E + E+A + L+ + I+
Sbjct: 32 ILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII 91
Query: 494 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 553
L + +V E L L + +D R + ++ + ++ +HQ
Sbjct: 92 RLYDYEITDQYIYMVMEC-GNIDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIHQHG 147
Query: 554 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN--TYISSKTAAGTPEWMAPEVLREDP 611
IVH DLK N L+ +K+ DFG++ T + + GT +M PE +++
Sbjct: 148 --IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 204
Query: 612 S-----------NEKSDVFSFGVILWELITLQKPWRNST-PSQVISAVGFKGRRLEIPKN 659
S + KSDV+S G IL+ + + P++ + A+ +E P
Sbjct: 205 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 264
Query: 660 VNPMVAALIETCWAEEPEIRPSFPSIME 687
+ +++ C +P+ R S P ++
Sbjct: 265 PEKDLQDVLKCCLKRDPKQRISIPELLA 292
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 181 bits (460), Expect = 2e-51
Identities = 58/268 (21%), Positives = 109/268 (40%), Gaps = 24/268 (8%)
Query: 437 IKKKIGEGSFGTVYHAEWRNSD-VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN--IV 493
I K+IG G V+ A+K + +E + E+A + L+ + I+
Sbjct: 13 ILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII 72
Query: 494 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 553
L + +V E L L + +D R + ++ + ++ +HQ
Sbjct: 73 RLYDYEITDQYIYMVMEC-GNIDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIHQHG 128
Query: 554 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN--TYISSKTAAGTPEWMAPEVLREDP 611
IVH DLK N L+ +K+ DFG++ T + + GT +M PE +++
Sbjct: 129 --IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185
Query: 612 S-----------NEKSDVFSFGVILWELITLQKPWRNST-PSQVISAVGFKGRRLEIPKN 659
S + KSDV+S G IL+ + + P++ + A+ +E P
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 245
Query: 660 VNPMVAALIETCWAEEPEIRPSFPSIME 687
+ +++ C +P+ R S P ++
Sbjct: 246 PEKDLQDVLKCCLKRDPKQRISIPELLA 273
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 4e-51
Identities = 57/268 (21%), Positives = 108/268 (40%), Gaps = 24/268 (8%)
Query: 437 IKKKIGEGSFGTVYHAEWRNSD-VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN--IV 493
I K+IG G V+ A+K + +E + E+A + L+ + I+
Sbjct: 60 ILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII 119
Query: 494 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 553
L + +V E L L + +D R + ++ + ++ +HQ
Sbjct: 120 RLYDYEITDQYIYMVMEC-GNIDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIHQHG 175
Query: 554 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN--TYISSKTAAGTPEWMAPEVLREDP 611
IVH DLK N L+ +K+ DFG++ T + + G +M PE +++
Sbjct: 176 --IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMS 232
Query: 612 SN-----------EKSDVFSFGVILWELITLQKPWRNST-PSQVISAVGFKGRRLEIPKN 659
S+ KSDV+S G IL+ + + P++ + A+ +E P
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 292
Query: 660 VNPMVAALIETCWAEEPEIRPSFPSIME 687
+ +++ C +P+ R S P ++
Sbjct: 293 PEKDLQDVLKCCLKRDPKQRISIPELLA 320
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 4e-51
Identities = 59/298 (19%), Positives = 114/298 (38%), Gaps = 24/298 (8%)
Query: 415 STSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHED 472
S+ LY + + I L +K+GEG F V E + A+K ++ E +
Sbjct: 11 SSGRENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE--QQ 68
Query: 473 RFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN----LSIVTEYLSRGSLYKLL-HIPDAR 527
+E RE + + HPNI+ L+ ++ + RG+L+ + + D
Sbjct: 69 DREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKG 128
Query: 528 VVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 587
+ E L + + +G+ +H HRDLK N+L+ + D G
Sbjct: 129 NFLTEDQILWLLLGICRGLEAIHA--KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACI 186
Query: 588 TYISSKTAA---------GTPEWMAPEVLRE---DPSNEKSDVFSFGVILWELITLQKPW 635
S+ A T + APE+ +E++DV+S G +L+ ++ + P+
Sbjct: 187 HVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPY 246
Query: 636 R-NSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQF 692
++ + + + L+ + +P RP P ++ L+
Sbjct: 247 DMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEAL 304
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 7e-51
Identities = 61/279 (21%), Positives = 105/279 (37%), Gaps = 41/279 (14%)
Query: 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD----VAVKILIEQEFHEDRFKEFLREVAIM 484
+ EL +KIG G FG+V+ A+K + + LREV
Sbjct: 10 TTEFHEL---EKIGSGEFGSVFKC--VKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAH 64
Query: 485 KGL-RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL-HIPDARVVVDERLRLNMAYDV 542
L +H ++V A E ++ I EY + GSL + E ++ V
Sbjct: 65 AVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQV 124
Query: 543 AKGMNYLHQRRPPIVHRDLKSPNLLVD-------------------STYTVKVCDFGLSR 583
+G+ Y+H +VH D+K N+ + + K+ D G
Sbjct: 125 GRGLRYIHSMS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT 182
Query: 584 SKPNTYISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQ 642
+ + G ++A EVL+E+ K+D+F+ + + + RN
Sbjct: 183 RISSP----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWH 238
Query: 643 VISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPS 681
I +GR IP+ ++ L++ +PE RPS
Sbjct: 239 EI----RQGRLPRIPQVLSQEFTELLKVMIHPDPERRPS 273
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 9e-51
Identities = 77/274 (28%), Positives = 129/274 (47%), Gaps = 25/274 (9%)
Query: 440 KIGEGSFGTVYHAEWRN-SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA 498
IG G FG VY R+ + VA+K + EF E+ + RHP++V L+G
Sbjct: 46 LIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIE--EFETEIETLSFCRHPHLVSLIGF 103
Query: 499 VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVV-DERLRLNMAYDVAKGMNYLHQRRPPIV 557
E + ++ +Y+ G+L + L+ D + RL + A+G++YLH I+
Sbjct: 104 CDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT--RAII 161
Query: 558 HRDLKSPNLLVDSTYTVKVCDFGLSRSKP---NTYISSKTAAGTPEWMAPEVLREDPSNE 614
HRD+KS N+L+D + K+ DFG+S+ T++S+ GT ++ PE + E
Sbjct: 162 HRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTV-VKGTLGYIDPEYFIKGRLTE 220
Query: 615 KSDVFSFGVILWELITLQKPWRNSTPSQVISAVG-----FKGRRLE------IPKNVNP- 662
KSDV+SFGV+L+E++ + S P ++++ +LE + + P
Sbjct: 221 KSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPE 280
Query: 663 ---MVAALIETCWAEEPEIRPSFPSIMETLQQFL 693
C A E RPS ++ L+ L
Sbjct: 281 SLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL 314
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 1e-50
Identities = 75/291 (25%), Positives = 134/291 (46%), Gaps = 35/291 (12%)
Query: 437 IKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIV 493
+++ + EG F VY A+ + A+K L+ E E++ + ++EV MK L HPNIV
Sbjct: 32 VRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE--EEKNRAIIQEVCFMKKLSGHPNIV 89
Query: 494 LLMGAVTEPPNLS-------IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM 546
A + S ++ L +G L + L ++R + L + Y + +
Sbjct: 90 QFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAV 149
Query: 547 NYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAA---------- 596
++H+++PPI+HRDLK NLL+ + T+K+CDFG + + + S +A
Sbjct: 150 QHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEIT 209
Query: 597 --GTPEWMAPEVL---REDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG 651
TP + PE++ P EK D+++ G IL+ L Q P+ + ++++
Sbjct: 210 RNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNG----- 264
Query: 652 RRLEIPKNVN--PMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQP 700
+ IP + + +LI PE R S ++ LQ+ + P
Sbjct: 265 -KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNP 314
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 1e-50
Identities = 63/277 (22%), Positives = 110/277 (39%), Gaps = 32/277 (11%)
Query: 437 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 494
+ +G G FG V+ A+ + D A+K I E ++ +REV + L HP IV
Sbjct: 9 PIQCLGRGGFGVVFEAKNKVDDCNYAIKR-IRLPNRELAREKVMREVKALAKLEHPGIVR 67
Query: 495 LMGAVTEPPN------------LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDV 542
A E L I + + +L ++ + + L++ +
Sbjct: 68 YFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQI 127
Query: 543 AKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAA------ 596
A+ + +LH + ++HRDLK N+ VKV DFGL +
Sbjct: 128 AEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 185
Query: 597 ------GTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK 650
GT +M+PE + + + K D+FS G+IL+EL L + ++ V
Sbjct: 186 RHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL--LYPFSTQMERVRTLTDVR-N 242
Query: 651 GRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687
+ + P +++ + P RP +I+E
Sbjct: 243 LKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 2e-49
Identities = 64/285 (22%), Positives = 112/285 (39%), Gaps = 45/285 (15%)
Query: 437 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 494
+G+G+FG V A A+K + E++ L EV ++ L H +V
Sbjct: 10 EIAVLGQGAFGQVVKARNALDSRYYAIKKI---RHTEEKLSTILSEVMLLASLNHQYVVR 66
Query: 495 LMGAVTEPPNLS-------------IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYD 541
A E N I EY G+LY L I + +
Sbjct: 67 YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDL--IHSENLNQQRDEYWRLFRQ 124
Query: 542 VAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISS--------- 592
+ + ++Y+H + I+HRDLK N+ +D + VK+ DFGL+++ +
Sbjct: 125 ILEALSYIHSQG--IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 593 -----KTAAGTPEWMAPEVLREDPS-NEKSDVFSFGVILWELITLQKPWRNSTPSQVISA 646
+A GT ++A EVL NEK D++S G+I +E+ + ++
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM--IYPFSTGMERVNILKK 240
Query: 647 VGFKGRRLEIP----KNVNPMVAALIETCWAEEPEIRPSFPSIME 687
+ + +E P N + +I +P RP +++
Sbjct: 241 L--RSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 2e-48
Identities = 64/287 (22%), Positives = 109/287 (37%), Gaps = 26/287 (9%)
Query: 437 IKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 494
+ +G+G+ V+ + + A+K+ +RE ++K L H NIV
Sbjct: 13 LSDILGQGATANVFRGRHKKTGDLFAIKV-FNNISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 495 LMGAVTEPP---NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 551
L A+ E + ++ E+ GSLY +L P + E L + DV GMN+L +
Sbjct: 72 LF-AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 552 RRPPIVHRDLKSPNLLV----DSTYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEV 606
IVHR++K N++ D K+ DFG +R + + + GT E++ P++
Sbjct: 131 NG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF--VSLYGTEEYLHPDM 186
Query: 607 LREDPS--------NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPK 658
D++S GV + T P+R + V +K +
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSG 246
Query: 659 NVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQPLSAQP 705
E + P S+ LQ L + L A
Sbjct: 247 --AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQ 291
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 7e-48
Identities = 78/255 (30%), Positives = 125/255 (49%), Gaps = 26/255 (10%)
Query: 437 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 494
+KIG+GSFG V+ + VA+KI I+ E ED ++ +E+ ++ P +
Sbjct: 26 KLEKIGKGSFGEVFKGIDNRTQKVVAIKI-IDLEEAEDEIEDIQQEITVLSQCDSPYVTK 84
Query: 495 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 554
G+ + L I+ EYL GS LL +DE + ++ KG++YLH +
Sbjct: 85 YYGSYLKDTKLWIIMEYLGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK- 139
Query: 555 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNE 614
+HRD+K+ N+L+ VK+ DFG++ +T I T GTP WMAPEV+++ +
Sbjct: 140 -KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDS 198
Query: 615 KSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA-------- 666
K+D++S G+ EL + P P +V+ IPKN P +
Sbjct: 199 KADIWSLGITAIELARGEPPHSELHPMKVL---------FLIPKNNPPTLEGNYSKPLKE 249
Query: 667 LIETCWAEEPEIRPS 681
+E C +EP RP+
Sbjct: 250 FVEACLNKEPSFRPT 264
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 1e-47
Identities = 72/208 (34%), Positives = 113/208 (54%), Gaps = 9/208 (4%)
Query: 440 KIGEGSFGTVYHAEWRN-SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA 498
+G G FG VY + + VAVK L E E + +F EV ++ H N++ L G
Sbjct: 37 ILGRGGFGKVYKGRLADGTLVAVKRLKE-ERTQGGELQFQTEVEMISMAVHRNLLRLRGF 95
Query: 499 VTEPPNLSIVTEYLSRGSLYKLLH-IPDARVVVDERLRLNMAYDVAKGMNYLHQR-RPPI 556
P +V Y++ GS+ L P+++ +D R +A A+G+ YLH P I
Sbjct: 96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKI 155
Query: 557 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKP--NTYISSKTA-AGTPEWMAPEVLREDPSN 613
+HRD+K+ N+L+D + V DFGL++ +T+++ TA GT +APE L S+
Sbjct: 156 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT--TAVRGTIGHIAPEYLSTGKSS 213
Query: 614 EKSDVFSFGVILWELITLQKPWRNSTPS 641
EK+DVF +GV+L ELIT Q+ + + +
Sbjct: 214 EKTDVFGYGVMLLELITGQRAFDLARLA 241
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 170 bits (431), Expect = 9e-47
Identities = 62/313 (19%), Positives = 112/313 (35%), Gaps = 51/313 (16%)
Query: 437 IKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 494
+ +G+G+ V+ + + A+K+ +RE ++K L H NIV
Sbjct: 13 LSDILGQGATANVFRGRHKKTGDLFAIKV-FNNISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 495 LMGAVTEPP---NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 551
L A+ E + ++ E+ GSLY +L P + E L + DV GMN+L +
Sbjct: 72 LF-AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 552 RRPPIVHRDLKSPNLLV----DSTYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEV 606
IVHR++K N++ D K+ DFG +R + + + GT E++ P++
Sbjct: 131 NG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF--VSLYGTEEYLHPDM 186
Query: 607 LREDPS--------NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLE--- 655
D++S GV + T P+R + V +K +
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSG 246
Query: 656 ------------------------IPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 691
+ + + ++ ++ + E F
Sbjct: 247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306
Query: 692 FLMSSVCQPLSAQ 704
L V S Q
Sbjct: 307 ILHRMVIHVFSLQ 319
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 4e-46
Identities = 74/257 (28%), Positives = 124/257 (48%), Gaps = 18/257 (7%)
Query: 437 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKE-FLREVAIMKGLRHPNIV 493
I + +G+G FG VY A + S +A+K+L + + + + REV I LRHPNI+
Sbjct: 13 IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNIL 72
Query: 494 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 553
L G + + ++ EY G++Y+ L DE+ ++A ++Y H +R
Sbjct: 73 RLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYCHSKR 129
Query: 554 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSN 613
++HRD+K NLL+ S +K+ DFG S P++ GT +++ PE++ +
Sbjct: 130 --VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTDLCGTLDYLPPEMIEGRMHD 185
Query: 614 EKSDVFSFGVILWELITLQKPWRNSTPSQV---ISAVGFKGRRLEIPKNVNPMVAALIET 670
EK D++S GV+ +E + + P+ +T + IS V F P V LI
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-----FPDFVTEGARDLISR 240
Query: 671 CWAEEPEIRPSFPSIME 687
P RP ++E
Sbjct: 241 LLKHNPSQRPMLREVLE 257
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 5e-46
Identities = 71/294 (24%), Positives = 127/294 (43%), Gaps = 22/294 (7%)
Query: 406 LMEANLSVMSTSNRELYLEEEG--LEIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAV 461
L E L E +L ++ E++ + ++G G+ G V+ + S +A
Sbjct: 4 LEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMAR 63
Query: 462 KILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL 521
K+ I E + +RE+ ++ P IV GA +SI E++ GSL ++L
Sbjct: 64 KL-IHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL 122
Query: 522 HIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFG- 580
+ E++ ++ V KG+ YL ++ I+HRD+K N+LV+S +K+CDFG
Sbjct: 123 KKAG---RIPEQILGKVSIAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGV 178
Query: 581 ---LSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRN 637
L S N+++ GT +M+PE L+ + +SD++S G+ L E+ + P
Sbjct: 179 SGQLIDSMANSFV------GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 232
Query: 638 STPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 691
++ G ++E P + +I E L
Sbjct: 233 PDAKELELMF---GCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDY 283
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 8e-46
Identities = 67/246 (27%), Positives = 122/246 (49%), Gaps = 11/246 (4%)
Query: 439 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 496
+KIG+G+ GTVY A + VA++ + + + + + + E+ +M+ ++PNIV +
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQ-MNLQ-QQPKKELIINEILVMRENKNPNIVNYL 83
Query: 497 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 556
+ L +V EYL+ GSL ++ +DE + + + + +LH + +
Sbjct: 84 DSYLVGDELWVVMEYLAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQ--V 137
Query: 557 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKS 616
+HRD+KS N+L+ +VK+ DFG T GTP WMAPEV+ K
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 197
Query: 617 DVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR-RLEIPKNVNPMVAALIETCWAEE 675
D++S G++ E+I + P+ N P + + + G L+ P+ ++ + + C +
Sbjct: 198 DIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMD 257
Query: 676 PEIRPS 681
E R S
Sbjct: 258 VEKRGS 263
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 1e-45
Identities = 67/246 (27%), Positives = 124/246 (50%), Gaps = 11/246 (4%)
Query: 439 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 496
KIGEGS G V A ++S VAVK+ ++ + R + EV IM+ +H N+V +
Sbjct: 51 VKIGEGSTGIVCLAREKHSGRQVAVKM-MDLR-KQQRRELLFNEVVIMRDYQHFNVVEMY 108
Query: 497 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 556
+ L ++ E+L G+L ++ +V ++E + V + + YLH + +
Sbjct: 109 KSYLVGEELWVLMEFLQGGALTDIVS----QVRLNEEQIATVCEAVLQALAYLHAQG--V 162
Query: 557 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKS 616
+HRD+KS ++L+ VK+ DFG K+ GTP WMAPEV+ +
Sbjct: 163 IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEV 222
Query: 617 DVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR-RLEIPKNVNPMVAALIETCWAEE 675
D++S G+++ E++ + P+ + +P Q + + +L+ V+P++ +E +
Sbjct: 223 DIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRD 282
Query: 676 PEIRPS 681
P+ R +
Sbjct: 283 PQERAT 288
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 2e-45
Identities = 70/257 (27%), Positives = 126/257 (49%), Gaps = 18/257 (7%)
Query: 437 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFL-REVAIMKGLRHPNIV 493
I + +G+G FG VY A + + +A+K+L + + ++ + L RE+ I LRHPNI+
Sbjct: 18 IGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNIL 77
Query: 494 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 553
+ + + ++ E+ RG LYK L R DE+ ++A ++Y H+R+
Sbjct: 78 RMYNYFHDRKRIYLMLEFAPRGELYKEL-QKHGR--FDEQRSATFMEELADALHYCHERK 134
Query: 554 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSN 613
++HRD+K NLL+ +K+ DFG S P+ + +T GT +++ PE++ +
Sbjct: 135 --VIHRDIKPENLLMGYKGELKIADFGWSVHAPS--LRRRTMCGTLDYLPPEMIEGKTHD 190
Query: 614 EKSDVFSFGVILWELITLQKPWRNSTPSQV---ISAVGFKGRRLEIPKNVNPMVAALIET 670
EK D++ GV+ +E + P+ + + ++ I V K P ++ LI
Sbjct: 191 EKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLK-----FPPFLSDGSKDLISK 245
Query: 671 CWAEEPEIRPSFPSIME 687
P R +ME
Sbjct: 246 LLRYHPPQRLPLKGVME 262
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 3e-45
Identities = 47/216 (21%), Positives = 90/216 (41%), Gaps = 25/216 (11%)
Query: 437 IKKKIGEGSFGTVYHAEWRNSDVAVKIL---------------IEQEFHEDRFKEFLREV 481
I + + +G F + E N A+K ++ + ++ +F E+
Sbjct: 35 IIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNEL 94
Query: 482 AIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLH-----IPDARVVVDERLRL 536
I+ +++ + G +T + I+ EY+ S+ K + + ++
Sbjct: 95 QIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIK 154
Query: 537 NMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAA 596
+ V +Y+H + I HRD+K N+L+D VK+ DFG S + I K +
Sbjct: 155 CIIKSVLNSFSYIHNEK-NICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKI--KGSR 211
Query: 597 GTPEWMAPEVL--REDPSNEKSDVFSFGVILWELIT 630
GT E+M PE + K D++S G+ L+ +
Sbjct: 212 GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFY 247
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 8e-45
Identities = 58/233 (24%), Positives = 99/233 (42%), Gaps = 17/233 (7%)
Query: 437 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 494
+K+++G G FG V +++ VA+K QE + + E+ IMK L HPN+V
Sbjct: 18 MKERLGTGGFGYVLRWIHQDTGEQVAIKQ-CRQELSPKNRERWCLEIQIMKKLNHPNVVS 76
Query: 495 LMGAVTEPPNLS------IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 548
L+ + EY G L K L+ + + E + D++ + Y
Sbjct: 77 AREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRY 136
Query: 549 LHQRRPPIVHRDLKSPNLLVDST---YTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAP 604
LH+ R I+HRDLK N+++ K+ D G ++ GT +++AP
Sbjct: 137 LHENR--IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELC--TEFVGTLQYLAP 192
Query: 605 EVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP 657
E+L + D +SFG + +E IT +P+ + + I
Sbjct: 193 ELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIV 245
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 8e-45
Identities = 76/275 (27%), Positives = 124/275 (45%), Gaps = 42/275 (15%)
Query: 437 IKKKIGEGSFGTVYHAE--WRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 494
+++ IG G+ V A + VA+K I E + E L+E+ M HPNIV
Sbjct: 19 LQEVIGSGATAVVQAAYCAPKKEKVAIKR-INLEKCQTSMDELLKEIQAMSQCHHPNIVS 77
Query: 495 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARV-----VVDERLRLNMAYDVAKGMNYL 549
+ L +V + LS GS+ ++ A+ V+DE + +V +G+ YL
Sbjct: 78 YYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYL 137
Query: 550 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFG----LSRSKPNTYISS-KTAAGTPEWMAP 604
H+ +HRD+K+ N+L+ +V++ DFG L+ T KT GTP WMAP
Sbjct: 138 HKNG--QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAP 195
Query: 605 EVLREDPS-NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPM 663
EV+ + + K+D++SFG+ EL T P+ P +V+ + +N P
Sbjct: 196 EVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL---------MLTLQNDPPS 246
Query: 664 VAA-----------------LIETCWAEEPEIRPS 681
+ +I C ++PE RP+
Sbjct: 247 LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPT 281
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 2e-44
Identities = 69/248 (27%), Positives = 126/248 (50%), Gaps = 11/248 (4%)
Query: 437 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 494
+ +K+GEGS+G+VY A + + VA+K + E +E ++E++IM+ P++V
Sbjct: 33 VLEKLGEGSYGSVYKAIHKETGQIVAIKQVP----VESDLQEIIKEISIMQQCDSPHVVK 88
Query: 495 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 554
G+ + +L IV EY GS+ ++ + + + E + KG+ YLH R
Sbjct: 89 YYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTL--TEDEIATILQSTLKGLEYLHFMR- 145
Query: 555 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNE 614
+HRD+K+ N+L+++ K+ DFG++ +T T GTP WMAPEV++E N
Sbjct: 146 -KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNC 204
Query: 615 KSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR-RLEIPKNVNPMVAALIETCWA 673
+D++S G+ E+ + P+ + P + I + P+ + ++ C
Sbjct: 205 VADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLV 264
Query: 674 EEPEIRPS 681
+ PE R +
Sbjct: 265 KSPEQRAT 272
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 1e-43
Identities = 66/266 (24%), Positives = 111/266 (41%), Gaps = 25/266 (9%)
Query: 437 IKKKIGEGSFGTVYHAE-WRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVL 494
K +G G+ GT+ + + N DVAVK + + F REV +++ HPN++
Sbjct: 28 PKDVLGHGAEGTIVYRGMFDNRDVAVKRI-----LPECFSFADREVQLLRESDEHPNVIR 82
Query: 495 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 554
+ I E + +L + + D + + G+ +LH
Sbjct: 83 YFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAH--LGLEPITLLQQTTSGLAHLHSLN- 138
Query: 555 PIVHRDLKSPNLLV-----DSTYTVKVCDFGLSR---SKPNTYISSKTAAGTPEWMAPEV 606
IVHRDLK N+L+ + DFGL + +++ GT W+APE+
Sbjct: 139 -IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEM 197
Query: 607 LREDPS---NEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVG-FKGRRLEIPKNVN 661
L ED D+FS G + + +I+ P+ S Q +G L K+ +
Sbjct: 198 LSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHED 257
Query: 662 PMVAALIETCWAEEPEIRPSFPSIME 687
+ LIE A +P+ RPS +++
Sbjct: 258 VIARELIEKMIAMDPQKRPSAKHVLK 283
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 2e-43
Identities = 67/258 (25%), Positives = 118/258 (45%), Gaps = 22/258 (8%)
Query: 439 KKIGEGSFGTVYHAEWRNS--DVAVKIL----IEQEFHEDRFKEFLREVAIMKGLRHPNI 492
+ +G+G F + ++ A KI+ + + ++ E++I + L H ++
Sbjct: 21 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMS---MEISIHRSLAHQHV 77
Query: 493 VLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 552
V G + + +V E R SL +L R + E + G YLH+
Sbjct: 78 VGFHGFFEDNDFVFVVLELCRRRSLLELH---KRRKALTEPEARYYLRQIVLGCQYLHRN 134
Query: 553 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPS 612
R ++HRDLK NL ++ VK+ DFGL+ K GTP ++APEVL +
Sbjct: 135 R--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH 192
Query: 613 NEKSDVFSFGVILWELITLQKPWRNSTPSQV---ISAVGFKGRRLEIPKNVNPMVAALIE 669
+ + DV+S G I++ L+ + P+ S + I + IPK++NP+ A+LI+
Sbjct: 193 SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS-----IPKHINPVAASLIQ 247
Query: 670 TCWAEEPEIRPSFPSIME 687
+P RP+ ++
Sbjct: 248 KMLQTDPTARPTINELLN 265
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 2e-43
Identities = 63/255 (24%), Positives = 113/255 (44%), Gaps = 15/255 (5%)
Query: 439 KKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKE-FLREVAIMKGLRHPNIVLL 495
+G+GSF VY AE ++ +VA+K++ ++ ++ + EV I L+HP+I+ L
Sbjct: 17 NLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILEL 76
Query: 496 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 555
+ + +V E G + + L E + + + GM YLH
Sbjct: 77 YNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKP--FSENEARHFMHQIITGMLYLHSHG-- 132
Query: 556 IVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEK 615
I+HRDL NLL+ +K+ DFGL+ + T GTP +++PE+ +
Sbjct: 133 ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLE 192
Query: 616 SDVFSFGVILWELITLQKPWRNSTPSQV---ISAVGFKGRRLEIPKNVNPMVAALIETCW 672
SDV+S G + + L+ + P+ T + ++ +P ++ LI
Sbjct: 193 SDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYE-----MPSFLSIEAKDLIHQLL 247
Query: 673 AEEPEIRPSFPSIME 687
P R S S+++
Sbjct: 248 RRNPADRLSLSSVLD 262
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 2e-43
Identities = 71/253 (28%), Positives = 128/253 (50%), Gaps = 14/253 (5%)
Query: 437 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 494
I ++G+G+FG VY A+ + + A K+ IE + E+ ++++ E+ I+ HP IV
Sbjct: 23 IVGELGDGAFGKVYKAKNKETGALAAAKV-IETK-SEEELEDYIVEIEILATCDHPYIVK 80
Query: 495 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 554
L+GA L I+ E+ G++ ++ D + E + + + +N+LH +R
Sbjct: 81 LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGL--TEPQIQVVCRQMLEALNFLHSKR- 137
Query: 555 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV-----LRE 609
I+HRDLK+ N+L+ +++ DFG+S T + GTP WMAPEV +++
Sbjct: 138 -IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKD 196
Query: 610 DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR-RLEIPKNVNPMVAALI 668
P + K+D++S G+ L E+ ++ P P +V+ + L P + +
Sbjct: 197 TPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDFL 256
Query: 669 ETCWAEEPEIRPS 681
+ + PE RPS
Sbjct: 257 KIALDKNPETRPS 269
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 1e-42
Identities = 68/260 (26%), Positives = 120/260 (46%), Gaps = 26/260 (10%)
Query: 439 KKIGEGSFGTVYHAEWRNS--DVAVKIL----IEQEFHEDRFKEFLREVAIMKGLRHPNI 492
+ +G+G F + ++ A KI+ + + ++ E++I + L H ++
Sbjct: 47 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMS---MEISIHRSLAHQHV 103
Query: 493 VLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 552
V G + + +V E R SL +L R + E + G YLH+
Sbjct: 104 VGFHGFFEDNDFVFVVLELCRRRSLLELH---KRRKALTEPEARYYLRQIVLGCQYLHRN 160
Query: 553 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISS-----KTAAGTPEWMAPEVL 607
R ++HRDLK NL ++ VK+ DFGL+ T + K GTP ++APEVL
Sbjct: 161 R--VIHRDLKLGNLFLNEDLEVKIGDFGLA-----TKVEYDGERKKVLCGTPNYIAPEVL 213
Query: 608 REDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAAL 667
+ + + DV+S G I++ L+ + P+ S + + K IPK++NP+ A+L
Sbjct: 214 SKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI--KKNEYSIPKHINPVAASL 271
Query: 668 IETCWAEEPEIRPSFPSIME 687
I+ +P RP+ ++
Sbjct: 272 IQKMLQTDPTARPTINELLN 291
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 3e-42
Identities = 70/262 (26%), Positives = 121/262 (46%), Gaps = 37/262 (14%)
Query: 437 IKKKIGEGSFGTVYHAEWRNSD--VAVKIL-IEQEFHEDRFKEFLREVAIMKGLRHPNIV 493
++IG GSFG VY A + VA+K + + +++++ ++EV ++ LRHPN +
Sbjct: 58 DLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTI 117
Query: 494 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 553
G +V EY GS LL + + E + + +G+ YLH
Sbjct: 118 QYRGCYLREHTAWLVMEYCL-GSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHSHN 174
Query: 554 PPIVHRDLKSPNLLVDSTYTVKVCDFGLS--RSKPNTYISSKTAAGTPEWMAPEV---LR 608
++HRD+K+ N+L+ VK+ DFG + + N+++ GTP WMAPEV +
Sbjct: 175 --MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV------GTPYWMAPEVILAMD 226
Query: 609 EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA-- 666
E + K DV+S G+ EL + P N + I +N +P + +
Sbjct: 227 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL---------YHIAQNESPALQSGH 277
Query: 667 -------LIETCWAEEPEIRPS 681
+++C + P+ RP+
Sbjct: 278 WSEYFRNFVDSCLQKIPQDRPT 299
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 2e-41
Identities = 68/278 (24%), Positives = 129/278 (46%), Gaps = 31/278 (11%)
Query: 428 LEIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAI-M 484
+E++ +L ++G G++G V S +AVK I + K L ++ I M
Sbjct: 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKR-IRATVNSQEQKRLLMDLDISM 60
Query: 485 KGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL-HIPDARVVVDERLRLNMAYDVA 543
+ + P V GA+ ++ I E + SL K + D + E + +A +
Sbjct: 61 RTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIV 119
Query: 544 KGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMA 603
K + +LH + ++HRD+K N+L+++ VK+CDFG+S + ++ AG +MA
Sbjct: 120 KALEHLHSKLS-VIHRDVKPSNVLINALGQVKMCDFGISGYLVDD-VAKDIDAGCKPYMA 177
Query: 604 PEVLREDPS----NEKSDVFSFGVILWELITLQKPWRN-STPSQVISAVGFKGRRLEIPK 658
PE + + + + KSD++S G+ + EL L+ P+ + TP Q + + +
Sbjct: 178 PERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQ---------VVE 228
Query: 659 NVNPMVAA---------LIETCWAEEPEIRPSFPSIME 687
+P + A C + + RP++P +M+
Sbjct: 229 EPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 2e-41
Identities = 52/241 (21%), Positives = 96/241 (39%), Gaps = 29/241 (12%)
Query: 437 IKKKIGEG--SFGTVYHAE--WRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNI 492
+ IG+G TV A V V+ + + + E+ + K HPNI
Sbjct: 29 LLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNI 88
Query: 493 VLLMGAVTEPPNLSIVTEYLSRGSLYKLL--HIPDARVVVDERLRLNMAYDVAKGMNYLH 550
V L +VT +++ GS L+ H D ++E + V K ++Y+H
Sbjct: 89 VPYRATFIADNELWVVTSFMAYGSAKDLICTHFMD---GMNELAIAYILQGVLKALDYIH 145
Query: 551 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS------RSKPNT-YISSKTAAGTPEWMA 603
VHR +K+ ++L+ V + + + + K + W++
Sbjct: 146 HMG--YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLS 203
Query: 604 PEVLREDPS--NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVN 661
PEVL+++ + KSD++S G+ EL P+++ +Q++ LE
Sbjct: 204 PEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML---------LEKLNGTV 254
Query: 662 P 662
P
Sbjct: 255 P 255
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 2e-41
Identities = 73/297 (24%), Positives = 129/297 (43%), Gaps = 47/297 (15%)
Query: 414 MSTSNRELYLEEEGL------EIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILI 465
M++ + L+E L + + + +G G++G VY + A+K++
Sbjct: 2 MASDSPARSLDEIDLSALRDPAGIFE---LVELVGNGTYGQVYKGRHVKTGQLAAIKVM- 57
Query: 466 EQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGA------VTEPPNLSIVTEYLSRGSLY 518
+ D +E +E+ ++K H NI GA L +V E+ GS+
Sbjct: 58 --DVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVT 115
Query: 519 KLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCD 578
L+ + E + ++ +G+++LHQ + ++HRD+K N+L+ VK+ D
Sbjct: 116 DLIKNTKGNTL-KEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLVD 172
Query: 579 FGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPS-----NEKSDVFSFGVILWELITLQK 633
FG+S T T GTP WMAPEV+ D + + KSD++S G+ E+
Sbjct: 173 FGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 232
Query: 634 PWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAAL---------IETCWAEEPEIRPS 681
P + P + + F IP+N P + + IE+C + RP+
Sbjct: 233 PLCDMHPMRAL----FL-----IPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPA 280
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 3e-41
Identities = 59/198 (29%), Positives = 102/198 (51%), Gaps = 19/198 (9%)
Query: 437 IKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 494
+K+++G+G+F V + + + A KI+ ++ F++ RE I + L+HPNIV
Sbjct: 10 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 69
Query: 495 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPD---ARVVVDERLRLNMAYDVAKGMNYLHQ 551
L ++ E +V + ++ G L+ + AR E + + + + Y H
Sbjct: 70 LHDSIQEESFHYLVFDLVTGGELF------EDIVAREFYSEADASHCIQQILESIAYCHS 123
Query: 552 RRPPIVHRDLKSPNLLVDSTY---TVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVL 607
IVHR+LK NLL+ S VK+ DFGL+ + AGTP +++PEVL
Sbjct: 124 NG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW--HGFAGTPGYLSPEVL 179
Query: 608 REDPSNEKSDVFSFGVIL 625
++DP ++ D+++ GVIL
Sbjct: 180 KKDPYSKPVDIWACGVIL 197
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 4e-41
Identities = 75/259 (28%), Positives = 121/259 (46%), Gaps = 21/259 (8%)
Query: 437 IKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 494
+ K IG+G+F V A +VA+KI+ + + + ++ REV IMK L HPNIV
Sbjct: 19 LLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVK 78
Query: 495 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMA----YDVAKGMNYLH 550
L + L ++ EY S G ++ L V R++ A + + Y H
Sbjct: 79 LFEVIETEKTLYLIMEYASGGEVFDYL-------VAHGRMKEKEARSKFRQIVSAVQYCH 131
Query: 551 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKTAAGTPEWMAPEVLRE 609
Q+R IVHRDLK+ NLL+D+ +K+ DFG S + G P + APE+ +
Sbjct: 132 QKR--IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL--DAFCGAPPYAAPELFQG 187
Query: 610 DPSN-EKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI 668
+ + DV+S GVIL+ L++ P+ ++ V + IP ++ L+
Sbjct: 188 KKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV--LRGKYRIPFYMSTDCENLL 245
Query: 669 ETCWAEEPEIRPSFPSIME 687
+ P R + IM+
Sbjct: 246 KRFLVLNPIKRGTLEQIMK 264
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 1e-40
Identities = 58/272 (21%), Positives = 117/272 (43%), Gaps = 16/272 (5%)
Query: 420 ELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHA--EWRNSDVAVKILIEQEFHEDRFKEF 477
L + + + ++L ++G G+ G V+ +AVK + + +++ K
Sbjct: 12 YLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQ-MRRSGNKEENKRI 70
Query: 478 LREVAI-MKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRL 536
L ++ + +K P IV G ++ I E + + + + ER+
Sbjct: 71 LMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQG---PIPERILG 127
Query: 537 NMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAA 596
M + K + YL ++ ++HRD+K N+L+D +K+CDFG+S + + +A
Sbjct: 128 KMTVAIVKALYYLKEKHG-VIHRDVKPSNILLDERGQIKLCDFGISGRLVDD-KAKDRSA 185
Query: 597 GTPEWMAPEVLREDPSNE-----KSDVFSFGVILWELITLQKPWRNSTP--SQVISAVGF 649
G +MAPE + + ++DV+S G+ L EL T Q P++N + +
Sbjct: 186 GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQE 245
Query: 650 KGRRLEIPKNVNPMVAALIETCWAEEPEIRPS 681
+ L + + ++ C ++ RP
Sbjct: 246 EPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPK 277
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 1e-40
Identities = 70/293 (23%), Positives = 128/293 (43%), Gaps = 36/293 (12%)
Query: 411 LSVMSTSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQE 468
+S+ S+ ++ E+ + +L +IG G++G+V + S +AVK I
Sbjct: 1 MSIESSGKLKI-SPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKR-IRST 58
Query: 469 FHEDRFKEFLREVAI-MKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLH--IPD 525
E K+ L ++ + M+ P IV GA+ + I E +S S K
Sbjct: 59 VDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSV 117
Query: 526 ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK 585
V+ E + + K +N+L + I+HRD+K N+L+D + +K+CDFG+S
Sbjct: 118 LDDVIPEEILGKITLATVKALNHLKENLK-IIHRDIKPSNILLDRSGNIKLCDFGISGQL 176
Query: 586 PNTYISSKTAAGTPEWMAPEVLREDPSNE----KSDVFSFGVILWELITLQKPWRN-STP 640
++ I+ AG +MAPE + S + +SDV+S G+ L+EL T + P+ ++
Sbjct: 177 VDS-IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV 235
Query: 641 SQVISAVGFKGRRLEIPKNVNPMVAA------------LIETCWAEEPEIRPS 681
++ + K P ++ + C ++ RP
Sbjct: 236 FDQLTQ---------VVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPK 279
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 3e-40
Identities = 62/238 (26%), Positives = 108/238 (45%), Gaps = 8/238 (3%)
Query: 464 LIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHI 523
+ + RF++ V + + + + + + + + LS +
Sbjct: 125 FVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPED 184
Query: 524 PDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 583
+ E L + ++ VAKGM +L R+ +HRDL + N+L+ VK+CDFGL+R
Sbjct: 185 LYKDFLTLEHL-ICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLAR 241
Query: 584 S--KPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRN-ST 639
K Y+ A +WMAPE + + +SDV+SFGV+LWE+ +L P+
Sbjct: 242 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 301
Query: 640 PSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSV 697
+ + +G R+ P P + + CW EP RP+F ++E L L ++
Sbjct: 302 DEEFCRRL-KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 358
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 88.4 bits (219), Expect = 5e-19
Identities = 43/188 (22%), Positives = 73/188 (38%), Gaps = 19/188 (10%)
Query: 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD-------VAVKILIEQEFHEDRFKEFLREV 481
E L + K +G G+FG V A+ D VAVK+L E H + + + E+
Sbjct: 18 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH-RALMSEL 76
Query: 482 AIMKGL-RHPNIVLLMGAVTEPPN-LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMA 539
I+ + H N+V L+GA T+P L ++ E+ G+L L V
Sbjct: 77 KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFV----PYKTKG 132
Query: 540 YDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP 599
+G +Y+ + DLK + S+ + F +S +
Sbjct: 133 ARFRQGKDYVG-----AIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYK 187
Query: 600 EWMAPEVL 607
+++ E L
Sbjct: 188 DFLTLEHL 195
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 5e-40
Identities = 59/198 (29%), Positives = 102/198 (51%), Gaps = 19/198 (9%)
Query: 437 IKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 494
+K+++G+G+F V + + + A KI+ ++ F++ RE I + L+HPNIV
Sbjct: 33 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 92
Query: 495 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPD---ARVVVDERLRLNMAYDVAKGMNYLHQ 551
L ++ E +V + ++ G L+ + AR E + + + + Y H
Sbjct: 93 LHDSIQEESFHYLVFDLVTGGELF------EDIVAREFYSEADASHCIQQILESIAYCHS 146
Query: 552 RRPPIVHRDLKSPNLLVDSTY---TVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVL 607
IVHR+LK NLL+ S VK+ DFGL+ + AGTP +++PEVL
Sbjct: 147 NG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW--HGFAGTPGYLSPEVL 202
Query: 608 REDPSNEKSDVFSFGVIL 625
++DP ++ D+++ GVIL
Sbjct: 203 KKDPYSKPVDIWACGVIL 220
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 7e-40
Identities = 55/197 (27%), Positives = 100/197 (50%), Gaps = 16/197 (8%)
Query: 437 IKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 494
+ +++G+G+F V + + A I+ ++ ++ RE I + L+HPNIV
Sbjct: 15 LFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVR 74
Query: 495 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPD---ARVVVDERLRLNMAYDVAKGMNYLHQ 551
L +++E + ++ + ++ G L+ + AR E + + + + + HQ
Sbjct: 75 LHDSISEEGHHYLIFDLVTGGELF------EDIVAREYYSEADASHCIQQILEAVLHCHQ 128
Query: 552 RRPPIVHRDLKSPNLLVDSTY---TVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLR 608
+VHR+LK NLL+ S VK+ DFGL+ + AGTP +++PEVLR
Sbjct: 129 MG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLR 186
Query: 609 EDPSNEKSDVFSFGVIL 625
+DP + D+++ GVIL
Sbjct: 187 KDPYGKPVDLWACGVIL 203
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 1e-39
Identities = 60/197 (30%), Positives = 101/197 (51%), Gaps = 13/197 (6%)
Query: 434 ELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN 491
+ + +G G FG V+ E + +A KI I+ +D+ +E E+++M L H N
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKI-IKTRGMKDK-EEVKNEISVMNQLDHAN 147
Query: 492 IVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 551
++ L A ++ +V EY+ G L+ I D + E + + +G+ ++HQ
Sbjct: 148 LIQLYDAFESKNDIVLVMEYVDGGELFD--RIIDESYNLTELDTILFMKQICEGIRHMHQ 205
Query: 552 RRPPIVHRDLKSPNLLVDS--TYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVLR 608
I+H DLK N+L + +K+ DFGL+R KP + K GTPE++APEV+
Sbjct: 206 MY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL--KVNFGTPEFLAPEVVN 261
Query: 609 EDPSNEKSDVFSFGVIL 625
D + +D++S GVI
Sbjct: 262 YDFVSFPTDMWSVGVIA 278
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 2e-39
Identities = 52/201 (25%), Positives = 95/201 (47%), Gaps = 20/201 (9%)
Query: 437 IKKKIGEGSFGTVYHAEWRNS--DVAVKI-----LIEQEFHEDRFKEFLREVAIMKGLRH 489
I +++G G F V +++ + A K R +E REV+I++ + H
Sbjct: 16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSR-EEIEREVSILRQVLH 74
Query: 490 PNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 549
N++ L ++ ++ E +S G L+ L + + E + + G+NYL
Sbjct: 75 HNVITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYL 131
Query: 550 HQRRPPIVHRDLKSPNLLVDS----TYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAP 604
H ++ I H DLK N+++ +K+ DFGL+ + K GTPE++AP
Sbjct: 132 HTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNIFGTPEFVAP 187
Query: 605 EVLREDPSNEKSDVFSFGVIL 625
E++ +P ++D++S GVI
Sbjct: 188 EIVNYEPLGLEADMWSIGVIT 208
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 3e-39
Identities = 54/201 (26%), Positives = 95/201 (47%), Gaps = 20/201 (9%)
Query: 437 IKKKIGEGSFGTVYHAEWRNS--DVAVKI-----LIEQEFHEDRFKEFLREVAIMKGLRH 489
+ +++G G F V + + + A K L R +E REV I++ +RH
Sbjct: 9 MGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSR-EEIEREVNILREIRH 67
Query: 490 PNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 549
PNI+ L ++ ++ E +S G L+ L + + E + G++YL
Sbjct: 68 PNIITLHDIFENKTDVVLILELVSGGELFDFL---AEKESLTEDEATQFLKQILDGVHYL 124
Query: 550 HQRRPPIVHRDLKSPNLLVDST----YTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAP 604
H +R I H DLK N+++ +K+ DFG++ + K GTPE++AP
Sbjct: 125 HSKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF--KNIFGTPEFVAP 180
Query: 605 EVLREDPSNEKSDVFSFGVIL 625
E++ +P ++D++S GVI
Sbjct: 181 EIVNYEPLGLEADMWSIGVIT 201
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 4e-39
Identities = 50/201 (24%), Positives = 91/201 (45%), Gaps = 20/201 (9%)
Query: 437 IKKKIGEGSFGTVYHAEWRNS--DVAVKI-----LIEQEFHEDRFKEFLREVAIMKGLRH 489
+++G G F V +++ A K R ++ REV+I+K ++H
Sbjct: 15 TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSR-EDIEREVSILKEIQH 73
Query: 490 PNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 549
PN++ L ++ ++ E ++ G L+ L + + E + G+ YL
Sbjct: 74 PNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYL 130
Query: 550 HQRRPPIVHRDLKSPNLLVDST----YTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAP 604
H + I H DLK N+++ +K+ DFGL+ K GTPE++AP
Sbjct: 131 HSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFVAP 186
Query: 605 EVLREDPSNEKSDVFSFGVIL 625
E++ +P ++D++S GVI
Sbjct: 187 EIVNYEPLGLEADMWSIGVIT 207
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 4e-39
Identities = 82/295 (27%), Positives = 130/295 (44%), Gaps = 63/295 (21%)
Query: 437 IKKKIGEGSFGTVYHAEWRNSD----VAVKIL------------------------IEQE 468
+K +IG+GS+G V A N + A+K+L
Sbjct: 17 LKDEIGKGSYGVVKLA--YNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCI 74
Query: 469 FHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN---LSIVTEYLSRGSLYKLLHIPD 525
++ +E+AI+K L HPN+V L+ V + PN L +V E +++G + +
Sbjct: 75 QPRGPIEQVYQEIAILKKLDHPNVVKLV-EVLDDPNEDHLYMVFELVNQGPVME------ 127
Query: 526 ARVVVDERLRLNMA----YDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL 581
V + L + A D+ KG+ YLH ++ I+HRD+K NLLV +K+ DFG+
Sbjct: 128 --VPTLKPLSEDQARFYFQDLIKGIEYLHYQK--IIHRDIKPSNLLVGEDGHIKIADFGV 183
Query: 582 SRSKPNTYISS----KTAAGTPEWMAPEVLREDPSN---EKSDVFSFGVILWELITLQKP 634
S N + S GTP +MAPE L E + DV++ GV L+ + Q P
Sbjct: 184 S----NEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239
Query: 635 WRNSTPSQVISAVGFKGRRLEIPK--NVNPMVAALIETCWAEEPEIRPSFPSIME 687
+ + + S + K + LE P ++ + LI + PE R P I
Sbjct: 240 FMDERIMCLHSKI--KSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 4e-39
Identities = 61/198 (30%), Positives = 96/198 (48%), Gaps = 22/198 (11%)
Query: 437 IKKKIGEGSFGTVYHAEWRNS--DVAVK-ILIEQEFHEDRFKEFLREVAIMKGLRHPNIV 493
+ +G G+F V+ + R + A+K I F + + E+A++K ++H NIV
Sbjct: 13 FMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE---NEIAVLKKIKHENIV 69
Query: 494 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPD---ARVVVDERLRLNMAYDVAKGMNYLH 550
L + +V + +S G L+ D R V E+ + V + YLH
Sbjct: 70 TLEDIYESTTHYYLVMQLVSGGELF------DRILERGVYTEKDASLVIQQVLSAVKYLH 123
Query: 551 QRRPPIVHRDLKSPNLLVDSTY---TVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVL 607
+ IVHRDLK NLL + + + DFGLS+ + N + TA GTP ++APEVL
Sbjct: 124 ENG--IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM--STACGTPGYVAPEVL 179
Query: 608 REDPSNEKSDVFSFGVIL 625
+ P ++ D +S GVI
Sbjct: 180 AQKPYSKAVDCWSIGVIT 197
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 4e-39
Identities = 64/297 (21%), Positives = 121/297 (40%), Gaps = 26/297 (8%)
Query: 346 TADRDLQMQNPSGPSTHVIDSSNFIKGPLLRSPVKPFRHRKSHETSAFSTLKPYVTNNHL 405
++ D + + I + R+ ++ R S + + K
Sbjct: 8 SSGVDNKFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPK 67
Query: 406 LMEANLSVMSTSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKI 463
E EL E + K IG G V R + + AVKI
Sbjct: 68 GTENLYFQSMGPEDELPDWAAAKEFY-QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKI 126
Query: 464 L------IEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGAVTEPPNLSIVTEYLSRGS 516
+ + E E+ + RE I++ + HP+I+ L+ + + +V + + +G
Sbjct: 127 MEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGE 186
Query: 517 LY-KLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVK 575
L+ L +V + E+ ++ + + +++LH IVHRDLK N+L+D ++
Sbjct: 187 LFDYLT----EKVALSEKETRSIMRSLLEAVSFLHANN--IVHRDLKPENILLDDNMQIR 240
Query: 576 VCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVLREDPS------NEKSDVFSFGVIL 625
+ DFG S +P + + GTP ++APE+L+ ++ D+++ GVIL
Sbjct: 241 LSDFGFSCHLEPGEKL--RELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 4e-39
Identities = 70/198 (35%), Positives = 101/198 (51%), Gaps = 20/198 (10%)
Query: 437 IKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 494
I +G+GSFG V + R + + AVK++ + LREV ++K L HPNI+
Sbjct: 26 IVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMK 85
Query: 495 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPD---ARVVVDERLRLNMAYDVAKGMNYLHQ 551
L + + + IV E + G L+ D R E + V G+ Y+H+
Sbjct: 86 LFEILEDSSSFYIVGELYTGGELF------DEIIKRKRFSEHDAARIIKQVFSGITYMHK 139
Query: 552 RRPPIVHRDLKSPNLLVDST---YTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVL 607
IVHRDLK N+L++S +K+ DFGLS + NT + K GT ++APEVL
Sbjct: 140 HN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KDRIGTAYYIAPEVL 195
Query: 608 REDPSNEKSDVFSFGVIL 625
R +EK DV+S GVIL
Sbjct: 196 RG-TYDEKCDVWSAGVIL 212
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 5e-39
Identities = 56/205 (27%), Positives = 95/205 (46%), Gaps = 28/205 (13%)
Query: 437 IKKKIGEGSFGTVYHAEWRNS--DVAVKI-----LIEQEFHEDRFKEFLREVAIMKGLRH 489
I +++G G F V +++ + A K R +E REV+I++ + H
Sbjct: 16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCR-EEIEREVSILRQVLH 74
Query: 490 PNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAK----G 545
PNI+ L ++ ++ E +S G L+ + E L A K G
Sbjct: 75 PNIITLHDVYENRTDVVLILELVSGGELFD-------FLAQKESLSEEEATSFIKQILDG 127
Query: 546 MNYLHQRRPPIVHRDLKSPNLLVDST----YTVKVCDFGLSRS-KPNTYISSKTAAGTPE 600
+NYLH ++ I H DLK N+++ +K+ DFGL+ + K GTPE
Sbjct: 128 VNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNIFGTPE 183
Query: 601 WMAPEVLREDPSNEKSDVFSFGVIL 625
++APE++ +P ++D++S GVI
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 7e-39
Identities = 50/194 (25%), Positives = 95/194 (48%), Gaps = 13/194 (6%)
Query: 437 IKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 494
I +++G G+FG V+ + + K I + D+ E++IM L HP ++
Sbjct: 55 ILEELGSGAFGVVHRCVEKATGRVFVAKF-INTPYPLDK-YTVKNEISIMNQLHHPKLIN 112
Query: 495 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 554
L A + + ++ E+LS G L+ I + E +N +G+ ++H+
Sbjct: 113 LHDAFEDKYEMVLILEFLSGGELFD--RIAAEDYKMSEAEVINYMRQACEGLKHMHEHS- 169
Query: 555 PIVHRDLKSPNLLVDS--TYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVLREDP 611
IVH D+K N++ ++ +VK+ DFGL+ P+ + K T E+ APE++ +P
Sbjct: 170 -IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV--KVTTATAEFAAPEIVDREP 226
Query: 612 SNEKSDVFSFGVIL 625
+D+++ GV+
Sbjct: 227 VGFYTDMWAIGVLG 240
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 9e-39
Identities = 57/196 (29%), Positives = 98/196 (50%), Gaps = 13/196 (6%)
Query: 437 IKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 494
K+K+G G+FG V+ E R+S + +K I ++ + ++ E+ ++K L HPNI+
Sbjct: 26 FKRKLGSGAFGDVHLVEERSSGLERVIKT-INKDRSQVPMEQIEAEIEVLKSLDHPNIIK 84
Query: 495 LMGAVTEPPNLSIVTEYLSRGSLY-KLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 553
+ + N+ IV E G L +++ + E + + + Y H +
Sbjct: 85 IFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH 144
Query: 554 PPIVHRDLKSPNLLVDST---YTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVLRE 609
+VH+DLK N+L T +K+ DFGL+ K + + AAGT +MAPEV +
Sbjct: 145 --VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS--TNAAGTALYMAPEVFKR 200
Query: 610 DPSNEKSDVFSFGVIL 625
D K D++S GV++
Sbjct: 201 D-VTFKCDIWSAGVVM 215
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 148 bits (374), Expect = 9e-39
Identities = 60/285 (21%), Positives = 110/285 (38%), Gaps = 42/285 (14%)
Query: 437 IKKKIGEGSFGTVYHA-EWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVL 494
+K +G GS GTV ++ VAVK + D L E+ ++ HPN++
Sbjct: 19 SEKILGYGSSGTVVFQGSFQGRPVAVKRM-----LIDFCDIALMEIKLLTESDDHPNVIR 73
Query: 495 LMGAVTEPPNLSIVTEYLSRGSLYKLL----HIPDARVVVDERLRLNMAYDVAKGMNYLH 550
+ T L I E + +L L+ + + E +++ +A G+ +LH
Sbjct: 74 YYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 132
Query: 551 QRRPPIVHRDLKSPNLLVDST-------------YTVKVCDFGLSR----SKPNTYISSK 593
+ I+HRDLK N+LV ++ + + DFGL + + + +
Sbjct: 133 SLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLN 190
Query: 594 TAAGTPEWMAPEVLRED-------PSNEKSDVFSFGVILWELITLQKP--WRNSTPSQVI 644
+GT W APE+L E D+FS G + + +++ K + I
Sbjct: 191 NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNI 250
Query: 645 --SAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687
+ +++ LI +P RP+ ++
Sbjct: 251 IRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 2e-38
Identities = 53/209 (25%), Positives = 95/209 (45%), Gaps = 30/209 (14%)
Query: 437 IKKKIGEGSFGTVYHAEWRNS--DVAVKI-------LIEQEFHEDRFKEFLREVAIMKGL 487
K+ +G G V + + + AVKI E ++ + L+EV I++ +
Sbjct: 21 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 80
Query: 488 -RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPD---ARVVVDERLRLNMAYDVA 543
HPNI+ L +V + + +G L+ D +V + E+ + +
Sbjct: 81 SGHPNIIQLKDTYETNTFFFLVFDLMKKGELF------DYLTEKVTLSEKETRKIMRALL 134
Query: 544 KGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWM 602
+ + LH+ IVHRDLK N+L+D +K+ DFG S P + + GTP ++
Sbjct: 135 EVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL--REVCGTPSYL 190
Query: 603 APEVLREDPS------NEKSDVFSFGVIL 625
APE++ + ++ D++S GVI+
Sbjct: 191 APEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 4e-38
Identities = 71/217 (32%), Positives = 109/217 (50%), Gaps = 14/217 (6%)
Query: 437 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 494
KK+G G++G V + + A+KI+ + + L EVA++K L HPNI+
Sbjct: 41 RVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMK 100
Query: 495 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 554
L + N +V E G L+ + R+ +E + V G+ YLH+
Sbjct: 101 LYDFFEDKRNYYLVMECYKGGELFDEI---IHRMKFNEVDAAVIIKQVLSGVTYLHKHN- 156
Query: 555 PIVHRDLKSPNLLVDST---YTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVLRED 610
IVHRDLK NLL++S +K+ DFGLS + + K GT ++APEVLR+
Sbjct: 157 -IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM--KERLGTAYYIAPEVLRK- 212
Query: 611 PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 647
+EK DV+S GVIL+ L+ P+ T +++ V
Sbjct: 213 KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKV 249
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 4e-38
Identities = 55/199 (27%), Positives = 94/199 (47%), Gaps = 13/199 (6%)
Query: 437 IKKKIGEGSFGTVYHAEWRNS--DVAVKIL----IEQEFHEDRFKEFLREVAIMKGLRHP 490
+ + IG+G F V R + AVKI+ ++ RE +I L+HP
Sbjct: 28 LCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLST-EDLKREASICHMLKHP 86
Query: 491 NIVLLMGAVTEPPNLSIVTEYLSRGSLY-KLLHIPDARVVVDERLRLNMAYDVAKGMNYL 549
+IV L+ + L +V E++ L +++ DA V E + + + + + Y
Sbjct: 87 HIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYC 146
Query: 550 HQRRPPIVHRDLKSPNLLVDST---YTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV 606
H I+HRD+K +L+ S VK+ FG++ + + + GTP +MAPEV
Sbjct: 147 HDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEV 204
Query: 607 LREDPSNEKSDVFSFGVIL 625
++ +P + DV+ GVIL
Sbjct: 205 VKREPYGKPVDVWGCGVIL 223
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 141 bits (359), Expect = 5e-38
Identities = 72/261 (27%), Positives = 116/261 (44%), Gaps = 20/261 (7%)
Query: 437 IKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 494
+ + +GEG++G V A R + VAVKI ++ + D + +E+ I K L H N+V
Sbjct: 11 LVQTLGEGAYGEVQLAVNRVTEEAVAVKI-VDMKRAVDCPENIKKEICINKMLNHENVVK 69
Query: 495 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMA----YDVAKGMNYLH 550
G E + EY S G L+ R+ D + A + + G+ YLH
Sbjct: 70 FYGHRREGNIQYLFLEYCSGGELF-------DRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 551 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISS--KTAAGTPEWMAPEVLR 608
I HRD+K NLL+D +K+ DFGL+ GT ++APE+L+
Sbjct: 123 GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 609 EDP-SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP-KNVNPMVAA 666
E DV+S G++L ++ + PW + S + + + P K ++ A
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 240
Query: 667 LIETCWAEEPEIRPSFPSIME 687
L+ E P R + P I +
Sbjct: 241 LLHKILVENPSARITIPDIKK 261
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 9e-38
Identities = 57/197 (28%), Positives = 102/197 (51%), Gaps = 12/197 (6%)
Query: 436 LIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRH-PNI 492
L K++G G F V +++ + A K L ++ +D E L E+A+++ + P +
Sbjct: 32 LTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRV 91
Query: 493 VLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 552
+ L + ++ EY + G ++ L +P+ +V E + + + +G+ YLHQ
Sbjct: 92 INLHEVYENTSEIILILEYAAGGEIFSLC-LPELAEMVSENDVIRLIKQILEGVYYLHQN 150
Query: 553 RPPIVHRDLKSPNLLVDSTY---TVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVLR 608
IVH DLK N+L+ S Y +K+ DFG+SR + + GTPE++APE+L
Sbjct: 151 N--IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACEL--REIMGTPEYLAPEILN 206
Query: 609 EDPSNEKSDVFSFGVIL 625
DP +D+++ G+I
Sbjct: 207 YDPITTATDMWNIGIIA 223
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 1e-37
Identities = 61/288 (21%), Positives = 115/288 (39%), Gaps = 26/288 (9%)
Query: 343 WNVTADRDLQMQNPSGPSTHVIDSSNFIKGPLLRSPVKPFRHRKSHETSAFSTLKPYVTN 402
+ + A+ P P+ V+ + K + + + T + +
Sbjct: 80 FRIIAENKHGQSKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDI 139
Query: 403 NHLLMEANLSVMSTSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNS--DVA 460
+ + + Y I +++G G+FG V+ R + + A
Sbjct: 140 WKQYYPQPVEIKHDHVLDHYD-------------IHEELGTGAFGVVHRVTERATGNNFA 186
Query: 461 VKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKL 520
K + D+ + +E+ M LRHP +V L A + + ++ E++S G L++
Sbjct: 187 AKF-VMTPHESDK-ETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFE- 243
Query: 521 LHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST--YTVKVCD 578
+ D + E + V KG+ ++H+ VH DLK N++ + +K+ D
Sbjct: 244 -KVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLID 300
Query: 579 FGLSRS-KPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVIL 625
FGL+ P + K GT E+ APEV P +D++S GV+
Sbjct: 301 FGLTAHLDPKQSV--KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 2e-37
Identities = 60/207 (28%), Positives = 92/207 (44%), Gaps = 29/207 (14%)
Query: 437 IKKKIGEGSFGTVYHAEWRNS--DVAVKIL------IEQEFHEDRFKEFLREVAIMKGLR 488
+ K +G G+ G V A R + VA++I+ I D E+ I+K L
Sbjct: 139 MSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN 198
Query: 489 HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPD---ARVVVDERLRLNMAYDVAKG 545
HP I+ + + + IV E + G L+ D + E Y +
Sbjct: 199 HPCIIKIKNFF-DAEDYYIVLELMEGGELF------DKVVGNKRLKEATCKLYFYQMLLA 251
Query: 546 MNYLHQRRPPIVHRDLKSPNLLVDST---YTVKVCDFGLSRS-KPNTYISSKTAAGTPEW 601
+ YLH+ I+HRDLK N+L+ S +K+ DFG S+ + + +T GTP +
Sbjct: 252 VQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM--RTLCGTPTY 307
Query: 602 MAPEVLREDPS---NEKSDVFSFGVIL 625
+APEVL + N D +S GVIL
Sbjct: 308 LAPEVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-37
Identities = 38/239 (15%), Positives = 79/239 (33%), Gaps = 30/239 (12%)
Query: 437 IKKKIGEGSFGTVYHAEWRNSD-------VAVKILIEQEFHEDRFKEFLREVAIMKGLRH 489
+ +GEG+F VY A + + +K+ E F + + +K
Sbjct: 69 VHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWE--FYIGTQLMERLKPSMQ 126
Query: 490 PNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHI--PDARVVVDERLRLNMAYDVAKGMN 547
+ A +V E S G+L +++ V+ + L ++ A + +
Sbjct: 127 HMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIE 186
Query: 548 YLHQRRPPIVHRDLKSPNLLVDSTYT-----------VKVCDFGLSRSK----PNTYISS 592
+H I+H D+K N ++ + + + + D G S T
Sbjct: 187 QVHDCE--IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIF-- 242
Query: 593 KTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG 651
T + E+L P N + D F ++ ++ + + F+
Sbjct: 243 TAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRR 301
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 3e-37
Identities = 72/217 (33%), Positives = 110/217 (50%), Gaps = 14/217 (6%)
Query: 437 IKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 494
I +G+GSFG V + R + + AVK++ + LREV ++K L HPNI+
Sbjct: 26 IVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMK 85
Query: 495 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 554
L + + + IV E + G L+ + R E + V G+ Y+H+
Sbjct: 86 LFEILEDSSSFYIVGELYTGGELFDEI---IKRKRFSEHDAARIIKQVFSGITYMHKHN- 141
Query: 555 PIVHRDLKSPNLLVDST---YTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVLRED 610
IVHRDLK N+L++S +K+ DFGLS + NT + K GT ++APEVLR
Sbjct: 142 -IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KDRIGTAYYIAPEVLRG- 197
Query: 611 PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 647
+EK DV+S GVIL+ L++ P+ ++ V
Sbjct: 198 TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV 234
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 3e-37
Identities = 61/207 (29%), Positives = 92/207 (44%), Gaps = 29/207 (14%)
Query: 437 IKKKIGEGSFGTVYHAEWRNS--DVAVKIL------IEQEFHEDRFKEFLREVAIMKGLR 488
+ K +G G+ G V A R + VA+KI+ I D E+ I+K L
Sbjct: 14 MSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN 73
Query: 489 HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPD---ARVVVDERLRLNMAYDVAKG 545
HP I+ + + + IV E + G L+ D + E Y +
Sbjct: 74 HPCIIKIKNFF-DAEDYYIVLELMEGGELF------DKVVGNKRLKEATCKLYFYQMLLA 126
Query: 546 MNYLHQRRPPIVHRDLKSPNLLVDST---YTVKVCDFGLSRS-KPNTYISSKTAAGTPEW 601
+ YLH+ I+HRDLK N+L+ S +K+ DFG S+ + + +T GTP +
Sbjct: 127 VQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM--RTLCGTPTY 182
Query: 602 MAPEVLREDPS---NEKSDVFSFGVIL 625
+APEVL + N D +S GVIL
Sbjct: 183 LAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 3e-37
Identities = 46/194 (23%), Positives = 95/194 (48%), Gaps = 14/194 (7%)
Query: 437 IKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 494
I + +G G FG V+ +S K ++ + D+ +E++I+ RH NI+
Sbjct: 9 IAEDLGRGEFGIVHRCVETSSKKTYMAKF-VKVK-GTDQ-VLVKKEISILNIARHRNILH 65
Query: 495 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 554
L + L ++ E++S +++ I + ++ER ++ + V + + +LH
Sbjct: 66 LHESFESMEELVMIFEFISGLDIFE--RINTSAFELNEREIVSYVHQVCEALQFLHSHN- 122
Query: 555 PIVHRDLKSPNLLVDS--TYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVLREDP 611
I H D++ N++ + + T+K+ +FG +R KP + PE+ APEV + D
Sbjct: 123 -IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--RLLFTAPEYYAPEVHQHDV 179
Query: 612 SNEKSDVFSFGVIL 625
+ +D++S G ++
Sbjct: 180 VSTATDMWSLGTLV 193
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 4e-37
Identities = 59/198 (29%), Positives = 94/198 (47%), Gaps = 22/198 (11%)
Query: 437 IKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 494
++ IG GS+G V A + + A K I + F ED F +E+ IMK L HPNI+
Sbjct: 13 LENTIGRGSWGEVKIAVQKGTRIRRAAKK-IPKYFVEDV-DRFKQEIEIMKSLDHPNIIR 70
Query: 495 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPD---ARVVVDERLRLNMAYDVAKGMNYLHQ 551
L + ++ +V E + G L+ + + V E + DV + Y H+
Sbjct: 71 LYETFEDNTDIYLVMELCTGGELF------ERVVHKRVFRESDAARIMKDVLSAVAYCHK 124
Query: 552 RRPPIVHRDLKSPNLLVDST---YTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVL 607
+ HRDLK N L + +K+ DFGL+ KP + +T GTP +++P+VL
Sbjct: 125 LN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM--RTKVGTPYYVSPQVL 180
Query: 608 REDPSNEKSDVFSFGVIL 625
+ D +S GV++
Sbjct: 181 EG-LYGPECDEWSAGVMM 197
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 7e-37
Identities = 63/262 (24%), Positives = 117/262 (44%), Gaps = 26/262 (9%)
Query: 437 IKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFL------REVAIMKGLR 488
+G G+FG V+ A + N +V VK + +++ ED + E E+AI+ +
Sbjct: 28 TMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVE 87
Query: 489 HPNIVLLMGAVTEPPNLSIVTEYLSRGS-LYKLLHIPDARVVVDERLRLNMAYDVAKGMN 547
H NI+ ++ +V E G L+ + D +DE L + + +
Sbjct: 88 HANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFI---DRHPRLDEPLASYIFRQLVSAVG 144
Query: 548 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEV 606
YL + I+HRD+K N+++ +T+K+ DFG + + T GT E+ APEV
Sbjct: 145 YLRLKD--IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLF--YTFCGTIEYCAPEV 200
Query: 607 LREDP-SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 665
L +P + +++S GV L+ L+ + P+ + + A + P V+ +
Sbjct: 201 LMGNPYRGPELEMWSLGVTLYTLVFEENPFCE--LEETVEA------AIHPPYLVSKELM 252
Query: 666 ALIETCWAEEPEIRPSFPSIME 687
+L+ PE R + ++
Sbjct: 253 SLVSGLLQPVPERRTTLEKLVT 274
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 7e-37
Identities = 56/198 (28%), Positives = 95/198 (47%), Gaps = 23/198 (11%)
Query: 437 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 494
++ ++G G+ VY + + + A+K+L + + E+ ++ L HPNI+
Sbjct: 57 VESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKI----VRTEIGVLLRLSHPNIIK 112
Query: 495 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPD---ARVVVDERLRLNMAYDVAKGMNYLHQ 551
L P +S+V E ++ G L+ D + ER + + + + YLH+
Sbjct: 113 LKEIFETPTEISLVLELVTGGELF------DRIVEKGYYSERDAADAVKQILEAVAYLHE 166
Query: 552 RRPPIVHRDLKSPNLLVDSTY---TVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVL 607
IVHRDLK NLL + +K+ DFGLS+ + + KT GTP + APE+L
Sbjct: 167 NG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM--KTVCGTPGYCAPEIL 222
Query: 608 REDPSNEKSDVFSFGVIL 625
R + D++S G+I
Sbjct: 223 RGCAYGPEVDMWSVGIIT 240
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 7e-37
Identities = 72/261 (27%), Positives = 114/261 (43%), Gaps = 20/261 (7%)
Query: 437 IKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 494
+ + +GEG++G V A R + VAVKI ++ + D + +E+ I K L H N+V
Sbjct: 11 LVQTLGEGAYGEVQLAVNRVTEEAVAVKI-VDMKRAVDCPENIKKEICINKMLNHENVVK 69
Query: 495 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAK----GMNYLH 550
G E + EY S G L+ R+ D + A G+ YLH
Sbjct: 70 FYGHRREGNIQYLFLEYCSGGELF-------DRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 551 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISS--KTAAGTPEWMAPEVLR 608
I HRD+K NLL+D +K+ DFGL+ GT ++APE+L+
Sbjct: 123 GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 609 EDP-SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP-KNVNPMVAA 666
E DV+S G++L ++ + PW + S + + + P K ++ A
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 240
Query: 667 LIETCWAEEPEIRPSFPSIME 687
L+ E P R + P I +
Sbjct: 241 LLHKILVENPSARITIPDIKK 261
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 8e-37
Identities = 74/262 (28%), Positives = 122/262 (46%), Gaps = 26/262 (9%)
Query: 437 IKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFL-REVAIMKGLRHPNIV 493
+ +G G+FG V E + VAVKIL Q+ + RE+ +K RHP+I+
Sbjct: 15 LGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHII 74
Query: 494 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMA----YDVAKGMNYL 549
L ++ P + +V EY+S G L+ + R+ A + ++Y
Sbjct: 75 KLYQVISTPTDFFMVMEYVSGGELF-------DYICKHGRVEEMEARRLFQQILSAVDYC 127
Query: 550 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISS---KTAAGTPEWMAPEV 606
H+ +VHRDLK N+L+D+ K+ DFGLS N +T+ G+P + APEV
Sbjct: 128 HRHM--VVHRDLKPENVLLDAHMNAKIADFGLS----NMMSDGEFLRTSCGSPNYAAPEV 181
Query: 607 LREDP-SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 665
+ + + D++S GVIL+ L+ P+ + + + +G IP+ +N VA
Sbjct: 182 ISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKI--RGGVFYIPEYLNRSVA 239
Query: 666 ALIETCWAEEPEIRPSFPSIME 687
L+ +P R + I E
Sbjct: 240 TLLMHMLQVDPLKRATIKDIRE 261
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-36
Identities = 59/196 (30%), Positives = 91/196 (46%), Gaps = 16/196 (8%)
Query: 436 LIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNI 492
L K +GEGSF + S AVKI I + + +E+ +K HPNI
Sbjct: 14 LKDKPLGEGSFSICRKCVHKKSNQAFAVKI-ISKRMEANTQ----KEITALKLCEGHPNI 68
Query: 493 VLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 552
V L + + +V E L+ G L++ I + E + + ++++H
Sbjct: 69 VKLHEVFHDQLHTFLVMELLNGGELFE--RI-KKKKHFSETEASYIMRKLVSAVSHMHDV 125
Query: 553 RPPIVHRDLKSPNLLV---DSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRE 609
+VHRDLK NLL + +K+ DFG +R KP KT T + APE+L +
Sbjct: 126 G--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQ 183
Query: 610 DPSNEKSDVFSFGVIL 625
+ +E D++S GVIL
Sbjct: 184 NGYDESCDLWSLGVIL 199
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-36
Identities = 43/297 (14%), Positives = 92/297 (30%), Gaps = 47/297 (15%)
Query: 431 RWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKIL-IEQEFHEDRFKEFLREVAIMKGL 487
R L+ +G+ A + + V + + + K+ EV ++ L
Sbjct: 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLL 135
Query: 488 R----------------------HPNIVLLMGAVTEPPNLSIVTEYL----SRGSLYKLL 521
R P ++ + ++ +++ + + +L
Sbjct: 136 RGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFG 195
Query: 522 HIPDARVVVDERL----RLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVC 577
+ + + L RL + V + + LH +VH L+ ++++D V +
Sbjct: 196 EVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQRGGVFLT 253
Query: 578 DFGLSRSKPNTYISSKTAA-GTPEWMAPEVLREDPSNEK-----SDVFSFGVILWELITL 631
F + +S PE A +L + D ++ G+ ++ +
Sbjct: 254 GFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCA 313
Query: 632 QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMET 688
P + + KN+ V AL+E E R MET
Sbjct: 314 DLPNTDDAALGGSEWI------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 364
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 1e-36
Identities = 64/208 (30%), Positives = 94/208 (45%), Gaps = 25/208 (12%)
Query: 436 LIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNI 492
L + +GEG+ V + + AVKI IE++ R REV ++ + H N+
Sbjct: 16 LQEDVLGEGAHARVQTCINLITSQEYAVKI-IEKQPGHIR-SRVFREVEMLYQCQGHRNV 73
Query: 493 VLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 552
+ L+ E +V E + GS+ L HI R +E + DVA +++LH +
Sbjct: 74 LELIEFFEEEDRFYLVFEKMRGGSI--LSHI-HKRRHFNELEASVVVQDVASALDFLHNK 130
Query: 553 RPPIVHRDLKSPNLLV---DSTYTVKVCDFGLSRS-KPNTYISS------KTAAGTPEWM 602
I HRDLK N+L + VK+CDF L K N S T G+ E+M
Sbjct: 131 G--IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYM 188
Query: 603 APEVLREDPSNEKS-----DVFSFGVIL 625
APEV+ D++S GVIL
Sbjct: 189 APEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 1e-36
Identities = 59/283 (20%), Positives = 111/283 (39%), Gaps = 28/283 (9%)
Query: 437 IKKKIGEGSFGTVYHAEWR--NSDVAVKIL----IEQEFHEDRFKEFLREVAIMKGLRH- 489
+ +G G FG+VY N VA+K + I EV ++K +
Sbjct: 47 VGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 106
Query: 490 -PNIVLLMGAVTEPPNLSIVTEYLS-RGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 547
++ L+ P + ++ E L+ + R + E L + + V + +
Sbjct: 107 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI---TERGALQEELARSFFWQVLEAVR 163
Query: 548 YLHQRRPPIVHRDLKSPNLLVDS-TYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV 606
+ H ++HRD+K N+L+D +K+ DFG +T GT + PE
Sbjct: 164 HCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--TDFDGTRVYSPPEW 219
Query: 607 LREDP-SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 665
+R + V+S G++L++++ P+ + ++I ++ + V+
Sbjct: 220 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD--EEIIRG------QVFFRQRVSSECQ 271
Query: 666 ALIETCWAEEPEIRPSFPSIMET--LQQFLMSSVCQPLSAQPL 706
LI C A P RP+F I +Q L+ + L
Sbjct: 272 HLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSL 314
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-36
Identities = 66/218 (30%), Positives = 113/218 (51%), Gaps = 15/218 (6%)
Query: 437 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIV 493
++ +G+GSFG V + + + AVK++ +++ + + LREV ++K L HPNI+
Sbjct: 30 GQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIM 89
Query: 494 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 553
L + +V E + G L+ + +R E + V G+ Y+H+ +
Sbjct: 90 KLYEFFEDKGYFYLVGEVYTGGELFDEI---ISRKRFSEVDAARIIRQVLSGITYMHKNK 146
Query: 554 PPIVHRDLKSPNLLVDST---YTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVLRE 609
IVHRDLK NLL++S +++ DFGLS + + + K GT ++APEVL
Sbjct: 147 --IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM--KDKIGTAYYIAPEVLHG 202
Query: 610 DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 647
+EK DV+S GVIL+ L++ P+ + ++ V
Sbjct: 203 -TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV 239
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 2e-36
Identities = 51/196 (26%), Positives = 92/196 (46%), Gaps = 18/196 (9%)
Query: 437 IKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIM-KGLRHPNIV 493
+K+ IG GS+ + + + AVKI+ + ++ E+ I+ + +HPNI+
Sbjct: 26 VKEDIGVGSYSVCKRCIHKATNMEFAVKII------DKSKRDPTEEIEILLRYGQHPNII 79
Query: 494 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 553
L + + +VTE + G L + + ER + + + K + YLH +
Sbjct: 80 TLKDVYDDGKYVYVVTELMKGGELLDKIL---RQKFFSEREASAVLFTITKTVEYLHAQG 136
Query: 554 PPIVHRDLKSPNLLV----DSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRE 609
+VHRDLK N+L + ++++CDFG ++ T T ++APEVL
Sbjct: 137 --VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLER 194
Query: 610 DPSNEKSDVFSFGVIL 625
+ D++S GV+L
Sbjct: 195 QGYDAACDIWSLGVLL 210
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 6e-36
Identities = 58/264 (21%), Positives = 103/264 (39%), Gaps = 28/264 (10%)
Query: 437 IKKKIGEGSFGTVYHAEWR--NSDVAVKIL----IEQEFHEDRFKEFLREVAIMKGLR-- 488
+ +G+G FGTV+ VA+K++ + EVA++ +
Sbjct: 35 LGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAG 94
Query: 489 --HPNIVLLMGAVTEPPNLSIVTEYLSRGS-LYKLLHIPDARVVVDERLRLNMAYDVAKG 545
HP ++ L+ +V E L+ + + + E V
Sbjct: 95 GGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYI---TEKGPLGEGPSRCFFGQVVAA 151
Query: 546 MNYLHQRRPPIVHRDLKSPNLLVDS-TYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAP 604
+ + H R +VHRD+K N+L+D K+ DFG + GT + P
Sbjct: 152 IQHCHSRG--VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY--TDFDGTRVYSPP 207
Query: 605 EVLREDP-SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPM 663
E + + V+S G++L++++ P+ +++ A L P +V+P
Sbjct: 208 EWISRHQYHALPATVWSLGILLYDMVCGDIPFERD--QEILEA------ELHFPAHVSPD 259
Query: 664 VAALIETCWAEEPEIRPSFPSIME 687
ALI C A +P RPS I+
Sbjct: 260 CCALIRRCLAPKPSSRPSLEEILL 283
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 7e-36
Identities = 64/269 (23%), Positives = 121/269 (44%), Gaps = 30/269 (11%)
Query: 436 LIKKKIGEGSFGTVYHAEWRNSD----VAVKILIEQEF--HEDRFKEFLREVAIMKGLRH 489
L+ +GEGS+G V +S+ AVKIL +++ + +E+ +++ LRH
Sbjct: 8 LMGDLLGEGSYGKVKEV--LDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH 65
Query: 490 PNIVLL---MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYD----V 542
N++ L + + +V EY + ++L V ++R + A+ +
Sbjct: 66 KNVIQLVDVLYNEE-KQKMYMVMEYCV-CGMQEMLDS-----VPEKRFPVCQAHGYFCQL 118
Query: 543 AKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISS--KTAAGTPE 600
G+ YLH + IVH+D+K NLL+ + T+K+ G++ + +T+ G+P
Sbjct: 119 IDGLEYLHSQG--IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPA 176
Query: 601 WMAPEVLREDP--SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPK 658
+ PE+ S K D++S GV L+ + T P+ ++ + IP
Sbjct: 177 FQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENI--GKGSYAIPG 234
Query: 659 NVNPMVAALIETCWAEEPEIRPSFPSIME 687
+ P ++ L++ EP R S I +
Sbjct: 235 DCGPPLSDLLKGMLEYEPAKRFSIRQIRQ 263
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-35
Identities = 65/228 (28%), Positives = 112/228 (49%), Gaps = 25/228 (10%)
Query: 437 IKKKIGEGSFGTVYHAEWRNSD--VAVKIL-----------IEQEFHEDRFKEFLREVAI 483
+K+G G++G V + +N A+K++ + + E +E E+++
Sbjct: 40 KVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISL 99
Query: 484 MKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVA 543
+K L HPNI+ L + +VTE+ G L++ + R DE N+ +
Sbjct: 100 LKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI---INRHKFDECDAANIMKQIL 156
Query: 544 KGMNYLHQRRPPIVHRDLKSPNLLVDST---YTVKVCDFGLSRS-KPNTYISSKTAAGTP 599
G+ YLH+ IVHRD+K N+L+++ +K+ DFGLS + + + GT
Sbjct: 157 SGICYLHKHN--IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL--RDRLGTA 212
Query: 600 EWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 647
++APEVL++ NEK DV+S GVI++ L+ P+ +I V
Sbjct: 213 YYIAPEVLKKK-YNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKV 259
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-35
Identities = 63/255 (24%), Positives = 121/255 (47%), Gaps = 20/255 (7%)
Query: 437 IKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKE-FLREVAIMKGLRHPNIV 493
I K+G G TVY AE N VA+K + ++ + F REV L H NIV
Sbjct: 15 IVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIV 74
Query: 494 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 553
++ E +V EY+ +L + + + + +N + G+ + H R
Sbjct: 75 SMIDVDEEDDCYYLVMEYIEGPTLSEYIE---SHGPLSVDTAINFTNQILDGIKHAHDMR 131
Query: 554 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI-SSKTAAGTPEWMAPEVLREDPS 612
IVHRD+K N+L+DS T+K+ DFG++++ T + + GT ++ +PE + + +
Sbjct: 132 --IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEAT 189
Query: 613 NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPK-------NVNPMVA 665
+E +D++S G++L+E++ + P+ T ++ K + +P ++ ++
Sbjct: 190 DECTDIYSIGIVLYEMLVGEPPFNGETA----VSIAIKHIQDSVPNVTTDVRKDIPQSLS 245
Query: 666 ALIETCWAEEPEIRP 680
+I ++ R
Sbjct: 246 NVILRATEKDKANRY 260
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 4e-35
Identities = 43/299 (14%), Positives = 87/299 (29%), Gaps = 56/299 (18%)
Query: 434 ELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLR-EVAIMKGLR-- 488
L+ +G+ A + + V + E + ++ EV ++ LR
Sbjct: 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133
Query: 489 -----------------------HPNIVLLMGAVTEPPNLSIVTEY-LSRGSLYK----L 520
++ + + LS Y + +L L
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193
Query: 521 LHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFG 580
L + RL + V + + LH +VH L+ ++++D V + F
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQRGGVFLTGFE 251
Query: 581 LSRSKPNTYISSKTAAGTPEWMAPEVL-----------REDPSNEKSDVFSFGVILWELI 629
+ ++ + + PE+ R D ++ G++++ +
Sbjct: 252 HLV-RDGAR---VVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW 307
Query: 630 TLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMET 688
P + KN+ V AL+E E R MET
Sbjct: 308 CADLPITKDAALGGSEWI------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 360
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 5e-35
Identities = 65/204 (31%), Positives = 100/204 (49%), Gaps = 24/204 (11%)
Query: 437 IKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 494
K IG G+FG + VAVK + ++ + RE+ + LRHPNIV
Sbjct: 24 FVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ---REIINHRSLRHPNIVR 80
Query: 495 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYD----VAKGMNYLH 550
+ P +L+I+ EY S G LY R+ R + A + G++Y H
Sbjct: 81 FKEVILTPTHLAIIMEYASGGELY-------ERICNAGRFSEDEARFFFQQLLSGVSYCH 133
Query: 551 QRRPPIVHRDLKSPNLLVDSTYT--VKVCDFGLSR-SKPNTYISSKTAAGTPEWMAPEVL 607
+ I HRDLK N L+D + +K+CDFG S+ S ++ K+ GTP ++APEVL
Sbjct: 134 SMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP--KSTVGTPAYIAPEVL 189
Query: 608 REDPSN-EKSDVFSFGVILWELIT 630
+ + +DV+S GV L+ ++
Sbjct: 190 LRQEYDGKIADVWSCGVTLYVMLV 213
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 5e-35
Identities = 70/262 (26%), Positives = 103/262 (39%), Gaps = 54/262 (20%)
Query: 437 IKKKIGEGSFGTVYHAEWRNS--DVAVKIL----IEQEFHEDRFKEFLREVAIMKGLRHP 490
+K IG+GS+G V A + A+KI+ I Q +D + EV +MK L HP
Sbjct: 30 LKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDV-ERIKTEVRLMKKLHHP 88
Query: 491 NIVLLMGAVTEPPNLSIVTEYLSRGSLY-------------------------------- 518
NI L + + +V E G L
Sbjct: 89 NIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEE 148
Query: 519 -----KLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS--T 571
V E+L N+ + ++YLH + I HRD+K N L + +
Sbjct: 149 AINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG--ICHRDIKPENFLFSTNKS 206
Query: 572 YTVKVCDFGLSR----SKPNTYISSKTAAGTPEWMAPEVLR--EDPSNEKSDVFSFGVIL 625
+ +K+ DFGLS+ Y T AGTP ++APEVL + K D +S GV+L
Sbjct: 207 FEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266
Query: 626 WELITLQKPWRNSTPSQVISAV 647
L+ P+ + IS V
Sbjct: 267 HLLLMGAVPFPGVNDADTISQV 288
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-34
Identities = 73/260 (28%), Positives = 124/260 (47%), Gaps = 23/260 (8%)
Query: 437 IKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFL-REVAIMKGLRHPNIV 493
I++ +GEGSFG V A VA+K + Q + + RE++ +K LRHP+I+
Sbjct: 13 IRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHII 72
Query: 494 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMA----YDVAKGMNYL 549
L +T P ++ +V EY G L+ + V +R+ + + + Y
Sbjct: 73 KLYDVITTPTDIVMVIEYAG-GELFDYI-------VEKKRMTEDEGRRFFQQIICAIEYC 124
Query: 550 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPNTYISSKTAAGTPEWMAPEVLR 608
H+ + IVHRDLK NLL+D VK+ DFGLS ++ KT+ G+P + APEV+
Sbjct: 125 HRHK--IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFL--KTSCGSPNYAAPEVIN 180
Query: 609 EDP-SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAAL 667
+ + DV+S G++L+ ++ + P+ + + V +P ++P +L
Sbjct: 181 GKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV--NSCVYVMPDFLSPGAQSL 238
Query: 668 IETCWAEEPEIRPSFPSIME 687
I +P R + I
Sbjct: 239 IRRMIVADPMQRITIQEIRR 258
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 133 bits (335), Expect = 4e-34
Identities = 36/297 (12%), Positives = 67/297 (22%), Gaps = 50/297 (16%)
Query: 435 LLIKKKIGEGSFGTVYHAEWRNSD--VAVKIL-IEQEFHEDRFKEFLREVAIMKGLRHPN 491
L + + + G V+ A+K+ + E + L +
Sbjct: 64 LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGES 123
Query: 492 IVLLMGA--------------------------VTEPPNLSIVTEYLSRGSLYKLLHIPD 525
N ++ S L L D
Sbjct: 124 PEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD 182
Query: 526 ARVVVDERL----RLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL 581
V + + + L + +VH NL + + + D
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKG--LVHGHFTPDNLFIMPDGRLMLGDVSA 240
Query: 582 SRSKPNTYISSKTAAGTPEWMAPEVL---REDPSNEKSDVFSFGVILWELITLQKPWRNS 638
+ A+ P AP + + G+ ++ + L P+
Sbjct: 241 LWKVG----TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV 296
Query: 639 TPSQ-------VISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMET 688
TP + G + V LI + R MET
Sbjct: 297 TPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 5e-34
Identities = 55/262 (20%), Positives = 105/262 (40%), Gaps = 36/262 (13%)
Query: 437 IKKKIGEGSFGTVYHAE--WRNSDVAVKILIEQEFHEDRFKE-FLREVAIMKGLRHPNIV 493
+++ +G G G VY AE R VA+K++ E + F+ RE L+ P++V
Sbjct: 38 LRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVV 97
Query: 494 LLMGAV----TEPPNLSIVTEYLSRGSLYKLLH----IPDARVVVDERLRLNMAYDVAKG 545
+ L + ++ L +L + R V + +
Sbjct: 98 ----PIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAV-------AIVRQIGSA 146
Query: 546 MNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI-SSKTAAGTPEWMAP 604
++ H HRD+K N+LV + + DFG++ + + + GT +MAP
Sbjct: 147 LDAAHAAG--ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAP 204
Query: 605 EVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPK------ 658
E E + ++D+++ +L+E +T P++ S + + + IP+
Sbjct: 205 ERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHI-----NQAIPRPSTVRP 259
Query: 659 NVNPMVAALIETCWAEEPEIRP 680
+ A+I A+ PE R
Sbjct: 260 GIPVAFDAVIARGMAKNPEDRY 281
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 1e-33
Identities = 72/262 (27%), Positives = 123/262 (46%), Gaps = 26/262 (9%)
Query: 437 IKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFL-REVAIMKGLRHPNIV 493
+ +G G+FG V + VAVKIL Q+ + RE+ +K RHP+I+
Sbjct: 20 LGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHII 79
Query: 494 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMA----YDVAKGMNYL 549
L ++ P ++ +V EY+S G L+ + + RL + + G++Y
Sbjct: 80 KLYQVISTPSDIFMVMEYVSGGELF-------DYICKNGRLDEKESRRLFQQILSGVDYC 132
Query: 550 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISS---KTAAGTPEWMAPEV 606
H+ +VHRDLK N+L+D+ K+ DFGLS N +T+ G+P + APEV
Sbjct: 133 HRHM--VVHRDLKPENVLLDAHMNAKIADFGLS----NMMSDGEFLRTSCGSPNYAAPEV 186
Query: 607 LREDP-SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 665
+ + + D++S GVIL+ L+ P+ + + + P+ +NP V
Sbjct: 187 ISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKI--CDGIFYTPQYLNPSVI 244
Query: 666 ALIETCWAEEPEIRPSFPSIME 687
+L++ +P R + I E
Sbjct: 245 SLLKHMLQVDPMKRATIKDIRE 266
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 52/291 (17%), Positives = 99/291 (34%), Gaps = 25/291 (8%)
Query: 414 MSTSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAE--WRNSDVAVKILIEQEFHE 471
RE + E + I + + + +
Sbjct: 43 NRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSP 102
Query: 472 DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVD 531
++ M N V + + L I + + +L ++ + +
Sbjct: 103 SPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDRE 162
Query: 532 ERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS 591
+ L++ +A+ + +LH + ++HRDLK N+ VKV DFGL +
Sbjct: 163 HGVCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEE 220
Query: 592 SKTAA------------GTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNST 639
GT +M+PE + + + K D+FS G+IL+EL+
Sbjct: 221 QTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFST--QME 278
Query: 640 PSQVISAVGFKGRRLEIPK---NVNPMVAALIETCWAEEPEIRPSFPSIME 687
++I+ V R L+ P P +++ + P RP I+E
Sbjct: 279 RVRIITDV----RNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIE 325
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 18/57 (31%), Positives = 30/57 (52%), Gaps = 3/57 (5%)
Query: 439 KKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIV 493
+ +G G FG V+ A+ + + + A+K I E ++ +REV + L HP IV
Sbjct: 12 QCMGRGGFGVVFEAKNKVDDCNYAIKR-IRLPNRELAREKVMREVKALAKLEHPGIV 67
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 52/201 (25%), Positives = 85/201 (42%), Gaps = 24/201 (11%)
Query: 436 LIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNI 492
L K+ +G G G V R + A+K+L + +EV P+I
Sbjct: 32 LSKQVLGLGVNGKVLECFHRRTGQKCALKLL-------YDSPKARQEVDHHWQASGGPHI 84
Query: 493 VLLMGA----VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVV-DERLRLNMAYDVAKGMN 547
V ++ L I+ E + G L+ I + ER + D+ +
Sbjct: 85 VCILDVYENMHHGKRCLLIIMECMEGGELFS--RIQERGDQAFTEREAAEIMRDIGTAIQ 142
Query: 548 YLHQRRPPIVHRDLKSPNLLVDSTY---TVKVCDFGLSRSKPNTYISSKTAAGTPEWMAP 604
+LH I HRD+K NLL S +K+ DFG ++ + +T TP ++AP
Sbjct: 143 FLHSHN--IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL--QTPCYTPYYVAP 198
Query: 605 EVLREDPSNEKSDVFSFGVIL 625
EVL + ++ D++S GVI+
Sbjct: 199 EVLGPEKYDKSCDMWSLGVIM 219
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 5e-33
Identities = 53/202 (26%), Positives = 86/202 (42%), Gaps = 25/202 (12%)
Query: 436 LIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNI 492
+ + +G G G V + + A+K+L + REV + + P+I
Sbjct: 65 VTSQVLGLGINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHI 117
Query: 493 VLLMGA----VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVV-DERLRLNMAYDVAKGMN 547
V ++ L IV E L G L+ I D ER + + + +
Sbjct: 118 VRIVDVYENLYAGRKCLLIVMECLDGGELFS--RIQDRGDQAFTEREASEIMKSIGEAIQ 175
Query: 548 YLHQRRPPIVHRDLKSPNLLVDSTY---TVKVCDFGLSRS-KPNTYISSKTAAGTPEWMA 603
YLH I HRD+K NLL S +K+ DFG ++ + + T TP ++A
Sbjct: 176 YLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL--TTPCYTPYYVA 231
Query: 604 PEVLREDPSNEKSDVFSFGVIL 625
PEVL + ++ D++S GVI+
Sbjct: 232 PEVLGPEKYDKSCDMWSLGVIM 253
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 6e-33
Identities = 57/207 (27%), Positives = 97/207 (46%), Gaps = 28/207 (13%)
Query: 439 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEF-----LREVAIMKGLRHPN 491
KIGEGS+G V+ R++ VA+K +F E LRE+ ++K L+HPN
Sbjct: 9 GKIGEGSYGVVFKCRNRDTGQIVAIK-----KFLESEDDPVIKKIALREIRMLKQLKHPN 63
Query: 492 IVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 551
+V L+ L +V EY ++ L + V E L ++ + + +N+ H+
Sbjct: 64 LVNLLEVFRRKRRLHLVFEYCDH-TVLHELD--RYQRGVPEHLVKSITWQTLQAVNFCHK 120
Query: 552 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPE----WM-APEV 606
+HRD+K N+L+ +K+CDFG +R ++ + E W +PE+
Sbjct: 121 HN--CIHRDVKPENILITKHSVIKLCDFGFARL-----LTGPSDYYDDEVATRWYRSPEL 173
Query: 607 LREDPSNEKS-DVFSFGVILWELITLQ 632
L D DV++ G + EL++
Sbjct: 174 LVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 36/212 (16%)
Query: 440 KIGEGSFGTVYHAEWRNSD--VAVK-ILIEQEFHEDRFKE-----FLREVAIMKGLRHPN 491
KIGEG++GTV+ A+ R + VA+K + ++ + E LRE+ ++K L+H N
Sbjct: 9 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDD------DEGVPSSALREICLLKELKHKN 62
Query: 492 IVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 551
IV L + L++V E+ + L K +D + + + + KG+ + H
Sbjct: 63 IVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFD--SCNGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 552 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK---PNTYISSKTAAGTPE----WM-A 603
R ++HRDLK NLL++ +K+ +FGL+R+ Y + E W
Sbjct: 120 RN--VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--------SAEVVTLWYRP 169
Query: 604 PEVLREDPS-NEKSDVFSFGVILWELITLQKP 634
P+VL + D++S G I EL +P
Sbjct: 170 PDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 70/261 (26%), Positives = 124/261 (47%), Gaps = 27/261 (10%)
Query: 437 IKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDR-FKE-FLREVAIMKGLRHPNI 492
+ + +G G V+ A + DVAVK+L + D F F RE L HP I
Sbjct: 16 LGEILGFGGMSEVHLARDLRDHRDVAVKVL-RADLARDPSFYLRFRREAQNAAALNHPAI 74
Query: 493 VLL--MGAVTEPPNLS--IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 548
V + G P IV EY+ +L ++H + + + + D + +N+
Sbjct: 75 VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNF 131
Query: 549 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR---SKPNTYISSKTAAGTPEWMAPE 605
HQ I+HRD+K N+++ +T VKV DFG++R N+ + GT ++++PE
Sbjct: 132 SHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 606 VLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP------KN 659
R D + +SDV+S G +L+E++T + P+ +P +V ++ R + +
Sbjct: 190 QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP----VSVAYQHVREDPIPPSARHEG 245
Query: 660 VNPMVAALIETCWAEEPEIRP 680
++ + A++ A+ PE R
Sbjct: 246 LSADLDAVVLKALAKNPENRY 266
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 4e-32
Identities = 54/210 (25%), Positives = 96/210 (45%), Gaps = 34/210 (16%)
Query: 439 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEF-----LREVAIMKGLRHPN 491
+GEGS+G V +++ VA+K +F E + +RE+ ++K LRH N
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIK-----KFLESDDDKMVKKIAMREIKLLKQLRHEN 85
Query: 492 IVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 551
+V L+ + +V E++ ++ L +D ++ + + G+ + H
Sbjct: 86 LVNLLEVCKKKKRWYLVFEFVDH-TILDDLE--LFPNGLDYQVVQKYLFQIINGIGFCHS 142
Query: 552 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR---SKPNTYISSKTAAGTPE----WM-A 603
I+HRD+K N+LV + VK+CDFG +R + Y E W A
Sbjct: 143 HN--IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY--------DDEVATRWYRA 192
Query: 604 PEVLREDPSNEKS-DVFSFGVILWELITLQ 632
PE+L D K+ DV++ G ++ E+ +
Sbjct: 193 PELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-31
Identities = 55/266 (20%), Positives = 96/266 (36%), Gaps = 38/266 (14%)
Query: 437 IKKKIGEGSFGTVYHAEWRNSD---VAVKILIEQEFHEDRFKE-FLREVAIMKGLRHPNI 492
+K I G G +Y A RN + V +K L+ + + + E + + HP+I
Sbjct: 84 VKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS--GDAEAQAMAMAERQFLAEVVHPSI 141
Query: 493 VLLMGAVTEPPNLS-----IVTEYLSRGSLYKLL--HIPDARVVVDERLRLNMAYDVAKG 545
V + V IV EY+ SL + +P A + ++
Sbjct: 142 VQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEA-------IAYLLEILPA 194
Query: 546 MNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPE 605
++YLH +V+ DLK N+++ +K+ D G + GTP + APE
Sbjct: 195 LSYLHSIG--LVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF----GYLYGTPGFQAPE 247
Query: 606 VLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 665
++R P+ +D+++ G L L + L+
Sbjct: 248 IVRTGPT-VATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDD----PVLKTY----DSYG 298
Query: 666 ALIETCWAEEPEIRPSFPSIMETLQQ 691
L+ +P R F + E Q
Sbjct: 299 RLLRRAIDPDPRQR--FTTAEEMSAQ 322
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-31
Identities = 62/211 (29%), Positives = 102/211 (48%), Gaps = 34/211 (16%)
Query: 439 KKIGEGSFGTVYHAEWRNSD-VAVK-ILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLM 496
K IG GSFG V+ A+ SD VA+K +L ++ F RE+ IM+ ++HPN+V L
Sbjct: 46 KVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFK-------NRELQIMRIVKHPNVVDLK 98
Query: 497 GAVTEPPN------LSIVTEYLSRGSLYKLL-HIPDARVVVDERLRLNMAYDVAKGMNYL 549
+ L++V EY+ ++Y+ H + + L Y + + + Y+
Sbjct: 99 AFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYI 157
Query: 550 HQRRPPIVHRDLKSPNLLVDS-TYTVKVCDFGLSRS----KPNT-YISSKTAAGTPEWM- 602
H I HRD+K NLL+D + +K+ DFG ++ +PN YI S+ +
Sbjct: 158 HSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSR-------YYR 208
Query: 603 APEV-LREDPSNEKSDVFSFGVILWELITLQ 632
APE+ D++S G ++ EL+ Q
Sbjct: 209 APELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 61/238 (25%), Positives = 108/238 (45%), Gaps = 12/238 (5%)
Query: 437 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQE-FHEDRFKEFLREVAIMKGLRHPNIV 493
K +GEGSF TV A + A+KIL ++ E++ RE +M L HP V
Sbjct: 34 FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 93
Query: 494 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 553
L + L Y G L L +I + R A ++ + YLH +
Sbjct: 94 KLYFTFQDDEKLYFGLSYAKNGEL--LKYIRKIGSFDETCTRFYTA-EIVSALEYLHGKG 150
Query: 554 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAA--GTPEWMAPEVLREDP 611
I+HRDLK N+L++ +++ DFG ++ ++ + GT ++++PE+L E
Sbjct: 151 --IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS 208
Query: 612 SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE 669
+ + SD+++ G I+++L+ P+R + + + P+ P L+E
Sbjct: 209 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI--IKLEYDFPEKFFPKARDLVE 264
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 8e-31
Identities = 66/208 (31%), Positives = 108/208 (51%), Gaps = 35/208 (16%)
Query: 439 KKIGEGSFGTVYHAEWRNSD-VAVK-ILIEQEFHEDRFKE-----FLREVAIMKGLRHPN 491
+K+GEG++G VY A+ VA+K I ++ E E +RE++++K L HPN
Sbjct: 27 EKVGEGTYGVVYKAKDSQGRIVALKRIRLDAE------DEGIPSTAIREISLLKELHHPN 80
Query: 492 IVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 551
IV L+ + L++V E++ + L K+L + + + + Y + +G+ + HQ
Sbjct: 81 IVSLIDVIHSERCLTLVFEFMEK-DLKKVLD--ENKTGLQDSQIKIYLYQLLRGVAHCHQ 137
Query: 552 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK---PNTYISSKTAAGTPE----WM-A 603
R I+HRDLK NLL++S +K+ DFGL+R+ +Y T E W A
Sbjct: 138 HR--ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY--------THEVVTLWYRA 187
Query: 604 PEVLREDPS-NEKSDVFSFGVILWELIT 630
P+VL + D++S G I E+IT
Sbjct: 188 PDVLMGSKKYSTSVDIWSIGCIFAEMIT 215
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-30
Identities = 66/212 (31%), Positives = 102/212 (48%), Gaps = 39/212 (18%)
Query: 439 KKIGEGSFGTVYHAEWRNSD--VAVK-ILIEQEFHEDRFKE-----FLREVAIMKGLRHP 490
+GEG F TVY A +N++ VA+K I + H K+ LRE+ +++ L HP
Sbjct: 16 DFLGEGQFATVYKARDKNTNQIVAIKKIKLG---HRSEAKDGINRTALREIKLLQELSHP 72
Query: 491 NIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLH 550
NI+ L+ A N+S+V +++ L ++ D +V+ +G+ YLH
Sbjct: 73 NIIGLLDAFGHKSNISLVFDFMET-DLEVIIK--DNSLVLTPSHIKAYMLMTLQGLEYLH 129
Query: 551 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK---PNTYISSKTAAGTPE----WM- 602
Q I+HRDLK NLL+D +K+ DFGL++S Y T + W
Sbjct: 130 QHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--------THQVVTRWYR 179
Query: 603 APEVL---RE-DPSNEKSDVFSFGVILWELIT 630
APE+L R D+++ G IL EL+
Sbjct: 180 APELLFGARMYGVG---VDMWAVGCILAELLL 208
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 65/207 (31%), Positives = 99/207 (47%), Gaps = 35/207 (16%)
Query: 440 KIGEGSFGTVYHAEWR-NSDVAVK-ILIEQEFHEDRFKE-----FLREVAIMKGLRHPNI 492
KIGEG++G VY A+ A+K I +E+E E +RE++I+K L+H NI
Sbjct: 9 KIGEGTYGVVYKAQNNYGETFALKKIRLEKE------DEGIPSTTIREISILKELKHSNI 62
Query: 493 VLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 552
V L + L +V E+L + L KLL ++ + + G+ Y H R
Sbjct: 63 VKLYDVIHTKKRLVLVFEHLDQ-DLKKLLD--VCEGGLESVTAKSFLLQLLNGIAYCHDR 119
Query: 553 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK---PNTYISSKTAAGTPE----WM-AP 604
R ++HRDLK NLL++ +K+ DFGL+R+ Y T E W AP
Sbjct: 120 R--VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY--------THEIVTLWYRAP 169
Query: 605 EVLREDPS-NEKSDVFSFGVILWELIT 630
+VL + D++S G I E++
Sbjct: 170 DVLMGSKKYSTTIDIWSVGCIFAEMVN 196
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 5e-30
Identities = 68/212 (32%), Positives = 103/212 (48%), Gaps = 35/212 (16%)
Query: 439 KKIGEGSFGTVYHAEWRNS--DVAVK-ILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 495
K IG GSFG VY A+ +S VA+K +L ++ RFK RE+ IM+ L H NIV L
Sbjct: 60 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFK--NRELQIMRKLDHCNIVRL 112
Query: 496 MGAVTEPPN------LSIVTEYLSRGSLYKLL-HIPDARVVVDERLRLNMAYDVAKGMNY 548
L++V +Y+ ++Y++ H A+ + Y + + + Y
Sbjct: 113 RYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 171
Query: 549 LHQRRPPIVHRDLKSPNLLVDS-TYTVKVCDFGLSRS----KPNT-YISSKTAAGTPEWM 602
+H I HRD+K NLL+D T +K+CDFG ++ +PN YI S+ +
Sbjct: 172 IHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR-------YY 222
Query: 603 -APEV-LREDPSNEKSDVFSFGVILWELITLQ 632
APE+ DV+S G +L EL+ Q
Sbjct: 223 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-29
Identities = 62/213 (29%), Positives = 99/213 (46%), Gaps = 42/213 (19%)
Query: 440 KIGEGSFGTVYHAEWRNSD--VAVK-ILIEQEFHEDRFKE-----FLREVAIMKGLRHPN 491
K+GEG++G VY A ++ VA+K I +E E +E +REV+++K L+H N
Sbjct: 41 KLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE------EEGVPGTAIREVSLLKELQHRN 94
Query: 492 IVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 551
I+ L + L ++ EY L K + D V R+ + Y + G+N+ H
Sbjct: 95 IIELKSVIHHNHRLHLIFEYAEN-DLKKYM---DKNPDVSMRVIKSFLYQLINGVNFCHS 150
Query: 552 RRPPIVHRDLKSPNLLVDSTYT-----VKVCDFGLSRSK---PNTYISSKTAAGTPE--- 600
RR +HRDLK NLL+ + +K+ DFGL+R+ + T E
Sbjct: 151 RR--CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF--------THEIIT 200
Query: 601 -WM-APEVLREDPS-NEKSDVFSFGVILWELIT 630
W PE+L + D++S I E++
Sbjct: 201 LWYRPPEILLGSRHYSTSVDIWSIACIWAEMLM 233
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 65/213 (30%), Positives = 97/213 (45%), Gaps = 36/213 (16%)
Query: 440 KIGEGSFGTVYHAEWRNSD--VAVK-ILIEQEFHEDRFKEF----LREVAIMKGLR---H 489
+IG G++GTVY A +S VA+K + + +REVA+++ L H
Sbjct: 16 EIGVGAYGTVYKARDPHSGHFVALKSVRVPNG--GGGGGGLPISTVREVALLRRLEAFEH 73
Query: 490 PNIVLLMGAVT-----EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAK 544
PN+V LM +++V E++ + L L + E ++ M +
Sbjct: 74 PNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLM-RQFLR 131
Query: 545 GMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR--SKPNTYISSKTAAGTPE-- 600
G+++LH IVHRDLK N+LV S TVK+ DFGL+R S TP
Sbjct: 132 GLDFLHANC--IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL--------TPVVV 181
Query: 601 --WM-APEVLREDPSNEKSDVFSFGVILWELIT 630
W APEVL + D++S G I E+
Sbjct: 182 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR 214
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 63/214 (29%), Positives = 108/214 (50%), Gaps = 44/214 (20%)
Query: 440 KIGEGSFGTVYHAEWRNSD--VAVK-ILIEQEFHEDRFKE-----FLREVAIMKGLRHPN 491
K+G G++ TVY + + VA+K + ++ E E +RE+++MK L+H N
Sbjct: 12 KLGNGTYATVYKGLNKTTGVYVALKEVKLDSE-------EGTPSTAIREISLMKELKHEN 64
Query: 492 IVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMA------YDVAKG 545
IV L + L++V E++ L K + D+R V + L + + + +G
Sbjct: 65 IVRLYDVIHTENKLTLVFEFMDN-DLKKYM---DSRTVGNTPRGLELNLVKYFQWQLLQG 120
Query: 546 MNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK---PNTYISSKTAAGTPE-- 600
+ + H+ + I+HRDLK NLL++ +K+ DFGL+R+ NT+ + E
Sbjct: 121 LAFCHENK--ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF--------SSEVV 170
Query: 601 --WM-APEVLREDPS-NEKSDVFSFGVILWELIT 630
W AP+VL + + D++S G IL E+IT
Sbjct: 171 TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMIT 204
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-29
Identities = 62/239 (25%), Positives = 112/239 (46%), Gaps = 19/239 (7%)
Query: 437 IKKKIGEGSFGTVYHAEWRNSD--VAVKIL----IEQEFHEDRFKEFLREVAIMKGLRHP 490
I K IG G+FG V + +N+D A+KIL + + F+E E ++
Sbjct: 78 ILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFRE---ERDVLVNGDSK 134
Query: 491 NIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLH 550
I L A + NL +V +Y G L LL + R+ +E R +A ++ ++ +H
Sbjct: 135 WITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLP-EEMARFYLA-EMVIAIDSVH 192
Query: 551 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKTAAGTPEWMAPEVLRE 609
Q VHRD+K N+L+D +++ DFG + + + S A GTP++++PE+L+
Sbjct: 193 QLH--YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 250
Query: 610 DPSNEKS-----DVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPM 663
+ D +S GV ++E++ + P+ + + + R + P V +
Sbjct: 251 MEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDV 309
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-29
Identities = 69/249 (27%), Positives = 126/249 (50%), Gaps = 11/249 (4%)
Query: 434 ELLIKKKIGEGSFGTVYHAEWRNSDV--AVKILIEQEF-HEDRFKEFLREVAIMKGLRHP 490
E L K +G+G+FG V + + + A+KIL ++ +D L E +++ RHP
Sbjct: 151 EYL--KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP 208
Query: 491 NIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLH 550
+ L + L V EY + G L+ H+ RV ++R R A ++ ++YLH
Sbjct: 209 FLTALKYSFQTHDRLCFVMEYANGGELF--FHLSRERVFSEDRARFYGA-EIVSALDYLH 265
Query: 551 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRED 610
+ +V+RDLK NL++D +K+ DFGL + + KT GTPE++APEVL ++
Sbjct: 266 SEKN-VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDN 324
Query: 611 PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIET 670
D + GV+++E++ + P+ N ++ + + + P+ + P +L+
Sbjct: 325 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--EIRFPRTLGPEAKSLLSG 382
Query: 671 CWAEEPEIR 679
++P+ R
Sbjct: 383 LLKKDPKQR 391
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-29
Identities = 62/205 (30%), Positives = 108/205 (52%), Gaps = 29/205 (14%)
Query: 439 KKIGEGSFGTVYHAEWRNSD--VAVK-ILIEQEFHEDRF-KEFLREVAIMKGLRHPNIVL 494
K+GEG++ TVY + + +D VA+K I +E HE+ +REV+++K L+H NIV
Sbjct: 8 DKLGEGTYATVYKGKSKLTDNLVALKEIRLE---HEEGAPCTAIREVSLLKDLKHANIVT 64
Query: 495 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 554
L + +L++V EYL + L + L D +++ + + +G+ Y H+++
Sbjct: 65 LHDIIHTEKSLTLVFEYLDK-DLKQYLD--DCGNIINMHNVKLFLFQLLRGLAYCHRQK- 120
Query: 555 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK---PNTYISSKTAAGTPE----WM-APEV 606
++HRDLK NLL++ +K+ DFGL+R+K TY E W P++
Sbjct: 121 -VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY--------DNEVVTLWYRPPDI 171
Query: 607 LREDPS-NEKSDVFSFGVILWELIT 630
L + + D++ G I +E+ T
Sbjct: 172 LLGSTDYSTQIDMWGVGCIFYEMAT 196
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 6e-29
Identities = 68/251 (27%), Positives = 122/251 (48%), Gaps = 16/251 (6%)
Query: 434 ELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHE-DRFKEFLREVAIMKGLRHP 490
+ L K +G+G+FG V + + A+KIL ++ D + E +++ RHP
Sbjct: 8 DYL--KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 491 NIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLH 550
+ L A L V EY + G L+ H+ RV +ER R A ++ + YLH
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGGELF--FHLSRERVFTEERARFYGA-EIVSALEYLH 122
Query: 551 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAA--GTPEWMAPEVLR 608
R +V+RD+K NL++D +K+ DFGL K + GTPE++APEVL
Sbjct: 123 SRD--VVYRDIKLENLMLDKDGHIKITDFGLC--KEGISDGATMKTFCGTPEYLAPEVLE 178
Query: 609 EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI 668
++ D + GV+++E++ + P+ N ++ + + + P+ ++P +L+
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME--EIRFPRTLSPEAKSLL 236
Query: 669 ETCWAEEPEIR 679
++P+ R
Sbjct: 237 AGLLKKDPKQR 247
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-28
Identities = 69/252 (27%), Positives = 125/252 (49%), Gaps = 17/252 (6%)
Query: 437 IKKKIGEGSFGTVYHAEWRNSDV--AVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIV 493
I + IG+GSFG V + ++ A+K + +Q+ E + + +E+ IM+GL HP +V
Sbjct: 19 ILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLV 78
Query: 494 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 553
L + + ++ +V + L G L H+ +E ++L + ++ ++YL +R
Sbjct: 79 NLWYSFQDEEDMFMVVDLLLGGDLR--YHLQQNVHFKEETVKLFIC-ELVMALDYLQNQR 135
Query: 554 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVLREDPS 612
I+HRD+K N+L+D V + DF ++ T T AGT +MAPE+
Sbjct: 136 --IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET--QITTMAGTKPYMAPEMFSSRKG 191
Query: 613 NEKS---DVFSFGVILWELITLQKPW--RNSTPSQVISAVGFKGRRLEIPKNVNPMVAAL 667
S D +S GV +EL+ ++P+ R+ST S+ I F+ + P + + +L
Sbjct: 192 AGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT-FETTVVTYPSAWSQEMVSL 250
Query: 668 IETCWAEEPEIR 679
++ P+ R
Sbjct: 251 LKKLLEPNPDQR 262
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-28
Identities = 54/256 (21%), Positives = 110/256 (42%), Gaps = 15/256 (5%)
Query: 419 RELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQE-FHEDRFK 475
+ + + + ++ + I K IG G+F V + + + A+KI+ + +
Sbjct: 47 EPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVS 106
Query: 476 EFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLR 535
F E ++ I L A + L +V EY G L LL R+ + R
Sbjct: 107 CFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAE-MAR 165
Query: 536 LNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKT 594
+A ++ ++ +H+ VHRD+K N+L+D +++ DFG + + + + S
Sbjct: 166 FYLA-EIVMAIDSVHRLG--YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLV 222
Query: 595 AAGTPEWMAPEVLREDPSNEKS-------DVFSFGVILWELITLQKPWRNSTPSQVISAV 647
A GTP++++PE+L+ + D ++ GV +E+ Q P+ + ++ +
Sbjct: 223 AVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKI 282
Query: 648 GFKGRRLEIPKNVNPM 663
L +P +
Sbjct: 283 VHYKEHLSLPLVDEGV 298
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 5e-28
Identities = 64/216 (29%), Positives = 103/216 (47%), Gaps = 44/216 (20%)
Query: 440 KIGEGSFGTVYHA-EWRNSD--VAVK-ILIEQEFHEDRFKE-----FLREVAIMKGLR-- 488
+IGEG++G V+ A + +N VA+K + ++ +E +REVA+++ L
Sbjct: 18 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG------EEGMPLSTIREVAVLRHLETF 71
Query: 489 -HPNIVLLMGAVT-----EPPNLSIVTEYLSRGSLYKLL-HIPDARVVVDERLRLNMAYD 541
HPN+V L T L++V E++ + L L +P V +M +
Sbjct: 72 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVP--EPGVPTETIKDMMFQ 128
Query: 542 VAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR--SKPNTYISSKTAAGTP 599
+ +G+++LH R +VHRDLK N+LV S+ +K+ DFGL+R S T
Sbjct: 129 LLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--------TS 178
Query: 600 E----WM-APEVLREDPSNEKSDVFSFGVILWELIT 630
W APEVL + D++S G I E+
Sbjct: 179 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR 214
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-27
Identities = 63/266 (23%), Positives = 120/266 (45%), Gaps = 13/266 (4%)
Query: 407 MEANLSVMSTSNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKIL 464
++ L+ + + + + K +G GSFG V + + S A+KIL
Sbjct: 15 VKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL 74
Query: 465 IEQEFHEDRFKE-FLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHI 523
+Q+ + + E L E I++ + P +V L + + NL +V EY++ G ++ H+
Sbjct: 75 DKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF--SHL 132
Query: 524 PDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 583
+ R A + YLH +++RDLK NLL+D ++V DFG ++
Sbjct: 133 RRIGRFSEPHARFYAA-QIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK 189
Query: 584 SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQV 643
+ T GTPE +APE++ N+ D ++ GV+++E+ P+ P Q+
Sbjct: 190 RVKGR---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246
Query: 644 ISAVGFKGRRLEIPKNVNPMVAALIE 669
+ ++ P + + + L+
Sbjct: 247 YEKIVSG--KVRFPSHFSSDLKDLLR 270
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-27
Identities = 60/237 (25%), Positives = 103/237 (43%), Gaps = 22/237 (9%)
Query: 437 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQE-FHEDRFKEFLREVAIMKGLRHPNIV 493
+ K IG G+FG V +++ A+K+L + E F E IM P +V
Sbjct: 73 VVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVV 132
Query: 494 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMA--Y--DVAKGMNYL 549
L A + L +V EY+ G L L+ + + A Y +V ++ +
Sbjct: 133 QLFYAFQDDRYLYMVMEYMPGGDLVNLMS--------NYDVPEKWARFYTAEVVLALDAI 184
Query: 550 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS-RSKPNTYISSKTAAGTPEWMAPEVLR 608
H +HRD+K N+L+D + +K+ DFG + + TA GTP++++PEVL+
Sbjct: 185 HSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLK 242
Query: 609 EDPSNEK----SDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVN 661
+ D +S GV L+E++ P+ + S + L P + +
Sbjct: 243 SQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDND 299
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 5e-27
Identities = 71/250 (28%), Positives = 118/250 (47%), Gaps = 21/250 (8%)
Query: 439 KKIGEGSFGTVYHAEWRNSD--VAVKIL----IEQEFHEDRFKEFLREVAIM-KGLRHPN 491
K +G+GSFG V+ AE++ ++ A+K L + + D + + E ++ HP
Sbjct: 23 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMD---DDVECTMVEKRVLSLAWEHPF 79
Query: 492 IVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 551
+ + NL V EYL+ G L HI R A ++ G+ +LH
Sbjct: 80 LTHMFCTFQTKENLFFVMEYLNGGDLM--YHIQSCHKFDLSRATFYAA-EIILGLQFLHS 136
Query: 552 RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAA--GTPEWMAPEVLRE 609
+ IV+RDLK N+L+D +K+ DFG+ K N +KT GTP+++APE+L
Sbjct: 137 KG--IVYRDLKLDNILLDKDGHIKIADFGMC--KENMLGDAKTNTFCGTPDYIAPEILLG 192
Query: 610 DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE 669
N D +SFGV+L+E++ Q P+ ++ ++ P+ + L+
Sbjct: 193 QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NPFYPRWLEKEAKDLLV 250
Query: 670 TCWAEEPEIR 679
+ EPE R
Sbjct: 251 KLFVREPEKR 260
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 5e-27
Identities = 57/220 (25%), Positives = 107/220 (48%), Gaps = 41/220 (18%)
Query: 437 IKKKIGEGSFGTVYHAEWR--NSDVAVK-ILIEQEFHEDRFKEFLREVAIMKGLR---HP 490
+++ G+G+FGTV + + VA+K + + RF+ RE+ IM+ L HP
Sbjct: 27 VERMAGQGTFGTVQLGKEKSTGMSVAIKKV-----IQDPRFR--NRELQIMQDLAVLHHP 79
Query: 491 NIVLLMGAVTEPPN--------LSIVTEYLSRGSLYKLL-HIPDARVVVDERL-RLNMAY 540
NIV L + L++V EY+ +L++ + +V L ++ + +
Sbjct: 80 NIVQLQ-SYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFL-F 136
Query: 541 DVAKGMNYLHQRRPPIVHRDLKSPNLLVD-STYTVKVCDFGLSRS----KPNT-YISSKT 594
+ + + LH + HRD+K N+LV+ + T+K+CDFG ++ +PN YI S+
Sbjct: 137 QLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSR- 195
Query: 595 AAGTPEWM-APEVLREDPSNEKS-DVFSFGVILWELITLQ 632
+ APE++ + + D++S G I E++ +
Sbjct: 196 ------YYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 60/217 (27%), Positives = 103/217 (47%), Gaps = 35/217 (16%)
Query: 440 KIGEGSFGTVYHAEWRNSD--VAVK-ILIEQEFHEDRFKE-F----LREVAIMKGLRHPN 491
KIG+G+FG V+ A R + VA+K +L+E E KE F LRE+ I++ L+H N
Sbjct: 24 KIGQGTFGEVFKARHRKTGQKVALKKVLMENE------KEGFPITALREIKILQLLKHEN 77
Query: 492 IVLLMGAVTEP--------PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVA 543
+V L+ ++ +V ++ L LL V + +
Sbjct: 78 VVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVL--VKFTLSEIKRVMQMLL 134
Query: 544 KGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPE--- 600
G+ Y+H+ + I+HRD+K+ N+L+ +K+ DFGL+R+ + +S+ T
Sbjct: 135 NGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLARAF-SLAKNSQPNRYTNRVVT 191
Query: 601 -WM-APEVLREDPS-NEKSDVFSFGVILWELITLQKP 634
W PE+L + D++ G I+ E+ T + P
Sbjct: 192 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSP 227
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-26
Identities = 60/224 (26%), Positives = 106/224 (47%), Gaps = 16/224 (7%)
Query: 422 YLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDV--AVKIL----IEQEFHEDRFK 475
+LE + + W + +G G FG V+ + + + A K L +++ ++
Sbjct: 176 WLEAQPMGEDWFLDF--RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKR---KGYQ 230
Query: 476 EFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSL-YKLLHIPDARVVVDE-R 533
+ E I+ + IV L A +L +V ++ G + Y + ++ + E R
Sbjct: 231 GAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPR 290
Query: 534 LRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSK 593
A + G+ +LHQR I++RDLK N+L+D V++ D GL+ +K
Sbjct: 291 AIFYTA-QIVSGLEHLHQRN--IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTK 347
Query: 594 TAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRN 637
AGTP +MAPE+L + + D F+ GV L+E+I + P+R
Sbjct: 348 GYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRA 391
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 64/241 (26%), Positives = 123/241 (51%), Gaps = 14/241 (5%)
Query: 434 ELLIKKKIGEGSFGTVYHAEWRNSDV-----AVKILIEQEFHEDRFKEFLREVAIMKGLR 488
ELL K +G+GSFG V+ + + A+K+L + E I+ +
Sbjct: 27 ELL--KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN 84
Query: 489 HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 548
HP IV L A L ++ ++L G L+ + + +E ++ +A ++A +++
Sbjct: 85 HPFIVKLHYAFQTEGKLYLILDFLRGGDLF--TRLSKEVMFTEEDVKFYLA-ELALALDH 141
Query: 549 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLR 608
LH I++RDLK N+L+D +K+ DFGLS+ + + + GT E+MAPEV+
Sbjct: 142 LHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN 199
Query: 609 EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI 668
+ +D +SFGV+++E++T P++ + ++ + +L +P+ ++P +L+
Sbjct: 200 RRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKA--KLGMPQFLSPEAQSLL 257
Query: 669 E 669
Sbjct: 258 R 258
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-26
Identities = 74/252 (29%), Positives = 129/252 (51%), Gaps = 17/252 (6%)
Query: 434 ELLIKKKIGEGSFGTVYHAEWRNSDV--AVKILIEQEFHEDRFKEFLR-EVAIM-KGLRH 489
L K IG+GSFG V A + +V AVK+L ++ + + ++ + E ++ K ++H
Sbjct: 41 HFL--KVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKH 98
Query: 490 PNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 549
P +V L + L V +Y++ G L+ H+ R ++ R R A ++A + YL
Sbjct: 99 PFLVGLHFSFQTADKLYFVLDYINGGELF--YHLQRERCFLEPRARFYAA-EIASALGYL 155
Query: 550 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAA--GTPEWMAPEVL 607
H IV+RDLK N+L+DS + + DFGL K N +S T+ GTPE++APEVL
Sbjct: 156 HSLN--IVYRDLKPENILLDSQGHIVLTDFGLC--KENIEHNSTTSTFCGTPEYLAPEVL 211
Query: 608 REDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAAL 667
+ P + D + G +L+E++ P+ + +++ + K L++ N+ L
Sbjct: 212 HKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK--PLQLKPNITNSARHL 269
Query: 668 IETCWAEEPEIR 679
+E ++ R
Sbjct: 270 LEGLLQKDRTKR 281
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 4e-26
Identities = 55/231 (23%), Positives = 97/231 (41%), Gaps = 29/231 (12%)
Query: 423 LEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVA 482
L E + K+G G++G VY A+ ++ ++Q RE+A
Sbjct: 11 LSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIA 70
Query: 483 IMKGLRHPNIVLLMGAVTEPPNLSI--VTEYLSRGSLYKLLHIPDARVVVDERLRLNMA- 539
+++ L+HPN++ L + + + +Y L+ ++ A + ++L
Sbjct: 71 LLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGM 129
Query: 540 -----YDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY----TVKVCDFGLSR--SKP-N 587
Y + G++YLH ++HRDLK N+LV VK+ D G +R + P
Sbjct: 130 VKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK 187
Query: 588 TYISSKTAAGTPE----WM-APEVLREDPSNEKS-DVFSFGVILWELITLQ 632
A P W APE+L K+ D+++ G I EL+T +
Sbjct: 188 PL-----ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 5e-26
Identities = 62/235 (26%), Positives = 116/235 (49%), Gaps = 11/235 (4%)
Query: 439 KKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLR-EVAIM-KGLRHPNIVL 494
+G+GSFG V +E + +D AVKIL + +D E E ++ + P +
Sbjct: 347 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 406
Query: 495 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 554
L L V EY++ G L HI + A ++A G+ +L +
Sbjct: 407 LHSCFQTMDRLYFVMEYVNGGDLM--YHIQQVGRFKEPHAVFYAA-EIAIGLFFLQSKG- 462
Query: 555 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNE 614
I++RDLK N+++DS +K+ DFG+ + +++KT GTP+++APE++ P +
Sbjct: 463 -IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGK 521
Query: 615 KSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE 669
D ++FGV+L+E++ Q P+ ++ ++ + PK+++ A+ +
Sbjct: 522 SVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH--NVAYPKSMSKEAVAICK 574
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 6e-26
Identities = 45/208 (21%), Positives = 73/208 (35%), Gaps = 58/208 (27%)
Query: 436 LIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNI 492
+ + +G G G V + + A+K+L + REV + + P+I
Sbjct: 21 VTSQVLGLGINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHI 73
Query: 493 VLLMGA----VTEPPNLSIVTEYLSRGSLY----KLLHIP----DARVVVDERLRLNMAY 540
V ++ L IV E L G L+ +A ++
Sbjct: 74 VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM---------K 124
Query: 541 DVAKGMNYLHQRRPPIVHRDLKSPNLLVDST---YTVKVCDFGLSRSKPNTYISSKTAAG 597
+ + + YLH I HRD+K NLL S +K+ DFG
Sbjct: 125 SIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGF---------------- 166
Query: 598 TPEWMAPEVLREDPSNEKSDVFSFGVIL 625
A E E ++ D++S GVI+
Sbjct: 167 -----AKETTGE-KYDKSCDMWSLGVIM 188
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 7e-26
Identities = 59/215 (27%), Positives = 108/215 (50%), Gaps = 15/215 (6%)
Query: 434 ELLIKKKIGEGSFGTVYHAEWRNSDV--AVKILIEQEFHE-DRFKEFLREVAIM-KGLRH 489
+LL + IG GS+ V + +D A+K++ ++ ++ + E + + H
Sbjct: 12 DLL--RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNH 69
Query: 490 PNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 549
P +V L L V EY++ G L + H+ R + +E R A +++ +NYL
Sbjct: 70 PFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSA-EISLALNYL 126
Query: 550 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAA--GTPEWMAPEVL 607
H+R I++RDLK N+L+DS +K+ D+G+ K T+ GTP ++APE+L
Sbjct: 127 HERG--IIYRDLKLDNVLLDSEGHIKLTDYGMC--KEGLRPGDTTSTFCGTPNYIAPEIL 182
Query: 608 REDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQ 642
R + D ++ GV+++E++ + P+ S
Sbjct: 183 RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 217
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 8e-26
Identities = 66/252 (26%), Positives = 116/252 (46%), Gaps = 17/252 (6%)
Query: 434 ELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLR-EVAIM-KGLRH 489
E + + +G+GSFG V A + + AVK+L + +D E E I+ H
Sbjct: 26 EFI--RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNH 83
Query: 490 PNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 549
P + L P L V E+++ G L HI +R + R R A ++ + +L
Sbjct: 84 PFLTQLFCCFQTPDRLFFVMEFVNGGDLM--FHIQKSRRFDEARARFYAA-EIISALMFL 140
Query: 550 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAA--GTPEWMAPEVL 607
H + I++RDLK N+L+D K+ DFG+ K TA GTP+++APE+L
Sbjct: 141 HDKG--IIYRDLKLDNVLLDHEGHCKLADFGMC--KEGICNGVTTATFCGTPDYIAPEIL 196
Query: 608 REDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAAL 667
+E D ++ GV+L+E++ P+ + A+ + P ++ +
Sbjct: 197 QEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND--EVVYPTWLHEDATGI 254
Query: 668 IETCWAEEPEIR 679
+++ + P +R
Sbjct: 255 LKSFMTKNPTMR 266
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 9e-26
Identities = 65/252 (25%), Positives = 119/252 (47%), Gaps = 17/252 (6%)
Query: 434 ELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHE-DRFKEFLREVAIM-KGLRH 489
L +G+GSFG V +E + +D AVKIL + + D + + E ++ +
Sbjct: 23 NFL--MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKP 80
Query: 490 PNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 549
P + L L V EY++ G L HI + A ++A G+ +L
Sbjct: 81 PFLTQLHSCFQTMDRLYFVMEYVNGGDLM--YHIQQVGRFKEPHAVFYAA-EIAIGLFFL 137
Query: 550 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAA--GTPEWMAPEVL 607
+ I++RDLK N+++DS +K+ DFG+ K N + T GTP+++APE++
Sbjct: 138 QSKG--IIYRDLKLDNVMLDSEGHIKIADFGMC--KENIWDGVTTKTFCGTPDYIAPEII 193
Query: 608 REDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAAL 667
P + D ++FGV+L+E++ Q P+ ++ ++ + PK+++ A+
Sbjct: 194 AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH--NVAYPKSMSKEAVAI 251
Query: 668 IETCWAEEPEIR 679
+ + P R
Sbjct: 252 CKGLMTKHPGKR 263
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 1e-25
Identities = 56/222 (25%), Positives = 99/222 (44%), Gaps = 15/222 (6%)
Query: 422 YLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDV--AVKIL----IEQEFHEDRFK 475
+LE + + + +G+G FG V + R + A K L I++
Sbjct: 175 WLERQPVTKNTFRQY--RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR---KGEA 229
Query: 476 EFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLR 535
L E I++ + +V L A L +V ++ G L ++ + R
Sbjct: 230 MALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAV 289
Query: 536 LNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTA 595
A ++ G+ LH+ R IV+RDLK N+L+D +++ D GL+ P + K
Sbjct: 290 FYAA-EICCGLEDLHRER--IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-TIKGR 345
Query: 596 AGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRN 637
GT +MAPEV++ + D ++ G +L+E+I Q P++
Sbjct: 346 VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQ 387
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-25
Identities = 58/215 (26%), Positives = 108/215 (50%), Gaps = 15/215 (6%)
Query: 434 ELLIKKKIGEGSFGTVYHAEWRNSDV--AVKILIEQEFHE-DRFKEFLREVAIM-KGLRH 489
+LL + IG GS+ V + +D A++++ ++ ++ + E + + H
Sbjct: 55 DLL--RVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNH 112
Query: 490 PNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 549
P +V L L V EY++ G L + H+ R + +E R A +++ +NYL
Sbjct: 113 PFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSA-EISLALNYL 169
Query: 550 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAA--GTPEWMAPEVL 607
H+R I++RDLK N+L+DS +K+ D+G+ K T+ GTP ++APE+L
Sbjct: 170 HERG--IIYRDLKLDNVLLDSEGHIKLTDYGMC--KEGLRPGDTTSTFCGTPNYIAPEIL 225
Query: 608 REDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQ 642
R + D ++ GV+++E++ + P+ S
Sbjct: 226 RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 260
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 60/236 (25%), Positives = 117/236 (49%), Gaps = 13/236 (5%)
Query: 437 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLR-EVAIMKGLRHPNIV 493
I + +G GSFG V+ R++ A+K+L ++ + E E ++ + HP I+
Sbjct: 10 ILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFII 69
Query: 494 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 553
+ G + + ++ +Y+ G L+ + ++ + + A +V + YLH +
Sbjct: 70 RMWGTFQDAQQIFMIMDYIEGGELF--SLLRKSQRFPNPVAKFYAA-EVCLALEYLHSKD 126
Query: 554 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSN 613
I++RDLK N+L+D +K+ DFG ++ P+ + T GTP+++APEV+ P N
Sbjct: 127 --IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---TYTLCGTPDYIAPEVVSTKPYN 181
Query: 614 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE 669
+ D +SFG++++E++ P+ +S + + L P N V L+
Sbjct: 182 KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA--ELRFPPFFNEDVKDLLS 235
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-25
Identities = 57/205 (27%), Positives = 99/205 (48%), Gaps = 14/205 (6%)
Query: 439 KKIGEGSFGTVYHAEWRNSDV--AVKIL----IEQEFHEDRFKEFLREVAIMKGLRHPNI 492
+ IG G FG VY ++ A+K L I+ + E ++++ P I
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 254
Query: 493 VLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 552
V + A P LS + + ++ G L+ H+ V + +R A ++ G+ ++H R
Sbjct: 255 VCMSYAFHTPDKLSFILDLMNGGDLH--YHLSQHGVFSEADMRFYAA-EIILGLEHMHNR 311
Query: 553 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPS 612
+V+RDLK N+L+D V++ D GL+ + GT +MAPEVL++ +
Sbjct: 312 F--VVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVGTHGYMAPEVLQKGVA 367
Query: 613 NEKS-DVFSFGVILWELITLQKPWR 636
+ S D FS G +L++L+ P+R
Sbjct: 368 YDSSADWFSLGCMLFKLLRGHSPFR 392
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 30/250 (12%), Positives = 70/250 (28%), Gaps = 42/250 (16%)
Query: 440 KIGEGSFGTVYHA--EWRNSDVAVKILIEQEFHEDRFKE-FLREVAIMKGLRHPNIVLLM 496
G + A + VA+ + Q D + L + + P + ++
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97
Query: 497 GAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPI 556
V +V E++ GSL ++ D +R +A + H+ +
Sbjct: 98 DVVHTRAGGLVVAEWIRGGSLQEVA---DTSPSPVGAIR--AMQSLAAAADAAHRA--GV 150
Query: 557 VHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKS 616
+ V V + +N +
Sbjct: 151 ALSIDHPSRVRVSIDGDVVLAYPATMP---------------------------DANPQD 183
Query: 617 DVFSFGVILWELITLQKPWRNSTPSQVISAVGF-KGRRLEIPKNVNPMV----AALIETC 671
D+ G L+ L+ + P + ++ + P +++ + +A+
Sbjct: 184 DIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARS 243
Query: 672 WAEEPEIRPS 681
+ IR +
Sbjct: 244 VQGDGGIRSA 253
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 63/247 (25%), Positives = 121/247 (48%), Gaps = 24/247 (9%)
Query: 434 ELLIKKKIGEGSFGTVY---HAEWRNSDV--AVKIL----IEQEFHEDRFKEFLREVAIM 484
ELL + +G+G +G V+ N+ A+K+L I + + E I+
Sbjct: 20 ELL--RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVR--NAKDTAHTKAERNIL 75
Query: 485 KGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAK 544
+ ++HP IV L+ A L ++ EYLS G L+ + + + +++ +A +++
Sbjct: 76 EEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELF--MQLEREGIFMEDTACFYLA-EISM 132
Query: 545 GMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAA--GTPEWM 602
+ +LHQ+ I++RDLK N++++ VK+ DFGL K + + + T GT E+M
Sbjct: 133 ALGHLHQKG--IIYRDLKPENIMLNHQGHVKLTDFGLC--KESIHDGTVTHTFCGTIEYM 188
Query: 603 APEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNP 662
APE+L N D +S G ++++++T P+ + I + +L +P +
Sbjct: 189 APEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC--KLNLPPYLTQ 246
Query: 663 MVAALIE 669
L++
Sbjct: 247 EARDLLK 253
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 47/211 (22%), Positives = 87/211 (41%), Gaps = 24/211 (11%)
Query: 437 IKKKIGEGSFGTVYHA-EWRNSDVAVKILIEQEFHEDRFKEF---------LREVAIMKG 486
+++ I GS+G V + VA+K + LRE+ ++
Sbjct: 26 VQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNH 85
Query: 487 LRHPNIVLLMGAVTEPPNLS------IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAY 540
HPNI+ L +VTE + L +++H V+ + ++ M Y
Sbjct: 86 FHHPNILGLRDIFV-HFEEPAMHKLYLVTELMRT-DLAQVIHDQRI-VISPQHIQYFM-Y 141
Query: 541 DVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPE 600
+ G++ LH+ +VHRDL N+L+ + +CDF L+R +
Sbjct: 142 HILLGLHVLHEAG--VVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVT-HRW 198
Query: 601 WMAPEVLREDPSNEKS-DVFSFGVILWELIT 630
+ APE++ + K D++S G ++ E+
Sbjct: 199 YRAPELVMQFKGFTKLVDMWSAGCVMAEMFN 229
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 54/211 (25%), Positives = 104/211 (49%), Gaps = 33/211 (15%)
Query: 437 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIV 493
+ +K+G G + V+ A ++ V VKIL + K+ RE+ I++ LR PNI+
Sbjct: 40 LVRKLGRGKYSEVFEAINITNNEKVVVKIL-----KPVKKKKIKREIKILENLRGGPNII 94
Query: 494 LLMGAVTEPP--NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ 551
L V +P ++V E+++ +L + D +R M Y++ K ++Y H
Sbjct: 95 TLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYM-YEILKALDYCHS 148
Query: 552 RRPPIVHRDLKSPNLLVDSTY-TVKVCDFGLSRSKP-----NTYISSKTAAGTPEWM-AP 604
I+HRD+K N+++D + +++ D+GL+ N ++S+ + P
Sbjct: 149 MG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASR-------YFKGP 199
Query: 605 EVLREDPSNEKS-DVFSFGVILWELITLQKP 634
E+L + + S D++S G +L +I ++P
Sbjct: 200 ELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 7e-24
Identities = 59/214 (27%), Positives = 100/214 (46%), Gaps = 30/214 (14%)
Query: 437 IKKKIGEGSFGTVYHA--EWRNSDVAVKILIEQEFHEDRF-KEFLREVAIMKGLRHPNIV 493
+K +GEG++G V A + VA+K + + F + F LRE+ I+K +H NI+
Sbjct: 15 LKSLLGEGAYGVVCSATHKPTGEIVAIKKI--EPFDKPLFALRTLREIKILKHFKHENII 72
Query: 494 LLMGAVTEPPNLS------IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 547
+ P + I+ E + L++++ +++ D+ ++ + Y + +
Sbjct: 73 TIFNIQR-PDSFENFNEVYIIQELMQT-DLHRVIS---TQMLSDDHIQYFI-YQTLRAVK 126
Query: 548 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWM----- 602
LH ++HRDLK NLL++S +KVCDFGL+R + + G M
Sbjct: 127 VLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVA 184
Query: 603 -----APEVLREDPS-NEKSDVFSFGVILWELIT 630
APEV+ + DV+S G IL EL
Sbjct: 185 TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL 218
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 60/201 (29%), Positives = 100/201 (49%), Gaps = 19/201 (9%)
Query: 439 KKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRF-KEFLREVAIMKGLRHPNIVLL 495
K IG G+ G V A +VA+K + + F K RE+ +MK + H NI+ L
Sbjct: 31 KPIGSGAQGIVCAAYDAILERNVAIK-KLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 89
Query: 496 MGAVTEPPNLS------IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 549
+ T +L IV E + +L +++ + + ER+ + Y + G+ +L
Sbjct: 90 LNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQME----LDHERMSYLL-YQMLCGIKHL 143
Query: 550 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRE 609
H I+HRDLK N++V S T+K+ DFGL+R+ +++ + T + APEV+
Sbjct: 144 HSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRAPEVILG 200
Query: 610 DPSNEKSDVFSFGVILWELIT 630
E D++S G I+ E+I
Sbjct: 201 MGYKENVDIWSVGCIMGEMIK 221
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 4e-23
Identities = 64/238 (26%), Positives = 108/238 (45%), Gaps = 40/238 (16%)
Query: 437 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRF-KEFLREVAIMKGLRHPNIV 493
IK IG GS+G VY A +N++ VA+K + + F + K LRE+ I+ L+ I+
Sbjct: 30 IKHLIGRGSYGYVYLAYDKNTEKNVAIK-KVNRMFEDLIDCKRILREITILNRLKSDYII 88
Query: 494 LLMGAVTEPPNLS------IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 547
L + P +L IV E L KL P + +E ++ + Y++ G N
Sbjct: 89 RLY-DLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIF--LTEEHIKTIL-YNLLLGEN 143
Query: 548 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWM----- 602
++H+ I+HRDLK N L++ +VKVCDFGL+R+ + ++
Sbjct: 144 FIHESG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHN 201
Query: 603 -----------------APEVLREDPS-NEKSDVFSFGVILWELITLQKPWRNSTPSQ 642
APE++ + + D++S G I EL+ + + N ++
Sbjct: 202 KNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNR 259
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-23
Identities = 60/247 (24%), Positives = 102/247 (41%), Gaps = 69/247 (27%)
Query: 437 IKKKIGEGSFGTVYHAEWR--NSDVAVK-ILIEQEFHEDRFKEFLREVAIMKGLRHPNIV 493
+ K +G GSFG V A+K +L + R+K RE+ IMK L H NI+
Sbjct: 11 LGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP-----RYK--NRELDIMKVLDHVNII 63
Query: 494 LL--------------------------------MGAVTEPPN------LSIVTEYLSRG 515
L + N L+++ EY+
Sbjct: 64 KLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-D 122
Query: 516 SLYKLL-HIPDARVVV-DERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS-TY 572
+L+K+L + + + + + Y + + + ++H I HRD+K NLLV+S
Sbjct: 123 TLHKVLKSFIRSGRSIPMNLISIYI-YQLFRAVGFIHSLG--ICHRDIKPQNLLVNSKDN 179
Query: 573 TVKVCDFGLSRS----KPNT-YISSKTAAGTPEWM-APEVLREDPS-NEKSDVFSFGVIL 625
T+K+CDFG ++ +P+ YI S+ + APE++ D++S G +
Sbjct: 180 TLKLCDFGSAKKLIPSEPSVAYICSR-------FYRAPELMLGATEYTPSIDLWSIGCVF 232
Query: 626 WELITLQ 632
ELI +
Sbjct: 233 GELILGK 239
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 5e-23
Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 29/208 (13%)
Query: 437 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRF-KEFLREVAIMKGLRHPNIV 493
K IG G+ G V A D VA+K + + F K RE+ +MK + H NI+
Sbjct: 66 NLKPIGSGAQGIVCAAYDAVLDRNVAIK-KLSRPFQNQTHAKRAYRELVLMKCVNHKNII 124
Query: 494 LLMGAVTEPPNLS------IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 547
L+ T L +V E + +L +++ + + ER+ + Y + G+
Sbjct: 125 SLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQME----LDHERMSYLL-YQMLCGIK 178
Query: 548 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWM----- 602
+LH I+HRDLK N++V S T+K+ DFGL+R+ +++ TP +
Sbjct: 179 HLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM------TPYVVTRYYR 230
Query: 603 APEVLREDPSNEKSDVFSFGVILWELIT 630
APEV+ E D++S G I+ E++
Sbjct: 231 APEVILGMGYKENVDIWSVGCIMGEMVR 258
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 8e-23
Identities = 62/242 (25%), Positives = 102/242 (42%), Gaps = 45/242 (18%)
Query: 437 IKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRF-KEFLREVAIMKGLRHPNIV 493
I+ IG GS+G V A + VA+K I + F + K LRE+AI+ L H ++V
Sbjct: 57 IRHLIGTGSYGHVCEAYDKLEKRVVAIK-KILRVFEDLIDCKRILREIAILNRLNHDHVV 115
Query: 494 LLMGAVTEPPNLS------IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 547
++ + P ++ +V E KL P + + ++ + Y++ G+
Sbjct: 116 KVL-DIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVY--LTELHIKTLL-YNLLVGVK 170
Query: 548 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWM----- 602
Y+H I+HRDLK N LV+ +VKVCDFGL+R+ + +P
Sbjct: 171 YVHSAG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLV 228
Query: 603 ----------------------APEVLREDPSNEKS-DVFSFGVILWELITLQKPWRNST 639
APE++ + ++ DV+S G I EL+ + K
Sbjct: 229 TFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYH 288
Query: 640 PS 641
Sbjct: 289 AD 290
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-22
Identities = 57/233 (24%), Positives = 111/233 (47%), Gaps = 31/233 (13%)
Query: 414 MSTSNRELYLEEEGLEIRW---SELLIKKKIGEGSFGTVYHA--EWRNSDVAVKILIEQE 468
+S ++ + +++ + W + +G G++G+V A + VA+K L
Sbjct: 2 LSLIRKKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF 61
Query: 469 FHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS------IVTEYLSRGSLYKLLH 522
E K RE+ ++K ++H N++ L+ T +L +V ++ L K++
Sbjct: 62 QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMG 120
Query: 523 IPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS 582
+ +E+++ + Y + KG+ Y+H +VHRDLK NL V+ +K+ DFGL+
Sbjct: 121 LK----FSEEKIQYLV-YQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLA 173
Query: 583 RSKPNT---YISSKTAAGTPEW-MAPEVLREDPSNEKS-DVFSFGVILWELIT 630
R Y+ ++ W APEV+ ++ D++S G I+ E++T
Sbjct: 174 RHADAEMTGYVVTR-------WYRAPEVILSWMHYNQTVDIWSVGCIMAEMLT 219
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 2e-22
Identities = 55/207 (26%), Positives = 100/207 (48%), Gaps = 27/207 (13%)
Query: 437 IKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRF-KEFLREVAIMKGLRHPNIV 493
+G G++G+V A VAVK + + F K RE+ ++K ++H N++
Sbjct: 33 NLSPVGSGAYGSVCAAFDTKTGLRVAVKK-LSRPFQSIIHAKRTYRELRLLKHMKHENVI 91
Query: 494 LLMGAVTEPPNLS------IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 547
L+ T +L +VT + L ++ + + D+ ++ + Y + +G+
Sbjct: 92 GLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVK---CQKLTDDHVQFLI-YQILRGLK 146
Query: 548 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT---YISSKTAAGTPEWMAP 604
Y+H I+HRDLK NL V+ +K+ DFGL+R + Y++ T + AP
Sbjct: 147 YIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVA------TRWYRAP 198
Query: 605 EVLREDPS-NEKSDVFSFGVILWELIT 630
E++ N+ D++S G I+ EL+T
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLT 225
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 8e-22
Identities = 58/206 (28%), Positives = 103/206 (50%), Gaps = 29/206 (14%)
Query: 439 KKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRF-KEFLREVAIMKGLRHPNIVLL 495
+ +G G++G V A + VA+K + + F + F K RE+ ++K +RH N++ L
Sbjct: 31 QPVGSGAYGAVCSAVDGRTGAKVAIK-KLYRPFQSELFAKRAYRELRLLKHMRHENVIGL 89
Query: 496 MGAVTEPPNLS------IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 549
+ T L +V ++ L KL+ + ++R++ + Y + KG+ Y+
Sbjct: 90 LDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMK---HEKLGEDRIQFLV-YQMLKGLRYI 144
Query: 550 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT---YISSKTAAGTPEWM-APE 605
H I+HRDLK NL V+ +K+ DFGL+R + Y+ ++ W APE
Sbjct: 145 HAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTR-------WYRAPE 195
Query: 606 VLREDPSNEKS-DVFSFGVILWELIT 630
V+ ++ D++S G I+ E+IT
Sbjct: 196 VILNWMRYTQTVDIWSVGCIMAEMIT 221
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 2e-21
Identities = 60/261 (22%), Positives = 118/261 (45%), Gaps = 44/261 (16%)
Query: 434 ELLIKKKIGEGSFGTVYHAEWRNSDV-----AVKIL-----------IEQEFHEDRFKEF 477
ELL K +G G++G V+ + A+K+L E E ++
Sbjct: 57 ELL--KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTE---RQV 111
Query: 478 LREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLN 537
L + + P +V L A L ++ +Y++ G L+ H+ + +++
Sbjct: 112 LEHIR-----QSPFLVTLHYAFQTETKLHLILDYINGGELF--THLSQRERFTEHEVQIY 164
Query: 538 MAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAA- 596
+ ++ + +LH+ I++RD+K N+L+DS V + DFGL SK ++ A
Sbjct: 165 VG-EIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGL--SKEFVADETERAYD 219
Query: 597 --GTPEWMAPEVLREDPSNEKSDV--FSFGVILWELITLQKPW----RNSTPSQVISAVG 648
GT E+MAP+++R S V +S GV+++EL+T P+ ++ +++ +
Sbjct: 220 FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL 279
Query: 649 FKGRRLEIPKNVNPMVAALIE 669
P+ ++ + LI+
Sbjct: 280 KS--EPPYPQEMSALAKDLIQ 298
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 6e-21
Identities = 59/223 (26%), Positives = 98/223 (43%), Gaps = 38/223 (17%)
Query: 437 IKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRF-KEFLREVAIMKGLR-HPNI 492
+ KK+G+G++G V+ + R VAVK I F + RE+ I+ L H NI
Sbjct: 13 LVKKLGKGAYGIVWKSIDRRTGEVVAVK-KIFDAFQNSTDAQRTFREIMILTELSGHENI 71
Query: 493 VLLMGAVTEPPNLS---IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 549
V L+ + N +V +Y+ L+ ++ A ++ + + Y + K + YL
Sbjct: 72 VNLLNVLR-ADNDRDVYLVFDYME-TDLHAVIR---ANILEPVHKQYVV-YQLIKVIKYL 125
Query: 550 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWM------- 602
H ++HRD+K N+L+++ VKV DFGLSRS N + +
Sbjct: 126 HSGG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDD 183
Query: 603 --------------APEVLREDPS-NEKSDVFSFGVILWELIT 630
APE+L + D++S G IL E++
Sbjct: 184 QPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILC 226
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 1e-20
Identities = 56/216 (25%), Positives = 98/216 (45%), Gaps = 32/216 (14%)
Query: 437 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRF-KEFLREVAIMKGLRHPNIV 493
K +G G G V+ A + D VA+K ++ + + K LRE+ I++ L H NIV
Sbjct: 15 DLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV---LTDPQSVKHALREIKIIRRLDHDNIV 71
Query: 494 LLMGAVTEPPNLS--------------IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMA 539
+ + + IV EY+ L +L +++E RL M
Sbjct: 72 KVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLE---QGPLLEEHARLFM- 126
Query: 540 YDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST-YTVKVCDFGLSRSKPNTYISSKTAAG- 597
Y + +G+ Y+H ++HRDLK NL +++ +K+ DFGL+R Y +
Sbjct: 127 YQLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEG 184
Query: 598 --TPEWMAPEVLREDPS-NEKSDVFSFGVILWELIT 630
T + +P +L + + D+++ G I E++T
Sbjct: 185 LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLT 220
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 2e-20
Identities = 57/218 (26%), Positives = 101/218 (46%), Gaps = 38/218 (17%)
Query: 437 IKKKIGEGSFGTVYHA--EWRNSDVAVKILIEQEFHEDRF-KEFLREVAIMKGLRHPNIV 493
IGEG++G V A VA+K + F + + LRE+ I+ RH NI+
Sbjct: 31 NLSYIGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 494 LLMGAVTEPPNLS------IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 547
+ + P + IV + + LYKLL + + ++ + + Y + +G+
Sbjct: 89 GINDIIR-APTIEQMKDVYIVQDLME-TDLYKLLK---TQHLSNDHICYFL-YQILRGLK 142
Query: 548 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWM----- 602
Y+H ++HRDLK NLL+++T +K+CDFGL+R + ++
Sbjct: 143 YIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLAR-------VADPDHDHTGFLTEYVA 193
Query: 603 -----APEVLREDPS-NEKSDVFSFGVILWELITLQKP 634
APE++ + D++S G IL E+++ +P
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS-NRP 230
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 9e-19
Identities = 49/221 (22%), Positives = 101/221 (45%), Gaps = 40/221 (18%)
Query: 437 IKKKIGEGSFGTVYHAE--WRNSDVAVKILIEQE-FHEDRFKEFLREVAIMKGLR----- 488
+ +K+G G F TV+ A+ N+ VA+KI+ + + E E+ +++ +
Sbjct: 23 LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE----AAEDEIKLLQRVNDADNT 78
Query: 489 ------HPNIVLLMGAVT----EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNM 538
+I+ L+ ++ +V E L +L L+ + R + ++ +
Sbjct: 79 KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIKKYEHRGIPLIYVK-QI 136
Query: 539 AYDVAKGMNYLHQRRPPIVHRDLKSPNLLVD------STYTVKVCDFGLSRSKPN---TY 589
+ + G++Y+H RR I+H D+K N+L++ + +K+ D G +
Sbjct: 137 SKQLLLGLDYMH-RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS 195
Query: 590 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT 630
I ++ E+ +PEVL P +D++S +++ELIT
Sbjct: 196 IQTR------EYRSPEVLLGAPWGCGADIWSTACLIFELIT 230
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 2e-18
Identities = 62/240 (25%), Positives = 108/240 (45%), Gaps = 32/240 (13%)
Query: 410 NLSVMSTSNRELYLEEEG-LEIRWSELL-----IKKKIGEGSFGTVYHA--EWRNSDVAV 461
+ N Y +++G + + + K IG+GSFG V A + VA+
Sbjct: 68 RQGMTGGPNNGGYDDDQGSYVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVAL 127
Query: 462 KILIEQEFHEDRFKEFLREVAIMKGLRH------PNIVLLMGAVTEPPNLSIVTEYLSRG 515
K++ + ++ E+ I++ LR N++ ++ T ++ + E LS
Sbjct: 128 KMVRN---EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSM- 183
Query: 516 SLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPN-LLVDSTYT- 573
+LY+L+ + +R A+ + + ++ LH+ R I+H DLK N LL +
Sbjct: 184 NLYELIKKNKFQGFSLPLVR-KFAHSILQCLDALHKNR--IIHCDLKPENILLKQQGRSG 240
Query: 574 VKVCDFGLS---RSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT 630
+KV DFG S + TYI S+ + APEV+ D++S G IL EL+T
Sbjct: 241 IKVIDFGSSCYEHQRVYTYIQSRF------YRAPEVILGARYGMPIDMWSLGCILAELLT 294
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 7e-18
Identities = 60/207 (28%), Positives = 89/207 (42%), Gaps = 24/207 (11%)
Query: 437 IKKKIGEGSFGTVYHAEW--RNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHP---- 490
I IG+GSFG V A VA+KI+ + + EV +++ +
Sbjct: 58 IDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN---KKAFLNQAQIEVRLLELMNKHDTEM 114
Query: 491 --NIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 548
IV L +L +V E LS +LY LL + R V R A + + +
Sbjct: 115 KYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTR-KFAQQMCTALLF 172
Query: 549 LHQRRPPIVHRDLKSPN-LLVDSTYT-VKVCDFGLS---RSKPNTYISSKTAAGTPEWMA 603
L I+H DLK N LL + + +K+ DFG S + YI S+ + +
Sbjct: 173 LATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF------YRS 226
Query: 604 PEVLREDPSNEKSDVFSFGVILWELIT 630
PEVL P + D++S G IL E+ T
Sbjct: 227 PEVLLGMPYDLAIDMWSLGCILVEMHT 253
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 78.0 bits (191), Expect = 1e-15
Identities = 38/202 (18%), Positives = 68/202 (33%), Gaps = 48/202 (23%)
Query: 430 IRWSELL------IKKKIGEGSFGTVYHAEWRNSDVAVKIL------IEQEFHEDRFKEF 477
+ +S L +KIGEG FG V+ ++ VA+KI+ + H+ F+E
Sbjct: 11 VPFSHCLPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEI 70
Query: 478 LREVAIMKGL---------RHPNIVLLMGAV----TEPPNLSIVTEY------------- 511
L E+ I K L R + L + PP L ++
Sbjct: 71 LPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPD 130
Query: 512 -LSRGSLYKLLHIPDA--------RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLK 562
L+ +L + ++ + + + + + HRDL
Sbjct: 131 FFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASL-AVAEASLRFEHRDLH 189
Query: 563 SPNLLVDSTYTVKVCDFGLSRS 584
N+L+ T K+ +S
Sbjct: 190 WGNVLLKKTSLKKLHYTLNGKS 211
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 54/238 (22%), Positives = 94/238 (39%), Gaps = 66/238 (27%)
Query: 437 IKKKIGEGSFGTVYHA--EWRNSDVAVKILI-EQEFHEDRFKEFLREVAIMKGLRH---- 489
+ +K+G+G+FG V AVK++ +++ E I+K +++
Sbjct: 39 VIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA----KIEADILKKIQNDDIN 94
Query: 490 -PNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL--------HIPDARVVVDERLRLNMAY 540
NIV G ++ ++ E L SLY+++ HI D +
Sbjct: 95 NNNIVKYHGKFMYYDHMCLIFEPLGP-SLYEIITRNNYNGFHIEDIK---------LYCI 144
Query: 541 DVAKGMNYLHQRRPPIVHRDLKSPN-LLVDSTYT------------------------VK 575
++ K +NYL + + H DLK N LL D + +K
Sbjct: 145 EILKALNYLRKMS--LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIK 202
Query: 576 VCDFG---LSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT 630
+ DFG + I+++ + APEV+ + SD++SFG +L EL T
Sbjct: 203 LIDFGCATFKSDYHGSIINTRQ------YRAPEVILNLGWDVSSDMWSFGCVLAELYT 254
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 5e-15
Identities = 52/234 (22%), Positives = 91/234 (38%), Gaps = 62/234 (26%)
Query: 437 IKKKIGEGSFGTVYHA---EWRNSDVAVKILI-EQEFHEDRFKEFLREVAIMKGLRHP-- 490
I +GEG+FG V S VA+KI+ ++ E E+ ++K ++
Sbjct: 23 IVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA----RLEINVLKKIKEKDK 78
Query: 491 ----NIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL--------HIPDARVVVDERLRLNM 538
VL+ ++ I E L + + ++ L +P R +M
Sbjct: 79 ENKFLCVLMSDWFNFHGHMCIAFELLGK-NTFEFLKENNFQPYPLPHVR---------HM 128
Query: 539 AYDVAKGMNYLHQRRPPIVHRDLKSPN-LLVDSTYT------------------VKVCDF 579
AY + + +LH+ + + H DLK N L V+S + ++V DF
Sbjct: 129 AYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADF 186
Query: 580 G---LSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT 630
G T ++++ + PEV+ E + DV+S G IL+E
Sbjct: 187 GSATFDHEHHTTIVATRH------YRPPEVILELGWAQPCDVWSIGCILFEYYR 234
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 6e-15
Identities = 58/234 (24%), Positives = 88/234 (37%), Gaps = 62/234 (26%)
Query: 437 IKKKIGEGSFGTVYHA---EWRNSDVAVKILI-EQEFHEDRFKEFLREVAIMKGLRHP-- 490
I +GEG+FG V + VAVKI+ + E E+ +++ L
Sbjct: 18 IVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA----RSEIQVLEHLNTTDP 73
Query: 491 ----NIVLLMGAVTEPPNLSIVTEYLSRGSLYKLL--------HIPDARVVVDERLRLNM 538
V ++ ++ IV E L S Y + + R M
Sbjct: 74 NSTFRCVQMLEWFEHHGHICIVFELLGL-STYDFIKENGFLPFRLDHIR---------KM 123
Query: 539 AYDVAKGMNYLHQRRPPIVHRDLKSPN-LLVDSTYT------------------VKVCDF 579
AY + K +N+LH + + H DLK N L V S YT +KV DF
Sbjct: 124 AYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDF 181
Query: 580 G---LSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT 630
G +T +S++ + APEV+ ++ DV+S G IL E
Sbjct: 182 GSATYDDEHHSTLVSTRH------YRAPEVILALGWSQPCDVWSIGCILIEYYL 229
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 50/259 (19%), Positives = 93/259 (35%), Gaps = 76/259 (29%)
Query: 437 IKKKIGEGSFGTVYHAE--WRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR-----H 489
+ +K+G G F TV+ + VA+K++ E + + E+ ++K +R
Sbjct: 41 VIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETAL---DEIRLLKSVRNSDPND 97
Query: 490 PN---IVLLMGAVTEP-PN---LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDV 542
PN +V L+ N + +V E L L K + + + + ++ + V
Sbjct: 98 PNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVK-KIIQQV 155
Query: 543 AKGMNYLHQRRPPIVHRDLKSPNLLV---------------------------------- 568
+G++YLH + I+H D+K N+L+
Sbjct: 156 LQGLDYLH-TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAP 214
Query: 569 ---------------DSTYTVKVCDFGLSR--SKPNTYISSKTAAGTPEWMAPEVLREDP 611
VK+ D G + K T T ++ + EVL
Sbjct: 215 ATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ-----TRQYRSLEVLIGSG 269
Query: 612 SNEKSDVFSFGVILWELIT 630
N +D++S + +EL T
Sbjct: 270 YNTPADIWSTACMAFELAT 288
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 49/218 (22%), Positives = 83/218 (38%), Gaps = 30/218 (13%)
Query: 437 IKKKIGEGSFGTVYHAE--WRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRH-PNIV 493
+ +KIG GSFG +Y +VA+K E + + + E I K ++ I
Sbjct: 13 LGRKIGSGSFGDIYLGTDIAAGEEVAIK----LECVKTKHPQLHIESKIYKMMQGGVGIP 68
Query: 494 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 553
+ E +V E L SL L + + + L L A + + Y+H +
Sbjct: 69 TIRWCGAEGDYNVMVMELLGP-SLEDLFNFCSRKFSLKTVLLL--ADQMISRIEYIHSKN 125
Query: 554 PPIVHRDLKSPNLLV---DSTYTVKVCDFGLSRSKPNTYISSKTA-----------AGTP 599
+HRD+K N L+ V + DFGL++ Y ++T GT
Sbjct: 126 --FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK----YRDARTHQHIPYRENKNLTGTA 179
Query: 600 EWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRN 637
+ + + + D+ S G +L PW+
Sbjct: 180 RYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQG 217
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 38/227 (16%), Positives = 77/227 (33%), Gaps = 28/227 (12%)
Query: 437 IKKKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 495
+ IG+G FG +Y A+ +S V + E+ + P +
Sbjct: 39 VGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQK 98
Query: 496 MGAVTEPPNLSIVTEYLS-----RGSLYKLLHIP-------DARVVVDERLRLNMAYDVA 543
+ L + + S G Y+ + + +R ++
Sbjct: 99 WIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLS 158
Query: 544 KGM----NYLHQRRPPIVHRDLKSPNLLVDSTYTVKV--CDFGLSRS-------KPNTYI 590
+ Y+H+ VH D+K+ NLL++ +V D+GL+ K
Sbjct: 159 LRILDILEYIHEHE--YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAAD 216
Query: 591 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRN 637
+ GT E+ + + + + D+ G + + +T PW +
Sbjct: 217 PKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWED 263
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 6e-09
Identities = 50/226 (22%), Positives = 85/226 (37%), Gaps = 44/226 (19%)
Query: 437 IKKKIGEGSFGTVYHAE--WRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRH-PNIV 493
+ KKIG G+FG + + + N VA+K+ E + R + E K L I
Sbjct: 13 VGKKIGCGNFGELRLGKNLYTNEYVAIKL----EPMKSRAPQLHLEYRFYKQLGSGDGIP 68
Query: 494 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM----NYL 549
+ ++V E L SL L + D L +A + Y+
Sbjct: 69 QVYYFGPCGKYNAMVLELLGP-SLEDLFDL------CDRTFSLKTVLMIAIQLISRMEYV 121
Query: 550 HQRRPPIVHRDLKSPNLLV-----DSTYTVKVCDFGLSRS--KPNT-----YISSKTAAG 597
H + +++RD+K N L+ + + + DF L++ P T Y K+ G
Sbjct: 122 HSKN--LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTG 179
Query: 598 TPEWMAP------EVLREDPSNEKSDVFSFGVILWELITLQKPWRN 637
T +M+ E R D D+ + G + + PW+
Sbjct: 180 TARYMSINTHLGKEQSRRD------DLEALGHMFMYFLRGSLPWQG 219
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 46/224 (20%), Positives = 80/224 (35%), Gaps = 40/224 (17%)
Query: 437 IKKKIGEGSFGTVYHAE--WRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRH-PNIV 493
+ ++IGEGSFG ++ N VA+K E + E K L I
Sbjct: 14 VGRRIGEGSFGVIFEGTNLLNNQQVAIK----FEPRRSDAPQLRDEYRTYKLLAGCTGIP 69
Query: 494 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM----NYL 549
+ E + +V + L SL LL + + + AK M +
Sbjct: 70 NVYYFGQEGLHNVLVIDLLGP-SLEDLLDL------CGRKFSVKTVAMAAKQMLARVQSI 122
Query: 550 HQRRPPIVHRDLKSPNLLVDSTYT-----VKVCDFGLSRSKPNTYISSKTAA-------- 596
H++ +V+RD+K N L+ + + V DFG+ + Y T
Sbjct: 123 HEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF----YRDPVTKQHIPYREKK 176
Query: 597 ---GTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRN 637
GT +M+ + + D+ + G + + PW+
Sbjct: 177 NLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQG 220
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 51/218 (23%), Positives = 86/218 (39%), Gaps = 30/218 (13%)
Query: 437 IKKKIGEGSFGTVYHAE--WRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIV 493
+ +KIG GSFG +Y N +VA+K E + + + L E I + L+ I
Sbjct: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIK----LENVKTKHPQLLYESKIYRILQGGTGIP 66
Query: 494 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM----NYL 549
+ E +V + L SL L + +L L +A M ++
Sbjct: 67 NVRWFGVEGDYNVLVMDLLGP-SLEDLFNF------CSRKLSLKTVLMLADQMINRVEFV 119
Query: 550 HQRRPPIVHRDLKSPNLLV---DSTYTVKVCDFGLSRS--KPNT-----YISSKTAAGTP 599
H + +HRD+K N L+ V + DFGL++ +T Y +K GT
Sbjct: 120 HSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTA 177
Query: 600 EWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRN 637
+ + + + D+ S G +L + PW+
Sbjct: 178 RYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 6e-08
Identities = 36/194 (18%), Positives = 66/194 (34%), Gaps = 32/194 (16%)
Query: 437 IKKKIGEGSFGTVYHAE----------WRNSDVAVKI-------LIEQEFHEDRFKEF-L 478
+K + G +Y A + ++K+ EQ F + K +
Sbjct: 46 LKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQV 105
Query: 479 REVAIMKGLRHPNIVLLMG-AVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLN 537
+ + I MG V + +V L R SL L + + V+ ER L
Sbjct: 106 NKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQSALDVSP-KHVLSERSVLQ 163
Query: 538 MAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKV--CDFGLSRS-------KPNT 588
+A + + +LH+ VH ++ + N+ VD +V +G +
Sbjct: 164 VACRLLDALEFLHENE--YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYV 221
Query: 589 YISSKTAAGTPEWM 602
S G E++
Sbjct: 222 EGSRSPHEGDLEFI 235
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 7e-08
Identities = 44/193 (22%), Positives = 72/193 (37%), Gaps = 33/193 (17%)
Query: 437 IKKKIGEGSFGTVYHAE--WRNSDVAVKIL-IE-----QEFHEDRFKEFLREVAIMKGLR 488
+ KKIG G FG +Y A + A ++ +E F E +F + + + +K
Sbjct: 41 LGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWI 100
Query: 489 HPNIVLLMG-------AVTEPPNLS---IVTEYLSRGSLYKLLHIPDARVVVDERLRLNM 538
+ +G +TE S +V E L L K+ + L +
Sbjct: 101 ERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGI-DLQKIS---GQNGTFKKSTVLQL 156
Query: 539 AYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKV--CDFGLSRS-------KPNTY 589
+ + Y+H+ VH D+K+ NLL+ +V D+GLS K
Sbjct: 157 GIRMLDVLEYIHENE--YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQE 214
Query: 590 ISSKTAAGTPEWM 602
K GT E+
Sbjct: 215 NPRKGHNGTIEFT 227
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.8 bits (110), Expect = 3e-05
Identities = 47/316 (14%), Positives = 92/316 (29%), Gaps = 70/316 (22%)
Query: 22 TEESYQLQLAMALRLSSQA--ASADDPHFLALSSCDRHTDSAETVSHR-----FWVNGCL 74
+E L L L Q + LS AE++ W +
Sbjct: 300 PDEVKSL-LLKYLDCRPQDLPREVLTTNPRRLSII------AESIRDGLATWDNWKHVNC 352
Query: 75 SYFDRILDGFYLIHGMDPYT-----WSIGTNQRDAGLIPP------------YKSLKAVD 117
I++ ++ ++P + A IP + V+
Sbjct: 353 DKLTTIIESS--LNVLEPAEYRKMFDRLSVFPPSA-HIPTILLSLIWFDVIKSDVMVVVN 409
Query: 118 PCNNLSIKVILIDKSSDPNLKELHNRVLSLLCDRITAEEAVHQLA----NLVCNHMGGTT 173
+ S L++K + + + L L ++ E A+H+ N+
Sbjct: 410 KLHKYS----LVEKQPKESTISIPSIYLELKV-KLENEYALHRSIVDHYNIPKTFDSDDL 464
Query: 174 STEEEEFDKQW-SECAEHLKDC--------LNSVVLPIGSLSVGLCVHRALLFKVLADLI 224
D+ + S HLK+ V L L + H + + ++
Sbjct: 465 IPPYL--DQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIR-HDSTAWNASGSIL 521
Query: 225 NLPCRIAKGCKYCRRDDASSCLVQIGPDREYLVDLLED------PGVLSKPDSSLNRTAS 278
N ++ Y +D P E LV+ + D ++ + L R A
Sbjct: 522 NTLQQLKFYKPYICDND---------PKYERLVNAILDFLPKIEENLICSKYTDLLRIAL 572
Query: 279 VFVSSPLYHPRFKAVE 294
+ ++ K V+
Sbjct: 573 MAEDEAIFEEAHKQVQ 588
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.5 bits (104), Expect = 1e-04
Identities = 94/621 (15%), Positives = 180/621 (28%), Gaps = 185/621 (29%)
Query: 59 DSAETVSHR-FWVNGCLSYFDRILDGFYLIHGMDP-YTW---SIGTNQRDAGLIPPYKSL 113
A + + R FW LS + ++ F + + Y + I T QR P +
Sbjct: 58 KDAVSGTLRLFWT--LLSKQEEMVQKF-VEEVLRINYKFLMSPIKTEQRQ----PSMMTR 110
Query: 114 KAVDPCNNLSIKVILIDK---SSDPNLKELHNRVLSLLCDRITAEEAVHQLANLVCNH-M 169
++ + L + K S +L +L L + A V +
Sbjct: 111 MYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLEL------------RPAKNVLIDGV 158
Query: 170 GGTTSTEEEEFDKQW---SECAEHLKDCLNSVVLPIGSLSVGLCVHRALLFKVLADLINL 226
G K W C + C I L++ C + ++L L
Sbjct: 159 LG--------SGKTWVALDVCLSYKVQCKMD--FKIFWLNLKNCNSPETVLEMLQKL--- 205
Query: 227 PCRIAKGCKYCRRDDASSCL-VQIGPDREYLVDLLEDPG------VLSKPDSSLNRTASV 279
+ R D SS + ++I + L LL+ VL + + +
Sbjct: 206 -LYQID-PNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLL--NVQNAKAWNA 261
Query: 280 F-VSSP-LYHPRFKAVETVENIRSLAKLYFIDNHSPKFDLDDDPSGTAIDQDYKPDPQAL 337
F +S L RFK V + + +D+HS + ++L
Sbjct: 262 FNLSCKILLTTRFKQVTDFLSA-ATTTHISLDHHSMTLT--------------PDEVKSL 306
Query: 338 FQRASWNVTADRDLQMQNPSGPSTHVIDSSNFIKGPLLRSPV-KPFRHRKSHETSAFSTL 396
+ +DL P + ++N P S + + R + +
Sbjct: 307 L--LKYLDCRPQDL-------P--REVLTTN----PRRLSIIAESIRDGLAT----WDNW 347
Query: 397 KPYVTNNHL--LMEANLSVMSTSN-RELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAE 453
K +V + L ++E++L+V+ + R+++ L + I +
Sbjct: 348 K-HVNCDKLTTIIESSLNVLEPAEYRKMFDR---LSVFPPSAHIPTI--------LLSLI 395
Query: 454 WRNSDVAVKILIEQEFH-----EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIV 508
W + + +++ + H E + KE + SI
Sbjct: 396 WFDVIKSDVMVVVNKLHKYSLVEKQPKESTISI-------P----------------SIY 432
Query: 509 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM-----NYL------HQRRPPIV 557
E + LH R +VD + +D + Y H +
Sbjct: 433 LELKVKLENEYALH----RSIVD-HYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHP 487
Query: 558 HRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVL---------- 607
R + + DF ++ K + W A +
Sbjct: 488 ERMTLFRMVFL---------DFR--------FLEQKIRHDSTAWNASGSILNTLQQLKFY 530
Query: 608 -----REDPSNEK--SDVFSF 621
DP E+ + + F
Sbjct: 531 KPYICDNDPKYERLVNAILDF 551
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 706 | |||
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.86 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.76 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.61 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.19 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.98 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.97 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.77 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.62 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.29 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.27 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.26 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.97 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.87 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.83 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.66 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.61 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.27 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.13 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.13 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.87 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.77 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.7 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.69 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.46 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.37 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.33 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.02 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.94 | |
| 3kd4_A | 506 | Putative protease; structural genomics, joint cent | 95.56 | |
| 3isr_A | 293 | Transglutaminase-like enzymes, putative cysteine; | 95.38 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.82 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 93.92 | |
| 2f4m_A | 295 | Peptide N-glycanase; glycoproteins, ubiquitin-depe | 92.69 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.51 | |
| 1x3z_A | 335 | Peptide: N-glycanase; hydrolase-hydrolase inhibito | 81.5 |
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-53 Score=452.45 Aligned_cols=264 Identities=38% Similarity=0.626 Sum_probs=222.7
Q ss_pred cCcccccCceEEEEEeccCCceEEEEEEEcCCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCce
Q 005247 426 EGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNL 505 (706)
Q Consensus 426 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 505 (706)
..+++..+++++.++||+|+||+||+|++++ .||||+++.........+.|.+|+.+|++++|||||++++++.+ +.+
T Consensus 29 ~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~ 106 (307)
T 3omv_A 29 YYWEIEASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNL 106 (307)
T ss_dssp CCCBCCTTSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSC
T ss_pred cCcEEcHHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeE
Confidence 3478889999999999999999999998654 59999987766677778899999999999999999999998865 568
Q ss_pred EEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccC
Q 005247 506 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK 585 (706)
Q Consensus 506 ~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~ 585 (706)
+||||||++|+|.++++... ..+++..+..|+.||+.||+|||+++ ||||||||+||||+.++++||+|||+|+..
T Consensus 107 ~iVmEy~~gGsL~~~l~~~~--~~l~~~~~~~i~~qia~gL~yLH~~~--IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 182 (307)
T 3omv_A 107 AIVTQWCEGSSLYKHLHVQE--TKFQMFQLIDIARQTAQGMDYLHAKN--IIHRDMKSNNIFLHEGLTVKIGDFGLATVK 182 (307)
T ss_dssp EEEEECCSSCBHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCSSSEEEETTEEEEECCCSSCBC-
T ss_pred EEEEEcCCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCccCHHHEEECCCCcEEEeeccCceec
Confidence 99999999999999997433 35899999999999999999999999 999999999999999999999999999875
Q ss_pred CCC--cccCCCCCCCCCccCcccccc---CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCc-c---cCC
Q 005247 586 PNT--YISSKTAAGTPEWMAPEVLRE---DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR-R---LEI 656 (706)
Q Consensus 586 ~~~--~~~~~~~~Gt~~Y~APE~l~~---~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~-~---l~~ 656 (706)
... .......+||+.|||||++.+ ..|+.++|||||||+||||+||+.||...+.......+..... . ..+
T Consensus 183 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~ 262 (307)
T 3omv_A 183 SRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKL 262 (307)
T ss_dssp -----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTS
T ss_pred ccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccc
Confidence 432 222345689999999999964 3589999999999999999999999988766554444332322 2 245
Q ss_pred CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHh
Q 005247 657 PKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS 695 (706)
Q Consensus 657 p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s 695 (706)
+.++++++.+||.+||+.||++|||+.||++.|+.+..+
T Consensus 263 ~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~ 301 (307)
T 3omv_A 263 YKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS 301 (307)
T ss_dssp CTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred cccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence 678999999999999999999999999999999877544
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-53 Score=453.81 Aligned_cols=264 Identities=34% Similarity=0.577 Sum_probs=230.6
Q ss_pred ccccCceEEEEEeccCCceEEEEEEEcC-------CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccC
Q 005247 429 EIRWSELLIKKKIGEGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE 501 (706)
Q Consensus 429 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~-------~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~ 501 (706)
.+..++|.+.+.||+|+||+||+|++.+ ..||||++... .....+.|.+|+++|++++|||||++++++.+
T Consensus 9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~ 86 (299)
T 4asz_A 9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVE 86 (299)
T ss_dssp BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEee
Confidence 4566789999999999999999998752 34999998653 44556789999999999999999999999999
Q ss_pred CCceEEEEEeccCCchhhhcccCC----------CcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCC
Q 005247 502 PPNLSIVTEYLSRGSLYKLLHIPD----------ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST 571 (706)
Q Consensus 502 ~~~~~lV~E~~~ggsL~~~l~~~~----------~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~ 571 (706)
++.++||||||++|+|.++++... ....+++..++.|+.||+.||+|||+++ ||||||||+|||++.+
T Consensus 87 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDlKp~NILl~~~ 164 (299)
T 4asz_A 87 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGEN 164 (299)
T ss_dssp SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGG
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccCHhhEEECCC
Confidence 999999999999999999996432 2346899999999999999999999999 9999999999999999
Q ss_pred CcEEEeecCccccCCCCcc--cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhh
Q 005247 572 YTVKVCDFGLSRSKPNTYI--SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVG 648 (706)
Q Consensus 572 ~~vKL~DFGla~~~~~~~~--~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~ 648 (706)
+++||+|||+|+....... ......||+.|||||++.+..++.++|||||||+||||+| |+.||...+..++...+.
T Consensus 165 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~ 244 (299)
T 4asz_A 165 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT 244 (299)
T ss_dssp GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 9999999999986443221 2234568999999999999999999999999999999998 899999999888887774
Q ss_pred hcCcccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhcc
Q 005247 649 FKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSV 697 (706)
Q Consensus 649 ~~~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~~ 697 (706)
.+.+++.|..+++++.+||.+||+.||++|||+.+|++.|+++.+..+
T Consensus 245 -~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~p 292 (299)
T 4asz_A 245 -QGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKASP 292 (299)
T ss_dssp -HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred -cCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCC
Confidence 556778899999999999999999999999999999999999887643
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-53 Score=454.38 Aligned_cols=263 Identities=35% Similarity=0.566 Sum_probs=225.8
Q ss_pred cccccCceEEEEEeccCCceEEEEEEEcC-------CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEecccc
Q 005247 428 LEIRWSELLIKKKIGEGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 500 (706)
Q Consensus 428 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~-------~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~ 500 (706)
..+...+|.+.++||+|+||+||+|++.+ ..||||++... .....+.|.+|+++|++++|||||++++++.
T Consensus 36 ~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~ 113 (329)
T 4aoj_A 36 HHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCT 113 (329)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred cccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 34666789999999999999999998753 34999998643 4555678999999999999999999999999
Q ss_pred CCCceEEEEEeccCCchhhhcccCCC------------cccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEE
Q 005247 501 EPPNLSIVTEYLSRGSLYKLLHIPDA------------RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLV 568 (706)
Q Consensus 501 ~~~~~~lV~E~~~ggsL~~~l~~~~~------------~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl 568 (706)
+.+.++||||||++|+|.++++.... ...+++..++.|+.||+.||+|||+++ ||||||||+||||
T Consensus 114 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLKp~NILl 191 (329)
T 4aoj_A 114 EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLV 191 (329)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE
T ss_pred ECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHhhEEE
Confidence 99999999999999999999964321 245899999999999999999999999 9999999999999
Q ss_pred CCCCcEEEeecCccccCCCCc--ccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 005247 569 DSTYTVKVCDFGLSRSKPNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVIS 645 (706)
Q Consensus 569 ~~~~~vKL~DFGla~~~~~~~--~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~ 645 (706)
+.++++||+|||+|+...... .......||+.|||||++.+..++.++|||||||+||||+| |+.||...+..+...
T Consensus 192 ~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~ 271 (329)
T 4aoj_A 192 GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID 271 (329)
T ss_dssp ETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHH
T ss_pred CCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 999999999999998654322 22345679999999999999999999999999999999999 899999999888877
Q ss_pred HhhhcCcccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHh
Q 005247 646 AVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS 695 (706)
Q Consensus 646 ~i~~~~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s 695 (706)
.+. .+.+++.|..+++++.+||.+||+.||++|||+.||++.|+.+.+.
T Consensus 272 ~i~-~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 272 CIT-QGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp HHH-HTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHH-cCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 774 5567888999999999999999999999999999999999998875
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-54 Score=463.69 Aligned_cols=252 Identities=28% Similarity=0.476 Sum_probs=221.2
Q ss_pred cCceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEE
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 509 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~ 509 (706)
.++|++++.||+|+||+||+|++.. ..||||++..........+.+.+|+.+|++++|||||++++++.+++.+||||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 4689999999999999999999874 45999999887777777889999999999999999999999999999999999
Q ss_pred EeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCc
Q 005247 510 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 589 (706)
Q Consensus 510 E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 589 (706)
|||+||+|.+++...+ ...+++..++.|+.||+.||+|||++| ||||||||+||||+.+|++||+|||+|+......
T Consensus 103 Ey~~gg~L~~~i~~~~-~~~~~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQK-GVLFQEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp ECCTTCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT--CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred eCCCCCcHHHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 9999999999996432 335789999999999999999999999 9999999999999999999999999998766543
Q ss_pred ccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHHH
Q 005247 590 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE 669 (706)
Q Consensus 590 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI~ 669 (706)
......+||+.|||||++.+..|+.++|||||||+||||++|+.||...+..+....+.. ....+++..+++++++||.
T Consensus 180 ~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~-~~~~~~~~~~s~~~~~li~ 258 (350)
T 4b9d_A 180 ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIIS-GSFPPVSLHYSYDLRSLVS 258 (350)
T ss_dssp HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH-TCCCCCCTTSCHHHHHHHH
T ss_pred ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHc-CCCCCCCccCCHHHHHHHH
Confidence 333456899999999999999999999999999999999999999999998888877743 3445677889999999999
Q ss_pred HhhhhCCCCCCCHHHHHH
Q 005247 670 TCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 670 ~cL~~dP~~RPS~~eIl~ 687 (706)
+||++||++|||+.|+++
T Consensus 259 ~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 259 QLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp HHTCSSGGGSCCHHHHHT
T ss_pred HHccCChhHCcCHHHHhc
Confidence 999999999999999986
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-53 Score=451.27 Aligned_cols=260 Identities=31% Similarity=0.535 Sum_probs=227.0
Q ss_pred ccccCceEEEEEeccCCceEEEEEEEcC-------CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccC
Q 005247 429 EIRWSELLIKKKIGEGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE 501 (706)
Q Consensus 429 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~-------~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~ 501 (706)
++...++++.++||+|+||+||+|.+.+ ..||||++.... .....+.|.+|+.++++++|||||++++++.+
T Consensus 22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~ 100 (308)
T 4gt4_A 22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVTK 100 (308)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE
Confidence 4667789999999999999999998642 349999986543 33445789999999999999999999999999
Q ss_pred CCceEEEEEeccCCchhhhcccCC-------------CcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEE
Q 005247 502 PPNLSIVTEYLSRGSLYKLLHIPD-------------ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLV 568 (706)
Q Consensus 502 ~~~~~lV~E~~~ggsL~~~l~~~~-------------~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl 568 (706)
++.++||||||++|+|.++++... ....+++..+..|+.||+.||+|||+++ ||||||||+||||
T Consensus 101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLK~~NILl 178 (308)
T 4gt4_A 101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLV 178 (308)
T ss_dssp SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE
T ss_pred CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCccccceEE
Confidence 999999999999999999995422 1345889999999999999999999999 9999999999999
Q ss_pred CCCCcEEEeecCccccCCCC--cccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 005247 569 DSTYTVKVCDFGLSRSKPNT--YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVIS 645 (706)
Q Consensus 569 ~~~~~vKL~DFGla~~~~~~--~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~ 645 (706)
++++++||+|||+|+..... ........||+.|||||++.+..++.++|||||||+||||+| |..||.+.+..++..
T Consensus 179 ~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~ 258 (308)
T 4gt4_A 179 YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE 258 (308)
T ss_dssp CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHH
T ss_pred CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 99999999999999865332 222345689999999999999999999999999999999998 899999999888887
Q ss_pred HhhhcCcccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 005247 646 AVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQF 692 (706)
Q Consensus 646 ~i~~~~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~l 692 (706)
.+. .+.+++.|..+++++.+||.+||+.||++|||+.||++.|+.+
T Consensus 259 ~i~-~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 259 MIR-NRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHH-cCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 774 5667788999999999999999999999999999999999753
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-52 Score=439.42 Aligned_cols=247 Identities=32% Similarity=0.515 Sum_probs=213.7
Q ss_pred eEEEEEeccCCceEEEEEEEcCCc--eEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccC----CCceEEE
Q 005247 435 LLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE----PPNLSIV 508 (706)
Q Consensus 435 y~i~~~LG~G~fG~Vy~a~~~~~~--vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~----~~~~~lV 508 (706)
|++.++||+|+||+||+|.+..++ ||+|++..........+.|.+|+.+|++++|||||++++++.+ .+.++||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 478889999999999999987654 8999998777777777889999999999999999999999864 3558999
Q ss_pred EEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECC-CCcEEEeecCccccCCC
Q 005247 509 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS-TYTVKVCDFGLSRSKPN 587 (706)
Q Consensus 509 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~-~~~vKL~DFGla~~~~~ 587 (706)
||||+||+|.++++.. ..+++..++.|+.||+.||+|||+++++||||||||+||||+. ++.+||+|||+|+....
T Consensus 108 mEy~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp EECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 9999999999999743 3589999999999999999999999888999999999999974 78999999999986544
Q ss_pred CcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHhhhcCcccCCCCCCcHHHHH
Q 005247 588 TYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNST-PSQVISAVGFKGRRLEIPKNVNPMVAA 666 (706)
Q Consensus 588 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~-~~~~~~~i~~~~~~l~~p~~~s~el~d 666 (706)
. ...+.+||+.|||||++.+ .|+.++|||||||+||||+||+.||.... .......+.....+..++..+++++++
T Consensus 185 ~--~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 261 (290)
T 3fpq_A 185 S--FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKE 261 (290)
T ss_dssp T--SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHH
T ss_pred C--ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHH
Confidence 3 2346789999999999865 69999999999999999999999997654 444455554444455667788999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHH
Q 005247 667 LIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 667 LI~~cL~~dP~~RPS~~eIl~ 687 (706)
||.+||+.||++|||+.|+++
T Consensus 262 li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 262 IIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp HHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHccCChhHCcCHHHHhc
Confidence 999999999999999999875
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-52 Score=453.23 Aligned_cols=270 Identities=31% Similarity=0.548 Sum_probs=232.8
Q ss_pred cCcccccCceEEEEEeccCCceEEEEEEEcCC-------ceEEEEEeccccchHHHHHHHHHHHHHHcCCC-CceeEEec
Q 005247 426 EGLEIRWSELLIKKKIGEGSFGTVYHAEWRNS-------DVAVKILIEQEFHEDRFKEFLREVAIMKGLRH-PNIVLLMG 497 (706)
Q Consensus 426 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~-------~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~H-pnIv~l~~ 497 (706)
..+++..++|++++.||+|+||+||+|.+.+. .||||++.... .....+.|.+|+.+|+++.| ||||++++
T Consensus 57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~l~g 135 (353)
T 4ase_A 57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLG 135 (353)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEEEEE
Confidence 44788899999999999999999999987653 38899886543 44556789999999999965 89999999
Q ss_pred cccCC-CceEEEEEeccCCchhhhcccCCC-------------cccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCC
Q 005247 498 AVTEP-PNLSIVTEYLSRGSLYKLLHIPDA-------------RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKS 563 (706)
Q Consensus 498 ~~~~~-~~~~lV~E~~~ggsL~~~l~~~~~-------------~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp 563 (706)
+|.++ +.++||||||++|+|.++++.... ...+++..+..|+.||++||+|||+++ ||||||||
T Consensus 136 ~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~--iiHRDLK~ 213 (353)
T 4ase_A 136 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAA 213 (353)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSG
T ss_pred EEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC--eecCccCc
Confidence 98664 568999999999999999964321 345889999999999999999999999 99999999
Q ss_pred CcEEECCCCcEEEeecCccccCCCC--cccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCh
Q 005247 564 PNLLVDSTYTVKVCDFGLSRSKPNT--YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTP 640 (706)
Q Consensus 564 ~NILl~~~~~vKL~DFGla~~~~~~--~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~ 640 (706)
+|||++.++++||+|||+|+..... ........||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+.
T Consensus 214 ~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~ 293 (353)
T 4ase_A 214 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 293 (353)
T ss_dssp GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred cceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999999875432 223345678999999999999999999999999999999998 8999988765
Q ss_pred HHHHHHhhhcCcccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhccC
Q 005247 641 SQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVC 698 (706)
Q Consensus 641 ~~~~~~i~~~~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~~~ 698 (706)
.+.+......+.++..|..+++++.+||.+||+.||++|||+.+|++.|+++++....
T Consensus 294 ~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~~~ 351 (353)
T 4ase_A 294 DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQ 351 (353)
T ss_dssp SHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC-
T ss_pred HHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHhhC
Confidence 5555555456778899999999999999999999999999999999999999987543
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-52 Score=451.49 Aligned_cols=247 Identities=28% Similarity=0.435 Sum_probs=220.1
Q ss_pred CceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEE
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 510 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E 510 (706)
..|++.++||+|+||+||+|.++.+ .||||++....... .+.+.+|+.+|+.++|||||++++++.+++.+|||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmE 151 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 151 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS--GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH--HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 5699999999999999999998754 49999997654322 3468899999999999999999999999999999999
Q ss_pred eccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcc
Q 005247 511 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 590 (706)
Q Consensus 511 ~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~ 590 (706)
||+||+|.++++.. .+++..++.|+.||+.||+|||++| ||||||||+||||+.+|++||+|||+|+.......
T Consensus 152 y~~gg~L~~~l~~~----~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 225 (346)
T 4fih_A 152 FLEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 225 (346)
T ss_dssp CCTTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred CCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEECCCCCEEEecCcCceecCCCCC
Confidence 99999999999642 4899999999999999999999999 99999999999999999999999999988766555
Q ss_pred cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcC-cccCCCCCCcHHHHHHHH
Q 005247 591 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG-RRLEIPKNVNPMVAALIE 669 (706)
Q Consensus 591 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~-~~l~~p~~~s~el~dLI~ 669 (706)
...+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+....+.... ..+..+..+++++++||.
T Consensus 226 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~ 305 (346)
T 4fih_A 226 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLD 305 (346)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHH
T ss_pred cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHH
Confidence 5567899999999999999999999999999999999999999999998888777764332 234455678999999999
Q ss_pred HhhhhCCCCCCCHHHHHH
Q 005247 670 TCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 670 ~cL~~dP~~RPS~~eIl~ 687 (706)
+||+.||++|||+.|+++
T Consensus 306 ~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 306 RLLVRDPAQRATAAELLK 323 (346)
T ss_dssp HHSCSSTTTSCCHHHHTT
T ss_pred HHcCCChhHCcCHHHHhc
Confidence 999999999999999876
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-53 Score=449.57 Aligned_cols=247 Identities=25% Similarity=0.420 Sum_probs=220.9
Q ss_pred CceEEEEEeccCCceEEEEEEEcCC--ceEEEEEecccc-chHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEE
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 509 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~ 509 (706)
++|++++.||+|+||+||+|++..+ .||+|++.+... .....+.+.+|+++|++++|||||++++++.+++.+|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5799999999999999999998754 499999976543 2234567899999999999999999999999999999999
Q ss_pred EeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCC-
Q 005247 510 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT- 588 (706)
Q Consensus 510 E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~- 588 (706)
|||+||+|.++++.. ..+++..++.++.||+.||+|||++| ||||||||+|||++.++.+||+|||+|+.....
T Consensus 112 Ey~~gG~L~~~i~~~---~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 112 SYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186 (311)
T ss_dssp CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence 999999999999743 35999999999999999999999999 999999999999999999999999999875432
Q ss_pred -cccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHH
Q 005247 589 -YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAAL 667 (706)
Q Consensus 589 -~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dL 667 (706)
.....+.+||+.|||||++.+..|+.++|||||||++|||++|+.||...+..+....+.. ..+.+|..+++++++|
T Consensus 187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~--~~~~~p~~~s~~~~dl 264 (311)
T 4aw0_A 187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIK--LEYDFPEKFFPKARDL 264 (311)
T ss_dssp TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--TCCCCCTTCCHHHHHH
T ss_pred CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc--CCCCCCcccCHHHHHH
Confidence 2234567999999999999999999999999999999999999999999998888877743 3467888999999999
Q ss_pred HHHhhhhCCCCCCCHHHHH
Q 005247 668 IETCWAEEPEIRPSFPSIM 686 (706)
Q Consensus 668 I~~cL~~dP~~RPS~~eIl 686 (706)
|.+||++||++|||++|++
T Consensus 265 i~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 265 VEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp HHHHSCSSGGGSTTSGGGT
T ss_pred HHHHccCCHhHCcChHHHc
Confidence 9999999999999999864
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-52 Score=446.83 Aligned_cols=254 Identities=28% Similarity=0.415 Sum_probs=221.0
Q ss_pred ccCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEE
Q 005247 431 RWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIV 508 (706)
Q Consensus 431 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV 508 (706)
....|++.++||+|+||+||+|+++.+ .||||++..... ..+|+.+++.++|||||++++++.+++.+|||
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~iv 128 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------RVEELVACAGLSSPRIVPLYGAVREGPWVNIF 128 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 446799999999999999999998754 599999976543 24699999999999999999999999999999
Q ss_pred EEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCC-cEEEeecCccccCCC
Q 005247 509 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY-TVKVCDFGLSRSKPN 587 (706)
Q Consensus 509 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~-~vKL~DFGla~~~~~ 587 (706)
||||+||+|.++++.. ..+++..++.|+.||+.||+|||++| ||||||||+||||+.+| .+||+|||+|+....
T Consensus 129 mEy~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~ 203 (336)
T 4g3f_A 129 MELLEGGSLGQLIKQM---GCLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFGHALCLQP 203 (336)
T ss_dssp ECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCCGGGEEECTTSCCEEECCCTTCEEC--
T ss_pred EeccCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEeCCCCEEEEeeCCCCeEccC
Confidence 9999999999999743 35999999999999999999999999 99999999999999887 699999999987543
Q ss_pred Ccc-----cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcc-cCCCCCCc
Q 005247 588 TYI-----SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR-LEIPKNVN 661 (706)
Q Consensus 588 ~~~-----~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~-l~~p~~~s 661 (706)
... .....+||+.|||||++.+..|+.++|||||||++|||++|+.||...+..+....+...... ..+++.++
T Consensus 204 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s 283 (336)
T 4g3f_A 204 DGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCA 283 (336)
T ss_dssp ----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSC
T ss_pred CCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCC
Confidence 211 223468999999999999999999999999999999999999999988777766666544333 35788999
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhc
Q 005247 662 PMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 696 (706)
Q Consensus 662 ~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~ 696 (706)
+++.+||.+||++||++|||+.||++.|...+...
T Consensus 284 ~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~ 318 (336)
T 4g3f_A 284 PLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEV 318 (336)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhh
Confidence 99999999999999999999999999999988764
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-53 Score=447.78 Aligned_cols=251 Identities=26% Similarity=0.391 Sum_probs=214.1
Q ss_pred cccCceEEEEEeccCCceEEEEEEEc-----CCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCc
Q 005247 430 IRWSELLIKKKIGEGSFGTVYHAEWR-----NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN 504 (706)
Q Consensus 430 i~~~~y~i~~~LG~G~fG~Vy~a~~~-----~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 504 (706)
+..++|++++.||+|+||+||+|++. +..||+|++.+..........+.+|+.+|++++|||||++++++.+++.
T Consensus 21 ~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 100 (304)
T 3ubd_A 21 ADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGK 100 (304)
T ss_dssp CCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTE
T ss_pred CCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCE
Confidence 34468999999999999999999873 2349999997655443333468899999999999999999999999999
Q ss_pred eEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCcccc
Q 005247 505 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 584 (706)
Q Consensus 505 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~ 584 (706)
+|+|||||+||+|.++++.. ..+++..++.++.||+.||+|||++| ||||||||+|||++.+|.+||+|||+|+.
T Consensus 101 ~~ivmEy~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~ 175 (304)
T 3ubd_A 101 LYLILDFLRGGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKE 175 (304)
T ss_dssp EEEEECCCTTCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTTSCEEEESSEEEEC
T ss_pred EEEEEEcCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHeEEcCCCCEEeccccccee
Confidence 99999999999999999743 35899999999999999999999999 99999999999999999999999999987
Q ss_pred CCCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHH
Q 005247 585 KPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV 664 (706)
Q Consensus 585 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el 664 (706)
.........+.+||+.|||||++.+..|+.++|||||||++|||+||+.||.+.+..+....+.. ..+.+|..+|+++
T Consensus 176 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~--~~~~~p~~~s~~~ 253 (304)
T 3ubd_A 176 SIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK--AKLGMPQFLSPEA 253 (304)
T ss_dssp -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTSCHHH
T ss_pred ccCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHc--CCCCCCCcCCHHH
Confidence 65544455678999999999999999999999999999999999999999999998888877743 4567888999999
Q ss_pred HHHHHHhhhhCCCCCCCH-----HHHHH
Q 005247 665 AALIETCWAEEPEIRPSF-----PSIME 687 (706)
Q Consensus 665 ~dLI~~cL~~dP~~RPS~-----~eIl~ 687 (706)
++||.+||++||++|||+ +|+++
T Consensus 254 ~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 254 QSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp HHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred HHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 999999999999999984 67765
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-51 Score=431.77 Aligned_cols=246 Identities=30% Similarity=0.479 Sum_probs=203.2
Q ss_pred CceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccch-HHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEE
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 509 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~-~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~ 509 (706)
++|++++.||+|+||+||+|.+.. ..||+|++.+..... ...+.+.+|+.+|++++|||||++++++.+++.+++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 689999999999999999999864 459999997654433 33567899999999999999999999999999999999
Q ss_pred EeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCc
Q 005247 510 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 589 (706)
Q Consensus 510 E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 589 (706)
||+ +|+|.+++... ..+++..++.++.||+.||+|||++| ||||||||+|||++.++++||+|||+|+......
T Consensus 93 Ey~-~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 166 (275)
T 3hyh_A 93 EYA-GNELFDYIVQR---DKMSEQEARRFFQQIISAVEYCHRHK--IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN 166 (275)
T ss_dssp ECC-CEEHHHHHHHS---CSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred eCC-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence 999 67999988643 35999999999999999999999999 9999999999999999999999999998755432
Q ss_pred ccCCCCCCCCCccCccccccCCC-CchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHH
Q 005247 590 ISSKTAAGTPEWMAPEVLREDPS-NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI 668 (706)
Q Consensus 590 ~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI 668 (706)
...+.+||+.|||||++.+..+ +.++|||||||++|||+||+.||...+..+....+.. ....+|..+++++++||
T Consensus 167 -~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~li 243 (275)
T 3hyh_A 167 -FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISN--GVYTLPKFLSPGAAGLI 243 (275)
T ss_dssp ---------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--TCCCCCTTSCHHHHHHH
T ss_pred -ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc--CCCCCCCCCCHHHHHHH
Confidence 3356789999999999998876 5799999999999999999999999888877777643 45667889999999999
Q ss_pred HHhhhhCCCCCCCHHHHHH
Q 005247 669 ETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 669 ~~cL~~dP~~RPS~~eIl~ 687 (706)
.+||+.||++|||++|+++
T Consensus 244 ~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 244 KRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp HHHSCSSGGGSCCHHHHHH
T ss_pred HHHccCChhHCcCHHHHHc
Confidence 9999999999999999987
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-51 Score=453.60 Aligned_cols=248 Identities=27% Similarity=0.431 Sum_probs=221.4
Q ss_pred cCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEE
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 509 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~ 509 (706)
...|+++++||+|+||.||+|.+..+ .||||++....... .+.+.+|+.+|+.++|||||++++++.+.+.+||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm 227 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 227 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS--GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH--HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence 35699999999999999999998754 49999997654322 356889999999999999999999999999999999
Q ss_pred EeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCc
Q 005247 510 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 589 (706)
Q Consensus 510 E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 589 (706)
|||+||+|.++++.. .+++..++.|+.||+.||+|||++| ||||||||+||||+.+|.+||+|||+|+......
T Consensus 228 Ey~~gG~L~~~i~~~----~l~e~~~~~~~~qil~aL~ylH~~~--IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~ 301 (423)
T 4fie_A 228 EFLEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 301 (423)
T ss_dssp ECCTTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSTTTEEECTTCCEEECCCTTCEECCSSC
T ss_pred eCCCCCcHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCCCCEEEecCccceECCCCC
Confidence 999999999999633 4899999999999999999999999 9999999999999999999999999998876555
Q ss_pred ccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcC-cccCCCCCCcHHHHHHH
Q 005247 590 ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG-RRLEIPKNVNPMVAALI 668 (706)
Q Consensus 590 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~-~~l~~p~~~s~el~dLI 668 (706)
....+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+....+.... ..+..+..+++++++||
T Consensus 302 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli 381 (423)
T 4fie_A 302 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFL 381 (423)
T ss_dssp CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHH
T ss_pred ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHH
Confidence 45567899999999999999999999999999999999999999999998888877765332 24455678999999999
Q ss_pred HHhhhhCCCCCCCHHHHHH
Q 005247 669 ETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 669 ~~cL~~dP~~RPS~~eIl~ 687 (706)
.+||+.||++|||+.|+++
T Consensus 382 ~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 382 DRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp HHHSCSSTTTSCCHHHHTT
T ss_pred HHHcCCChhHCcCHHHHhc
Confidence 9999999999999999876
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-49 Score=420.98 Aligned_cols=248 Identities=25% Similarity=0.386 Sum_probs=193.0
Q ss_pred CceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCC-------
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP------- 503 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~------- 503 (706)
++|++++.||+|+||+||+|+++.+ .||||++.... .....+.+.+|+.+|++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 4799999999999999999998744 59999986554 3445578999999999999999999999986543
Q ss_pred -----ceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEee
Q 005247 504 -----NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCD 578 (706)
Q Consensus 504 -----~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~D 578 (706)
.+|+|||||++|+|.++++........++..++.|+.||+.||+|||++| ||||||||+|||++.++++||+|
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~--IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc--CccccCcHHHeEECCCCcEEEcc
Confidence 36899999999999999975544334556778899999999999999999 99999999999999999999999
Q ss_pred cCccccCCCCcc------------cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHH
Q 005247 579 FGLSRSKPNTYI------------SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPS-QVIS 645 (706)
Q Consensus 579 FGla~~~~~~~~------------~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~-~~~~ 645 (706)
||+|+....... .....+||+.|||||++.+..|+.++|||||||++|||++ ||...... ....
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~ 238 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLT 238 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHH
Confidence 999987543221 1234579999999999999999999999999999999996 88653321 1122
Q ss_pred HhhhcCcccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 646 AVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 646 ~i~~~~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
.+. .....+.+...++.+.+||.+||++||++|||+.|+++
T Consensus 239 ~~~-~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 239 DVR-NLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHH-TTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHh-cCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 221 11112222345677899999999999999999999976
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-49 Score=419.08 Aligned_cols=257 Identities=29% Similarity=0.473 Sum_probs=202.0
Q ss_pred CceEEEEEeccCCceEEEEEEEcCCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCC----ceEEE
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP----NLSIV 508 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~----~~~lV 508 (706)
.+|.+.++||+|+||+||+|+++++.||||++.... .....+..|+..+.+++|||||++++++.+++ .++||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 468899999999999999999999899999986432 11122335666667889999999999987654 47999
Q ss_pred EEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhc------CCCcccccCCCCcEEECCCCcEEEeecCcc
Q 005247 509 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR------RPPIVHRDLKSPNLLVDSTYTVKVCDFGLS 582 (706)
Q Consensus 509 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~------g~~IIHrDLKp~NILl~~~~~vKL~DFGla 582 (706)
||||++|+|.++++.. .+++..+..++.|++.||+|||++ .++||||||||+||||+.++++||+|||+|
T Consensus 80 ~Ey~~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred ecCCCCCcHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 9999999999999743 488999999999999999999987 123999999999999999999999999999
Q ss_pred ccCCCCcc----cCCCCCCCCCccCccccccC------CCCchhHHHHHHHHHHHHHhCCCCCCC----------C----
Q 005247 583 RSKPNTYI----SSKTAAGTPEWMAPEVLRED------PSNEKSDVFSFGVILWELITLQKPWRN----------S---- 638 (706)
Q Consensus 583 ~~~~~~~~----~~~~~~Gt~~Y~APE~l~~~------~~s~ksDVwSLGviL~ELltG~~Pf~~----------~---- 638 (706)
+....... .....+||+.|||||++.+. .++.++|||||||+||||+||..||.. .
T Consensus 156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~ 235 (303)
T 3hmm_A 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence 86433221 22345799999999999765 357799999999999999999766532 1
Q ss_pred -ChHHHHHHhhhcCcccCCCCC-----CcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhc
Q 005247 639 -TPSQVISAVGFKGRRLEIPKN-----VNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 696 (706)
Q Consensus 639 -~~~~~~~~i~~~~~~l~~p~~-----~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~ 696 (706)
...+....+.....++.+|.. ++..+.+||.+||+.||++|||+.||++.|+++.++.
T Consensus 236 ~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~ 299 (303)
T 3hmm_A 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred chHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHc
Confidence 122333333334445555543 3467899999999999999999999999999988763
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-48 Score=409.56 Aligned_cols=278 Identities=71% Similarity=1.172 Sum_probs=235.6
Q ss_pred cccCcccccCceEEEEEeccCCceEEEEEEEcCCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCC
Q 005247 424 EEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP 503 (706)
Q Consensus 424 ~~~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 503 (706)
....+++...+|++.+.||+|+||.||+|++.++.||+|++..........+.+.+|+.++++++||||+++++++.+.+
T Consensus 28 ~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 107 (309)
T 3p86_A 28 DGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP 107 (309)
T ss_dssp ----CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred CcccccCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence 34557788899999999999999999999998889999999887777777889999999999999999999999999999
Q ss_pred ceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccc
Q 005247 504 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 583 (706)
Q Consensus 504 ~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~ 583 (706)
..++||||+.+|+|.+++........+++..++.++.||+.||+|||++|++|+||||||+|||++.++.+||+|||+++
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 187 (309)
T 3p86_A 108 NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR 187 (309)
T ss_dssp CCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC---
T ss_pred ceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCc
Confidence 99999999999999999976554445899999999999999999999998779999999999999999999999999998
Q ss_pred cCCCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHH
Q 005247 584 SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPM 663 (706)
Q Consensus 584 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~e 663 (706)
.............||+.|+|||++.+..++.++||||||+++|||++|+.||...+..+....+.....+..++..++++
T Consensus 188 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (309)
T 3p86_A 188 LKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQ 267 (309)
T ss_dssp --------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHH
T ss_pred cccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHH
Confidence 76555444556789999999999999999999999999999999999999999999888888777777788899999999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhccCCCC
Q 005247 664 VAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQPL 701 (706)
Q Consensus 664 l~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~~~~~~ 701 (706)
+.+||.+||+.||++|||+.++++.|+.++.+..+.+.
T Consensus 268 l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~~ 305 (309)
T 3p86_A 268 VAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPN 305 (309)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-------
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999999999988766543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=420.94 Aligned_cols=249 Identities=22% Similarity=0.338 Sum_probs=210.8
Q ss_pred CceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccC------CCc
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE------PPN 504 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~------~~~ 504 (706)
++|++++.||+|+||+||+|.+..+ .||||++..........+.+.+|+.+|+.++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 5799999999999999999998754 49999997766666667889999999999999999999998653 467
Q ss_pred eEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCcccc
Q 005247 505 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 584 (706)
Q Consensus 505 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~ 584 (706)
+|||||||. |+|.+++... ..+++..+..|+.||+.||+|||++| ||||||||+|||++.++.+||+|||+|+.
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~---~~l~~~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NIl~~~~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSS---QPLTLEHVRYFLYQLLRGLKYMHSAQ--VIHRDLKPSNLLVNENCELKIGDFGMARG 207 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSS---SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEEeCCC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCc--CcCCCcCccccccCCCCCEEEeecceeee
Confidence 899999996 6799988643 36999999999999999999999999 99999999999999999999999999986
Q ss_pred CCCC----cccCCCCCCCCCccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCccc-----
Q 005247 585 KPNT----YISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRL----- 654 (706)
Q Consensus 585 ~~~~----~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l----- 654 (706)
.... .....+.+||+.|||||++.+. .++.++||||+||++|||++|+.||.+.+..+....+......+
T Consensus 208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~ 287 (398)
T 4b99_A 208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVI 287 (398)
T ss_dssp C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGT
T ss_pred cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence 5432 2233567899999999998875 46899999999999999999999999988877766553211100
Q ss_pred ------------------------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 655 ------------------------EIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 655 ------------------------~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
.+.+.+++++.+||.+||..||++|||+.|+++
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 288 QAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp C-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 012357899999999999999999999999876
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=402.04 Aligned_cols=244 Identities=25% Similarity=0.336 Sum_probs=198.1
Q ss_pred cCceEEEEEeccCCceEEEEEEEc-----CCceEEEEEeccccchHHHHHHHHHHHHHHcC-CCCceeEEeccccCCCce
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWR-----NSDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNL 505 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~-----~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~ 505 (706)
.+.|++.+.||+|+||+||+|+++ +..||+|++..... ...+.+|+++|+.+ +||||+++++++.+.+++
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~----~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH----PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC----HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC----HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 467999999999999999999874 23499998865432 24678899999998 699999999999999999
Q ss_pred EEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCC-CcEEEeecCcccc
Q 005247 506 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST-YTVKVCDFGLSRS 584 (706)
Q Consensus 506 ~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~-~~vKL~DFGla~~ 584 (706)
++||||+++|+|.++++ .+++..++.++.||+.||+|||++| ||||||||+|||++.+ +.+||+|||+|+.
T Consensus 96 ~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g--IiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG--IVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp EEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 99999999999999984 3889999999999999999999999 9999999999999876 7999999999975
Q ss_pred CCCCcc----------------------------cCCCCCCCCCccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCC
Q 005247 585 KPNTYI----------------------------SSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPW 635 (706)
Q Consensus 585 ~~~~~~----------------------------~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSLGviL~ELltG~~Pf 635 (706)
...... ...+.+||+.|+|||++.+. .++.++||||+||++|||++|+.||
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf 247 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence 433211 12345799999999999876 4899999999999999999999999
Q ss_pred CCCC-hHHHHHHhhhc----------------------------------------------------CcccCCCCCCcH
Q 005247 636 RNST-PSQVISAVGFK----------------------------------------------------GRRLEIPKNVNP 662 (706)
Q Consensus 636 ~~~~-~~~~~~~i~~~----------------------------------------------------~~~l~~p~~~s~ 662 (706)
...+ ..+....+... .........+++
T Consensus 248 ~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~ 327 (361)
T 4f9c_A 248 YKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPD 327 (361)
T ss_dssp SCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCH
T ss_pred CCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCH
Confidence 6543 32222221100 000122346789
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 663 MVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 663 el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
++.+||.+||+.||++|||++|+++
T Consensus 328 ~a~DLl~~lL~~dP~~R~ta~eaL~ 352 (361)
T 4f9c_A 328 EAYDLLDKLLDLNPASRITAEEALL 352 (361)
T ss_dssp HHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred HHHHHHHHHCcCChhHCcCHHHHhc
Confidence 9999999999999999999999875
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=423.83 Aligned_cols=249 Identities=24% Similarity=0.395 Sum_probs=218.7
Q ss_pred cCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEE
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 509 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~ 509 (706)
.++|++++.||+|+||.||+|.++.+ .||+|++.... ....+.+.+|+.+|+.++|||||+++++|.+.+.++|||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~ 233 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 233 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc--hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 36899999999999999999998755 49999986643 334567889999999999999999999999999999999
Q ss_pred EeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCC--CcEEEeecCccccCCC
Q 005247 510 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST--YTVKVCDFGLSRSKPN 587 (706)
Q Consensus 510 E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~--~~vKL~DFGla~~~~~ 587 (706)
|||+||+|.+++.... ..+++..+..++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||+|+....
T Consensus 234 E~~~gg~L~~~i~~~~--~~l~e~~~~~~~~qi~~al~ylH~~~--iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~ 309 (573)
T 3uto_A 234 EFMSGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309 (573)
T ss_dssp ECCCCCBHHHHHTCTT--SCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred eecCCCcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence 9999999999986332 35899999999999999999999999 9999999999999854 8999999999987654
Q ss_pred CcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCccc--CCCCCCcHHHH
Q 005247 588 TYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRL--EIPKNVNPMVA 665 (706)
Q Consensus 588 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l--~~p~~~s~el~ 665 (706)
.. .....+||+.|||||++.+..|+.++|||||||++|||++|..||.+.+..+....+......+ ..+..++++++
T Consensus 310 ~~-~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 388 (573)
T 3uto_A 310 KQ-SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK 388 (573)
T ss_dssp TS-EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHH
T ss_pred CC-ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence 32 2346689999999999999999999999999999999999999999999888887775443332 23467899999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHH
Q 005247 666 ALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 666 dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
+||.+||+.||.+|||+.|+++
T Consensus 389 dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 389 DFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHccCChhHCcCHHHHhc
Confidence 9999999999999999999976
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=426.48 Aligned_cols=251 Identities=25% Similarity=0.384 Sum_probs=212.5
Q ss_pred cccccCceEEEEEeccCCceEEEEEEEcCCc--eEEEEEeccccc----hHHHHHHHHHHHHHHcCCCCceeEEeccccC
Q 005247 428 LEIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFH----EDRFKEFLREVAIMKGLRHPNIVLLMGAVTE 501 (706)
Q Consensus 428 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~--vAVKvl~~~~~~----~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~ 501 (706)
..+..++|++++.||+|+||+||+|+++.++ ||+|++.+.... .........++.+++.++|||||+++++|.+
T Consensus 184 ~~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~ 263 (689)
T 3v5w_A 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT 263 (689)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC
T ss_pred CCCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE
Confidence 3455678999999999999999999987654 999999765332 1222333445677788899999999999999
Q ss_pred CCceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCc
Q 005247 502 PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL 581 (706)
Q Consensus 502 ~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGl 581 (706)
.+.+|+|||||+||+|.+++... ..+++..++.|+.||+.||+|||++| ||||||||+||||+.+|++||+|||+
T Consensus 264 ~~~lylVmEy~~GGdL~~~l~~~---~~l~E~~a~~y~~qIl~aL~yLH~~g--IiHRDLKPeNILld~~G~vKL~DFGl 338 (689)
T 3v5w_A 264 PDKLSFILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGL 338 (689)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CCEEEEEEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHeEEeCCCCEEecccce
Confidence 99999999999999999999743 35999999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCcccCCCCCCCCCccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHhhhcCcccCCC
Q 005247 582 SRSKPNTYISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTP---SQVISAVGFKGRRLEIP 657 (706)
Q Consensus 582 a~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~---~~~~~~i~~~~~~l~~p 657 (706)
|+..... ...+.+||+.|||||++.+ ..|+.++|||||||+||||++|+.||...+. .++...+ ....+.+|
T Consensus 339 A~~~~~~--~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i--~~~~~~~p 414 (689)
T 3v5w_A 339 ACDFSKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT--LTMAVELP 414 (689)
T ss_dssp CEECSSC--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHH--HHCCCCCC
T ss_pred eeecCCC--CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhh--cCCCCCCC
Confidence 9876543 2356799999999999974 5799999999999999999999999976432 2233333 34456788
Q ss_pred CCCcHHHHHHHHHhhhhCCCCCCC-----HHHHHH
Q 005247 658 KNVNPMVAALIETCWAEEPEIRPS-----FPSIME 687 (706)
Q Consensus 658 ~~~s~el~dLI~~cL~~dP~~RPS-----~~eIl~ 687 (706)
..+++++++||.+||++||.+|++ +++|++
T Consensus 415 ~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 415 DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp TTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred ccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 999999999999999999999998 688776
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=369.68 Aligned_cols=261 Identities=29% Similarity=0.595 Sum_probs=232.8
Q ss_pred cccccCceEEEEEeccCCceEEEEEEEcCCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCC--Cce
Q 005247 428 LEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP--PNL 505 (706)
Q Consensus 428 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~--~~~ 505 (706)
..+..++|++.+.||+|+||.||+|.+.++.+|+|++..........+.+.+|+.++++++||||+++++++.+. +..
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (271)
T 3kmu_A 5 SGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHP 84 (271)
T ss_dssp CCCCGGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSC
T ss_pred CCCCHHHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCe
Confidence 456778999999999999999999999988899999988776777778899999999999999999999999877 788
Q ss_pred EEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccC
Q 005247 506 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK 585 (706)
Q Consensus 506 ~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~ 585 (706)
++||||+++|+|.++++... ...+++..++.++.||+.||.|||+++++|+||||||+||+++.++.++|+|||++...
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 85 TLITHWMPYGSLYNVLHEGT-NFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp EEEEECCTTCBHHHHHHSCS-SCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred EeeecccCCCcHHHHHhhcc-cCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeee
Confidence 99999999999999997533 23589999999999999999999998878999999999999999999999999987653
Q ss_pred CCCcccCCCCCCCCCccCccccccCCCCc---hhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcH
Q 005247 586 PNTYISSKTAAGTPEWMAPEVLREDPSNE---KSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNP 662 (706)
Q Consensus 586 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~---ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~ 662 (706)
.. ....||+.|+|||++.+..++. ++||||||+++|||++|+.||......+....+.....+..++..+++
T Consensus 164 ~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (271)
T 3kmu_A 164 QS-----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISP 238 (271)
T ss_dssp SC-----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCH
T ss_pred cc-----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCH
Confidence 22 3457899999999998765544 899999999999999999999998888877777667777888899999
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 005247 663 MVAALIETCWAEEPEIRPSFPSIMETLQQFLM 694 (706)
Q Consensus 663 el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~ 694 (706)
++.+||.+||+.||++|||+.++++.|+++..
T Consensus 239 ~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 239 HVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 99999999999999999999999999998753
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=382.07 Aligned_cols=278 Identities=29% Similarity=0.503 Sum_probs=214.7
Q ss_pred cCcccccCceEEEEEeccCCceEEEEEEEcCC-----ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEecccc
Q 005247 426 EGLEIRWSELLIKKKIGEGSFGTVYHAEWRNS-----DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 500 (706)
Q Consensus 426 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~-----~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~ 500 (706)
+...+..++|++.+.||+|+||.||+|.+..+ .||+|++..........+.+.+|+.++++++||||+++++++.
T Consensus 16 ~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 95 (323)
T 3qup_A 16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSL 95 (323)
T ss_dssp CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEE
T ss_pred hhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceee
Confidence 34567778999999999999999999987644 4899998766555666788999999999999999999999987
Q ss_pred CCCce------EEEEEeccCCchhhhcccC---CCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCC
Q 005247 501 EPPNL------SIVTEYLSRGSLYKLLHIP---DARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST 571 (706)
Q Consensus 501 ~~~~~------~lV~E~~~ggsL~~~l~~~---~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~ 571 (706)
..... ++||||+.+|+|.+++... .....+++..++.++.||+.||.|||++| |+||||||+|||++.+
T Consensus 96 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--ivH~Dikp~NIli~~~ 173 (323)
T 3qup_A 96 RSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN--FIHRDLAARNCMLAED 173 (323)
T ss_dssp CC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTT
T ss_pred ccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC--cccCCCCcceEEEcCC
Confidence 76654 9999999999999998532 12225889999999999999999999999 9999999999999999
Q ss_pred CcEEEeecCccccCCCCcc--cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhh
Q 005247 572 YTVKVCDFGLSRSKPNTYI--SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVG 648 (706)
Q Consensus 572 ~~vKL~DFGla~~~~~~~~--~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~ 648 (706)
+.+||+|||+++....... ......+++.|+|||++.+..++.++||||||+++|||++ |..||......+....+.
T Consensus 174 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~ 253 (323)
T 3qup_A 174 MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI 253 (323)
T ss_dssp SCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH
T ss_pred CCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHh
Confidence 9999999999986543321 2234456789999999999999999999999999999999 899999888877776653
Q ss_pred hcCcccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhccCCCCCCCCC
Q 005247 649 FKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQPLSAQPL 706 (706)
Q Consensus 649 ~~~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~~~~~~s~~p~ 706 (706)
.......+..+++++.+||.+||+.||++|||+.++++.|++++......+.+..||
T Consensus 254 -~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~pl 310 (323)
T 3qup_A 254 -GGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDPL 310 (323)
T ss_dssp -TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-----------
T ss_pred -cCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCCCC
Confidence 455677788999999999999999999999999999999999999988888888775
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=383.82 Aligned_cols=250 Identities=29% Similarity=0.466 Sum_probs=223.1
Q ss_pred cccCceEEEEEeccCCceEEEEEEEc--CCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEE
Q 005247 430 IRWSELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI 507 (706)
Q Consensus 430 i~~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l 507 (706)
...++|++.+.||+|+||.||+|.+. +..||+|++..........+.+.+|+.+++.++||||+++++++...+..++
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 91 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYL 91 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence 44678999999999999999999985 4459999998877777777889999999999999999999999999999999
Q ss_pred EEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCC
Q 005247 508 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 587 (706)
Q Consensus 508 V~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 587 (706)
||||+++|+|.+++... ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++....
T Consensus 92 v~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 92 IMEYASGGEVFDYLVAH---GRMKEKEARSKFRQIVSAVQYCHQKR--IVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp EECCCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred EEECCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 99999999999998643 35889999999999999999999999 99999999999999999999999999976543
Q ss_pred CcccCCCCCCCCCccCccccccCCCC-chhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHH
Q 005247 588 TYISSKTAAGTPEWMAPEVLREDPSN-EKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA 666 (706)
Q Consensus 588 ~~~~~~~~~Gt~~Y~APE~l~~~~~s-~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~d 666 (706)
.. .....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||...+..+....+.. ....+|..+++++.+
T Consensus 167 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~ 243 (328)
T 3fe3_A 167 GG-KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLR--GKYRIPFYMSTDCEN 243 (328)
T ss_dssp SC-GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTSCHHHHH
T ss_pred CC-ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCCCCCCCCCHHHHH
Confidence 32 23567899999999999988875 799999999999999999999999988887777643 345667889999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHH
Q 005247 667 LIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 667 LI~~cL~~dP~~RPS~~eIl~ 687 (706)
||.+||+.||.+|||++|+++
T Consensus 244 li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 244 LLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp HHHHHCCSSTTTSCCHHHHTT
T ss_pred HHHHHCCCChhHCcCHHHHhc
Confidence 999999999999999999976
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-44 Score=380.37 Aligned_cols=270 Identities=36% Similarity=0.526 Sum_probs=228.9
Q ss_pred cccccCceEEEEEeccCCceEEEEEEEcCC-----ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCC
Q 005247 428 LEIRWSELLIKKKIGEGSFGTVYHAEWRNS-----DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP 502 (706)
Q Consensus 428 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~-----~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~ 502 (706)
.++..++|++.+.||+|+||.||+|.+..+ .||||++.... .....+.+.+|+.+++.++||||+++++++.+.
T Consensus 44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 122 (325)
T 3kul_A 44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG 122 (325)
T ss_dssp CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGG
T ss_pred cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 356678999999999999999999988532 29999986543 455567899999999999999999999999999
Q ss_pred CceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCcc
Q 005247 503 PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS 582 (706)
Q Consensus 503 ~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla 582 (706)
+..++||||+++++|.++++... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a 198 (325)
T 3kul_A 123 RLAMIVTEYMENGSLDTFLRTHD--GQFTIMQLVGMLRGVGAGMRYLSDLG--YVHRDLAARNVLVDSNLVCKVSDFGLS 198 (325)
T ss_dssp GCCEEEEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCSSC
T ss_pred CccEEEeeCCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEECCCCCEEECCCCcc
Confidence 99999999999999999996432 35889999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCcc---cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCCC
Q 005247 583 RSKPNTYI---SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPK 658 (706)
Q Consensus 583 ~~~~~~~~---~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p~ 658 (706)
+....... ......+|+.|+|||++.+..++.++||||||+++|||++ |..||......+....+. ...+...+.
T Consensus 199 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~ 277 (325)
T 3kul_A 199 RVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE-EGYRLPAPM 277 (325)
T ss_dssp EECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH-TTCCCCCCT
T ss_pred cccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH-cCCCCCCCC
Confidence 87544321 1223456778999999999999999999999999999999 999999988888777664 445677788
Q ss_pred CCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhccCCCCCC
Q 005247 659 NVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQPLSA 703 (706)
Q Consensus 659 ~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~~~~~~s~ 703 (706)
.+++++.+||.+||..||++|||+.+|++.|+.++.+....+.++
T Consensus 278 ~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~~~~~~ 322 (325)
T 3kul_A 278 GCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESLRATA 322 (325)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC------
T ss_pred CcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcccccccC
Confidence 999999999999999999999999999999999999877665554
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=385.99 Aligned_cols=265 Identities=32% Similarity=0.578 Sum_probs=229.6
Q ss_pred cccccCceEEEEEeccCCceEEEEEEEcC---------CceEEEEEeccccchHHHHHHHHHHHHHHcC-CCCceeEEec
Q 005247 428 LEIRWSELLIKKKIGEGSFGTVYHAEWRN---------SDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMG 497 (706)
Q Consensus 428 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~---------~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~ 497 (706)
+++..++|++.+.||+|+||.||+|++.+ ..||+|++... ......+.+.+|+.+++.+ +||||+++++
T Consensus 76 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 154 (370)
T 2psq_A 76 WEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLG 154 (370)
T ss_dssp TBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT-CBHHHHHHHHHHHHHHHHSCCCTTBCCEEE
T ss_pred ccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC-cCHHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence 45667899999999999999999998742 13899998654 3455667899999999999 8999999999
Q ss_pred cccCCCceEEEEEeccCCchhhhcccCCC-------------cccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCC
Q 005247 498 AVTEPPNLSIVTEYLSRGSLYKLLHIPDA-------------RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSP 564 (706)
Q Consensus 498 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~-------------~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~ 564 (706)
++.+.+.+++||||+.+|+|.+++..... ...+++..++.++.||+.||+|||++| |+||||||+
T Consensus 155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~ 232 (370)
T 2psq_A 155 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAAR 232 (370)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGG
T ss_pred EEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchh
Confidence 99999999999999999999999964321 234788999999999999999999999 999999999
Q ss_pred cEEECCCCcEEEeecCccccCCCCc--ccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChH
Q 005247 565 NLLVDSTYTVKVCDFGLSRSKPNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPS 641 (706)
Q Consensus 565 NILl~~~~~vKL~DFGla~~~~~~~--~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~ 641 (706)
|||++.++.+||+|||+++...... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 233 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~ 312 (370)
T 2psq_A 233 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 312 (370)
T ss_dssp GEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred hEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 9999999999999999998654432 12234567889999999999999999999999999999999 99999988877
Q ss_pred HHHHHhhhcCcccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhc
Q 005247 642 QVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 696 (706)
Q Consensus 642 ~~~~~i~~~~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~ 696 (706)
+....+. ...+...+..++.++.+||.+||+.||++|||+.++++.|++++...
T Consensus 313 ~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~ 366 (370)
T 2psq_A 313 ELFKLLK-EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 366 (370)
T ss_dssp GHHHHHH-TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHh-cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 7766553 45567788899999999999999999999999999999999998654
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=382.34 Aligned_cols=250 Identities=26% Similarity=0.451 Sum_probs=220.4
Q ss_pred ccCceEEEEEeccCCceEEEEEEEcC--CceEEEEEecccc-chHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEE
Q 005247 431 RWSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI 507 (706)
Q Consensus 431 ~~~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l 507 (706)
..++|++++.||+|+||+||+|++.. ..||+|++.+... .....+.+.+|+.+++.++||||+++++++.+.+.+++
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 82 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEE
Confidence 45789999999999999999999864 4499999876432 22335678899999999999999999999999999999
Q ss_pred EEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCC
Q 005247 508 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 587 (706)
Q Consensus 508 V~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 587 (706)
||||+++|+|.+++... ..+++..++.++.||+.||+|||++| |+||||||+|||++.+|.+||+|||+++....
T Consensus 83 v~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 83 VMEYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EEECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 99999999999998643 35889999999999999999999999 99999999999999999999999999986544
Q ss_pred CcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHH
Q 005247 588 TYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAAL 667 (706)
Q Consensus 588 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dL 667 (706)
........+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+.. ....+|..+++++.+|
T Consensus 158 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~l 235 (337)
T 1o6l_A 158 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM--EEIRFPRTLSPEAKSL 235 (337)
T ss_dssp TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTSCHHHHHH
T ss_pred CCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHc--CCCCCCCCCCHHHHHH
Confidence 43344567899999999999999999999999999999999999999999888777766643 3556788999999999
Q ss_pred HHHhhhhCCCCCC-----CHHHHHH
Q 005247 668 IETCWAEEPEIRP-----SFPSIME 687 (706)
Q Consensus 668 I~~cL~~dP~~RP-----S~~eIl~ 687 (706)
|.+||+.||++|| ++.+|++
T Consensus 236 i~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 236 LAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp HHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 9999999999999 8999977
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=364.02 Aligned_cols=261 Identities=34% Similarity=0.590 Sum_probs=228.7
Q ss_pred CcccccCceEEEEEeccCCceEEEEEEEcC-CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCce
Q 005247 427 GLEIRWSELLIKKKIGEGSFGTVYHAEWRN-SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNL 505 (706)
Q Consensus 427 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 505 (706)
.+.+..++|++.+.||+|+||.||+|.+.+ ..||+|++....... +.+.+|+.++++++||||+++++++.+.+..
T Consensus 4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (269)
T 4hcu_A 4 KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI 80 (269)
T ss_dssp -CBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred cEEeChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCH---HHHHHHHHHHHhCCCCCEeeEEEEEecCCce
Confidence 356777899999999999999999999854 459999987655443 4688999999999999999999999999999
Q ss_pred EEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccC
Q 005247 506 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK 585 (706)
Q Consensus 506 ~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~ 585 (706)
++||||+++++|.++++... ..+++..++.++.|++.||.|||++| |+||||||+||+++.++.+||+|||+++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 156 (269)
T 4hcu_A 81 CLVFEFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFV 156 (269)
T ss_dssp EEEEECCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECGGGCEEECCTTGGGGB
T ss_pred EEEEEeCCCCcHHHHHHhcC--cccCHHHHHHHHHHHHHHHHHHHhCC--eecCCcchheEEEcCCCCEEeccccccccc
Confidence 99999999999999996433 35889999999999999999999999 999999999999999999999999999865
Q ss_pred CCCc-ccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCCCCCcHH
Q 005247 586 PNTY-ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPM 663 (706)
Q Consensus 586 ~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~e 663 (706)
.... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||......+....+. ...+...+..+++.
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 235 (269)
T 4hcu_A 157 LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKPRLASTH 235 (269)
T ss_dssp CCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TTCCCCCCTTSCHH
T ss_pred cccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh-cCccCCCCCcCCHH
Confidence 4432 22334567888999999999999999999999999999999 999999988877776664 44566677889999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHh
Q 005247 664 VAALIETCWAEEPEIRPSFPSIMETLQQFLMS 695 (706)
Q Consensus 664 l~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s 695 (706)
+.+||.+||+.||++|||+.++++.|+++..+
T Consensus 236 ~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 236 VYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 99999999999999999999999999999875
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=365.40 Aligned_cols=259 Identities=39% Similarity=0.663 Sum_probs=215.8
Q ss_pred cccccCceEEEEEeccCCceEEEEEEEcCCceEEEEEeccccc--hHHHHHHHHHHHHHHcCCCCceeEEeccccCCCce
Q 005247 428 LEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFH--EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNL 505 (706)
Q Consensus 428 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKvl~~~~~~--~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 505 (706)
+++..++|++.+.||+|+||.||+|.+.++.+|+|++...... ....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 2 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (271)
T 3dtc_A 2 LEIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNL 81 (271)
T ss_dssp CBCCTTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--C
T ss_pred CccchhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCce
Confidence 3567789999999999999999999999888999998654322 23346788999999999999999999999999999
Q ss_pred EEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcC-CCcccccCCCCcEEECC--------CCcEEE
Q 005247 506 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR-PPIVHRDLKSPNLLVDS--------TYTVKV 576 (706)
Q Consensus 506 ~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g-~~IIHrDLKp~NILl~~--------~~~vKL 576 (706)
++||||+++++|.++++.. .+++..++.++.|++.||.|||+++ .+|+||||||+|||++. ++.+||
T Consensus 82 ~lv~e~~~~~~L~~~~~~~----~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl 157 (271)
T 3dtc_A 82 CLVMEFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI 157 (271)
T ss_dssp EEEEECCTTEEHHHHHTSS----CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred EEEEEcCCCCCHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEE
Confidence 9999999999999998632 5889999999999999999999998 33889999999999986 678999
Q ss_pred eecCccccCCCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCC
Q 005247 577 CDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEI 656 (706)
Q Consensus 577 ~DFGla~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~ 656 (706)
+|||++....... .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||...........+........+
T Consensus 158 ~Dfg~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 235 (271)
T 3dtc_A 158 TDFGLAREWHRTT--KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPI 235 (271)
T ss_dssp CCCCC---------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCC
T ss_pred ccCCccccccccc--ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCC
Confidence 9999998654432 23557999999999999999999999999999999999999999998887777777666667788
Q ss_pred CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 005247 657 PKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQF 692 (706)
Q Consensus 657 p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~l 692 (706)
+..+++.+.+||.+||+.||++|||+.++++.|+++
T Consensus 236 ~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 236 PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred CcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 889999999999999999999999999999999754
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=381.61 Aligned_cols=269 Identities=31% Similarity=0.559 Sum_probs=229.0
Q ss_pred ccCcccccCceEEEEEeccCCceEEEEEEEcC-------CceEEEEEeccccchHHHHHHHHHHHHHHcC-CCCceeEEe
Q 005247 425 EEGLEIRWSELLIKKKIGEGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLM 496 (706)
Q Consensus 425 ~~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~-------~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~ 496 (706)
...+++..++|++.+.||+|+||.||+|.+.+ ..||||++.... .....+.+.+|+.+++++ +||||++++
T Consensus 14 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpniv~~~ 92 (359)
T 3vhe_A 14 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLL 92 (359)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC-CHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence 34567888999999999999999999998543 349999986543 445567899999999999 799999999
Q ss_pred ccccCCCc-eEEEEEeccCCchhhhcccCCC-------------------------------------------------
Q 005247 497 GAVTEPPN-LSIVTEYLSRGSLYKLLHIPDA------------------------------------------------- 526 (706)
Q Consensus 497 ~~~~~~~~-~~lV~E~~~ggsL~~~l~~~~~------------------------------------------------- 526 (706)
+++.+.+. .++||||+.+|+|.++++....
T Consensus 93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (359)
T 3vhe_A 93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS 172 (359)
T ss_dssp EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence 99877554 8999999999999999964432
Q ss_pred --------------cccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCC--cc
Q 005247 527 --------------RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT--YI 590 (706)
Q Consensus 527 --------------~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~--~~ 590 (706)
...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..... ..
T Consensus 173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 250 (359)
T 3vhe_A 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 250 (359)
T ss_dssp -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCE
T ss_pred cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCCCcEEEEeccceeeecccccch
Confidence 122889999999999999999999999 999999999999999999999999999865332 22
Q ss_pred cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHHH
Q 005247 591 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIE 669 (706)
Q Consensus 591 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI~ 669 (706)
......||+.|+|||++.+..++.++||||||+++|||++ |..||......+..............+..+++++.+||.
T Consensus 251 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 330 (359)
T 3vhe_A 251 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTML 330 (359)
T ss_dssp EC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHH
T ss_pred hccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence 2344568899999999999999999999999999999998 999998877655555555566677888899999999999
Q ss_pred HhhhhCCCCCCCHHHHHHHHHHHHHhc
Q 005247 670 TCWAEEPEIRPSFPSIMETLQQFLMSS 696 (706)
Q Consensus 670 ~cL~~dP~~RPS~~eIl~~L~~ll~s~ 696 (706)
+||+.||++|||+.++++.|+.++...
T Consensus 331 ~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 331 DCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 999999999999999999999998753
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=373.24 Aligned_cols=249 Identities=27% Similarity=0.453 Sum_probs=218.3
Q ss_pred ccCceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEE
Q 005247 431 RWSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIV 508 (706)
Q Consensus 431 ~~~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV 508 (706)
...+|++.+.||+|+||.||+|.+.. ..||+|++....... .+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 95 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH--HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEE
Confidence 34679999999999999999998754 459999987654333 35788999999999999999999999999999999
Q ss_pred EEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCC
Q 005247 509 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 588 (706)
Q Consensus 509 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 588 (706)
|||+.+|+|.+++... .+++..++.++.|++.||.|||++| |+||||||+|||++.++.+||+|||++......
T Consensus 96 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (297)
T 3fxz_A 96 MEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (297)
T ss_dssp EECCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EECCCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence 9999999999998643 4889999999999999999999999 999999999999999999999999999876655
Q ss_pred cccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhc-CcccCCCCCCcHHHHHH
Q 005247 589 YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-GRRLEIPKNVNPMVAAL 667 (706)
Q Consensus 589 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~-~~~l~~p~~~s~el~dL 667 (706)
........||+.|+|||++.+..++.++||||||+++|||++|..||...+.......+... ......+..+++.+.+|
T Consensus 170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 249 (297)
T 3fxz_A 170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDF 249 (297)
T ss_dssp TCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHH
T ss_pred ccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHH
Confidence 44556678999999999999999999999999999999999999999988876665554332 33455677899999999
Q ss_pred HHHhhhhCCCCCCCHHHHHH
Q 005247 668 IETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 668 I~~cL~~dP~~RPS~~eIl~ 687 (706)
|.+||+.||++|||+.++++
T Consensus 250 i~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 250 LNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp HHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHccCChhHCcCHHHHhh
Confidence 99999999999999999976
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=379.97 Aligned_cols=272 Identities=32% Similarity=0.578 Sum_probs=234.9
Q ss_pred cCcccccCceEEEEEeccCCceEEEEEEEcC---------CceEEEEEeccccchHHHHHHHHHHHHHHcC-CCCceeEE
Q 005247 426 EGLEIRWSELLIKKKIGEGSFGTVYHAEWRN---------SDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLL 495 (706)
Q Consensus 426 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~---------~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l 495 (706)
..+++..++|++.+.||+|+||.||+|.+.+ ..||+|++... ......+.+.+|+.+++.+ +||||+++
T Consensus 62 ~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~ 140 (382)
T 3tt0_A 62 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINL 140 (382)
T ss_dssp TTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhhh
Confidence 3456778899999999999999999998743 23899998654 3455667899999999999 89999999
Q ss_pred eccccCCCceEEEEEeccCCchhhhcccCCC-------------cccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCC
Q 005247 496 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDA-------------RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLK 562 (706)
Q Consensus 496 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~-------------~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLK 562 (706)
++++.+.+..++||||+.+|+|.+++..... ...+++..++.++.||+.||+|||+++ |+|||||
T Consensus 141 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlk 218 (382)
T 3tt0_A 141 LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLA 218 (382)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCC
T ss_pred eeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--EecCCCC
Confidence 9999999999999999999999999964321 235899999999999999999999999 9999999
Q ss_pred CCcEEECCCCcEEEeecCccccCCCCc--ccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 005247 563 SPNLLVDSTYTVKVCDFGLSRSKPNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNST 639 (706)
Q Consensus 563 p~NILl~~~~~vKL~DFGla~~~~~~~--~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~ 639 (706)
|+|||++.++.+||+|||+++...... .......+|+.|+|||++.+..++.++||||||+++|||++ |..||....
T Consensus 219 p~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~ 298 (382)
T 3tt0_A 219 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 298 (382)
T ss_dssp GGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999999998654432 22334567889999999999999999999999999999999 999999988
Q ss_pred hHHHHHHhhhcCcccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhccCCCC
Q 005247 640 PSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQPL 701 (706)
Q Consensus 640 ~~~~~~~i~~~~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~~~~~~ 701 (706)
..+....+. ...+...+..+++++.+||.+||+.||++|||+.+|++.|++++.....+..
T Consensus 299 ~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~ 359 (382)
T 3tt0_A 299 VEELFKLLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEM 359 (382)
T ss_dssp HHHHHHHHH-TTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC-
T ss_pred HHHHHHHHH-cCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCCC
Confidence 877766653 5556777889999999999999999999999999999999999987655443
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=366.96 Aligned_cols=252 Identities=29% Similarity=0.450 Sum_probs=210.7
Q ss_pred cccCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccch------------------------HHHHHHHHHHHH
Q 005247 430 IRWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHE------------------------DRFKEFLREVAI 483 (706)
Q Consensus 430 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~------------------------~~~~~~~~Ei~i 483 (706)
+..++|++.+.||+|+||.||+|.+..+ .||+|++....... ...+.+.+|+.+
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 4467899999999999999999988654 49999986653211 123568899999
Q ss_pred HHcCCCCceeEEeccccC--CCceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccC
Q 005247 484 MKGLRHPNIVLLMGAVTE--PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDL 561 (706)
Q Consensus 484 L~~L~HpnIv~l~~~~~~--~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDL 561 (706)
++.++||||+++++++.+ .+..++||||+++++|.+++.. ..+++..++.++.||+.||+|||++| |+||||
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dl 163 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL----KPLSEDQARFYFQDLIKGIEYLHYQK--IIHRDI 163 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS----SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCC
T ss_pred HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCC
Confidence 999999999999999876 5678999999999999887642 35899999999999999999999999 999999
Q ss_pred CCCcEEECCCCcEEEeecCccccCCCCcccCCCCCCCCCccCccccccCC---CCchhHHHHHHHHHHHHHhCCCCCCCC
Q 005247 562 KSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDP---SNEKSDVFSFGVILWELITLQKPWRNS 638 (706)
Q Consensus 562 Kp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~---~s~ksDVwSLGviL~ELltG~~Pf~~~ 638 (706)
||+|||++.++.+||+|||+++.............||+.|+|||++.+.. ++.++||||||+++|+|++|+.||...
T Consensus 164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 243 (298)
T 2zv2_A 164 KPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243 (298)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CHHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence 99999999999999999999987655433345668999999999998765 378899999999999999999999988
Q ss_pred ChHHHHHHhhhcCcccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 639 TPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 639 ~~~~~~~~i~~~~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
........+.......+....+++++.+||.+||+.||++|||+.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 244 RIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp SHHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cHHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 8777666665444444445678999999999999999999999999875
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=369.12 Aligned_cols=266 Identities=32% Similarity=0.584 Sum_probs=230.3
Q ss_pred cCcccccCceEEEEEeccCCceEEEEEEEcC-------CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEecc
Q 005247 426 EGLEIRWSELLIKKKIGEGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA 498 (706)
Q Consensus 426 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~-------~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~ 498 (706)
..+++..++|++.+.||+|+||.||+|.+.. ..||+|++.... .....+.+.+|+.+++.++||||++++++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 94 (314)
T 2ivs_A 16 PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELRDLLSEFNVLKQVNHPHVIKLYGA 94 (314)
T ss_dssp TTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred cccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCceeeEEEE
Confidence 4467778899999999999999999998732 348999886443 45566789999999999999999999999
Q ss_pred ccCCCceEEEEEeccCCchhhhcccCCC---------------------cccccHHHHHHHHHHHHHHHHHHHhcCCCcc
Q 005247 499 VTEPPNLSIVTEYLSRGSLYKLLHIPDA---------------------RVVVDERLRLNMAYDVAKGMNYLHQRRPPIV 557 (706)
Q Consensus 499 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~---------------------~~~l~~~~~~~ia~qIl~aL~yLHs~g~~II 557 (706)
+.+.+..++||||+.+++|.+++..... ...+++..++.++.||+.||.|||++| |+
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iv 172 (314)
T 2ivs_A 95 CSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--LV 172 (314)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT--EE
T ss_pred EecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC--Cc
Confidence 9999999999999999999999964322 234889999999999999999999999 99
Q ss_pred cccCCCCcEEECCCCcEEEeecCccccCCCCc--ccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCC
Q 005247 558 HRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKP 634 (706)
Q Consensus 558 HrDLKp~NILl~~~~~vKL~DFGla~~~~~~~--~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~P 634 (706)
||||||+||+++.++.+||+|||+++...... .......+|+.|+|||++.+..++.++||||||+++|||++ |..|
T Consensus 173 H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 252 (314)
T 2ivs_A 173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252 (314)
T ss_dssp CCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred ccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999999998654332 12334567889999999999999999999999999999999 9999
Q ss_pred CCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHh
Q 005247 635 WRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS 695 (706)
Q Consensus 635 f~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s 695 (706)
|......+....+. .......+..+++++.+||.+||+.||++|||+.++++.|++++..
T Consensus 253 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 253 YPGIPPERLFNLLK-TGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp STTCCGGGHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCCHHHHHHHhh-cCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 99888877766553 4456677889999999999999999999999999999999999875
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=365.52 Aligned_cols=263 Identities=32% Similarity=0.557 Sum_probs=215.8
Q ss_pred CcccccCceEEEEEeccCCceEEEEEEEcCC-----ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccC
Q 005247 427 GLEIRWSELLIKKKIGEGSFGTVYHAEWRNS-----DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE 501 (706)
Q Consensus 427 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~-----~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~ 501 (706)
.+++..++|++.+.||+|+||.||+|.+..+ .||+|++... ......+.+.+|+.++++++||||+++++++.
T Consensus 9 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~- 86 (281)
T 1mp8_A 9 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 86 (281)
T ss_dssp CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred ceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-
Confidence 4567788999999999999999999987543 2777776443 24455678999999999999999999999985
Q ss_pred CCceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCc
Q 005247 502 PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL 581 (706)
Q Consensus 502 ~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGl 581 (706)
.+..++||||+.+++|.+++.... ..+++..++.++.|++.||.|||++| |+||||||+|||++.++.+||+|||+
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~ 162 (281)
T 1mp8_A 87 ENPVWIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGL 162 (281)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECC---
T ss_pred cCccEEEEecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHEEECCCCCEEECcccc
Confidence 456899999999999999997432 35889999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCcc-cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCCCC
Q 005247 582 SRSKPNTYI-SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKN 659 (706)
Q Consensus 582 a~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p~~ 659 (706)
++....... ......+|+.|+|||++.+..++.++||||||+++|||++ |..||......+....+. ...+..++..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~-~~~~~~~~~~ 241 (281)
T 1mp8_A 163 SRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPN 241 (281)
T ss_dssp ----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-TTCCCCCCTT
T ss_pred ccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHH-cCCCCCCCCC
Confidence 987544321 2234456789999999999999999999999999999997 999999888777776664 4456678889
Q ss_pred CcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhc
Q 005247 660 VNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 696 (706)
Q Consensus 660 ~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~ 696 (706)
+++++.+||.+||+.||++|||+.++++.|++++.+.
T Consensus 242 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 278 (281)
T 1mp8_A 242 CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278 (281)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 9999999999999999999999999999999998764
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=376.33 Aligned_cols=266 Identities=34% Similarity=0.542 Sum_probs=227.5
Q ss_pred cccccCceEEEEEeccCCceEEEEEEEcC-------CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEecccc
Q 005247 428 LEIRWSELLIKKKIGEGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 500 (706)
Q Consensus 428 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~-------~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~ 500 (706)
+++..++|++.+.||+|+||.||+|.+.+ ..||+|++.... .....+.+.+|+.+++.++||||+++++++.
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 45677899999999999999999999864 449999986543 4455678999999999999999999999999
Q ss_pred CCCceEEEEEeccCCchhhhcccCCC---------------------cccccHHHHHHHHHHHHHHHHHHHhcCCCcccc
Q 005247 501 EPPNLSIVTEYLSRGSLYKLLHIPDA---------------------RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHR 559 (706)
Q Consensus 501 ~~~~~~lV~E~~~ggsL~~~l~~~~~---------------------~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHr 559 (706)
+.+..++||||+++|+|.+++..... ...+++..++.++.||+.||.|||++| |+||
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--ivH~ 198 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHR 198 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCS
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecC
Confidence 99999999999999999999864321 146889999999999999999999999 9999
Q ss_pred cCCCCcEEECCCCcEEEeecCccccCCCCc--ccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCC
Q 005247 560 DLKSPNLLVDSTYTVKVCDFGLSRSKPNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWR 636 (706)
Q Consensus 560 DLKp~NILl~~~~~vKL~DFGla~~~~~~~--~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~ 636 (706)
||||+|||++.++.+||+|||+++...... .......+|+.|+|||++.+..++.++||||||+++|||++ |..||.
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 278 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 278 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence 999999999999999999999987543221 12234567899999999999999999999999999999999 999999
Q ss_pred CCChHHHHHHhhhcCcccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhcc
Q 005247 637 NSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSV 697 (706)
Q Consensus 637 ~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~~ 697 (706)
.....+....+. ......++..+++++.+||.+||+.||++|||+.++++.|+++.....
T Consensus 279 ~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~ 338 (343)
T 1luf_A 279 GMAHEEVIYYVR-DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE 338 (343)
T ss_dssp TSCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred CCChHHHHHHHh-CCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence 988877776663 445567788999999999999999999999999999999999886643
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=385.23 Aligned_cols=264 Identities=35% Similarity=0.570 Sum_probs=229.2
Q ss_pred cCcccccCceEEEEEeccCCceEEEEEEEc--CCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCC
Q 005247 426 EGLEIRWSELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP 503 (706)
Q Consensus 426 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 503 (706)
..+.+..++|++.+.||+|+||.||+|.+. +..||+|++... ......+.+.+|+.++++++||||+++++++...+
T Consensus 107 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 185 (377)
T 3cbl_A 107 DKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ 185 (377)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred cccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCC
Confidence 456778889999999999999999999986 445999987643 34455567899999999999999999999999999
Q ss_pred ceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccc
Q 005247 504 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 583 (706)
Q Consensus 504 ~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~ 583 (706)
..++||||+++|+|.++++..+ ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 186 ~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nil~~~~~~~kl~DfG~s~ 261 (377)
T 3cbl_A 186 PIYIVMELVQGGDFLTFLRTEG--ARLRVKTLLQMVGDAAAGMEYLESKC--CIHRDLAARNCLVTEKNVLKISDFGMSR 261 (377)
T ss_dssp SCEEEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred CcEEEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--cCCcccCHHHEEEcCCCcEEECcCCCce
Confidence 9999999999999999996432 35889999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCcccC--CCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCCCCC
Q 005247 584 SKPNTYISS--KTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNV 660 (706)
Q Consensus 584 ~~~~~~~~~--~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~ 660 (706)
......... ....++..|+|||++.+..++.++||||||+++|||++ |..||......+....+. ...+++.|..+
T Consensus 262 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~ 340 (377)
T 3cbl_A 262 EEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE-KGGRLPCPELC 340 (377)
T ss_dssp ECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHH-TTCCCCCCTTC
T ss_pred ecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCC
Confidence 654432211 12234678999999999899999999999999999998 999999988777666553 55677888899
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHh
Q 005247 661 NPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS 695 (706)
Q Consensus 661 s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s 695 (706)
++++.+||.+||+.||++|||+.+|++.|+++.+.
T Consensus 341 ~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 341 PDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 99999999999999999999999999999998764
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-43 Score=362.49 Aligned_cols=262 Identities=33% Similarity=0.572 Sum_probs=227.1
Q ss_pred cCcccccCceEEEEEeccCCceEEEEEEEcCC-ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCc
Q 005247 426 EGLEIRWSELLIKKKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN 504 (706)
Q Consensus 426 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~-~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 504 (706)
..+++..++|++.+.||+|+||.||++.+.+. .||+|++....... +.+.+|+.+++.++||||+++++++.+.+.
T Consensus 17 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 93 (283)
T 3gen_A 17 GSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQRP 93 (283)
T ss_dssp CTTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CCccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCH---HHHHHHHHHHhcCCCCCEeeEEEEEecCCC
Confidence 45677888999999999999999999988765 49999987655443 468899999999999999999999999999
Q ss_pred eEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCcccc
Q 005247 505 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 584 (706)
Q Consensus 505 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~ 584 (706)
.++||||+.+++|.+++... ...+++..++.++.|++.||.|||++| |+||||||+||+++.++.+||+|||+++.
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 169 (283)
T 3gen_A 94 IFIITEYMANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRY 169 (283)
T ss_dssp EEEEECCCTTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTTSCEEECSTTGGGG
T ss_pred eEEEEeccCCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCccceEEEcCCCCEEEcccccccc
Confidence 99999999999999999643 235899999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCc-ccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCCCCCcH
Q 005247 585 KPNTY-ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNP 662 (706)
Q Consensus 585 ~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~ 662 (706)
..... .......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||......+....+. ...+...+..+++
T Consensus 170 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 248 (283)
T 3gen_A 170 VLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRPHLASE 248 (283)
T ss_dssp BCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-TTCCCCCCTTCCH
T ss_pred ccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHh-cccCCCCCCcCCH
Confidence 54432 12234457788999999999999999999999999999998 999999988877776663 4455667788899
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHh
Q 005247 663 MVAALIETCWAEEPEIRPSFPSIMETLQQFLMS 695 (706)
Q Consensus 663 el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s 695 (706)
.+.+||.+||+.||++|||+.++++.|++++..
T Consensus 249 ~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 249 KVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp HHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 999999999999999999999999999999865
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=383.49 Aligned_cols=252 Identities=24% Similarity=0.406 Sum_probs=214.2
Q ss_pred ccccCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEecccc-chHHHHHHHHHHHHHHcC-CCCceeEEeccccCCCc
Q 005247 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPN 504 (706)
Q Consensus 429 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~ 504 (706)
.+..++|++++.||+|+||+||+|++..+ .||+|++.+... .....+.+.+|..+++.+ +||||+++++++.+.+.
T Consensus 19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 98 (353)
T 3txo_A 19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR 98 (353)
T ss_dssp ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence 35567899999999999999999998754 499999876532 223456788999999988 69999999999999999
Q ss_pred eEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCcccc
Q 005247 505 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 584 (706)
Q Consensus 505 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~ 584 (706)
+++||||+.+|+|.++++.. ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++.
T Consensus 99 ~~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NILl~~~g~ikL~DFG~a~~ 173 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQKS---RRFDEARARFYAAEIISALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKE 173 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCHHHEEECCCCCEEEccccceee
Confidence 99999999999999998643 35899999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHH
Q 005247 585 KPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV 664 (706)
Q Consensus 585 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el 664 (706)
...........+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+.. ....+|..+++++
T Consensus 174 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~--~~~~~p~~~~~~~ 251 (353)
T 3txo_A 174 GICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN--DEVVYPTWLHEDA 251 (353)
T ss_dssp SCC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTSCHHH
T ss_pred cccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHc--CCCCCCCCCCHHH
Confidence 54444445677899999999999999999999999999999999999999999998888777743 4556778899999
Q ss_pred HHHHHHhhhhCCCCCCCH------HHHHH
Q 005247 665 AALIETCWAEEPEIRPSF------PSIME 687 (706)
Q Consensus 665 ~dLI~~cL~~dP~~RPS~------~eIl~ 687 (706)
.+||.+||+.||.+||++ .++++
T Consensus 252 ~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 252 TGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp HHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred HHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 999999999999999998 77765
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-43 Score=367.16 Aligned_cols=269 Identities=30% Similarity=0.501 Sum_probs=229.8
Q ss_pred cCcccccCceEEEEEeccCCceEEEEEEEcC-------CceEEEEEeccccchHHHHHHHHHHHHHHcC-CCCceeEEec
Q 005247 426 EGLEIRWSELLIKKKIGEGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMG 497 (706)
Q Consensus 426 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~-------~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~ 497 (706)
..+++..++|++.+.||+|+||.||+|.+.+ ..||+|++.... .....+.+.+|+.+++++ +||||+++++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 94 (313)
T 1t46_A 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLG 94 (313)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEEE
Confidence 3466778899999999999999999998632 349999986543 344557899999999999 8999999999
Q ss_pred cccCCCceEEEEEeccCCchhhhcccCCC---------------cccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCC
Q 005247 498 AVTEPPNLSIVTEYLSRGSLYKLLHIPDA---------------RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLK 562 (706)
Q Consensus 498 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~---------------~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLK 562 (706)
++.+.+..++||||+++|+|.+++..... ...+++..++.++.||+.||.|||++| |+|||||
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlk 172 (313)
T 1t46_A 95 ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLA 172 (313)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCS
T ss_pred EEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCc
Confidence 99999999999999999999999964322 224889999999999999999999999 9999999
Q ss_pred CCcEEECCCCcEEEeecCccccCCCCcc--cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 005247 563 SPNLLVDSTYTVKVCDFGLSRSKPNTYI--SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNST 639 (706)
Q Consensus 563 p~NILl~~~~~vKL~DFGla~~~~~~~~--~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~ 639 (706)
|+||+++.++.+||+|||+++....... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||....
T Consensus 173 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 252 (313)
T 1t46_A 173 ARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (313)
T ss_dssp GGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred cceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence 9999999999999999999987654322 1234457889999999999999999999999999999999 999998876
Q ss_pred hHHHHHHhhhcCcccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhcc
Q 005247 640 PSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSV 697 (706)
Q Consensus 640 ~~~~~~~i~~~~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~~ 697 (706)
.............+...+..+++++.+||.+||+.||.+|||+.++++.|++++.+..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 310 (313)
T 1t46_A 253 VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST 310 (313)
T ss_dssp SSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred chhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhh
Confidence 6555544444555666678899999999999999999999999999999999998754
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=390.67 Aligned_cols=262 Identities=35% Similarity=0.636 Sum_probs=228.9
Q ss_pred ccCcccccCceEEEEEeccCCceEEEEEEEcCCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCC-
Q 005247 425 EEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP- 503 (706)
Q Consensus 425 ~~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~- 503 (706)
...+++..++|++.+.||+|+||.||+|.+.++.||||+++... ..+.|.+|+.+|++++||||+++++++.+..
T Consensus 185 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 260 (450)
T 1k9a_A 185 RSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 260 (450)
T ss_dssp HTTCBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTS
T ss_pred ccccccChHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCC
Confidence 34577888999999999999999999999998899999986543 3357899999999999999999999976654
Q ss_pred ceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccc
Q 005247 504 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 583 (706)
Q Consensus 504 ~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~ 583 (706)
..++||||+.+|+|.++++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 261 ~~~iv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG~a~ 337 (450)
T 1k9a_A 261 GLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTK 337 (450)
T ss_dssp CEEEEEECCTTCBHHHHHHHHC-TTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred ceEEEEEecCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEECCCCCEEEeeCCCcc
Confidence 7899999999999999997432 224788999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCCCCCcH
Q 005247 584 SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNP 662 (706)
Q Consensus 584 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~ 662 (706)
...... ....++..|+|||++.+..++.++||||||+++|||++ |..||......+....+. .+.++..|..+++
T Consensus 338 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~~p~~~~~ 413 (450)
T 1k9a_A 338 EASSTQ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPP 413 (450)
T ss_dssp ECC---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHH-TTCCCCCCTTCCH
T ss_pred cccccc---cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCcCCH
Confidence 644321 23467889999999999999999999999999999998 999999888777776663 4567788899999
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhcc
Q 005247 663 MVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSV 697 (706)
Q Consensus 663 el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~~ 697 (706)
++.+||.+||+.||.+|||+.+|++.|+++.....
T Consensus 414 ~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~~l 448 (450)
T 1k9a_A 414 AVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHEL 448 (450)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHhhc
Confidence 99999999999999999999999999999987643
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=388.19 Aligned_cols=251 Identities=25% Similarity=0.378 Sum_probs=221.3
Q ss_pred cCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEE
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 509 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~ 509 (706)
.++|++.+.||+|+||.||+|.+..+ .+|+|++..........+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 46799999999999999999988644 4999999877766667788999999999999999999999999999999999
Q ss_pred EeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEEC---CCCcEEEeecCccccCC
Q 005247 510 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVD---STYTVKVCDFGLSRSKP 586 (706)
Q Consensus 510 E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~---~~~~vKL~DFGla~~~~ 586 (706)
||+.+|+|.+.+... ..+++..+..++.||+.||.|||++| |+||||||+|||++ .++.+||+|||+++...
T Consensus 90 E~~~gg~L~~~i~~~---~~~~e~~~~~i~~qil~aL~~lH~~g--ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~ 164 (444)
T 3soa_A 90 DLVTGGELFEDIVAR---EYYSEADASHCIQQILEAVLHCHQMG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE 164 (444)
T ss_dssp CCCBCCBHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred EeCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence 999999999988643 35899999999999999999999999 99999999999998 46789999999998776
Q ss_pred CCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCC--CCCcHHH
Q 005247 587 NTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP--KNVNPMV 664 (706)
Q Consensus 587 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p--~~~s~el 664 (706)
..........||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.......+.+ ..+++++
T Consensus 165 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 244 (444)
T 3soa_A 165 GEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEA 244 (444)
T ss_dssp TTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred CCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHH
Confidence 55444556789999999999999999999999999999999999999999988888877775544433332 4789999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHH
Q 005247 665 AALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 665 ~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
.+||.+||+.||++|||+.|+++
T Consensus 245 ~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 245 KDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHcCCChhHCCCHHHHhc
Confidence 99999999999999999999987
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=370.87 Aligned_cols=261 Identities=33% Similarity=0.530 Sum_probs=217.8
Q ss_pred cccCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEE
Q 005247 430 IRWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI 507 (706)
Q Consensus 430 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l 507 (706)
+..++|++.+.||+|+||.||+|.+..+ .||+|++.. ......+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 84 (310)
T 3s95_A 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNF 84 (310)
T ss_dssp ECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred eChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc--CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEE
Confidence 4567899999999999999999998754 489998744 345666789999999999999999999999999999999
Q ss_pred EEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCC
Q 005247 508 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 587 (706)
Q Consensus 508 V~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 587 (706)
||||+.+++|.++++... ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++....
T Consensus 85 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 160 (310)
T 3s95_A 85 ITEYIKGGTLRGIIKSMD--SQYPWSQRVSFAKDIASGMAYLHSMN--IIHRDLNSHNCLVRENKNVVVADFGLARLMVD 160 (310)
T ss_dssp EEECCTTCBHHHHHHHCC--TTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEECTTSCEEECCCTTCEECC-
T ss_pred EEEecCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCcCeEEECCCCCEEEeecccceeccc
Confidence 999999999999997532 35889999999999999999999999 99999999999999999999999999986543
Q ss_pred Cccc--------------CCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh-hcCc
Q 005247 588 TYIS--------------SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVG-FKGR 652 (706)
Q Consensus 588 ~~~~--------------~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~-~~~~ 652 (706)
.... .....||+.|+|||++.+..++.++||||||+++|||++|..||............. ....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~ 240 (310)
T 3s95_A 161 EKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL 240 (310)
T ss_dssp -------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHH
T ss_pred ccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccc
Confidence 3211 115579999999999999999999999999999999999999987543321110000 0011
Q ss_pred ccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhc
Q 005247 653 RLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 696 (706)
Q Consensus 653 ~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~ 696 (706)
....+..+++.+.+||.+||+.||++|||+.++++.|+++....
T Consensus 241 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~ 284 (310)
T 3s95_A 241 DRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284 (310)
T ss_dssp HHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 23356788999999999999999999999999999999987654
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=360.17 Aligned_cols=259 Identities=34% Similarity=0.629 Sum_probs=226.2
Q ss_pred cccccCceEEEEEeccCCceEEEEEEEcCC-ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceE
Q 005247 428 LEIRWSELLIKKKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS 506 (706)
Q Consensus 428 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~-~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 506 (706)
+++..++|++.+.||+|+||.||+|.+.++ .||+|++....... +.+.+|+.++++++||||+++++++.+.+..+
T Consensus 3 ~~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (268)
T 3sxs_A 3 MELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE---DEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIY 79 (268)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCH---HHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred eEechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcH---HHHHHHHHHHHhCCCCCEeeEEEEEccCCceE
Confidence 456778999999999999999999988766 49999987655443 46889999999999999999999999999999
Q ss_pred EEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCC
Q 005247 507 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP 586 (706)
Q Consensus 507 lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~ 586 (706)
+||||+++++|.+++.... ..+++..++.++.|++.||.|||++| |+||||||+||+++.++.+||+|||++....
T Consensus 80 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 155 (268)
T 3sxs_A 80 IVTEYISNGCLLNYLRSHG--KGLEPSQLLEMCYDVCEGMAFLESHQ--FIHRDLAARNCLVDRDLCVKVSDFGMTRYVL 155 (268)
T ss_dssp EEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCSGGGEEECTTCCEEECCTTCEEECC
T ss_pred EEEEccCCCcHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCcceEEECCCCCEEEccCccceecc
Confidence 9999999999999996432 35889999999999999999999999 9999999999999999999999999998654
Q ss_pred CCc-ccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHH
Q 005247 587 NTY-ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV 664 (706)
Q Consensus 587 ~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el 664 (706)
... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||......+....+. .......+..+++.+
T Consensus 156 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l 234 (268)
T 3sxs_A 156 DDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS-QGHRLYRPHLASDTI 234 (268)
T ss_dssp TTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-TTCCCCCCTTSCHHH
T ss_pred hhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHH-cCCCCCCCCcChHHH
Confidence 432 22334456778999999999889999999999999999999 999999888877766653 445566677889999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 005247 665 AALIETCWAEEPEIRPSFPSIMETLQQFLM 694 (706)
Q Consensus 665 ~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~ 694 (706)
.+||.+||+.||++|||+.++++.|+.+..
T Consensus 235 ~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 235 YQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp HHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred HHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 999999999999999999999999988754
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=376.11 Aligned_cols=250 Identities=26% Similarity=0.449 Sum_probs=219.1
Q ss_pred cCceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEE
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 509 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~ 509 (706)
.++|++.+.||+|+||.||+|.+.. ..||+|++..........+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 4679999999999999999999864 45999999877767777788999999999999999999999999999999999
Q ss_pred EeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCC---CcEEEeecCccccCC
Q 005247 510 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST---YTVKVCDFGLSRSKP 586 (706)
Q Consensus 510 E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~---~~vKL~DFGla~~~~ 586 (706)
||+.+|+|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||++....
T Consensus 108 e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~ 182 (362)
T 2bdw_A 108 DLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182 (362)
T ss_dssp CCCCSCBHHHHHTTC---SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence 999999999988643 35889999999999999999999999 9999999999999764 459999999998765
Q ss_pred CCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCC--CCCcHHH
Q 005247 587 NTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP--KNVNPMV 664 (706)
Q Consensus 587 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p--~~~s~el 664 (706)
... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.......+.+ ..+++++
T Consensus 183 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 261 (362)
T 2bdw_A 183 DSE-AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA 261 (362)
T ss_dssp TCC-SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHH
T ss_pred CCc-ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence 432 2345689999999999999999999999999999999999999999988877777665443333222 4679999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHH
Q 005247 665 AALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 665 ~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
.+||.+||+.||++|||+.++++
T Consensus 262 ~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 262 KSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHHHHHHcCCChhhCcCHHHHhc
Confidence 99999999999999999999876
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=363.63 Aligned_cols=264 Identities=35% Similarity=0.628 Sum_probs=212.2
Q ss_pred ccCcccccCceEEEEEeccCCceEEEEEEEcCCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCc
Q 005247 425 EEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN 504 (706)
Q Consensus 425 ~~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 504 (706)
....++..++|++.+.||+|+||.||+|++.+ .+|+|++..........+.+.+|+.+++.++||||++++++. ....
T Consensus 16 ~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~ 93 (289)
T 3og7_A 16 ADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQ 93 (289)
T ss_dssp --CCBCCTTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSS
T ss_pred CCCCccCccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCc
Confidence 34568888999999999999999999998655 599999987776777778999999999999999999999965 4566
Q ss_pred eEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCcccc
Q 005247 505 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 584 (706)
Q Consensus 505 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~ 584 (706)
.++||||+.+++|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++.
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 169 (289)
T 3og7_A 94 LAIVTQWCEGSSLYHHLHASE--TKFEMKKLIDIARQTARGMDYLHAKS--IIHRDLKSNNIFLHEDNTVKIGDFGLATE 169 (289)
T ss_dssp CEEEEECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETTTEEEECCCC----
T ss_pred cEEEEEecCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCccceEEECCCCCEEEccceeccc
Confidence 899999999999999986433 35889999999999999999999999 99999999999999999999999999976
Q ss_pred CCCC--cccCCCCCCCCCccCccccc---cCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcC-cc---cC
Q 005247 585 KPNT--YISSKTAAGTPEWMAPEVLR---EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG-RR---LE 655 (706)
Q Consensus 585 ~~~~--~~~~~~~~Gt~~Y~APE~l~---~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~-~~---l~ 655 (706)
.... ........||+.|+|||++. +..++.++||||||+++|+|++|+.||......+......... .. ..
T Consensus 170 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (289)
T 3og7_A 170 KSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSK 249 (289)
T ss_dssp --------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTS
T ss_pred cccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhh
Confidence 4421 11223457999999999987 5678889999999999999999999998765544433332222 22 22
Q ss_pred CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 005247 656 IPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLM 694 (706)
Q Consensus 656 ~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~ 694 (706)
....+++++.+||.+||+.||++|||+.++++.|+++.+
T Consensus 250 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 250 VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred ccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 445789999999999999999999999999999998764
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=374.27 Aligned_cols=270 Identities=32% Similarity=0.498 Sum_probs=224.1
Q ss_pred cCcccccCceEEEEEeccCCceEEEEEEEcC-------CceEEEEEeccccchHHHHHHHHHHHHHHcC-CCCceeEEec
Q 005247 426 EGLEIRWSELLIKKKIGEGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMG 497 (706)
Q Consensus 426 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~-------~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~ 497 (706)
..+++..++|++.+.||+|+||.||+|.+.+ ..||+|++.... .....+.+.+|+.+++++ +||||+++++
T Consensus 38 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 116 (344)
T 1rjb_A 38 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLG 116 (344)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cCcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 3467788999999999999999999998732 249999986443 334456889999999999 8999999999
Q ss_pred cccCCCceEEEEEeccCCchhhhcccCCCc--------------------ccccHHHHHHHHHHHHHHHHHHHhcCCCcc
Q 005247 498 AVTEPPNLSIVTEYLSRGSLYKLLHIPDAR--------------------VVVDERLRLNMAYDVAKGMNYLHQRRPPIV 557 (706)
Q Consensus 498 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~--------------------~~l~~~~~~~ia~qIl~aL~yLHs~g~~II 557 (706)
++...+..++||||+++|+|.+++...... ..+++..++.++.||+.||.|||++| |+
T Consensus 117 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--iv 194 (344)
T 1rjb_A 117 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CV 194 (344)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EE
T ss_pred EEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--cc
Confidence 999999999999999999999999644321 24788999999999999999999999 99
Q ss_pred cccCCCCcEEECCCCcEEEeecCccccCCCCc--ccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCC
Q 005247 558 HRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKP 634 (706)
Q Consensus 558 HrDLKp~NILl~~~~~vKL~DFGla~~~~~~~--~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~P 634 (706)
||||||+|||++.++.+||+|||++....... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..|
T Consensus 195 H~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 274 (344)
T 1rjb_A 195 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274 (344)
T ss_dssp ETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred cCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCC
Confidence 99999999999999999999999997643321 12234457889999999999999999999999999999998 9999
Q ss_pred CCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhccC
Q 005247 635 WRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVC 698 (706)
Q Consensus 635 f~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~~~ 698 (706)
|.....................+..+++++.+||.+||+.||.+|||+.++++.|+.++.....
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~ 338 (344)
T 1rjb_A 275 YPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEE 338 (344)
T ss_dssp STTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-----
T ss_pred cccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHHH
Confidence 9887765555555455566777888999999999999999999999999999999999877544
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=366.34 Aligned_cols=269 Identities=30% Similarity=0.544 Sum_probs=227.6
Q ss_pred cCcccccCceEEEEEeccCCceEEEEEEEcC-------CceEEEEEeccccchHHHHHHHHHHHHHHcC-CCCceeEEec
Q 005247 426 EGLEIRWSELLIKKKIGEGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMG 497 (706)
Q Consensus 426 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~-------~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~ 497 (706)
..+++..++|++.+.||+|+||.||+|.+.+ ..||+|++.... .....+.+.+|+.+++++ +||||+++++
T Consensus 20 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 98 (316)
T 2xir_A 20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLG 98 (316)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence 3456778899999999999999999998632 349999986543 445567899999999999 6999999999
Q ss_pred cccCCC-ceEEEEEeccCCchhhhcccCCC-------------cccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCC
Q 005247 498 AVTEPP-NLSIVTEYLSRGSLYKLLHIPDA-------------RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKS 563 (706)
Q Consensus 498 ~~~~~~-~~~lV~E~~~ggsL~~~l~~~~~-------------~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp 563 (706)
++...+ .+++||||+.+++|.+++..... ...+++..++.++.||+.||.|||++| |+||||||
T Consensus 99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp 176 (316)
T 2xir_A 99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAA 176 (316)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSG
T ss_pred EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC--cccccCcc
Confidence 987654 48999999999999999965432 123789999999999999999999999 99999999
Q ss_pred CcEEECCCCcEEEeecCccccCCCCc--ccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCh
Q 005247 564 PNLLVDSTYTVKVCDFGLSRSKPNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTP 640 (706)
Q Consensus 564 ~NILl~~~~~vKL~DFGla~~~~~~~--~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~ 640 (706)
+||+++.++.+||+|||+++...... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.....
T Consensus 177 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~ 256 (316)
T 2xir_A 177 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 256 (316)
T ss_dssp GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred ceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccch
Confidence 99999999999999999998654322 12234567889999999999999999999999999999998 9999988765
Q ss_pred HHHHHHhhhcCcccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhcc
Q 005247 641 SQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSV 697 (706)
Q Consensus 641 ~~~~~~i~~~~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~~ 697 (706)
.+..............+..+++++.++|.+||+.||.+|||+.++++.|++++....
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 313 (316)
T 2xir_A 257 DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313 (316)
T ss_dssp SHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred hHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 554444444556677788899999999999999999999999999999999998754
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=371.12 Aligned_cols=253 Identities=24% Similarity=0.365 Sum_probs=208.4
Q ss_pred cccccCceEEEEEeccCCceEEEEEEEc-----CCceEEEEEeccccc--hHHHHHHHHHHHHHHcCCCCceeEEecccc
Q 005247 428 LEIRWSELLIKKKIGEGSFGTVYHAEWR-----NSDVAVKILIEQEFH--EDRFKEFLREVAIMKGLRHPNIVLLMGAVT 500 (706)
Q Consensus 428 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~-----~~~vAVKvl~~~~~~--~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~ 500 (706)
..+..++|++.+.||+|+||.||+|++. +..||+|++...... ......+.+|+.+++.++||||+++++++.
T Consensus 12 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 91 (327)
T 3a62_A 12 EKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQ 91 (327)
T ss_dssp -CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEE
T ss_pred CCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEE
Confidence 3456789999999999999999999873 345999998765432 233456789999999999999999999999
Q ss_pred CCCceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecC
Q 005247 501 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFG 580 (706)
Q Consensus 501 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFG 580 (706)
..+.+++||||+.+++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~Nill~~~~~~kl~Dfg 166 (327)
T 3a62_A 92 TGGKLYLILEYLSGGELFMQLERE---GIFMEDTACFYLAEISMALGHLHQKG--IIYRDLKPENIMLNHQGHVKLTDFG 166 (327)
T ss_dssp CSSCEEEEEECCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTTSCEEECCCS
T ss_pred cCCEEEEEEeCCCCCcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCC--EEcccCCHHHeEECCCCcEEEEeCC
Confidence 999999999999999999998643 35889999999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCC
Q 005247 581 LSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNV 660 (706)
Q Consensus 581 la~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~ 660 (706)
+++.............||+.|+|||++.+..++.++||||||+++|+|++|+.||...+..+....+.. ....+|..+
T Consensus 167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~--~~~~~p~~~ 244 (327)
T 3a62_A 167 LCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILK--CKLNLPPYL 244 (327)
T ss_dssp CC----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH--TCCCCCTTS
T ss_pred cccccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh--CCCCCCCCC
Confidence 998654433334567899999999999999999999999999999999999999999888777666533 355678889
Q ss_pred cHHHHHHHHHhhhhCCCCCC-----CHHHHHH
Q 005247 661 NPMVAALIETCWAEEPEIRP-----SFPSIME 687 (706)
Q Consensus 661 s~el~dLI~~cL~~dP~~RP-----S~~eIl~ 687 (706)
++++.+||.+||..||++|| ++.++++
T Consensus 245 ~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 245 TQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp CHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred CHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 99999999999999999999 7788876
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=355.10 Aligned_cols=260 Identities=34% Similarity=0.599 Sum_probs=227.2
Q ss_pred cccccCceEEEEEeccCCceEEEEEEEcCC-ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceE
Q 005247 428 LEIRWSELLIKKKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS 506 (706)
Q Consensus 428 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~-~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 506 (706)
+.+..++|++.+.||+|+||.||+|.+.+. .||+|++....... +.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (267)
T 3t9t_A 3 WVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC 79 (267)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred eEEchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCH---HHHHHHHHHHHhCCCCCEeeEEEEEccCCCeE
Confidence 456778999999999999999999998644 59999987654433 57889999999999999999999999999999
Q ss_pred EEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCC
Q 005247 507 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP 586 (706)
Q Consensus 507 lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~ 586 (706)
+||||+++++|.+++.... ..+++..++.++.|++.||.|||++| ++||||||+||+++.++.+||+|||++....
T Consensus 80 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 155 (267)
T 3t9t_A 80 LVTEFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVL 155 (267)
T ss_dssp EEECCCTTCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECGGGCEEECCTTGGGGBC
T ss_pred EEEeCCCCCcHHHHHhhCc--ccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEECCCCCEEEcccccccccc
Confidence 9999999999999996432 35889999999999999999999999 9999999999999999999999999998654
Q ss_pred CCc-ccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHH
Q 005247 587 NTY-ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV 664 (706)
Q Consensus 587 ~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el 664 (706)
... .......++..|+|||++.+..++.++||||||+++|+|++ |..||......+....+. ...+...+..+++.+
T Consensus 156 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~l 234 (267)
T 3t9t_A 156 DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKPRLASTHV 234 (267)
T ss_dssp CHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TTCCCCCCTTSCHHH
T ss_pred cccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHh-cCCcCCCCccCcHHH
Confidence 322 12234567889999999999999999999999999999999 899999888877776663 344566677889999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHHHHHHHHh
Q 005247 665 AALIETCWAEEPEIRPSFPSIMETLQQFLMS 695 (706)
Q Consensus 665 ~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s 695 (706)
.+||.+||+.||++|||+.++++.|+++..+
T Consensus 235 ~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 235 YQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 9999999999999999999999999999875
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-43 Score=380.07 Aligned_cols=262 Identities=32% Similarity=0.565 Sum_probs=216.4
Q ss_pred ccccCceEEEEEeccCCceEEEEEEEc-----CCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCC
Q 005247 429 EIRWSELLIKKKIGEGSFGTVYHAEWR-----NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP 503 (706)
Q Consensus 429 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~-----~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 503 (706)
++...+|++.+.||+|+||.||+|++. +..||+|++.... .....+.+.+|+.++++++||||+++++++.+.+
T Consensus 41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 119 (373)
T 2qol_A 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK 119 (373)
T ss_dssp BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence 456678999999999999999999875 3459999986543 4556678999999999999999999999999999
Q ss_pred ceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccc
Q 005247 504 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 583 (706)
Q Consensus 504 ~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~ 583 (706)
..++||||+++|+|.++++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 120 ~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 195 (373)
T 2qol_A 120 PVMIVTEYMENGSLDSFLRKHD--AQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLGR 195 (373)
T ss_dssp SCEEEEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC----
T ss_pred ceEEEEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEEcCCCCEEECcCcccc
Confidence 9999999999999999997433 35889999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCccc---CCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCCCC
Q 005247 584 SKPNTYIS---SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKN 659 (706)
Q Consensus 584 ~~~~~~~~---~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p~~ 659 (706)
........ .....++..|+|||++.+..++.++||||||+++|||++ |+.||......+....+. ...+.+.+..
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~ 274 (373)
T 2qol_A 196 VLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-EGYRLPPPMD 274 (373)
T ss_dssp ------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHH-TTEECCCCTT
T ss_pred ccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCcc
Confidence 75443211 122345778999999999999999999999999999998 999999888877776653 4456667788
Q ss_pred CcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhc
Q 005247 660 VNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 696 (706)
Q Consensus 660 ~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~ 696 (706)
++.++.+||.+||+.||++||++.+|++.|++++.+.
T Consensus 275 ~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 275 CPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp CBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred ccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 9999999999999999999999999999999998764
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=361.56 Aligned_cols=250 Identities=25% Similarity=0.355 Sum_probs=209.3
Q ss_pred CceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEE
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 510 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E 510 (706)
++|++++.||+|+||+||+|.+..+ .||+|++..........+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 5799999999999999999998654 49999998776666667788999999999999999999999999999999999
Q ss_pred eccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcc
Q 005247 511 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 590 (706)
Q Consensus 511 ~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~ 590 (706)
|+.+ +|.+++... ...+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~-~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~--ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 156 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp CCSE-EHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS
T ss_pred cCCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeecccceecCCccc
Confidence 9986 555544322 235899999999999999999999999 99999999999999999999999999987665544
Q ss_pred cCCCCCCCCCccCccccccCC-CCchhHHHHHHHHHHHHHhCCCC-CCCCChHHHHHHhhhcC-----------------
Q 005247 591 SSKTAAGTPEWMAPEVLREDP-SNEKSDVFSFGVILWELITLQKP-WRNSTPSQVISAVGFKG----------------- 651 (706)
Q Consensus 591 ~~~~~~Gt~~Y~APE~l~~~~-~s~ksDVwSLGviL~ELltG~~P-f~~~~~~~~~~~i~~~~----------------- 651 (706)
......||+.|+|||++.+.. ++.++||||||+++|+|++|..| |...+..+....+....
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (292)
T 3o0g_A 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccc
Confidence 455678899999999998766 79999999999999999998887 45555544444432110
Q ss_pred ----------cccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 652 ----------RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 652 ----------~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
......+.+++++++||.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 011223457899999999999999999999999876
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=372.64 Aligned_cols=246 Identities=23% Similarity=0.414 Sum_probs=212.5
Q ss_pred cccCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEecccc-chHHHHHHHHHHHHHHcC-CCCceeEEeccccCCCce
Q 005247 430 IRWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNL 505 (706)
Q Consensus 430 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~ 505 (706)
+..++|++++.||+|+||.||+|++..+ .||+|++.+... .....+.+.+|..+++++ +||||+++++++.+.+.+
T Consensus 6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 85 (345)
T 3a8x_A 6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 85 (345)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEE
Confidence 4567899999999999999999998754 499999976654 345567788999999988 899999999999999999
Q ss_pred EEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccC
Q 005247 506 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK 585 (706)
Q Consensus 506 ~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~ 585 (706)
++||||+.+|+|.+++... ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++..
T Consensus 86 ~lv~e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~DFG~a~~~ 160 (345)
T 3a8x_A 86 FFVIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 160 (345)
T ss_dssp EEEECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCCCCEEEEeccccccc
Confidence 9999999999999998643 35899999999999999999999999 999999999999999999999999999865
Q ss_pred CCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC---------ChHHHHHHhhhcCcccCC
Q 005247 586 PNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNS---------TPSQVISAVGFKGRRLEI 656 (706)
Q Consensus 586 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~---------~~~~~~~~i~~~~~~l~~ 656 (706)
..........+||+.|+|||++.+..++.++|||||||++|||++|+.||... ........+ ......+
T Consensus 161 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i--~~~~~~~ 238 (345)
T 3a8x_A 161 LRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI--LEKQIRI 238 (345)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHH--HHCCCCC
T ss_pred cCCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHH--HcCCCCC
Confidence 44333445678999999999999999999999999999999999999999752 222233333 2345667
Q ss_pred CCCCcHHHHHHHHHhhhhCCCCCCCH
Q 005247 657 PKNVNPMVAALIETCWAEEPEIRPSF 682 (706)
Q Consensus 657 p~~~s~el~dLI~~cL~~dP~~RPS~ 682 (706)
|..+++++.+||.+||+.||.+||++
T Consensus 239 p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 239 PRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp CTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred CCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 88999999999999999999999995
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=377.17 Aligned_cols=252 Identities=25% Similarity=0.415 Sum_probs=218.8
Q ss_pred ccccCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEecccc-chHHHHHHHHHHHHHHcC-CCCceeEEeccccCCCc
Q 005247 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPN 504 (706)
Q Consensus 429 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~ 504 (706)
.+..++|++++.||+|+||.||+|++..+ .||+|++..... .....+.+.+|..+++.+ +||||+++++++.+.+.
T Consensus 16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 95 (353)
T 2i0e_A 16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 95 (353)
T ss_dssp ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence 45668999999999999999999998764 499999876532 123346788999999988 79999999999999999
Q ss_pred eEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCcccc
Q 005247 505 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 584 (706)
Q Consensus 505 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~ 584 (706)
+++||||++||+|.++++.. ..+++..++.++.||+.||+|||++| |+||||||+|||++.+|.+||+|||+++.
T Consensus 96 ~~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 170 (353)
T 2i0e_A 96 LYFVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKE 170 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence 99999999999999998643 25899999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHH
Q 005247 585 KPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV 664 (706)
Q Consensus 585 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el 664 (706)
...........+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+.. ....+|..+++++
T Consensus 171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~ 248 (353)
T 2i0e_A 171 NIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME--HNVAYPKSMSKEA 248 (353)
T ss_dssp CCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTSCHHH
T ss_pred cccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHh--CCCCCCCCCCHHH
Confidence 54433345677899999999999999999999999999999999999999999888887777643 4566788999999
Q ss_pred HHHHHHhhhhCCCCCCC-----HHHHHH
Q 005247 665 AALIETCWAEEPEIRPS-----FPSIME 687 (706)
Q Consensus 665 ~dLI~~cL~~dP~~RPS-----~~eIl~ 687 (706)
.+||.+||+.||.+||+ +.+|++
T Consensus 249 ~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 249 VAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp HHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred HHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 99999999999999995 577765
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=359.78 Aligned_cols=257 Identities=37% Similarity=0.667 Sum_probs=216.5
Q ss_pred ccccCceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHH-----HHHHHHHHHHHHcCCCCceeEEeccccC
Q 005247 429 EIRWSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDR-----FKEFLREVAIMKGLRHPNIVLLMGAVTE 501 (706)
Q Consensus 429 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~-----~~~~~~Ei~iL~~L~HpnIv~l~~~~~~ 501 (706)
.+..++|++.+.||+|+||.||+|.+.. ..||+|++......... .+.+.+|+.++++++||||+++++++.+
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 94 (287)
T 4f0f_A 15 TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN 94 (287)
T ss_dssp BCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT
T ss_pred hhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC
Confidence 4556889999999999999999999864 45999998654432221 1678999999999999999999999976
Q ss_pred CCceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCc-----EEE
Q 005247 502 PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYT-----VKV 576 (706)
Q Consensus 502 ~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~-----vKL 576 (706)
.. ++||||+.+++|.+++.... ..+++..++.++.|++.||+|||++|++|+||||||+|||++.++. +||
T Consensus 95 ~~--~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl 170 (287)
T 4f0f_A 95 PP--RMVMEFVPCGDLYHRLLDKA--HPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKV 170 (287)
T ss_dssp TT--EEEEECCTTCBHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred CC--eEEEEecCCCCHHHHHhccc--CCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEe
Confidence 65 79999999999988886433 3588999999999999999999999877999999999999988776 999
Q ss_pred eecCccccCCCCcccCCCCCCCCCccCccccc--cCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHhhhcCc
Q 005247 577 CDFGLSRSKPNTYISSKTAAGTPEWMAPEVLR--EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQV--ISAVGFKGR 652 (706)
Q Consensus 577 ~DFGla~~~~~~~~~~~~~~Gt~~Y~APE~l~--~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~--~~~i~~~~~ 652 (706)
+|||+++..... .....||+.|+|||++. ...++.++||||||+++|+|++|+.||........ ...+.....
T Consensus 171 ~Dfg~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 247 (287)
T 4f0f_A 171 ADFGLSQQSVHS---VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL 247 (287)
T ss_dssp CCCTTCBCCSSC---EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCC
T ss_pred CCCCcccccccc---ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCC
Confidence 999999865442 24567999999999984 45578999999999999999999999987654443 344444556
Q ss_pred ccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 005247 653 RLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQF 692 (706)
Q Consensus 653 ~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~l 692 (706)
+..++..+++++.+||.+||+.||++|||+.++++.|+++
T Consensus 248 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 248 RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 6778889999999999999999999999999999999753
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=362.48 Aligned_cols=262 Identities=25% Similarity=0.403 Sum_probs=219.3
Q ss_pred cccCceEEEEEeccCCceEEEEEEEcC--CceEEEEEecccc-chHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceE
Q 005247 430 IRWSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS 506 (706)
Q Consensus 430 i~~~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 506 (706)
+..++|++.+.||+|+||.||+|.+.. ..||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+.++
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 87 (294)
T 4eqm_A 8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYY 87 (294)
T ss_dssp CEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEE
T ss_pred HhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEE
Confidence 345789999999999999999998864 4599999865433 3455678999999999999999999999999999999
Q ss_pred EEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCC
Q 005247 507 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP 586 (706)
Q Consensus 507 lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~ 586 (706)
+||||+++++|.+++... ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++...
T Consensus 88 lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 88 LVMEYIEGPTLSEYIESH---GPLSVDTAINFTNQILDGIKHAHDMR--IVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp EEEECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred EEEeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 999999999999999643 35889999999999999999999999 9999999999999999999999999998754
Q ss_pred CCc-ccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcc---cCCCCCCcH
Q 005247 587 NTY-ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR---LEIPKNVNP 662 (706)
Q Consensus 587 ~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~---l~~p~~~s~ 662 (706)
... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||...+..+........... ...+..+++
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (294)
T 4eqm_A 163 ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQ 242 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCH
T ss_pred cccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCH
Confidence 432 2233457999999999999999999999999999999999999999988876655444222211 234577899
Q ss_pred HHHHHHHHhhhhCCCCCC-CHHHHHHHHHHHHHhc
Q 005247 663 MVAALIETCWAEEPEIRP-SFPSIMETLQQFLMSS 696 (706)
Q Consensus 663 el~dLI~~cL~~dP~~RP-S~~eIl~~L~~ll~s~ 696 (706)
.+.++|.+||+.||.+|| +++++.+.|+.++...
T Consensus 243 ~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~ 277 (294)
T 4eqm_A 243 SLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN 277 (294)
T ss_dssp HHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred HHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence 999999999999999998 9999999999887654
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=366.27 Aligned_cols=264 Identities=24% Similarity=0.429 Sum_probs=213.8
Q ss_pred ccccCceEEEEEeccCCceEEEEEEEcCC---------ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccc
Q 005247 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNS---------DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAV 499 (706)
Q Consensus 429 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~---------~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~ 499 (706)
++..++|++.+.||+|+||.||+|.+..+ .||+|++.... ....+.+.+|+.+++.++||||+++++++
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 81 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH--RNYSESFFEAASMMSKLSHKHLVLNYGVC 81 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG--GGGHHHHHHHHHHHHTSCCTTBCCEEEEE
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence 45677899999999999999999987643 38999885543 33456899999999999999999999999
Q ss_pred cCCCceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCc------
Q 005247 500 TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYT------ 573 (706)
Q Consensus 500 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~------ 573 (706)
.+.+..++||||+.+++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.
T Consensus 82 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~ 157 (289)
T 4fvq_A 82 VCGDENILVQEFVKFGSLDTYLKKNK--NCINILWKLEVAKQLAAAMHFLEENT--LIHGNVCAKNILLIREEDRKTGNP 157 (289)
T ss_dssp CCTTCCEEEEECCTTCBHHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEEECCBGGGTBC
T ss_pred EeCCCCEEEEECCCCCCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHhhCC--eECCCcCcceEEEecCCccccccc
Confidence 99999999999999999999997433 34889999999999999999999999 999999999999988887
Q ss_pred --EEEeecCccccCCCCcccCCCCCCCCCccCcccccc-CCCCchhHHHHHHHHHHHHHhCC-CCCCCCChHHHHHHhhh
Q 005247 574 --VKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQ-KPWRNSTPSQVISAVGF 649 (706)
Q Consensus 574 --vKL~DFGla~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~ELltG~-~Pf~~~~~~~~~~~i~~ 649 (706)
+||+|||++...... ....||+.|+|||++.+ ..++.++||||||+++|||++|. .||............
T Consensus 158 ~~~kl~Dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~-- 231 (289)
T 4fvq_A 158 PFIKLSDPGISITVLPK----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY-- 231 (289)
T ss_dssp CEEEECCCCSCTTTSCH----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH--
T ss_pred ceeeeccCcccccccCc----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHh--
Confidence 999999998765432 23457889999999987 67899999999999999999964 555555544433322
Q ss_pred cCcccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhccCCCCCCCC
Q 005247 650 KGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQPLSAQP 705 (706)
Q Consensus 650 ~~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~~~~~~s~~p 705 (706)
.....++...++++.+||.+||+.||++|||+.++++.|++++......+.+..|
T Consensus 232 -~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~~~~~~~~ 286 (289)
T 4fvq_A 232 -EDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPRGSHHH 286 (289)
T ss_dssp -HTTCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC------------
T ss_pred -hccCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCCCCCcccc
Confidence 2345566777899999999999999999999999999999999988887777665
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=365.80 Aligned_cols=255 Identities=27% Similarity=0.341 Sum_probs=209.0
Q ss_pred cccccCceEEEEEeccCCceEEEEEEEcC-CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceE
Q 005247 428 LEIRWSELLIKKKIGEGSFGTVYHAEWRN-SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS 506 (706)
Q Consensus 428 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 506 (706)
.+.-.++|++++.||+|+||+||+|.+.. ..||+|++..........+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 16 ~q~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 95 (311)
T 3niz_A 16 FQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLT 95 (311)
T ss_dssp EECSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEE
T ss_pred ecchHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEE
Confidence 44556889999999999999999999854 45999998766555555678899999999999999999999999999999
Q ss_pred EEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCC
Q 005247 507 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP 586 (706)
Q Consensus 507 lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~ 586 (706)
+||||+.+ +|.+++.... ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++...
T Consensus 96 lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 170 (311)
T 3niz_A 96 LVFEFMEK-DLKKVLDENK--TGLQDSQIKIYLYQLLRGVAHCHQHR--ILHRDLKPQNLLINSDGALKLADFGLARAFG 170 (311)
T ss_dssp EEEECCSE-EHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEETT
T ss_pred EEEcCCCC-CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCchHhEEECCCCCEEEccCcCceecC
Confidence 99999985 7777775432 35889999999999999999999999 9999999999999999999999999998766
Q ss_pred CCcccCCCCCCCCCccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcc------------
Q 005247 587 NTYISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR------------ 653 (706)
Q Consensus 587 ~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~------------ 653 (706)
..........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+....+......
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 250 (311)
T 3niz_A 171 IPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL 250 (311)
T ss_dssp SCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTS
T ss_pred CCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhcc
Confidence 54444456688999999999977 56899999999999999999999999887665555443211000
Q ss_pred ----------------cCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 654 ----------------LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 654 ----------------l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
..+.+.+++++.+||.+||+.||++|||+.|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 251 PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred chhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0122457789999999999999999999999976
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=375.48 Aligned_cols=250 Identities=24% Similarity=0.413 Sum_probs=216.9
Q ss_pred cCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccch----HHHHHHHHHHHHHHcCCCCceeEEeccccCCCce
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHE----DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNL 505 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 505 (706)
.+.|++.+.||+|+||.||+|.+..+ .||+|++....... ...+.+.+|+.+++.++||||+++++++.+.+.+
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 35799999999999999999998744 59999987654322 1246788999999999999999999999999999
Q ss_pred EEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCC----cEEEeecCc
Q 005247 506 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY----TVKVCDFGL 581 (706)
Q Consensus 506 ~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~----~vKL~DFGl 581 (706)
++||||+++|+|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++ .+||+|||+
T Consensus 91 ~lv~e~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~~~vkl~DFG~ 165 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (361)
T ss_dssp EEEEECCCSCBHHHHHTTC---SCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred EEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence 9999999999999999643 35899999999999999999999999 99999999999998776 799999999
Q ss_pred cccCCCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCccc--CCCCC
Q 005247 582 SRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRL--EIPKN 659 (706)
Q Consensus 582 a~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l--~~p~~ 659 (706)
+....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+....... ..+..
T Consensus 166 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (361)
T 2yab_A 166 AHEIEDGV-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQ 244 (361)
T ss_dssp CEECCTTC-CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTT
T ss_pred ceEcCCCC-ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccC
Confidence 98765432 2346689999999999999999999999999999999999999999988888777764333222 23367
Q ss_pred CcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 660 VNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 660 ~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
+++++++||.+||..||++|||+.|+++
T Consensus 245 ~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 245 TSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 8999999999999999999999999985
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=389.10 Aligned_cols=266 Identities=32% Similarity=0.572 Sum_probs=230.3
Q ss_pred ccCcccccCceEEEEEeccCCceEEEEEEEcC-CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCC
Q 005247 425 EEGLEIRWSELLIKKKIGEGSFGTVYHAEWRN-SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP 503 (706)
Q Consensus 425 ~~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 503 (706)
...+++..++|++.+.||+|+||.||+|.+.+ ..||||++...... .+.+.+|+.+|+.++||||+++++++. ..
T Consensus 180 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~ 255 (454)
T 1qcf_A 180 KDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS---VEAFLAEANVMKTLQHDKLVKLHAVVT-KE 255 (454)
T ss_dssp TTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBC---HHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred ccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCcc---HHHHHHHHHHHhhCCCCCEeeEEEEEe-CC
Confidence 45578888999999999999999999999864 45999998764432 468999999999999999999999987 56
Q ss_pred ceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccc
Q 005247 504 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 583 (706)
Q Consensus 504 ~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~ 583 (706)
..++||||+.+|+|.++++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 256 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DFG~a~ 332 (454)
T 1qcf_A 256 PIYIITEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASLVCKIADFGLAR 332 (454)
T ss_dssp SCEEEECCCTTCBHHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTTCCEEECSTTGGG
T ss_pred ccEEEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHHEEECCCCcEEEeeCCCce
Confidence 7899999999999999997432 224788899999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCc-ccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCCCCCc
Q 005247 584 SKPNTY-ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVN 661 (706)
Q Consensus 584 ~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s 661 (706)
...... .......++..|+|||++....++.++||||||+++|||++ |+.||...+..+....+. ...+++.|..++
T Consensus 333 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~~ 411 (454)
T 1qcf_A 333 VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-RGYRMPRPENCP 411 (454)
T ss_dssp GBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-HTCCCCCCTTSC
T ss_pred EcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCC
Confidence 754432 12234456789999999999999999999999999999999 999999988877776664 456677888999
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhccC
Q 005247 662 PMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVC 698 (706)
Q Consensus 662 ~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~~~ 698 (706)
+++.+||.+||+.||++|||+.+|++.|+.+......
T Consensus 412 ~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~~ 448 (454)
T 1qcf_A 412 EELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATES 448 (454)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSCC
T ss_pred HHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcccc
Confidence 9999999999999999999999999999998876543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=363.20 Aligned_cols=263 Identities=31% Similarity=0.501 Sum_probs=214.7
Q ss_pred cccccCceEEEEEeccCCceEEEEEEE----c--CCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccC
Q 005247 428 LEIRWSELLIKKKIGEGSFGTVYHAEW----R--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE 501 (706)
Q Consensus 428 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~----~--~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~ 501 (706)
.++..++|++++.||+|+||.||+|++ . +..||+|++... .....+.+.+|+.++++++||||+++++++..
T Consensus 5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 82 (295)
T 3ugc_A 5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYS 82 (295)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECH
T ss_pred CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 345678999999999999999999984 2 334999988643 45556789999999999999999999998754
Q ss_pred --CCceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeec
Q 005247 502 --PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDF 579 (706)
Q Consensus 502 --~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DF 579 (706)
...+++||||+++++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 83 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~kl~Df 158 (295)
T 3ugc_A 83 AGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDF 158 (295)
T ss_dssp HHHTSCEEEEECCTTCBHHHHHHHCG--GGCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCC
T ss_pred CCCCceEEEEEeCCCCCHHHHHHhcc--cccCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHhhEEEcCCCeEEEccC
Confidence 356899999999999999996443 34889999999999999999999999 999999999999999999999999
Q ss_pred CccccCCCCcc---cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH--------------
Q 005247 580 GLSRSKPNTYI---SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQ-------------- 642 (706)
Q Consensus 580 Gla~~~~~~~~---~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~-------------- 642 (706)
|+++....... ......++..|+|||++.+..++.++||||||+++|||++|..||.......
T Consensus 159 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (295)
T 3ugc_A 159 GLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 238 (295)
T ss_dssp CSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHH
T ss_pred cccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhH
Confidence 99987543321 2233457778999999999999999999999999999999999986532210
Q ss_pred -HHHHhhhcCcccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhc
Q 005247 643 -VISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 696 (706)
Q Consensus 643 -~~~~i~~~~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~ 696 (706)
..........+.+.+..+++++.+||.+||+.||++|||+.++++.|+++..+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 239 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 111112344566778899999999999999999999999999999999998753
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=357.92 Aligned_cols=267 Identities=31% Similarity=0.526 Sum_probs=228.9
Q ss_pred cccccCceEEEE-EeccCCceEEEEEEEc----CCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCC
Q 005247 428 LEIRWSELLIKK-KIGEGSFGTVYHAEWR----NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP 502 (706)
Q Consensus 428 ~~i~~~~y~i~~-~LG~G~fG~Vy~a~~~----~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~ 502 (706)
+.+..++|.+.+ .||+|+||.||+|.+. +..||+|++.... .....+.+.+|+.+++.++||||+++++++ ..
T Consensus 4 ~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~ 81 (287)
T 1u59_A 4 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QA 81 (287)
T ss_dssp CBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ES
T ss_pred ccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc-chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cC
Confidence 456677888887 9999999999999863 3349999986543 455667899999999999999999999999 45
Q ss_pred CceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCcc
Q 005247 503 PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS 582 (706)
Q Consensus 503 ~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla 582 (706)
+..++||||+.+++|.+++... ...+++..++.++.||+.||.|||++| |+||||||+||+++.++.+||+|||++
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~Dfg~~ 157 (287)
T 1u59_A 82 EALMLVMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFGLS 157 (287)
T ss_dssp SSEEEEEECCTTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEETTEEEECCCTTC
T ss_pred CCcEEEEEeCCCCCHHHHHHhC--CccCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCchheEEEcCCCCEEECcccce
Confidence 6689999999999999998633 235889999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCcc---cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCCC
Q 005247 583 RSKPNTYI---SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPK 658 (706)
Q Consensus 583 ~~~~~~~~---~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p~ 658 (706)
........ ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+....+. ...+..++.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~-~~~~~~~~~ 236 (287)
T 1u59_A 158 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPP 236 (287)
T ss_dssp EECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH-TTCCCCCCT
T ss_pred eeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHh-cCCcCCCCC
Confidence 87543321 1233456889999999998889999999999999999998 999999888777666553 455677888
Q ss_pred CCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhccCCCC
Q 005247 659 NVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQPL 701 (706)
Q Consensus 659 ~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~~~~~~ 701 (706)
.+++++.+||.+||+.||++||++.++++.|++++.+......
T Consensus 237 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~ 279 (287)
T 1u59_A 237 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 279 (287)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCS
T ss_pred CcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCccc
Confidence 9999999999999999999999999999999999988766543
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-42 Score=356.23 Aligned_cols=267 Identities=32% Similarity=0.601 Sum_probs=223.7
Q ss_pred cCceEEEEEeccCCceEEEEEEEcCC-----ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCce-
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRNS-----DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNL- 505 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~~-----~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~- 505 (706)
...|++.+.||+|+||.||+|.+..+ .+|+|++... ......+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 20 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 98 (298)
T 3pls_A 20 RVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI-TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLP 98 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred ceEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc-ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCc
Confidence 34577889999999999999986433 3888887543 3445667899999999999999999999999776655
Q ss_pred EEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccC
Q 005247 506 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK 585 (706)
Q Consensus 506 ~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~ 585 (706)
++||||+.+++|.+++.... ..+++..++.++.|++.||+|||++| |+||||||+||+++.++.+||+|||+++..
T Consensus 99 ~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 174 (298)
T 3pls_A 99 HVLLPYMCHGDLLQFIRSPQ--RNPTVKDLISFGLQVARGMEYLAEQK--FVHRDLAARNCMLDESFTVKVADFGLARDI 174 (298)
T ss_dssp EEEECCCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECCTTSSCTT
T ss_pred EEEEecccCCCHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCCCcEEeCcCCCcccc
Confidence 99999999999999997533 35789999999999999999999999 999999999999999999999999999865
Q ss_pred CCCc----ccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhC-CCCCCCCChHHHHHHhhhcCcccCCCCCC
Q 005247 586 PNTY----ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNV 660 (706)
Q Consensus 586 ~~~~----~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG-~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~ 660 (706)
.... .......+|+.|+|||.+.+..++.++||||||+++|+|++| .+||...+..+....+ ........+..+
T Consensus 175 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 253 (298)
T 3pls_A 175 LDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFL-AQGRRLPQPEYC 253 (298)
T ss_dssp TTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHH-HTTCCCCCCTTC
T ss_pred cCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHh-hcCCCCCCCccc
Confidence 4422 122345678899999999999999999999999999999995 5556666666655554 345566778889
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhccCCCCCCC
Q 005247 661 NPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQPLSAQ 704 (706)
Q Consensus 661 s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~~~~~~s~~ 704 (706)
++.+.+||.+||+.||.+|||+.++++.|++++.........+-
T Consensus 254 ~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~~~~~l 297 (298)
T 3pls_A 254 PDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDHYVQL 297 (298)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSCCBCCC
T ss_pred hHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhccchhhC
Confidence 99999999999999999999999999999999998766554443
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=378.58 Aligned_cols=252 Identities=27% Similarity=0.453 Sum_probs=218.0
Q ss_pred ccccCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEecccc-chHHHHHHHHHHHHHHcC-CCCceeEEeccccCCCc
Q 005247 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPN 504 (706)
Q Consensus 429 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~ 504 (706)
.+..++|++.+.||+|+||.||+|+++.+ .||+|++..... .....+.+.+|..+++.+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 45668999999999999999999998754 499999876432 122345677899999876 89999999999999999
Q ss_pred eEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCcccc
Q 005247 505 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 584 (706)
Q Consensus 505 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~ 584 (706)
+++||||+++|+|.+++... ..+++..++.++.||+.||+|||++| |+||||||+|||++.+|.+||+|||+++.
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 99999999999999998643 35889999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHH
Q 005247 585 KPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV 664 (706)
Q Consensus 585 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el 664 (706)
...........+||+.|+|||++.+..++.++|||||||++|||++|..||...+..+....+.. ....+|..+++++
T Consensus 168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~ 245 (345)
T 1xjd_A 168 NMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM--DNPFYPRWLEKEA 245 (345)
T ss_dssp CCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTSCHHH
T ss_pred cccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh--CCCCCCcccCHHH
Confidence 54433345677899999999999999999999999999999999999999999888887777643 3456778899999
Q ss_pred HHHHHHhhhhCCCCCCCHH-HHHH
Q 005247 665 AALIETCWAEEPEIRPSFP-SIME 687 (706)
Q Consensus 665 ~dLI~~cL~~dP~~RPS~~-eIl~ 687 (706)
.+||.+||+.||++||++. +|++
T Consensus 246 ~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 246 KDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp HHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred HHHHHHHhcCCHhHcCCChHHHHc
Confidence 9999999999999999997 6653
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=369.90 Aligned_cols=247 Identities=25% Similarity=0.445 Sum_probs=218.1
Q ss_pred ccCceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEE
Q 005247 431 RWSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFH-EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI 507 (706)
Q Consensus 431 ~~~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l 507 (706)
..++|++.+.||+|+||.||+|++.. ..||+|++...... ....+.+.+|+.+++.++||||+++++++.+...+++
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 83 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 83 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEE
Confidence 45789999999999999999999864 44999998764322 2334677899999999999999999999999999999
Q ss_pred EEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCC
Q 005247 508 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 587 (706)
Q Consensus 508 V~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 587 (706)
||||+.+|+|.+++... ..+++..++.++.||+.||+|||++| |+||||||+|||++.+|.+||+|||+++....
T Consensus 84 v~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 84 IMDYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp EECCCCSCBHHHHHHHT---SSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred EEeCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 99999999999999743 35889999999999999999999999 99999999999999999999999999987554
Q ss_pred CcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHH
Q 005247 588 TYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAAL 667 (706)
Q Consensus 588 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dL 667 (706)
. ....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+.. ....+|..+++++.+|
T Consensus 159 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~--~~~~~p~~~~~~~~~l 233 (318)
T 1fot_A 159 V---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN--AELRFPPFFNEDVKDL 233 (318)
T ss_dssp C---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH--CCCCCCTTSCHHHHHH
T ss_pred c---cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCCCCCCCCCHHHHHH
Confidence 3 2456899999999999999999999999999999999999999999888777766643 3456788899999999
Q ss_pred HHHhhhhCCCCCC-----CHHHHHH
Q 005247 668 IETCWAEEPEIRP-----SFPSIME 687 (706)
Q Consensus 668 I~~cL~~dP~~RP-----S~~eIl~ 687 (706)
|.+||+.||++|| +++++++
T Consensus 234 i~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 234 LSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp HHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred HHHHhccCHHHcCCCcCCCHHHHhc
Confidence 9999999999999 8888875
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=362.81 Aligned_cols=265 Identities=31% Similarity=0.507 Sum_probs=223.9
Q ss_pred CcccccCceEEEE-EeccCCceEEEEEEEc--C--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccC
Q 005247 427 GLEIRWSELLIKK-KIGEGSFGTVYHAEWR--N--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE 501 (706)
Q Consensus 427 ~~~i~~~~y~i~~-~LG~G~fG~Vy~a~~~--~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~ 501 (706)
.+.+...+|++.+ .||+|+||.||+|.+. . ..||+|++..........+.+.+|+.+++.++||||+++++++ .
T Consensus 10 ~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~ 88 (291)
T 1xbb_A 10 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-E 88 (291)
T ss_dssp -CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-E
T ss_pred eeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-C
Confidence 3556678899998 9999999999999653 2 3499999876655555677899999999999999999999999 5
Q ss_pred CCceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCc
Q 005247 502 PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL 581 (706)
Q Consensus 502 ~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGl 581 (706)
.+..++||||+.+++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+||+++.++.+||+|||+
T Consensus 89 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~ 163 (291)
T 1xbb_A 89 AESWMLVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGL 163 (291)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCTT
T ss_pred CCCcEEEEEeCCCCCHHHHHHhC---cCCCHHHHHHHHHHHHHHHHHHHhCC--eEcCCCCcceEEEeCCCcEEEccCCc
Confidence 56789999999999999999743 34889999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCcc---cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCC
Q 005247 582 SRSKPNTYI---SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIP 657 (706)
Q Consensus 582 a~~~~~~~~---~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p 657 (706)
+........ ......+++.|+|||++.+..++.++||||||+++|+|++ |+.||......+....+. ...+..++
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~ 242 (291)
T 1xbb_A 164 SKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCP 242 (291)
T ss_dssp CEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCC
T ss_pred ceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCC
Confidence 986543321 1223456789999999998889999999999999999999 999999988877766653 45567778
Q ss_pred CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhccC
Q 005247 658 KNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVC 698 (706)
Q Consensus 658 ~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~~~ 698 (706)
..+++++.+||.+||+.||++|||+.++++.|++++.+...
T Consensus 243 ~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~ 283 (291)
T 1xbb_A 243 AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 283 (291)
T ss_dssp TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhh
Confidence 89999999999999999999999999999999999987643
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=362.84 Aligned_cols=257 Identities=34% Similarity=0.645 Sum_probs=213.1
Q ss_pred cccCceEEEEEeccCCceEEEEEEEcCCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEE
Q 005247 430 IRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 509 (706)
Q Consensus 430 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~ 509 (706)
+..++|++.+.||+|+||.||++++.+..||+|++... ...+.+.+|+.++++++||||+++++++.+ ..++||
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~ 78 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVM 78 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEETTEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEE
T ss_pred CCHhHeeeeeEeecCCCceEEEEEECCeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEE
Confidence 56678999999999999999999999888999987532 345688999999999999999999999874 479999
Q ss_pred EeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHh---cCCCcccccCCCCcEEECCCCc-EEEeecCccccC
Q 005247 510 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ---RRPPIVHRDLKSPNLLVDSTYT-VKVCDFGLSRSK 585 (706)
Q Consensus 510 E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs---~g~~IIHrDLKp~NILl~~~~~-vKL~DFGla~~~ 585 (706)
||+++++|.++++.......++...++.++.|++.||+|||+ +| |+||||||+|||++.++. +||+|||++...
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~--ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~ 156 (307)
T 2eva_A 79 EYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA--LIHRDLKPPNLLLVAGGTVLKICDFGTACDI 156 (307)
T ss_dssp ECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSC--CCCCCCSGGGEEEETTTTEEEECCCCC----
T ss_pred EcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCC--eecCCCChhHEEEeCCCCEEEEccccccccc
Confidence 999999999999765544457889999999999999999999 67 999999999999988876 799999999765
Q ss_pred CCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHhhhcCcccCCCCCCcHHH
Q 005247 586 PNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQV-ISAVGFKGRRLEIPKNVNPMV 664 (706)
Q Consensus 586 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~-~~~i~~~~~~l~~p~~~s~el 664 (706)
... .....||+.|+|||++.+..++.++||||||+++|||++|+.||........ .........+...+..+++.+
T Consensus 157 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 233 (307)
T 2eva_A 157 QTH---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPI 233 (307)
T ss_dssp -----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHHH
T ss_pred ccc---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHHH
Confidence 432 2345699999999999999999999999999999999999999986543222 111223445566778899999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhcc
Q 005247 665 AALIETCWAEEPEIRPSFPSIMETLQQFLMSSV 697 (706)
Q Consensus 665 ~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~~ 697 (706)
.+||.+||+.||++|||+.++++.|+++.....
T Consensus 234 ~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 266 (307)
T 2eva_A 234 ESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFP 266 (307)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCC
T ss_pred HHHHHHHhcCChhhCcCHHHHHHHHHHHHHhcc
Confidence 999999999999999999999999999987643
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=378.14 Aligned_cols=265 Identities=30% Similarity=0.498 Sum_probs=226.1
Q ss_pred cccccCceEEEEEeccCCceEEEEEEEcC-------CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEecccc
Q 005247 428 LEIRWSELLIKKKIGEGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 500 (706)
Q Consensus 428 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~-------~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~ 500 (706)
.++..++|++++.||+|+||.||+|.+.+ ..||||++... ........+.+|+.++++++||||+++++++.
T Consensus 66 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 144 (367)
T 3l9p_A 66 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSL 144 (367)
T ss_dssp CBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc-cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 34567889999999999999999998543 24999987543 34455567899999999999999999999999
Q ss_pred CCCceEEEEEeccCCchhhhcccCC----CcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCC---c
Q 005247 501 EPPNLSIVTEYLSRGSLYKLLHIPD----ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY---T 573 (706)
Q Consensus 501 ~~~~~~lV~E~~~ggsL~~~l~~~~----~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~---~ 573 (706)
+....++||||+.+|+|.++++... ....+++..++.++.||+.||+|||++| |+||||||+|||++.++ .
T Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~ 222 (367)
T 3l9p_A 145 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRV 222 (367)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCC
T ss_pred cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEEecCCCCce
Confidence 9999999999999999999996432 2245889999999999999999999999 99999999999998554 5
Q ss_pred EEEeecCccccCCC--CcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhc
Q 005247 574 VKVCDFGLSRSKPN--TYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFK 650 (706)
Q Consensus 574 vKL~DFGla~~~~~--~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~ 650 (706)
+||+|||+++.... .........||+.|+|||++.+..++.++|||||||++|||++ |..||......+....+. .
T Consensus 223 ~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~-~ 301 (367)
T 3l9p_A 223 AKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT-S 301 (367)
T ss_dssp EEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-T
T ss_pred EEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-c
Confidence 99999999974321 1122234567999999999999999999999999999999998 999999988887777664 4
Q ss_pred CcccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhc
Q 005247 651 GRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 696 (706)
Q Consensus 651 ~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~ 696 (706)
..+...+..++..+.+||.+||+.||++|||+.+|++.|+.+....
T Consensus 302 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~ 347 (367)
T 3l9p_A 302 GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347 (367)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred CCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence 5566778899999999999999999999999999999999988654
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=359.25 Aligned_cols=264 Identities=36% Similarity=0.619 Sum_probs=230.1
Q ss_pred cCcccccCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCC
Q 005247 426 EGLEIRWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP 503 (706)
Q Consensus 426 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 503 (706)
..+++...+|++.+.||+|+||.||+|.+..+ .||+|++.... ...+.+.+|+.+++.++||||+++++++.+.+
T Consensus 6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 82 (288)
T 3kfa_A 6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 82 (288)
T ss_dssp CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS---THHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 35677889999999999999999999998754 48999886533 34567889999999999999999999999999
Q ss_pred ceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccc
Q 005247 504 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 583 (706)
Q Consensus 504 ~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~ 583 (706)
..++||||+.+++|.+++.... ...+++..++.++.||+.||.|||++| |+||||||+||+++.++.+||+|||++.
T Consensus 83 ~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~l~Dfg~~~ 159 (288)
T 3kfa_A 83 PFYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSR 159 (288)
T ss_dssp SEEEEEECCTTEEHHHHHHHCC-TTTSCHHHHHHHHHHHHHHHHHHHHHT--CCCSCCSGGGEEECGGGCEEECCCCGGG
T ss_pred CEEEEEEcCCCCcHHHHHHhcc-cCCccHhHHHHHHHHHHHHHHHHHHCC--ccCCCCCcceEEEcCCCCEEEccCccce
Confidence 9999999999999999996432 235889999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCc-ccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCCCCCc
Q 005247 584 SKPNTY-ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVN 661 (706)
Q Consensus 584 ~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s 661 (706)
...... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...........+. ...+...+..++
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 238 (288)
T 3kfa_A 160 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCP 238 (288)
T ss_dssp TSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH-TTCCCCCCTTCC
T ss_pred eccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-ccCCCCCCCCCC
Confidence 755432 22234456889999999999999999999999999999999 999999888777766653 445667788899
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhc
Q 005247 662 PMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 696 (706)
Q Consensus 662 ~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~ 696 (706)
+.+.+||.+||..||.+|||+.++++.|++++...
T Consensus 239 ~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~ 273 (288)
T 3kfa_A 239 EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273 (288)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence 99999999999999999999999999999988653
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=362.49 Aligned_cols=269 Identities=30% Similarity=0.503 Sum_probs=221.4
Q ss_pred ccCcccccCceEEEEEeccCCceEEEEEEEcCC-----ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccc
Q 005247 425 EEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNS-----DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAV 499 (706)
Q Consensus 425 ~~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~-----~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~ 499 (706)
...+.+..++|++.+.||+|+||.||+|.+... .||+|++..........+.+.+|+.++++++||||+++++++
T Consensus 26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 105 (313)
T 3brb_A 26 LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVC 105 (313)
T ss_dssp TTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred HHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence 345667788999999999999999999977542 499999877666667778899999999999999999999998
Q ss_pred cCCC-----ceEEEEEeccCCchhhhcccC---CCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCC
Q 005247 500 TEPP-----NLSIVTEYLSRGSLYKLLHIP---DARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST 571 (706)
Q Consensus 500 ~~~~-----~~~lV~E~~~ggsL~~~l~~~---~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~ 571 (706)
.+.+ ..++||||+.+++|.+++... .....+++..++.++.||+.||.|||++| |+||||||+||+++.+
T Consensus 106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~~~ 183 (313)
T 3brb_A 106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN--FLHRDLAARNCMLRDD 183 (313)
T ss_dssp EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCSGGGEEECTT
T ss_pred eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCC
Confidence 7654 359999999999999998422 23346899999999999999999999999 9999999999999999
Q ss_pred CcEEEeecCccccCCCCc--ccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhh
Q 005247 572 YTVKVCDFGLSRSKPNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVG 648 (706)
Q Consensus 572 ~~vKL~DFGla~~~~~~~--~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~ 648 (706)
+.+||+|||+++...... .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+....+.
T Consensus 184 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 263 (313)
T 3brb_A 184 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLL 263 (313)
T ss_dssp SCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH
T ss_pred CcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHH
Confidence 999999999998654332 12234467889999999999999999999999999999999 899999888777766553
Q ss_pred hcCcccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhc
Q 005247 649 FKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 696 (706)
Q Consensus 649 ~~~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~ 696 (706)
...+...+..+++++.+||.+||..||.+|||+.++++.|++++.+.
T Consensus 264 -~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 264 -HGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp -TTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred -cCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 45566778889999999999999999999999999999999998764
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=355.17 Aligned_cols=266 Identities=33% Similarity=0.579 Sum_probs=227.4
Q ss_pred cCcccccCceEEEEEeccCCceEEEEEEEcCC-ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCc
Q 005247 426 EGLEIRWSELLIKKKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN 504 (706)
Q Consensus 426 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~-~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 504 (706)
..+++..++|++.+.||+|+||.||+|.+.+. .||+|++...... .+.+.+|+.+++.++||||+++++++.. +.
T Consensus 6 ~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~ 81 (279)
T 1qpc_A 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EP 81 (279)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred hhcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCccc---HHHHHHHHHHHHhCCCcCcceEEEEEcC-CC
Confidence 45778889999999999999999999998765 5999998665433 3578899999999999999999999864 55
Q ss_pred eEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCcccc
Q 005247 505 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 584 (706)
Q Consensus 505 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~ 584 (706)
.++||||+.+++|.+++.... ...+++..++.++.|++.||.|||++| |+||||||+||+++.++.+||+|||++..
T Consensus 82 ~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 158 (279)
T 1qpc_A 82 IYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARL 158 (279)
T ss_dssp CEEEEECCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred cEEEEecCCCCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHhhEEEcCCCCEEECCCccccc
Confidence 899999999999999996421 125889999999999999999999999 99999999999999999999999999987
Q ss_pred CCCCc-ccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCCCCCcH
Q 005247 585 KPNTY-ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNP 662 (706)
Q Consensus 585 ~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~ 662 (706)
..... .......++..|+|||++.+..++.++||||||+++|||++ |..||......+....+. .......+..+++
T Consensus 159 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 237 (279)
T 1qpc_A 159 IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRPDNCPE 237 (279)
T ss_dssp CSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCH
T ss_pred ccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHh-cccCCCCcccccH
Confidence 65432 22234457889999999998889999999999999999999 899999888777766653 3445667788999
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhccCC
Q 005247 663 MVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQ 699 (706)
Q Consensus 663 el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~~~~ 699 (706)
++.+||.+||+.||++|||+.++++.|++++.....+
T Consensus 238 ~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~ 274 (279)
T 1qpc_A 238 ELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQ 274 (279)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC---
T ss_pred HHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccCC
Confidence 9999999999999999999999999999999876543
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=364.99 Aligned_cols=264 Identities=33% Similarity=0.543 Sum_probs=222.4
Q ss_pred cccccCceEEEEEeccCCceEEEEEEEcCC------ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccC
Q 005247 428 LEIRWSELLIKKKIGEGSFGTVYHAEWRNS------DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE 501 (706)
Q Consensus 428 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~------~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~ 501 (706)
.++...+|++.+.||+|+||.||+|.+..+ .||+|++.... .......+.+|+.+++.++||||+++++++.+
T Consensus 39 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 117 (333)
T 1mqb_A 39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK 117 (333)
T ss_dssp CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred ccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec
Confidence 356778999999999999999999987643 28999986543 44556689999999999999999999999999
Q ss_pred CCceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCc
Q 005247 502 PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL 581 (706)
Q Consensus 502 ~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGl 581 (706)
.+..++||||+.+++|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+
T Consensus 118 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~ 193 (333)
T 1mqb_A 118 YKPMMIITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFGL 193 (333)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred CCCcEEEEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChheEEECCCCcEEECCCCc
Confidence 999999999999999999996432 35889999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCcc---cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCC
Q 005247 582 SRSKPNTYI---SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIP 657 (706)
Q Consensus 582 a~~~~~~~~---~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p 657 (706)
++....... ......+|+.|+|||++.+..++.++||||||+++|||++ |..||......+....+. ...+.+.+
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~-~~~~~~~~ 272 (333)
T 1mqb_A 194 SRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN-DGFRLPTP 272 (333)
T ss_dssp -----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TTCCCCCC
T ss_pred chhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH-CCCcCCCc
Confidence 987543321 1123346788999999999999999999999999999999 999999888877766663 44566677
Q ss_pred CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhcc
Q 005247 658 KNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSV 697 (706)
Q Consensus 658 ~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~~ 697 (706)
..+++.+.+||.+||+.||++||++.++++.|++++....
T Consensus 273 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~ 312 (333)
T 1mqb_A 273 MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 312 (333)
T ss_dssp TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence 8899999999999999999999999999999999986543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=379.29 Aligned_cols=247 Identities=22% Similarity=0.419 Sum_probs=211.1
Q ss_pred ccccCceEEEEEeccCCceEEEEEEEcCCc--eEEEEEeccccch-HHHHHHHHHHHHHHcC-CCCceeEEeccccCCCc
Q 005247 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHE-DRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPN 504 (706)
Q Consensus 429 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~--vAVKvl~~~~~~~-~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~ 504 (706)
.+..++|++++.||+|+||+||+|++..++ ||+|++.+..... ...+.+.+|..++.++ +||||+++++++.+.+.
T Consensus 48 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 127 (396)
T 4dc2_A 48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 127 (396)
T ss_dssp -CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCE
Confidence 355678999999999999999999987654 9999997754432 3345678899999877 89999999999999999
Q ss_pred eEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCcccc
Q 005247 505 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 584 (706)
Q Consensus 505 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~ 584 (706)
+++||||+.+|+|..++... ..+++..++.++.||+.||+|||++| ||||||||+|||++.++.+||+|||+++.
T Consensus 128 ~~lV~E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~g~ikL~DFGla~~ 202 (396)
T 4dc2_A 128 LFFVIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKE 202 (396)
T ss_dssp EEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEEEcCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEECCCCCEEEeecceeee
Confidence 99999999999999998643 35899999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC---------hHHHHHHhhhcCcccC
Q 005247 585 KPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNST---------PSQVISAVGFKGRRLE 655 (706)
Q Consensus 585 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~---------~~~~~~~i~~~~~~l~ 655 (706)
...........+||+.|+|||++.+..++.++|||||||++|||++|+.||.... .......+ ....+.
T Consensus 203 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i--~~~~~~ 280 (396)
T 4dc2_A 203 GLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI--LEKQIR 280 (396)
T ss_dssp CCCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHH--HHCCCC
T ss_pred cccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHH--hccccC
Confidence 4444444567889999999999999999999999999999999999999996432 12222333 345667
Q ss_pred CCCCCcHHHHHHHHHhhhhCCCCCCCH
Q 005247 656 IPKNVNPMVAALIETCWAEEPEIRPSF 682 (706)
Q Consensus 656 ~p~~~s~el~dLI~~cL~~dP~~RPS~ 682 (706)
+|..+++++.+||.+||+.||.+||++
T Consensus 281 ~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 281 IPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp CCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred CCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 888999999999999999999999985
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=366.51 Aligned_cols=268 Identities=31% Similarity=0.575 Sum_probs=230.5
Q ss_pred cCcccccCceEEEEEeccCCceEEEEEEEcC---------CceEEEEEeccccchHHHHHHHHHHHHHHcC-CCCceeEE
Q 005247 426 EGLEIRWSELLIKKKIGEGSFGTVYHAEWRN---------SDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLL 495 (706)
Q Consensus 426 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~---------~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l 495 (706)
..+++..++|++.+.||+|+||.||+|.+.+ ..||+|++.... .....+.+.+|+.+++.+ +||||+++
T Consensus 28 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~ 106 (334)
T 2pvf_A 28 PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINL 106 (334)
T ss_dssp TTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeE
Confidence 3456778899999999999999999998742 348999986543 455567899999999999 89999999
Q ss_pred eccccCCCceEEEEEeccCCchhhhcccCCC-------------cccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCC
Q 005247 496 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDA-------------RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLK 562 (706)
Q Consensus 496 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~-------------~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLK 562 (706)
++++.+.+..++||||+.+|+|.+++..... ...+++..++.++.||+.||.|||++| |+|||||
T Consensus 107 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlk 184 (334)
T 2pvf_A 107 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLA 184 (334)
T ss_dssp EEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCS
T ss_pred EEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCc
Confidence 9999999999999999999999999964331 124788999999999999999999999 9999999
Q ss_pred CCcEEECCCCcEEEeecCccccCCCCcc--cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 005247 563 SPNLLVDSTYTVKVCDFGLSRSKPNTYI--SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNST 639 (706)
Q Consensus 563 p~NILl~~~~~vKL~DFGla~~~~~~~~--~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~ 639 (706)
|+|||++.++.+||+|||+++....... ......+|+.|+|||++.+..++.++||||||+++|||++ |..||....
T Consensus 185 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 264 (334)
T 2pvf_A 185 ARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 264 (334)
T ss_dssp GGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC
Confidence 9999999999999999999986554321 2234467889999999999889999999999999999999 999999888
Q ss_pred hHHHHHHhhhcCcccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhcc
Q 005247 640 PSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSV 697 (706)
Q Consensus 640 ~~~~~~~i~~~~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~~ 697 (706)
..+....+. ...+...+..+++++.+||.+||+.||.+|||+.++++.|++++....
T Consensus 265 ~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~ 321 (334)
T 2pvf_A 265 VEELFKLLK-EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 321 (334)
T ss_dssp HHHHHHHHH-HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HHHHHHHHh-cCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence 777666553 445667788899999999999999999999999999999999987654
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=361.37 Aligned_cols=250 Identities=26% Similarity=0.362 Sum_probs=205.5
Q ss_pred CceEEEEEeccCCceEEEEEEEc-CCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEEe
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWR-NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY 511 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~-~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~ 511 (706)
++|++++.||+|+||.||+|++. +..||+|++..........+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 57999999999999999999885 44599999866544444446788999999999999999999999999999999999
Q ss_pred ccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCccc
Q 005247 512 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS 591 (706)
Q Consensus 512 ~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~ 591 (706)
+.+ +|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++........
T Consensus 82 ~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 156 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK 156 (288)
T ss_dssp CSE-EHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred cCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEEeECccccccCccccc
Confidence 976 8888886432 35889999999999999999999999 999999999999999999999999999765443333
Q ss_pred CCCCCCCCCccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhc-Ccc----------------
Q 005247 592 SKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-GRR---------------- 653 (706)
Q Consensus 592 ~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~-~~~---------------- 653 (706)
.....||+.|+|||++.+. .++.++||||||+++|||++|+.||...+..+....+... +..
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T 1ob3_A 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236 (288)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccccc
Confidence 3456789999999999764 5899999999999999999999999988776655443211 000
Q ss_pred ----------cCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 654 ----------LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 654 ----------l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
..+...+++++.+||.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0122457899999999999999999999999875
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-43 Score=371.70 Aligned_cols=261 Identities=30% Similarity=0.431 Sum_probs=212.5
Q ss_pred cCcccccCceEEEEEeccCCceEEEEEEEcCCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCC--
Q 005247 426 EGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP-- 503 (706)
Q Consensus 426 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~-- 503 (706)
.++.+...+|++.+.||+|+||.||+|++.+..||||++.... .....+.+|+.++++++||||+++++++....
T Consensus 17 ~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 93 (322)
T 3soc_A 17 ENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQD---KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSV 93 (322)
T ss_dssp CCEEETTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSS
T ss_pred cccccchhhchhhheecccCceEEEEEEECCCEEEEEEeecCc---hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCC
Confidence 4466778899999999999999999999998889999986542 33345667999999999999999999987654
Q ss_pred --ceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhc----------CCCcccccCCCCcEEECCC
Q 005247 504 --NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR----------RPPIVHRDLKSPNLLVDST 571 (706)
Q Consensus 504 --~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~----------g~~IIHrDLKp~NILl~~~ 571 (706)
.+++||||+++|+|.++++.. .+++..++.++.||+.||+|||++ + |+||||||+|||++.+
T Consensus 94 ~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~--ivH~Dlkp~Nill~~~ 167 (322)
T 3soc_A 94 DVDLWLITAFHEKGSLSDFLKAN----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA--ISHRDIKSKNVLLKNN 167 (322)
T ss_dssp SEEEEEEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE--EECSCCSGGGEEECTT
T ss_pred CceEEEEEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC--EEeCCCChHhEEECCC
Confidence 369999999999999999643 388999999999999999999999 8 9999999999999999
Q ss_pred CcEEEeecCccccCCCCcc--cCCCCCCCCCccCccccccC-----CCCchhHHHHHHHHHHHHHhCCCCCCCCC-----
Q 005247 572 YTVKVCDFGLSRSKPNTYI--SSKTAAGTPEWMAPEVLRED-----PSNEKSDVFSFGVILWELITLQKPWRNST----- 639 (706)
Q Consensus 572 ~~vKL~DFGla~~~~~~~~--~~~~~~Gt~~Y~APE~l~~~-----~~s~ksDVwSLGviL~ELltG~~Pf~~~~----- 639 (706)
+.+||+|||+++....... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||....
T Consensus 168 ~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~ 247 (322)
T 3soc_A 168 LTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247 (322)
T ss_dssp CCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCC
T ss_pred CeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhcc
Confidence 9999999999976443222 23346799999999999874 34568899999999999999999997532
Q ss_pred -----------hHHHHHHhhhcCcccCCCC-----CCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHh
Q 005247 640 -----------PSQVISAVGFKGRRLEIPK-----NVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS 695 (706)
Q Consensus 640 -----------~~~~~~~i~~~~~~l~~p~-----~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s 695 (706)
.......+.....+..++. ..++++.+||.+||+.||++|||+.++++.|+++...
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 248 PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp TTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred chhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 1222222222222232222 2346799999999999999999999999999998764
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=367.42 Aligned_cols=268 Identities=31% Similarity=0.502 Sum_probs=228.1
Q ss_pred cCcccccCceEEEEEeccCCceEEEEEEEcCC-------ceEEEEEeccccchHHHHHHHHHHHHHHcC-CCCceeEEec
Q 005247 426 EGLEIRWSELLIKKKIGEGSFGTVYHAEWRNS-------DVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMG 497 (706)
Q Consensus 426 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~-------~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~ 497 (706)
..+++..++|++.+.||+|+||.||+|.+.++ .||+|++.... .....+.+.+|+.+++.+ +||||+++++
T Consensus 39 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 117 (333)
T 2i1m_A 39 EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLG 117 (333)
T ss_dssp GGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 34677889999999999999999999988542 38899886543 445567899999999999 8999999999
Q ss_pred cccCCCceEEEEEeccCCchhhhcccCC-----------CcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcE
Q 005247 498 AVTEPPNLSIVTEYLSRGSLYKLLHIPD-----------ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNL 566 (706)
Q Consensus 498 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~-----------~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NI 566 (706)
++.+.+..++||||+++|+|.+++.... ....+++..++.++.||+.||.|||++| |+||||||+||
T Consensus 118 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NI 195 (333)
T 2i1m_A 118 ACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNV 195 (333)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGC
T ss_pred EEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCcccceE
Confidence 9999999999999999999999985321 1235789999999999999999999999 99999999999
Q ss_pred EECCCCcEEEeecCccccCCCCc--ccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 005247 567 LVDSTYTVKVCDFGLSRSKPNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQV 643 (706)
Q Consensus 567 Ll~~~~~vKL~DFGla~~~~~~~--~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~ 643 (706)
|++.++.+||+|||+++...... .......+|+.|+|||++.+..++.++||||||+++|||++ |..||........
T Consensus 196 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 275 (333)
T 2i1m_A 196 LLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK 275 (333)
T ss_dssp EEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH
T ss_pred EECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH
Confidence 99999999999999997643221 12234456889999999999999999999999999999998 8999988766555
Q ss_pred HHHhhhcCcccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhc
Q 005247 644 ISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 696 (706)
Q Consensus 644 ~~~i~~~~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~ 696 (706)
...+.........+..+++.+.+||.+||+.||.+|||+.++++.|+++....
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 328 (333)
T 2i1m_A 276 FYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED 328 (333)
T ss_dssp HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence 55554455566677889999999999999999999999999999999987653
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=353.47 Aligned_cols=250 Identities=26% Similarity=0.436 Sum_probs=219.8
Q ss_pred cCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEE
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 509 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~ 509 (706)
.++|++.+.||+|+||.||+|.+..+ .||+|++..........+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 46899999999999999999988744 5999999887777777788999999999999999999999999999999999
Q ss_pred EeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCc---EEEeecCccccCC
Q 005247 510 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYT---VKVCDFGLSRSKP 586 (706)
Q Consensus 510 E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~---vKL~DFGla~~~~ 586 (706)
||+.+++|.+.+... ..+++..++.++.|++.||.|||++| |+||||||+||+++.++. +||+|||++....
T Consensus 85 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp CCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 999999998888633 35889999999999999999999999 999999999999976655 9999999997765
Q ss_pred CCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCC--CCCCcHHH
Q 005247 587 NTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEI--PKNVNPMV 664 (706)
Q Consensus 587 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~--p~~~s~el 664 (706)
... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||......+....+......... ...+++++
T Consensus 160 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T 3kk8_A 160 DSE-AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA 238 (284)
T ss_dssp SSC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred cCc-cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHH
Confidence 443 234567999999999999999999999999999999999999999998887777766544433332 25789999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHH
Q 005247 665 AALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 665 ~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
.+||.+||+.||++|||+.++++
T Consensus 239 ~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 239 KSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHHHcccChhhCCCHHHHhc
Confidence 99999999999999999999987
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=367.43 Aligned_cols=259 Identities=31% Similarity=0.530 Sum_probs=215.6
Q ss_pred cccCceEEEEEeccCCceEEEEEEEcCC--ce----EEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCC
Q 005247 430 IRWSELLIKKKIGEGSFGTVYHAEWRNS--DV----AVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP 503 (706)
Q Consensus 430 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~--~v----AVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 503 (706)
+...+|++.+.||+|+||.||+|.+..+ .+ |+|.+.... .....+.+.+|+.++++++||||+++++++.+..
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 90 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST 90 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC
Confidence 4567899999999999999999987543 34 555553322 2334568999999999999999999999998754
Q ss_pred ceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccc
Q 005247 504 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 583 (706)
Q Consensus 504 ~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~ 583 (706)
.++++||+.+|+|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 91 -~~~v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 165 (327)
T 3poz_A 91 -VQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp -EEEEEECCTTCBHHHHHHHST--TSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCTTHHH
T ss_pred -eEEEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCChheEEECCCCCEEEccCccee
Confidence 789999999999999996433 35889999999999999999999999 9999999999999999999999999997
Q ss_pred cCCCCcc--cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCCCCC
Q 005247 584 SKPNTYI--SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNV 660 (706)
Q Consensus 584 ~~~~~~~--~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~ 660 (706)
....... ......+|+.|+|||++.+..++.++||||||+++|||++ |..||......+....+. ...+...+..+
T Consensus 166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~ 244 (327)
T 3poz_A 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLPQPPIC 244 (327)
T ss_dssp HHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-TTCCCCCCTTB
T ss_pred EccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHH-cCCCCCCCccC
Confidence 6443221 2233456889999999999999999999999999999999 999999888777666553 45566778889
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHh
Q 005247 661 NPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS 695 (706)
Q Consensus 661 s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s 695 (706)
+..+.+||.+||+.||++||++.++++.|+.+...
T Consensus 245 ~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 245 TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp CHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 99999999999999999999999999999998764
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=355.84 Aligned_cols=263 Identities=32% Similarity=0.533 Sum_probs=219.0
Q ss_pred cccCceEEEEEeccCCceEEEEEEEcCCc-----eEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccc-cCCC
Q 005247 430 IRWSELLIKKKIGEGSFGTVYHAEWRNSD-----VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAV-TEPP 503 (706)
Q Consensus 430 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~-----vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~-~~~~ 503 (706)
....+|++.+.||+|+||.||+|.+..+. +|+|.+... ......+.+.+|+.++++++||||+++++++ ..++
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 100 (298)
T 3f66_A 22 PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 100 (298)
T ss_dssp GGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS
T ss_pred ccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC-CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCC
Confidence 34457999999999999999999865332 677776543 3445567899999999999999999999984 5567
Q ss_pred ceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccc
Q 005247 504 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 583 (706)
Q Consensus 504 ~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~ 583 (706)
..++||||+.+|+|.++++... ..+++..++.++.|++.||.|||++| |+||||||+||+++.++.+||+|||+++
T Consensus 101 ~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~ql~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~a~ 176 (298)
T 3f66_A 101 SPLVVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKYLASKK--FVHRDLAARNCMLDEKFTVKVADFGLAR 176 (298)
T ss_dssp CCEEEEECCTTCBHHHHHHCTT--CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECSCGGGC
T ss_pred ceEEEEeCCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEECCCCCEEECcccccc
Confidence 7899999999999999996433 35788999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCcc----cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCCC
Q 005247 584 SKPNTYI----SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPK 658 (706)
Q Consensus 584 ~~~~~~~----~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p~ 658 (706)
....... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||...+..+....+ ........+.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 255 (298)
T 3f66_A 177 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-LQGRRLLQPE 255 (298)
T ss_dssp CCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHH-HTTCCCCCCT
T ss_pred cccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHH-hcCCCCCCCc
Confidence 6544321 1234457789999999999999999999999999999999 56677776666655554 3455566678
Q ss_pred CCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhccC
Q 005247 659 NVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVC 698 (706)
Q Consensus 659 ~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~~~ 698 (706)
.++..+.++|.+||+.||++|||+.++++.|+.++.+...
T Consensus 256 ~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~ 295 (298)
T 3f66_A 256 YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 295 (298)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCC
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 8999999999999999999999999999999999987544
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=373.91 Aligned_cols=248 Identities=25% Similarity=0.385 Sum_probs=219.6
Q ss_pred cccCceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceE
Q 005247 430 IRWSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFH-EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS 506 (706)
Q Consensus 430 i~~~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 506 (706)
...++|++++.||+|+||.||+|++.. ..||+|++...... ....+.+.+|+.+++.++||||+++++++.+.+.++
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 117 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 456789999999999999999999864 45999998765322 233567889999999999999999999999999999
Q ss_pred EEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCC
Q 005247 507 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP 586 (706)
Q Consensus 507 lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~ 586 (706)
+||||+++|+|.+++... ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++...
T Consensus 118 lv~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~ 192 (350)
T 1rdq_E 118 MVMEYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp EEEECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCccceEEECCCCCEEEcccccceecc
Confidence 999999999999999743 35889999999999999999999999 9999999999999999999999999998764
Q ss_pred CCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHH
Q 005247 587 NTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA 666 (706)
Q Consensus 587 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~d 666 (706)
.. ....+||+.|+|||++.+..++.++|||||||++|||++|..||...+..+....+.. ....+|..+++++.+
T Consensus 193 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~--~~~~~p~~~~~~~~~ 267 (350)
T 1rdq_E 193 GR---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS--GKVRFPSHFSSDLKD 267 (350)
T ss_dssp SC---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTCCHHHHH
T ss_pred CC---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHc--CCCCCCCCCCHHHHH
Confidence 43 2456899999999999999999999999999999999999999999888887777643 356678899999999
Q ss_pred HHHHhhhhCCCCCCC-----HHHHHH
Q 005247 667 LIETCWAEEPEIRPS-----FPSIME 687 (706)
Q Consensus 667 LI~~cL~~dP~~RPS-----~~eIl~ 687 (706)
||.+||+.||.+||+ +++|++
T Consensus 268 li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 268 LLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp HHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred HHHHHhhcCHHhccCCccCCHHHHHh
Confidence 999999999999998 888876
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=357.85 Aligned_cols=260 Identities=36% Similarity=0.642 Sum_probs=218.4
Q ss_pred cCcccccCceEEEEEeccCCceEEEEEEEcCCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccC-CCc
Q 005247 426 EGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE-PPN 504 (706)
Q Consensus 426 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~-~~~ 504 (706)
..+.+..++|++.+.||+|+||.||++++.++.||+|++.... ..+.+.+|+.+++.++||||+++++++.+ .+.
T Consensus 14 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (278)
T 1byg_A 14 SGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 89 (278)
T ss_dssp -CCBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--C
T ss_pred ccccCChhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCc
Confidence 4466778899999999999999999999998889999986442 34678899999999999999999998654 457
Q ss_pred eEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCcccc
Q 005247 505 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 584 (706)
Q Consensus 505 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~ 584 (706)
.++||||+++++|.+++.... ...+++..++.++.|++.||.|||++| |+||||||+||+++.++.+||+|||++..
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~ 166 (278)
T 1byg_A 90 LYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKE 166 (278)
T ss_dssp CEEEECCCTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTSCEEECCCCC---
T ss_pred eEEEEecCCCCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCcceEEEeCCCcEEEeecccccc
Confidence 899999999999999986432 223788899999999999999999999 99999999999999999999999999876
Q ss_pred CCCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCCCCCcHH
Q 005247 585 KPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPM 663 (706)
Q Consensus 585 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~e 663 (706)
..... ....+++.|+|||++.+..++.++||||||+++|+|++ |..||......+....+. .......+..+++.
T Consensus 167 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 242 (278)
T 1byg_A 167 ASSTQ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPA 242 (278)
T ss_dssp ------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT-TTCCCCCCTTCCHH
T ss_pred ccccc---cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-cCCCCCCcccCCHH
Confidence 54432 34467889999999999999999999999999999998 999999888777766653 44566778889999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhc
Q 005247 664 VAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 696 (706)
Q Consensus 664 l~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~ 696 (706)
+.++|.+||+.||++|||+.++++.|+++....
T Consensus 243 l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 243 VYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence 999999999999999999999999999987664
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=368.20 Aligned_cols=260 Identities=30% Similarity=0.514 Sum_probs=217.8
Q ss_pred ccccCceEEEEEeccCCceEEEEEEEcCCc------eEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCC
Q 005247 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD------VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP 502 (706)
Q Consensus 429 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~------vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~ 502 (706)
.+...+|++.+.||+|+||.||+|.+..++ +|+|++.... .....+.+.+|+.+++.++||||+++++++. .
T Consensus 9 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~ 86 (325)
T 3kex_A 9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-G 86 (325)
T ss_dssp BCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT-SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-B
T ss_pred hcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc-cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-C
Confidence 345678999999999999999999886543 5556553322 2222346778999999999999999999886 4
Q ss_pred CceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCcc
Q 005247 503 PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS 582 (706)
Q Consensus 503 ~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla 582 (706)
+..++||||+.+|+|.+++... ...+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++
T Consensus 87 ~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg~a 162 (325)
T 3kex_A 87 SSLQLVTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEHG--MVHRNLAARNVLLKSPSQVQVADFGVA 162 (325)
T ss_dssp SSEEEEEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHTT--CCCSCCSSTTEEESSSSCEEECSCSGG
T ss_pred CccEEEEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhCC--CCCCccchheEEECCCCeEEECCCCcc
Confidence 5689999999999999998643 346888999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCcc--cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCCCC
Q 005247 583 RSKPNTYI--SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKN 659 (706)
Q Consensus 583 ~~~~~~~~--~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p~~ 659 (706)
+....... ......+|..|+|||++.+..++.++||||||+++|+|++ |..||......+....+. ...+...+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~ 241 (325)
T 3kex_A 163 DLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE-KGERLAQPQI 241 (325)
T ss_dssp GGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHH-TTCBCCCCTT
T ss_pred cccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHH-cCCCCCCCCc
Confidence 87544322 2234567889999999999999999999999999999999 999999888777666653 4556777888
Q ss_pred CcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHh
Q 005247 660 VNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS 695 (706)
Q Consensus 660 ~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s 695 (706)
++.++.+||.+||+.||.+|||+.++++.|+++...
T Consensus 242 ~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 242 CTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp BCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred CcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 999999999999999999999999999999998764
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-42 Score=364.72 Aligned_cols=249 Identities=23% Similarity=0.407 Sum_probs=215.1
Q ss_pred CceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccch----HHHHHHHHHHHHHHcCCCCceeEEeccccCCCceE
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHE----DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS 506 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 506 (706)
+.|++.+.||+|+||.||+|.+.. ..||+|++....... ...+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 569999999999999999999874 459999987654322 12467889999999999999999999999999999
Q ss_pred EEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCC----cEEEeecCcc
Q 005247 507 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY----TVKVCDFGLS 582 (706)
Q Consensus 507 lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~----~vKL~DFGla 582 (706)
+||||+++++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++ .+||+|||++
T Consensus 91 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 165 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165 (326)
T ss_dssp EEEECCCSCBHHHHHTTS---SCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEcCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHHCC--eEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence 999999999999999643 35899999999999999999999999 99999999999998877 8999999999
Q ss_pred ccCCCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCccc--CCCCCC
Q 005247 583 RSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRL--EIPKNV 660 (706)
Q Consensus 583 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l--~~p~~~ 660 (706)
+...... ......||+.|+|||++.+..++.++||||||+++|+|++|..||......+....+....... ..+..+
T Consensus 166 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (326)
T 2y0a_A 166 HKIDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT 244 (326)
T ss_dssp EECCTTS-CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTS
T ss_pred eECCCCC-ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccC
Confidence 8765432 2345679999999999999999999999999999999999999999888777766654332222 223578
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 661 NPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 661 s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
++.+.+||.+||+.||++|||+.++++
T Consensus 245 ~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 245 SALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 999999999999999999999999987
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=384.73 Aligned_cols=266 Identities=34% Similarity=0.562 Sum_probs=225.9
Q ss_pred cCcccccCceEEEEEeccCCceEEEEEEEcCC-ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCc
Q 005247 426 EGLEIRWSELLIKKKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN 504 (706)
Q Consensus 426 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~-~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 504 (706)
..+++..++|++.+.||+|+||.||+|.+.++ .||||++...... .+.+.+|+.+|++++||||+++++++.+ +.
T Consensus 177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~ 252 (452)
T 1fmk_A 177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP 252 (452)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred cccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEcC-Cc
Confidence 44678888999999999999999999998765 4999998765433 3578999999999999999999999876 67
Q ss_pred eEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCcccc
Q 005247 505 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 584 (706)
Q Consensus 505 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~ 584 (706)
.++||||+.+|+|.++++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 253 ~~iv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG~a~~ 329 (452)
T 1fmk_A 253 IYIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARL 329 (452)
T ss_dssp CEEEECCCTTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCTTC-
T ss_pred eEEEehhhcCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEECCCCCEEECCCcccee
Confidence 899999999999999996321 234889999999999999999999999 99999999999999999999999999987
Q ss_pred CCCCc-ccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCCCCCcH
Q 005247 585 KPNTY-ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNP 662 (706)
Q Consensus 585 ~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~ 662 (706)
..... .......++..|+|||++.+..++.++||||||+++|||++ |+.||......+....+. .+.+++.+..+++
T Consensus 330 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~~~ 408 (452)
T 1fmk_A 330 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPE 408 (452)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTSCH
T ss_pred cCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCH
Confidence 54332 12234457789999999999999999999999999999999 999999988877777663 5567778889999
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhccCC
Q 005247 663 MVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQ 699 (706)
Q Consensus 663 el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~~~~ 699 (706)
.+.+||.+||+.||++|||+.+|++.|+.++.+..++
T Consensus 409 ~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~ 445 (452)
T 1fmk_A 409 SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 445 (452)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCC
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCcc
Confidence 9999999999999999999999999999998776543
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=355.16 Aligned_cols=262 Identities=31% Similarity=0.501 Sum_probs=222.0
Q ss_pred cccccCceEEEEEeccCCceEEEEEEEcCCc-----eEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCC
Q 005247 428 LEIRWSELLIKKKIGEGSFGTVYHAEWRNSD-----VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP 502 (706)
Q Consensus 428 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~-----vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~ 502 (706)
+.+..++|++.+.||+|+||.||+|.+.+.. ||+|++.... .....+.+.+|+.+++.++||||+++++++.++
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 85 (281)
T 3cc6_A 7 YGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE 85 (281)
T ss_dssp CSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS
T ss_pred ceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC
Confidence 4567789999999999999999999875432 8899876543 445567899999999999999999999998754
Q ss_pred CceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCcc
Q 005247 503 PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS 582 (706)
Q Consensus 503 ~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla 582 (706)
..++||||+.+++|.+++.... ..+++..++.++.|++.||.|||++| |+||||||+||+++.++.+||+|||++
T Consensus 86 -~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 160 (281)
T 3cc6_A 86 -PTWIIMELYPYGELGHYLERNK--NSLKVLTLVLYSLQICKAMAYLESIN--CVHRDIAVRNILVASPECVKLGDFGLS 160 (281)
T ss_dssp -SCEEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEEETTEEEECCCCGG
T ss_pred -CCEEEEecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEECCCCcEEeCccCCC
Confidence 5689999999999999996432 34889999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCcc-cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCCCCC
Q 005247 583 RSKPNTYI-SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNV 660 (706)
Q Consensus 583 ~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~ 660 (706)
........ ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||......+....+. .......+..+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~ 239 (281)
T 3cc6_A 161 RYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE-KGDRLPKPDLC 239 (281)
T ss_dssp GCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHH-HTCCCCCCTTC
T ss_pred cccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHh-cCCCCCCCCCC
Confidence 87554321 2234567889999999999999999999999999999998 999998877776665553 44556677889
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhc
Q 005247 661 NPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 696 (706)
Q Consensus 661 s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~ 696 (706)
++.+.+||.+||+.||++|||+.++++.|++++...
T Consensus 240 ~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 275 (281)
T 3cc6_A 240 PPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME 275 (281)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhh
Confidence 999999999999999999999999999999988653
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=378.11 Aligned_cols=247 Identities=28% Similarity=0.435 Sum_probs=208.1
Q ss_pred cccCceEEEEEeccCCceEEEEEEEcCCc--eEEEEEeccccc-hHHHHHHHHHHHH-HHcCCCCceeEEeccccCCCce
Q 005247 430 IRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFH-EDRFKEFLREVAI-MKGLRHPNIVLLMGAVTEPPNL 505 (706)
Q Consensus 430 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~--vAVKvl~~~~~~-~~~~~~~~~Ei~i-L~~L~HpnIv~l~~~~~~~~~~ 505 (706)
...++|++++.||+|+||.||+|+++.++ ||+|++.+.... ....+.+.+|..+ ++.++||||+++++++.+.+.+
T Consensus 35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~ 114 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL 114 (373)
T ss_dssp CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEE
Confidence 34568999999999999999999987654 899999776543 2334566777776 5678999999999999999999
Q ss_pred EEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccC
Q 005247 506 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK 585 (706)
Q Consensus 506 ~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~ 585 (706)
++||||+.+|+|.++++.. ..+++..++.++.||+.||+|||++| |+||||||+|||++.+|.+||+|||+++..
T Consensus 115 ~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 115 YFVLDYINGGELFYHLQRE---RCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred EEEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 9999999999999998643 35889999999999999999999999 999999999999999999999999999864
Q ss_pred CCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHH
Q 005247 586 PNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 665 (706)
Q Consensus 586 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~ 665 (706)
..........+||+.|+|||++.+..++.++|||||||++|||++|..||...+..+....+.. ....++..+++++.
T Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~ 267 (373)
T 2r5t_A 190 IEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN--KPLQLKPNITNSAR 267 (373)
T ss_dssp BCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHH--SCCCCCSSSCHHHH
T ss_pred ccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh--cccCCCCCCCHHHH
Confidence 4333345677899999999999999999999999999999999999999999888887777643 35567788999999
Q ss_pred HHHHHhhhhCCCCCCCHH
Q 005247 666 ALIETCWAEEPEIRPSFP 683 (706)
Q Consensus 666 dLI~~cL~~dP~~RPS~~ 683 (706)
+||.+||+.||.+||++.
T Consensus 268 ~li~~lL~~dp~~R~~~~ 285 (373)
T 2r5t_A 268 HLLEGLLQKDRTKRLGAK 285 (373)
T ss_dssp HHHHHHTCSSGGGSTTTT
T ss_pred HHHHHHcccCHHhCCCCC
Confidence 999999999999999975
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=372.01 Aligned_cols=253 Identities=24% Similarity=0.360 Sum_probs=210.9
Q ss_pred cCceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccc---hHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceE
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFH---EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS 506 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~---~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 506 (706)
.+.|++.+.||+|+||.||+|.+.. ..||+|++...... ....+.+.+|+.+++.++||||+++++++.+.+.++
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 4579999999999999999998864 45999998653221 112467889999999999999999999999999999
Q ss_pred EEEEeccCCchhhhcccC-CCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCc---EEEeecCcc
Q 005247 507 IVTEYLSRGSLYKLLHIP-DARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYT---VKVCDFGLS 582 (706)
Q Consensus 507 lV~E~~~ggsL~~~l~~~-~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~---vKL~DFGla 582 (706)
+||||+++++|.+++... .....+++..++.++.||+.||.|||+++ |+||||||+|||++.++. +||+|||++
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 999999999998877432 22335889999999999999999999999 999999999999986654 999999999
Q ss_pred ccCCCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCccc--CCCCCC
Q 005247 583 RSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRL--EIPKNV 660 (706)
Q Consensus 583 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l--~~p~~~ 660 (706)
+.............||+.|+|||++.+..++.++|||||||++|+|++|..||.... .+....+....... .....+
T Consensus 181 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~~~~~~ 259 (351)
T 3c0i_A 181 IQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSHI 259 (351)
T ss_dssp EECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHHHHTTS
T ss_pred eEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCccccccC
Confidence 876655444456789999999999999999999999999999999999999998754 34444443222211 122578
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 661 NPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 661 s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
++++.+||.+||..||++|||+.++++
T Consensus 260 s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 260 SESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 999999999999999999999999986
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=358.35 Aligned_cols=270 Identities=25% Similarity=0.429 Sum_probs=210.1
Q ss_pred ccCceEEEEEeccCCceEEEEEEEc--CCceEEEEEeccc-cchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEE
Q 005247 431 RWSELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQE-FHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI 507 (706)
Q Consensus 431 ~~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKvl~~~~-~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l 507 (706)
...+|++.+.||+|+||.||+|.+. +..||+|++.... ......+.+.+|+.+++.++||||+++++++...+..++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 3468999999999999999999875 4459999987533 345566789999999999999999999999999999999
Q ss_pred EEEeccCCchhhhcccC-CCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCC
Q 005247 508 VTEYLSRGSLYKLLHIP-DARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP 586 (706)
Q Consensus 508 V~E~~~ggsL~~~l~~~-~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~ 586 (706)
||||+.+++|.+++... .....+++..++.++.||+.||.|||++| |+||||||+||+++.++.+||+|||++....
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 99999999999998531 12345889999999999999999999999 9999999999999999999999999998765
Q ss_pred CCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHhhhcCcccCCCCCCcHHH
Q 005247 587 NTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNST--PSQVISAVGFKGRRLEIPKNVNPMV 664 (706)
Q Consensus 587 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~--~~~~~~~i~~~~~~l~~p~~~s~el 664 (706)
..........|++.|+|||++.+..++.++||||||+++|+|++|+.||.... .......+.........+..+++++
T Consensus 188 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 267 (310)
T 2wqm_A 188 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEEL 267 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHHH
T ss_pred CCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHHH
Confidence 44333445678999999999999999999999999999999999999997643 2333333332222233346789999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhccCCCCC
Q 005247 665 AALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQPLS 702 (706)
Q Consensus 665 ~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~~~~~~s 702 (706)
.+||.+||+.||++|||+.++++.|+++.......+.+
T Consensus 268 ~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~~~ 305 (310)
T 2wqm_A 268 RQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLEH 305 (310)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-----
T ss_pred HHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhhhh
Confidence 99999999999999999999999999999888776654
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=385.26 Aligned_cols=252 Identities=27% Similarity=0.456 Sum_probs=211.0
Q ss_pred ccccCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEecccc-chHHHHHHHHHHHHHHcCCCCceeEEeccccCCCce
Q 005247 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNL 505 (706)
Q Consensus 429 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 505 (706)
.+..++|++.+.||+|+||.||+|.+..+ .||+|++..... .......+.+|+.+++.++||||+++++++.+.+.+
T Consensus 144 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 223 (446)
T 4ejn_A 144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRL 223 (446)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEE
T ss_pred CCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEE
Confidence 34567899999999999999999998654 499999876432 234456788999999999999999999999999999
Q ss_pred EEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHh-cCCCcccccCCCCcEEECCCCcEEEeecCcccc
Q 005247 506 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ-RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 584 (706)
Q Consensus 506 ~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs-~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~ 584 (706)
++||||+++|+|.+++... ..+++..+..++.||+.||+|||+ +| ||||||||+|||++.++.+||+|||+++.
T Consensus 224 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~g--iiHrDlkp~NIll~~~~~~kl~DFG~a~~ 298 (446)
T 4ejn_A 224 CFVMEYANGGELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKE 298 (446)
T ss_dssp EEEECCCSSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHHTC--CCCCCCCGGGEEECSSSCEEECCCCCCCT
T ss_pred EEEEeeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCC--EEECCCCHHHEEECCCCCEEEccCCCcee
Confidence 9999999999999998643 358899999999999999999998 88 99999999999999999999999999987
Q ss_pred CCCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHH
Q 005247 585 KPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV 664 (706)
Q Consensus 585 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el 664 (706)
...........+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+.. ....+|..+++++
T Consensus 299 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~--~~~~~p~~~~~~~ 376 (446)
T 4ejn_A 299 GIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM--EEIRFPRTLGPEA 376 (446)
T ss_dssp TCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTSCHHH
T ss_pred ccCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHh--CCCCCCccCCHHH
Confidence 55444445667899999999999999999999999999999999999999999888777776643 3456788899999
Q ss_pred HHHHHHhhhhCCCCCC-----CHHHHHH
Q 005247 665 AALIETCWAEEPEIRP-----SFPSIME 687 (706)
Q Consensus 665 ~dLI~~cL~~dP~~RP-----S~~eIl~ 687 (706)
.+||.+||+.||.+|| ++.++++
T Consensus 377 ~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 377 KSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp HHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 9999999999999999 9999986
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=365.09 Aligned_cols=265 Identities=31% Similarity=0.559 Sum_probs=226.0
Q ss_pred cCcccccCceEEEEEeccCCceEEEEEEEc-------CCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEecc
Q 005247 426 EGLEIRWSELLIKKKIGEGSFGTVYHAEWR-------NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA 498 (706)
Q Consensus 426 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~-------~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~ 498 (706)
..+++..++|++.+.||+|+||.||+|.+. +..||+|++.... .......+.+|+.+++.++||||++++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 96 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGV 96 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCEeeeEEE
Confidence 346777889999999999999999999865 3459999876443 34455678999999999999999999999
Q ss_pred ccCCCceEEEEEeccCCchhhhcccCC-------CcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCC
Q 005247 499 VTEPPNLSIVTEYLSRGSLYKLLHIPD-------ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST 571 (706)
Q Consensus 499 ~~~~~~~~lV~E~~~ggsL~~~l~~~~-------~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~ 571 (706)
+.+.+..++||||+.+|+|.++++... ....+++..++.++.||+.||.|||++| |+||||||+||+++.+
T Consensus 97 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~NIli~~~ 174 (322)
T 1p4o_A 97 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAED 174 (322)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEECTT
T ss_pred EccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--CccCCCccceEEEcCC
Confidence 999999999999999999999986321 1134688999999999999999999999 9999999999999999
Q ss_pred CcEEEeecCccccCCCCc--ccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhh
Q 005247 572 YTVKVCDFGLSRSKPNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVG 648 (706)
Q Consensus 572 ~~vKL~DFGla~~~~~~~--~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~ 648 (706)
+.+||+|||+++...... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||......+....+.
T Consensus 175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 254 (322)
T 1p4o_A 175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 254 (322)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH
T ss_pred CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHH
Confidence 999999999987643322 11233456889999999999999999999999999999999 899999888777666653
Q ss_pred hcCcccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 005247 649 FKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLM 694 (706)
Q Consensus 649 ~~~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~ 694 (706)
.......+..++..+.+||.+||+.||++|||+.++++.|++.+.
T Consensus 255 -~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 255 -EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp -TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred -cCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 444566778899999999999999999999999999999987654
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=366.27 Aligned_cols=248 Identities=20% Similarity=0.355 Sum_probs=215.0
Q ss_pred cCceEEEEEeccCCceEEEEEEEcCCc--eEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEE
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 509 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~--vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~ 509 (706)
.++|++.+.||+|+||.||+|.+..++ +|+|++... ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 80 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEE
Confidence 468999999999999999999987554 899988643 234457889999999999999999999999999999999
Q ss_pred EeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECC--CCcEEEeecCccccCCC
Q 005247 510 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS--TYTVKVCDFGLSRSKPN 587 (706)
Q Consensus 510 E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~--~~~vKL~DFGla~~~~~ 587 (706)
||+++++|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+|||++. ++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~g--ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~ 156 (321)
T 1tki_A 81 EFISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred EeCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence 9999999999996432 35899999999999999999999999 999999999999987 78999999999987654
Q ss_pred CcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccC--CCCCCcHHHH
Q 005247 588 TYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLE--IPKNVNPMVA 665 (706)
Q Consensus 588 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~--~p~~~s~el~ 665 (706)
.. ......||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+........ ....+++++.
T Consensus 157 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 235 (321)
T 1tki_A 157 GD-NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM 235 (321)
T ss_dssp TC-EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred CC-ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHH
Confidence 32 22345789999999999998899999999999999999999999999888877776643333222 2257899999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHH
Q 005247 666 ALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 666 dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
+||.+||..||.+|||+.|+++
T Consensus 236 ~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 236 DFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHcCCChhHCcCHHHHhc
Confidence 9999999999999999999987
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-42 Score=354.38 Aligned_cols=261 Identities=27% Similarity=0.517 Sum_probs=220.2
Q ss_pred ccccCceEEEEEeccCCceEEEEEEEcCCc--eEEEEEeccccch-HHHHHHHHHHHHHHcCCCCceeEEeccccCCCce
Q 005247 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNL 505 (706)
Q Consensus 429 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~--vAVKvl~~~~~~~-~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 505 (706)
....++|++.+.||+|+||.||+|.+..++ ||+|++....... .....+.+|+.+++.++||||+++++++.+.+..
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (279)
T 3fdn_A 5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 84 (279)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred eeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEE
Confidence 345678999999999999999999987654 9999986543222 2245788999999999999999999999999999
Q ss_pred EEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccC
Q 005247 506 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK 585 (706)
Q Consensus 506 ~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~ 585 (706)
++||||+++++|.+++... ..+++..++.++.||+.||+|||++| |+||||||+||+++.++.+||+|||++...
T Consensus 85 ~lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~ 159 (279)
T 3fdn_A 85 YLILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHA 159 (279)
T ss_dssp EEEECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT--CEECCCCGGGEEECTTSCEEECSCCEESCC
T ss_pred EEEEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHhEEEcCCCCEEEEeccccccC
Confidence 9999999999999998633 34889999999999999999999999 999999999999999999999999998765
Q ss_pred CCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHH
Q 005247 586 PNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 665 (706)
Q Consensus 586 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~ 665 (706)
.... .....||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+. .....++..+++.+.
T Consensus 160 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 235 (279)
T 3fdn_A 160 PSSR--RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS--RVEFTFPDFVTEGAR 235 (279)
T ss_dssp ----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--HTCCCCCTTSCHHHH
T ss_pred Cccc--ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHH--hCCCCCCCcCCHHHH
Confidence 4432 245678999999999999999999999999999999999999999988877776653 345567788999999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHHHHHHHhccCCC
Q 005247 666 ALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQP 700 (706)
Q Consensus 666 dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~~~~~ 700 (706)
+||.+||+.||++|||+.++++. .++......+
T Consensus 236 ~li~~~l~~~p~~Rps~~e~l~h--~~~~~~~~~~ 268 (279)
T 3fdn_A 236 DLISRLLKHNPSQRPMLREVLEH--PWITANSSKP 268 (279)
T ss_dssp HHHHHHCCSSGGGSCCHHHHHHC--HHHHHHCSSC
T ss_pred HHHHHHhccChhhCCCHHHHhhC--ccccCCccCc
Confidence 99999999999999999999984 3444443333
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=358.92 Aligned_cols=261 Identities=31% Similarity=0.493 Sum_probs=215.4
Q ss_pred ccccCceEEEEEeccCCceEEEEEEE------cCCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCC
Q 005247 429 EIRWSELLIKKKIGEGSFGTVYHAEW------RNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP 502 (706)
Q Consensus 429 ~i~~~~y~i~~~LG~G~fG~Vy~a~~------~~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~ 502 (706)
.+....|++.+.||+|+||.||+|.+ .+..||+|++.... .....+.+.+|+.+++.++||||+++++++...
T Consensus 17 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (302)
T 4e5w_A 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTED 95 (302)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred hhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence 44566799999999999999999984 23449999986543 233446788999999999999999999998776
Q ss_pred --CceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecC
Q 005247 503 --PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFG 580 (706)
Q Consensus 503 --~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFG 580 (706)
..+++||||+++++|.+++.... ..+++..++.++.|++.||+|||++| |+||||||+||+++.++.+||+|||
T Consensus 96 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg 171 (302)
T 4e5w_A 96 GGNGIKLIMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFG 171 (302)
T ss_dssp --CCEEEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCT
T ss_pred CCceEEEEEEeCCCCcHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHhhcCC--cccCCCchheEEEcCCCCEEECccc
Confidence 66899999999999999995332 34889999999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCc---ccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC--------------ChHHH
Q 005247 581 LSRSKPNTY---ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNS--------------TPSQV 643 (706)
Q Consensus 581 la~~~~~~~---~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~--------------~~~~~ 643 (706)
++....... .......+|..|+|||++.+..++.++||||||+++|+|++|..||... .....
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (302)
T 4e5w_A 172 LTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR 251 (302)
T ss_dssp TCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHH
T ss_pred ccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHH
Confidence 998755432 2234556888999999999999999999999999999999999876322 11122
Q ss_pred HHHhhhcCcccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 005247 644 ISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLM 694 (706)
Q Consensus 644 ~~~i~~~~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~ 694 (706)
.........+...+..+++++.+||.+||+.||.+|||+.++++.|+++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll~ 302 (302)
T 4e5w_A 252 LVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302 (302)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred HHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence 222223455677888999999999999999999999999999999999873
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-42 Score=364.98 Aligned_cols=250 Identities=29% Similarity=0.381 Sum_probs=207.4
Q ss_pred cCceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEE
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 509 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~ 509 (706)
.++|++++.||+|+||.||+|.+.. ..||+|++..... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 84 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc-cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 4689999999999999999998874 4499999865432 223357889999999999999999999999999999999
Q ss_pred EeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCC-
Q 005247 510 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT- 588 (706)
Q Consensus 510 E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~- 588 (706)
||+++++|.+++... ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++.....
T Consensus 85 e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 85 EYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp ECCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred EcCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 999999999999743 35899999999999999999999999 999999999999999999999999999764322
Q ss_pred -cccCCCCCCCCCccCccccccCCC-CchhHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHhhhcCcccCCCCCCcHHHH
Q 005247 589 -YISSKTAAGTPEWMAPEVLREDPS-NEKSDVFSFGVILWELITLQKPWRNSTPSQV-ISAVGFKGRRLEIPKNVNPMVA 665 (706)
Q Consensus 589 -~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~-~~~i~~~~~~l~~p~~~s~el~ 665 (706)
........||+.|+|||++.+..+ +.++||||||+++|+|++|+.||........ ................+++++.
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHH
T ss_pred cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHH
Confidence 222345689999999999988775 7789999999999999999999987655322 2222222233333467899999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHH
Q 005247 666 ALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 666 dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
+||.+||+.||++|||+.|+++
T Consensus 240 ~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 240 ALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHHccCChhhCcCHHHHhh
Confidence 9999999999999999999976
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=389.52 Aligned_cols=262 Identities=36% Similarity=0.616 Sum_probs=228.6
Q ss_pred CcccccCceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCc
Q 005247 427 GLEIRWSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN 504 (706)
Q Consensus 427 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 504 (706)
.+++...+|++.+.||+|+||.||+|.+.+ ..||||++...... .+.|.+|+.+|++++||||+++++++.+.+.
T Consensus 214 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 290 (495)
T 1opk_A 214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 290 (495)
T ss_dssp CCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc---hHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence 366778899999999999999999999875 45999998654332 4678999999999999999999999999999
Q ss_pred eEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCcccc
Q 005247 505 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 584 (706)
Q Consensus 505 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~ 584 (706)
+++||||+.+|+|.++++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 291 ~~lv~E~~~~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 367 (495)
T 1opk_A 291 FYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN--FIHRNLAARNCLVGENHLVKVADFGLSRL 367 (495)
T ss_dssp CEEEEECCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECGGGCEEECCTTCEEC
T ss_pred EEEEEEccCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChhhEEECCCCcEEEeeccccee
Confidence 999999999999999996432 235889999999999999999999999 99999999999999999999999999987
Q ss_pred CCCCc-ccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCCCCCcH
Q 005247 585 KPNTY-ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNP 662 (706)
Q Consensus 585 ~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~ 662 (706)
..... .......++..|+|||++.+..++.++||||||+++|||++ |..||...+..+....+ ....++..+..+++
T Consensus 368 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 446 (495)
T 1opk_A 368 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-EKDYRMERPEGCPE 446 (495)
T ss_dssp CTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH-HTTCCCCCCTTCCH
T ss_pred ccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCCCCCCCCCCCH
Confidence 64332 22234456789999999999999999999999999999999 99999988877776655 35567778899999
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHh
Q 005247 663 MVAALIETCWAEEPEIRPSFPSIMETLQQFLMS 695 (706)
Q Consensus 663 el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s 695 (706)
++.+||.+||+.||++|||+.+|++.|+.++..
T Consensus 447 ~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 447 KVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred HHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 999999999999999999999999999887643
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-42 Score=375.02 Aligned_cols=253 Identities=25% Similarity=0.439 Sum_probs=215.8
Q ss_pred CcccccCceEEEEEeccCCceEEEEEEEcCCc--eEEEEEecccc-chHHHHHHHHHHHHHHcCCCCceeEEeccccCCC
Q 005247 427 GLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP 503 (706)
Q Consensus 427 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~--vAVKvl~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 503 (706)
...+..++|++++.||+|+||.||+|.+..++ ||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+
T Consensus 9 ~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 88 (384)
T 4fr4_A 9 NEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEE 88 (384)
T ss_dssp CCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred CCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 34566789999999999999999999987654 99999866432 2233567889999999999999999999999999
Q ss_pred ceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccc
Q 005247 504 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 583 (706)
Q Consensus 504 ~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~ 583 (706)
..++||||+.+|+|.++++.. ..+++..++.++.||+.||.|||++| |+||||||+|||++.+|.+||+|||++.
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~vkL~DFG~a~ 163 (384)
T 4fr4_A 89 DMFMVVDLLLGGDLRYHLQQN---VHFKEETVKLFICELVMALDYLQNQR--IIHRDMKPDNILLDEHGHVHITDFNIAA 163 (384)
T ss_dssp EEEEEECCCTTEEHHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEECCCCCEEEeccceee
Confidence 999999999999999999743 35899999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCcccCCCCCCCCCccCcccccc---CCCCchhHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHhhhcCcccCCC
Q 005247 584 SKPNTYISSKTAAGTPEWMAPEVLRE---DPSNEKSDVFSFGVILWELITLQKPWRNSTP---SQVISAVGFKGRRLEIP 657 (706)
Q Consensus 584 ~~~~~~~~~~~~~Gt~~Y~APE~l~~---~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~---~~~~~~i~~~~~~l~~p 657 (706)
...... .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... .+....+ ......+|
T Consensus 164 ~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~--~~~~~~~p 240 (384)
T 4fr4_A 164 MLPRET-QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTF--ETTVVTYP 240 (384)
T ss_dssp ECCTTC-CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHH--HHCCCCCC
T ss_pred eccCCC-ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHH--hhcccCCC
Confidence 765432 3456789999999999974 4588999999999999999999999975433 2333332 34456778
Q ss_pred CCCcHHHHHHHHHhhhhCCCCCCC-HHHHHH
Q 005247 658 KNVNPMVAALIETCWAEEPEIRPS-FPSIME 687 (706)
Q Consensus 658 ~~~s~el~dLI~~cL~~dP~~RPS-~~eIl~ 687 (706)
..+++++.+||.+||+.||.+||+ +.+++.
T Consensus 241 ~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 241 SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred CcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 899999999999999999999998 777664
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=358.82 Aligned_cols=251 Identities=25% Similarity=0.399 Sum_probs=207.1
Q ss_pred cCceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEE
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 509 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~ 509 (706)
.++|++++.||+|+||.||+|.+.. ..||+|++..........+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 3679999999999999999999874 45999998777666666778899999999999999999999999999999999
Q ss_pred EeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCc
Q 005247 510 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 589 (706)
Q Consensus 510 E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 589 (706)
||+.+++|.++++.. ..+++..++.++.|++.||.|||++| |+||||||+||+++.++.+||+|||++.......
T Consensus 82 e~~~~~~l~~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 82 EYCDHTVLHELDRYQ---RGVPEHLVKSITWQTLQAVNFCHKHN--CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp ECCSEEHHHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EeCCCchHHHHHhhh---cCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 999999999988643 34889999999999999999999999 9999999999999999999999999998766544
Q ss_pred ccCCCCCCCCCccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhc------------------
Q 005247 590 ISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK------------------ 650 (706)
Q Consensus 590 ~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~------------------ 650 (706)
.......||+.|+|||++.+ ..++.++||||||+++|+|++|..||......+....+...
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
T 4agu_A 157 DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF 236 (311)
T ss_dssp ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGG
T ss_pred cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccc
Confidence 44456689999999999976 56799999999999999999999999988776655443211
Q ss_pred -CcccCC----------CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 651 -GRRLEI----------PKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 651 -~~~l~~----------p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
....+. .+.+++++.+||.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp TTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred ccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 001111 1467889999999999999999999999986
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=382.97 Aligned_cols=255 Identities=25% Similarity=0.382 Sum_probs=219.0
Q ss_pred CcccccCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCceeEEeccccCCC
Q 005247 427 GLEIRWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFH-EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP 503 (706)
Q Consensus 427 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 503 (706)
.+.+..++|++++.||+|+||+||+|++..+ .||+|++.+.... ....+.+.+|+.+++.++||||+++++++.+.+
T Consensus 63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 142 (410)
T 3v8s_A 63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 142 (410)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 3456778999999999999999999998754 4999998653221 112235778999999999999999999999999
Q ss_pred ceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccc
Q 005247 504 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 583 (706)
Q Consensus 504 ~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~ 583 (706)
.+++||||++||+|.++++.. .+++..++.++.||+.||+|||++| ||||||||+|||++.++.+||+|||+++
T Consensus 143 ~~~lV~E~~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~g~ikL~DFG~a~ 216 (410)
T 3v8s_A 143 YLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCM 216 (410)
T ss_dssp EEEEEECCCTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeeECCCCCEEEeccceeE
Confidence 999999999999999998633 4889999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCc-ccCCCCCCCCCccCccccccCC----CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCC-
Q 005247 584 SKPNTY-ISSKTAAGTPEWMAPEVLREDP----SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP- 657 (706)
Q Consensus 584 ~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~----~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p- 657 (706)
...... ....+.+||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+..+....+......+.+|
T Consensus 217 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~ 296 (410)
T 3v8s_A 217 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPD 296 (410)
T ss_dssp ECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCT
T ss_pred eeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCC
Confidence 755432 2334678999999999998765 7889999999999999999999999998888877775443334444
Q ss_pred -CCCcHHHHHHHHHhhhhCCCC--CCCHHHHHH
Q 005247 658 -KNVNPMVAALIETCWAEEPEI--RPSFPSIME 687 (706)
Q Consensus 658 -~~~s~el~dLI~~cL~~dP~~--RPS~~eIl~ 687 (706)
..+++++++||.+||+.+|.+ ||++++|++
T Consensus 297 ~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 297 DNDISKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred cccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 478999999999999999988 999999986
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=353.58 Aligned_cols=261 Identities=18% Similarity=0.223 Sum_probs=217.4
Q ss_pred ccccCceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcC-CCCceeEEeccccCCCce
Q 005247 429 EIRWSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNL 505 (706)
Q Consensus 429 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~ 505 (706)
.+..++|++.+.||+|+||.||+|.+.. ..||+|++...... +.+.+|+.+++.+ +|+|++++++++.+....
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~ 81 (298)
T 1csn_A 6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN 81 (298)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc----HHHHHHHHHHHHHhcCCCCCeEEeecCCCcee
Confidence 3456789999999999999999999754 45999998654322 3577899999999 799999999999999999
Q ss_pred EEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCc-----EEEeecC
Q 005247 506 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYT-----VKVCDFG 580 (706)
Q Consensus 506 ~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~-----vKL~DFG 580 (706)
++||||+ +++|.+++...+ ..+++..++.++.||+.||.|||++| |+||||||+|||++.++. +||+|||
T Consensus 82 ~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg 156 (298)
T 1csn_A 82 VLVIDLL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFG 156 (298)
T ss_dssp EEEEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred EEEEEec-CCCHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEeccCCCCCCCeEEEEECc
Confidence 9999999 999999997443 24889999999999999999999999 999999999999987765 9999999
Q ss_pred ccccCCCCcc-------cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHhhhc
Q 005247 581 LSRSKPNTYI-------SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNST---PSQVISAVGFK 650 (706)
Q Consensus 581 la~~~~~~~~-------~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~---~~~~~~~i~~~ 650 (706)
+++....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.... ..+....+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (298)
T 1csn_A 157 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK 236 (298)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH
T ss_pred cccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhh
Confidence 9986544321 2345679999999999999999999999999999999999999998743 33333333211
Q ss_pred ---CcccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhccC
Q 005247 651 ---GRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVC 698 (706)
Q Consensus 651 ---~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~~~ 698 (706)
.........+++++.+||.+||+.||++|||+.+|++.|++++.....
T Consensus 237 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~ 287 (298)
T 1csn_A 237 KQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT 287 (298)
T ss_dssp HHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred ccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCC
Confidence 112233457899999999999999999999999999999999987544
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=366.89 Aligned_cols=266 Identities=30% Similarity=0.455 Sum_probs=217.5
Q ss_pred CcccccCceEEEEEeccCCceEEEEEEEc-CCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCce
Q 005247 427 GLEIRWSELLIKKKIGEGSFGTVYHAEWR-NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNL 505 (706)
Q Consensus 427 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~-~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 505 (706)
.++...++|++.+.||+|+||.||+|.+. +..||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 110 (321)
T 2qkw_B 33 DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES--SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEM 110 (321)
T ss_dssp CCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCC--SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCC
T ss_pred HHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence 34556678999999999999999999876 4459999875543 33456889999999999999999999999999999
Q ss_pred EEEEEeccCCchhhhcccCCC-cccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCcccc
Q 005247 506 SIVTEYLSRGSLYKLLHIPDA-RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 584 (706)
Q Consensus 506 ~lV~E~~~ggsL~~~l~~~~~-~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~ 584 (706)
++||||+++|+|.+++..... ...+++..++.++.||+.||.|||++| |+||||||+||+++.++.+||+|||+++.
T Consensus 111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 188 (321)
T 2qkw_B 111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA--IIHRDVKSINILLDENFVPKITDFGISKK 188 (321)
T ss_dssp EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCSTTEEECTTCCEEECCCTTCEE
T ss_pred EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC--eecCCCCHHHEEECCCCCEEEeecccccc
Confidence 999999999999999964432 235889999999999999999999999 99999999999999999999999999976
Q ss_pred CCCCc--ccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh------hcC-----
Q 005247 585 KPNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVG------FKG----- 651 (706)
Q Consensus 585 ~~~~~--~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~------~~~----- 651 (706)
..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||....+.+...... ...
T Consensus 189 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (321)
T 2qkw_B 189 GTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQI 268 (321)
T ss_dssp CSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSS
T ss_pred cccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHh
Confidence 44321 12234468999999999999999999999999999999999999997654432111000 000
Q ss_pred ----cccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhc
Q 005247 652 ----RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 696 (706)
Q Consensus 652 ----~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~ 696 (706)
....++..++..+.++|.+||+.||++|||+.++++.|+.+++..
T Consensus 269 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~ 317 (321)
T 2qkw_B 269 VDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317 (321)
T ss_dssp SSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred cChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence 011223345678999999999999999999999999999998653
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=363.81 Aligned_cols=259 Identities=31% Similarity=0.533 Sum_probs=214.5
Q ss_pred cccCceEEEEEeccCCceEEEEEEEcCC--ce----EEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCC
Q 005247 430 IRWSELLIKKKIGEGSFGTVYHAEWRNS--DV----AVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP 503 (706)
Q Consensus 430 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~--~v----AVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 503 (706)
+...+|++.+.||+|+||.||+|.+..+ .+ ++|.+.... .....+.+.+|+.+++.++||||+++++++....
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 90 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST 90 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC
Confidence 4567899999999999999999998544 35 555543322 2334568899999999999999999999998754
Q ss_pred ceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccc
Q 005247 504 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 583 (706)
Q Consensus 504 ~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~ 583 (706)
.++++||+.+|+|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++
T Consensus 91 -~~~v~~~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kL~DfG~a~ 165 (327)
T 3lzb_A 91 -VQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp -EEEEECCCSSCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCTTC--
T ss_pred -ceEEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhCC--CcCCCCCHHHEEEcCCCCEEEccCccee
Confidence 789999999999999986433 35889999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCcc--cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCCCCC
Q 005247 584 SKPNTYI--SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNV 660 (706)
Q Consensus 584 ~~~~~~~--~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~ 660 (706)
....... ......+|+.|+|||++.+..++.++||||||+++|||++ |..||......+....+. .......+..+
T Consensus 166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~ 244 (327)
T 3lzb_A 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLPQPPIC 244 (327)
T ss_dssp --------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-TTCCCCCCTTB
T ss_pred EccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCCCCccC
Confidence 7543321 2233456789999999999999999999999999999999 999999988877766553 45567778889
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHh
Q 005247 661 NPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS 695 (706)
Q Consensus 661 s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s 695 (706)
+.++.+||.+||..||.+|||+.++++.|+++...
T Consensus 245 ~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 245 TIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 99999999999999999999999999999999854
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=360.13 Aligned_cols=246 Identities=27% Similarity=0.448 Sum_probs=214.1
Q ss_pred ceEEEEEeccCCceEEEEEEEc--CCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEEe
Q 005247 434 ELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY 511 (706)
Q Consensus 434 ~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~ 511 (706)
.|...+.||+|+||.||+|.+. +..||||++..... ...+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 123 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEF 123 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--CSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch--hHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEec
Confidence 4778889999999999999986 45599999865432 2345788999999999999999999999999999999999
Q ss_pred ccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCccc
Q 005247 512 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS 591 (706)
Q Consensus 512 ~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~ 591 (706)
+++++|.+++... .+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.........
T Consensus 124 ~~~~~L~~~l~~~----~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 197 (321)
T 2c30_A 124 LQGGALTDIVSQV----RLNEEQIATVCEAVLQALAYLHAQG--VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK 197 (321)
T ss_dssp CCSCBHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC
T ss_pred CCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCcEEEeeeeeeeecccCccc
Confidence 9999999998632 4889999999999999999999999 999999999999999999999999999876654444
Q ss_pred CCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCc-ccCCCCCCcHHHHHHHHH
Q 005247 592 SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR-RLEIPKNVNPMVAALIET 670 (706)
Q Consensus 592 ~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~-~l~~p~~~s~el~dLI~~ 670 (706)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||......+....+..... ....+..+++++.+||.+
T Consensus 198 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 277 (321)
T 2c30_A 198 RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLER 277 (321)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHH
T ss_pred cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHH
Confidence 4567899999999999999999999999999999999999999998887776665543222 223345688999999999
Q ss_pred hhhhCCCCCCCHHHHHH
Q 005247 671 CWAEEPEIRPSFPSIME 687 (706)
Q Consensus 671 cL~~dP~~RPS~~eIl~ 687 (706)
||+.||++|||+.++++
T Consensus 278 ~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 278 MLVRDPQERATAQELLD 294 (321)
T ss_dssp HSCSSTTTSCCHHHHHT
T ss_pred HccCChhhCcCHHHHhc
Confidence 99999999999999976
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=352.25 Aligned_cols=254 Identities=31% Similarity=0.498 Sum_probs=215.5
Q ss_pred cccccCceEEEEEeccCCceEEEEEEEcCCc--eEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccC----
Q 005247 428 LEIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE---- 501 (706)
Q Consensus 428 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~--vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~---- 501 (706)
.......|++.+.||+|+||.||+|.+..+. ||+|++..........+.+.+|+.+++.++||||+++++++..
T Consensus 21 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (290)
T 1t4h_A 21 MSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKG 100 (290)
T ss_dssp ECTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSS
T ss_pred cccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCC
Confidence 3445567999999999999999999987654 8889988777777778889999999999999999999998754
Q ss_pred CCceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEEC-CCCcEEEeecC
Q 005247 502 PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVD-STYTVKVCDFG 580 (706)
Q Consensus 502 ~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~-~~~~vKL~DFG 580 (706)
...+++||||+++++|.+++... ..+++..++.++.||+.||.|||+++++|+||||||+|||++ .++.+||+|||
T Consensus 101 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg 177 (290)
T 1t4h_A 101 KKCIVLVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLG 177 (290)
T ss_dssp CEEEEEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTT
T ss_pred CceEEEEEEecCCCCHHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCC
Confidence 45689999999999999999643 358899999999999999999999887799999999999997 78899999999
Q ss_pred ccccCCCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHhhhcCcccCCCCC
Q 005247 581 LSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTP-SQVISAVGFKGRRLEIPKN 659 (706)
Q Consensus 581 la~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~-~~~~~~i~~~~~~l~~p~~ 659 (706)
++....... .....||+.|+|||++.+ .++.++||||||+++|+|++|+.||..... ......+........++..
T Consensus 178 ~~~~~~~~~--~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (290)
T 1t4h_A 178 LATLKRASF--AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKV 254 (290)
T ss_dssp GGGGCCTTS--BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGC
T ss_pred Ccccccccc--cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCC
Confidence 997655432 235679999999998864 589999999999999999999999987544 4444444333344556677
Q ss_pred CcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 660 VNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 660 ~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
.++++.+||.+||+.||.+|||+.++++
T Consensus 255 ~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 255 AIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 8899999999999999999999999975
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=354.83 Aligned_cols=258 Identities=28% Similarity=0.436 Sum_probs=217.6
Q ss_pred ccCceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccc--cCCCceE
Q 005247 431 RWSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAV--TEPPNLS 506 (706)
Q Consensus 431 ~~~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~--~~~~~~~ 506 (706)
..++|++.+.||+|+||.||+|.+.. ..||+|++..........+.+.+|+.++++++||||+++++++ ......+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence 35689999999999999999999864 4499999987766677778899999999999999999999987 4467799
Q ss_pred EEEEeccCCchhhhcccCC-CcccccHHHHHHHHHHHHHHHHHHHhcC---CCcccccCCCCcEEECCCCcEEEeecCcc
Q 005247 507 IVTEYLSRGSLYKLLHIPD-ARVVVDERLRLNMAYDVAKGMNYLHQRR---PPIVHRDLKSPNLLVDSTYTVKVCDFGLS 582 (706)
Q Consensus 507 lV~E~~~ggsL~~~l~~~~-~~~~l~~~~~~~ia~qIl~aL~yLHs~g---~~IIHrDLKp~NILl~~~~~vKL~DFGla 582 (706)
+||||+++++|.+++.... ....+++..++.++.|++.||+|||+++ .+|+||||||+||+++.++.+||+|||++
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~ 163 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence 9999999999999986422 2234889999999999999999999987 34999999999999999999999999999
Q ss_pred ccCCCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcH
Q 005247 583 RSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNP 662 (706)
Q Consensus 583 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~ 662 (706)
+.............||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+. ......++..+++
T Consensus 164 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~ 242 (279)
T 2w5a_A 164 RILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR-EGKFRRIPYRYSD 242 (279)
T ss_dssp HHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-HTCCCCCCTTSCH
T ss_pred eeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHh-hcccccCCcccCH
Confidence 876543322234578999999999999999999999999999999999999999888777666653 3444567788999
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 005247 663 MVAALIETCWAEEPEIRPSFPSIMETL 689 (706)
Q Consensus 663 el~dLI~~cL~~dP~~RPS~~eIl~~L 689 (706)
++.+||.+||+.||++|||+.+|++.+
T Consensus 243 ~l~~li~~~l~~~p~~Rps~~~ll~~~ 269 (279)
T 2w5a_A 243 ELNEIITRMLNLKDYHRPSVEEILENP 269 (279)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred HHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence 999999999999999999999998743
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=371.98 Aligned_cols=248 Identities=29% Similarity=0.491 Sum_probs=211.8
Q ss_pred ccCceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccch-HHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEE
Q 005247 431 RWSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI 507 (706)
Q Consensus 431 ~~~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~-~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l 507 (706)
..++|++.+.||+|+||.||+|.+.. ..||+|++....... ...+.+.+|+.+++.++||||+++++++...+..++
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 86 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM 86 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 45789999999999999999999854 459999986543222 123578899999999999999999999999999999
Q ss_pred EEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCC
Q 005247 508 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 587 (706)
Q Consensus 508 V~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 587 (706)
||||+ +|+|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.....
T Consensus 87 v~E~~-~g~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 87 VIEYA-GGELFDYIVEK---KRMTEDEGRRFFQQIICAIEYCHRHK--IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp EECCC-CEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHT--CCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred EEECC-CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 99999 67888888533 35889999999999999999999999 99999999999999999999999999987654
Q ss_pred CcccCCCCCCCCCccCccccccCCC-CchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHH
Q 005247 588 TYISSKTAAGTPEWMAPEVLREDPS-NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA 666 (706)
Q Consensus 588 ~~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~d 666 (706)
.. .....+||+.|+|||++.+..+ +.++||||||+++|+|++|+.||...........+ ......+|..+++++.+
T Consensus 161 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i--~~~~~~~p~~~s~~~~~ 237 (336)
T 3h4j_B 161 GN-FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV--NSCVYVMPDFLSPGAQS 237 (336)
T ss_dssp SB-TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC--CSSCCCCCTTSCHHHHH
T ss_pred Cc-ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH--HcCCCCCcccCCHHHHH
Confidence 43 3356689999999999988876 78999999999999999999999876554433322 23345677889999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHH
Q 005247 667 LIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 667 LI~~cL~~dP~~RPS~~eIl~ 687 (706)
||.+||+.||.+|||+.|+++
T Consensus 238 li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 238 LIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp HHHTTSCSSGGGSCCHHHHTT
T ss_pred HHHHHcCCChhHCcCHHHHHh
Confidence 999999999999999999987
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=357.57 Aligned_cols=251 Identities=30% Similarity=0.564 Sum_probs=202.9
Q ss_pred ccCceEEEEEeccCCceEEEEEEEcCCceEEEEEeccccchHHHHHHHHHHHHHHc--CCCCceeEEeccccC----CCc
Q 005247 431 RWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKG--LRHPNIVLLMGAVTE----PPN 504 (706)
Q Consensus 431 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~--L~HpnIv~l~~~~~~----~~~ 504 (706)
..++|++.+.||+|+||.||+|++.+..||||++... ....+.+|.+++.. ++||||+++++++.. ...
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~ 80 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQ 80 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEECCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCce
Confidence 4568999999999999999999998888999998543 22455667777666 789999999998543 355
Q ss_pred eEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHH--------hcCCCcccccCCCCcEEECCCCcEEE
Q 005247 505 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLH--------QRRPPIVHRDLKSPNLLVDSTYTVKV 576 (706)
Q Consensus 505 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLH--------s~g~~IIHrDLKp~NILl~~~~~vKL 576 (706)
.++||||+++|+|.++++.. .+++..++.++.||+.||+||| +++ |+||||||+|||++.++.+||
T Consensus 81 ~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 81 LWLITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA--IAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp EEEEECCCTTCBHHHHHTTC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE--EECSCCCGGGEEECTTSCEEE
T ss_pred eEEehhhccCCCHHHHHhhc----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC--eecCCCChHhEEEcCCCCEEE
Confidence 89999999999999999633 4889999999999999999999 888 999999999999999999999
Q ss_pred eecCccccCCCCcc----cCCCCCCCCCccCccccccC------CCCchhHHHHHHHHHHHHHhC----------CCCCC
Q 005247 577 CDFGLSRSKPNTYI----SSKTAAGTPEWMAPEVLRED------PSNEKSDVFSFGVILWELITL----------QKPWR 636 (706)
Q Consensus 577 ~DFGla~~~~~~~~----~~~~~~Gt~~Y~APE~l~~~------~~s~ksDVwSLGviL~ELltG----------~~Pf~ 636 (706)
+|||+++....... ......||+.|+|||++.+. .++.++||||||+++|||++| ..||.
T Consensus 155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~ 234 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234 (301)
T ss_dssp CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence 99999975433221 12345799999999999877 345799999999999999999 88886
Q ss_pred CCCh-----HHHHHHhhhcCcccCCCC-----CCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 005247 637 NSTP-----SQVISAVGFKGRRLEIPK-----NVNPMVAALIETCWAEEPEIRPSFPSIMETLQQF 692 (706)
Q Consensus 637 ~~~~-----~~~~~~i~~~~~~l~~p~-----~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~l 692 (706)
.... ......+.....+..++. .+++++.+||.+||+.||++|||+.+|++.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 235 DVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 5322 222222322333334432 3568899999999999999999999999999875
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=362.22 Aligned_cols=263 Identities=34% Similarity=0.619 Sum_probs=222.4
Q ss_pred cccCceEEEEEeccCCceEEEEEEEcCCc----eEEEEEeccccchHHHHHHHHHHHHHHcC-CCCceeEEeccccCCCc
Q 005247 430 IRWSELLIKKKIGEGSFGTVYHAEWRNSD----VAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPN 504 (706)
Q Consensus 430 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~----vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~ 504 (706)
+..++|++.+.||+|+||.||+|.+..++ +++|.+.... .....+.+.+|+.+++++ +||||+++++++.+.+.
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 100 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 100 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc-chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCc
Confidence 55689999999999999999999886553 4788775432 334456788999999999 89999999999999999
Q ss_pred eEEEEEeccCCchhhhcccCC-------------CcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCC
Q 005247 505 LSIVTEYLSRGSLYKLLHIPD-------------ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST 571 (706)
Q Consensus 505 ~~lV~E~~~ggsL~~~l~~~~-------------~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~ 571 (706)
.++||||+++++|.+++.... ....+++..++.++.||+.||.|||++| |+||||||+|||++.+
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~~ 178 (327)
T 1fvr_A 101 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGEN 178 (327)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECGG
T ss_pred eEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCccceEEEcCC
Confidence 999999999999999996432 2246889999999999999999999999 9999999999999999
Q ss_pred CcEEEeecCccccCCCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhc
Q 005247 572 YTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFK 650 (706)
Q Consensus 572 ~~vKL~DFGla~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~ 650 (706)
+.+||+|||+++..... .......+++.|+|||++.+..++.++||||||+++|||++ |..||......+....+. .
T Consensus 179 ~~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~-~ 256 (327)
T 1fvr_A 179 YVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-Q 256 (327)
T ss_dssp GCEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG-G
T ss_pred CeEEEcccCcCcccccc-ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhh-c
Confidence 99999999998754322 12234567889999999999889999999999999999998 999999988877776663 4
Q ss_pred CcccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhcc
Q 005247 651 GRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSV 697 (706)
Q Consensus 651 ~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~~ 697 (706)
..+...+..+++++.+||.+||+.||.+|||+.++++.|++++....
T Consensus 257 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 257 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 45566778899999999999999999999999999999999997753
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=363.12 Aligned_cols=257 Identities=29% Similarity=0.411 Sum_probs=211.1
Q ss_pred ccccCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEecccc---chHHHHHHHHHHHHHHcCCCCceeEEeccccCCC
Q 005247 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEF---HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP 503 (706)
Q Consensus 429 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~---~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 503 (706)
....++|++.+.||+|+||.||+|.+..+ .||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+
T Consensus 22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 101 (345)
T 3hko_A 22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ 101 (345)
T ss_dssp HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence 33457899999999999999999998655 489999865432 3445678999999999999999999999999999
Q ss_pred ceEEEEEeccCCchhhhcccC-------------------------------------CCcccccHHHHHHHHHHHHHHH
Q 005247 504 NLSIVTEYLSRGSLYKLLHIP-------------------------------------DARVVVDERLRLNMAYDVAKGM 546 (706)
Q Consensus 504 ~~~lV~E~~~ggsL~~~l~~~-------------------------------------~~~~~l~~~~~~~ia~qIl~aL 546 (706)
..++||||+++|+|.+++... .....+++..++.++.||+.||
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 181 (345)
T 3hko_A 102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181 (345)
T ss_dssp EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence 999999999999999998520 0122356788999999999999
Q ss_pred HHHHhcCCCcccccCCCCcEEECCCC--cEEEeecCccccCCC----CcccCCCCCCCCCccCcccccc--CCCCchhHH
Q 005247 547 NYLHQRRPPIVHRDLKSPNLLVDSTY--TVKVCDFGLSRSKPN----TYISSKTAAGTPEWMAPEVLRE--DPSNEKSDV 618 (706)
Q Consensus 547 ~yLHs~g~~IIHrDLKp~NILl~~~~--~vKL~DFGla~~~~~----~~~~~~~~~Gt~~Y~APE~l~~--~~~s~ksDV 618 (706)
+|||+++ |+||||||+|||++.++ .+||+|||+++.... .........||+.|+|||++.+ ..++.++||
T Consensus 182 ~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di 259 (345)
T 3hko_A 182 HYLHNQG--ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDA 259 (345)
T ss_dssp HHHHHTT--EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHH
T ss_pred HHHHHCC--ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHH
Confidence 9999999 99999999999998766 899999999975322 1112345679999999999975 678899999
Q ss_pred HHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCC--CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 619 FSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP--KNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 619 wSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p--~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
||||+++|||++|+.||......+....+.........+ ..+++++.+||.+||+.||.+||++.++++
T Consensus 260 wslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 330 (345)
T 3hko_A 260 WSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQ 330 (345)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred HHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 999999999999999999988877777665444433332 357899999999999999999999999987
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=363.20 Aligned_cols=254 Identities=22% Similarity=0.351 Sum_probs=211.6
Q ss_pred cccccCceEEEEEeccCCceEEEEEEEcCC-ceEEEEEeccccchHHHHHHHHHHHHHHcCCC--CceeEEeccccCCCc
Q 005247 428 LEIRWSELLIKKKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRH--PNIVLLMGAVTEPPN 504 (706)
Q Consensus 428 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~-~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~H--pnIv~l~~~~~~~~~ 504 (706)
+++....|++.+.||+|+||.||++.+... .||+|++..........+.+.+|+.+++.++| +||+++++++.+.+.
T Consensus 4 i~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 83 (343)
T 3dbq_A 4 ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 83 (343)
T ss_dssp EESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred eeeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE
Confidence 456778899999999999999999987544 49999998777677777889999999999976 999999999999999
Q ss_pred eEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCcccc
Q 005247 505 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 584 (706)
Q Consensus 505 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~ 584 (706)
.++||| +.+++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ ++.+||+|||+++.
T Consensus 84 ~~lv~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~--iiHrDikp~NIll~-~~~~kl~DFG~a~~ 156 (343)
T 3dbq_A 84 IYMVME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-DGMLKLIDFGIANQ 156 (343)
T ss_dssp EEEEEC-CCSEEHHHHHHHS---CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE-TTEEEECCCSSSCC
T ss_pred EEEEEe-CCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEE-CCcEEEeecccccc
Confidence 999999 5678999999743 35889999999999999999999999 99999999999996 57899999999987
Q ss_pred CCCCcc--cCCCCCCCCCccCcccccc-----------CCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHhhhc
Q 005247 585 KPNTYI--SSKTAAGTPEWMAPEVLRE-----------DPSNEKSDVFSFGVILWELITLQKPWRNSTPS-QVISAVGFK 650 (706)
Q Consensus 585 ~~~~~~--~~~~~~Gt~~Y~APE~l~~-----------~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~-~~~~~i~~~ 650 (706)
...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .....+...
T Consensus 157 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 236 (343)
T 3dbq_A 157 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP 236 (343)
T ss_dssp C------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCT
T ss_pred cCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcC
Confidence 644322 2235679999999999865 67889999999999999999999999875432 333333334
Q ss_pred CcccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 005247 651 GRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMET 688 (706)
Q Consensus 651 ~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~ 688 (706)
.....++...+.++.+||.+||+.||.+|||+.++++.
T Consensus 237 ~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 237 NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 55667788889999999999999999999999999863
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-42 Score=361.08 Aligned_cols=250 Identities=25% Similarity=0.379 Sum_probs=201.7
Q ss_pred cCceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCC------
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP------ 503 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~------ 503 (706)
.++|++++.||+|+||.||+|.+.. ..||||++.... .....+.+.+|+.++++++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 4679999999999999999999864 459999987554 3345578999999999999999999999875433
Q ss_pred ---------------------------------------------------ceEEEEEeccCCchhhhcccCCCcccccH
Q 005247 504 ---------------------------------------------------NLSIVTEYLSRGSLYKLLHIPDARVVVDE 532 (706)
Q Consensus 504 ---------------------------------------------------~~~lV~E~~~ggsL~~~l~~~~~~~~l~~ 532 (706)
..++||||+++++|.++++........++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 37999999999999999986655555677
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCc------------ccCCCCCCCCC
Q 005247 533 RLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY------------ISSKTAAGTPE 600 (706)
Q Consensus 533 ~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~------------~~~~~~~Gt~~ 600 (706)
..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++...... .......||+.
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHHhCC--eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 788999999999999999999 9999999999999999999999999998765432 12344579999
Q ss_pred ccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHHHHhhhhCCCCCC
Q 005247 601 WMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRP 680 (706)
Q Consensus 601 Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI~~cL~~dP~~RP 680 (706)
|+|||++.+..++.++||||||+++|||++|..|+... ......+. ...........++++.+||.+||+.||++||
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~--~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 318 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER--VRIITDVR-NLKFPLLFTQKYPQEHMMVQDMLSPSPTERP 318 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH--HHHHHHHH-TTCCCHHHHHHCHHHHHHHHHHHCSSGGGSC
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH--HHHHHHhh-ccCCCcccccCChhHHHHHHHHccCCCCcCC
Confidence 99999999999999999999999999999987764221 11111111 1111222234568899999999999999999
Q ss_pred CHHHHHH
Q 005247 681 SFPSIME 687 (706)
Q Consensus 681 S~~eIl~ 687 (706)
|+.++++
T Consensus 319 s~~~~l~ 325 (332)
T 3qd2_B 319 EATDIIE 325 (332)
T ss_dssp CHHHHHH
T ss_pred CHHHHhh
Confidence 9999976
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=368.71 Aligned_cols=257 Identities=21% Similarity=0.304 Sum_probs=212.9
Q ss_pred cccccCceEEEEEeccC--CceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCC
Q 005247 428 LEIRWSELLIKKKIGEG--SFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP 503 (706)
Q Consensus 428 ~~i~~~~y~i~~~LG~G--~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 503 (706)
+....++|++++.||+| +||.||+|.+.. ..||+|++..........+.+.+|+.+++.++||||+++++++.+.+
T Consensus 20 ~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 99 (389)
T 3gni_B 20 FLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN 99 (389)
T ss_dssp CCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred ccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECC
Confidence 34556789999999999 999999999874 45999999887767777788999999999999999999999999999
Q ss_pred ceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccc
Q 005247 504 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 583 (706)
Q Consensus 504 ~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~ 583 (706)
.+++||||+.+|+|.+++.... ...+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||.+.
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~kl~dfg~~~ 176 (389)
T 3gni_B 100 ELWVVTSFMAYGSAKDLICTHF-MDGMNELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVDGKVYLSGLRSNL 176 (389)
T ss_dssp EEEEEEECCTTCBHHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCGGGCE
T ss_pred EEEEEEEccCCCCHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEcccccce
Confidence 9999999999999999986432 234889999999999999999999999 9999999999999999999999999876
Q ss_pred cCCCC-------cccCCCCCCCCCccCcccccc--CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCc--
Q 005247 584 SKPNT-------YISSKTAAGTPEWMAPEVLRE--DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR-- 652 (706)
Q Consensus 584 ~~~~~-------~~~~~~~~Gt~~Y~APE~l~~--~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~-- 652 (706)
..... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+..+....+.....
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 256 (389)
T 3gni_B 177 SMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPC 256 (389)
T ss_dssp ECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-------
T ss_pred eeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCc
Confidence 43211 112233578999999999988 5789999999999999999999999987665544433211100
Q ss_pred ------------------------------------------ccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 653 ------------------------------------------RLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 653 ------------------------------------------~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
....+..+++++.+||.+||+.||++|||+.|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~ 333 (389)
T 3gni_B 257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN 333 (389)
T ss_dssp -------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 11244567899999999999999999999999985
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=352.99 Aligned_cols=251 Identities=26% Similarity=0.429 Sum_probs=220.6
Q ss_pred ccCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEecccc-chHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEE
Q 005247 431 RWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI 507 (706)
Q Consensus 431 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l 507 (706)
..++|++.+.||+|+||.||+|.+..+ .+|+|++..... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 456899999999999999999998754 489999876543 34556788999999999999999999999999999999
Q ss_pred EEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCC
Q 005247 508 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 587 (706)
Q Consensus 508 V~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 587 (706)
||||+.+++|.+++... ..+++..++.++.||+.||+|||++| |+||||||+||+++.++.+||+|||++.....
T Consensus 93 v~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 93 VLELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp EEECCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 99999999999988643 35889999999999999999999999 99999999999999999999999999987654
Q ss_pred CcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHH
Q 005247 588 TYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAAL 667 (706)
Q Consensus 588 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dL 667 (706)
.........||+.|+|||++.+..++.++||||||+++|+|++|+.||......+....+. .....++..+++++.+|
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l 245 (294)
T 2rku_A 168 DGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK--KNEYSIPKHINPVAASL 245 (294)
T ss_dssp TTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--TTCCCCCTTSCHHHHHH
T ss_pred CccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh--hccCCCccccCHHHHHH
Confidence 4334455679999999999999999999999999999999999999999888777665553 34556778899999999
Q ss_pred HHHhhhhCCCCCCCHHHHHHH
Q 005247 668 IETCWAEEPEIRPSFPSIMET 688 (706)
Q Consensus 668 I~~cL~~dP~~RPS~~eIl~~ 688 (706)
|.+||+.||++|||+.++++.
T Consensus 246 i~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 246 IQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp HHHHTCSSGGGSCCGGGGGGS
T ss_pred HHHHcccChhhCcCHHHHhhC
Confidence 999999999999999999873
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=359.65 Aligned_cols=265 Identities=29% Similarity=0.458 Sum_probs=219.1
Q ss_pred cccCceEEEEEeccCCceEEEEEEEc------CCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCC-
Q 005247 430 IRWSELLIKKKIGEGSFGTVYHAEWR------NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP- 502 (706)
Q Consensus 430 i~~~~y~i~~~LG~G~fG~Vy~a~~~------~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~- 502 (706)
+....|++++.||+|+||.||++... +..||+|++.... .....+.+.+|+.+++.++||||+++++++.+.
T Consensus 28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (318)
T 3lxp_A 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA-GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG 106 (318)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc-ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCC
Confidence 44445699999999999999988653 3449999987553 445567899999999999999999999998764
Q ss_pred -CceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCc
Q 005247 503 -PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL 581 (706)
Q Consensus 503 -~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGl 581 (706)
..+++||||+++++|.+++... .+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~i~~~l~~~l~~LH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg~ 180 (318)
T 3lxp_A 107 AASLQLVMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHAQH--YIHRDLAARNVLLDNDRLVKIGDFGL 180 (318)
T ss_dssp TTEEEEEECCCTTCBHHHHGGGS----CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCGGG
T ss_pred CceEEEEEecccCCcHHHHHhhC----CCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEEcCCCCEEECCccc
Confidence 5689999999999999999643 3889999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCcc---cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH--------------HH
Q 005247 582 SRSKPNTYI---SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQ--------------VI 644 (706)
Q Consensus 582 a~~~~~~~~---~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~--------------~~ 644 (706)
+........ ......+|..|+|||++.+..++.++||||||+++|+|++|..||....... ..
T Consensus 181 a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 260 (318)
T 3lxp_A 181 AKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRL 260 (318)
T ss_dssp CEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHH
T ss_pred cccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHH
Confidence 987654321 2334568889999999999999999999999999999999999997543211 11
Q ss_pred HHhhhcCcccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhccCCCC
Q 005247 645 SAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQPL 701 (706)
Q Consensus 645 ~~i~~~~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~~~~~~ 701 (706)
............+..+++++.+||.+||+.||++|||+.++++.|+.+......++.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~~p 317 (318)
T 3lxp_A 261 TELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQAP 317 (318)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC---
T ss_pred HHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccCCC
Confidence 122233456677888999999999999999999999999999999999988766554
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=390.57 Aligned_cols=271 Identities=30% Similarity=0.509 Sum_probs=226.9
Q ss_pred CcccccCceEEEE-EeccCCceEEEEEEEcC----CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccC
Q 005247 427 GLEIRWSELLIKK-KIGEGSFGTVYHAEWRN----SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE 501 (706)
Q Consensus 427 ~~~i~~~~y~i~~-~LG~G~fG~Vy~a~~~~----~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~ 501 (706)
.+.+...++.+.+ .||+|+||.||+|.+.. ..||||+++... .....+.+.+|+.+|+.++||||+++++++..
T Consensus 329 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~ 407 (613)
T 2ozo_A 329 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA 407 (613)
T ss_dssp CSBCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES
T ss_pred ceeccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc
Confidence 3455666777777 89999999999998752 238999986543 33345789999999999999999999999876
Q ss_pred CCceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCc
Q 005247 502 PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL 581 (706)
Q Consensus 502 ~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGl 581 (706)
+..++||||+.+|+|.+++... ...+++..++.++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+
T Consensus 408 -~~~~lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NILl~~~~~vkL~DFGl 482 (613)
T 2ozo_A 408 -EALMLVMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN--FVHRNLAARNVLLVNRHYAKISDFGL 482 (613)
T ss_dssp -SSEEEEEECCTTCBHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCCST
T ss_pred -CCeEEEEEeCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCcCCHHHEEEcCCCcEEEeeccC
Confidence 5689999999999999998643 335889999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCcc---cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCC
Q 005247 582 SRSKPNTYI---SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIP 657 (706)
Q Consensus 582 a~~~~~~~~---~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p 657 (706)
++....... ......+++.|+|||++.+..++.++|||||||++|||++ |+.||...+..+....+. .+.++.+|
T Consensus 483 a~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~-~~~~~~~p 561 (613)
T 2ozo_A 483 SKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECP 561 (613)
T ss_dssp TTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHH-TTCCCCCC
T ss_pred cccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCCCC
Confidence 987543321 1123345789999999999999999999999999999998 999999988877776664 55678888
Q ss_pred CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhccCCCCCCC
Q 005247 658 KNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQPLSAQ 704 (706)
Q Consensus 658 ~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~~~~~~s~~ 704 (706)
..+++++.+||.+||+.||++||++.+|++.|+.++.+........+
T Consensus 562 ~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~~~~~s 608 (613)
T 2ozo_A 562 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGGS 608 (613)
T ss_dssp TTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCSCCCSS
T ss_pred CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhccccCCcc
Confidence 99999999999999999999999999999999999988766544433
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=361.11 Aligned_cols=252 Identities=24% Similarity=0.347 Sum_probs=196.3
Q ss_pred cCceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEE
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 509 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~ 509 (706)
.++|++++.||+|+||.||+|.+.. ..||+|++.... .....+.+.+|+.+++.++||||+++++++..++..++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS-EEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCS-TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc-ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 3579999999999999999998764 449999986543 2223357889999999999999999999999999999999
Q ss_pred EeccCCchhhhcccC---CCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCC
Q 005247 510 EYLSRGSLYKLLHIP---DARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP 586 (706)
Q Consensus 510 E~~~ggsL~~~l~~~---~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~ 586 (706)
||+. ++|.+++... .....+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++...
T Consensus 83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK--ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 9998 5898887532 12235889999999999999999999999 9999999999999999999999999998765
Q ss_pred CCcccCCCCCCCCCccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCc-------------
Q 005247 587 NTYISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR------------- 652 (706)
Q Consensus 587 ~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~------------- 652 (706)
..........||+.|+|||++.+. .++.++|||||||++|||++|+.||...+..+....+.....
T Consensus 160 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (317)
T 2pmi_A 160 IPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKL 239 (317)
T ss_dssp SCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGC
T ss_pred CCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhh
Confidence 443344566889999999999874 689999999999999999999999998887666554421100
Q ss_pred -------------------ccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 653 -------------------RLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 653 -------------------~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
....+..++.++.+||.+||+.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 240 PKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp TTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 01122357889999999999999999999999976
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=359.62 Aligned_cols=260 Identities=23% Similarity=0.359 Sum_probs=211.2
Q ss_pred cccCceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCC--ce
Q 005247 430 IRWSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP--NL 505 (706)
Q Consensus 430 i~~~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~--~~ 505 (706)
...++|++.+.||+|+||.||+|.+.. ..||+|++...... ...+.+.+|+.++++++||||+++++++...+ ..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceE
Confidence 345689999999999999999999874 45999998654322 23467789999999999999999999987655 78
Q ss_pred EEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEE----CCCCcEEEeecCc
Q 005247 506 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLV----DSTYTVKVCDFGL 581 (706)
Q Consensus 506 ~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl----~~~~~vKL~DFGl 581 (706)
++||||+++++|.+++........+++..++.++.||+.||+|||++| |+||||||+|||+ +.++.+||+|||+
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~ 162 (319)
T 4euu_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (319)
T ss_dssp EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence 999999999999999976554445899999999999999999999999 9999999999999 7888899999999
Q ss_pred cccCCCCcccCCCCCCCCCccCccccc--------cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHhhh
Q 005247 582 SRSKPNTYISSKTAAGTPEWMAPEVLR--------EDPSNEKSDVFSFGVILWELITLQKPWRNSTP----SQVISAVGF 649 (706)
Q Consensus 582 a~~~~~~~~~~~~~~Gt~~Y~APE~l~--------~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~----~~~~~~i~~ 649 (706)
++...... ......||+.|+|||++. +..++.++|||||||++|||++|+.||..... .+....+..
T Consensus 163 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (319)
T 4euu_A 163 ARELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (319)
T ss_dssp CEECCTTC-CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred ceecCCCC-ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence 98765443 234567999999999986 56789999999999999999999999975332 222222221
Q ss_pred cCc-------------------c----cCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 005247 650 KGR-------------------R----LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 693 (706)
Q Consensus 650 ~~~-------------------~----l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll 693 (706)
... . ..++..++..+.+||.+||+.||++|||+.|+++....-.
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 111 0 1122345678999999999999999999999998876543
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=389.18 Aligned_cols=267 Identities=34% Similarity=0.561 Sum_probs=231.5
Q ss_pred ccCcccccCceEEEEEeccCCceEEEEEEEcCC-ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCC
Q 005247 425 EEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP 503 (706)
Q Consensus 425 ~~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~-~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 503 (706)
...+++..++|++.+.||+|+||.||+|.+.++ .||||++...... .+.|.+|+.+|++++|+||+++++++.+ +
T Consensus 259 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~-~ 334 (535)
T 2h8h_A 259 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-E 334 (535)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred ccceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEee-c
Confidence 345778889999999999999999999998765 4999998765433 3578999999999999999999999876 6
Q ss_pred ceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccc
Q 005247 504 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 583 (706)
Q Consensus 504 ~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~ 583 (706)
..++||||+.+|+|.++++... ...+++..++.++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+++
T Consensus 335 ~~~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~ 411 (535)
T 2h8h_A 335 PIYIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLAR 411 (535)
T ss_dssp SCEEEECCCTTEEHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCTTSTT
T ss_pred cceEeeehhcCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEEcCCCcEEEcccccce
Confidence 7899999999999999996321 234788999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCc-ccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCCCCCc
Q 005247 584 SKPNTY-ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVN 661 (706)
Q Consensus 584 ~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s 661 (706)
...... .......++..|+|||++.+..++.++||||||++||||++ |+.||......+....+. ...++..+..++
T Consensus 412 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~~ 490 (535)
T 2h8h_A 412 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECP 490 (535)
T ss_dssp TCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCC
T ss_pred ecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCC
Confidence 765432 12234456789999999999999999999999999999999 899999988877777663 556777888999
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhccCC
Q 005247 662 PMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQ 699 (706)
Q Consensus 662 ~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~~~~ 699 (706)
.++.+||.+||+.||++|||+.+|++.|+.++.+...+
T Consensus 491 ~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~ 528 (535)
T 2h8h_A 491 ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 528 (535)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSCS
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCcc
Confidence 99999999999999999999999999999988765543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=382.15 Aligned_cols=256 Identities=24% Similarity=0.366 Sum_probs=218.7
Q ss_pred cccccCceEEEEEeccCCceEEEEEEEcCCc--eEEEEEeccccch-HHHHHHHHHHHHHHcCCCCceeEEeccccCCCc
Q 005247 428 LEIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN 504 (706)
Q Consensus 428 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~--vAVKvl~~~~~~~-~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 504 (706)
+.+..++|++++.||+|+||+||+|++..++ ||+|++.+..... ...+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 69 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~ 148 (437)
T 4aw2_A 69 MRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNN 148 (437)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred ccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCE
Confidence 4566789999999999999999999987654 9999986533211 122347889999999999999999999999999
Q ss_pred eEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCcccc
Q 005247 505 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 584 (706)
Q Consensus 505 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~ 584 (706)
+++||||+.+|+|.+++... ...+++..++.++.||+.||+|||++| ||||||||+|||++.++.+||+|||+++.
T Consensus 149 ~~lV~Ey~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILl~~~g~vkL~DFGla~~ 224 (437)
T 4aw2_A 149 LYLVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMNGHIRLADFGSCLK 224 (437)
T ss_dssp EEEEECCCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEecCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeeEcCCCCEEEcchhhhhh
Confidence 99999999999999999743 235899999999999999999999999 99999999999999999999999999976
Q ss_pred CCCCc-ccCCCCCCCCCccCccccc-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCC
Q 005247 585 KPNTY-ISSKTAAGTPEWMAPEVLR-----EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPK 658 (706)
Q Consensus 585 ~~~~~-~~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~ 658 (706)
..... ......+||+.|+|||++. ...++.++|||||||++|||++|+.||...+..+....+.....++.+|.
T Consensus 225 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~ 304 (437)
T 4aw2_A 225 LMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPT 304 (437)
T ss_dssp CCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCS
T ss_pred cccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCc
Confidence 54332 2234568999999999997 45689999999999999999999999999988888777754444445554
Q ss_pred ---CCcHHHHHHHHHhhhhCCCC--CCCHHHHHH
Q 005247 659 ---NVNPMVAALIETCWAEEPEI--RPSFPSIME 687 (706)
Q Consensus 659 ---~~s~el~dLI~~cL~~dP~~--RPS~~eIl~ 687 (706)
.+++++++||++||+.+|++ ||+++++++
T Consensus 305 ~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 305 QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred ccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 58999999999999988888 999999876
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=366.07 Aligned_cols=251 Identities=29% Similarity=0.438 Sum_probs=200.1
Q ss_pred ccccCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceE
Q 005247 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS 506 (706)
Q Consensus 429 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 506 (706)
....++|++++.||+|+||.||++.+..+ .||+|++....... +.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 16 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 92 (361)
T 3uc3_A 16 MHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID---ENVQREIINHRSLRHPNIVRFKEVILTPTHLA 92 (361)
T ss_dssp CCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC---HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc---HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEE
Confidence 44567899999999999999999998644 49999987654332 46779999999999999999999999999999
Q ss_pred EEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCc--EEEeecCcccc
Q 005247 507 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYT--VKVCDFGLSRS 584 (706)
Q Consensus 507 lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~--vKL~DFGla~~ 584 (706)
+||||+.+|+|.+++... ..+++..++.++.||+.||+|||++| |+||||||+|||++.++. +||+|||+++.
T Consensus 93 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~ql~~~L~~LH~~~--ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~ 167 (361)
T 3uc3_A 93 IIMEYASGGELYERICNA---GRFSEDEARFFFQQLLSGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKS 167 (361)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--CCSCCCCGGGEEECSSSSCCEEECCCCCC--
T ss_pred EEEEeCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCceEEEeecCcccc
Confidence 999999999999998633 25899999999999999999999999 999999999999987765 99999999875
Q ss_pred CCCCcccCCCCCCCCCccCccccccCCCCch-hHHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHhhhcCcccCCCCC
Q 005247 585 KPNTYISSKTAAGTPEWMAPEVLREDPSNEK-SDVFSFGVILWELITLQKPWRNSTP----SQVISAVGFKGRRLEIPKN 659 (706)
Q Consensus 585 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~k-sDVwSLGviL~ELltG~~Pf~~~~~----~~~~~~i~~~~~~l~~p~~ 659 (706)
..... ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||..... ......+.......+....
T Consensus 168 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (361)
T 3uc3_A 168 SVLHS-QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIR 246 (361)
T ss_dssp --------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSC
T ss_pred ccccC-CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCC
Confidence 33222 2345679999999999988887665 8999999999999999999987543 2333333223333344446
Q ss_pred CcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 005247 660 VNPMVAALIETCWAEEPEIRPSFPSIMET 688 (706)
Q Consensus 660 ~s~el~dLI~~cL~~dP~~RPS~~eIl~~ 688 (706)
+++++.+||.+||+.||++|||+.|+++.
T Consensus 247 ~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 247 ISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp CCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 89999999999999999999999999873
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=354.07 Aligned_cols=264 Identities=34% Similarity=0.570 Sum_probs=215.9
Q ss_pred cccccCceEEEEEeccCCceEEEEEEEcCC-----ceEEEEEecccc-chHHHHHHHHHHHHHHcCCCCceeEEeccccC
Q 005247 428 LEIRWSELLIKKKIGEGSFGTVYHAEWRNS-----DVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE 501 (706)
Q Consensus 428 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~-----~vAVKvl~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~ 501 (706)
..+..++|++.+.||+|+||.||+|.+... .||+|++..... .....+.+.+|+.++++++||||+++++++..
T Consensus 13 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 92 (291)
T 1u46_A 13 CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT 92 (291)
T ss_dssp EECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc
Confidence 345667899999999999999999986432 378898765432 23556789999999999999999999999987
Q ss_pred CCceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCc
Q 005247 502 PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL 581 (706)
Q Consensus 502 ~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGl 581 (706)
.. .++||||+.+++|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+
T Consensus 93 ~~-~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~ 167 (291)
T 1u46_A 93 PP-MKMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGL 167 (291)
T ss_dssp SS-CEEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCCTT
T ss_pred CC-ceeeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEEcCCCCEEEccccc
Confidence 65 89999999999999998643 235889999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCcc---cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCC
Q 005247 582 SRSKPNTYI---SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIP 657 (706)
Q Consensus 582 a~~~~~~~~---~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p 657 (706)
+........ ......+|..|+|||++.+..++.++||||||+++|+|++ |+.||...+..+....+.....+...+
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 247 (291)
T 1u46_A 168 MRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRP 247 (291)
T ss_dssp CEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCC
T ss_pred cccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCC
Confidence 987544321 1234467889999999999889999999999999999999 999999998888877776666677778
Q ss_pred CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhc
Q 005247 658 KNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 696 (706)
Q Consensus 658 ~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~ 696 (706)
..++.++.++|.+||..||++|||+.++++.|+++..+.
T Consensus 248 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 286 (291)
T 1u46_A 248 EDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTD 286 (291)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred cCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccc
Confidence 899999999999999999999999999999999886543
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=369.43 Aligned_cols=260 Identities=31% Similarity=0.539 Sum_probs=211.3
Q ss_pred CceEEEEEeccCCceEEEEEEEcCC-----ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEecccc-CCCceE
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRNS-----DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT-EPPNLS 506 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~~-----~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~-~~~~~~ 506 (706)
..|++.+.||+|+||.||+|.+... .+|+|.+... ......+.+.+|+.++++++||||+++++++. ..+..+
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 167 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 167 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC-SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeE
Confidence 4588999999999999999987532 2788876543 24455678999999999999999999999854 456789
Q ss_pred EEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCC
Q 005247 507 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP 586 (706)
Q Consensus 507 lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~ 586 (706)
+||||+.+|+|.++++... ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++...
T Consensus 168 lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 168 VVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EEEECCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEEECCCCCCHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC--EecCccchheEEECCCCCEEEeecccccccc
Confidence 9999999999999997433 34788999999999999999999999 9999999999999999999999999998654
Q ss_pred CCcc----cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCCCCCc
Q 005247 587 NTYI----SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVN 661 (706)
Q Consensus 587 ~~~~----~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s 661 (706)
.... ......+|+.|+|||++.+..++.++||||||+++|||++ |..||...+..+....+ ....+...|..++
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~-~~~~~~~~p~~~~ 322 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-LQGRRLLQPEYCP 322 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHH-HTTCCCCCCTTCC
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHH-HcCCCCCCCCCCC
Confidence 3221 1233457889999999999999999999999999999999 67888877666655554 3455667788899
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhccC
Q 005247 662 PMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVC 698 (706)
Q Consensus 662 ~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~~~ 698 (706)
..+.+||.+||+.||++|||+.++++.|++++.+...
T Consensus 323 ~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~ 359 (373)
T 3c1x_A 323 DPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 359 (373)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccc
Confidence 9999999999999999999999999999999987654
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=353.30 Aligned_cols=251 Identities=26% Similarity=0.421 Sum_probs=191.5
Q ss_pred ccCceEEEEEeccCCceEEEEEEEc--CCceEEEEEeccccch-HHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEE
Q 005247 431 RWSELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI 507 (706)
Q Consensus 431 ~~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKvl~~~~~~~-~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l 507 (706)
..++|++.+.||+|+||.||+|++. +..||+|++....... ...+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 3468999999999999999999975 4459999986543221 224678899999999999999999999999999999
Q ss_pred EEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCC
Q 005247 508 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 587 (706)
Q Consensus 508 V~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 587 (706)
||||+++++|.+++.... ..+++..++.++.|++.||.|||++| |+||||||+||+++.++.+||+|||++.....
T Consensus 89 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNRV--KPFSENEARHFMHQIITGMLYLHSHG--ILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EEECCTTEEHHHHHHTCS--SCCCHHHHHHHHHHHHHHHHHHHHTT--EECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EEecCCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 999999999999987432 35889999999999999999999999 99999999999999999999999999987654
Q ss_pred CcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHH
Q 005247 588 TYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAAL 667 (706)
Q Consensus 588 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dL 667 (706)
.........||+.|+|||++.+..++.++||||||+++|+|++|+.||......+....+ .......+..++.++.+|
T Consensus 165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l 242 (278)
T 3cok_A 165 PHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV--VLADYEMPSFLSIEAKDL 242 (278)
T ss_dssp ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----C--CSSCCCCCTTSCHHHHHH
T ss_pred CCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHH--hhcccCCccccCHHHHHH
Confidence 433344567999999999999989999999999999999999999999877655554443 223455677899999999
Q ss_pred HHHhhhhCCCCCCCHHHHHH
Q 005247 668 IETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 668 I~~cL~~dP~~RPS~~eIl~ 687 (706)
|.+||+.||++|||+.++++
T Consensus 243 i~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 243 IHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp HHHHSCSSGGGSCCHHHHTT
T ss_pred HHHHcccCHhhCCCHHHHhc
Confidence 99999999999999999876
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=361.45 Aligned_cols=256 Identities=18% Similarity=0.237 Sum_probs=212.3
Q ss_pred ccCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcC-CCCceeEEeccccCCCceEE
Q 005247 431 RWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSI 507 (706)
Q Consensus 431 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~l 507 (706)
..++|++.+.||+|+||.||+|.+..+ .||||++...... +.+.+|+.+++.+ +||||+++++++...+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l 82 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAM 82 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEE
Confidence 357899999999999999999997544 4999998654322 3578899999999 89999999999999999999
Q ss_pred EEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCc-----EEEeecCcc
Q 005247 508 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYT-----VKVCDFGLS 582 (706)
Q Consensus 508 V~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~-----vKL~DFGla 582 (706)
||||+ +++|.+++... ...+++..++.++.||+.||+|||++| |+||||||+|||++.++. +||+|||++
T Consensus 83 v~e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~--iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a 157 (330)
T 2izr_A 83 VLELL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN--LIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157 (330)
T ss_dssp EEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTCTTSEEECCCTTC
T ss_pred EEEeC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeeccCCCCCCceEEEEEcccc
Confidence 99999 99999999743 235899999999999999999999999 999999999999998887 999999999
Q ss_pred ccCCCCcc-------cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHhhhcCc
Q 005247 583 RSKPNTYI-------SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQ---VISAVGFKGR 652 (706)
Q Consensus 583 ~~~~~~~~-------~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~---~~~~i~~~~~ 652 (706)
+....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+ ....+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~ 237 (330)
T 2izr_A 158 KEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKR 237 (330)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHH
T ss_pred eeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhc
Confidence 86443221 1246689999999999999999999999999999999999999998754333 2333211111
Q ss_pred cc---CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhc
Q 005247 653 RL---EIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 696 (706)
Q Consensus 653 ~l---~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~ 696 (706)
.. .....++ ++.+||.+||+.||.+||++.+|++.|++++...
T Consensus 238 ~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~ 283 (330)
T 2izr_A 238 ATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK 283 (330)
T ss_dssp HSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred cCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence 11 1123455 9999999999999999999999999999998764
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=379.84 Aligned_cols=252 Identities=29% Similarity=0.501 Sum_probs=220.4
Q ss_pred cccccCceEEEEEeccCCceEEEEEEEc--CCceEEEEEeccccch-HHHHHHHHHHHHHHcCCCCceeEEeccccCCCc
Q 005247 428 LEIRWSELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN 504 (706)
Q Consensus 428 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKvl~~~~~~~-~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 504 (706)
..+..++|.+.+.||+|+||.||+|.+. +..||+|++....... ...+.+.+|+.+++.++||||+++++++...+.
T Consensus 11 ~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~ 90 (476)
T 2y94_A 11 GRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSD 90 (476)
T ss_dssp SCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred CCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 3456689999999999999999999986 4459999987643222 234678899999999999999999999999999
Q ss_pred eEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCcccc
Q 005247 505 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 584 (706)
Q Consensus 505 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~ 584 (706)
.++||||+++|+|.+++... ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++..
T Consensus 91 ~~lv~E~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDLkp~NIll~~~~~vkL~DFG~a~~ 165 (476)
T 2y94_A 91 IFMVMEYVSGGELFDYICKN---GRLDEKESRRLFQQILSGVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNM 165 (476)
T ss_dssp EEEEEECCSSEEHHHHTTSS---SSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred EEEEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--CCcccccHHHEEEecCCCeEEEeccchhh
Confidence 99999999999999999743 35899999999999999999999999 99999999999999999999999999987
Q ss_pred CCCCcccCCCCCCCCCccCccccccCCC-CchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHH
Q 005247 585 KPNTYISSKTAAGTPEWMAPEVLREDPS-NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPM 663 (706)
Q Consensus 585 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~e 663 (706)
..... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+. ......|..++++
T Consensus 166 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~~ 242 (476)
T 2y94_A 166 MSDGE-FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKIC--DGIFYTPQYLNPS 242 (476)
T ss_dssp CCTTC-CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHH--TTCCCCCTTCCHH
T ss_pred ccccc-cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHh--cCCcCCCccCCHH
Confidence 65432 2346689999999999998776 689999999999999999999999888777766663 3345677889999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 664 VAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 664 l~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
+.+||.+||+.||.+|||+.++++
T Consensus 243 ~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 243 VISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHcCCCchhCcCHHHHHh
Confidence 999999999999999999999987
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=367.73 Aligned_cols=264 Identities=17% Similarity=0.216 Sum_probs=209.8
Q ss_pred cccCceEEEEEeccCCceEEEEEEEcC-------CceEEEEEeccccchHH---------HHHHHHHHHHHHcCCCCcee
Q 005247 430 IRWSELLIKKKIGEGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDR---------FKEFLREVAIMKGLRHPNIV 493 (706)
Q Consensus 430 i~~~~y~i~~~LG~G~fG~Vy~a~~~~-------~~vAVKvl~~~~~~~~~---------~~~~~~Ei~iL~~L~HpnIv 493 (706)
+..++|++.+.||+|+||.||+|.+.. ..||+|++......... ...+..|+..++.++|+||+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 456789999999999999999998854 35999998665321110 12344566778888999999
Q ss_pred EEeccccCC----CceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEEC
Q 005247 494 LLMGAVTEP----PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVD 569 (706)
Q Consensus 494 ~l~~~~~~~----~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~ 569 (706)
++++++... ...++||||+ +++|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||++
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~--iiHrDlkp~Nill~ 186 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA--KRFSRKTVLQLSLRILDILEYIHEHE--YVHGDIKASNLLLN 186 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEE
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eEEecCCHHHEEEe
Confidence 999998664 4589999999 999999997532 35899999999999999999999999 99999999999998
Q ss_pred --CCCcEEEeecCccccCCCCcc-------cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh
Q 005247 570 --STYTVKVCDFGLSRSKPNTYI-------SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTP 640 (706)
Q Consensus 570 --~~~~vKL~DFGla~~~~~~~~-------~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~ 640 (706)
.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~ 266 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 889999999999976443211 11344599999999999999999999999999999999999999986433
Q ss_pred HHHHHHhhhcCcc---------cCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhccC
Q 005247 641 SQVISAVGFKGRR---------LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVC 698 (706)
Q Consensus 641 ~~~~~~i~~~~~~---------l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~~~ 698 (706)
............. ...+..+++++.+||.+||+.||++||++.+|++.|++++.....
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~ 333 (364)
T 3op5_A 267 DPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGS 333 (364)
T ss_dssp CHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred CHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence 2222111111111 011267899999999999999999999999999999999987543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=360.78 Aligned_cols=249 Identities=26% Similarity=0.433 Sum_probs=219.7
Q ss_pred cCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEecccc-chHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEE
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIV 508 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV 508 (706)
..+|++.+.||+|+||.||++.+..+ .+|+|++..... .....+.+.+|+.+++.++|+||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 46799999999999999999998754 489999876543 345567889999999999999999999999999999999
Q ss_pred EEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCC
Q 005247 509 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 588 (706)
Q Consensus 509 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 588 (706)
|||+.+++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++......
T Consensus 120 ~e~~~~~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 120 LELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194 (335)
T ss_dssp ECCCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EecCCCCCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC--CEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence 9999999999988643 35889999999999999999999999 999999999999999999999999999876544
Q ss_pred cccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHH
Q 005247 589 YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI 668 (706)
Q Consensus 589 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI 668 (706)
........||+.|+|||++.+..++.++||||||+++|+|++|+.||......+....+. .....++..+++++.+||
T Consensus 195 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li 272 (335)
T 2owb_A 195 GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK--KNEYSIPKHINPVAASLI 272 (335)
T ss_dssp TCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--HTCCCCCTTSCHHHHHHH
T ss_pred cccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHh--cCCCCCCccCCHHHHHHH
Confidence 334456679999999999999999999999999999999999999999888777665553 234567788999999999
Q ss_pred HHhhhhCCCCCCCHHHHHH
Q 005247 669 ETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 669 ~~cL~~dP~~RPS~~eIl~ 687 (706)
.+||+.||++|||+.++++
T Consensus 273 ~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 273 QKMLQTDPTARPTINELLN 291 (335)
T ss_dssp HHHTCSSGGGSCCGGGGGG
T ss_pred HHHccCChhHCcCHHHHhc
Confidence 9999999999999999987
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=360.78 Aligned_cols=262 Identities=33% Similarity=0.500 Sum_probs=216.5
Q ss_pred cccCceEEEEEeccCCceEEEEEEE----c--CCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEecccc--C
Q 005247 430 IRWSELLIKKKIGEGSFGTVYHAEW----R--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT--E 501 (706)
Q Consensus 430 i~~~~y~i~~~LG~G~fG~Vy~a~~----~--~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~--~ 501 (706)
+...+|++.+.||+|+||.||+|++ . +..||+|++... .....+.+.+|+.++++++|+||+++++++. +
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 97 (327)
T 3lxl_A 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPG 97 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC
Confidence 4567899999999999999999984 2 334999988654 3455578999999999999999999999875 4
Q ss_pred CCceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCc
Q 005247 502 PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL 581 (706)
Q Consensus 502 ~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGl 581 (706)
....++||||+++++|.+++.... ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~ 173 (327)
T 3lxl_A 98 RQSLRLVMEYLPSGCLRDFLQRHR--ARLDASRLLLYSSQICKGMEYLGSRR--CVHRDLAARNILVESEAHVKIADFGL 173 (327)
T ss_dssp SCEEEEEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCGGG
T ss_pred CceEEEEEeecCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChhhEEECCCCCEEEccccc
Confidence 566899999999999999996422 35899999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCcc---cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH--------------HHH
Q 005247 582 SRSKPNTYI---SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPS--------------QVI 644 (706)
Q Consensus 582 a~~~~~~~~---~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~--------------~~~ 644 (706)
++....... ......+|..|+|||++.+..++.++||||||+++|+|++|+.||...... ...
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 253 (327)
T 3lxl_A 174 AKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRL 253 (327)
T ss_dssp CEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHH
T ss_pred ceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHH
Confidence 987543321 233456888899999999999999999999999999999999998654322 112
Q ss_pred HHhhhcCcccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhcc
Q 005247 645 SAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSV 697 (706)
Q Consensus 645 ~~i~~~~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~~ 697 (706)
........+...+..+++++.+||.+||+.||++|||+.++++.|+.++....
T Consensus 254 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 306 (327)
T 3lxl_A 254 LELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR 306 (327)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred HHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 22223445667788999999999999999999999999999999999886554
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=356.92 Aligned_cols=261 Identities=25% Similarity=0.375 Sum_probs=209.2
Q ss_pred ccCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEecccc-chHHHHHHHHHHHHHHcCCCCceeEEeccccCCCc---
Q 005247 431 RWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN--- 504 (706)
Q Consensus 431 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~--- 504 (706)
..++|++.+.||+|+||.||+|.+..+ .||+|++..... .....+.+.+|+.++++++||||+++++++.....
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 356899999999999999999997644 499999876543 34556788999999999999999999999876544
Q ss_pred -eEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccc
Q 005247 505 -LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 583 (706)
Q Consensus 505 -~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~ 583 (706)
.++||||+++++|.++++.. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred ccEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 49999999999999999643 35889999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCc---ccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcc--cCCCC
Q 005247 584 SKPNTY---ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR--LEIPK 658 (706)
Q Consensus 584 ~~~~~~---~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~--l~~p~ 658 (706)
...... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||......+........... ...+.
T Consensus 165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (311)
T 3ork_A 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE 244 (311)
T ss_dssp -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHST
T ss_pred cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccC
Confidence 654322 1223456899999999999999999999999999999999999999988877765554333222 12345
Q ss_pred CCcHHHHHHHHHhhhhCCCCCCCHH-HHHHHHHHHHHhc
Q 005247 659 NVNPMVAALIETCWAEEPEIRPSFP-SIMETLQQFLMSS 696 (706)
Q Consensus 659 ~~s~el~dLI~~cL~~dP~~RPS~~-eIl~~L~~ll~s~ 696 (706)
.+++++.+||.+||+.||++||++. ++...|.+.....
T Consensus 245 ~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~ 283 (311)
T 3ork_A 245 GLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGE 283 (311)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTC
T ss_pred CCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCC
Confidence 7899999999999999999999555 4555666665443
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-42 Score=377.76 Aligned_cols=255 Identities=22% Similarity=0.338 Sum_probs=215.7
Q ss_pred cccccCceEEEEEeccCCceEEEEEEEcC--CceEEEEEecccc-chHHHHHHHHHHHHHHcCCCCceeEEeccccCCCc
Q 005247 428 LEIRWSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN 504 (706)
Q Consensus 428 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 504 (706)
..+..++|++++.||+|+||.||+|+++. ..||+|++.+... .....+.+.+|..++..++||||+++++++.+.+.
T Consensus 56 ~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~ 135 (412)
T 2vd5_A 56 VRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENY 135 (412)
T ss_dssp HSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred ccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE
Confidence 45667899999999999999999999864 4599999875432 12233457899999999999999999999999999
Q ss_pred eEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCcccc
Q 005247 505 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 584 (706)
Q Consensus 505 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~ 584 (706)
+++||||+++|+|.++++..+ ..+++..++.++.||+.||+|||++| ||||||||+|||++.++++||+|||+++.
T Consensus 136 ~~lVmE~~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILld~~g~vkL~DFGla~~ 211 (412)
T 2vd5_A 136 LYLVMEYYVGGDLLTLLSKFG--ERIPAEMARFYLAEIVMAIDSVHRLG--YVHRDIKPDNILLDRCGHIRLADFGSCLK 211 (412)
T ss_dssp EEEEECCCCSCBHHHHHHHHS--SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEcCCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccCHHHeeecCCCCEEEeechhhee
Confidence 999999999999999996432 25889999999999999999999999 99999999999999999999999999987
Q ss_pred CCCCcc-cCCCCCCCCCccCccccc-------cCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCC
Q 005247 585 KPNTYI-SSKTAAGTPEWMAPEVLR-------EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEI 656 (706)
Q Consensus 585 ~~~~~~-~~~~~~Gt~~Y~APE~l~-------~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~ 656 (706)
...... .....+||+.|+|||++. +..++.++|||||||++|||++|+.||...+..+....+........+
T Consensus 212 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~ 291 (412)
T 2vd5_A 212 LRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSL 291 (412)
T ss_dssp CCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCC
T ss_pred ccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCC
Confidence 544322 234568999999999997 356899999999999999999999999998888877776533333333
Q ss_pred C---CCCcHHHHHHHHHhhhhCCCCC---CCHHHHHH
Q 005247 657 P---KNVNPMVAALIETCWAEEPEIR---PSFPSIME 687 (706)
Q Consensus 657 p---~~~s~el~dLI~~cL~~dP~~R---PS~~eIl~ 687 (706)
| ..+++++++||++||+ +|++| |++++|++
T Consensus 292 p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 292 PLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp C----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred CccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 3 6799999999999999 99998 58888865
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=357.16 Aligned_cols=268 Identities=28% Similarity=0.472 Sum_probs=202.1
Q ss_pred cCcccccCceEEEEEeccCCceEEEEEEEc--CCceEEEEEeccccchHHHHHHHHHHHHHHcCC-CCceeEEeccc---
Q 005247 426 EGLEIRWSELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGAV--- 499 (706)
Q Consensus 426 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~--- 499 (706)
..+++...+|++.+.||+|+||.||+|.+. +..||+|++... .....+.+.+|+.+++++. ||||+++++++
T Consensus 21 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 98 (337)
T 3ll6_A 21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIG 98 (337)
T ss_dssp CEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEEC
T ss_pred ceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhcccccccc
Confidence 445666779999999999999999999985 445999988554 3445568899999999996 99999999988
Q ss_pred -----cCCCceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcE
Q 005247 500 -----TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTV 574 (706)
Q Consensus 500 -----~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~v 574 (706)
.....+++||||+. |+|.+++........+++..++.++.||+.||.|||+++++|+||||||+|||++.++.+
T Consensus 99 ~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~ 177 (337)
T 3ll6_A 99 KEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTI 177 (337)
T ss_dssp TTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCE
T ss_pred ccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCE
Confidence 34455899999996 689888864333446899999999999999999999988779999999999999999999
Q ss_pred EEeecCccccCCCCcc------------cCCCCCCCCCccCcccc---ccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 005247 575 KVCDFGLSRSKPNTYI------------SSKTAAGTPEWMAPEVL---REDPSNEKSDVFSFGVILWELITLQKPWRNST 639 (706)
Q Consensus 575 KL~DFGla~~~~~~~~------------~~~~~~Gt~~Y~APE~l---~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~ 639 (706)
||+|||+++....... ......||+.|+|||++ .+..++.++||||||+++|+|++|+.||....
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 257 (337)
T 3ll6_A 178 KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA 257 (337)
T ss_dssp EBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred EEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchh
Confidence 9999999987543211 11244689999999998 56678899999999999999999999997655
Q ss_pred hHHHHHHhhhcCcccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhccCCC
Q 005247 640 PSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQP 700 (706)
Q Consensus 640 ~~~~~~~i~~~~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~~~~~ 700 (706)
...... .......+...+..+.+||.+||+.||++|||+.++++.|+.+.......+
T Consensus 258 ~~~~~~----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~~ 314 (337)
T 3ll6_A 258 KLRIVN----GKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNP 314 (337)
T ss_dssp ------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCCT
T ss_pred HHHhhc----CcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCCC
Confidence 433322 223344556778899999999999999999999999999999987754433
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=358.35 Aligned_cols=265 Identities=30% Similarity=0.501 Sum_probs=221.7
Q ss_pred ccccCceEEEEEeccCCceEEEEEEEc-------CCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccC
Q 005247 429 EIRWSELLIKKKIGEGSFGTVYHAEWR-------NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE 501 (706)
Q Consensus 429 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~-------~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~ 501 (706)
++..++|++.+.||+|+||.||+|.+. +..||+|++... ........+.+|+.++++++||||+++++++.+
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 104 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 104 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc-cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC
Confidence 466789999999999999999999843 234999998543 244556688999999999999999999999999
Q ss_pred CCceEEEEEeccCCchhhhcccCCC----cccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECC---CCcE
Q 005247 502 PPNLSIVTEYLSRGSLYKLLHIPDA----RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS---TYTV 574 (706)
Q Consensus 502 ~~~~~lV~E~~~ggsL~~~l~~~~~----~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~---~~~v 574 (706)
.+..++||||+++++|.+++..... ...+++..++.++.||+.||.|||++| |+||||||+|||++. +..+
T Consensus 105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--i~H~dlkp~NIli~~~~~~~~~ 182 (327)
T 2yfx_A 105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVA 182 (327)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCE
T ss_pred CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eecCcCCHhHEEEecCCCcceE
Confidence 9999999999999999999964321 235888999999999999999999999 999999999999984 4469
Q ss_pred EEeecCccccCCCC--cccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcC
Q 005247 575 KVCDFGLSRSKPNT--YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKG 651 (706)
Q Consensus 575 KL~DFGla~~~~~~--~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~ 651 (706)
||+|||++...... ........+|+.|+|||++.+..++.++||||||+++|+|++ |..||......+....+. ..
T Consensus 183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~-~~ 261 (327)
T 2yfx_A 183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT-SG 261 (327)
T ss_dssp EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-TT
T ss_pred EECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHh-cC
Confidence 99999998743221 112234567899999999999999999999999999999998 999999888777666553 44
Q ss_pred cccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhcc
Q 005247 652 RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSV 697 (706)
Q Consensus 652 ~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~~ 697 (706)
.....+..+++.+.+||.+||+.||.+||++.++++.|+.+.....
T Consensus 262 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~ 307 (327)
T 2yfx_A 262 GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 307 (327)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHH
Confidence 5667788899999999999999999999999999999998886553
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-41 Score=355.32 Aligned_cols=250 Identities=23% Similarity=0.392 Sum_probs=215.4
Q ss_pred cCceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccch----HHHHHHHHHHHHHHcCCCCceeEEeccccCCCce
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHE----DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNL 505 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 505 (706)
.+.|++.+.||+|+||.||+|.+.. ..||+|++....... ...+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 4579999999999999999999864 459999987654322 1246788999999999999999999999999999
Q ss_pred EEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCC----cEEEeecCc
Q 005247 506 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY----TVKVCDFGL 581 (706)
Q Consensus 506 ~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~----~vKL~DFGl 581 (706)
++||||+++++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+||+++.++ .+||+|||+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~--ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~ 165 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (321)
T ss_dssp EEEECCCCSCBHHHHHHTC---SCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred EEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence 9999999999999999743 35899999999999999999999999 99999999999999887 799999999
Q ss_pred cccCCCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcc--cCCCCC
Q 005247 582 SRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR--LEIPKN 659 (706)
Q Consensus 582 a~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~--l~~p~~ 659 (706)
+....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||......+....+...... ..++..
T Consensus 166 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (321)
T 2a2a_A 166 AHEIEDGV-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSH 244 (321)
T ss_dssp CEECCTTC-CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTT
T ss_pred ceecCccc-cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcc
Confidence 98765432 234567999999999999999999999999999999999999999988887776665432221 122357
Q ss_pred CcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 660 VNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 660 ~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
+++.+.+||.+||+.||++|||+.++++
T Consensus 245 ~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 245 TSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp CCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred cCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 8999999999999999999999999986
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=348.84 Aligned_cols=249 Identities=27% Similarity=0.490 Sum_probs=217.5
Q ss_pred cccCceEEEEEeccCCceEEEEEEEcCCc--eEEEEEeccccch-HHHHHHHHHHHHHHcCCCCceeEEeccccCCCceE
Q 005247 430 IRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS 506 (706)
Q Consensus 430 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~--vAVKvl~~~~~~~-~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 506 (706)
+..++|++.+.||+|+||.||+|.+..++ ||+|++....... ...+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 90 (284)
T 2vgo_A 11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIY 90 (284)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEE
Confidence 44578999999999999999999987554 8999986543222 22357889999999999999999999999999999
Q ss_pred EEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCC
Q 005247 507 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP 586 (706)
Q Consensus 507 lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~ 586 (706)
+||||+++++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+||+++.++.+||+|||++....
T Consensus 91 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 91 LMLEFAPRGELYKELQKH---GRFDEQRSATFMEELADALHYCHERK--VIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp EEECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred EEEEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 999999999999998643 25889999999999999999999999 9999999999999999999999999987654
Q ss_pred CCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHH
Q 005247 587 NTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA 666 (706)
Q Consensus 587 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~d 666 (706)
.. ......|++.|+|||++.+..++.++||||||+++|+|++|..||......+....+. .....++..++.++.+
T Consensus 166 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 241 (284)
T 2vgo_A 166 SL--RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIV--NVDLKFPPFLSDGSKD 241 (284)
T ss_dssp SS--CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--TTCCCCCTTSCHHHHH
T ss_pred cc--ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHh--ccccCCCCcCCHHHHH
Confidence 43 2345679999999999999999999999999999999999999999888766665553 3455677889999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHH
Q 005247 667 LIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 667 LI~~cL~~dP~~RPS~~eIl~ 687 (706)
||.+||+.||.+|||+.++++
T Consensus 242 li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 242 LISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp HHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHhhcCHhhCCCHHHHhh
Confidence 999999999999999999987
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=360.72 Aligned_cols=261 Identities=27% Similarity=0.433 Sum_probs=203.9
Q ss_pred cccccCceEEEEEeccCCceEEEEEEEcCCceEEEEEeccccchHHHHHHHHHHHH--HHcCCCCceeEEeccc-----c
Q 005247 428 LEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAI--MKGLRHPNIVLLMGAV-----T 500 (706)
Q Consensus 428 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKvl~~~~~~~~~~~~~~~Ei~i--L~~L~HpnIv~l~~~~-----~ 500 (706)
..+..++|++.+.||+|+||.||+|++.+..||+|++.... ...+..|.++ +..++|+||+++++.+ .
T Consensus 8 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 82 (336)
T 3g2f_A 8 PSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN-----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTAD 82 (336)
T ss_dssp -CCCTTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTT
T ss_pred CCcChHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccc-----hhhHHHHHHHHHHHhccCcchhhheecccccccC
Confidence 34667899999999999999999999988889999986542 1234444444 4458999999998733 3
Q ss_pred CCCceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhc---------CCCcccccCCCCcEEECCC
Q 005247 501 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR---------RPPIVHRDLKSPNLLVDST 571 (706)
Q Consensus 501 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~---------g~~IIHrDLKp~NILl~~~ 571 (706)
....+++||||+++|+|.++++... .++..++.++.||+.||.|||++ + |+||||||+|||++.+
T Consensus 83 ~~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~--ivH~Dikp~Nill~~~ 156 (336)
T 3g2f_A 83 GRMEYLLVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA--ISHRDLNSRNVLVKND 156 (336)
T ss_dssp SCEEEEEEECCCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC--EECSSCSGGGEEECTT
T ss_pred CCceEEEEEecCCCCcHHHHHhhcc----cchhHHHHHHHHHHHHHHHHHhhhccccccccc--eeecccccceEEEcCC
Confidence 3446789999999999999996433 57888999999999999999999 8 9999999999999999
Q ss_pred CcEEEeecCccccCCCCc--------ccCCCCCCCCCccCcccccc-------CCCCchhHHHHHHHHHHHHHhCCCCCC
Q 005247 572 YTVKVCDFGLSRSKPNTY--------ISSKTAAGTPEWMAPEVLRE-------DPSNEKSDVFSFGVILWELITLQKPWR 636 (706)
Q Consensus 572 ~~vKL~DFGla~~~~~~~--------~~~~~~~Gt~~Y~APE~l~~-------~~~s~ksDVwSLGviL~ELltG~~Pf~ 636 (706)
+.+||+|||+++...... .......||+.|+|||++.+ ..++.++|||||||++|||++|..||.
T Consensus 157 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~ 236 (336)
T 3g2f_A 157 GTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF 236 (336)
T ss_dssp SCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGS
T ss_pred CcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCC
Confidence 999999999997654321 12234579999999999987 345678999999999999999977764
Q ss_pred CCCh------------------HHHHHHhhhcCcccCCCCC------CcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 005247 637 NSTP------------------SQVISAVGFKGRRLEIPKN------VNPMVAALIETCWAEEPEIRPSFPSIMETLQQF 692 (706)
Q Consensus 637 ~~~~------------------~~~~~~i~~~~~~l~~p~~------~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~l 692 (706)
.... ......+.....+..++.. +++++.+||.+||+.||++|||+.|+++.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~l 316 (336)
T 3g2f_A 237 PGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL 316 (336)
T ss_dssp TTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred CccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHH
Confidence 3211 1112222223334444443 446899999999999999999999999999999
Q ss_pred HHhccCC
Q 005247 693 LMSSVCQ 699 (706)
Q Consensus 693 l~s~~~~ 699 (706)
+......
T Consensus 317 l~~~~~~ 323 (336)
T 3g2f_A 317 MMIWERN 323 (336)
T ss_dssp HHCCCC-
T ss_pred HHHHHhc
Confidence 9776553
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-41 Score=366.58 Aligned_cols=249 Identities=23% Similarity=0.383 Sum_probs=214.3
Q ss_pred cCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEE
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 509 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~ 509 (706)
.+.|++.+.||+|+||.||+|.+..+ .+|+|++.... ......+.+|+.+++.++||||+++++++.+...+++||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 127 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 127 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEE
Confidence 46799999999999999999998754 48999886543 233457889999999999999999999999999999999
Q ss_pred EeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECC--CCcEEEeecCccccCCC
Q 005247 510 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS--TYTVKVCDFGLSRSKPN 587 (706)
Q Consensus 510 E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~--~~~vKL~DFGla~~~~~ 587 (706)
||+.+|+|.+++.... ..+++..++.++.||+.||+|||++| |+||||||+|||++. .+.+||+|||+++....
T Consensus 128 E~~~gg~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 128 EFLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp ECCCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred EcCCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 9999999999986432 35899999999999999999999999 999999999999974 56899999999987654
Q ss_pred CcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcc--cCCCCCCcHHHH
Q 005247 588 TYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR--LEIPKNVNPMVA 665 (706)
Q Consensus 588 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~--l~~p~~~s~el~ 665 (706)
.. ......||+.|+|||++.+..++.++|||||||++|||++|..||...+..+....+...... ......+++++.
T Consensus 204 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 282 (387)
T 1kob_A 204 DE-IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK 282 (387)
T ss_dssp TS-CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHH
T ss_pred Cc-ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHH
Confidence 32 223457999999999999999999999999999999999999999998877776666433322 233457899999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHH
Q 005247 666 ALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 666 dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
+||.+||+.||++|||+.++++
T Consensus 283 ~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 283 DFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHHHcCCChhHCcCHHHHhh
Confidence 9999999999999999999986
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=351.04 Aligned_cols=248 Identities=29% Similarity=0.515 Sum_probs=218.7
Q ss_pred CceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEE
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 510 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E 510 (706)
..|++.+.||+|+||.||+|.+.. ..||+|++...... ...+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS-TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH-HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 569999999999999999998864 45999998765432 345788999999999999999999999999999999999
Q ss_pred eccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcc
Q 005247 511 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 590 (706)
Q Consensus 511 ~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~ 590 (706)
|+.+++|.+++.. ..+++..++.++.||+.||.|||++| |+||||||+||+++.++.+||+|||++........
T Consensus 101 ~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 174 (303)
T 3a7i_A 101 YLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 174 (303)
T ss_dssp CCTTEEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC
T ss_pred eCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChheEEECCCCCEEEeecccceecCcccc
Confidence 9999999999863 24889999999999999999999999 99999999999999999999999999987655444
Q ss_pred cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHHHH
Q 005247 591 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIET 670 (706)
Q Consensus 591 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI~~ 670 (706)
......||+.|+|||++.+..++.++||||||+++|+|++|..||...........+. ......++..++..+.+||.+
T Consensus 175 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~ 253 (303)
T 3a7i_A 175 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIP-KNNPPTLEGNYSKPLKEFVEA 253 (303)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH-HSCCCCCCSSCCHHHHHHHHH
T ss_pred ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhh-cCCCCCCccccCHHHHHHHHH
Confidence 4456789999999999999999999999999999999999999999888776665553 344556777899999999999
Q ss_pred hhhhCCCCCCCHHHHHHH
Q 005247 671 CWAEEPEIRPSFPSIMET 688 (706)
Q Consensus 671 cL~~dP~~RPS~~eIl~~ 688 (706)
||+.||++|||+.++++.
T Consensus 254 ~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 254 CLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp HCCSSGGGSCCHHHHTTC
T ss_pred HcCCChhhCcCHHHHhhC
Confidence 999999999999999873
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=356.06 Aligned_cols=263 Identities=19% Similarity=0.262 Sum_probs=210.1
Q ss_pred ccCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEecccc-chHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEE
Q 005247 431 RWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI 507 (706)
Q Consensus 431 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l 507 (706)
..++|++.+.||+|+||.||+|.+..+ .||+|++..... .....+.+.+|+.+++.++||||+++++++...+..++
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 357899999999999999999998644 499999865433 33445788999999999999999999999999999999
Q ss_pred EEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCC
Q 005247 508 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 587 (706)
Q Consensus 508 V~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 587 (706)
||||+++++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.....
T Consensus 112 v~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQ---GPLAPPRAVAIVRQIGSALDAAHAAG--ATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp EEECCCCEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred EEEecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCc--CCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 99999999999999743 35889999999999999999999999 99999999999999999999999999876544
Q ss_pred Cc-ccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCc-ccCCCCCCcHHHH
Q 005247 588 TY-ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR-RLEIPKNVNPMVA 665 (706)
Q Consensus 588 ~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~-~l~~p~~~s~el~ 665 (706)
.. .......|++.|+|||++.+..++.++||||||+++|+|++|+.||...........+..... ....+..+++++.
T Consensus 187 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 266 (309)
T 2h34_A 187 EKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFD 266 (309)
T ss_dssp ----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHH
T ss_pred cccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHH
Confidence 32 122355789999999999999999999999999999999999999988776544443322222 2345678999999
Q ss_pred HHHHHhhhhCCCCCC-CHHHHHHHHHHHHHhccC
Q 005247 666 ALIETCWAEEPEIRP-SFPSIMETLQQFLMSSVC 698 (706)
Q Consensus 666 dLI~~cL~~dP~~RP-S~~eIl~~L~~ll~s~~~ 698 (706)
+||.+||+.||++|| +++++++.|++++.....
T Consensus 267 ~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~ 300 (309)
T 2h34_A 267 AVIARGMAKNPEDRYVTCGDLSAAAHAALATADQ 300 (309)
T ss_dssp HHHHHHTCSSGGGSCSSHHHHHHHHHHTCC----
T ss_pred HHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhcc
Confidence 999999999999999 999999999998876543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=346.06 Aligned_cols=252 Identities=26% Similarity=0.369 Sum_probs=214.2
Q ss_pred cCceEEEEEeccCCceEEEEEEEcCCc--eEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEE
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 509 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~--vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~ 509 (706)
.++|++.+.||+|+||.||+|.+.++. +|+|++...... ..+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE--DVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM 85 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence 357999999999999999999987664 889988664332 2467889999999999999999999999999999999
Q ss_pred EeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEE---CCCCcEEEeecCccccCC
Q 005247 510 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLV---DSTYTVKVCDFGLSRSKP 586 (706)
Q Consensus 510 E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl---~~~~~vKL~DFGla~~~~ 586 (706)
||+++++|.+++... ..+++..++.++.|++.||+|||++| |+||||||+||++ +.++.+||+|||++....
T Consensus 86 e~~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 86 ELCTGGELFERVVHK---RVFRESDAARIMKDVLSAVAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp ECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred eccCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 999999999988643 35889999999999999999999999 9999999999999 788899999999998655
Q ss_pred CCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCC--CCCCcHHH
Q 005247 587 NTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEI--PKNVNPMV 664 (706)
Q Consensus 587 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~--p~~~s~el 664 (706)
... ......||+.|+|||++.+. ++.++||||||+++|+|++|..||......+....+.......+. ...+++++
T Consensus 161 ~~~-~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (277)
T 3f3z_A 161 PGK-MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQA 238 (277)
T ss_dssp TTS-CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHH
T ss_pred Ccc-chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHH
Confidence 432 23456799999999998765 899999999999999999999999998887777666433222211 13689999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHH--HHHHH
Q 005247 665 AALIETCWAEEPEIRPSFPSIME--TLQQF 692 (706)
Q Consensus 665 ~dLI~~cL~~dP~~RPS~~eIl~--~L~~l 692 (706)
.+||.+||+.||++|||+.++++ .+++.
T Consensus 239 ~~li~~~l~~dp~~R~s~~~~l~h~~~~~~ 268 (277)
T 3f3z_A 239 ESLIRRLLTKSPKQRITSLQALEHEWFEKQ 268 (277)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred HHHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence 99999999999999999999986 44443
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=365.72 Aligned_cols=253 Identities=22% Similarity=0.349 Sum_probs=211.4
Q ss_pred cccccCceEEEEEeccCCceEEEEEEEcC-CceEEEEEeccccchHHHHHHHHHHHHHHcCC--CCceeEEeccccCCCc
Q 005247 428 LEIRWSELLIKKKIGEGSFGTVYHAEWRN-SDVAVKILIEQEFHEDRFKEFLREVAIMKGLR--HPNIVLLMGAVTEPPN 504 (706)
Q Consensus 428 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~--HpnIv~l~~~~~~~~~ 504 (706)
..+....|++.+.||+|+||.||+|.+.. ..||||++..........+.+.+|+.+++.++ ||||+++++++...+.
T Consensus 51 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~ 130 (390)
T 2zmd_A 51 ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 130 (390)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred ccccCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCE
Confidence 34556679999999999999999998764 34999999877666777789999999999996 5999999999999999
Q ss_pred eEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCcccc
Q 005247 505 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 584 (706)
Q Consensus 505 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~ 584 (706)
+++||| +.+++|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++ ++.+||+|||+++.
T Consensus 131 ~~lv~E-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~-~~~~kl~DFG~a~~ 203 (390)
T 2zmd_A 131 IYMVME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-DGMLKLIDFGIANQ 203 (390)
T ss_dssp EEEEEE-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCCGGGEEES-SSCEEECCCSSSCC
T ss_pred EEEEEe-cCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEEE-CCeEEEEecCcccc
Confidence 999999 56889999997433 5788899999999999999999999 99999999999995 57899999999987
Q ss_pred CCCCcc--cCCCCCCCCCccCcccccc-----------CCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHhhhc
Q 005247 585 KPNTYI--SSKTAAGTPEWMAPEVLRE-----------DPSNEKSDVFSFGVILWELITLQKPWRNSTP-SQVISAVGFK 650 (706)
Q Consensus 585 ~~~~~~--~~~~~~Gt~~Y~APE~l~~-----------~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~-~~~~~~i~~~ 650 (706)
...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ......+...
T Consensus 204 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~ 283 (390)
T 2zmd_A 204 MQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP 283 (390)
T ss_dssp C---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCT
T ss_pred ccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCc
Confidence 643321 2345679999999999875 3688999999999999999999999987543 2334444344
Q ss_pred CcccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 651 GRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 651 ~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
.....++...+.++.+||.+||+.||.+|||+.++++
T Consensus 284 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 284 NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence 4556677888999999999999999999999999986
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-41 Score=360.85 Aligned_cols=246 Identities=27% Similarity=0.439 Sum_probs=212.1
Q ss_pred CceEEEEEeccCCceEEEEEEEcCC--ceEEEEEecccc-chHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEE
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 509 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~ 509 (706)
..|++.+.||+|+||.||+|.+..+ .||+|++..... .....+.+.+|+.++++++||||+++++++...+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4599999999999999999997543 499999876543 3445578999999999999999999999999999999999
Q ss_pred EeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCc
Q 005247 510 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 589 (706)
Q Consensus 510 E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 589 (706)
||+. |+|.+++... ...+++..++.++.|++.||.|||++| |+||||||+|||++.++.+||+|||++......
T Consensus 134 e~~~-g~l~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~- 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 207 (348)
T ss_dssp ECCS-EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred ecCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEeeccCceecCCC-
Confidence 9997 5787777532 235889999999999999999999999 999999999999999999999999999865432
Q ss_pred ccCCCCCCCCCccCccccc---cCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHH
Q 005247 590 ISSKTAAGTPEWMAPEVLR---EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA 666 (706)
Q Consensus 590 ~~~~~~~Gt~~Y~APE~l~---~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~d 666 (706)
....||+.|+|||++. +..++.++||||||+++|||++|+.||...+.......+.....+...+..+++.+.+
T Consensus 208 ---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 284 (348)
T 1u5q_A 208 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRN 284 (348)
T ss_dssp ---CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHH
T ss_pred ---CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHH
Confidence 3567999999999985 5678999999999999999999999999888777666655444444456678999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHH
Q 005247 667 LIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 667 LI~~cL~~dP~~RPS~~eIl~ 687 (706)
||.+||+.||++|||+.++++
T Consensus 285 li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 285 FVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp HHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHcccChhhCcCHHHHhh
Confidence 999999999999999999976
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=349.30 Aligned_cols=256 Identities=24% Similarity=0.392 Sum_probs=198.0
Q ss_pred cccccCceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCce
Q 005247 428 LEIRWSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNL 505 (706)
Q Consensus 428 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 505 (706)
+++..++|++.+.||+|+||.||+|.+.. ..||+|++..........+.+.++...++.++||||+++++++.+.+..
T Consensus 2 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~ 81 (290)
T 3fme_A 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV 81 (290)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred CcccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence 45677899999999999999999999854 4599999876554444445555666668888999999999999999999
Q ss_pred EEEEEeccCCchhhhccc-CCCcccccHHHHHHHHHHHHHHHHHHHhc-CCCcccccCCCCcEEECCCCcEEEeecCccc
Q 005247 506 SIVTEYLSRGSLYKLLHI-PDARVVVDERLRLNMAYDVAKGMNYLHQR-RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 583 (706)
Q Consensus 506 ~lV~E~~~ggsL~~~l~~-~~~~~~l~~~~~~~ia~qIl~aL~yLHs~-g~~IIHrDLKp~NILl~~~~~vKL~DFGla~ 583 (706)
++||||+.+ +|.+++.. ......+++..++.++.||+.||.|||++ | |+||||||+||+++.++.+||+|||+++
T Consensus 82 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T 3fme_A 82 WICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISG 158 (290)
T ss_dssp EEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC--CCCCCCSGGGCEECTTCCEEBCCC----
T ss_pred EEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEECCCCCEEEeecCCcc
Confidence 999999975 88777642 11234689999999999999999999998 9 9999999999999999999999999998
Q ss_pred cCCCCcccCCCCCCCCCccCcccc----ccCCCCchhHHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHhhhcCcccCCCC
Q 005247 584 SKPNTYISSKTAAGTPEWMAPEVL----REDPSNEKSDVFSFGVILWELITLQKPWRNS-TPSQVISAVGFKGRRLEIPK 658 (706)
Q Consensus 584 ~~~~~~~~~~~~~Gt~~Y~APE~l----~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~-~~~~~~~~i~~~~~~l~~p~ 658 (706)
...... ......||+.|+|||++ .+..++.++||||||+++|+|++|+.||... ..................+.
T Consensus 159 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (290)
T 3fme_A 159 YLVDDV-AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPAD 237 (290)
T ss_dssp ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTT
T ss_pred cccccc-cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccc
Confidence 755432 22345799999999996 5567899999999999999999999999864 33333333333333333445
Q ss_pred CCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 659 NVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 659 ~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
.+++++.+||.+||+.||++|||+.++++
T Consensus 238 ~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 238 KFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred cCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 78999999999999999999999999987
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=361.08 Aligned_cols=247 Identities=26% Similarity=0.370 Sum_probs=195.2
Q ss_pred ccCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEE
Q 005247 431 RWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIV 508 (706)
Q Consensus 431 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV 508 (706)
..+.|++.+.||+|+||.||+|.+.++ .||+|++.... ..+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 126 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV 126 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence 346799999999999999999998754 49999987543 235678899999999999999999999999999999
Q ss_pred EEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECC---CCcEEEeecCccccC
Q 005247 509 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS---TYTVKVCDFGLSRSK 585 (706)
Q Consensus 509 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~---~~~vKL~DFGla~~~ 585 (706)
|||+.+++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++. ++.+||+|||+++..
T Consensus 127 ~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~ 201 (349)
T 2w4o_A 127 LELVTGGELFDRIVEK---GYYSERDAADAVKQILEAVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201 (349)
T ss_dssp ECCCCSCBHHHHHTTC---SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred EEeCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence 9999999999998743 35889999999999999999999999 999999999999975 889999999999865
Q ss_pred CCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHhhhcCcc--cCCCCCCcH
Q 005247 586 PNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQ-VISAVGFKGRR--LEIPKNVNP 662 (706)
Q Consensus 586 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~-~~~~i~~~~~~--l~~p~~~s~ 662 (706)
.... ......||+.|+|||++.+..++.++|||||||++|||++|..||......+ ....+...... .+....++.
T Consensus 202 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 280 (349)
T 2w4o_A 202 EHQV-LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSL 280 (349)
T ss_dssp ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCH
T ss_pred Cccc-ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCH
Confidence 4432 2345679999999999999999999999999999999999999998766544 33333322222 123357899
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 663 MVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 663 el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
++.+||.+||+.||++|||+.++++
T Consensus 281 ~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 281 NAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHccCChhhCcCHHHHhc
Confidence 9999999999999999999999876
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=345.56 Aligned_cols=252 Identities=29% Similarity=0.489 Sum_probs=209.4
Q ss_pred cccccCceEEEEEeccCCceEEEEEEEc--CCceEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCceeEEeccccCCCc
Q 005247 428 LEIRWSELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFH-EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN 504 (706)
Q Consensus 428 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKvl~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 504 (706)
..+..++|++.+.||+|+||.||+|.+. +..||+|++...... ....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 85 (276)
T 2h6d_A 6 GRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTD 85 (276)
T ss_dssp -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred CcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCe
Confidence 4456789999999999999999999986 455999998654322 2234678899999999999999999999999999
Q ss_pred eEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCcccc
Q 005247 505 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 584 (706)
Q Consensus 505 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~ 584 (706)
.++||||+.+++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+||+++.++.+||+|||++..
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~dfg~~~~ 160 (276)
T 2h6d_A 86 FFMVMEYVSGGELFDYICKH---GRVEEMEARRLFQQILSAVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNM 160 (276)
T ss_dssp EEEEEECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHC--SSCCCCCGGGEEECTTSCEEECCCCGGGC
T ss_pred EEEEEeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChhhEEECCCCCEEEeecccccc
Confidence 99999999999999998643 24889999999999999999999999 99999999999999999999999999987
Q ss_pred CCCCcccCCCCCCCCCccCccccccCCC-CchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHH
Q 005247 585 KPNTYISSKTAAGTPEWMAPEVLREDPS-NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPM 663 (706)
Q Consensus 585 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~e 663 (706)
..... ......||+.|+|||++.+..+ +.++||||||+++|+|++|..||......+....+. .....++..++.+
T Consensus 161 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 237 (276)
T 2h6d_A 161 MSDGE-FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIR--GGVFYIPEYLNRS 237 (276)
T ss_dssp CCC--------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HCCCCCCTTSCHH
T ss_pred cCCCc-ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhh--cCcccCchhcCHH
Confidence 65432 2235578999999999988766 689999999999999999999999888777666553 2344567889999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 664 VAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 664 l~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
+.+||.+||+.||++|||+.++++
T Consensus 238 l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 238 VATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHccCChhhCCCHHHHHh
Confidence 999999999999999999999987
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=360.81 Aligned_cols=252 Identities=25% Similarity=0.302 Sum_probs=198.2
Q ss_pred cccCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEE
Q 005247 430 IRWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI 507 (706)
Q Consensus 430 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l 507 (706)
...++|++++.||+|+||.||+|.+..+ .||+|++..........+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 3456899999999999999999987654 49999987665555556778899999999999999999999999999999
Q ss_pred EEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEE-----CCCCcEEEeecCcc
Q 005247 508 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLV-----DSTYTVKVCDFGLS 582 (706)
Q Consensus 508 V~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl-----~~~~~vKL~DFGla 582 (706)
||||+.+ +|.+++.... .+++..++.++.||+.||.|||++| |+||||||+|||+ +.++.+||+|||++
T Consensus 111 v~e~~~~-~L~~~~~~~~---~~~~~~~~~i~~ql~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a 184 (329)
T 3gbz_A 111 IFEYAEN-DLKKYMDKNP---DVSMRVIKSFLYQLINGVNFCHSRR--CLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184 (329)
T ss_dssp EEECCSE-EHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred EEecCCC-CHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--EECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence 9999975 9999886433 4889999999999999999999999 9999999999999 45556999999999
Q ss_pred ccCCCCcccCCCCCCCCCccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCccc-------
Q 005247 583 RSKPNTYISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRL------- 654 (706)
Q Consensus 583 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l------- 654 (706)
+.............||+.|+|||++.+. .++.++|||||||++|||++|..||......+....+.......
T Consensus 185 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (329)
T 3gbz_A 185 RAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPG 264 (329)
T ss_dssp HHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred cccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhh
Confidence 8755443344556789999999999875 48999999999999999999999999888766655542110000
Q ss_pred ---------C------------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 655 ---------E------------IPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 655 ---------~------------~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
. ++..+++++.+||.+||+.||++|||+.|+++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 265 VTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp GGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 0 01126789999999999999999999999875
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=362.78 Aligned_cols=266 Identities=32% Similarity=0.557 Sum_probs=219.8
Q ss_pred ccCcccccCceEEEEEeccCCceEEEEEEEcCCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCc
Q 005247 425 EEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN 504 (706)
Q Consensus 425 ~~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 504 (706)
...+++..++|++.+.||+|+||.||+|.+.+ .+|+|++..........+.+.+|+.++++++|+||+++++++.+.+.
T Consensus 25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (319)
T 2y4i_B 25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH 103 (319)
T ss_dssp GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred cccccCCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence 45577888999999999999999999998765 59999987654444444567889999999999999999999999999
Q ss_pred eEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCcccc
Q 005247 505 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 584 (706)
Q Consensus 505 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~ 584 (706)
.++||||+.+++|.+++.... ..+++..++.++.||+.||+|||++| |+||||||+||+++ ++.+||+|||+++.
T Consensus 104 ~~iv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~ 178 (319)
T 2y4i_B 104 LAIITSLCKGRTLYSVVRDAK--IVLDVNKTRQIAQEIVKGMGYLHAKG--ILHKDLKSKNVFYD-NGKVVITDFGLFSI 178 (319)
T ss_dssp EEEECBCCCSEEHHHHTTSSC--CCCCSHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSTTEEEC---CCEECCCSCCC-
T ss_pred eEEEeecccCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChhhEEEe-CCCEEEeecCCccc
Confidence 999999999999999997433 35889999999999999999999999 99999999999998 67999999999875
Q ss_pred CCCC-----cccCCCCCCCCCccCcccccc---------CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhc
Q 005247 585 KPNT-----YISSKTAAGTPEWMAPEVLRE---------DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK 650 (706)
Q Consensus 585 ~~~~-----~~~~~~~~Gt~~Y~APE~l~~---------~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~ 650 (706)
.... ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||...........+...
T Consensus 179 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~ 258 (319)
T 2y4i_B 179 SGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTG 258 (319)
T ss_dssp ---------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTT
T ss_pred cccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccC
Confidence 4321 112234468999999999875 35788999999999999999999999998887777666544
Q ss_pred CcccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhc
Q 005247 651 GRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 696 (706)
Q Consensus 651 ~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~ 696 (706)
......+..++.++.+||.+||..||++|||+.++++.|+++....
T Consensus 259 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 259 MKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp CCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred CCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 3333344578899999999999999999999999999999887654
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=377.14 Aligned_cols=249 Identities=29% Similarity=0.452 Sum_probs=214.3
Q ss_pred cCceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEE
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 509 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~ 509 (706)
.++|++.+.||+|+||+||+|.+.. ..||+|++............+.+|+.++++++||||+++++++.+.+.+++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 3579999999999999999999864 45999998765444444568899999999999999999999999999999999
Q ss_pred EeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEEC---CCCcEEEeecCccccCC
Q 005247 510 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVD---STYTVKVCDFGLSRSKP 586 (706)
Q Consensus 510 E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~---~~~~vKL~DFGla~~~~ 586 (706)
||+.+|+|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||+++...
T Consensus 101 e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 175 (486)
T 3mwu_A 101 ELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (486)
T ss_dssp CCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred EcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence 999999999988633 35899999999999999999999999 99999999999995 45679999999998654
Q ss_pred CCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCC--CCCCcHHH
Q 005247 587 NTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEI--PKNVNPMV 664 (706)
Q Consensus 587 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~--p~~~s~el 664 (706)
... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||...+..+....+......... +..+++++
T Consensus 176 ~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 253 (486)
T 3mwu_A 176 QNT-KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDA 253 (486)
T ss_dssp CC-----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHH
T ss_pred CCC-ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHH
Confidence 432 2345679999999999876 5899999999999999999999999999988888777655444333 35789999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHH
Q 005247 665 AALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 665 ~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
++||.+||+.||.+|||+.++++
T Consensus 254 ~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 254 KDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHcCCChhhCcCHHHHhc
Confidence 99999999999999999999987
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=366.87 Aligned_cols=251 Identities=25% Similarity=0.357 Sum_probs=199.3
Q ss_pred ccCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCC-CCceeEEeccccCCC--ce
Q 005247 431 RWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGAVTEPP--NL 505 (706)
Q Consensus 431 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~--~~ 505 (706)
..++|++++.||+|+||.||+|.+..+ .||+|++..........+.+.+|+.+++.+. ||||+++++++...+ .+
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 356899999999999999999988644 4999998766556666778899999999997 999999999986544 68
Q ss_pred EEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccC
Q 005247 506 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK 585 (706)
Q Consensus 506 ~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~ 585 (706)
++||||+. ++|..+++.. .+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++..
T Consensus 87 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 159 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRAN----ILEPVHKQYVVYQLIKVIKYLHSGG--LLHRDMKPSNILLNAECHVKVADFGLSRSF 159 (388)
T ss_dssp EEEEECCS-EEHHHHHHHT----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred EEEecccC-cCHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence 99999997 5898888642 4888999999999999999999999 999999999999999999999999999764
Q ss_pred CCC---------------------cccCCCCCCCCCccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH
Q 005247 586 PNT---------------------YISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQV 643 (706)
Q Consensus 586 ~~~---------------------~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~ 643 (706)
... .......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~ 239 (388)
T 3oz6_A 160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ 239 (388)
T ss_dssp SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 321 111234579999999999987 6789999999999999999999999998877666
Q ss_pred HHHhhhcCcc---------------------------------------------cCCCCCCcHHHHHHHHHhhhhCCCC
Q 005247 644 ISAVGFKGRR---------------------------------------------LEIPKNVNPMVAALIETCWAEEPEI 678 (706)
Q Consensus 644 ~~~i~~~~~~---------------------------------------------l~~p~~~s~el~dLI~~cL~~dP~~ 678 (706)
...+...... ...+..+++++.+||.+||+.||++
T Consensus 240 ~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~ 319 (388)
T 3oz6_A 240 LERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNK 319 (388)
T ss_dssp HHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCccc
Confidence 5544211000 0112367899999999999999999
Q ss_pred CCCHHHHHHH
Q 005247 679 RPSFPSIMET 688 (706)
Q Consensus 679 RPS~~eIl~~ 688 (706)
|||+.|+++.
T Consensus 320 R~t~~e~l~H 329 (388)
T 3oz6_A 320 RISANDALKH 329 (388)
T ss_dssp SCCHHHHTTS
T ss_pred CCCHHHHhCC
Confidence 9999999874
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=388.50 Aligned_cols=262 Identities=31% Similarity=0.511 Sum_probs=221.7
Q ss_pred cccccCceEEE-EEeccCCceEEEEEEEc--C--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCC
Q 005247 428 LEIRWSELLIK-KKIGEGSFGTVYHAEWR--N--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP 502 (706)
Q Consensus 428 ~~i~~~~y~i~-~~LG~G~fG~Vy~a~~~--~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~ 502 (706)
+.+....+.+. +.||+|+||.||+|.+. . ..||||+++.........+.+.+|+.++++++||||+++++++..
T Consensus 363 ~~~~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~- 441 (635)
T 4fl3_A 363 VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA- 441 (635)
T ss_dssp SBCCGGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-
T ss_pred ccccchhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 34445556654 48999999999999653 2 349999997766555566789999999999999999999999865
Q ss_pred CceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCcc
Q 005247 503 PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS 582 (706)
Q Consensus 503 ~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla 582 (706)
+..++||||+.+|+|.++++.. ..+++..++.|+.||+.||+|||+++ ||||||||+|||++.++.+||+|||++
T Consensus 442 ~~~~lv~E~~~~g~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~yLH~~~--iiHrDLkp~NILl~~~~~~kL~DFGla 516 (635)
T 4fl3_A 442 ESWMLVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLS 516 (635)
T ss_dssp SSEEEEEECCTTEEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCTTHH
T ss_pred CCEEEEEEccCCCCHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHHHHCC--EeCCCCChHhEEEeCCCCEEEEEcCCc
Confidence 4588999999999999999643 35889999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCc---ccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCCC
Q 005247 583 RSKPNTY---ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPK 658 (706)
Q Consensus 583 ~~~~~~~---~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p~ 658 (706)
+...... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+....+. ...+...+.
T Consensus 517 ~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~-~~~~~~~p~ 595 (635)
T 4fl3_A 517 KALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPA 595 (635)
T ss_dssp HHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCT
T ss_pred cccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCC
Confidence 8654332 12233456789999999999999999999999999999998 999999998887777664 556778889
Q ss_pred CCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhc
Q 005247 659 NVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 696 (706)
Q Consensus 659 ~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~ 696 (706)
.+++++.+||.+||+.||++||++.+|++.|++++.+.
T Consensus 596 ~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l 633 (635)
T 4fl3_A 596 GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 633 (635)
T ss_dssp TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 99999999999999999999999999999999998764
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-41 Score=353.79 Aligned_cols=249 Identities=21% Similarity=0.245 Sum_probs=203.2
Q ss_pred ccccCceEEEEEeccCCceEEEEEEEc--CCceEEEEEeccccchHHHHHHHHHHHHHHcC-CCCceeEEeccccCCCce
Q 005247 429 EIRWSELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNL 505 (706)
Q Consensus 429 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~ 505 (706)
.+..++|++.++||+|+||+||+|.+. +..||||++............+..|+..+..+ +|+||+++++++.+.+..
T Consensus 53 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~ 132 (311)
T 3p1a_A 53 SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGIL 132 (311)
T ss_dssp CHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred chhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEE
Confidence 344568999999999999999999987 44599999866555555555666666666555 899999999999999999
Q ss_pred EEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccC
Q 005247 506 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK 585 (706)
Q Consensus 506 ~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~ 585 (706)
++||||+ +++|.+++...+ ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 133 ~lv~e~~-~~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kl~DFG~a~~~ 207 (311)
T 3p1a_A 133 YLQTELC-GPSLQQHCEAWG--ASLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPANIFLGPRGRCKLGDFGLLVEL 207 (311)
T ss_dssp EEEEECC-CCBHHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECGGGCEEECCCTTCEEC
T ss_pred EEEEecc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCCCCEEEccceeeeec
Confidence 9999999 668888875432 35899999999999999999999999 999999999999999999999999998876
Q ss_pred CCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHH
Q 005247 586 PNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 665 (706)
Q Consensus 586 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~ 665 (706)
.... ......||+.|+|||++.+ .++.++||||||+++|||++|..|+..... ...+........++..+++++.
T Consensus 208 ~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~ 282 (311)
T 3p1a_A 208 GTAG-AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQGYLPPEFTAGLSSELR 282 (311)
T ss_dssp C-------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTTTCCCHHHHTTSCHHHH
T ss_pred ccCC-CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhccCCCcccccCCCHHHH
Confidence 5432 2345679999999999876 689999999999999999999777654322 2223223333445678899999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHH
Q 005247 666 ALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 666 dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
+||.+||+.||++|||+.++++
T Consensus 283 ~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 283 SVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp HHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHcCCChhhCcCHHHHHh
Confidence 9999999999999999999975
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=358.22 Aligned_cols=254 Identities=24% Similarity=0.379 Sum_probs=210.1
Q ss_pred ccccCceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceE
Q 005247 429 EIRWSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS 506 (706)
Q Consensus 429 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 506 (706)
....++|++.+.||+|+||.||+|.+.. ..||+|++..........+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 100 (331)
T 4aaa_A 21 FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWY 100 (331)
T ss_dssp CBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred hhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEE
Confidence 3456789999999999999999999874 45999998777666666778899999999999999999999999999999
Q ss_pred EEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCC
Q 005247 507 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP 586 (706)
Q Consensus 507 lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~ 586 (706)
+||||+.+++|.+++.... .+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++...
T Consensus 101 lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 175 (331)
T 4aaa_A 101 LVFEFVDHTILDDLELFPN---GLDYQVVQKYLFQIINGIGFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFARTLA 175 (331)
T ss_dssp EEEECCSEEHHHHHHHSTT---CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred EEEecCCcchHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCC--EEccCcChheEEEcCCCcEEEEeCCCceeec
Confidence 9999999999988875332 4889999999999999999999999 9999999999999999999999999998765
Q ss_pred CCcccCCCCCCCCCccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcC--------------
Q 005247 587 NTYISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG-------------- 651 (706)
Q Consensus 587 ~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~-------------- 651 (706)
..........||+.|+|||++.+. .++.++||||||+++|+|++|+.||......+....+....
T Consensus 176 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (331)
T 4aaa_A 176 APGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN 255 (331)
T ss_dssp --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHC
T ss_pred CCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhc
Confidence 544444566799999999999875 68999999999999999999999999887665544332110
Q ss_pred -----ccc----------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 652 -----RRL----------EIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 652 -----~~l----------~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
... ...+.+++++.+||.+||+.||++|||+.|+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000 012367899999999999999999999999886
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=355.67 Aligned_cols=255 Identities=31% Similarity=0.487 Sum_probs=210.2
Q ss_pred EEEEeccCCceEEEEEEEcCCceEEEEEeccc--cchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEEeccC
Q 005247 437 IKKKIGEGSFGTVYHAEWRNSDVAVKILIEQE--FHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSR 514 (706)
Q Consensus 437 i~~~LG~G~fG~Vy~a~~~~~~vAVKvl~~~~--~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~~~g 514 (706)
..+.||+|+||.||+|.+.++.+|+|++.... ......+.+.+|+.+++.++||||+++++++.+.+..++||||+++
T Consensus 35 ~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 114 (307)
T 2nru_A 35 GGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPN 114 (307)
T ss_dssp TCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred cCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCC
Confidence 45789999999999999988889999986542 2334567899999999999999999999999999999999999999
Q ss_pred CchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcc--cC
Q 005247 515 GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI--SS 592 (706)
Q Consensus 515 gsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~--~~ 592 (706)
++|.+++........+++..++.++.||+.||.|||++| |+||||||+||+++.++.+||+|||+++....... ..
T Consensus 115 ~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 192 (307)
T 2nru_A 115 GSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH--HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMT 192 (307)
T ss_dssp CBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEEC
T ss_pred CcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEcCCCcEEEeecccccccccccccccc
Confidence 999999975544556899999999999999999999999 99999999999999999999999999876543221 22
Q ss_pred CCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH----HHHhhhc---------CcccCCCCC
Q 005247 593 KTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQV----ISAVGFK---------GRRLEIPKN 659 (706)
Q Consensus 593 ~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~----~~~i~~~---------~~~l~~p~~ 659 (706)
....||+.|+|||++.+ .++.++||||||+++|+|++|..||......+. ...+... ......+..
T Consensus 193 ~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (307)
T 2nru_A 193 SRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADST 271 (307)
T ss_dssp SSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCHH
T ss_pred cccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccchH
Confidence 34578999999998865 478899999999999999999999976543221 1111110 111122334
Q ss_pred CcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 005247 660 VNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLM 694 (706)
Q Consensus 660 ~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~ 694 (706)
++..+.++|.+||+.||.+|||+.++++.|+++..
T Consensus 272 ~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 272 SVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp HHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 56789999999999999999999999999998754
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=355.03 Aligned_cols=256 Identities=32% Similarity=0.558 Sum_probs=206.8
Q ss_pred ccCceEEEEEeccCCceEEEEEEEcCCceEEEEEeccccchHHHHHHHHHHHHHHcC--CCCceeEEeccccCC----Cc
Q 005247 431 RWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGL--RHPNIVLLMGAVTEP----PN 504 (706)
Q Consensus 431 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L--~HpnIv~l~~~~~~~----~~ 504 (706)
..++|++.+.||+|+||.||+|++.+..||+|++.... ...+.+|.+++..+ +||||+++++++... ..
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 109 (337)
T 3mdy_A 35 IAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTE-----EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ 109 (337)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred cccceEEEeEeecCCCeEEEEEEECCceEEEEEEeccc-----cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence 34689999999999999999999998889999985432 23445566666554 899999999998776 67
Q ss_pred eEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhc--------CCCcccccCCCCcEEECCCCcEEE
Q 005247 505 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR--------RPPIVHRDLKSPNLLVDSTYTVKV 576 (706)
Q Consensus 505 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~--------g~~IIHrDLKp~NILl~~~~~vKL 576 (706)
.++||||+++|+|.++++.. .+++..++.++.|++.||.|||++ + |+||||||+|||++.++.+||
T Consensus 110 ~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dikp~Nill~~~~~~kl 183 (337)
T 3mdy_A 110 LYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA--IAHRDLKSKNILVKKNGTCCI 183 (337)
T ss_dssp EEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC--EECSCCCGGGEEECTTSCEEE
T ss_pred eEEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC--EEecccchHHEEECCCCCEEE
Confidence 89999999999999999643 488999999999999999999998 7 999999999999999999999
Q ss_pred eecCccccCCCCccc----CCCCCCCCCccCccccccCCCCch------hHHHHHHHHHHHHHhC----------CCCCC
Q 005247 577 CDFGLSRSKPNTYIS----SKTAAGTPEWMAPEVLREDPSNEK------SDVFSFGVILWELITL----------QKPWR 636 (706)
Q Consensus 577 ~DFGla~~~~~~~~~----~~~~~Gt~~Y~APE~l~~~~~s~k------sDVwSLGviL~ELltG----------~~Pf~ 636 (706)
+|||+++........ .....||+.|+|||++.+...+.+ +|||||||++|||++| +.||.
T Consensus 184 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~ 263 (337)
T 3mdy_A 184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH 263 (337)
T ss_dssp CCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred EeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHh
Confidence 999999765433221 235579999999999988766554 9999999999999999 77776
Q ss_pred CCCh-----HHHHHHhhhcCcccCCCC-----CCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhcc
Q 005247 637 NSTP-----SQVISAVGFKGRRLEIPK-----NVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSV 697 (706)
Q Consensus 637 ~~~~-----~~~~~~i~~~~~~l~~p~-----~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~~ 697 (706)
.... ......+.....+..++. .+++++.+||.+||+.||.+|||+.++++.|+++..+..
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 334 (337)
T 3mdy_A 264 DLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQD 334 (337)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred hhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhcc
Confidence 5321 222222323333344443 567889999999999999999999999999999998753
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=393.17 Aligned_cols=252 Identities=25% Similarity=0.435 Sum_probs=220.8
Q ss_pred ccccCceEEEEEeccCCceEEEEEEEcCCc--eEEEEEecccc-chHHHHHHHHHHHHHHcC-CCCceeEEeccccCCCc
Q 005247 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEF-HEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPN 504 (706)
Q Consensus 429 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~--vAVKvl~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~ 504 (706)
.+..++|++++.||+|+||.||+|++.+++ ||||++.+... .....+.+..|..++..+ +|+||+++++++.+.+.
T Consensus 337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~ 416 (674)
T 3pfq_A 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 416 (674)
T ss_dssp ---CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE
T ss_pred cccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE
Confidence 456789999999999999999999987654 99999876432 223346788899999988 69999999999999999
Q ss_pred eEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCcccc
Q 005247 505 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 584 (706)
Q Consensus 505 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~ 584 (706)
+++||||+.+|+|.++++.. ..+++..++.++.||+.||+|||++| ||||||||+||||+.++.+||+|||+++.
T Consensus 417 ~~lV~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g--IiHrDLKp~NILl~~~g~ikL~DFGla~~ 491 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKE 491 (674)
T ss_dssp EEEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTS--EECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred EEEEEeCcCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eEeccCChhhEEEcCCCcEEEeecceeec
Confidence 99999999999999999743 35899999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHH
Q 005247 585 KPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV 664 (706)
Q Consensus 585 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el 664 (706)
...........+||+.|+|||++.+..++.++||||||+++|||++|+.||...+..+....+. ...+.+|..+++++
T Consensus 492 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~ 569 (674)
T 3pfq_A 492 NIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM--EHNVAYPKSMSKEA 569 (674)
T ss_dssp CCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--SSCCCCCTTSCHHH
T ss_pred cccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHH--hCCCCCCccCCHHH
Confidence 5444444567889999999999999999999999999999999999999999998888887774 45567888999999
Q ss_pred HHHHHHhhhhCCCCCCCH-----HHHHH
Q 005247 665 AALIETCWAEEPEIRPSF-----PSIME 687 (706)
Q Consensus 665 ~dLI~~cL~~dP~~RPS~-----~eIl~ 687 (706)
.+||.+||+.||++||++ ++|++
T Consensus 570 ~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 570 VAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp HHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred HHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 999999999999999997 66664
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=362.25 Aligned_cols=245 Identities=25% Similarity=0.429 Sum_probs=207.1
Q ss_pred cCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcC-CCCceeEEeccccCCCceEEE
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSIV 508 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~lV 508 (706)
.++|++.+.||+|+||.||+|.++.+ .||+|++..... ...+|++++.++ +||||+++++++.+.+..++|
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv 94 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR------DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVV 94 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEE
Confidence 46799999999999999999998754 499999876542 234688888877 799999999999999999999
Q ss_pred EEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCC----CcEEEeecCcccc
Q 005247 509 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST----YTVKVCDFGLSRS 584 (706)
Q Consensus 509 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~----~~vKL~DFGla~~ 584 (706)
|||+.+|+|.+++... ..+++..++.++.||+.||+|||++| |+||||||+|||+... +.+||+|||++..
T Consensus 95 ~E~~~gg~L~~~i~~~---~~~~~~~~~~~~~qi~~al~~lH~~g--ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 95 TELMKGGELLDKILRQ---KFFSEREASAVLFTITKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp ECCCCSCBHHHHHHTC---TTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred EeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 9999999999998643 35899999999999999999999999 9999999999998543 3599999999987
Q ss_pred CCCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCC---CChHHHHHHhhhcCccc--CCCCC
Q 005247 585 KPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRN---STPSQVISAVGFKGRRL--EIPKN 659 (706)
Q Consensus 585 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~---~~~~~~~~~i~~~~~~l--~~p~~ 659 (706)
...........+||+.|+|||++.+..++.++|||||||++|||++|..||.. ....+....+......+ ..+..
T Consensus 170 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 249 (342)
T 2qr7_A 170 LRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNS 249 (342)
T ss_dssp CBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTT
T ss_pred CcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCcccccc
Confidence 65544344567899999999999988889999999999999999999999986 34455555554333222 23467
Q ss_pred CcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 660 VNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 660 ~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
+++++.+||.+||..||++|||+.++++
T Consensus 250 ~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 250 VSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 8999999999999999999999999986
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=347.99 Aligned_cols=250 Identities=26% Similarity=0.460 Sum_probs=206.7
Q ss_pred CceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEE
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 510 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E 510 (706)
++|.+.+.||+|+||.||+|.+..+ .+|+|++..... ....+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS-QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc-chhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 5799999999999999999998644 489999876542 2234678899999999999999999999999999999999
Q ss_pred eccCCchhhhcccC-CCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEE---CCCCcEEEeecCccccCC
Q 005247 511 YLSRGSLYKLLHIP-DARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLV---DSTYTVKVCDFGLSRSKP 586 (706)
Q Consensus 511 ~~~ggsL~~~l~~~-~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl---~~~~~vKL~DFGla~~~~ 586 (706)
|+++++|.+++... .....+++..++.++.||+.||+|||++| |+||||||+||++ +.++.+||+|||++....
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH--VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 99999999988432 12245889999999999999999999999 9999999999999 456789999999998654
Q ss_pred CCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCC-CCCCcHHHH
Q 005247 587 NTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEI-PKNVNPMVA 665 (706)
Q Consensus 587 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~-p~~~s~el~ 665 (706)
... ......||+.|+|||++. ..++.++||||||+++|+|++|+.||......+....+......... ...+++++.
T Consensus 179 ~~~-~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (285)
T 3is5_A 179 SDE-HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAV 256 (285)
T ss_dssp ---------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHHHH
T ss_pred Ccc-cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHHHH
Confidence 432 234567999999999986 46889999999999999999999999998887776666544433332 234789999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHH
Q 005247 666 ALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 666 dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
+||.+||+.||++|||+.|+++
T Consensus 257 ~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 257 DLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp HHHHHHTCSCTTTSCCHHHHHT
T ss_pred HHHHHHccCChhhCcCHHHHhc
Confidence 9999999999999999999975
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=346.02 Aligned_cols=246 Identities=25% Similarity=0.346 Sum_probs=208.3
Q ss_pred cCceEEEEEeccCCceEEEEEEEc--CCceEEEEEeccccchHHHHHHHHHHHHHHcC-CCCceeEEeccccCCCceEEE
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSIV 508 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~lV 508 (706)
.++|++.+.||+|+||.||+|.+. +..||+|++............+.+|+.++..+ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 467999999999999999999986 45599999987655556667889999999999 899999999999999999999
Q ss_pred EEeccCCchhhhcccCC-CcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCC----------------
Q 005247 509 TEYLSRGSLYKLLHIPD-ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST---------------- 571 (706)
Q Consensus 509 ~E~~~ggsL~~~l~~~~-~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~---------------- 571 (706)
|||+++++|.+++.... ....+++..++.++.||+.||.|||++| |+||||||+|||++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~ 167 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDWA 167 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC------------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeecCCCHHHEEEcCCCCCccccccccccccc
Confidence 99999999999996421 1135889999999999999999999999 9999999999999844
Q ss_pred ---CcEEEeecCccccCCCCcccCCCCCCCCCccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHh
Q 005247 572 ---YTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAV 647 (706)
Q Consensus 572 ---~~vKL~DFGla~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i 647 (706)
..+||+|||++...... ....||+.|+|||++.+. .++.++||||||+++|+|++|..|+...... ..+
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~---~~~ 240 (289)
T 1x8b_A 168 SNKVMFKIGDLGHVTRISSP----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW---HEI 240 (289)
T ss_dssp --CCCEEECCCTTCEETTCS----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH---HHH
T ss_pred CCceEEEEcccccccccCCc----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHH---HHH
Confidence 47999999999876543 245699999999999876 5668999999999999999998877554322 222
Q ss_pred hhcCcccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 648 GFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 648 ~~~~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
.......++..+++++.+||.+||+.||++|||+.++++
T Consensus 241 -~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 241 -RQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp -HTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -HcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 234445677889999999999999999999999999875
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=376.57 Aligned_cols=255 Identities=31% Similarity=0.426 Sum_probs=213.0
Q ss_pred cCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEE
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 509 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~ 509 (706)
.+.|++++.||+|+||.||+|.+..+ .||+|++............+.+|+.+++.++||||+++++++.+.+.+++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 35799999999999999999998754 4999998766544444567899999999999999999999999999999999
Q ss_pred EeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECC---CCcEEEeecCccccCC
Q 005247 510 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS---TYTVKVCDFGLSRSKP 586 (706)
Q Consensus 510 E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~---~~~vKL~DFGla~~~~ 586 (706)
||+.+|+|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++. ++.+||+|||+++...
T Consensus 116 e~~~~g~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~ 190 (494)
T 3lij_A 116 ECYKGGELFDEIIHR---MKFNEVDAAVIIKQVLSGVTYLHKHN--IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE 190 (494)
T ss_dssp ECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred ecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence 999999999888633 35889999999999999999999999 999999999999976 4459999999998765
Q ss_pred CCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCC--CCCCcHHH
Q 005247 587 NTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEI--PKNVNPMV 664 (706)
Q Consensus 587 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~--p~~~s~el 664 (706)
... ......||+.|+|||++. ..++.++|||||||++|+|++|..||...+..+....+......... ...+++++
T Consensus 191 ~~~-~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 268 (494)
T 3lij_A 191 NQK-KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGA 268 (494)
T ss_dssp TTB-CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHH
T ss_pred CCc-cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHH
Confidence 432 234567999999999986 46899999999999999999999999999988888777554444332 25789999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHH--HHHHHH
Q 005247 665 AALIETCWAEEPEIRPSFPSIME--TLQQFL 693 (706)
Q Consensus 665 ~dLI~~cL~~dP~~RPS~~eIl~--~L~~ll 693 (706)
++||.+||+.||.+|||+.++++ .+++..
T Consensus 269 ~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 299 (494)
T 3lij_A 269 KDLIKQMLQFDSQRRISAQQALEHPWIKEMC 299 (494)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHTCHHHHHHH
T ss_pred HHHHHHHCCCChhhCccHHHHhcCcccccCc
Confidence 99999999999999999999986 355543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-41 Score=352.11 Aligned_cols=253 Identities=26% Similarity=0.296 Sum_probs=203.4
Q ss_pred cccCceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccc---hHHHHHHHHHHHHHHcC---CCCceeEEeccccC
Q 005247 430 IRWSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFH---EDRFKEFLREVAIMKGL---RHPNIVLLMGAVTE 501 (706)
Q Consensus 430 i~~~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~---~~~~~~~~~Ei~iL~~L---~HpnIv~l~~~~~~ 501 (706)
+..++|++.+.||+|+||+||+|.+.. ..||+|++...... ......+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 446789999999999999999999754 45999998643321 11123555677776666 59999999999876
Q ss_pred CC-----ceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEE
Q 005247 502 PP-----NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKV 576 (706)
Q Consensus 502 ~~-----~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL 576 (706)
.. ..++||||+. ++|.+++..... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPP-PGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCT-TCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCTTTEEECTTSCEEE
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCEEE
Confidence 54 4789999997 599999875432 24899999999999999999999999 999999999999999999999
Q ss_pred eecCccccCCCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcc---
Q 005247 577 CDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR--- 653 (706)
Q Consensus 577 ~DFGla~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~--- 653 (706)
+|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+......
T Consensus 162 ~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 240 (308)
T 3g33_A 162 ADFGLARIYSYQM-ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE 240 (308)
T ss_dssp CSCSCTTTSTTCC-CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred eeCccccccCCCc-ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 9999998655432 234568999999999999999999999999999999999999999998877766554321100
Q ss_pred ----------------------cCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 654 ----------------------LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 654 ----------------------l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
....+.+++++.+||.+||+.||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 241 DDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp TTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 0112467899999999999999999999999876
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=363.52 Aligned_cols=259 Identities=21% Similarity=0.250 Sum_probs=202.6
Q ss_pred cccCceEEEEEeccCCceEEEEEEEcC-----CceEEEEEeccccchH---------HHHHHHHHHHHHHcCCCCceeEE
Q 005247 430 IRWSELLIKKKIGEGSFGTVYHAEWRN-----SDVAVKILIEQEFHED---------RFKEFLREVAIMKGLRHPNIVLL 495 (706)
Q Consensus 430 i~~~~y~i~~~LG~G~fG~Vy~a~~~~-----~~vAVKvl~~~~~~~~---------~~~~~~~Ei~iL~~L~HpnIv~l 495 (706)
+..++|++.+.||+|+||.||+|.+.. ..+|+|+......... ....+.+|+.+++.++||||+++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~ 113 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF 113 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence 446789999999999999999999854 4489999865532111 11346688899999999999999
Q ss_pred eccccC----CCceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCC
Q 005247 496 MGAVTE----PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST 571 (706)
Q Consensus 496 ~~~~~~----~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~ 571 (706)
++++.. ....++||||+ +++|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~ 187 (345)
T 2v62_A 114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHENE--YVHGDIKAANLLLGYK 187 (345)
T ss_dssp EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEESS
T ss_pred ecccccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCcCHHHEEEccC
Confidence 999876 67899999999 999999997443 6899999999999999999999999 9999999999999887
Q ss_pred C--cEEEeecCccccCCCCc-------ccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH
Q 005247 572 Y--TVKVCDFGLSRSKPNTY-------ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQ 642 (706)
Q Consensus 572 ~--~vKL~DFGla~~~~~~~-------~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~ 642 (706)
+ .+||+|||+++...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.......
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~ 267 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP 267 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence 7 99999999997653221 11144579999999999999999999999999999999999999996532211
Q ss_pred HHHHhhhcCcccCCC---------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 005247 643 VISAVGFKGRRLEIP---------KNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLM 694 (706)
Q Consensus 643 ~~~~i~~~~~~l~~p---------~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~ 694 (706)
.............++ ..+++++.+||.+||+.||++|||+.+|++.|+++-.
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 268 VAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred HHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 111111111111222 2789999999999999999999999999999987643
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=344.05 Aligned_cols=258 Identities=24% Similarity=0.426 Sum_probs=215.8
Q ss_pred CceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccch----HHHHHHHHHHHHHHcCCCCceeEEeccccCCCceE
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHE----DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS 506 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 506 (706)
++|++.+.||+|+||.||+|.+.. ..||+|++....... ...+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 579999999999999999999874 459999987654322 12467889999999999999999999999999999
Q ss_pred EEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCC----cEEEeecCcc
Q 005247 507 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY----TVKVCDFGLS 582 (706)
Q Consensus 507 lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~----~vKL~DFGla 582 (706)
+||||+++++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+||+++.++ .+||+|||++
T Consensus 85 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~ 159 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEK---ESLTEDEATQFLKQILDGVHYLHSKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159 (283)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEeecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence 999999999999998632 35889999999999999999999999 99999999999998877 8999999999
Q ss_pred ccCCCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcc--cCCCCCC
Q 005247 583 RSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR--LEIPKNV 660 (706)
Q Consensus 583 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~--l~~p~~~ 660 (706)
....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||......+....+...... ...+..+
T Consensus 160 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T 3bhy_A 160 HKIEAGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNT 238 (283)
T ss_dssp EECC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTC
T ss_pred eeccCCC-cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccC
Confidence 8755432 223457899999999999999999999999999999999999999988877766655432222 1233578
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHH--HHHHHHHhc
Q 005247 661 NPMVAALIETCWAEEPEIRPSFPSIME--TLQQFLMSS 696 (706)
Q Consensus 661 s~el~dLI~~cL~~dP~~RPS~~eIl~--~L~~ll~s~ 696 (706)
++.+.+||.+||+.||++|||+.++++ .++.+....
T Consensus 239 ~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~ 276 (283)
T 3bhy_A 239 SELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRN 276 (283)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHCC
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHHh
Confidence 899999999999999999999999998 566655443
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=349.39 Aligned_cols=255 Identities=27% Similarity=0.457 Sum_probs=209.6
Q ss_pred ccccCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceE
Q 005247 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS 506 (706)
Q Consensus 429 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 506 (706)
.....+|.....||+|+||.||+|.+..+ .||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 18 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 95 (295)
T 2clq_A 18 DYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIK 95 (295)
T ss_dssp EECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC--C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred cccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc--hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEE
Confidence 34445555566899999999999998654 48999886543 334567889999999999999999999999999999
Q ss_pred EEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECC-CCcEEEeecCccccC
Q 005247 507 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS-TYTVKVCDFGLSRSK 585 (706)
Q Consensus 507 lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~-~~~vKL~DFGla~~~ 585 (706)
+||||+++++|.+++........+++..++.++.||+.||.|||++| |+||||||+||+++. ++.+||+|||++...
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~ 173 (295)
T 2clq_A 96 IFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRL 173 (295)
T ss_dssp EEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTCCEEECCTTTCEES
T ss_pred EEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC--EEccCCChhhEEEECCCCCEEEeeccccccc
Confidence 99999999999999975544445778899999999999999999999 999999999999987 889999999999876
Q ss_pred CCCcccCCCCCCCCCccCccccccCC--CCchhHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHhhhcCcccCCCCCCcH
Q 005247 586 PNTYISSKTAAGTPEWMAPEVLREDP--SNEKSDVFSFGVILWELITLQKPWRNSTPSQ-VISAVGFKGRRLEIPKNVNP 662 (706)
Q Consensus 586 ~~~~~~~~~~~Gt~~Y~APE~l~~~~--~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~-~~~~i~~~~~~l~~p~~~s~ 662 (706)
...........||+.|+|||++.+.. ++.++||||||+++|+|++|+.||....... .............++..+++
T Consensus 174 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (295)
T 2clq_A 174 AGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSA 253 (295)
T ss_dssp CC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCH
T ss_pred CCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCH
Confidence 54433345667999999999997654 7899999999999999999999997644322 22222233445667888999
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 663 MVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 663 el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
++.+||.+||+.||++||++.++++
T Consensus 254 ~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 254 EAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp HHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHHccCChhhCCCHHHHhc
Confidence 9999999999999999999999975
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=351.65 Aligned_cols=255 Identities=25% Similarity=0.407 Sum_probs=207.9
Q ss_pred CcccccCceEEEEEeccCCceEEEEEEEc--CCceEEEEEeccccchHHHHHHHHHHHHHHcC-CCCceeEEeccccC--
Q 005247 427 GLEIRWSELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTE-- 501 (706)
Q Consensus 427 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~-- 501 (706)
.+....++|++.+.||+|+||.||+|.+. +..||+|++...... .+.+.+|+.+++++ +||||+++++++..
T Consensus 18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 94 (326)
T 2x7f_A 18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE---EEEIKQEINMLKKYSHHRNIATYYGAFIKKN 94 (326)
T ss_dssp CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST---THHHHHHHHHHHHHCCSTTBCCEEEEEEECC
T ss_pred hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc---HHHHHHHHHHHHhccCCCCeeeeeeEEeecc
Confidence 34456788999999999999999999985 445999998654332 35788999999998 79999999999866
Q ss_pred ----CCceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEe
Q 005247 502 ----PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVC 577 (706)
Q Consensus 502 ----~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~ 577 (706)
.+..++||||+.+++|.+++.... ...+++..++.++.||+.||.|||++| |+||||||+||+++.++.+||+
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~kl~ 171 (326)
T 2x7f_A 95 PPGMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLV 171 (326)
T ss_dssp --CCCCEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTCCEEEC
T ss_pred CccccceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCcHHHEEEcCCCCEEEe
Confidence 467899999999999999996432 245889999999999999999999999 9999999999999999999999
Q ss_pred ecCccccCCCCcccCCCCCCCCCccCccccc-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCc
Q 005247 578 DFGLSRSKPNTYISSKTAAGTPEWMAPEVLR-----EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR 652 (706)
Q Consensus 578 DFGla~~~~~~~~~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~ 652 (706)
|||++..............||+.|+|||++. +..++.++||||||+++|+|++|..||...........+.....
T Consensus 172 Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 251 (326)
T 2x7f_A 172 DFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPA 251 (326)
T ss_dssp CCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC
T ss_pred eCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc
Confidence 9999987654433345567999999999997 56688999999999999999999999998887766655544444
Q ss_pred ccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 653 RLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 653 ~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
....+..+++.+.+||.+||..||.+||++.++++
T Consensus 252 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 252 PRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp CCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ccCCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 44445678999999999999999999999999987
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=341.52 Aligned_cols=250 Identities=29% Similarity=0.386 Sum_probs=209.4
Q ss_pred cCceEEEEEeccCCceEEEEEEEc--CCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEE
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 509 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~ 509 (706)
.++|++.+.||+|+||.||+|.+. +..||+|++..... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC-TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc-hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 357999999999999999999986 44599999875543 234568889999999999999999999999999999999
Q ss_pred EeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCc
Q 005247 510 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 589 (706)
Q Consensus 510 E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 589 (706)
||+++++|.+++... ..+++..++.++.|++.||.|||++| |+||||||+||+++.++.+||+|||++.......
T Consensus 85 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 85 EYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp ECCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred EecCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 999999999998643 35889999999999999999999999 9999999999999999999999999987643221
Q ss_pred --ccCCCCCCCCCccCccccccCCC-CchhHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHhhhcCcccCCCCCCcHHHH
Q 005247 590 --ISSKTAAGTPEWMAPEVLREDPS-NEKSDVFSFGVILWELITLQKPWRNSTPSQ-VISAVGFKGRRLEIPKNVNPMVA 665 (706)
Q Consensus 590 --~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDVwSLGviL~ELltG~~Pf~~~~~~~-~~~~i~~~~~~l~~p~~~s~el~ 665 (706)
.......||+.|+|||++.+..+ +.++||||||+++|+|++|..||....... .................+++.+.
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHH
T ss_pred chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHH
Confidence 12345678999999999988765 778999999999999999999998765432 22222222222333457899999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHH
Q 005247 666 ALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 666 dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
+||.+||+.||++|||+.++++
T Consensus 240 ~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 240 ALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHHCCCCchhCCCHHHHhc
Confidence 9999999999999999999876
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=381.06 Aligned_cols=255 Identities=25% Similarity=0.382 Sum_probs=217.5
Q ss_pred ccccCceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccch-HHHHHHHHHHHHHHcCCCCceeEEeccccCCCce
Q 005247 429 EIRWSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNL 505 (706)
Q Consensus 429 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~-~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 505 (706)
.+..++|++.+.||+|+||.||+|++.. ..||+|++.+..... ...+.+.+|+.+++.++||||+++++++.+.+.+
T Consensus 181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 260 (543)
T 3c4z_A 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDL 260 (543)
T ss_dssp CCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred cCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEE
Confidence 3556789999999999999999999864 449999987654322 2346788999999999999999999999999999
Q ss_pred EEEEEeccCCchhhhcccCC-CcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCcccc
Q 005247 506 SIVTEYLSRGSLYKLLHIPD-ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 584 (706)
Q Consensus 506 ~lV~E~~~ggsL~~~l~~~~-~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~ 584 (706)
++||||++||+|.+++.... ....+++..++.++.||+.||.|||++| |+||||||+|||++.+|.+||+|||+++.
T Consensus 261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--IvHrDLKP~NILl~~~g~vkL~DFGla~~ 338 (543)
T 3c4z_A 261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLDDDGNVRISDLGLAVE 338 (543)
T ss_dssp EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC--CcccCCChHHEEEeCCCCEEEeecceeee
Confidence 99999999999999986432 2346899999999999999999999999 99999999999999999999999999987
Q ss_pred CCCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHhhhcCcccCCCCCC
Q 005247 585 KPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNST----PSQVISAVGFKGRRLEIPKNV 660 (706)
Q Consensus 585 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~----~~~~~~~i~~~~~~l~~p~~~ 660 (706)
...........+||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+....+. .....+|..+
T Consensus 339 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~--~~~~~~p~~~ 416 (543)
T 3c4z_A 339 LKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVL--EQAVTYPDKF 416 (543)
T ss_dssp CCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHH--HCCCCCCTTS
T ss_pred ccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHh--hcccCCCccc
Confidence 6554434455689999999999999999999999999999999999999998753 334444432 3345678899
Q ss_pred cHHHHHHHHHhhhhCCCCCCCH-----HHHHH
Q 005247 661 NPMVAALIETCWAEEPEIRPSF-----PSIME 687 (706)
Q Consensus 661 s~el~dLI~~cL~~dP~~RPS~-----~eIl~ 687 (706)
++++.+||.+||+.||++||++ .+|++
T Consensus 417 s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 417 SPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred CHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 9999999999999999999965 66664
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=362.02 Aligned_cols=246 Identities=25% Similarity=0.374 Sum_probs=206.0
Q ss_pred eEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEEec
Q 005247 435 LLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYL 512 (706)
Q Consensus 435 y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~~ 512 (706)
+...+.||+|+||.||+|.+.. ..||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 168 (373)
T 2x4f_A 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG--MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYV 168 (373)
T ss_dssp EEEEEECC-----CEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred eecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc--cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCC
Confidence 4447889999999999998864 459999987653 234568899999999999999999999999999999999999
Q ss_pred cCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEE--CCCCcEEEeecCccccCCCCcc
Q 005247 513 SRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLV--DSTYTVKVCDFGLSRSKPNTYI 590 (706)
Q Consensus 513 ~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl--~~~~~vKL~DFGla~~~~~~~~ 590 (706)
++++|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+++......
T Consensus 169 ~~~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~- 243 (373)
T 2x4f_A 169 DGGELFDRIIDE--SYNLTELDTILFMKQICEGIRHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE- 243 (373)
T ss_dssp TTCEEHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC-
T ss_pred CCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc-
Confidence 999999988633 235889999999999999999999999 9999999999999 567899999999998765432
Q ss_pred cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccC--CCCCCcHHHHHHH
Q 005247 591 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLE--IPKNVNPMVAALI 668 (706)
Q Consensus 591 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~--~p~~~s~el~dLI 668 (706)
......||+.|+|||++.+..++.++|||||||++|||++|..||...+..+....+......+. ....+++++.+||
T Consensus 244 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 323 (373)
T 2x4f_A 244 KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFI 323 (373)
T ss_dssp BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHH
T ss_pred ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHH
Confidence 23455799999999999999999999999999999999999999999888777766643332222 2357899999999
Q ss_pred HHhhhhCCCCCCCHHHHHH
Q 005247 669 ETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 669 ~~cL~~dP~~RPS~~eIl~ 687 (706)
.+||+.||.+|||+.++++
T Consensus 324 ~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 324 SKLLIKEKSWRISASEALK 342 (373)
T ss_dssp HTTSCSSGGGSCCHHHHHH
T ss_pred HHHcCCChhhCCCHHHHhc
Confidence 9999999999999999987
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=374.31 Aligned_cols=247 Identities=26% Similarity=0.351 Sum_probs=200.7
Q ss_pred cCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCC------C
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP------P 503 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~------~ 503 (706)
.++|++++.||+|+||.||+|.+..+ .||||++..........+.+.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 57899999999999999999988754 499999987665667778899999999999999999999998654 3
Q ss_pred ceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccc
Q 005247 504 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 583 (706)
Q Consensus 504 ~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~ 583 (706)
..++||||+.++ |.+.+.. .+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++
T Consensus 141 ~~~lv~E~~~~~-l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDlkp~NIll~~~~~~kl~DFG~a~ 212 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR 212 (464)
T ss_dssp EEEEEEECCSEE-HHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred eEEEEEeCCCCC-HHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChHhEEEeCCCCEEEEEEEeee
Confidence 569999999764 5555542 3788999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCc-----------
Q 005247 584 SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR----------- 652 (706)
Q Consensus 584 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~----------- 652 (706)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+.....
T Consensus 213 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~ 291 (464)
T 3ttj_A 213 TAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 291 (464)
T ss_dssp ----CC-CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSC
T ss_pred ecCCCc-ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcc
Confidence 765432 23567899999999999999999999999999999999999999998876655544321100
Q ss_pred ---------c-----cC----CCCC-----------CcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 653 ---------R-----LE----IPKN-----------VNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 653 ---------~-----l~----~p~~-----------~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
. .. ++.. .++++.+||.+||..||++|||+.|+++
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0 00 0000 1567999999999999999999999987
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=356.69 Aligned_cols=251 Identities=24% Similarity=0.333 Sum_probs=208.7
Q ss_pred CcccccCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCC-----CCceeEEeccc
Q 005247 427 GLEIRWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLR-----HPNIVLLMGAV 499 (706)
Q Consensus 427 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~-----HpnIv~l~~~~ 499 (706)
...+..++|++++.||+|+||.||+|.+..+ .||+|++... ....+.+..|+.+++.+. ||||+++++++
T Consensus 29 ~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~ 105 (360)
T 3llt_A 29 KGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI---KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKF 105 (360)
T ss_dssp TTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEE
T ss_pred cceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc---hhhhhhhHHHHHHHHHhcccCCCCCCeeccccee
Confidence 3445568999999999999999999998544 4999998642 344457788999999986 99999999999
Q ss_pred cCCCceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECC---------
Q 005247 500 TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS--------- 570 (706)
Q Consensus 500 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~--------- 570 (706)
...+..++||||+ +++|.+++..... ..+++..++.++.||+.||+|||++| |+||||||+|||++.
T Consensus 106 ~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~~~~ 181 (360)
T 3llt_A 106 MYYDHMCLIFEPL-GPSLYEIITRNNY-NGFHIEDIKLYCIEILKALNYLRKMS--LTHTDLKPENILLDDPYFEKSLIT 181 (360)
T ss_dssp EETTEEEEEECCC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCTTCCEEEEE
T ss_pred eECCeeEEEEcCC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCcccEEEccccccccccc
Confidence 9999999999999 8899999975432 24889999999999999999999999 999999999999975
Q ss_pred ----------------CCcEEEeecCccccCCCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCC
Q 005247 571 ----------------TYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKP 634 (706)
Q Consensus 571 ----------------~~~vKL~DFGla~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~P 634 (706)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|+|++|+.|
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p 258 (360)
T 3llt_A 182 VRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY---HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLL 258 (360)
T ss_dssp EECTTTCCEEEEEEESCCCEEECCCTTCEETTSC---CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred hhcccccccccccccCCCCEEEEeccCceecCCC---CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCC
Confidence 789999999999865443 2456799999999999999999999999999999999999999
Q ss_pred CCCCChHHHHHHhhhcCcc------------------------cCCCC--------------------CCcHHHHHHHHH
Q 005247 635 WRNSTPSQVISAVGFKGRR------------------------LEIPK--------------------NVNPMVAALIET 670 (706)
Q Consensus 635 f~~~~~~~~~~~i~~~~~~------------------------l~~p~--------------------~~s~el~dLI~~ 670 (706)
|...+..+....+...... ...|. ..++.+.+||.+
T Consensus 259 f~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 338 (360)
T 3llt_A 259 FRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYS 338 (360)
T ss_dssp CCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHH
T ss_pred CCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHH
Confidence 9988776655444321111 01111 123778899999
Q ss_pred hhhhCCCCCCCHHHHHH
Q 005247 671 CWAEEPEIRPSFPSIME 687 (706)
Q Consensus 671 cL~~dP~~RPS~~eIl~ 687 (706)
||+.||++|||+.|+++
T Consensus 339 ~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 339 ILQIDPTLRPSPAELLK 355 (360)
T ss_dssp HCCSSGGGSCCHHHHTT
T ss_pred HhcCChhhCCCHHHHhc
Confidence 99999999999999875
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=374.31 Aligned_cols=249 Identities=28% Similarity=0.471 Sum_probs=211.9
Q ss_pred cCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccch-----------HHHHHHHHHHHHHHcCCCCceeEEecc
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHE-----------DRFKEFLREVAIMKGLRHPNIVLLMGA 498 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~-----------~~~~~~~~Ei~iL~~L~HpnIv~l~~~ 498 (706)
.++|++++.||+|+||+||+|.+..+ .||+|++....... ...+.+.+|+.++++++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 46799999999999999999998754 49999987654322 234678899999999999999999999
Q ss_pred ccCCCceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCC---cEE
Q 005247 499 VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY---TVK 575 (706)
Q Consensus 499 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~---~vK 575 (706)
+.+...+++||||+.+|+|.+++... ..+++..++.++.||+.||+|||++| |+||||||+|||++.++ .+|
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~k 189 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINR---HKFDECDAANIMKQILSGICYLHKHN--IVHRDIKPENILLENKNSLLNIK 189 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESSTTCCSSEE
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCcHHHEEEecCCCCccEE
Confidence 99999999999999999999988633 35899999999999999999999999 99999999999998776 699
Q ss_pred EeecCccccCCCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccC
Q 005247 576 VCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLE 655 (706)
Q Consensus 576 L~DFGla~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~ 655 (706)
|+|||++....... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||...+..+....+........
T Consensus 190 l~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 267 (504)
T 3q5i_A 190 IVDFGLSSFFSKDY-KLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFD 267 (504)
T ss_dssp ECCCTTCEECCTTS-CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred EEECCCCEEcCCCC-ccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 99999998765443 2345679999999999874 689999999999999999999999999998888877754443322
Q ss_pred --CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 656 --IPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 656 --~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
.+..+++++.+||.+||+.||.+|||+.|+++
T Consensus 268 ~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 268 FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 22678999999999999999999999999986
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=347.15 Aligned_cols=247 Identities=26% Similarity=0.394 Sum_probs=211.6
Q ss_pred cCceEEEEEeccCCceEEEEEEEc--CCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEE
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 509 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~ 509 (706)
.++|++.+.||+|+||.||+|++. +..||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA--FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM 85 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc--cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence 357999999999999999999986 44599999875432 22356889999999999999999999999999999999
Q ss_pred EeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEE---CCCCcEEEeecCccccCC
Q 005247 510 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLV---DSTYTVKVCDFGLSRSKP 586 (706)
Q Consensus 510 E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl---~~~~~vKL~DFGla~~~~ 586 (706)
||+++++|.+++... ..+++..++.++.|++.||.|||++| |+||||||+||++ +.++.+||+|||++....
T Consensus 86 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 86 QLVSGGELFDRILER---GVYTEKDASLVIQQVLSAVKYLHENG--IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp CCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred EcCCCccHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 999999999988633 35889999999999999999999999 9999999999999 778899999999987654
Q ss_pred CCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcc--cCCCCCCcHHH
Q 005247 587 NTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR--LEIPKNVNPMV 664 (706)
Q Consensus 587 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~--l~~p~~~s~el 664 (706)
... .....||+.|+|||++.+..++.++||||||+++|+|++|..||......+....+...... ...+..+++++
T Consensus 161 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 238 (304)
T 2jam_A 161 NGI--MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESA 238 (304)
T ss_dssp CBT--THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHH
T ss_pred CCc--cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHH
Confidence 432 23456899999999999999999999999999999999999999988887776666443332 23446789999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHH
Q 005247 665 AALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 665 ~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
.+||.+||+.||++|||+.++++
T Consensus 239 ~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 239 KDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp HHHHHHHHCSSTTTSCCHHHHHT
T ss_pred HHHHHHHcCCChhHCcCHHHHhc
Confidence 99999999999999999999986
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=354.97 Aligned_cols=269 Identities=21% Similarity=0.301 Sum_probs=214.0
Q ss_pred ccCcccccCceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEecccc--
Q 005247 425 EEGLEIRWSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT-- 500 (706)
Q Consensus 425 ~~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~-- 500 (706)
...+.+..++|++.+.||+|+||.||++.+.. ..||+|++... .....+.+.+|+.+++.++||||+++++++.
T Consensus 21 g~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 98 (317)
T 2buj_A 21 GHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRE 98 (317)
T ss_dssp EEEEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEE
T ss_pred ccEEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEec
Confidence 34456777899999999999999999999754 45999988653 3455678899999999999999999999986
Q ss_pred --CCCceEEEEEeccCCchhhhcccC-CCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEe
Q 005247 501 --EPPNLSIVTEYLSRGSLYKLLHIP-DARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVC 577 (706)
Q Consensus 501 --~~~~~~lV~E~~~ggsL~~~l~~~-~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~ 577 (706)
.....++||||+.+|+|.+++... .....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+
T Consensus 99 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~ 176 (317)
T 2buj_A 99 RGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG--YAHRDLKPTNILLGDEGQPVLM 176 (317)
T ss_dssp ETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEEC
T ss_pred cCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCCCCEEEE
Confidence 345789999999999999998631 12346899999999999999999999999 9999999999999999999999
Q ss_pred ecCccccCCCCccc---------CCCCCCCCCccCccccccCC---CCchhHHHHHHHHHHHHHhCCCCCCCCC--hHHH
Q 005247 578 DFGLSRSKPNTYIS---------SKTAAGTPEWMAPEVLREDP---SNEKSDVFSFGVILWELITLQKPWRNST--PSQV 643 (706)
Q Consensus 578 DFGla~~~~~~~~~---------~~~~~Gt~~Y~APE~l~~~~---~s~ksDVwSLGviL~ELltG~~Pf~~~~--~~~~ 643 (706)
|||++......... .....||+.|+|||++.+.. ++.++||||||+++|+|++|+.||.... ....
T Consensus 177 dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~ 256 (317)
T 2buj_A 177 DLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSV 256 (317)
T ss_dssp CCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCH
T ss_pred ecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchh
Confidence 99998764321110 12235799999999987654 6889999999999999999999995421 1111
Q ss_pred HHHhhhcCcccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhccC
Q 005247 644 ISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVC 698 (706)
Q Consensus 644 ~~~i~~~~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~~~ 698 (706)
...+ ......+.+..+++++.+||.+||+.||.+|||+.++++.|+++......
T Consensus 257 ~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~ 310 (317)
T 2buj_A 257 ALAV-QNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPG 310 (317)
T ss_dssp HHHH-HCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC
T ss_pred hHHh-hccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCC
Confidence 1222 22334455567899999999999999999999999999999987654433
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=355.96 Aligned_cols=252 Identities=26% Similarity=0.316 Sum_probs=203.9
Q ss_pred ccCceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccch---HHHHHHHHHHHHHHcCCCCceeEEeccccCCCce
Q 005247 431 RWSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHE---DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNL 505 (706)
Q Consensus 431 ~~~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~---~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 505 (706)
..++|++.+.||+|+||.||+|.+.. ..||+|++....... ...+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 45789999999999999999999864 459999986533221 1234678999999999999999999999999999
Q ss_pred EEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccC
Q 005247 506 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK 585 (706)
Q Consensus 506 ~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~ 585 (706)
++||||+.+ +|.+++.... ..+++..++.++.|++.||+|||++| |+||||||+|||++.++.+||+|||+++..
T Consensus 88 ~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSF 162 (346)
T ss_dssp EEEEECCSE-EHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred EEEEEcCCC-CHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCCHHHEEEcCCCCEEEEecccceec
Confidence 999999986 8888876432 35788899999999999999999999 999999999999999999999999999876
Q ss_pred CCCcccCCCCCCCCCccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCccc----------
Q 005247 586 PNTYISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRL---------- 654 (706)
Q Consensus 586 ~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l---------- 654 (706)
...........||+.|+|||++.+. .++.++|||||||++|||++|..||...+..+....+.......
T Consensus 163 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 242 (346)
T 1ua2_A 163 GSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS 242 (346)
T ss_dssp TSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred cCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhcc
Confidence 6554445567899999999999764 58899999999999999999999999888766665543211000
Q ss_pred ----------------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 655 ----------------EIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 655 ----------------~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
.+...++.++.+||.+||+.||++|||+.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 291 (346)
T 1ua2_A 243 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291 (346)
T ss_dssp STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence 011456789999999999999999999999976
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=359.74 Aligned_cols=246 Identities=26% Similarity=0.354 Sum_probs=203.4
Q ss_pred cCceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCC------
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP------ 503 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~------ 503 (706)
.++|++.+.||+|+||.||+|.+.. ..||+|++..........+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 3679999999999999999999864 45999998665555566778999999999999999999999987653
Q ss_pred ceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccc
Q 005247 504 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 583 (706)
Q Consensus 504 ~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~ 583 (706)
.+++||||+ +++|.++++.. .+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 176 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLAR 176 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence 469999999 78999998642 4889999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCcccCCCCCCCCCccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcC-----------
Q 005247 584 SKPNTYISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG----------- 651 (706)
Q Consensus 584 ~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~----------- 651 (706)
..... .....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+....+....
T Consensus 177 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~ 253 (367)
T 1cm8_A 177 QADSE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL 253 (367)
T ss_dssp ECCSS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred ccccc---cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 76543 345678999999999987 678999999999999999999999999877655544432110
Q ss_pred ------------------cccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 652 ------------------RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 652 ------------------~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
....+...+++++.+||.+||+.||++|||+.++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 254 QSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp SCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 001233567899999999999999999999999987
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=359.03 Aligned_cols=249 Identities=25% Similarity=0.350 Sum_probs=199.5
Q ss_pred CceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEE
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 510 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E 510 (706)
++|++++.||+|+||.||+|.+..+ .||+|++..... ......+.+|+.+++.++||||+++++++...+..++|||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 80 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc-cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence 5799999999999999999998744 499999854331 1222245679999999999999999999999999999999
Q ss_pred eccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcc
Q 005247 511 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 590 (706)
Q Consensus 511 ~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~ 590 (706)
|+. |+|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 155 (324)
T 3mtl_A 81 YLD-KDLKQYLDDCG--NIINMHNVKLFLFQLLRGLAYCHRQK--VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 155 (324)
T ss_dssp CCS-EEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred ccc-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence 997 48888876432 35889999999999999999999999 99999999999999999999999999987655444
Q ss_pred cCCCCCCCCCccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcc----------------
Q 005247 591 SSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR---------------- 653 (706)
Q Consensus 591 ~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~---------------- 653 (706)
......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||...+..+....+......
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (324)
T 3mtl_A 156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 235 (324)
T ss_dssp -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHH
T ss_pred ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhc
Confidence 4455678999999999987 56899999999999999999999999988876665544221100
Q ss_pred ------------cCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 654 ------------LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 654 ------------l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
......+++++.+||.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 236 TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp HTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 1112357889999999999999999999999987
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=353.45 Aligned_cols=256 Identities=25% Similarity=0.437 Sum_probs=214.7
Q ss_pred cccccCceEEE-EEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCC-CCceeEEeccccCCC
Q 005247 428 LEIRWSELLIK-KKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGAVTEPP 503 (706)
Q Consensus 428 ~~i~~~~y~i~-~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~ 503 (706)
.+...+.|.+. +.||+|+||.||+|.+.. ..||+|++............+.+|+.+++.+. ||||+++++++.+.+
T Consensus 23 ~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~ 102 (327)
T 3lm5_A 23 MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTS 102 (327)
T ss_dssp HHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred HHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCC
Confidence 34445677777 899999999999999874 45999998776555555578899999999995 699999999999999
Q ss_pred ceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECC---CCcEEEeecC
Q 005247 504 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS---TYTVKVCDFG 580 (706)
Q Consensus 504 ~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~---~~~vKL~DFG 580 (706)
..++||||+.+|+|.+++... ....+++..++.++.||+.||+|||++| |+||||||+|||++. ++.+||+|||
T Consensus 103 ~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~~g--ivH~Dikp~NIl~~~~~~~~~~kL~Dfg 179 (327)
T 3lm5_A 103 EIILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQNN--IVHLDLKPQNILLSSIYPLGDIKIVDFG 179 (327)
T ss_dssp EEEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESCBTTBCCEEECCGG
T ss_pred eEEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCChHHEEEecCCCCCcEEEeeCc
Confidence 999999999999999998543 2346899999999999999999999999 999999999999987 7899999999
Q ss_pred ccccCCCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCc--ccCCCC
Q 005247 581 LSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR--RLEIPK 658 (706)
Q Consensus 581 la~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~--~l~~p~ 658 (706)
+++...... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...+..+....+..... ......
T Consensus 180 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 258 (327)
T 3lm5_A 180 MSRKIGHAC-ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFS 258 (327)
T ss_dssp GCEEC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTT
T ss_pred cccccCCcc-ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhc
Confidence 998765432 22456799999999999999999999999999999999999999999888777665543332 233446
Q ss_pred CCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 659 NVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 659 ~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
.+++.+.+||.+||+.||++|||+.++++
T Consensus 259 ~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 259 SVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 78999999999999999999999999976
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=375.86 Aligned_cols=250 Identities=29% Similarity=0.447 Sum_probs=216.8
Q ss_pred ccCceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEE
Q 005247 431 RWSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFH-EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI 507 (706)
Q Consensus 431 ~~~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l 507 (706)
..++|++.+.||+|+||.||+|.+.. ..||||++...... ....+.+.+|+.++++++||||+++++++.+.+.+++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 34689999999999999999999864 45999998765432 3345688999999999999999999999999999999
Q ss_pred EEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEE---CCCCcEEEeecCcccc
Q 005247 508 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLV---DSTYTVKVCDFGLSRS 584 (706)
Q Consensus 508 V~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl---~~~~~vKL~DFGla~~ 584 (706)
||||+.+|+|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||+ +.++.+||+|||+++.
T Consensus 104 v~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISR---KRFSEVDAARIIRQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp EECCCCSCBHHHHHHTC---SCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred EEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 99999999999988643 35899999999999999999999999 9999999999999 5678999999999976
Q ss_pred CCCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCC--CCCcH
Q 005247 585 KPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP--KNVNP 662 (706)
Q Consensus 585 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p--~~~s~ 662 (706)
..... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||...+..+....+.........+ ..+++
T Consensus 179 ~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 256 (484)
T 3nyv_A 179 FEASK-KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSE 256 (484)
T ss_dssp BCCCC-SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCH
T ss_pred ccccc-ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCH
Confidence 54332 2234579999999999876 68999999999999999999999999999888887776554444333 57899
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 663 MVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 663 el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
++++||.+||+.||.+|||+.++++
T Consensus 257 ~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 257 SAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHCCCChhHCcCHHHHhh
Confidence 9999999999999999999999987
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=343.40 Aligned_cols=258 Identities=20% Similarity=0.262 Sum_probs=210.4
Q ss_pred cCceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEecc-ccCCCceEEE
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA-VTEPPNLSIV 508 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~-~~~~~~~~lV 508 (706)
.++|++.+.||+|+||.||+|.+.. ..||+|++...... +.+.+|+.+++.++|++++..+.. ....+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch----hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEE
Confidence 4689999999999999999999754 45999998665432 357889999999998776555544 4666778999
Q ss_pred EEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEE---CCCCcEEEeecCccccC
Q 005247 509 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLV---DSTYTVKVCDFGLSRSK 585 (706)
Q Consensus 509 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl---~~~~~vKL~DFGla~~~ 585 (706)
|||+ +++|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+|||+ +.++.+||+|||+++..
T Consensus 84 ~e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 84 MELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp EECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred EEec-CCCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 9999 899999996332 35899999999999999999999999 9999999999999 47889999999999865
Q ss_pred CCCcc-------cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHhhh---cCc
Q 005247 586 PNTYI-------SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTP---SQVISAVGF---KGR 652 (706)
Q Consensus 586 ~~~~~-------~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~---~~~~~~i~~---~~~ 652 (706)
..... ......||+.|+|||++.+..++.++||||||+++|||++|+.||..... .+....+.. ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence 44322 22456799999999999999999999999999999999999999986432 222222211 111
Q ss_pred ccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhccC
Q 005247 653 RLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVC 698 (706)
Q Consensus 653 ~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~~~ 698 (706)
...++..+++++.+||.+||+.||++|||+.+|++.|++++.....
T Consensus 239 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~ 284 (296)
T 3uzp_A 239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence 1223477899999999999999999999999999999999987644
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=344.42 Aligned_cols=258 Identities=20% Similarity=0.265 Sum_probs=206.5
Q ss_pred cCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEecc-ccCCCceEEE
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGA-VTEPPNLSIV 508 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~-~~~~~~~~lV 508 (706)
.++|++.+.||+|+||.||+|.+..+ .||+|++...... ..+.+|+.+++.++|++++..+.. +...+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 36799999999999999999997544 4999986554322 357789999999988776655554 4667778999
Q ss_pred EEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEE---CCCCcEEEeecCccccC
Q 005247 509 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLV---DSTYTVKVCDFGLSRSK 585 (706)
Q Consensus 509 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl---~~~~~vKL~DFGla~~~ 585 (706)
|||+ +++|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+|||+ +.++.+||+|||+++..
T Consensus 84 ~e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp EECC-CCBHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred EEcc-CCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 9999 899999986432 24899999999999999999999999 9999999999999 78899999999999865
Q ss_pred CCCcc-------cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHhhh---cCc
Q 005247 586 PNTYI-------SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPS---QVISAVGF---KGR 652 (706)
Q Consensus 586 ~~~~~-------~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~---~~~~~i~~---~~~ 652 (706)
..... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...... .....+.. ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence 44321 223567999999999999999999999999999999999999999764332 22222211 111
Q ss_pred ccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhccC
Q 005247 653 RLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVC 698 (706)
Q Consensus 653 ~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~~~ 698 (706)
.......+++++.+||.+||+.||++|||+.++++.|++++.....
T Consensus 239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~ 284 (296)
T 4hgt_A 239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCC
Confidence 1223367899999999999999999999999999999999987543
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=360.01 Aligned_cols=243 Identities=24% Similarity=0.399 Sum_probs=208.5
Q ss_pred cCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccch------HHHHHHHHHHHHHHcCCCCceeEEeccccCCC
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHE------DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP 503 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 503 (706)
.++|++.+.||+|+||.||+|.+..+ .||+|++....... ...+.+.+|+.+++.++||||+++++++.+.+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 46899999999999999999987654 49999987654322 13346778999999999999999999999999
Q ss_pred ceEEEEEeccCC-chhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCcc
Q 005247 504 NLSIVTEYLSRG-SLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS 582 (706)
Q Consensus 504 ~~~lV~E~~~gg-sL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla 582 (706)
.+++||||+.+| +|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~Dfg~a 177 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRH---PRLDEPLASYIFRQLVSAVGYLRLKD--IIHRDIKDENIVIAEDFTIKLIDFGSA 177 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTC---CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEEEeCCCCccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eEEeccCHHHEEEcCCCcEEEeecccc
Confidence 999999999777 999998743 25899999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCcccCCCCCCCCCccCccccccCCC-CchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCc
Q 005247 583 RSKPNTYISSKTAAGTPEWMAPEVLREDPS-NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVN 661 (706)
Q Consensus 583 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s 661 (706)
+...... ......||+.|+|||++.+..+ +.++||||||+++|+|++|..||..... ........+..++
T Consensus 178 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~~~~~~~~~~~~~ 248 (335)
T 3dls_A 178 AYLERGK-LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE--------TVEAAIHPPYLVS 248 (335)
T ss_dssp EECCTTC-CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG--------GTTTCCCCSSCCC
T ss_pred eECCCCC-ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH--------HHhhccCCCcccC
Confidence 8765432 2345679999999999998876 7899999999999999999999976322 1233455667789
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 005247 662 PMVAALIETCWAEEPEIRPSFPSIMET 688 (706)
Q Consensus 662 ~el~dLI~~cL~~dP~~RPS~~eIl~~ 688 (706)
+++.+||.+||+.||++|||+.++++.
T Consensus 249 ~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 249 KELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 999999999999999999999999873
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=357.08 Aligned_cols=252 Identities=24% Similarity=0.388 Sum_probs=211.4
Q ss_pred cccccCceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCce
Q 005247 428 LEIRWSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNL 505 (706)
Q Consensus 428 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 505 (706)
.++..++|++.+.||+|+||.||+|.+.. ..||+|++.... .....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 28 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 106 (360)
T 3eqc_A 28 GELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI 106 (360)
T ss_dssp CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEE
T ss_pred cccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEE
Confidence 45667899999999999999999999874 449999986653 455567899999999999999999999999999999
Q ss_pred EEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhc-CCCcccccCCCCcEEECCCCcEEEeecCcccc
Q 005247 506 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR-RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 584 (706)
Q Consensus 506 ~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~-g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~ 584 (706)
++||||+++++|.++++.. ..+++..+..++.|++.||.|||++ | |+||||||+|||++.++.+||+|||++..
T Consensus 107 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 181 (360)
T 3eqc_A 107 SICMEHMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQ 181 (360)
T ss_dssp EEEECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEECTTCCEEECCCCCCHH
T ss_pred EEEEECCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHhCC--EEcCCccHHHEEECCCCCEEEEECCCCcc
Confidence 9999999999999999643 2588999999999999999999996 8 99999999999999999999999999865
Q ss_pred CCCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh----------------
Q 005247 585 KPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVG---------------- 648 (706)
Q Consensus 585 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~---------------- 648 (706)
.... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...+..+....+.
T Consensus 182 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (360)
T 3eqc_A 182 LIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 259 (360)
T ss_dssp HHHH--C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------
T ss_pred cccc--cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCccc
Confidence 4222 2235679999999999999999999999999999999999999998776654432211
Q ss_pred -------------------------hcCcccC-CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 649 -------------------------FKGRRLE-IPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 649 -------------------------~~~~~l~-~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
....... .+..++.++.+||.+||+.||++|||+.++++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 260 PGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp --------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 0111112 22357899999999999999999999999987
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=362.69 Aligned_cols=263 Identities=29% Similarity=0.427 Sum_probs=210.4
Q ss_pred cCcccccCceEEEEEeccCCceEEEEEEEc-CCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCc
Q 005247 426 EGLEIRWSELLIKKKIGEGSFGTVYHAEWR-NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN 504 (706)
Q Consensus 426 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~-~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 504 (706)
..+.+..++|++.+.||+|+||.||+|.+. ++.||+|++...... .....+.+|+.+++.++||||+++++++...+.
T Consensus 23 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 101 (326)
T 3uim_A 23 RELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE 101 (326)
T ss_dssp HHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSC
T ss_pred HHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCc-hHHHHHHHHHHHHHhccCCCccceEEEEecCCc
Confidence 345667788999999999999999999865 456999998654322 112368899999999999999999999999999
Q ss_pred eEEEEEeccCCchhhhcccCC-CcccccHHHHHHHHHHHHHHHHHHHhc---CCCcccccCCCCcEEECCCCcEEEeecC
Q 005247 505 LSIVTEYLSRGSLYKLLHIPD-ARVVVDERLRLNMAYDVAKGMNYLHQR---RPPIVHRDLKSPNLLVDSTYTVKVCDFG 580 (706)
Q Consensus 505 ~~lV~E~~~ggsL~~~l~~~~-~~~~l~~~~~~~ia~qIl~aL~yLHs~---g~~IIHrDLKp~NILl~~~~~vKL~DFG 580 (706)
.++||||+.+|+|.++++... ....+++..++.++.|++.||+|||++ | |+||||||+|||++.++.+||+|||
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--ivH~Dlkp~Nil~~~~~~~kl~Dfg 179 (326)
T 3uim_A 102 RLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK--IIHRDVKAANILLDEEFEAVVGDFG 179 (326)
T ss_dssp CEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC--EECCCCSGGGEEECTTCCEEECCCS
T ss_pred eEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeCCCchhhEEECCCCCEEeccCc
Confidence 999999999999999996533 334589999999999999999999999 8 9999999999999999999999999
Q ss_pred ccccCCCCcc-cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC-----ChHHHHHHhhh--cCc
Q 005247 581 LSRSKPNTYI-SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNS-----TPSQVISAVGF--KGR 652 (706)
Q Consensus 581 la~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~-----~~~~~~~~i~~--~~~ 652 (706)
+++....... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||... ........+.. ...
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 259 (326)
T 3uim_A 180 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 259 (326)
T ss_dssp SCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSC
T ss_pred cccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhch
Confidence 9986543322 233456999999999999999999999999999999999999999521 11111111110 000
Q ss_pred ----------ccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHH
Q 005247 653 ----------RLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 691 (706)
Q Consensus 653 ----------~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ 691 (706)
....+...++.+.+||.+||+.||.+|||+.+|++.|+.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 260 KLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp CSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred hhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 011222344789999999999999999999999999975
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=358.51 Aligned_cols=243 Identities=27% Similarity=0.409 Sum_probs=184.6
Q ss_pred CceEEE---EEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCC-CCceeEEeccccCCCceE
Q 005247 433 SELLIK---KKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGAVTEPPNLS 506 (706)
Q Consensus 433 ~~y~i~---~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~ 506 (706)
.+|++. +.||+|+||.||+|.+..+ .||+|++... ....+.+|+.+++.+. ||||+++++++.+....+
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~ 82 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTF 82 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEE
Confidence 345554 7899999999999998744 4999998643 2346778999999997 999999999999999999
Q ss_pred EEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCC---cEEEeecCccc
Q 005247 507 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY---TVKVCDFGLSR 583 (706)
Q Consensus 507 lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~---~vKL~DFGla~ 583 (706)
+||||+.+|+|.+++... ..+++..++.++.||+.||+|||++| |+||||||+|||++.++ .+||+|||+++
T Consensus 83 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~ 157 (325)
T 3kn6_A 83 LVMELLNGGELFERIKKK---KHFSETEASYIMRKLVSAVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFAR 157 (325)
T ss_dssp EEECCCCSCBHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEC----CEEEECCCTTCE
T ss_pred EEEEccCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCHHHEEEecCCCcccEEEeccccce
Confidence 999999999999999743 35899999999999999999999999 99999999999997665 89999999998
Q ss_pred cCCCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-------HHHHHHhhhcCcccCC
Q 005247 584 SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTP-------SQVISAVGFKGRRLEI 656 (706)
Q Consensus 584 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~-------~~~~~~i~~~~~~l~~ 656 (706)
.............||+.|+|||++.+..++.++||||||+++|+|++|+.||..... .+....+.. ....+
T Consensus 158 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~--~~~~~ 235 (325)
T 3kn6_A 158 LKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKK--GDFSF 235 (325)
T ss_dssp ECCC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTT--TCCCC
T ss_pred ecCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHc--CCCCC
Confidence 765554444567889999999999999999999999999999999999999976443 334444422 22222
Q ss_pred C----CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 657 P----KNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 657 p----~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
+ ..+++++.+||.+||+.||.+|||+.++++
T Consensus 236 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 236 EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred CcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 2 368999999999999999999999999864
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=363.45 Aligned_cols=246 Identities=25% Similarity=0.369 Sum_probs=195.5
Q ss_pred cCceEEE-EEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHH-cCCCCceeEEeccccC----CC
Q 005247 432 WSELLIK-KKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMK-GLRHPNIVLLMGAVTE----PP 503 (706)
Q Consensus 432 ~~~y~i~-~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~-~L~HpnIv~l~~~~~~----~~ 503 (706)
.++|.+. +.||+|+||+||+|.+..+ .||||++... ..+.+|+.++. ..+||||+++++++.. ..
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~ 132 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 132 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCc
Confidence 3567776 7899999999999998754 4999998643 35667888874 4589999999998764 56
Q ss_pred ceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECC---CCcEEEeecC
Q 005247 504 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS---TYTVKVCDFG 580 (706)
Q Consensus 504 ~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~---~~~vKL~DFG 580 (706)
.+++||||+.+|+|.+++.... ...+++..++.++.||+.||.|||++| |+||||||+|||++. ++.+||+|||
T Consensus 133 ~~~lv~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 133 CLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp EEEEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEEEEeCCCCcHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCcceEEEecCCCCccEEEEecc
Confidence 7899999999999999997432 235899999999999999999999999 999999999999987 7899999999
Q ss_pred ccccCCCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH----HHHHhhhcCcccC-
Q 005247 581 LSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQ----VISAVGFKGRRLE- 655 (706)
Q Consensus 581 la~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~----~~~~i~~~~~~l~- 655 (706)
+++...... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+........
T Consensus 210 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~ 288 (400)
T 1nxk_A 210 FAKETTSHN-SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 288 (400)
T ss_dssp TCEECC------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCT
T ss_pred cccccCCCC-ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCC
Confidence 998654332 2346789999999999999999999999999999999999999997654322 2233322222222
Q ss_pred -CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 005247 656 -IPKNVNPMVAALIETCWAEEPEIRPSFPSIMET 688 (706)
Q Consensus 656 -~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~ 688 (706)
....+++++.+||.+||+.||++|||+.++++.
T Consensus 289 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 289 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 225789999999999999999999999999873
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=351.51 Aligned_cols=262 Identities=31% Similarity=0.507 Sum_probs=216.5
Q ss_pred cccccCceEEEEEeccCCceEEEEEEEc------CCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccC
Q 005247 428 LEIRWSELLIKKKIGEGSFGTVYHAEWR------NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE 501 (706)
Q Consensus 428 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~------~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~ 501 (706)
..+...+|++++.||+|+||.||+|... +..||+|++... .....+.+.+|+.+++.++||||+++++++..
T Consensus 36 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 113 (326)
T 2w1i_A 36 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYS 113 (326)
T ss_dssp -CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC
T ss_pred cccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Confidence 4456778999999999999999999852 334999998653 34556789999999999999999999998866
Q ss_pred CC--ceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeec
Q 005247 502 PP--NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDF 579 (706)
Q Consensus 502 ~~--~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DF 579 (706)
.+ ..++||||+++++|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+||+++.++.+||+||
T Consensus 114 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~~~~~~kL~Df 189 (326)
T 2w1i_A 114 AGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDF 189 (326)
T ss_dssp ----CCEEEECCCTTCBHHHHHHHST--TSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCC
T ss_pred cCCCceEEEEECCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEEcCCCcEEEecC
Confidence 54 7899999999999999997443 34889999999999999999999999 999999999999999999999999
Q ss_pred CccccCCCCcc---cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH------------H--
Q 005247 580 GLSRSKPNTYI---SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPS------------Q-- 642 (706)
Q Consensus 580 Gla~~~~~~~~---~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~------------~-- 642 (706)
|+++....... ......++..|+|||++.+..++.++||||||+++|||++|..||...... .
T Consensus 190 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (326)
T 2w1i_A 190 GLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 269 (326)
T ss_dssp TTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHH
T ss_pred cchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhH
Confidence 99987654321 123445778899999999988999999999999999999999998643110 0
Q ss_pred -HHHHhhhcCcccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHh
Q 005247 643 -VISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS 695 (706)
Q Consensus 643 -~~~~i~~~~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s 695 (706)
..........+.+.+..+++++.+||.+||+.||++|||+.++++.|+++..+
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 270 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 01111123445667888999999999999999999999999999999998765
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=344.98 Aligned_cols=251 Identities=25% Similarity=0.404 Sum_probs=208.4
Q ss_pred cCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccc--hHHHHHHHHHHHHHHcCCCCceeEEeccc--cCCCce
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFH--EDRFKEFLREVAIMKGLRHPNIVLLMGAV--TEPPNL 505 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~--~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~--~~~~~~ 505 (706)
.++|++.+.||+|+||.||+|.+..+ .+|+|++...... ....+.+.+|+.+++.++||||+++++++ .+....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 36799999999999999999998654 4999998654322 23456889999999999999999999998 455678
Q ss_pred EEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccC
Q 005247 506 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK 585 (706)
Q Consensus 506 ~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~ 585 (706)
++||||+.++ |.+++.... ...+++..++.++.||+.||.|||++| |+||||||+||+++.++.+||+|||++...
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVP-EKRFPVCQAHGYFCQLIDGLEYLHSQG--IVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp EEEEECCSEE-HHHHHHHST-TCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEehhccCC-HHHHHHhCc-ccccCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEcCCCcEEeecccccccc
Confidence 9999999876 666664322 235889999999999999999999999 999999999999999999999999999865
Q ss_pred CCC--cccCCCCCCCCCccCccccccCCC--CchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCc
Q 005247 586 PNT--YISSKTAAGTPEWMAPEVLREDPS--NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVN 661 (706)
Q Consensus 586 ~~~--~~~~~~~~Gt~~Y~APE~l~~~~~--s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s 661 (706)
... ........||+.|+|||++.+... +.++||||||+++|+|++|+.||...+..+....+.. ....++..++
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~--~~~~~~~~~~ 237 (305)
T 2wtk_C 160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGK--GSYAIPGDCG 237 (305)
T ss_dssp CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH--CCCCCCSSSC
T ss_pred CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhc--CCCCCCCccC
Confidence 432 112235578999999999987543 7899999999999999999999998887777666533 3456778899
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 005247 662 PMVAALIETCWAEEPEIRPSFPSIMET 688 (706)
Q Consensus 662 ~el~dLI~~cL~~dP~~RPS~~eIl~~ 688 (706)
+.+.+||.+||+.||.+|||+.++++.
T Consensus 238 ~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 238 PPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 999999999999999999999999863
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=367.00 Aligned_cols=249 Identities=28% Similarity=0.368 Sum_probs=189.8
Q ss_pred CceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccC-----CCce
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE-----PPNL 505 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~-----~~~~ 505 (706)
++|++++.||+|+||.||+|.+.. ..||||++..........+.+.+|+.+|+.++||||+++++++.. ...+
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 689999999999999999998764 459999987665566667889999999999999999999999843 3568
Q ss_pred EEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccC
Q 005247 506 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK 585 (706)
Q Consensus 506 ~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~ 585 (706)
++||||+ +++|.++++.. ..+++..++.++.||+.||+|||++| ||||||||+|||++.++.+||+|||+++..
T Consensus 133 ~lv~e~~-~~~L~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~--iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 206 (458)
T 3rp9_A 133 YVVLEIA-DSDFKKLFRTP---VYLTELHIKTLLYNLLVGVKYVHSAG--ILHRDLKPANCLVNQDCSVKVCDFGLARTV 206 (458)
T ss_dssp EEEECCC-SEEHHHHHHSS---CCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred EEEEecc-ccchhhhcccC---CCCCHHHHHHHHHHHHHHHHHHHhCC--cCCCCCChhhEEECCCCCEeecccccchhc
Confidence 9999998 56898888643 35899999999999999999999999 999999999999999999999999999875
Q ss_pred CCCc---------------------------ccCCCCCCCCCccCcccc-ccCCCCchhHHHHHHHHHHHHHh-------
Q 005247 586 PNTY---------------------------ISSKTAAGTPEWMAPEVL-REDPSNEKSDVFSFGVILWELIT------- 630 (706)
Q Consensus 586 ~~~~---------------------------~~~~~~~Gt~~Y~APE~l-~~~~~s~ksDVwSLGviL~ELlt------- 630 (706)
.... ......+||+.|+|||++ .+..++.++|||||||++|||++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~ 286 (458)
T 3rp9_A 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVA 286 (458)
T ss_dssp TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCS
T ss_pred cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccc
Confidence 4221 112345789999999986 45679999999999999999999
Q ss_pred ----CCCCCCCCCh--------------------HHHHHHhh-hcC----------------------------cccCCC
Q 005247 631 ----LQKPWRNSTP--------------------SQVISAVG-FKG----------------------------RRLEIP 657 (706)
Q Consensus 631 ----G~~Pf~~~~~--------------------~~~~~~i~-~~~----------------------------~~l~~p 657 (706)
|+++|.+... .+....+. ..+ ......
T Consensus 287 ~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (458)
T 3rp9_A 287 YHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERF 366 (458)
T ss_dssp SGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGS
T ss_pred ccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHC
Confidence 6666655431 01111100 000 001123
Q ss_pred CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 658 KNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 658 ~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
+.+++++.+||.+||..||++|||+.|+++
T Consensus 367 ~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~ 396 (458)
T 3rp9_A 367 PASSADAIHLLKRMLVFNPNKRITINECLA 396 (458)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 456899999999999999999999999987
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=363.62 Aligned_cols=262 Identities=23% Similarity=0.358 Sum_probs=213.7
Q ss_pred cccCceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCC--ce
Q 005247 430 IRWSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP--NL 505 (706)
Q Consensus 430 i~~~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~--~~ 505 (706)
....+|++.+.||+|+||.||+|.+.. ..||+|++..... ....+.+.+|++++++++||||+++++++...+ ..
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 84 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCee
Confidence 345689999999999999999999874 4599999865432 223467789999999999999999999987655 68
Q ss_pred EEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEE----CCCCcEEEeecCc
Q 005247 506 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLV----DSTYTVKVCDFGL 581 (706)
Q Consensus 506 ~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl----~~~~~vKL~DFGl 581 (706)
++||||+.+|+|.++++.......+++..++.++.||+.||+|||++| |+||||||+|||+ +.++.+||+|||+
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~ 162 (396)
T 4eut_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (396)
T ss_dssp EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence 999999999999999976554445899999999999999999999999 9999999999999 7788899999999
Q ss_pred cccCCCCcccCCCCCCCCCccCcccccc--------CCCCchhHHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHhhh
Q 005247 582 SRSKPNTYISSKTAAGTPEWMAPEVLRE--------DPSNEKSDVFSFGVILWELITLQKPWRNST----PSQVISAVGF 649 (706)
Q Consensus 582 a~~~~~~~~~~~~~~Gt~~Y~APE~l~~--------~~~s~ksDVwSLGviL~ELltG~~Pf~~~~----~~~~~~~i~~ 649 (706)
++...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... ..+....+..
T Consensus 163 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 241 (396)
T 4eut_A 163 ARELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (396)
T ss_dssp CEECCCGG-GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred ceEccCCC-ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence 98765543 2345679999999999875 456789999999999999999999996422 2233333321
Q ss_pred cCcc-------------------c----CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHh
Q 005247 650 KGRR-------------------L----EIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS 695 (706)
Q Consensus 650 ~~~~-------------------l----~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s 695 (706)
.... . .++..++..+.++|.+||+.||++||++.++++.++.++..
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 1110 0 11233457899999999999999999999999999998865
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=345.45 Aligned_cols=250 Identities=27% Similarity=0.469 Sum_probs=209.6
Q ss_pred cccCceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEE
Q 005247 430 IRWSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI 507 (706)
Q Consensus 430 i~~~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l 507 (706)
....+|++.+.||+|+||.||+|.+.. ..||+|++..... .+.+.+|+.+++.++||||+++++++...+..++
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI 101 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence 345679999999999999999999874 4599999865432 3568899999999999999999999999999999
Q ss_pred EEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCC
Q 005247 508 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 587 (706)
Q Consensus 508 V~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 587 (706)
||||+.+++|.+++... ...+++..++.++.||+.||.|||++| ++||||||+||+++.++.+||+|||++.....
T Consensus 102 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (314)
T 3com_A 102 VMEYCGAGSVSDIIRLR--NKTLTEDEIATILQSTLKGLEYLHFMR--KIHRDIKAGNILLNTEGHAKLADFGVAGQLTD 177 (314)
T ss_dssp EEECCTTEEHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred EeecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence 99999999999998632 235889999999999999999999999 99999999999999999999999999987655
Q ss_pred CcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcC-cccCCCCCCcHHHHH
Q 005247 588 TYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG-RRLEIPKNVNPMVAA 666 (706)
Q Consensus 588 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~-~~l~~p~~~s~el~d 666 (706)
.........||+.|+|||++.+..++.++||||||+++|+|++|..||...........+.... .....+..++..+.+
T Consensus 178 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 257 (314)
T 3com_A 178 TMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTD 257 (314)
T ss_dssp TBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHH
T ss_pred hccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHH
Confidence 5444456679999999999999999999999999999999999999999877666554443222 233445668999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHH
Q 005247 667 LIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 667 LI~~cL~~dP~~RPS~~eIl~ 687 (706)
||.+||..||.+|||+.++++
T Consensus 258 li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 258 FVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp HHHHHTCSCTTTSCCHHHHTT
T ss_pred HHHHHccCChhhCcCHHHHHh
Confidence 999999999999999999986
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=352.50 Aligned_cols=256 Identities=30% Similarity=0.513 Sum_probs=211.1
Q ss_pred ccCceEEEEEeccCCceEEEEEEEcCCceEEEEEeccccchHHHHHHHHHHHHHHc--CCCCceeEEeccccCCC----c
Q 005247 431 RWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKG--LRHPNIVLLMGAVTEPP----N 504 (706)
Q Consensus 431 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~--L~HpnIv~l~~~~~~~~----~ 504 (706)
..++|++.+.||+|+||.||+|++.+..||+|++... ....+.+|+++++. ++||||+++++++.... .
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~ 114 (342)
T 1b6c_B 40 IARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 114 (342)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCC
T ss_pred ccccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccce
Confidence 3568999999999999999999998888999998543 23567788888887 78999999999988776 7
Q ss_pred eEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHH--------hcCCCcccccCCCCcEEECCCCcEEE
Q 005247 505 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLH--------QRRPPIVHRDLKSPNLLVDSTYTVKV 576 (706)
Q Consensus 505 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLH--------s~g~~IIHrDLKp~NILl~~~~~vKL 576 (706)
.++||||+.+|+|.++++.. .+++..++.++.|++.||.||| +++ |+||||||+|||++.++.+||
T Consensus 115 ~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~NIll~~~~~~kL 188 (342)
T 1b6c_B 115 LWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA--IAHRDLKSKNILVKKNGTCCI 188 (342)
T ss_dssp EEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE--EECSCCSGGGEEECTTSCEEE
T ss_pred eEEEEeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC--eeeCCCCHHHEEECCCCCEEE
Confidence 89999999999999999643 4889999999999999999999 788 999999999999999999999
Q ss_pred eecCccccCCCCcc----cCCCCCCCCCccCccccccCC------CCchhHHHHHHHHHHHHHhC----------CCCCC
Q 005247 577 CDFGLSRSKPNTYI----SSKTAAGTPEWMAPEVLREDP------SNEKSDVFSFGVILWELITL----------QKPWR 636 (706)
Q Consensus 577 ~DFGla~~~~~~~~----~~~~~~Gt~~Y~APE~l~~~~------~s~ksDVwSLGviL~ELltG----------~~Pf~ 636 (706)
+|||++........ ......||+.|+|||++.+.. ++.++||||||+++|||++| ..||.
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~ 268 (342)
T 1b6c_B 189 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 268 (342)
T ss_dssp CCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred EECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcc
Confidence 99999976443221 224557999999999998763 23689999999999999999 78987
Q ss_pred CCC-----hHHHHHHhhhcCcccCCCC-----CCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhcc
Q 005247 637 NST-----PSQVISAVGFKGRRLEIPK-----NVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSV 697 (706)
Q Consensus 637 ~~~-----~~~~~~~i~~~~~~l~~p~-----~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~~ 697 (706)
... .......+.....+..++. .++..+.+||.+||+.||++|||+.+|++.|+++..+..
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~~ 339 (342)
T 1b6c_B 269 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 339 (342)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTTC
T ss_pred ccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHhc
Confidence 643 2333333323333344443 345789999999999999999999999999999987743
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=347.93 Aligned_cols=251 Identities=28% Similarity=0.498 Sum_probs=207.1
Q ss_pred ccCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEE
Q 005247 431 RWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIV 508 (706)
Q Consensus 431 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV 508 (706)
..+.|++.+.||+|+||.||+|.+..+ .+|+|++.... ....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 94 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIM 94 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC--HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEE
Confidence 346899999999999999999998744 48999875442 23356888999999999999999999999999999999
Q ss_pred EEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCC
Q 005247 509 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 588 (706)
Q Consensus 509 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 588 (706)
|||+++++|.+++.... ..+++..++.++.||+.||.|||++| ++||||||+||+++.++.+||+|||++......
T Consensus 95 ~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 170 (302)
T 2j7t_A 95 IEFCPGGAVDAIMLELD--RGLTEPQIQVVCRQMLEALNFLHSKR--IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT 170 (302)
T ss_dssp EECCTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH
T ss_pred EEeCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEECCCCCEEEEECCCCcccccc
Confidence 99999999999886422 34889999999999999999999999 999999999999999999999999987543222
Q ss_pred cccCCCCCCCCCccCccccc-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCc-ccCCCCCCcH
Q 005247 589 YISSKTAAGTPEWMAPEVLR-----EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR-RLEIPKNVNP 662 (706)
Q Consensus 589 ~~~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~-~l~~p~~~s~ 662 (706)
........||+.|+|||++. +..++.++||||||+++|+|++|..||...+.......+..... ....+..++.
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (302)
T 2j7t_A 171 LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSV 250 (302)
T ss_dssp HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCH
T ss_pred ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCH
Confidence 22234567899999999983 66789999999999999999999999998887766655533322 2344567899
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 663 MVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 663 el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
++.+||.+||+.||++|||+.++++
T Consensus 251 ~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 251 EFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp HHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred HHHHHHHHHcccChhhCCCHHHHhc
Confidence 9999999999999999999999976
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=353.42 Aligned_cols=252 Identities=21% Similarity=0.371 Sum_probs=214.2
Q ss_pred ccccCceEEEEEeccCCceEEEEEEEcCCceEEEEEeccccch---------------HHHHHHHHHHHHHHcCCCCcee
Q 005247 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHE---------------DRFKEFLREVAIMKGLRHPNIV 493 (706)
Q Consensus 429 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKvl~~~~~~~---------------~~~~~~~~Ei~iL~~L~HpnIv 493 (706)
....++|++.+.||+|+||.||+|.+.+..||+|++....... ...+.+.+|+.++++++||||+
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 106 (348)
T 2pml_X 27 DKYINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCL 106 (348)
T ss_dssp CEEETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBC
T ss_pred ccccCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcc
Confidence 3456799999999999999999999977779999986543221 1126889999999999999999
Q ss_pred EEeccccCCCceEEEEEeccCCchhhh------cccCCCcccccHHHHHHHHHHHHHHHHHHHh-cCCCcccccCCCCcE
Q 005247 494 LLMGAVTEPPNLSIVTEYLSRGSLYKL------LHIPDARVVVDERLRLNMAYDVAKGMNYLHQ-RRPPIVHRDLKSPNL 566 (706)
Q Consensus 494 ~l~~~~~~~~~~~lV~E~~~ggsL~~~------l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs-~g~~IIHrDLKp~NI 566 (706)
++++++.+.+..++||||+++++|.++ +... ....+++..++.++.||+.||.|||+ +| |+||||||+||
T Consensus 107 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dl~p~Ni 183 (348)
T 2pml_X 107 TCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN-YTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNI 183 (348)
T ss_dssp CCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS-SCCCCCHHHHHHHHHHHHHHHHHHHHTSC--EECCCCCGGGE
T ss_pred eEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc-cccCCCHHHHHHHHHHHHHHHHHHhccCC--EeecCCChHhE
Confidence 999999999999999999999999998 5432 13568999999999999999999999 99 99999999999
Q ss_pred EECCCCcEEEeecCccccCCCCcccCCCCCCCCCccCccccccC-CCCc-hhHHHHHHHHHHHHHhCCCCCCCCCh-HHH
Q 005247 567 LVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRED-PSNE-KSDVFSFGVILWELITLQKPWRNSTP-SQV 643 (706)
Q Consensus 567 Ll~~~~~vKL~DFGla~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~-ksDVwSLGviL~ELltG~~Pf~~~~~-~~~ 643 (706)
+++.++.+||+|||++...... ......||+.|+|||++.+. .++. ++||||||+++|||++|..||..... .+.
T Consensus 184 l~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 261 (348)
T 2pml_X 184 LMDKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL 261 (348)
T ss_dssp EECTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHH
T ss_pred EEcCCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence 9999999999999999875443 23456799999999999887 5666 99999999999999999999988766 555
Q ss_pred HHHhhhcCcccCCC-------------------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 644 ISAVGFKGRRLEIP-------------------KNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 644 ~~~i~~~~~~l~~p-------------------~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
...+.. ....++ ..+++++.+||.+||+.||.+|||+.++++
T Consensus 262 ~~~i~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 262 FNNIRT--KNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HHHHTS--CCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHhc--cCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 555532 233344 678999999999999999999999999986
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=360.70 Aligned_cols=250 Identities=28% Similarity=0.402 Sum_probs=198.8
Q ss_pred cCceEEEEEeccCCceEEEEEEEcCCc--eEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCC-----Cc
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP-----PN 504 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~--vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~-----~~ 504 (706)
.++|++.+.||+|+||.||+|.+..++ ||||++..........+.+.+|+.+++.++|+||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 468999999999999999999987654 99999976655566678899999999999999999999998766 56
Q ss_pred eEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCcccc
Q 005247 505 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 584 (706)
Q Consensus 505 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~ 584 (706)
.++||||+. ++|.++++.. ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++.
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDlkp~NILl~~~~~~kL~DFGla~~ 178 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTP---IFLTEEHIKTILYNLLLGENFIHESG--IIHRDLKPANCLLNQDCSVKVCDFGLART 178 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSS---CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEecCC-cCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence 899999986 5999998743 35899999999999999999999999 99999999999999999999999999987
Q ss_pred CCCCcc----------------------cCCCCCCCCCccCcccc-ccCCCCchhHHHHHHHHHHHHHhCCCC-------
Q 005247 585 KPNTYI----------------------SSKTAAGTPEWMAPEVL-REDPSNEKSDVFSFGVILWELITLQKP------- 634 (706)
Q Consensus 585 ~~~~~~----------------------~~~~~~Gt~~Y~APE~l-~~~~~s~ksDVwSLGviL~ELltG~~P------- 634 (706)
...... .....+||+.|+|||++ .+..++.++|||||||++|||++|..|
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~ 258 (432)
T 3n9x_A 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN 258 (432)
T ss_dssp C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGG
T ss_pred ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccc
Confidence 543221 12567899999999986 456689999999999999999985443
Q ss_pred ----CCCCCh-----------------HHH------------------------HHHhhhcCcccC-----CCCCCcHHH
Q 005247 635 ----WRNSTP-----------------SQV------------------------ISAVGFKGRRLE-----IPKNVNPMV 664 (706)
Q Consensus 635 ----f~~~~~-----------------~~~------------------------~~~i~~~~~~l~-----~p~~~s~el 664 (706)
|.+.+. .+. ...+........ ..+.+++++
T Consensus 259 ~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 338 (432)
T 3n9x_A 259 RFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDG 338 (432)
T ss_dssp CCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHH
T ss_pred ccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHH
Confidence 333220 000 011100001111 114689999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHH
Q 005247 665 AALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 665 ~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
.+||.+||+.||++|||+.|+++
T Consensus 339 ~dLl~~mL~~dP~~R~ta~e~L~ 361 (432)
T 3n9x_A 339 INLLESMLKFNPNKRITIDQALD 361 (432)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHHhcCCcccCCCHHHHhc
Confidence 99999999999999999999987
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=379.31 Aligned_cols=253 Identities=25% Similarity=0.343 Sum_probs=216.2
Q ss_pred ccccCceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCceeEEeccccCCCce
Q 005247 429 EIRWSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFH-EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNL 505 (706)
Q Consensus 429 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~ 505 (706)
.+..++|++.+.||+|+||.||+|.+.. ..||+|++...... ......+.+|+.+++.++||||+++++++.+.+.+
T Consensus 180 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 259 (576)
T 2acx_A 180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDAL 259 (576)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEE
Confidence 3567789999999999999999999864 45999998764322 22345688999999999999999999999999999
Q ss_pred EEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccC
Q 005247 506 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK 585 (706)
Q Consensus 506 ~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~ 585 (706)
++||||++||+|.+++.... ...+++..++.++.||+.||+|||++| ||||||||+|||++.+|.+||+|||+++..
T Consensus 260 ~lVmEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~g--IvHrDLKPeNILld~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 260 CLVLTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRER--IVYRDLKPENILLDDHGHIRISDLGLAVHV 336 (576)
T ss_dssp EEEECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCchheEEEeCCCCeEEEecccceec
Confidence 99999999999999986443 234899999999999999999999999 999999999999999999999999999876
Q ss_pred CCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHhhhcCcccCCCCCCc
Q 005247 586 PNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNST----PSQVISAVGFKGRRLEIPKNVN 661 (706)
Q Consensus 586 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~----~~~~~~~i~~~~~~l~~p~~~s 661 (706)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+....+ ......++..++
T Consensus 337 ~~~~-~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i--~~~~~~~p~~~s 413 (576)
T 2acx_A 337 PEGQ-TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV--KEVPEEYSERFS 413 (576)
T ss_dssp CTTC-CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHH--HHCCCCCCTTSC
T ss_pred ccCc-cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHh--hcccccCCccCC
Confidence 5432 2235689999999999999999999999999999999999999998753 23333333 234556778899
Q ss_pred HHHHHHHHHhhhhCCCCCC-----CHHHHHH
Q 005247 662 PMVAALIETCWAEEPEIRP-----SFPSIME 687 (706)
Q Consensus 662 ~el~dLI~~cL~~dP~~RP-----S~~eIl~ 687 (706)
+++.+||.+||+.||.+|| ++.+|++
T Consensus 414 ~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 414 PQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp HHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred HHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 9999999999999999999 7888876
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=341.12 Aligned_cols=251 Identities=23% Similarity=0.376 Sum_probs=213.8
Q ss_pred ccCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEecccc---c----hHHHHHHHHHHHHHHcCC-CCceeEEecccc
Q 005247 431 RWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEF---H----EDRFKEFLREVAIMKGLR-HPNIVLLMGAVT 500 (706)
Q Consensus 431 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~---~----~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~ 500 (706)
..++|++.+.||+|+||.||+|.+..+ .||+|++..... . ....+.+.+|+.+++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 457899999999999999999998654 499999865431 1 233467889999999995 999999999999
Q ss_pred CCCceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecC
Q 005247 501 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFG 580 (706)
Q Consensus 501 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFG 580 (706)
..+..++||||+++++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+||+++.++.+||+|||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg 169 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFG 169 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCT
T ss_pred cCCeEEEEEeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEcCCCcEEEeccc
Confidence 999999999999999999999643 35889999999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCcccCCCCCCCCCccCccccc------cCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCccc
Q 005247 581 LSRSKPNTYISSKTAAGTPEWMAPEVLR------EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRL 654 (706)
Q Consensus 581 la~~~~~~~~~~~~~~Gt~~Y~APE~l~------~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l 654 (706)
++....... ......|++.|+|||++. ...++.++||||||+++|+|++|..||...+.......+.......
T Consensus 170 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 248 (298)
T 1phk_A 170 FSCQLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQF 248 (298)
T ss_dssp TCEECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC
T ss_pred chhhcCCCc-ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCccc
Confidence 998755432 234567899999999985 4567889999999999999999999999888777666654443333
Q ss_pred CCC--CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 655 EIP--KNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 655 ~~p--~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
..+ ..++.++.+||.+||+.||++|||+.++++
T Consensus 249 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 249 GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 322 468899999999999999999999999975
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=355.15 Aligned_cols=257 Identities=18% Similarity=0.247 Sum_probs=210.1
Q ss_pred ccCceEEEEEeccCCceEEEEEEEcC----------CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEE-----
Q 005247 431 RWSELLIKKKIGEGSFGTVYHAEWRN----------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL----- 495 (706)
Q Consensus 431 ~~~~y~i~~~LG~G~fG~Vy~a~~~~----------~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l----- 495 (706)
..++|++.+.||+|+||.||+|.+.. ..||+|++... +.+.+|+.++++++||||+++
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~ 112 (352)
T 2jii_A 40 SGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLY 112 (352)
T ss_dssp TSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred cCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhc
Confidence 35789999999999999999998864 45999998654 367899999999999999884
Q ss_pred ----------eccccC-CCceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCC
Q 005247 496 ----------MGAVTE-PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSP 564 (706)
Q Consensus 496 ----------~~~~~~-~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~ 564 (706)
++++.. ....++||||+ +++|.+++.... ...+++..++.++.||+.||.|||++| |+||||||+
T Consensus 113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~ 188 (352)
T 2jii_A 113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLHENE--YVHGNVTAE 188 (352)
T ss_dssp TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCGG
T ss_pred cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHH
Confidence 444443 67789999999 999999997431 246899999999999999999999999 999999999
Q ss_pred cEEECCCC--cEEEeecCccccCCCCcc-------cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCC
Q 005247 565 NLLVDSTY--TVKVCDFGLSRSKPNTYI-------SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPW 635 (706)
Q Consensus 565 NILl~~~~--~vKL~DFGla~~~~~~~~-------~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf 635 (706)
|||++.++ .+||+|||+++....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||
T Consensus 189 NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 268 (352)
T 2jii_A 189 NIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPW 268 (352)
T ss_dssp GEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred HEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 99999988 899999999976543211 123457999999999999999999999999999999999999999
Q ss_pred CCCC--hHHHHHHhh-hcCcccCCC------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhccC
Q 005247 636 RNST--PSQVISAVG-FKGRRLEIP------KNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVC 698 (706)
Q Consensus 636 ~~~~--~~~~~~~i~-~~~~~l~~p------~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~~~ 698 (706)
.... ......... .......++ ..+++++.+||.+||+.||++|||+.+|++.|++++.....
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~ 340 (352)
T 2jii_A 269 TNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRV 340 (352)
T ss_dssp GGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred ccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCC
Confidence 8754 222222221 111112222 25689999999999999999999999999999999987643
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=355.23 Aligned_cols=247 Identities=26% Similarity=0.319 Sum_probs=198.0
Q ss_pred cCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCC------
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP------ 503 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~------ 503 (706)
.++|++++.||+|+||.||+|.+..+ .||+|++..........+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 47899999999999999999988644 4999999876656666788999999999999999999999987655
Q ss_pred ceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccc
Q 005247 504 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 583 (706)
Q Consensus 504 ~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~ 583 (706)
..++||||+.+ +|.+++.. .+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 175 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR 175 (371)
T ss_dssp EEEEEEECCSE-EHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred ceEEEEEcCCC-CHHHHHhh-----ccCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCCCCEEEEEeeccc
Confidence 68999999975 77777752 3788999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcc----------
Q 005247 584 SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR---------- 653 (706)
Q Consensus 584 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~---------- 653 (706)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+......
T Consensus 176 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 254 (371)
T 2xrw_A 176 TAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 254 (371)
T ss_dssp ---------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSC
T ss_pred cccccc-ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 755432 234567999999999999999999999999999999999999999988776655444211100
Q ss_pred ----------cC--------------CCC------CCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 654 ----------LE--------------IPK------NVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 654 ----------l~--------------~p~------~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
.. ++. ..++++.+||.+||+.||++|||+.|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 00 111 12578999999999999999999999987
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=352.47 Aligned_cols=252 Identities=24% Similarity=0.313 Sum_probs=205.1
Q ss_pred ccCceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccC-------
Q 005247 431 RWSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE------- 501 (706)
Q Consensus 431 ~~~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~------- 501 (706)
..++|++++.||+|+||.||+|.+.. ..||+|++............+.+|+.+++.++||||+++++++..
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence 35789999999999999999999864 459999886655444445678899999999999999999998866
Q ss_pred -CCceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecC
Q 005247 502 -PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFG 580 (706)
Q Consensus 502 -~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFG 580 (706)
.+..++||||+.+ +|.+.+.... ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||
T Consensus 95 ~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 95 CKGSIYLVFDFCEH-DLAGLLSNVL--VKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp --CEEEEEEECCSE-EHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCceEEEEEeccCC-CHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcCCCCEEEccch
Confidence 4468999999976 6666665332 34889999999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCC----cccCCCCCCCCCccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcc--
Q 005247 581 LSRSKPNT----YISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR-- 653 (706)
Q Consensus 581 la~~~~~~----~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~-- 653 (706)
+++..... ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||......+....+......
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 249 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 249 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 99765422 112245678999999999976 45799999999999999999999999998877666554321111
Q ss_pred cCCCCC----------------------------CcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 654 LEIPKN----------------------------VNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 654 l~~p~~----------------------------~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
....+. .++++.+||.+||+.||++|||+.|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 111111 2678999999999999999999999987
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=341.64 Aligned_cols=249 Identities=30% Similarity=0.476 Sum_probs=213.5
Q ss_pred cCceEEEEEeccCCceEEEEEEEc--CCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEE
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 509 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~ 509 (706)
.++|++.+.||+|+||.||+|.+. +..||+|++..........+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence 468999999999999999999986 445999999776555555678899999999999999999999999999999999
Q ss_pred EeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCC---CcEEEeecCccccCC
Q 005247 510 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST---YTVKVCDFGLSRSKP 586 (706)
Q Consensus 510 E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~---~~vKL~DFGla~~~~ 586 (706)
||+.+++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+||+++.+ +.+||+|||++....
T Consensus 101 e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~ 175 (287)
T 2wei_A 101 ELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (287)
T ss_dssp CCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred EccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence 999999999888633 25889999999999999999999999 9999999999999654 479999999987654
Q ss_pred CCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCC--CCCcHHH
Q 005247 587 NTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP--KNVNPMV 664 (706)
Q Consensus 587 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p--~~~s~el 664 (706)
... ......||+.|+|||++.+. ++.++||||||+++|+|++|..||...+..+....+.........+ ..+++++
T Consensus 176 ~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (287)
T 2wei_A 176 QNT-KMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDA 253 (287)
T ss_dssp CCS-SCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHH
T ss_pred CCC-ccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHH
Confidence 332 22344588999999998764 8899999999999999999999999988877776665444333333 5789999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHH
Q 005247 665 AALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 665 ~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
.+||.+||+.||++|||+.++++
T Consensus 254 ~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 254 KDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcccChhhCcCHHHHhc
Confidence 99999999999999999999987
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=360.99 Aligned_cols=249 Identities=27% Similarity=0.396 Sum_probs=196.2
Q ss_pred cCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccc------hHHHHHHHHHHHHHHcCCCCceeEEeccccCCC
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFH------EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP 503 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~------~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 503 (706)
.++|.+.+.||+|+||.||+|.+..+ .||+|++...... ......+.+|+.++++++||||+++++++.. +
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~ 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-S
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence 56899999999999999999998755 4999998765422 1223357899999999999999999999865 4
Q ss_pred ceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCC---cEEEeecC
Q 005247 504 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY---TVKVCDFG 580 (706)
Q Consensus 504 ~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~---~vKL~DFG 580 (706)
..++||||+.+|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~~~~kl~DFG 287 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVGN---KRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFG 287 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSSS---CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSSSCCEEECCSS
T ss_pred ceEEEEEcCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCCCcceEEEeecc
Confidence 579999999999999988643 35899999999999999999999999 99999999999997544 59999999
Q ss_pred ccccCCCCcccCCCCCCCCCccCcccccc---CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHhhhcCcc--c
Q 005247 581 LSRSKPNTYISSKTAAGTPEWMAPEVLRE---DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQ-VISAVGFKGRR--L 654 (706)
Q Consensus 581 la~~~~~~~~~~~~~~Gt~~Y~APE~l~~---~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~-~~~~i~~~~~~--l 654 (706)
+++...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....... ....+...... .
T Consensus 288 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~ 366 (419)
T 3i6u_A 288 HSKILGETS-LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP 366 (419)
T ss_dssp TTTSCC------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCH
T ss_pred cceecCCCc-cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCc
Confidence 998765432 2345689999999999864 567889999999999999999999997654332 22222211111 1
Q ss_pred CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 655 EIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 655 ~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
..+..+++++.+||.+||+.||++|||+.++++
T Consensus 367 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 367 EVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 223578999999999999999999999999986
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=352.31 Aligned_cols=245 Identities=25% Similarity=0.357 Sum_probs=205.1
Q ss_pred cCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCce----
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNL---- 505 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~---- 505 (706)
.++|.+.+.||+|+||.||+|.+..+ .||+|++..........+.+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 36899999999999999999988754 499999977666666678899999999999999999999999877654
Q ss_pred --EEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccc
Q 005247 506 --SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 583 (706)
Q Consensus 506 --~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~ 583 (706)
++||||+. ++|.+++.. .+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 192 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM-----EFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLAR 192 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred eEEEEEcccc-ccHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCcCHHHeEECCCCCEEEEecCccc
Confidence 99999997 588877742 3889999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCcccCCCCCCCCCccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcc---------
Q 005247 584 SKPNTYISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR--------- 653 (706)
Q Consensus 584 ~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~--------- 653 (706)
..... .....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||...+..+....+......
T Consensus 193 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 269 (371)
T 4exu_A 193 HADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKL 269 (371)
T ss_dssp ----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTC
T ss_pred ccccC---cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHh
Confidence 65443 245678999999999987 67899999999999999999999999988766655444211000
Q ss_pred --------------------cCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 654 --------------------LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 654 --------------------l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
...+..+++++.+||.+||+.||++|||+.|+++
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 270 NDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp SCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 1123467899999999999999999999999976
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=380.27 Aligned_cols=264 Identities=32% Similarity=0.562 Sum_probs=223.4
Q ss_pred cCcccccCceEEEEEeccCCceEEEEEEEcCC-----ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEecccc
Q 005247 426 EGLEIRWSELLIKKKIGEGSFGTVYHAEWRNS-----DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 500 (706)
Q Consensus 426 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~-----~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~ 500 (706)
..+++..++|++.+.||+|+||.||+|.+..+ .+|+|++... ......+.+.+|+.++++++||||+++++++.
T Consensus 383 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 461 (656)
T 2j0j_A 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT 461 (656)
T ss_dssp GGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST-TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 34566778999999999999999999988543 2777776433 24455678999999999999999999999985
Q ss_pred CCCceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecC
Q 005247 501 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFG 580 (706)
Q Consensus 501 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFG 580 (706)
+ +..++||||+++|+|.++++... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||
T Consensus 462 ~-~~~~lv~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDikp~NILl~~~~~vkL~DFG 536 (656)
T 2j0j_A 462 E-NPVWIIMELCTLGELRSFLQVRK--FSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFG 536 (656)
T ss_dssp S-SSCEEEEECCTTCBHHHHHHHTT--TTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCCC
T ss_pred c-CceEEEEEcCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchHhEEEeCCCCEEEEecC
Confidence 4 56899999999999999997432 34889999999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCcc-cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCCC
Q 005247 581 LSRSKPNTYI-SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPK 658 (706)
Q Consensus 581 la~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p~ 658 (706)
+++....... ......+|+.|+|||++.+..++.++||||||+++|||++ |..||......+....+. ...+..++.
T Consensus 537 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~-~~~~~~~~~ 615 (656)
T 2j0j_A 537 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPP 615 (656)
T ss_dssp CCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-HTCCCCCCT
T ss_pred CCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-cCCCCCCCc
Confidence 9987644321 2233457789999999999999999999999999999997 999999988877776664 455677888
Q ss_pred CCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhc
Q 005247 659 NVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 696 (706)
Q Consensus 659 ~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~ 696 (706)
.+++.+.+||.+||..||++|||+.+|++.|++++...
T Consensus 616 ~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~ 653 (656)
T 2j0j_A 616 NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 653 (656)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 99999999999999999999999999999999998653
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=347.78 Aligned_cols=246 Identities=26% Similarity=0.389 Sum_probs=198.6
Q ss_pred CceEEE-EEeccCCceEEEEEEEc--CCceEEEEEeccccchHHHHHHHHHHHHHHcC-CCCceeEEeccccCCCceEEE
Q 005247 433 SELLIK-KKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSIV 508 (706)
Q Consensus 433 ~~y~i~-~~LG~G~fG~Vy~a~~~--~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~lV 508 (706)
+.|++. +.||+|+||.||+|.+. +..||+|++..... ...+.+.+|+.+++++ +||||+++++++.+.+.+++|
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv 89 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG--HIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV 89 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS--CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 568885 78999999999999875 44599999876532 2345788999999985 799999999999999999999
Q ss_pred EEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCc---EEEeecCccccC
Q 005247 509 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYT---VKVCDFGLSRSK 585 (706)
Q Consensus 509 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~---vKL~DFGla~~~ 585 (706)
|||+++++|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++. +||+|||++...
T Consensus 90 ~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 90 FEKMRGGSILSHIHKR---RHFNELEASVVVQDVASALDFLHNKG--IAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp EECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred EEcCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 9999999999999643 35889999999999999999999999 999999999999988765 999999998764
Q ss_pred CCCc-------ccCCCCCCCCCccCcccccc-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-------------
Q 005247 586 PNTY-------ISSKTAAGTPEWMAPEVLRE-----DPSNEKSDVFSFGVILWELITLQKPWRNSTP------------- 640 (706)
Q Consensus 586 ~~~~-------~~~~~~~Gt~~Y~APE~l~~-----~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~------------- 640 (706)
.... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 244 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence 3211 11224569999999999975 4578899999999999999999999987542
Q ss_pred --HHHHHHhhhcCcccCCC----CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 641 --SQVISAVGFKGRRLEIP----KNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 641 --~~~~~~i~~~~~~l~~p----~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
......+.. ....++ ..+++++.+||.+||+.||++|||+.++++
T Consensus 245 ~~~~~~~~i~~--~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 245 CQNMLFESIQE--GKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHHHH--CCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHhc--cCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 223333322 223333 468999999999999999999999999987
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=340.42 Aligned_cols=250 Identities=27% Similarity=0.414 Sum_probs=209.1
Q ss_pred cCceEEEEEeccCCceEEEEEEEc--CCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccC--------
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE-------- 501 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~-------- 501 (706)
..+|++.+.||+|+||.||+|.+. +..||+|++.... +.+.+|+.+++.++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 467999999999999999999986 4559999986543 256789999999999999999998753
Q ss_pred --------CCceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCc
Q 005247 502 --------PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYT 573 (706)
Q Consensus 502 --------~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~ 573 (706)
...+++||||+++++|.+++.... ...+++..++.++.||+.||.|||++| |+||||||+||+++.++.
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIHSKK--LINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTE
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHEEEcCCCC
Confidence 345799999999999999996432 235889999999999999999999999 999999999999999999
Q ss_pred EEEeecCccccCCCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcc
Q 005247 574 VKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR 653 (706)
Q Consensus 574 vKL~DFGla~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~ 653 (706)
+||+|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||... ......+ ..
T Consensus 161 ~kl~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~----~~ 233 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDG-KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDL----RD 233 (284)
T ss_dssp EEECCCTTCEESSCCS-CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHH----HT
T ss_pred EEECcchhheeccccc-cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHh----hc
Confidence 9999999988765432 234567999999999999999999999999999999999999887432 1222222 12
Q ss_pred cCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhcc
Q 005247 654 LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSV 697 (706)
Q Consensus 654 l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~~ 697 (706)
..++..+++.+.+||.+||+.||++|||+.++++.|..+.++..
T Consensus 234 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~ 277 (284)
T 2a19_B 234 GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277 (284)
T ss_dssp TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence 23567789999999999999999999999999999998876543
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=352.47 Aligned_cols=250 Identities=24% Similarity=0.395 Sum_probs=212.6
Q ss_pred cCceEEEEEeccCCceEEEEEEEc--CCceEEEEEecccc--c----hHHHHHHHHHHHHHHcC-CCCceeEEeccccCC
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEF--H----EDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEP 502 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKvl~~~~~--~----~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~ 502 (706)
..+|++.+.||+|+||.||+|.+. +..||||++..... . ....+.+.+|+.+++++ +||||+++++++...
T Consensus 93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 172 (365)
T 2y7j_A 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS 172 (365)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS
T ss_pred hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC
Confidence 467999999999999999999986 45699999865432 1 22345788999999999 799999999999999
Q ss_pred CceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCcc
Q 005247 503 PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS 582 (706)
Q Consensus 503 ~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla 582 (706)
+..++||||+.+++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++
T Consensus 173 ~~~~lv~e~~~g~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~g--i~H~Dlkp~NIl~~~~~~ikl~DfG~~ 247 (365)
T 2y7j_A 173 SFMFLVFDLMRKGELFDYLTEK---VALSEKETRSIMRSLLEAVSFLHANN--IVHRDLKPENILLDDNMQIRLSDFGFS 247 (365)
T ss_dssp SEEEEEECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred CEEEEEEEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEEEecCcc
Confidence 9999999999999999998632 35889999999999999999999999 999999999999999999999999998
Q ss_pred ccCCCCcccCCCCCCCCCccCcccccc------CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCC
Q 005247 583 RSKPNTYISSKTAAGTPEWMAPEVLRE------DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEI 656 (706)
Q Consensus 583 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~------~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~ 656 (706)
....... ......||+.|+|||++.+ ..++.++||||||+++|+|++|..||...........+.........
T Consensus 248 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 326 (365)
T 2y7j_A 248 CHLEPGE-KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSS 326 (365)
T ss_dssp EECCTTC-CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCH
T ss_pred cccCCCc-ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC
Confidence 8765432 2345689999999999864 35788999999999999999999999988777666655433333222
Q ss_pred --CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 657 --PKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 657 --p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
+..++..+.+||.+||+.||++|||+.++++
T Consensus 327 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 327 PEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 2578899999999999999999999999976
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=356.15 Aligned_cols=246 Identities=23% Similarity=0.344 Sum_probs=190.1
Q ss_pred cCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCC------C
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP------P 503 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~------~ 503 (706)
.++|++++.||+|+||.||+|.+..+ .||+|++..........+.+.+|+.+++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 36899999999999999999988654 499999866555556677899999999999999999999988654 5
Q ss_pred ceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccc
Q 005247 504 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 583 (706)
Q Consensus 504 ~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~ 583 (706)
..++|+|++ +++|.++++. ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kL~DFG~a~ 180 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR 180 (367)
T ss_dssp CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECC-----
T ss_pred eEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHhhEEECCCCCEEEeeccccc
Confidence 689999999 6899998864 24889999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCcccCCCCCCCCCccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcc---------
Q 005247 584 SKPNTYISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR--------- 653 (706)
Q Consensus 584 ~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~--------- 653 (706)
..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+....+......
T Consensus 181 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~ 257 (367)
T 2fst_X 181 HTADE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 257 (367)
T ss_dssp -------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTC
T ss_pred ccccc---CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence 75433 245689999999999987 67899999999999999999999999988765554443211000
Q ss_pred ------------c--------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 654 ------------L--------EIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 654 ------------l--------~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
. .....+++++.+||.+||+.||.+|||+.++++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 258 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 0 012356889999999999999999999999976
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=342.43 Aligned_cols=256 Identities=22% Similarity=0.350 Sum_probs=211.0
Q ss_pred cCcccccCceEEEEEeccCCceEEEEEEEcC-CceEEEEEeccccchHHHHHHHHHHHHHHcCC--CCceeEEeccccCC
Q 005247 426 EGLEIRWSELLIKKKIGEGSFGTVYHAEWRN-SDVAVKILIEQEFHEDRFKEFLREVAIMKGLR--HPNIVLLMGAVTEP 502 (706)
Q Consensus 426 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~--HpnIv~l~~~~~~~ 502 (706)
+.+++...+|++.+.||+|+||.||++.+.. ..||+|++..........+.+.+|+.++++++ |+||+++++++...
T Consensus 21 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~ 100 (313)
T 3cek_A 21 QSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD 100 (313)
T ss_dssp CEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS
T ss_pred eeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecC
Confidence 3466777889999999999999999998764 34999999877666777788999999999997 59999999999999
Q ss_pred CceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCcc
Q 005247 503 PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS 582 (706)
Q Consensus 503 ~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla 582 (706)
+..++||| +.+++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||+++ +.+||+|||++
T Consensus 101 ~~~~lv~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~-~~~kL~Dfg~~ 173 (313)
T 3cek_A 101 QYIYMVME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVD-GMLKLIDFGIA 173 (313)
T ss_dssp SEEEEEEC-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEET-TEEEECCCSSS
T ss_pred CEEEEEEe-cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEEEC-CeEEEeecccc
Confidence 99999999 5688999999743 25889999999999999999999999 999999999999964 89999999999
Q ss_pred ccCCCCcc--cCCCCCCCCCccCcccccc-----------CCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHhh
Q 005247 583 RSKPNTYI--SSKTAAGTPEWMAPEVLRE-----------DPSNEKSDVFSFGVILWELITLQKPWRNSTPS-QVISAVG 648 (706)
Q Consensus 583 ~~~~~~~~--~~~~~~Gt~~Y~APE~l~~-----------~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~-~~~~~i~ 648 (706)
........ ......||+.|+|||++.+ ..++.++||||||+++|+|++|..||...... .....+.
T Consensus 174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 253 (313)
T 3cek_A 174 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII 253 (313)
T ss_dssp CC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH
T ss_pred ccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHH
Confidence 86543321 1234578999999999876 46788999999999999999999999875432 3333333
Q ss_pred hcCcccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 005247 649 FKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMET 688 (706)
Q Consensus 649 ~~~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~ 688 (706)
.......++...+.++.+||.+||+.||++|||+.++++.
T Consensus 254 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 254 DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 3445566778889999999999999999999999999863
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=345.99 Aligned_cols=258 Identities=28% Similarity=0.445 Sum_probs=194.0
Q ss_pred CcccccCceEEEEEeccCCceEEEEEEEc--CCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCc
Q 005247 427 GLEIRWSELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN 504 (706)
Q Consensus 427 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 504 (706)
.+.+..++|++.+.||+|+||.||+|.+. +..||+|++..... ....+.+.+|+.+++.++||||+++++++...+.
T Consensus 9 p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 87 (303)
T 2vwi_A 9 PWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDE 87 (303)
T ss_dssp ----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSSC
T ss_pred ccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCC
Confidence 45677889999999999999999999874 45699998754332 2345678899999999999999999999999999
Q ss_pred eEEEEEeccCCchhhhccc-----CCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeec
Q 005247 505 LSIVTEYLSRGSLYKLLHI-----PDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDF 579 (706)
Q Consensus 505 ~~lV~E~~~ggsL~~~l~~-----~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DF 579 (706)
.++||||+++++|.+++.. ......+++..++.++.||+.||.|||++| |+||||||+||+++.++.+||+||
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~df 165 (303)
T 2vwi_A 88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG--QIHRDVKAGNILLGEDGSVQIADF 165 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTCCEEECCC
T ss_pred cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCCChhhEEEcCCCCEEEEec
Confidence 9999999999999999853 112345889999999999999999999999 999999999999999999999999
Q ss_pred CccccCCCCc-----ccCCCCCCCCCccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCc-
Q 005247 580 GLSRSKPNTY-----ISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR- 652 (706)
Q Consensus 580 Gla~~~~~~~-----~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~- 652 (706)
|++....... .......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.................
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 245 (303)
T 2vwi_A 166 GVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPP 245 (303)
T ss_dssp HHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCC
T ss_pred cchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCC
Confidence 9987644321 11234578999999999876 5689999999999999999999999988776665543322111
Q ss_pred -------ccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 653 -------RLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 653 -------~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
.......+++++.+||.+||+.||.+|||+.++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 246 SLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp CTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 11233567899999999999999999999999986
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=364.38 Aligned_cols=245 Identities=16% Similarity=0.160 Sum_probs=195.1
Q ss_pred cccCceEEEEEeccCCceEEEEEEEc--CCceEEEEEeccc-cchHHHHHHHHHHH---HHHcCCCCceeEEe-------
Q 005247 430 IRWSELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQE-FHEDRFKEFLREVA---IMKGLRHPNIVLLM------- 496 (706)
Q Consensus 430 i~~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKvl~~~~-~~~~~~~~~~~Ei~---iL~~L~HpnIv~l~------- 496 (706)
...++|++.+.||+|+||.||+|.+. +..||||++.... ......+.+.+|+. +++.++||||++++
T Consensus 70 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~ 149 (377)
T 3byv_A 70 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 149 (377)
T ss_dssp CCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCS
T ss_pred CCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhh
Confidence 34578999999999999999999875 5569999987543 23445678899994 55556899999998
Q ss_pred ccccCCC-----------------ceEEEEEeccCCchhhhcccCC----CcccccHHHHHHHHHHHHHHHHHHHhcCCC
Q 005247 497 GAVTEPP-----------------NLSIVTEYLSRGSLYKLLHIPD----ARVVVDERLRLNMAYDVAKGMNYLHQRRPP 555 (706)
Q Consensus 497 ~~~~~~~-----------------~~~lV~E~~~ggsL~~~l~~~~----~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~ 555 (706)
+++.+.+ ..++||||+ +|+|.+++.... ....+++..++.|+.||+.||+|||++|
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-- 226 (377)
T 3byv_A 150 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG-- 226 (377)
T ss_dssp EEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred hhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC--
Confidence 4444332 378999999 679999986321 1223445888899999999999999999
Q ss_pred cccccCCCCcEEECCCCcEEEeecCccccCCCCcccCCCCCCCCCccCccccccC-----------CCCchhHHHHHHHH
Q 005247 556 IVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRED-----------PSNEKSDVFSFGVI 624 (706)
Q Consensus 556 IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-----------~~s~ksDVwSLGvi 624 (706)
|+||||||+|||++.++.+||+|||+++..... .....| +.|+|||++.+. .++.++|||||||+
T Consensus 227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAR---VVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTCE---EECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred eecCCCCHHHEEEcCCCCEEEEechhheecCCc---ccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 999999999999999999999999999865442 245577 999999999887 89999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 625 LWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 625 L~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
+|||++|+.||........... ....+..+++++.+||.+||+.||++|||+.++++
T Consensus 303 l~elltg~~Pf~~~~~~~~~~~------~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 303 IYWIWCADLPITKDAALGGSEW------IFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHSSCCC------CCSGG------GGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHCCCCCcccccccchhh------hhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 9999999999976554332222 12334678999999999999999999999999986
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=357.58 Aligned_cols=253 Identities=23% Similarity=0.365 Sum_probs=208.1
Q ss_pred ccccCceEEEEEeccCCceEEEEEEE-----cCCceEEEEEecccc--chHHHHHHHHHHHHHHcC-CCCceeEEecccc
Q 005247 429 EIRWSELLIKKKIGEGSFGTVYHAEW-----RNSDVAVKILIEQEF--HEDRFKEFLREVAIMKGL-RHPNIVLLMGAVT 500 (706)
Q Consensus 429 ~i~~~~y~i~~~LG~G~fG~Vy~a~~-----~~~~vAVKvl~~~~~--~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~ 500 (706)
.+...+|++.+.||+|+||.||+|++ .+..||||++..... .....+.+.+|+.+++.+ +||||+++++++.
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 129 (355)
T 1vzo_A 50 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ 129 (355)
T ss_dssp CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred cccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEe
Confidence 34567899999999999999999988 345599999864332 112234567899999999 6999999999999
Q ss_pred CCCceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecC
Q 005247 501 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFG 580 (706)
Q Consensus 501 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFG 580 (706)
..+.+++||||+.+++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 130 ~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~DfG 204 (355)
T 1vzo_A 130 TETKLHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFG 204 (355)
T ss_dssp ETTEEEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEESCSS
T ss_pred eCceEEEEeecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCcEEEeeCC
Confidence 999999999999999999999643 35889999999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCc-ccCCCCCCCCCccCcccccc--CCCCchhHHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHhhhcCcc
Q 005247 581 LSRSKPNTY-ISSKTAAGTPEWMAPEVLRE--DPSNEKSDVFSFGVILWELITLQKPWRNST----PSQVISAVGFKGRR 653 (706)
Q Consensus 581 la~~~~~~~-~~~~~~~Gt~~Y~APE~l~~--~~~s~ksDVwSLGviL~ELltG~~Pf~~~~----~~~~~~~i~~~~~~ 653 (706)
+++...... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... .......+ ....
T Consensus 205 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~--~~~~ 282 (355)
T 1vzo_A 205 LSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI--LKSE 282 (355)
T ss_dssp EEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH--HHCC
T ss_pred CCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHH--hccC
Confidence 998654322 22335679999999999986 347899999999999999999999997533 22222222 2334
Q ss_pred cCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHHH
Q 005247 654 LEIPKNVNPMVAALIETCWAEEPEIRP-----SFPSIMET 688 (706)
Q Consensus 654 l~~p~~~s~el~dLI~~cL~~dP~~RP-----S~~eIl~~ 688 (706)
..++..++..+.+||.+||..||++|| +++++++.
T Consensus 283 ~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 283 PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 567788999999999999999999999 99999873
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=343.82 Aligned_cols=255 Identities=27% Similarity=0.352 Sum_probs=207.6
Q ss_pred cccccCceEEEEEeccCCceEEEEEEEc---CCceEEEEEeccccchHHHHHHHHHHHHHHcC---CCCceeEEecccc-
Q 005247 428 LEIRWSELLIKKKIGEGSFGTVYHAEWR---NSDVAVKILIEQEFHEDRFKEFLREVAIMKGL---RHPNIVLLMGAVT- 500 (706)
Q Consensus 428 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~---~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L---~HpnIv~l~~~~~- 500 (706)
+....++|++.+.||+|+||.||+|.+. +..||+|++............+.+|+.+++.+ +||||+++++++.
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~ 85 (326)
T 1blx_A 6 LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTV 85 (326)
T ss_dssp CCCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred ccCchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeee
Confidence 3344578999999999999999999984 23499999865543332223455677766655 8999999999986
Q ss_pred ----CCCceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEE
Q 005247 501 ----EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKV 576 (706)
Q Consensus 501 ----~~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL 576 (706)
.....++||||+. |+|.+++..... ..+++..++.++.||+.||.|||++| |+||||||+||+++.++.+||
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~g--i~H~dlkp~Nili~~~~~~kl 161 (326)
T 1blx_A 86 SRTDRETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKL 161 (326)
T ss_dssp EECSSEEEEEEEEECCS-CBHHHHHHHSCT-TCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEE
T ss_pred cccCCCceEEEEEecCC-CCHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHHHeEEcCCCCEEE
Confidence 5667899999997 599998864322 24889999999999999999999999 999999999999999999999
Q ss_pred eecCccccCCCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcC-----
Q 005247 577 CDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG----- 651 (706)
Q Consensus 577 ~DFGla~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~----- 651 (706)
+|||+++...... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||......+....+....
T Consensus 162 ~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 240 (326)
T 1blx_A 162 ADFGLARIYSFQM-ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 240 (326)
T ss_dssp CSCCSCCCCCGGG-GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred ecCcccccccCCC-CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCc
Confidence 9999998765332 2345678999999999999999999999999999999999999999887766554442110
Q ss_pred --------------------cccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 652 --------------------RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 652 --------------------~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
....+...++..+.+||.+||+.||++|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 241 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 001234568899999999999999999999999985
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=345.38 Aligned_cols=245 Identities=24% Similarity=0.354 Sum_probs=203.9
Q ss_pred cCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCc-----
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN----- 504 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~----- 504 (706)
.++|.+.+.||+|+||.||+|.+..+ .||+|++..........+.+.+|+.+++.++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 36899999999999999999998644 59999987665566667789999999999999999999999887654
Q ss_pred -eEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccc
Q 005247 505 -LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 583 (706)
Q Consensus 505 -~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~ 583 (706)
+++||||+. ++|.+++.. .+++..++.++.||+.||.|||++| |+||||||+||+++.++.+||+|||+++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 174 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL-----KFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLAR 174 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS-----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred eEEEEecccc-CCHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEeECCCCcEEEeeccccc
Confidence 499999997 588887742 3889999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCcccCCCCCCCCCccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcC-----------
Q 005247 584 SKPNTYISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG----------- 651 (706)
Q Consensus 584 ~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~----------- 651 (706)
..... .....+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||...+..+....+....
T Consensus 175 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 251 (353)
T 3coi_A 175 HADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKL 251 (353)
T ss_dssp C-----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTC
T ss_pred CCCCC---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHH
Confidence 65433 235678999999999987 678999999999999999999999999877655544332100
Q ss_pred ------------------cccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 652 ------------------RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 652 ------------------~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
........+++++.+||.+||+.||++|||+.++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 252 NDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp SCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 001233567899999999999999999999999976
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=350.45 Aligned_cols=248 Identities=25% Similarity=0.376 Sum_probs=205.7
Q ss_pred cCceEEEEEeccCCceEEEEEEEcCCc--eEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCC-----Cc
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP-----PN 504 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~--vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~-----~~ 504 (706)
..+|++++.||+|+||.||+|.+..++ ||+|++.... .....+.+.+|+.++++++||||+++++++... ..
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc-CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 358999999999999999999887544 9999986433 445557889999999999999999999988654 46
Q ss_pred eEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCcccc
Q 005247 505 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 584 (706)
Q Consensus 505 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~ 584 (706)
.++||||+. ++|.++++.. .+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++.
T Consensus 105 ~~iv~e~~~-~~L~~~l~~~----~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp EEEEEECCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEcccC-cCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 899999997 4898888633 4889999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCcc---cCCCCCCCCCccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcc-------
Q 005247 585 KPNTYI---SSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR------- 653 (706)
Q Consensus 585 ~~~~~~---~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~------- 653 (706)
...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....+......
T Consensus 178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 257 (364)
T 3qyz_A 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 257 (364)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHH
T ss_pred cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 553321 1244589999999998765 45899999999999999999999999888766655444211000
Q ss_pred ----------------------cCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 654 ----------------------LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 654 ----------------------l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
..+...+++++.+||.+||+.||++|||+.|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1122567899999999999999999999999986
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=344.85 Aligned_cols=249 Identities=27% Similarity=0.397 Sum_probs=199.7
Q ss_pred cCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccc------hHHHHHHHHHHHHHHcCCCCceeEEeccccCCC
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFH------EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP 503 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~------~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 503 (706)
.++|++.+.||+|+||.||+|.+..+ .||||++...... ......+.+|+.+++.++||||+++++++...+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 35799999999999999999998754 4999998654321 223346889999999999999999999987655
Q ss_pred ceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCc---EEEeecC
Q 005247 504 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYT---VKVCDFG 580 (706)
Q Consensus 504 ~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~---vKL~DFG 580 (706)
.++||||+.+++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++. +||+|||
T Consensus 89 -~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg 162 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVGN---KRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFG 162 (322)
T ss_dssp -EEEEEECCTTEETHHHHSTT---CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred -eEEEEecCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEecCCCCCeEEEccCc
Confidence 89999999999999988643 35889999999999999999999999 999999999999987654 9999999
Q ss_pred ccccCCCCcccCCCCCCCCCccCccccc---cCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHhhhcCcc--c
Q 005247 581 LSRSKPNTYISSKTAAGTPEWMAPEVLR---EDPSNEKSDVFSFGVILWELITLQKPWRNSTPS-QVISAVGFKGRR--L 654 (706)
Q Consensus 581 la~~~~~~~~~~~~~~Gt~~Y~APE~l~---~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~-~~~~~i~~~~~~--l 654 (706)
+++...... ......||+.|+|||++. ...++.++||||||+++|+|++|..||...... .....+...... .
T Consensus 163 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 241 (322)
T 2ycf_A 163 HSKILGETS-LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP 241 (322)
T ss_dssp TCEECCCCH-HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCH
T ss_pred cceeccccc-ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCc
Confidence 998765432 123456899999999974 466889999999999999999999999765433 222222211111 1
Q ss_pred CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 655 EIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 655 ~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
..+..+++++.+||.+||+.||++|||+.++++
T Consensus 242 ~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 242 EVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 223578999999999999999999999999984
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=352.09 Aligned_cols=260 Identities=17% Similarity=0.198 Sum_probs=212.0
Q ss_pred cCcccccCceEEEEEeccCCceEEEEEE-----E--cCCceEEEEEeccccchHHHHHHHHHHHHHHcCC---CCceeEE
Q 005247 426 EGLEIRWSELLIKKKIGEGSFGTVYHAE-----W--RNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR---HPNIVLL 495 (706)
Q Consensus 426 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~-----~--~~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~---HpnIv~l 495 (706)
..+++...+|.+.+.||+|+||.||+|. + .+..||+|++.... ...+.+|+.+++.++ |+||+.+
T Consensus 58 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~l~~~~~~~iv~~ 132 (365)
T 3e7e_A 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----PWEFYIGTQLMERLKPSMQHMFMKF 132 (365)
T ss_dssp CEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-----HHHHHHHHHHHHHSCGGGGGGBCCE
T ss_pred eeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----hhHHHHHHHHHHHhhhhhhhhhhhh
Confidence 4456777899999999999999999994 2 34459999985432 246777888888886 8999999
Q ss_pred eccccCCCceEEEEEeccCCchhhhcccC--CCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECC---
Q 005247 496 MGAVTEPPNLSIVTEYLSRGSLYKLLHIP--DARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS--- 570 (706)
Q Consensus 496 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~--~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~--- 570 (706)
++++...+..++||||+++|+|.++++.. .....+++..++.++.||+.||+|||++| ||||||||+|||++.
T Consensus 133 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--ivHrDiKp~NIll~~~~~ 210 (365)
T 3e7e_A 133 YSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGFL 210 (365)
T ss_dssp EEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECGGGT
T ss_pred heeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEeccccc
Confidence 99999999999999999999999999631 12345899999999999999999999999 999999999999988
Q ss_pred --------CCcEEEeecCccccCC--CCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh
Q 005247 571 --------TYTVKVCDFGLSRSKP--NTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTP 640 (706)
Q Consensus 571 --------~~~vKL~DFGla~~~~--~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~ 640 (706)
++.+||+|||+++... .........+||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 211 ~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 290 (365)
T 3e7e_A 211 EQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEG 290 (365)
T ss_dssp CC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEET
T ss_pred CccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCC
Confidence 8999999999996432 122233566899999999999999999999999999999999999999965432
Q ss_pred HHHHHHhhhcCcccCCCCCCcHHHHHHHHHhhhhCCCCC-CCHHHHHHHHHHHHHhccC
Q 005247 641 SQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIR-PSFPSIMETLQQFLMSSVC 698 (706)
Q Consensus 641 ~~~~~~i~~~~~~l~~p~~~s~el~dLI~~cL~~dP~~R-PS~~eIl~~L~~ll~s~~~ 698 (706)
... ...........++.+.+++..||+.+|.+| |++.++.+.|+.++.....
T Consensus 291 ~~~------~~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~~~ 343 (365)
T 3e7e_A 291 GEC------KPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYT 343 (365)
T ss_dssp TEE------EECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHHTT
T ss_pred Cce------eechhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHhhh
Confidence 110 000111111346789999999999999999 7899999999999877543
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=340.52 Aligned_cols=257 Identities=24% Similarity=0.404 Sum_probs=194.2
Q ss_pred cccCcccccCceEEEEEeccCCceEEEEEEEc--CCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccC
Q 005247 424 EEEGLEIRWSELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE 501 (706)
Q Consensus 424 ~~~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~ 501 (706)
....+....++|++.+.||+|+||.||+|.+. +..||+|++..........+.+.++..+++.++||||+++++++.+
T Consensus 16 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~ 95 (318)
T 2dyl_A 16 GGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT 95 (318)
T ss_dssp SSSEEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred cchhhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEec
Confidence 44556677889999999999999999999986 4459999997765444444555566667888899999999999999
Q ss_pred CCceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhc-CCCcccccCCCCcEEECCCCcEEEeecC
Q 005247 502 PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR-RPPIVHRDLKSPNLLVDSTYTVKVCDFG 580 (706)
Q Consensus 502 ~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~-g~~IIHrDLKp~NILl~~~~~vKL~DFG 580 (706)
.+..++||||+ ++.+..+.... ...+++..++.++.||+.||.|||++ | |+||||||+||+++.++.+||+|||
T Consensus 96 ~~~~~lv~e~~-~~~~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dlkp~Nil~~~~~~~kl~dfg 170 (318)
T 2dyl_A 96 NTDVFIAMELM-GTCAEKLKKRM--QGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFG 170 (318)
T ss_dssp SSEEEEEECCC-SEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHHHC--CCCCCCCGGGEEECTTSCEEECCCT
T ss_pred CCcEEEEEecc-CCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhhCC--EEeCCCCHHHEEECCCCCEEEEECC
Confidence 99999999999 55565555422 23588999999999999999999995 9 9999999999999999999999999
Q ss_pred ccccCCCCcccCCCCCCCCCccCccccc-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHhhhcCccc
Q 005247 581 LSRSKPNTYISSKTAAGTPEWMAPEVLR-----EDPSNEKSDVFSFGVILWELITLQKPWRNST-PSQVISAVGFKGRRL 654 (706)
Q Consensus 581 la~~~~~~~~~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~-~~~~~~~i~~~~~~l 654 (706)
++....... ......||+.|+|||++. +..++.++||||||+++|+|++|+.||.... ..+....+. .....
T Consensus 171 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~ 248 (318)
T 2dyl_A 171 ISGRLVDDK-AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVL-QEEPP 248 (318)
T ss_dssp TC---------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH-HSCCC
T ss_pred CchhccCCc-cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHh-ccCCC
Confidence 997654432 223457899999999994 4568899999999999999999999998743 334443332 23333
Q ss_pred CC--CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 655 EI--PKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 655 ~~--p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
.+ ...+++++.+||.+||+.||.+||++.++++
T Consensus 249 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 249 LLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 33 3468999999999999999999999999987
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=357.58 Aligned_cols=250 Identities=24% Similarity=0.295 Sum_probs=201.1
Q ss_pred ccccCceEEEEEeccCCceEEEEEEEcCCc-eEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCC----
Q 005247 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD-VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP---- 503 (706)
Q Consensus 429 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~-vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~---- 503 (706)
+....+|++.+.||+|+||.||+|++..+. +|+|++..... ...+|+.+++.++||||+++++++...+
T Consensus 36 ~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~ 109 (394)
T 4e7w_A 36 EQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKD 109 (394)
T ss_dssp CEEEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSS
T ss_pred CcccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc------hHHHHHHHHHhCCCCCcceEEEEEEecCCCCC
Confidence 344568999999999999999999986554 88888755432 1236999999999999999999984433
Q ss_pred --ceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEEC-CCCcEEEeecC
Q 005247 504 --NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVD-STYTVKVCDFG 580 (706)
Q Consensus 504 --~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~-~~~~vKL~DFG 580 (706)
.+++||||+.++.+..+.........+++..++.++.||+.||+|||++| |+||||||+|||++ .++.+||+|||
T Consensus 110 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~kL~DFG 187 (394)
T 4e7w_A 110 EVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFG 187 (394)
T ss_dssp CEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred ceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence 37899999987655444332223346889999999999999999999999 99999999999998 79999999999
Q ss_pred ccccCCCCcccCCCCCCCCCccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcC--------
Q 005247 581 LSRSKPNTYISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG-------- 651 (706)
Q Consensus 581 la~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~-------- 651 (706)
+++...... ......+|+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+....+....
T Consensus 188 ~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~ 266 (394)
T 4e7w_A 188 SAKILIAGE-PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQI 266 (394)
T ss_dssp TCEECCTTC-CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred CcccccCCC-CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 998754432 23456789999999999775 58999999999999999999999999887665554432110
Q ss_pred ---------cc----------cCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 652 ---------RR----------LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 652 ---------~~----------l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
.. ..++..+++++.+||.+||+.||.+|||+.++++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp HHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 00 1134468899999999999999999999999986
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=353.75 Aligned_cols=254 Identities=25% Similarity=0.336 Sum_probs=202.8
Q ss_pred ccccCceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEecccc------
Q 005247 429 EIRWSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT------ 500 (706)
Q Consensus 429 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~------ 500 (706)
+....+|++++.||+|+||.||+|.+.. ..||+|++..... ...+|+.+++.++||||+++++++.
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc------hHHHHHHHHHHcCCCCccchhheeeecCccc
Confidence 4456789999999999999999998864 4599998865432 2237999999999999999999883
Q ss_pred --------------------------------CCCceEEEEEeccCCchhhhccc-CCCcccccHHHHHHHHHHHHHHHH
Q 005247 501 --------------------------------EPPNLSIVTEYLSRGSLYKLLHI-PDARVVVDERLRLNMAYDVAKGMN 547 (706)
Q Consensus 501 --------------------------------~~~~~~lV~E~~~ggsL~~~l~~-~~~~~~l~~~~~~~ia~qIl~aL~ 547 (706)
.....++||||+++ +|.+.+.. ......+++..++.++.||+.||+
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ---------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 33448899999985 77776642 112346889999999999999999
Q ss_pred HHHhcCCCcccccCCCCcEEEC-CCCcEEEeecCccccCCCCcccCCCCCCCCCccCccccccCC-CCchhHHHHHHHHH
Q 005247 548 YLHQRRPPIVHRDLKSPNLLVD-STYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDP-SNEKSDVFSFGVIL 625 (706)
Q Consensus 548 yLHs~g~~IIHrDLKp~NILl~-~~~~vKL~DFGla~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~-~s~ksDVwSLGviL 625 (706)
|||++| |+||||||+|||++ .++.+||+|||+++...... ......+|+.|+|||++.+.. ++.++|||||||++
T Consensus 156 ~LH~~g--i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 156 FIHSLG--ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE-PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp HHHTTT--EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS-CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HHHHCc--CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC-CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 999999 99999999999997 68899999999998654432 234567899999999988754 89999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHhhhcCc---------------------------ccCCCCCCcHHHHHHHHHhhhhCCCC
Q 005247 626 WELITLQKPWRNSTPSQVISAVGFKGR---------------------------RLEIPKNVNPMVAALIETCWAEEPEI 678 (706)
Q Consensus 626 ~ELltG~~Pf~~~~~~~~~~~i~~~~~---------------------------~l~~p~~~s~el~dLI~~cL~~dP~~ 678 (706)
|||++|+.||.+.+..+....+..... ...++..+++++.+||.+||+.||++
T Consensus 233 ~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 312 (383)
T 3eb0_A 233 GELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDL 312 (383)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhh
Confidence 999999999998877666554421100 11145678999999999999999999
Q ss_pred CCCHHHHHH--HHHHH
Q 005247 679 RPSFPSIME--TLQQF 692 (706)
Q Consensus 679 RPS~~eIl~--~L~~l 692 (706)
|||+.|+++ .++.+
T Consensus 313 R~t~~e~l~hp~f~~~ 328 (383)
T 3eb0_A 313 RINPYEAMAHPFFDHL 328 (383)
T ss_dssp SCCHHHHHTSGGGHHH
T ss_pred CCCHHHHhcCHHHHHH
Confidence 999999986 44444
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=360.63 Aligned_cols=246 Identities=25% Similarity=0.330 Sum_probs=196.9
Q ss_pred cCceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccC------CC
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE------PP 503 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~------~~ 503 (706)
..+|++.+.||+|+||.||+|.+.. ..||||++..... .+.+|+++++.++||||+++++++.. ..
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~ 126 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 126 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcce
Confidence 4579999999999999999999864 4599998865431 23479999999999999999988742 22
Q ss_pred ceEEEEEeccCCchhhhccc-CCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCC-CcEEEeecCc
Q 005247 504 NLSIVTEYLSRGSLYKLLHI-PDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST-YTVKVCDFGL 581 (706)
Q Consensus 504 ~~~lV~E~~~ggsL~~~l~~-~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~-~~vKL~DFGl 581 (706)
.+++||||+.+ +|.+++.. ......+++..++.++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||+
T Consensus 127 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NILl~~~~~~~kl~DFG~ 203 (420)
T 1j1b_A 127 YLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGS 203 (420)
T ss_dssp EEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred eEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChhhEEEeCCCCeEEeccchh
Confidence 36799999976 55555431 122346889999999999999999999999 9999999999999954 6789999999
Q ss_pred cccCCCCcccCCCCCCCCCccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhc-C--------
Q 005247 582 SRSKPNTYISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-G-------- 651 (706)
Q Consensus 582 a~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~-~-------- 651 (706)
++...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+....+... +
T Consensus 204 a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~ 282 (420)
T 1j1b_A 204 AKQLVRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 282 (420)
T ss_dssp CEECCTTC-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred hhhcccCC-CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 98654432 23456789999999999775 7899999999999999999999999988765554433211 0
Q ss_pred ------cccC------------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 652 ------RRLE------------IPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 652 ------~~l~------------~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
.... ++..+++++.+||.+||..||.+|||+.|+++
T Consensus 283 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 283 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 0111 33567899999999999999999999999986
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=337.32 Aligned_cols=247 Identities=23% Similarity=0.338 Sum_probs=198.1
Q ss_pred cCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccc----------
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAV---------- 499 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~---------- 499 (706)
.++|++.+.||+|+||.||+|.+..+ .||+|++... .....+.+.+|+.+++.++||||+++++++
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 87 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD 87 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence 46899999999999999999998754 4999988654 345567899999999999999999999876
Q ss_pred ----cCCCceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEEC-CCCcE
Q 005247 500 ----TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVD-STYTV 574 (706)
Q Consensus 500 ----~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~-~~~~v 574 (706)
.+.+..++||||+. |+|.+++.. ..+++..++.++.||+.||+|||++| |+||||||+|||++ .++.+
T Consensus 88 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~ 160 (320)
T 2i6l_A 88 VGSLTELNSVYIVQEYME-TDLANVLEQ----GPLLEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVL 160 (320)
T ss_dssp ---CCSCSEEEEEEECCS-EEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTTEE
T ss_pred cccccccCceeEEeeccC-CCHHHHhhc----CCccHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCeE
Confidence 34467899999997 599999863 24889999999999999999999999 99999999999997 56799
Q ss_pred EEeecCccccCCCCcc---cCCCCCCCCCccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhc
Q 005247 575 KVCDFGLSRSKPNTYI---SSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK 650 (706)
Q Consensus 575 KL~DFGla~~~~~~~~---~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~ 650 (706)
||+|||+++....... ......+|..|+|||++.+ ..++.++||||||+++|||++|+.||......+....+...
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 240 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILES 240 (320)
T ss_dssp EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 9999999987543211 2234467999999999876 67899999999999999999999999988766554443211
Q ss_pred Cc----------------------------ccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 651 GR----------------------------RLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 651 ~~----------------------------~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
.. ....+..+++++.+||.+||+.||++|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 10 01123568999999999999999999999999976
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=343.02 Aligned_cols=248 Identities=25% Similarity=0.350 Sum_probs=203.0
Q ss_pred cCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCC-----Cc
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP-----PN 504 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~-----~~ 504 (706)
.++|++.+.||+|+||.||+|.+..+ .||+|++.... .......+.+|+.+++.++||||+++++++... ..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD-KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc-cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 47899999999999999999998744 49999985432 344556788999999999999999999987654 67
Q ss_pred eEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCcccc
Q 005247 505 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 584 (706)
Q Consensus 505 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~ 584 (706)
.++||||+. ++|.+++.. ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++.
T Consensus 89 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp EEEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 899999997 589888864 24889999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCcc----------cCCCCCCCCCccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcc
Q 005247 585 KPNTYI----------SSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR 653 (706)
Q Consensus 585 ~~~~~~----------~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~ 653 (706)
...... ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||...+..+....+......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT 241 (353)
T ss_dssp CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Confidence 543211 1223578999999998765 67899999999999999999999999988765544332110000
Q ss_pred ------------------------------cCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 654 ------------------------------LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 654 ------------------------------l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
......+++++.+||.+||+.||++|||+.++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0112468899999999999999999999999976
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=344.19 Aligned_cols=258 Identities=25% Similarity=0.421 Sum_probs=186.5
Q ss_pred ccCcccccCceEEEEEeccCCceEEEEEEEc--CCceEEEEEeccccchHHHHHHHHHHH-HHHcCCCCceeEEeccccC
Q 005247 425 EEGLEIRWSELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVA-IMKGLRHPNIVLLMGAVTE 501 (706)
Q Consensus 425 ~~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKvl~~~~~~~~~~~~~~~Ei~-iL~~L~HpnIv~l~~~~~~ 501 (706)
...+.+..++|++.+.||+|+||.||+|.+. +..||+|++..... ......+..|+. +++.++||||+++++++..
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~ 92 (327)
T 3aln_A 14 EQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD-EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR 92 (327)
T ss_dssp CEEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC-HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC
T ss_pred HHhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC-chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe
Confidence 3446677889999999999999999999987 44599999876543 334455566665 7777899999999999999
Q ss_pred CCceEEEEEeccCCchhhhccc--CCCcccccHHHHHHHHHHHHHHHHHHHhc-CCCcccccCCCCcEEECCCCcEEEee
Q 005247 502 PPNLSIVTEYLSRGSLYKLLHI--PDARVVVDERLRLNMAYDVAKGMNYLHQR-RPPIVHRDLKSPNLLVDSTYTVKVCD 578 (706)
Q Consensus 502 ~~~~~lV~E~~~ggsL~~~l~~--~~~~~~l~~~~~~~ia~qIl~aL~yLHs~-g~~IIHrDLKp~NILl~~~~~vKL~D 578 (706)
.+..++||||+.+ +|.+++.. ......+++..++.++.|++.||.|||++ | |+||||||+|||++.++.+||+|
T Consensus 93 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--ivH~dlkp~NIll~~~~~~kl~D 169 (327)
T 3aln_A 93 EGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCD 169 (327)
T ss_dssp SSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS--CCCSCCCGGGEEEETTTEEEECC
T ss_pred CCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC--EeECCCCHHHEEEcCCCCEEEcc
Confidence 9999999999975 77777642 11234588999999999999999999998 9 99999999999999999999999
Q ss_pred cCccccCCCCcccCCCCCCCCCccCcccc----ccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCccc
Q 005247 579 FGLSRSKPNTYISSKTAAGTPEWMAPEVL----REDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRL 654 (706)
Q Consensus 579 FGla~~~~~~~~~~~~~~Gt~~Y~APE~l----~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l 654 (706)
||+++...... ......||+.|+|||++ .+..++.++||||||+++|+|++|+.||...................
T Consensus 170 fg~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 248 (327)
T 3aln_A 170 FGISGQLVDSI-AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPP 248 (327)
T ss_dssp CSSSCC-------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCC
T ss_pred CCCceeccccc-ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCC
Confidence 99998765432 22344799999999998 45678999999999999999999999998754322111111122222
Q ss_pred CC----CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 655 EI----PKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 655 ~~----p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
.+ ...+++.+.+||.+||+.||++|||+.++++
T Consensus 249 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 249 QLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 22 2468999999999999999999999999976
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=341.68 Aligned_cols=243 Identities=22% Similarity=0.344 Sum_probs=199.3
Q ss_pred ccCceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCC-CCceeEEeccccC--CCce
Q 005247 431 RWSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGAVTE--PPNL 505 (706)
Q Consensus 431 ~~~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~--~~~~ 505 (706)
..++|++++.||+|+||.||+|.+.. ..||+|++.... .+.+.+|+.+++.++ ||||+++++++.+ ....
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~ 108 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 108 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence 34789999999999999999998754 459999986432 357889999999997 9999999999987 5678
Q ss_pred EEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCC-cEEEeecCcccc
Q 005247 506 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY-TVKVCDFGLSRS 584 (706)
Q Consensus 506 ~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~-~vKL~DFGla~~ 584 (706)
++||||+.+++|.++++ .+++..++.++.||+.||+|||++| |+||||||+|||++.++ .+||+|||+++.
T Consensus 109 ~lv~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~ 180 (330)
T 3nsz_A 109 ALVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 180 (330)
T ss_dssp EEEEECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEcCCCCEEEEEeCCCceE
Confidence 99999999999999885 3788899999999999999999999 99999999999999776 899999999986
Q ss_pred CCCCcccCCCCCCCCCccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHhhh-------------
Q 005247 585 KPNTYISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNST-PSQVISAVGF------------- 649 (706)
Q Consensus 585 ~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~ELltG~~Pf~~~~-~~~~~~~i~~------------- 649 (706)
..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.... ..+....+..
T Consensus 181 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 259 (330)
T 3nsz_A 181 YHPGQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 259 (330)
T ss_dssp CCTTC-CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred cCCCC-ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHH
Confidence 54432 2345678999999999987 668999999999999999999999995433 2222211100
Q ss_pred cCc----------------------ccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 650 KGR----------------------RLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 650 ~~~----------------------~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
... ....+..+++++.+||.+||+.||++|||+.|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 260 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp TTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred hccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000 00112237899999999999999999999999986
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=355.51 Aligned_cols=247 Identities=23% Similarity=0.288 Sum_probs=205.0
Q ss_pred ccCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcC------CCCceeEEeccccCC
Q 005247 431 RWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGL------RHPNIVLLMGAVTEP 502 (706)
Q Consensus 431 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L------~HpnIv~l~~~~~~~ 502 (706)
...+|++++.||+|+||.||+|.+..+ .||||++... ....+.+.+|+.+++.+ +|+||+++++++...
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 171 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR 171 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC
Confidence 456799999999999999999988754 4999998653 33345677788888776 577999999999999
Q ss_pred CceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCc--EEEeecC
Q 005247 503 PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYT--VKVCDFG 580 (706)
Q Consensus 503 ~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~--vKL~DFG 580 (706)
+..++||||+. ++|.+++..... ..+++..++.++.||+.||+|||+++ ||||||||+|||++.++. +||+|||
T Consensus 172 ~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NILl~~~~~~~vkL~DFG 247 (429)
T 3kvw_A 172 NHICMTFELLS-MNLYELIKKNKF-QGFSLPLVRKFAHSILQCLDALHKNR--IIHCDLKPENILLKQQGRSGIKVIDFG 247 (429)
T ss_dssp TEEEEEECCCC-CBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHHT--EECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred CeEEEEEeccC-CCHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEccCCCcceEEeecc
Confidence 99999999996 589888864432 24889999999999999999999999 999999999999999887 9999999
Q ss_pred ccccCCCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcc-------
Q 005247 581 LSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR------- 653 (706)
Q Consensus 581 la~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~------- 653 (706)
+++..... .....||+.|+|||++.+..++.++|||||||++|||++|..||...+..+....+......
T Consensus 248 ~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~ 324 (429)
T 3kvw_A 248 SSCYEHQR---VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLD 324 (429)
T ss_dssp TCEETTCC---CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred cceecCCc---ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence 99765443 24568999999999999999999999999999999999999999988776655443211000
Q ss_pred --------------------------------------------------cCCCCCCcHHHHHHHHHhhhhCCCCCCCHH
Q 005247 654 --------------------------------------------------LEIPKNVNPMVAALIETCWAEEPEIRPSFP 683 (706)
Q Consensus 654 --------------------------------------------------l~~p~~~s~el~dLI~~cL~~dP~~RPS~~ 683 (706)
..++...++++.+||.+||+.||++|||+.
T Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~ 404 (429)
T 3kvw_A 325 ASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPG 404 (429)
T ss_dssp TBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred hhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHH
Confidence 001223478899999999999999999999
Q ss_pred HHHH
Q 005247 684 SIME 687 (706)
Q Consensus 684 eIl~ 687 (706)
|+++
T Consensus 405 e~L~ 408 (429)
T 3kvw_A 405 QALR 408 (429)
T ss_dssp HHHT
T ss_pred HHhC
Confidence 9987
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=341.26 Aligned_cols=249 Identities=22% Similarity=0.291 Sum_probs=204.9
Q ss_pred ccccCceEEEEEeccCCceEEEEEEEc---CCceEEEEEeccccchHHHHHHHHHHHHHHcCCCC------ceeEEeccc
Q 005247 429 EIRWSELLIKKKIGEGSFGTVYHAEWR---NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHP------NIVLLMGAV 499 (706)
Q Consensus 429 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~---~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~Hp------nIv~l~~~~ 499 (706)
++..++|++.+.||+|+||.||+|.+. +..||+|++... ....+.+.+|+.+++.++|+ +|+++++++
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~ 86 (339)
T 1z57_A 10 DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWF 86 (339)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEE
T ss_pred CCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccc
Confidence 345678999999999999999999873 345999998643 34456788899999888654 599999999
Q ss_pred cCCCceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECC---------
Q 005247 500 TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS--------- 570 (706)
Q Consensus 500 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~--------- 570 (706)
...+..++||||+ +++|.+++.... ...+++..++.++.||+.||+|||++| |+||||||+|||++.
T Consensus 87 ~~~~~~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~~ 162 (339)
T 1z57_A 87 EHHGHICIVFELL-GLSTYDFIKENG-FLPFRLDHIRKMAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNP 162 (339)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCCCEEEEEC-
T ss_pred ccCCcEEEEEcCC-CCCHHHHHHhcC-CCCCcHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeccccccccCC
Confidence 9999999999999 889999986443 235789999999999999999999999 999999999999987
Q ss_pred ----------CCcEEEeecCccccCCCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh
Q 005247 571 ----------TYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTP 640 (706)
Q Consensus 571 ----------~~~vKL~DFGla~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~ 640 (706)
++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|..||...+.
T Consensus 163 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 239 (339)
T 1z57_A 163 KIKRDERTLINPDIKVVDFGSATYDDEH---HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDS 239 (339)
T ss_dssp ---CEEEEESCCCEEECCCSSCEETTSC---CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCH
T ss_pred ccccccccccCCCceEeeCcccccCccc---cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh
Confidence 668999999999865433 2456799999999999999999999999999999999999999998776
Q ss_pred HHHHHHhhhcCcc------------------------------------------cCCCCCCcHHHHHHHHHhhhhCCCC
Q 005247 641 SQVISAVGFKGRR------------------------------------------LEIPKNVNPMVAALIETCWAEEPEI 678 (706)
Q Consensus 641 ~~~~~~i~~~~~~------------------------------------------l~~p~~~s~el~dLI~~cL~~dP~~ 678 (706)
.+....+...... ...+...++++.+||.+||+.||.+
T Consensus 240 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 319 (339)
T 1z57_A 240 KEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK 319 (339)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred HHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccc
Confidence 6554433211000 1112234678999999999999999
Q ss_pred CCCHHHHHH
Q 005247 679 RPSFPSIME 687 (706)
Q Consensus 679 RPS~~eIl~ 687 (706)
|||+.|+++
T Consensus 320 Rpt~~ell~ 328 (339)
T 1z57_A 320 RITLREALK 328 (339)
T ss_dssp SCCHHHHTT
T ss_pred ccCHHHHhc
Confidence 999999975
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=354.97 Aligned_cols=248 Identities=15% Similarity=0.086 Sum_probs=184.9
Q ss_pred ccCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEecccc-chHHHHHHHHHH---HHHHcCCCCceeEEeccc-----
Q 005247 431 RWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREV---AIMKGLRHPNIVLLMGAV----- 499 (706)
Q Consensus 431 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~-~~~~~~~~~~Ei---~iL~~L~HpnIv~l~~~~----- 499 (706)
...+|++.+.||+|+||.||+|.+..+ .||+|++..... .....+.+.+|+ .+++. +||||++++..+
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d 138 (371)
T 3q60_A 60 GERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSD 138 (371)
T ss_dssp CEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCE
T ss_pred CceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeeh
Confidence 345699999999999999999998754 499999987654 334456677785 45555 799988865333
Q ss_pred --cCC-----------------CceEEEEEeccCCchhhhcccCCCcccccHHHH------HHHHHHHHHHHHHHHhcCC
Q 005247 500 --TEP-----------------PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLR------LNMAYDVAKGMNYLHQRRP 554 (706)
Q Consensus 500 --~~~-----------------~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~------~~ia~qIl~aL~yLHs~g~ 554 (706)
... ..+++||||+. |+|.+++...+. .+++..+ ..++.||+.||+|||++|
T Consensus 139 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~- 214 (371)
T 3q60_A 139 AVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF--VYVFRGDEGILALHILTAQLIRLAANLQSKG- 214 (371)
T ss_dssp EEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred heecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc--ccchhhhhhhhhHHHHHHHHHHHHHHHHHCC-
Confidence 211 33799999998 899999964321 2344444 677799999999999999
Q ss_pred CcccccCCCCcEEECCCCcEEEeecCccccCCCCcccCCCCCCCCCccCcccccc--CCCCchhHHHHHHHHHHHHHhCC
Q 005247 555 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRE--DPSNEKSDVFSFGVILWELITLQ 632 (706)
Q Consensus 555 ~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~Gt~~Y~APE~l~~--~~~s~ksDVwSLGviL~ELltG~ 632 (706)
||||||||+|||++.++.+||+|||+++...... ....+|+.|+|||++.+ ..++.++|||||||++|||++|+
T Consensus 215 -ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~ 290 (371)
T 3q60_A 215 -LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG---PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290 (371)
T ss_dssp -EEETTCSGGGEEECTTSCEEECCGGGEEETTCEE---EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred -CccCcCCHHHEEECCCCCEEEEecceeeecCCCc---cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence 9999999999999999999999999998765432 14556799999999987 67899999999999999999999
Q ss_pred CCCCCCChHHHHHH-----hhhcCcc--cCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 633 KPWRNSTPSQVISA-----VGFKGRR--LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 633 ~Pf~~~~~~~~~~~-----i~~~~~~--l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
.||....+...... ....... .+.+..+++.+.+||.+||+.||++|||+.++++
T Consensus 291 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 291 LPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp CSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 99987644221100 0011112 2333578999999999999999999999999975
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=345.16 Aligned_cols=254 Identities=23% Similarity=0.342 Sum_probs=200.1
Q ss_pred cccccCceEEEEEeccCCceEEEEEEEcC-CceEEEEEecccc---------chHHHHHHHHHHHHHHcCCCCceeEEec
Q 005247 428 LEIRWSELLIKKKIGEGSFGTVYHAEWRN-SDVAVKILIEQEF---------HEDRFKEFLREVAIMKGLRHPNIVLLMG 497 (706)
Q Consensus 428 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~-~~vAVKvl~~~~~---------~~~~~~~~~~Ei~iL~~L~HpnIv~l~~ 497 (706)
+....++|++.+.||+|+||.||+|.+.. ..||+|++..... .....+.+.+|+.+++.++||||+++++
T Consensus 17 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 96 (362)
T 3pg1_A 17 LHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRD 96 (362)
T ss_dssp HHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSE
T ss_pred HHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceee
Confidence 44556889999999999999999998754 4599999854322 2334578999999999999999999999
Q ss_pred cc-----cCCCceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCC
Q 005247 498 AV-----TEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY 572 (706)
Q Consensus 498 ~~-----~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~ 572 (706)
++ .....+++||||+. |+|.+++... ...+++..++.++.||+.||.|||++| |+||||||+|||++.++
T Consensus 97 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~~~ 171 (362)
T 3pg1_A 97 IFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ--RIVISPQHIQYFMYHILLGLHVLHEAG--VVHRDLHPGNILLADNN 171 (362)
T ss_dssp EEEECCTTTCCEEEEEEECCS-EEHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTC
T ss_pred eEEeccCCCcceEEEEEccCC-CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCc--CEecCCChHHEEEcCCC
Confidence 98 33446899999997 5777777633 235899999999999999999999999 99999999999999999
Q ss_pred cEEEeecCccccCCCCcccCCCCCCCCCccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcC
Q 005247 573 TVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG 651 (706)
Q Consensus 573 ~vKL~DFGla~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~ 651 (706)
.+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....+....
T Consensus 172 ~~kl~Dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~ 250 (362)
T 3pg1_A 172 DITICDFNLAREDTADA-NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVV 250 (362)
T ss_dssp CEEECCTTC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred CEEEEecCccccccccc-ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHc
Confidence 99999999997544332 2345678999999999987 678999999999999999999999999887666554442110
Q ss_pred c------------------------------ccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 652 R------------------------------RLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 652 ~------------------------------~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
. ....+..+++.+.+||.+||+.||++|||+.++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 251 GTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp CCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 0 01123467889999999999999999999999976
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=332.49 Aligned_cols=245 Identities=27% Similarity=0.447 Sum_probs=194.7
Q ss_pred CceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccC---------
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE--------- 501 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~--------- 501 (706)
++|++.+.||+|+||.||+|.+.. ..||+|++... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc---HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 579999999999999999999864 45999998543 3456788999999999999999999988744
Q ss_pred ----CCceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEe
Q 005247 502 ----PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVC 577 (706)
Q Consensus 502 ----~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~ 577 (706)
.+..++||||+++++|.+++.... ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSEN--LNQQRDEYWRLFRQILEALSYIHSQG--IIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSC--GGGCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEEC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccc--cccchHHHHHHHHHHHHHHHHHHhCC--eecccCCHHhEEEcCCCCEEEe
Confidence 356899999999999999997432 35778899999999999999999999 9999999999999999999999
Q ss_pred ecCccccCCCCc--------------ccCCCCCCCCCccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCC-hH
Q 005247 578 DFGLSRSKPNTY--------------ISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNST-PS 641 (706)
Q Consensus 578 DFGla~~~~~~~--------------~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSLGviL~ELltG~~Pf~~~~-~~ 641 (706)
|||++....... .......||+.|+|||++.+. .++.++||||||+++|+|++ ||.... ..
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~ 235 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERV 235 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHH
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHH
Confidence 999998654321 122345689999999999865 68999999999999999998 665432 22
Q ss_pred HHHHHhhhcC--cccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 642 QVISAVGFKG--RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 642 ~~~~~i~~~~--~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
+....+.... .+..++...++.+.+||.+||+.||.+|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 236 NILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 2333332111 123345567788999999999999999999999986
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=350.17 Aligned_cols=248 Identities=21% Similarity=0.276 Sum_probs=198.0
Q ss_pred cccCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCC--------CCceeEEeccc
Q 005247 430 IRWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLR--------HPNIVLLMGAV 499 (706)
Q Consensus 430 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~--------HpnIv~l~~~~ 499 (706)
+..++|++.+.||+|+||.||+|.+..+ .||+|++... ....+.+.+|+.+++.++ |+||+++++++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~ 110 (397)
T 1wak_A 34 LFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDF 110 (397)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEE
T ss_pred hcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecce
Confidence 3457899999999999999999988654 4999998643 344567889999999885 78899999998
Q ss_pred c----CCCceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhc-CCCcccccCCCCcEEECCCC--
Q 005247 500 T----EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR-RPPIVHRDLKSPNLLVDSTY-- 572 (706)
Q Consensus 500 ~----~~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~-g~~IIHrDLKp~NILl~~~~-- 572 (706)
. ....+++||||+. ++|.+.+.... ...+++..++.++.||+.||.|||++ | |+||||||+|||++.++
T Consensus 111 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~g--ivHrDikp~NIll~~~~~~ 186 (397)
T 1wak_A 111 KISGVNGTHICMVFEVLG-HHLLKWIIKSN-YQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQY 186 (397)
T ss_dssp EEEETTEEEEEEEECCCC-CBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECCCCSGGGEEECCCHHH
T ss_pred eecCCCCceEEEEEeccC-ccHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHeeEeccchh
Confidence 7 5667999999995 45555553221 23588999999999999999999998 9 99999999999998775
Q ss_pred -----------------------------------------------cEEEeecCccccCCCCcccCCCCCCCCCccCcc
Q 005247 573 -----------------------------------------------TVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPE 605 (706)
Q Consensus 573 -----------------------------------------------~vKL~DFGla~~~~~~~~~~~~~~Gt~~Y~APE 605 (706)
.+||+|||+++..... .....||+.|+|||
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y~aPE 263 (397)
T 1wak_A 187 IRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRSLE 263 (397)
T ss_dssp HHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGGGCCHH
T ss_pred hhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---CccCCCCCcccCCh
Confidence 7999999999876543 34567999999999
Q ss_pred ccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH------HHHHHhhh-cCc--------------------------
Q 005247 606 VLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPS------QVISAVGF-KGR-------------------------- 652 (706)
Q Consensus 606 ~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~------~~~~~i~~-~~~-------------------------- 652 (706)
++.+..++.++|||||||++|||++|+.||...+.. .....+.. .+.
T Consensus 264 ~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 343 (397)
T 1wak_A 264 VLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHIT 343 (397)
T ss_dssp HHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCC
T ss_pred hhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccc
Confidence 999999999999999999999999999999765421 11111100 000
Q ss_pred -------------ccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 653 -------------RLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 653 -------------~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
....+...++.+.+||.+||+.||++|||+.|+++
T Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 344 KLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred ccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 01123344578899999999999999999999975
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=346.22 Aligned_cols=253 Identities=21% Similarity=0.256 Sum_probs=191.1
Q ss_pred ccccCceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCc--
Q 005247 429 EIRWSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN-- 504 (706)
Q Consensus 429 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~-- 504 (706)
....++|++.+.||+|+||.||+|.+.. ..||||++....... ..+.+|+..++.++||||+++++++...+.
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR---NRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC---CHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc---HHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 3456789999999999999999999874 459999886543222 355677888888999999999999854332
Q ss_pred -----eEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHH--hcCCCcccccCCCCcEEECC-CCcEEE
Q 005247 505 -----LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLH--QRRPPIVHRDLKSPNLLVDS-TYTVKV 576 (706)
Q Consensus 505 -----~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLH--s~g~~IIHrDLKp~NILl~~-~~~vKL 576 (706)
.++||||+.++.+..+.........+++..++.++.|++.||.||| ++| |+||||||+|||++. ++.+||
T Consensus 96 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~--ivH~Dlkp~NIll~~~~~~~kl 173 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN--VCHRDIKPHNVLVNEADGTLKL 173 (360)
T ss_dssp TTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC--CBCSCCCGGGEEEETTTTEEEE
T ss_pred ccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC--eecCcCCHHHEEEeCCCCcEEE
Confidence 7899999987533333222223345889999999999999999999 888 999999999999996 899999
Q ss_pred eecCccccCCCCcccCCCCCCCCCccCccccccCC-CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCc---
Q 005247 577 CDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDP-SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR--- 652 (706)
Q Consensus 577 ~DFGla~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~-~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~--- 652 (706)
+|||+++...... ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...+.......+.....
T Consensus 174 ~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 252 (360)
T 3e3p_A 174 CDFGSAKKLSPSE-PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPS 252 (360)
T ss_dssp CCCTTCBCCCTTS-CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred eeCCCceecCCCC-CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCC
Confidence 9999998765433 234567899999999997655 89999999999999999999999998887666554421100
Q ss_pred ---------------------------ccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 653 ---------------------------RLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 653 ---------------------------~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
....+...++++.+||.+||+.||.+|||+.|+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 253 REVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp HHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 01122336789999999999999999999999986
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=359.23 Aligned_cols=256 Identities=20% Similarity=0.307 Sum_probs=211.3
Q ss_pred cCceEEEEEeccCCceEEEEEEEc--CCceEEEEEeccccchHHHHHHHHHHHHHHcCCC-CceeEEeccccCCCceEEE
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRH-PNIVLLMGAVTEPPNLSIV 508 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~H-pnIv~l~~~~~~~~~~~lV 508 (706)
.++|++++.||+|+||.||+|.+. +..||||++...... ..+.+|+.+++.++| ++|..+..++.+.+..++|
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lv 81 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLV 81 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEE
Confidence 468999999999999999999976 445999987655433 247789999999986 5666677777788889999
Q ss_pred EEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEE---CCCCcEEEeecCccccC
Q 005247 509 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLV---DSTYTVKVCDFGLSRSK 585 (706)
Q Consensus 509 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl---~~~~~vKL~DFGla~~~ 585 (706)
|||+ +++|.+++.... ..+++..++.|+.||+.||+|||+++ ||||||||+|||| +.++.+||+|||+++..
T Consensus 82 me~~-g~sL~~ll~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (483)
T 3sv0_A 82 MDLL-GPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (483)
T ss_dssp EECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred EECC-CCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence 9999 899999997432 35899999999999999999999999 9999999999999 58889999999999865
Q ss_pred CCCcc-------cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHhhh---cCc
Q 005247 586 PNTYI-------SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPS---QVISAVGF---KGR 652 (706)
Q Consensus 586 ~~~~~-------~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~---~~~~~i~~---~~~ 652 (706)
..... ......||+.|+|||++.+..++.++|||||||+||||++|+.||...... +.+..+.. ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (483)
T 3sv0_A 157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS 236 (483)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC
T ss_pred cCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc
Confidence 44321 223667999999999999999999999999999999999999999875432 22222211 111
Q ss_pred ccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhc
Q 005247 653 RLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 696 (706)
Q Consensus 653 ~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~ 696 (706)
...++..++.++.+||.+||+.+|++||++.+|++.|++++...
T Consensus 237 ~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~ 280 (483)
T 3sv0_A 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE 280 (483)
T ss_dssp HHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence 22334678999999999999999999999999999999998754
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=338.20 Aligned_cols=244 Identities=25% Similarity=0.393 Sum_probs=197.1
Q ss_pred ccccCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccch----HHHHHHHHHHHHHHcC----CCCceeEEecc
Q 005247 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHE----DRFKEFLREVAIMKGL----RHPNIVLLMGA 498 (706)
Q Consensus 429 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~----~~~~~~~~Ei~iL~~L----~HpnIv~l~~~ 498 (706)
+...++|++.+.||+|+||.||+|.+..+ .||+|++....... .....+.+|+.+++++ +|+||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 44467899999999999999999988544 49999986554322 2233466799999888 89999999999
Q ss_pred ccCCCceEEEEEe-ccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEEC-CCCcEEE
Q 005247 499 VTEPPNLSIVTEY-LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVD-STYTVKV 576 (706)
Q Consensus 499 ~~~~~~~~lV~E~-~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~-~~~~vKL 576 (706)
+...+..++|||+ +.+++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+||+++ .++.+||
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~kl 181 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEK---GPLGEGPSRCFFGQVVAAIQHCHSRG--VVHRDIKDENILIDLRRGCAKL 181 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHT--EECCCCSGGGEEEETTTTEEEE
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChhhEEEeCCCCeEEE
Confidence 9999999999999 7899999999643 35889999999999999999999999 99999999999998 8899999
Q ss_pred eecCccccCCCCcccCCCCCCCCCccCccccccCCCC-chhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccC
Q 005247 577 CDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSN-EKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLE 655 (706)
Q Consensus 577 ~DFGla~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s-~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~ 655 (706)
+|||+++...... .....||..|+|||++.+..+. .++||||||+++|+|++|+.||.... +. ......
T Consensus 182 ~dfg~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--~~------~~~~~~ 251 (312)
T 2iwi_A 182 IDFGSGALLHDEP--YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ--EI------LEAELH 251 (312)
T ss_dssp CCCSSCEECCSSC--BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--HH------HHTCCC
T ss_pred EEcchhhhcccCc--ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH--HH------hhhccC
Confidence 9999998765432 3456799999999999877764 58999999999999999999997532 11 123456
Q ss_pred CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 656 IPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 656 ~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
++..++.++.+||.+||+.||++|||+.++++
T Consensus 252 ~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 252 FPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 77889999999999999999999999999987
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=336.53 Aligned_cols=248 Identities=20% Similarity=0.257 Sum_probs=201.4
Q ss_pred cccCceEEEEEeccCCceEEEEEEEcCC---ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCc------eeEEecccc
Q 005247 430 IRWSELLIKKKIGEGSFGTVYHAEWRNS---DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN------IVLLMGAVT 500 (706)
Q Consensus 430 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~---~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~Hpn------Iv~l~~~~~ 500 (706)
...++|++.+.||+|+||.||+|.+..+ .||+|++... ....+.+.+|+.+++.++|++ ++.+++++.
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~ 92 (355)
T 2eu9_A 16 WLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFN 92 (355)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEE
T ss_pred eecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeee
Confidence 4457899999999999999999988643 4999998643 344567888999999887655 899999999
Q ss_pred CCCceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEE------------
Q 005247 501 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLV------------ 568 (706)
Q Consensus 501 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl------------ 568 (706)
..+..++||||+ +++|.+++.... ...+++..++.++.||+.||.|||++| |+||||||+|||+
T Consensus 93 ~~~~~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~~~~ 168 (355)
T 2eu9_A 93 FHGHMCIAFELL-GKNTFEFLKENN-FQPYPLPHVRHMAYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEH 168 (355)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEESCCCEEEEECCC
T ss_pred eCCeEEEEEecc-CCChHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEeccccccccccc
Confidence 999999999999 556666664332 235889999999999999999999999 9999999999999
Q ss_pred -------CCCCcEEEeecCccccCCCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH
Q 005247 569 -------DSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPS 641 (706)
Q Consensus 569 -------~~~~~vKL~DFGla~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~ 641 (706)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|..||......
T Consensus 169 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 245 (355)
T 2eu9_A 169 KSCEEKSVKNTSIRVADFGSATFDHEH---HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR 245 (355)
T ss_dssp -CCCEEEESCCCEEECCCTTCEETTSC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ccccccccCCCcEEEeecCcccccccc---ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence 56789999999999865433 24568999999999999999999999999999999999999999987766
Q ss_pred HHHHHhhhcCcc------------------------------------------cCCCCCCcHHHHHHHHHhhhhCCCCC
Q 005247 642 QVISAVGFKGRR------------------------------------------LEIPKNVNPMVAALIETCWAEEPEIR 679 (706)
Q Consensus 642 ~~~~~i~~~~~~------------------------------------------l~~p~~~s~el~dLI~~cL~~dP~~R 679 (706)
+....+...... .......+.++.+||.+||+.||++|
T Consensus 246 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 325 (355)
T 2eu9_A 246 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR 325 (355)
T ss_dssp HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence 554433211100 00111235689999999999999999
Q ss_pred CCHHHHHH
Q 005247 680 PSFPSIME 687 (706)
Q Consensus 680 PS~~eIl~ 687 (706)
||+.++++
T Consensus 326 pt~~e~l~ 333 (355)
T 2eu9_A 326 ITLAEALL 333 (355)
T ss_dssp CCHHHHTT
T ss_pred cCHHHHhc
Confidence 99999985
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=342.37 Aligned_cols=245 Identities=22% Similarity=0.375 Sum_probs=205.5
Q ss_pred cccccCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccch----HHHHHHHHHHHHHHcCC--CCceeEEeccc
Q 005247 428 LEIRWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHE----DRFKEFLREVAIMKGLR--HPNIVLLMGAV 499 (706)
Q Consensus 428 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~----~~~~~~~~Ei~iL~~L~--HpnIv~l~~~~ 499 (706)
.+...++|++.+.||+|+||.||+|.+..+ .||+|++....... ...+.+.+|+.+++.++ |+||+++++++
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~ 117 (320)
T 3a99_A 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117 (320)
T ss_dssp --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence 445567899999999999999999988644 49999987654322 12245668999999996 59999999999
Q ss_pred cCCCceEEEEEeccC-CchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEEC-CCCcEEEe
Q 005247 500 TEPPNLSIVTEYLSR-GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVD-STYTVKVC 577 (706)
Q Consensus 500 ~~~~~~~lV~E~~~g-gsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~-~~~~vKL~ 577 (706)
...+..++|||++.+ ++|.+++... ..+++..++.++.||+.||+|||++| |+||||||+|||++ .++.+||+
T Consensus 118 ~~~~~~~lv~e~~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~kL~ 192 (320)
T 3a99_A 118 ERPDSFVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLI 192 (320)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEEC
T ss_pred ecCCcEEEEEEcCCCCccHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cEeCCCCHHHEEEeCCCCCEEEe
Confidence 999999999999976 8999998642 35889999999999999999999999 99999999999998 78899999
Q ss_pred ecCccccCCCCcccCCCCCCCCCccCccccccCCC-CchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCC
Q 005247 578 DFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPS-NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEI 656 (706)
Q Consensus 578 DFGla~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~ 656 (706)
|||+++...... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||.... +. ......+
T Consensus 193 Dfg~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--~~------~~~~~~~ 262 (320)
T 3a99_A 193 DFGSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--EI------IRGQVFF 262 (320)
T ss_dssp CCTTCEECCSSC--BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--HH------HHCCCCC
T ss_pred eCcccccccccc--ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh--hh------hcccccc
Confidence 999998765432 245679999999999987766 678999999999999999999997532 11 1223456
Q ss_pred CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 657 PKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 657 p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
+..+++++.+||.+||+.||++|||+.++++
T Consensus 263 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 263 RQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 6789999999999999999999999999987
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=342.17 Aligned_cols=249 Identities=20% Similarity=0.299 Sum_probs=198.2
Q ss_pred ccccCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCC-----------CCceeEE
Q 005247 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLR-----------HPNIVLL 495 (706)
Q Consensus 429 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~-----------HpnIv~l 495 (706)
.+...+|++.+.||+|+||.||+|.+..+ .||+|++... ....+.+.+|+.+++++. |+||+++
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~ 91 (373)
T 1q8y_A 15 PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL 91 (373)
T ss_dssp EETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred cccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC---ccchhhhhHHHHHHHHhhcccccchhccccchHHHH
Confidence 34567899999999999999999997544 4999998643 234457788999998876 7899999
Q ss_pred eccccCCC----ceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhc-CCCcccccCCCCcEEEC-
Q 005247 496 MGAVTEPP----NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR-RPPIVHRDLKSPNLLVD- 569 (706)
Q Consensus 496 ~~~~~~~~----~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~-g~~IIHrDLKp~NILl~- 569 (706)
++++...+ .+++|||++ +++|.+++..... ..+++..++.++.||+.||+|||++ | |+||||||+|||++
T Consensus 92 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~~--ivH~Dikp~NIll~~ 167 (373)
T 1q8y_A 92 LDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEH-RGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEI 167 (373)
T ss_dssp CEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEE
T ss_pred HHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhc-cCCcHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChHHeEEec
Confidence 99987544 689999999 8899999864322 3488999999999999999999998 9 99999999999994
Q ss_pred -----CCCcEEEeecCccccCCCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH---
Q 005247 570 -----STYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPS--- 641 (706)
Q Consensus 570 -----~~~~vKL~DFGla~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~--- 641 (706)
..+.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus 168 ~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 244 (373)
T 1q8y_A 168 VDSPENLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 244 (373)
T ss_dssp EETTTTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred cCCCcCcceEEEcccccccccCCC---CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccC
Confidence 4458999999999876543 24557899999999999999999999999999999999999999865421
Q ss_pred ---HHHHHhhh-c---------------------------------------CcccCCCCCCcHHHHHHHHHhhhhCCCC
Q 005247 642 ---QVISAVGF-K---------------------------------------GRRLEIPKNVNPMVAALIETCWAEEPEI 678 (706)
Q Consensus 642 ---~~~~~i~~-~---------------------------------------~~~l~~p~~~s~el~dLI~~cL~~dP~~ 678 (706)
+....+.. . .....++..+++++.+||.+||+.||++
T Consensus 245 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 324 (373)
T 1q8y_A 245 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK 324 (373)
T ss_dssp CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred ChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccc
Confidence 11111100 0 0112334456788999999999999999
Q ss_pred CCCHHHHHH
Q 005247 679 RPSFPSIME 687 (706)
Q Consensus 679 RPS~~eIl~ 687 (706)
|||+.|+++
T Consensus 325 Rpt~~ell~ 333 (373)
T 1q8y_A 325 RADAGGLVN 333 (373)
T ss_dssp CBCHHHHHT
T ss_pred cCCHHHHhh
Confidence 999999987
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=348.41 Aligned_cols=248 Identities=22% Similarity=0.372 Sum_probs=181.1
Q ss_pred CceEE-EEEeccCCceEEEEEEEc----CCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccc--cCCCce
Q 005247 433 SELLI-KKKIGEGSFGTVYHAEWR----NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAV--TEPPNL 505 (706)
Q Consensus 433 ~~y~i-~~~LG~G~fG~Vy~a~~~----~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~--~~~~~~ 505 (706)
+.|++ .++||+|+||.||+|.+. +..||+|++...... ..+.+|+.+++.++||||+++++++ ......
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 95 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKV 95 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence 34665 457999999999999975 345999998654433 3677899999999999999999998 456789
Q ss_pred EEEEEeccCCchhhhcccC------CCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEE----CCCCcEE
Q 005247 506 SIVTEYLSRGSLYKLLHIP------DARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLV----DSTYTVK 575 (706)
Q Consensus 506 ~lV~E~~~ggsL~~~l~~~------~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl----~~~~~vK 575 (706)
++||||+.+ +|.+++... .....+++..++.++.||+.||+|||++| |+||||||+|||+ +.++.+|
T Consensus 96 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~k 172 (405)
T 3rgf_A 96 WLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVK 172 (405)
T ss_dssp EEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECCSSTTTTCEE
T ss_pred EEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeCCCcCHHHeEEecCCCCCCcEE
Confidence 999999965 777776421 12234889999999999999999999999 9999999999999 6778999
Q ss_pred EeecCccccCCCCc---ccCCCCCCCCCccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChH---------H
Q 005247 576 VCDFGLSRSKPNTY---ISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPS---------Q 642 (706)
Q Consensus 576 L~DFGla~~~~~~~---~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~---------~ 642 (706)
|+|||+++...... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... +
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 252 (405)
T 3rgf_A 173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD 252 (405)
T ss_dssp ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHH
T ss_pred EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHH
Confidence 99999998755322 223456799999999999875 4899999999999999999999999765432 1
Q ss_pred HHHHhh-hcCccc-----------------------------------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHH
Q 005247 643 VISAVG-FKGRRL-----------------------------------EIPKNVNPMVAALIETCWAEEPEIRPSFPSIM 686 (706)
Q Consensus 643 ~~~~i~-~~~~~l-----------------------------------~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl 686 (706)
....+. ..+... ......++.+.+||.+||+.||.+|||+.|++
T Consensus 253 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L 332 (405)
T 3rgf_A 253 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM 332 (405)
T ss_dssp HHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 111110 000000 00112367899999999999999999999997
Q ss_pred H
Q 005247 687 E 687 (706)
Q Consensus 687 ~ 687 (706)
+
T Consensus 333 ~ 333 (405)
T 3rgf_A 333 Q 333 (405)
T ss_dssp T
T ss_pred c
Confidence 6
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=336.61 Aligned_cols=245 Identities=23% Similarity=0.352 Sum_probs=173.6
Q ss_pred cCceEEEE-EeccCCceEEEEEEEc--CCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccC----CCc
Q 005247 432 WSELLIKK-KIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE----PPN 504 (706)
Q Consensus 432 ~~~y~i~~-~LG~G~fG~Vy~a~~~--~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~----~~~ 504 (706)
.++|++.+ .||+|+||.||+|.+. +..||+|++.... .. ..+....++.++||||+++++++.. ...
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~---~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 100 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP---KA---RQEVDHHWQASGGPHIVCILDVYENMHHGKRC 100 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH---HH---HHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH---HH---HHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence 46788855 6999999999999987 4459999986532 11 1122333566789999999999865 445
Q ss_pred eEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECC---CCcEEEeecCc
Q 005247 505 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS---TYTVKVCDFGL 581 (706)
Q Consensus 505 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~---~~~vKL~DFGl 581 (706)
.++||||+.+|+|.+++.... ...+++..++.++.||+.||.|||++| |+||||||+|||++. ++.+||+|||+
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~--ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQERG-DQAFTEREAAEIMRDIGTAIQFLHSHN--IAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEEeccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEEecCCCceEEEecccc
Confidence 899999999999999997443 235899999999999999999999999 999999999999976 45699999999
Q ss_pred cccCCCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHH----hhhcCc--ccC
Q 005247 582 SRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISA----VGFKGR--RLE 655 (706)
Q Consensus 582 a~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~----i~~~~~--~l~ 655 (706)
++...... .....||+.|+|||++.+..++.++||||||+++|+|++|..||........... +..... ...
T Consensus 178 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (336)
T 3fhr_A 178 AKETTQNA--LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNP 255 (336)
T ss_dssp CEEC------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTT
T ss_pred ceeccccc--cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCch
Confidence 98655432 2456789999999999888899999999999999999999999987655443211 111111 122
Q ss_pred CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 656 IPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 656 ~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
....+++++.+||.+||+.||.+|||+.++++
T Consensus 256 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 256 EWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp TSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 23578999999999999999999999999987
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=339.68 Aligned_cols=251 Identities=25% Similarity=0.258 Sum_probs=201.6
Q ss_pred ccccCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCC-CC-----ceeEEecccc
Q 005247 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HP-----NIVLLMGAVT 500 (706)
Q Consensus 429 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~-Hp-----nIv~l~~~~~ 500 (706)
+...++|++.+.||+|+||+||+|.+..+ .||||++... ......+.+|+.+++.++ |+ +|+++++++.
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~ 126 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM 126 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec
Confidence 34467999999999999999999998754 4999998643 334456778888888774 44 4999999999
Q ss_pred CCCceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEEC--CCCcEEEee
Q 005247 501 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVD--STYTVKVCD 578 (706)
Q Consensus 501 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~--~~~~vKL~D 578 (706)
..+..++||||+. ++|.+++..... ..+++..++.++.||+.||.|||++..+||||||||+|||++ .++.+||+|
T Consensus 127 ~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~D 204 (382)
T 2vx3_A 127 FRNHLCLVFEMLS-YNLYDLLRNTNF-RGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVD 204 (382)
T ss_dssp ETTEEEEEEECCC-CBHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred cCCceEEEEecCC-CCHHHHHhhcCc-CCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence 9999999999996 599999864432 248899999999999999999995322399999999999994 477899999
Q ss_pred cCccccCCCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCccc----
Q 005247 579 FGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRL---- 654 (706)
Q Consensus 579 FGla~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l---- 654 (706)
||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+.......
T Consensus 205 FG~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 281 (382)
T 2vx3_A 205 FGSSCQLGQR---IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHI 281 (382)
T ss_dssp CTTCEETTCC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred ccCceecccc---cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 9999876543 245689999999999999999999999999999999999999999887766655442110000
Q ss_pred ------------CCC------------------C----------------------------CCcHHHHHHHHHhhhhCC
Q 005247 655 ------------EIP------------------K----------------------------NVNPMVAALIETCWAEEP 676 (706)
Q Consensus 655 ------------~~p------------------~----------------------------~~s~el~dLI~~cL~~dP 676 (706)
.++ + ..++++.+||.+||+.||
T Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP 361 (382)
T 2vx3_A 282 LDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDP 361 (382)
T ss_dssp HTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCT
T ss_pred HHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCCh
Confidence 000 0 001478999999999999
Q ss_pred CCCCCHHHHHH
Q 005247 677 EIRPSFPSIME 687 (706)
Q Consensus 677 ~~RPS~~eIl~ 687 (706)
++|||+.|+++
T Consensus 362 ~~Rpta~e~L~ 372 (382)
T 2vx3_A 362 KTRIQPYYALQ 372 (382)
T ss_dssp TTSCCHHHHTT
T ss_pred hhCCCHHHHhc
Confidence 99999999875
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=344.09 Aligned_cols=250 Identities=26% Similarity=0.391 Sum_probs=193.1
Q ss_pred cccccCceEEEEEeccCCceEE-EEEEEcCCceEEEEEeccccchHHHHHHHHHHHHHHcC-CCCceeEEeccccCCCce
Q 005247 428 LEIRWSELLIKKKIGEGSFGTV-YHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNL 505 (706)
Q Consensus 428 ~~i~~~~y~i~~~LG~G~fG~V-y~a~~~~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~ 505 (706)
+.+...+|.+.+.||+|+||+| |++...+..||||++...... .+.+|+.+++.+ +||||+++++++.+....
T Consensus 19 ~~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~-----~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 93 (432)
T 3p23_A 19 VIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS-----FADREVQLLRESDEHPNVIRYFCTEKDRQFQ 93 (432)
T ss_dssp EEETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE-----ECHHHHHHHHHSCCCTTBCCEEEEEEETTEE
T ss_pred EEEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH-----HHHHHHHHHHhccCCCCcCeEEEEEecCCEE
Confidence 4555667999999999999984 555666777999998654322 355799999999 799999999999999999
Q ss_pred EEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECC-----CCcEEEeecC
Q 005247 506 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS-----TYTVKVCDFG 580 (706)
Q Consensus 506 ~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~-----~~~vKL~DFG 580 (706)
++||||+. |+|.+++..... ...+..++.++.||+.||.|||++| |+||||||+|||++. ...+||+|||
T Consensus 94 ~lv~E~~~-g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NIll~~~~~~~~~~~kL~DFG 168 (432)
T 3p23_A 94 YIAIELCA-ATLQEYVEQKDF--AHLGLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFG 168 (432)
T ss_dssp EEEEECCS-EEHHHHHHSSSC--CCCSSCHHHHHHHHHHHHHHHHHTT--CCCCCCSTTSEEECCCBTTTBCCEEECCTT
T ss_pred EEEEECCC-CCHHHHHHhcCC--CccchhHHHHHHHHHHHHHHHHHCc--CEeCCCCHHHEEEecCCCCCceeEEEeccc
Confidence 99999996 599999864432 2445566789999999999999999 999999999999953 3368899999
Q ss_pred ccccCCCCc---ccCCCCCCCCCccCccccc---cCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcc
Q 005247 581 LSRSKPNTY---ISSKTAAGTPEWMAPEVLR---EDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRR 653 (706)
Q Consensus 581 la~~~~~~~---~~~~~~~Gt~~Y~APE~l~---~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~ 653 (706)
+++...... .......||+.|+|||++. ...++.++|||||||++|||++ |..||..................
T Consensus 169 ~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~ 248 (432)
T 3p23_A 169 LCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLD 248 (432)
T ss_dssp EEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCT
T ss_pred ceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCcc
Confidence 998765332 2234567999999999997 4567889999999999999999 89999766554443332211111
Q ss_pred -cCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 654 -LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 654 -l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
...+...+..+.+||.+||+.||.+|||+.++++
T Consensus 249 ~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 249 CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 1222345677899999999999999999999984
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-37 Score=320.66 Aligned_cols=232 Identities=15% Similarity=0.152 Sum_probs=191.6
Q ss_pred cccCceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceE
Q 005247 430 IRWSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFH-EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS 506 (706)
Q Consensus 430 i~~~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 506 (706)
+..++|++.+.||+|+||.||+|.+.. ..||+|++...... ....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 345689999999999999999999874 45999998765433 455678999999999999999999999999999999
Q ss_pred EEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCC
Q 005247 507 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP 586 (706)
Q Consensus 507 lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~ 586 (706)
+||||++|++|.++++.. .....+..++.||+.||+|||++| |+||||||+|||++.++.+||+++|
T Consensus 108 lv~e~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH~~g--ivH~Dikp~NIll~~~g~~kl~~~~------ 174 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRAG--VALSIDHPSRVRVSIDGDVVLAYPA------ 174 (286)
T ss_dssp EEEECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEETTSCEEECSCC------
T ss_pred EEEEecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHHCC--CccCCCCcccEEEcCCCCEEEEecc------
Confidence 999999999999998532 244567889999999999999999 9999999999999999999998543
Q ss_pred CCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHh-hh-cCcc---cCCCCCCc
Q 005247 587 NTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAV-GF-KGRR---LEIPKNVN 661 (706)
Q Consensus 587 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i-~~-~~~~---l~~p~~~s 661 (706)
|++ .++.++||||||+++|||++|+.||...+..+..... .. .... ...+..++
T Consensus 175 --------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T 3uqc_A 175 --------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIP 233 (286)
T ss_dssp --------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSC
T ss_pred --------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCC
Confidence 333 3689999999999999999999999876653321100 00 1111 12346789
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhc
Q 005247 662 PMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 696 (706)
Q Consensus 662 ~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~ 696 (706)
+++.+||.+||+.||++| |+.++++.|+++....
T Consensus 234 ~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 234 FQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp HHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred HHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 999999999999999999 9999999999987654
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=338.37 Aligned_cols=245 Identities=24% Similarity=0.372 Sum_probs=185.6
Q ss_pred CceEEEEEeccCCceEEEEE-EEcCCceEEEEEeccccchHHHHHHHHHHHHHHcC-CCCceeEEeccccCCCceEEEEE
Q 005247 433 SELLIKKKIGEGSFGTVYHA-EWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSIVTE 510 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a-~~~~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~lV~E 510 (706)
+.|.+.+.||+|+||+||.+ ...+..||||++.... .+.+.+|+.+++.+ +||||+++++++.+.+..++|||
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~-----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E 89 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF-----CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALE 89 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH-----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEe
Confidence 34666789999999999755 4456679999986532 24677899999876 89999999999999999999999
Q ss_pred eccCCchhhhcccCCCcc----cccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCC-------------Cc
Q 005247 511 YLSRGSLYKLLHIPDARV----VVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDST-------------YT 573 (706)
Q Consensus 511 ~~~ggsL~~~l~~~~~~~----~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~-------------~~ 573 (706)
|+. |+|.+++....... ...+..++.++.||+.||+|||++| |+||||||+|||++.+ +.
T Consensus 90 ~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 90 LCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp CCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred cCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCcccccccccCCCceE
Confidence 995 69999996433211 1133356789999999999999999 9999999999999654 48
Q ss_pred EEEeecCccccCCCCcc----cCCCCCCCCCccCcccccc-------CCCCchhHHHHHHHHHHHHHh-CCCCCCCCChH
Q 005247 574 VKVCDFGLSRSKPNTYI----SSKTAAGTPEWMAPEVLRE-------DPSNEKSDVFSFGVILWELIT-LQKPWRNSTPS 641 (706)
Q Consensus 574 vKL~DFGla~~~~~~~~----~~~~~~Gt~~Y~APE~l~~-------~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~ 641 (706)
+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|||++ |..||......
T Consensus 167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~ 246 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246 (434)
T ss_dssp EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence 99999999987654321 1234579999999999976 568999999999999999999 89999766543
Q ss_pred HHHHHhhhcCcccCC-----CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 642 QVISAVGFKGRRLEI-----PKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 642 ~~~~~i~~~~~~l~~-----p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
+.. +......... +..+++++.+||.+||+.||.+|||+.++++
T Consensus 247 ~~~--i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 247 ESN--IIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HHH--HHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHH--HhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 321 1111111111 1235689999999999999999999999986
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-36 Score=314.06 Aligned_cols=224 Identities=25% Similarity=0.398 Sum_probs=180.2
Q ss_pred cCceEEE-EEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHH-HcCCCCceeEEeccccC----CC
Q 005247 432 WSELLIK-KKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIM-KGLRHPNIVLLMGAVTE----PP 503 (706)
Q Consensus 432 ~~~y~i~-~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL-~~L~HpnIv~l~~~~~~----~~ 503 (706)
.++|.+. +.||+|+||.||+|.+..+ .||+|++... ..+.+|+.++ +.++||||+++++++.. ..
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 88 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 88 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCc
Confidence 3567777 7899999999999998644 5999998643 3566788888 56689999999998876 66
Q ss_pred ceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECC---CCcEEEeecC
Q 005247 504 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS---TYTVKVCDFG 580 (706)
Q Consensus 504 ~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~---~~~vKL~DFG 580 (706)
..++||||+++|+|.+++.... ...+++..++.++.||+.||.|||++| |+||||||+|||++. ++.+||+|||
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 89 CLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp EEEEEECCCCSCBHHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred eEEEEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 7899999999999999997532 235899999999999999999999999 999999999999998 7899999999
Q ss_pred ccccCCCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh--hcCcccCCC-
Q 005247 581 LSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVG--FKGRRLEIP- 657 (706)
Q Consensus 581 la~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~--~~~~~l~~p- 657 (706)
++.... +..++.++||||||+++|||++|+.||............. .......++
T Consensus 166 ~a~~~~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (299)
T 3m2w_A 166 FAKETT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 223 (299)
T ss_dssp TCEECT----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCH
T ss_pred cccccc----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCc
Confidence 886432 2346789999999999999999999998765543322111 111122233
Q ss_pred ---CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 658 ---KNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 658 ---~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
..+++++.+||.+||+.||++|||+.++++
T Consensus 224 ~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 224 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 578999999999999999999999999987
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=333.37 Aligned_cols=245 Identities=16% Similarity=0.148 Sum_probs=187.5
Q ss_pred cccCceEEEEEeccCCceEEEEEEEc--CCceEEEEEecccc-chHHHHHHHHHHHHHHcCCC-CceeE-----------
Q 005247 430 IRWSELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRH-PNIVL----------- 494 (706)
Q Consensus 430 i~~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKvl~~~~~-~~~~~~~~~~Ei~iL~~L~H-pnIv~----------- 494 (706)
....+|...+.||+|+||.||+|.+. ++.||||++..... .....+.+.+|+.+++.++| .|...
T Consensus 75 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~ 154 (413)
T 3dzo_A 75 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 154 (413)
T ss_dssp SCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCC
T ss_pred CCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccch
Confidence 44567899999999999999999987 55699999863322 22335678899999999977 32111
Q ss_pred ----------EeccccC-----CCceEEEEEeccCCchhhhccc----CCCcccccHHHHHHHHHHHHHHHHHHHhcCCC
Q 005247 495 ----------LMGAVTE-----PPNLSIVTEYLSRGSLYKLLHI----PDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 555 (706)
Q Consensus 495 ----------l~~~~~~-----~~~~~lV~E~~~ggsL~~~l~~----~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~ 555 (706)
+..++.. ...++++|+++ +++|.++++. ......+++..++.++.||+.||+|||++|
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-- 231 (413)
T 3dzo_A 155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG-- 231 (413)
T ss_dssp EEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred hhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 1111111 12356777765 6799988841 223446888899999999999999999999
Q ss_pred cccccCCCCcEEECCCCcEEEeecCccccCCCCcccCCCCCCCCCccCcccc----------ccCCCCchhHHHHHHHHH
Q 005247 556 IVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVL----------REDPSNEKSDVFSFGVIL 625 (706)
Q Consensus 556 IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~Gt~~Y~APE~l----------~~~~~s~ksDVwSLGviL 625 (706)
||||||||+|||++.++.+||+|||+++..... ....+| +.|+|||++ .+..++.++|||||||++
T Consensus 232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil 307 (413)
T 3dzo_A 232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307 (413)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred cccCCcccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence 999999999999999999999999998876543 345677 999999999 555678899999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 626 WELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 626 ~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
|||++|+.||...+..+....+ +.....+++++.+||.+||+.||++||++.++++
T Consensus 308 ~elltg~~Pf~~~~~~~~~~~~------~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 308 YWIWCADLPNTDDAALGGSEWI------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHSSCCCCTTGGGSCSGGG------GSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHCCCCCCCcchhhhHHHH------HhhcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 9999999999876654332222 2233578899999999999999999999766643
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=352.68 Aligned_cols=245 Identities=21% Similarity=0.273 Sum_probs=198.4
Q ss_pred ccccCceEEEEEeccCCceEEEEEEEcC---CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCc-
Q 005247 429 EIRWSELLIKKKIGEGSFGTVYHAEWRN---SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN- 504 (706)
Q Consensus 429 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~---~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~- 504 (706)
++..++|++.+.||+|+||.||+|.+.. ..||||++.... .....+.+.+|+.++++++||||+++++++...+.
T Consensus 76 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 154 (681)
T 2pzi_A 76 DIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG-DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRH 154 (681)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTT
T ss_pred CEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC-CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCC
Confidence 3445789999999999999999999853 459999875432 34556788999999999999999999999987665
Q ss_pred ----eEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecC
Q 005247 505 ----LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFG 580 (706)
Q Consensus 505 ----~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFG 580 (706)
.++||||+++++|.+++.. .+++..++.++.||+.||.|||++| ||||||||+|||++.+ .+||+|||
T Consensus 155 ~~~~~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g--iiHrDlkp~NIll~~~-~~kl~DFG 226 (681)
T 2pzi_A 155 GDPVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG--LVYNDLKPENIMLTEE-QLKLIDLG 226 (681)
T ss_dssp SCEEEEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSS-CEEECCCT
T ss_pred CCceeEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC--CeecccChHHeEEeCC-cEEEEecc
Confidence 7999999999999987753 4889999999999999999999999 9999999999999875 89999999
Q ss_pred ccccCCCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCC
Q 005247 581 LSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNV 660 (706)
Q Consensus 581 la~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~ 660 (706)
+++..... ....||+.|+|||++.+.. +.++|||||||++|+|++|..||........ .........
T Consensus 227 ~a~~~~~~----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~--------~~~~~~~~~ 293 (681)
T 2pzi_A 227 AVSRINSF----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL--------PEDDPVLKT 293 (681)
T ss_dssp TCEETTCC----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC--------CTTCHHHHH
T ss_pred cchhcccC----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc--------ccccccccc
Confidence 99876543 4567999999999997764 8899999999999999999988865321100 000000123
Q ss_pred cHHHHHHHHHhhhhCCCCCC-CHHHHHHHHHHHHHh
Q 005247 661 NPMVAALIETCWAEEPEIRP-SFPSIMETLQQFLMS 695 (706)
Q Consensus 661 s~el~dLI~~cL~~dP~~RP-S~~eIl~~L~~ll~s 695 (706)
++.+.+||.+||+.||++|| +++++...|..++..
T Consensus 294 ~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~ 329 (681)
T 2pzi_A 294 YDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLRE 329 (681)
T ss_dssp CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHHH
T ss_pred CHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHHH
Confidence 57899999999999999999 577777777776643
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=352.81 Aligned_cols=260 Identities=23% Similarity=0.327 Sum_probs=205.4
Q ss_pred cCceEEEEEeccCCceEEEEEEEc--CCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccC------CC
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE------PP 503 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~--~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~------~~ 503 (706)
.++|++.+.||+|+||.||+|.+. +..||+|++... ......+.+.+|+.+++.++||||+++++++.. .+
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 468999999999999999999875 445999987654 345566789999999999999999999998765 66
Q ss_pred ceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCc---EEEeecC
Q 005247 504 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYT---VKVCDFG 580 (706)
Q Consensus 504 ~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~---vKL~DFG 580 (706)
..++||||+++|+|.+++........+++..++.++.||+.||+|||++| |+||||||+||+++.++. +||+|||
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g--IVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT--BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEeecCCCceeEEEcccc
Confidence 78999999999999999976555556889999999999999999999999 999999999999987664 9999999
Q ss_pred ccccCCCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHH---------HHhh-h-
Q 005247 581 LSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVI---------SAVG-F- 649 (706)
Q Consensus 581 la~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~---------~~i~-~- 649 (706)
++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||......... ..+. .
T Consensus 170 ~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~ 248 (676)
T 3qa8_A 170 YAKELDQGE-LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYD 248 (676)
T ss_dssp CCCBTTSCC-CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCC
T ss_pred ccccccccc-ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhh
Confidence 998765443 234568999999999999999999999999999999999999999764322110 0000 0
Q ss_pred -cCc------cc----CCCCCCcHHHHHHHHHhhhhCCCCCCCHHH-----HHHHHHHHHHh
Q 005247 650 -KGR------RL----EIPKNVNPMVAALIETCWAEEPEIRPSFPS-----IMETLQQFLMS 695 (706)
Q Consensus 650 -~~~------~l----~~p~~~s~el~dLI~~cL~~dP~~RPS~~e-----Il~~L~~ll~s 695 (706)
... .. .+...+++.+.+||.+||..||++|||+.+ ..+.++.++..
T Consensus 249 ~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~ 310 (676)
T 3qa8_A 249 DLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSL 310 (676)
T ss_dssp CCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCC
T ss_pred hhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhc
Confidence 000 01 122346789999999999999999999988 55666766654
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-37 Score=327.03 Aligned_cols=240 Identities=20% Similarity=0.214 Sum_probs=186.2
Q ss_pred cccCceEEEEEeccCCceEEEEEEEcCCceEEEEEecccc------chHHHHHHHHHHHHHHcCC---------------
Q 005247 430 IRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEF------HEDRFKEFLREVAIMKGLR--------------- 488 (706)
Q Consensus 430 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKvl~~~~~------~~~~~~~~~~Ei~iL~~L~--------------- 488 (706)
+..++|++.+.||+|+||+||+|++.+..||||++..... .....+.+.+|+.+++.++
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 3456789999999999999999999888899999976532 2233467888999988886
Q ss_pred -----------CCceeEEeccccC-------------CCceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHH
Q 005247 489 -----------HPNIVLLMGAVTE-------------PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAK 544 (706)
Q Consensus 489 -----------HpnIv~l~~~~~~-------------~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~ 544 (706)
||||+++++++.+ .+..++||||+.+|++.+.+.. ..+++..++.++.||+.
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTA 172 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHH
Confidence 4555555555553 6789999999999977666642 34789999999999999
Q ss_pred HHHHHH-hcCCCcccccCCCCcEEECCCC--------------------cEEEeecCccccCCCCcccCCCCCCCCCccC
Q 005247 545 GMNYLH-QRRPPIVHRDLKSPNLLVDSTY--------------------TVKVCDFGLSRSKPNTYISSKTAAGTPEWMA 603 (706)
Q Consensus 545 aL~yLH-s~g~~IIHrDLKp~NILl~~~~--------------------~vKL~DFGla~~~~~~~~~~~~~~Gt~~Y~A 603 (706)
||+||| ++| ||||||||+|||++.++ .+||+|||+|+..... ...||+.|+|
T Consensus 173 aL~~lH~~~~--ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y~a 245 (336)
T 2vuw_A 173 SLAVAEASLR--FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVSMD 245 (336)
T ss_dssp HHHHHHHHHC--CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCTTC
T ss_pred HHHHHHHhCC--EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----cEEEeecccC
Confidence 999999 999 99999999999999887 8999999999865432 4579999999
Q ss_pred ccccccCCCCchhHHHHHHHH-HHHHHhCCCCCCCCCh-HHHHHHhhhc-Cc----ccCCCCCCcHHHHHHHHHhhhhCC
Q 005247 604 PEVLREDPSNEKSDVFSFGVI-LWELITLQKPWRNSTP-SQVISAVGFK-GR----RLEIPKNVNPMVAALIETCWAEEP 676 (706)
Q Consensus 604 PE~l~~~~~s~ksDVwSLGvi-L~ELltG~~Pf~~~~~-~~~~~~i~~~-~~----~l~~p~~~s~el~dLI~~cL~~dP 676 (706)
||++.+.. +.++||||||++ .+++++|..||..... ......+... .. ....+..+++++.+||.+||+.|
T Consensus 246 PE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d- 323 (336)
T 2vuw_A 246 EDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS- 323 (336)
T ss_dssp SGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-
T ss_pred hhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-
Confidence 99998776 889999998777 7788889999854211 1111111101 11 11122357899999999999976
Q ss_pred CCCCCHHHHH
Q 005247 677 EIRPSFPSIM 686 (706)
Q Consensus 677 ~~RPS~~eIl 686 (706)
|+.|++
T Consensus 324 ----sa~e~l 329 (336)
T 2vuw_A 324 ----SATDLL 329 (336)
T ss_dssp ----SHHHHH
T ss_pred ----CHHHHH
Confidence 888887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-29 Score=291.26 Aligned_cols=185 Identities=14% Similarity=0.091 Sum_probs=131.6
Q ss_pred EeccCCceEEEEEEE--cCCceEEEEEecccc--------chHHHHHHHHHHHHHHcC-CCCceeEEeccccCCCceEEE
Q 005247 440 KIGEGSFGTVYHAEW--RNSDVAVKILIEQEF--------HEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPPNLSIV 508 (706)
Q Consensus 440 ~LG~G~fG~Vy~a~~--~~~~vAVKvl~~~~~--------~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~~~~lV 508 (706)
.++.|++|.+..+.. -+..+++|++..... .+...++|.+|+++|+++ .|+||+++++++++++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 456677776665533 467799999976532 123456799999999999 699999999999999999999
Q ss_pred EEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCC
Q 005247 509 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 588 (706)
Q Consensus 509 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 588 (706)
|||++|++|.+++...+ .+++. +|+.||+.||+|||++| ||||||||+|||++.+|++||+|||+|+.....
T Consensus 321 MEyv~G~~L~d~i~~~~---~l~~~---~I~~QIl~AL~ylH~~G--IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGE---EIDRE---KILGSLLRSLAALEKQG--FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp EECCCSEEHHHHHHTTC---CCCHH---HHHHHHHHHHHHHHHTT--CEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred EecCCCCcHHHHHHhCC---CCCHH---HHHHHHHHHHHHHHHCC--ceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 99999999999997543 45543 58899999999999999 999999999999999999999999999887665
Q ss_pred cccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCC
Q 005247 589 YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQK 633 (706)
Q Consensus 589 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~ 633 (706)
.....+.+||+.|||||++.+. +..++|+|++|++++++.++..
T Consensus 393 ~~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 393 CSWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp -CCSHHHHHHHHHHHHHHC------------------CCCCTTHH
T ss_pred CccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccc
Confidence 5455667899999999999764 5678999999999888765533
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.5e-26 Score=262.61 Aligned_cols=185 Identities=17% Similarity=0.233 Sum_probs=147.7
Q ss_pred EEEEeccCCceEEEEEEEcCCceEEEEEeccccch------HHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEE
Q 005247 437 IKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHE------DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 510 (706)
Q Consensus 437 i~~~LG~G~fG~Vy~a~~~~~~vAVKvl~~~~~~~------~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E 510 (706)
..+.||+|+||.||++...+..+++|+........ ...+.+.+|++++++++||||+++..++...+..++|||
T Consensus 340 ~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE 419 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS 419 (540)
T ss_dssp --------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred CCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence 35689999999999998888889999876544322 123568999999999999999955555556667799999
Q ss_pred eccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcc
Q 005247 511 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 590 (706)
Q Consensus 511 ~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~ 590 (706)
|+++++|.++++. +..++.|++.||+|||+++ |+||||||+|||++. ++||+|||+++.......
T Consensus 420 ~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g--IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~ 484 (540)
T 3en9_A 420 YINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND--VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDED 484 (540)
T ss_dssp CCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT--EECTTCCTTSEEESS--SEEECCCTTCEECCCHHH
T ss_pred CCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc--CccCCCCHHHEEECC--eEEEEECccCEECCCccc
Confidence 9999999999874 5579999999999999999 999999999999998 999999999998765322
Q ss_pred c-------CCCCCCCCCccCcccccc--CCCCchhHHHHHHHHHHHHHhCCCCCC
Q 005247 591 S-------SKTAAGTPEWMAPEVLRE--DPSNEKSDVFSFGVILWELITLQKPWR 636 (706)
Q Consensus 591 ~-------~~~~~Gt~~Y~APE~l~~--~~~s~ksDVwSLGviL~ELltG~~Pf~ 636 (706)
. .....||+.|||||++.. ..|+..+|+|+..+-..+-..++.+|.
T Consensus 485 ~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 485 KAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred cccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 1 135679999999999987 567888999999998888888777764
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=6.2e-22 Score=207.94 Aligned_cols=147 Identities=19% Similarity=0.163 Sum_probs=115.9
Q ss_pred cCceEEEEEeccCCceEEEEEEEc-CCceEEEEEeccccch----------------HHHHHHHHHHHHHHcCCCCceeE
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWR-NSDVAVKILIEQEFHE----------------DRFKEFLREVAIMKGLRHPNIVL 494 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~-~~~vAVKvl~~~~~~~----------------~~~~~~~~Ei~iL~~L~HpnIv~ 494 (706)
...|.+.+.||+|+||.||+|.+. +..||+|++....... .....+.+|+.+++.++ | ++
T Consensus 89 ~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~ 165 (282)
T 1zar_A 89 GKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LA 165 (282)
T ss_dssp TSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SS
T ss_pred CeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CC
Confidence 445677899999999999999983 3459999985432111 23467889999999998 4 66
Q ss_pred EeccccCCCceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcE
Q 005247 495 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTV 574 (706)
Q Consensus 495 l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~v 574 (706)
+.+++.. +..++||||++|++|.+ +.. .....++.|++.||.|||++| |+||||||+|||++ ++.+
T Consensus 166 v~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g--iiHrDlkp~NILl~-~~~v 231 (282)
T 1zar_A 166 VPKVYAW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVS-EEGI 231 (282)
T ss_dssp SCCEEEE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEE-TTEE
T ss_pred cCeEEec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC--CEeCCCCHHHEEEE-CCcE
Confidence 6665433 56799999999999998 532 123469999999999999999 99999999999999 9999
Q ss_pred EEeecCccccCCCCcccCCCCCCCCCccCccccc
Q 005247 575 KVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLR 608 (706)
Q Consensus 575 KL~DFGla~~~~~~~~~~~~~~Gt~~Y~APE~l~ 608 (706)
||+|||+++. +..|+|||.+.
T Consensus 232 kl~DFG~a~~-------------~~~~~a~e~l~ 252 (282)
T 1zar_A 232 WIIDFPQSVE-------------VGEEGWREILE 252 (282)
T ss_dssp EECCCTTCEE-------------TTSTTHHHHHH
T ss_pred EEEECCCCeE-------------CCCCCHHHHHH
Confidence 9999999863 33568899874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=1.5e-18 Score=179.37 Aligned_cols=138 Identities=19% Similarity=0.175 Sum_probs=105.3
Q ss_pred ceEEEEEeccCCceEEEEEEE--cCCc--eEEEEEeccccc----------------------hHHHHHHHHHHHHHHcC
Q 005247 434 ELLIKKKIGEGSFGTVYHAEW--RNSD--VAVKILIEQEFH----------------------EDRFKEFLREVAIMKGL 487 (706)
Q Consensus 434 ~y~i~~~LG~G~fG~Vy~a~~--~~~~--vAVKvl~~~~~~----------------------~~~~~~~~~Ei~iL~~L 487 (706)
-|.+.+.||+|+||.||+|.+ .+.. ||||++...... ......+.+|+.+++.+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 478899999999999999988 5667 999987543211 01123678899999999
Q ss_pred CCCce--eEEeccccCCCceEEEEEeccC-C----chhhhcccCCCcccccHHHHHHHHHHHHHHHHHHH-hcCCCcccc
Q 005247 488 RHPNI--VLLMGAVTEPPNLSIVTEYLSR-G----SLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLH-QRRPPIVHR 559 (706)
Q Consensus 488 ~HpnI--v~l~~~~~~~~~~~lV~E~~~g-g----sL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLH-s~g~~IIHr 559 (706)
.|+++ +.+++. +..++||||+.+ | +|.++.. ..++..+..++.|++.||.||| ++| ||||
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~------~~~~~~~~~i~~qi~~~l~~lH~~~g--ivHr 195 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGR------ELKELDVEGIFNDVVENVKRLYQEAE--LVHA 195 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGG------GGGGSCHHHHHHHHHHHHHHHHHTSC--EECS
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhh------ccChHHHHHHHHHHHHHHHHHHHHCC--EEeC
Confidence 87653 334432 356899999942 4 5555432 1234567889999999999999 999 9999
Q ss_pred cCCCCcEEECCCCcEEEeecCccccC
Q 005247 560 DLKSPNLLVDSTYTVKVCDFGLSRSK 585 (706)
Q Consensus 560 DLKp~NILl~~~~~vKL~DFGla~~~ 585 (706)
||||+|||++. .++|+|||+|...
T Consensus 196 Dlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 196 DLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCHHHEEEcC--cEEEEECcccccC
Confidence 99999999988 8999999998754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.61 E-value=5.4e-16 Score=169.51 Aligned_cols=139 Identities=16% Similarity=0.167 Sum_probs=99.3
Q ss_pred CceEEEEEeccCCceEEEEEEEc-CCceEEEEEeccccc---------------h-HHH----HHHHHHHHHHHcCCCCc
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWR-NSDVAVKILIEQEFH---------------E-DRF----KEFLREVAIMKGLRHPN 491 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~-~~~vAVKvl~~~~~~---------------~-~~~----~~~~~Ei~iL~~L~Hpn 491 (706)
.=|.+.+.||+|+||.||+|.+. +..||||+++..... . ... ....+|...|.++.+.+
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 34899999999999999999875 456999997532110 0 000 11235666666664433
Q ss_pred ee--EEeccccCCCceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEEC
Q 005247 492 IV--LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVD 569 (706)
Q Consensus 492 Iv--~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~ 569 (706)
+. ..++. ...++||||+.|++|..+.... ....++.||+.+|.+||++| ||||||||.|||++
T Consensus 175 v~vp~p~~~----~~~~LVME~i~G~~L~~l~~~~---------~~~~l~~qll~~l~~lH~~g--IVHrDLKp~NILl~ 239 (397)
T 4gyi_A 175 FPVPEPIAQ----SRHTIVMSLVDALPMRQVSSVP---------DPASLYADLIALILRLAKHG--LIHGDFNEFNILIR 239 (397)
T ss_dssp CSCCCEEEE----ETTEEEEECCSCEEGGGCCCCS---------CHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEE
T ss_pred CCCCeeeec----cCceEEEEecCCccHhhhcccH---------HHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEe
Confidence 32 22221 1237999999999987765321 23567899999999999999 99999999999998
Q ss_pred CCC----------cEEEeecCccccCC
Q 005247 570 STY----------TVKVCDFGLSRSKP 586 (706)
Q Consensus 570 ~~~----------~vKL~DFGla~~~~ 586 (706)
+++ .+.|+||+.+....
T Consensus 240 ~dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 240 EEKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp EEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred CCCCcccccccccceEEEEeCCcccCC
Confidence 776 38999999876543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.19 E-value=2.7e-11 Score=124.00 Aligned_cols=141 Identities=16% Similarity=0.058 Sum_probs=109.6
Q ss_pred CceEEEEEeccCCceEEEEEEEcCCceEEEEEeccccchHHHHHHHHHHHHHHcCC-CCceeEEeccccCCCceEEEEEe
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGAVTEPPNLSIVTEY 511 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~lV~E~ 511 (706)
..|++...++.|+.+.||++...+..+++|+........ ...+.+|+.+++.+. +..+.++++++...+..++||||
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~ 91 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT--TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTS--TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred ccceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCC--HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence 468888999999999999998777789999975421111 135778999998884 66788888888888889999999
Q ss_pred ccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 005247 512 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR-------------------------------------- 553 (706)
Q Consensus 512 ~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g-------------------------------------- 553 (706)
++|.+|.+.+. +......++.+++++|..||+..
T Consensus 92 i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T 3tm0_A 92 ADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp CSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred cCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence 99999887642 11123467889999999999810
Q ss_pred -------------------CCcccccCCCCcEEECCCCcEEEeecCccc
Q 005247 554 -------------------PPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 583 (706)
Q Consensus 554 -------------------~~IIHrDLKp~NILl~~~~~vKL~DFGla~ 583 (706)
+.++|+|++|.|||++.++.+.|+||+.+.
T Consensus 164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 238999999999999876666799998653
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.98 E-value=1.1e-09 Score=117.72 Aligned_cols=142 Identities=15% Similarity=0.172 Sum_probs=105.2
Q ss_pred EEEEeccCCceEEEEEEEcCCceEEEEEe--ccccchHHHHHHHHHHHHHHcCC--CCceeEEeccccCC---CceEEEE
Q 005247 437 IKKKIGEGSFGTVYHAEWRNSDVAVKILI--EQEFHEDRFKEFLREVAIMKGLR--HPNIVLLMGAVTEP---PNLSIVT 509 (706)
Q Consensus 437 i~~~LG~G~fG~Vy~a~~~~~~vAVKvl~--~~~~~~~~~~~~~~Ei~iL~~L~--HpnIv~l~~~~~~~---~~~~lV~ 509 (706)
.++.|+.|.++.||++...+..+++|+.. .... ......+.+|+.+++.+. +..+++++.++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~-~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKL-LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECSSCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEECCceEEEEeCCCCCCCC-CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 46789999999999998877778888754 2211 112346778999999886 45577888877666 4589999
Q ss_pred EeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhc-------------------------------------
Q 005247 510 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR------------------------------------- 552 (706)
Q Consensus 510 E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~------------------------------------- 552 (706)
||++|..+.+..- ..++......++.++++.|..||+.
T Consensus 121 e~v~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 121 EFVSGRVLWDQSL-----PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp ECCCCBCCCCTTC-----TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EecCCeecCCCcc-----ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 9999987754221 1256777888999999999999983
Q ss_pred -------------------CCCcccccCCCCcEEECCCCc--EEEeecCcccc
Q 005247 553 -------------------RPPIVHRDLKSPNLLVDSTYT--VKVCDFGLSRS 584 (706)
Q Consensus 553 -------------------g~~IIHrDLKp~NILl~~~~~--vKL~DFGla~~ 584 (706)
.+.++|+|++|.|||++.++. +.|+||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 134899999999999987653 69999998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.97 E-value=8.6e-10 Score=111.55 Aligned_cols=135 Identities=17% Similarity=0.101 Sum_probs=96.1
Q ss_pred CceEEEEEeccCCceEEEEEEEc-CCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCc--eeEEeccccCCCceEEEE
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWR-NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN--IVLLMGAVTEPPNLSIVT 509 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~-~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~Hpn--Iv~l~~~~~~~~~~~lV~ 509 (706)
..+.+....+.|..+.||++... +..+++|+..... ...+.+|+.+++.+.+.+ +.+++++....+..++||
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~-----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~ 94 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLL 94 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEE
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCccc-----chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEE
Confidence 44555444446667999999764 3459999865431 135678888888885434 566888887778899999
Q ss_pred EeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 005247 510 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR------------------------------------ 553 (706)
Q Consensus 510 E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g------------------------------------ 553 (706)
||++|.+|. ... .. ...++.+++..|..||+..
T Consensus 95 e~i~G~~l~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (264)
T 1nd4_A 95 GEVPGQDLL--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ 163 (264)
T ss_dssp ECCSSEETT--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred EecCCcccC--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence 999998884 221 11 1246677788888888643
Q ss_pred --------------------CCcccccCCCCcEEECCCCcEEEeecCccc
Q 005247 554 --------------------PPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 583 (706)
Q Consensus 554 --------------------~~IIHrDLKp~NILl~~~~~vKL~DFGla~ 583 (706)
..++|+|++|.|||++.++.+.|+||+.+.
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 128999999999999877667799999764
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.77 E-value=5.7e-09 Score=109.55 Aligned_cols=185 Identities=19% Similarity=0.173 Sum_probs=119.6
Q ss_pred EEeccCCceEEEEEEEcCCceEEEEEeccccchHHHHHHHHHHHHHHcCC-CCc--eeEEeccccCCC---ceEEEEEec
Q 005247 439 KKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPN--IVLLMGAVTEPP---NLSIVTEYL 512 (706)
Q Consensus 439 ~~LG~G~fG~Vy~a~~~~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~-Hpn--Iv~l~~~~~~~~---~~~lV~E~~ 512 (706)
+.++.|....||++. ..+++|+-.. ......+.+|..+++.+. +.. +.+++......+ ..++||+++
T Consensus 26 ~~~~~G~~n~v~~v~---~~~vlR~~~~----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN---RDFIFKFPKH----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CEEEECSSEEEEEST---TSEEEEEESS----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred EecCCCCcceEEEEC---CEEEEEecCC----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 458999999999873 6788888532 233467889999998773 322 344554443333 357899999
Q ss_pred cCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 005247 513 SRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR--------------------------------------- 553 (706)
Q Consensus 513 ~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g--------------------------------------- 553 (706)
+|.+|.+... ..++......++.+++..|..||+..
T Consensus 99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 9988865321 12566677778888888888888621
Q ss_pred -----------------CCcccccCCCCcEEECC--CCcEEEeecCccccCCCCcccCCCCCCCCCccCcccccc-----
Q 005247 554 -----------------PPIVHRDLKSPNLLVDS--TYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRE----- 609 (706)
Q Consensus 554 -----------------~~IIHrDLKp~NILl~~--~~~vKL~DFGla~~~~~~~~~~~~~~Gt~~Y~APE~l~~----- 609 (706)
+.++|+|++|.||+++. ...+.|+||+.+.......... .......-..|+....
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~-~~~~~~~~~~~~~~~~~l~~Y 252 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFI-SLMEDDEEYGMEFVSKILNHY 252 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHH-TTCCTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHH-HHHhhccccCHHHHHHHHHHc
Confidence 23799999999999988 5568999999876532211000 0000000022332211
Q ss_pred CCC---------CchhHHHHHHHHHHHHHhCCCCCC
Q 005247 610 DPS---------NEKSDVFSFGVILWELITLQKPWR 636 (706)
Q Consensus 610 ~~~---------s~ksDVwSLGviL~ELltG~~Pf~ 636 (706)
... ....+.|++|.++|.+.+|..+|.
T Consensus 253 ~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 253 KHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp TCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred CCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 011 123689999999999999987763
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.29 E-value=6.3e-06 Score=86.72 Aligned_cols=135 Identities=19% Similarity=0.166 Sum_probs=92.0
Q ss_pred EEEeccCCceEEEEEEEcCCceEEEEEeccccchHHHHHHHHHHHHHHcCCCC---ceeEEecccc-CCCceEEEEEecc
Q 005247 438 KKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHP---NIVLLMGAVT-EPPNLSIVTEYLS 513 (706)
Q Consensus 438 ~~~LG~G~fG~Vy~a~~~~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~Hp---nIv~l~~~~~-~~~~~~lV~E~~~ 513 (706)
++.++.|....||+. +..+++|+-. .......+.+|..+|+.+.+. .+.+.+.+.. ..+..++|||+++
T Consensus 24 v~~l~~G~~n~v~~v---g~~~VlR~~~----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~ 96 (306)
T 3tdw_A 24 VESLGEGFRNYAILV---NGDWVFRFPK----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ 96 (306)
T ss_dssp EEEEEECSSEEEEEE---TTTEEEEEES----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred eeecCCCcceeEEEE---CCEEEEEecC----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence 456889999999988 6778888842 223446788999999988642 2455555553 4556789999999
Q ss_pred CCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcC----------------------------------------
Q 005247 514 RGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR---------------------------------------- 553 (706)
Q Consensus 514 ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g---------------------------------------- 553 (706)
|.++....- ..++......++.++.+.|..||+..
T Consensus 97 G~~l~~~~~-----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 97 GQILGEDGM-----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp SEECHHHHH-----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred CeECchhhh-----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 988765311 01234444455555555555555422
Q ss_pred ------------------CCcccccCCCCcEEECC---CCc-EEEeecCcccc
Q 005247 554 ------------------PPIVHRDLKSPNLLVDS---TYT-VKVCDFGLSRS 584 (706)
Q Consensus 554 ------------------~~IIHrDLKp~NILl~~---~~~-vKL~DFGla~~ 584 (706)
+.++|+|++|.|||++. ++. +.|+||+.+..
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 23699999999999987 345 58999997754
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.26 E-value=3.8e-06 Score=85.75 Aligned_cols=132 Identities=16% Similarity=0.161 Sum_probs=92.5
Q ss_pred EeccCCce-EEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCC-CCceeEEeccccCCCceEEEEEeccCC
Q 005247 440 KIGEGSFG-TVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGAVTEPPNLSIVTEYLSRG 515 (706)
Q Consensus 440 ~LG~G~fG-~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~lV~E~~~gg 515 (706)
.+..|..+ .||+..... ..+++|+-... ....+.+|...|+.+. +--+.+++.++.+++..++|||+++|.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~ 105 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS-----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK 105 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH-----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC-----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence 44445555 689886543 35888875432 3456778999988774 333667788888888899999999998
Q ss_pred chhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCC-----------------------------------------
Q 005247 516 SLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP----------------------------------------- 554 (706)
Q Consensus 516 sL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~----------------------------------------- 554 (706)
++.+.... .......+..++...|..||...+
T Consensus 106 ~~~~~~~~-------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (272)
T 4gkh_A 106 TAFQVLEE-------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ 178 (272)
T ss_dssp EHHHHHHH-------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred cccccccC-------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence 87765431 112233456677777777775321
Q ss_pred ---------------CcccccCCCCcEEECCCCcEEEeecCccc
Q 005247 555 ---------------PIVHRDLKSPNLLVDSTYTVKVCDFGLSR 583 (706)
Q Consensus 555 ---------------~IIHrDLKp~NILl~~~~~vKL~DFGla~ 583 (706)
.++|+|+.+.|||++.++.+-|+||+.+.
T Consensus 179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 26899999999999987777899998764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.97 E-value=2.1e-05 Score=82.58 Aligned_cols=140 Identities=15% Similarity=0.097 Sum_probs=77.9
Q ss_pred EEEeccCCceEEEEEEEcCCceEEEEEeccccchHHHHHHHHHHHHHHcCC--CCceeEEecc------ccCCCceEEEE
Q 005247 438 KKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR--HPNIVLLMGA------VTEPPNLSIVT 509 (706)
Q Consensus 438 ~~~LG~G~fG~Vy~a~~~~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~--HpnIv~l~~~------~~~~~~~~lV~ 509 (706)
.+.|+.|..+.||++...+..+++|+.... .. .+..|+.+++.|. .-.+.+++.. ....+..+++|
T Consensus 37 ~~~l~gG~~n~~~~v~~~~~~~vlk~~~~~---~~---~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~ 110 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTDSGAVCLKRIHRP---EK---KALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVY 110 (346)
T ss_dssp EEECC----CEEEEEEETTEEEEEEEECSC---HH---HHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEE
T ss_pred eeeccccccCcEEEEEeCCCCEEEEecCCC---HH---HHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEE
Confidence 456777789999999877667889987542 22 2234444444442 1123333331 12356678999
Q ss_pred EeccCCchhh-----------h---ccc--CCC--c-------ccccHHH------------------------------
Q 005247 510 EYLSRGSLYK-----------L---LHI--PDA--R-------VVVDERL------------------------------ 534 (706)
Q Consensus 510 E~~~ggsL~~-----------~---l~~--~~~--~-------~~l~~~~------------------------------ 534 (706)
+|++|.++.. . +|. ... . ....+..
T Consensus 111 ~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 190 (346)
T 2q83_A 111 DWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQ 190 (346)
T ss_dssp ECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHH
T ss_pred EeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHH
Confidence 9999865420 0 110 000 0 0000100
Q ss_pred -HHHHHHHHHHHHHHHHh-----------cCCCcccccCCCCcEEECCCCcEEEeecCccc
Q 005247 535 -RLNMAYDVAKGMNYLHQ-----------RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 583 (706)
Q Consensus 535 -~~~ia~qIl~aL~yLHs-----------~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~ 583 (706)
...+..++..++.+|++ ..+.++|+|+++.|||++.++.+.|+||+.+.
T Consensus 191 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 191 EIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 11122234446666763 22359999999999999878889999999764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.87 E-value=0.00011 Score=78.33 Aligned_cols=85 Identities=6% Similarity=-0.033 Sum_probs=54.3
Q ss_pred eEEEEEe-ccCCceEEEEEEEc--------CCceEEEEEecccc-chHHHHHHHHHHHHHHcCC-C--CceeEEeccccC
Q 005247 435 LLIKKKI-GEGSFGTVYHAEWR--------NSDVAVKILIEQEF-HEDRFKEFLREVAIMKGLR-H--PNIVLLMGAVTE 501 (706)
Q Consensus 435 y~i~~~L-G~G~fG~Vy~a~~~--------~~~vAVKvl~~~~~-~~~~~~~~~~Ei~iL~~L~-H--pnIv~l~~~~~~ 501 (706)
....+.| +.|....+|++... +..+++|+...... .......+.+|+.+++.+. + ..+.+++.+..+
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~ 101 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT 101 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence 3446788 88999999998765 55688887533220 0000124567777777663 2 345667766655
Q ss_pred C---CceEEEEEeccCCchhh
Q 005247 502 P---PNLSIVTEYLSRGSLYK 519 (706)
Q Consensus 502 ~---~~~~lV~E~~~ggsL~~ 519 (706)
. +..++|||+++|.++.+
T Consensus 102 ~~~~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 102 GDVLGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp STTTSSCEEEEECCCCBCCCB
T ss_pred CCccCCceEEEEecCCCChhh
Confidence 4 45789999999877654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.66 E-value=7.9e-05 Score=80.79 Aligned_cols=77 Identities=17% Similarity=0.142 Sum_probs=47.6
Q ss_pred EEEEeccCCceEEEEEEEc--CCceEEEEEecccc--ch---HHHHHHHHHHHHHHcCCC--C-ceeEEeccccCCCceE
Q 005247 437 IKKKIGEGSFGTVYHAEWR--NSDVAVKILIEQEF--HE---DRFKEFLREVAIMKGLRH--P-NIVLLMGAVTEPPNLS 506 (706)
Q Consensus 437 i~~~LG~G~fG~Vy~a~~~--~~~vAVKvl~~~~~--~~---~~~~~~~~Ei~iL~~L~H--p-nIv~l~~~~~~~~~~~ 506 (706)
..+.||.|.++.||++... +..+++|....... .. .....+..|.++++.+.. + .+.+++.+ +....+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 3678999999999999643 45689997643211 00 112345678888877632 2 34455544 234568
Q ss_pred EEEEeccCC
Q 005247 507 IVTEYLSRG 515 (706)
Q Consensus 507 lV~E~~~gg 515 (706)
+|||++++.
T Consensus 112 lvmE~l~g~ 120 (397)
T 2olc_A 112 TVMEDLSHL 120 (397)
T ss_dssp EEECCCTTS
T ss_pred EEEEeCCCc
Confidence 999999764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.61 E-value=0.00026 Score=74.90 Aligned_cols=77 Identities=19% Similarity=0.140 Sum_probs=60.0
Q ss_pred EEEEEeccCCceEEEEEEEcCCceEEEEEeccccchHHHHHHHHHHHHHHcCC---CCceeEEeccccCCCceEEEEEec
Q 005247 436 LIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR---HPNIVLLMGAVTEPPNLSIVTEYL 512 (706)
Q Consensus 436 ~i~~~LG~G~fG~Vy~a~~~~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~---HpnIv~l~~~~~~~~~~~lV~E~~ 512 (706)
.-.+.|+.|.+..+|+....+..+++|+.... ....+.+|...|+.|. ...+++++.+....+..++|||++
T Consensus 39 ~~~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l 113 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLINDEVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEAL 113 (312)
T ss_dssp CEEEEECCSSSSEEEEEESSSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECC
T ss_pred eeeEEeCCccceeeeEEEECCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEec
Confidence 34678999999999999877777899886532 2356778888888773 356778888777778899999999
Q ss_pred cCCch
Q 005247 513 SRGSL 517 (706)
Q Consensus 513 ~ggsL 517 (706)
++..+
T Consensus 114 ~G~~~ 118 (312)
T 3jr1_A 114 NKSKN 118 (312)
T ss_dssp CCCCC
T ss_pred cCCCC
Confidence 98764
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.27 E-value=0.00068 Score=70.83 Aligned_cols=146 Identities=14% Similarity=0.171 Sum_probs=80.2
Q ss_pred ceEEEEEeccCCceEEEEEEEcCCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCc--eeEEeccc------cCCCce
Q 005247 434 ELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN--IVLLMGAV------TEPPNL 505 (706)
Q Consensus 434 ~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~Hpn--Iv~l~~~~------~~~~~~ 505 (706)
...-.+.|+.|....+|++...+..+++|+..... .. ..+..|+.+++.+...+ +.+++... ...+..
T Consensus 23 ~~~~~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~~-~~---~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~ 98 (322)
T 2ppq_A 23 SLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRV-EK---NDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRP 98 (322)
T ss_dssp CEEEEEEECC---EEEEEEEESSCCEEEEEECC----C---CHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEE
T ss_pred cceEeeccCCCcccceEEEEeCCccEEEEEeCCCC-CH---HHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEE
Confidence 34456788889999999998777788999875421 11 23445666666553211 33333221 123557
Q ss_pred EEEEEeccCCchhhh--------------cccC--C--Cc-----ccccHHHHH--------H----HHHHHHHHHHHHH
Q 005247 506 SIVTEYLSRGSLYKL--------------LHIP--D--AR-----VVVDERLRL--------N----MAYDVAKGMNYLH 550 (706)
Q Consensus 506 ~lV~E~~~ggsL~~~--------------l~~~--~--~~-----~~l~~~~~~--------~----ia~qIl~aL~yLH 550 (706)
+++|+|++|..+... ++.. . .. ....+.... . +...+...+++++
T Consensus 99 ~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~ 178 (322)
T 2ppq_A 99 AALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLA 178 (322)
T ss_dssp EEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHH
T ss_pred EEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHH
Confidence 899999988654210 1110 0 00 000011100 0 0112444556665
Q ss_pred hc-----CCCcccccCCCCcEEECCCCcEEEeecCccc
Q 005247 551 QR-----RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 583 (706)
Q Consensus 551 s~-----g~~IIHrDLKp~NILl~~~~~vKL~DFGla~ 583 (706)
.. ...++|+|+++.|||++.++.+.|+||+.+.
T Consensus 179 ~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 179 AHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 32 1248999999999999877666899998664
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.13 E-value=0.00048 Score=75.39 Aligned_cols=77 Identities=16% Similarity=0.154 Sum_probs=46.3
Q ss_pred CCcccccCCCCcEEECCCCcEEEeecCccccCCCCcccCCCC-CCCCCccCccccccCC---CCchhHHHHHHHHHHHHH
Q 005247 554 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTA-AGTPEWMAPEVLREDP---SNEKSDVFSFGVILWELI 629 (706)
Q Consensus 554 ~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~-~Gt~~Y~APE~l~~~~---~s~ksDVwSLGviL~ELl 629 (706)
+.++|+|++|.|||++.++ ++|+||+.+......+.-.... .-...|++|+...... ......+..+...+|+.+
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y 310 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNLF 310 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHHH
Confidence 3499999999999998776 9999999876533211100000 0012355555443211 122355667787888777
Q ss_pred hC
Q 005247 630 TL 631 (706)
Q Consensus 630 tG 631 (706)
++
T Consensus 311 ~~ 312 (420)
T 2pyw_A 311 NK 312 (420)
T ss_dssp HH
T ss_pred HH
Confidence 55
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.13 E-value=0.0033 Score=62.96 Aligned_cols=143 Identities=17% Similarity=0.205 Sum_probs=95.2
Q ss_pred CchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHh-cCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcccCC
Q 005247 515 GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ-RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSK 593 (706)
Q Consensus 515 gsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs-~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~ 593 (706)
-+|.++|+..+ .++.++++|.++.|.+.+|..+-. .. -..+=+.|..|++..+|+|-..+ +.+.
T Consensus 33 vSL~eIL~~~~--~PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 33 LSLEEILRLYN--QPINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred ccHHHHHHHcC--CCcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecCCceeccc-cccc----------
Confidence 47888887544 469999999999999999877622 22 12233457899999999987763 1110
Q ss_pred CCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHHHHhhh
Q 005247 594 TAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWA 673 (706)
Q Consensus 594 ~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI~~cL~ 673 (706)
.....+.|||... ...+.+.=|||||+++|.-+--..| ..-+..+|+.+-+||..|..
T Consensus 98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~-------------------e~eE~eLS~~LE~LL~~Mt~ 155 (229)
T 2yle_A 98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK-------------------ENEERELSPPLEQLIDHMAN 155 (229)
T ss_dssp -----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC-------------------TTEEECCCHHHHHHHHHHTT
T ss_pred --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC-------------------cccchhhCHHHHHHHHHHHh
Confidence 1223466888763 3456889999999999998742211 12335689999999999986
Q ss_pred h-------------------------CCCCCCCHHHHHHHHHHHHH
Q 005247 674 E-------------------------EPEIRPSFPSIMETLQQFLM 694 (706)
Q Consensus 674 ~-------------------------dP~~RPS~~eIl~~L~~ll~ 694 (706)
. .+..|+++++|++.-+.-+.
T Consensus 156 ~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~~hl~ 201 (229)
T 2yle_A 156 TVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCAAHLP 201 (229)
T ss_dssp CCC--------------------CCSCCCCCCSHHHHHHHHHTTSS
T ss_pred cccccccccccccccccccccccccccccCcCCHHHHHHHHHhhcc
Confidence 6 24688999999887665444
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.87 E-value=0.006 Score=63.31 Aligned_cols=71 Identities=13% Similarity=0.173 Sum_probs=42.4
Q ss_pred EEEeccCCceEEEEEEEcCCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCce-eEEeccccCCCceEEEEEec-cCC
Q 005247 438 KKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNI-VLLMGAVTEPPNLSIVTEYL-SRG 515 (706)
Q Consensus 438 ~~~LG~G~fG~Vy~a~~~~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnI-v~l~~~~~~~~~~~lV~E~~-~gg 515 (706)
++.|+.|....+|++ ..+++|+-.... .......+|+.+++.+...++ .+++.+.. +.-++++||+ +|.
T Consensus 23 i~~l~gG~tN~~~~~----~~~vlR~~~~~~---~~~~~r~~E~~~l~~l~~~g~~P~~~~~~~--~~~~~v~e~i~~g~ 93 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA----GDLCLRIPGKGT---EEYINRANEAVAAREAAKAGVSPEVLHVDP--ATGVMVTRYIAGAQ 93 (301)
T ss_dssp CEEEESCSSEEEEEE----TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEECT--TTCCEEEECCTTCE
T ss_pred eeEcCCcccccccee----eeEEEECCCCCc---cceeCHHHHHHHHHHHHHcCCCCceEEEEC--CCCEEEEeecCCCc
Confidence 678889999999998 678888864321 001112356666665532111 45554433 3347899999 665
Q ss_pred ch
Q 005247 516 SL 517 (706)
Q Consensus 516 sL 517 (706)
++
T Consensus 94 ~l 95 (301)
T 3dxq_A 94 TM 95 (301)
T ss_dssp EC
T ss_pred cC
Confidence 54
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.77 E-value=0.0018 Score=68.22 Aligned_cols=32 Identities=34% Similarity=0.370 Sum_probs=27.4
Q ss_pred CcccccCCCCcEEECCC----CcEEEeecCccccCC
Q 005247 555 PIVHRDLKSPNLLVDST----YTVKVCDFGLSRSKP 586 (706)
Q Consensus 555 ~IIHrDLKp~NILl~~~----~~vKL~DFGla~~~~ 586 (706)
.++|||+.+.|||++.+ +.+.|+||+.+....
T Consensus 184 ~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~ 219 (333)
T 3csv_A 184 VFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH 219 (333)
T ss_dssp EEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred eeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence 49999999999999874 689999999887543
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.70 E-value=0.0061 Score=62.82 Aligned_cols=79 Identities=15% Similarity=0.102 Sum_probs=52.9
Q ss_pred cCceEEEEEeccCCceEEEEEEEc-CCceEEEEEeccccchHHHHHHHHHHHHHHcCCC---CceeEEeccccCCCceEE
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWR-NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRH---PNIVLLMGAVTEPPNLSI 507 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~-~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~H---pnIv~l~~~~~~~~~~~l 507 (706)
..+..-++.+|.|..+.||+++.. ++.+++|+-...... ....|.+|...|+.|.. --+.+++.+. ..++
T Consensus 14 G~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~l 87 (288)
T 3f7w_A 14 GREVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPA--LDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTL 87 (288)
T ss_dssp CCCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCC--CTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEE
T ss_pred CCCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcc--hhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceE
Confidence 345667899999999999999875 456888875433211 12356788888887742 2244455432 2478
Q ss_pred EEEeccCCc
Q 005247 508 VTEYLSRGS 516 (706)
Q Consensus 508 V~E~~~ggs 516 (706)
||||+.++.
T Consensus 88 v~e~l~~~~ 96 (288)
T 3f7w_A 88 AMEWVDERP 96 (288)
T ss_dssp EEECCCCCC
T ss_pred EEEeecccC
Confidence 999987754
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.69 E-value=0.0033 Score=69.23 Aligned_cols=73 Identities=16% Similarity=0.233 Sum_probs=47.5
Q ss_pred EEEEeccCCceEEEEEEEc---------CCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCc-eeEEeccccCCCceE
Q 005247 437 IKKKIGEGSFGTVYHAEWR---------NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN-IVLLMGAVTEPPNLS 506 (706)
Q Consensus 437 i~~~LG~G~fG~Vy~a~~~---------~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~Hpn-Iv~l~~~~~~~~~~~ 506 (706)
-++.|+.|....||++... +..+++|+..... . ...+.+|..+++.+...+ ..++++.+.+ .
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g 148 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-T---ESHLVAESVIFTLLSERHLGPKLYGIFSG----G 148 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-c---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----C
Confidence 3567888999999999865 2458888863211 1 134457888888774222 3566665543 3
Q ss_pred EEEEeccCCch
Q 005247 507 IVTEYLSRGSL 517 (706)
Q Consensus 507 lV~E~~~ggsL 517 (706)
+|+||++|.+|
T Consensus 149 ~v~e~l~G~~l 159 (429)
T 1nw1_A 149 RLEEYIPSRPL 159 (429)
T ss_dssp EEECCCCEEEC
T ss_pred EEEEEeCCccc
Confidence 89999987454
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.46 E-value=0.0091 Score=66.43 Aligned_cols=74 Identities=15% Similarity=0.092 Sum_probs=46.5
Q ss_pred EEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCce-eEEeccccCCCceEEEEEecc
Q 005247 437 IKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNI-VLLMGAVTEPPNLSIVTEYLS 513 (706)
Q Consensus 437 i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnI-v~l~~~~~~~~~~~lV~E~~~ 513 (706)
-++.|+.|-...+|++...+ ..+++|+..... .. .-.-.+|..+++.|...++ .++++.+. + .+||||++
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~--~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~ 184 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKT--DE-IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMD 184 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-C--CS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCC
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCCh--hh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeC
Confidence 35678889999999998876 568888763221 10 0011478888888864333 56676663 2 35999998
Q ss_pred CCch
Q 005247 514 RGSL 517 (706)
Q Consensus 514 ggsL 517 (706)
|.+|
T Consensus 185 G~~l 188 (458)
T 2qg7_A 185 GYAL 188 (458)
T ss_dssp SEEC
T ss_pred CccC
Confidence 7554
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.37 E-value=0.0052 Score=66.70 Aligned_cols=139 Identities=14% Similarity=0.158 Sum_probs=77.7
Q ss_pred EEEeccCCceEEEEEEEcC---------CceEEEEEeccccchHHHHHHHHHHHHHHcCC-CCceeEEeccccCCCceEE
Q 005247 438 KKKIGEGSFGTVYHAEWRN---------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGAVTEPPNLSI 507 (706)
Q Consensus 438 ~~~LG~G~fG~Vy~a~~~~---------~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~l 507 (706)
++.|..|-...+|++...+ ..+++|+.-.. . .......+|..+++.|. +.-..++++.+.+ .+
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~--~-~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~ 127 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI--L-QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GR 127 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc--c-chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----cc
Confidence 3567778888899987642 45777774111 1 12345568888887774 2223566666554 29
Q ss_pred EEEeccCCchhhh-----------------cccCC---Ccccc-cHHHHHHHHHHHHH-------------------HHH
Q 005247 508 VTEYLSRGSLYKL-----------------LHIPD---ARVVV-DERLRLNMAYDVAK-------------------GMN 547 (706)
Q Consensus 508 V~E~~~ggsL~~~-----------------l~~~~---~~~~l-~~~~~~~ia~qIl~-------------------aL~ 547 (706)
||||++|.+|..- +|... .+... -..++.++..++.. .+.
T Consensus 128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 207 (379)
T 3feg_A 128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG 207 (379)
T ss_dssp EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence 9999988665321 11111 01111 23444445443321 233
Q ss_pred HHH----hcC--CCcccccCCCCcEEECCC----CcEEEeecCccc
Q 005247 548 YLH----QRR--PPIVHRDLKSPNLLVDST----YTVKVCDFGLSR 583 (706)
Q Consensus 548 yLH----s~g--~~IIHrDLKp~NILl~~~----~~vKL~DFGla~ 583 (706)
.|. ..+ ..++|+|+.+.|||++.+ +.+.|+||..+.
T Consensus 208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 332 221 248999999999999876 689999998765
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.33 E-value=0.022 Score=59.32 Aligned_cols=75 Identities=11% Similarity=0.083 Sum_probs=45.5
Q ss_pred EEeccCCceEEEEEEEcC-CceEEEEEeccccchHHHHHHHHHHHHHHcCCC--CceeEEecc-----ccCCCceEEEEE
Q 005247 439 KKIGEGSFGTVYHAEWRN-SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRH--PNIVLLMGA-----VTEPPNLSIVTE 510 (706)
Q Consensus 439 ~~LG~G~fG~Vy~a~~~~-~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~H--pnIv~l~~~-----~~~~~~~~lV~E 510 (706)
..|+ |....||++...+ ..+++|+........ ..+..|..+++.+.. -.+++++.. ....+..+++|+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~---~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~ 107 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERWTA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFP 107 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTSCH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEE
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCCCH---HHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEE
Confidence 4566 8888999987644 368999875332222 345567777766632 123444443 112345678999
Q ss_pred eccCCch
Q 005247 511 YLSRGSL 517 (706)
Q Consensus 511 ~~~ggsL 517 (706)
+++|..+
T Consensus 108 ~i~G~~~ 114 (328)
T 1zyl_A 108 SVGGRQF 114 (328)
T ss_dssp CCCCEEC
T ss_pred ecCCCCC
Confidence 9987554
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.02 E-value=0.019 Score=61.34 Aligned_cols=73 Identities=15% Similarity=0.226 Sum_probs=41.1
Q ss_pred EEEeccCCceEEEEEEEcC----------CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCc-eeEEeccccCCCceE
Q 005247 438 KKKIGEGSFGTVYHAEWRN----------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN-IVLLMGAVTEPPNLS 506 (706)
Q Consensus 438 ~~~LG~G~fG~Vy~a~~~~----------~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~Hpn-Iv~l~~~~~~~~~~~ 506 (706)
.+.|+.|....+|++...+ ..+++|+..... . .......|..+++.+...+ +.++++.+. -+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~--~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~ 110 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV--D-ELYNTISEFEVYKTMSKYKIAPQLLNTFN----GG 110 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG--G-GTSCHHHHHHHHHHHHHTTSSCCEEEEET----TE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc--c-ceecHHHHHHHHHHHHhcCCCCceEEecC----Cc
Confidence 5678889899999998754 457777753321 1 1112346777777664222 345554432 37
Q ss_pred EEEEeccCCch
Q 005247 507 IVTEYLSRGSL 517 (706)
Q Consensus 507 lV~E~~~ggsL 517 (706)
+||||++|.++
T Consensus 111 ~v~e~i~G~~l 121 (369)
T 3c5i_A 111 RIEEWLYGDPL 121 (369)
T ss_dssp EEEECCCSEEC
T ss_pred EEEEEecCCcC
Confidence 89999987554
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.94 E-value=0.029 Score=59.45 Aligned_cols=30 Identities=20% Similarity=0.360 Sum_probs=26.8
Q ss_pred CcccccCCCCcEEECCCCcEEEeecCcccc
Q 005247 555 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 584 (706)
Q Consensus 555 ~IIHrDLKp~NILl~~~~~vKL~DFGla~~ 584 (706)
.++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp EEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred eeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 489999999999999878899999987664
|
| >3kd4_A Putative protease; structural genomics, joint center for STR genomics, JCSG, protein structure initiative, PSI-2, hydrol; HET: MSE; 2.00A {Parabacteroides distasonis atcc 8503} | Back alignment and structure |
|---|
Probab=95.56 E-value=0.016 Score=65.24 Aligned_cols=106 Identities=11% Similarity=0.142 Sum_probs=73.0
Q ss_pred HHHHHHHHHhcCcCCHHHHHHHHHHHHHHhcCCCCCC-chhhhhhhHHHHHHHHHhhhCCeeEEeeecccccchhhHHHH
Q 005247 139 ELHNRVLSLLCDRITAEEAVHQLANLVCNHMGGTTST-EEEEFDKQWSECAEHLKDCLNSVVLPIGSLSVGLCVHRALLF 217 (706)
Q Consensus 139 ~l~~~~~~~~~~~~~~~~~~~~la~~V~~~m~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~v~~~g~~~~g~~r~ra~lf 217 (706)
.+++.|.++..+..+..+.++.|..+|.+++.=.... +.... .-.....-|+. +.|.|+-.|+||
T Consensus 229 ~i~~~a~~l~~~~~~~~ek~~~iy~~V~~~i~y~~~~~~~~g~--~~~~a~~vl~~------------~~G~C~d~a~Ll 294 (506)
T 3kd4_A 229 ESKTFAQFLTDKSGNEQEKVNIIRDHILNNLSTCPIPMAMTGY--TVRDIDTVLRS------------AYGTPLEIAQLL 294 (506)
T ss_dssp HHHHHHHHHHSSCSSHHHHHHHHHHHHHHHCEECCCCGGGGTT--CCCCHHHHHHH------------TEECHHHHHHHH
T ss_pred HHHHHHHHHHhcCCCHHHHHHHHHHHHHhccEecceecccCCC--CCCCHHHHHHh------------CCcchHHHHHHH
Confidence 3556667777788888899999999999988411100 00000 00011122322 369999999999
Q ss_pred HHHhhhcCCCccccccccc------CC--CCCCCeeEEEeCCCchhhhhc
Q 005247 218 KVLADLINLPCRIAKGCKY------CR--RDDASSCLVQIGPDREYLVDL 259 (706)
Q Consensus 218 k~lad~~~~~~~lv~g~~~------~~--~~~~~~~~~~~~~~~~~~vdl 259 (706)
..|+-.+||||++|-+.-. .+ .-.|+++.|.+ +++.|++|-
T Consensus 295 ~AllRa~GIpA~~v~~~t~~~~~~~~~lp~~nh~i~~v~~-~g~~y~lDa 343 (506)
T 3kd4_A 295 NVMLNAAGIPSEVLAVYPGHLDTDACGLAAIQTLAVKATV-DGKDQYLSA 343 (506)
T ss_dssp HHHHHHTTCCEEEEEEEETTSCGGGCCSTTCCEEEEEEEE-TTEEEEESS
T ss_pred HHHHHHCCCCcEEEEEEcCCCCCccCCCCCCCEEEEEEEE-CCEEEEEec
Confidence 9999999999999988311 11 23789999999 789999997
|
| >3isr_A Transglutaminase-like enzymes, putative cysteine; protease, hutchinsoni MCSG, structural genomics; 1.90A {Cytophaga hutchinsonii} | Back alignment and structure |
|---|
Probab=95.38 E-value=0.0095 Score=62.39 Aligned_cols=95 Identities=15% Similarity=0.195 Sum_probs=66.5
Q ss_pred HHHHHHHHhcCcCCHHHHHHHHHHHHHHhcCCCCCCchhhhhhhHHHHHHHHHhhhCCeeEEeeecccccchhhHHHHHH
Q 005247 140 LHNRVLSLLCDRITAEEAVHQLANLVCNHMGGTTSTEEEEFDKQWSECAEHLKDCLNSVVLPIGSLSVGLCVHRALLFKV 219 (706)
Q Consensus 140 l~~~~~~~~~~~~~~~~~~~~la~~V~~~m~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~~g~~~~g~~r~ra~lfk~ 219 (706)
+.+.|.++..+..+..+.+.+|...|.+.+.=-....... . ....-| .-+.|+|++-|.||-.
T Consensus 128 i~~~A~~~~~~~~~~~~~~~ai~~~v~~~~~Y~~~~~~~~--~---~a~~~l------------~~~~G~C~d~A~l~va 190 (293)
T 3isr_A 128 LQKLAYKEFGKIENVYSKVLAITDWIYNNVEYISGSTNSQ--T---SAFDTI------------TERAGVCRDFAHLGIA 190 (293)
T ss_dssp SHHHHHHHHTTCCSHHHHHHHHHHHHHHHSEECTTSCCTT--C---CHHHHH------------HHCEECHHHHHHHHHH
T ss_pred HHHHHHHHhccCCCHHHHHHHHHHHHHhhcEEeccCCCCC--C---CHHHhh------------cCCcEehHHHHHHHHH
Confidence 5556666666777778899999999999765111110000 0 011112 2368999999999999
Q ss_pred HhhhcCCCcccccccccC--CCCCCCeeEEEeCC
Q 005247 220 LADLINLPCRIAKGCKYC--RRDDASSCLVQIGP 251 (706)
Q Consensus 220 lad~~~~~~~lv~g~~~~--~~~~~~~~~~~~~~ 251 (706)
|+-.+|||||+|.|.-.. ..+.|+|+.|.++.
T Consensus 191 l~Ra~GIPAR~VsGy~~~~~~~~~HAW~Evyl~g 224 (293)
T 3isr_A 191 LCRALSIPARYFTGYAFKLNPPDFHACFEAYIGG 224 (293)
T ss_dssp HHHHTTCCEEEEEEEETTCSSCCEEEEEEEEETT
T ss_pred HHHHCCCCEEEEEEECCCCCCCCeEEEEEEEECC
Confidence 999999999999993222 25789999999954
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=93.92 E-value=0.063 Score=59.01 Aligned_cols=74 Identities=12% Similarity=0.143 Sum_probs=44.8
Q ss_pred EEEEeccCCceEEEEEEEc---------CCceEEEEEeccccchHHHHHHHHHHHHHHcCC-CCceeEEeccccCCCceE
Q 005247 437 IKKKIGEGSFGTVYHAEWR---------NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGAVTEPPNLS 506 (706)
Q Consensus 437 i~~~LG~G~fG~Vy~a~~~---------~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~ 506 (706)
-++.|..|-...+|++... +..+++++.-... . ..-...+|..+++.+. +.-..++++.+. -+
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t--~-~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~ 146 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV--G-KFYDSKVELDVFRYLSNINIAPNIIADFP----EG 146 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TE
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc--c-hhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CC
Confidence 3566777889999999876 4568888743211 1 1112246777776663 222344554332 27
Q ss_pred EEEEeccCCch
Q 005247 507 IVTEYLSRGSL 517 (706)
Q Consensus 507 lV~E~~~ggsL 517 (706)
+|+||++|.+|
T Consensus 147 ~I~efI~G~~l 157 (424)
T 3mes_A 147 RIEEFIDGEPL 157 (424)
T ss_dssp EEEECCCSEEC
T ss_pred EEEEEeCCccC
Confidence 89999998664
|
| >2f4m_A Peptide N-glycanase; glycoproteins, ubiquitin-dependent protein degradation, NUCL excision repair, peptide:N-glycanase; 1.85A {Mus musculus} SCOP: d.3.1.4 PDB: 2f4o_A* | Back alignment and structure |
|---|
Probab=92.69 E-value=0.046 Score=56.95 Aligned_cols=42 Identities=19% Similarity=0.184 Sum_probs=39.0
Q ss_pred cccccchhhHHHHHHHhhhcCCCcccccccccCCCCCCCeeEEEeCC
Q 005247 205 LSVGLCVHRALLFKVLADLINLPCRIAKGCKYCRRDDASSCLVQIGP 251 (706)
Q Consensus 205 ~~~g~~r~ra~lfk~lad~~~~~~~lv~g~~~~~~~~~~~~~~~~~~ 251 (706)
-+.|+|++-|.||-.|+-.+|||||+|-| | +.|+|+-|.++.
T Consensus 138 ~r~G~C~d~A~lf~al~Ra~GIpAR~V~G--y---~~HaW~Evy~~g 179 (295)
T 2f4m_A 138 TRCGRCGEWANCFTLCCRALGFEARYVWD--Y---TDHVWTEVYSPS 179 (295)
T ss_dssp HCEESHHHHHHHHHHHHHHTTCCEEEEEE--T---TTEEEEEEEETT
T ss_pred cCCEeeHHHHHHHHHHHHHCCCCEEEEcC--C---CCEEEEEEEECC
Confidence 47899999999999999999999999999 4 899999999954
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=91.51 E-value=0.19 Score=54.46 Aligned_cols=29 Identities=24% Similarity=0.395 Sum_probs=24.4
Q ss_pred cccccCCCCcEEE------CCCCcEEEeecCcccc
Q 005247 556 IVHRDLKSPNLLV------DSTYTVKVCDFGLSRS 584 (706)
Q Consensus 556 IIHrDLKp~NILl------~~~~~vKL~DFGla~~ 584 (706)
++|+|+.+.|||+ +.+..++++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4566799999987753
|
| >1x3z_A Peptide: N-glycanase; hydrolase-hydrolase inhibitor complex; HET: SUC; 2.80A {Saccharomyces cerevisiae} SCOP: d.3.1.4 PDB: 1x3w_A* 3esw_A* | Back alignment and structure |
|---|
Probab=81.50 E-value=0.69 Score=48.76 Aligned_cols=44 Identities=20% Similarity=0.209 Sum_probs=39.0
Q ss_pred ecccccchhhHHHHHHHhhhcCCCcccccccccCCCCCCCeeEEEeCCC
Q 005247 204 SLSVGLCVHRALLFKVLADLINLPCRIAKGCKYCRRDDASSCLVQIGPD 252 (706)
Q Consensus 204 ~~~~g~~r~ra~lfk~lad~~~~~~~lv~g~~~~~~~~~~~~~~~~~~~ 252 (706)
.-+.|.|.|=|-||=.|+=.+|||+|+|-| ..+|+|+-|..+..
T Consensus 178 ~tr~G~C~e~A~lF~~llRalGi~aR~V~~-----~~~H~W~EV~~~~~ 221 (335)
T 1x3z_A 178 ETRKGRCGEWCNLFTLILKSFGLDVRYVWN-----REDHVWCEYFSNFL 221 (335)
T ss_dssp HHCEECHHHHHHHHHHHHHTTTCCEEEEEE-----TTTEEEEEEEETTT
T ss_pred HhCCcChHHHHHHHHHHHHHCCCCeEEEec-----CCCcEEEEEEECCC
Confidence 346899999999999999999999999987 47899999999553
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 706 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-82 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 9e-76 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-73 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-72 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 6e-72 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-70 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-70 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-70 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-69 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-69 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-69 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 7e-69 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-68 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-68 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-68 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-68 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 6e-68 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-66 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-66 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-66 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-66 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-66 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 5e-66 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-65 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-64 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-64 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 8e-64 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-63 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-62 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 8e-62 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-60 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 6e-59 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-58 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-57 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-57 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 6e-57 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-56 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-55 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-53 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-52 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-52 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-51 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-51 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-50 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 8e-50 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-49 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-47 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-46 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-46 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-46 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-46 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-45 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 8e-43 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-42 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-41 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-41 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-41 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 5e-39 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 9e-37 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-34 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-33 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-27 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 8e-20 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 259 bits (664), Expect = 4e-82
Identities = 95/276 (34%), Positives = 155/276 (56%), Gaps = 15/276 (5%)
Query: 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR 488
EI ++ + ++IG GSFGTVY +W DVAVK+L + + F EV +++ R
Sbjct: 4 EIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 62
Query: 489 HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 548
H NI+L MG T P L+IVT++ SLY LHI + + + +++A A+GM+Y
Sbjct: 63 HVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDY 119
Query: 549 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR--SKPNTYISSKTAAGTPEWMAPEV 606
LH + I+HRDLKS N+ + TVK+ DFGL+ S+ + + +G+ WMAPEV
Sbjct: 120 LHAK--SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 177
Query: 607 LR---EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRL----EIPKN 659
+R ++P + +SDV++FG++L+EL+T Q P+ N I + +G ++ N
Sbjct: 178 IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSN 237
Query: 660 VNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS 695
+ L+ C ++ + RP FP I+ +++ S
Sbjct: 238 CPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 242 bits (619), Expect = 9e-76
Identities = 93/267 (34%), Positives = 138/267 (51%), Gaps = 13/267 (4%)
Query: 427 GLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKG 486
G + EL + + IG+G FG V ++R + VAVK + + FL E ++M
Sbjct: 1 GWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQ----AFLAEASVMTQ 56
Query: 487 LRHPNIVLLMGAVTEPPN-LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKG 545
LRH N+V L+G + E L IVTEY+++GSL L R V+ L + DV +
Sbjct: 57 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEA 115
Query: 546 MNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPE 605
M YL VHRDL + N+LV KV DFGL++ +T T +W APE
Sbjct: 116 MEYLEGN--NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---QDTGKLPVKWTAPE 170
Query: 606 VLREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVNPMV 664
LRE + KSDV+SFG++LWE+ + + P+ V+ V KG +++ P P V
Sbjct: 171 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPAV 229
Query: 665 AALIETCWAEEPEIRPSFPSIMETLQQ 691
+++ CW + +RPSF + E L+
Sbjct: 230 YEVMKNCWHLDAAMRPSFLQLREQLEH 256
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 235 bits (601), Expect = 4e-73
Identities = 87/270 (32%), Positives = 141/270 (52%), Gaps = 9/270 (3%)
Query: 429 EIRWSELLIKKKIGEGSFGTVYHAEWR-NSDVAVKILIEQEFHEDRFKEFLREVAIMKGL 487
E+ L + +++G G FG V+ + ++ VAVK L + D FL E +MK L
Sbjct: 9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---AFLAEANLMKQL 65
Query: 488 RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 547
+H +V L VT+ P + I+TEY+ GSL L P + + L+MA +A+GM
Sbjct: 66 QHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMA 123
Query: 548 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEV 606
++ +R +HRDL++ N+LV T + K+ DFGL+R + N Y + + A +W APE
Sbjct: 124 FIEER--NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 181
Query: 607 LREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA 666
+ KSDV+SFG++L E++T + + + +G R+ P N +
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQ 241
Query: 667 LIETCWAEEPEIRPSFPSIMETLQQFLMSS 696
L+ CW E PE RP+F + L+ F ++
Sbjct: 242 LMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 234 bits (599), Expect = 2e-72
Identities = 84/290 (28%), Positives = 148/290 (51%), Gaps = 21/290 (7%)
Query: 419 RELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD----VAVKILIEQEFHEDRF 474
++L+L+ + L I ++G G+FG+V +R VA+K+L +Q +
Sbjct: 1 KKLFLKRDNLLI------ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADT 53
Query: 475 KEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERL 534
+E +RE IM L +P IV L+G V + L +V E G L+K L R +
Sbjct: 54 EEMMREAQIMHQLDNPYIVRLIG-VCQAEALMLVMEMAGGGPLHKFLV--GKREEIPVSN 110
Query: 535 RLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR---SKPNTYIS 591
+ + V+ GM YL ++ VHRDL + N+L+ + + K+ DFGLS+ + + Y +
Sbjct: 111 VAELLHQVSMGMKYLEEK--NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 168
Query: 592 SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFK 650
+W APE + + +SDV+S+GV +WE ++ QKP++ +V++ + +
Sbjct: 169 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-Q 227
Query: 651 GRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQP 700
G+R+E P P + AL+ CW + E RP F ++ + ++ S +
Sbjct: 228 GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 277
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 232 bits (593), Expect = 6e-72
Identities = 72/259 (27%), Positives = 119/259 (45%), Gaps = 9/259 (3%)
Query: 437 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 494
+ IG GS+G ++ + K L E + + EV +++ L+HPNIV
Sbjct: 8 VLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVR 67
Query: 495 LMGAVTEPPN--LSIVTEYLSRGSLYKLLH-IPDARVVVDERLRLNMAYDVAKGMNYLHQ 551
+ + N L IV EY G L ++ R +DE L + + + H+
Sbjct: 68 YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR 127
Query: 552 R---RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLR 608
R ++HRDLK N+ +D VK+ DFGL+R + +K GTP +M+PE +
Sbjct: 128 RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMN 187
Query: 609 EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI 668
NEKSD++S G +L+EL L P+ + ++ + +G+ IP + + +I
Sbjct: 188 RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI-REGKFRRIPYRYSDELNEII 246
Query: 669 ETCWAEEPEIRPSFPSIME 687
+ RPS I+E
Sbjct: 247 TRMLNLKDYHRPSVEEILE 265
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 229 bits (585), Expect = 1e-70
Identities = 85/277 (30%), Positives = 135/277 (48%), Gaps = 15/277 (5%)
Query: 431 RWSELLIKKKIGEGSFGTVYHAEWRNSD----VAVKILIEQEFHEDRFKEFLREVAIMKG 486
R L K++G G+FGTV ++ VAVKIL + E L E +M+
Sbjct: 5 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQ 64
Query: 487 LRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM 546
L +P IV ++G + E + +V E G L K L V ++ + + + V+ GM
Sbjct: 65 LDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGM 120
Query: 547 NYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR---SKPNTYISSKTAAGTPEWMA 603
YL + VHRDL + N+L+ + + K+ DFGLS+ + N Y + +W A
Sbjct: 121 KYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 178
Query: 604 PEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNP 662
PE + + KSDV+SFGV++WE + QKP+R S+V + + KG R+ P
Sbjct: 179 PECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPAGCPR 237
Query: 663 MVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQ 699
+ L+ CW + E RP F ++ L+ + V +
Sbjct: 238 EMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNE 274
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (582), Expect = 2e-70
Identities = 90/265 (33%), Positives = 136/265 (51%), Gaps = 11/265 (4%)
Query: 430 IRWSELLIKKKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLR 488
I +L K++G G FG V + +WR DVA+K++ E ED EF+ E +M L
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLS 57
Query: 489 HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 548
H +V L G T+ + I+TEY++ G L L R + L M DV + M Y
Sbjct: 58 HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRF--QTQQLLEMCKDVCEAMEY 115
Query: 549 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVL 607
L + +HRDL + N LV+ VKV DFGLSR + Y SS + W PEVL
Sbjct: 116 LESK--QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVL 173
Query: 608 REDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA 666
+ KSD+++FGV++WE+ +L K P+ T S+ + +G RL P + V
Sbjct: 174 MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRPHLASEKVYT 232
Query: 667 LIETCWAEEPEIRPSFPSIMETLQQ 691
++ +CW E+ + RP+F ++ +
Sbjct: 233 IMYSCWHEKADERPTFKILLSNILD 257
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 227 bits (580), Expect = 4e-70
Identities = 91/269 (33%), Positives = 135/269 (50%), Gaps = 11/269 (4%)
Query: 430 IRWSELLIKKKIGEGSFGTVYHAEWRNSD-VAVKILIEQEFHEDRFKEFLREVAIMKGLR 488
I SEL ++IG G FG V+ W N D VA+K + E E ++F+ E +M L
Sbjct: 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLS 58
Query: 489 HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 548
HP +V L G E + +V E++ G L L L M DV +GM Y
Sbjct: 59 HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF--AAETLLGMCLDVCEGMAY 116
Query: 549 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-SKPNTYISSKTAAGTPEWMAPEVL 607
L + ++HRDL + N LV +KV DFG++R + Y SS +W +PEV
Sbjct: 117 LEE--ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVF 174
Query: 608 REDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA 666
+ KSDV+SFGV++WE+ + K P+ N + S+V+ + G RL P+ + V
Sbjct: 175 SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKPRLASTHVYQ 233
Query: 667 LIETCWAEEPEIRPSFPSIMETLQQFLMS 695
++ CW E PE RP+F ++ L + S
Sbjct: 234 IMNHCWKERPEDRPAFSRLLRQLAEIAES 262
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 226 bits (578), Expect = 1e-69
Identities = 79/261 (30%), Positives = 129/261 (49%), Gaps = 14/261 (5%)
Query: 435 LLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNI 492
L +IG GSF TVY + VA L +++ + + F E ++KGL+HPNI
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70
Query: 493 VLLMGA----VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 548
V + V + +VTE ++ G+L L V+ ++ + + KG+ +
Sbjct: 71 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQF 127
Query: 549 LHQRRPPIVHRDLKSPNLLVDS-TYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVL 607
LH R PPI+HRDLK N+ + T +VK+ D GL+ K ++ +K GTPE+MAPE+
Sbjct: 128 LHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF--AKAVIGTPEFMAPEMY 185
Query: 608 REDPSNEKSDVFSFGVILWELITLQKPWRNS-TPSQVISAVGFKGRRLEIPKNVNPMVAA 666
E +E DV++FG+ + E+ T + P+ +Q+ V + K P V
Sbjct: 186 EE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKE 244
Query: 667 LIETCWAEEPEIRPSFPSIME 687
+IE C + + R S ++
Sbjct: 245 IIEGCIRQNKDERYSIKDLLN 265
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (582), Expect = 1e-69
Identities = 89/293 (30%), Positives = 133/293 (45%), Gaps = 34/293 (11%)
Query: 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD-------VAVKILIEQEFHEDRFKEFLREV 481
E L K +G G+FG V +A VAVK+L E+ +R + + E+
Sbjct: 33 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSER-EALMSEL 91
Query: 482 AIMKGL-RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLH------------------ 522
+M L H NIV L+GA T + ++ EY G L L
Sbjct: 92 KMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKR 151
Query: 523 --IPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFG 580
+ V+ L AY VAKGM +L + VHRDL + N+LV VK+CDFG
Sbjct: 152 LEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK--SCVHRDLAARNVLVTHGKVVKICDFG 209
Query: 581 LSR--SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQK-PWRN 637
L+R + Y+ A +WMAPE L E KSDV+S+G++LWE+ +L P+
Sbjct: 210 LARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 269
Query: 638 STPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQ 690
+ G +++ P + ++++CWA + RPSFP++ L
Sbjct: 270 IPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 227 bits (579), Expect = 2e-69
Identities = 89/276 (32%), Positives = 140/276 (50%), Gaps = 17/276 (6%)
Query: 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD-----VAVKILIEQEFHEDRFKEFLREVAI 483
EI S + I++ IG G FG V + VA+K L + + E + ++FL E +I
Sbjct: 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTL-KSGYTEKQRRDFLSEASI 80
Query: 484 MKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVA 543
M HPN++ L G VT+ + I+TE++ GSL L D + + M +A
Sbjct: 81 MGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF--TVIQLVGMLRGIA 138
Query: 544 KGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN-----TYISSKTAAGT 598
GM YL VHRDL + N+LV+S KV DFGLSR + TY S+
Sbjct: 139 AGMKYLADMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIP 196
Query: 599 PEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIP 657
W APE ++ SDV+S+G+++WE+++ ++P+ + T VI+A+ + RL P
Sbjct: 197 IRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE-QDYRLPPP 255
Query: 658 KNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 693
+ + L+ CW ++ RP F I+ TL + +
Sbjct: 256 MDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI 291
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 225 bits (574), Expect = 7e-69
Identities = 94/271 (34%), Positives = 138/271 (50%), Gaps = 9/271 (3%)
Query: 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKG 486
E+ +++ +K K+G G +G VY W+ VAVK L E +EFL+E A+MK
Sbjct: 13 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV---EEFLKEAAVMKE 69
Query: 487 LRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM 546
++HPN+V L+G T P I+TE+++ G+L L + R V + L MA ++ M
Sbjct: 70 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAM 128
Query: 547 NYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP-NTYISSKTAAGTPEWMAPE 605
YL + +HRDL + N LV + VKV DFGLSR +TY + A +W APE
Sbjct: 129 EYLE--KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 186
Query: 606 VLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 665
L + + KSDV++FGV+LWE+ T + + K R+E P+ V
Sbjct: 187 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY 246
Query: 666 ALIETCWAEEPEIRPSFPSIMETLQQFLMSS 696
L+ CW P RPSF I + + S
Sbjct: 247 ELMRACWQWNPSDRPSFAEIHQAFETMFQES 277
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 224 bits (572), Expect = 1e-68
Identities = 68/259 (26%), Positives = 127/259 (49%), Gaps = 14/259 (5%)
Query: 437 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 494
I ++G+G+FG VY A+ + + A K++ + E+ ++++ E+ I+ HPNIV
Sbjct: 16 IIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVK 73
Query: 495 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 554
L+ A NL I+ E+ + G++ ++ + + E + +NYLH +
Sbjct: 74 LLDAFYYENNLWILIEFCAGGAVDAVML--ELERPLTESQIQVVCKQTLDALNYLHDNK- 130
Query: 555 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVL-----RE 609
I+HRDLK+ N+L +K+ DFG+S T + GTP WMAPEV+ ++
Sbjct: 131 -IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 189
Query: 610 DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR-RLEIPKNVNPMVAALI 668
P + K+DV+S G+ L E+ ++ P P +V+ + L P + +
Sbjct: 190 RPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFL 249
Query: 669 ETCWAEEPEIRPSFPSIME 687
+ C + + R + +++
Sbjct: 250 KKCLEKNVDARWTTSQLLQ 268
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (570), Expect = 2e-68
Identities = 90/270 (33%), Positives = 137/270 (50%), Gaps = 9/270 (3%)
Query: 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD-VAVKILIEQEFHEDRFKEFLREVAIMKGL 487
EI L ++ K+G+G FG V+ W + VA+K L + FL+E +MK L
Sbjct: 13 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKL 69
Query: 488 RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMN 547
RH +V L V+E P + IVTEY+S+GSL L + + ++MA +A GM
Sbjct: 70 RHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMA 127
Query: 548 YLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEV 606
Y+ + VHRDL++ N+LV KV DFGL+R + N Y + + A +W APE
Sbjct: 128 YVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 185
Query: 607 LREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA 666
KSDV+SFG++L EL T + ++ + +G R+ P +
Sbjct: 186 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD 245
Query: 667 LIETCWAEEPEIRPSFPSIMETLQQFLMSS 696
L+ CW +EPE RP+F + L+ + S+
Sbjct: 246 LMCQCWRKEPEERPTFEYLQAFLEDYFTST 275
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 224 bits (572), Expect = 2e-68
Identities = 91/284 (32%), Positives = 140/284 (49%), Gaps = 24/284 (8%)
Query: 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNS----DVAVKILIEQEFHEDRFKEFLREVAIM 484
+ W+++ + IGEG+FG V A + D A+K +++ +D ++F E+ ++
Sbjct: 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKR-MKEYASKDDHRDFAGELEVL 64
Query: 485 KGL-RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLH-------------IPDARVVV 530
L HPNI+ L+GA L + EY G+L L +
Sbjct: 65 CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 124
Query: 531 DERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 590
+ L+ A DVA+GM+YL Q +HRDL + N+LV Y K+ DFGLSR Y+
Sbjct: 125 SSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSRG-QEVYV 181
Query: 591 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGF 649
WMA E L SDV+S+GV+LWE+++L P+ T +++ +
Sbjct: 182 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP- 240
Query: 650 KGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 693
+G RLE P N + V L+ CW E+P RPSF I+ +L + L
Sbjct: 241 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (566), Expect = 5e-68
Identities = 92/272 (33%), Positives = 137/272 (50%), Gaps = 15/272 (5%)
Query: 430 IRWSELLIKKKIGEGSFGTVYHAEWRNSD-----VAVKILIEQEFHEDRF-KEFLREVAI 483
I +L + +K+G+GSFG V EW VAVK L + +F+REV
Sbjct: 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 484 MKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVA 543
M L H N++ L G V PP + +VTE GSL L ++ R A VA
Sbjct: 65 MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVA 121
Query: 544 KGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP---NTYISSKTAAGTPE 600
+GM YL +R +HRDL + NLL+ + VK+ DFGL R+ P + Y+ +
Sbjct: 122 EGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 179
Query: 601 WMAPEVLREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKN 659
W APE L+ + SD + FGV LWE+ T + PW SQ++ + +G RL P++
Sbjct: 180 WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED 239
Query: 660 VNPMVAALIETCWAEEPEIRPSFPSIMETLQQ 691
+ ++ CWA +PE RP+F ++ + L +
Sbjct: 240 CPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (565), Expect = 6e-68
Identities = 72/262 (27%), Positives = 126/262 (48%), Gaps = 14/262 (5%)
Query: 431 RWS--ELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRF-KEFLREVAIMK 485
+W+ + I + +G+G FG VY A + S +A+K+L + + + + REV I
Sbjct: 2 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 61
Query: 486 GLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKG 545
LRHPNI+ L G + + ++ EY G++Y+ L DE+ ++A
Sbjct: 62 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANA 118
Query: 546 MNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPE 605
++Y H +R ++HRD+K NLL+ S +K+ DFG S P++ T GT +++ PE
Sbjct: 119 LSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTTLCGTLDYLPPE 174
Query: 606 VLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 665
++ +EK D++S GV+ +E + + P+ +T + + P V
Sbjct: 175 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGAR 232
Query: 666 ALIETCWAEEPEIRPSFPSIME 687
LI P RP ++E
Sbjct: 233 DLISRLLKHNPSQRPMLREVLE 254
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (558), Expect = 1e-66
Identities = 84/276 (30%), Positives = 128/276 (46%), Gaps = 14/276 (5%)
Query: 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD------VAVKILIEQEFHEDRFKEFLREVA 482
EI S + +K IG G FG VY + S VA+K L + + E + +FL E
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL-KAGYTEKQRVDFLGEAG 61
Query: 483 IMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDV 542
IM H NI+ L G +++ + I+TEY+ G+L K + + + M +
Sbjct: 62 IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDK--FLREKDGEFSVLQLVGMLRGI 119
Query: 543 AKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKT---AAGTP 599
A GM YL VHRDL + N+LV+S KV DFGLSR + ++ T
Sbjct: 120 AAGMKYLA--NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPI 177
Query: 600 EWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKN 659
W APE + SDV+SFG+++WE++T + + + G RL P +
Sbjct: 178 RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMD 237
Query: 660 VNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS 695
+ L+ CW +E RP F I+ L + + +
Sbjct: 238 CPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 219 bits (559), Expect = 1e-66
Identities = 92/301 (30%), Positives = 138/301 (45%), Gaps = 35/301 (11%)
Query: 424 EEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD-------VAVKILIEQEFHEDRFKE 476
+ LE + + + IGEG+FG V+ A VAVK+L ++E D +
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML-KEEASADMQAD 62
Query: 477 FLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLH-------------- 522
F RE A+M +PNIV L+G + ++ EY++ G L + L
Sbjct: 63 FQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSD 122
Query: 523 -------IPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVK 575
+ +L +A VA GM YL +R+ VHRDL + N LV VK
Sbjct: 123 LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLATRNCLVGENMVVK 180
Query: 576 VCDFGLSRSKP--NTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQK 633
+ DFGLSR+ + Y + A WM PE + + +SDV+++GV+LWE+ +
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240
Query: 634 -PWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQF 692
P+ +VI V G L P+N + L+ CW++ P RPSF SI LQ+
Sbjct: 241 QPYYGMAHEEVIYYVR-DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299
Query: 693 L 693
Sbjct: 300 C 300
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (556), Expect = 2e-66
Identities = 86/272 (31%), Positives = 135/272 (49%), Gaps = 14/272 (5%)
Query: 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD-----VAVKILIEQEFHEDRFKEFLREVAI 483
EI+ + + + IGEG FG V+ + + + VA+K R ++FL+E
Sbjct: 3 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR-EKFLQEALT 61
Query: 484 MKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVA 543
M+ HP+IV L+G +TE + I+ E + G L L + + D + AY ++
Sbjct: 62 MRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSL--DLASLILYAYQLS 118
Query: 544 KGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWM 602
+ YL +R VHRD+ + N+LV S VK+ DFGLSR + +TY + +WM
Sbjct: 119 TALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM 176
Query: 603 APEVLREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVISAVGFKGRRLEIPKNVN 661
APE + SDV+ FGV +WE++ P++ + VI + G RL +P N
Sbjct: 177 APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI-ENGERLPMPPNCP 235
Query: 662 PMVAALIETCWAEEPEIRPSFPSIMETLQQFL 693
P + +L+ CWA +P RP F + L L
Sbjct: 236 PTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (558), Expect = 3e-66
Identities = 91/292 (31%), Positives = 136/292 (46%), Gaps = 17/292 (5%)
Query: 414 MSTSNRELYLEEEGLEIRWSELLI--KKKIGEGSFGTVYHAEWRNSD-----VAVKILIE 466
+S N EL + + I S L++ + IG G FG VYH ++D AVK L
Sbjct: 6 LSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-N 64
Query: 467 QEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN-LSIVTEYLSRGSLYKLLHIPD 525
+ +FL E IMK HPN++ L+G +V Y+ G L +
Sbjct: 65 RITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET 124
Query: 526 ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-- 583
V + + VAKGM +L VHRDL + N ++D +TVKV DFGL+R
Sbjct: 125 HNPTVKDLIG--FGLQVAKGMKFLAS--KKFVHRDLAARNCMLDEKFTVKVADFGLARDM 180
Query: 584 --SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPS 641
+ ++ + A +WMA E L+ KSDV+SFGV+LWEL+T P +
Sbjct: 181 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 240
Query: 642 QVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 693
I+ +GRRL P+ + ++ CW + E+RPSF ++ +
Sbjct: 241 FDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 292
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (556), Expect = 3e-66
Identities = 68/254 (26%), Positives = 125/254 (49%), Gaps = 11/254 (4%)
Query: 437 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 494
+KIG+G+ GTVY A + VA++ + Q + + + + E+ +M+ ++PNIV
Sbjct: 24 RFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ--QQPKKELIINEILVMRENKNPNIVN 81
Query: 495 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 554
+ + L +V EYL+ GSL ++ +DE + + + + +LH +
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQ- 136
Query: 555 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNE 614
++HRD+KS N+L+ +VK+ DFG T GTP WMAPEV+
Sbjct: 137 -VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195
Query: 615 KSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR-RLEIPKNVNPMVAALIETCWA 673
K D++S G++ E+I + P+ N P + + + G L+ P+ ++ + + C
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLD 255
Query: 674 EEPEIRPSFPSIME 687
+ E R S +++
Sbjct: 256 MDVEKRGSAKELLQ 269
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (556), Expect = 5e-66
Identities = 83/294 (28%), Positives = 136/294 (46%), Gaps = 29/294 (9%)
Query: 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD-------VAVKILIEQEFHEDRFKEFLREV 481
E + L K +G G+FG V A VAVK+ ++ H + + E+
Sbjct: 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKM-LKPSAHLTEREALMSEL 77
Query: 482 AIMKGL-RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLH---------------IPD 525
++ L H NIV L+GA T ++TEY G L L + D
Sbjct: 78 KVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 137
Query: 526 ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-- 583
+ +D L+ +Y VAKGM +L + +HRDL + N+L+ K+CDFGL+R
Sbjct: 138 DELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLTHGRITKICDFGLARDI 195
Query: 584 SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPS-Q 642
+ Y+ A +WMAPE + +SDV+S+G+ LWEL +L P
Sbjct: 196 KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255
Query: 643 VISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 696
+ +G R+ P++ + +++TCW +P RP+F I++ +++ + S
Sbjct: 256 KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 216 bits (551), Expect = 3e-65
Identities = 68/274 (24%), Positives = 125/274 (45%), Gaps = 19/274 (6%)
Query: 420 ELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKIL-IEQEFHEDRFKE 476
EL+ +++ E +S+L ++IG GSFG VY A + VA+K + + +++++
Sbjct: 6 ELFFKDD-PEKLFSDL---REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD 61
Query: 477 FLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRL 536
++EV ++ LRHPN + G +V EY + L + + E
Sbjct: 62 IIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIA 118
Query: 537 NMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAA 596
+ + +G+ YLH ++HRD+K+ N+L+ VK+ DFG + +
Sbjct: 119 AVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----NSFV 172
Query: 597 GTPEWMAPEVLR---EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR 653
GTP WMAPEV+ E + K DV+S G+ EL + P N + +
Sbjct: 173 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP 232
Query: 654 LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687
+ + +++C + P+ RP+ +++
Sbjct: 233 ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (545), Expect = 2e-64
Identities = 80/272 (29%), Positives = 132/272 (48%), Gaps = 14/272 (5%)
Query: 430 IRWSELLIKKKIGEGSFGTVYHAEWRNSD------VAVKILIEQEFHEDRFKEFLREVAI 483
++ +E K +G G+FGTVY W VA+K L E + KE L E +
Sbjct: 6 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-KEILDEAYV 64
Query: 484 MKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVA 543
M + +P++ L+G + ++T+ + G L L ++ + + + + LN +A
Sbjct: 65 MASVDNPHVCRLLGICLTS-TVQLITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIA 121
Query: 544 KGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR--SKPNTYISSKTAAGTPEW 601
KGMNYL RR +VHRDL + N+LV + VK+ DFGL++ ++ +W
Sbjct: 122 KGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 179
Query: 602 MAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVN 661
MA E + +SDV+S+GV +WEL+T + P+ IS++ KG RL P
Sbjct: 180 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 239
Query: 662 PMVAALIETCWAEEPEIRPSFPSIMETLQQFL 693
V ++ CW + + RP F ++ +
Sbjct: 240 IDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (544), Expect = 2e-64
Identities = 88/301 (29%), Positives = 151/301 (50%), Gaps = 22/301 (7%)
Query: 417 SNRELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNSD-------VAVKILIEQEF 469
S ++Y+ +E E+ ++ + +++G+GSFG VY + VA+K + E
Sbjct: 5 SAADVYVPDE-WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS 63
Query: 470 HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPD---- 525
+R EFL E ++MK ++V L+G V++ ++ E ++RG L L
Sbjct: 64 MRER-IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMA 122
Query: 526 ---ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS 582
+ MA ++A GM YL+ VHRDL + N +V +TVK+ DFG++
Sbjct: 123 NNPVLAPPSLSKMIQMAGEIADGMAYLNAN--KFVHRDLAARNCMVAEDFTVKIGDFGMT 180
Query: 583 R--SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQK-PWRNST 639
R + + Y WM+PE L++ SDV+SFGV+LWE+ TL + P++ +
Sbjct: 181 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 240
Query: 640 PSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQ 699
QV+ V +G L+ P N M+ L+ CW P++RPSF I+ ++++ + +
Sbjct: 241 NEQVLRFV-MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 299
Query: 700 P 700
Sbjct: 300 V 300
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (542), Expect = 8e-64
Identities = 62/258 (24%), Positives = 117/258 (45%), Gaps = 11/258 (4%)
Query: 428 LEIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMK 485
+E++ + ++G G+ G V+ + S +A K+ I E + +RE+ ++
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKL-IHLEIKPAIRNQIIRELQVLH 59
Query: 486 GLRHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKG 545
P IV GA +SI E++ GSL ++L + E++ ++ V KG
Sbjct: 60 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKG 116
Query: 546 MNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPE 605
+ YL ++ I+HRD+K N+LV+S +K+CDFG+S ++ + + GT +M+PE
Sbjct: 117 LTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPE 173
Query: 606 VLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 665
L+ + +SD++S G+ L E+ + P ++ F + P
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM--FGCQVEGDAAETPPRPR 231
Query: 666 ALIETCWAEEPEIRPSFP 683
+ + RP
Sbjct: 232 TPGRPLSSYGMDSRPPMA 249
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (537), Expect = 2e-63
Identities = 89/294 (30%), Positives = 148/294 (50%), Gaps = 29/294 (9%)
Query: 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD---------VAVKILIEQEFHEDRFKEFLR 479
E+ L++ K +GEG+FG V AE D VAVK+L + + E + +
Sbjct: 9 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLIS 67
Query: 480 EVAIMKGL-RHPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHI-------------PD 525
E+ +MK + +H NI+ L+GA T+ L ++ EY S+G+L + L +
Sbjct: 68 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 127
Query: 526 ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR-- 583
+ + ++ AY VA+GM YL + +HRDL + N+LV +K+ DFGL+R
Sbjct: 128 PEEQLSSKDLVSCAYQVARGMEYLASK--KCIHRDLAARNVLVTEDNVMKIADFGLARDI 185
Query: 584 SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQV 643
+ Y + +WMAPE L + +SDV+SFGV+LWE+ TL P +
Sbjct: 186 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 245
Query: 644 ISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL-MSS 696
+ + +G R++ P N + ++ CW P RP+F ++E L + + ++S
Sbjct: 246 LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS 299
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 5e-62
Identities = 74/257 (28%), Positives = 117/257 (45%), Gaps = 12/257 (4%)
Query: 437 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 494
+ + +GEG++G V A R ++ VAVKI ++ + D + +E+ I K L H N+V
Sbjct: 9 LVQTLGEGAYGEVQLAVNRVTEEAVAVKI-VDMKRAVDCPENIKKEICINKMLNHENVVK 67
Query: 495 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 554
G E + EY S G L+ + + + E + + G+ YLH
Sbjct: 68 FYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG- 123
Query: 555 PIVHRDLKSPNLLVDSTYTVKVCDFGLSR--SKPNTYISSKTAAGTPEWMAPEVLREDP- 611
I HRD+K NLL+D +K+ DFGL+ N GT ++APE+L+
Sbjct: 124 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182
Query: 612 SNEKSDVFSFGVILWELITLQKPWRNSTPS-QVISAVGFKGRRLEIPKNVNPMVAALIET 670
E DV+S G++L ++ + PW + S Q S K L K ++ AL+
Sbjct: 183 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHK 242
Query: 671 CWAEEPEIRPSFPSIME 687
E P R + P I +
Sbjct: 243 ILVENPSARITIPDIKK 259
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (526), Expect = 8e-62
Identities = 78/298 (26%), Positives = 126/298 (42%), Gaps = 47/298 (15%)
Query: 434 ELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIV 493
+++++ IG+G FG V+ +WR +VAVKI +E +R E+ LRH NI+
Sbjct: 4 TIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENIL 60
Query: 494 LLMGAVTEP----PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 549
+ A + L +V++Y GSL+ L+ R V + +A A G+ +L
Sbjct: 61 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN----RYTVTVEGMIKLALSTASGLAHL 116
Query: 550 HQ------RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR----SKPNTYISSKTAAGTP 599
H +P I HRDLKS N+LV T + D GL+ + I+ GT
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176
Query: 600 EWMAPEVLRED------PSNEKSDVFSFGVILWELITLQKPWRNSTPSQ----------- 642
+MAPEVL + S +++D+++ G++ WE+ Q
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236
Query: 643 ----VISAVGFKGRRLEIPKNVNPM-----VAALIETCWAEEPEIRPSFPSIMETLQQ 691
+ V + R IP +A ++ CW R + I +TL Q
Sbjct: 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 1e-60
Identities = 85/292 (29%), Positives = 133/292 (45%), Gaps = 26/292 (8%)
Query: 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD-------VAVKILIEQEFHEDRFKEFLREV 481
E L + K +G G+FG V A+ D VAVK+L E H +
Sbjct: 9 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 68
Query: 482 AIMKGLRHPNIVLLMGAVTEPPN-LSIVTEYLSRGSLYKLLH-------------IPDAR 527
++ H N+V L+GA T+P L ++ E+ G+L L +
Sbjct: 69 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 128
Query: 528 VVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR--SK 585
+ + ++ VAKGM +L R+ +HRDL + N+L+ VK+CDFGL+R K
Sbjct: 129 DFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYK 186
Query: 586 PNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQK-PWRNSTPSQVI 644
Y+ A +WMAPE + + +SDV+SFGV+LWE+ +L P+ +
Sbjct: 187 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 246
Query: 645 SAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 696
+G R+ P P + + CW EP RP+F ++E L L ++
Sbjct: 247 CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 298
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 6e-59
Identities = 62/255 (24%), Positives = 108/255 (42%), Gaps = 12/255 (4%)
Query: 437 IKKKIGEGSFGTVYHAEWRNSD--VAVKIL-IEQEFHEDRFKEFLREVAIMKGLRHPNIV 493
K +GEGSF TV A + A+KIL E++ RE +M L HP V
Sbjct: 12 FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 71
Query: 494 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 553
L + L Y G L K + + DE ++ + YLH
Sbjct: 72 KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLH--G 126
Query: 554 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSR--SKPNTYISSKTAAGTPEWMAPEVLREDP 611
I+HRDLK N+L++ +++ DFG ++ S + + + GT ++++PE+L E
Sbjct: 127 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS 186
Query: 612 SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETC 671
+ + SD+++ G I+++L+ P+R + + + P+ P L+E
Sbjct: 187 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI--IKLEYDFPEKFFPKARDLVEKL 244
Query: 672 WAEEPEIRPSFPSIM 686
+ R +
Sbjct: 245 LVLDATKRLGCEEME 259
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 199 bits (507), Expect = 2e-58
Identities = 62/257 (24%), Positives = 114/257 (44%), Gaps = 13/257 (5%)
Query: 437 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 494
I +++G G+FG V+ R + A K ++ HE + +E+ M LRHP +V
Sbjct: 30 IHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVN 87
Query: 495 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 554
L A + + ++ E++S G L++ + D + E + V KG+ ++H+
Sbjct: 88 LHDAFEDDNEMVMIYEFMSGGELFE--KVADEHNKMSEDEAVEYMRQVCKGLCHMHENN- 144
Query: 555 PIVHRDLKSPNLLVDS--TYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPS 612
VH DLK N++ + + +K+ DFGL+ + S K GT E+ APEV P
Sbjct: 145 -YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL-DPKQSVKVTTGTAEFAAPEVAEGKPV 202
Query: 613 NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRL--EIPKNVNPMVAALIET 670
+D++S GV+ + L++ P+ + + V + ++ I
Sbjct: 203 GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRK 262
Query: 671 CWAEEPEIRPSFPSIME 687
+P R + +E
Sbjct: 263 LLLADPNTRMTIHQALE 279
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 197 bits (502), Expect = 1e-57
Identities = 60/257 (23%), Positives = 118/257 (45%), Gaps = 13/257 (5%)
Query: 437 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 494
I +++G G+FG V+ + + K I + D+ E++IM L HP ++
Sbjct: 33 ILEELGSGAFGVVHRCVEKATGRVFVAKF-INTPYPLDK-YTVKNEISIMNQLHHPKLIN 90
Query: 495 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 554
L A + + ++ E+LS G L+ + D + + E +N +G+ ++H+
Sbjct: 91 LHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK--MSEAEVINYMRQACEGLKHMHEHS- 147
Query: 555 PIVHRDLKSPNLLVDSTY--TVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPS 612
IVH D+K N++ ++ +VK+ DFGL+ I T T E+ APE++ +P
Sbjct: 148 -IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT-TATAEFAAPEIVDREPV 205
Query: 613 NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRL--EIPKNVNPMVAALIET 670
+D+++ GV+ + L++ P+ + + V + +V+P I+
Sbjct: 206 GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKN 265
Query: 671 CWAEEPEIRPSFPSIME 687
+EP R + +E
Sbjct: 266 LLQKEPRKRLTVHDALE 282
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 195 bits (496), Expect = 2e-57
Identities = 69/258 (26%), Positives = 122/258 (47%), Gaps = 14/258 (5%)
Query: 437 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 494
+ +G G+F V AE + + VA+K I ++ E + E+A++ ++HPNIV
Sbjct: 13 FRDVLGTGAFSEVILAEDKRTQKLVAIKC-IAKKALEGKEGSMENEIAVLHKIKHPNIVA 71
Query: 495 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 554
L +L ++ + +S G L+ + + ER + + V + YLH
Sbjct: 72 LDDIYESGGHLYLIMQLVSGGELFDRIV---EKGFYTERDASRLIFQVLDAVKYLHD--L 126
Query: 555 PIVHRDLKSPNLLV---DSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDP 611
IVHRDLK NLL D + + DFGLS+ + + S TA GTP ++APEVL + P
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS-TACGTPGYVAPEVLAQKP 185
Query: 612 SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP--KNVNPMVAALIE 669
++ D +S GVI + L+ P+ + +++ + + P +++ I
Sbjct: 186 YSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIR 245
Query: 670 TCWAEEPEIRPSFPSIME 687
++PE R + ++
Sbjct: 246 HLMEKDPEKRFTCEQALQ 263
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 6e-57
Identities = 52/257 (20%), Positives = 118/257 (45%), Gaps = 14/257 (5%)
Query: 437 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 494
I + +G G FG V+ +S K + + + K +E++I+ RH NI+
Sbjct: 9 IAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK---KEISILNIARHRNILH 65
Query: 495 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 554
L + L ++ E++S +++ ++ + ++ER ++ + V + + +LH
Sbjct: 66 LHESFESMEELVMIFEFISGLDIFERIN--TSAFELNEREIVSYVHQVCEALQFLHSHN- 122
Query: 555 PIVHRDLKSPNLLVDS--TYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPS 612
I H D++ N++ + + T+K+ +FG +R + + PE+ APEV + D
Sbjct: 123 -IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-NFRLLFTAPEYYAPEVHQHDVV 180
Query: 613 NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRL--EIPKNVNPMVAALIET 670
+ +D++S G +++ L++ P+ T Q+I + E K ++ ++
Sbjct: 181 STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDR 240
Query: 671 CWAEEPEIRPSFPSIME 687
+E + R + ++
Sbjct: 241 LLVKERKSRMTASEALQ 257
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (490), Expect = 2e-56
Identities = 66/252 (26%), Positives = 118/252 (46%), Gaps = 11/252 (4%)
Query: 437 IKKKIGEGSFGTVYHAEWRNSD--VAVKIL-IEQEFHEDRFKEFLREVAIM-KGLRHPNI 492
+ K +G+GSFG V+ AE++ ++ A+K L + +D + + E ++ HP +
Sbjct: 6 LHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL 65
Query: 493 VLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR 552
+ NL V EYL+ G L + + D A ++ G+ +LH +
Sbjct: 66 THMFCTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQFLHSK 122
Query: 553 RPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPS 612
IV+RDLK N+L+D +K+ DFG+ + + T GTP+++APE+L
Sbjct: 123 G--IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKY 180
Query: 613 NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCW 672
N D +SFGV+L+E++ Q P+ ++ ++ + P+ + L+ +
Sbjct: 181 NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI--RMDNPFYPRWLEKEAKDLLVKLF 238
Query: 673 AEEPEIRPSFPS 684
EPE R
Sbjct: 239 VREPEKRLGVRG 250
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 187 bits (477), Expect = 4e-55
Identities = 61/277 (22%), Positives = 119/277 (42%), Gaps = 26/277 (9%)
Query: 437 IKKKIGEGSFGTVYHAEWRNSD--VAVKIL-------IEQEFHEDRFKEFLREVAIMKGL 487
K+ +G G V + + AVKI+ E ++ + L+EV I++ +
Sbjct: 7 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 66
Query: 488 R-HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM 546
HPNI+ L +V + + +G L+ L +V + E+ + + + +
Sbjct: 67 SGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT---EKVTLSEKETRKIMRALLEVI 123
Query: 547 NYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV 606
LH+ IVHRDLK N+L+D +K+ DFG S + GTP ++APE+
Sbjct: 124 CALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE-KLREVCGTPSYLAPEI 180
Query: 607 LREDPS------NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIP--K 658
+ + ++ D++S GVI++ L+ P+ + ++ + + P
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD 240
Query: 659 NVNPMVAALIETCWAEEPEIRPSFPSIMET--LQQFL 693
+ + V L+ +P+ R + + QQ++
Sbjct: 241 DYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 277
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 185 bits (470), Expect = 1e-53
Identities = 60/260 (23%), Positives = 116/260 (44%), Gaps = 15/260 (5%)
Query: 437 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKE-FLREVAIMKGLRHPNIV 493
I + +G GSFG V+ R++ A+K+L ++ + E E ++ + HP I+
Sbjct: 8 ILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFII 67
Query: 494 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 553
+ G + + ++ +Y+ +L + + A +V + YLH
Sbjct: 68 RMWGTFQDAQQIFMIMDYIEG---GELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH--S 122
Query: 554 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSN 613
I++RDLK N+L+D +K+ DFG ++ P+ T GTP+++APEV+ P N
Sbjct: 123 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT---YTLCGTPDYIAPEVVSTKPYN 179
Query: 614 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWA 673
+ D +SFG++++E++ P+ +S + + L P N V L+
Sbjct: 180 KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI--LNAELRFPPFFNEDVKDLLSRLIT 237
Query: 674 EEPEIRPSFPSIMETLQQFL 693
+ R ++ +
Sbjct: 238 RDLSQRL--GNLQNGTEDVK 255
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 181 bits (459), Expect = 1e-52
Identities = 65/257 (25%), Positives = 115/257 (44%), Gaps = 17/257 (6%)
Query: 437 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRF-KEFLREVAIMKGLRHPNIV 493
+ + +G G V+ A VAVK+L + F F RE L HP IV
Sbjct: 11 LGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIV 70
Query: 494 LLMGAVTEPPNLS----IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 549
+ IV EY+ +L ++H + + + + D + +N+
Sbjct: 71 AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFS 127
Query: 550 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR---SKPNTYISSKTAAGTPEWMAPEV 606
HQ I+HRD+K N+++ +T VKV DFG++R N+ + GT ++++PE
Sbjct: 128 HQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 185
Query: 607 LREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR--LEIPKNVNPMV 664
R D + +SDV+S G +L+E++T + P+ +P V + + ++ +
Sbjct: 186 ARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADL 245
Query: 665 AALIETCWAEEPEIRPS 681
A++ A+ PE R
Sbjct: 246 DAVVLKALAKNPENRYQ 262
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 3e-52
Identities = 64/260 (24%), Positives = 118/260 (45%), Gaps = 12/260 (4%)
Query: 437 IKKKIGEGSFGTVYHAEWRNSD--VAVKIL-IEQEFHEDRFKEFLREVAIMKGLRHPNIV 493
K +G+G+FG V + + A+KIL E +D + E +++ RHP +
Sbjct: 9 YLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 68
Query: 494 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 553
L A L V EY + G L+ L V E ++ + YLH
Sbjct: 69 ALKYAFQTHDRLCFVMEYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLH--S 123
Query: 554 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSN 613
+V+RD+K NL++D +K+ DFGL + + + KT GTPE++APEVL ++
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYG 183
Query: 614 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWA 673
D + GV+++E++ + P+ N ++ + + P+ ++P +L+
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI--LMEEIRFPRTLSPEAKSLLAGLLK 241
Query: 674 EEPEIRPSFPSIMETLQQFL 693
++P+ R ++ +
Sbjct: 242 KDPKQRLG--GGPSDAKEVM 259
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 181 bits (460), Expect = 1e-51
Identities = 62/253 (24%), Positives = 110/253 (43%), Gaps = 15/253 (5%)
Query: 437 IKKKIGEGSFGTVYHAEWRNSD--VAVKIL----IEQEFHEDRFKEFLREVAIMKGLRHP 490
+ + IG G FG VY ++ A+K L I+ + E ++++ P
Sbjct: 8 VHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCP 67
Query: 491 NIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLH 550
IV + A P LS + + ++ G L+ L V E A ++ G+ ++H
Sbjct: 68 FIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGLEHMH 124
Query: 551 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLRED 610
R +V+RDLK N+L+D V++ D GL+ + GT +MAPEVL++
Sbjct: 125 NRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVGTHGYMAPEVLQKG 180
Query: 611 -PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVIS-AVGFKGRRLEIPKNVNPMVAALI 668
+ +D FS G +L++L+ P+R +E+P + +P + +L+
Sbjct: 181 VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLL 240
Query: 669 ETCWAEEPEIRPS 681
E + R
Sbjct: 241 EGLLQRDVNRRLG 253
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (451), Expect = 3e-51
Identities = 62/283 (21%), Positives = 120/283 (42%), Gaps = 25/283 (8%)
Query: 437 IKKKIGEGSFGTVYHAEWRNSD--VAVKIL----IEQEFHEDRFKEFLREVAIMKGLRHP 490
+++G G F V +++ A K + + ++ REV+I+K ++HP
Sbjct: 14 TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 73
Query: 491 NIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLH 550
N++ L ++ ++ E ++ G L+ + + E + G+ YLH
Sbjct: 74 NVITLHEVYENKTDVILILELVAGGELF---DFLAEKESLTEEEATEFLKQILNGVYYLH 130
Query: 551 QRRPPIVHRDLKSPNLLVDS----TYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV 606
I H DLK N+++ +K+ DFGL+ K GTPE++APE+
Sbjct: 131 SL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN-EFKNIFGTPEFVAPEI 187
Query: 607 LREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRL--EIPKNVNPMV 664
+ +P ++D++S GVI + L++ P+ T + ++ V E N + +
Sbjct: 188 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALA 247
Query: 665 AALIETCWAEEPEIRPSFPSIME-------TLQQFLMSSVCQP 700
I ++P+ R + ++ QQ L S+ P
Sbjct: 248 KDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSSAWSHP 290
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 175 bits (445), Expect = 2e-50
Identities = 48/278 (17%), Positives = 97/278 (34%), Gaps = 26/278 (9%)
Query: 437 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 494
+ +KIG GSFG +Y + VA+K+ + H + E I K ++ +
Sbjct: 11 LGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP----QLHIESKIYKMMQGGVGIP 66
Query: 495 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 554
+ + +++ L SL L + + + L +A + + Y+H +
Sbjct: 67 TIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKF--SLKTVLLLADQMISRIEYIHSKN- 123
Query: 555 PIVHRDLKSPNLLVDST---YTVKVCDFGLSR-------SKPNTYISSKTAAGTPEWMAP 604
+HRD+K N L+ V + DFGL++ + Y +K GT + +
Sbjct: 124 -FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 182
Query: 605 EVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAV------GFKGRRLEIPK 658
+ + D+ S G +L PW+ + + K
Sbjct: 183 NTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCK 242
Query: 659 NVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 696
A + C + + +P + + + +
Sbjct: 243 GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 8e-50
Identities = 66/282 (23%), Positives = 116/282 (41%), Gaps = 32/282 (11%)
Query: 427 GLEIRWSELL-----IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLR 479
GL+I+ + ++ + +G G G V + + A+K+L + R
Sbjct: 1 GLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-------QDCPKARR 53
Query: 480 EVAIM-KGLRHPNIVLLMGA----VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERL 534
EV + + + P+IV ++ L IV E L G L+ + + ER
Sbjct: 54 EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF-TERE 112
Query: 535 RLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY---TVKVCDFGLSRSKPNTYIS 591
+ + + + YLH I HRD+K NLL S +K+ DFG ++ + S
Sbjct: 113 ASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-S 169
Query: 592 SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG 651
T TP ++APEVL + ++ D++S GVI++ L+ P+ ++ + + +
Sbjct: 170 LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI 229
Query: 652 RRLEI------PKNVNPMVAALIETCWAEEPEIRPSFPSIME 687
R + V+ V LI EP R + M
Sbjct: 230 RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 3e-49
Identities = 54/261 (20%), Positives = 102/261 (39%), Gaps = 24/261 (9%)
Query: 437 IKKKIGEGSFGTVYHAEWRNSD--VAVKIL----IEQEFHEDRFKEFLREVAIMKGLR-- 488
+ +G G FG+VY + + VA+K + I EV ++K +
Sbjct: 8 VGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 67
Query: 489 HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 548
++ L+ P + ++ E L R + E L + + V + + +
Sbjct: 68 FSGVIRLLDWFERPDSFVLILERPEPVQD--LFDFITERGALQEELARSFFWQVLEAVRH 125
Query: 549 LHQRRPPIVHRDLKSPNLLVD-STYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVL 607
H ++HRD+K N+L+D + +K+ DFG +T GT + PE +
Sbjct: 126 CHNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWI 181
Query: 608 REDP-SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA 666
R + V+S G++L++++ P+ + ++ + V+
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR--------GQVFFRQRVSSECQH 233
Query: 667 LIETCWAEEPEIRPSFPSIME 687
LI C A P RP+F I
Sbjct: 234 LIRWCLALRPSDRPTFEEIQN 254
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 168 bits (426), Expect = 1e-47
Identities = 44/277 (15%), Positives = 93/277 (33%), Gaps = 28/277 (10%)
Query: 437 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 494
+ ++IGEGSFG ++ ++ VA+K + + E K L +
Sbjct: 9 VGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP----QLRDEYRTYKLLAGCTGIP 64
Query: 495 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 554
+ + +++ L SL LL + + V A + + +H++
Sbjct: 65 NVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAM--AAKQMLARVQSIHEKS- 121
Query: 555 PIVHRDLKSPNLLVDSTYT-----VKVCDFGLSR-------SKPNTYISSKTAAGTPEWM 602
+V+RD+K N L+ + + V DFG+ + + Y K +GT +M
Sbjct: 122 -LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180
Query: 603 APEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQV------ISAVGFKGRRLEI 656
+ + + D+ + G + + PW+ + I E+
Sbjct: 181 SINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL 240
Query: 657 PKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 693
+ + P + + + L
Sbjct: 241 CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 277
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 167 bits (423), Expect = 1e-46
Identities = 64/260 (24%), Positives = 115/260 (44%), Gaps = 15/260 (5%)
Query: 437 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKE-FLREVAIMKGLRHPNIV 493
K +G GSFG V + + S A+KIL +Q+ + + E L E I++ + P +V
Sbjct: 45 RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 494 LLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRR 553
L + + NL +V EY++ G ++ L E A + YLH
Sbjct: 105 KLEFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHSLD 161
Query: 554 PPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSN 613
+++RDLK NLL+D ++V DFG ++ T GTPE +APE++ N
Sbjct: 162 --LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WTLCGTPEALAPEIILSKGYN 216
Query: 614 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWA 673
+ D ++ GV+++E+ P+ P Q+ + ++ P + + + L+
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG--KVRFPSHFSSDLKDLLRNLLQ 274
Query: 674 EEPEIRPSFPSIMETLQQFL 693
+ R F ++ +
Sbjct: 275 VDLTKR--FGNLKNGVNDIK 292
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 1e-46
Identities = 71/286 (24%), Positives = 119/286 (41%), Gaps = 39/286 (13%)
Query: 434 ELLIKKKIGEGSFGTVYHAEWRNSD--VAVKIL---IEQEFHEDRFKEFLREVAIMKGLR 488
E L +GEG F TVY A +N++ VA+K + E + + LRE+ +++ L
Sbjct: 1 EKL--DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS 58
Query: 489 HPNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 548
HPNI+ L+ A N+S+V +++ + I D +V+ +G+ Y
Sbjct: 59 HPNIIGLLDAFGHKSNISLVFDFMET---DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEY 115
Query: 549 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLR 608
LHQ I+HRDLK NLL+D +K+ DFGL++S + + T + APE+L
Sbjct: 116 LHQH--WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLF 173
Query: 609 EDPS-NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAV-------------------- 647
D+++ G IL EL+ + ++ +
Sbjct: 174 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 233
Query: 648 -----GFKGRRL-EIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687
F G L I + LI+ + P R + ++
Sbjct: 234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 2e-46
Identities = 69/287 (24%), Positives = 122/287 (42%), Gaps = 41/287 (14%)
Query: 437 IKKKIGEGSFGTVYHAEWRNSD---VAVKILIEQEFHEDRFKEFLREVAIMKGL---RHP 490
+IGEG++G V+ A + VA+K + Q E +REVA+++ L HP
Sbjct: 11 CVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHP 70
Query: 491 NIVLLMGAVTEPPN-----LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKG 545
N+V L T L++V E++ + L +P+ V +M + + +G
Sbjct: 71 NVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGV--PTETIKDMMFQLLRG 128
Query: 546 MNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPE 605
+++LH R +VHRDLK N+LV S+ +K+ DFGL+R + ++ + T + APE
Sbjct: 129 LDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARIY-SFQMALTSVVVTLWYRAPE 185
Query: 606 VLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAV------------------ 647
VL + D++S G I E+ + +R S+ + +
Sbjct: 186 VLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 245
Query: 648 -------GFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687
+ +++ + L+ C P R S S +
Sbjct: 246 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 163 bits (413), Expect = 4e-46
Identities = 61/280 (21%), Positives = 110/280 (39%), Gaps = 34/280 (12%)
Query: 437 IKKKIGEGSFGTVYHAEWRNSD-VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLL 495
+KIGEG++G VY A+ + A+K + ++ E +RE++I+K L+H NIV L
Sbjct: 6 GLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKL 65
Query: 496 MGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPP 555
+ L +V E+L + L ++ + + G+ Y H RR
Sbjct: 66 YDVIHTKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDRR-- 120
Query: 556 IVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPS-NE 614
++HRDLK NLL++ +K+ DFGL+R+ T + AP+VL +
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYST 180
Query: 615 KSDVFSFGVILWELITLQKPWRNSTPSQVISAV--------------------------- 647
D++S G I E++ + + + + +
Sbjct: 181 TIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV 240
Query: 648 GFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687
K ++ L+ +P R + +E
Sbjct: 241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 1e-45
Identities = 58/281 (20%), Positives = 115/281 (40%), Gaps = 34/281 (12%)
Query: 437 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 494
+KIGEG++G VY A + + VA+K + E +RE++++K L HPNIV
Sbjct: 6 KVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVK 65
Query: 495 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 554
L+ + L +V E+L + + + + + + +G+ + H
Sbjct: 66 LLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKS--YLFQLLQGLAFCHSH-- 121
Query: 555 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDP-SN 613
++HRDLK NLL+++ +K+ DFGL+R+ + T + APE+L +
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 181
Query: 614 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAV-------------------------- 647
D++S G I E++T + + + + +
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 241
Query: 648 -GFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687
+ ++ ++ +L+ +P R S + +
Sbjct: 242 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 8e-43
Identities = 59/295 (20%), Positives = 98/295 (33%), Gaps = 47/295 (15%)
Query: 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKG 486
E+ +++ K IG GSFG VY A+ +S VA+K +++ + + RE+ IM+
Sbjct: 19 EVSYTDT---KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRK 69
Query: 487 LRHPNIVLLMGAVTEP------PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAY 540
L H NIV L L++V +Y+ H A+ + Y
Sbjct: 70 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 129
Query: 541 DVAKGMNYLHQRRPPIVHRDLK-SPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTP 599
+ + + Y+H I HRD+K LL T +K+CDFG ++ +
Sbjct: 130 QLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY 187
Query: 600 EWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAV------------ 647
+ DV+S G +L EL+ Q + + + +
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 247
Query: 648 ---------------GFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687
P AL P R +
Sbjct: 248 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 2e-42
Identities = 62/290 (21%), Positives = 109/290 (37%), Gaps = 46/290 (15%)
Query: 437 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 494
IGEG++G V A + VA+K + E H+ + LRE+ I+ RH NI+
Sbjct: 12 NLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIG 70
Query: 495 LMGAVTEPP----NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLH 550
+ + P + +L LYKLL + Y + +G+ Y+H
Sbjct: 71 INDIIRAPTIEQMKDVYLVTHLMGADLYKLLK----TQHLSNDHICYFLYQILRGLKYIH 126
Query: 551 QRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR---SKPNTYISSKTAAGTPEWMAPEVL 607
++HRDLK NLL+++T +K+CDFGL+R + T + APE++
Sbjct: 127 SAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 184
Query: 608 -REDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAV------------------- 647
+ D++S G IL E+++ + + ++ +
Sbjct: 185 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 244
Query: 648 ----------GFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687
K + N + L++ P R +
Sbjct: 245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 2e-41
Identities = 58/270 (21%), Positives = 118/270 (43%), Gaps = 20/270 (7%)
Query: 437 IKKKIGEGSFGTVYHAE-----WRNSDVAVKILIEQEFHEDR--FKEFLREVAIMKGLRH 489
+ K +G G++G V+ A+K+L + + + E +++ +R
Sbjct: 28 LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ 87
Query: 490 -PNIVLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 548
P +V L A L ++ +Y++ G L+ L R E ++ + +
Sbjct: 88 SPFLVTLHYAFQTETKLHLILDYINGGELFTHLS---QRERFTEHEVQIYVGEIVLALEH 144
Query: 549 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS-KPNTYISSKTAAGTPEWMAPEVL 607
LH+ I++RD+K N+L+DS V + DFGLS+ + + GT E+MAP+++
Sbjct: 145 LHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV 202
Query: 608 REDPS--NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR--LEIPKNVNPM 663
R S ++ D +S GV+++EL+T P+ + + + + P+ ++ +
Sbjct: 203 RGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSAL 262
Query: 664 VAALIETCWAEEPEIRPSFPSIMETLQQFL 693
LI+ ++P+ R +
Sbjct: 263 AKDLIQRLLMKDPKKRLG--CGPRDADEIK 290
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (378), Expect = 3e-41
Identities = 62/282 (21%), Positives = 111/282 (39%), Gaps = 36/282 (12%)
Query: 437 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 494
+KIGEG++GTV+ A+ R + VA+K + + E LRE+ ++K L+H NIV
Sbjct: 6 KLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVR 65
Query: 495 LMGAVTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP 554
L + L++V E+ + + +D + + + + KG+ + H R
Sbjct: 66 LHDVLHSDKKLTLVFEFCDQ---DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN- 121
Query: 555 PIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPS-N 613
++HRDLK NLL++ +K+ +FGL+R+ T + P+VL +
Sbjct: 122 -VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYS 180
Query: 614 EKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG---------------------- 651
D++S G I EL +P F+
Sbjct: 181 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240
Query: 652 ------RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687
+ + +N L++ P R S ++
Sbjct: 241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (378), Expect = 6e-41
Identities = 57/296 (19%), Positives = 111/296 (37%), Gaps = 50/296 (16%)
Query: 437 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 494
KIG+G+FG V+ A R + VA+K ++ + E LRE+ I++ L+H N+V
Sbjct: 14 KLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVN 73
Query: 495 LMGAVTEPP--------NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM 546
L+ ++ +V ++ + + V + + G+
Sbjct: 74 LIEICRTKASPYNRCKGSIYLVFDFCEHDLAG---LLSNVLVKFTLSEIKRVMQMLLNGL 130
Query: 547 NYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR----SKPNTYISSKTAAGTPEWM 602
Y+H+ + I+HRD+K+ N+L+ +K+ DFGL+R +K + T +
Sbjct: 131 YYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYR 188
Query: 603 APEVLREDPS-NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAV-------------- 647
PE+L + D++ G I+ E+ T + +T ++ +
Sbjct: 189 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 248
Query: 648 ----------------GFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687
K + +P LI+ +P R +
Sbjct: 249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 5e-39
Identities = 63/289 (21%), Positives = 108/289 (37%), Gaps = 48/289 (16%)
Query: 437 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 494
+ +G G++G V A + VA+K L E K RE+ ++K +RH N++
Sbjct: 22 DLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIG 81
Query: 495 LMGAVTEPPNLS------IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 548
L+ T L +V ++ + H + E + Y + KG+ Y
Sbjct: 82 LLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK-----LGEDRIQFLVYQMLKGLRY 136
Query: 549 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLR 608
+H HRDLK NL V+ +K+ DFGL+R + T + APEV+
Sbjct: 137 IHAAGII--HRDLKPGNLAVNEDCELKILDFGLARQADSEM---TGYVVTRWYRAPEVIL 191
Query: 609 ED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGF------------------ 649
+ D++S G I+ E+IT + ++ S + +
Sbjct: 192 NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 251
Query: 650 -----------KGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687
K I N +P+ L+E + E R + +
Sbjct: 252 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 9e-37
Identities = 61/276 (22%), Positives = 110/276 (39%), Gaps = 18/276 (6%)
Query: 437 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 494
K IG G+ G V A D VA+K L ++ K RE+ +MK + H NI+
Sbjct: 21 NLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIS 80
Query: 495 LMGAVTEPP------NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNY 548
L+ T ++ +V E + + D + Y + G+ +
Sbjct: 81 LLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL------DHERMSYLLYQMLCGIKH 134
Query: 549 LHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLR 608
LH +HRDLK N++V S T+K+ DFGL+R+ +++ + T + APEV+
Sbjct: 135 LHSAGI--IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY-VVTRYYRAPEVIL 191
Query: 609 EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI 668
E D++S G I+ E++ + + + V + P+ + + +
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV-IEQLGTPCPEFMKKLQPTVR 250
Query: 669 ETCWAEEPEIRPSFPSIMETLQQFLMSSVCQPLSAQ 704
+FP + S + ++Q
Sbjct: 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQ 286
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 131 bits (329), Expect = 4e-34
Identities = 51/231 (22%), Positives = 106/231 (45%), Gaps = 24/231 (10%)
Query: 422 YLEEEGLEIRWS---ELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKE 476
Y + E + W + + +K+G G + V+ A ++ V VKIL + K+
Sbjct: 21 YWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL-----KPVKKKK 75
Query: 477 FLREVAIMKGLR-HPNIVLLMGAVTEPPN--LSIVTEYLSRGSLYKLLHIPDARVVVDER 533
RE+ I++ LR PNI+ L V +P + ++V E+++ +L + +
Sbjct: 76 IKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT------LTDY 129
Query: 534 LRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS-TYTVKVCDFGLSRSKPNTYISS 592
Y++ K ++Y H I+HRD+K N+++D +++ D+GL+ +
Sbjct: 130 DIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY-HPGQEY 186
Query: 593 KTAAGTPEWMAPEVLREDPS-NEKSDVFSFGVILWELITLQKPWRNSTPSQ 642
+ + PE+L + + D++S G +L +I ++P+ + +
Sbjct: 187 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY 237
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (326), Expect = 1e-33
Identities = 62/288 (21%), Positives = 113/288 (39%), Gaps = 46/288 (15%)
Query: 437 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 494
+G G++G+V A + VAVK L K RE+ ++K ++H N++
Sbjct: 22 NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 81
Query: 495 LMGAVTEPPNLS-----IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYL 549
L+ T +L + +L L ++ + + + Y + +G+ Y+
Sbjct: 82 LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLKYI 137
Query: 550 HQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV-LR 608
H I+HRDLK NL V+ +K+ DFGL+R + T + APE+ L
Sbjct: 138 HSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLN 192
Query: 609 EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVI---------------------SAV 647
N+ D++S G I+ EL+T + + + + SA
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 252
Query: 648 GFKGRRLEIPK--------NVNPMVAALIETCWAEEPEIRPSFPSIME 687
+ ++PK NP+ L+E + + R + +
Sbjct: 253 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 112 bits (280), Expect = 2e-27
Identities = 44/221 (19%), Positives = 92/221 (41%), Gaps = 28/221 (12%)
Query: 437 IKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVL 494
+ +K+G G F TV+ A+ ++ VA+KI+ + + + + E+ +++ + +
Sbjct: 17 LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAE---DEIKLLQRVNDADNTK 73
Query: 495 LMGAVTE-------------PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYD 541
P + +V + G L + ++
Sbjct: 74 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133
Query: 542 VAKGMNYLHQRRPPIVHRDLKSPNLLVDS------TYTVKVCDFGLSRSKPNTYISSKTA 595
+ G++Y+H+R I+H D+K N+L++ +K+ D G + Y +S
Sbjct: 134 LLLGLDYMHRRCG-IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI-- 190
Query: 596 AGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWR 636
T E+ +PEVL P +D++S +++ELIT +
Sbjct: 191 -QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE 230
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 85.6 bits (211), Expect = 8e-20
Identities = 33/187 (17%), Positives = 53/187 (28%), Gaps = 33/187 (17%)
Query: 437 IKKKIGEGSFGTVYHAEWRNS-DVAVKIL--------IEQEFHEDRFKEFLREVAIMKGL 487
I K +GEG V++ + VK +E + F
Sbjct: 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 63
Query: 488 RHPNIVLLMGAVTEPPNLSIVTEY-LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGM 546
+ L G L++ Y ++ L V + + + +
Sbjct: 64 EFRALQKLQG-------LAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEV 116
Query: 547 NYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEV 606
+ R IVH DL N+LV + + DF S E E+
Sbjct: 117 AKFYHR--GIVHGDLSQYNVLVSE-EGIWIIDFPQSVE-------------VGEEGWREI 160
Query: 607 LREDPSN 613
L D N
Sbjct: 161 LERDVRN 167
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 706 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.86 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.33 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.75 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 96.91 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.09 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 95.86 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.6 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-52 Score=434.66 Aligned_cols=264 Identities=36% Similarity=0.609 Sum_probs=222.8
Q ss_pred CcccccCceEEEEEeccCCceEEEEEEEcCCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceE
Q 005247 427 GLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS 506 (706)
Q Consensus 427 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 506 (706)
++++..++|++.+.||+|+||+||+|++++ .||||++..........+.|.+|+.+|++++||||+++++++.+ +.++
T Consensus 2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~ 79 (276)
T d1uwha_ 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLA 79 (276)
T ss_dssp CCBCCTTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCE
T ss_pred CcccccccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEE
Confidence 467888999999999999999999998654 59999997776667778899999999999999999999998765 5689
Q ss_pred EEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCC
Q 005247 507 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP 586 (706)
Q Consensus 507 lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~ 586 (706)
+||||+++|+|.++++..+ ..+++..+..++.||+.||+|||+++ ||||||||+|||++.++++||+|||+|+...
T Consensus 80 lv~Ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~~--ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~ 155 (276)
T d1uwha_ 80 IVTQWCEGSSLYHHLHIIE--TKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFLHEDLTVKIGDFGLATVKS 155 (276)
T ss_dssp EEEECCCEEEHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETTSSEEECCCCCSCC--
T ss_pred EEEecCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHhcCC--EeccccCHHHEEEcCCCCEEEccccceeecc
Confidence 9999999999999996433 35899999999999999999999999 9999999999999999999999999998754
Q ss_pred CCc--ccCCCCCCCCCccCcccccc---CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCc----ccCCC
Q 005247 587 NTY--ISSKTAAGTPEWMAPEVLRE---DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR----RLEIP 657 (706)
Q Consensus 587 ~~~--~~~~~~~Gt~~Y~APE~l~~---~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~----~l~~p 657 (706)
... .......||+.|||||++.+ ..++.++|||||||++|||+||+.||...+............. ...++
T Consensus 156 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~ 235 (276)
T d1uwha_ 156 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVR 235 (276)
T ss_dssp ----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSC
T ss_pred ccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhcc
Confidence 322 22345689999999999964 3578999999999999999999999988766554443332222 23466
Q ss_pred CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhc
Q 005247 658 KNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 696 (706)
Q Consensus 658 ~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~ 696 (706)
.++++++.+||.+||+.||++|||+.+|++.|+.+.++.
T Consensus 236 ~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~ 274 (276)
T d1uwha_ 236 SNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274 (276)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence 789999999999999999999999999999999988763
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-52 Score=431.71 Aligned_cols=255 Identities=28% Similarity=0.439 Sum_probs=211.1
Q ss_pred cCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccC--CCceEE
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE--PPNLSI 507 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~--~~~~~l 507 (706)
.++|++++.||+|+||+||+|+++.+ .||+|++......+...+.+.+|++++++++||||+++++++.+ ++.+++
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 36799999999999999999998754 49999998877777777889999999999999999999998854 456899
Q ss_pred EEEeccCCchhhhcccC-CCcccccHHHHHHHHHHHHHHHHHHHhcC---CCcccccCCCCcEEECCCCcEEEeecCccc
Q 005247 508 VTEYLSRGSLYKLLHIP-DARVVVDERLRLNMAYDVAKGMNYLHQRR---PPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 583 (706)
Q Consensus 508 V~E~~~ggsL~~~l~~~-~~~~~l~~~~~~~ia~qIl~aL~yLHs~g---~~IIHrDLKp~NILl~~~~~vKL~DFGla~ 583 (706)
|||||++|+|.+++... .....+++..++.++.||+.||+|||+++ .+||||||||+|||++.++.+||+|||+|+
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 99999999999998532 22346899999999999999999999865 249999999999999999999999999998
Q ss_pred cCCCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHH
Q 005247 584 SKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPM 663 (706)
Q Consensus 584 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~e 663 (706)
.............||+.|||||++.+..++.++|||||||++|||+||+.||...+..+....+. ......+|..++++
T Consensus 163 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~-~~~~~~~~~~~s~~ 241 (269)
T d2java1 163 ILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR-EGKFRRIPYRYSDE 241 (269)
T ss_dssp HC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH-HTCCCCCCTTSCHH
T ss_pred ecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHH-cCCCCCCCcccCHH
Confidence 76655444556789999999999999999999999999999999999999999988888777764 33445678899999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 664 VAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 664 l~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
+.+||.+||+.||++|||+.|+++
T Consensus 242 l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 242 LNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHcCCChhHCcCHHHHHh
Confidence 999999999999999999999875
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-51 Score=426.32 Aligned_cols=247 Identities=29% Similarity=0.524 Sum_probs=220.5
Q ss_pred cCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccch-HHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEE
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHE-DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIV 508 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~-~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV 508 (706)
.++|++++.||+|+||+||+|.++.+ .||+|++.+..... ...+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence 36899999999999999999998754 49999987644322 2346788999999999999999999999999999999
Q ss_pred EEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCC
Q 005247 509 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 588 (706)
Q Consensus 509 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 588 (706)
||||++|+|.+++... ..+++..++.++.||+.||+|||++| ||||||||+|||++.++.+||+|||+|......
T Consensus 85 mEy~~~g~L~~~l~~~---~~l~e~~~~~i~~qi~~al~~lH~~~--ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 85 LEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp EECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred EeecCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 9999999999999743 35899999999999999999999999 999999999999999999999999999876554
Q ss_pred cccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHH
Q 005247 589 YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI 668 (706)
Q Consensus 589 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI 668 (706)
. .....||+.|||||++.+..++.++|||||||++|||++|+.||...+..+....+. .....+|..+++++++||
T Consensus 160 ~--~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~li 235 (263)
T d2j4za1 160 R--RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS--RVEFTFPDFVTEGARDLI 235 (263)
T ss_dssp C--CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--TTCCCCCTTSCHHHHHHH
T ss_pred c--ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHH--cCCCCCCccCCHHHHHHH
Confidence 2 345689999999999999999999999999999999999999999998888777663 445678889999999999
Q ss_pred HHhhhhCCCCCCCHHHHHH
Q 005247 669 ETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 669 ~~cL~~dP~~RPS~~eIl~ 687 (706)
.+||+.||++|||++|+++
T Consensus 236 ~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 236 SRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp HHHTCSSGGGSCCHHHHHT
T ss_pred HHHccCCHhHCcCHHHHHc
Confidence 9999999999999999986
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.2e-51 Score=430.16 Aligned_cols=262 Identities=33% Similarity=0.567 Sum_probs=218.5
Q ss_pred ccccCceEEEEEeccCCceEEEEEEEcCCc-----eEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCC
Q 005247 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD-----VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP 503 (706)
Q Consensus 429 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~-----vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 503 (706)
++..++|++.+.||+|+||+||+|.+..++ ||||.+... ......+.|.+|+.+|++++|||||++++++.+++
T Consensus 22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~ 100 (299)
T d1jpaa_ 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST 100 (299)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence 455678999999999999999999886432 566665433 34556678999999999999999999999999999
Q ss_pred ceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccc
Q 005247 504 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 583 (706)
Q Consensus 504 ~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~ 583 (706)
.+++|||||++|+|.+++.... ..+++..++.++.||++||+|||+++ ||||||||+|||++.++++||+|||+++
T Consensus 101 ~~~iv~Ey~~~g~L~~~~~~~~--~~l~~~~~~~i~~qia~gl~yLH~~~--iiHrDlKp~NILl~~~~~~Kl~DFGla~ 176 (299)
T d1jpaa_ 101 PVMIITEFMENGSLDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLADMN--YVHRDLAARNILVNSNLVCKVSDFGLSR 176 (299)
T ss_dssp SCEEEEECCTTEEHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC----
T ss_pred EEEEEEEecCCCcceeeecccc--CCCCHHHHHHHHHHHHHHHHHHhhCC--CccCccccceEEECCCCcEEECCcccce
Confidence 9999999999999999887433 35899999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCcc-----cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCC
Q 005247 584 SKPNTYI-----SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIP 657 (706)
Q Consensus 584 ~~~~~~~-----~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p 657 (706)
....... ......||+.|||||.+.+..++.++|||||||++|||+| |+.||...+..+....+. ...+++.|
T Consensus 177 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~-~~~~~~~~ 255 (299)
T d1jpaa_ 177 FLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE-QDYRLPPP 255 (299)
T ss_dssp -------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TTCCCCCC
T ss_pred EccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCC
Confidence 6543221 1122457899999999999999999999999999999998 899999998888877764 55677888
Q ss_pred CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhc
Q 005247 658 KNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 696 (706)
Q Consensus 658 ~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~ 696 (706)
..+++++.+||.+||+.||++|||+.||++.|++++++.
T Consensus 256 ~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p 294 (299)
T d1jpaa_ 256 MDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP 294 (299)
T ss_dssp TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcCh
Confidence 899999999999999999999999999999999999864
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-51 Score=420.85 Aligned_cols=258 Identities=34% Similarity=0.603 Sum_probs=215.8
Q ss_pred cccCceEEEEEeccCCceEEEEEEEcCC-ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEE
Q 005247 430 IRWSELLIKKKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIV 508 (706)
Q Consensus 430 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~-~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV 508 (706)
++.++|++++.||+|+||+||+|.+.++ .||||++....... +.|.+|+.++++++||||+++++++.+++..++|
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~---~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv 78 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 78 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCH---HHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred CChHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcH---HHHHHHHHHHHhcCCCCcccccceeccCCceEEE
Confidence 3457899999999999999999998654 49999986654333 5789999999999999999999999999999999
Q ss_pred EEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCC
Q 005247 509 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 588 (706)
Q Consensus 509 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 588 (706)
|||+++|+|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++.....
T Consensus 79 ~E~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qia~gl~~lH~~~--iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 154 (263)
T d1sm2a_ 79 FEFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 154 (263)
T ss_dssp EECCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCTTCSGGGEEECGGGCEEECSCC--------
T ss_pred EEecCCCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHhhhccc--eeecccchhheeecCCCCeEecccchheeccCC
Confidence 99999999999986433 35889999999999999999999999 999999999999999999999999999875543
Q ss_pred cc-cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhC-CCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHH
Q 005247 589 YI-SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA 666 (706)
Q Consensus 589 ~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG-~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~d 666 (706)
.. ......||+.|+|||++.+..++.++|||||||++|||+|+ .+||...+..+....+. ...+...|..+++++.+
T Consensus 155 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~-~~~~~~~p~~~~~~l~~ 233 (263)
T d1sm2a_ 155 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKPRLASTHVYQ 233 (263)
T ss_dssp ----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHH-HTCCCCCCTTSCHHHHH
T ss_pred CceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHH-hcCCCCCccccCHHHHH
Confidence 22 23346789999999999999999999999999999999995 66677677766666664 45667788899999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHHHHHHHHh
Q 005247 667 LIETCWAEEPEIRPSFPSIMETLQQFLMS 695 (706)
Q Consensus 667 LI~~cL~~dP~~RPS~~eIl~~L~~ll~s 695 (706)
||.+||+.||++|||+++|++.|++++.+
T Consensus 234 li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 234 IMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 99999999999999999999999998765
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-51 Score=423.11 Aligned_cols=265 Identities=33% Similarity=0.578 Sum_probs=228.7
Q ss_pred cccCcccccCceEEEEEeccCCceEEEEEEEcCC-ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCC
Q 005247 424 EEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP 502 (706)
Q Consensus 424 ~~~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~-~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~ 502 (706)
.++.+++..++|++.+.||+|+||.||+|.+++. .||||++...... .+.|.+|+.++++++|||||++++++.+
T Consensus 4 ~~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~- 79 (272)
T d1qpca_ 4 WEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ- 79 (272)
T ss_dssp TTCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred CCCCeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCC---HHHHHHHHHHHHhCCCCCEeEEEeeecc-
Confidence 3566888899999999999999999999998754 5999998765433 2578999999999999999999998765
Q ss_pred CceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCcc
Q 005247 503 PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS 582 (706)
Q Consensus 503 ~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla 582 (706)
+..++||||+++|+|.+++.... ...+++..++.|+.||+.||.|||+++ |+||||||+||||++++.+||+|||+|
T Consensus 80 ~~~~iv~Ey~~~g~L~~~~~~~~-~~~l~~~~~~~i~~qi~~gl~~lH~~~--ivHrDiKp~NIll~~~~~~Kl~DFGla 156 (272)
T d1qpca_ 80 EPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLA 156 (272)
T ss_dssp SSCEEEEECCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCeEEEEEeCCCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccchhheeeecccceeeccccce
Confidence 56799999999999999875432 235889999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCc-ccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCC-CCCCCCChHHHHHHhhhcCcccCCCCCC
Q 005247 583 RSKPNTY-ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQ-KPWRNSTPSQVISAVGFKGRRLEIPKNV 660 (706)
Q Consensus 583 ~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~-~Pf~~~~~~~~~~~i~~~~~~l~~p~~~ 660 (706)
+...... .......||+.|+|||++.+..++.++|||||||++|||+||. +||...+..+....+ ....++..|..+
T Consensus 157 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i-~~~~~~~~p~~~ 235 (272)
T d1qpca_ 157 RLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL-ERGYRMVRPDNC 235 (272)
T ss_dssp EECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH-HTTCCCCCCTTC
T ss_pred EEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHH-HhcCCCCCcccC
Confidence 8765433 2334567899999999999999999999999999999999965 556666666666665 356677888999
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhc
Q 005247 661 NPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 696 (706)
Q Consensus 661 s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~ 696 (706)
++++.+||.+||+.||++|||+++|++.|+.+..+.
T Consensus 236 ~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ftst 271 (272)
T d1qpca_ 236 PEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (272)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred hHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhcC
Confidence 999999999999999999999999999999998764
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.5e-51 Score=429.67 Aligned_cols=262 Identities=36% Similarity=0.601 Sum_probs=226.6
Q ss_pred CcccccCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCc
Q 005247 427 GLEIRWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN 504 (706)
Q Consensus 427 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 504 (706)
.+++..++|++.+.||+|+||+||+|.+.++ .||||++...... .+.|.+|+.+|++++|||||++++++.+++.
T Consensus 11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (287)
T d1opja_ 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 87 (287)
T ss_dssp TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch---HHHHHHHHHHHHhCCCCCEecCCccEeeCCe
Confidence 4778889999999999999999999998754 4999998655433 3578999999999999999999999999999
Q ss_pred eEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCcccc
Q 005247 505 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 584 (706)
Q Consensus 505 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~ 584 (706)
+++||||+++|+|.+++.... ...+++..++.++.||+.||+|||++| ||||||||+|||++.++++||+|||+|+.
T Consensus 88 ~~iv~E~~~~g~l~~~l~~~~-~~~~~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlKp~NILl~~~~~~Kl~DFG~a~~ 164 (287)
T d1opja_ 88 FYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRL 164 (287)
T ss_dssp CEEEEECCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCCTTT
T ss_pred eEEEeecccCcchHHHhhhcc-ccchHHHHHHHHHHHHHHHHHHHHHCC--cccCccccCeEEECCCCcEEEccccceee
Confidence 999999999999999986432 246889999999999999999999999 99999999999999999999999999987
Q ss_pred CCCCcc-cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCC-CCChHHHHHHhhhcCcccCCCCCCcH
Q 005247 585 KPNTYI-SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWR-NSTPSQVISAVGFKGRRLEIPKNVNP 662 (706)
Q Consensus 585 ~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~-~~~~~~~~~~i~~~~~~l~~p~~~s~ 662 (706)
...... ......|++.|+|||++.+..++.++|||||||++|||++|..||. ..+..+....+ ....++++|..+++
T Consensus 165 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i-~~~~~~~~~~~~~~ 243 (287)
T d1opja_ 165 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-EKDYRMERPEGCPE 243 (287)
T ss_dssp CCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH-HTTCCCCCCTTCCH
T ss_pred cCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHH-hcCCCCCCCccchH
Confidence 654322 2234458899999999999999999999999999999999766654 45555444444 45667888999999
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHh
Q 005247 663 MVAALIETCWAEEPEIRPSFPSIMETLQQFLMS 695 (706)
Q Consensus 663 el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s 695 (706)
++.+||.+||+.||++|||+.+|++.|+.++.+
T Consensus 244 ~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 244 KVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 999999999999999999999999999887654
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-50 Score=427.68 Aligned_cols=247 Identities=27% Similarity=0.462 Sum_probs=218.9
Q ss_pred CceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEE
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 510 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E 510 (706)
++|++.+.||+|+||+||+|.+.. ..||||++....... .+.+.+|+.++++++||||+++++++.+++.+++|||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~--~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 97 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH--HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEE
Confidence 469999999999999999999764 459999987654332 3578999999999999999999999999999999999
Q ss_pred eccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcc
Q 005247 511 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 590 (706)
Q Consensus 511 ~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~ 590 (706)
||++|+|.+++... .+++..++.++.||+.||+|||++| ||||||||+|||++.++++||+|||+|+.......
T Consensus 98 y~~gg~L~~~~~~~----~l~~~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 171 (293)
T d1yhwa1 98 YLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (293)
T ss_dssp CCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred ecCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCcHHHeEECCCCcEeeccchhheeeccccc
Confidence 99999999987632 4899999999999999999999999 99999999999999999999999999987665544
Q ss_pred cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhc-CcccCCCCCCcHHHHHHHH
Q 005247 591 SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-GRRLEIPKNVNPMVAALIE 669 (706)
Q Consensus 591 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~-~~~l~~p~~~s~el~dLI~ 669 (706)
.....+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+... ...+..+..+++++++||.
T Consensus 172 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~ 251 (293)
T d1yhwa1 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 251 (293)
T ss_dssp CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHH
T ss_pred cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHH
Confidence 556778999999999999999999999999999999999999999988877666555433 3346667889999999999
Q ss_pred HhhhhCCCCCCCHHHHHH
Q 005247 670 TCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 670 ~cL~~dP~~RPS~~eIl~ 687 (706)
+||+.||++|||+.|+++
T Consensus 252 ~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 252 RCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp HHTCSSTTTSCCHHHHTT
T ss_pred HHccCChhHCcCHHHHhc
Confidence 999999999999999975
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-50 Score=419.99 Aligned_cols=264 Identities=30% Similarity=0.519 Sum_probs=226.8
Q ss_pred ccccCceEEEEE-eccCCceEEEEEEEcCC----ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCC
Q 005247 429 EIRWSELLIKKK-IGEGSFGTVYHAEWRNS----DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP 503 (706)
Q Consensus 429 ~i~~~~y~i~~~-LG~G~fG~Vy~a~~~~~----~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 503 (706)
-+..++|.+.+. ||+|+||+||+|.++.+ .||||++.... .....+.|.+|+++|++++|||||++++++.. +
T Consensus 4 ~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~ 81 (285)
T d1u59a_ 4 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E 81 (285)
T ss_dssp BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-S
T ss_pred eecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc-CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-C
Confidence 345567888884 99999999999976532 38999986543 45567889999999999999999999999865 4
Q ss_pred ceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccc
Q 005247 504 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 583 (706)
Q Consensus 504 ~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~ 583 (706)
.+++||||+++|+|.+++.... ..+++..++.++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+++
T Consensus 82 ~~~lvmE~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~gL~ylH~~~--iiHrDlKp~Nill~~~~~~Kl~DFGla~ 157 (285)
T d1u59a_ 82 ALMLVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFGLSK 157 (285)
T ss_dssp SEEEEEECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEETTEEEECCCTTCE
T ss_pred eEEEEEEeCCCCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCcCchhheeeccCCceeeccchhhh
Confidence 5899999999999999875332 35899999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCc---ccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCCCC
Q 005247 584 SKPNTY---ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKN 659 (706)
Q Consensus 584 ~~~~~~---~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p~~ 659 (706)
...... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||...+..+....+. .+.++++|+.
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~-~~~~~~~p~~ 236 (285)
T d1u59a_ 158 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPPE 236 (285)
T ss_dssp ECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH-TTCCCCCCTT
T ss_pred cccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCc
Confidence 754332 22334578999999999999999999999999999999998 899999888877776664 5667888999
Q ss_pred CcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhccCC
Q 005247 660 VNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSVCQ 699 (706)
Q Consensus 660 ~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~~~~ 699 (706)
+++++.+||.+||+.||++|||+.+|++.|+....+...+
T Consensus 237 ~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~~ 276 (285)
T d1u59a_ 237 CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 276 (285)
T ss_dssp CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhhc
Confidence 9999999999999999999999999999999887664443
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-50 Score=417.25 Aligned_cols=247 Identities=32% Similarity=0.524 Sum_probs=212.5
Q ss_pred eEEEEEeccCCceEEEEEEEcCCc--eEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccC----CCceEEE
Q 005247 435 LLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE----PPNLSIV 508 (706)
Q Consensus 435 y~i~~~LG~G~fG~Vy~a~~~~~~--vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~----~~~~~lV 508 (706)
|++.++||+|+||+||+|.+..++ ||+|++..........+.+.+|+++|++++||||+++++++.+ ...+++|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 477889999999999999987654 8999988777677777889999999999999999999998754 4558999
Q ss_pred EEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEEC-CCCcEEEeecCccccCCC
Q 005247 509 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVD-STYTVKVCDFGLSRSKPN 587 (706)
Q Consensus 509 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~-~~~~vKL~DFGla~~~~~ 587 (706)
|||+++|+|.++++.. ..+++..++.++.||+.||+|||+++++||||||||+|||++ .++.+||+|||+|+....
T Consensus 91 mE~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp EECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EeCCCCCcHHHHHhcc---ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 9999999999999643 358999999999999999999999987899999999999996 578999999999986544
Q ss_pred CcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHhhhcCcccCCCCCCcHHHHH
Q 005247 588 TYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTP-SQVISAVGFKGRRLEIPKNVNPMVAA 666 (706)
Q Consensus 588 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~-~~~~~~i~~~~~~l~~p~~~s~el~d 666 (706)
.. ....+||+.|||||++.+ .++.++|||||||++|||++|+.||..... .+....+.....+..++..+++++++
T Consensus 168 ~~--~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 244 (270)
T d1t4ha_ 168 SF--AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKE 244 (270)
T ss_dssp TS--BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHH
T ss_pred Cc--cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHH
Confidence 32 346789999999999865 599999999999999999999999976544 44445554444455677788999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHH
Q 005247 667 LIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 667 LI~~cL~~dP~~RPS~~eIl~ 687 (706)
||.+||+.||++|||++|+++
T Consensus 245 li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 245 IIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp HHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHccCCHhHCcCHHHHhC
Confidence 999999999999999999975
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-50 Score=420.91 Aligned_cols=249 Identities=29% Similarity=0.387 Sum_probs=208.8
Q ss_pred CceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEE
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 510 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E 510 (706)
++|++++.||+|+||+||+|.++.+ .||||++..... .+..+.+.+|+.+|++++||||+++++++.+++..++|||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 5799999999999999999998754 499999876542 2334678999999999999999999999999999999999
Q ss_pred eccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCC--
Q 005247 511 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT-- 588 (706)
Q Consensus 511 ~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~-- 588 (706)
|+++|+|.++++.. ..+++..++.++.||+.||+|||++| ||||||||+|||++.++++||+|||+|+.....
T Consensus 84 y~~gg~L~~~l~~~---~~l~e~~~~~i~~qi~~al~ylH~~~--IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 84 YCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp CCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred ccCCCcHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHcC--CccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence 99999999999743 36899999999999999999999999 999999999999999999999999999865432
Q ss_pred cccCCCCCCCCCccCccccccCCC-CchhHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHhhhcCcccCCCCCCcHHHHH
Q 005247 589 YISSKTAAGTPEWMAPEVLREDPS-NEKSDVFSFGVILWELITLQKPWRNSTPSQV-ISAVGFKGRRLEIPKNVNPMVAA 666 (706)
Q Consensus 589 ~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~-~~~i~~~~~~l~~p~~~s~el~d 666 (706)
.......+||+.|||||++.+..+ +.++|||||||++|||++|+.||........ .............+..+++++.+
T Consensus 159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 238 (271)
T d1nvra_ 159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 238 (271)
T ss_dssp ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHH
T ss_pred cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHH
Confidence 222356789999999999988876 5789999999999999999999977654333 23332223333344678999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHH
Q 005247 667 LIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 667 LI~~cL~~dP~~RPS~~eIl~ 687 (706)
||.+||+.||++|||++|+++
T Consensus 239 li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 239 LLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp HHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHcCCChhHCcCHHHHhc
Confidence 999999999999999999865
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-50 Score=430.56 Aligned_cols=261 Identities=33% Similarity=0.512 Sum_probs=222.5
Q ss_pred CcccccCceEEEEEeccCCceEEEEEEEcCC-------ceEEEEEeccccchHHHHHHHHHHHHHHcC-CCCceeEEecc
Q 005247 427 GLEIRWSELLIKKKIGEGSFGTVYHAEWRNS-------DVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGA 498 (706)
Q Consensus 427 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~-------~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~ 498 (706)
.+++..++|++++.||+|+||+||+|++.+. .||+|++.... .......+.+|+.+++++ +|||||+++++
T Consensus 31 kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~ 109 (325)
T d1rjba_ 31 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGA 109 (325)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEEE
Confidence 3677888999999999999999999987643 27888775433 334456789999999998 89999999999
Q ss_pred ccCCCceEEEEEeccCCchhhhcccCCC--------------------cccccHHHHHHHHHHHHHHHHHHHhcCCCccc
Q 005247 499 VTEPPNLSIVTEYLSRGSLYKLLHIPDA--------------------RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVH 558 (706)
Q Consensus 499 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~--------------------~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIH 558 (706)
+.+.+..++|||||++|+|.++++.... ...+++..++.++.||+.||+|||+++ |||
T Consensus 110 ~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~--IiH 187 (325)
T d1rjba_ 110 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVH 187 (325)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EEE
T ss_pred EeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eee
Confidence 9999999999999999999999964321 235788999999999999999999999 999
Q ss_pred ccCCCCcEEECCCCcEEEeecCccccCCCCcc--cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCC
Q 005247 559 RDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI--SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPW 635 (706)
Q Consensus 559 rDLKp~NILl~~~~~vKL~DFGla~~~~~~~~--~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf 635 (706)
|||||+|||++.++++||+|||+|+....... ......||+.|||||++.+..++.++|||||||++|||+| |..||
T Consensus 188 RDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf 267 (325)
T d1rjba_ 188 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 267 (325)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred ccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCC
Confidence 99999999999999999999999986443321 2234568999999999999999999999999999999998 89999
Q ss_pred CCCChHHHHHHhhhcCcccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 005247 636 RNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQ 690 (706)
Q Consensus 636 ~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~ 690 (706)
.+.+..+....+.....+++.|..+++++++||.+||+.||++|||++||++.|.
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 268 PGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp TTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 9877766666665677788899999999999999999999999999999999985
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-50 Score=418.40 Aligned_cols=250 Identities=32% Similarity=0.527 Sum_probs=215.1
Q ss_pred EEeccCCceEEEEEEEcCC----ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEEeccC
Q 005247 439 KKIGEGSFGTVYHAEWRNS----DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEYLSR 514 (706)
Q Consensus 439 ~~LG~G~fG~Vy~a~~~~~----~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~~~g 514 (706)
++||+|+||+||+|.+.++ .||||++..........+.|.+|+.+|++++|||||++++++.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 4799999999999986532 39999987665556666789999999999999999999999865 457899999999
Q ss_pred CchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcc---c
Q 005247 515 GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI---S 591 (706)
Q Consensus 515 gsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~---~ 591 (706)
|+|.++++.. ..+++..++.++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+++....... .
T Consensus 92 g~L~~~l~~~---~~l~~~~~~~i~~qi~~gl~ylH~~~--iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 166 (277)
T d1xbba_ 92 GPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 166 (277)
T ss_dssp EEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred CcHHHHHhhc---cCCCHHHHHHHHHHHHHHHhhHHhCC--cccCCCcchhhcccccCcccccchhhhhhcccccccccc
Confidence 9999998743 35899999999999999999999999 99999999999999999999999999986543321 2
Q ss_pred CCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHHHH
Q 005247 592 SKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALIET 670 (706)
Q Consensus 592 ~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI~~ 670 (706)
.....||+.|+|||++.+..++.++|||||||++|||+| |+.||...+..+....+. .+.++++|..+++++++||.+
T Consensus 167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~~~~~~~li~~ 245 (277)
T d1xbba_ 167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPAGCPREMYDLMNL 245 (277)
T ss_dssp ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHH
T ss_pred ccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHH-cCCCCCCCcccCHHHHHHHHH
Confidence 234578999999999999999999999999999999998 899999988887776664 567788899999999999999
Q ss_pred hhhhCCCCCCCHHHHHHHHHHHHHh
Q 005247 671 CWAEEPEIRPSFPSIMETLQQFLMS 695 (706)
Q Consensus 671 cL~~dP~~RPS~~eIl~~L~~ll~s 695 (706)
||+.||++|||+.+|++.|+.+..+
T Consensus 246 cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 246 CWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp HTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred HcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 9999999999999999999988654
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-50 Score=426.49 Aligned_cols=250 Identities=25% Similarity=0.412 Sum_probs=217.8
Q ss_pred ccCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEecccc-chHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEE
Q 005247 431 RWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSI 507 (706)
Q Consensus 431 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~l 507 (706)
..++|++++.||+|+||+||+|.+..+ .||||++..... .....+.+.+|++++++++||||+++++++.+++.+++
T Consensus 6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 85 (288)
T d1uu3a_ 6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 85 (288)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEE
T ss_pred CCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEE
Confidence 346799999999999999999998744 599999876442 23345678999999999999999999999999999999
Q ss_pred EEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCC
Q 005247 508 VTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPN 587 (706)
Q Consensus 508 V~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~ 587 (706)
||||+++|+|.+++... ..+++..++.++.|++.||+|||++| ||||||||+|||++.++.+||+|||+|+....
T Consensus 86 vmEy~~gg~L~~~~~~~---~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 86 GLSYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp EECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EEEccCCCCHHHhhhcc---CCCCHHHHHHHHHHHHHHHHhhcccc--EEcCcCCccccccCCCceEEecccccceeccc
Confidence 99999999999988643 35899999999999999999999999 99999999999999999999999999987543
Q ss_pred Cc--ccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHH
Q 005247 588 TY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVA 665 (706)
Q Consensus 588 ~~--~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~ 665 (706)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+. ...+.+|..++++++
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~ 238 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII--KLEYDFPEKFFPKAR 238 (288)
T ss_dssp ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--TTCCCCCTTCCHHHH
T ss_pred CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHH--cCCCCCCccCCHHHH
Confidence 22 22345689999999999999999999999999999999999999999998888777764 345678889999999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHH
Q 005247 666 ALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 666 dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
+||.+||+.||++|||++|++.
T Consensus 239 ~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 239 DLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp HHHHTTSCSSGGGSTTSGGGTC
T ss_pred HHHHHHccCCHhHCcCHHHHcC
Confidence 9999999999999999998754
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-49 Score=415.63 Aligned_cols=261 Identities=33% Similarity=0.539 Sum_probs=218.5
Q ss_pred ccccCceEEEEEeccCCceEEEEEEEcCC------ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCC
Q 005247 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNS------DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP 502 (706)
Q Consensus 429 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~------~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~ 502 (706)
++..+.|++.+.||+|+||.||+|.++.+ .||||++.... .....+.|.+|+.++++++|||||++++++.+.
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~ 81 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 81 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc-ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence 56677899999999999999999987643 38999885543 445566899999999999999999999999999
Q ss_pred CceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCcc
Q 005247 503 PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS 582 (706)
Q Consensus 503 ~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla 582 (706)
+..++||||+.++++.+++.... ..+++..++.++.||+.||+|||+++ ||||||||+||||+.++++||+|||++
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~~i~~gl~~lH~~~--iiHrDlKp~NILl~~~~~~Kl~DFGla 157 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFGLS 157 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred CceEEEEEecccCcchhhhhccc--ccccHHHHHHHHHHHHHhhhhccccc--cccCccccceEEECCCCeEEEcccchh
Confidence 99999999999999998875432 35889999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCcc---cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCC-CCCCChHHHHHHhhhcCcccCCCC
Q 005247 583 RSKPNTYI---SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKP-WRNSTPSQVISAVGFKGRRLEIPK 658 (706)
Q Consensus 583 ~~~~~~~~---~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~P-f~~~~~~~~~~~i~~~~~~l~~p~ 658 (706)
+....... ......||+.|+|||++.+..++.++|||||||++|||+++..| |...+..+....+ ..+.+++.|.
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i-~~~~~~~~~~ 236 (283)
T d1mqba_ 158 RVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI-NDGFRLPTPM 236 (283)
T ss_dssp ----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH-HTTCCCCCCT
T ss_pred hcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHH-hccCCCCCch
Confidence 87543221 22335689999999999999999999999999999999996555 5555666665555 4566788889
Q ss_pred CCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHh
Q 005247 659 NVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS 695 (706)
Q Consensus 659 ~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s 695 (706)
.++.++.+||.+||+.||++|||+.+|++.|+++++.
T Consensus 237 ~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 237 DCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp TCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred hhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 9999999999999999999999999999999999875
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-50 Score=425.34 Aligned_cols=249 Identities=27% Similarity=0.495 Sum_probs=217.1
Q ss_pred CceEEEEEeccCCceEEEEEEEcCCc--eEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEE
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 510 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~~~--vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E 510 (706)
+.|++++.||+|+||+||+|.+..++ ||+|++.... ....+.+.+|+++|++++|||||++++++.+++.+++|||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE 89 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 89 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS--SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence 46899999999999999999987554 8999986643 3345678899999999999999999999999999999999
Q ss_pred eccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcc
Q 005247 511 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 590 (706)
Q Consensus 511 ~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~ 590 (706)
||++|+|.+++.... ..+++..+..++.||+.||.|||++| ||||||||+|||++.++++||+|||+|+.......
T Consensus 90 y~~~g~L~~~~~~~~--~~l~e~~~~~i~~qi~~gL~ylH~~~--ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~ 165 (288)
T d2jfla1 90 FCAGGAVDAVMLELE--RPLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ 165 (288)
T ss_dssp CCTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH
T ss_pred cCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--EEEeecChhheeECCCCCEEEEechhhhccCCCcc
Confidence 999999999875322 35899999999999999999999999 99999999999999999999999999976554433
Q ss_pred cCCCCCCCCCccCccccc-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcC-cccCCCCCCcHHH
Q 005247 591 SSKTAAGTPEWMAPEVLR-----EDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG-RRLEIPKNVNPMV 664 (706)
Q Consensus 591 ~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~-~~l~~p~~~s~el 664 (706)
......||+.|+|||++. +..++.++|||||||++|||++|+.||...+..+....+.... ..+..+..+++++
T Consensus 166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~ 245 (288)
T d2jfla1 166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNF 245 (288)
T ss_dssp HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHH
T ss_pred cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHH
Confidence 345678999999999984 4567899999999999999999999999988888777765433 2445567899999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHH
Q 005247 665 AALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 665 ~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
++||.+||+.||++|||+.|+++
T Consensus 246 ~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 246 KDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHHHccCChhHCcCHHHHhc
Confidence 99999999999999999999976
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-50 Score=415.12 Aligned_cols=263 Identities=32% Similarity=0.561 Sum_probs=217.4
Q ss_pred CcccccCceEEEEEeccCCceEEEEEEEcCC---c--eEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccC
Q 005247 427 GLEIRWSELLIKKKIGEGSFGTVYHAEWRNS---D--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE 501 (706)
Q Consensus 427 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~---~--vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~ 501 (706)
++++..++|++++.||+|+||.||+|.+..+ . ||||++.. .......+.+.+|+.++++++||||+++++++.+
T Consensus 1 ~~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~-~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 79 (273)
T d1mp8a_ 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKN-CTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE 79 (273)
T ss_dssp CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTT-TTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred CCCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecc-ccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 3678888999999999999999999987543 2 55555432 2345556789999999999999999999999864
Q ss_pred CCceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCc
Q 005247 502 PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL 581 (706)
Q Consensus 502 ~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGl 581 (706)
+.+++||||+++|+|.+++.... ..+++..++.++.||++||.|||+++ ||||||||+||+++.++.+||+|||+
T Consensus 80 -~~~~iv~E~~~~g~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDlKp~NIll~~~~~~Kl~DfG~ 154 (273)
T d1mp8a_ 80 -NPVWIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGL 154 (273)
T ss_dssp -SSCEEEEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECC---
T ss_pred -CeEEEEEEeccCCcHHhhhhccC--CCCCHHHHHHHHHHHHHHhhhhcccC--eeccccchhheeecCCCcEEEccchh
Confidence 67899999999999999875332 35899999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCc-ccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCCCC
Q 005247 582 SRSKPNTY-ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKN 659 (706)
Q Consensus 582 a~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p~~ 659 (706)
|+...... .......||+.|+|||++.+..++.++|||||||++|||++ |..||...+..+....+. .+.++++|.+
T Consensus 155 a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~ 233 (273)
T d1mp8a_ 155 SRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPN 233 (273)
T ss_dssp ----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-TTCCCCCCTT
T ss_pred heeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCCCC
Confidence 98754322 23345578999999999999999999999999999999998 899999998888887774 5667788999
Q ss_pred CcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhc
Q 005247 660 VNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 696 (706)
Q Consensus 660 ~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~ 696 (706)
+++++.+||.+||+.||++|||+.||++.|+.++.+.
T Consensus 234 ~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 270 (273)
T d1mp8a_ 234 CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 270 (273)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 9999999999999999999999999999999998763
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=411.89 Aligned_cols=253 Identities=33% Similarity=0.577 Sum_probs=224.7
Q ss_pred ccCceEEEEEeccCCceEEEEEEEcCC-ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEE
Q 005247 431 RWSELLIKKKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 509 (706)
Q Consensus 431 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~-~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~ 509 (706)
+.++|+++++||+|+||+||+|+++++ .||||+++...... +.|++|+.++++++||||+++++++.+++.+++||
T Consensus 2 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~---~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~ 78 (258)
T d1k2pa_ 2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 78 (258)
T ss_dssp CCCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCH---HHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEE
T ss_pred ChHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCH---HHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Confidence 346788999999999999999998755 59999998765443 47899999999999999999999999999999999
Q ss_pred EeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCc
Q 005247 510 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 589 (706)
Q Consensus 510 E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 589 (706)
||+++|+|..++.... ..+++..++.++.||++||+|||++| |+||||||+|||++.++.+||+|||+++......
T Consensus 79 Ey~~~g~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~~LH~~~--iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 154 (258)
T d1k2pa_ 79 EYMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 154 (258)
T ss_dssp ECCTTEEHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHHTT--BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS
T ss_pred EccCCCcHHHhhhccc--cCCcHHHHHHHHHHHHHHHHHHhhcC--cccccccceeEEEcCCCcEEECcchhheeccCCC
Confidence 9999999999876433 35788999999999999999999999 9999999999999999999999999998654432
Q ss_pred c-cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHH
Q 005247 590 I-SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAAL 667 (706)
Q Consensus 590 ~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dL 667 (706)
. ......||+.|+|||++.+..++.++||||||+++|||+| |+.||...+..+....+. ...++..|..+++++.+|
T Consensus 155 ~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~~~~l~~l 233 (258)
T d1k2pa_ 155 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRPHLASEKVYTI 233 (258)
T ss_dssp CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH-TTCCCCCCTTCCHHHHHH
T ss_pred ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHH-hCCCCCCcccccHHHHHH
Confidence 2 2334678999999999999999999999999999999998 899999999888877774 566788899999999999
Q ss_pred HHHhhhhCCCCCCCHHHHHHHHHH
Q 005247 668 IETCWAEEPEIRPSFPSIMETLQQ 691 (706)
Q Consensus 668 I~~cL~~dP~~RPS~~eIl~~L~~ 691 (706)
|.+||+.||++|||+++|++.|.+
T Consensus 234 i~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 234 MYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp HHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred HHHHccCCHhHCcCHHHHHHHhhC
Confidence 999999999999999999998853
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-49 Score=426.43 Aligned_cols=251 Identities=26% Similarity=0.448 Sum_probs=224.1
Q ss_pred cccCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEecccc-chHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceE
Q 005247 430 IRWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS 506 (706)
Q Consensus 430 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 506 (706)
+..++|++++.||+|+||+||+|+++.+ .||+|++.+... .....+.+.+|+.+|+.++||||+++++++.+++.++
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 81 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence 3457899999999999999999998654 499999976543 2234567889999999999999999999999999999
Q ss_pred EEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCC
Q 005247 507 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP 586 (706)
Q Consensus 507 lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~ 586 (706)
+|||||+||+|.+++... ..+++..++.++.||+.||+|||++| ||||||||+|||++.+|.+||+|||+|+...
T Consensus 82 iv~ey~~gg~L~~~~~~~---~~~~e~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~ 156 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EEEECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred cceeccCCCchhhhhhcc---cCCcHHHHHHHHHHHhhhhhhhhhcC--ccccccCHHHeEecCCCCEEEeecccccccc
Confidence 999999999999998743 35899999999999999999999999 9999999999999999999999999998765
Q ss_pred CCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHH
Q 005247 587 NTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAA 666 (706)
Q Consensus 587 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~d 666 (706)
.........+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+. ...+.+|..+++++++
T Consensus 157 ~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~d 234 (337)
T d1o6la_ 157 SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL--MEEIRFPRTLSPEAKS 234 (337)
T ss_dssp CTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HCCCCCCTTSCHHHHH
T ss_pred cCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHh--cCCCCCCccCCHHHHH
Confidence 54445567889999999999999999999999999999999999999999999888777764 3457788999999999
Q ss_pred HHHHhhhhCCCCCCC-----HHHHHH
Q 005247 667 LIETCWAEEPEIRPS-----FPSIME 687 (706)
Q Consensus 667 LI~~cL~~dP~~RPS-----~~eIl~ 687 (706)
||.+||++||.+||+ ++++++
T Consensus 235 li~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 235 LLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp HHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HHHhhccCCchhhcccccccHHHHHc
Confidence 999999999999994 888876
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.2e-49 Score=420.34 Aligned_cols=245 Identities=25% Similarity=0.403 Sum_probs=215.9
Q ss_pred ceEEEEEeccCCceEEEEEEEcCCc--eEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEE
Q 005247 434 ELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFH-EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 510 (706)
Q Consensus 434 ~y~i~~~LG~G~fG~Vy~a~~~~~~--vAVKvl~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E 510 (706)
.|++++.||+|+||+||+|.+..++ ||||++...... ....+.+.+|+.+|++++|||||++++++.+++..++|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 5999999999999999999987554 999998766543 4456789999999999999999999999999999999999
Q ss_pred eccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcc
Q 005247 511 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 590 (706)
Q Consensus 511 ~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~ 590 (706)
||.+|+|..++... ..+++..++.++.||+.||.|||++| ||||||||+|||++.++++||+|||+|+.....
T Consensus 96 ~~~~g~l~~~~~~~---~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~-- 168 (309)
T d1u5ra_ 96 YCLGSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 168 (309)
T ss_dssp CCSEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred ecCCCchHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEECCCCCEEEeecccccccCCC--
Confidence 99999997766432 35899999999999999999999999 999999999999999999999999999865432
Q ss_pred cCCCCCCCCCccCcccccc---CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHH
Q 005247 591 SSKTAAGTPEWMAPEVLRE---DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAAL 667 (706)
Q Consensus 591 ~~~~~~Gt~~Y~APE~l~~---~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dL 667 (706)
....||+.|||||++.+ ..|+.++|||||||++|||++|..||...+..+....+.........+..+++++++|
T Consensus 169 --~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~l 246 (309)
T d1u5ra_ 169 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNF 246 (309)
T ss_dssp --CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHH
T ss_pred --CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHH
Confidence 45689999999999864 4588999999999999999999999999888877777655555555567799999999
Q ss_pred HHHhhhhCCCCCCCHHHHHH
Q 005247 668 IETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 668 I~~cL~~dP~~RPS~~eIl~ 687 (706)
|.+||+.||++|||+.|+++
T Consensus 247 i~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 247 VDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp HHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHCcCChhHCcCHHHHHh
Confidence 99999999999999999976
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-50 Score=425.18 Aligned_cols=256 Identities=24% Similarity=0.412 Sum_probs=212.4
Q ss_pred ccccCceEEEEEeccCCceEEEEEEEcCCc--eEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceE
Q 005247 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS 506 (706)
Q Consensus 429 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~--vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 506 (706)
++..++|++++.||+|+||+||+|.+..++ ||+|++.... .....+.+.+|+.+|++++|||||+++++|.+++.++
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 80 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 80 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 566789999999999999999999987554 9999987543 3444578899999999999999999999999999999
Q ss_pred EEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHh-cCCCcccccCCCCcEEECCCCcEEEeecCccccC
Q 005247 507 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ-RRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK 585 (706)
Q Consensus 507 lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs-~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~ 585 (706)
+||||+++|+|.+++... ..+++..++.++.||+.||.|||+ +| ||||||||+|||++.++++||+|||+|+..
T Consensus 81 iVmEy~~gg~L~~~l~~~---~~l~~~~~~~~~~qil~aL~yLH~~~~--IiHRDiKP~NILl~~~~~vkl~DFGla~~~ 155 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL 155 (322)
T ss_dssp EEEECCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred EEEEcCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHhCC--EEccccCHHHeeECCCCCEEEeeCCCcccc
Confidence 999999999999999743 358999999999999999999997 58 999999999999999999999999999864
Q ss_pred CCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh-----------------
Q 005247 586 PNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVG----------------- 648 (706)
Q Consensus 586 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~----------------- 648 (706)
... ...+.+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+......
T Consensus 156 ~~~--~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (322)
T d1s9ja_ 156 IDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233 (322)
T ss_dssp HHH--TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------
T ss_pred CCC--ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccc
Confidence 332 2346789999999999999999999999999999999999999997755432211100
Q ss_pred ------------------------hcCcccCCC-CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH--HHHHH
Q 005247 649 ------------------------FKGRRLEIP-KNVNPMVAALIETCWAEEPEIRPSFPSIME--TLQQF 692 (706)
Q Consensus 649 ------------------------~~~~~l~~p-~~~s~el~dLI~~cL~~dP~~RPS~~eIl~--~L~~l 692 (706)
.......++ ..+++++.+||.+||+.||++|||++|+++ .+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp ------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred cccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence 001111122 246889999999999999999999999988 45543
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.2e-49 Score=419.95 Aligned_cols=248 Identities=26% Similarity=0.406 Sum_probs=201.0
Q ss_pred CceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEE
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 510 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E 510 (706)
+.|++++.||+|+||+||+|+++.+ .||||++....... ..+.+.+|+.+|++++||||+++++++.+++.+++|||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 5699999999999999999998754 49999987655432 33568899999999999999999999999999999999
Q ss_pred eccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEEC---CCCcEEEeecCccccCCC
Q 005247 511 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVD---STYTVKVCDFGLSRSKPN 587 (706)
Q Consensus 511 ~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~---~~~~vKL~DFGla~~~~~ 587 (706)
||+||+|.+++... ..+++..+..++.||+.||+|||++| ||||||||+|||+. .++.+||+|||+|+....
T Consensus 88 ~~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~ 162 (307)
T d1a06a_ 88 LVSGGELFDRIVEK---GFYTERDASRLIFQVLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP 162 (307)
T ss_dssp CCCSCBHHHHHHTC---SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred ccCCCcHHHhhhcc---cCCCHHHHHHHHHHHHHHHHhhhhce--eeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence 99999999999743 35999999999999999999999999 99999999999994 578999999999987654
Q ss_pred CcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCccc--CCCCCCcHHHH
Q 005247 588 TYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRL--EIPKNVNPMVA 665 (706)
Q Consensus 588 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l--~~p~~~s~el~ 665 (706)
.. ...+.+||+.|||||++.+..++.++|||||||++|||++|+.||......+....+......+ +.+..+|+++.
T Consensus 163 ~~-~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 241 (307)
T d1a06a_ 163 GS-VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAK 241 (307)
T ss_dssp -----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHH
T ss_pred CC-eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHH
Confidence 33 2345789999999999999999999999999999999999999999988888777765444433 34468999999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHH
Q 005247 666 ALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 666 dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
+||.+||+.||++|||+.|+++
T Consensus 242 ~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 242 DFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHccCCHhHCcCHHHHhc
Confidence 9999999999999999999987
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-49 Score=414.17 Aligned_cols=266 Identities=33% Similarity=0.561 Sum_probs=222.4
Q ss_pred cccCcccccCceEEEEEeccCCceEEEEEEEcCC-ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCC
Q 005247 424 EEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRNS-DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP 502 (706)
Q Consensus 424 ~~~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~-~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~ 502 (706)
....+++..++|++.+.||+|+||.||+|.++++ .||||++....... +.|.+|+.++++++|||||++++++.+
T Consensus 8 ~~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~---~~~~~E~~~l~~l~h~nIv~~~g~~~~- 83 (285)
T d1fmka3 8 AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLYAVVSE- 83 (285)
T ss_dssp STTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCH---HHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred CCcceEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCH---HHHHHHHHHHHhcccCCEeEEEEEEec-
Confidence 3456788889999999999999999999998765 49999986554433 578999999999999999999999865
Q ss_pred CceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCcc
Q 005247 503 PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS 582 (706)
Q Consensus 503 ~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla 582 (706)
+.+++||||+++|+|..++.... ...+++..++.++.||+.||+|||+++ |+||||||+||||+.++++||+|||++
T Consensus 84 ~~~~lv~Ey~~~g~l~~~~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH~~~--ivH~DlKp~NIll~~~~~~kl~DfGla 160 (285)
T d1fmka3 84 EPIYIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLA 160 (285)
T ss_dssp SSCEEEECCCTTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCTT
T ss_pred CCeEEEEEecCCCchhhhhhhcc-cccchHHHHHHHHHHHHHHHHHHhhhh--eecccccceEEEECCCCcEEEcccchh
Confidence 55789999999999998886432 235899999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCc-ccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCC-CCCCChHHHHHHhhhcCcccCCCCCC
Q 005247 583 RSKPNTY-ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKP-WRNSTPSQVISAVGFKGRRLEIPKNV 660 (706)
Q Consensus 583 ~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~P-f~~~~~~~~~~~i~~~~~~l~~p~~~ 660 (706)
+...... .......||+.|+|||++.+..++.++||||||+++|||++|..| |......+....+. ...+.+++..+
T Consensus 161 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~-~~~~~~~~~~~ 239 (285)
T d1fmka3 161 RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPEC 239 (285)
T ss_dssp C--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTS
T ss_pred hhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH-hcCCCCCCccc
Confidence 8754332 223446789999999999999999999999999999999996555 55566666666553 45677889999
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhcc
Q 005247 661 NPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSV 697 (706)
Q Consensus 661 s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~~ 697 (706)
++++++||.+||+.||++|||+++|++.|+.++.+..
T Consensus 240 ~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~ 276 (285)
T d1fmka3 240 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 276 (285)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred CHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence 9999999999999999999999999999999886654
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-49 Score=409.48 Aligned_cols=258 Identities=36% Similarity=0.649 Sum_probs=221.3
Q ss_pred CcccccCceEEEEEeccCCceEEEEEEEcCCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccC-CCce
Q 005247 427 GLEIRWSELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE-PPNL 505 (706)
Q Consensus 427 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~-~~~~ 505 (706)
++++..++|++.+.||+|+||.||+|.++++.||||+++... ..+.+.+|+.++++++||||+++++++.+ .+.+
T Consensus 1 ~w~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~ 76 (262)
T d1byga_ 1 GWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 76 (262)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CC
T ss_pred CCccCHHHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcE
Confidence 367888999999999999999999999999999999986543 33578999999999999999999998854 5678
Q ss_pred EEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccC
Q 005247 506 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSK 585 (706)
Q Consensus 506 ~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~ 585 (706)
++||||+++|+|.+++.... ...+++..++.++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+++..
T Consensus 77 ~lv~ey~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~al~ylH~~~--ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~ 153 (262)
T d1byga_ 77 YIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEA 153 (262)
T ss_dssp EEEECCCTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred EEEEeccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHhhccccccCc--eeccccchHhheecCCCCEeecccccceec
Confidence 99999999999999996332 235889999999999999999999999 999999999999999999999999999865
Q ss_pred CCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHH
Q 005247 586 PNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMV 664 (706)
Q Consensus 586 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el 664 (706)
... .....+|..|+|||++.+..++.++||||||+++|||+| |+.||...+..+....+. .+.++++|..+++++
T Consensus 154 ~~~---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~~ 229 (262)
T d1byga_ 154 SST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPAV 229 (262)
T ss_dssp -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT-TTCCCCCCTTCCHHH
T ss_pred CCC---CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCCCCccCCHHH
Confidence 433 235578999999999999999999999999999999998 788999888888887774 567788899999999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHHHHHHHHh
Q 005247 665 AALIETCWAEEPEIRPSFPSIMETLQQFLMS 695 (706)
Q Consensus 665 ~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s 695 (706)
++||.+||+.||.+|||+.+|++.|+++..+
T Consensus 230 ~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 230 YEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 9999999999999999999999999998654
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-48 Score=409.89 Aligned_cols=249 Identities=23% Similarity=0.403 Sum_probs=218.0
Q ss_pred CceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccch----HHHHHHHHHHHHHHcCCCCceeEEeccccCCCceE
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHE----DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLS 506 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~ 506 (706)
+.|++++.||+|+||+||+|.++.+ .||||++.+..... ...+.+.+|+.+|++++||||+++++++.+++.++
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 5699999999999999999998744 59999997654322 23568999999999999999999999999999999
Q ss_pred EEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCC----cEEEeecCcc
Q 005247 507 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY----TVKVCDFGLS 582 (706)
Q Consensus 507 lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~----~vKL~DFGla 582 (706)
+|||||++|+|.+++... ..+++..++.++.||+.||+|||+++ ||||||||+|||++.++ .+||+|||++
T Consensus 90 iv~E~~~gg~L~~~i~~~---~~l~~~~~~~~~~qi~~al~yLH~~~--ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a 164 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164 (293)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEcCCCccccchhccc---cccchhHHHHHHHHHHHHHHhhhhcc--eeecccccceEEEecCCCcccceEecchhhh
Confidence 999999999999999643 35899999999999999999999999 99999999999998776 5999999999
Q ss_pred ccCCCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcc--cCCCCCC
Q 005247 583 RSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR--LEIPKNV 660 (706)
Q Consensus 583 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~--l~~p~~~ 660 (706)
....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+...... ...+.++
T Consensus 165 ~~~~~~~-~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (293)
T d1jksa_ 165 HKIDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT 243 (293)
T ss_dssp EECTTSC-BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTS
T ss_pred hhcCCCc-cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCC
Confidence 8765443 335678999999999999999999999999999999999999999999888887776443332 2234688
Q ss_pred cHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 661 NPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 661 s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
++++++||.+||+.||++|||++|+++
T Consensus 244 s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 244 SALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 999999999999999999999999986
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-48 Score=409.91 Aligned_cols=266 Identities=31% Similarity=0.557 Sum_probs=217.2
Q ss_pred CcccccCceEEEEEeccCCceEEEEEEEcCC-------ceEEEEEeccccchHHHHHHHHHHHHHHcC-CCCceeEEecc
Q 005247 427 GLEIRWSELLIKKKIGEGSFGTVYHAEWRNS-------DVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGA 498 (706)
Q Consensus 427 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~-------~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~ 498 (706)
.+++..++|++++.||+|+||.||+|.+.+. .||||++.... .....+.+.+|..++.++ +|+||+.++++
T Consensus 7 ~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~ 85 (299)
T d1ywna1 7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGA 85 (299)
T ss_dssp HHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence 4677788999999999999999999987542 38999876443 344456788888888776 68999999998
Q ss_pred ccCC-CceEEEEEeccCCchhhhcccCCC-------------cccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCC
Q 005247 499 VTEP-PNLSIVTEYLSRGSLYKLLHIPDA-------------RVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSP 564 (706)
Q Consensus 499 ~~~~-~~~~lV~E~~~ggsL~~~l~~~~~-------------~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~ 564 (706)
+.++ ..+++|||||++|+|.++++.... ...+++..++.++.||+.||+|||+++ ||||||||+
T Consensus 86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--ivHrDlKp~ 163 (299)
T d1ywna1 86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAAR 163 (299)
T ss_dssp ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGG
T ss_pred eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC--CcCCcCCcc
Confidence 7654 568999999999999999864321 235889999999999999999999999 999999999
Q ss_pred cEEECCCCcEEEeecCccccCCCCc--ccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhC-CCCCCCCChH
Q 005247 565 NLLVDSTYTVKVCDFGLSRSKPNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPS 641 (706)
Q Consensus 565 NILl~~~~~vKL~DFGla~~~~~~~--~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG-~~Pf~~~~~~ 641 (706)
|||++.++++||+|||+|+...... .......||+.|+|||++.+..++.++|||||||++|||++| ..||......
T Consensus 164 NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~ 243 (299)
T d1ywna1 164 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 243 (299)
T ss_dssp GEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred ceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999999998654332 223456799999999999999999999999999999999997 5678777655
Q ss_pred HHHHHhhhcCcccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHh
Q 005247 642 QVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS 695 (706)
Q Consensus 642 ~~~~~i~~~~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s 695 (706)
+........+.++.+|..+++++.+||.+||+.||++|||+.||++.|++++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 244 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 555555556778888999999999999999999999999999999999999875
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-48 Score=412.39 Aligned_cols=262 Identities=35% Similarity=0.571 Sum_probs=226.2
Q ss_pred cccccCceEEEEEeccCCceEEEEEEEcC-------CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEecccc
Q 005247 428 LEIRWSELLIKKKIGEGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVT 500 (706)
Q Consensus 428 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~-------~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~ 500 (706)
+++..++|++++.||+|+||+||+|++++ +.||||++... ......+.|.+|+.++++++||||+++++++.
T Consensus 8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChh-cChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 56677899999999999999999998764 34999987643 34555678999999999999999999999999
Q ss_pred CCCceEEEEEeccCCchhhhcccCC---------------------CcccccHHHHHHHHHHHHHHHHHHHhcCCCcccc
Q 005247 501 EPPNLSIVTEYLSRGSLYKLLHIPD---------------------ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHR 559 (706)
Q Consensus 501 ~~~~~~lV~E~~~ggsL~~~l~~~~---------------------~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHr 559 (706)
+.+..+++|||+.+|+|.++++... ....+++..++.|+.||+.||+|||+++ ||||
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--ivHr 164 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHR 164 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCS
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC--eEee
Confidence 9999999999999999999985321 1234788899999999999999999999 9999
Q ss_pred cCCCCcEEECCCCcEEEeecCccccCCCC--cccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCC-CCCC
Q 005247 560 DLKSPNLLVDSTYTVKVCDFGLSRSKPNT--YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQ-KPWR 636 (706)
Q Consensus 560 DLKp~NILl~~~~~vKL~DFGla~~~~~~--~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~-~Pf~ 636 (706)
||||+|||++.++++||+|||+|+..... ........||+.|+|||.+.+..++.++|||||||++|||++|. .||.
T Consensus 165 DlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~ 244 (301)
T d1lufa_ 165 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 244 (301)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred EEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCC
Confidence 99999999999999999999999754332 22233567899999999999999999999999999999999985 6788
Q ss_pred CCChHHHHHHhhhcCcccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHH
Q 005247 637 NSTPSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFL 693 (706)
Q Consensus 637 ~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll 693 (706)
..+..+....+. .+.++++|..+++++.+||.+||+.||++||||.||++.|+++.
T Consensus 245 ~~~~~e~~~~v~-~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 245 GMAHEEVIYYVR-DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TSCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCHHHHHHHHH-cCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 888888877764 45577888999999999999999999999999999999999874
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.8e-48 Score=418.68 Aligned_cols=249 Identities=24% Similarity=0.395 Sum_probs=217.3
Q ss_pred cCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEE
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 509 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~ 509 (706)
.++|++++.||+|+||.||+|.+..+ .||||++.... ....+.+.+|+.+|++++||||+++++++.+++.+++||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 102 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 102 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 35899999999999999999998754 49999986543 344568899999999999999999999999999999999
Q ss_pred EeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEEC--CCCcEEEeecCccccCCC
Q 005247 510 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVD--STYTVKVCDFGLSRSKPN 587 (706)
Q Consensus 510 E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~--~~~~vKL~DFGla~~~~~ 587 (706)
|||+||+|.+++.... ..+++..++.|+.||+.||+|||++| ||||||||+|||++ .++.+||+|||+++....
T Consensus 103 E~~~gg~L~~~l~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 103 EFMSGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp CCCCSCBHHHHHTCTT--SCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred EcCCCCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcC--CeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence 9999999999985432 35899999999999999999999999 99999999999995 467899999999987654
Q ss_pred CcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCccc--CCCCCCcHHHH
Q 005247 588 TYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRL--EIPKNVNPMVA 665 (706)
Q Consensus 588 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l--~~p~~~s~el~ 665 (706)
.. ......||+.|||||++.+..++.++|||||||++|||++|+.||.+.+..+....+......+ .....++++++
T Consensus 179 ~~-~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 257 (350)
T d1koaa2 179 KQ-SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK 257 (350)
T ss_dssp TS-CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHH
T ss_pred cc-ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence 33 2346789999999999999999999999999999999999999999988888877775443332 23356899999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHH
Q 005247 666 ALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 666 dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
+||.+||+.||++|||+.|+++
T Consensus 258 ~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 258 DFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp HHHHHHCCSSGGGSCCHHHHHH
T ss_pred HHHHHHccCChhHCcCHHHHhc
Confidence 9999999999999999999977
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.2e-48 Score=413.84 Aligned_cols=246 Identities=25% Similarity=0.446 Sum_probs=219.3
Q ss_pred cCceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEE
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFH-EDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIV 508 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV 508 (706)
.++|++++.||+|+||+||+|+++. ..||||++...... ....+.+.+|+.+++.++||||+++++++.+++.+++|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 4689999999999999999999874 45999998765332 23456789999999999999999999999999999999
Q ss_pred EEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCC
Q 005247 509 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 588 (706)
Q Consensus 509 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 588 (706)
|||+.||+|..++.... .+++..++.++.||+.||+|||++| ||||||||+|||++.+|.+||+|||+|+.....
T Consensus 83 mE~~~gg~l~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 83 MDYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp ECCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eeecCCccccccccccc---cccccHHHHHHHHHHHhhhhhccCc--EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 99999999999887433 4788889999999999999999999 999999999999999999999999999886554
Q ss_pred cccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHH
Q 005247 589 YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI 668 (706)
Q Consensus 589 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI 668 (706)
. ...+||+.|||||++.+..++.++|||||||++|||++|+.||...+..+....+.. ....+|..+++++.++|
T Consensus 158 ~---~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~li 232 (316)
T d1fota_ 158 T---YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN--AELRFPPFFNEDVKDLL 232 (316)
T ss_dssp B---CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH--CCCCCCTTSCHHHHHHH
T ss_pred c---ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHc--CCCCCCCCCCHHHHHHH
Confidence 2 467899999999999999999999999999999999999999999998888777643 34567889999999999
Q ss_pred HHhhhhCCCCCC-----CHHHHHH
Q 005247 669 ETCWAEEPEIRP-----SFPSIME 687 (706)
Q Consensus 669 ~~cL~~dP~~RP-----S~~eIl~ 687 (706)
.+||.+||.+|+ |++++++
T Consensus 233 ~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 233 SRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp HHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred HHHhhhCHHhccccchhhHHHHHc
Confidence 999999999996 8999986
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4.5e-48 Score=417.41 Aligned_cols=249 Identities=23% Similarity=0.381 Sum_probs=217.8
Q ss_pred cCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEE
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 509 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~ 509 (706)
.+.|++++.||+|+||+||+|.+..+ .||||++.... ....+.+.+|+.+|++++||||+++++++.+++.+++||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 105 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 105 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 35799999999999999999998644 49999987653 233467889999999999999999999999999999999
Q ss_pred EeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEEC--CCCcEEEeecCccccCCC
Q 005247 510 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVD--STYTVKVCDFGLSRSKPN 587 (706)
Q Consensus 510 E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~--~~~~vKL~DFGla~~~~~ 587 (706)
|||+||+|.+++.... ..+++..++.|+.||+.||+|||++| ||||||||+|||++ .++.+||+|||+|+....
T Consensus 106 E~~~gg~L~~~~~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~ 181 (352)
T d1koba_ 106 EFLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 181 (352)
T ss_dssp ECCCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred EcCCCChHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccccccccccccCCCeEEEeecccceecCC
Confidence 9999999998875432 35899999999999999999999999 99999999999997 578999999999987654
Q ss_pred CcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcc--cCCCCCCcHHHH
Q 005247 588 TYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR--LEIPKNVNPMVA 665 (706)
Q Consensus 588 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~--l~~p~~~s~el~ 665 (706)
.. ......||+.|+|||++.+..++.++|||||||++|||+||+.||.+.+..+....+...... ...+..+++++.
T Consensus 182 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 260 (352)
T d1koba_ 182 DE-IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK 260 (352)
T ss_dssp TS-CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHH
T ss_pred CC-ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence 32 234568999999999999999999999999999999999999999999888887776544333 234467999999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHH
Q 005247 666 ALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 666 dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
+||.+||+.||.+|||+.|+++
T Consensus 261 ~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 261 DFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHHHccCChhHCcCHHHHhc
Confidence 9999999999999999999976
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-48 Score=411.13 Aligned_cols=258 Identities=31% Similarity=0.523 Sum_probs=217.2
Q ss_pred ccCceEEEEEeccCCceEEEEEEEcCC------ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCc
Q 005247 431 RWSELLIKKKIGEGSFGTVYHAEWRNS------DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN 504 (706)
Q Consensus 431 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~------~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 504 (706)
+..+|++++.||+|+||+||+|.+..+ .||+|.+.... .....+.|.+|+.++++++|||||++++++.++ .
T Consensus 7 k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~ 84 (317)
T d1xkka_ 7 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 84 (317)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-S
T ss_pred CHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-C
Confidence 345799999999999999999988644 26777764332 333457899999999999999999999999875 5
Q ss_pred eEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCcccc
Q 005247 505 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 584 (706)
Q Consensus 505 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~ 584 (706)
.++++|++.+|+|.+++.... ..+++..++.++.||+.||+|||+++ ||||||||+|||++.++++||+|||+|+.
T Consensus 85 ~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~~--iiHrDlKp~NIll~~~~~~kl~DFGla~~ 160 (317)
T d1xkka_ 85 VQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKL 160 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHTS--SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCCSHHHH
T ss_pred eeEEEEeccCCcccccccccc--cCCCHHHHHHHHHHHHHHHHHHHHcC--cccCcchhhcceeCCCCCeEeecccccee
Confidence 678889999999998876443 35889999999999999999999999 99999999999999999999999999987
Q ss_pred CCCCcc--cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCCCCCc
Q 005247 585 KPNTYI--SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKNVN 661 (706)
Q Consensus 585 ~~~~~~--~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s 661 (706)
...... ......||+.|+|||++.+..++.++|||||||++|||+| |..||...+..+....+ ..+.+++.|..++
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i-~~~~~~~~p~~~~ 239 (317)
T d1xkka_ 161 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-EKGERLPQPPICT 239 (317)
T ss_dssp TTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHH-HHTCCCCCCTTBC
T ss_pred cccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHH-HcCCCCCCCcccC
Confidence 544322 2234468999999999999999999999999999999998 79999988877776655 4567788899999
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHh
Q 005247 662 PMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS 695 (706)
Q Consensus 662 ~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s 695 (706)
+++.+||.+||+.||++|||+.+|++.|.++.++
T Consensus 240 ~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 240 IDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 9999999999999999999999999999888654
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-48 Score=406.00 Aligned_cols=258 Identities=35% Similarity=0.580 Sum_probs=215.7
Q ss_pred cccCceEEEEEeccCCceEEEEEEEcCC-----ceEEEEEecccc-chHHHHHHHHHHHHHHcCCCCceeEEeccccCCC
Q 005247 430 IRWSELLIKKKIGEGSFGTVYHAEWRNS-----DVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP 503 (706)
Q Consensus 430 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~-----~vAVKvl~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~ 503 (706)
+..++|++.+.||+|+||.||+|++... .||||++..... .....+.|.+|+.+|++++||||+++++++.+ +
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~ 83 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-P 83 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-c
Confidence 4567899999999999999999986532 389998865543 33456789999999999999999999999976 4
Q ss_pred ceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccc
Q 005247 504 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 583 (706)
Q Consensus 504 ~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~ 583 (706)
..++||||+++|++.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 84 ~~~lv~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDikp~NIll~~~~~vkl~DfGl~~ 159 (273)
T d1u46a_ 84 PMKMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMR 159 (273)
T ss_dssp SCEEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred chheeeeeecCcchhhhhhcc--cCCCCHHHHHHHHHHHHHHHHHhhhCC--EeeeeecHHHhccccccceeeccchhhh
Confidence 678999999999999887643 235899999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCcc---cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhhcCcccCCCCC
Q 005247 584 SKPNTYI---SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTPSQVISAVGFKGRRLEIPKN 659 (706)
Q Consensus 584 ~~~~~~~---~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~~~~~~~i~~~~~~l~~p~~ 659 (706)
....... ......|+..|+|||++.+..++.++||||||+++|||+| |..||...+..+....+.....+++.+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 239 (273)
T d1u46a_ 160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED 239 (273)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTT
T ss_pred hcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCccc
Confidence 7644322 2234467889999999999999999999999999999998 89999999999988888777778888999
Q ss_pred CcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHH
Q 005247 660 VNPMVAALIETCWAEEPEIRPSFPSIMETLQQF 692 (706)
Q Consensus 660 ~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~l 692 (706)
+++++.+||.+||+.||++|||+.+|++.|++.
T Consensus 240 ~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 240 CPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 999999999999999999999999999988864
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-48 Score=409.98 Aligned_cols=264 Identities=34% Similarity=0.621 Sum_probs=224.8
Q ss_pred ccccCceEEEEEeccCCceEEEEEEEcCCc----eEEEEEeccccchHHHHHHHHHHHHHHcC-CCCceeEEeccccCCC
Q 005247 429 EIRWSELLIKKKIGEGSFGTVYHAEWRNSD----VAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMGAVTEPP 503 (706)
Q Consensus 429 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~----vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~~~~~~~ 503 (706)
.+++++|++.+.||+|+||.||+|.+++++ ||||.+.... ..+..+.+.+|+++|+++ +||||+++++++.+.+
T Consensus 6 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~ 84 (309)
T d1fvra_ 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 84 (309)
T ss_dssp BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred ccCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC
Confidence 367789999999999999999999887653 5666654332 334456899999999999 7999999999999999
Q ss_pred ceEEEEEeccCCchhhhcccC-------------CCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECC
Q 005247 504 NLSIVTEYLSRGSLYKLLHIP-------------DARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS 570 (706)
Q Consensus 504 ~~~lV~E~~~ggsL~~~l~~~-------------~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~ 570 (706)
.+++||||+++|+|.++++.. .....+++..+..++.||+.||.|||+++ ||||||||+|||++.
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~--iiHrDlkp~NIL~~~ 162 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGE 162 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECG
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC--ccccccccceEEEcC
Confidence 999999999999999999643 22356899999999999999999999999 999999999999999
Q ss_pred CCcEEEeecCccccCCCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCC-CCCCCCChHHHHHHhhh
Q 005247 571 TYTVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQ-KPWRNSTPSQVISAVGF 649 (706)
Q Consensus 571 ~~~vKL~DFGla~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~-~Pf~~~~~~~~~~~i~~ 649 (706)
++.+||+|||+++...... ......||..|+|||.+.+..++.++|||||||++|||++|. .||...+..+....+.
T Consensus 163 ~~~~kl~DfG~a~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~- 240 (309)
T d1fvra_ 163 NYVAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP- 240 (309)
T ss_dssp GGCEEECCTTCEESSCEEC-CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG-
T ss_pred CCceEEccccccccccccc-cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHH-
Confidence 9999999999998654432 223557899999999999999999999999999999999975 5788888888777764
Q ss_pred cCcccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhcc
Q 005247 650 KGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSSV 697 (706)
Q Consensus 650 ~~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~~ 697 (706)
.+.++++|..+++++.+||.+||+.||++|||+.+|++.|++++.+..
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~ 288 (309)
T d1fvra_ 241 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288 (309)
T ss_dssp GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred hcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCc
Confidence 556788899999999999999999999999999999999999997643
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=404.91 Aligned_cols=265 Identities=32% Similarity=0.588 Sum_probs=226.7
Q ss_pred CcccccCceEEEEEeccCCceEEEEEEEcCC---------ceEEEEEeccccchHHHHHHHHHHHHHHcC-CCCceeEEe
Q 005247 427 GLEIRWSELLIKKKIGEGSFGTVYHAEWRNS---------DVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLM 496 (706)
Q Consensus 427 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~---------~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~ 496 (706)
.+++..++|++++.||+|+||.||+|+..+. .||||++.... .......+.+|...+.++ +|||||+++
T Consensus 7 ~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~ 85 (299)
T d1fgka_ 7 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLL 85 (299)
T ss_dssp TTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEecc
Confidence 3778889999999999999999999986543 38999886543 445567888999999888 799999999
Q ss_pred ccccCCCceEEEEEeccCCchhhhcccCC-------------CcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCC
Q 005247 497 GAVTEPPNLSIVTEYLSRGSLYKLLHIPD-------------ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKS 563 (706)
Q Consensus 497 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~-------------~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp 563 (706)
+++.+++..++||||+++|+|.+++.... ....+++..++.++.||+.||+|||+++ ||||||||
T Consensus 86 ~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~--ivHrDiKp 163 (299)
T d1fgka_ 86 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAA 163 (299)
T ss_dssp EEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSG
T ss_pred cccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC--EEeeeecc
Confidence 99999999999999999999999996432 1245899999999999999999999999 99999999
Q ss_pred CcEEECCCCcEEEeecCccccCCCCc--ccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCh
Q 005247 564 PNLLVDSTYTVKVCDFGLSRSKPNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNSTP 640 (706)
Q Consensus 564 ~NILl~~~~~vKL~DFGla~~~~~~~--~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~~ 640 (706)
+|||++.++.+||+|||+++...... .......||+.|+|||.+.+..++.++||||||+++|||++ |..||...+.
T Consensus 164 ~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~ 243 (299)
T d1fgka_ 164 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 243 (299)
T ss_dssp GGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred cceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH
Confidence 99999999999999999998654332 22345678999999999999999999999999999999998 6889998888
Q ss_pred HHHHHHhhhcCcccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHh
Q 005247 641 SQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMS 695 (706)
Q Consensus 641 ~~~~~~i~~~~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s 695 (706)
.+....+. .+.++..|..+++++++||.+||+.||++|||+.||++.|++++..
T Consensus 244 ~~~~~~i~-~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 244 EELFKLLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp HHHHHHHH-TTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHH-cCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence 77776664 5678888999999999999999999999999999999999999764
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.2e-47 Score=399.50 Aligned_cols=257 Identities=25% Similarity=0.381 Sum_probs=213.6
Q ss_pred cCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEecccc-chHHHHHHHHHHHHHHcCCCCceeEEeccccCCC----c
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP----N 504 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~----~ 504 (706)
.++|++.+.||+|+||+||+|.+..+ .||||++..... .....+.+.+|+.+++.++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 35799999999999999999998644 599999976544 3455678999999999999999999999986544 3
Q ss_pred eEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCcccc
Q 005247 505 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 584 (706)
Q Consensus 505 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~ 584 (706)
+++||||++|++|.+++... ..+++..++.++.||+.||+|||++| ||||||||+|||++.++.++|+|||.+..
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~---~~l~~~~~~~i~~qi~~al~~lH~~~--iiHrDiKP~NIll~~~~~~~l~d~~~~~~ 160 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARA 160 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred EEEEEECCCCCEehhhhccc---CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCccccCcccccCccccceeehhhhhhh
Confidence 78999999999999988643 35899999999999999999999999 99999999999999999999999998865
Q ss_pred CCCCc---ccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcc--cCCCCC
Q 005247 585 KPNTY---ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR--LEIPKN 659 (706)
Q Consensus 585 ~~~~~---~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~--l~~p~~ 659 (706)
..... ......+||+.|+|||++.+..++.++|||||||++|||+||+.||...+..+....+...... ......
T Consensus 161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (277)
T d1o6ya_ 161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG 240 (277)
T ss_dssp CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSS
T ss_pred hccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccC
Confidence 43322 2334567999999999999999999999999999999999999999998887776665443332 234568
Q ss_pred CcHHHHHHHHHhhhhCCCCCC-CHHHHHHHHHHHH
Q 005247 660 VNPMVAALIETCWAEEPEIRP-SFPSIMETLQQFL 693 (706)
Q Consensus 660 ~s~el~dLI~~cL~~dP~~RP-S~~eIl~~L~~ll 693 (706)
+|+++.+||.+||++||++|| |+++++..|.++.
T Consensus 241 ~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 241 LSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 999999999999999999999 8999999988764
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-48 Score=412.06 Aligned_cols=248 Identities=27% Similarity=0.470 Sum_probs=218.2
Q ss_pred CceEEEEEeccCCceEEEEEEEcCCc--eEEEEEecccc-chHHHHHHHHHHHHHH-cCCCCceeEEeccccCCCceEEE
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEF-HEDRFKEFLREVAIMK-GLRHPNIVLLMGAVTEPPNLSIV 508 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~~~--vAVKvl~~~~~-~~~~~~~~~~Ei~iL~-~L~HpnIv~l~~~~~~~~~~~lV 508 (706)
++|++++.||+|+||+||+|++..++ ||||++.+... .....+.+..|..++. .++||||+++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999997554 99999975432 2233456667777665 68999999999999999999999
Q ss_pred EEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCC
Q 005247 509 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 588 (706)
Q Consensus 509 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 588 (706)
|||+++|+|.++++.. ..+++..++.++.||+.||+|||+++ ||||||||+|||++.++++||+|||+++.....
T Consensus 82 mEy~~~g~L~~~i~~~---~~~~e~~~~~~~~qi~~al~ylH~~~--iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp EECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EeecCCCcHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCcccceeecCCCceeccccchhhhcccc
Confidence 9999999999999743 35889999999999999999999999 999999999999999999999999999876655
Q ss_pred cccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHH
Q 005247 589 YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI 668 (706)
Q Consensus 589 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI 668 (706)
........||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+.. ..+.+|..+++++++||
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~--~~~~~p~~~s~~~~dli 234 (320)
T d1xjda_ 157 DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM--DNPFYPRWLEKEAKDLL 234 (320)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTSCHHHHHHH
T ss_pred cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHc--CCCCCCccCCHHHHHHH
Confidence 5555667899999999999999999999999999999999999999999998888877743 35677889999999999
Q ss_pred HHhhhhCCCCCCCHH-HHHH
Q 005247 669 ETCWAEEPEIRPSFP-SIME 687 (706)
Q Consensus 669 ~~cL~~dP~~RPS~~-eIl~ 687 (706)
.+||+.||++||++. ++++
T Consensus 235 ~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 235 VKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp HHHSCSSGGGSBTTBSCGGG
T ss_pred HHhcccCCCCCcCHHHHHHh
Confidence 999999999999995 6754
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-47 Score=403.61 Aligned_cols=268 Identities=31% Similarity=0.510 Sum_probs=231.7
Q ss_pred cCcccccCceEEEEEeccCCceEEEEEEEcC-------CceEEEEEeccccchHHHHHHHHHHHHHHcC-CCCceeEEec
Q 005247 426 EGLEIRWSELLIKKKIGEGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGL-RHPNIVLLMG 497 (706)
Q Consensus 426 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~-------~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIv~l~~ 497 (706)
..+++..++|++.+.||+|+||.||+|++.+ ..||||++.... .......+.+|+.+++++ +|||||++++
T Consensus 16 ~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g 94 (311)
T d1t46a_ 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLG 94 (311)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence 3467888999999999999999999998743 238999986543 445556899999999999 6999999999
Q ss_pred cccCCCceEEEEEeccCCchhhhcccCC---------------CcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCC
Q 005247 498 AVTEPPNLSIVTEYLSRGSLYKLLHIPD---------------ARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLK 562 (706)
Q Consensus 498 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~---------------~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLK 562 (706)
++.+.+..++|||||++|+|.++++... ....+++..+..++.||+.||+|||+++ +||||||
T Consensus 95 ~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~--ivHrDLK 172 (311)
T d1t46a_ 95 ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLA 172 (311)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCS
T ss_pred EEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccc
Confidence 9999999999999999999999986432 2335889999999999999999999999 9999999
Q ss_pred CCcEEECCCCcEEEeecCccccCCCCc--ccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 005247 563 SPNLLVDSTYTVKVCDFGLSRSKPNTY--ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELIT-LQKPWRNST 639 (706)
Q Consensus 563 p~NILl~~~~~vKL~DFGla~~~~~~~--~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELlt-G~~Pf~~~~ 639 (706)
|+|||++.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||+| |.+||...+
T Consensus 173 p~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~ 252 (311)
T d1t46a_ 173 ARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (311)
T ss_dssp GGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred cccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999999998765432 23345678999999999999999999999999999999999 566677777
Q ss_pred hHHHHHHhhhcCcccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhc
Q 005247 640 PSQVISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 696 (706)
Q Consensus 640 ~~~~~~~i~~~~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~ 696 (706)
..+.+..+...+.++..+..+++++.+||.+||+.||++|||+.+|++.|++.+.+.
T Consensus 253 ~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~~ 309 (311)
T d1t46a_ 253 VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (311)
T ss_dssp SSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhccC
Confidence 666666665677788888999999999999999999999999999999999988763
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8e-48 Score=415.14 Aligned_cols=246 Identities=25% Similarity=0.386 Sum_probs=219.1
Q ss_pred cCceEEEEEeccCCceEEEEEEEcC--CceEEEEEecccc-chHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEE
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEF-HEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIV 508 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV 508 (706)
.++|++++.||+|+||.||+|.++. ..||||++..... .....+.+.+|+.+|+.++||||+++++++.+...+++|
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence 3689999999999999999999874 4599999865432 223456789999999999999999999999999999999
Q ss_pred EEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCC
Q 005247 509 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNT 588 (706)
Q Consensus 509 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~ 588 (706)
|||+.+|+|..++... ..+++..++.++.||+.||.|||++| ||||||||+|||++.+|++||+|||+|+.....
T Consensus 120 ~e~~~~g~l~~~l~~~---~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp EECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred cccccccchhhhHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 9999999999998643 25899999999999999999999999 999999999999999999999999999876543
Q ss_pred cccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCcHHHHHHH
Q 005247 589 YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVNPMVAALI 668 (706)
Q Consensus 589 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s~el~dLI 668 (706)
. ....||+.|||||++.+..++.++|||||||++|||+||+.||.+.+.......+.. ....+|..+++++.+||
T Consensus 195 ~---~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~li 269 (350)
T d1rdqe_ 195 T---WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS--GKVRFPSHFSSDLKDLL 269 (350)
T ss_dssp B---CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTCCHHHHHHH
T ss_pred c---ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhc--CCCCCCccCCHHHHHHH
Confidence 2 457899999999999999999999999999999999999999999988887777643 34567889999999999
Q ss_pred HHhhhhCCCCCC-----CHHHHHH
Q 005247 669 ETCWAEEPEIRP-----SFPSIME 687 (706)
Q Consensus 669 ~~cL~~dP~~RP-----S~~eIl~ 687 (706)
.+||+.||.+|+ |++++++
T Consensus 270 ~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 270 RNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp HHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred HHHhhhCHHhccccccccHHHHHc
Confidence 999999999994 8999986
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.7e-47 Score=397.06 Aligned_cols=250 Identities=23% Similarity=0.357 Sum_probs=216.6
Q ss_pred cCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccc-------hHHHHHHHHHHHHHHcCC-CCceeEEeccccC
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFH-------EDRFKEFLREVAIMKGLR-HPNIVLLMGAVTE 501 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~-------~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~ 501 (706)
.++|++.+.||+|+||+||+|++..+ .||||++...... ....+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 46899999999999999999998654 4999998765432 223456889999999997 9999999999999
Q ss_pred CCceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCc
Q 005247 502 PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL 581 (706)
Q Consensus 502 ~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGl 581 (706)
++..++||||+++|+|.++++.. ..+++..++.++.||+.||+|||++| ||||||||+|||++.++.+||+|||+
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred CcceEEEEEcCCCchHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcC--CcccccccceEEEcCCCCeEEccchh
Confidence 99999999999999999999743 35899999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCcccCCCCCCCCCccCcccccc------CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccC
Q 005247 582 SRSKPNTYISSKTAAGTPEWMAPEVLRE------DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLE 655 (706)
Q Consensus 582 a~~~~~~~~~~~~~~Gt~~Y~APE~l~~------~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~ 655 (706)
++...... ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||...+..+....+........
T Consensus 157 a~~~~~~~-~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~ 235 (277)
T d1phka_ 157 SCQLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFG 235 (277)
T ss_dssp CEECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred eeEccCCC-ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence 98765543 3356789999999999863 3468899999999999999999999999988887776654443333
Q ss_pred --CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 656 --IPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 656 --~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
...++|+++++||.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 236 SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 33479999999999999999999999999875
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-47 Score=402.30 Aligned_cols=270 Identities=31% Similarity=0.573 Sum_probs=232.1
Q ss_pred cccccccCcccccCceEEEEEeccCCceEEEEEEEcC-------CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCce
Q 005247 420 ELYLEEEGLEIRWSELLIKKKIGEGSFGTVYHAEWRN-------SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNI 492 (706)
Q Consensus 420 ~~~~~~~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~-------~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnI 492 (706)
+.++. +.+++..++|++++.||+|+||+||+|.+++ +.||||++.... .......|.+|+.++++++||||
T Consensus 8 ~~~~~-~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l~h~nI 85 (308)
T d1p4oa_ 8 DVYVP-DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHV 85 (308)
T ss_dssp SCCCC-CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTB
T ss_pred cCcCc-cceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc-ChHHHHHHHHHHHHHHHcCCCCE
Confidence 34443 3588999999999999999999999998753 459999986543 44555689999999999999999
Q ss_pred eEEeccccCCCceEEEEEeccCCchhhhcccC-------CCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCc
Q 005247 493 VLLMGAVTEPPNLSIVTEYLSRGSLYKLLHIP-------DARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPN 565 (706)
Q Consensus 493 v~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~-------~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~N 565 (706)
+++++++..++..++||||+.+|+|.+++... .....+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 86 v~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~--ivHrDlk~~N 163 (308)
T d1p4oa_ 86 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARN 163 (308)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGG
T ss_pred eeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeeceEcCCc
Confidence 99999999999999999999999999988532 12234678889999999999999999999 9999999999
Q ss_pred EEECCCCcEEEeecCccccCCCCcc--cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhC-CCCCCCCChHH
Q 005247 566 LLVDSTYTVKVCDFGLSRSKPNTYI--SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITL-QKPWRNSTPSQ 642 (706)
Q Consensus 566 ILl~~~~~vKL~DFGla~~~~~~~~--~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG-~~Pf~~~~~~~ 642 (706)
||++.++++||+|||+++....... ......||+.|+|||.+.+..++.++||||||+++|||+|| ..||...+..+
T Consensus 164 iLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~ 243 (308)
T d1p4oa_ 164 CMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ 243 (308)
T ss_dssp EEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH
T ss_pred eeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999986543322 22345689999999999999999999999999999999998 57888888888
Q ss_pred HHHHhhhcCcccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHH
Q 005247 643 VISAVGFKGRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLM 694 (706)
Q Consensus 643 ~~~~i~~~~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~ 694 (706)
....+. .+.+++.|..+++.+.+||.+||+.||++|||+.+|++.|++.+.
T Consensus 244 ~~~~i~-~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 244 VLRFVM-EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp HHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHHHHH-hCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 877664 566788889999999999999999999999999999999887654
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=9.1e-47 Score=408.91 Aligned_cols=250 Identities=24% Similarity=0.350 Sum_probs=210.3
Q ss_pred ccCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccch----HHHHHHHHHHHHHHcCCCCceeEEeccccCCCc
Q 005247 431 RWSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHE----DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPN 504 (706)
Q Consensus 431 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~----~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~ 504 (706)
..++|++++.||+|+||.||+|++..+ .||||++....... .......+|+.+++.++||||+++++++.+++.
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~ 81 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 81 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence 346899999999999999999998754 49999986543322 222233445778888899999999999999999
Q ss_pred eEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCcccc
Q 005247 505 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 584 (706)
Q Consensus 505 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~ 584 (706)
+++||||+++|+|.+++... ..+++..++.++.||+.||+|||++| ||||||||+|||++.+|.+||+|||+|+.
T Consensus 82 ~~ivmE~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~ylH~~~--iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEEEECCCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEEEecCCCcHHHHHHhc---ccccHHHHHHHHHHHHHHHHHHHHCC--ccceeeccceeEEcCCCcEEEeeeceeee
Confidence 99999999999999999643 35889999999999999999999999 99999999999999999999999999987
Q ss_pred CCCCcccCCCCCCCCCccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHh-hhcCcccCCCCCCcH
Q 005247 585 KPNTYISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAV-GFKGRRLEIPKNVNP 662 (706)
Q Consensus 585 ~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i-~~~~~~l~~p~~~s~ 662 (706)
.... ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||......+..... ........+|..+++
T Consensus 157 ~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 234 (364)
T d1omwa3 157 FSKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSP 234 (364)
T ss_dssp CSSS--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCH
T ss_pred cCCC--cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCH
Confidence 6543 2346689999999999975 56899999999999999999999999876544333222 124456677889999
Q ss_pred HHHHHHHHhhhhCCCCCCC-----HHHHHH
Q 005247 663 MVAALIETCWAEEPEIRPS-----FPSIME 687 (706)
Q Consensus 663 el~dLI~~cL~~dP~~RPS-----~~eIl~ 687 (706)
++++||.+||+.||++||| ++++++
T Consensus 235 ~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 235 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp HHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred HHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 9999999999999999999 788876
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-47 Score=404.81 Aligned_cols=248 Identities=21% Similarity=0.356 Sum_probs=215.9
Q ss_pred cCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEE
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVT 509 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~ 509 (706)
+++|++++.||+|+||+||+|.+..+ .||+|++.... .....+.+|+.+|+.++||||+++++++.+++.+|+||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvm 80 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 56899999999999999999998755 49999986653 22346789999999999999999999999999999999
Q ss_pred EeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECC--CCcEEEeecCccccCCC
Q 005247 510 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS--TYTVKVCDFGLSRSKPN 587 (706)
Q Consensus 510 E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~--~~~vKL~DFGla~~~~~ 587 (706)
|||+||+|.++++..+ ..+++..++.|+.||+.||+|||++| |+||||||+|||++. ...+||+|||+++....
T Consensus 81 E~~~gg~L~~~i~~~~--~~l~e~~~~~i~~qi~~al~yLH~~~--iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~ 156 (321)
T d1tkia_ 81 EFISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred ecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcC--CCcccccccceeecCCCceEEEEcccchhhcccc
Confidence 9999999999997433 35899999999999999999999999 999999999999985 45899999999987654
Q ss_pred CcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCccc--CCCCCCcHHHH
Q 005247 588 TYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRL--EIPKNVNPMVA 665 (706)
Q Consensus 588 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l--~~p~~~s~el~ 665 (706)
.. ......+|+.|+|||.+.+..++.++|||||||++|+|++|..||...+..+....+......+ ..+..++++++
T Consensus 157 ~~-~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 235 (321)
T d1tkia_ 157 GD-NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM 235 (321)
T ss_dssp TC-EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred CC-cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHH
Confidence 32 2345678999999999999999999999999999999999999999999888887775433322 22347899999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHH
Q 005247 666 ALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 666 dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
+||.+||..||++|||++|+++
T Consensus 236 ~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 236 DFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHccCChhHCcCHHHHhc
Confidence 9999999999999999999987
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-46 Score=396.88 Aligned_cols=256 Identities=32% Similarity=0.539 Sum_probs=214.5
Q ss_pred EEEEEeccCCceEEEEEEEcCC-----ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccC-CCceEEEE
Q 005247 436 LIKKKIGEGSFGTVYHAEWRNS-----DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE-PPNLSIVT 509 (706)
Q Consensus 436 ~i~~~LG~G~fG~Vy~a~~~~~-----~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~-~~~~~lV~ 509 (706)
.+.++||+|+||+||+|.+..+ .||||++.. .......+.|.+|+++|++++||||+++++++.+ ++.+++||
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~-~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 108 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR-ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 108 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECC-CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECc-ccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence 4478899999999999987543 278888754 3355667889999999999999999999999764 56789999
Q ss_pred EeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCc
Q 005247 510 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTY 589 (706)
Q Consensus 510 E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~ 589 (706)
|||++|+|.++++... ...++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 109 E~~~~g~l~~~~~~~~--~~~~~~~~~~i~~qia~gL~~lH~~~--iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp ECCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred EEeecCchhhhhcccc--ccchHHHHHHHHHHHHHhhhhhcccC--cccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence 9999999999987443 34778889999999999999999999 9999999999999999999999999998754332
Q ss_pred c----cCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHhhhcCcccCCCCCCcHHH
Q 005247 590 I----SSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNST-PSQVISAVGFKGRRLEIPKNVNPMV 664 (706)
Q Consensus 590 ~----~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~-~~~~~~~i~~~~~~l~~p~~~s~el 664 (706)
. ......||+.|+|||.+.+..++.++||||||+++|||+||..||.... ..+....+ ..+.++..|..+++++
T Consensus 185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i-~~g~~~~~p~~~~~~l 263 (311)
T d1r0pa_ 185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-LQGRRLLQPEYCPDPL 263 (311)
T ss_dssp CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHH-HTTCCCCCCTTCCHHH
T ss_pred cccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHH-HcCCCCCCcccCcHHH
Confidence 1 2233568999999999999999999999999999999999877776543 33334443 4567788889999999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhcc
Q 005247 665 AALIETCWAEEPEIRPSFPSIMETLQQFLMSSV 697 (706)
Q Consensus 665 ~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~~ 697 (706)
.+||.+||+.||++||++.||++.|++++.+..
T Consensus 264 ~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~ 296 (311)
T d1r0pa_ 264 YEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 296 (311)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred HHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhh
Confidence 999999999999999999999999999987643
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-47 Score=396.84 Aligned_cols=246 Identities=26% Similarity=0.311 Sum_probs=203.9
Q ss_pred EEEEeccCCceEEEEEEEcCC--ceEEEEEeccccch---HHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEEe
Q 005247 437 IKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHE---DRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY 511 (706)
Q Consensus 437 i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~---~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~ 511 (706)
.++.||+|+||+||+|.+..+ .||||++....... ...+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 468999999999999998654 49999986543222 2235688999999999999999999999999999999999
Q ss_pred ccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCccc
Q 005247 512 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS 591 (706)
Q Consensus 512 ~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~ 591 (706)
+.++++..+... ...+++..+..++.||+.||+|||++| ||||||||+|||++.++.+||+|||+++........
T Consensus 82 ~~~~~~~~~~~~---~~~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~ 156 (299)
T d1ua2a_ 82 METDLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA 156 (299)
T ss_dssp CSEEHHHHHTTC---CSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred hcchHHhhhhhc---ccCCCHHHHHHHHHHHHHHHHHhhccc--eecccCCcceEEecCCCccccccCccccccCCCccc
Confidence 999887776653 335889999999999999999999999 999999999999999999999999999887666555
Q ss_pred CCCCCCCCCccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcc-----------------
Q 005247 592 SKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR----------------- 653 (706)
Q Consensus 592 ~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~----------------- 653 (706)
....+||+.|+|||++.+. .++.++|||||||++|||++|..||...+..+....+......
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (299)
T d1ua2a_ 157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236 (299)
T ss_dssp CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCC
T ss_pred ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhh
Confidence 5677899999999998755 5799999999999999999999999988877766554311000
Q ss_pred ---------cCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 654 ---------LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 654 ---------l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
......+++++.+||.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp CCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 0012356889999999999999999999999976
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-46 Score=395.14 Aligned_cols=252 Identities=25% Similarity=0.347 Sum_probs=206.6
Q ss_pred CceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEE
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 510 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E 510 (706)
++|++++.||+|+||+||+|++.. +.||||++..........+.+.+|+++|++++||||+++++++.+++.+++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 589999999999999999999874 459999986654444445688999999999999999999999999999999999
Q ss_pred eccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcc
Q 005247 511 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 590 (706)
Q Consensus 511 ~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~ 590 (706)
|+.++.+...... ....+++..++.++.||+.||+|||++| ||||||||+|||++.++++||+|||+|+.......
T Consensus 82 ~~~~~~~~~~~~~--~~~~l~e~~~~~~~~qil~~L~yLH~~~--IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~ 157 (298)
T d1gz8a_ 82 FLHQDLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 157 (298)
T ss_dssp CCSEEHHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB
T ss_pred ecCCchhhhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhcCC--EEccccCchheeecccCcceeccCCcceeccCCcc
Confidence 9976544433332 2235899999999999999999999999 99999999999999999999999999987665555
Q ss_pred cCCCCCCCCCccCccccccCC-CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhc-Cc---------------c
Q 005247 591 SSKTAAGTPEWMAPEVLREDP-SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK-GR---------------R 653 (706)
Q Consensus 591 ~~~~~~Gt~~Y~APE~l~~~~-~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~-~~---------------~ 653 (706)
......||+.|+|||++.... ++.++|||||||++|+|++|+.||...+..+....+... +. .
T Consensus 158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T d1gz8a_ 158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237 (298)
T ss_dssp CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccc
Confidence 556678999999999987766 478999999999999999999999988776655443211 00 0
Q ss_pred cC-----------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 005247 654 LE-----------IPKNVNPMVAALIETCWAEEPEIRPSFPSIMET 688 (706)
Q Consensus 654 l~-----------~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~ 688 (706)
.. ....+++++.+||.+||+.||++|||++|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 00 113567899999999999999999999999873
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=4.7e-46 Score=388.76 Aligned_cols=250 Identities=24% Similarity=0.305 Sum_probs=208.3
Q ss_pred CceEEEEEeccCCceEEEEEEEcC-CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEEe
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRN-SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTEY 511 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~-~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E~ 511 (706)
++|+++++||+|+||+||+|+++. ..||||++..........+.+.+|+.+|++++||||+++++++..++..+++||+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 589999999999999999998864 4499999976655555567899999999999999999999999999999999999
Q ss_pred ccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCccc
Q 005247 512 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYIS 591 (706)
Q Consensus 512 ~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~~ 591 (706)
+.++.+..+.+.. ..+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||.+.........
T Consensus 82 ~~~~~~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~--IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 156 (286)
T d1ob3a_ 82 LDQDLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK 156 (286)
T ss_dssp CSEEHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred ehhhhHHHHHhhc---CCcchhhhHHHHHHHHHHHHHhccCc--EEecCCCCceeeEcCCCCEEecccccceecccCccc
Confidence 9887777776533 35999999999999999999999999 999999999999999999999999999876555444
Q ss_pred CCCCCCCCCccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCc------------------
Q 005247 592 SKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR------------------ 652 (706)
Q Consensus 592 ~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~------------------ 652 (706)
.....+++.|+|||.+.+. .++.++|||||||++|||++|+.||...+..+....+.....
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T d1ob3a_ 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236 (286)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccc
Confidence 4566799999999999765 468999999999999999999999998877666554321000
Q ss_pred ---------ccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 653 ---------RLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 653 ---------~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
.......+++.+.+||++||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 01234567899999999999999999999999974
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-46 Score=389.42 Aligned_cols=251 Identities=27% Similarity=0.368 Sum_probs=205.6
Q ss_pred cCceEEEEEeccCCceEEEEEEEcCC---ceEEEEEeccccchHHHHHHHHHHHHHHcC---CCCceeEEecccc-----
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRNS---DVAVKILIEQEFHEDRFKEFLREVAIMKGL---RHPNIVLLMGAVT----- 500 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~~---~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L---~HpnIv~l~~~~~----- 500 (706)
.++|++++.||+|+||+||+|.+..+ .||||++............+.+|+.+++.| +||||+++++++.
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 36899999999999999999998533 389999876544433334566777776655 7999999999874
Q ss_pred CCCceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecC
Q 005247 501 EPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFG 580 (706)
Q Consensus 501 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFG 580 (706)
.....+++|||+.++.+....... ...+++..++.++.||+.||+|||+++ ||||||||+|||++.++.+||+|||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~yLH~~~--ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECSCC
T ss_pred cCceEEEEEEeccCCchhhhhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecCCCccEEEEcCCCCeeecchh
Confidence 345689999999988776554322 235889999999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcC---------
Q 005247 581 LSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG--------- 651 (706)
Q Consensus 581 la~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~--------- 651 (706)
+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+....
T Consensus 162 ~~~~~~~~~-~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 240 (305)
T d1blxa_ 162 LARIYSFQM-ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 240 (305)
T ss_dssp SCCCCCGGG-GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred hhhhhcccc-cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccc
Confidence 988654432 3456789999999999999999999999999999999999999999988777665542110
Q ss_pred ----------------cccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 652 ----------------RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 652 ----------------~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
....++..+++++.+||.+||+.||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp TTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 011234567899999999999999999999999876
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-46 Score=399.51 Aligned_cols=245 Identities=26% Similarity=0.396 Sum_probs=201.0
Q ss_pred cCceEEEE-EeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHc-CCCCceeEEeccccC----CC
Q 005247 432 WSELLIKK-KIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKG-LRHPNIVLLMGAVTE----PP 503 (706)
Q Consensus 432 ~~~y~i~~-~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~-L~HpnIv~l~~~~~~----~~ 503 (706)
.++|++.+ .||+|+||+||+|.+..+ .||||++... ..+.+|+.++.+ .+||||+++++++.+ ..
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~ 82 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 82 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCC
Confidence 35798875 599999999999998654 4999998643 356789988755 589999999998864 46
Q ss_pred ceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECC---CCcEEEeecC
Q 005247 504 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS---TYTVKVCDFG 580 (706)
Q Consensus 504 ~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~---~~~vKL~DFG 580 (706)
.+|+|||||+||+|.+++...+ ...+++..++.|+.||+.||+|||++| |+||||||+|||++. .+.+||+|||
T Consensus 83 ~~~ivmEy~~gg~L~~~i~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~~--iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 83 CLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp EEEEEEECCCSEEHHHHHHSCS-CCCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEEEECCCCCcHHHHHHhcC-CCCcCHHHHHHHHHHHHHHHHHHHHcC--Cccccccccccccccccccccccccccc
Confidence 6899999999999999997432 235999999999999999999999999 999999999999975 5679999999
Q ss_pred ccccCCCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh--hcCcccCCC-
Q 005247 581 LSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVG--FKGRRLEIP- 657 (706)
Q Consensus 581 la~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~--~~~~~l~~p- 657 (706)
+|+...... ......||+.|+|||++.+..++.++|||||||++|+|+||+.||.+.+..+....+. .......+|
T Consensus 160 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~ 238 (335)
T d2ozaa1 160 FAKETTSHN-SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 238 (335)
T ss_dssp TCEECCCCC-CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCT
T ss_pred eeeeccCCC-ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCC
Confidence 998765433 3356789999999999999999999999999999999999999998766544433321 122223333
Q ss_pred ---CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 658 ---KNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 658 ---~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
..+++++.+||.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 239 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 257899999999999999999999999977
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=390.98 Aligned_cols=240 Identities=22% Similarity=0.389 Sum_probs=203.0
Q ss_pred CceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccch----HHHHHHHHHHHHHHcCC--CCceeEEeccccCCCc
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHE----DRFKEFLREVAIMKGLR--HPNIVLLMGAVTEPPN 504 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~----~~~~~~~~Ei~iL~~L~--HpnIv~l~~~~~~~~~ 504 (706)
++|++.+.||+|+||+||+|.+..+ .||||++....... .....+.+|+.++++++ ||||+++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 5799999999999999999998744 59999987643321 11234678999999986 8999999999999999
Q ss_pred eEEEEEeccC-CchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECC-CCcEEEeecCcc
Q 005247 505 LSIVTEYLSR-GSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS-TYTVKVCDFGLS 582 (706)
Q Consensus 505 ~~lV~E~~~g-gsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~-~~~vKL~DFGla 582 (706)
.++||||+.+ +++.+++... ..+++..++.++.||+.||+|||++| ||||||||+|||++. ++.+||+|||+|
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~---~~l~e~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NIll~~~~~~vkl~DFG~a 158 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSG 158 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEEEeccCcchHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC--CccccCcccceEEecCCCeEEECccccc
Confidence 9999999976 5777777532 35899999999999999999999999 999999999999985 479999999999
Q ss_pred ccCCCCcccCCCCCCCCCccCccccccCCC-CchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcccCCCCCCc
Q 005247 583 RSKPNTYISSKTAAGTPEWMAPEVLREDPS-NEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRLEIPKNVN 661 (706)
Q Consensus 583 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l~~p~~~s 661 (706)
+...... ..+..||+.|+|||++.+..+ +.++|||||||++|||++|+.||...+ +. ......++..+|
T Consensus 159 ~~~~~~~--~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--~i------~~~~~~~~~~~s 228 (273)
T d1xwsa_ 159 ALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--EI------IRGQVFFRQRVS 228 (273)
T ss_dssp EECCSSC--BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--HH------HHCCCCCSSCCC
T ss_pred eeccccc--ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch--HH------hhcccCCCCCCC
Confidence 8755432 346789999999999988765 567899999999999999999997532 11 123456778899
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 662 PMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 662 ~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
+++++||.+||+.||++|||++|+++
T Consensus 229 ~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 229 SECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 99999999999999999999999976
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-44 Score=372.46 Aligned_cols=250 Identities=24% Similarity=0.335 Sum_probs=212.9
Q ss_pred CceEEEEEeccCCceEEEEEEEcCCc--eEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCCceEEEEE
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRNSD--VAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPPNLSIVTE 510 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~~~--vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~~~~lV~E 510 (706)
++|++++.||+|+||+||+|++..++ ||||+++.........+.+.+|+.+|+.++||||+++++++.+....++|++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 58999999999999999999987554 9999998776666777899999999999999999999999999999999999
Q ss_pred eccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCCCCcc
Q 005247 511 YLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKPNTYI 590 (706)
Q Consensus 511 ~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~~~~~ 590 (706)
++.+++|..+++.. ..+++..++.++.|++.||+|||++| ||||||||+|||++.++.+||+|||.++.......
T Consensus 82 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~q~~~aL~~lH~~~--IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~ 156 (292)
T d1unla_ 82 FCDQDLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp CCSEEHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred eccccccccccccc---cccchhHHHHHHHHHHHHHHHhhcCC--EeeecccCcccccccCCceeeeecchhhcccCCCc
Confidence 99999998887643 35789999999999999999999999 99999999999999999999999999988766554
Q ss_pred cCCCCCCCCCccCccccccCC-CCchhHHHHHHHHHHHHHhCCCCCC-CCChHHHHHHhhhc------------------
Q 005247 591 SSKTAAGTPEWMAPEVLREDP-SNEKSDVFSFGVILWELITLQKPWR-NSTPSQVISAVGFK------------------ 650 (706)
Q Consensus 591 ~~~~~~Gt~~Y~APE~l~~~~-~s~ksDVwSLGviL~ELltG~~Pf~-~~~~~~~~~~i~~~------------------ 650 (706)
......+++.|+|||++.+.. ++.++|||||||++|||++|+.||. +.+..+....+...
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (292)
T d1unla_ 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccc
Confidence 555667889999999988765 6899999999999999999999864 44444443332210
Q ss_pred ---------CcccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 651 ---------GRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 651 ---------~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
.........+++++.+||++||+.||.+|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0112233467889999999999999999999999876
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-44 Score=383.77 Aligned_cols=251 Identities=25% Similarity=0.349 Sum_probs=205.4
Q ss_pred cCceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCC------
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP------ 503 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~------ 503 (706)
.++|++++.||+|+||+||+|.+.. ..||||++..........+.+.+|+.+|+.++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 4689999999999999999999874 44999999776666677788999999999999999999999987654
Q ss_pred ceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccc
Q 005247 504 NLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 583 (706)
Q Consensus 504 ~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~ 583 (706)
.+++||||+ +.+|..+.+. ..+++..++.++.||+.||+|||++| ||||||||+|||++.++.+||+|||+|+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~~--IiHrDiKp~NIL~~~~~~~kl~Dfg~a~ 169 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLAR 169 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecc-cccHHHHHHh----ccccHHHHHHHHHHHHHHHHHHHhCC--CcccccCcchhhccccccccccccccee
Confidence 479999999 5677777653 24899999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCcccCCCCCCCCCccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcC-----------
Q 005247 584 SKPNTYISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG----------- 651 (706)
Q Consensus 584 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~----------- 651 (706)
..... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...+..+....+....
T Consensus 170 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (346)
T d1cm8a_ 170 QADSE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL 246 (346)
T ss_dssp ECCSS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred ccCCc---cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhh
Confidence 76554 2467899999999999875 56899999999999999999999998877655443321100
Q ss_pred ------------------cccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH--HHHH
Q 005247 652 ------------------RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMET--LQQF 692 (706)
Q Consensus 652 ------------------~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~--L~~l 692 (706)
.......++++++.+||.+||..||.+|||++|+++. ++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 247 QSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp SCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred cchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 0112345678999999999999999999999999873 5443
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-44 Score=382.36 Aligned_cols=257 Identities=30% Similarity=0.483 Sum_probs=200.4
Q ss_pred CceEEEEEeccCCceEEEEEEEcCCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCC----ceEEE
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP----NLSIV 508 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~----~~~lV 508 (706)
.+|.+.+.||+|+||.||+|++++..||||++.... ........|+..++.++||||+++++++.+.+ .+++|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 468899999999999999999998899999985432 11122234555556789999999999987544 57999
Q ss_pred EEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhc------CCCcccccCCCCcEEECCCCcEEEeecCcc
Q 005247 509 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQR------RPPIVHRDLKSPNLLVDSTYTVKVCDFGLS 582 (706)
Q Consensus 509 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~------g~~IIHrDLKp~NILl~~~~~vKL~DFGla 582 (706)
|||+++|+|.++++.. .+++..++.++.|++.||.|||+. .++||||||||+|||++.++++||+|||++
T Consensus 80 ~Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EecccCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 9999999999999743 488999999999999999999973 123999999999999999999999999999
Q ss_pred ccCCCCc----ccCCCCCCCCCccCccccccCC------CCchhHHHHHHHHHHHHHhCCCCCCCC--------------
Q 005247 583 RSKPNTY----ISSKTAAGTPEWMAPEVLREDP------SNEKSDVFSFGVILWELITLQKPWRNS-------------- 638 (706)
Q Consensus 583 ~~~~~~~----~~~~~~~Gt~~Y~APE~l~~~~------~s~ksDVwSLGviL~ELltG~~Pf~~~-------------- 638 (706)
+...... .......||+.|+|||++.+.. ++.++|||||||+||||+||..||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence 7643322 1234567999999999987653 567899999999999999998876431
Q ss_pred -ChHHHHHHhhhcCcccCCCCC-----CcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhc
Q 005247 639 -TPSQVISAVGFKGRRLEIPKN-----VNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 696 (706)
Q Consensus 639 -~~~~~~~~i~~~~~~l~~p~~-----~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~ 696 (706)
........+.....++.++.. ....+.+||.+||+.||++|||+.||++.|+++..+.
T Consensus 236 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 299 (303)
T d1vjya_ 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred chHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence 122223333233334444433 2356999999999999999999999999999988664
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-43 Score=375.17 Aligned_cols=251 Identities=23% Similarity=0.310 Sum_probs=200.9
Q ss_pred cCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccC--------
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE-------- 501 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~-------- 501 (706)
.++|+++++||+|+||+||+|.+..+ .||||++..........+.+.+|+.+|++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 47899999999999999999998644 49999986665555556778999999999999999999998754
Q ss_pred CCceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCc
Q 005247 502 PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGL 581 (706)
Q Consensus 502 ~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGl 581 (706)
.+..++||||+.++.+..+... ...+++..++.++.||+.||.|||++| ||||||||+|||++.++.+||+|||+
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~---~~~~~~~~~~~i~~qil~~l~~lH~~~--ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCT---TCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred CceEEEEEeccCCCccchhhhc---ccccccHHHHHHHHHHHHHHHHhccCC--EEecCcCchheeecCCCcEEeeecce
Confidence 3468999999988776655442 235888999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCc----ccCCCCCCCCCccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCccc--
Q 005247 582 SRSKPNTY----ISSKTAAGTPEWMAPEVLRED-PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRRL-- 654 (706)
Q Consensus 582 a~~~~~~~----~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~l-- 654 (706)
++...... ......+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+....+.......
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 243 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 97654321 122345799999999999765 68999999999999999999999999888766655443211110
Q ss_pred CCC----------------------------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 655 EIP----------------------------KNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 655 ~~p----------------------------~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
... ...++++.+||.+||+.||++|||++|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 000 012567889999999999999999999975
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-43 Score=379.20 Aligned_cols=249 Identities=24% Similarity=0.361 Sum_probs=200.4
Q ss_pred CceEEEEEeccCCceEEEEEEEcC--CceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCCC----ceE
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRN--SDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEPP----NLS 506 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~~----~~~ 506 (706)
.+|++++.||+|+||+||+|.++. +.||||++.... .....+.+.+|+.+|+.++||||+++++++.... ..+
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 469999999999999999999864 449999986543 4455678999999999999999999999986543 234
Q ss_pred EEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCccccCC
Q 005247 507 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRSKP 586 (706)
Q Consensus 507 lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~~~ 586 (706)
++++++.+|+|.++++.. .+++..++.++.||+.||+|||++| ||||||||+|||++.++.+||+|||+++...
T Consensus 87 ~l~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~~~--iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160 (345)
T ss_dssp EEEEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEeecCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence 555667799999999643 4899999999999999999999999 9999999999999999999999999997654
Q ss_pred CCcc---cCCCCCCCCCccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcC-----------
Q 005247 587 NTYI---SSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKG----------- 651 (706)
Q Consensus 587 ~~~~---~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~----------- 651 (706)
.... .....+||+.|+|||++.. ..++.++||||+||++|||++|+.||...+..+.........
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (345)
T d1pmea_ 161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 240 (345)
T ss_dssp GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTC
T ss_pred CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhh
Confidence 3321 2345679999999999854 567899999999999999999999998877655443331100
Q ss_pred -------------cc-----cCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 005247 652 -------------RR-----LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMET 688 (706)
Q Consensus 652 -------------~~-----l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~ 688 (706)
.. .....++++++.+||.+||+.||.+|||+.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 01234678899999999999999999999999873
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-43 Score=380.04 Aligned_cols=250 Identities=25% Similarity=0.301 Sum_probs=201.3
Q ss_pred ceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccC------CCce
Q 005247 434 ELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE------PPNL 505 (706)
Q Consensus 434 ~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~------~~~~ 505 (706)
+|+.+++||+|+||+||+|++..+ .||||++..... .+.+|+.+|++++||||++++++|.. ..++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 689999999999999999999754 499999876532 23479999999999999999998843 3357
Q ss_pred EEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCC-cEEEeecCcccc
Q 005247 506 SIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY-TVKVCDFGLSRS 584 (706)
Q Consensus 506 ~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~-~vKL~DFGla~~ 584 (706)
++|||||+++.+..+.+.......+++..++.++.||+.||+|||++| ||||||||+|||++.++ .+||+|||+++.
T Consensus 95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~--IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC--CcccCCCcceEEEecCCCceeEecccchhh
Confidence 899999987655544433233446899999999999999999999999 99999999999999775 899999999987
Q ss_pred CCCCcccCCCCCCCCCccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhc-------------
Q 005247 585 KPNTYISSKTAAGTPEWMAPEVLRE-DPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFK------------- 650 (706)
Q Consensus 585 ~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~------------- 650 (706)
..... ...+..||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...+..+....+...
T Consensus 173 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~ 251 (350)
T d1q5ka_ 173 LVRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251 (350)
T ss_dssp CCTTS-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred ccCCc-ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhc
Confidence 65433 2345789999999999875 46899999999999999999999999888766655443210
Q ss_pred --Cccc------------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH--HHHHH
Q 005247 651 --GRRL------------EIPKNVNPMVAALIETCWAEEPEIRPSFPSIME--TLQQF 692 (706)
Q Consensus 651 --~~~l------------~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~--~L~~l 692 (706)
.... .....+++++.+||.+||+.||++|||+.|+++ .++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp C---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred cchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 0000 112457899999999999999999999999986 35444
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.2e-43 Score=369.44 Aligned_cols=255 Identities=20% Similarity=0.277 Sum_probs=203.1
Q ss_pred CceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCc-eeEEeccccCCCceEEEE
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPN-IVLLMGAVTEPPNLSIVT 509 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~Hpn-Iv~l~~~~~~~~~~~lV~ 509 (706)
++|++++.||+|+||.||+|.+..+ .||||++...... +.+.+|+++++.++|+| |+.+..++.+.+..++||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm 82 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 82 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence 4699999999999999999998744 5999998765332 35778999999998665 556666677888899999
Q ss_pred EeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECC---CCcEEEeecCccccCC
Q 005247 510 EYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS---TYTVKVCDFGLSRSKP 586 (706)
Q Consensus 510 E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~---~~~vKL~DFGla~~~~ 586 (706)
||+. ++|...+.... ..+++..+..++.|++.||+|||++| ||||||||+|||++. +..+||+|||+|+...
T Consensus 83 e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~ 157 (299)
T d1ckia_ 83 ELLG-PSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 157 (299)
T ss_dssp ECCC-CBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred EEcC-Cchhhhhhhcc--CCCcHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence 9995 46655554322 35899999999999999999999999 999999999999864 4579999999998654
Q ss_pred CCc-------ccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh------hcCcc
Q 005247 587 NTY-------ISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVG------FKGRR 653 (706)
Q Consensus 587 ~~~-------~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~------~~~~~ 653 (706)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+. .....
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (299)
T d1ckia_ 158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 237 (299)
T ss_dssp CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH
T ss_pred ccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh
Confidence 322 12345679999999999999999999999999999999999999998765544332221 11112
Q ss_pred cCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhc
Q 005247 654 LEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 696 (706)
Q Consensus 654 l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~ 696 (706)
...+.++|+++.+||.+||+.||++||++.+|.+.|++++...
T Consensus 238 ~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 238 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp HHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred hHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 2345689999999999999999999999999999999987643
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.1e-42 Score=365.44 Aligned_cols=256 Identities=19% Similarity=0.239 Sum_probs=211.4
Q ss_pred cCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCCC-CceeEEeccccCCCceEEE
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRH-PNIVLLMGAVTEPPNLSIV 508 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~H-pnIv~l~~~~~~~~~~~lV 508 (706)
.++|++++.||+|+||+||+|.+..+ .||||++...... ..+.+|+++++.+.| +||+.+++++.+....++|
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v 79 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 79 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence 46899999999999999999998754 4999998654322 246678889999975 8999999999999999999
Q ss_pred EEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECC-----CCcEEEeecCccc
Q 005247 509 TEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDS-----TYTVKVCDFGLSR 583 (706)
Q Consensus 509 ~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~-----~~~vKL~DFGla~ 583 (706)
|||+ +++|.++++..+ ..+++..+..++.|++.||+|||++| ||||||||+|||++. .+.+||+|||+|+
T Consensus 80 me~~-~~~l~~~~~~~~--~~~~~~~~~~i~~q~~~~l~~lH~~g--iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 80 IDLL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp EECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred EEec-CCCHHHHHHhhc--cchhhHHHHHHHHHHHHHHHHHHHCC--ceeccCCccceeecCcccccCCceEEcccceeE
Confidence 9998 679998886443 35889999999999999999999999 999999999999964 5789999999998
Q ss_pred cCCCC-------cccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHhhhc---
Q 005247 584 SKPNT-------YISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPS---QVISAVGFK--- 650 (706)
Q Consensus 584 ~~~~~-------~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~---~~~~~i~~~--- 650 (706)
..... ........||+.|||||++.+..++.++||||||+++|||++|..||.+.... +....+...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 234 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred EcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC
Confidence 64332 11234567999999999999999999999999999999999999999765432 222222111
Q ss_pred CcccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHHHHHhc
Q 005247 651 GRRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIMETLQQFLMSS 696 (706)
Q Consensus 651 ~~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~~L~~ll~s~ 696 (706)
.....+..++|+++.+||..|+..+|++||+++.+.+.|++++...
T Consensus 235 ~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~ 280 (293)
T d1csna_ 235 TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280 (293)
T ss_dssp SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred CChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence 1122345678999999999999999999999999999999988654
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-43 Score=378.41 Aligned_cols=252 Identities=23% Similarity=0.366 Sum_probs=209.1
Q ss_pred ccCceEEEEEeccCCceEEEEEEEc-----CCceEEEEEecccc--chHHHHHHHHHHHHHHcCCC-CceeEEeccccCC
Q 005247 431 RWSELLIKKKIGEGSFGTVYHAEWR-----NSDVAVKILIEQEF--HEDRFKEFLREVAIMKGLRH-PNIVLLMGAVTEP 502 (706)
Q Consensus 431 ~~~~y~i~~~LG~G~fG~Vy~a~~~-----~~~vAVKvl~~~~~--~~~~~~~~~~Ei~iL~~L~H-pnIv~l~~~~~~~ 502 (706)
..++|++++.||+|+||+||+|.+. ++.||||++..... .....+.+.+|+.++++++| |||+++++++.+.
T Consensus 22 ~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~ 101 (322)
T d1vzoa_ 22 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 101 (322)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred chhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC
Confidence 4578999999999999999999863 33499999865432 12234568899999999976 8999999999999
Q ss_pred CceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCcc
Q 005247 503 PNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLS 582 (706)
Q Consensus 503 ~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla 582 (706)
..++++|||+.+|+|.+++.... .+.+..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||++
T Consensus 102 ~~~~~v~e~~~~~~L~~~i~~~~---~~~e~~~~~~~~Qi~~al~~lH~~~--ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 102 TKLHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp TEEEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred CceeeeeecccccHHHHHHHhcc---cccHHHHHHHHHHHHHHHHHhhcCC--EEeccCCccceeecCCCCEEEeeccch
Confidence 99999999999999999986443 4678899999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCc-ccCCCCCCCCCccCccccccC--CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhh--hcCcccCCC
Q 005247 583 RSKPNTY-ISSKTAAGTPEWMAPEVLRED--PSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVG--FKGRRLEIP 657 (706)
Q Consensus 583 ~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~--~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~--~~~~~l~~p 657 (706)
+...... .......|++.|+|||.+.+. .++.++|||||||+||||++|+.||...+..+....+. .......+|
T Consensus 177 ~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~ 256 (322)
T d1vzoa_ 177 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP 256 (322)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCC
T ss_pred hhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCc
Confidence 8654332 234466799999999999765 46889999999999999999999998765444333332 123356677
Q ss_pred CCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHH
Q 005247 658 KNVNPMVAALIETCWAEEPEIRP-----SFPSIME 687 (706)
Q Consensus 658 ~~~s~el~dLI~~cL~~dP~~RP-----S~~eIl~ 687 (706)
..+++++.+||.+||++||++|| |++|+++
T Consensus 257 ~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 257 QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 89999999999999999999999 4888876
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-43 Score=375.05 Aligned_cols=247 Identities=23% Similarity=0.317 Sum_probs=203.9
Q ss_pred cCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccCC-----Cc
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTEP-----PN 504 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~~-----~~ 504 (706)
.++|++++.||+|+||+||+|.+..+ .||||++..........+.+.+|+.+|++++||||+++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 36799999999999999999998754 499999877666666677899999999999999999999988533 34
Q ss_pred eEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCcccc
Q 005247 505 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 584 (706)
Q Consensus 505 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~ 584 (706)
.+++|+++.+|+|.++++.. .+++..++.++.||+.||+|||++| ||||||||+|||++.++.+||+|||++..
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~----~l~e~~~~~i~~qil~aL~~LH~~g--iiHrDiKp~NILi~~~~~~kl~dfg~a~~ 170 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH 170 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred eEEEEEeecCCchhhhcccc----cccHHHHHHHHHHHHHHHHHHHhCC--CcccccCCccccccccccccccccchhcc
Confidence 46667778899999998643 4899999999999999999999999 99999999999999999999999999976
Q ss_pred CCCCcccCCCCCCCCCccCccccccCC-CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCcc----------
Q 005247 585 KPNTYISSKTAAGTPEWMAPEVLREDP-SNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGRR---------- 653 (706)
Q Consensus 585 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~-~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~~---------- 653 (706)
.... .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+.......+......
T Consensus 171 ~~~~---~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 247 (348)
T d2gfsa1 171 TDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 247 (348)
T ss_dssp CTGG---GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCC
T ss_pred cCcc---cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhcc
Confidence 5443 34678899999999977764 588999999999999999999999988766555444211110
Q ss_pred -----------cC--------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 654 -----------LE--------IPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 654 -----------l~--------~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
.. ....+++++.+||.+||+.||++|||+.|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 248 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp CHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred chhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 00 12367899999999999999999999999987
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-42 Score=373.96 Aligned_cols=246 Identities=25% Similarity=0.303 Sum_probs=195.1
Q ss_pred CceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCCCCceeEEeccccC------CCc
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNIVLLMGAVTE------PPN 504 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~~~~------~~~ 504 (706)
++|+++++||+|+||+||+|.+..+ .||||++..........+.+.+|+.++++++||||++++++|.. .+.
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 5799999999999999999998754 49999998877777777889999999999999999999999853 467
Q ss_pred eEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEeecCcccc
Q 005247 505 LSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCDFGLSRS 584 (706)
Q Consensus 505 ~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~DFGla~~ 584 (706)
+|+||||+.++.+..+ . ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++.
T Consensus 97 ~~iv~Ey~~~~l~~~~-~-----~~~~~~~i~~~~~qil~gl~~LH~~g--iiHrDlKP~Nil~~~~~~~kl~df~~~~~ 168 (355)
T d2b1pa1 97 VYLVMELMDANLCQVI-Q-----MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_dssp EEEEEECCSEEHHHHH-T-----SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred eEEEEeccchHHHHhh-h-----cCCCHHHHHHHHHHHHHHHHHhhhcc--cccccCCccccccccccceeeechhhhhc
Confidence 8999999987655544 2 24789999999999999999999999 99999999999999999999999999887
Q ss_pred CCCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhhcCc------------
Q 005247 585 KPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQVISAVGFKGR------------ 652 (706)
Q Consensus 585 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~~~~~i~~~~~------------ 652 (706)
..... ......+|+.|+|||++.+..++.++||||+||++|||++|+.||.+.+.......+.....
T Consensus 169 ~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 247 (355)
T d2b1pa1 169 AGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247 (355)
T ss_dssp -------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCH
T ss_pred ccccc-ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhh
Confidence 65433 33566799999999999999999999999999999999999999988776554433310000
Q ss_pred --------cc--------------CC------CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 653 --------RL--------------EI------PKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 653 --------~l--------------~~------p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
.. .. +...++++.+||++||..||++|||++|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00 00 0123578899999999999999999999986
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.9e-42 Score=365.80 Aligned_cols=242 Identities=22% Similarity=0.345 Sum_probs=196.8
Q ss_pred cCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCC-CCceeEEeccccC--CCceE
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGAVTE--PPNLS 506 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~--~~~~~ 506 (706)
.++|+++++||+|+||+||+|++..+ .||||++.... .+.+.+|+.+|+.++ ||||+++++++.. ....+
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~ 108 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 108 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCcee
Confidence 35799999999999999999998754 49999986432 356889999999995 9999999999864 45689
Q ss_pred EEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCC-cEEEeecCccccC
Q 005247 507 IVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTY-TVKVCDFGLSRSK 585 (706)
Q Consensus 507 lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~-~vKL~DFGla~~~ 585 (706)
+||||+.+++|..+.+ .+++..++.++.||+.||+|||++| ||||||||+|||++.++ .+||+|||+|+..
T Consensus 109 ~v~e~~~~~~L~~~~~------~l~e~~i~~i~~qil~aL~~LH~~g--IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~ 180 (328)
T d3bqca1 109 LVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 180 (328)
T ss_dssp EEEECCCSCBGGGTTT------SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCGGGCEEC
T ss_pred EEEeecCCCcHHHHhc------CCCHHHHHHHHHHHHHHHHHHhhcc--cccccccccceEEcCCCCeeeecccccceec
Confidence 9999999999987643 4889999999999999999999999 99999999999998654 6999999999876
Q ss_pred CCCcccCCCCCCCCCccCccccccCC-CCchhHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHhhh-------------c
Q 005247 586 PNTYISSKTAAGTPEWMAPEVLREDP-SNEKSDVFSFGVILWELITLQKPWRNSTPSQ-VISAVGF-------------K 650 (706)
Q Consensus 586 ~~~~~~~~~~~Gt~~Y~APE~l~~~~-~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~-~~~~i~~-------------~ 650 (706)
.... ......+|+.|+|||.+.+.. ++.++||||+||++|||++|+.||....... ....+.. .
T Consensus 181 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 259 (328)
T d3bqca1 181 HPGQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259 (328)
T ss_dssp CTTC-CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred cCCC-cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhc
Confidence 5432 235668999999999988754 7999999999999999999999997654322 1111100 0
Q ss_pred C----------------------cccCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 005247 651 G----------------------RRLEIPKNVNPMVAALIETCWAEEPEIRPSFPSIME 687 (706)
Q Consensus 651 ~----------------------~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~eIl~ 687 (706)
. ........+++++.+||++||+.||++|||++|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 000111346889999999999999999999999976
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.7e-37 Score=332.92 Aligned_cols=248 Identities=19% Similarity=0.296 Sum_probs=187.4
Q ss_pred cCceEEEEEeccCCceEEEEEEEcCC--ceEEEEEeccccchHHHHHHHHHHHHHHcCC-----------CCceeEEecc
Q 005247 432 WSELLIKKKIGEGSFGTVYHAEWRNS--DVAVKILIEQEFHEDRFKEFLREVAIMKGLR-----------HPNIVLLMGA 498 (706)
Q Consensus 432 ~~~y~i~~~LG~G~fG~Vy~a~~~~~--~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~-----------HpnIv~l~~~ 498 (706)
.++|+++++||+|+||+||+|++..+ .||||+++... ...+.+.+|+.+++.++ |+||++++++
T Consensus 12 ~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~---~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~ 88 (362)
T d1q8ya_ 12 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 88 (362)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc---cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEE
Confidence 35699999999999999999998654 49999986543 23356778888888775 4789999988
Q ss_pred ccC--CCceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHh-cCCCcccccCCCCcEEECCCC---
Q 005247 499 VTE--PPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ-RRPPIVHRDLKSPNLLVDSTY--- 572 (706)
Q Consensus 499 ~~~--~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs-~g~~IIHrDLKp~NILl~~~~--- 572 (706)
+.. ....+++++++..+..............+++..++.++.||+.||+|||+ +| |+||||||+|||++.++
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~--IvHrDlKp~NIll~~~~~~~ 166 (362)
T d1q8ya_ 89 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPE 166 (362)
T ss_dssp EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEEETTT
T ss_pred eeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC--cccccCChhHeeeeccCccc
Confidence 754 34566777776555443333323334468899999999999999999998 88 99999999999998655
Q ss_pred ---cEEEeecCccccCCCCcccCCCCCCCCCccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH------H
Q 005247 573 ---TVKVCDFGLSRSKPNTYISSKTAAGTPEWMAPEVLREDPSNEKSDVFSFGVILWELITLQKPWRNSTPSQ------V 643 (706)
Q Consensus 573 ---~vKL~DFGla~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSLGviL~ELltG~~Pf~~~~~~~------~ 643 (706)
.+||+|||.+...... .....||+.|+|||++.+..++.++||||+||++++|++|+.||....... .
T Consensus 167 ~~~~~kl~dfg~s~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~ 243 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243 (362)
T ss_dssp TEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred ccceeeEeecccccccccc---cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence 3999999999865443 246689999999999999999999999999999999999999997543211 0
Q ss_pred HHH-hhhcC---------------------------------------cccCCCCCCcHHHHHHHHHhhhhCCCCCCCHH
Q 005247 644 ISA-VGFKG---------------------------------------RRLEIPKNVNPMVAALIETCWAEEPEIRPSFP 683 (706)
Q Consensus 644 ~~~-i~~~~---------------------------------------~~l~~p~~~s~el~dLI~~cL~~dP~~RPS~~ 683 (706)
... +...+ .....+...++++.+||.+||..||++|||++
T Consensus 244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~ 323 (362)
T d1q8ya_ 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 323 (362)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence 000 00000 01112233467899999999999999999999
Q ss_pred HHHH
Q 005247 684 SIME 687 (706)
Q Consensus 684 eIl~ 687 (706)
|+++
T Consensus 324 e~L~ 327 (362)
T d1q8ya_ 324 GLVN 327 (362)
T ss_dssp HHHT
T ss_pred HHhc
Confidence 9976
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.86 E-value=3.5e-22 Score=194.93 Aligned_cols=165 Identities=18% Similarity=0.139 Sum_probs=119.0
Q ss_pred EEEEEeccCCceEEEEEEEc-CCceEEEEEecccc----------------chHHHHHHHHHHHHHHcCCCCceeEEecc
Q 005247 436 LIKKKIGEGSFGTVYHAEWR-NSDVAVKILIEQEF----------------HEDRFKEFLREVAIMKGLRHPNIVLLMGA 498 (706)
Q Consensus 436 ~i~~~LG~G~fG~Vy~a~~~-~~~vAVKvl~~~~~----------------~~~~~~~~~~Ei~iL~~L~HpnIv~l~~~ 498 (706)
.+.++||+|+||+||+|.+. +..||||++..... .......+.+|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 57899999999999999875 45699998753211 01122345678999999999999988765
Q ss_pred ccCCCceEEEEEeccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCcccccCCCCcEEECCCCcEEEee
Q 005247 499 VTEPPNLSIVTEYLSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRPPIVHRDLKSPNLLVDSTYTVKVCD 578 (706)
Q Consensus 499 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~~IIHrDLKp~NILl~~~~~vKL~D 578 (706)
.. .+++|||+++..+.+ ++...+..++.|++.+|+|||++| |+||||||+|||++++ .++|+|
T Consensus 83 ~~----~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g--iiHrDiKP~NILv~~~-~~~liD 145 (191)
T d1zara2 83 EG----NAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVSEE-GIWIID 145 (191)
T ss_dssp ET----TEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEETT-EEEECC
T ss_pred cC----CEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC--EEEccCChhheeeeCC-CEEEEE
Confidence 32 379999998866544 233445678999999999999999 9999999999999865 589999
Q ss_pred cCccccCCCCcccCCCCCCCCCccCcc-----ccccCCCCchhHHHHHHHHH
Q 005247 579 FGLSRSKPNTYISSKTAAGTPEWMAPE-----VLREDPSNEKSDVFSFGVIL 625 (706)
Q Consensus 579 FGla~~~~~~~~~~~~~~Gt~~Y~APE-----~l~~~~~s~ksDVwSLGviL 625 (706)
||+|+....+.. ..|.... .+....|..++|+||+.--+
T Consensus 146 FG~a~~~~~~~~--------~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 146 FPQSVEVGEEGW--------REILERDVRNIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CTTCEETTSTTH--------HHHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred CCCcccCCCCCc--------HHHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence 999876543321 0121110 01234567889999975433
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.33 E-value=5.4e-07 Score=89.22 Aligned_cols=141 Identities=14% Similarity=0.028 Sum_probs=95.4
Q ss_pred CceEEEEEeccCCceEEEEEEEcCCceEEEEEeccccchHHHHHHHHHHHHHHcCC-CCceeEEeccccCCCceEEEEEe
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGAVTEPPNLSIVTEY 511 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~~~~~lV~E~ 511 (706)
..|+..+..+.++.+.||+....+..+++|+........ ...+.+|...+..+. +--+.+++.+..+++..++||++
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~--~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~ 91 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT--TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTS--TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred hceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCcccc--hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEe
Confidence 456666665556667999998777778888865432211 224567777777663 33356777777778889999999
Q ss_pred ccCCchhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHhcCC-------------------------------------
Q 005247 512 LSRGSLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQRRP------------------------------------- 554 (706)
Q Consensus 512 ~~ggsL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs~g~------------------------------------- 554 (706)
++|.++.+..... .....++.++.+.+..||+...
T Consensus 92 l~G~~~~~~~~~~--------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T d1j7la_ 92 ADGVLCSEEYEDE--------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp CSSEEHHHHTTTC--------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCS
T ss_pred ccccccccccccc--------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccccc
Confidence 9998876543211 1122345556666666665321
Q ss_pred --------------------CcccccCCCCcEEECCCCcEEEeecCccc
Q 005247 555 --------------------PIVHRDLKSPNLLVDSTYTVKVCDFGLSR 583 (706)
Q Consensus 555 --------------------~IIHrDLKp~NILl~~~~~vKL~DFGla~ 583 (706)
.++|+|+.|.|||+++++.+-|+||+.+.
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred chHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 16899999999999887666799998654
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.75 E-value=3.9e-05 Score=74.96 Aligned_cols=128 Identities=19% Similarity=0.150 Sum_probs=80.3
Q ss_pred EeccCCc-eEEEEEEEcCCc-eEEEEEeccccchHHHHHHHHHHHHHHcCC--CCceeEEeccccCCCceEEEEEeccCC
Q 005247 440 KIGEGSF-GTVYHAEWRNSD-VAVKILIEQEFHEDRFKEFLREVAIMKGLR--HPNIVLLMGAVTEPPNLSIVTEYLSRG 515 (706)
Q Consensus 440 ~LG~G~f-G~Vy~a~~~~~~-vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~--HpnIv~l~~~~~~~~~~~lV~E~~~gg 515 (706)
.+..|.. +.||+....+.. +++|.-..... ..+..|...++.+. .-.+.+++.+..+++..++||++++|.
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~-----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~ 91 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL-----NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ 91 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT-----SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH-----hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecc
Confidence 4555553 689999876554 67776543321 23556777776653 233567777777888899999999887
Q ss_pred chhhhcccCCCcccccHHHHHHHHHHHHHHHHHHHh--------------------------------------------
Q 005247 516 SLYKLLHIPDARVVVDERLRLNMAYDVAKGMNYLHQ-------------------------------------------- 551 (706)
Q Consensus 516 sL~~~l~~~~~~~~l~~~~~~~ia~qIl~aL~yLHs-------------------------------------------- 551 (706)
++.+... .. ...+.++...|..||+
T Consensus 92 ~~~~~~~--------~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (255)
T d1nd4a_ 92 DLLSSHL--------AP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAE 160 (255)
T ss_dssp ETTTSCC--------CH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHH
T ss_pred ccccccc--------cH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHH
Confidence 6643210 00 0112233333333332
Q ss_pred -------cC-----CCcccccCCCCcEEECCCCcEEEeecCccc
Q 005247 552 -------RR-----PPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 583 (706)
Q Consensus 552 -------~g-----~~IIHrDLKp~NILl~~~~~vKL~DFGla~ 583 (706)
.. +.++|+|+.|.|||++.+..+-|+||+.+.
T Consensus 161 ~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 161 LFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 11 127999999999999887667899998654
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=96.91 E-value=0.00032 Score=73.86 Aligned_cols=77 Identities=16% Similarity=0.098 Sum_probs=44.9
Q ss_pred EEEeccCCceEEEEEEEcC--CceEEEEEecc-----ccchHHHHHHHHHHHHHHcCC---CCceeEEeccccCCCceEE
Q 005247 438 KKKIGEGSFGTVYHAEWRN--SDVAVKILIEQ-----EFHEDRFKEFLREVAIMKGLR---HPNIVLLMGAVTEPPNLSI 507 (706)
Q Consensus 438 ~~~LG~G~fG~Vy~a~~~~--~~vAVKvl~~~-----~~~~~~~~~~~~Ei~iL~~L~---HpnIv~l~~~~~~~~~~~l 507 (706)
.+.||.|....||++.... ..+++|.-... ............|.+.|+.+. ...+++++.+ ++...++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 5578999999999997653 34777753211 000111123445777776552 2345566654 3445689
Q ss_pred EEEeccCCc
Q 005247 508 VTEYLSRGS 516 (706)
Q Consensus 508 V~E~~~ggs 516 (706)
|||++.+..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997644
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.09 E-value=0.0068 Score=60.66 Aligned_cols=147 Identities=13% Similarity=0.042 Sum_probs=74.9
Q ss_pred CceEEEEEeccCCceEEEEEEEcCCceEEEEEeccccchHHHHHHHHHHHHHHcCCC-----CceeEEec---cccCCCc
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRNSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRH-----PNIVLLMG---AVTEPPN 504 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~H-----pnIv~l~~---~~~~~~~ 504 (706)
++..-.+.|..|.--+.|+++..+..+++|+..... .. +.+..|+.++..|.. |..+...+ +......
T Consensus 18 g~~~~~~~i~~G~~N~ny~v~t~~g~yVLri~~~~~-~~---~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~ 93 (316)
T d2ppqa1 18 GSLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRV-EK---NDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGR 93 (316)
T ss_dssp CCEEEEEEECC---EEEEEEEESSCCEEEEEECC----C---CHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTE
T ss_pred CCceEeecCCCCcccCeEEEEECCCcEEEEEcCCCC-CH---HHHHHHHHHHHhhhhccccccccceecCCCcceeeecc
Confidence 455566778888889999999888889999874432 22 234445666665532 22221100 0111233
Q ss_pred eEEEEEeccCCchhhhc--------------c----c---CCCcc-----------------cccHHHHHHHHHHHHHHH
Q 005247 505 LSIVTEYLSRGSLYKLL--------------H----I---PDARV-----------------VVDERLRLNMAYDVAKGM 546 (706)
Q Consensus 505 ~~lV~E~~~ggsL~~~l--------------~----~---~~~~~-----------------~l~~~~~~~ia~qIl~aL 546 (706)
...++.+..+......- + . ..... ..........+..+...+
T Consensus 94 ~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 173 (316)
T d2ppqa1 94 PAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYL 173 (316)
T ss_dssp EEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHH
T ss_pred cceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhh
Confidence 45566666553321110 0 0 00000 000011122222333333
Q ss_pred HHHHhcC--CCcccccCCCCcEEECCCCcEEEeecCccc
Q 005247 547 NYLHQRR--PPIVHRDLKSPNLLVDSTYTVKVCDFGLSR 583 (706)
Q Consensus 547 ~yLHs~g--~~IIHrDLKp~NILl~~~~~vKL~DFGla~ 583 (706)
...+..+ .++||+|+.++||+++++...-|+||+.+.
T Consensus 174 ~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 174 AAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp HHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 3333211 249999999999999988777899999765
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=95.86 E-value=0.0078 Score=60.95 Aligned_cols=70 Identities=11% Similarity=0.076 Sum_probs=41.5
Q ss_pred CCceEEEEEEEc-CCceEEEEEeccccchHHHHHHHHHHHHHHcCCCCce--eEEec-----cccCCCceEEEEEeccCC
Q 005247 444 GSFGTVYHAEWR-NSDVAVKILIEQEFHEDRFKEFLREVAIMKGLRHPNI--VLLMG-----AVTEPPNLSIVTEYLSRG 515 (706)
Q Consensus 444 G~fG~Vy~a~~~-~~~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~HpnI--v~l~~-----~~~~~~~~~lV~E~~~gg 515 (706)
+.--.||+++.. +..+++|+......+. +++..|...+..|....| +..+. .+...+..+.+++++.|.
T Consensus 33 s~EN~vy~v~~~dg~~~VlK~~rp~~~s~---~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 33 SYENRVYQFQDEDRRRFVVKFYRPERWTA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp CSSSEEEEECCTTCCCEEEEEECTTTSCH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred cccceeEEEEcCCCCEEEEEEeCCCCCCH---HHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 334689999865 4569999976543333 356667777776642222 11111 123345678899998764
Q ss_pred c
Q 005247 516 S 516 (706)
Q Consensus 516 s 516 (706)
.
T Consensus 110 ~ 110 (325)
T d1zyla1 110 Q 110 (325)
T ss_dssp E
T ss_pred C
Confidence 4
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.60 E-value=0.01 Score=61.72 Aligned_cols=76 Identities=16% Similarity=0.211 Sum_probs=48.0
Q ss_pred CceEEEEEeccCCceEEEEEEEcCC---------ceEEEEEeccccchHHHHHHHHHHHHHHcCC-CCceeEEeccccCC
Q 005247 433 SELLIKKKIGEGSFGTVYHAEWRNS---------DVAVKILIEQEFHEDRFKEFLREVAIMKGLR-HPNIVLLMGAVTEP 502 (706)
Q Consensus 433 ~~y~i~~~LG~G~fG~Vy~a~~~~~---------~vAVKvl~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIv~l~~~~~~~ 502 (706)
++++ ++.|+.|-.-.+|++...+. .+.+++.- .. .. .....+|..+++.+. +.-..++++++.+
T Consensus 43 ~~l~-v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~-~~--~idr~~E~~i~~~ls~~gl~Pkll~~~~~- 116 (395)
T d1nw1a_ 43 EHLR-ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NP-ET--ESHLVAESVIFTLLSERHLGPKLYGIFSG- 116 (395)
T ss_dssp GGEE-EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SC-CC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT-
T ss_pred cceE-EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Cc-ch--hhHHHHHHHHHHHHHhCCCCCeEEEEcCC-
Confidence 3444 46788899999999986532 25555543 21 11 123457888888774 3334467777653
Q ss_pred CceEEEEEeccCCch
Q 005247 503 PNLSIVTEYLSRGSL 517 (706)
Q Consensus 503 ~~~~lV~E~~~ggsL 517 (706)
.+|+||++|.+|
T Consensus 117 ---g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 ---GRLEEYIPSRPL 128 (395)
T ss_dssp ---EEEECCCCEEEC
T ss_pred ---ceEEEEeccccC
Confidence 689999987554
|